Citrus Sinensis ID: 011302
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 489 | 2.2.26 [Sep-21-2011] | |||||||
| Q64FQ2 | 525 | Protein kinase PINOID 2 O | yes | no | 0.959 | 0.893 | 0.613 | 1e-173 | |
| Q94E49 | 493 | Protein kinase PINOID 2 O | yes | no | 0.977 | 0.969 | 0.594 | 1e-153 | |
| A2YBX5 | 589 | Protein kinase G11A OS=Or | N/A | no | 0.799 | 0.663 | 0.518 | 1e-121 | |
| Q0DCT8 | 589 | Protein kinase G11A OS=Or | no | no | 0.799 | 0.663 | 0.518 | 1e-121 | |
| Q9LFA2 | 934 | Serine/threonine-protein | no | no | 0.830 | 0.434 | 0.505 | 1e-117 | |
| P15792 | 609 | Protein kinase PVPK-1 OS= | N/A | no | 0.854 | 0.686 | 0.491 | 1e-116 | |
| O64682 | 438 | Protein kinase PINOID OS= | no | no | 0.883 | 0.986 | 0.473 | 1e-114 | |
| Q05999 | 578 | Serine/threonine-protein | no | no | 0.748 | 0.633 | 0.5 | 1e-107 | |
| Q2QM77 | 484 | Protein kinase PINOID OS= | no | no | 0.738 | 0.745 | 0.492 | 1e-105 | |
| P93025 | 915 | Phototropin-2 OS=Arabidop | no | no | 0.668 | 0.357 | 0.446 | 8e-91 |
| >sp|Q64FQ2|PID2_ARATH Protein kinase PINOID 2 OS=Arabidopsis thaliana GN=PID2 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 608 bits (1568), Expect = e-173, Method: Compositional matrix adjust.
Identities = 324/528 (61%), Positives = 377/528 (71%), Gaps = 59/528 (11%)
Query: 8 NESDYDSSSSSITVPDSSRS---FMSNLSFGSRRSSISLCSSSAADQTSLYNSHKPHKAN 64
NESDY+SS+ PDSSR S+ + SSIS S+ + YN KPHKAN
Sbjct: 11 NESDYESSTVG---PDSSRRTSWLSSSFTASPSCSSISHLSNHGLNS---YNQSKPHKAN 64
Query: 65 QAAWEAMKRLRRAQGR-VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQ-CFYAMKVV 122
Q AWEAM RLRR GR VGL+HFRLL+RLGSGDIG+VYLCQIR G P+ FYAMKVV
Sbjct: 65 QVAWEAMARLRRCCGRAVGLEHFRLLKRLGSGDIGSVYLCQIR----GSPETAFYAMKVV 120
Query: 123 DREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQR 182
D+EA+A++KKL RA+MEK IL MLDHPF PTLYA FEASHYS LVMEYCPGGDLYA R R
Sbjct: 121 DKEAVAVKKKLGRAEMEKKILGMLDHPFCPTLYAAFEASHYSFLVMEYCPGGDLYAVRLR 180
Query: 183 QPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242
QP KRF ISS +FYAAETL+ALEYLHMMGIVYRDLKPENVL+REDGH+MLSDFDLSFKCD
Sbjct: 181 QPSKRFTISSTRFYAAETLVALEYLHMMGIVYRDLKPENVLIREDGHVMLSDFDLSFKCD 240
Query: 243 VVPKLLRP-------KLSFEAIEKYEKCSIPSCAT-PMQPVLSCFSSVSHGKKNKKKAVT 294
VVP+ L + + I KCS PSC T P+ PV+SCFS S + +KK V
Sbjct: 241 VVPQFLSDNDRDRGHQEDDDDISIRRKCSTPSCTTTPLNPVISCFSPTS--SRRRKKNVV 298
Query: 295 VTTIREQVDGDHHDQELLDD-------------------------PEVVAEPINARSKSF 329
TTI E G + D P + AEPINARSKSF
Sbjct: 299 TTTIHENAAGTSDSVKSNDVSRTFSRSPSSCSRVSNGLRDISGGCPSIFAEPINARSKSF 358
Query: 330 VGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFP 389
VGTHEYLAPEVISGQGHGSAVDWWT G+FLYEM++G TPFKG+NNEKTL+NILK PLTFP
Sbjct: 359 VGTHEYLAPEVISGQGHGSAVDWWTYGIFLYEMIFGRTPFKGDNNEKTLVNILKAPLTFP 418
Query: 390 RIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIRSIKP 449
++ V+S KE+E++V QDLI KLLVKNPKKR+GSLKGS+EIKRHEFF+G+NWALIRSIKP
Sbjct: 419 KVIVNSPKEYEDMVNAQDLIIKLLVKNPKKRLGSLKGSIEIKRHEFFEGVNWALIRSIKP 478
Query: 450 PEVPNNDLYCKIKK-----KVYVPK---LSKQERDAPYQIPTHHFDYF 489
P VP + K K Y+P +S++ER+ PY + +++FDYF
Sbjct: 479 PWVPKEETSHKTKGDNRSVNYYLPPRFMMSRKERNEPYHV-SNYFDYF 525
|
Serine/threonine-protein kinase involved in the regulation of auxin signaling. Plays a minor role in the regulation of cellular auxin efflux and cotyledon organogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q94E49|PID2_ORYSJ Protein kinase PINOID 2 OS=Oryza sativa subsp. japonica GN=PID2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 542 bits (1397), Expect = e-153, Method: Compositional matrix adjust.
Identities = 297/500 (59%), Positives = 356/500 (71%), Gaps = 22/500 (4%)
Query: 4 ATATNESDYDSSSSSITVPDSSRSFMSNLSFGSRRSSISLCSSSAADQTSLYNSHKPHKA 63
A ESDYDSS SS+T PDS RS++S++ S S+ S + A +KPHKA
Sbjct: 2 AAIKEESDYDSSRSSLTAPDSRRSWISDIGSSSSVSARSFGGDTPASSCR----YKPHKA 57
Query: 64 NQAAWEAMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNP------MVGLPQCFY 117
NQA WEA++RLR GRVGL+HFRL+RRLGSGD+GNVYLC++R P C Y
Sbjct: 58 NQAEWEAIRRLRAGAGRVGLEHFRLVRRLGSGDLGNVYLCRLREPWSSSSMTTTAGGCLY 117
Query: 118 AMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLY 177
AMKVVD++ALA RKKL RA++E+ IL LDHPFLPTLYA+FEASHY+CLVME+CPGGDL+
Sbjct: 118 AMKVVDKDALAFRKKLRRAEVERDILRTLDHPFLPTLYADFEASHYACLVMEFCPGGDLH 177
Query: 178 AARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237
ARQRQPG+RF +SS +FY AET+LALEYLHMMG+VYRDLKPENVLVR DGHIMLSDFDL
Sbjct: 178 VARQRQPGRRFTVSSTRFYVAETVLALEYLHMMGVVYRDLKPENVLVRGDGHIMLSDFDL 237
Query: 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATP-MQPVLSCFSSVSHGKKNKKKA---- 292
S KCDVVPKLLRP S A K SC P +QPVLSC H + K+
Sbjct: 238 SLKCDVVPKLLRPARSAAAGGKPPLPPPSSCVPPTIQPVLSCIFRGVHKCHHAKECAGGG 297
Query: 293 -VTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVD 351
+ + + E + VV EP+ ARSKSFVGTHEYLAPEVISGQGHGSAVD
Sbjct: 298 AAAGNNGDGDGNDEEAETETAEPEVVVVEPVAARSKSFVGTHEYLAPEVISGQGHGSAVD 357
Query: 352 WWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRI-GVSSSKEFEEVVKLQDLIS 410
WWTLGVF+YEMLYG TPFKGE+NEKTLINI+K+P+TFPR+ G +++ E+EE+ QDL+
Sbjct: 358 WWTLGVFMYEMLYGRTPFKGESNEKTLINIIKQPVTFPRLAGAAAAGEWEEMKTAQDLML 417
Query: 411 KLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIRSIKPPEVPNNDLYCKIKKKVYVPKL 470
+LL KNPKKR+GS GS E+KRH FFKG+NWAL+RS++ KKV +
Sbjct: 418 QLLAKNPKKRLGSTMGSAEVKRHPFFKGVNWALVRSVR--PPEVPAPPAPAPKKVMT--M 473
Query: 471 SKQERDAPYQI-PTHHFDYF 489
SK+ER PY P +HFDYF
Sbjct: 474 SKKERQEPYNYRPENHFDYF 493
|
Serine/threonine-protein kinase involved in the regulation of auxin signaling. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YBX5|G11A_ORYSI Protein kinase G11A OS=Oryza sativa subsp. indica GN=OsI_021818 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 435 bits (1118), Expect = e-121, Method: Compositional matrix adjust.
Identities = 229/442 (51%), Positives = 287/442 (64%), Gaps = 51/442 (11%)
Query: 35 GSRRSSISLC----SSSAADQT---SLYNSHKPHKANQAAWEAMKRLRRAQGRVGLDHFR 87
G R S S C SS +D++ S+ + KPHKAN + WEA++ +R G +GL HF+
Sbjct: 137 GERGFSSSRCRPSTSSDVSDESACSSISSVTKPHKANDSRWEAIQMIRTRDGILGLSHFK 196
Query: 88 LLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD 147
LL++LG GDIG+VYL ++ + ++AMKV+D+ +LA RKKL RA EK IL LD
Sbjct: 197 LLKKLGCGDIGSVYLSELNG-----TKSYFAMKVMDKASLASRKKLLRAQTEKEILQCLD 251
Query: 148 HPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYL 207
HPFLPTLY FE +SCLVME+CPGGDL+ RQRQ GK F + KFY AE LLA+EYL
Sbjct: 252 HPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQRGKYFPEQAVKFYVAEILLAMEYL 311
Query: 208 HMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLR-PKLSFEAIEKYEK---- 262
HM+GI+YRDLKPENVLVREDGHIMLSDFDLS +C V P L+R EA+ K +
Sbjct: 312 HMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIRSSNPDAEALRKNNQAYCV 371
Query: 263 --------CSI-PSCATPMQPVLSCFSS--VSHGKKNKKKAVTVTTIREQVDGDHHDQEL 311
C I PSCATP +CF S KK++K V ++
Sbjct: 372 QPACVEPSCMIQPSCATPT----TCFGPRFFSKSKKDRKPKPEVVN------------QV 415
Query: 312 LDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKG 371
PE++AEP +ARS SFVGTHEYLAPE+I G+GHGSAVDWWT G+FLYE+L+G TPFKG
Sbjct: 416 SPWPELIAEPSDARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKG 475
Query: 372 ENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIK 431
N TL N++ +PL FP V S +DLI LLVK P++R+G +G+ EIK
Sbjct: 476 SGNRATLFNVIGQPLRFPEYPVVS-------FSARDLIRGLLVKEPQQRLGCKRGATEIK 528
Query: 432 RHEFFKGINWALIRSIKPPEVP 453
+H FF+G+NWALIR PPEVP
Sbjct: 529 QHPFFEGVNWALIRCASPPEVP 550
|
May play a role in the regulation of metabolism and signal transduction processes. Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0DCT8|G11A_ORYSJ Protein kinase G11A OS=Oryza sativa subsp. japonica GN=Os06g0291600 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 435 bits (1118), Expect = e-121, Method: Compositional matrix adjust.
Identities = 229/442 (51%), Positives = 287/442 (64%), Gaps = 51/442 (11%)
Query: 35 GSRRSSISLC----SSSAADQT---SLYNSHKPHKANQAAWEAMKRLRRAQGRVGLDHFR 87
G R S S C SS +D++ S+ + KPHKAN + WEA++ +R G +GL HF+
Sbjct: 137 GERGFSSSRCRPSTSSDVSDESACSSISSVTKPHKANDSRWEAIQMIRTRDGILGLSHFK 196
Query: 88 LLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD 147
LL++LG GDIG+VYL ++ + ++AMKV+D+ +LA RKKL RA EK IL LD
Sbjct: 197 LLKKLGCGDIGSVYLSELSG-----TKSYFAMKVMDKASLASRKKLLRAQTEKEILQCLD 251
Query: 148 HPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYL 207
HPFLPTLY FE +SCLVME+CPGGDL+ RQRQ GK F + KFY AE LLA+EYL
Sbjct: 252 HPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQRGKYFPEQAVKFYVAEILLAMEYL 311
Query: 208 HMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLR-PKLSFEAIEKYEK---- 262
HM+GI+YRDLKPENVLVREDGHIMLSDFDLS +C V P L+R EA+ K +
Sbjct: 312 HMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIRSSNPDAEALRKNNQAYCV 371
Query: 263 --------CSI-PSCATPMQPVLSCFSS--VSHGKKNKKKAVTVTTIREQVDGDHHDQEL 311
C I PSCATP +CF S KK++K V ++
Sbjct: 372 QPACVEPSCMIQPSCATPT----TCFGPRFFSKSKKDRKPKPEVVN------------QV 415
Query: 312 LDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKG 371
PE++AEP +ARS SFVGTHEYLAPE+I G+GHGSAVDWWT G+FLYE+L+G TPFKG
Sbjct: 416 SPWPELIAEPSDARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKG 475
Query: 372 ENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIK 431
N TL N++ +PL FP V S +DLI LLVK P++R+G +G+ EIK
Sbjct: 476 SGNRATLFNVIGQPLRFPEYPVVS-------FSARDLIRGLLVKEPQQRLGCKRGATEIK 528
Query: 432 RHEFFKGINWALIRSIKPPEVP 453
+H FF+G+NWALIR PPEVP
Sbjct: 529 QHPFFEGVNWALIRCASPPEVP 550
|
May play a role in the regulation of metabolism and signal transduction processes. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFA2|KIPK_ARATH Serine/threonine-protein kinase KIPK OS=Arabidopsis thaliana GN=KIPK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 422 bits (1085), Expect = e-117, Method: Compositional matrix adjust.
Identities = 229/453 (50%), Positives = 285/453 (62%), Gaps = 47/453 (10%)
Query: 22 PDSSRSFMSNLS----FGSRRSSISLCSSSAADQTSLYNSHKPHKANQAAWEAMKRLRRA 77
P SS F +LS G S S+ S + S N KPH + WEA+K ++
Sbjct: 472 PTSSEKFEFSLSSKDSLGDYSRSTSISEESNLSRFSCGN--KPHMSMDVRWEAIKHIKVQ 529
Query: 78 QGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRAD 137
G +GL HF LL++LG GDIG VYL + ++G C +A+KV+D E LA RKK RA
Sbjct: 530 YGSLGLRHFNLLKKLGCGDIGTVYLAE----LIGT-NCLFAIKVMDNEFLARRKKSPRAQ 584
Query: 138 MEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYA 197
E+ IL MLDHPFLPTLYA+F + + SCLVMEYCPGGDL+ RQ+Q G+ F +A+FY
Sbjct: 585 AEREILKMLDHPFLPTLYAQFTSDNLSCLVMEYCPGGDLHVLRQKQLGRCFPEPAARFYV 644
Query: 198 AETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPK------ 251
AE LLALEYLHM+GI+YRDLKPEN+LVREDGHIML+DFDLS +C V P L+R
Sbjct: 645 AEILLALEYLHMLGIIYRDLKPENILVREDGHIMLTDFDLSLRCAVNPTLVRSNSPPGKD 704
Query: 252 -LSFEAIEKYEKCSIPSCATPMQPVLSCF-----SSVSHGKKNKKKAVTVTTIREQVDGD 305
C P C T +SCF S+ G+K K+ GD
Sbjct: 705 PARISGPYNTSNCIQPFCITEPSCQVSCFSPRLSSNQQQGRKPKR-------------GD 751
Query: 306 H--HDQELLDD--PEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYE 361
H Q+ L P++VAEP ARS SFVGTHEYLAPE+I G+GHG+AVDWWT GV LYE
Sbjct: 752 HLSKTQQHLSRSLPQLVAEPTEARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGVLLYE 811
Query: 362 MLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRI 421
+LYG TPFKG NN++TL N++ + L FP + S + +DLI LLVK P+ R+
Sbjct: 812 LLYGKTPFKGYNNDETLANVVLQNLKFPDSPLVS-------FQAKDLIRGLLVKEPENRL 864
Query: 422 GSLKGSVEIKRHEFFKGINWALIRSIKPPEVPN 454
GS KGSVEIKRH FF+G+NWALIR PPE+P+
Sbjct: 865 GSEKGSVEIKRHPFFEGLNWALIRCAIPPELPD 897
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P15792|KPK1_PHAVU Protein kinase PVPK-1 OS=Phaseolus vulgaris PE=2 SV=1 | Back alignment and function description |
|---|
Score = 419 bits (1076), Expect = e-116, Method: Compositional matrix adjust.
Identities = 222/452 (49%), Positives = 283/452 (62%), Gaps = 34/452 (7%)
Query: 16 SSSITVPDSSRSFMSNLSFGSRRSSISLCSSSAADQTSLYNS--------HKPHKANQAA 67
S +V S S ++N S + S+C +S S +S +KPHKAN
Sbjct: 151 SECASVDKSCESEVANSSDFNESRKTSICRASTGSDASDESSTSSLSSVLYKPHKANDIR 210
Query: 68 WEAMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREAL 127
WEA++ +R G + + HFRLL++LG GDIG+VYL ++ +AMKV+++ L
Sbjct: 211 WEAIQAVRTRDGMLEMRHFRLLKKLGCGDIGSVYLAELSGTRTS-----FAMKVMNKTEL 265
Query: 128 AIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKR 187
A RKKL RA E+ IL LDHPFLPTLY FE +SCLVME+CPGGDL+A RQRQPGK
Sbjct: 266 ANRKKLLRAQTEREILQSLDHPFLPTLYTHFETEIFSCLVMEFCPGGDLHALRQRQPGKY 325
Query: 188 FGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKL 247
F + +FY AE LL+LEYLHM+GI+YRDLKPENVLVREDGHIMLSDFDLS +C V P L
Sbjct: 326 FSEHAVRFYVAEVLLSLEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCSVSPTL 385
Query: 248 LRPKLSFEAIEKYEKCSIPSCATP---MQPVL---SCFSSVSHGKKNKKKAVTVTTIREQ 301
++ + + + C PSC P MQP SCF+ + + +
Sbjct: 386 VKSSNNLQT-KSSGYCVQPSCIEPTCVMQPDCIKPSCFT------PRFLSGKSKKDKKSK 438
Query: 302 VDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYE 361
D H+Q + PE++AEP NARS SFVGTHEYLAPE+I G+GHGSAVDWWT G+FLYE
Sbjct: 439 PKNDMHNQ-VTPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYE 497
Query: 362 MLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRI 421
+L+G TPFKG N TL N++ +PL FP S +DLI LLVK P+ R+
Sbjct: 498 LLFGRTPFKGSANRATLFNVIGQPLRFPESPTVS-------FAARDLIRGLLVKEPQHRL 550
Query: 422 GSLKGSVEIKRHEFFKGINWALIRSIKPPEVP 453
+G+ EIK+H FF+ +NWALIR PPEVP
Sbjct: 551 AYRRGATEIKQHPFFQNVNWALIRCATPPEVP 582
|
Phaseolus vulgaris (taxid: 3885) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64682|PID_ARATH Protein kinase PINOID OS=Arabidopsis thaliana GN=PID PE=1 SV=1 | Back alignment and function description |
|---|
Score = 412 bits (1060), Expect = e-114, Method: Compositional matrix adjust.
Identities = 228/482 (47%), Positives = 305/482 (63%), Gaps = 50/482 (10%)
Query: 8 NESDYDSSSSSITVPDSSRSFMSNLSFGSRRSSISLCSSSAADQTSLYNSHKPHKANQAA 67
E +++S I+ S S S LSF + S+I + + S KPH+++ A
Sbjct: 7 GEMSLGTTNSPISSGTESCSSFSRLSFDAPPSTIP--------EEESFLSLKPHRSSDFA 58
Query: 68 WEAMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREAL 127
+ ++R R+ QG D FRL+RR+G+GDIG VYLC++ ++AMKVVD+EAL
Sbjct: 59 YAEIRR-RKKQGLTFRD-FRLMRRIGAGDIGTVYLCRLAGDEEESRSSYFAMKVVDKEAL 116
Query: 128 AIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKR 187
A++KK+HRA+MEK IL MLDHPFLPTLYAEFEASH+SC+VMEYC GGDL++ R RQP +R
Sbjct: 117 ALKKKMHRAEMEKTILKMLDHPFLPTLYAEFEASHFSCIVMEYCSGGDLHSLRHRQPHRR 176
Query: 188 FGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKL 247
F +SSA+FYAAE L+ALEYLHM+GI+YRDLKPEN+LVR DGHIMLSDFDLS D
Sbjct: 177 FSLSSARFYAAEVLVALEYLHMLGIIYRDLKPENILVRSDGHIMLSDFDLSLCSD----- 231
Query: 248 LRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHH 307
S A+E S ++P L ++ ++ + + ++V
Sbjct: 232 -----SIAAVES-------SSSSPENQQL----------RSPRRFTRLARLFQRVLRSKK 269
Query: 308 DQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTT 367
Q L VAEP+ ARS SFVGTHEY+APEV SG HG+AVDWW GVFLYEM+YG T
Sbjct: 270 VQTLEPTRLFVAEPVTARSGSFVGTHEYVAPEVASGGSHGNAVDWWAFGVFLYEMIYGKT 329
Query: 368 PFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGS 427
PF N+ L NI+K+ L+FP S + FE + ++LIS LL K+P KR+GS +G+
Sbjct: 330 PFVAPTNDVILRNIVKRQLSFP--TDSPATMFE--LHARNLISGLLNKDPTKRLGSRRGA 385
Query: 428 VEIKRHEFFKGINWALIRSIKPPEVPNNDLYCKIKKKVYVPKLSKQERDAPYQIPTHHFD 487
E+K H FFKG+N+ALIR++ PPE+P++ +KK + S + + P FD
Sbjct: 386 AEVKVHPFFKGLNFALIRTLTPPEIPSS----VVKKPMKSATFSGRSSNKPAA-----FD 436
Query: 488 YF 489
YF
Sbjct: 437 YF 438
|
Serine/threonine-protein kinase involved in the regulation of auxin signaling. Acts as a positive regulator of cellular auxin efflux and regulates organ development by enhancing polar auxin transport. Phosphorylates conserved serine residues in the PIN auxin efflux carriers. Phosphorylation of PIN proteins is required and sufficient for apical-basal PIN polarity that enables directional intercellular auxin fluxes, which mediate differential growth, tissue patterning and organogenesis. Acts in association with PIN1 to control the establishment of bilateral symmetry and promotion of cotyledon outgrowth. Regulates root gravitropism through modulation of PIN2-dependent basipetal auxin transport. Required for polarization of PIN3-dependent auxin transport for hypocotyl gravitropic response. The protein kinase activity of PID is essential for its auxin efflux regulatory function. PID kinase and PP2A phosphatase activities antagonistically regulate phosphorylation of PIN proteins, affecting PIN sorting. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q05999|KPK7_ARATH Serine/threonine-protein kinase AtPK7 OS=Arabidopsis thaliana GN=PK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 389 bits (1000), Expect = e-107, Method: Compositional matrix adjust.
Identities = 208/416 (50%), Positives = 266/416 (63%), Gaps = 50/416 (12%)
Query: 57 SHKPHKANQ-AAWEAMKRLR-RAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQ 114
++KPH+ N W A++ +R R + F+L+++LG GDIGNVYL ++ V
Sbjct: 151 AYKPHRDNNDKRWVAIQEVRSRVGSSLEAKDFKLIKKLGGGDIGNVYLAELIGTGVS--- 207
Query: 115 CFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGG 174
+A+KV+++ A+A RKKL RA EK IL LDHPFLPTLY+ FE SCLVME+CPGG
Sbjct: 208 --FAVKVMEKAAIAARKKLVRAQTEKEILQSLDHPFLPTLYSHFETEMNSCLVMEFCPGG 265
Query: 175 DLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSD 234
DL++ RQ+Q GK F +A+FY AE LLA+EYLHM+GI+YRDLKPENVLVREDGHIMLSD
Sbjct: 266 DLHSLRQKQRGKYFPEQAARFYVAEVLLAMEYLHMLGIIYRDLKPENVLVREDGHIMLSD 325
Query: 235 FDLSFKCDVVPKLLRPKLSFEAIEKYEK----CSIPSCATP---------MQPVLSCFSS 281
FDLS +C V P L+R F AI K C P+C +QPV CF+
Sbjct: 326 FDLSLRCAVSPTLVR----FAAITLESKSSSYCIQPTCVDQSSCIVQPDCIQPV--CFTP 379
Query: 282 --VSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPE 339
+S GK KK IR PE++AEP +ARS SFVGTHEYLAPE
Sbjct: 380 RFLSKGKHRKKSNDMSRQIRPL-------------PELIAEPTSARSMSFVGTHEYLAPE 426
Query: 340 VISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEF 399
+I G+GHGSAVDWWT G+FLYE+L+G TPF+G +N TL N++ +PL FP E
Sbjct: 427 IIKGEGHGSAVDWWTFGIFLYELLFGITPFRGGDNRATLFNVVGQPLRFP--------EH 478
Query: 400 EEV-VKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIRSIKPPEVPN 454
V +DLI LLVK P+ R+ +G+ EIK+H FF+ +NWALIR PP++P
Sbjct: 479 PNVSFAARDLIRGLLVKEPQHRLAYRRGATEIKQHPFFQSVNWALIRCTSPPQIPQ 534
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2QM77|PID_ORYSJ Protein kinase PINOID OS=Oryza sativa subsp. japonica GN=PID PE=2 SV=1 | Back alignment and function description |
|---|
Score = 384 bits (985), Expect = e-105, Method: Compositional matrix adjust.
Identities = 196/398 (49%), Positives = 255/398 (64%), Gaps = 37/398 (9%)
Query: 59 KPHKANQAAWEAMKRLRRAQGR-VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFY 117
+PH++ AW A++ +G F+L+RR+G GDIG VYLC++R+ C Y
Sbjct: 83 RPHRSGDVAWAAIRAASTTSAAPLGPRDFKLVRRIGGGDIGTVYLCRLRSSPERESPCMY 142
Query: 118 AMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS-HYSCLVMEYCPGGDL 176
AMKVVDR A+A ++KL RA EK IL LDHPFLPTL+A+F+A+ H+SC VME+CPGGDL
Sbjct: 143 AMKVVDRRAVARKQKLGRAAAEKRILRQLDHPFLPTLFADFDATPHFSCAVMEFCPGGDL 202
Query: 177 YAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFD 236
++ R R P +RF + SA+FYAAE LLA+EYLHMMGIVYRDLKPENVL+R DGHIML+DFD
Sbjct: 203 HSLRHRMPSRRFPLPSARFYAAEVLLAIEYLHMMGIVYRDLKPENVLIRADGHIMLTDFD 262
Query: 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVT 296
LS + P L + ++ S + SCF H + K++ V
Sbjct: 263 LSLQSTTSPSL------DGDTDTDDEASGGA---------SCFP--DHLLRFKRRRNAVA 305
Query: 297 TIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLG 356
R P VAEP++ARS SFVGTHEY+APEV SG HG+AVDWW G
Sbjct: 306 APR---------------PRFVAEPVDARSCSFVGTHEYVAPEVASGGAHGAAVDWWAYG 350
Query: 357 VFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKN 416
VFLYE++YG TPF G NE TL NI+++PL FP S + +DLI++LL K+
Sbjct: 351 VFLYELIYGRTPFAGATNEATLRNIVRRPLAFPSGSGSCGPADADA---RDLIARLLAKD 407
Query: 417 PKKRIGSLKGSVEIKRHEFFKGINWALIRSIKPPEVPN 454
P R+GS +G+ ++K H FFK +N AL+RS +PP VP
Sbjct: 408 PAARLGSRRGAADVKSHPFFKSLNLALLRSSRPPVVPG 445
|
Serine/threonine-protein kinase involved in the regulation of auxin signaling. May control polar auxin transport and probably plays a role in the pattern formation and organogenesis in the rice shoot. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P93025|PHOT2_ARATH Phototropin-2 OS=Arabidopsis thaliana GN=PHOT2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 334 bits (857), Expect = 8e-91, Method: Compositional matrix adjust.
Identities = 175/392 (44%), Positives = 243/392 (61%), Gaps = 65/392 (16%)
Query: 60 PHKANQAAWEAMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAM 119
PH +W+A+K+++ + VGL HF+ ++ LGSGD G+V+L +++ G + YAM
Sbjct: 551 PHNKESTSWKAIKKIQASGETVGLHHFKPIKPLGSGDTGSVHLVELK----GTGE-LYAM 605
Query: 120 KVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAA 179
K +++ + R K HRA +E+ I+++LDHPFLPTLYA F+ S + CL+ ++CPGG+L+A
Sbjct: 606 KAMEKTMMLNRNKAHRACIEREIISLLDHPFLPTLYASFQTSTHVCLITDFCPGGELFAL 665
Query: 180 RQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSF 239
RQP K SA+FYAAE ++ LEYLH +GIVYRDLKPEN+L+++DGHI+L+DFDLSF
Sbjct: 666 LDRQPMKILTEDSARFYAAEVVIGLEYLHCLGIVYRDLKPENILLKKDGHIVLADFDLSF 725
Query: 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIR 299
P+L+ P A P S +++K + +
Sbjct: 726 MTTCTPQLIIP------------------AAP-----------SKRRRSKSQPL------ 750
Query: 300 EQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFL 359
P VAEP + +S SFVGT EY+APE+I+G GH SA+DWW LG+ L
Sbjct: 751 ---------------PTFVAEP-STQSNSFVGTEEYIAPEIITGAGHTSAIDWWALGILL 794
Query: 360 YEMLYGTTPFKGENNEKTLINILKKPLTFP-RIGVSSSKEFEEVVKLQDLISKLLVKNPK 418
YEMLYG TPF+G+N +KT NIL K LTFP I VS +V Q LI+ LL ++P
Sbjct: 795 YEMLYGRTPFRGKNRQKTFANILHKDLTFPSSIPVS-------LVGRQ-LINTLLNRDPS 846
Query: 419 KRIGSLKGSVEIKRHEFFKGINWALIRSIKPP 450
R+GS G+ EIK+H FF+GINW LIR + PP
Sbjct: 847 SRLGSKGGANEIKQHAFFRGINWPLIRGMSPP 878
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for photo-induced movements. Mediates calcium spiking of extra- and intracellular origins in response to blue light. Involved in hypocotyl phototropism. Contributes to the chloroplast accumulation in low blue light and mediates their translocation (avoidance response) at high fluence. Regulates stomata opening and photomorphogenesis response of leaf tissue. Not involved in hypocotyl elongation inhibition, anthocyanin accumulation or cotyledon opening. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 489 | ||||||
| 225445430 | 470 | PREDICTED: protein kinase PINOID 2-like | 0.926 | 0.963 | 0.806 | 0.0 | |
| 356563039 | 490 | PREDICTED: protein kinase PINOID 2-like | 0.965 | 0.963 | 0.748 | 0.0 | |
| 356511648 | 481 | PREDICTED: protein kinase PINOID 2-like | 0.952 | 0.968 | 0.759 | 0.0 | |
| 255566941 | 504 | serine/threonine protein kinase, putativ | 0.940 | 0.912 | 0.782 | 0.0 | |
| 156481452 | 487 | putative serine/threonine protein kinase | 0.963 | 0.967 | 0.790 | 0.0 | |
| 224136105 | 458 | predicted protein [Populus trichocarpa] | 0.924 | 0.986 | 0.781 | 0.0 | |
| 357477953 | 490 | Protein kinase G11A [Medicago truncatula | 0.965 | 0.963 | 0.763 | 0.0 | |
| 449443103 | 499 | PREDICTED: protein kinase PINOID 2-like | 0.942 | 0.923 | 0.705 | 0.0 | |
| 356508315 | 497 | PREDICTED: protein kinase PINOID 2-like | 0.955 | 0.939 | 0.653 | 1e-180 | |
| 297822235 | 525 | kinase family protein [Arabidopsis lyrat | 0.959 | 0.893 | 0.628 | 1e-176 |
| >gi|225445430|ref|XP_002285044.1| PREDICTED: protein kinase PINOID 2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 757 bits (1954), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 380/471 (80%), Positives = 407/471 (86%), Gaps = 18/471 (3%)
Query: 19 ITVPDSSRSFMSNLSFGSRRSSISLCSSSAADQTSLYNSHKPHKANQAAWEAMKRLRRAQ 78
ITVPDSSRS+MSNLSFGSR S S+ SHKPHKANQAAWEAMKRLR +
Sbjct: 18 ITVPDSSRSWMSNLSFGSRSSVSVCSSAD--------TSHKPHKANQAAWEAMKRLRGEK 69
Query: 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADM 138
GRVGLDHFR+LRRLGSGDIGNVYLCQIRNP+VGLPQ FYAMKVVDREALAIR KL RA+M
Sbjct: 70 GRVGLDHFRMLRRLGSGDIGNVYLCQIRNPVVGLPQSFYAMKVVDREALAIRNKLQRAEM 129
Query: 139 EKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAA 198
EK IL +LDHPFLPTLYAEF+ASHYSCLVME+CPGGDL+AARQRQPGKRF ISSAKFYAA
Sbjct: 130 EKEILGILDHPFLPTLYAEFDASHYSCLVMEFCPGGDLHAARQRQPGKRFSISSAKFYAA 189
Query: 199 ETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIE 258
ETL+ALEYLHMMG+VYRDLKPENVLVREDGHIMLSDFDLS KCDVVPKLLRPK EA
Sbjct: 190 ETLVALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLKCDVVPKLLRPKPDQEATG 249
Query: 259 KYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318
K K S PSCATPMQPVLSCFS+ NKKK +V TI D QE+ DPE+V
Sbjct: 250 KKVKSSTPSCATPMQPVLSCFSA-----SNKKKKGSVRTIVASQADD--VQEI--DPELV 300
Query: 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTL 378
AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYE+LYG TPFKGENNEKTL
Sbjct: 301 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYELLYGRTPFKGENNEKTL 360
Query: 379 INILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438
INILK+PLTFPRIGVSSSKEFEE+VK+QDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG
Sbjct: 361 INILKQPLTFPRIGVSSSKEFEEMVKVQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 420
Query: 439 INWALIRSIKPPEVPNNDLYCKIKKKVYVPKLSKQERDAPYQIPTHHFDYF 489
+NWALIRS+KPPEVP + L I+ + +PKLSK+ERDAPYQIP HHFDYF
Sbjct: 421 VNWALIRSVKPPEVPRDHLQKIIRSRASLPKLSKKERDAPYQIP-HHFDYF 470
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356563039|ref|XP_003549773.1| PREDICTED: protein kinase PINOID 2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 744 bits (1922), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 364/486 (74%), Positives = 410/486 (84%), Gaps = 14/486 (2%)
Query: 4 ATATNESDYDSSSSSITVPDSSRSFMSNLSFGSRRSSISLCSSSAADQTSLYNSHKPHKA 63
T +E DYDSSSSSITVP+SSRS+M+NLSFGSRR S+ S+ ++ KPHKA
Sbjct: 19 TTTRDEPDYDSSSSSITVPESSRSWMTNLSFGSRRRRSSVSVCSSTAESP---HAKPHKA 75
Query: 64 NQAAWEAMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVD 123
N AAWEAM+RLRR +G+VGLDHFRLLRRLGSGDIGNVYLCQIRNP+VGLPQCFYAMKVVD
Sbjct: 76 NHAAWEAMRRLRRDKGQVGLDHFRLLRRLGSGDIGNVYLCQIRNPIVGLPQCFYAMKVVD 135
Query: 124 REALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQ 183
REALAIRKKL RA+MEK IL MLDHPFLPTLY EF+ASHYSCL+ME+CPGGDLYAARQRQ
Sbjct: 136 REALAIRKKLQRAEMEKEILAMLDHPFLPTLYTEFDASHYSCLLMEFCPGGDLYAARQRQ 195
Query: 184 PGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243
PGKRF I+S+KFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIML+DFDLS KCDV
Sbjct: 196 PGKRFSIASSKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLTDFDLSLKCDV 255
Query: 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVD 303
VPKLLR K E K K S+P+C PMQPVLSCF S S + KKKA T IRE V+
Sbjct: 256 VPKLLRSKTRLERSIKSTKRSMPACTAPMQPVLSCFLSSS---RKKKKATVTTVIRENVE 312
Query: 304 GDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEML 363
+ +DPE+VAEPI+A+SKSFVGTHEYLAPEVI GQGHGSAVDWWT GVFLYEML
Sbjct: 313 VEE------NDPELVAEPIDAKSKSFVGTHEYLAPEVILGQGHGSAVDWWTFGVFLYEML 366
Query: 364 YGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGS 423
YG TPFKGENNEKTL+NILK+PL FPRI V +SKEFEE+V +QDLISKLLVKNP KRIGS
Sbjct: 367 YGRTPFKGENNEKTLVNILKQPLAFPRIVVGTSKEFEEMVNVQDLISKLLVKNPSKRIGS 426
Query: 424 LKGSVEIKRHEFFKGINWALIRSIKPPEVPNNDLYCKIKKKVYVPKLSKQERDAPYQIPT 483
L GSVEIKRHEFFKG+NWALIR+++PPEVP+ K++ +V +PKLSK +RD PYQ+ +
Sbjct: 427 LMGSVEIKRHEFFKGVNWALIRAVRPPEVPSE--MNKLRSRVLLPKLSKTDRDQPYQLRS 484
Query: 484 HHFDYF 489
HHF+YF
Sbjct: 485 HHFEYF 490
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356511648|ref|XP_003524535.1| PREDICTED: protein kinase PINOID 2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 743 bits (1917), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 367/483 (75%), Positives = 411/483 (85%), Gaps = 17/483 (3%)
Query: 8 NESDYDSSSSSITVPDSSRSFMSNLSFGSRRSSISLCSSSAADQTSLYNSH-KPHKANQA 66
+E DYDSSSSSITVP+SSRS+M+NLSFGSRR SS + +++ + H KPHKANQA
Sbjct: 15 DEPDYDSSSSSITVPESSRSWMTNLSFGSRRRR----SSVSVSSSTMESPHAKPHKANQA 70
Query: 67 AWEAMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREA 126
AWEAM+RL R +G+VGLDHFRLLRRLGSGD+GNVYLCQIRNP+VGLPQCFYAMKVVDREA
Sbjct: 71 AWEAMRRLWRDKGQVGLDHFRLLRRLGSGDLGNVYLCQIRNPVVGLPQCFYAMKVVDREA 130
Query: 127 LAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGK 186
LAIRKKL RA+MEK IL MLDHPFLPTLY EF+ASHYSCLVME+CPGGDLYAARQRQPGK
Sbjct: 131 LAIRKKLQRAEMEKEILAMLDHPFLPTLYTEFDASHYSCLVMEFCPGGDLYAARQRQPGK 190
Query: 187 RFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPK 246
RF I+SAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIML+DFDLS KCDV+PK
Sbjct: 191 RFSIASAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLTDFDLSLKCDVIPK 250
Query: 247 LLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDH 306
LLR K E K K S+P+C PMQPVLSCF S S KKKA T IRE V+ +
Sbjct: 251 LLRSKTRLERSIKSTKRSVPACTAPMQPVLSCFLSSS----KKKKATVTTVIRENVEVEE 306
Query: 307 HDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGT 366
+DPE+VAEPI+A+SKSFVGTHEYLAPEVI GQGHGSAVDWWT GVFLYEMLYG
Sbjct: 307 ------NDPELVAEPIDAKSKSFVGTHEYLAPEVILGQGHGSAVDWWTFGVFLYEMLYGR 360
Query: 367 TPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKG 426
TPFKGENNEKTL+NILK+PL+FPRI VSSSKEFEE+VK+QDLISKLLVKNP KRIGS G
Sbjct: 361 TPFKGENNEKTLVNILKQPLSFPRIAVSSSKEFEEMVKVQDLISKLLVKNPSKRIGSCMG 420
Query: 427 SVEIKRHEFFKGINWALIRSIKPPEVPNNDLYCKIKKKVYVPKLSKQERDAPYQIPTHHF 486
SVEIKRHEFFKG+NWALIRS++PPEVP+ KI+ +V +PKLSK + D PYQ+ +HHF
Sbjct: 421 SVEIKRHEFFKGVNWALIRSVRPPEVPSE--INKIRSRVLLPKLSKTDSDQPYQLRSHHF 478
Query: 487 DYF 489
+YF
Sbjct: 479 EYF 481
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255566941|ref|XP_002524453.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223536241|gb|EEF37893.1| serine/threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 730 bits (1885), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 389/497 (78%), Positives = 427/497 (85%), Gaps = 37/497 (7%)
Query: 19 ITVPDSSRSFMSNLSFGSRRSSISLCSSSAADQTSLYNSHKPHKANQAAWEAMKRLRRAQ 78
ITVPDSSRS+MSNLSFGSRRSS+S+ SS A ++SLY+++KPHKANQAAWEA+KRL+ A
Sbjct: 19 ITVPDSSRSWMSNLSFGSRRSSVSVTSSLA--ESSLYSTYKPHKANQAAWEAIKRLQIAN 76
Query: 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADM 138
GRVGLDHFRLLRRLGSGD+GNVYLCQIRNP+VGLPQCFYAMKVVD+EAL IR KL RA++
Sbjct: 77 GRVGLDHFRLLRRLGSGDLGNVYLCQIRNPVVGLPQCFYAMKVVDKEALVIRNKLQRAEV 136
Query: 139 EKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAA 198
EK IL MLDHPFLPTLYAEFEASHYSCLVME+CPGGDLYAARQRQPG+RF ISSAKFYAA
Sbjct: 137 EKEILGMLDHPFLPTLYAEFEASHYSCLVMEFCPGGDLYAARQRQPGRRFSISSAKFYAA 196
Query: 199 ETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLR----PKLSF 254
ETLLALEYLHMMGI+YRDLKPENVLVREDGHIMLSDFDL KCDVVPK++R P LS
Sbjct: 197 ETLLALEYLHMMGIIYRDLKPENVLVREDGHIMLSDFDLCLKCDVVPKVIRSTKKPNLS- 255
Query: 255 EAIE-----KYEKCSI-PSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVD----- 303
EAI+ E C I PSCATP+QPVLSCFSS KKKA VTTI E+VD
Sbjct: 256 EAIDDDDHKNIETCFITPSCATPIQPVLSCFSS----SNKKKKATKVTTITERVDNNHGE 311
Query: 304 ------GDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGV 357
HH QELL DPE+VAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGV
Sbjct: 312 HHNHHHHHHHHQELLVDPELVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGV 371
Query: 358 FLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNP 417
FLYEMLYG TPFKGENNEKTLINILK+PL+FPRI VSSSKE+EE+VK+QDLISKLLVKNP
Sbjct: 372 FLYEMLYGRTPFKGENNEKTLINILKQPLSFPRIIVSSSKEYEEMVKVQDLISKLLVKNP 431
Query: 418 KKRIGSLKGSVEIKRHEFFKGINWALIRSIKPPEVPNNDLYCKIKK-----KVYVPKLSK 472
KKRIGSLKGSVEIKRHEFFKG+NWALIRS++PPEVPN+ CKI+ + +PKLSK
Sbjct: 432 KKRIGSLKGSVEIKRHEFFKGVNWALIRSVRPPEVPND--ICKIRNISRNSRAQIPKLSK 489
Query: 473 QERDAPYQIPTHHFDYF 489
+ER+APYQI HHFDYF
Sbjct: 490 KEREAPYQI--HHFDYF 504
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|156481452|gb|ABU68435.1| putative serine/threonine protein kinase [Populus tomentosa] | Back alignment and taxonomy information |
|---|
Score = 727 bits (1877), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 382/483 (79%), Positives = 422/483 (87%), Gaps = 12/483 (2%)
Query: 11 DYDSSSSSITVPDSSRSFMSNLSFGSRRSSISLCSSSAADQTSLYNSH-KPHKANQAAWE 69
DYDSSSSS TVPDSSRS+MSNLSFGSRRSSIS+ SS A + + KPHKANQAAW+
Sbjct: 13 DYDSSSSSTTVPDSSRSWMSNLSFGSRRSSISISSSVADSASICSTARVKPHKANQAAWQ 72
Query: 70 AMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAI 129
A+KRL+RA GRVGLDHFRLLRRLGSGDIGNVYLCQIRNP+VGLPQCFYAMKVVD+EALAI
Sbjct: 73 AIKRLQRATGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPVVGLPQCFYAMKVVDKEALAI 132
Query: 130 RKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFG 189
R KL RA+MEK IL MLDHPFLPTLYAEFEASHYSCLV EYCPGGDLYAARQRQP KRF
Sbjct: 133 RNKLQRAEMEKEILGMLDHPFLPTLYAEFEASHYSCLVTEYCPGGDLYAARQRQPWKRFS 192
Query: 190 ISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLR 249
ISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLR
Sbjct: 193 ISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLR 252
Query: 250 PKLSFEAIEKYEKCSI---PSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDH 306
K S EAI +++ + P CATP+ PVLSCFSS K+K TTIRE+VD
Sbjct: 253 SKPSLEAIVRHKNETTSFAPFCATPIHPVLSCFSS----SNKKRKPRITTTIRERVDDQG 308
Query: 307 HDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGT 366
+D++++D E+VAEPI+ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYG
Sbjct: 309 YDEDVVDT-ELVAEPISARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGR 367
Query: 367 TPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKG 426
TPFKGENNEKTLINILK+PLTFPRIGV+SSKEFEE+VKLQDL+ KLLVKNPK+RIGSLKG
Sbjct: 368 TPFKGENNEKTLINILKQPLTFPRIGVNSSKEFEEMVKLQDLVGKLLVKNPKRRIGSLKG 427
Query: 427 SVEIKRHEFFKGINWALIRSIKPPEVPNNDLYCKIKKKVYVPKLSKQERDAPYQIPTHHF 486
SVEIKRHEFFKG+NWALIRSIKPPE P++ C+ + + ++P LSK+ER PYQIP+ HF
Sbjct: 428 SVEIKRHEFFKGVNWALIRSIKPPESPSD--LCRFRSRAHIPMLSKKERQEPYQIPS-HF 484
Query: 487 DYF 489
+YF
Sbjct: 485 EYF 487
|
Source: Populus tomentosa Species: Populus tomentosa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224136105|ref|XP_002322241.1| predicted protein [Populus trichocarpa] gi|222869237|gb|EEF06368.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 720 bits (1859), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 365/467 (78%), Positives = 403/467 (86%), Gaps = 15/467 (3%)
Query: 29 MSNLSFGSRRSSISLCSSSAADQTSLYNSH-KPHKANQAAWEAMKRLRRAQGRVGLDHFR 87
MSNLSFGSRRSSIS+ SS A + + KPHKANQAAW+A+KRL+RA GRVGLDHFR
Sbjct: 1 MSNLSFGSRRSSISISSSVADSASICSTARMKPHKANQAAWQAIKRLQRATGRVGLDHFR 60
Query: 88 LLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD 147
LLRRLGSGDIGNVYLCQIRNP+VGLPQCFYAMKVVD+EALAIR KL RA+MEK IL MLD
Sbjct: 61 LLRRLGSGDIGNVYLCQIRNPVVGLPQCFYAMKVVDKEALAIRNKLQRAEMEKEILGMLD 120
Query: 148 HPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYL 207
HPFLPTLYAEFEASHYSCLV EYCPGGDLYAARQRQP KRF ISSAKFYAAETLLALEYL
Sbjct: 121 HPFLPTLYAEFEASHYSCLVTEYCPGGDLYAARQRQPWKRFSISSAKFYAAETLLALEYL 180
Query: 208 HMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEK----- 262
HMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLR K S EAI +++
Sbjct: 181 HMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRSKPSLEAIVRHKNETTSF 240
Query: 263 CSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322
+ CATP+ PVLSCFSS K+K TTI EQ+DG +D+E+ + E+VAEPI
Sbjct: 241 APLTFCATPIHPVLSCFSS----SNKKRKPRITTTITEQIDGQGYDEEV--ETELVAEPI 294
Query: 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINIL 382
+ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYG TPFKGENNEKTLINIL
Sbjct: 295 SARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGRTPFKGENNEKTLINIL 354
Query: 383 KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWA 442
K+PLTFPRIGV+SSKEFEE+VKLQDL+ KLLVKNPK+RIGSLKGSVEIKRHEFFKG+NWA
Sbjct: 355 KQPLTFPRIGVNSSKEFEEMVKLQDLVGKLLVKNPKRRIGSLKGSVEIKRHEFFKGVNWA 414
Query: 443 LIRSIKPPEVPNNDLYCKIKKKVYVPKLSKQERDAPYQIPTHHFDYF 489
LIRSIKPPE P++ C+ + + ++P LSK+ER PYQIP+ HF+YF
Sbjct: 415 LIRSIKPPESPSD--LCRFRSRAHIPMLSKKERQEPYQIPS-HFEYF 458
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357477953|ref|XP_003609262.1| Protein kinase G11A [Medicago truncatula] gi|355510317|gb|AES91459.1| Protein kinase G11A [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 717 bits (1851), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 371/486 (76%), Positives = 406/486 (83%), Gaps = 14/486 (2%)
Query: 9 ESDYDSSSSSITVPDSSRSFMSNLSFGSRRSSISLCSSSAADQTS--LYNSHKPHKANQA 66
E DYDSSSSSITVP+S+RS+MSNLSFGSRR S+ SS TS L ++ KPHKANQ
Sbjct: 14 EPDYDSSSSSITVPESTRSWMSNLSFGSRRRRSSVSVSSTTTYTSSVLGSNAKPHKANQV 73
Query: 67 AWEAMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREA 126
AWEAM RLR QGRVGLDHFRLL+RLGSGDIGNVYLCQIRNP+VGLPQCFYAMKVVDREA
Sbjct: 74 AWEAMSRLRLDQGRVGLDHFRLLKRLGSGDIGNVYLCQIRNPVVGLPQCFYAMKVVDREA 133
Query: 127 LAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGK 186
LAIRKKL RA+MEK IL MLDHPFLPTLY +F+ASHYSCLVME+CPGGDLYA RQRQPGK
Sbjct: 134 LAIRKKLQRAEMEKEILGMLDHPFLPTLYTDFDASHYSCLVMEFCPGGDLYACRQRQPGK 193
Query: 187 RFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPK 246
RF +SS+KFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS KCDVVPK
Sbjct: 194 RFSLSSSKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSLKCDVVPK 253
Query: 247 LLRPKLSFEAIEKYE---KCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVD 303
LLR K E K +CS PSC +PMQPVLSCF S S KKK T IRE V
Sbjct: 254 LLRSKTRLERSIKTTTTMRCSTPSCISPMQPVLSCFLSSS---TKKKKTKLETVIRENV- 309
Query: 304 GDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEML 363
+ E+ DP+ VAEPI ARSKSFVGTHEYLAPEVI GQGHGSAVDWWT GVFLYEML
Sbjct: 310 --QEEFEVDLDPDFVAEPIEARSKSFVGTHEYLAPEVILGQGHGSAVDWWTFGVFLYEML 367
Query: 364 YGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGS 423
YG TPFKGENNEKTL+NILK+PLTFPRIGVSS+ EFEE+VK+QDLISKLLVKNP KRIGS
Sbjct: 368 YGRTPFKGENNEKTLVNILKQPLTFPRIGVSSNYEFEEMVKVQDLISKLLVKNPSKRIGS 427
Query: 424 LKGSVEIKRHEFFKGINWALIRSIKPPEVPNNDLYCKIKKKVYVPKLSKQERDAPYQIPT 483
GSVEIKRHEFFKG+NWALIRS++PPEVP++ K + +V VPKLSK++RD P+Q+
Sbjct: 428 CLGSVEIKRHEFFKGVNWALIRSVRPPEVPSDK--NKTRNRVLVPKLSKKDRDQPFQL-K 484
Query: 484 HHFDYF 489
H FDYF
Sbjct: 485 HQFDYF 490
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449443103|ref|XP_004139320.1| PREDICTED: protein kinase PINOID 2-like [Cucumis sativus] gi|449526910|ref|XP_004170456.1| PREDICTED: protein kinase PINOID 2-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 659 bits (1700), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 345/489 (70%), Positives = 387/489 (79%), Gaps = 28/489 (5%)
Query: 19 ITVPDSSRSFMSNLSFGSRRSSISLCSSSAADQTSLYNSH------KPHKANQAAWEAMK 72
ITVPDS+RS+MSNLSFGSRR S SSSAAD L N KPHKAN+ WEAM+
Sbjct: 21 ITVPDSTRSWMSNLSFGSRRRS----SSSAADGGGLENITSGTMMVKPHKANEVGWEAMR 76
Query: 73 RLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKK 132
LRRA+G VGL+ FRL+RR+GSGDIGNVYLC+IRNPMVGLP+ FYAMKVVDREA+ +R K
Sbjct: 77 WLRRAKGEVGLEDFRLIRRVGSGDIGNVYLCEIRNPMVGLPKWFYAMKVVDREAVCVRNK 136
Query: 133 LHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISS 192
RADMEK IL +LDHPFLPTLYA FEASHYSCLVME+CPGGDLYAAR R P KRF I S
Sbjct: 137 ERRADMEKEILKLLDHPFLPTLYAHFEASHYSCLVMEFCPGGDLYAARLRLPNKRFSIPS 196
Query: 193 AKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKL 252
AKFYAAE +LALEYLHMMGI+YRDLKPENVLVREDGHIMLSDFDL KCDVVPKLLR +
Sbjct: 197 AKFYAAEIILALEYLHMMGIIYRDLKPENVLVREDGHIMLSDFDLCLKCDVVPKLLRSRT 256
Query: 253 S-----FEAIEKYEKCSIPSC-ATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQV-DGD 305
+ + S SC A P+QPVLSCFS ++K+ TVTTI E D
Sbjct: 257 TASDRHVRSSSYSFSTSSSSCAAAPIQPVLSCFSL-----SRRQKSTTVTTITEHASDSI 311
Query: 306 HHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYG 365
+ +E +PE++AEPINARSKSFVGTHEYLAPEVISGQGHGS VDWWTLG+FLYEMLYG
Sbjct: 312 YSGEEFDPEPELIAEPINARSKSFVGTHEYLAPEVISGQGHGSGVDWWTLGIFLYEMLYG 371
Query: 366 TTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLK 425
TPFKGENNEKTL+NILK+PL FPRIG+SSSKE+EE+VK++DLI KLLVKNPKKRIGSLK
Sbjct: 372 KTPFKGENNEKTLMNILKQPLKFPRIGISSSKEYEEMVKVEDLIKKLLVKNPKKRIGSLK 431
Query: 426 GSVEIKRHEFFKGINWALIRSIK-----PPEVPNNDLYCKIKKKVYVPKLSKQERDAPYQ 480
GSVEIKRHEFFKGINWALIRS++ + NN Y K Y+PKLSK++R PYQ
Sbjct: 432 GSVEIKRHEFFKGINWALIRSVRPPQIPNNNIINNLNYSKHPSN-YLPKLSKKQRQQPYQ 490
Query: 481 IPTHHFDYF 489
IP HHFDYF
Sbjct: 491 IPNHHFDYF 499
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356508315|ref|XP_003522903.1| PREDICTED: protein kinase PINOID 2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 637 bits (1642), Expect = e-180, Method: Compositional matrix adjust.
Identities = 339/519 (65%), Positives = 386/519 (74%), Gaps = 52/519 (10%)
Query: 1 MVAATATNESDYDSSSSSITVPDSSRSFMSNLSFGSRRSS----ISLCSSSAADQTSLYN 56
M + T SD DS+ SSIT+ DS+RS++S SF SS + LC+++
Sbjct: 1 MASTTRDESSDNDSTCSSITLADSTRSWLSTFSFRRSSSSNSSSLPLCAAA--------- 51
Query: 57 SHKPHKANQAAWEAMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQC- 115
P A+WEAM+RLR G +GLD+FRLLRRLGSGDIGNVYLCQI+N MVG PQ
Sbjct: 52 ---PDTTKSASWEAMRRLRLDTGGIGLDNFRLLRRLGSGDIGNVYLCQIQNSMVGRPQSL 108
Query: 116 FYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGD 175
+YAMKVVDREALA+RKKL RA+MEK IL M+DHPFLPTLYA F+ASHYSC VM++CPGGD
Sbjct: 109 YYAMKVVDREALAVRKKLQRAEMEKQILAMMDHPFLPTLYAAFDASHYSCFVMDFCPGGD 168
Query: 176 LYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235
L++ARQRQPGKRF ISS KFYAAETL+ALEYLHM GIVYRDLKPENVL+REDGHIMLSDF
Sbjct: 169 LFSARQRQPGKRFTISSTKFYAAETLVALEYLHMKGIVYRDLKPENVLIREDGHIMLSDF 228
Query: 236 DLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSC-ATPMQPVLSCFSSVSHGKKNKKKAVT 294
DL KCDVVPKLLR K S E+ K + S PSC A PM SCFS+ S +KK VT
Sbjct: 229 DLCLKCDVVPKLLRSKTSSESSVKTRRSSAPSCVAAPMH---SCFSASS----KRKKVVT 281
Query: 295 VTTIREQVDG---------------------DHHDQELLD-DPEVVAEPINARSKSFVGT 332
IRE +D D+ L + D E+VAEPINARSKSFVGT
Sbjct: 282 TAIIRENMDATNKKVLLFKVKKFLSKFVLGHDYCTSGLGEHDTEIVAEPINARSKSFVGT 341
Query: 333 HEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPR-- 390
HEYLAPEVISG GHGSAVDWWT GVFLYEMLYG TPFKGENNEKTL+NILK+PL FPR
Sbjct: 342 HEYLAPEVISGNGHGSAVDWWTFGVFLYEMLYGRTPFKGENNEKTLMNILKQPLAFPRVS 401
Query: 391 IGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIRSIKPP 450
SSSKEFEE+VK+QDLISKLLVKNPKKRIG GSVEIKRHEFFKG+NWALIRS++PP
Sbjct: 402 SVSSSSKEFEEMVKVQDLISKLLVKNPKKRIGCCMGSVEIKRHEFFKGVNWALIRSVRPP 461
Query: 451 EVPNNDLYCKIKKKVYVPKLSKQERDAPYQIPTHHFDYF 489
EVP KI+ +V + KLSK+++D PYQI THHFDYF
Sbjct: 462 EVPAE--LNKIRSRVSLQKLSKKDKDQPYQI-THHFDYF 497
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297822235|ref|XP_002879000.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297324839|gb|EFH55259.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 625 bits (1611), Expect = e-176, Method: Compositional matrix adjust.
Identities = 332/528 (62%), Positives = 382/528 (72%), Gaps = 59/528 (11%)
Query: 8 NESDYDSSSSSITVPDSSRS---FMSNLSFGSRRSSISLCSSSAADQTSLYNSHKPHKAN 64
NESDY+SS++ PDSSR S+ + SSIS S++ + YN KPHKAN
Sbjct: 11 NESDYESSTAG---PDSSRRTSWLSSSFTASPSCSSISHLSNNGLNN---YNQSKPHKAN 64
Query: 65 QAAWEAMKRLRRAQGR-VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQ-CFYAMKVV 122
Q AWEAM RLRR GR VGL+HFRLL+RLGSGDIG+VYLCQIR G P+ FYAMKVV
Sbjct: 65 QVAWEAMARLRRCCGRAVGLEHFRLLKRLGSGDIGSVYLCQIR----GSPETAFYAMKVV 120
Query: 123 DREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQR 182
D+EA+A++KKL RA+MEK IL MLDHPF PTLYA FEASHYS LVMEYCPGGDLYAAR R
Sbjct: 121 DKEAVAVKKKLGRAEMEKKILGMLDHPFCPTLYAAFEASHYSFLVMEYCPGGDLYAARLR 180
Query: 183 QPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242
QP KRF ISS +FYAAETL+ALEYLHMMGIVYRDLKPENVL+REDGH+MLSDFDLSFKCD
Sbjct: 181 QPSKRFTISSTRFYAAETLVALEYLHMMGIVYRDLKPENVLIREDGHVMLSDFDLSFKCD 240
Query: 243 VVPKLLRP-------KLSFEAIEKYEKCSIPSC-ATPMQPVLSCFSSVSHGKKNKKKAVT 294
VVP+LL + E I KCS PSC ATP+ PV+SCFS S + +KK V
Sbjct: 241 VVPQLLNDNDRDRGHQGDDEDISIRRKCSTPSCTATPLNPVISCFSPTS--SRRRKKNVV 298
Query: 295 VTTIREQVDGDHHDQELLDD-------------------------PEVVAEPINARSKSF 329
TTI E G H + D P + AEPINARSKSF
Sbjct: 299 TTTIHENAAGTSHTVKSNDVSRTFSRSPSSCSRVSNGLRDISGGCPSIFAEPINARSKSF 358
Query: 330 VGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFP 389
VGTHEYLAPEVISGQGHGSAVDWWT G+FLYEM++G TPFKGENNEKTL+NILK PLTFP
Sbjct: 359 VGTHEYLAPEVISGQGHGSAVDWWTYGIFLYEMIFGRTPFKGENNEKTLVNILKAPLTFP 418
Query: 390 RIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIRSIKP 449
++ V+S KE+E++V QDLI KLLVKNPKKR+GSLKGS+EIKRHEFF+G+NWALIRSIKP
Sbjct: 419 KVIVNSPKEYEDMVNAQDLIIKLLVKNPKKRLGSLKGSIEIKRHEFFEGVNWALIRSIKP 478
Query: 450 PEVPNNDLYCKIKK-----KVYVPK---LSKQERDAPYQIPTHHFDYF 489
P VP + K K Y+P +S++ERD PY + +HFDYF
Sbjct: 479 PWVPKEETSHKTKGDNRSVNYYLPPRFMMSRKERDEPYHV-ANHFDYF 525
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 489 | ||||||
| TAIR|locus:2043813 | 525 | PID2 "PINOID2" [Arabidopsis th | 0.498 | 0.464 | 0.65 | 7.5e-148 | |
| TAIR|locus:2133837 | 506 | D6PKL1 "D6 protein kinase like | 0.785 | 0.758 | 0.506 | 4.1e-104 | |
| TAIR|locus:2160922 | 586 | D6PKL2 "D6 protein kinase like | 0.775 | 0.646 | 0.513 | 1.4e-103 | |
| TAIR|locus:2178388 | 498 | D6PK "D6 protein kinase" [Arab | 0.777 | 0.763 | 0.508 | 7.7e-103 | |
| UNIPROTKB|Q5I6E9 | 700 | Adi3 "AvrPto-dependent Pto-int | 0.777 | 0.542 | 0.497 | 6.2e-101 | |
| TAIR|locus:2055017 | 765 | AT2G44830 [Arabidopsis thalian | 0.768 | 0.491 | 0.502 | 8.2e-99 | |
| TAIR|locus:2062268 | 438 | PID "PINOID" [Arabidopsis thal | 0.380 | 0.424 | 0.590 | 2e-98 | |
| TAIR|locus:2085191 | 934 | KIPK "KCBP-interacting protein | 0.775 | 0.405 | 0.512 | 5.8e-98 | |
| TAIR|locus:2032785 | 499 | RSH3 "root hair specific 3" [A | 0.404 | 0.396 | 0.507 | 1.6e-96 | |
| TAIR|locus:2049485 | 949 | AT2G36350 [Arabidopsis thalian | 0.779 | 0.401 | 0.497 | 3.7e-96 |
| TAIR|locus:2043813 PID2 "PINOID2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 801 (287.0 bits), Expect = 7.5e-148, Sum P(2) = 7.5e-148
Identities = 169/260 (65%), Positives = 185/260 (71%)
Query: 55 YNSHKPHKANQAAWEAMKRLRRAQGR-VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLP 113
YN KPHKANQ AWEAM RLRR GR VGL+HFRLL+RLGSGDIG+VYLCQIR G P
Sbjct: 55 YNQSKPHKANQVAWEAMARLRRCCGRAVGLEHFRLLKRLGSGDIGSVYLCQIR----GSP 110
Query: 114 Q-CFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCP 172
+ FYAMKVVD+EA+A++KKL RA+MEK IL MLDHPF PTLYA FEASHYS LVMEYCP
Sbjct: 111 ETAFYAMKVVDKEAVAVKKKLGRAEMEKKILGMLDHPFCPTLYAAFEASHYSFLVMEYCP 170
Query: 173 GGDLYAARQRQPGKRFGISSAKFXXXXXXXXXXXXHMMGIVYRDLKPENVLVREDGHIML 232
GGDLYA R RQP KRF ISS +F HMMGIVYRDLKPENVL+REDGH+ML
Sbjct: 171 GGDLYAVRLRQPSKRFTISSTRFYAAETLVALEYLHMMGIVYRDLKPENVLIREDGHVML 230
Query: 233 SDFDLSFKCDVVPKLL----RPKLSFEA---IEKYEKCSIPSCAT-PMQPVLSCFSSVSH 284
SDFDLSFKCDVVP+ L R + E I KCS PSC T P+ PV+SCFS S
Sbjct: 231 SDFDLSFKCDVVPQFLSDNDRDRGHQEDDDDISIRRKCSTPSCTTTPLNPVISCFSPTS- 289
Query: 285 GXXXXXXAVTVTTIREQVDG 304
V TTI E G
Sbjct: 290 -SRRRKKNVVTTTIHENAAG 308
|
|
| TAIR|locus:2133837 D6PKL1 "D6 protein kinase like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1031 (368.0 bits), Expect = 4.1e-104, P = 4.1e-104
Identities = 204/403 (50%), Positives = 268/403 (66%)
Query: 52 TSLYNSHKPHKANQAAWEAMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVG 111
+S ++KPHKAN WEA++ +R G +GL+HFRLL+RLG GDIG V+L ++
Sbjct: 89 SSFSGNNKPHKANDVRWEAIQAVRTKHGVLGLNHFRLLKRLGCGDIGTVHLAELHGT--- 145
Query: 112 LPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYC 171
+CF+AMKV+D+ ALA RKKL RA E+ IL LDHPFLPTLY+ FE +SCLVME+C
Sbjct: 146 --RCFFAMKVMDKGALASRKKLLRAQTEREILQCLDHPFLPTLYSHFETEKFSCLVMEFC 203
Query: 172 PGGDLYAARQRQPGKRFGISSAKFXXXXXXXXXXXXHMMGIVYRDLKPENVLVREDGHIM 231
PGGDL+ RQRQPGKRF +AKF HM+GI+YRDLKPENVLVR+DGH+M
Sbjct: 204 PGGDLHTLRQRQPGKRFSEQAAKFYVAEVLLAMEYLHMLGIIYRDLKPENVLVRDDGHVM 263
Query: 232 LSDFDLSFKCDVVPKLLRPK-LSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGXXXXX 290
LSDFDLS +C V P ++R L+ E + C+ P+C QP SC S+ +
Sbjct: 264 LSDFDLSLRCTVSPTVVRSTVLASEGQKNSGYCAQPACI--QQP--SCISAPT--TCFSP 317
Query: 291 XAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAV 350
+ + +++ + ++ PE+VAEP +ARS SFVGTHEYLAPE+I G+GHGSAV
Sbjct: 318 RYFSSKSKKDKKMKNETGNQVSPLPELVAEPTSARSMSFVGTHEYLAPEIIKGEGHGSAV 377
Query: 351 DWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLIS 410
DWWT G+FLYE+L+G TPFKG N TL N++ +PL FP V S +DLI
Sbjct: 378 DWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVS-------FAARDLIR 430
Query: 411 KLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIRSIKPPEVP 453
LLVK P+ R+ +G+ E+K+H FF+G+NWAL+R PPE+P
Sbjct: 431 SLLVKEPQHRLAYKRGATEMKQHPFFEGVNWALVRCASPPEIP 473
|
|
| TAIR|locus:2160922 D6PKL2 "D6 protein kinase like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1026 (366.2 bits), Expect = 1.4e-103, P = 1.4e-103
Identities = 205/399 (51%), Positives = 264/399 (66%)
Query: 58 HKPHKANQAAWEAMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFY 117
+KPHKAN WEA++ +R G +GL HFRLL+RLG GDIG+VYL ++ +C++
Sbjct: 163 NKPHKANDLRWEAIQAVRVRDGLLGLSHFRLLKRLGCGDIGSVYLSELSGT-----KCYF 217
Query: 118 AMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLY 177
AMKV+D+ +LA RKKL RA E+ IL LDHPFLPTLY FE +SCLVME+CPGGDL+
Sbjct: 218 AMKVMDKTSLASRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLH 277
Query: 178 AARQRQPGKRFGISSAKFXXXXXXXXXXXXHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237
RQRQPGK F + KF HM+GIVYRDLKPENVLVREDGHIMLSDFDL
Sbjct: 278 TLRQRQPGKHFSEQAVKFYIAESLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDL 337
Query: 238 SFKCDVVPKLLRPK-LSFEAIEKYEKCSIPSCATP--MQPVLSCFSSVSHGXXXXXXAVT 294
S +C V P L++ + + + K C P+C P +QP SC + + +
Sbjct: 338 SLRCLVSPTLVKSAAIESDPLRKNVYCVQPACIEPSCIQP--SCTVPTTCFSPRLFSSKS 395
Query: 295 VTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWT 354
+ + D + + L PE+VAEP +ARS SFVGTHEYLAPE+I G+GHGSAVDWWT
Sbjct: 396 KKDRKPKNDTANQVRPL---PELVAEPTDARSMSFVGTHEYLAPEIIKGEGHGSAVDWWT 452
Query: 355 LGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLV 414
G+FLYE+L+G TPFKG N +TL N++ +PL FP V S +DLI LL+
Sbjct: 453 FGIFLYELLFGRTPFKGSGNRQTLFNVVGQPLRFPETPVVS-------FAARDLIRGLLM 505
Query: 415 KNPKKRIGSLKGSVEIKRHEFFKGINWALIRSIKPPEVP 453
K P++R+G +G+ E+K+H FF+G+NWALIR PPE+P
Sbjct: 506 KEPQQRLGFKRGATEVKQHPFFEGVNWALIRCATPPEIP 544
|
|
| TAIR|locus:2178388 D6PK "D6 protein kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1019 (363.8 bits), Expect = 7.7e-103, P = 7.7e-103
Identities = 203/399 (50%), Positives = 262/399 (65%)
Query: 58 HKPHKANQAAWEAMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFY 117
+KPHKAN WEA++ +R G +GL+HFRLL+RLG GDIG V+L ++ +C++
Sbjct: 81 NKPHKANDVRWEAIQAVRTKHGGLGLNHFRLLKRLGCGDIGTVHLAELNGT-----RCYF 135
Query: 118 AMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLY 177
AMKV+D+ ALA RKKL RA E+ IL LDHPFLPTLY+ FE +SCLVME+CPGGDL+
Sbjct: 136 AMKVMDKTALASRKKLLRAQTEREILQCLDHPFLPTLYSHFETEKFSCLVMEFCPGGDLH 195
Query: 178 AARQRQPGKRFGISSAKFXXXXXXXXXXXXHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237
RQRQPGKRF +AKF HM+GI+YRDLKPENVLVR+DGH+MLSDFDL
Sbjct: 196 TLRQRQPGKRFTEQAAKFYVAEVLLAMEYLHMLGIIYRDLKPENVLVRDDGHVMLSDFDL 255
Query: 238 SFKCDVVPKLLRP-KLSFEAIEKYE-KCSI-PSCATPMQPVLSCFSSVSHGXXXXXXAVT 294
S +C V ++R + E + K CS P+C QP SC S +
Sbjct: 256 SLRCTVSLSIVRSANVGSEGLSKNSVSCSQQPACI--QQP--SCISMAPTSCFGPRFFSS 311
Query: 295 VTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWT 354
+ ++ ++ + ++ PE+VAEP ARS SFVGTHEYLAPE+I G+GHGSAVDWWT
Sbjct: 312 KSKKDKKPKTENGNHQVTPLPELVAEPTGARSMSFVGTHEYLAPEIIKGEGHGSAVDWWT 371
Query: 355 LGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLV 414
G+FLYE+L+G TPFKG N TL N++ +PL FP V S +DLI LLV
Sbjct: 372 FGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVS-------FAARDLIRSLLV 424
Query: 415 KNPKKRIGSLKGSVEIKRHEFFKGINWALIRSIKPPEVP 453
K P+ R+ +G+ EIK+H FF+G+NWAL+R PPE+P
Sbjct: 425 KEPQHRLAYKRGATEIKQHPFFEGVNWALVRCASPPEIP 463
|
|
| UNIPROTKB|Q5I6E9 Adi3 "AvrPto-dependent Pto-interacting protein 3" [Solanum lycopersicum (taxid:4081)] | Back alignment and assigned GO terms |
|---|
Score = 1001 (357.4 bits), Expect = 6.2e-101, P = 6.2e-101
Identities = 198/398 (49%), Positives = 254/398 (63%)
Query: 56 NSHKPHKANQAAWEAMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQC 115
+++KPHK N W+A+ +R G +G+ HF+LL+RLG GDIG+VYL ++ +C
Sbjct: 278 SANKPHKGNDPRWKAILAIRARDGILGMSHFKLLKRLGCGDIGSVYLSELSGT-----RC 332
Query: 116 FYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGD 175
++AMKV+D+ +LA RKKL RA E+ IL +LDHPFLPTLY FE +SCLVMEYCPGGD
Sbjct: 333 YFAMKVMDKASLASRKKLTRAQTEREILQLLDHPFLPTLYTHFETDRFSCLVMEYCPGGD 392
Query: 176 LYAARQRQPGKRFGISSAKFXXXXXXXXXXXXHMMGIVYRDLKPENVLVREDGHIMLSDF 235
L+ RQRQPGK F +A+F HM+G+VYRDLKPENVLVR+DGHIMLSDF
Sbjct: 393 LHTLRQRQPGKHFSEYAARFYAAEVLLALEYLHMLGVVYRDLKPENVLVRDDGHIMLSDF 452
Query: 236 DLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGXXXXXXAVTV 295
DLS +C V P L+R + C P+C ++P C
Sbjct: 453 DLSLRCAVSPTLIRISSDDPSKRGAAFCVQPAC---IEPTTVCMQPACFLPRLFPQKSKK 509
Query: 296 TTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTL 355
T + + D + PE+VAEP +ARS SFVGTHEYLAPE+I G+GHGSAVDWWT
Sbjct: 510 KTPKPRADSGFQANSM---PELVAEPTSARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTF 566
Query: 356 GVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVK 415
G+FL+E+LYG TPFKG N TL N++ + L FP +S +DLI LLVK
Sbjct: 567 GIFLHELLYGKTPFKGSGNRATLFNVVGQQLKFPDSPATSYAS-------RDLIRGLLVK 619
Query: 416 NPKKRIGSLKGSVEIKRHEFFKGINWALIRSIKPPEVP 453
P+ R+G +G+ EIK+H FF+G+NWALIR PPEVP
Sbjct: 620 EPQNRLGVKRGATEIKQHPFFEGVNWALIRCSTPPEVP 657
|
|
| TAIR|locus:2055017 AT2G44830 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 981 (350.4 bits), Expect = 8.2e-99, P = 8.2e-99
Identities = 201/400 (50%), Positives = 255/400 (63%)
Query: 58 HKPHKANQAAWEAMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFY 117
+KPHK N W A+ +R G +G+ HF+LL+RLG GDIG+VYL ++ +C +
Sbjct: 335 NKPHKGNDPWWNAILAIRTRDGILGMSHFKLLKRLGCGDIGSVYLAELSGT-----RCHF 389
Query: 118 AMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLY 177
A+KV+D+ +L RKKL+RA E+ IL +LDHPFLPTLY FE +SCLVMEYCPGGDL+
Sbjct: 390 AVKVMDKASLEDRKKLNRAQTERDILQLLDHPFLPTLYTHFETDRFSCLVMEYCPGGDLH 449
Query: 178 AARQRQPGKRFGISSAKFXXXXXXXXXXXXHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237
RQRQPGK F +A+F HM+G+VYRDLKPENVLVR+DGHIMLSDFDL
Sbjct: 450 TLRQRQPGKHFSEYAARFYAAEVLLALEYLHMLGVVYRDLKPENVLVRDDGHIMLSDFDL 509
Query: 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVL---SCFSSVSHGXXXXXXAVT 294
S +C V P L++ + + C P+C P + SCF S +
Sbjct: 510 SLRCAVSPTLIKT-FDSDPSRRGAFCVQPACMEPTSACIIQPSCFLPRSIFPNKNKKNKS 568
Query: 295 VTTIREQVDG-DHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWW 353
T Q D H L PE+VAEP N RS SFVGTHEYLAPE+I G+GHGSAVDWW
Sbjct: 569 RKT---QADFFKSHSGSL---PELVAEP-NTRSMSFVGTHEYLAPEIIKGEGHGSAVDWW 621
Query: 354 TLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLL 413
T G+F++E+LYG TPFKG N TL N++ + L FP +S +DLI LL
Sbjct: 622 TFGIFVHELLYGKTPFKGSGNRATLFNVVGEQLKFPESPATSYAG-------RDLIQALL 674
Query: 414 VKNPKKRIGSLKGSVEIKRHEFFKGINWALIRSIKPPEVP 453
VK+PK R+G+ +G+ EIK+H FF+G+NWALIR PPEVP
Sbjct: 675 VKDPKNRLGTKRGATEIKQHPFFEGVNWALIRCSTPPEVP 714
|
|
| TAIR|locus:2062268 PID "PINOID" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 586 (211.3 bits), Expect = 2.0e-98, Sum P(2) = 2.0e-98
Identities = 111/188 (59%), Positives = 141/188 (75%)
Query: 57 SHKPHKANQAAWEAMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCF 116
S KPH+++ A+ ++R R+ QG D FRL+RR+G+GDIG VYLC++ +
Sbjct: 48 SLKPHRSSDFAYAEIRR-RKKQGLTFRD-FRLMRRIGAGDIGTVYLCRLAGDEEESRSSY 105
Query: 117 YAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDL 176
+AMKVVD+EALA++KK+HRA+MEK IL MLDHPFLPTLYAEFEASH+SC+VMEYC GGDL
Sbjct: 106 FAMKVVDKEALALKKKMHRAEMEKTILKMLDHPFLPTLYAEFEASHFSCIVMEYCSGGDL 165
Query: 177 YAARQRQPGKRFGISSAKFXXXXXXXXXXXXHMMGIVYRDLKPENVLVREDGHIMLSDFD 236
++ R RQP +RF +SSA+F HM+GI+YRDLKPEN+LVR DGHIMLSDFD
Sbjct: 166 HSLRHRQPHRRFSLSSARFYAAEVLVALEYLHMLGIIYRDLKPENILVRSDGHIMLSDFD 225
Query: 237 LSFKCDVV 244
LS D +
Sbjct: 226 LSLCSDSI 233
|
|
| TAIR|locus:2085191 KIPK "KCBP-interacting protein kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 973 (347.6 bits), Expect = 5.8e-98, P = 5.8e-98
Identities = 211/412 (51%), Positives = 262/412 (63%)
Query: 58 HKPHKANQAAWEAMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFY 117
+KPH + WEA+K ++ G +GL HF LL++LG GDIG VYL ++ +G C +
Sbjct: 510 NKPHMSMDVRWEAIKHIKVQYGSLGLRHFNLLKKLGCGDIGTVYLAEL----IGT-NCLF 564
Query: 118 AMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLY 177
A+KV+D E LA RKK RA E+ IL MLDHPFLPTLYA+F + + SCLVMEYCPGGDL+
Sbjct: 565 AIKVMDNEFLARRKKSPRAQAEREILKMLDHPFLPTLYAQFTSDNLSCLVMEYCPGGDLH 624
Query: 178 AARQRQPGKRFGISSAKFXXXXXXXXXXXXHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237
RQ+Q G+ F +A+F HM+GI+YRDLKPEN+LVREDGHIML+DFDL
Sbjct: 625 VLRQKQLGRCFPEPAARFYVAEILLALEYLHMLGIIYRDLKPENILVREDGHIMLTDFDL 684
Query: 238 SFKCDVVPKLLR----PKLSFEAIE-KYE--KCSIPSCATPMQPVLSCFSSVSHGXXXXX 290
S +C V P L+R P I Y C P C T +SCFS
Sbjct: 685 SLRCAVNPTLVRSNSPPGKDPARISGPYNTSNCIQPFCITEPSCQVSCFSPRLSSNQQQG 744
Query: 291 XAVTVTTIREQVDGDH--HDQELLDD--PEVVAEPINARSKSFVGTHEYLAPEVISGQGH 346
R+ GDH Q+ L P++VAEP ARS SFVGTHEYLAPE+I G+GH
Sbjct: 745 --------RKPKRGDHLSKTQQHLSRSLPQLVAEPTEARSNSFVGTHEYLAPEIIKGEGH 796
Query: 347 GSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQ 406
G+AVDWWT GV LYE+LYG TPFKG NN++TL N++ + L FP + S F+ +
Sbjct: 797 GAAVDWWTFGVLLYELLYGKTPFKGYNNDETLANVVLQNLKFPDSPLVS---FQA----K 849
Query: 407 DLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIRSIKPPEVPNNDLY 458
DLI LLVK P+ R+GS KGSVEIKRH FF+G+NWALIR PPE+P D Y
Sbjct: 850 DLIRGLLVKEPENRLGSEKGSVEIKRHPFFEGLNWALIRCAIPPELP--DFY 899
|
|
| TAIR|locus:2032785 RSH3 "root hair specific 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 535 (193.4 bits), Expect = 1.6e-96, Sum P(2) = 1.6e-96
Identities = 102/201 (50%), Positives = 136/201 (67%)
Query: 49 ADQTSLYNSHKPHKANQAAWEAMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNP 108
++ TS NS KPH W+A+ L+ ++G+ FR+L+RLG GDIG+VYL +++
Sbjct: 76 SESTSTNNSSKPHTGGDIRWDAVNSLKSRGIKLGISDFRVLKRLGYGDIGSVYLVELKGA 135
Query: 109 MVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVM 168
P ++AMKV+D+ +L R KL RA E+ IL+ LDHPFLPTLY+ FE + CLVM
Sbjct: 136 N---PTTYFAMKVMDKASLVSRNKLLRAQTEREILSQLDHPFLPTLYSHFETDKFYCLVM 192
Query: 169 EYCPGGDLYAARQRQPGKRFGISSAKFXXXXXXXXXXXXHMMGIVYRDLKPENVLVREDG 228
E+C GG+LY+ RQ+QP K F +A+F HM+GIVYRDLKPENVLVR+DG
Sbjct: 193 EFCSGGNLYSLRQKQPNKCFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDDG 252
Query: 229 HIMLSDFDLSFKCDVVPKLLR 249
HIMLSDFDLS +C V P L++
Sbjct: 253 HIMLSDFDLSLRCSVNPTLVK 273
|
|
| TAIR|locus:2049485 AT2G36350 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 956 (341.6 bits), Expect = 3.7e-96, P = 3.7e-96
Identities = 203/408 (49%), Positives = 259/408 (63%)
Query: 58 HKPHKANQAAWEAMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFY 117
+KPH + WEA+K ++ G +GL HF LL++LG GDIG VYL ++ VG C +
Sbjct: 531 NKPHMSMDVRWEAVKHVKLQYGSLGLRHFNLLKKLGCGDIGTVYLAEL----VGT-NCLF 585
Query: 118 AMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLY 177
A+KV+D E LA RKK RA E+ IL MLDHPFLPTLYA+F + + SCLVMEYCPGGDL+
Sbjct: 586 AIKVMDNEFLARRKKTPRAQAERAILKMLDHPFLPTLYAQFTSDNLSCLVMEYCPGGDLH 645
Query: 178 AARQRQPGKRFGISSAKFXXXXXXXXXXXXHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237
RQ+Q + F + +F HM+G++YRDLKPEN+LVREDGHIML+DFDL
Sbjct: 646 VLRQKQLSRCFSEPATRFYVAEILLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDL 705
Query: 238 SFKCDVVPKLLR----PKLSFEAIE-KYE--KCSIPSCATPMQPVLSCFSSVSHGXXXXX 290
S +C V P LLR P+ + Y C P C P V CFS
Sbjct: 706 SLRCAVNPTLLRSTSPPEKDPARMSGPYSTSNCIQPLCIEPSCRV-PCFSP-----RLLS 759
Query: 291 XAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAV 350
R+ D Q+ P++VAEP ARS SFVGTHEYLAPE+I G+GHG+AV
Sbjct: 760 TQARNQKPRKPKRPDLLTQQFRSLPQLVAEPTEARSNSFVGTHEYLAPEIIKGEGHGAAV 819
Query: 351 DWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLIS 410
DWWT GV LYE+LYG TPFKG +NE+TL N++ + L FP + S F+ ++LI
Sbjct: 820 DWWTFGVLLYELLYGKTPFKGYDNEETLSNVVYQNLKFPDSPLVS---FQA----KELIR 872
Query: 411 KLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIRSIKPPEVPNNDLY 458
+LLVK+P+ R+GS KG+ EIKRH FF+G+NWALIR PPE+P D+Y
Sbjct: 873 RLLVKDPESRLGSEKGAAEIKRHPFFEGLNWALIRCAIPPELP--DIY 918
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q94E49 | PID2_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.594 | 0.9775 | 0.9695 | yes | no |
| Q64FQ2 | PID2_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6136 | 0.9591 | 0.8933 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 489 | |||
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-166 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-71 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-70 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 7e-53 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-47 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-46 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-45 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-45 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-42 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-42 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-39 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-39 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 8e-37 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-36 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-36 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-34 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-33 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-33 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-32 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-32 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-32 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-31 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-31 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-31 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-31 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-30 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-30 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-29 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-29 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-29 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-29 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-28 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-28 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-28 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-28 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-28 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-28 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-28 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-27 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-27 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-27 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-27 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-26 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-26 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-26 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-26 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-26 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-25 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-25 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-25 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-25 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-25 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-25 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-25 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-25 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-25 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-25 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-24 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-24 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-24 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-24 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-24 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-24 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-24 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-24 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-24 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-24 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-24 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-24 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-23 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-23 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-23 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-23 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-23 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-23 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-23 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-23 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-23 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-23 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-23 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-22 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-22 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-22 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-22 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-22 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-22 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-22 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-22 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-22 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-21 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-21 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-21 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-21 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-21 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-21 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-21 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-21 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-20 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-20 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-20 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-20 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-20 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 8e-20 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-19 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-19 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-19 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-19 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-19 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-19 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-19 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-18 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-18 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-18 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-18 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-18 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-18 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-18 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-17 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-17 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-17 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-17 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-17 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-17 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-17 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-17 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 8e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-16 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-16 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-16 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-16 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-15 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-15 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-15 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-15 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-15 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-15 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-15 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-15 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-14 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-14 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-14 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 8e-14 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-14 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-14 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 9e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-13 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-13 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-13 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-13 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-12 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-12 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-12 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 9e-12 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-11 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-11 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-11 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-11 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-11 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-11 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-11 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-10 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-10 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-10 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-10 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-10 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-10 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-09 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-09 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-09 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-09 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-09 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-09 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-09 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-09 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 8e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 8e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-09 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 9e-09 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-08 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-08 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-08 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-08 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-08 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-08 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-08 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-08 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-08 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-08 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-08 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-08 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-08 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-08 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-08 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-08 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 9e-08 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-07 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-07 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-07 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-07 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-07 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-07 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-07 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-07 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-07 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-07 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-07 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-07 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-07 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-07 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-07 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-07 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-07 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-07 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-07 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-07 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 9e-07 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-06 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-06 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-06 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-06 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-06 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-06 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-06 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-06 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-06 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-06 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-06 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-06 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-06 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-06 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-06 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-06 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-06 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-06 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-06 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-06 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-06 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-06 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-06 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-06 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-06 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 7e-06 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 9e-06 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-05 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-05 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-05 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-05 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-05 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-05 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-05 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-05 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-05 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-05 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-05 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-05 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-05 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-05 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-05 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-05 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-05 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-05 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-05 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-05 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-05 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-05 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-05 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-05 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-05 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-05 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-05 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-05 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 8e-05 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 8e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 8e-05 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-05 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-05 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 9e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 9e-05 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-05 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-04 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-04 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-04 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-04 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-04 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-04 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-04 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-04 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-04 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-04 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-04 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-04 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-04 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-04 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-04 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-04 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-04 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-04 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-04 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-04 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-04 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-04 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-04 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-04 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-04 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-04 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 5e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-04 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-04 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-04 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-04 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-04 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-04 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-04 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-04 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-04 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-04 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-04 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 8e-04 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-04 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-04 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-04 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 0.001 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 0.001 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 0.001 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 0.001 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 0.001 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 0.001 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 0.001 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 0.001 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 0.001 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 0.001 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 0.001 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 0.001 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 0.002 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 0.002 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 0.002 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 0.002 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 0.002 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 0.002 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 0.002 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 0.002 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 0.002 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 0.002 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 0.003 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 0.003 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 0.003 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 0.004 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 470 bits (1212), Expect = e-166
Identities = 180/374 (48%), Positives = 223/374 (59%), Gaps = 63/374 (16%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
HF+ ++ LG GD+G V+L +++ G +A+KV+D++ + R K+ R E+ IL
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKG--TGK---LFALKVLDKKEMIKRNKVKRVLTEQEIL 55
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLA 203
LDHPFLPTLYA F+ Y CLVM+YCPGG+L+ QRQPGK A+FYAAE LLA
Sbjct: 56 ATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLA 115
Query: 204 LEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKC 263
LEYLH++GIVYRDLKPEN+L+ E GHIMLSDFDLS + DV P + L
Sbjct: 116 LEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRK--------- 166
Query: 264 SIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323
S E +E +
Sbjct: 167 ------------------GSRRSSVNSIPS----------------------ETFSEEPS 186
Query: 324 ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILK 383
RS SFVGT EY+APEVISG GHGSAVDWWTLG+ LYEMLYGTTPFKG N ++T NILK
Sbjct: 187 FRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILK 246
Query: 384 KPLTFP-RIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWA 442
K +TFP VSSS +DLI KLLVK+P KR+GS +G+ EIK+H FF+G+NWA
Sbjct: 247 KEVTFPGSPPVSSS--------ARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWA 298
Query: 443 LIRSIKPPEVPNND 456
LIR PP +P D
Sbjct: 299 LIRHTTPPIIPRPD 312
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 230 bits (589), Expect = 1e-71
Identities = 127/376 (33%), Positives = 179/376 (47%), Gaps = 77/376 (20%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADM-EKVI 142
D F +++ +G G G V+L + ++ YAMKV+ R++ I++ E+ I
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDT-----GQVYAMKVL-RKSDMIKRNQIAHVRAERDI 54
Query: 143 LTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLL 202
L D P++ LY F+ + LVMEY PGGDL R+ F +A+FY AE +L
Sbjct: 55 LADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVL 112
Query: 203 ALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEK 262
AL+ +H +G ++RD+KP+N+L+ DGHI L+DF L K
Sbjct: 113 ALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKK---------------------- 150
Query: 263 CSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322
K K RE D H+ D+ V
Sbjct: 151 ----------------------MNKAKD--------REYYLNDSHNLLFRDNVLVRRRDH 180
Query: 323 N---ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLI 379
R+ S VGT +Y+APEV+ G +G DWW+LGV LYEMLYG PF + ++T
Sbjct: 181 KQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYN 240
Query: 380 NIL--KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437
I+ K+ L FP S E DLI +LL +P+ R+GS + EIK H FFK
Sbjct: 241 KIINWKESLRFPPDPP-VSPEA------IDLICRLLC-DPEDRLGSFE---EIKSHPFFK 289
Query: 438 GINWALIRSIKPPEVP 453
GI+W +R KPP VP
Sbjct: 290 GIDWENLRETKPPFVP 305
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 225 bits (577), Expect = 1e-70
Identities = 113/356 (31%), Positives = 164/356 (46%), Gaps = 79/356 (22%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
D F+ + +G G V L + + YA+K++D+ L KK+ +EK +L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKET--NKE---YAIKILDKRQLIKEKKVKYVKIEKEVL 55
Query: 144 TMLD-HPFLPTLYAEF--EASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAET 200
T L+ HP + LY F E + Y V+EY P G+L ++ +FYAAE
Sbjct: 56 TRLNGHPGIIKLYYTFQDEENLY--FVLEYAPNGELLQYIRKY--GSLDEKCTRFYAAEI 111
Query: 201 LLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKY 260
LLALEYLH GI++RDLKPEN+L+ +D HI ++DF + K+L P S E+ +
Sbjct: 112 LLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTA-------KVLDPNSSPESNKGD 164
Query: 261 EKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320
S +KN+++
Sbjct: 165 ATNID-----------------SQIEKNRRRF---------------------------- 179
Query: 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLIN 380
SFVGT EY++PE+++ + G + D W LG +Y+ML G PF+G N T
Sbjct: 180 ------ASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK 233
Query: 381 ILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436
ILK +FP F K DLI KLLV +P+ R+G +G E+K H FF
Sbjct: 234 ILKLEYSFPPN-------FPPDAK--DLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 182 bits (463), Expect = 7e-53
Identities = 111/374 (29%), Positives = 179/374 (47%), Gaps = 60/374 (16%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
D F ++ +G G G V L Q ++ YAMK + + + ++++ E+ IL
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDT-----GHIYAMKKLRKSEMLEKEQVAHVRAERDIL 55
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLA 203
D+P++ LY F+ +Y L+MEY PGGD+ ++ F +FY AET+LA
Sbjct: 56 AEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILA 113
Query: 204 LEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKC 263
++ +H +G ++RD+KP+N+L+ GHI LSDF L C + K R + + +
Sbjct: 114 IDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGL---CTGLKKSHRTEF-YRILSHALPS 169
Query: 264 SIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323
+ +P+ S + K ++A+ +T
Sbjct: 170 NFLD--FISKPMSS--KRKAETWKRNRRALAYST-------------------------- 199
Query: 324 ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINIL- 382
VGT +Y+APEV G+ DWW+LGV +YEML G PF +N ++T I+
Sbjct: 200 ------VGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIIN 253
Query: 383 -KKPLTFP-RIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440
K+ L FP + +S + +DLI +L ++R+G+ G EIK H FFKG++
Sbjct: 254 WKETLQFPDEVPLSP--------EAKDLIKRLCC-EAERRLGN-NGVNEIKSHPFFKGVD 303
Query: 441 WALIRSIKPPEVPN 454
W IR P +P
Sbjct: 304 WEHIRERPAPIIPE 317
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 6e-47
Identities = 116/380 (30%), Positives = 180/380 (47%), Gaps = 63/380 (16%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
+ F ++ +G G G V L Q ++ YAMK + + + + +L E+ +L
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDT-----GKIYAMKTLLKSEMFKKDQLAHVKAERDVL 55
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLA 203
D P++ +LY F+ + Y L+ME+ PGGDL + F +FY AE +LA
Sbjct: 56 AESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLA 113
Query: 204 LEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS---FKCD---VVPKLLRPKLSFEAI 257
+E +H +G ++RD+KP+N+L+ GHI LSDF LS K KLL+ K + I
Sbjct: 114 IEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRI 173
Query: 258 EKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317
+ ++ S M S ++ KKN++ T
Sbjct: 174 DNRNSVAVDSINLTM----SSKDQIATWKKNRRLMAYST--------------------- 208
Query: 318 VAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKT 377
V P +Y+APE+ QG+G DWW+LG ++E L G PF EN+ +T
Sbjct: 209 VGTP------------DYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHET 256
Query: 378 LINIL--KKPLTFPR-IGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHE 434
I+ ++ L FP I +S E DLI +L+ N + R+G G+ EIK H
Sbjct: 257 YRKIINWRETLYFPDDIHLSVEAE--------DLIRRLIT-NAENRLGR-GGAHEIKSHP 306
Query: 435 FFKGINWALIRSIKPPEVPN 454
FF+G++W IR I+ P +P
Sbjct: 307 FFRGVDWDTIRQIRAPFIPQ 326
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 2e-46
Identities = 112/376 (29%), Positives = 167/376 (44%), Gaps = 62/376 (16%)
Query: 85 HFRLLRRLGSGDIGNVYL-CQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
F ++ +G G G V L ++ + YAMK + + + +R + E+ IL
Sbjct: 2 MFVKIKTIGIGAFGEVCLVRKVDTNAL------YAMKTLRKADVLMRNQAAHVKAERDIL 55
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGI---SSAKFYAAET 200
D+ ++ LY F+ VM+Y PGGD+ + R GI A+FY AE
Sbjct: 56 AEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLL-----IRLGIFEEDLARFYIAEL 110
Query: 201 LLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKY 260
A+E +H MG ++RD+KP+N+L+ DGHI L+DF L C + KY
Sbjct: 111 TCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGL---CT--------GFRWTHDSKY 159
Query: 261 EKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320
+ M+P S + + K + R+ H
Sbjct: 160 YQKGDHHRQDSMEP----SEEWSEIDRCRLKPLERRRKRQHQRCLAH------------- 202
Query: 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLIN 380
S VGT Y+APEV+ G+ DWW++GV LYEML G PF + +T +
Sbjct: 203 -------SLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLK 255
Query: 381 IL--KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438
++ + L P S+E DLI + L + R+G G+ EIK H FFKG
Sbjct: 256 VINWETTLHIPSQA-KLSRE------ASDLILR-LCCGAEDRLGK-NGADEIKAHPFFKG 306
Query: 439 INWA-LIRSIKPPEVP 453
I++A LIR K P +P
Sbjct: 307 IDFASLIRRQKAPYIP 322
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 2e-45
Identities = 63/147 (42%), Positives = 93/147 (63%), Gaps = 7/147 (4%)
Query: 92 LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFL 151
LG G G V L + ++ YAMKV+ ++ + RK++ E+ IL+ ++HPF+
Sbjct: 1 LGKGSFGKVLLVRKKDT-----GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFI 55
Query: 152 PTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMG 211
L+ F+ LV+EY PGG+L++ ++ RF A+FYAAE +LALEYLH +G
Sbjct: 56 VKLHYAFQTEEKLYLVLEYAPGGELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLG 113
Query: 212 IVYRDLKPENVLVREDGHIMLSDFDLS 238
I+YRDLKPEN+L+ DGHI L+DF L+
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLA 140
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 7e-45
Identities = 64/153 (41%), Positives = 87/153 (56%), Gaps = 9/153 (5%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTM 145
+ +L +LG G G VYL + + A+KV+ ++ I+K R E IL
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKT-----GKLVAIKVIKKKK--IKKDRERILREIKILKK 53
Query: 146 LDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALE 205
L HP + LY FE LVMEYC GGDL+ +++ R A+FY + L ALE
Sbjct: 54 LKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKR--GRLSEDEARFYLRQILSALE 111
Query: 206 YLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
YLH GIV+RDLKPEN+L+ EDGH+ L+DF L+
Sbjct: 112 YLHSKGIVHRDLKPENILLDEDGHVKLADFGLA 144
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 1e-42
Identities = 57/114 (50%), Positives = 72/114 (63%), Gaps = 10/114 (8%)
Query: 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINIL 382
+R+ +F GT EYLAPEV+ G+G+G AVDWW+LGV LYEML G PF E+ ++ IL
Sbjct: 147 GSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKIL 206
Query: 383 KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436
K PL FP +S + +DLIS LL K+P KR+GS EIK H FF
Sbjct: 207 KDPLRFPE-FLSP--------EARDLISGLLQKDPTKRLGSGGAE-EIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 2e-42
Identities = 63/154 (40%), Positives = 93/154 (60%), Gaps = 11/154 (7%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKL--HRADMEKV 141
D F ++ LG+G G V L + + +YA+K++ + + ++ K H + EK
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGS-----GKYYALKILSKAKI-VKLKQVEHVLN-EKR 53
Query: 142 ILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETL 201
IL + HPFL LY F+ LVMEY PGG+L++ ++ RF A+FYAA+ +
Sbjct: 54 ILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK--SGRFPEPVARFYAAQVV 111
Query: 202 LALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235
LALEYLH + IVYRDLKPEN+L+ DG+I ++DF
Sbjct: 112 LALEYLHSLDIVYRDLKPENLLLDSDGYIKITDF 145
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 5e-39
Identities = 108/372 (29%), Positives = 174/372 (46%), Gaps = 62/372 (16%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
D F L+ +G G G V L Q ++ YAMK++ + + ++++ E+ IL
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDT-----GHIYAMKILRKADMLEKEQVAHIRAERDIL 55
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLA 203
D ++ ++ F+ L+ME+ PGGD+ ++ + +FY AET+LA
Sbjct: 56 VEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLA 113
Query: 204 LEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKC 263
++ +H +G ++RD+KP+N+L+ GH+ LSDF L ++K +
Sbjct: 114 IDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLC----------------TGLKKAHRT 157
Query: 264 SIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323
T P F +++ +K+KA T R Q+
Sbjct: 158 EFYRNLTHNPPSDFSFQNMN----SKRKAETWKKNRRQL--------------------- 192
Query: 324 ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINIL- 382
+ S VGT +Y+APEV G+ DWW+LGV +YEML G PF E ++T ++
Sbjct: 193 --AYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMN 250
Query: 383 -KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINW 441
K+ L FP E K +DLI + + + RIGS G EIK H FF+G++W
Sbjct: 251 WKETLVFP-------PEVPISEKAKDLILRFCT-DSENRIGS-NGVEEIKSHPFFEGVDW 301
Query: 442 ALIRSIKPPEVP 453
IR +P +P
Sbjct: 302 GHIRE-RPAAIP 312
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 6e-39
Identities = 57/133 (42%), Positives = 77/133 (57%), Gaps = 12/133 (9%)
Query: 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK 384
R+ + GT EYLAPE+I +G+G AVDWW LG+ +YEML G PF +N + IL+
Sbjct: 154 RTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG 213
Query: 385 PLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLK-GSVEIKRHEFFKGINW-A 442
+ FP F K DLI LL + KR+G+LK G +IK H +F GI+W A
Sbjct: 214 KVRFP-------SFFSPDAK--DLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIA 264
Query: 443 LI-RSIKPPEVPN 454
L+ R I+ P +P
Sbjct: 265 LLQRKIEAPFIPK 277
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 139 bits (350), Expect = 8e-37
Identities = 111/374 (29%), Positives = 178/374 (47%), Gaps = 66/374 (17%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
+ F L+ +G G G V L Q ++ YAMK++ + + ++++ E+ IL
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDT-----GHVYAMKILRKADMLEKEQVGHIRAERDIL 55
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLA 203
D ++ ++ F+ L+ME+ PGGD+ ++ +FY AET+LA
Sbjct: 56 VEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLA 113
Query: 204 LEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKC 263
++ +H +G ++RD+KP+N+L+ GH+ LSDF L C + K R E Y
Sbjct: 114 IDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL---CTGLKKAHR-------TEFYRNL 163
Query: 264 --SIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEP 321
S+PS T F +++ +K+KA T R Q+
Sbjct: 164 NHSLPSDFT--------FQNMN----SKRKAETWKRNRRQL------------------- 192
Query: 322 INARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINI 381
+ S VGT +Y+APEV G+ DWW+LGV +YEML G PF E ++T +
Sbjct: 193 ----AFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKV 248
Query: 382 L--KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439
+ K+ L FP E K +DLI + + + RIG+ G EIK + FF+G+
Sbjct: 249 MNWKETLIFP-------PEVPISEKAKDLILRFCCEW-EHRIGA-PGVEEIKTNPFFEGV 299
Query: 440 NWALIRSIKPPEVP 453
+W IR +P +P
Sbjct: 300 DWEHIRE-RPAAIP 312
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 4e-36
Identities = 60/153 (39%), Positives = 81/153 (52%), Gaps = 8/153 (5%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTM 145
+ LLR+LGSG G VY + + A+K++ + KK A E IL
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGT-----GKIVAVKILKKR-SEKSKKDQTARREIRILRR 54
Query: 146 LDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALE 205
L HP + L FE + LVMEYC GGDL+ R G AK A + L LE
Sbjct: 55 LSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSR--GGPLSEDEAKKIALQILRGLE 112
Query: 206 YLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
YLH GI++RDLKPEN+L+ E+G + ++DF L+
Sbjct: 113 YLHSNGIIHRDLKPENILLDENGVVKIADFGLA 145
|
Length = 260 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 8e-36
Identities = 58/126 (46%), Positives = 72/126 (57%), Gaps = 8/126 (6%)
Query: 316 EVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNE 375
++ K VGT +Y+APEVI GQGH VDWW+LG LYE L G PF GE E
Sbjct: 148 QINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE 207
Query: 376 KTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEF 435
+ NIL + +P S + DLISKLLV +P+KR+G+ K EIK H F
Sbjct: 208 EIFQNILNGKIEWPEDVEVSD-------EAIDLISKLLVPDPEKRLGA-KSIEEIKNHPF 259
Query: 436 FKGINW 441
FKGI+W
Sbjct: 260 FKGIDW 265
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 1e-34
Identities = 53/151 (35%), Positives = 83/151 (54%), Gaps = 13/151 (8%)
Query: 92 LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFL 151
+ G G V+L + ++ YA+KV+ + + + ++ + E+ IL+ P++
Sbjct: 1 ISKGAYGRVFLAKKKST-----GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYV 55
Query: 152 PTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGI---SSAKFYAAETLLALEYLH 208
LY F+ LVMEY PGGDL + + G A+ Y AE +LALEYLH
Sbjct: 56 VKLYYSFQGKKNLYLVMEYLPGGDLASLL-----ENVGSLDEDVARIYIAEIVLALEYLH 110
Query: 209 MMGIVYRDLKPENVLVREDGHIMLSDFDLSF 239
GI++RDLKP+N+L+ +GH+ L+DF LS
Sbjct: 111 SNGIIHRDLKPDNILIDSNGHLKLTDFGLSK 141
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 2e-33
Identities = 108/373 (28%), Positives = 174/373 (46%), Gaps = 54/373 (14%)
Query: 86 FRLLRRLGSGDIGNVYL-CQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILT 144
F ++ LG G G V L C++ YAMK + ++ + R ++ E+ IL
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDT------HALYAMKTLRKKDVLNRNQVAHVKAERDILA 56
Query: 145 MLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLAL 204
D+ ++ LY F+ VM+Y PGGD+ + R + F A+FY AE LA+
Sbjct: 57 EADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAI 114
Query: 205 EYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCS 264
E +H MG ++RD+KP+N+L+ DGHI L+DF L + KY +
Sbjct: 115 ESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLC-----------TGFRWTHNSKYYQKG 163
Query: 265 IPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINA 324
M+P S + N + + T+ ++ H Q L
Sbjct: 164 SHIRQDSMEP-----SDLWDDVSNCRCGDRLKTLEQRATKQH--QRCL------------ 204
Query: 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK 384
+ S VGT Y+APEV+ +G+ DWW++GV L+EML G PF +T + ++
Sbjct: 205 -AHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINW 263
Query: 385 PLTF---PRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINW 441
T P++ +S + DLI+KL + ++R+G G+ +IK H FF +++
Sbjct: 264 ENTLHIPPQVKLSP--------EAVDLITKLCC-SAEERLGR-NGADDIKAHPFFSEVDF 313
Query: 442 AL-IRSIKPPEVP 453
+ IR+ P VP
Sbjct: 314 SSDIRTQPAPYVP 326
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 55/134 (41%), Positives = 82/134 (61%), Gaps = 12/134 (8%)
Query: 324 ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILK 383
+ +F GT +Y+APE++S Q +G AVDWW LGV LYEML G +PF+G++ ++ +IL+
Sbjct: 151 VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE 210
Query: 384 KPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL-KGSVEIKRHEFFKGINWA 442
+ +PR SKE + ++ L KNP+KR+G L G +IK H FF+ I+W
Sbjct: 211 DEVRYPR---WLSKE------AKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWD 261
Query: 443 LI--RSIKPPEVPN 454
+ + IKPP P
Sbjct: 262 KLERKEIKPPFKPK 275
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-32
Identities = 50/115 (43%), Positives = 67/115 (58%), Gaps = 11/115 (9%)
Query: 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINIL 382
+ +FVGT EY+APEV+ G+G+G AVD W+LGV LYE+L G PF G++ L +
Sbjct: 150 GEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKI 209
Query: 383 KKP-LTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436
KP FP S E +DLI KLLVK+P+KR+ + E +H FF
Sbjct: 210 GKPKPPFPPPEWDISPEA------KDLIRKLLVKDPEKRL----TAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 4e-32
Identities = 62/137 (45%), Positives = 80/137 (58%), Gaps = 18/137 (13%)
Query: 325 RSKSFVGTHEYLAPEVISG--QGHGSAVDWWTLGVFLYEMLYGTTPF--KGENNEKTLIN 380
R+ SF GT EY+APEVI G GH AVDWW+LGV +E+L G +PF GE N ++ I+
Sbjct: 162 RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEIS 221
Query: 381 --ILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438
ILK FP K + D I KLL K+PKKR+G+ G+ EIK H FF+G
Sbjct: 222 RRILKSKPPFP-------KTMSAEAR--DFIQKLLEKDPKKRLGA-NGADEIKNHPFFQG 271
Query: 439 INWALI--RSIKPPEVP 453
I+W + + I P P
Sbjct: 272 IDWDDLAAKRIPAPFKP 288
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 4e-32
Identities = 61/155 (39%), Positives = 95/155 (61%), Gaps = 7/155 (4%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
+ F ++ + +G G VYL + + Q F AMK ++++ L +R ++ + +E+ IL
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETR----QRF-AMKKINKQNLILRNQIQQVFVERDIL 55
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLA 203
T ++PF+ +++ FE + C+VMEY GGD A + G + A+ Y AET+LA
Sbjct: 56 TFAENPFVVSMFCSFETKRHLCMVMEYVEGGDC-ATLLKNIGA-LPVDMARMYFAETVLA 113
Query: 204 LEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
LEYLH GIV+RDLKP+N+L+ GHI L+DF LS
Sbjct: 114 LEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLS 148
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 3e-31
Identities = 58/154 (37%), Positives = 93/154 (60%), Gaps = 11/154 (7%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVD-REALAIRKKLHRADMEKVI 142
D ++ +G+G G V+L + R + + +YA+KV+ E + ++++ H + EK +
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDR-----ISEHYYALKVMAIPEVIRLKQEQHVHN-EKRV 54
Query: 143 LTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYA-ARQRQPGKRFGISSAKFYAAETL 201
L + HPF+ L+ + ++MEY PGG+L++ R RF S+ FYA+E +
Sbjct: 55 LKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNS---GRFSNSTGLFYASEIV 111
Query: 202 LALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235
ALEYLH IVYRDLKPEN+L+ ++GHI L+DF
Sbjct: 112 CALEYLHSKEIVYRDLKPENILLDKEGHIKLTDF 145
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 6e-31
Identities = 47/122 (38%), Positives = 78/122 (63%), Gaps = 14/122 (11%)
Query: 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNE--KTLINIL 382
++ +F GT EY+APE+I +G+ +VD+W+LG+ LYE+L G PF ++ + + +IL
Sbjct: 148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDIL 207
Query: 383 K--KPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSV-EIKRHEFFKGI 439
K L FP ++K DLI +LL +NP++R+G+LKG + +IK+H++F G
Sbjct: 208 KGNGKLEFPNYIDKAAK---------DLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGF 258
Query: 440 NW 441
+W
Sbjct: 259 DW 260
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 7e-31
Identities = 58/138 (42%), Positives = 80/138 (57%), Gaps = 12/138 (8%)
Query: 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTL 378
A+ + R+ + GT EYLAPEVI +GH AVDWW LG+ +YEML G PF +N
Sbjct: 148 AKKLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIY 207
Query: 379 INILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLK-GSVEIKRHEFFK 437
IL L FPR + K DLI KLLV + +R+G++K G+ ++K H +FK
Sbjct: 208 EKILAGKLEFPR-------HLDLYAK--DLIKKLLVVDRTRRLGNMKNGADDVKNHRWFK 258
Query: 438 GINWALI--RSIKPPEVP 453
++W + R +KPP VP
Sbjct: 259 SVDWDDVPQRKLKPPIVP 276
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 7e-31
Identities = 59/183 (32%), Positives = 83/183 (45%), Gaps = 15/183 (8%)
Query: 92 LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFL 151
LG G G VYL + + A+K++ +E L E IL L+HP +
Sbjct: 1 LGEGGFGTVYLARDKKT-----GKKVAIKIIKKEDS--SSLLEELLREIEILKKLNHPNI 53
Query: 152 PTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMG 211
LY FE ++ LVMEYC GG L + GK + L LEYLH G
Sbjct: 54 VKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHSNG 112
Query: 212 IVYRDLKPENVLV-REDGHIMLSDFDLSFKCDVVPKLLRPK------LSFEAIEKYEKCS 264
I++RDLKPEN+L+ ++G + L+DF LS LL+ ++ E + S
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 265 IPS 267
S
Sbjct: 173 EKS 175
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 54/135 (40%), Positives = 73/135 (54%), Gaps = 12/135 (8%)
Query: 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTL 378
A+ + R+ + GT EYLAPEVI +GHG AVDWWT+GV LYE + G PF + +
Sbjct: 165 AKKVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY 224
Query: 379 INILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVE-IKRHEFFK 437
IL L FP F+ + +DL+ LL + KR+G+LKG V +K H +F
Sbjct: 225 EKILAGRLKFPNW-------FDG--RARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFH 275
Query: 438 GINWALI--RSIKPP 450
G NW + R P
Sbjct: 276 GANWDKLYARYYPAP 290
|
Length = 329 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 54/135 (40%), Positives = 77/135 (57%), Gaps = 12/135 (8%)
Query: 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINIL 382
+ +F GT EY+APE++ GHG AVDWW+LG +Y+ML G PF EN +KT+ IL
Sbjct: 154 GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL 213
Query: 383 KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKG-SVEIKRHEFFKGINW 441
K L P ++ DL+ KLL +NP R+G+ G + E++ H FF+ +NW
Sbjct: 214 KGKLNLPPYLTPEAR---------DLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNW 264
Query: 442 --ALIRSIKPPEVPN 454
L R ++PP P
Sbjct: 265 DDLLARKVEPPFKPL 279
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 63/138 (45%), Positives = 89/138 (64%), Gaps = 19/138 (13%)
Query: 325 RSKSFVGTHEYLAPEVISGQ-GHGSAVDWWTLGVFLYEMLYGTTPF--KGENNEKTLIN- 380
R+ SF GT EY+APE+I G+ GHG AVDWW+LG+ ++E+L G +PF +GE N ++ ++
Sbjct: 162 RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR 221
Query: 381 -ILKKPLTFP-RIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGS-LKGSVEIKRHEFFK 437
ILK FP IG + QDL+ KLL K+PKKR+G+ +G+ EIK H FFK
Sbjct: 222 RILKCDPPFPSFIGPEA----------QDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFK 271
Query: 438 GINWALI--RSIKPPEVP 453
G++W + R + PP P
Sbjct: 272 GLDWEALALRKVNPPFRP 289
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 57/131 (43%), Positives = 78/131 (59%), Gaps = 12/131 (9%)
Query: 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK 384
++ +F GT EYLAPE++ G G+ AVDWWTLGV LYEML G PF EN + IL++
Sbjct: 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE 208
Query: 385 PLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWA-- 442
PL FP G +DL+ LL ++P +R+G G+ EIK H FF ++W
Sbjct: 209 PLRFPD-GFDR--------DAKDLLIGLLSRDPTRRLGY-NGAQEIKNHPFFSQLSWKKL 258
Query: 443 LIRSIKPPEVP 453
L++ I+PP P
Sbjct: 259 LMKGIQPPFKP 269
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 63/151 (41%), Positives = 92/151 (60%), Gaps = 7/151 (4%)
Query: 89 LRRLGSGDIGNVYLC-QIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD 147
L+ LG G G V+L +I P G YAMKV+ + L +R ++ R ME+ IL ++
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQ---LYAMKVLKKATLKVRDRV-RTKMERDILAEVN 56
Query: 148 HPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYL 207
HPF+ L+ F+ L++++ GGDL+ ++ F KFY AE LAL++L
Sbjct: 57 HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHL 114
Query: 208 HMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
H +GI+YRDLKPEN+L+ E+GHI L+DF LS
Sbjct: 115 HSLGIIYRDLKPENILLDEEGHIKLTDFGLS 145
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 6e-29
Identities = 54/154 (35%), Positives = 88/154 (57%), Gaps = 7/154 (4%)
Query: 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILT 144
HF LLR +G G G V + Q R+ + +AMK ++++ + + E+ IL
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDT-----KKMFAMKYMNKQKCVEKGSVRNVLNERRILQ 55
Query: 145 MLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLAL 204
L+HPFL L+ F+ LV++ GGDL ++ +F KF+ E +LAL
Sbjct: 56 ELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLAL 113
Query: 205 EYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
EYLH GI++RD+KP+N+L+ E GH+ ++DF+++
Sbjct: 114 EYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIA 147
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 53/132 (40%), Positives = 76/132 (57%), Gaps = 9/132 (6%)
Query: 324 ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINIL- 382
+ S VG+ +Y+APEV+ G+G+ VD+W+LG LYE L G PF G +T N+
Sbjct: 153 TYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKY 212
Query: 383 -KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINW 441
K+ L P V F + DLI+KL+ +P +R GSL+ +IK H FFK ++W
Sbjct: 213 WKETLQRP---VYDDPRFNLSDEAWDLITKLI-NDPSRRFGSLE---DIKNHPFFKEVDW 265
Query: 442 ALIRSIKPPEVP 453
+R +KPP VP
Sbjct: 266 NELRELKPPFVP 277
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 51/116 (43%), Positives = 67/116 (57%), Gaps = 6/116 (5%)
Query: 326 SKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP 385
+K FVGT +YLAPE I G G DWW+LG ++E L+G PF E + NIL +
Sbjct: 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRR 209
Query: 386 LTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINW 441
+ +P KEF + DLI++LL +P KR+G+ G EIK H FFK INW
Sbjct: 210 INWPE----EVKEFCSPEAV-DLINRLLCMDPAKRLGA-NGYQEIKSHPFFKSINW 259
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 55/145 (37%), Positives = 80/145 (55%), Gaps = 9/145 (6%)
Query: 92 LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFL 151
LG G G V L ++++ +A+K V + + + EK IL +HPF+
Sbjct: 1 LGVGGFGRVELVKVKSKNR-----TFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFI 55
Query: 152 PTLYAEFEASHYSCLVMEYCPGGDLYAA-RQRQPGKRFGISSAKFYAAETLLALEYLHMM 210
LY F+ Y ++MEYC GG+L+ R R F +A+FY A +LA EYLH
Sbjct: 56 VKLYRTFKDKKYIYMLMEYCLGGELWTILRDR---GLFDEYTARFYIACVVLAFEYLHNR 112
Query: 211 GIVYRDLKPENVLVREDGHIMLSDF 235
GI+YRDLKPEN+L+ +G++ L DF
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDF 137
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 56/139 (40%), Positives = 80/139 (57%), Gaps = 14/139 (10%)
Query: 320 EPINARSK--SFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKT 377
E I+ K SF GT EY+APEV++ +GH + DWW+ GV ++EML G+ PF+G++ ++T
Sbjct: 147 ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET 206
Query: 378 LINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGS-LKGSVEIKRHEFF 436
+ ILK L P+ + Q L+ L +NP R+G+ G EIKRH FF
Sbjct: 207 MTMILKAKLGMPQFLSPEA---------QSLLRALFKRNPANRLGAGPDGVEEIKRHPFF 257
Query: 437 KGINWALI--RSIKPPEVP 453
I+W + R IKPP P
Sbjct: 258 STIDWNKLYRREIKPPFKP 276
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 56/155 (36%), Positives = 77/155 (49%), Gaps = 11/155 (7%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTM 145
FR L LG G G V L + + YA+K + + + R ++ EK I
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKT-----GELYAIKALKKGDIIARDEVESLMCEKRIFET 55
Query: 146 LD---HPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLL 202
+ HPFL L+A F+ + C VMEY GGDL F A FYAA +L
Sbjct: 56 ANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVL 112
Query: 203 ALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237
L+YLH IVYRDLK +N+L+ +G + ++DF L
Sbjct: 113 GLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGL 147
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 52/131 (39%), Positives = 80/131 (61%), Gaps = 12/131 (9%)
Query: 326 SKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP 385
+++F GT +Y+APE+I+ Q +G +VDWW GV LYEML G PF GE+ ++ +I++
Sbjct: 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN 217
Query: 386 LTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGS-LKGSVEIKRHEFFKGINWALI 444
+++P+ S SKE + K LL K+P KR+G G +I+ H FF+ I+W +
Sbjct: 218 VSYPK---SLSKEAVSICK------GLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKL 268
Query: 445 --RSIKPPEVP 453
R I+PP P
Sbjct: 269 ERREIQPPFKP 279
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 7e-28
Identities = 53/137 (38%), Positives = 80/137 (58%), Gaps = 20/137 (14%)
Query: 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINIL-- 382
R+ +F GT E+LAPEV++ + AVDWW LGV +YEML G +PF G++ E+ +I+
Sbjct: 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND 216
Query: 383 --KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGS-LKGSVEIKRHEFFKGI 439
+ P R +S ++ +LL +NP++R+GS K + ++K+ FF+ I
Sbjct: 217 EVRYPRFLSREAIS-------------IMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263
Query: 440 NWA--LIRSIKPPEVPN 454
NW L R IKPP VP
Sbjct: 264 NWDDLLARKIKPPFVPT 280
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 56/150 (37%), Positives = 82/150 (54%), Gaps = 8/150 (5%)
Query: 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DH 148
+ LG G G V L +++ YA+KV+ ++ + + EK +L + H
Sbjct: 1 KVLGKGSFGKVLLAELKGT-----DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKH 55
Query: 149 PFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLH 208
PFL L++ F+ VMEY GGDL QR RF A+FYAAE +L L++LH
Sbjct: 56 PFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLH 113
Query: 209 MMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
GI+YRDLK +NVL+ +GHI ++DF +
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKIADFGMC 143
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 55/135 (40%), Positives = 72/135 (53%), Gaps = 11/135 (8%)
Query: 322 INARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINI 381
+ + +F GT EYLAPEV+ Q + VDWW LG LYEMLYG PF + + NI
Sbjct: 149 HSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI 208
Query: 382 LKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINW 441
L KPL + +S S + L+ LL K+ KR+G+ +EIK H FF INW
Sbjct: 209 LNKPLRL-KPNISVSA--------RHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINW 259
Query: 442 A--LIRSIKPPEVPN 454
+ + I PP PN
Sbjct: 260 DDLVNKKITPPFNPN 274
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 54/133 (40%), Positives = 80/133 (60%), Gaps = 14/133 (10%)
Query: 324 ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILK 383
++ +F GT +Y+APE++ GQ + +VDWW+ GV LYEML G +PF GE+ ++ +IL
Sbjct: 151 GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN 210
Query: 384 KPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWAL 443
FPR SKE +D +SKL ++P KR+G G +I++H FF+GI+W
Sbjct: 211 DRPHFPR---WISKE------AKDCLSKLFERDPTKRLGV-DG--DIRQHPFFRGIDWER 258
Query: 444 I--RSIKPPEVPN 454
+ R I PP P
Sbjct: 259 LEKREIPPPFKPK 271
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 7e-27
Identities = 54/146 (36%), Positives = 79/146 (54%), Gaps = 7/146 (4%)
Query: 92 LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFL 151
LG G G V L + + +YAMK++ +E + + ++ E +L HPFL
Sbjct: 3 LGKGTFGKVILVREKAT-----GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFL 57
Query: 152 PTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMG 211
L F+ C VMEY GG+L+ R+ + F A+FY AE + AL YLH
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCD 115
Query: 212 IVYRDLKPENVLVREDGHIMLSDFDL 237
+VYRDLK EN+++ +DGHI ++DF L
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGL 141
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 56/147 (38%), Positives = 86/147 (58%), Gaps = 8/147 (5%)
Query: 92 LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEK-VILTMLDHPF 150
+G G G V L + + FYA+KV+ ++A+ +K+ E+ V+L + HPF
Sbjct: 3 IGKGSFGKVLLAKHK-----ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPF 57
Query: 151 LPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMM 210
L L+ F+ + V++Y GG+L+ QR+ + F A+FYAAE AL YLH +
Sbjct: 58 LVGLHYSFQTADKLYFVLDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSL 115
Query: 211 GIVYRDLKPENVLVREDGHIMLSDFDL 237
I+YRDLKPEN+L+ GH++L+DF L
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGL 142
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 54/134 (40%), Positives = 74/134 (55%), Gaps = 12/134 (8%)
Query: 324 ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILK 383
A K+F GT EYLAPEV+ +G AVDWW LGV +YEM+ G PF +++EK IL
Sbjct: 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 209
Query: 384 KPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSV-EIKRHEFFKGINWA 442
+ + FPR +K L++ LL K+PK+R+G EI H FF INW
Sbjct: 210 EEIRFPRTLSPEAK---------SLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQ 260
Query: 443 LI--RSIKPPEVPN 454
+ + ++PP P
Sbjct: 261 DVVQKKLEPPFKPQ 274
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 59/149 (39%), Positives = 79/149 (53%), Gaps = 9/149 (6%)
Query: 92 LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFL 151
LG G G V CQ++ YA K +D++ L RK A EK IL + F+
Sbjct: 1 LGKGGFGEVCACQVKAT-----GKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFI 55
Query: 152 PTLYAEFEASHYSCLVMEYCPGGDL--YAARQRQPGKRFGISSAKFYAAETLLALEYLHM 209
+L FE CLVM GGDL + +PG F + A FYAA+ + LE+LH
Sbjct: 56 VSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPG--FPEARAIFYAAQIICGLEHLHQ 113
Query: 210 MGIVYRDLKPENVLVREDGHIMLSDFDLS 238
IVYRDLKPENVL+ + G++ +SD L+
Sbjct: 114 RRIVYRDLKPENVLLDDHGNVRISDLGLA 142
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 58/156 (37%), Positives = 89/156 (57%), Gaps = 8/156 (5%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADM-EKVILT 144
F LLR LG+G G V+L +R YAMKV+ + + + K E+ +L
Sbjct: 2 FELLRVLGTGAYGKVFL--VRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLE 59
Query: 145 MLDH-PFLPTLYAEFEASHYSCLVMEYCPGGDLYA-ARQRQPGKRFGISSAKFYAAETLL 202
+ PFL TL+ F+ L+++Y GG+L+ QR+ F S + Y AE +L
Sbjct: 60 AVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVL 116
Query: 203 ALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
AL++LH +GI+YRD+K EN+L+ +GH++L+DF LS
Sbjct: 117 ALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLS 152
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 8e-26
Identities = 55/153 (35%), Positives = 85/153 (55%), Gaps = 7/153 (4%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVI 142
L F + LG+G G V + + + G + +YA+K + + + K++ EK I
Sbjct: 17 LSDFEMGETLGTGSFGRVRIAKHK----GTGE-YYAIKCLKKREILKMKQVQHVAQEKSI 71
Query: 143 LTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLL 202
L L HPF+ + F+ + ++E+ GG+L+ R+ G RF AKFY AE +L
Sbjct: 72 LMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFT-HLRKAG-RFPNDVAKFYHAELVL 129
Query: 203 ALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235
A EYLH I+YRDLKPEN+L+ GH+ ++DF
Sbjct: 130 AFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDF 162
|
Length = 329 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-25
Identities = 56/156 (35%), Positives = 85/156 (54%), Gaps = 29/156 (18%)
Query: 327 KSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL 386
K GT EY+APEVI QG+G VDWW +G+ LYE L G PF G+ E+ ++ +
Sbjct: 174 KQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI 233
Query: 387 TFPRIGVSSSKEFEEVVKL--QDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINW-AL 443
+P E +E + QDLIS+LL +NP +R+G+ G+ E+K+H FF G++W L
Sbjct: 234 EWP--------EGDEALPADAQDLISRLLRQNPLERLGT-GGAFEVKQHRFFLGLDWNGL 284
Query: 444 IRSIKPPEVPNNDLYCKIKKKVYVPKLSKQERDAPY 479
+R +K ++P+L ++ D Y
Sbjct: 285 LR----------------QKAEFIPQLESED-DTSY 303
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 60/168 (35%), Positives = 89/168 (52%), Gaps = 10/168 (5%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
F + +G G G V + +R G YAMKV+ + L ++ + + E+ IL
Sbjct: 1 KDFDVKSLVGRGHFGEVQV--VREKATG---DIYAMKVMKKSVLLAQETVSFFEEERDIL 55
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLA 203
++ + P++P L F+ LVMEY PGGDL + R + F A+FY AE +LA
Sbjct: 56 SISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQ-FDEDMAQFYLAELVLA 114
Query: 204 LEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD----VVPKL 247
+ +H MG V+RD+KPENVL+ GHI L+DF + + V KL
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKL 162
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 57/138 (41%), Positives = 82/138 (59%), Gaps = 16/138 (11%)
Query: 320 EPINARSKSFVGTHEYLAPEVISG--QGHGSAVDWWTLGVFLYEMLYGTTPFK--GENNE 375
E R+ SF GT EY+AP+++ G GH AVDWW++GV +YE+L G +PF GE N
Sbjct: 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS 216
Query: 376 KTLIN--ILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGS-LKGSVEIKR 432
+ I+ ILK +P +E + K D+I +LL+K+PKKR+G + EIK+
Sbjct: 217 QAEISRRILKSEPPYP-------QEMSALAK--DIIQRLLMKDPKKRLGCGPSDADEIKK 267
Query: 433 HEFFKGINWALIRSIKPP 450
H FF+ INW + + K P
Sbjct: 268 HPFFQKINWDDLAAKKVP 285
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 3e-25
Identities = 51/151 (33%), Positives = 83/151 (54%), Gaps = 8/151 (5%)
Query: 89 LRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL-TMLD 147
L+ + G G+VYL + R ++A+KV+ + + + ++ E+ I+ +
Sbjct: 1 LKPISKGAFGSVYLAKKR-----STGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGE 55
Query: 148 HPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYL 207
P++ LY F++ Y LVMEY GGD + + G AK Y AE +L +E L
Sbjct: 56 SPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGG--LPEDWAKQYIAEVVLGVEDL 113
Query: 208 HMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
H GI++RD+KPEN+L+ + GH+ L+DF LS
Sbjct: 114 HQRGIIHRDIKPENLLIDQTGHLKLTDFGLS 144
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 49/156 (31%), Positives = 83/156 (53%), Gaps = 8/156 (5%)
Query: 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILT 144
+ +++++G G G VYL + ++ Y +K +D ++ +++ A E IL
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSD-----GKLYVLKEIDLSNMSEKERE-DALNEVKILK 54
Query: 145 MLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAA--RQRQPGKRFGISSAKFYAAETLL 202
L+HP + Y FE C+VMEY GGDL +Q++ GK F + + L
Sbjct: 55 KLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL 114
Query: 203 ALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
AL+YLH I++RD+KP+N+ + +G + L DF +S
Sbjct: 115 ALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGIS 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 56/146 (38%), Positives = 81/146 (55%), Gaps = 7/146 (4%)
Query: 92 LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFL 151
LG G G V L +R G +YAMK++ +E + + ++ E +L HPFL
Sbjct: 3 LGKGTFGKVIL--VREKATGR---YYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 57
Query: 152 PTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMG 211
L F+ C VMEY GG+L+ R+ + F A+FY AE + ALEYLH
Sbjct: 58 TALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD 115
Query: 212 IVYRDLKPENVLVREDGHIMLSDFDL 237
+VYRD+K EN+++ +DGHI ++DF L
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGL 141
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 53/145 (36%), Positives = 82/145 (56%), Gaps = 8/145 (5%)
Query: 92 LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTM-LDHPF 150
LG G G V L +++ F+A+K + ++ + + +E+ +L + +HPF
Sbjct: 3 LGKGSFGKVMLAELKGT-----NEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPF 57
Query: 151 LPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMM 210
L L+ F+ + VMEY GGDL Q RF + A+FYAAE + L++LH
Sbjct: 58 LTHLFCTFQTKEHLFFVMEYLNGGDL--MFHIQSSGRFDEARARFYAAEIICGLQFLHKK 115
Query: 211 GIVYRDLKPENVLVREDGHIMLSDF 235
GI+YRDLK +NVL+ +DGHI ++DF
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADF 140
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 5e-25
Identities = 56/133 (42%), Positives = 77/133 (57%), Gaps = 12/133 (9%)
Query: 324 ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILK 383
A K+F GT EYLAPEV+ +G AVDWW LGV +YEM+ G PF +++EK IL
Sbjct: 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 209
Query: 384 KPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRI-GSLKGSVEIKRHEFFKGINWA 442
+ + FPR + +K L+S LL+K+P KR+ G + EI RH FF G+NW
Sbjct: 210 EDIKFPRTLSADAKS---------LLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQ 260
Query: 443 LI--RSIKPPEVP 453
+ + + PP P
Sbjct: 261 DVYDKKLVPPFKP 273
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 56/149 (37%), Positives = 86/149 (57%), Gaps = 8/149 (5%)
Query: 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DH 148
+ LG G G V+L +++ G Q F+A+K + ++ + + + +EK +L++ +H
Sbjct: 1 KMLGKGSFGKVFLAELK----GTNQ-FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 55
Query: 149 PFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLH 208
PFL LY F+ VMEY GGDL Q +F + A FYAAE + L++LH
Sbjct: 56 PFLTHLYCTFQTKENLFFVMEYLNGGDLMF--HIQSCHKFDLPRATFYAAEIICGLQFLH 113
Query: 209 MMGIVYRDLKPENVLVREDGHIMLSDFDL 237
GIVYRDLK +N+L+ DGHI ++DF +
Sbjct: 114 SKGIVYRDLKLDNILLDTDGHIKIADFGM 142
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 9e-25
Identities = 49/137 (35%), Positives = 77/137 (56%), Gaps = 11/137 (8%)
Query: 323 NARSKSFVGTHEYLAPEVI-SGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINI 381
N + +F GT EYLAPEV+ +G+ VD+W+LGV ++EM G +PF E+ ++ NI
Sbjct: 150 NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI 209
Query: 382 LKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINW 441
+ FP+ +S + + LL +NP+ R+G+ + +VE+K H FF I+W
Sbjct: 210 AFGKVRFPKNVLSDEG--------RQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDW 261
Query: 442 ALI--RSIKPPEVPNND 456
L+ + I PP P D
Sbjct: 262 DLLSKKQITPPFKPIVD 278
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 58/162 (35%), Positives = 95/162 (58%), Gaps = 23/162 (14%)
Query: 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINIL 382
+A++ +F GT +Y+APE++ GQ + ++VDWW+ GV LYEML G +PF G + E+ +I
Sbjct: 150 DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR 209
Query: 383 KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWA 442
+PR +K D++ KL V+ P++R+G +KG +I++H FF+ I+W+
Sbjct: 210 MDNPCYPRWLTREAK---------DILVKLFVREPERRLG-VKG--DIRQHPFFREIDWS 257
Query: 443 LI--RSIKPPEVPN----NDLYCKIKKKVYV---PKLSKQER 475
+ R I+PP P ND C K ++ P+LS +R
Sbjct: 258 ALEEREIEPPFKPKVKSAND--CSNFDKEFLNEKPRLSVTDR 297
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 59/154 (38%), Positives = 85/154 (55%), Gaps = 13/154 (8%)
Query: 89 LRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIR--KKLHRADMEKVILTML 146
L+ LG G G V+ Q+R +AMKV+ ++A +R K E+ IL +
Sbjct: 1 LKVLGKGGYGKVF--QVRKVTGADTGKIFAMKVL-KKATIVRNQKDTAHTKAERNILEAV 57
Query: 147 DHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGI---SSAKFYAAETLLA 203
HPF+ L F+ L++EY GG+L+ +R+ GI +A FY +E LA
Sbjct: 58 KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLERE-----GIFMEDTACFYLSEISLA 112
Query: 204 LEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237
LE+LH GI+YRDLKPEN+L+ GH+ L+DF L
Sbjct: 113 LEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGL 146
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 51/131 (38%), Positives = 81/131 (61%), Gaps = 12/131 (9%)
Query: 326 SKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP 385
+K+F GT +Y+APE+I+ Q +G +VDWW GV LYEML G PF+GE+ ++ +I++
Sbjct: 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN 217
Query: 386 LTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIG-SLKGSVEIKRHEFFKGINWALI 444
+ +P+ S SKE + K L+ K+P KR+G +G +IK H FF+ I+W +
Sbjct: 218 VAYPK---SMSKEAVAICK------GLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL 268
Query: 445 --RSIKPPEVP 453
+ ++PP P
Sbjct: 269 ERKEVQPPYKP 279
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 49/118 (41%), Positives = 65/118 (55%), Gaps = 13/118 (11%)
Query: 323 NARSKSFVGTHEYLAPEVI-SGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNE---KTL 378
++ +FVGT Y+APEV+ G G+G VD W+LGV LYE+L G PF GEN + +
Sbjct: 152 SSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLI 211
Query: 379 INILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436
IL PL F SS E + +DLI K L K+P KR + EI +H +F
Sbjct: 212 RRILGPPLEFDEPKWSSGSE-----EAKDLIKKCLNKDPSKRPTAE----EILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 3e-24
Identities = 59/157 (37%), Positives = 89/157 (56%), Gaps = 10/157 (6%)
Query: 86 FRLLRRLGSGDIGNVYLC-QIRNPMVGLPQCFYAMKVVDREALAIRKKL--HRADMEKVI 142
F LL+ LG+G G V+L ++ G YAMKV+ + AL + K H V+
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGK---LYAMKVLQKAALVQKAKTVEHTRTERNVL 58
Query: 143 LTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYA-ARQRQPGKRFGISSAKFYAAETL 201
+ PFL TL+ F+ L+++Y GG+++ QR F +FY+ E +
Sbjct: 59 EHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEII 115
Query: 202 LALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
LALE+LH +GIVYRD+K EN+L+ +GH++L+DF LS
Sbjct: 116 LALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLS 152
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 53/157 (33%), Positives = 78/157 (49%), Gaps = 13/157 (8%)
Query: 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILT 144
F++L ++G G G V+L + ++ A+K + + L ++ E+ ILT
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDT-----GEIVALKRMKKSLLFKLNEVRHVLTERDILT 56
Query: 145 MLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGI---SSAKFYAAETL 201
+L L F+ Y L MEY PGGD R G+ A+FY AE
Sbjct: 57 TTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDF-----RTLLNNLGVLSEDHARFYMAEMF 111
Query: 202 LALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
A++ LH +G ++RDLKPEN L+ GHI L+DF LS
Sbjct: 112 EAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLS 148
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 49/132 (37%), Positives = 73/132 (55%), Gaps = 13/132 (9%)
Query: 326 SKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP 385
+ +F GT +Y+APE++ +G +VDWW +GV LYEML G PF+ EN + IL
Sbjct: 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE 212
Query: 386 LTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLK--GSVEIKRHEFFKGINWAL 443
+ +P S++ +++K + KNP R+GSL G I RH FFK ++W
Sbjct: 213 VVYP---TWLSQDAVDILK------AFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEK 263
Query: 444 I--RSIKPPEVP 453
+ R I+PP P
Sbjct: 264 LNRRQIEPPFRP 275
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 62/145 (42%), Positives = 76/145 (52%), Gaps = 18/145 (12%)
Query: 320 EPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLI 379
E N + +F GT EYLAPEV+ Q + VDWW LG LYEMLYG PF N +
Sbjct: 148 EH-NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 206
Query: 380 NILKKPLTF-PRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438
NIL KPL P I S+ + L+ LL K+ KR+G+ +EIK H FF
Sbjct: 207 NILNKPLQLKPNITNSA----------RHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP 256
Query: 439 INW--ALIRSIKPPEVPN----NDL 457
INW + + I PP PN NDL
Sbjct: 257 INWDDLINKKITPPFNPNVSGPNDL 281
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 57/147 (38%), Positives = 80/147 (54%), Gaps = 20/147 (13%)
Query: 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINIL 382
+ +F GT +Y+APE++ +G +VDWW LGV +YEM+ G PF+ +N + +IL
Sbjct: 150 GVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL 209
Query: 383 KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIG---SLKGSVEIKRHEFFKGI 439
+ +P V SKE ++K + KNP KR+G S G IK+H FFK I
Sbjct: 210 HDDVLYP---VWLSKEAVSILK------AFMTKNPNKRLGCVASQGGEDAIKQHPFFKEI 260
Query: 440 NWALI--RSIKPPEVPNNDLYCKIKKK 464
+W L+ R IKPP P KIK K
Sbjct: 261 DWVLLEQRKIKPPFKP------KIKTK 281
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 55/145 (37%), Positives = 80/145 (55%), Gaps = 8/145 (5%)
Query: 92 LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTM-LDHPF 150
LG G G V L +++ G + YA+KV+ ++ + + EK IL + HPF
Sbjct: 3 LGKGSFGKVMLAELK----GTDE-VYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPF 57
Query: 151 LPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMM 210
L L+ F+ VMEY GGDL Q Q ++F ++FYAAE LAL +LH
Sbjct: 58 LTALHCCFQTKDRLFFVMEYVNGGDLMF--QIQRSRKFDEPRSRFYAAEVTLALMFLHRH 115
Query: 211 GIVYRDLKPENVLVREDGHIMLSDF 235
G++YRDLK +N+L+ +GH L+DF
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADF 140
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 51/131 (38%), Positives = 81/131 (61%), Gaps = 12/131 (9%)
Query: 326 SKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP 385
+++F GT +Y+APE+I+ Q +G +VDWW GV LYEML G PF GE+ ++ +I++
Sbjct: 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN 217
Query: 386 LTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIG-SLKGSVEIKRHEFFKGINWALI 444
+++P+ S SKE + K L+ K+P KR+G +G +I+ H FF+ I+W +
Sbjct: 218 VSYPK---SLSKEAVSICK------GLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKL 268
Query: 445 --RSIKPPEVP 453
R I+PP P
Sbjct: 269 ENREIQPPFKP 279
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 62/188 (32%), Positives = 97/188 (51%), Gaps = 16/188 (8%)
Query: 54 LYNSHKPHKANQAAWEAMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRN---PMV 110
L N K + + + KR + ++ + F +R LG+G G V L +N P V
Sbjct: 4 LKNLQLHKKKDSDSTKEPKR----KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPV 59
Query: 111 GLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEY 170
A+K ++ + +K++ E+ IL ++HPF LY F+ Y LV+E+
Sbjct: 60 -------AIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEF 112
Query: 171 CPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHI 230
GG+ + +R KRF FYAA+ +L EYL + IVYRDLKPEN+L+ +DG I
Sbjct: 113 VIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFI 170
Query: 231 MLSDFDLS 238
++DF +
Sbjct: 171 KMTDFGFA 178
|
Length = 340 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 60/150 (40%), Positives = 83/150 (55%), Gaps = 10/150 (6%)
Query: 92 LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL---TMLDH 148
+G G G VY Q+R YAMKV+ ++ + +K++ E+ IL + +
Sbjct: 1 IGKGTFGQVY--QVRKKDTRR---IYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDES 55
Query: 149 PFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLH 208
PF+ L F+ LV +Y GG+L+ Q++ RF AKFY AE +LALE+LH
Sbjct: 56 PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKE--GRFSEDRAKFYIAELVLALEHLH 113
Query: 209 MMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
IVYRDLKPEN+L+ GHI L DF LS
Sbjct: 114 KYDIVYRDLKPENILLDATGHIALCDFGLS 143
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 61/157 (38%), Positives = 80/157 (50%), Gaps = 9/157 (5%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTM 145
FR R LG G G V CQ+R YA K ++++ + RK A EK IL
Sbjct: 2 FRHYRVLGKGGFGEVCACQVR-----ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEK 56
Query: 146 LDHPFLPTLYAEFEASHYSCLVMEYCPGGDL--YAARQRQPGKRFGISSAKFYAAETLLA 203
++ F+ +L +E CLV+ GGDL + PG F A FYAAE
Sbjct: 57 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPG--FDEERAVFYAAEITCG 114
Query: 204 LEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240
LE LH IVYRDLKPEN+L+ + GHI +SD L+ +
Sbjct: 115 LEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVE 151
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 1e-23
Identities = 45/157 (28%), Positives = 72/157 (45%), Gaps = 14/157 (8%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVD--REALAIRKKLHRADMEKVIL 143
+ LG G G+VYL ++ A+K V+ ++ + L R E IL
Sbjct: 2 WTRGELLGRGSFGSVYLALDKDT-----GELMAVKSVELSGDSEEELEALER---EIRIL 53
Query: 144 TMLDHPFLPT-LYAEF-EASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETL 201
+ L HP + +E E + + +EY GG L + ++ + + Y + L
Sbjct: 54 SSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK--FGKLPEPVIRKYTRQIL 111
Query: 202 LALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
L YLH GIV+RD+K N+LV DG + L+DF +
Sbjct: 112 EGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCA 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 55/147 (37%), Positives = 87/147 (59%), Gaps = 8/147 (5%)
Query: 92 LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEK-VILTMLDHPF 150
+G G G V L + ++ FYA+KV+ ++ + +K+ + E+ V+L L HPF
Sbjct: 3 IGKGSFGKVLLAKRKSD-----GSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPF 57
Query: 151 LPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMM 210
L L+ F+ + V++Y GG+L+ QR+ + F A+FYAAE A+ YLH +
Sbjct: 58 LVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSL 115
Query: 211 GIVYRDLKPENVLVREDGHIMLSDFDL 237
I+YRDLKPEN+L+ GH++L+DF L
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGL 142
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 55/136 (40%), Positives = 74/136 (54%), Gaps = 20/136 (14%)
Query: 326 SKSFVGTHEYLAPEV---ISGQG---HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLI 379
SK VGT +Y+APEV ++G G +G DWW+LGV YEM+YG +PF + KT
Sbjct: 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYN 219
Query: 380 NIL--KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437
NI+ ++ L FP S +F DLI LL K+R+G +G + H FF
Sbjct: 220 NIMNFQRFLKFPE-DPKVSSDF------LDLIQSLLC-GQKERLG-YEG---LCCHPFFS 267
Query: 438 GINWALIRSIKPPEVP 453
I+W IR+ PP VP
Sbjct: 268 KIDWNNIRNSLPPFVP 283
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-23
Identities = 58/147 (39%), Positives = 86/147 (58%), Gaps = 8/147 (5%)
Query: 92 LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKK-LHRADMEKVILTMLDHPF 150
+G G G V L + + + FYA+KV+ ++A+ +K+ H V+L + HPF
Sbjct: 3 IGKGSFGKVLLARHKAE-----EKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF 57
Query: 151 LPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMM 210
L L+ F+ + V++Y GG+L+ QR+ + F A+FYAAE AL YLH +
Sbjct: 58 LVGLHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSL 115
Query: 211 GIVYRDLKPENVLVREDGHIMLSDFDL 237
IVYRDLKPEN+L+ GHI+L+DF L
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGL 142
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 3e-23
Identities = 55/147 (37%), Positives = 82/147 (55%), Gaps = 8/147 (5%)
Query: 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEK-VILTMLDH 148
R +G G V L +++ + YAMKV+ +E + + + EK V T +H
Sbjct: 1 RVIGRGSYAKVLLVELKKT-----RRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNH 55
Query: 149 PFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLH 208
PFL L++ F+ V+E+ GGDL QRQ ++ A+FY+AE LAL +LH
Sbjct: 56 PFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLH 113
Query: 209 MMGIVYRDLKPENVLVREDGHIMLSDF 235
GI+YRDLK +NVL+ +GHI L+D+
Sbjct: 114 ERGIIYRDLKLDNVLLDAEGHIKLTDY 140
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 5e-23
Identities = 54/131 (41%), Positives = 71/131 (54%), Gaps = 11/131 (8%)
Query: 326 SKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP 385
+ +F GT EYLAPEV+ + + VDWW LG LYEMLYG PF + + NIL KP
Sbjct: 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP 212
Query: 386 LTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALI- 444
L P + V DL+ LL K+ ++R+G+ +EIK H FF INW +
Sbjct: 213 LQLPG---------GKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDLY 263
Query: 445 -RSIKPPEVPN 454
+ I PP PN
Sbjct: 264 HKRITPPYNPN 274
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 6e-23
Identities = 52/131 (39%), Positives = 75/131 (57%), Gaps = 11/131 (8%)
Query: 326 SKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP 385
+ +F GT EYLAPEVI Q + + VDWW LG LYEMLYG PF + + NIL KP
Sbjct: 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP 212
Query: 386 LTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALI- 444
L R G S + ++ +LL K+ ++R+G+ + +EI+ H FF+ ++W +
Sbjct: 213 LVL-RPGASLTA--------WSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLE 263
Query: 445 -RSIKPPEVPN 454
+ I PP PN
Sbjct: 264 QKKIPPPFNPN 274
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 6e-23
Identities = 47/131 (35%), Positives = 73/131 (55%), Gaps = 14/131 (10%)
Query: 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK 384
R+ +F GT +Y+APE++ G + +VDWW+ GV LYEML G +PF G++ ++ +I
Sbjct: 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD 211
Query: 385 PLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALI 444
+PR SK D++ KL ++P +R+G + I+ H FFK INW +
Sbjct: 212 TPHYPRWITKESK---------DILEKLFERDPTRRLGVVG---NIRGHPFFKTINWTAL 259
Query: 445 --RSIKPPEVP 453
R + PP P
Sbjct: 260 EKRELDPPFKP 270
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 6e-23
Identities = 62/157 (39%), Positives = 79/157 (50%), Gaps = 9/157 (5%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTM 145
FR R LG G G V CQ+R YA K ++++ + RK A EK IL
Sbjct: 2 FRQYRVLGKGGFGEVCACQVR-----ATGKMYACKRLEKKRIKKRKGESMALNEKQILEK 56
Query: 146 LDHPFLPTLYAEFEASHYSCLVMEYCPGGDL--YAARQRQPGKRFGISSAKFYAAETLLA 203
++ F+ L +E CLV+ GGDL + PG F A FYAAE L
Sbjct: 57 VNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG--FEEERALFYAAEILCG 114
Query: 204 LEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240
LE LH VYRDLKPEN+L+ + GHI +SD L+ K
Sbjct: 115 LEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVK 151
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 1e-22
Identities = 56/146 (38%), Positives = 81/146 (55%), Gaps = 7/146 (4%)
Query: 92 LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFL 151
LG G G V L +R G +YAMK++ +E + + ++ E +L HPFL
Sbjct: 3 LGKGTFGKVIL--VREKASGK---YYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFL 57
Query: 152 PTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMG 211
+L F+ C VMEY GG+L+ R+ + F +FY AE + AL+YLH
Sbjct: 58 TSLKYSFQTKDRLCFVMEYVNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGK 115
Query: 212 IVYRDLKPENVLVREDGHIMLSDFDL 237
IVYRDLK EN+++ +DGHI ++DF L
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGL 141
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 2e-22
Identities = 57/157 (36%), Positives = 90/157 (57%), Gaps = 8/157 (5%)
Query: 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKL--HRADMEKVI 142
+F LL+ LG+G G V+L +R YAMKV+ + + + K H +V+
Sbjct: 1 NFELLKVLGTGAYGKVFL--VRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 58
Query: 143 LTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYA-ARQRQPGKRFGISSAKFYAAETL 201
+ PFL TL+ F+ L+++Y GG+L+ QR+ RF + Y+ E +
Sbjct: 59 EHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIV 115
Query: 202 LALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
LALE+LH +GI+YRD+K EN+L+ +GH++L+DF LS
Sbjct: 116 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 152
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 52/133 (39%), Positives = 74/133 (55%), Gaps = 12/133 (9%)
Query: 324 ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILK 383
A K+F GT EYLAPEV+ +G AVDWW LGV +YEM+ G PF +++E+ IL
Sbjct: 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 209
Query: 384 KPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRI-GSLKGSVEIKRHEFFKGINW- 441
+ + FPR +K L++ LL K+PK+R+ G + E+ H FF INW
Sbjct: 210 EEIRFPRTLSPEAKS---------LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 260
Query: 442 -ALIRSIKPPEVP 453
+ + + PP P
Sbjct: 261 DVVQKKLLPPFKP 273
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 2e-22
Identities = 58/151 (38%), Positives = 78/151 (51%), Gaps = 11/151 (7%)
Query: 92 LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFL 151
LG G G V CQ+R YA K ++++ L RK A +EK IL + F+
Sbjct: 1 LGKGGFGEVSACQMR-----ATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFI 55
Query: 152 PTLYAEFEASHYSCLVMEYCPGGDL----YAARQRQPGKRFGISSAKFYAAETLLALEYL 207
+L F+ CLVM GGDL Y + PG F A FY A+ + LE+L
Sbjct: 56 VSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPG--FPEPRACFYTAQIISGLEHL 113
Query: 208 HMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
H I+YRDLKPENVL+ DG++ +SD L+
Sbjct: 114 HQRRIIYRDLKPENVLLDNDGNVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 55/133 (41%), Positives = 76/133 (57%), Gaps = 12/133 (9%)
Query: 324 ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILK 383
A K+F GT EYLAPEV+ +G AVDWW LGV +YEM+ G PF +++EK IL
Sbjct: 151 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 210
Query: 384 KPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRI-GSLKGSVEIKRHEFFKGINWA 442
+ + FPR +K L+S LL K+PK+R+ G + EI +H+FF GI W
Sbjct: 211 EEIRFPRTLSPEAKS---------LLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQ 261
Query: 443 LI--RSIKPPEVP 453
+ + + PP P
Sbjct: 262 DVYEKKLVPPFKP 274
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 4e-22
Identities = 51/129 (39%), Positives = 74/129 (57%), Gaps = 14/129 (10%)
Query: 330 VGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFP 389
+GT +YLAPE++ G+ HG AVDWW LGV L+E L G PF E ++ NIL + + +P
Sbjct: 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600
Query: 390 RIGVSSSKEFEEVVKL--QDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIRSI 447
E EE + + Q+ I LL +P KR G LK E+K+H F G++W +++
Sbjct: 601 --------EGEEKLSVNAQNAIEILLTMDPTKRAG-LK---ELKQHPLFHGVDWENLQNQ 648
Query: 448 KPPEVPNND 456
P +P D
Sbjct: 649 TMPFIPQPD 657
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 6e-22
Identities = 57/149 (38%), Positives = 82/149 (55%), Gaps = 8/149 (5%)
Query: 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DH 148
R LG G G V L +++ YA+KV+ ++ + + EK IL++ +H
Sbjct: 1 RVLGKGSFGKVMLARLKES-----GRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNH 55
Query: 149 PFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLH 208
PFL LY F+ VME+ GGDL Q+ +RF + A+FYAAE AL +LH
Sbjct: 56 PFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLH 113
Query: 209 MMGIVYRDLKPENVLVREDGHIMLSDFDL 237
GI+YRDLK +NVL+ +GH L+DF +
Sbjct: 114 DKGIIYRDLKLDNVLLDHEGHCKLADFGM 142
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 6e-22
Identities = 56/147 (38%), Positives = 85/147 (57%), Gaps = 8/147 (5%)
Query: 92 LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEK-VILTMLDHPF 150
+G G G V L + + L YA+KV+ ++ + RK+ E+ V+L + HPF
Sbjct: 3 IGKGSFGKVLLAKRK-----LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPF 57
Query: 151 LPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMM 210
L L+ F+ + V+++ GG+L+ QR+ + F A+FYAAE AL YLH +
Sbjct: 58 LVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSI 115
Query: 211 GIVYRDLKPENVLVREDGHIMLSDFDL 237
IVYRDLKPEN+L+ GH++L+DF L
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGL 142
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 6e-22
Identities = 53/138 (38%), Positives = 75/138 (54%), Gaps = 19/138 (13%)
Query: 325 RSKSFVGTHEYLAPEVI----SGQGH-GSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLI 379
+S VGT +Y++PE++ G+G G DWW+LGV +YEMLYG TPF E+ +T
Sbjct: 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG 218
Query: 380 NIL--KKPLTFP--RIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEF 435
I+ K+ FP VS +DLI +L+ P+ R+G G + K H F
Sbjct: 219 KIMNHKEHFQFPPDVTDVSEEA--------KDLIRRLICS-PETRLGR-NGLQDFKDHPF 268
Query: 436 FKGINWALIRSIKPPEVP 453
F+GI+W IR+ P VP
Sbjct: 269 FEGIDWDNIRNSTAPYVP 286
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 2e-21
Identities = 53/146 (36%), Positives = 80/146 (54%), Gaps = 7/146 (4%)
Query: 92 LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFL 151
+G G G V + R+ Q YA+K + + + R ++ E+ +L ++ PF+
Sbjct: 1 IGKGSFGKVMQVRKRDT-----QRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFI 55
Query: 152 PTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMG 211
L F++ LV+ + GG+L+ QR+ RF +S A+FY AE L ALE LH
Sbjct: 56 VPLKFSFQSPEKLYLVLAFINGGELFHHLQRE--GRFDLSRARFYTAELLCALENLHKFN 113
Query: 212 IVYRDLKPENVLVREDGHIMLSDFDL 237
++YRDLKPEN+L+ GHI L DF L
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGL 139
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 52/142 (36%), Positives = 78/142 (54%), Gaps = 22/142 (15%)
Query: 326 SKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPF--------KGENNEKT 377
+ +F GT Y+APE++ G+ +G +VDWW LGV ++EM+ G +PF +N E
Sbjct: 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDY 212
Query: 378 LIN-ILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLK--GSVEIKRHE 434
L IL+K + PR S S VK ++ L K+PK+R+G G +IK H
Sbjct: 213 LFQVILEKQIRIPR---SLS------VKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHP 263
Query: 435 FFKGINWALI--RSIKPPEVPN 454
FF+ I+W L+ + + PP PN
Sbjct: 264 FFRNIDWDLLEQKQVLPPYKPN 285
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 2e-21
Identities = 52/147 (35%), Positives = 83/147 (56%), Gaps = 8/147 (5%)
Query: 92 LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPF 150
LG G G V L +++ ++A+K + ++ + I + +EK +L + ++PF
Sbjct: 3 LGKGSFGKVLLAELKGK-----GEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPF 57
Query: 151 LPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMM 210
L LY F+ + VME+ GGDL Q + RF + A FYAAE + L++LH
Sbjct: 58 LTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSK 115
Query: 211 GIVYRDLKPENVLVREDGHIMLSDFDL 237
GI+YRDLK +NV++ DGHI ++DF +
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGM 142
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 3e-21
Identities = 55/147 (37%), Positives = 81/147 (55%), Gaps = 8/147 (5%)
Query: 92 LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFL 151
LG G G V L ++ G +YAMK++ +E + + ++ E +L HPFL
Sbjct: 3 LGKGTFGKVIL--VKEKATGR---YYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 57
Query: 152 PTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHM-M 210
L F+ C VMEY GG+L+ R+ + F A+FY AE + AL+YLH
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEK 115
Query: 211 GIVYRDLKPENVLVREDGHIMLSDFDL 237
+VYRDLK EN+++ +DGHI ++DF L
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGL 142
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 5e-21
Identities = 47/135 (34%), Positives = 75/135 (55%), Gaps = 16/135 (11%)
Query: 327 KSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFK--GENNEKTLIN--IL 382
K GT Y+APEV+ G+ + +VDW+ LG LYEM+ G +PF+ E EK + L
Sbjct: 152 KGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL 211
Query: 383 KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSV-EIKRHEFFKGINW 441
+ + +P +F + +DL LL K+P+KR+G GS E++ H FK +NW
Sbjct: 212 EMAVEYP-------DKFSP--EAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNW 262
Query: 442 ALIRS--IKPPEVPN 454
+ + ++PP +P+
Sbjct: 263 RRLEAGMLEPPFIPD 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 5e-21
Identities = 53/137 (38%), Positives = 68/137 (49%), Gaps = 17/137 (12%)
Query: 325 RSKSFVGTHEYLAPEVISGQGH----GSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLIN 380
R + VGT +Y++PEV+ QG G DWW++GVFLYEML G TPF ++ T
Sbjct: 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK 258
Query: 381 IL--KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438
I+ K LTFP + E + +DLI L R+G G EIK H FFK
Sbjct: 259 IMDHKNSLTFP-------DDIEISKQAKDLICAFLTDRE-VRLGR-NGVDEIKSHPFFKN 309
Query: 439 --INWALIRSIKPPEVP 453
+ IR P VP
Sbjct: 310 DQWTFDNIRETVAPVVP 326
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 94.4 bits (233), Expect = 6e-21
Identities = 59/157 (37%), Positives = 83/157 (52%), Gaps = 11/157 (7%)
Query: 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILT 144
+R+LR+LG G G VYL + R A+KV+ ++ + K++ R E IL
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKL--------VALKVLAKKLESKSKEVERFLREIQILA 52
Query: 145 MLDHP-FLPTLYAEFEASHYSCLVMEYCPGGDLYA-ARQRQPGKRFGISSAKFYAAETLL 202
L+HP + LY F+ LVMEY GG L ++ S A F A+ L
Sbjct: 53 SLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILS 112
Query: 203 ALEYLHMMGIVYRDLKPENVLVREDGH-IMLSDFDLS 238
ALEYLH GI++RD+KPEN+L+ DG + L DF L+
Sbjct: 113 ALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLA 149
|
Length = 384 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 9e-21
Identities = 59/153 (38%), Positives = 76/153 (49%), Gaps = 5/153 (3%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTM 145
FR R LG G G V CQ+R YA K ++++ + RK A EK IL
Sbjct: 2 FRQYRVLGKGGFGEVCACQVR-----ATGKMYACKKLEKKRIKKRKGESMALNEKQILEK 56
Query: 146 LDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALE 205
++ F+ +L +E CLV+ GGDL F A FYAAE LE
Sbjct: 57 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLE 116
Query: 206 YLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
LH IVYRDLKPEN+L+ + GHI +SD L+
Sbjct: 117 DLHQERIVYRDLKPENILLDDHGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 1e-20
Identities = 50/157 (31%), Positives = 74/157 (47%), Gaps = 15/157 (9%)
Query: 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILT 144
F +L ++G G G VY + R+ G A+KV+ E+ ++K+ E IL
Sbjct: 1 LFEILEKIGKGGFGEVY--KARHKRTGKE---VAIKVIKLESKEKKEKIIN---EIQILK 52
Query: 145 MLDHPFLPTLYAEFEASHYSCLVMEYCPGG---DLYAARQRQPGKRFGISSAKFYAAETL 201
HP + Y + +VME+C GG DL + + S + E L
Sbjct: 53 KCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKST----NQTLTESQIAYVCKELL 108
Query: 202 LALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
LEYLH GI++RD+K N+L+ DG + L DF LS
Sbjct: 109 KGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLS 145
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 56/149 (37%), Positives = 82/149 (55%), Gaps = 8/149 (5%)
Query: 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-H 148
R +G G V L +++ YAMKVV +E + + + EK + +
Sbjct: 1 RVIGRGSYAKVLLVRLKKN-----DQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSN 55
Query: 149 PFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLH 208
PFL L++ F+ + LV+EY GGDL QRQ ++ A+FYAAE +AL +LH
Sbjct: 56 PFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLH 113
Query: 209 MMGIVYRDLKPENVLVREDGHIMLSDFDL 237
GI+YRDLK +NVL+ DGHI L+D+ +
Sbjct: 114 ERGIIYRDLKLDNVLLDADGHIKLTDYGM 142
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 56/149 (37%), Positives = 82/149 (55%), Gaps = 8/149 (5%)
Query: 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DH 148
R +G G V L +++ + YAMKVV +E + + + EK + +H
Sbjct: 1 RVIGRGSYAKVLLVRLKKT-----ERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 55
Query: 149 PFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLH 208
PFL L++ F+ V+EY GGDL QRQ ++ A+FY+AE LAL YLH
Sbjct: 56 PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLH 113
Query: 209 MMGIVYRDLKPENVLVREDGHIMLSDFDL 237
GI+YRDLK +NVL+ +GHI L+D+ +
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKLTDYGM 142
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 2e-20
Identities = 53/140 (37%), Positives = 80/140 (57%), Gaps = 16/140 (11%)
Query: 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTL 378
A+ ++ R+ + GT EY+APE++ GHG A DWWTLG+F+YE+L G PF NE L
Sbjct: 178 AKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA--NEPLL 235
Query: 379 I--NILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL-KGSVEIKRHEF 435
I IL+ + FP+ ++ K L+ KLL + KR G+L KG+ +K H +
Sbjct: 236 IYQKILEGIIYFPKFLDNNCKH---------LMKKLLSHDLTKRYGNLKKGAQNVKEHPW 286
Query: 436 FKGINWA--LIRSIKPPEVP 453
F I+W L ++++ P P
Sbjct: 287 FGNIDWVSLLHKNVEVPYKP 306
|
Length = 340 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-20
Identities = 55/151 (36%), Positives = 79/151 (52%), Gaps = 8/151 (5%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTM 145
F L LG G G V L + + YA+K++ ++ + + +EK +L +
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGT-----DELYAIKILKKDVIIQDDDVECTMVEKRVLAL 56
Query: 146 LDHP-FLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLAL 204
P FL L++ F+ VMEY GGDL Q Q GK F A FYAAE + L
Sbjct: 57 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGK-FKEPHAVFYAAEIAIGL 114
Query: 205 EYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235
+LH GI+YRDLK +NV++ +GHI ++DF
Sbjct: 115 FFLHSKGIIYRDLKLDNVMLDAEGHIKIADF 145
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 8e-20
Identities = 53/152 (34%), Positives = 80/152 (52%), Gaps = 7/152 (4%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTM 145
F ++ LG G G V C R YAMK + ++ + +R ++ E+ IL
Sbjct: 3 FVKIKTLGIGAFGEV--CLARKVDTK---ALYAMKTLRKKDVLLRNQVAHVKAERDILAE 57
Query: 146 LDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALE 205
D+ ++ LY F+ VM+Y PGGD+ + R F A+FY AE A+E
Sbjct: 58 ADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVE 115
Query: 206 YLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237
+H MG ++RD+KP+N+L+ DGHI L+DF L
Sbjct: 116 SVHKMGFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 50/139 (35%), Positives = 75/139 (53%), Gaps = 20/139 (14%)
Query: 326 SKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFK------GENNEKTLI 379
+ +F GT Y+APE++ G+ +G +VDWW LGV ++EM+ G +PF N E L
Sbjct: 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLF 212
Query: 380 N-ILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGS--LKGSVEIKRHEFF 436
IL+KP+ PR VK ++ L K+PK+R+G G +IK H FF
Sbjct: 213 QVILEKPIRIPRF---------LSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFF 263
Query: 437 KGINWALI--RSIKPPEVP 453
+ I+W L+ + + PP P
Sbjct: 264 RSIDWDLLEKKQVTPPFKP 282
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-19
Identities = 55/159 (34%), Positives = 84/159 (52%), Gaps = 19/159 (11%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTM 145
F +++ + G G VYL + +N YA+KVV + + + +H+ E+ L +
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNN-----SKLYAVKVVKKADMINKNMVHQVQAERDALAL 60
Query: 146 LDHPFLPTLYAEFEASHYSCLVMEYCPGGDL------YAARQRQPGKRFGISSAKFYAAE 199
PF+ LY ++++ LVMEY GGD+ Y F A Y +E
Sbjct: 61 SKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYG--------YFDEEMAVKYISE 112
Query: 200 TLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
LAL+YLH GI++RDLKP+N+L+ +GHI L+DF LS
Sbjct: 113 VALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 2e-19
Identities = 48/142 (33%), Positives = 76/142 (53%), Gaps = 22/142 (15%)
Query: 326 SKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFK--------GENNEKT 377
+ +F GT Y+APE++ G+ +G +VDWW LGV ++EM+ G +PF +N E
Sbjct: 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 212
Query: 378 LIN-ILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL--KGSVEIKRHE 434
L IL+K + PR VK ++ L K+PK+R+G G +I+ H
Sbjct: 213 LFQVILEKQIRIPR---------SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 263
Query: 435 FFKGINWALI--RSIKPPEVPN 454
FF+ ++W L+ + + PP PN
Sbjct: 264 FFRNVDWDLMEQKQVVPPFKPN 285
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 2e-19
Identities = 54/158 (34%), Positives = 85/158 (53%), Gaps = 12/158 (7%)
Query: 92 LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML---DH 148
+G G G VY C R G YAMK +D++ + +++ A E+++L+++ D
Sbjct: 2 IGRGGFGEVYGC--RKADTGK---MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 56
Query: 149 PFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLH 208
PF+ + F +++ GGDL+ Q G F + +FYAAE +L LE++H
Sbjct: 57 PFIVCMSYAFHTPDKLSFILDLMNGGDLHY-HLSQHGV-FSEAEMRFYAAEIILGLEHMH 114
Query: 209 MMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPK 246
+VYRDLKP N+L+ E GH+ +SD L+ CD K
Sbjct: 115 NRFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKK 150
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 55/174 (31%), Positives = 96/174 (55%), Gaps = 14/174 (8%)
Query: 71 MKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIR 130
++++R+ Q + + + +++ +G G G V L + ++ Q YAMK++ + + R
Sbjct: 32 VRKIRKLQMKA--EDYDVVKVIGRGAFGEVQLVRHKSS-----QKVYAMKLLSKFEMIKR 84
Query: 131 KKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDL--YAARQRQPGKRF 188
E+ I+ + P++ L+ F+ Y +VMEY PGGDL + P K
Sbjct: 85 SDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKW- 143
Query: 189 GISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242
AKFY AE +LAL+ +H MG+++RD+KP+N+L+ + GH+ L+DF K D
Sbjct: 144 ----AKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 2e-19
Identities = 60/155 (38%), Positives = 78/155 (50%), Gaps = 9/155 (5%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTM 145
FR R LG G G V CQ+R YA K ++++ + RK A EK IL
Sbjct: 2 FRHYRVLGKGGFGEVCACQVR-----ATGKMYACKKLEKKRIKKRKGEAMALNEKRILEK 56
Query: 146 LDHPFLPTLYAEFEASHYSCLVMEYCPGGDL--YAARQRQPGKRFGISSAKFYAAETLLA 203
++ F+ +L +E CLV+ GGDL + PG F A FYAAE
Sbjct: 57 VNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG--FDEQRAIFYAAELCCG 114
Query: 204 LEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
LE L IVYRDLKPEN+L+ + GHI +SD L+
Sbjct: 115 LEDLQRERIVYRDLKPENILLDDRGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 5e-19
Identities = 50/152 (32%), Positives = 85/152 (55%), Gaps = 6/152 (3%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
D F +L+ +G G G V + +++N YAMK++++ + R + E+ +L
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNT-----GQVYAMKILNKWEMLKRAETACFREERDVL 55
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLA 203
D ++ L+ F+ + LVM+Y GGDL + R A+FY AE +LA
Sbjct: 56 VNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLA 114
Query: 204 LEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235
++ +H +G V+RD+KP+NVL+ ++GHI L+DF
Sbjct: 115 IDSVHQLGYVHRDIKPDNVLLDKNGHIRLADF 146
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 52/173 (30%), Positives = 91/173 (52%), Gaps = 22/173 (12%)
Query: 77 AQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRA 136
+ R+ + F +++ +G G G V L + ++ + YAMK++ + + + R+
Sbjct: 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSS-----KQVYAMKLLSKFEM-----IKRS 85
Query: 137 DM-----EKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGIS 191
D E+ I+ + ++ L+ F+ Y +VMEY PGGDL + I
Sbjct: 86 DSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN-----YDIP 140
Query: 192 S--AKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242
A+FY AE +LAL+ +H MG ++RD+KP+N+L+ + GH+ L+DF K D
Sbjct: 141 EKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 51/137 (37%), Positives = 80/137 (58%), Gaps = 15/137 (10%)
Query: 325 RSKSFVGTHEYLAPEVIS----GQG-HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLI 379
+S VGT +Y++PE++ G G +G DWW+LGV +YEMLYG TPF E+ +T
Sbjct: 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG 218
Query: 380 NIL--KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437
I+ ++ FP S + E K DLI +L+ ++R+G G + K+H FF+
Sbjct: 219 KIMNHEERFQFP----SHITDVSEEAK--DLIQRLICSR-ERRLGQ-NGIEDFKKHAFFE 270
Query: 438 GINWALIRSIKPPEVPN 454
GI+W IR+++ P +P+
Sbjct: 271 GIDWENIRNLEAPYIPD 287
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 3e-18
Identities = 39/112 (34%), Positives = 57/112 (50%), Gaps = 14/112 (12%)
Query: 328 SFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKT---LINILKK 384
S GT Y+APEV+ QG+ AVDWW+LGV YE L G P++G +
Sbjct: 158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETA 217
Query: 385 PLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436
+ +P + S E D I+KLL ++P+KR+G ++K H +F
Sbjct: 218 DVLYP---ATWSTE------AIDAINKLLERDPQKRLGD--NLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-18
Identities = 56/153 (36%), Positives = 81/153 (52%), Gaps = 8/153 (5%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTM 145
F L LG G G V L + + YA+K++ ++ + + +EK +L +
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGT-----DELYAIKILKKDVVIQDDDVECTMVEKRVLAL 56
Query: 146 LDHP-FLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLAL 204
D P FL L++ F+ VMEY GGDL Q Q GK F A FYAAE + L
Sbjct: 57 QDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQ-QVGK-FKEPQAVFYAAEISVGL 114
Query: 205 EYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237
+LH GI+YRDLK +NV++ +GHI ++DF +
Sbjct: 115 FFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGM 147
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-18
Identities = 51/163 (31%), Positives = 88/163 (53%), Gaps = 12/163 (7%)
Query: 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADME 139
R+ + + +++ +G G G V L + ++ + YAMK++ + + R E
Sbjct: 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKST-----RKVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 140 KVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDL--YAARQRQPGKRFGISSAKFYA 197
+ I+ + P++ L+ F+ Y +VMEY PGGDL + P K A+FY
Sbjct: 94 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW-----ARFYT 148
Query: 198 AETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240
AE +LAL+ +H MG ++RD+KP+N+L+ + GH+ L+DF K
Sbjct: 149 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 52/158 (32%), Positives = 83/158 (52%), Gaps = 12/158 (7%)
Query: 92 LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML---DH 148
+G G G VY C R G YAMK +D++ + +++ A E+++L+++ D
Sbjct: 2 IGRGGFGEVYGC--RKADTGK---MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 56
Query: 149 PFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLH 208
PF+ + F C +++ GGDL+ + F +FYA E +L LE++H
Sbjct: 57 PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMH 114
Query: 209 MMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPK 246
+VYRDLKP N+L+ E GH+ +SD L+ CD K
Sbjct: 115 NRFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKK 150
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 4e-18
Identities = 51/147 (34%), Positives = 74/147 (50%), Gaps = 5/147 (3%)
Query: 92 LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFL 151
LG G G V Q++N YA K +D++ L + A +EK IL ++ PF+
Sbjct: 1 LGKGGFGEVCAVQVKNT-----GKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFI 55
Query: 152 PTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMG 211
L FE+ + CLVM GGDL + + Y+A+ + +LH M
Sbjct: 56 VNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD 115
Query: 212 IVYRDLKPENVLVREDGHIMLSDFDLS 238
IVYRD+KPENVL+ + G+ LSD L+
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLA 142
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 6e-18
Identities = 42/142 (29%), Positives = 72/142 (50%), Gaps = 20/142 (14%)
Query: 320 EPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENN----E 375
E I R VGT Y+APEV+ + + + DWW LG +YEM+ G +PF+ E
Sbjct: 156 ETIRGR----VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKRE 211
Query: 376 KTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIG-SLKGSVEIKRHE 434
+ + + + S++F E + + +LL K+P R+G +G+ E+K H
Sbjct: 212 EVERRVKEDQEEY-------SEKFSEAAR--SICRQLLTKDPGFRLGCRGEGAEEVKAHP 262
Query: 435 FFKGINWALIRS--IKPPEVPN 454
FF+ N+ + + ++PP P+
Sbjct: 263 FFRTANFKRLEAGMLEPPFCPD 284
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 1e-17
Identities = 44/128 (34%), Positives = 73/128 (57%), Gaps = 8/128 (6%)
Query: 330 VGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFP 389
VGT Y+APEV++ Q + + D+W LG +YEM+ G +PF+G + + ++ L
Sbjct: 162 VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE 221
Query: 390 RIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLK-GSVEIKRHEFFKGINWALIRS-- 446
S +F E K + LL K+PK+R+G + G+ E+KRH FF+ +N+ + +
Sbjct: 222 E---VYSAKFSEEAK--SICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGM 276
Query: 447 IKPPEVPN 454
+ PP VP+
Sbjct: 277 LDPPFVPD 284
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 50/157 (31%), Positives = 86/157 (54%), Gaps = 6/157 (3%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
D F +++ +G G G V + ++++ + YAMK++++ + R + E+ +L
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHT-----ERIYAMKILNKWEMLKRAETACFREERNVL 55
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLA 203
D ++ TL+ F+ +Y LVM+Y GGDL + R A+FY AE +LA
Sbjct: 56 VNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLA 114
Query: 204 LEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240
+ +H + V+RD+KP+NVL+ +GHI L+DF K
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLK 151
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 1e-17
Identities = 43/155 (27%), Positives = 63/155 (40%), Gaps = 8/155 (5%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTM 145
L ++LG G G VY + A+K + A + R + + M
Sbjct: 1 LELGKKLGEGAFGEVYKG-TLKGDGEGTETKVAVKTLKEGA----SEEEREEFLEEASIM 55
Query: 146 --LDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLA 203
L HP + L +V EY PGGDL R+ G++ + A +
Sbjct: 56 KKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLL-DFLRKHGEKLTLKDLLQMALQIAKG 114
Query: 204 LEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+EYL V+RDL N LV E+ + +SDF LS
Sbjct: 115 MEYLESKNFVHRDLAARNCLVTENLVVKISDFGLS 149
|
Length = 258 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-17
Identities = 45/137 (32%), Positives = 75/137 (54%), Gaps = 16/137 (11%)
Query: 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPF--KGENNEKTLIN-- 380
++K + GT ++APE++ G+ + +VD++ LGV LYEM+ PF +GE E +
Sbjct: 153 KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR 212
Query: 381 ILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSV-EIKRHEFFKGI 439
IL +T+P +SK F E LL K+P+KR+G G+ ++ H F+ +
Sbjct: 213 ILNDSVTYPDKFSPASKSFCE---------ALLAKDPEKRLGFRDGNCDGLRTHPLFRDL 263
Query: 440 NWALIRS--IKPPEVPN 454
NW + + + PP VP+
Sbjct: 264 NWRQLEAGMLPPPFVPD 280
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (200), Expect = 4e-17
Identities = 35/94 (37%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 327 KSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL 386
K+ VGT YL+PE+ + + D W+LG LYE+ PF+GEN + + ILK
Sbjct: 161 KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKG-- 218
Query: 387 TFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKR 420
+P I S E L++L+S LL K+P++R
Sbjct: 219 QYPPIPSQYSSE------LRNLVSSLLQKDPEER 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 55/153 (35%), Positives = 81/153 (52%), Gaps = 8/153 (5%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTM 145
F L LG G G V L + + G + YA+K++ ++ + + +EK +L +
Sbjct: 2 FNFLMVLGKGSFGKVMLAERK----GTDE-LYAIKILKKDVVIQDDDVECTMVEKRVLAL 56
Query: 146 LDHP-FLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLAL 204
P FL L++ F+ VMEY GGDL Q Q RF A FYAAE + L
Sbjct: 57 SGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYQIQQVGRFKEPHAVFYAAEIAIGL 114
Query: 205 EYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237
+LH GI+YRDLK +NV++ +GHI ++DF +
Sbjct: 115 FFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGM 147
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 51/136 (37%), Positives = 77/136 (56%), Gaps = 15/136 (11%)
Query: 325 RSKSFVGTHEYLAPEVIS----GQG-HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLI 379
+S VGT +Y++PE++ G+G +G DWW+LGV +YEMLYG TPF E+ +T
Sbjct: 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG 218
Query: 380 NIL--KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437
I+ K+ FP + + E K DLI +L+ + R+G G + K+H FF
Sbjct: 219 KIMNHKERFQFP----AQVTDVSEDAK--DLIRRLICSR-EHRLGQ-NGIEDFKQHPFFT 270
Query: 438 GINWALIRSIKPPEVP 453
GI+W IR+ + P +P
Sbjct: 271 GIDWDNIRNCEAPYIP 286
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 5e-17
Identities = 45/153 (29%), Positives = 69/153 (45%), Gaps = 5/153 (3%)
Query: 87 RLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAI-RKKLHRADMEKVILTM 145
L ++LG G G VY ++ + A+K + +A ++ R E I+
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGK-GDGKEVEVAVKTLKEDASEQQIEEFLR---EARIMRK 57
Query: 146 LDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALE 205
LDHP + L +VMEY PGGDL ++ K +S +A + +E
Sbjct: 58 LDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGME 117
Query: 206 YLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
YL ++RDL N LV E+ + +SDF LS
Sbjct: 118 YLESKNFIHRDLAARNCLVGENLVVKISDFGLS 150
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 7e-17
Identities = 40/159 (25%), Positives = 69/159 (43%), Gaps = 16/159 (10%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMK---VVDREALAIRKKLHRADMEK 140
++ LG G G VY + + YA+K V E RK+L +++
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHK-----PTGKIYALKKIHVDGDEE--FRKQL-LRELKT 52
Query: 141 VILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAET 200
+ + P++ Y F +V+EY GG L ++ + A +
Sbjct: 53 LRSC--ESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGK--IPEPVLAYIARQI 108
Query: 201 LLALEYLH-MMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
L L+YLH I++RD+KP N+L+ G + ++DF +S
Sbjct: 109 LKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGIS 147
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 8e-17
Identities = 54/138 (39%), Positives = 73/138 (52%), Gaps = 17/138 (12%)
Query: 325 RSKSFVGTHEYLAPEVISGQG----HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLIN 380
R + VGT +Y++PEV+ QG +G DWW++GVFLYEML G TPF ++ T
Sbjct: 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK 258
Query: 381 IL--KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438
I+ K LTFP S + ++LI L + + R+G G EIKRH FFK
Sbjct: 259 IMNHKNSLTFPDDNDISKEA-------KNLICAFLT-DREVRLGR-NGVEEIKRHLFFKN 309
Query: 439 INWAL--IRSIKPPEVPN 454
WA +R P VP+
Sbjct: 310 DQWAWETLRDTVAPVVPD 327
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 1e-16
Identities = 44/135 (32%), Positives = 72/135 (53%), Gaps = 24/135 (17%)
Query: 331 GTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPR 390
GT+ Y+APE++ + + VDW+ +G +YEM+ G TPFK ++ EK LK+
Sbjct: 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFK-DHKEKVAKEELKR------ 208
Query: 391 IGVSSSKEFEEVVKLQ---------DLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINW 441
+ E+ VK + D+ L K P+ R+GS + + + ++HEFFK IN+
Sbjct: 209 ------RTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINF 262
Query: 442 ALIRS--IKPPEVPN 454
+ + I PP VP+
Sbjct: 263 PRLEAGLIPPPFVPD 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 4e-16
Identities = 47/157 (29%), Positives = 86/157 (54%), Gaps = 6/157 (3%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
+ F +L+ +G G G V + +++N +AMK++++ + R + E+ +L
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNA-----DKVFAMKILNKWEMLKRAETACFREERDVL 55
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLA 203
D+ ++ TL+ F+ + LVM+Y GGDL + R A+FY AE ++A
Sbjct: 56 VNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIA 114
Query: 204 LEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240
++ +H + V+RD+KP+N+L+ +GHI L+DF K
Sbjct: 115 IDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLK 151
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 5e-16
Identities = 45/155 (29%), Positives = 70/155 (45%), Gaps = 10/155 (6%)
Query: 87 RLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAI-RKKLHRADMEKVILTM 145
L ++LG G G VY +++ G + A+K + +A ++ R E I+
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGK-GGKKKVEVAVKTLKEDASEQQIEEFLR---EARIMRK 57
Query: 146 LDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQ--RQPGKRFGISSAKFYAAETLLA 203
LDHP + L +VMEY GGDL R+ + +S +A +
Sbjct: 58 LDHPNVVKLLGVCTEEEPLYIVMEYMEGGDL---LSYLRKNRPKLSLSDLLSFALQIARG 114
Query: 204 LEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+EYL ++RDL N LV E+ + +SDF LS
Sbjct: 115 MEYLESKNFIHRDLAARNCLVGENLVVKISDFGLS 149
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 7e-16
Identities = 50/153 (32%), Positives = 83/153 (54%), Gaps = 10/153 (6%)
Query: 305 DHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVIS-GQGHGSAVDWWTLGVFLYEML 363
D H + D + + + + VGTH Y+APEV+ G + S+ DW++LG L+++L
Sbjct: 131 DEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLL 190
Query: 364 YGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGS 423
G +PF+ ++ K I + LT + V F +L+ L+ LL ++ KR+G
Sbjct: 191 RGHSPFR-QHKTKDKHEIDRMTLT---VNVELPDSFSP--ELKSLLEGLLQRDVSKRLGC 244
Query: 424 L-KGSVEIKRHEFFKGINW--ALIRSIKPPEVP 453
L +G+ E+K H FFKGI+W ++ PP +P
Sbjct: 245 LGRGAQEVKEHVFFKGIDWQQVYLQKYPPPLIP 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 45/152 (29%), Positives = 63/152 (41%), Gaps = 16/152 (10%)
Query: 88 LLRRLGSGDIGNVYLCQIRNPMVGLPQ-CFYAMKVV--DREALAIRKKLHRADMEKVILT 144
++G G G VY V L A+K + K++ E +L
Sbjct: 4 RGNKIGGGTFGKVYTA------VNLDTGELMAVKEIRIQDNDPKTIKEIAD---EMKVLE 54
Query: 145 MLDHPFLPTLYA-EFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLA 203
+L HP L Y E + MEYC GG L + G+ + Y + L
Sbjct: 55 LLKHPNLVKYYGVEVHREKV-YIFMEYCSGGTL--EELLEHGRILDEHVIRVYTLQLLEG 111
Query: 204 LEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235
L YLH GIV+RD+KP N+ + +G I L DF
Sbjct: 112 LAYLHSHGIVHRDIKPANIFLDHNGVIKLGDF 143
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 41/163 (25%), Positives = 71/163 (43%), Gaps = 18/163 (11%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
H + +++LG G G V LC+ A+K ++ ++ HR+D E+ I
Sbjct: 4 RHLKFIKQLGEGHFGKVELCRYDPLGDN-TGEQVAVKSLNHSG----EEQHRSDFEREIE 58
Query: 144 TM--LDHPFLPTL----YAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKF-- 195
+ LDH + S L+MEY P G L R R I+ +
Sbjct: 59 ILRTLDHENIVKYKGVCEKPGGRSL--RLIMEYLPSGSL---RDYLQRHRDQINLKRLLL 113
Query: 196 YAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
++++ ++YL ++RDL N+LV + + +SDF L+
Sbjct: 114 FSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 77.5 bits (189), Expect = 2e-15
Identities = 47/153 (30%), Positives = 69/153 (45%), Gaps = 8/153 (5%)
Query: 321 PINARSKSFVGTHEYLAPEVISGQGH---GSAVDWWTLGVFLYEMLYGTTPFKGENN--- 374
I A + VGT Y+APEV+ G S+ D W+LG+ LYE+L G PF+GE N
Sbjct: 160 SIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSA 219
Query: 375 -EKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGS-LKGSVEIKR 432
+TL IL+ P +S S DL+ KLL K+PK R+ S S ++
Sbjct: 220 TSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279
Query: 433 HEFFKGINWALIRSIKPPEVPNNDLYCKIKKKV 465
H K + + + L ++ +
Sbjct: 280 HLKLKESDLSDLLKPDDSAPLRLSLPPSLEALI 312
|
Length = 384 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 2e-15
Identities = 40/130 (30%), Positives = 72/130 (55%), Gaps = 14/130 (10%)
Query: 330 VGTHEYLAPEVIS-GQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTF 388
VGTH Y+APEV+ G + S+ DW++LG L+++L G +PF+ K
Sbjct: 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT--------KDKHEI 207
Query: 389 PRIGVSSSKEF--EEVVKLQDLISKLLVKNPKKRIGSL-KGSVEIKRHEFFKGINWALI- 444
R+ ++ + E +L+ L+ LL ++ +R+G L +G+ E+K H FF+ ++W ++
Sbjct: 208 DRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVF 267
Query: 445 -RSIKPPEVP 453
+ PP +P
Sbjct: 268 LQKYPPPLIP 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 52/137 (37%), Positives = 72/137 (52%), Gaps = 17/137 (12%)
Query: 325 RSKSFVGTHEYLAPEVISGQG----HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLIN 380
R + VGT +Y++PEV+ QG +G DWW++GVFL+EML G TPF ++ T
Sbjct: 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSK 258
Query: 381 IL--KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438
I+ K L FP ++ E ++LI L + + R+G G EIK+H FFK
Sbjct: 259 IMDHKNSLNFP-------EDVEISKHAKNLICAFLT-DREVRLGR-NGVEEIKQHPFFKN 309
Query: 439 --INWALIRSIKPPEVP 453
NW IR P VP
Sbjct: 310 DQWNWDNIRETAAPVVP 326
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 46/140 (32%), Positives = 75/140 (53%), Gaps = 14/140 (10%)
Query: 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLIN 380
P + VGT Y+APEVI+ + + + DWW LG +YEM+ G +PF+ + E+
Sbjct: 153 PEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFR-KRKER---- 207
Query: 381 ILKKPLTFPRIGVSS---SKEFEEVVKLQDLISKLLVKNPKKRIGSL-KGSVEIKRHEFF 436
+K+ R+ S++F E K + LL KNPK+R+G G+ +K+H F
Sbjct: 208 -VKREEVDRRVKEDQEEYSEKFSEDAK--SICRMLLTKNPKERLGCRGNGAAGVKQHPIF 264
Query: 437 KGINWALIRS--IKPPEVPN 454
K IN+ + + ++PP P+
Sbjct: 265 KNINFKRLEANMLEPPFCPD 284
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 2e-15
Identities = 49/155 (31%), Positives = 80/155 (51%), Gaps = 8/155 (5%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTM 145
F++L++LG G G+VY + R FYA+K VD +++ +K+ A E IL
Sbjct: 2 FKVLKKLGKGSYGSVYKVK-RLS----DNQFYALKEVDLGSMS-QKEREDAVNEIRILAS 55
Query: 146 LDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKF--YAAETLLA 203
++HP + + F + C+VMEY P GDL A ++ KR I + + L
Sbjct: 56 VNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115
Query: 204 LEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
L+ LH I++RDLK N+L+ + + + D +S
Sbjct: 116 LQALHEQKILHRDLKSANILLVANDLVKIGDLGIS 150
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 4e-15
Identities = 33/110 (30%), Positives = 50/110 (45%), Gaps = 10/110 (9%)
Query: 326 SKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP 385
+ VGT ++APEVI+G+ + D W+LG+ E+ G P+ K L I
Sbjct: 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNG 213
Query: 386 LTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEF 435
R S EF +D + K L KNP+KR + ++ +H F
Sbjct: 214 PPGLRNPEKWSDEF------KDFLKKCLQKNPEKRPTAE----QLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 4e-15
Identities = 47/164 (28%), Positives = 75/164 (45%), Gaps = 24/164 (14%)
Query: 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKV--- 141
+++L +G G G VY + N G F A+K + E K+ ++ +
Sbjct: 1 NYQLGDLIGRGAFGVVY--KGLNLETGD---FVAIKQISLE------KIKEEALKSIMQE 49
Query: 142 --ILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGI---SSAKFY 196
+L L HP + E S +++EY G L RQ K+FG S Y
Sbjct: 50 IDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSL-----RQIIKKFGPFPESLVAVY 104
Query: 197 AAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240
+ L L YLH G+++RD+K N+L +DG + L+DF ++ K
Sbjct: 105 VYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATK 148
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 5e-15
Identities = 47/160 (29%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVD-REALAIRKKLHRADMEKVI 142
+ L RLG G G+V C+++N +A+K + ++K++ R E I
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNT-----GMIFALKTITTDPNPDLQKQILR---ELEI 52
Query: 143 LTMLDHPFLPTLYAEFEASHYSCL--VMEYCPGGDLYA--ARQRQPGKRFGISSAKFYAA 198
P++ Y F S + MEYC GG L + + ++ G R G A
Sbjct: 53 NKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAE 112
Query: 199 ETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
L L YLH I++RD+KP N+L+ G + L DF +S
Sbjct: 113 SVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVS 152
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 7e-15
Identities = 48/159 (30%), Positives = 77/159 (48%), Gaps = 15/159 (9%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVI 142
+ + L++R+GSG G+VY + R+ G +K+ + I ++ E +
Sbjct: 2 QEDYELIQRIGSGTYGDVY--KARDIATGELVAIKVIKLEPGDDFEIIQQ------EISM 53
Query: 143 LTMLDHPFLPTLYAEFEASHYSCLVMEYCPGG---DLYAARQRQPGKRFGISSAKFYAAE 199
L HP + + + +VMEYC GG D+Y R P I+ + E
Sbjct: 54 LKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQ-VTRGPLSELQIA---YVCRE 109
Query: 200 TLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
TL L YLH G ++RD+K N+L+ EDG + L+DF +S
Sbjct: 110 TLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 8e-15
Identities = 46/178 (25%), Positives = 89/178 (50%), Gaps = 17/178 (9%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTM 145
+ +++++G G G +YL + + C +K +D + +++K + E ++L
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAK---SDSEHC--VIKEIDLTKMPVKEK-EASKKEVILLAK 55
Query: 146 LDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALE 205
+ HP + T +A F+ + +VMEYC GGDL RQ G F + + L L+
Sbjct: 56 MKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK 115
Query: 206 YLHMMGIVYRDLKPENVLVREDGHIM-LSDF----------DLSFKCDVVPKLLRPKL 252
++H I++RD+K +N+ + ++G + L DF +L++ C P L P++
Sbjct: 116 HIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEI 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 46/160 (28%), Positives = 68/160 (42%), Gaps = 16/160 (10%)
Query: 84 DHFRLLRRLGSGDIGNVY--LCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKV 141
D + L+ +G G VY +C N V A+K +D E ++ K
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKV-------AIKRIDLEKCQTSVD----ELRKE 49
Query: 142 ILTM--LDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYA-ARQRQPGKRFGISSAKFYAA 198
+ M +HP + Y F LVM Y GG L + P +
Sbjct: 50 VQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLK 109
Query: 199 ETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
E L LEYLH G ++RD+K N+L+ EDG + ++DF +S
Sbjct: 110 EVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVS 149
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 22/160 (13%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKL----HRADMEKV 141
+++L R+G G G V+ + R + V + +A+R+ ++A E
Sbjct: 2 YKILGRIGEGAHGIVFKAKDRE----------TGETVALKKVALRRLEGGIPNQALREIK 51
Query: 142 ILTMLDHPFLPTLYAEF-EASHYSCLVMEYCPGGDLYAA--RQRQPGKRFGISSAKFYAA 198
L HP++ L F S + LVMEY P DL + +P + K Y
Sbjct: 52 ALQACQHPYVVKLLDVFPHGSGFV-LVMEYMPS-DLSEVLRDEERP---LPEAQVKSYMR 106
Query: 199 ETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
L + Y+H GI++RDLKP N+L+ DG + ++DF L+
Sbjct: 107 MLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLA 146
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 6e-14
Identities = 48/167 (28%), Positives = 72/167 (43%), Gaps = 36/167 (21%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEK----- 140
+ + ++G G G VY A E +A+ KK+ R + EK
Sbjct: 1 YEKIAQIGEGTYGQVY---------------KARNKKTGELVAL-KKI-RMENEKEGFPI 43
Query: 141 ------VILTMLDHPFLPTLY----AEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGI 190
+L L HP + L ++ + S Y +V EY DL P +F
Sbjct: 44 TAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIY--MVFEYMDH-DL-TGLLDSPEVKFTE 99
Query: 191 SSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237
S K Y + L L+YLH GI++RD+K N+L+ DG + L+DF L
Sbjct: 100 SQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGL 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 8e-14
Identities = 54/174 (31%), Positives = 81/174 (46%), Gaps = 34/174 (19%)
Query: 304 GDHHDQELLDDPEVVAEPINAR--------------------SKSFVGTHEYLAPEVISG 343
GDH Q+ +D +P N R + S VGT Y+APEV+
Sbjct: 163 GDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR 222
Query: 344 QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTF---PRIGVSSSKEFE 400
G+ DWW++GV LYEML G PF + +T + ++ + P+ +S
Sbjct: 223 TGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSP----- 277
Query: 401 EVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWAL-IRSIKPPEVP 453
+ DLI K L + P+ R+G G+ EIK H FFK I+++ +R P +P
Sbjct: 278 ---EASDLIIK-LCRGPEDRLGK-NGADEIKAHPFFKTIDFSSDLRQQSAPYIP 326
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 8e-14
Identities = 47/160 (29%), Positives = 70/160 (43%), Gaps = 21/160 (13%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVV--DREALAIRKKLHRADMEKVIL 143
F +L +LG G G+VY + G A+KVV + + I K E IL
Sbjct: 5 FDILEKLGEGSYGSVYKA--IHKETGQV---VAIKVVPVEEDLQEIIK-------EISIL 52
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGG---DLYAARQRQPGKRFGISSAKFYAAET 200
D P++ Y + + +VMEYC G D+ K +T
Sbjct: 53 KQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITN----KTLTEEEIAAILYQT 108
Query: 201 LLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240
L LEYLH ++RD+K N+L+ E+G L+DF +S +
Sbjct: 109 LKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQ 148
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 9e-14
Identities = 48/157 (30%), Positives = 66/157 (42%), Gaps = 11/157 (7%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREA-LAIRKKLHRADMEKVI 142
D L LG+G+ G V R A+K + E AI+K++ E I
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPT-----GKIMAVKTIRLEINEAIQKQIL---RELDI 52
Query: 143 LTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLL 202
L + P++ Y F + + MEY GG L + G R A L
Sbjct: 53 LHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQG-RIPERILGKIAVAVLK 111
Query: 203 ALEYLH-MMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
L YLH I++RD+KP N+LV G I L DF +S
Sbjct: 112 GLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVS 148
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (175), Expect = 9e-14
Identities = 35/111 (31%), Positives = 53/111 (47%), Gaps = 16/111 (14%)
Query: 331 GTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNE----KTLINILKKPL 386
GT +Y +PE I G + + DWW +GV YE+L G PFK + +E ++L+ +K L
Sbjct: 168 GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKL 227
Query: 387 TFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437
F + VS D + +L N R+ + EI +H F K
Sbjct: 228 PFIKN-VSK--------NANDFVQSMLKYNINYRLTNYN---EIIKHPFLK 266
|
Length = 267 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 49/153 (32%), Positives = 74/153 (48%), Gaps = 8/153 (5%)
Query: 305 DHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY 364
DH + D V P K VGT Y+APEV+ + + + DWW LG LYEM+
Sbjct: 137 DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA 196
Query: 365 GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424
G +PF+ K I + + S++F + L LL K+PK+R+G
Sbjct: 197 GQSPFQ---QRKKKIKREEVERLVKEVQEEYSEKFSP--DARSLCKMLLCKDPKERLGCQ 251
Query: 425 -KGSVEIKRHEFFKGINWALIRS--IKPPEVPN 454
G+ E+K H FK IN+ + + ++PP P+
Sbjct: 252 GGGAREVKEHPLFKQINFKRLEAGMLEPPFKPD 284
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 44/161 (27%), Positives = 77/161 (47%), Gaps = 23/161 (14%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNP--MVGLPQCFYAMKVVDREALAIRKKLHRAD--ME-- 139
++++++LG G G+VYL + + +V A+K ++KK + + M
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELV-------AIKK-------MKKKFYSWEECMNLR 46
Query: 140 --KVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYA 197
K + + +HP + L F + V EY G +LY + + GK F S +
Sbjct: 47 EVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSII 105
Query: 198 AETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ L L ++H G +RDLKPEN+LV + ++DF L+
Sbjct: 106 YQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLA 146
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 45/170 (26%), Positives = 75/170 (44%), Gaps = 15/170 (8%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTM 145
F +L ++G G G V+ ++ YAMK +D + R++ D E +L
Sbjct: 2 FEILNKIGKGSFGVVF--KVVRKADKR---VYAMKQIDLSKMNRREREEAID-EARVLAK 55
Query: 146 LDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSA-KFYAAETLLAL 204
LD ++ Y F +VMEY GDL+ + Q G+ +F+ + LL L
Sbjct: 56 LDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFF-IQILLGL 114
Query: 205 EYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSF 254
+LH I++RD+K N+ + ++ + D V KLL +F
Sbjct: 115 AHLHSKKILHRDIKSLNLFLDAYDNVKIGDLG-------VAKLLSDNTNF 157
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 50/154 (32%), Positives = 71/154 (46%), Gaps = 6/154 (3%)
Query: 92 LGSGDIGNVYLCQIRN--PMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHP 149
+G G G VYL M+ + Q + R + + E L LDH
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 150 FLPTLYAEFEASH-YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLH 208
+ Y FE + Y + +EY PGG + + R G RF +F+ + L L YLH
Sbjct: 69 NIVQ-YLGFETTEEYLSIFLEYVPGGSI-GSCLRTYG-RFEEQLVRFFTEQVLEGLAYLH 125
Query: 209 MMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242
GI++RDLK +N+LV DG +SDF +S K D
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKKSD 159
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 3e-13
Identities = 51/158 (32%), Positives = 75/158 (47%), Gaps = 20/158 (12%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVI--L 143
F LL +G G G VY + A+KV+D E + D+++ I L
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRT-----NQVVAIKVIDLEE----AEDEIEDIQQEIQFL 53
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGG---DLYAARQRQPGKRFGISSAKFYAAET 200
+ P++ Y F ++MEYC GG DL +PGK + F E
Sbjct: 54 SQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-----KPGK-LDETYIAFILREV 107
Query: 201 LLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
LL LEYLH G ++RD+K N+L+ E+G + L+DF +S
Sbjct: 108 LLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVS 145
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 4e-13
Identities = 43/157 (27%), Positives = 74/157 (47%), Gaps = 21/157 (13%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNP-------MVGLPQCFYAMKVVDREALAIRKKLHRADM 138
+ +LR +G G G L Q N + LP+ A++ +EA
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEA------------ 49
Query: 139 EKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAA 198
V+L + HP + FEA + +VMEYC GGDL + Q GK F + +
Sbjct: 50 --VLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV 107
Query: 199 ETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235
+ L ++++H +++RD+K +N+ + ++G + L DF
Sbjct: 108 QMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDF 144
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (168), Expect = 6e-13
Identities = 45/161 (27%), Positives = 67/161 (41%), Gaps = 13/161 (8%)
Query: 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAI-RKKLHRADMEKVILTMLDH 148
++LG G G VY +++ + A+K + +A RK + E ++ L H
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEV--AVKTLKEDASEEERKDFLK---EARVMKKLGH 55
Query: 149 PFLPTLYAEFEASHYSCLVMEYCPGGDL--YAARQRQPGKRFG---ISSAKF--YAAETL 201
P + L LV+EY GGDL Y + R +S +A +
Sbjct: 56 PNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115
Query: 202 LALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242
+EYL V+RDL N LV ED + +SDF LS
Sbjct: 116 KGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 43/157 (27%), Positives = 77/157 (49%), Gaps = 9/157 (5%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
D + ++ LG G G VY Q + + F A K++ E+ ++L +E IL
Sbjct: 5 DIWEIIGELGDGAFGKVYKAQHKETGL-----FAAAKIIQIES---EEELEDFMVEIDIL 56
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLA 203
+ HP + LY + + +++E+C GG L + + + ++ + L A
Sbjct: 57 SECKHPNIVGLYEAYFYENKLWILIEFCDGGAL-DSIMLELERGLTEPQIRYVCRQMLEA 115
Query: 204 LEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240
L +LH +++RDLK N+L+ DG + L+DF +S K
Sbjct: 116 LNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAK 152
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 2e-12
Identities = 38/111 (34%), Positives = 56/111 (50%), Gaps = 10/111 (9%)
Query: 327 KSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL 386
S VGT ++APEVI + +G VD W+LG+ EM G P+ E + L I K +
Sbjct: 174 NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI 233
Query: 387 TFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437
+ S EF +D ++K LVK+P+KR + E+ +H F K
Sbjct: 234 PPLKNPEKWSPEF------KDFLNKCLVKDPEKR----PSAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 3e-12
Identities = 45/163 (27%), Positives = 76/163 (46%), Gaps = 26/163 (15%)
Query: 88 LLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLH----------RAD 137
L +RLG G G VYL + + K V E L + K++ +A+
Sbjct: 4 LQQRLGKGSFGTVYLVKDK-------------KAVAEERLKVLKEIPVGELNPNETVQAN 50
Query: 138 MEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQ--RQPGKRFGISSAKF 195
E +L+ LDHP + +A F C++ EYC G DL + + GK +
Sbjct: 51 QEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCE 110
Query: 196 YAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ + LL + Y+H I++RDLK +N+ ++ + + + DF +S
Sbjct: 111 WFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN-LLKIGDFGVS 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 36/100 (36%), Positives = 54/100 (54%)
Query: 139 EKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAA 198
E VIL++L HP + Y F + + MEY GG LY RQ G+ F +Y
Sbjct: 49 EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLF 108
Query: 199 ETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ + A+ Y+H GI++RD+K N+ + + G I L DF +S
Sbjct: 109 QIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGIS 148
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 3e-12
Identities = 50/171 (29%), Positives = 75/171 (43%), Gaps = 32/171 (18%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
F L+ +G G G VY + R+ G A+K++D D E+ I
Sbjct: 6 GIFELVEVIGEGTYGKVY--KARHKKTGQ---LVAIKIMD----------IIEDEEEEIK 50
Query: 144 T---ML----DHPFLPTLYAEFEASHYSC------LVMEYCPGG---DLYAARQRQPGKR 187
+L +HP + T Y F + LVME C GG DL R+ GKR
Sbjct: 51 EEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDL-VKGLRKKGKR 109
Query: 188 FGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ ETL L YLH +++RD+K +N+L+ ++ + L DF +S
Sbjct: 110 LKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 4e-12
Identities = 42/151 (27%), Positives = 73/151 (48%), Gaps = 7/151 (4%)
Query: 89 LRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDH 148
+R +G G G V+LC+ + Q +K + E + + + A E +L +L H
Sbjct: 5 IRVVGRGAFGIVHLCRRKAD-----QKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLSH 58
Query: 149 PFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLH 208
P + Y F +VMEY PGG L Q++ + + + LLAL ++H
Sbjct: 59 PNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH 118
Query: 209 MMGIVYRDLKPENVLVREDGHIM-LSDFDLS 238
I++RDLK +N+L+ + ++ + DF +S
Sbjct: 119 TKLILHRDLKTQNILLDKHKMVVKIGDFGIS 149
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 7e-12
Identities = 42/158 (26%), Positives = 69/158 (43%), Gaps = 22/158 (13%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRK-KLHRADMEK-- 140
+ ++ L ++G G G VY A + +AI+K +L + + E
Sbjct: 19 ELYKNLEKIGEGASGEVYK---------------ATDRATGKEVAIKKMRLRKQNKELII 63
Query: 141 ---VILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYA 197
+I+ HP + Y + +VMEY GG L Q R +
Sbjct: 64 NEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSL-TDIITQNFVRMNEPQIAYVC 122
Query: 198 AETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235
E L LEYLH +++RD+K +N+L+ +DG + L+DF
Sbjct: 123 REVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADF 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 9e-12
Identities = 48/157 (30%), Positives = 79/157 (50%), Gaps = 9/157 (5%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
+ + ++ LG G G VY + +N G A KV++ ++ ++L +E IL
Sbjct: 12 EVWEIIGELGDGAFGKVY--KAKNKETGA---LAAAKVIETKS---EEELEDYMVEIEIL 63
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLA 203
+HP++ L F +++E+CPGG + A + + + + L A
Sbjct: 64 ATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAI-MLELDRGLTEPQIQVICRQMLEA 122
Query: 204 LEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240
L+YLH M I++RDLK NVL+ DG I L+DF +S K
Sbjct: 123 LQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAK 159
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 44/152 (28%), Positives = 68/152 (44%), Gaps = 15/152 (9%)
Query: 92 LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVV-----DREALAIRKKLHRADMEKVILTML 146
LGSG G+VY + F+A+K V + K+L + E +L+ L
Sbjct: 8 LGSGSFGSVYE-----GLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQ---EIALLSKL 59
Query: 147 DHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEY 206
HP + + +E PGG L A+ + F + Y + LL LEY
Sbjct: 60 QHPNIVQYLGTEREEDNLYIFLELVPGGSL--AKLLKKYGSFPEPVIRLYTRQILLGLEY 117
Query: 207 LHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
LH V+RD+K N+LV +G + L+DF ++
Sbjct: 118 LHDRNTVHRDIKGANILVDTNGVVKLADFGMA 149
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 50/156 (32%), Positives = 76/156 (48%), Gaps = 15/156 (9%)
Query: 92 LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADM------EKVILTM 145
+GSG G+VYL N G A+K V+ +++ K + M E +L
Sbjct: 8 IGSGSFGSVYLGM--NASSGE---LMAVKQVELPSVSASSKDRKRSMLDALAREIALLKE 62
Query: 146 LDHP-FLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLAL 204
L H + L + +A H + + +EY PGG + AA G F + + + + L L
Sbjct: 63 LQHENIVQYLGSSLDADHLN-IFLEYVPGGSV-AALLNNYGA-FEETLVRNFVRQILKGL 119
Query: 205 EYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240
YLH GI++RD+K N+LV G I +SDF +S K
Sbjct: 120 NYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKK 155
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 33/113 (29%), Positives = 54/113 (47%), Gaps = 10/113 (8%)
Query: 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK 384
R KS VGT ++APEVIS +G+ VD W+LG+ + EM+ G P+ E + + I
Sbjct: 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN 230
Query: 385 PLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437
+ S L+ + ++LV++P +R + E+ H F
Sbjct: 231 LPPKLKNLHKVSPR------LRSFLDRMLVRDPAQR----ATAAELLNHPFLA 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-11
Identities = 39/132 (29%), Positives = 64/132 (48%), Gaps = 10/132 (7%)
Query: 131 KKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGI 190
K+ + E +L+ + HP + FE + +VM+YC GGDLY Q G F
Sbjct: 41 KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPE 100
Query: 191 SSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF----------DLSFK 240
+ + LAL+++H I++RD+K +N+ + +DG I L DF +L+
Sbjct: 101 DQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART 160
Query: 241 CDVVPKLLRPKL 252
C P L P++
Sbjct: 161 CIGTPYYLSPEI 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 29/94 (30%), Positives = 45/94 (47%), Gaps = 8/94 (8%)
Query: 327 KSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL 386
K+ +GT Y+APEV G+ + D W+LG LYEM PF+ + + + +
Sbjct: 159 KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG-- 216
Query: 387 TFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKR 420
+P I S++ LQ+ I +L PK R
Sbjct: 217 KYPPIPPIYSQD------LQNFIRSMLQVKPKLR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 41/122 (33%), Positives = 63/122 (51%), Gaps = 16/122 (13%)
Query: 322 INARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLI-- 379
+N+ +K+FVGT Y+APE I G + D W+LG+ L E+ G P+ EN+ I
Sbjct: 152 VNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFE 211
Query: 380 ---NILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436
I+ +P PR+ S +F QD ++ L+K+P++R S K E+ H F
Sbjct: 212 LLQYIVNEPP--PRL---PSGKFSP--DFQDFVNLCLIKDPRER-PSYK---ELLEHPFI 260
Query: 437 KG 438
K
Sbjct: 261 KK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 48/157 (30%), Positives = 75/157 (47%), Gaps = 9/157 (5%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
+ + ++ LG G G VY Q + V A KV+D ++ ++L +E IL
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGV-----LAAAKVIDTKS---EEELEDYMVEIDIL 56
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLA 203
DHP + L F + +++E+C GG + A + + + +TL A
Sbjct: 57 ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAV-MLELERPLTEPQIRVVCKQTLEA 115
Query: 204 LEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240
L YLH I++RDLK N+L DG I L+DF +S K
Sbjct: 116 LNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAK 152
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-11
Identities = 45/167 (26%), Positives = 76/167 (45%), Gaps = 21/167 (12%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADME------ 139
+ +L LGSG G VY + +N Q A+K ++ A K D
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNN----GQNLLALKEINVHNPAFGKDKRERDKSIGDIVS 57
Query: 140 --KVILTMLDHPFLPTLYAEFEASHYSCLVMEY---CPGGDLYAARQRQPGKRFGISSAK 194
+I L HP + Y F + +VM+ P G+ + + ++ +RF + +
Sbjct: 58 EVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNS-LKEKKQRF--TEER 114
Query: 195 FYA--AETLLALEYLHM-MGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ + +LAL YLH IV+RDL P N+++ ED + ++DF L+
Sbjct: 115 IWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA 161
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 4e-11
Identities = 47/161 (29%), Positives = 71/161 (44%), Gaps = 24/161 (14%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVV--DRE-----ALAIRKKLHRADM 138
+ L +LG G G VY + + A+K + D E + A+R
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKT-----GEIVALKKIRLDNEEEGIPSTALR-------- 47
Query: 139 EKVILTMLDHPFLPTLYAEFEASHYSC-LVMEYCPGGDLYAARQRQPGKRFGISSAKFYA 197
E +L L HP + L + + LV EYC DL ++PG + K
Sbjct: 48 EISLLKELKHPNIVKLL-DVIHTERKLYLVFEYCDM-DLKKYLDKRPGP-LSPNLIKSIM 104
Query: 198 AETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ L L Y H I++RDLKP+N+L+ DG + L+DF L+
Sbjct: 105 YQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLA 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 16/158 (10%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
+ F L++R+GSG G+VY + RN G +K+ E A+ ++ E +++
Sbjct: 9 EDFELIQRIGSGTYGDVY--KARNVNTGELAAIKVIKLEPGEDFAVVQQ------EIIMM 60
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGG---DLYAARQRQPGKRFGISSAKFYAAET 200
H + + + + ME+C GG D+Y P I+ + + ET
Sbjct: 61 KDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG--PLSESQIA---YVSRET 115
Query: 201 LLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
L L YLH G ++RD+K N+L+ ++GH+ L+DF +S
Sbjct: 116 LQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVS 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 6e-11
Identities = 32/97 (32%), Positives = 47/97 (48%), Gaps = 9/97 (9%)
Query: 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK 384
+ +FVGT ++APEVI G+ D W+LG+ E+ G P + + L I K
Sbjct: 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN 213
Query: 385 PLTFPRI-GVSSSKEFEEVVKLQDLISKLLVKNPKKR 420
P + G SK F +D +S L K+PK+R
Sbjct: 214 NP--PSLEGNKFSKPF------KDFVSLCLNKDPKER 242
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 7e-11
Identities = 45/159 (28%), Positives = 68/159 (42%), Gaps = 23/159 (14%)
Query: 89 LRRLGSGDIGNVYLCQ--IRNPMVGLPQCFYAMKVVDREAL-------AIRKKLHRADME 139
++LG G VY + +V + + +K+ +R+ A+R E
Sbjct: 5 GKKLGEGTYAVVYKARDKETGRIVAIKK----IKLGERKEAKDGINFTALR--------E 52
Query: 140 KVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAE 199
+L L HP + L F LV E+ DL + + K Y
Sbjct: 53 IKLLQELKHPNIIGLLDVFGHKSNINLVFEFMET-DLEKV-IKDKSIVLTPADIKSYMLM 110
Query: 200 TLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
TL LEYLH I++RDLKP N+L+ DG + L+DF L+
Sbjct: 111 TLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLA 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 3e-10
Identities = 28/94 (29%), Positives = 45/94 (47%), Gaps = 8/94 (8%)
Query: 327 KSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL 386
K++VGT Y++PE ++ + D W+LG +YE+ + PF N + I +
Sbjct: 168 KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK- 226
Query: 387 TFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKR 420
F RI S E L ++I +L +P KR
Sbjct: 227 -FRRIPYRYSSE------LNEVIKSMLNVDPDKR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 25/71 (35%), Positives = 40/71 (56%), Gaps = 3/71 (4%)
Query: 165 CLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLV 224
++MEY GG + + P IS E L+AL+Y+H +G+++RD+K N+LV
Sbjct: 78 WIIMEYAEGGSVRTLMKAGPIAEKYIS---VIIREVLVALKYIHKVGVIHRDIKAANILV 134
Query: 225 REDGHIMLSDF 235
G++ L DF
Sbjct: 135 TNTGNVKLCDF 145
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 46/153 (30%), Positives = 71/153 (46%), Gaps = 16/153 (10%)
Query: 89 LRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVV--DREALAIRKKLHRADMEKVILTML 146
L ++G G G VY + + A+K + E+ I K A E +L L
Sbjct: 4 LGKIGEGTYGVVYKARDKLTGE-----IVAIKKIKLRFESEGIPK---TALREIKLLKEL 55
Query: 147 DHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSA--KFYAAETLLAL 204
+HP + L F LV E+ DLY + + + G+ + K Y + L L
Sbjct: 56 NHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDR---QRGLPESLIKSYLYQLLQGL 111
Query: 205 EYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237
+ H GI++RDLKPEN+L+ +G + L+DF L
Sbjct: 112 AFCHSHGILHRDLKPENLLINTEGVLKLADFGL 144
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 4e-10
Identities = 34/111 (30%), Positives = 52/111 (46%), Gaps = 10/111 (9%)
Query: 326 SKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP 385
+ S GT ++APEVI G+ +G A D W+LG + EM G P+ N + +
Sbjct: 160 TGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSS 219
Query: 386 LTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436
P I S+E +D + K L ++PKKR + E+ +H F
Sbjct: 220 GEPPEIPEHLSEE------AKDFLRKCLRRDPKKR----PTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 5e-10
Identities = 34/112 (30%), Positives = 53/112 (47%), Gaps = 15/112 (13%)
Query: 327 KSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL 386
KS GT +++PEVISG+G+G D W++G + EML P+ + I +P
Sbjct: 165 KSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP- 223
Query: 387 TFPR--IGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436
T P+ VS ++ + + V+N KKR + E+ RH F
Sbjct: 224 TNPQLPSHVSPD--------ARNFLRRTFVENAKKRPSAE----ELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 7e-10
Identities = 47/181 (25%), Positives = 67/181 (37%), Gaps = 28/181 (15%)
Query: 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEK---- 140
H +LG G G V+LC++ NP LP + V L + K+ R D K
Sbjct: 6 HLLFKEKLGEGQFGEVHLCEVVNPQ-DLPTLQFPFNVRKGRPLLVAVKILRPDANKNARN 64
Query: 141 ------VILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDL-----------------Y 177
IL+ L P + L C++ EY GDL
Sbjct: 65 DFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGND 124
Query: 178 AARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237
A SS A + ++YL + V+RDL N LV E+ I ++DF +
Sbjct: 125 AVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGM 184
Query: 238 S 238
S
Sbjct: 185 S 185
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 7e-10
Identities = 42/153 (27%), Positives = 69/153 (45%), Gaps = 10/153 (6%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTM 145
F L R+G G G V+ + Q A+K++D E ++ E +L+
Sbjct: 6 FTKLERIGKGSFGEVF-----KGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQ 58
Query: 146 LDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALE 205
D P++ Y + ++MEY GG + P F I++ E L L+
Sbjct: 59 CDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATM---LKEILKGLD 115
Query: 206 YLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
YLH ++RD+K NVL+ E G + L+DF ++
Sbjct: 116 YLHSEKKIHRDIKAANVLLSEQGDVKLADFGVA 148
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 34/117 (29%), Positives = 57/117 (48%), Gaps = 16/117 (13%)
Query: 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINIL 382
A+ + +GT ++APEVI G+ + D W+LG+ EM G P+ + + + I
Sbjct: 153 MAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIP 212
Query: 383 KKP---LTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436
KP L+ P S EF D + K LVK+P++R ++++ +H F
Sbjct: 213 NKPPPTLSDPE---KWSPEF------NDFVKKCLVKDPEER----PSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 2e-09
Identities = 36/144 (25%), Positives = 58/144 (40%), Gaps = 20/144 (13%)
Query: 114 QCFYAMKVVDREALAIRKKLHRADM----------EKVILTMLDHPFLPTLYAEF--EAS 161
+ D + L K++ +M E IL L HP + Y ++
Sbjct: 15 TVRKVRRKSDGKILV-WKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSN 73
Query: 162 HYSCLVMEYCPGGDL--YAARQRQPGKRFGISSAKFYAAETLLALEYLHM-----MGIVY 214
+VMEYC GGDL + ++ K + LLAL H +++
Sbjct: 74 QTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLH 133
Query: 215 RDLKPENVLVREDGHIMLSDFDLS 238
RDLKP N+ + + ++ L DF L+
Sbjct: 134 RDLKPANIFLDANNNVKLGDFGLA 157
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 43/154 (27%), Positives = 67/154 (43%), Gaps = 16/154 (10%)
Query: 86 FRLLRRLGSGDIGNVYLCQIR--NPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
+ +L +G G G V C+ + +V + + K + + ++K R E +L
Sbjct: 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKK----FKESE-DDEDVKKTALR---EVKVL 54
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSA--KFYAAETL 201
L H + L F LV EY L + PG G+ + Y + L
Sbjct: 55 RQLRHENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPG---GLPPDAVRSYIWQLL 110
Query: 202 LALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235
A+ Y H I++RD+KPEN+LV E G + L DF
Sbjct: 111 QAIAYCHSHNIIHRDIKPENILVSESGVLKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 46/166 (27%), Positives = 74/166 (44%), Gaps = 25/166 (15%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVD-------------REALAIRKK 132
+ L +G G G VY + R+ G F A+K V RE +A+ K+
Sbjct: 1 YEELAEIGEGAYGTVY--KARDLNTGR---FVALKKVRVPLSEEGIPLSTLRE-IALLKQ 54
Query: 133 LHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISS 192
L + ++ +LD P E + + LV E+ DL + P +
Sbjct: 55 LESFEHPNIV-RLLDVCHGPRTDRELKLT----LVFEHVDQ-DLATYLSKCPKPGLPPET 108
Query: 193 AKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
K + L +++LH IV+RDLKP+N+LV DG + ++DF L+
Sbjct: 109 IKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLA 154
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 47/166 (28%), Positives = 76/166 (45%), Gaps = 11/166 (6%)
Query: 88 LLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD 147
+R +G G G V L + R Y +K ++ A R++ A+ E +L+ L
Sbjct: 4 FVRVVGKGSYGEVSLVRHRTDGKQ-----YVIKKLNLRN-ASRRERKAAEQEAQLLSQLK 57
Query: 148 HPFLPTLYAEFEASHYSC-LVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEY 206
HP + +E +VM +C GGDLY + Q GK + + + +AL+Y
Sbjct: 58 HPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQY 117
Query: 207 LHMMGIVYRDLKPENVLVREDGHIMLSDFD----LSFKCDVVPKLL 248
LH I++RDLK +NV + I + D L +CD+ L+
Sbjct: 118 LHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI 163
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 43/130 (33%), Positives = 67/130 (51%), Gaps = 16/130 (12%)
Query: 311 LLDDPEVVAEPINARSK--SFVGTHEYLAPEVIS-GQGHGSAVDWWTLGVFLYEMLYGTT 367
L D V A SK +FVGT ++APEVI+ G+ + + D W+LG+ +YEM G
Sbjct: 141 KLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNP 200
Query: 368 PFKGENNEKTLINILK-KPLTFPRI-GVSSSKEFEEVVKLQDLISKLLVKNPKKRIGS-- 423
P+ + + ++ I K KP PR+ SK L++ ++ L + PK+R+ +
Sbjct: 201 PYSDVDAFRAMMLIPKSKP---PRLEDNGYSKL------LREFVAACLDEEPKERLSAEE 251
Query: 424 LKGSVEIKRH 433
L S IK H
Sbjct: 252 LLKSKWIKAH 261
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 4e-09
Identities = 46/162 (28%), Positives = 68/162 (41%), Gaps = 31/162 (19%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRA--------D 137
F LR +G G G VY +A V E +AI+K + D
Sbjct: 17 FTDLREIGHGSFGAVY---------------FARDVRTNEVVAIKKMSYSGKQSNEKWQD 61
Query: 138 MEKVI--LTMLDHPFLPTLYAEFEASHYSCLVMEYCPG--GDLYAARQRQPGKRFGISSA 193
+ K + L L HP + H + LVMEYC G D+ ++P + I++
Sbjct: 62 IIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEV-HKKPLQEVEIAAI 120
Query: 194 KFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235
L L YLH ++RD+K N+L+ E G + L+DF
Sbjct: 121 ---CHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADF 159
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 6e-09
Identities = 44/157 (28%), Positives = 66/157 (42%), Gaps = 17/157 (10%)
Query: 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILT 144
+L +G G+ G+V L R V A+K + ++ A + L A ++T
Sbjct: 7 ELKLGATIGKGEFGDVMLGDYRGQKV-------AVKCLKDDSTAAQAFLAEAS----VMT 55
Query: 145 MLDHPFLPTLYAEFEASHYSCLVMEYCPGG---DLYAARQRQPGKRFGISSAKFYAAETL 201
L HP L L + +V EY G D +R R ++ +A +
Sbjct: 56 TLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRA---VITLAQQLGFALDVC 112
Query: 202 LALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+EYL V+RDL NVLV ED +SDF L+
Sbjct: 113 EGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLA 149
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (137), Expect = 7e-09
Identities = 38/137 (27%), Positives = 56/137 (40%), Gaps = 42/137 (30%)
Query: 332 THE-----YLAPEVISGQGH-GSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP 385
THE Y APE++ G H +AVD W++G EM+ G F G++ L I +
Sbjct: 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQI- 214
Query: 386 LTFPRIGVSSSKEFEEVVKLQ--------------------------DLISKLLVKNPKK 419
+G + + + V KL DL+SK+L NP K
Sbjct: 215 -----LGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAK 269
Query: 420 RIGSLKGSVEIKRHEFF 436
RI + E +H +F
Sbjct: 270 RISAK----EALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 8e-09
Identities = 46/158 (29%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVV--DREALAIRKKLHRADMEKVIL 143
+R + LG G G VYLC + L A+K V D ++ +K+++ + E +L
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGREL-----AVKQVPFDPDSPETKKEVNALECEIQLL 58
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGI---SSAKFYAAET 200
L H + Y + MEY PGG + + K +G + + Y +
Sbjct: 59 KNLQHERIVQYYGCLRDDETLSIFMEYMPGGSV-----KDQLKAYGALTETVTRKYTRQI 113
Query: 201 LLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
L +EYLH IV+RD+K N+L G++ L DF S
Sbjct: 114 LEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGAS 151
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 8e-09
Identities = 46/171 (26%), Positives = 73/171 (42%), Gaps = 28/171 (16%)
Query: 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVV----DREALAIRKKLHRAD 137
+ + L ++G G G V+ + + + A+K V ++E I A
Sbjct: 10 EVSKYEKLAKIGQGTFGEVFKARHKKT-----KQIVALKKVLMENEKEGFPIT-----AL 59
Query: 138 MEKVILTMLDHP----------FLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKR 187
E IL +L H T Y ++ S Y LV E+C DL A +
Sbjct: 60 REIKILQLLKHENVVNLIEICRTKATPYNRYKGSFY--LVFEFCEH-DL-AGLLSNKNVK 115
Query: 188 FGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
F +S K L L Y+H I++RD+K N+L+ +DG + L+DF L+
Sbjct: 116 FTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLA 166
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 9e-09
Identities = 40/175 (22%), Positives = 68/175 (38%), Gaps = 46/175 (26%)
Query: 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKV--- 141
+ LL+ +GSG G V A+ +AI KK+ + +
Sbjct: 1 RYELLKPIGSGAYGVVCS---------------AVDKRTGRKVAI-KKISNVFDDLIDAK 44
Query: 142 -------ILTMLDHP--------FLPTLYAEFEASHYSCLVMEYCPGGDLYAA-RQRQPG 185
+L L H P +F Y +V E DL+ + QP
Sbjct: 45 RILREIKLLRHLRHENIIGLLDILRPPSPEDFN-DVY--IVTELMET-DLHKVIKSPQP- 99
Query: 186 KRFGISSA--KFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
++ +++ + L L+YLH +++RDLKP N+LV + + + DF L+
Sbjct: 100 ----LTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLA 150
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 9e-09
Identities = 37/121 (30%), Positives = 63/121 (52%), Gaps = 10/121 (8%)
Query: 307 HDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGT 366
Q L D V E IN+ + +FVGT Y++PE I G + D W+LG+ + E+ G
Sbjct: 140 RGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199
Query: 367 TPF-------KGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKK 419
PF G+++ ++++L++ + P + SS F E L+D + L+K+P +
Sbjct: 200 FPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSD-FPED--LRDFVDACLLKDPTE 256
Query: 420 R 420
R
Sbjct: 257 R 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 35/114 (30%), Positives = 53/114 (46%), Gaps = 16/114 (14%)
Query: 327 KSFVGTHEYLAPEVISGQ---GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINIL- 382
+S GT Y+APEVI+G GHG A D W+LG + EM G P+ +NE ++ +
Sbjct: 161 QSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG 220
Query: 383 -KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEF 435
P S + +D + + L +PKKR + E+ +H F
Sbjct: 221 AGHKPPIPDSLQLSP-------EGKDFLDRCLESDPKKR----PTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 32/112 (28%), Positives = 55/112 (49%), Gaps = 10/112 (8%)
Query: 327 KSFVGTHEYLAPEVIS-GQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP 385
K+FVGT ++APEV+ G+ D W+ G+ E+ G P+ K L+ L+
Sbjct: 164 KTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND 223
Query: 386 LTFPRIGV-SSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436
P + + K++ + + +IS L K+P KR + E+ +H+FF
Sbjct: 224 --PPSLETGADYKKYSKSFR--KMISLCLQKDPSKR----PTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 45/175 (25%), Positives = 70/175 (40%), Gaps = 20/175 (11%)
Query: 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREAL-AIRKKLHRADM 138
+ L R L LG G G VY ++ P L A+K + A ++++ +
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQ--- 57
Query: 139 EKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDL--YAARQRQPGKRFGISSAKFY 196
E +++ L HP + L +C++ EY GDL + R P G S
Sbjct: 58 EAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVR-NSPHSDVGAESGDET 116
Query: 197 AAETLLALEYLHMM-------------GIVYRDLKPENVLVREDGHIMLSDFDLS 238
+L ++LH+ V+RDL N LV E + +SDF LS
Sbjct: 117 VKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLS 171
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 37/121 (30%), Positives = 61/121 (50%), Gaps = 9/121 (7%)
Query: 129 IRKKLHRADM-EKVILTMLDH--PFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPG 185
I K L ++ + LT++ H P + L+ + LV+++ GG L++ +
Sbjct: 22 ILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLN 81
Query: 186 KRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF----DLSFKC 241
K +AAE ++AL+ LH GIV RDL P N+L+ + GHI L+ F ++ C
Sbjct: 82 IPEEC--VKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC 139
Query: 242 D 242
D
Sbjct: 140 D 140
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 41/153 (26%), Positives = 69/153 (45%), Gaps = 10/153 (6%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTM 145
F L R+G G G VY + + A+K++D E ++ E +L+
Sbjct: 6 FTKLERIGKGSFGEVY-----KGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQ 58
Query: 146 LDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALE 205
D P++ Y + ++MEY GG + P + I++ E L L+
Sbjct: 59 CDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATI---LREILKGLD 115
Query: 206 YLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
YLH ++RD+K NVL+ E G + L+DF ++
Sbjct: 116 YLHSERKIHRDIKAANVLLSEQGDVKLADFGVA 148
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 2e-08
Identities = 34/106 (32%), Positives = 51/106 (48%), Gaps = 10/106 (9%)
Query: 318 VAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKT 377
V E + +FVGT Y++PE I G+ + A D W+LG+ L E G PF + +
Sbjct: 149 VLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLP-PGQPS 207
Query: 378 LINILKKPLTFPRIGVSS---SKEFEEVVKLQDLISKLLVKNPKKR 420
+++ P + + S EF +D IS L K+PKKR
Sbjct: 208 FFELMQAICDGPPPSLPAEEFSPEF------RDFISACLQKDPKKR 247
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 33/118 (27%), Positives = 53/118 (44%), Gaps = 10/118 (8%)
Query: 305 DHHDQELLDDPEV--VAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEM 362
D +D + D V + + + VGT YL+PE+ + + D W LGV LYE
Sbjct: 135 DAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYEC 194
Query: 363 LYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKR 420
G PF N ++ I++ FP + S++ L LI + L K+ ++R
Sbjct: 195 CTGKHPFDANNQGALILKIIRG--VFPPVSQMYSQQ------LAQLIDQCLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 36/96 (37%), Positives = 49/96 (51%), Gaps = 10/96 (10%)
Query: 326 SKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINIL-KK 384
+ SF GT YLAPE+ + + D W+LGV LYE+L PFKG + + + +L K
Sbjct: 228 ASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGK 287
Query: 385 PLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKR 420
FP VSS ++ L+ LL KNP R
Sbjct: 288 YDPFP-CPVSSG--------MKALLDPLLSKNPALR 314
|
Length = 478 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 32/99 (32%), Positives = 47/99 (47%), Gaps = 8/99 (8%)
Query: 323 NARSKSFVGTHEYLAPEVISGQG-HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINI 381
+ +KSF G+ ++APEVI+ QG +G A D W+LG + EM G P+ + I
Sbjct: 155 FSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKI 214
Query: 382 LKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKR 420
+ P I S E +D I K L ++P R
Sbjct: 215 GRSK-ELPPIPDHLSDE------AKDFILKCLQRDPSLR 246
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 40/153 (26%), Positives = 68/153 (44%), Gaps = 10/153 (6%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTM 145
F L ++G G G V+ + Q A+K++D E ++ E +L+
Sbjct: 6 FTKLEKIGKGSFGEVF-----KGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQ 58
Query: 146 LDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALE 205
D P++ Y + ++MEY GG + P I++ E L L+
Sbjct: 59 CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATI---LREILKGLD 115
Query: 206 YLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
YLH ++RD+K NVL+ E G + L+DF ++
Sbjct: 116 YLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA 148
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 33/100 (33%), Positives = 51/100 (51%), Gaps = 19/100 (19%)
Query: 328 SFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK--- 384
S VGT Y++PE I G+ D W+LG LYEM +PF G+ + L ++ KK
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD--KMNLYSLCKKIEK 222
Query: 385 ----PLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKR 420
PL + + E +L+DL+S+ + +P+KR
Sbjct: 223 CDYPPL--------PADHYSE--ELRDLVSRCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 47/152 (30%), Positives = 68/152 (44%), Gaps = 8/152 (5%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
+ + L ++G G G V+ C RN G Q K V+ E + KK+ A E +L
Sbjct: 1 EKYEKLSKIGEGSYGVVFKC--RNRETG--QIVAIKKFVESEDDPVIKKI--ALREIRML 54
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLA 203
L HP L L F LV EYC L + G + + +TL A
Sbjct: 55 KQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIW--QTLQA 112
Query: 204 LEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235
+ + H ++RD+KPEN+L+ + G I L DF
Sbjct: 113 VNFCHKHNCIHRDVKPENILITKQGQIKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 4e-08
Identities = 46/154 (29%), Positives = 72/154 (46%), Gaps = 15/154 (9%)
Query: 86 FRLLRRLGSGDIGNVYLCQ-IR-NPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
F LR +G G G VY + +R + +V + + Y+ K + + I K++ L
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR-------FL 69
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGG--DLYAARQRQPGKRFGISSAKFYAAETL 201
L HP + H + LVMEYC G DL ++P + I++ A L
Sbjct: 70 QKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAVTHGA---L 125
Query: 202 LALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235
L YLH +++RD+K N+L+ E G + L DF
Sbjct: 126 QGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDF 159
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 4e-08
Identities = 49/161 (30%), Positives = 70/161 (43%), Gaps = 17/161 (10%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
D +L LG G+ G+VY R V + AMK + E K ++ ME IL
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTM-----AMKEIRLEL--DESKFNQIIMELDIL 53
Query: 144 TMLDHPFLPTLYAEF--EASHYSCLVMEYCPGGD---LYAARQRQPGKRFGISSAKFYAA 198
P++ Y F E + Y C MEY G LYA G + +
Sbjct: 54 HKAVSPYIVDFYGAFFIEGAVYMC--MEYMDAGSLDKLYAGGVATEGIPEDV--LRRITY 109
Query: 199 ETLLALEYL-HMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ L++L I++RD+KP NVLV +G + L DF +S
Sbjct: 110 AVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVS 150
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 36/121 (29%), Positives = 62/121 (51%), Gaps = 18/121 (14%)
Query: 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLIN 380
P ++ + VGT ++APEV++ + +G VD W+LG+ EM+ G P+ EN + L
Sbjct: 168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY- 226
Query: 381 ILKKPLTFPRIGVSSSKEFEEVVKL----QDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436
I + + E + KL +D +++ L + +KR GS K E+ +H+F
Sbjct: 227 ---------LIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKR-GSAK---ELLQHQFL 273
Query: 437 K 437
K
Sbjct: 274 K 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 5e-08
Identities = 43/160 (26%), Positives = 70/160 (43%), Gaps = 18/160 (11%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREA-LAIRKKLHRADMEKVI 142
+ + LG+G+ G+V + A KVV A ++RK++ R E I
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGT-----VMAKKVVHIGAKSSVRKQILR---ELQI 56
Query: 143 LTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKF---YAAE 199
+ P++ + Y F + C+ ME+ G L K+ G + A
Sbjct: 57 MHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIY-----KKGGPIPVEILGKIAVA 111
Query: 200 TLLALEYLH-MMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ L YL+ + I++RD+KP N+LV G I L DF +S
Sbjct: 112 VVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVS 151
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 5e-08
Identities = 43/171 (25%), Positives = 60/171 (35%), Gaps = 16/171 (9%)
Query: 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALA-IRKKLHRADME 139
V D L R LG G G V+L + + + A+K + A RK R E
Sbjct: 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFER---E 58
Query: 140 KVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDL------------YAARQRQPGKR 187
+LT H + Y +V EY GDL + P
Sbjct: 59 AELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGE 118
Query: 188 FGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+S A + + YL V+RDL N LV D + + DF +S
Sbjct: 119 LTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMS 169
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 5e-08
Identities = 32/101 (31%), Positives = 45/101 (44%), Gaps = 3/101 (2%)
Query: 139 EKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKR-FGISSAKFYA 197
E I+ LDH L LY +H +V E P G L R R+ F IS+ YA
Sbjct: 46 EAAIMHSLDHENLIRLYG-VVLTHPLMMVTELAPLGSLLD-RLRKDALGHFLISTLCDYA 103
Query: 198 AETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ + YL ++RDL N+L+ D + + DF L
Sbjct: 104 VQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLM 144
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 29/96 (30%), Positives = 55/96 (57%), Gaps = 6/96 (6%)
Query: 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK 384
+ KS VGT ++APEVIS +G+ VD W+LG+ + EM+ G P+ + + + +K+
Sbjct: 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD----SPVQAMKR 228
Query: 385 PLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKR 420
P + ++ + V L+D + ++L + P++R
Sbjct: 229 LRDSPPPKLKNAHKISPV--LRDFLERMLTREPQER 262
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 7e-08
Identities = 31/137 (22%), Positives = 53/137 (38%), Gaps = 33/137 (24%)
Query: 329 FVGTHEYLAPEVI-SGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNE---KTLINILKK 384
+V T Y APE++ S + A+D W++G E+L F G + ++ +L
Sbjct: 166 YVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGT 225
Query: 385 PL--TFPRIGVSSSKEFEEVVKLQ-------------------DLISKLLVKNPKKRIGS 423
P I ++ + + L DL+ K+LV +PKKRI
Sbjct: 226 PSEEDLKFITSEKARNY--LKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRI-- 281
Query: 424 LKGSV-EIKRHEFFKGI 439
+ E H + +
Sbjct: 282 ---TADEALAHPYLAQL 295
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 9e-08
Identities = 36/121 (29%), Positives = 61/121 (50%), Gaps = 18/121 (14%)
Query: 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLIN 380
P ++ + VGT ++APEV++ + +G VD W+LG+ EM+ G P+ EN + L
Sbjct: 167 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY- 225
Query: 381 ILKKPLTFPRIGVSSSKEFEEVVKL----QDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436
I + + E + KL +D +++ L + +KR GS K E+ +H F
Sbjct: 226 ---------LIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKR-GSAK---ELLQHPFL 272
Query: 437 K 437
K
Sbjct: 273 K 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 32/109 (29%), Positives = 45/109 (41%), Gaps = 45/109 (41%)
Query: 326 SKSFVGTHEYLAPEVISGQGH-GSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK 384
K+ VGT Y+APEV+ G+G+ D W+LGV LYE+
Sbjct: 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------- 187
Query: 385 PLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433
+L+DLI K+L K+P+KR + EI H
Sbjct: 188 ------------------PELKDLIRKMLQKDPEKRPSAK----EILEH 214
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 46/169 (27%), Positives = 74/169 (43%), Gaps = 33/169 (19%)
Query: 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRK-----KLHRADME 139
H + +++LG G+ G+V LC + ++ E +A++K H D E
Sbjct: 5 HLKFIQQLGKGNFGSVELC-----------RYDPLQDNTGEVVAVKKLQHSTAEHLRDFE 53
Query: 140 KVI--LTMLDHPFLPTLYAEFEASHYSC------LVMEYCPGGDL--YAARQRQPGKRFG 189
+ I L L H + +++ YS LVMEY P G L Y + R+ R
Sbjct: 54 REIEILKSLQHDNI----VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRE---RLD 106
Query: 190 ISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
YA++ +EYL V+RDL N+LV + + + DF L+
Sbjct: 107 HRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLT 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 42/158 (26%), Positives = 76/158 (48%), Gaps = 16/158 (10%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTM 145
+ L++R+GSG G+VY + RN G +K+ + ++ ++ E ++
Sbjct: 11 YELIQRVGSGTYGDVY--KARNLHTGELAAVKIIKLEPGDDFSLIQQ------EIFMVKE 62
Query: 146 LDHPFLPTLYAEFEASHYSCLVMEYCPGG---DLYAARQRQPGKRFGISSAKFYAAETLL 202
H + + + + + MEYC GG D+Y P I+ + ETL
Sbjct: 63 CKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG--PLSELQIA---YVCRETLQ 117
Query: 203 ALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240
L YLH G ++RD+K N+L+ ++G + L+DF ++ K
Sbjct: 118 GLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAK 155
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 40/155 (25%), Positives = 68/155 (43%), Gaps = 13/155 (8%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTM 145
F L R+LGSG G V+ +N + A+K++ + L + D +K + +
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVR------VAIKILKSD-----DLLKQQDFQKEVQAL 56
Query: 146 --LDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLA 203
L H L +L+A ++ E G L A + G+ ++S A +
Sbjct: 57 KRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEG 116
Query: 204 LEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ YL ++RDL N+LV ED ++DF L+
Sbjct: 117 MAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLA 151
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 1e-07
Identities = 37/119 (31%), Positives = 62/119 (52%), Gaps = 20/119 (16%)
Query: 312 LDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPF-K 370
L D V + +N+ +K++VGT+ Y+APE ISG+ +G D W+LG+ E+ G P+ +
Sbjct: 136 LCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ 195
Query: 371 GENNEKTLINILKKPLTF---------PRIGVSSSKEFEEVVKLQDLISKLLVKNPKKR 420
+ N+ +L+ PL P + V +F E K I++ + K PK+R
Sbjct: 196 IQKNQGSLM-----PLQLLQCIVDEDPPVLPVG---QFSE--KFVHFITQCMRKQPKER 244
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 43/150 (28%), Positives = 66/150 (44%), Gaps = 19/150 (12%)
Query: 92 LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKV-ILTMLDHPF 150
LG G+ G VY L + A+KV+ L I +L + M ++ IL D P+
Sbjct: 9 LGHGNGGTVY-----KAYHLLTRRILAVKVI---PLDITVELQKQIMSELEILYKCDSPY 60
Query: 151 LPTLYAEFEASHYSCLVMEYCPGG--DLYAARQRQPGKRFGISSAKFYAAETLLALEYLH 208
+ Y F + + E+ GG D+Y R ++ K L YL
Sbjct: 61 IIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVAVVK--------GLTYLW 112
Query: 209 MMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ I++RD+KP N+LV G + L DF +S
Sbjct: 113 SLKILHRDVKPSNMLVNTRGQVKLCDFGVS 142
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 46/159 (28%), Positives = 67/159 (42%), Gaps = 27/159 (16%)
Query: 88 LLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD 147
L+ LGSG G V+L + R + A+K++ A++ + A ++ L
Sbjct: 8 FLKELGSGQFGVVHLGKWRG------KIDVAIKMIREGAMSEDDFIEEAK----VMMKLS 57
Query: 148 HPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLL----- 202
HP L LY +V EY G L + + GK E LL
Sbjct: 58 HPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGK---------LGTEWLLDMCSD 108
Query: 203 ---ALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
A+EYL G ++RDL N LV ED + +SDF L+
Sbjct: 109 VCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLA 147
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 42/163 (25%), Positives = 70/163 (42%), Gaps = 14/163 (8%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTM 145
F L+ +G+G G VY + R+ G M V + E I+ +++ ++
Sbjct: 18 FELVEVVGNGTYGQVY--KGRHVKTGQLAAIKVMDVTEDEEEEIKLEIN------MLKKY 69
Query: 146 LDHPFLPTLYAEF----EASHYS--CLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAE 199
H + T Y F H LVME+C G + + G + E
Sbjct: 70 SHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICRE 129
Query: 200 TLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242
L L +LH +++RD+K +NVL+ E+ + L DF +S + D
Sbjct: 130 ILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 172
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 36/114 (31%), Positives = 60/114 (52%), Gaps = 12/114 (10%)
Query: 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK 384
+ KS VGT ++APEVIS +G+ VD W+LG+ + EM+ G P+ E + + I +
Sbjct: 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI--R 231
Query: 385 PLTFPRIGVSSSKEFEEVVK-LQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437
PR+ K+ +V L+ + +LV+ P +R + E+ +H F K
Sbjct: 232 DNLPPRV-----KDSHKVSSVLRGFLDLMLVREPSQRATAQ----ELLQHPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 45/179 (25%), Positives = 68/179 (37%), Gaps = 21/179 (11%)
Query: 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLH-------RAD 137
+ +LG G G V+LC+ + F D L K L R D
Sbjct: 6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED 65
Query: 138 MEK--VILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYA-ARQRQPGKRFGISSAK 194
K IL+ L P + L C++MEY GDL ++ ++K
Sbjct: 66 FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125
Query: 195 FYAAETLL--------ALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS---FKCD 242
+ TLL + YL + V+RDL N LV ++ I ++DF +S + D
Sbjct: 126 SLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD 184
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 36/113 (31%), Positives = 61/113 (53%), Gaps = 12/113 (10%)
Query: 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK 384
R KS VGT ++APE+IS +G VD W+LG+ + EM+ G P+ E K + +++
Sbjct: 172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM-KMIRD 230
Query: 385 PLTFPRIGVSSSKEFEEVVK-LQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436
L P++ K +V L+ + +LLV++P +R + E+ +H F
Sbjct: 231 NLP-PKL-----KNLHKVSPSLKGFLDRLLVRDPAQR----ATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 43/162 (26%), Positives = 70/162 (43%), Gaps = 25/162 (15%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKV---- 141
F+ + ++G G G VY + RN + G E +A++K + E V
Sbjct: 2 FQKVEKIGEGTYGVVY--KARNKLTG-------------EVVALKKIRLDTETEGVPSTA 46
Query: 142 -----ILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFY 196
+L L+HP + L + LV E+ DL P + K Y
Sbjct: 47 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSY 105
Query: 197 AAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ L L + H +++RDLKP+N+L+ +G I L+DF L+
Sbjct: 106 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 147
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 34/113 (30%), Positives = 52/113 (46%), Gaps = 15/113 (13%)
Query: 317 VVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEK 376
V E +N+ + +F GT Y+APE I G+ + D W+LG+ L E+ PF E
Sbjct: 151 VSGELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP 210
Query: 377 T-LINILKKPLTF--------PRIGVSSSKEFEEVVKLQDLISKLLVKNPKKR 420
I +L + P G+ S+EF +D I + L K+P +R
Sbjct: 211 LGPIELLSYIVNMPNPELKDEPGNGIKWSEEF------KDFIKQCLEKDPTRR 257
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 17/162 (10%)
Query: 83 LDHFRLLRRLGSGDIGNVY--LCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEK 140
L +F++ +++G G VY +C + +V A+K V + K E
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVV-------ALKKVQIFEMMDAKARQDCLKEI 53
Query: 141 VILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDL-----YAARQRQPGKRFGISSAKF 195
+L LDHP + A F ++ +V+E GDL + +Q++ I
Sbjct: 54 DLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWK--- 110
Query: 196 YAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237
Y + ALE++H I++RD+KP NV + G + L D L
Sbjct: 111 YFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 37/136 (27%), Positives = 57/136 (41%), Gaps = 41/136 (30%)
Query: 332 THE-----YLAPEVISGQGH-GSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP 385
THE Y APEV+ G H + VD W++G EM F G++ + L++I
Sbjct: 169 THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHI---- 224
Query: 386 LTFPRIGVSSSKEFEEVVKLQD-------------------------LISKLLVKNPKKR 420
F +G + + + V KL+D L+ K+L +P KR
Sbjct: 225 --FKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKR 282
Query: 421 IGSLKGSVEIKRHEFF 436
I S K ++ H +F
Sbjct: 283 I-SAKAALT---HPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 34/101 (33%), Positives = 55/101 (54%), Gaps = 12/101 (11%)
Query: 327 KSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL 386
++F GT Y+APE+ + + D ++LGV LYE+L PF GEN E+ ++ K L
Sbjct: 203 RTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE----VMHKTL 258
Query: 387 T--FPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLK 425
+ + S S E +Q++++ LL +PK+R S K
Sbjct: 259 AGRYDPLPPSISPE------MQEIVTALLSSDPKRRPSSSK 293
|
Length = 496 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 46/154 (29%), Positives = 73/154 (47%), Gaps = 15/154 (9%)
Query: 86 FRLLRRLGSGDIGNVYLCQ-IR-NPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
F LR +G G G VY + +R N +V + + Y+ K + + I K++ L
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVK-------FL 79
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGG--DLYAARQRQPGKRFGISSAKFYAAETL 201
+ HP + H + LVMEYC G DL ++P + I++ A L
Sbjct: 80 QRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAITHGA---L 135
Query: 202 LALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235
L YLH +++RD+K N+L+ E G + L+DF
Sbjct: 136 QGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADF 169
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 4e-07
Identities = 29/96 (30%), Positives = 50/96 (52%), Gaps = 8/96 (8%)
Query: 328 SFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLT 387
+F GT Y++PE + QG+ S D W+LG LYEM F+G+N ++ I++ P
Sbjct: 164 TFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPT- 222
Query: 388 FPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGS 423
P + + S++ L ++ +L K+P R +
Sbjct: 223 -PSLPETYSRQ------LNSIMQSMLNKDPSLRPSA 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 42/154 (27%), Positives = 76/154 (49%), Gaps = 21/154 (13%)
Query: 89 LRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVV-DREALAIRKKLHRADMEKVILTMLD 147
+ R+GSG G VY ++ + G YA+KV+ +R+++ R E IL ++
Sbjct: 79 VNRIGSGAGGTVY--KVIHRPTGRL---YALKVIYGNHEDTVRRQICR---EIEILRDVN 130
Query: 148 HPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFY---AAETLLAL 204
HP + + F+ + +++E+ GG L I+ +F A + L +
Sbjct: 131 HPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH---------IADEQFLADVARQILSGI 181
Query: 205 EYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
YLH IV+RD+KP N+L+ ++ ++DF +S
Sbjct: 182 AYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVS 215
|
Length = 353 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 44/151 (29%), Positives = 68/151 (45%), Gaps = 15/151 (9%)
Query: 89 LRRLGSGDIGNVYLC--QIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML 146
L +G G G VY N +V + + Y+ K + + I K++ L L
Sbjct: 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVK-------FLQQL 78
Query: 147 DHPFLPTLYAEFEASHYSCLVMEYCPGG--DLYAARQRQPGKRFGISSAKFYAAETLLAL 204
HP + H + LVMEYC G DL ++P + I++ A L L
Sbjct: 79 KHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAITHGA---LQGL 134
Query: 205 EYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235
YLH +++RD+K N+L+ E G + L+DF
Sbjct: 135 AYLHSHNMIHRDIKAGNILLTEPGQVKLADF 165
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 51/161 (31%), Positives = 73/161 (45%), Gaps = 20/161 (12%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREAL-AIRKKLHRADMEKVI 142
D F L LG+G+ G V ++ + GL A K++ E AIR ++ R E +
Sbjct: 1 DDFEKLGELGAGNGGVV--TKVLHRPSGL---IMARKLIHLEIKPAIRNQIIR---ELKV 52
Query: 143 LTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQ---RQPGKRFG-ISSAKFYAA 198
L + P++ Y F + + ME+ GG L + R P G IS A
Sbjct: 53 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIA----- 107
Query: 199 ETLLALEYLH-MMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
L L YL I++RD+KP N+LV G I L DF +S
Sbjct: 108 -VLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 147
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 32/102 (31%), Positives = 44/102 (43%), Gaps = 11/102 (10%)
Query: 324 ARSKSFVGTHEYLAPEVI---SGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLIN 380
A+ KSF+GT ++APEV G+ D W LG+ E+ P + + L
Sbjct: 156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL 215
Query: 381 ILKKPLTFPRIGVSS--SKEFEEVVKLQDLISKLLVKNPKKR 420
I K P++ S F D I K L K+PKKR
Sbjct: 216 ISKSNFPPPKLKDKEKWSPVF------HDFIKKCLTKDPKKR 251
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 50.9 bits (121), Expect = 5e-07
Identities = 34/121 (28%), Positives = 60/121 (49%), Gaps = 18/121 (14%)
Query: 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLIN 380
P ++ + VGT ++APEV++ + +G VD W+LG+ EM+ G P+ EN + L
Sbjct: 167 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY- 225
Query: 381 ILKKPLTFPRIGVSSSKEFEEVVKL----QDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436
I + + E + +L +D +++ L + +R GS K E+ +H F
Sbjct: 226 ---------LIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRR-GSAK---ELLQHPFL 272
Query: 437 K 437
K
Sbjct: 273 K 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 6e-07
Identities = 33/121 (27%), Positives = 59/121 (48%), Gaps = 18/121 (14%)
Query: 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLIN 380
P ++ + VGT ++APEV++ + +G VD W+LG+ EM+ G P+ EN + L
Sbjct: 167 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY- 225
Query: 381 ILKKPLTFPRIGVSSSKEFEEVVKL----QDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436
I + + E + KL +D +++ L + +KR + E+ +H F
Sbjct: 226 ---------LIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAK----ELLQHPFL 272
Query: 437 K 437
K
Sbjct: 273 K 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 6e-07
Identities = 45/163 (27%), Positives = 74/163 (45%), Gaps = 17/163 (10%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
D + ++ +G G G VY ++ N G A+K++D I + E IL
Sbjct: 22 DTWEIIETIGKGTYGKVY--KVTNKKDG---SLAAVKILD----PISDVDEEIEAEYNIL 72
Query: 144 TML-DHPFLPTLYAEF-EASHYS----CLVMEYCPGGDLYAARQ--RQPGKRFGISSAKF 195
L +HP + Y F +A LV+E C GG + + G+R + +
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY 132
Query: 196 YAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
LL L++LH I++RD+K N+L+ +G + L DF +S
Sbjct: 133 ILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS 175
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 6e-07
Identities = 47/169 (27%), Positives = 72/169 (42%), Gaps = 24/169 (14%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDR--EALAIRKKLHRADMEKV 141
D ++ L +GSG G V C + + A+K + R ++ K+ +R E
Sbjct: 15 DRYQNLSPVGSGAYGQV--CSAFD--TKTGRKV-AIKKLSRPFQSAIHAKRTYR---ELR 66
Query: 142 ILTMLDHP--------FLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSA 193
+L +DH F P E Y LV G DL + Q +
Sbjct: 67 LLKHMDHENVIGLLDVFTPASSLEDFQDVY--LVTHLM-GADLNNIVKCQ---KLSDDHI 120
Query: 194 KFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242
+F + L L+Y+H GI++RDLKP N+ V ED + + DF L+ D
Sbjct: 121 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 7e-07
Identities = 41/163 (25%), Positives = 70/163 (42%), Gaps = 14/163 (8%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTM 145
F L+ +G+G G VY + R+ G M V E I+++++ ++
Sbjct: 8 FELVELVGNGTYGQVY--KGRHVKTGQLAAIKVMDVTGDEEEEIKQEIN------MLKKY 59
Query: 146 LDHPFLPTLYAEFEASHYS------CLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAE 199
H + T Y F + LVME+C G + + G + E
Sbjct: 60 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICRE 119
Query: 200 TLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242
L L +LH +++RD+K +NVL+ E+ + L DF +S + D
Sbjct: 120 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 162
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 8e-07
Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 23/161 (14%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREA------LAIRKKLHRADME 139
F+ L +LG G VY + RN G A+K + +A AIR E
Sbjct: 2 FKQLEKLGEGTYATVY--KGRNRTTGE---IVALKEIHLDAEEGTPSTAIR--------E 48
Query: 140 KVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDL--YAARQRQPGKRFGISSAKFYA 197
++ L H + L+ + LV EY DL Y G ++ K +
Sbjct: 49 ISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGA-LDPNTVKSFT 106
Query: 198 AETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ L + + H +++RDLKP+N+L+ + G + L+DF L+
Sbjct: 107 YQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLA 147
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 9e-07
Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 8/95 (8%)
Query: 326 SKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP 385
+++ VGT Y++PE+ G + D W LG LYE+L F N ++ I++
Sbjct: 158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGN 217
Query: 386 LTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKR 420
T P + V SS +L L+ LL ++P+KR
Sbjct: 218 YT-PVVSVYSS-------ELISLVHSLLQQDPEKR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 29/96 (30%), Positives = 43/96 (44%), Gaps = 8/96 (8%)
Query: 326 SKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP 385
S VGT ++APEVI G +A D W+LG + E+L G P+ N L I++
Sbjct: 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD 215
Query: 386 LTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRI 421
P + S E + D + + K+P R
Sbjct: 216 --HPPLPEGISPELK------DFLMQCFQKDPNLRP 243
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 43/151 (28%), Positives = 60/151 (39%), Gaps = 35/151 (23%)
Query: 317 VVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEK 376
V + I++ + SFVGT Y++PE + G + D W+LG+ L EM G P + K
Sbjct: 146 VSGQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPP-DAK 204
Query: 377 TLINI---------LKKPLTFPRIGVSSSKE----FE--------EVVKL---------Q 406
L + K+ S FE KL Q
Sbjct: 205 ELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQ 264
Query: 407 DLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437
D + K L KNPK+R LK E+ +H F K
Sbjct: 265 DFVDKCLKKNPKER-ADLK---ELTKHPFIK 291
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 37/132 (28%), Positives = 59/132 (44%), Gaps = 27/132 (20%)
Query: 329 FVGTHEYLAPEVISGQGHGS-AVDWWTLGVFLYEMLYGTTPFKGENNE---KTLINILKK 384
+V T Y APE++ H + VD W++G + E+L G T F G ++ K ++N++
Sbjct: 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGT 234
Query: 385 PLTFPRIGVSSS--------------KEFEEV-----VKLQDLISKLLVKNPKKRIGSLK 425
P +SS K+F+EV DL+ K+LV +P KRI
Sbjct: 235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRI---- 290
Query: 426 GSVEIKRHEFFK 437
+ E H +
Sbjct: 291 TAAEALAHPYLA 302
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 31/86 (36%), Positives = 45/86 (52%), Gaps = 2/86 (2%)
Query: 166 LVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVR 225
LVMEYC DL + P F S K + L L+YLH I++RDLK N+L+
Sbjct: 85 LVMEYCEQ-DLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLT 142
Query: 226 EDGHIMLSDFDLSFKCDVVPKLLRPK 251
+ G + ++DF L+ + K + PK
Sbjct: 143 DKGCLKIADFGLARTYGLPAKPMTPK 168
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 42/167 (25%), Positives = 70/167 (41%), Gaps = 20/167 (11%)
Query: 91 RLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEK---------- 140
+LG G G V+LC+ M +++ V + + + K+ R D K
Sbjct: 12 KLGEGQFGEVHLCEAEG-MEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEI 70
Query: 141 VILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDL--YAARQRQPG-------KRFGIS 191
I++ L P + L A S C++ EY GDL + +R S
Sbjct: 71 KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYS 130
Query: 192 SAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ F A + ++YL + V+RDL N LV ++ I ++DF +S
Sbjct: 131 TLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 22/50 (44%), Positives = 32/50 (64%), Gaps = 2/50 (4%)
Query: 322 INARSKSFVGTHEYLAPEVISG--QGHGSAVDWWTLGVFLYEMLYGTTPF 369
IN +++F GT +Y+APEVI +G+G+ D W+LG + EM G PF
Sbjct: 162 INPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 37/107 (34%), Positives = 48/107 (44%), Gaps = 22/107 (20%)
Query: 335 YLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFK----GENNEKTLINILKKPLTFPR 390
Y APEV A DWW+LG L+E+L G T + G N TL
Sbjct: 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTL-----------N 196
Query: 391 IGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVE-IKRHEFF 436
I S+E + L+ +LL NP +R+G+ VE IK H FF
Sbjct: 197 IPEWVSEE------ARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 41/158 (25%), Positives = 72/158 (45%), Gaps = 18/158 (11%)
Query: 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADM- 138
R LD+F ++G G G V + +++ + K+V + + +RK+ R +
Sbjct: 19 RTYLDNFI---KIGEGSTGIVCIATVKS----------SGKLVAVKKMDLRKQQRRELLF 65
Query: 139 -EKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYA 197
E VI+ H + +Y + +VME+ GG L I++
Sbjct: 66 NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAV---C 122
Query: 198 AETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235
L AL LH G+++RD+K +++L+ DG + LSDF
Sbjct: 123 LAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDF 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 31/101 (30%), Positives = 49/101 (48%), Gaps = 11/101 (10%)
Query: 139 EKVILTMLDHPFLPTLYAEFEASHYSCLVM-EYCPGGDLY---AARQRQPGKRFGISSAK 194
E IL ++HP + L F + ++CL++ Y DLY AA++ I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRY--KTDLYCYLAAKRNIA-----ICDIL 185
Query: 195 FYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235
L A++YLH I++RD+K EN+ + G + L DF
Sbjct: 186 AIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDF 226
|
Length = 391 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 50/194 (25%), Positives = 79/194 (40%), Gaps = 28/194 (14%)
Query: 84 DHFRLLRRLGSGDIGNVYL--CQIRNPMVGLPQCFYAMKVVDREAL---AIRKKLHRADM 138
D + L +LG G VY ++ +V L +++ + E AIR
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALK----VIRLQEEEGTPFTAIR-------- 52
Query: 139 EKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAA 198
E +L L H + L+ LV EY DL + PG + K +
Sbjct: 53 EASLLKGLKHANIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGG-LHPENVKLFLF 110
Query: 199 ETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL---------SFKCDVVPKLLR 249
+ L L Y+H I++RDLKP+N+L+ + G + L+DF L ++ +VV R
Sbjct: 111 QLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYR 170
Query: 250 PKLSFEAIEKYEKC 263
P +Y C
Sbjct: 171 PPDVLLGSTEYSTC 184
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 31/111 (27%), Positives = 50/111 (45%), Gaps = 12/111 (10%)
Query: 329 FVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGEN--NEKTLINILKKPL 386
+GT ++APEV+ G+ +G + D W++G + EM P+ E N LI +
Sbjct: 168 LLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT 227
Query: 387 TFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437
T P I S L+D+ + L P+ R S E+ +H F+
Sbjct: 228 TAPSIPEHLSPG------LRDVTLRCLELQPEDR----PPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 42/150 (28%), Positives = 59/150 (39%), Gaps = 12/150 (8%)
Query: 91 RLGSGDIGNVYLCQIR--NPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDH 148
R+G G+ G V+ ++R N V + C RE L K + E IL H
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSC--------RETLPPDLK-AKFLQEARILKQYSH 52
Query: 149 PFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLH 208
P + L +VME GGD + R G R + +EYL
Sbjct: 53 PNIVRLIGVCTQKQPIYIVMELVQGGD-FLTFLRTEGPRLKVKELIQMVENAAAGMEYLE 111
Query: 209 MMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
++RDL N LV E + +SDF +S
Sbjct: 112 SKHCIHRDLAARNCLVTEKNVLKISDFGMS 141
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 40/131 (30%), Positives = 61/131 (46%), Gaps = 22/131 (16%)
Query: 322 INARSKSFVGTHEYLAPEVI--SGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLI 379
I + + S VGT Y +PE++ + + D W LG +YE+ G TPF NN LI
Sbjct: 194 IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLI 253
Query: 380 NILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439
+ LK+ P G SKE L LI LL + K+R +L + +
Sbjct: 254 SELKRGPDLPIKG--KSKE------LNILIKNLLNLSAKERPSAL------------QCL 293
Query: 440 NWALIRSIKPP 450
+ +I+++ PP
Sbjct: 294 GYQIIKNVGPP 304
|
Length = 1021 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 40/150 (26%), Positives = 63/150 (42%), Gaps = 11/150 (7%)
Query: 90 RRLGSGDIGNVYLCQIRNPM-VGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDH 148
++G G+ G+VY ++ V + C + + RK L A+ IL DH
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLK-----RKFLQEAE----ILKQYDH 51
Query: 149 PFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLH 208
P + L +VME PGG L R+ R + + + +EYL
Sbjct: 52 PNIVKLIGVCVQKQPIYIVMELVPGGSLLT-FLRKKKNRLTVKKLLQMSLDAAAGMEYLE 110
Query: 209 MMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
++RDL N LV E+ + +SDF +S
Sbjct: 111 SKNCIHRDLAARNCLVGENNVLKISDFGMS 140
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 32/118 (27%), Positives = 51/118 (43%), Gaps = 17/118 (14%)
Query: 325 RSKSFVGTHEYLAPEVI-----SGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLI 379
+ +F+GT ++APEV+ + D W+LG+ L E+ P N + L+
Sbjct: 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLL 218
Query: 380 NILK-KPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436
ILK +P T + SS D + LVK+P R + E+ +H F
Sbjct: 219 KILKSEPPTLDQPSKWSS-------SFNDFLKSCLVKDPDDRP----TAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 26/95 (27%), Positives = 51/95 (53%), Gaps = 8/95 (8%)
Query: 326 SKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP 385
+++ +GT YL+PE+ + + + D W LG LYEM F+ N + ++ I++
Sbjct: 158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG- 216
Query: 386 LTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKR 420
++P + S + L++L+S+L +NP+ R
Sbjct: 217 -SYPPVSSHYSYD------LRNLVSQLFKRNPRDR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 43/158 (27%), Positives = 69/158 (43%), Gaps = 18/158 (11%)
Query: 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADM- 138
R LD F ++G G G V + + + K V + + +RK+ R +
Sbjct: 21 REYLDSFI---KIGEGSTGIVCIATEK----------HTGKQVAVKKMDLRKQQRRELLF 67
Query: 139 -EKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYA 197
E VI+ H + +Y + +VME+ GG L I++
Sbjct: 68 NEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATV---C 124
Query: 198 AETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235
L AL YLH G+++RD+K +++L+ DG I LSDF
Sbjct: 125 LSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDF 162
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 25/73 (34%), Positives = 39/73 (53%), Gaps = 9/73 (12%)
Query: 166 LVMEYCPGG---DLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENV 222
+VMEY GG D+ G+ + E L ALE+LH +++RD+K +N+
Sbjct: 93 VVMEYLAGGSLTDVVTETCMDEGQIAAVCR------ECLQALEFLHSNQVIHRDIKSDNI 146
Query: 223 LVREDGHIMLSDF 235
L+ DG + L+DF
Sbjct: 147 LLGMDGSVKLTDF 159
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 46/177 (25%), Positives = 72/177 (40%), Gaps = 27/177 (15%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRN--PMVGLPQCFYAMKVVDREALAIRKKLHRADMEKV 141
RL +LG G G V+LC+ +G A + + L K L RAD+ K
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEG----APEFDGQPVLVAVKML-RADVTKT 59
Query: 142 ----------ILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYA-ARQRQPGKRF-- 188
I++ L +P + L + C++ EY GDL QR+ F
Sbjct: 60 ARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTH 119
Query: 189 -------GISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
I++ + A + ++YL + V+RDL N LV I ++DF +S
Sbjct: 120 ANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 46/156 (29%), Positives = 70/156 (44%), Gaps = 17/156 (10%)
Query: 92 LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVV----DREALAIRKKLHRADMEKVILTMLD 147
+G G G VY + R+P G F A+K V + + L + A +++ L D
Sbjct: 8 IGVGAYGTVY--KARDPHSGH---FVALKSVRVQTNEDGLPLSTVREVALLKR--LEAFD 60
Query: 148 HPFLPTLY-----AEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLL 202
HP + L + + LV E+ DL + P + K + L
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 203 ALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
L++LH IV+RDLKPEN+LV G + L+DF L+
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLA 155
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 45/161 (27%), Positives = 72/161 (44%), Gaps = 15/161 (9%)
Query: 83 LDHFRLLRRLGSGDIGNVY--LCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEK 140
L +FR+ +++G G VY C + V L + ++D +A RAD K
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKK-VQIFDLMDAKA--------RADCIK 51
Query: 141 VI--LTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKF--Y 196
I L L+HP + YA F + +V+E GDL + ++ I Y
Sbjct: 52 EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKY 111
Query: 197 AAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237
+ ALE++H +++RD+KP NV + G + L D L
Sbjct: 112 FVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 41/151 (27%), Positives = 64/151 (42%), Gaps = 11/151 (7%)
Query: 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKK--LHRADMEKVILTMLD 147
+ LG G+ G+V + A+K + +E +A KK L A ++ LD
Sbjct: 1 KELGHGNFGSVVKGVYLMK--SGKEVEVAVKTLKQEHIAAGKKEFLREAS----VMAQLD 54
Query: 148 HPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYL 207
HP + L + LVME P G L +++ +S K A + + + YL
Sbjct: 55 HPCIVRLIGVCKGEPL-MLVMELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYL 111
Query: 208 HMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
V+RDL NVL+ +SDF +S
Sbjct: 112 ESKHFVHRDLAARNVLLVNRHQAKISDFGMS 142
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 25/100 (25%), Positives = 41/100 (41%), Gaps = 3/100 (3%)
Query: 142 ILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETL 201
I+ + H + L + + LVM+ DL R+ R S K + L
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRK--IRLTESQVKCILLQIL 129
Query: 202 LALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKC 241
L LH ++RDL P N+ + G ++DF L+ +
Sbjct: 130 NGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRY 169
|
Length = 335 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 51/198 (25%), Positives = 77/198 (38%), Gaps = 55/198 (27%)
Query: 64 NQAAWEAMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVD 123
N+ WE +R L+++GSG G+V C + G
Sbjct: 7 NKTVWELPERYTS------------LKQVGSGAYGSV--CSAIDKRTG------------ 40
Query: 124 REALAIRKKLHRADMEKVI-------LTMLDH-----------PFLP-TLYAEFEASHYS 164
E +AI KKL R ++ LT+L H F EF+ +
Sbjct: 41 -EKVAI-KKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFY-- 96
Query: 165 CLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLV 224
LVM Y + Q+ G ++ + L L+Y+H GI++RDLKP N+ V
Sbjct: 97 -LVMPY-----MQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAV 150
Query: 225 REDGHIMLSDFDLSFKCD 242
ED + + DF L+ D
Sbjct: 151 NEDCELKILDFGLARHAD 168
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 41/151 (27%), Positives = 61/151 (40%), Gaps = 6/151 (3%)
Query: 88 LLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD 147
L R +G G G+VY +P + A+K ++ E I+ D
Sbjct: 10 LGRCIGEGQFGDVYQGVYMSPEN--EKIAVAVKTCKNCTSPSVREKFLQ--EAYIMRQFD 65
Query: 148 HPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYL 207
HP + L + +VME P G+L + Q ++S Y+ + AL YL
Sbjct: 66 HPHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYL 123
Query: 208 HMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
V+RD+ NVLV + L DF LS
Sbjct: 124 ESKRFVHRDIAARNVLVSSPDCVKLGDFGLS 154
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 45/165 (27%), Positives = 63/165 (38%), Gaps = 17/165 (10%)
Query: 88 LLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD 147
L R LG G G V+L + N + A+K + LA RK R E +LT L
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR---EAELLTNLQ 65
Query: 148 HPFLPTLYAEFEASHYSCLVMEYCPGGDLYA--------------ARQRQPGKRFGISSA 193
H + Y +V EY GDL + RQ G+S
Sbjct: 66 HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125
Query: 194 KFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
A++ + YL V+RDL N LV + + + DF +S
Sbjct: 126 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 37/132 (28%), Positives = 52/132 (39%), Gaps = 32/132 (24%)
Query: 330 VGTHEYLAPEVISGQGH-GSAVDWWTLGVFLYEMLYGTTPFKGENNEKTL---INILKKP 385
V T Y APE++ G VD W +G E+L G+ F GEN+ + L L P
Sbjct: 161 VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTP 220
Query: 386 ----------------LTFP-----RIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424
+TFP + E + DL+ LLV +P KR+
Sbjct: 221 NEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEAL---DLLKGLLVYDPSKRL--- 274
Query: 425 KGSVEIKRHEFF 436
+ E RH +F
Sbjct: 275 -SAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 30/101 (29%), Positives = 50/101 (49%), Gaps = 11/101 (10%)
Query: 139 EKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLY----AARQRQPGKRFGISSAK 194
E VI+ HP + +Y+ + +VME+ GG L R + I++
Sbjct: 66 EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQ----IATVC 121
Query: 195 FYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235
L AL +LH G+++RD+K +++L+ DG + LSDF
Sbjct: 122 LAV---LKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDF 159
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 47/161 (29%), Positives = 71/161 (44%), Gaps = 17/161 (10%)
Query: 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVV--DREALAIRKKLHRADMEKVI 142
++RL + LG G G VYLC + L A+K V D E+ K+++ + E +
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGREL-----AVKQVQFDPESPETSKEVNALECEIQL 57
Query: 143 LTMLDHPFLPTLYAEFEASHYSCL--VMEYCPGGDLYAARQRQPGKRFGISSAKF---YA 197
L L H + Y L ME+ PGG + + K +G + Y
Sbjct: 58 LKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSI-----KDQLKSYGALTENVTRKYT 112
Query: 198 AETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ L + YLH IV+RD+K N+L G++ L DF S
Sbjct: 113 RQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGAS 153
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 36/155 (23%), Positives = 68/155 (43%), Gaps = 10/155 (6%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
+ +L+++LG+G G V++ N A+K + ++++ L A++ K
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTK------VAVKTLKPGTMSVQAFLEEANLMKT-- 57
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLA 203
L H L LYA ++ EY G L + G + + ++A+
Sbjct: 58 --LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEG 115
Query: 204 LEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ Y+ ++RDL+ NVLV E ++DF L+
Sbjct: 116 MAYIERKNYIHRDLRAANVLVSESLMCKIADFGLA 150
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 34/120 (28%), Positives = 52/120 (43%), Gaps = 25/120 (20%)
Query: 327 KSFVGTHEYLAPEV-ISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGEN------------ 373
+V T Y APE+ +S Q + A+D W++G L E+L FKG++
Sbjct: 167 TEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVL 226
Query: 374 ---NEKTLINI--------LKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIG 422
+E+TL I ++ P+ S + L DL+ KLL +P KRI
Sbjct: 227 GTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLAL-DLLEKLLAFDPTKRIS 285
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 5e-06
Identities = 29/73 (39%), Positives = 40/73 (54%), Gaps = 2/73 (2%)
Query: 168 MEYCPGGDLYAARQRQPGK-RFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRE 226
ME PGG L A + + G + + FY + L L+YLH IV+RD+K +NVLV
Sbjct: 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNT 143
Query: 227 -DGHIMLSDFDLS 238
G + +SDF S
Sbjct: 144 YSGVVKISDFGTS 156
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 6e-06
Identities = 37/160 (23%), Positives = 62/160 (38%), Gaps = 16/160 (10%)
Query: 92 LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFL 151
LG G G V+L + N + + A+K + + + R+ R E +LT+L H +
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQR---EAELLTVLQHQHI 69
Query: 152 PTLYAEFEASHYSCLVMEYCPGGDL-------------YAARQRQPGKRFGISSAKFYAA 198
Y +V EY GDL A + + + A+
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 199 ETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ + YL + V+RDL N LV + + + DF +S
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMS 169
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 6e-06
Identities = 47/178 (26%), Positives = 72/178 (40%), Gaps = 28/178 (15%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMV--GLPQCFYAMKVVDREALA-IRKKLHRADMEK 140
++ +R +G G G V+ Q R P + P A+K++ EA A ++ R E
Sbjct: 5 NNIEYVRDIGQGAFGRVF--QARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR---EA 59
Query: 141 VILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYA-ARQRQPGKRFGISSAKFYAAE 199
++ DHP + L CL+ EY GDL R R P + +S + A +
Sbjct: 60 ALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARK 119
Query: 200 TLL-------------------ALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
L + YL V+RDL N LV E+ + ++DF LS
Sbjct: 120 CGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 177
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 7e-06
Identities = 33/98 (33%), Positives = 49/98 (50%), Gaps = 4/98 (4%)
Query: 139 EKVILTMLDHPFLPTLYAEFEASHYSCLVM-EYCPGGDLYAARQRQPGKRFGISSAKFYA 197
E +L L HP + L +CLV+ +Y DLY + + G++ A
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY--RSDLYTYLGARL-RPLGLAQVTAVA 266
Query: 198 AETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235
+ L A++Y+H GI++RD+K ENVLV I L DF
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDF 304
|
Length = 461 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 8e-06
Identities = 38/149 (25%), Positives = 72/149 (48%), Gaps = 13/149 (8%)
Query: 92 LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVD--REALAIRKKLHRADMEKV-ILTMLDH 148
LG+G + Y Q R+ G A+K V R + ++++ A +++ ++ L+H
Sbjct: 8 LGTGAFSSCY--QARDVKTG---TLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNH 62
Query: 149 PFLPTLY-AEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYL 207
P + + A E SH++ L +E+ GG + + + + Y + L L YL
Sbjct: 63 PHIIRMLGATCEDSHFN-LFVEWMAGGSVSHLLSKYGAFKEAVIIN--YTEQLLRGLSYL 119
Query: 208 HMMGIVYRDLKPENVLVREDGHIM-LSDF 235
H I++RD+K N+L+ G + ++DF
Sbjct: 120 HENQIIHRDVKGANLLIDSTGQRLRIADF 148
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 8e-06
Identities = 38/112 (33%), Positives = 53/112 (47%), Gaps = 14/112 (12%)
Query: 318 VAEPINARSKSFVGTHEYLAPEVISGQGH-GSAVDWWTLGVFLYEMLYGTTPFKGENNEK 376
+A +A +V T Y APEVI H VD W++G + EML G T FKG++
Sbjct: 163 LARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD 222
Query: 377 TLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKN----PKKRIGSL 424
L ILK V+ E V KL+D +K +K+ P+K +L
Sbjct: 223 QLTQILK---------VTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTL 265
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 9e-06
Identities = 41/168 (24%), Positives = 73/168 (43%), Gaps = 27/168 (16%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADME---- 139
D + ++ +G G G V+ ++ N G + A+ I +H D E
Sbjct: 18 DTWEIIETIGKGTYGKVF--KVLNKKNG-----------SKAAVKILDPIHDIDEEIEAE 64
Query: 140 -KVILTMLDHPFLPTLYAEFEASHYSC-----LVMEYCPGG---DLYAARQRQPGKRFGI 190
++ + DHP + Y + LV+E C GG DL ++ G+R
Sbjct: 65 YNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKR-GERMEE 123
Query: 191 SSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ E L+ L++LH+ ++RD+K N+L+ +G + L DF +S
Sbjct: 124 PIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS 171
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 1e-05
Identities = 35/131 (26%), Positives = 51/131 (38%), Gaps = 29/131 (22%)
Query: 330 VGTHEYLAPEVISGQGH-GSAVDWWTLGVFLYEMLYGTTPFKGEN--------------- 373
V T Y PE++ G G VD W++G L E+ G F+G
Sbjct: 162 VITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSP 221
Query: 374 NEKT--------LINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLK 425
++ LK + R K + L DL+ KLL +PKKRI S
Sbjct: 222 TDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSAL-DLLDKLLTLDPKKRI-SAD 279
Query: 426 GSVEIKRHEFF 436
+++ HE+F
Sbjct: 280 QALQ---HEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 40/172 (23%), Positives = 67/172 (38%), Gaps = 18/172 (10%)
Query: 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVV-DREALAIRKKLHRADME 139
+ L R + LG G VY + G A+K + D+ +R++ E
Sbjct: 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKH---E 58
Query: 140 KVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYA-ARQRQPGKRFG--------- 189
++ + L HP + L ++ YC DL+ R P G
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 190 --ISSAKFYAAETLLA--LEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237
+ A F T +A +E+L +V++DL NVLV + ++ +SD L
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGL 170
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 39/165 (23%), Positives = 72/165 (43%), Gaps = 37/165 (22%)
Query: 86 FRLLRRLGSGDIGNVYLCQ-IRNPMVGLPQCFYAMKVVD------------REALAIRKK 132
+++L ++G G V Q + +YA+K + RE A+R+
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKT------GKYYAIKCMKKHFKSLEQVNNLREIQALRRL 54
Query: 133 LHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQ--RQPGKRFGI 190
+ IL +++ F + LV E +LY + ++P
Sbjct: 55 SPHPN----ILRLIEVLFDRK-------TGRLALVFELMDM-NLYELIKGRKRP---LPE 99
Query: 191 SSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235
K Y + L +L+++H GI +RD+KPEN+L+++D + L+DF
Sbjct: 100 KRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDD-ILKLADF 143
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 17/46 (36%), Positives = 31/46 (67%)
Query: 193 AKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+++ + L L+Y+H G+V+RDLKP N+L+ E+ + + DF L+
Sbjct: 110 IQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLA 155
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 29/95 (30%), Positives = 50/95 (52%), Gaps = 8/95 (8%)
Query: 326 SKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP 385
+ + VGT YL+PE+ + + + D W+LG LYE+ PF+G N + ++ I +
Sbjct: 159 AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQG- 217
Query: 386 LTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKR 420
F I + S++ L+ LIS+L +P+ R
Sbjct: 218 -YFAPISPNFSRD------LRSLISQLFKVSPRDR 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 30/105 (28%), Positives = 53/105 (50%), Gaps = 10/105 (9%)
Query: 318 VAEPINARSKSF--VGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNE 375
+++ ++++SK++ VGT Y++PE+ G+ + D W LG LYE+ F+ N
Sbjct: 148 ISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP 207
Query: 376 KTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKR 420
++ I+ TF I S + L+ LI +L +P KR
Sbjct: 208 ALVLKIMSG--TFAPISDRYSPD------LRQLILSMLNLDPSKR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 22/52 (42%), Positives = 31/52 (59%)
Query: 184 PGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235
P + I+ K + L L LH +GIV+RD+KPEN+LV DG + + DF
Sbjct: 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDF 353
|
Length = 507 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 48/160 (30%), Positives = 69/160 (43%), Gaps = 17/160 (10%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVV--DREALAIRKKLHRADMEKVIL 143
+R + LG G G VYLC + L A K V D E+ K++ + E +L
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGREL-----AAKQVQFDPESPETSKEVSALECEIQLL 58
Query: 144 TMLDHPFLPTLYAEFE--ASHYSCLVMEYCPGGDLYAARQRQPGKRFGI---SSAKFYAA 198
L H + Y A + MEY PGG + + K +G S + Y
Sbjct: 59 KNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSV-----KDQLKAYGALTESVTRKYTR 113
Query: 199 ETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ L + YLH IV+RD+K N+L G++ L DF S
Sbjct: 114 QILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGAS 153
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 24/78 (30%), Positives = 40/78 (51%), Gaps = 1/78 (1%)
Query: 327 KSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL 386
+S GT +++PEVISG+G+G D W+LG + EML P+ + I +P
Sbjct: 167 RSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQP- 225
Query: 387 TFPRIGVSSSKEFEEVVK 404
T P++ S+ + +
Sbjct: 226 TNPQLPSHISEHARDFLG 243
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 29/98 (29%), Positives = 43/98 (43%), Gaps = 13/98 (13%)
Query: 151 LPTLYAEFEASHYSC----------LVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAET 200
L TLY E + C L+MEY P G L R P + ++ +A +
Sbjct: 60 LKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSL---RDYLPKHKLNLAQLLLFAQQI 116
Query: 201 LLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ YLH ++RDL NVL+ D + + DF L+
Sbjct: 117 CEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLA 154
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 33/129 (25%), Positives = 53/129 (41%), Gaps = 27/129 (20%)
Query: 139 EKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRF--------GI 190
E +L L H + LY + LV EYC Q K++
Sbjct: 49 EICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC----------DQDLKKYFDSCNGDIDP 98
Query: 191 SSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL---------SFKC 241
K + + L L + H +++RDLKP+N+L+ ++G + L+DF L +
Sbjct: 99 EIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA 158
Query: 242 DVVPKLLRP 250
+VV RP
Sbjct: 159 EVVTLWYRP 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 48/162 (29%), Positives = 73/162 (45%), Gaps = 19/162 (11%)
Query: 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVV--DREALAIRKKLHRADMEKVI 142
++RL + LG G G VYLC + L A+K V D ++ K+++ + E +
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGREL-----AVKQVPFDPDSQETSKEVNALECEIQL 57
Query: 143 LTMLDHPFLPTLYA---EFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKF---Y 196
L L H + Y + E S V EY PGG + + K +G + Y
Sbjct: 58 LKNLRHDRIVQYYGCLRDPEEKKLSIFV-EYMPGGSI-----KDQLKAYGALTENVTRRY 111
Query: 197 AAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ L + YLH IV+RD+K N+L G++ L DF S
Sbjct: 112 TRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGAS 153
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 16/35 (45%), Positives = 24/35 (68%)
Query: 201 LLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235
L L+Y+H +++RDLKP N+LV ED + + DF
Sbjct: 117 LRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDF 151
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 33/152 (21%), Positives = 60/152 (39%), Gaps = 20/152 (13%)
Query: 89 LRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDH 148
++ L G VYL +G Y +K+ ++ E IL +L
Sbjct: 3 IKLLKGGLTNRVYL-------LGTKDEDYVLKINPSREKGADRER-----EVAILQLLAR 50
Query: 149 --PFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEY 206
+P + A E+ +S L+ME+ G L + + AE L L
Sbjct: 51 KGLPVPKVLASGESDGWSYLLMEWIEGETLDEVSEEEK------EDIAEQLAELLAKLHQ 104
Query: 207 LHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
L ++ + + DL P N+LV + + + D++ +
Sbjct: 105 LPLLVLCHGDLHPGNILVDDGKILGIIDWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 43/163 (26%), Positives = 69/163 (42%), Gaps = 19/163 (11%)
Query: 83 LDHFRLLRRLGSGDIGNVY--LCQIRNPMVGLP--QCFYAMKVVDREALAIRKKLHRADM 138
L +F++ +++G G VY C + V L Q F M D +A R D
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMM---DAKA--------RQDC 49
Query: 139 EKVI--LTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKF- 195
K I L L+HP + F + +V+E GDL + ++ I
Sbjct: 50 VKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVW 109
Query: 196 -YAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237
Y + A+E++H +++RD+KP NV + G + L D L
Sbjct: 110 KYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 36/126 (28%), Positives = 57/126 (45%), Gaps = 33/126 (26%)
Query: 329 FVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENN-------------- 374
+V T Y APEVI G G+ VD W++G + E++ G+ F+G ++
Sbjct: 182 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTP 241
Query: 375 --------EKTLIN-ILKKPL--------TFPRIGVSSSKEFEEVVKLQ--DLISKLLVK 415
+ T+ N + +P FP S E +++ Q DL+SK+LV
Sbjct: 242 SAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVI 301
Query: 416 NPKKRI 421
+P KRI
Sbjct: 302 DPDKRI 307
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 2e-05
Identities = 17/38 (44%), Positives = 27/38 (71%)
Query: 201 LLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
L AL+Y+H +++RDLKP N+L+ D + L+DF L+
Sbjct: 117 LKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLA 154
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 21/49 (42%), Positives = 31/49 (63%)
Query: 194 KFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242
+F + L L+Y+H GI++RDLKP NV V ED + + DF L+ + D
Sbjct: 121 QFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (108), Expect = 3e-05
Identities = 28/95 (29%), Positives = 43/95 (45%), Gaps = 3/95 (3%)
Query: 145 MLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLAL 204
M D+P LY L+M+Y GDL+ +++ + + K + + AL
Sbjct: 65 MKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEAL 122
Query: 205 EYLHMMGIVYRDLKPENVL-VREDGHIMLSDFDLS 238
LH I++ D+K ENVL R I L D+ L
Sbjct: 123 NDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLC 157
|
Length = 267 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 3e-05
Identities = 33/131 (25%), Positives = 52/131 (39%), Gaps = 30/131 (22%)
Query: 328 SFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTP-FKGENNEKTLINILK--- 383
S V T Y APEV+ + + VD W++G E+ + P F+G + L I
Sbjct: 165 SVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL-FRRRPLFRGTSEADQLDKIFDVIG 223
Query: 384 -------------KPLTFPRIGVSSSKEFEEVVK-----LQDLISKLLVKNPKKRIGSLK 425
+FP + + F+ V DL+ K+L NP KRI + +
Sbjct: 224 LPSEEEWPRNVSLPRSSFPS---YTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFE 280
Query: 426 GSVEIKRHEFF 436
+H +F
Sbjct: 281 A----LQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 3e-05
Identities = 35/117 (29%), Positives = 55/117 (47%), Gaps = 16/117 (13%)
Query: 324 ARSKSFVGTHEYLAPEVISGQGHGSAV-----DWWTLGVFLYEMLYGTTPFKGENNEKTL 378
R +F+GT ++APEVI+ + A D W+LG+ EM G P + + L
Sbjct: 166 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL 225
Query: 379 INILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEF 435
I + P PR+ SK++ + K Q I LVKN +R + ++ +H F
Sbjct: 226 FLIPRNPA--PRL---KSKKWSK--KFQSFIESCLVKNHSQR----PTTEQLMKHPF 271
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 45/151 (29%), Positives = 64/151 (42%), Gaps = 30/151 (19%)
Query: 328 SFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINI----- 381
S V T Y APE++ G + + AVD W++G E+L G F GEN L I
Sbjct: 192 SKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLG 251
Query: 382 ----------LKKPLTFPRIGVSSSKEFEEVVKLQ-----DLISKLLVKNPKKRIGSLKG 426
K PL K+ + + DL+ LL NP +RI S K
Sbjct: 252 TPNEDNWPQAKKLPLYTE-FTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERI-SAKE 309
Query: 427 SVEIKRHEFFKGINWALIRSIKPPEVPNNDL 457
+++ HE+FK + L P ++P N L
Sbjct: 310 ALK---HEYFK--SDPL--PCDPSQLPFNFL 333
|
Length = 335 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 44/188 (23%), Positives = 71/188 (37%), Gaps = 40/188 (21%)
Query: 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRK---------KLHR 135
+ L++ LG G G V C RN + + E +AI+K R
Sbjct: 1 RYELIKELGQGAYGIV--CSARN-----------AETSEEETVAIKKITNVFSKKILAKR 47
Query: 136 ADMEKVILTML-DHPFLPTLYAEFEASHYSCL--------VMEYCPGGDLYAA-RQRQPG 185
A E +L H + LY + + +ME DL+ R QP
Sbjct: 48 ALRELKLLRHFRGHKNITCLY-DMDIVFPGNFNELYLYEELMEA----DLHQIIRSGQPL 102
Query: 186 KRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVP 245
+ + + L L+Y+H +++RDLKP N+LV D + + DF L+ P
Sbjct: 103 TDAHF---QSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159
Query: 246 KLLRPKLS 253
++
Sbjct: 160 GENAGFMT 167
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 25/72 (34%), Positives = 38/72 (52%), Gaps = 3/72 (4%)
Query: 327 KSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL 386
KS GT +++PEVISG+G+G D W++ + EML P+ + I +P
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQP- 225
Query: 387 TFPRI--GVSSS 396
T P + GVS +
Sbjct: 226 TKPMLPDGVSDA 237
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 44/160 (27%), Positives = 70/160 (43%), Gaps = 12/160 (7%)
Query: 88 LLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD 147
L+R LG G G VY + + G P+ A+K V+ E ++R+++ E ++ +
Sbjct: 10 LIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN-ENASMRERIEFL-NEASVMKEFN 67
Query: 148 HPFLPTLYAEFEASHYSCLVMEYCPGGDL--YAARQRQPGKRFG-----ISSAKFY--AA 198
+ L + +VME GDL Y R R+P + KF AA
Sbjct: 68 CHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYL-RSRRPEAENNPGLGPPTLQKFIQMAA 126
Query: 199 ETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
E + YL V+RDL N +V ED + + DF ++
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMT 166
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 32/100 (32%), Positives = 47/100 (47%), Gaps = 2/100 (2%)
Query: 139 EKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAA 198
E +L L H + TL+ LV EY DL G + + K +
Sbjct: 53 EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLD-NCGNLMSMHNVKIFMF 110
Query: 199 ETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ L L Y H I++RDLKP+N+L+ E G + L+DF L+
Sbjct: 111 QLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 42/162 (25%), Positives = 59/162 (36%), Gaps = 14/162 (8%)
Query: 88 LLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD 147
L R LG G G V+L + N + A+K + + RK HR E +LT L
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHR---EAELLTNLQ 65
Query: 148 HPFLPTLYAEFEASHYSCLVMEYCPGGDL-----------YAARQRQPGKRFGISSAKFY 196
H + Y +V EY GDL + S
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 197 AAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
A + + YL V+RDL N LV E+ + + DF +S
Sbjct: 126 AQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMS 167
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 36/155 (23%), Positives = 68/155 (43%), Gaps = 11/155 (7%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
+ +L+++LG+G G V++ A+K + + +++ L A++ K
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTK------VAIKSLKQGSMSPEAFLAEANLMK--- 56
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLA 203
L HP L LYA ++ EY G L + G + I+ AA+
Sbjct: 57 -QLQHPRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEG 114
Query: 204 LEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ ++ ++RDL+ N+LV E ++DF L+
Sbjct: 115 MAFIERKNYIHRDLRAANILVSETLCCKIADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 34/121 (28%), Positives = 54/121 (44%), Gaps = 21/121 (17%)
Query: 323 NARSKSFVGTHEYLAPEVIS-----GQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKT 377
R +F+GT ++APEVI+ + + D W+LG+ E+ G P + +
Sbjct: 167 LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA 226
Query: 378 LINILKKP---LTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHE 434
L I + P L P + SK+F D IS+ L+KN ++R E+ H
Sbjct: 227 LFKIPRNPPPTLKSPE---NWSKKF------NDFISECLIKNYEQR----PFMEELLEHP 273
Query: 435 F 435
F
Sbjct: 274 F 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 29/121 (23%), Positives = 50/121 (41%), Gaps = 34/121 (28%)
Query: 329 FVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINIL----- 382
+V T Y APE++ G +G+ + VD W++G E+L F G++ L I
Sbjct: 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGT 217
Query: 383 ----------------------KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKR 420
K + P++ ++S + DL+S++L +P KR
Sbjct: 218 PDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQ------ALDLLSQMLHYDPHKR 271
Query: 421 I 421
I
Sbjct: 272 I 272
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 30/97 (30%), Positives = 49/97 (50%), Gaps = 9/97 (9%)
Query: 326 SKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK- 384
+ S VGT Y++PE I G+ D W+LG LYEM +PF G+ + L ++ +K
Sbjct: 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD--KMNLFSLCQKI 220
Query: 385 -PLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKR 420
+P + E KL++L+S + +P +R
Sbjct: 221 EQCDYPPLPTEHYSE-----KLRELVSMCIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 35/121 (28%), Positives = 58/121 (47%), Gaps = 15/121 (12%)
Query: 123 DREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAA--- 179
+R+A R +LH L DH + + +F++ L+MEY GGDL
Sbjct: 106 ERQAAYARSELH-------CLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQ 158
Query: 180 --RQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237
++ P + + + FY + +LAL+ +H +++RDLK N+ + G I L DF
Sbjct: 159 RLKEHLPFQEYEVGLL-FY--QIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGF 215
Query: 238 S 238
S
Sbjct: 216 S 216
|
Length = 478 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 41/147 (27%), Positives = 66/147 (44%), Gaps = 15/147 (10%)
Query: 91 RLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADM--EKVILTMLDH 148
++G G G V C R G A+K++D +RK+ R + E VI+ H
Sbjct: 28 KIGEGSTGIV--CIAREKHSGRQ---VAVKMMD-----LRKQQRRELLFNEVVIMRDYQH 77
Query: 149 PFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLH 208
+ +Y + ++ME+ GG L + R L AL YLH
Sbjct: 78 QNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLH 134
Query: 209 MMGIVYRDLKPENVLVREDGHIMLSDF 235
G+++RD+K +++L+ DG + LSDF
Sbjct: 135 SQGVIHRDIKSDSILLTLDGRVKLSDF 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 33/119 (27%), Positives = 51/119 (42%), Gaps = 30/119 (25%)
Query: 330 VGTHEYLAPEVISGQGH-GSAVDWWTLGVFLYEMLYGTTPFKGENNEKTL---INIL--- 382
V T Y APE++ G H SAVD W++G E+L F+ ++ + L ++L
Sbjct: 165 VVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTP 224
Query: 383 --------------------KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRI 421
KP + P + SS+ E V L+ ++LV +P KRI
Sbjct: 225 SLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAV---HLLCRMLVFDPDKRI 280
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 44/160 (27%), Positives = 68/160 (42%), Gaps = 29/160 (18%)
Query: 89 LRRLGSGDIGNVY--LCQIRNPMVGLPQCFYAMKVVDREA------LAIRKKLHRADMEK 140
L +LG G VY + +I +V A+KV+ + AIR E
Sbjct: 10 LEKLGEGSYATVYKGISRINGQLV-------ALKVISMKTEEGVPFTAIR--------EA 54
Query: 141 VILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISS--AKFYAA 198
+L L H + L+ V EY DL + PG G+ + +
Sbjct: 55 SLLKGLKHANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPG---GLHPYNVRLFMF 110
Query: 199 ETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ L L Y+H I++RDLKP+N+L+ G + L+DF L+
Sbjct: 111 QLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 6e-05
Identities = 20/57 (35%), Positives = 33/57 (57%)
Query: 186 KRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242
++ +F + L L+Y+H GI++RDLKP N+ V ED + + DF L+ + D
Sbjct: 113 EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 7e-05
Identities = 27/81 (33%), Positives = 42/81 (51%), Gaps = 5/81 (6%)
Query: 166 LVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVR 225
+VMEY GG L I++ E L ALE+LH +++RD+K +N+L+
Sbjct: 94 VVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQALEFLHSNQVIHRDIKSDNILLG 150
Query: 226 EDGHIMLSDFDLSFKCDVVPK 246
DG + L+DF F + P+
Sbjct: 151 MDGSVKLTDF--GFCAQITPE 169
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 7e-05
Identities = 25/78 (32%), Positives = 39/78 (50%), Gaps = 1/78 (1%)
Query: 327 KSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL 386
KS GT +++PEVISG+G+G D W++G + EML P+ + I +P
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP- 225
Query: 387 TFPRIGVSSSKEFEEVVK 404
T P + S + +K
Sbjct: 226 TNPVLPPHVSDHCRDFLK 243
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 7e-05
Identities = 19/54 (35%), Positives = 32/54 (59%)
Query: 185 GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
G + + K + + L L Y H +++RDLKP+N+L+ E G + L+DF L+
Sbjct: 98 GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLA 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 7e-05
Identities = 41/152 (26%), Positives = 66/152 (43%), Gaps = 11/152 (7%)
Query: 92 LGSGDIGNVYLCQIRNPM-VGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPF 150
LG G+ G V+ +++ V + C +E L K+ + E IL DHP
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTC--------KEDLPQELKI-KFLSEARILKQYDHPN 53
Query: 151 LPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMM 210
+ L +VME PGGD + +++ + KF A + + YL
Sbjct: 54 IVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKF-ALDAAAGMAYLESK 112
Query: 211 GIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242
++RDL N LV E+ + +SDF +S + D
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSRQED 144
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 8e-05
Identities = 38/124 (30%), Positives = 59/124 (47%), Gaps = 26/124 (20%)
Query: 321 PINARSKSFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLI 379
P+N S V T Y AP+V+ G + + +++D W++G + EM+ G F G NNE L+
Sbjct: 153 PVNTFSNEVV-TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLL 211
Query: 380 NILK-----KPLTFPRIGVSSSKEFE------EVVKLQ-----------DLISKLLVKNP 417
I + T+P G+S E++ LQ DL+ +LL NP
Sbjct: 212 KIFRIMGTPTESTWP--GISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNP 269
Query: 418 KKRI 421
+ RI
Sbjct: 270 ELRI 273
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 8e-05
Identities = 42/163 (25%), Positives = 67/163 (41%), Gaps = 27/163 (16%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
L++ +GSG G V+L + A+K + A++ + A ++
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLE------KRKVAIKTIREGAMSEEDFIEEAQ----VM 53
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLL- 202
L HP L LY CLV E+ G L + Q GK ++ ETLL
Sbjct: 54 MKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK---------FSQETLLG 104
Query: 203 -------ALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ YL +++RDL N LV E+ + +SDF ++
Sbjct: 105 MCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMT 147
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 8e-05
Identities = 48/160 (30%), Positives = 73/160 (45%), Gaps = 18/160 (11%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDRE-ALAIRKKLHRADMEKVI 142
D F + LG+G+ G V ++++ GL A K++ E AIR ++ R E +
Sbjct: 5 DDFERISELGAGNGGVVT--KVQHKPSGL---IMARKLIHLEIKPAIRNQIIR---ELQV 56
Query: 143 LTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDL---YAARQRQPGKRFGISSAKFYAAE 199
L + P++ Y F + + ME+ GG L +R P + G S
Sbjct: 57 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA----- 111
Query: 200 TLLALEYL-HMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
L L YL I++RD+KP N+LV G I L DF +S
Sbjct: 112 VLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVS 151
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 8e-05
Identities = 31/85 (36%), Positives = 44/85 (51%), Gaps = 13/85 (15%)
Query: 199 ETLLALEYLHMMGIVYRDLKPENVLVRE-DGHIMLSDF----DLSFKCDVVPK--LLRPK 251
+ L AL+ LH GIV+RD+KP+N++ E G + D DL + +PK LL P+
Sbjct: 263 QILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPR 322
Query: 252 LSFEAIEKYEKCSIPSCATPMQPVL 276
+ A E+Y I S TP P
Sbjct: 323 --YAAPEQY----IMSTQTPSAPSA 341
|
Length = 566 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 8e-05
Identities = 40/158 (25%), Positives = 66/158 (41%), Gaps = 15/158 (9%)
Query: 86 FRLLRRLGSGDIGNVY--LCQIRNPMVGLPQCFYAMKVV-DREALAIRKKLHRADMEKVI 142
++ LGSG G VY + V +P A+KV+ + + K++ E +
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIP---VAIKVLREETSPKANKEILD---EAYV 62
Query: 143 LTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDL--YAARQRQPGKRFGISSAKFYAAET 200
+ +DHP + L S L+ + P G L Y R G + +
Sbjct: 63 MASVDHPHVVRLLG-ICLSSQVQLITQLMPLGCLLDYV---RNHKDNIGSQYLLNWCVQI 118
Query: 201 LLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ YL +V+RDL NVLV+ H+ ++DF L+
Sbjct: 119 AKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 9e-05
Identities = 50/162 (30%), Positives = 73/162 (45%), Gaps = 22/162 (13%)
Query: 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHP 149
R LGSG G V LC R V + F A+KVVD E ++ K RA E L D
Sbjct: 38 RVLGSGATGTV-LCAKR---VSDGEPF-AVKVVDMEGMSEADKN-RAQAEVCCLLNCDFF 91
Query: 150 FLPTLYAEF--------EASHYSCLVMEYCPGGDLYAARQR-----QPGKRFGISSAKFY 196
+ + +F E LV++Y GDL RQ + + F A
Sbjct: 92 SIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDL---RQEIKSRAKTNRTFREHEAGLL 148
Query: 197 AAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ LLA+ ++H +++RD+K N+L+ +G + L DF S
Sbjct: 149 FIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFS 190
|
Length = 496 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 9e-05
Identities = 31/97 (31%), Positives = 51/97 (52%), Gaps = 9/97 (9%)
Query: 326 SKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK- 384
+ S VGT Y++PE I G+ D W+LG LYEM +PF G+ + L ++ KK
Sbjct: 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD--KMNLYSLCKKI 220
Query: 385 -PLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKR 420
+P + S + E +L+ L++ + +P+KR
Sbjct: 221 EQCDYPPL---PSDHYSE--ELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 9e-05
Identities = 19/54 (35%), Positives = 32/54 (59%)
Query: 185 GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
G + + K + + L L Y H +++RDLKP+N+L+ E G + L+DF L+
Sbjct: 98 GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLA 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 9e-05
Identities = 19/40 (47%), Positives = 28/40 (70%)
Query: 199 ETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ L L++LH +V+RDLKP+N+LV G I L+DF L+
Sbjct: 118 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 33/111 (29%), Positives = 50/111 (45%), Gaps = 12/111 (10%)
Query: 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK 384
+ +FVGT ++APEVI + S D W+LG+ E+ G P + + L I K
Sbjct: 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN 216
Query: 385 PLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEF 435
P + SK F+E I L K+P R + E+ +H+F
Sbjct: 217 NP--PTLTGEFSKPFKE------FIDACLNKDPSFR----PTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 32/108 (29%), Positives = 51/108 (47%), Gaps = 5/108 (4%)
Query: 139 EKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAA 198
E +++ L +P + F +VMEY GG L I++
Sbjct: 66 EILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAV---CR 122
Query: 199 ETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPK 246
E L ALE+LH +++RD+K +NVL+ DG + L+DF F + P+
Sbjct: 123 ECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDF--GFCAQITPE 168
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 1e-04
Identities = 35/116 (30%), Positives = 50/116 (43%), Gaps = 23/116 (19%)
Query: 329 FVGTHEYLAPEVISGQGHGS-AVDWWTLGVFLYEMLYGTTPFKGENN----EKTL----- 378
+V T Y APE++ G + VD W++G L EML G F G + EK +
Sbjct: 172 YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGP 231
Query: 379 -----INILKKPLT---FPRIGVSSSKEFEEVVKLQ-----DLISKLLVKNPKKRI 421
I +K P + K +E++ DL+ KLLV NP KR+
Sbjct: 232 PSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRL 287
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 38/101 (37%), Positives = 50/101 (49%), Gaps = 14/101 (13%)
Query: 329 FVGTHEYLAPEVISGQGHGS-AVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLT 387
+V T Y APEVI H + VD W++G + EML G FKG ++ L+ I+K
Sbjct: 175 YVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMK---- 230
Query: 388 FPRIGVSSSKEFEEVVKLQDLISKLLVKN----PKKRIGSL 424
+ + SKEF V KLQ +K VK KK SL
Sbjct: 231 ---VTGTPSKEF--VQKLQSEDAKNYVKKLPRFRKKDFRSL 266
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 42/173 (24%), Positives = 63/173 (36%), Gaps = 22/173 (12%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADM--EK 140
L R + LG G +Y + LP +A V + I + E
Sbjct: 4 LSAVRFMEELGECAFGKIYKGHLY-----LPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58
Query: 141 VILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAAR-QRQPGKRFGISSAK----- 194
++ L HP + L C++ EY GDL+ R P G SS +
Sbjct: 59 SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118
Query: 195 ---------FYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
A + +EYL V++DL N+L+ E H+ +SD LS
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLS 171
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 44/163 (26%), Positives = 65/163 (39%), Gaps = 30/163 (18%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADM------- 138
+L R+LG+G G V++ KV A+ K L M
Sbjct: 8 LKLERKLGAGQFGEVWMGTWNG----------TTKV------AV-KTLKPGTMSPEAFLQ 50
Query: 139 EKVILTMLDHPFLPTLYA---EFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKF 195
E I+ L H L LYA E E + +V EY G L + GK+ +
Sbjct: 51 EAQIMKKLRHDKLVQLYAVCSEEEPIY---IVTEYMSKGSLLDFLKSGEGKKLRLPQLVD 107
Query: 196 YAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
AA+ + YL ++RDL N+LV E+ ++DF L+
Sbjct: 108 MAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLA 150
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 24/66 (36%), Positives = 35/66 (53%)
Query: 318 VAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKT 377
++E NA +V T Y +PE++ G +G AVD W++G L E+ G F GE+
Sbjct: 150 LSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ 209
Query: 378 LINILK 383
L I K
Sbjct: 210 LFTIQK 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 17/40 (42%), Positives = 26/40 (65%)
Query: 196 YAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235
Y + L +E+ H I++RD+KPEN+LV + G + L DF
Sbjct: 105 YLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 40/135 (29%), Positives = 60/135 (44%), Gaps = 38/135 (28%)
Query: 332 THE-----YLAPEVISGQGHGS-AVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILK-- 383
THE Y APE++ G S VD W++G EM+ F G++ L I +
Sbjct: 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTL 216
Query: 384 -----------------KPLTFPRIGVSSSKEFEEVVKL-----QDLISKLLVKNPKKRI 421
KP TFP+ + ++ +VV DL+SK+LV +P KRI
Sbjct: 217 GTPDEDVWPGVTSLPDYKP-TFPKW---ARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRI 272
Query: 422 GSLKGSVEIKRHEFF 436
S K +++ H +F
Sbjct: 273 -SAKAALQ---HPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 18/43 (41%), Positives = 26/43 (60%)
Query: 327 KSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPF 369
KS GT ++APEVI+ G+G D W++G ++EM G P
Sbjct: 166 KSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 23/98 (23%), Positives = 46/98 (46%), Gaps = 2/98 (2%)
Query: 138 MEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYA 197
+E ++L ++HP + + + +C+V+ + DLY ++ I A
Sbjct: 106 IEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSR-PLPIDQALIIE 163
Query: 198 AETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235
+ L L YLH I++RD+K EN+ + + + + D
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDL 201
|
Length = 357 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 37/127 (29%), Positives = 57/127 (44%), Gaps = 34/127 (26%)
Query: 329 FVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENN-------------- 374
+V T Y APEVI G G+ VD W++G + EM+ GT F G ++
Sbjct: 177 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTP 236
Query: 375 --------EKTLINILK-----KPLTFPRI--GVSSSKEFEEVVKL-----QDLISKLLV 414
+ T+ N ++ +F + V + E KL +DL+SK+LV
Sbjct: 237 SDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLV 296
Query: 415 KNPKKRI 421
+P+KRI
Sbjct: 297 IDPEKRI 303
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 22/80 (27%), Positives = 34/80 (42%), Gaps = 1/80 (1%)
Query: 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINIL 382
N S G+ ++APEV+ + D W+LG + EML G PF + + I
Sbjct: 166 NGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG 225
Query: 383 KKPL-TFPRIGVSSSKEFEE 401
+ P S + +F E
Sbjct: 226 ENASPEIPSNISSEAIDFLE 245
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 2e-04
Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 5/81 (6%)
Query: 166 LVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVR 225
+VMEY GG L I++ E L AL++LH +++RD+K +N+L+
Sbjct: 93 VVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQALDFLHSNQVIHRDIKSDNILLG 149
Query: 226 EDGHIMLSDFDLSFKCDVVPK 246
DG + L+DF F + P+
Sbjct: 150 MDGSVKLTDF--GFCAQITPE 168
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 45/159 (28%), Positives = 67/159 (42%), Gaps = 17/159 (10%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVI 142
+ +LL+ +G G+ G+V L R V A+K + +A A E +
Sbjct: 5 MKELKLLQTIGKGEFGDVMLGDYRGNKV-------AVKCIKNDATA-----QAFLAEASV 52
Query: 143 LTMLDHPFLPTLYA---EFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAE 199
+T L H L L E + Y +V EY G L + + G ++ +
Sbjct: 53 MTQLRHSNLVQLLGVIVEEKGGLY--IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 110
Query: 200 TLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
A+EYL V+RDL NVLV ED +SDF L+
Sbjct: 111 VCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLT 149
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 19/49 (38%), Positives = 29/49 (59%)
Query: 194 KFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242
+F + L L+Y+H I++RDLKP N+ V ED + + DF L+ D
Sbjct: 123 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 21/71 (29%), Positives = 36/71 (50%), Gaps = 13/71 (18%)
Query: 168 MEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRED 227
M+ C GG + + + + + L L Y H +++RDLKP+N+L+ E
Sbjct: 93 MDDCGGG-------------LSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISER 139
Query: 228 GHIMLSDFDLS 238
G + L+DF L+
Sbjct: 140 GELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 18/37 (48%), Positives = 27/37 (72%), Gaps = 1/37 (2%)
Query: 203 ALEYLH-MMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
ALEYLH + +++RD+KP NVL+ +G + L DF +S
Sbjct: 115 ALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGIS 151
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 30/151 (19%), Positives = 59/151 (39%), Gaps = 14/151 (9%)
Query: 88 LLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD 147
+ + I ++ + N +V A+K ++ ++ ++ L E + L
Sbjct: 6 IGKCFEDLMIVHLAKHKPTNTLV-------AVKKINLDS-CSKEDLKLLQQEIITSRQLQ 57
Query: 148 HPFLPTLYAEFEASHYSCLVMEYCPGG---DLYAARQRQPGKRFGISSAKFYAAETLLAL 204
HP + F +V G DL + I+ F + L AL
Sbjct: 58 HPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIA---FILKDVLNAL 114
Query: 205 EYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235
+Y+H G ++R +K ++L+ DG ++LS
Sbjct: 115 DYIHSKGFIHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 24/81 (29%), Positives = 38/81 (46%), Gaps = 2/81 (2%)
Query: 166 LVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVR 225
+VMEY DL + + F S K + L + +LH I++RDLK N+L+
Sbjct: 83 MVMEYVEH-DLKSLMETMKQ-PFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLN 140
Query: 226 EDGHIMLSDFDLSFKCDVVPK 246
G + + DF L+ + K
Sbjct: 141 NRGILKICDFGLAREYGSPLK 161
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 43/154 (27%), Positives = 64/154 (41%), Gaps = 14/154 (9%)
Query: 87 RLLRRLGSGDIGNVY--LCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILT 144
+LLR+LG+G G V+ L P+ A+K + + + L A I+
Sbjct: 9 QLLRKLGAGQFGEVWEGLWNNTTPV--------AVKTLKPGTMDPKDFLAEAQ----IMK 56
Query: 145 MLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLAL 204
L HP L LYA +V E G L Q G+ + AA+ +
Sbjct: 57 KLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGM 116
Query: 205 EYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
YL ++RDL NVLV E+ ++DF L+
Sbjct: 117 AYLEAQNYIHRDLAARNVLVGENNICKVADFGLA 150
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 17/58 (29%), Positives = 33/58 (56%), Gaps = 1/58 (1%)
Query: 182 RQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIM-LSDFDLS 238
R PG+ + K + + L + + H G+++RDLKP+N+LV + ++ ++D L
Sbjct: 101 RGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 43/164 (26%), Positives = 74/164 (45%), Gaps = 21/164 (12%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLH--RADMEK 140
L ++ L+ +GSG G V C + ++G+ A+K + R + + H RA E
Sbjct: 20 LKRYQQLKPIGSGAQGIV--CAAFDTVLGIN---VAVKKLSR---PFQNQTHAKRAYREL 71
Query: 141 VILTMLDHPFLPTLYAEF------EASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAK 194
V+L ++H + +L F E LVME +R
Sbjct: 72 VLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERM-----S 126
Query: 195 FYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ + L +++LH GI++RDLKP N++V+ D + + DF L+
Sbjct: 127 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 170
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 39/132 (29%), Positives = 58/132 (43%), Gaps = 29/132 (21%)
Query: 329 FVGTHEYLAPEVISGQ-GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK--- 384
+V T Y APE++ G +G AVD W +G + EML G F G+++ L +I+K
Sbjct: 160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGN 219
Query: 385 ------------PLTFPRIGVSSSKEFEEVVK--------LQDLISKLLVKNPKKRIGSL 424
PL F + + KE E + K + DL + L +P R
Sbjct: 220 LIPRHQEIFQKNPL-FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRP--- 275
Query: 425 KGSVEIKRHEFF 436
S ++ HEFF
Sbjct: 276 -SSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 45/159 (28%), Positives = 73/159 (45%), Gaps = 16/159 (10%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDRE-ALAIRKKLHRADMEKVI 142
D F + LG+G+ G V+ ++ + GL A K++ E AIR ++ R E +
Sbjct: 5 DDFEKISELGAGNGGVVF--KVSHKPSGL---IMARKLIHLEIKPAIRNQIIR---ELQV 56
Query: 143 LTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQ---PGKRFGISSAKFYAAE 199
L + P++ Y F + + ME+ GG L ++ P + G S
Sbjct: 57 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGL 116
Query: 200 TLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
T L ++ I++RD+KP N+LV G I L DF +S
Sbjct: 117 TYLREKH----KIMHRDVKPSNILVNSRGEIKLCDFGVS 151
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 21/57 (36%), Positives = 32/57 (56%)
Query: 312 LDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTP 368
L D V + I++ + SFVGT Y++PE + G + D W++G+ L EM G P
Sbjct: 145 LCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 41/134 (30%), Positives = 62/134 (46%), Gaps = 30/134 (22%)
Query: 332 THE-----YLAPEVISGQGHGSA-VDWWTLGVFLYEMLYGTTPFKGENNEKTLINI---L 382
THE Y APE++ G H S VD W++G EM+ F G++ L I L
Sbjct: 161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRIL 220
Query: 383 KKPLTFPRIGVSSSKEFEE-------------VVKLQ----DLISKLLVKNPKKRIGSLK 425
P GV+S +++ V L+ DL+SK+L +P KRI + +
Sbjct: 221 GTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITA-R 279
Query: 426 GSVEIKRHEFFKGI 439
++E HE+FK +
Sbjct: 280 AALE---HEYFKDL 290
|
Length = 294 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 27/102 (26%), Positives = 42/102 (41%), Gaps = 12/102 (11%)
Query: 324 ARSKSFVGTHEYLAPEVISGQGHGSA----VDWWTLGVFLYEMLYGTTPFKGENNE-KTL 378
A+++S G Y+APE I D W+LG+ L E+ G P+K E + L
Sbjct: 170 AKTRS-AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVL 228
Query: 379 INILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKR 420
IL++ S +F + L K+ +KR
Sbjct: 229 TKILQEEPPSLPPNEGFSPDF------CSFVDLCLTKDHRKR 264
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 32/122 (26%), Positives = 51/122 (41%), Gaps = 35/122 (28%)
Query: 329 FVGTHEYLAPEV-ISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLT 387
+V T Y APE+ ++ +G+ A+D W++G L EML F G++ L IL
Sbjct: 169 YVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGV--- 225
Query: 388 FPRIGVSSSKEFEEVVKLQ----------------------------DLISKLLVKNPKK 419
+G S ++ ++ L+ DL+ K+L NP K
Sbjct: 226 ---LGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHK 282
Query: 420 RI 421
RI
Sbjct: 283 RI 284
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 32/120 (26%), Positives = 54/120 (45%), Gaps = 21/120 (17%)
Query: 304 GDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEML 363
GD LL P A + ++VGT Y+ PE+ + + D W+LG LYE+
Sbjct: 142 GDFGSARLLTSP-------GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELC 194
Query: 364 YGTTPFKGENNEKTLINILK---KPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKR 420
PF+ + + ++ + + KPL S +E L+ LI ++ +NP+ R
Sbjct: 195 TLKHPFQANSWKNLILKVCQGSYKPL-------PSHYSYE----LRSLIKQMFKRNPRSR 243
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 16/38 (42%), Positives = 27/38 (71%)
Query: 201 LLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
L +++LH GI++RDLKP N++V+ D + + DF L+
Sbjct: 128 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 165
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 5e-04
Identities = 40/135 (29%), Positives = 63/135 (46%), Gaps = 38/135 (28%)
Query: 332 THE-----YLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILK-- 383
THE Y APE++ G + + +AVD W+LG EM+ F G++ L I +
Sbjct: 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 217
Query: 384 -----------------KPLTFPRIGVSSSKEFEEVVKL-----QDLISKLLVKNPKKRI 421
KP +FP+ + ++F +VV +DL+S++L +P KRI
Sbjct: 218 GTPDEVVWPGVTSLPDYKP-SFPKW---ARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRI 273
Query: 422 GSLKGSVEIKRHEFF 436
S K ++ H FF
Sbjct: 274 -SAKAALA---HPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 5e-04
Identities = 24/75 (32%), Positives = 39/75 (52%), Gaps = 1/75 (1%)
Query: 312 LDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKG 371
L D V + I++ + SFVGT Y++PE + G + D W++G+ L E+ G P
Sbjct: 145 LCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIP- 203
Query: 372 ENNEKTLINILKKPL 386
+ K L I +P+
Sbjct: 204 PPDAKELEAIFGRPV 218
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 5e-04
Identities = 27/80 (33%), Positives = 40/80 (50%), Gaps = 13/80 (16%)
Query: 336 LAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPR----- 390
+APEVI GQ + D ++LG+ LYE L P N E+ L IL+ L
Sbjct: 71 MAPEVIQGQSYTEKADIYSLGITLYEALDYELP---YNEERELSAILEILLNGMPADDPR 127
Query: 391 -----IGVSSSKEFEEVVKL 405
GVS+++ FE+ ++L
Sbjct: 128 DRSNLEGVSAARSFEDFMRL 147
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 5e-04
Identities = 36/126 (28%), Positives = 52/126 (41%), Gaps = 33/126 (26%)
Query: 329 FVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGE---NNEKTLINILKKP 385
+V T Y APEVI G G+ VD W++G + EM+ F G + +I L P
Sbjct: 178 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237
Query: 386 ------------------------LTFPRI------GVSSSKEFEEVVKLQDLISKLLVK 415
LTFP++ S + + +DL+SK+LV
Sbjct: 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 297
Query: 416 NPKKRI 421
+P KRI
Sbjct: 298 DPAKRI 303
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 5e-04
Identities = 30/131 (22%), Positives = 51/131 (38%), Gaps = 26/131 (19%)
Query: 328 SFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGEN------------- 373
+ V T Y PE++ G + + +AVD W +G EM +G++
Sbjct: 185 NLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG 244
Query: 374 --NEKTLINILKKP-----LTFPRIGVSSSKEFEEVVKLQ-DLISKLLVKNPKKRIGSLK 425
E+T P +F + + F ++ DL+SKLL +P KR+ +
Sbjct: 245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASD 304
Query: 426 GSVEIKRHEFF 436
H +F
Sbjct: 305 A----LEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 42/166 (25%), Positives = 71/166 (42%), Gaps = 10/166 (6%)
Query: 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEK 140
V + LLR LG G G VY R+ + G + A+K V+ E+ ++R+++ +
Sbjct: 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN-ESASLRERIEFLNEAS 61
Query: 141 VILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYA-------ARQRQPGKRF-GISS 192
V+ H + L + +VME GDL + + PG+ +
Sbjct: 62 VMKGFTCHHVV-RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 120
Query: 193 AKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
AAE + YL+ V+RDL N +V D + + DF ++
Sbjct: 121 MIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMT 166
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 6e-04
Identities = 30/102 (29%), Positives = 47/102 (46%), Gaps = 11/102 (10%)
Query: 324 ARSKSFVGTHEYLAPEVISGQ---GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLIN 380
A+ KSF+GT ++APEV + + G+ D W +G+ E+ P + + L
Sbjct: 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL 220
Query: 381 ILKKPLTFPRI--GVSSSKEFEEVVKLQDLISKLLVKNPKKR 420
+ K P++ + S F VK+ L KNPKKR
Sbjct: 221 MTKSNFQPPKLKDKMKWSNSFHHFVKMA------LTKNPKKR 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 42/157 (26%), Positives = 75/157 (47%), Gaps = 16/157 (10%)
Query: 86 FRLLRRLGSGDIGNVY--LCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
++L +G+G G VY +C + V + + + +RE L I K L+ + I+
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRE-LLIMKNLNHIN----II 122
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGG----DLYAARQRQPGKRFGISSAKFYAAE 199
+ D+ + + + E + + +VME+ P + AR F + K Y+ +
Sbjct: 123 FLKDYYYTEC-FKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLV---KLYSYQ 178
Query: 200 TLLALEYLHMMGIVYRDLKPENVLVREDGHIM-LSDF 235
AL Y+H I +RDLKP+N+L+ + H + L DF
Sbjct: 179 LCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF 215
|
Length = 440 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 18/55 (32%), Positives = 30/55 (54%)
Query: 184 PGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
G+ K Y + L + + H +++RDLKP+N+L+ G I L+DF L+
Sbjct: 94 KGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLA 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 7e-04
Identities = 28/96 (29%), Positives = 45/96 (46%), Gaps = 1/96 (1%)
Query: 142 ILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETL 201
+L L+HP + L + + LV E+ DL P K Y + L
Sbjct: 51 LLKELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLL 109
Query: 202 LALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237
+ Y H +++RDLKP+N+L+ +G + L+DF L
Sbjct: 110 QGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGL 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 44/170 (25%), Positives = 72/170 (42%), Gaps = 31/170 (18%)
Query: 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEK 140
L+ L +GSG G VY + + + A+K + R K D++
Sbjct: 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVM-----AVKQMRRTGNKEENKRILMDLD- 65
Query: 141 VILTMLDHPFLPTLYAEF--EASHYSCL-VMEYCPGGDLYAARQRQP------GKRFGIS 191
V+L D P++ Y F ++ + C+ +M C D R + P GK
Sbjct: 66 VVLKSHDCPYIVKCYGYFITDSDVFICMELMSTC--LDKLLKRIQGPIPEDILGK----- 118
Query: 192 SAKFYAAETLLALEYL---HMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ AL YL H G+++RD+KP N+L+ G++ L DF +S
Sbjct: 119 ----MTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGIS 162
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 7e-04
Identities = 23/73 (31%), Positives = 34/73 (46%), Gaps = 1/73 (1%)
Query: 166 LVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVR 225
L+ME+ P G L R K + YA + ++YL V+RDL NVLV
Sbjct: 85 LIMEFLPSGSLKEYLPRNKNK-INLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE 143
Query: 226 EDGHIMLSDFDLS 238
+ + + DF L+
Sbjct: 144 SEHQVKIGDFGLT 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 8e-04
Identities = 30/111 (27%), Positives = 51/111 (45%), Gaps = 12/111 (10%)
Query: 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK 384
+ +FVGT ++APEVI + D W+LG+ E+ G P + + L I K
Sbjct: 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN 216
Query: 385 PLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEF 435
+ P + SK F ++ + L K+P+ R + E+ +H+F
Sbjct: 217 --SPPTLEGQYSKPF------KEFVEACLNKDPRFR----PTAKELLKHKF 255
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 8e-04
Identities = 32/107 (29%), Positives = 46/107 (42%), Gaps = 13/107 (12%)
Query: 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKG-----------EN 373
+ +FVGT ++APEVI + S D W+LG+ E+ G P +N
Sbjct: 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN 216
Query: 374 NEKTLINILKKPLT-FPRIGVSSSKEFEEVVKLQDLISKLLVKNPKK 419
N TL KPL F ++ F K + L K +V+ KK
Sbjct: 217 NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAK-ELLKHKFIVRFAKK 262
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 8e-04
Identities = 35/130 (26%), Positives = 56/130 (43%), Gaps = 29/130 (22%)
Query: 318 VAEPINARSKSFVGTHEYLAPEV-ISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGEN--N 374
+A + + +V T Y APE+ ++ Q + VD W+ G EML G F G++ N
Sbjct: 154 LARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN 213
Query: 375 EKTLI------------------NILKKPLTFPRIGVSSSKEFEEVVK-----LQDLISK 411
+ ++I N L+ + P+ F E K DL+ K
Sbjct: 214 QFSIITDLLGTPPDDVINTICSENTLRFVQSLPK---REPVPFSEKFKNADPSAIDLLEK 270
Query: 412 LLVKNPKKRI 421
+LV +P+KRI
Sbjct: 271 MLVFDPQKRI 280
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 8e-04
Identities = 45/168 (26%), Positives = 70/168 (41%), Gaps = 26/168 (15%)
Query: 83 LDHFRLLRRLGSGDIGNVYLC-QIRNPMVGLPQCFYAMKVV----DREALAIRKKLHRAD 137
L + +L +LG G G VY QI+ V A+K + +++ I A
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRV------VALKKILMHNEKDGFPIT-----AL 55
Query: 138 MEKVILTMLDHP-FLPTL---YAEFEASHYS----CLVMEYCPGGDLYAARQRQPGKRFG 189
E IL L HP +P + + S +V Y DL + P +
Sbjct: 56 REIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYM-DHDL-SGLLENPSVKLT 113
Query: 190 ISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237
S K Y + L + YLH I++RD+K N+L+ G + ++DF L
Sbjct: 114 ESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGL 161
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 8e-04
Identities = 41/154 (26%), Positives = 63/154 (40%), Gaps = 11/154 (7%)
Query: 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILT 144
L+ LG+G G V + R Q A+K++ +++ + + A ++
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRG------QYDVAIKMIKEGSMSEDEFIEEAK----VMM 54
Query: 145 MLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLAL 204
L H L LY +V EY G L R+ GKRF S + +
Sbjct: 55 KLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNY-LREHGKRFQPSQLLEMCKDVCEGM 113
Query: 205 EYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
YL ++RDL N LV + G + +SDF LS
Sbjct: 114 AYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLS 147
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 8e-04
Identities = 45/163 (27%), Positives = 66/163 (40%), Gaps = 39/163 (23%)
Query: 329 FVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGE---NNEKTLINILKKP 385
+V T Y APEVI G G+ VD W++G + EM+ G F G + +I L P
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP 244
Query: 386 LT------FPRI-----------GVSSSKEFEEVV-------------KLQDLISKLLVK 415
P + G S K F +V+ + +DL+SK+LV
Sbjct: 245 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVI 304
Query: 416 NPKKRIGSLKGSV-EIKRHEFFKGINWALIRSIKPPEVPNNDL 457
+ KRI SV E +H + PP++P+ L
Sbjct: 305 DASKRI-----SVDEALQHPYINVWYDPSEAEAPPPKIPDKQL 342
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 8e-04
Identities = 17/45 (37%), Positives = 29/45 (64%)
Query: 194 KFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+F+ + L AL+Y+H + +RDLKP+N+L D + + DF L+
Sbjct: 106 QFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 150
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 8e-04
Identities = 40/166 (24%), Positives = 67/166 (40%), Gaps = 15/166 (9%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNP-MVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILT 144
+L + LG G+ G+V Q+ L MK+ + ++ E +
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKL----DIHTYSEIEEFLSEAACMK 56
Query: 145 MLDHPFLPTLYA-EFEASHYSCL-----VMEYCPGGDL--YAARQRQPGKRFGISSAKF- 195
DHP + L FEAS + ++ + GDL + R G +
Sbjct: 57 DFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLL 116
Query: 196 -YAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240
+ + L +EYL ++RDL N ++RED + ++DF LS K
Sbjct: 117 KFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKK 162
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 9e-04
Identities = 18/46 (39%), Positives = 23/46 (50%), Gaps = 1/46 (2%)
Query: 337 APEVISGQGHGSAVDWWTLGVFLYEML-YGTTPFKGENNEKTLINI 381
APE S + D W+ G+ LYEM YG P+ G NN + I
Sbjct: 172 APEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI 217
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 20/52 (38%), Positives = 30/52 (57%), Gaps = 2/52 (3%)
Query: 323 NARSKSFVGTHEYLAPEVIS--GQGHGSAVDWWTLGVFLYEMLYGTTPFKGE 372
N ++ S G+ ++APEVI QG+ + VD W+LG + EM G P+ E
Sbjct: 164 NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 29/103 (28%), Positives = 48/103 (46%), Gaps = 8/103 (7%)
Query: 318 VAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKT 377
V E + + +GT Y++PE+ S + + D W LG +YEM F ++
Sbjct: 151 VLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL 210
Query: 378 LINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKR 420
+ I++ L P + S E L +LI+ +L K P+KR
Sbjct: 211 VYRIIEGKL--PPMPKDYSPE------LGELIATMLSKRPEKR 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 37/124 (29%), Positives = 56/124 (45%), Gaps = 16/124 (12%)
Query: 305 DHHDQELLDDPEVVAEPINA---RSKSFVGTHEYLAPEVISGQ---GHGSAVDWWTLGVF 358
D+ D +L D VA I A + KSF+GT ++APEV + + G+ D W +G+
Sbjct: 141 DNGDVKLADFG--VAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGIT 198
Query: 359 LYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSS--SKEFEEVVKLQDLISKLLVKN 416
E+ P + + L + K P++ + S F VK+ L KN
Sbjct: 199 AIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKIS------LTKN 252
Query: 417 PKKR 420
PKKR
Sbjct: 253 PKKR 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.001
Identities = 31/137 (22%), Positives = 56/137 (40%), Gaps = 33/137 (24%)
Query: 328 SFVGTHEYLAPEVI-SGQGHGSAVDWWTLGVFLYEMLYGTTPFKGEN---NEKTLINILK 383
+V T Y APE++ S + +A+D W++G EML F G+N K ++++L
Sbjct: 170 EYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLG 229
Query: 384 KPLT-----------------FPRIGVSSSKEFEEVV-----KLQDLISKLLVKNPKKRI 421
P PR + ++ + DL+S++L +P++RI
Sbjct: 230 SPSEEVLNRIGSDRVRKYIQNLPRK---QPVPWSKIFPKASPEALDLLSQMLQFDPEERI 286
Query: 422 GSLKGSVEIKRHEFFKG 438
+ +H F
Sbjct: 287 ----TVEQALQHPFLAQ 299
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 40/149 (26%), Positives = 60/149 (40%), Gaps = 15/149 (10%)
Query: 92 LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVV--DREALAIRKKLHRADMEKVILTMLDHP 149
LG G G VY + Q +V LA K+ + E +L L H
Sbjct: 8 LGKGAYGTVYC-----GLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHV 62
Query: 150 FLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFG-ISSAKF--YAAETLLALEY 206
+ + + ME+ PGG + + RFG + F Y + L + Y
Sbjct: 63 NIVQYLGTCLDDNTISIFMEFVPGGSISSIL-----NRFGPLPEPVFCKYTKQILDGVAY 117
Query: 207 LHMMGIVYRDLKPENVLVREDGHIMLSDF 235
LH +V+RD+K NV++ +G I L DF
Sbjct: 118 LHNNCVVHRDIKGNNVMLMPNGIIKLIDF 146
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 0.001
Identities = 16/40 (40%), Positives = 28/40 (70%)
Query: 199 ETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ L +++LH GI++RDLKP N++V+ D + + DF L+
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 166
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 16/40 (40%), Positives = 28/40 (70%)
Query: 199 ETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ L +++LH GI++RDLKP N++V+ D + + DF L+
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 36/125 (28%), Positives = 53/125 (42%), Gaps = 6/125 (4%)
Query: 118 AMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCL-VMEYCPGGDL 176
A+K++ +A + R E + L HP + L EA V EY PG L
Sbjct: 7 AIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTL 66
Query: 177 YAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDG---HIMLS 233
G + + + L AL H GIV+RDLKP+N++V + G H +
Sbjct: 67 REVLAAD-GALPAGETGRL-MLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVL 124
Query: 234 DFDLS 238
DF +
Sbjct: 125 DFGIG 129
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 43/157 (27%), Positives = 69/157 (43%), Gaps = 13/157 (8%)
Query: 86 FRLLRRLGSGDIGNVY--LCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
F+ ++ LGSG G VY L V +P A+K + REA + + D E ++
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP---VAIKEL-REATSPKANKEILD-EAYVM 63
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDL--YAARQRQPGKRFGISSAKFYAAETL 201
+D+P + L S L+ + P G L Y R+ G + +
Sbjct: 64 ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIA 119
Query: 202 LALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ YL +V+RDL NVLV+ H+ ++DF L+
Sbjct: 120 KGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 39/161 (24%), Positives = 67/161 (41%), Gaps = 18/161 (11%)
Query: 92 LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFL 151
+G G+ G V +I+ + + A+K + A + ++E V+ + HP +
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDA---AIKRMKEYASKDDHRDFAGELE-VLCKLGHHPNI 58
Query: 152 PTLYAEFEASHYSCLVMEYCPGGDLY------------AARQRQPGKRFGISSAKF--YA 197
L E Y L +EY P G+L A +SS + +A
Sbjct: 59 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 198 AETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
A+ ++YL ++RDL N+LV E+ ++DF LS
Sbjct: 119 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 159
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 43/163 (26%), Positives = 69/163 (42%), Gaps = 22/163 (13%)
Query: 92 LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHR--ADMEKVILTMLDHP 149
+G G+ G V +I+ + + MK K HR A +V+ + HP
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEY------ASKDDHRDFAGELEVLCKLGHHP 68
Query: 150 FLPTLYAEFEASHYSCLVMEYCPGGDLY----AARQRQPGKRFGI--SSAKFYAAETLLA 203
+ L E Y L +EY P G+L +R + F I S+A +++ LL
Sbjct: 69 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 128
Query: 204 --------LEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
++YL ++RDL N+LV E+ ++DF LS
Sbjct: 129 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 171
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.001
Identities = 19/43 (44%), Positives = 29/43 (67%), Gaps = 1/43 (2%)
Query: 197 AAETLLALEYL-HMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
A T+ AL YL + I++RD+KP N+L+ +G+I L DF +S
Sbjct: 113 AVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS 155
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 31/121 (25%), Positives = 50/121 (41%), Gaps = 15/121 (12%)
Query: 325 RSKSFVGTHEYLAPEVISGQGHGSA-----VDWWTLGVFLYEMLYGTTPFKGENNEKTLI 379
R SF+GT ++APEV+ + D W+LG+ L EM P N + L+
Sbjct: 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL 225
Query: 380 NILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439
I K P SK ++ +D + L K+P+ R + ++ H F +
Sbjct: 226 KIAKSE---PPTLSQPSK---WSMEFRDFLKTALDKHPETR----PSAAQLLEHPFVSSV 275
Query: 440 N 440
Sbjct: 276 T 276
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 17/51 (33%), Positives = 24/51 (47%)
Query: 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGEN 373
++ S VGT Y PE++ + +G D W G LY+M PF N
Sbjct: 167 ESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 18/45 (40%), Positives = 29/45 (64%)
Query: 194 KFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
K + + L L+YLH GI++RD+KP N+LV + + + DF L+
Sbjct: 106 KVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLA 150
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.002
Identities = 33/131 (25%), Positives = 53/131 (40%), Gaps = 28/131 (21%)
Query: 330 VGTHEYLAPEVISGQGH-GSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILK----- 383
V T Y APE++ G +A+D W++G E+L F G++ L I K
Sbjct: 167 VVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTP 226
Query: 384 --------------KPLTFPR-IGVSSSKEFEEVVKLQ---DLISKLLVKNPKKRIGSLK 425
K TF + K+F + DL+++LL +P KRI +
Sbjct: 227 TEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAE- 285
Query: 426 GSVEIKRHEFF 436
+ +H +F
Sbjct: 286 ---DALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.002
Identities = 32/116 (27%), Positives = 51/116 (43%), Gaps = 23/116 (19%)
Query: 329 FVGTHEYLAPEVI-SGQGHGSAVDWWTLGVFLYEMLYGTTPFKGE---NNEKTLINILKK 384
+V T Y APE++ + + +A+D W++G E+L F G+ + K + +L
Sbjct: 168 YVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGS 227
Query: 385 P----LTF-------------PRI-GVSSSKEFEEVVKLQ-DLISKLLVKNPKKRI 421
P L F P S ++ F L DL+ K+LV +P KRI
Sbjct: 228 PSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRI 283
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 43/154 (27%), Positives = 67/154 (43%), Gaps = 9/154 (5%)
Query: 87 RLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADM--EKVILT 144
++ + +G+G+ G V C R + G + A+K + A + R D E I+
Sbjct: 7 KIEKVIGAGEFGEV--CSGRLKLPGKREIPVAIKTLK----AGYTEKQRRDFLSEASIMG 60
Query: 145 MLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLAL 204
DHP + L S +V EY G L A ++ G +F + +
Sbjct: 61 QFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDG-QFTVIQLVGMLRGIASGM 119
Query: 205 EYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+YL MG V+RDL N+LV + +SDF LS
Sbjct: 120 KYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLS 153
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 20/45 (44%), Positives = 28/45 (62%)
Query: 201 LLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVP 245
L AL YLH GI++RD+K EN+ + E + +L DF + K D P
Sbjct: 195 LEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239
|
Length = 392 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 43/152 (28%), Positives = 73/152 (48%), Gaps = 17/152 (11%)
Query: 92 LGSGDIGNVY--LCQIRNPMVGLPQCFYAMKVV-DREALAIRKKLHRADMEKVILTMLDH 148
LGSG+ G V + ++R + + A+KV+ + ++R ++ R E I+ LD+
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDV-----AIKVLKNENEKSVRDEMMR---EAEIMHQLDN 54
Query: 149 PFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAA--ETLLALEY 206
P++ + EA LVME GG L + GK+ I+ + + + ++Y
Sbjct: 55 PYIVRMIGVCEAEAL-MLVMEMASGGPL---NKFLSGKKDEITVSNVVELMHQVSMGMKY 110
Query: 207 LHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
L V+RDL NVL+ + +SDF LS
Sbjct: 111 LEGKNFVHRDLAARNVLLVNQHYAKISDFGLS 142
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 28/96 (29%), Positives = 47/96 (48%), Gaps = 6/96 (6%)
Query: 330 VGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFP 389
VGT +Y+APE + G + D + LGV LY+ML + P++ + K + + P
Sbjct: 192 VGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI---SYRDVILSP 248
Query: 390 RIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLK 425
I V+ +E L + K L +P +R S++
Sbjct: 249 -IEVAPYREIPPF--LSQIAMKALAVDPAERYSSVQ 281
|
Length = 932 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.002
Identities = 42/170 (24%), Positives = 62/170 (36%), Gaps = 41/170 (24%)
Query: 87 RLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLH-------RADM- 138
+ + +G G+ G V +++ P +AI K L R D
Sbjct: 7 TIEKVIGGGEFGEVCRGRLKLPGK------------KEIDVAI-KTLKAGSSDKQRLDFL 53
Query: 139 -EKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGK---------RF 188
E I+ DHP + L S ++ EY G L + GK
Sbjct: 54 TEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLR 113
Query: 189 GISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
GI+S ++YL M V+RDL N+LV + +SDF LS
Sbjct: 114 GIASG----------MKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLS 153
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 32/102 (31%), Positives = 48/102 (47%), Gaps = 12/102 (11%)
Query: 324 ARSKSFVGTHEYLAPEVISGQGHGSAV-----DWWTLGVFLYEMLYGTTPFKGENNEKTL 378
R +F+GT ++APEVI+ + A D W+LG+ EM G P + + L
Sbjct: 176 GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL 235
Query: 379 INILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKR 420
I + P P++ SK++ + K D I LVKN R
Sbjct: 236 FLIPRNPP--PKL---KSKKWSK--KFIDFIEGCLVKNYLSR 270
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 43/181 (23%), Positives = 79/181 (43%), Gaps = 38/181 (20%)
Query: 83 LDHFRLLRRLGSGDIGNVYL-----CQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRAD 137
+ + ++R +G G +G VYL C R A+K + RE L+ L +
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRR----------VALKKI-REDLSENPLLKKRF 49
Query: 138 M-EKVILTMLDHP-FLP--TLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSA 193
+ E I L HP +P ++ ++ + +Y+ M Y G Y + S +
Sbjct: 50 LREAKIAADLIHPGIVPVYSICSDGDPVYYT---MPYIEG---YTLKSLLKSVWQKESLS 103
Query: 194 KFYAAETLLA------------LEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKC 241
K A +T + +EY+H G+++RDLKP+N+L+ G +++ D+ +
Sbjct: 104 KELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFK 163
Query: 242 D 242
Sbjct: 164 K 164
|
Length = 932 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 24/77 (31%), Positives = 40/77 (51%), Gaps = 9/77 (11%)
Query: 165 CLVMEYCPGGDLYAARQRQPGKRFGISS--AKFYAAETLLALEYLHMMGIVYRDLKPENV 222
+V EY DL ++ P +S A+ + + L L+Y+H +++RDLKP NV
Sbjct: 92 YIVQEYMET-DLANVLEQGP-----LSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANV 145
Query: 223 LVR-EDGHIMLSDFDLS 238
+ ED + + DF L+
Sbjct: 146 FINTEDLVLKIGDFGLA 162
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.004
Identities = 32/109 (29%), Positives = 44/109 (40%), Gaps = 27/109 (24%)
Query: 326 SKSFVGTHEYLAPEVISGQGHGSAV------DWWTLGVFLYEMLYGTTPFKGENNEKTLI 379
+K+ +G Y+APE I G D W+LG+ + EM G P+ E T
Sbjct: 158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE----TYA 213
Query: 380 NILKK--------PLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKR 420
NI + P T P G S QD ++K L K P +R
Sbjct: 214 NIFAQLSAIVDGDPPTLPS-GYSDDA--------QDFVAKCLNKIPNRR 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 489 | |||
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.97 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.91 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.9 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.9 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.89 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.87 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.85 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.84 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.84 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.82 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.8 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.8 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.76 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.75 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.74 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.69 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.56 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.55 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.54 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.52 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.49 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.48 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.45 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.36 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.28 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.26 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.21 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.14 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.06 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.04 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.95 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.88 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.75 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.72 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.66 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.63 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.58 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.41 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.41 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.39 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.35 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.31 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.27 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.26 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.17 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.1 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.09 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.0 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.96 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.92 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.81 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.75 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.74 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.68 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.6 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.59 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.57 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.48 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.34 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.24 | |
| PLN02236 | 344 | choline kinase | 97.03 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.98 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.88 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.86 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.7 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.68 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.63 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.58 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.53 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.28 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.03 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.81 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.7 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.15 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 94.95 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.88 | |
| PTZ00296 | 442 | choline kinase; Provisional | 94.86 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.32 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 93.97 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 93.56 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 93.35 |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-70 Score=523.79 Aligned_cols=369 Identities=62% Similarity=1.076 Sum_probs=309.1
Q ss_pred cCCCCCCccHHHHHHHHHHH-hhcCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHH
Q 011302 56 NSHKPHKANQAAWEAMKRLR-RAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLH 134 (489)
Q Consensus 56 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~ 134 (489)
...+++..+...|+++..++ .....+.+++|++++.||+|.-|+||+|+.++ +.+.+|+|++.++.+..++++.
T Consensus 48 ~~~kph~~~d~~w~a~~~~~~~~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~-----t~~~fAmKVmdK~~l~~rkKl~ 122 (459)
T KOG0610|consen 48 SGNKPHKGNDVRWEAISSIRNSKDGSLGLRHFRLLKRLGCGDIGTVYLVELRG-----TNCLFAMKVMDKESLASRKKLK 122 (459)
T ss_pred ccCCCCCCCchhhhhhccccccCCCccCHHHHHHHHHcCCCCceeEEEEEecC-----CCceEEEEEecHHHHhhhhHHH
Confidence 34567777777888888776 46677899999999999999999999999998 5689999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCcccccceeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCee
Q 011302 135 RADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVY 214 (489)
Q Consensus 135 ~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiH 214 (489)
++..|.+||+.++||+++.||+.|+.++..|||||||+||+|+.++++++++.|++..+++|+.+++.||+|||-.|||+
T Consensus 123 Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivY 202 (459)
T KOG0610|consen 123 RAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVY 202 (459)
T ss_pred HHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceee
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ecCCCCCeEeccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCcccccccccccccccccccc
Q 011302 215 RDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVT 294 (489)
Q Consensus 215 rDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (489)
||||||||||.++|++-|+||.++..+...|....+.-... ....++|.. ...+||.........+++...
T Consensus 203 RDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~------~~~~~~~~~---~~~s~f~~r~~~~~~~~~k~~ 273 (459)
T KOG0610|consen 203 RDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRS------SGSQPSCRS---RQPSCFSPRCLSSSKKRKKKD 273 (459)
T ss_pred ccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCC------CCCCccccc---ccccccccchhcccccccccc
Confidence 99999999999999999999999999876665543311100 001222222 223455443222111111000
Q ss_pred ccccccccCCCCCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCc
Q 011302 295 VTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENN 374 (489)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~ 374 (489)
. ... ..-....+++.+.+..+++||-.|+|||+|.|.+++.++|||+|||+|||||+|.+||.|.+.
T Consensus 274 ~------------~~~-~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~ 340 (459)
T KOG0610|consen 274 E------------SAS-RSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNN 340 (459)
T ss_pred c------------ccc-ccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCc
Confidence 0 000 122234456778899999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccccccCCCCCCCC
Q 011302 375 EKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIRSIKPPEVPN 454 (489)
Q Consensus 375 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~~~~~~p~~~~ 454 (489)
.+++.+|+..++.||...... ..++|||+++|.+||.+|++...+++||++||||++++|..++...||++|.
T Consensus 341 ~~Tl~NIv~~~l~Fp~~~~vs-------~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~ 413 (459)
T KOG0610|consen 341 KETLRNIVGQPLKFPEEPEVS-------SAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPK 413 (459)
T ss_pred hhhHHHHhcCCCcCCCCCcch-------hHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCcCCC
Confidence 999999999999999765332 2589999999999999999998889999999999999999999999999988
Q ss_pred cccc
Q 011302 455 NDLY 458 (489)
Q Consensus 455 ~~~~ 458 (489)
....
T Consensus 414 ~~d~ 417 (459)
T KOG0610|consen 414 PVDG 417 (459)
T ss_pred cccc
Confidence 6443
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-67 Score=512.51 Aligned_cols=349 Identities=36% Similarity=0.628 Sum_probs=271.7
Q ss_pred HHhhcCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccc
Q 011302 74 LRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPT 153 (489)
Q Consensus 74 ~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~ 153 (489)
++....+++.++|.++..||+|+||.||+|+.++ ++.+||+|++++..+..++++..+..|..+|...++|+||+
T Consensus 131 lR~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~-----Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVK 205 (550)
T KOG0605|consen 131 LRLRRTRLSLDDFELLKVIGKGAFGEVRLARKKD-----TGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVK 205 (550)
T ss_pred HHhccccCCcccchhheeeccccceeEEEEEEcc-----CCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEE
Confidence 4455567889999999999999999999999998 78999999999999999999999999999999999999999
Q ss_pred ccceeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEc
Q 011302 154 LYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLS 233 (489)
Q Consensus 154 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~ 233 (489)
||..|++.+++||||||++|||+..+|.+. +.|++..+++|+.+++.|++.||..|+|||||||+|+|||..||+||+
T Consensus 206 LyYsFQD~~~LYLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLS 283 (550)
T KOG0605|consen 206 LYYSFQDKEYLYLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLS 283 (550)
T ss_pred EEEEecCCCeeEEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeec
Confidence 999999999999999999999999999887 789999999999999999999999999999999999999999999999
Q ss_pred ccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccC
Q 011302 234 DFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLD 313 (489)
Q Consensus 234 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (489)
||||++-+.-... ...+. ...++...++.... ....... ....+. ++ ..
T Consensus 284 DFGLs~gl~~~~~----------~~~~~------~~~~~~~~~~~~~~-~~~~~~~--~~~~~~----------~~--~~ 332 (550)
T KOG0605|consen 284 DFGLSTGLDKKHR----------IESYR------LDEQMQINLSEAKP-SDFPKFN--TPRSTM----------SR--RE 332 (550)
T ss_pred cccccchhhhhhh----------hhhhc------chhhhhhhhccCCC-ccccccc--cccchh----------hH--HH
Confidence 9999843321100 00000 00000000000000 0000000 000000 00 00
Q ss_pred CccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCC--CCCCCC
Q 011302 314 DPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP--LTFPRI 391 (489)
Q Consensus 314 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~ 391 (489)
-.............+.+|||.|||||++.+.+|+..+|+||||||+||||.|.+||.+.+..+++.+|+... +.+|..
T Consensus 333 ~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~ 412 (550)
T KOG0605|consen 333 QLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEE 412 (550)
T ss_pred HHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc
Confidence 000000111123456899999999999999999999999999999999999999999999999999998755 666665
Q ss_pred CCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccccccCCCCCCCCcccccccccccccCcCc
Q 011302 392 GVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIRSIKPPEVPNNDLYCKIKKKVYVPKLS 471 (489)
Q Consensus 392 ~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 471 (489)
...+ .++.|||.+||. ||++|++ ..+++||++||||++++|+.|+...||++|... .+....+++++.
T Consensus 413 ~~~s-------~eA~DLI~rll~-d~~~RLG-~~G~~EIK~HPfF~~v~W~~l~~~~apfvP~v~---~~~DT~yFddF~ 480 (550)
T KOG0605|consen 413 VDLS-------DEAKDLITRLLC-DPENRLG-SKGAEEIKKHPFFKGVDWDHLREMPAPFVPQVN---SELDTQYFDDFP 480 (550)
T ss_pred Cccc-------HHHHHHHHHHhc-CHHHhcC-cccHHHHhcCCccccCCcchhhcCCCCCCCCCC---CcccccccccCc
Confidence 4444 258999999999 9999999 468889999999999999999999999998863 233344444444
Q ss_pred c
Q 011302 472 K 472 (489)
Q Consensus 472 ~ 472 (489)
.
T Consensus 481 e 481 (550)
T KOG0605|consen 481 E 481 (550)
T ss_pred c
Confidence 3
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-67 Score=495.63 Aligned_cols=283 Identities=42% Similarity=0.780 Sum_probs=255.5
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
+..++|+++++||+|+||+||.++.++ +++.||+|++++......+.......|..+|..++||+||+|+..|++
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~d-----t~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt 96 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKD-----TGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQT 96 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcc-----cCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEeccc
Confidence 456899999999999999999999997 789999999999998888888899999999999999999999999999
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~ 240 (489)
.+.+|||+||+.||+|+..|++. +.|++..++.|+.+|+.||.|||++|||||||||||||||.+|+++|+|||+++.
T Consensus 97 ~~kLylVld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~ 174 (357)
T KOG0598|consen 97 EEKLYLVLDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKE 174 (357)
T ss_pred CCeEEEEEeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchh
Confidence 99999999999999999999886 7899999999999999999999999999999999999999999999999999842
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
.-
T Consensus 175 ~~------------------------------------------------------------------------------ 176 (357)
T KOG0598|consen 175 DL------------------------------------------------------------------------------ 176 (357)
T ss_pred cc------------------------------------------------------------------------------
Confidence 11
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHH
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFE 400 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 400 (489)
.....+.++|||+.|||||++.+.+|+.++|+|||||++|||++|.+||.+.+....+.+|..+....+..-..
T Consensus 177 ~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls------ 250 (357)
T KOG0598|consen 177 KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLS------ 250 (357)
T ss_pred cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCC------
Confidence 01224566899999999999999999999999999999999999999999999999999999988443332111
Q ss_pred HHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcccc--ccCCCCCCCCcc
Q 011302 401 EVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALI--RSIKPPEVPNND 456 (489)
Q Consensus 401 ~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~~~ 456 (489)
.++++||+++|.+||++|+++...+++|.+||||+++||+.+ +.+.||+.|...
T Consensus 251 --~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~~ 306 (357)
T KOG0598|consen 251 --EEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNVT 306 (357)
T ss_pred --HHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCeecCCC
Confidence 248999999999999999997778889999999999999976 778899888753
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-66 Score=474.05 Aligned_cols=277 Identities=43% Similarity=0.801 Sum_probs=259.6
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
..+++|+.++.||.|+||+|.+++.+. ++.+||+|++++..+....+.+...+|..+|+.+.||++++|++.|.+
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~-----~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d 115 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKH-----SGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD 115 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEcc-----CCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc
Confidence 678999999999999999999999997 578999999999999988899999999999999999999999999999
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~ 240 (489)
.+++||||||++||.|+.++++. ++|++..+++|+.||+.||+|||+++||+|||||||||||.+|++||+|||+|+.
T Consensus 116 ~~~lymvmeyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~ 193 (355)
T KOG0616|consen 116 NSNLYMVMEYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKR 193 (355)
T ss_pred CCeEEEEEeccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEE
Confidence 99999999999999999999886 7899999999999999999999999999999999999999999999999999965
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
+.
T Consensus 194 v~------------------------------------------------------------------------------ 195 (355)
T KOG0616|consen 194 VS------------------------------------------------------------------------------ 195 (355)
T ss_pred ec------------------------------------------------------------------------------
Confidence 42
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHH
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFE 400 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 400 (489)
.++.++||||.|+|||++...+|+.++|+|||||++|||+.|.+||.+.+..+++.+|+.+.+.+|....+
T Consensus 196 ---~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~------ 266 (355)
T KOG0616|consen 196 ---GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSS------ 266 (355)
T ss_pred ---CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCH------
Confidence 24667899999999999999999999999999999999999999999999999999999999999976554
Q ss_pred HHhhHHHHHHHHhhcCcccccCCCC-ChHHHHcCCCcCCCCcccc--ccCCCCCCCC
Q 011302 401 EVVKLQDLISKLLVKNPKKRIGSLK-GSVEIKRHEFFKGINWALI--RSIKPPEVPN 454 (489)
Q Consensus 401 ~~~~l~~li~~~L~~dP~~R~~~~~-~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~ 454 (489)
+++|||.++|+.|-.+|.+... +..+|+.||||++++|..+ +.+.||++|.
T Consensus 267 ---~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~pp 320 (355)
T KOG0616|consen 267 ---DAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFEPP 320 (355)
T ss_pred ---HHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhccccCCCCCc
Confidence 4899999999999999988665 7889999999999999987 7788998883
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-64 Score=494.30 Aligned_cols=288 Identities=37% Similarity=0.615 Sum_probs=258.6
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCccccccee
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAEF 158 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~ 158 (489)
.....||.+++.||+|+|++|++|+.+. +++.||||++.++.+...++...+.+|..+|.+| +||+|++|+..|
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~-----t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF 143 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKA-----TGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF 143 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecC-----CCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe
Confidence 4567899999999999999999999998 6889999999999999888999999999999999 799999999999
Q ss_pred ecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 159 EASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
+|...+|+|+||+++|+|.+++++. +.|++..++.|+.||+.||+|||++||||||||||||||+.||++||+|||.|
T Consensus 144 QD~~sLYFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 144 QDEESLYFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSA 221 (604)
T ss_pred ecccceEEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeecccc
Confidence 9999999999999999999999987 78999999999999999999999999999999999999999999999999999
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
+.+........ ....
T Consensus 222 K~l~~~~~~~~-----------------------------------------------------------------~~~~ 236 (604)
T KOG0592|consen 222 KILSPSQKSQE-----------------------------------------------------------------NPVD 236 (604)
T ss_pred ccCChhhcccc-----------------------------------------------------------------CccC
Confidence 76653221100 0000
Q ss_pred ccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchh
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKE 398 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 398 (489)
......+..+++||..|.+||+|.....++.+|||+||||||+|+.|.+||.+.++..++.+|+...+.||.....
T Consensus 237 ~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~~fp~---- 312 (604)
T KOG0592|consen 237 PNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPEGFPE---- 312 (604)
T ss_pred cccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCCCCCH----
Confidence 0011223578999999999999999999999999999999999999999999999999999999999999875442
Q ss_pred HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccccccCCCCCC
Q 011302 399 FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIRSIKPPEV 452 (489)
Q Consensus 399 ~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~~~~~~p~~ 452 (489)
.+.|||.++|..||.+|+|+. +|++||||+++||+.+.++.||.+
T Consensus 313 -----~a~dLv~KLLv~dp~~Rlt~~----qIk~HpFF~~Vdw~nlw~~~PP~l 357 (604)
T KOG0592|consen 313 -----DARDLIKKLLVRDPSDRLTSQ----QIKAHPFFEGVDWENLWQQTPPKL 357 (604)
T ss_pred -----HHHHHHHHHHccCccccccHH----HHhhCcccccCChhhhhhcCCCcc
Confidence 489999999999999999997 999999999999999999999865
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-62 Score=494.98 Aligned_cols=284 Identities=40% Similarity=0.753 Sum_probs=257.2
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-CCCcccccce
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-HPFLPTLYAE 157 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~ 157 (489)
..+.+++|.++++||+|+||+|++|..+. ++++||||+++++.+-.++.++..+.|.+|+.... ||+++.|+.+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~-----~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~ 437 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKG-----TNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSC 437 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcC-----CCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccc
Confidence 56888999999999999999999999998 67899999999999888888999999999998886 9999999999
Q ss_pred eecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCC
Q 011302 158 FEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237 (489)
Q Consensus 158 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~ 237 (489)
|++.+++|+||||+.||++..+.+ ...|++..++.|+++|+.||.|||++||||||||.+|||||.+|++||+|||+
T Consensus 438 fQT~~~l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGl 514 (694)
T KOG0694|consen 438 FQTKEHLFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGL 514 (694)
T ss_pred cccCCeEEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccc
Confidence 999999999999999999644333 26799999999999999999999999999999999999999999999999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
++..
T Consensus 515 cKe~---------------------------------------------------------------------------- 518 (694)
T KOG0694|consen 515 CKEG---------------------------------------------------------------------------- 518 (694)
T ss_pred cccc----------------------------------------------------------------------------
Confidence 8421
Q ss_pred cccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCch
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSK 397 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 397 (489)
.....++.++||||.|||||++.+..|+.++|+|||||+|||||+|+.||.|+++.+++..|+...+.+|.....
T Consensus 519 --m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~--- 593 (694)
T KOG0694|consen 519 --MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSK--- 593 (694)
T ss_pred --CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccH---
Confidence 111346788999999999999999999999999999999999999999999999999999999999988876433
Q ss_pred hHHHHhhHHHHHHHHhhcCcccccCCC-CChHHHHcCCCcCCCCcccc--ccCCCCCCCCccc
Q 011302 398 EFEEVVKLQDLISKLLVKNPKKRIGSL-KGSVEIKRHEFFKGINWALI--RSIKPPEVPNNDL 457 (489)
Q Consensus 398 ~~~~~~~l~~li~~~L~~dP~~R~~~~-~~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~~~~ 457 (489)
++.++|++||.+||++|+++. ...++|++||||++|||+.| +.++||++|....
T Consensus 594 ------ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~ 650 (694)
T KOG0694|consen 594 ------EAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKG 650 (694)
T ss_pred ------HHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCC
Confidence 588999999999999999984 35679999999999999987 7799999988643
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-61 Score=460.01 Aligned_cols=279 Identities=30% Similarity=0.454 Sum_probs=236.8
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHH----HHHHHHHHHHHHHHHhCCCCCcccccce
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAI----RKKLHRADMEKVILTMLDHPFLPTLYAE 157 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~l~~~ 157 (489)
..+.|.+.+.||+|+||.|-+|..+. +++.||||++.+..... ......+.+|+++|++|+|||||+++++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~-----tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~ 244 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKK-----TGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDF 244 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcc-----cCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeee
Confidence 34789999999999999999999998 68999999999876553 2244457789999999999999999999
Q ss_pred eecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccC---CcEEEcc
Q 011302 158 FEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRED---GHIMLSD 234 (489)
Q Consensus 158 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~---~~vkl~D 234 (489)
|+..+..||||||++||+|++.+-.+ +.+.+...+.+++||+.||.|||++||+||||||+|||+..+ ..+||+|
T Consensus 245 f~~~ds~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 245 FEVPDSSYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred eecCCceEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecc
Confidence 99999999999999999999999887 679999999999999999999999999999999999999866 7899999
Q ss_pred cCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCC
Q 011302 235 FDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDD 314 (489)
Q Consensus 235 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (489)
||+|+...
T Consensus 323 FGlAK~~g------------------------------------------------------------------------ 330 (475)
T KOG0615|consen 323 FGLAKVSG------------------------------------------------------------------------ 330 (475)
T ss_pred cchhhccc------------------------------------------------------------------------
Confidence 99995321
Q ss_pred ccccccccccCCccccCCCCccCcchhcCCCC---CCcccHHHHHHHHHHHhhCCCCCCCCCcHH-HHHHHhcCCCCCCC
Q 011302 315 PEVVAEPINARSKSFVGTHEYLAPEVISGQGH---GSAVDWWTLGVFLYEMLYGTTPFKGENNEK-TLINILKKPLTFPR 390 (489)
Q Consensus 315 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~---~~~~DiwSlGvil~elltG~~Pf~~~~~~~-~~~~i~~~~~~~p~ 390 (489)
......++||||.|.|||++.+..+ ..++|||||||+||-+|+|.+||.+..... ...+|.++.+.+-.
T Consensus 331 -------~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p 403 (475)
T KOG0615|consen 331 -------EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGP 403 (475)
T ss_pred -------cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccC
Confidence 1234578899999999999987663 458899999999999999999998876655 77888888776542
Q ss_pred CCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcc----ccccCCCCCCCCc
Q 011302 391 IGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWA----LIRSIKPPEVPNN 455 (489)
Q Consensus 391 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~----~~~~~~~p~~~~~ 455 (489)
. .+.....++++||.+||..||++|+++. ++|+||||+..+.. .+.++.|+...++
T Consensus 404 ~-----~w~~Iseea~dlI~~mL~VdP~~R~s~~----eaL~hpW~~~~~~~s~~~~l~~~~~l~~~e~ 463 (475)
T KOG0615|consen 404 L-----QWDRISEEALDLINWMLVVDPENRPSAD----EALNHPWFKDAPCLSKQDILKKLQPLSIEEN 463 (475)
T ss_pred h-----hhhhhhHHHHHHHHHhhEeCcccCcCHH----HHhcChhhhcccccchHHHHhhcCccccccc
Confidence 2 2334556799999999999999999998 99999999977632 3455666655544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-59 Score=468.28 Aligned_cols=259 Identities=31% Similarity=0.520 Sum_probs=239.1
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
.+|...+.||+|||+.||.+++.. ++..||+|++.+..+......+.+.+|++|.+.|+|||||+++++|++.++
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~-----tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLD-----TGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcC-----CCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCc
Confidence 469999999999999999999976 688999999999988888888889999999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
+|||+|+|..++|..+++++ +.++|.+++.|++||+.||.|||+++|||||||..|++|+++.+|||+|||+|..+..
T Consensus 93 VYivLELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred eEEEEEecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecC
Confidence 99999999999999999865 7899999999999999999999999999999999999999999999999999965432
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
..
T Consensus 171 ------------------------------------------------------------------------------~~ 172 (592)
T KOG0575|consen 171 ------------------------------------------------------------------------------DG 172 (592)
T ss_pred ------------------------------------------------------------------------------cc
Confidence 12
Q ss_pred cCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHh
Q 011302 324 ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVV 403 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~ 403 (489)
.+..++||||.|+|||++...+++..+||||+|||+|.||+|++||...+-.+++.+|....+.+|.....
T Consensus 173 Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~--------- 243 (592)
T KOG0575|consen 173 ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSA--------- 243 (592)
T ss_pred cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCH---------
Confidence 35678899999999999999999999999999999999999999999999999999999999999873322
Q ss_pred hHHHHHHHHhhcCcccccCCCCChHHHHcCCCc-CCCC
Q 011302 404 KLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF-KGIN 440 (489)
Q Consensus 404 ~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f-~~~~ 440 (489)
+++|||.+||..||.+||++. +||.|+|| ++.-
T Consensus 244 ~A~dLI~~lL~~~P~~Rpsl~----~vL~h~Ff~~g~~ 277 (592)
T KOG0575|consen 244 EAKDLIRKLLRPNPSERPSLD----EVLDHPFFKSGFT 277 (592)
T ss_pred HHHHHHHHHhcCCcccCCCHH----HHhcCHhhhCCCc
Confidence 589999999999999999998 99999999 4443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-56 Score=427.62 Aligned_cols=259 Identities=31% Similarity=0.516 Sum_probs=226.2
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.++|.+.+.||.|+||+||+|+++. ++..||||.+.+..+. .+..+.+..|+.+|+.++|||||.|++++++++
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~-----~~~~VAIK~i~~~~l~-~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~ 82 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKK-----SGTEVAIKCIAKKKLN-KKLVELLLSEIKILKELKHPNIVRLLDCIEDDD 82 (429)
T ss_pred cccceehhhccCcceEEEEEeEecc-----CCceEEeeeehhhccC-HHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC
Confidence 4789999999999999999999998 5688999999887653 455667888999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccC------CcEEEcccC
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRED------GHIMLSDFD 236 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~------~~vkl~DFG 236 (489)
++|||||||.||||.++++++ +++++..++.++.||+.||++||+++||||||||+||||+.+ -.+||+|||
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 999999999999999999987 689999999999999999999999999999999999999864 358999999
Q ss_pred CCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcc
Q 011302 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPE 316 (489)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (489)
+|+.+..
T Consensus 161 fAR~L~~------------------------------------------------------------------------- 167 (429)
T KOG0595|consen 161 FARFLQP------------------------------------------------------------------------- 167 (429)
T ss_pred hhhhCCc-------------------------------------------------------------------------
Confidence 9976542
Q ss_pred ccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCc
Q 011302 317 VVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSS 396 (489)
Q Consensus 317 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 396 (489)
.....++||+|.|||||++..+.|+.|+|+||+|+|||+|++|++||+..+..+.+..+..+....|.......
T Consensus 168 ------~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s 241 (429)
T KOG0595|consen 168 ------GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELS 241 (429)
T ss_pred ------hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhcc
Confidence 11235679999999999999999999999999999999999999999999999999988876655554433322
Q ss_pred hhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 397 KEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 397 ~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
. .+.+|+..+|.+++..|.+.. +-+.|+++..
T Consensus 242 ~------~~~~Ll~~ll~~~~~~~~~~~----~~~~~~~l~~ 273 (429)
T KOG0595|consen 242 N------PLRELLISLLQRNPKDRISFE----DFFDHPFLAA 273 (429)
T ss_pred C------chhhhhhHHHhcCccccCchH----Hhhhhhhccc
Confidence 2 266999999999999999886 6777777754
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-56 Score=420.94 Aligned_cols=259 Identities=30% Similarity=0.449 Sum_probs=224.7
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
+..++.+.++.||+|..|+||+|+++. +++.||+|++.... .....+++.+|+++++..+||+||++|++|.+
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~-----t~~i~AlK~I~~~~--~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKP-----TGKIYALKVILLNI--DPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcC-----CCeEEEEEeecccC--CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 455678888999999999999999997 68999999994332 23455678889999999999999999999999
Q ss_pred Cc-eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHh-CCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 161 SH-YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHM-MGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 161 ~~-~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
+. .++|+||||+||+|.+++... +++++.....|+.++++||.|||+ ++||||||||+||||+..|.|||||||.+
T Consensus 149 ~~~~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS 226 (364)
T KOG0581|consen 149 NGEEISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVS 226 (364)
T ss_pred CCceEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEecccccc
Confidence 88 599999999999999998876 779999999999999999999995 89999999999999999999999999998
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
+.+.
T Consensus 227 ~~lv---------------------------------------------------------------------------- 230 (364)
T KOG0581|consen 227 GILV---------------------------------------------------------------------------- 230 (364)
T ss_pred HHhh----------------------------------------------------------------------------
Confidence 4332
Q ss_pred ccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCC-----CcHHHHHHHhcCC-CCCCCCC
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGE-----NNEKTLINILKKP-LTFPRIG 392 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~-----~~~~~~~~i~~~~-~~~p~~~ 392 (489)
+....+++||..|||||.+.+..|+.++||||||+.++||++|+.||... +..+.+..|+.++ ...|..
T Consensus 231 ----nS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~- 305 (364)
T KOG0581|consen 231 ----NSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG- 305 (364)
T ss_pred ----hhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc-
Confidence 22456789999999999999999999999999999999999999999874 5567888888753 344433
Q ss_pred CCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 393 VSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 393 ~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
..+ .++++||..||++||.+|+++. ++++|||++...
T Consensus 306 -~fS------~ef~~FV~~CL~Kdp~~R~s~~----qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 306 -EFS------PEFRSFVSCCLRKDPSERPSAK----QLLQHPFIKKFE 342 (364)
T ss_pred -cCC------HHHHHHHHHHhcCCcccCCCHH----HHhcCHHHhhcc
Confidence 122 2589999999999999999998 999999998654
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-57 Score=415.56 Aligned_cols=285 Identities=39% Similarity=0.724 Sum_probs=258.1
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccccccee
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEF 158 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 158 (489)
..+..++|..+++||+|.||+|-+|+.+. ++++||||+++++.+..+..+..-..|-++|+..+||++..|...|
T Consensus 163 ~kvTm~dFdfLKvLGkGTFGKVIL~rEKa-----t~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF 237 (516)
T KOG0690|consen 163 NKVTMEDFDFLKVLGKGTFGKVILCREKA-----TGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF 237 (516)
T ss_pred ceeccchhhHHHHhcCCccceEEEEeecc-----cCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh
Confidence 34678999999999999999999999887 6899999999999888788888888899999999999999999999
Q ss_pred ecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 159 EASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
+..+++|+||||+.||+|+-.+.+. +.|++..+++|..+|+.||.|||+++||+||||.+|+|+|.+|++||+|||++
T Consensus 238 Qt~drlCFVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLC 315 (516)
T KOG0690|consen 238 QTQDRLCFVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLC 315 (516)
T ss_pred ccCceEEEEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccc
Confidence 9999999999999999999888775 67999999999999999999999999999999999999999999999999997
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
+.-
T Consensus 316 KE~----------------------------------------------------------------------------- 318 (516)
T KOG0690|consen 316 KEE----------------------------------------------------------------------------- 318 (516)
T ss_pred hhc-----------------------------------------------------------------------------
Confidence 321
Q ss_pred ccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchh
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKE 398 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 398 (489)
........++||||.|+|||++....|+.++|+|.+||++|||++|+.||...+....+.-|+.+.+.||....+
T Consensus 319 -I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~---- 393 (516)
T KOG0690|consen 319 -IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSP---- 393 (516)
T ss_pred -ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCH----
Confidence 001234578999999999999999999999999999999999999999999999999999999999999976544
Q ss_pred HHHHhhHHHHHHHHhhcCcccccCCC-CChHHHHcCCCcCCCCcccc--ccCCCCCCCCccc
Q 011302 399 FEEVVKLQDLISKLLVKNPKKRIGSL-KGSVEIKRHEFFKGINWALI--RSIKPPEVPNNDL 457 (489)
Q Consensus 399 ~~~~~~l~~li~~~L~~dP~~R~~~~-~~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~~~~ 457 (489)
+++.|+..+|.+||.+|++.- +.+.+|.+|+||.+++|... +.+.||+-|....
T Consensus 394 -----eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVtS 450 (516)
T KOG0690|consen 394 -----EAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVTS 450 (516)
T ss_pred -----HHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCccc
Confidence 589999999999999999976 45789999999999999865 7899999887544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-56 Score=406.60 Aligned_cols=266 Identities=27% Similarity=0.414 Sum_probs=218.8
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
+.|+.+.++|+|+||.||+|++++ +++.||||.+..... ......-.++|+.+|+.|.|+|+|.|+++|.....
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~-----TgqIVAIKkF~Esed-d~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrk 75 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKD-----TGQIVAIKKFVESED-DPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRK 75 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCC-----cccEEEEEeeccCCc-cHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcce
Confidence 568889999999999999999998 789999999964322 12334457789999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
++||+|||+..-| +.+.+.+ ..++...++.|++|++.|+.|+|+++|||||||||||||+.+|.+||||||+|+.+..
T Consensus 76 lhLVFE~~dhTvL-~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 76 LHLVFEYCDHTVL-HELERYP-NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred eEEEeeecchHHH-HHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 9999999965444 5556654 4588999999999999999999999999999999999999999999999999954431
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
.+
T Consensus 154 ------------------------------------------------------------------------------pg 155 (396)
T KOG0593|consen 154 ------------------------------------------------------------------------------PG 155 (396)
T ss_pred ------------------------------------------------------------------------------Cc
Confidence 01
Q ss_pred cCCccccCCCCccCcchhcC-CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcC------------------
Q 011302 324 ARSKSFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK------------------ 384 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------------ 384 (489)
...+.++.|.+|+|||.+.| ..|+..+||||+||++.||++|++.|+|.++.+++..|...
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 12355789999999999998 67999999999999999999999999999988887776531
Q ss_pred -CCCCCCCCCCCchh--H-HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 385 -PLTFPRIGVSSSKE--F-EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 385 -~~~~p~~~~~~~~~--~-~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
.+.+|........+ + .....+.||+.+||..||++|++.+ +++.|+||.++
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~----qll~H~yFd~~ 290 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCE----QLLHHPYFDGF 290 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHH----HHhcChHHHHH
Confidence 12334333222221 1 2233578999999999999999987 99999999654
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-55 Score=437.98 Aligned_cols=263 Identities=29% Similarity=0.485 Sum_probs=235.4
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.+-|++++.||.|+.|.|-+|++.. +++.+|||++.+...-.......+.+|+.+|+.+.||||++||++|++..
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~-----TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~ 85 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAE-----TGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ 85 (786)
T ss_pred ccceeccccccCCCCceehhhhccc-----ccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCc
Confidence 3568899999999999999999987 78999999998774333445567888999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
++|||+||++||.|++++-+. ++|++.++..+++||+.||.|||..+||||||||+|+||+.++++||+|||+|....
T Consensus 86 ~lylvlEyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~ 163 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEV 163 (786)
T ss_pred eEEEEEEecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeeccc
Confidence 999999999999999999887 789999999999999999999999999999999999999999999999999983211
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
.
T Consensus 164 -------------------------------------------------------------------------------~ 164 (786)
T KOG0588|consen 164 -------------------------------------------------------------------------------P 164 (786)
T ss_pred -------------------------------------------------------------------------------C
Confidence 1
Q ss_pred ccCCccccCCCCccCcchhcCCCC-CCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHH
Q 011302 323 NARSKSFVGTHEYLAPEVISGQGH-GSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEE 401 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~~-~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 401 (489)
+....+.||+|.|.|||++.|.+| +.++||||.|||||.||+|+.||++++-..++.++.++.+..|.....
T Consensus 165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~------- 237 (786)
T KOG0588|consen 165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISS------- 237 (786)
T ss_pred CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCH-------
Confidence 223456799999999999999998 889999999999999999999999999999999999999999864433
Q ss_pred HhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcccc
Q 011302 402 VVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALI 444 (489)
Q Consensus 402 ~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~ 444 (489)
++++||++||..||++|++.. +|++|||+.+..-...
T Consensus 238 --eaQdLLr~ml~VDp~~RiT~~----eI~kHP~l~g~~~~~~ 274 (786)
T KOG0588|consen 238 --EAQDLLRRMLDVDPSTRITTE----EILKHPFLSGYTSLPS 274 (786)
T ss_pred --HHHHHHHHHhccCccccccHH----HHhhCchhhcCCCCCh
Confidence 599999999999999999998 9999999988765443
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-55 Score=419.44 Aligned_cols=289 Identities=36% Similarity=0.623 Sum_probs=251.7
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccccccee
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEF 158 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 158 (489)
..+..+.|+.-++||+|+||+||-|+.+. +++.||+|.+.+..+..+..-....+|..+|.+++.++||.|-.+|
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvra-----TGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf 254 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRA-----TGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF 254 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEec-----chhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee
Confidence 44677899999999999999999999988 6899999999999888887777889999999999999999999999
Q ss_pred ecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 159 EASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
++.+.+||||..|+||||.-.+.......|++..+++|+.+|+.||++||..+||+|||||+|||+|+.|+++|+|+|+|
T Consensus 255 eTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLA 334 (591)
T KOG0986|consen 255 ETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLA 334 (591)
T ss_pred cCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceE
Confidence 99999999999999999987777766668999999999999999999999999999999999999999999999999998
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
..+..
T Consensus 335 vei~~--------------------------------------------------------------------------- 339 (591)
T KOG0986|consen 335 VEIPE--------------------------------------------------------------------------- 339 (591)
T ss_pred EecCC---------------------------------------------------------------------------
Confidence 43321
Q ss_pred ccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcH----HHHHHHhcCCCCCCCCCCC
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNE----KTLINILKKPLTFPRIGVS 394 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~----~~~~~i~~~~~~~p~~~~~ 394 (489)
.....+.+||.+|||||++.+..|+...|+|||||+||||+.|+.||...... ++-+.++..+..+++...
T Consensus 340 ----g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS- 414 (591)
T KOG0986|consen 340 ----GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFS- 414 (591)
T ss_pred ----CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccC-
Confidence 11223448999999999999999999999999999999999999999765433 444555566666653221
Q ss_pred CchhHHHHhhHHHHHHHHhhcCcccccCCC-CChHHHHcCCCcCCCCcccc--ccCCCCCCCCcc-cccc
Q 011302 395 SSKEFEEVVKLQDLISKLLVKNPKKRIGSL-KGSVEIKRHEFFKGINWALI--RSIKPPEVPNND-LYCK 460 (489)
Q Consensus 395 ~~~~~~~~~~l~~li~~~L~~dP~~R~~~~-~~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~~~-~~~~ 460 (489)
.++++|.+.+|++||++|++.. ++.+++++||||+++||..+ ..+.||++|+.. +|++
T Consensus 415 --------~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~aVyak 476 (591)
T KOG0986|consen 415 --------EEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPGAVYAK 476 (591)
T ss_pred --------HHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCccccchh
Confidence 2589999999999999999987 67889999999999999976 678999998854 6665
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-54 Score=420.07 Aligned_cols=264 Identities=27% Similarity=0.431 Sum_probs=222.0
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-CCCcccccceeecC
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-HPFLPTLYAEFEAS 161 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~ 161 (489)
.++|.++++||.|+||.||+|+.+. ++..||||.+++....-.+. .-.+|+..|++|+ |||||+|++++.+.
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~-----~~~~VAIK~MK~Kf~s~ee~--~nLREvksL~kln~hpniikL~Evi~d~ 81 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKE-----TGELVAIKKMKKKFYSWEEC--MNLREVKSLRKLNPHPNIIKLKEVIRDN 81 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecC-----CCceeeHHHHHhhhccHHHH--HHHHHHHHHHhcCCCCcchhhHHHhhcc
Confidence 4789999999999999999999887 67889999998765543222 1346999999999 99999999999988
Q ss_pred c-eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcc
Q 011302 162 H-YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240 (489)
Q Consensus 162 ~-~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~ 240 (489)
+ ++|+||||| ..+|+++++.+ ++.|++..++.|+.||++||+|+|.+|+.|||||||||||..+..+||+|||+|+.
T Consensus 82 ~~~L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 82 DRILYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred CceEeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccc
Confidence 8 999999999 79999999887 68999999999999999999999999999999999999999999999999999965
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
+...
T Consensus 160 v~Sk---------------------------------------------------------------------------- 163 (538)
T KOG0661|consen 160 VRSK---------------------------------------------------------------------------- 163 (538)
T ss_pred cccC----------------------------------------------------------------------------
Confidence 5321
Q ss_pred ccccCCccccCCCCccCcchhcCCC-CCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhc--C-------------
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQG-HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILK--K------------- 384 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~-~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~--~------------- 384 (489)
...+.++-|.+|+|||+|.... |+.++||||+|||++|+++-++.|.|.++.+++.+|+. +
T Consensus 164 ---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 164 ---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred ---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 1235578999999999998765 79999999999999999999999999999999888864 1
Q ss_pred ----CCCCCCCCCCCchh--HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 385 ----PLTFPRIGVSSSKE--FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 385 ----~~~~p~~~~~~~~~--~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
.+.+|......... .....++.+||.+||.|||++|||+. ++|+||||+.
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~----~al~~pffq~ 296 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTAS----QALQHPFFQV 296 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHH----HHhcCccccc
Confidence 11222211111110 02334688999999999999999998 9999999974
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-55 Score=456.98 Aligned_cols=284 Identities=38% Similarity=0.672 Sum_probs=249.7
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccccccee
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEF 158 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 158 (489)
.++..++|.++++||+|+||.|.+++.++ +++.||+|++++..+..+....-|..|..+|...+.+.|+.|+.+|
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~-----t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF 144 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKS-----TEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF 144 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeec-----cccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh
Confidence 45677999999999999999999999998 6889999999998887777777888999999999999999999999
Q ss_pred ecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 159 EASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
+++.++||||||++||||..++.+. .++++..+++|+.+|+.||+-||+.|+|||||||+|||||..||+||+|||.+
T Consensus 145 QD~~~LYlVMdY~pGGDlltLlSk~--~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 145 QDERYLYLVMDYMPGGDLLTLLSKF--DRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred cCccceEEEEecccCchHHHHHhhc--CCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhH
Confidence 9999999999999999999999887 38999999999999999999999999999999999999999999999999986
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
-++..-
T Consensus 223 lkm~~d-------------------------------------------------------------------------- 228 (1317)
T KOG0612|consen 223 LKMDAD-------------------------------------------------------------------------- 228 (1317)
T ss_pred HhcCCC--------------------------------------------------------------------------
Confidence 332210
Q ss_pred ccccccCCccccCCCCccCcchhcC-----CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcC--CCCCCCC
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISG-----QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK--PLTFPRI 391 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~ 391 (489)
+.-+....+|||.|++||+|.. ..|+..+|+||+||++|||++|.+||+..+-.+++-+|+.- .+.||..
T Consensus 229 ---G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~ 305 (1317)
T KOG0612|consen 229 ---GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDE 305 (1317)
T ss_pred ---CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcc
Confidence 0112345589999999999952 34899999999999999999999999999999999999864 6777743
Q ss_pred CCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccccccCCCCCCCCc
Q 011302 392 GVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIRSIKPPEVPNN 455 (489)
Q Consensus 392 ~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~~~~~~p~~~~~ 455 (489)
.. .+.++++||+++|. +|+.|++- .++++++.||||.+++|+.|+...||++|..
T Consensus 306 ~~-------VSeeakdLI~~ll~-~~e~RLgr-ngiedik~HpFF~g~~W~~iR~~~pP~vPev 360 (1317)
T KOG0612|consen 306 TD-------VSEEAKDLIEALLC-DREVRLGR-NGIEDIKNHPFFEGIDWDNIRESVPPVVPEV 360 (1317)
T ss_pred cc-------cCHHHHHHHHHHhc-Chhhhccc-ccHHHHHhCccccCCChhhhhhcCCCCCCcC
Confidence 32 22369999999875 78899985 3667999999999999999999999999885
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-53 Score=427.03 Aligned_cols=261 Identities=38% Similarity=0.585 Sum_probs=230.3
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHH--HHHHHHHHHHHHHHHhCC-CCCcccccce
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAI--RKKLHRADMEKVILTMLD-HPFLPTLYAE 157 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~l~~~ 157 (489)
...+.|.+.+.||+|+||+|++|++.. ++..||+|+++++.... ......+.+|+.+++.+. ||||++++++
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~-----t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev 88 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRL-----TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEV 88 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeecc-----CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEE
Confidence 445799999999999999999999887 56899999887753221 123445667999999999 9999999999
Q ss_pred eecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccC-CcEEEcccC
Q 011302 158 FEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRED-GHIMLSDFD 236 (489)
Q Consensus 158 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~-~~vkl~DFG 236 (489)
+.....+|+|||||.||+|++++... +++.+.+++.+++||+.||+|||++||+||||||||||++.+ +++||+|||
T Consensus 89 ~~t~~~~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 89 FATPTKIYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred EecCCeEEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 99999999999999999999999884 789999999999999999999999999999999999999999 999999999
Q ss_pred CCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcc
Q 011302 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPE 316 (489)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (489)
++....
T Consensus 167 ~s~~~~-------------------------------------------------------------------------- 172 (370)
T KOG0583|consen 167 LSAISP-------------------------------------------------------------------------- 172 (370)
T ss_pred cccccC--------------------------------------------------------------------------
Confidence 984321
Q ss_pred ccccccccCCccccCCCCccCcchhcCCC-C-CCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCC
Q 011302 317 VVAEPINARSKSFVGTHEYLAPEVISGQG-H-GSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVS 394 (489)
Q Consensus 317 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~-~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~ 394 (489)
.......+.|||+.|+|||++.+.. | +.++||||+||+||.|++|+.||...+...++..|..+.+.+|....
T Consensus 173 ----~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~- 247 (370)
T KOG0583|consen 173 ----GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLL- 247 (370)
T ss_pred ----CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcC-
Confidence 0022456779999999999999988 8 68999999999999999999999999999999999999999997653
Q ss_pred CchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 395 SSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 395 ~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
+ .++++||++||..||.+|+++. +++.||||+.
T Consensus 248 -S------~~~~~Li~~mL~~~P~~R~t~~----~i~~h~w~~~ 280 (370)
T KOG0583|consen 248 -S------PEARSLIEKMLVPDPSTRITLL----EILEHPWFQK 280 (370)
T ss_pred -C------HHHHHHHHHHcCCCcccCCCHH----HHhhChhhcc
Confidence 1 1489999999999999999997 9999999996
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-54 Score=384.54 Aligned_cols=262 Identities=36% Similarity=0.605 Sum_probs=240.0
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccccccee
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEF 158 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 158 (489)
....+++|.+.+.||+|-||.||+|+.+. +.-.||+|++.++.+...+..+++.+|++|.+.|+||||+++|++|
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekk-----s~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f 91 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKK-----SLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF 91 (281)
T ss_pred cccchhhccccccccCCccccEeEeeecc-----CCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe
Confidence 34667999999999999999999999987 5788999999999888777888899999999999999999999999
Q ss_pred ecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 159 EASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
.+....||++||..+|+|+..++..+..++++..+..|+.|++.||.|+|.++||||||||+|+|++.+|.+||+|||.+
T Consensus 92 hd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGws 171 (281)
T KOG0580|consen 92 HDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWS 171 (281)
T ss_pred eccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCce
Confidence 99999999999999999999999777788999999999999999999999999999999999999999999999999986
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
-.
T Consensus 172 V~------------------------------------------------------------------------------ 173 (281)
T KOG0580|consen 172 VH------------------------------------------------------------------------------ 173 (281)
T ss_pred ee------------------------------------------------------------------------------
Confidence 11
Q ss_pred ccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchh
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKE 398 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 398 (489)
.+ ..+..++|||..|.+||++.+..++..+|+|++|++.||++.|.+||...+..+++.+|.+-.+.+|.....
T Consensus 174 -~p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~---- 247 (281)
T KOG0580|consen 174 -AP-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISG---- 247 (281)
T ss_pred -cC-CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccCh----
Confidence 11 345678899999999999999999999999999999999999999999999999999999988888854333
Q ss_pred HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 399 FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 399 ~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
.++|||.+||.++|.+|.... +++.|||...
T Consensus 248 -----~a~dlI~~ll~~~p~~r~~l~----~v~~hpwI~a 278 (281)
T KOG0580|consen 248 -----GAADLISRLLVKNPIERLALT----EVMDHPWIVA 278 (281)
T ss_pred -----hHHHHHHHHhccCccccccHH----HHhhhHHHHh
Confidence 489999999999999999876 9999999754
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-53 Score=421.63 Aligned_cols=281 Identities=36% Similarity=0.701 Sum_probs=240.4
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccccccee
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEF 158 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 158 (489)
..+..++|.+.+.||+|+||.||+|.++.. ....||+|++.+...........+.+|+.+++.++||||+++++++
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~ 100 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNE----DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF 100 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECC----CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE
Confidence 345678999999999999999999987752 2468999999877655555667788899999999999999999999
Q ss_pred ecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 159 EASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
.+++.+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus 101 ~~~~~~~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a 178 (340)
T PTZ00426 101 KDESYLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFA 178 (340)
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCC
Confidence 9999999999999999999998875 57999999999999999999999999999999999999999999999999997
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
+....
T Consensus 179 ~~~~~--------------------------------------------------------------------------- 183 (340)
T PTZ00426 179 KVVDT--------------------------------------------------------------------------- 183 (340)
T ss_pred eecCC---------------------------------------------------------------------------
Confidence 32210
Q ss_pred ccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchh
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKE 398 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 398 (489)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+..+...+|....
T Consensus 184 ------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~----- 252 (340)
T PTZ00426 184 ------RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLD----- 252 (340)
T ss_pred ------CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCC-----
Confidence 112347999999999999998999999999999999999999999998888888888887766654321
Q ss_pred HHHHhhHHHHHHHHhhcCcccccCCC-CChHHHHcCCCcCCCCcccc--ccCCCCCCCCc
Q 011302 399 FEEVVKLQDLISKLLVKNPKKRIGSL-KGSVEIKRHEFFKGINWALI--RSIKPPEVPNN 455 (489)
Q Consensus 399 ~~~~~~l~~li~~~L~~dP~~R~~~~-~~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~~ 455 (489)
..+.+||++||+.||++|++.. ..++++++||||++++|..+ +.+.+|..|..
T Consensus 253 ----~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~ 308 (340)
T PTZ00426 253 ----NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKY 308 (340)
T ss_pred ----HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCC
Confidence 2488999999999999998632 45679999999999999876 45566766663
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-53 Score=412.50 Aligned_cols=270 Identities=33% Similarity=0.572 Sum_probs=225.2
Q ss_pred hcCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHH-----------HHHHHHHHHHHHHh
Q 011302 77 AQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRK-----------KLHRADMEKVILTM 145 (489)
Q Consensus 77 ~~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~-----------~~~~~~~E~~~l~~ 145 (489)
.+.+..+++|++++.||+|.||.|-+|++.. .++.||||++.+....... -.+++.+|+.+|++
T Consensus 90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~-----~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKk 164 (576)
T KOG0585|consen 90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEV-----DGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKK 164 (576)
T ss_pred cccceehhheehhhhhcCCccceEEEEeecC-----CCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHh
Confidence 4456678999999999999999999999886 6899999999876554221 23577889999999
Q ss_pred CCCCCcccccceeecC--ceEEEEEeecCCCchHHHHHhCCCCC-CChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCe
Q 011302 146 LDHPFLPTLYAEFEAS--HYSCLVMEYCPGGDLYAARQRQPGKR-FGISSAKFYAAETLLALEYLHMMGIVYRDLKPENV 222 (489)
Q Consensus 146 l~hpnIv~l~~~~~~~--~~~~lV~E~~~gg~L~~~l~~~~~~~-l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NI 222 (489)
|+|||||+|+++..+. +.+|||+|||..|.+...- ..+. |++.+++.|+++++.||+|||.+|||||||||.|+
T Consensus 165 l~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNL 241 (576)
T KOG0585|consen 165 LHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNL 241 (576)
T ss_pred cCCcCeeEEEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhhe
Confidence 9999999999999754 5899999999999985532 2244 99999999999999999999999999999999999
Q ss_pred EeccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCcccccccccccccccccccccccccccc
Q 011302 223 LVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQV 302 (489)
Q Consensus 223 Ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (489)
||+.+|+|||+|||.+-.+...
T Consensus 242 Ll~~~g~VKIsDFGVs~~~~~~---------------------------------------------------------- 263 (576)
T KOG0585|consen 242 LLSSDGTVKISDFGVSNEFPQG---------------------------------------------------------- 263 (576)
T ss_pred EEcCCCcEEeeccceeeecccC----------------------------------------------------------
Confidence 9999999999999987221100
Q ss_pred CCCCCCccccCCccccccccccCCccccCCCCccCcchhcCC---C-CCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHH
Q 011302 303 DGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQ---G-HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTL 378 (489)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~---~-~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~ 378 (489)
..++ ........+|||.|+|||.+.+. . .+.+.||||+||+||.|+.|+.||.+....+++
T Consensus 264 --~~~~-------------~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~ 328 (576)
T KOG0585|consen 264 --SDEG-------------SDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF 328 (576)
T ss_pred --Cccc-------------cHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH
Confidence 0000 00111225899999999999873 2 378999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 379 INILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 379 ~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
.+|...++.+|...... ..++|||.+||.+||+.|++.. +|+.|||-..
T Consensus 329 ~KIvn~pL~fP~~pe~~-------e~~kDli~~lL~KdP~~Ri~l~----~ik~Hpwvt~ 377 (576)
T KOG0585|consen 329 DKIVNDPLEFPENPEIN-------EDLKDLIKRLLEKDPEQRITLP----DIKLHPWVTR 377 (576)
T ss_pred HHHhcCcccCCCccccc-------HHHHHHHHHHhhcChhheeehh----hheecceecc
Confidence 99999999999765322 3589999999999999999997 9999999743
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-54 Score=423.16 Aligned_cols=255 Identities=30% Similarity=0.523 Sum_probs=228.7
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
++|.+.+.||+|+||+||+|+.+. +.+.||||.+.+.... .+.++.+.+|+++++.++|||||.++++|+...+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~-----t~~~vAik~i~K~gr~-~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~ 75 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKY-----TIQVVAIKFIDKSGRN-EKELKNLRQEVRILRSLKHPNIVEMLESFETSAH 75 (808)
T ss_pred cchhHHHHhcCCccceeeeccccc-----ceeEEEEEEehhcCCc-hHHHHHHHHHHHHHHhcCCcchhhHHHhhcccce
Confidence 689999999999999999999887 6789999999876433 3456678889999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
+++|+|||.| +|+.++... +.++++.++.++.+++.||.|||+++|+|||+||.|||++.+|++|+||||+|+.+..
T Consensus 76 ~~vVte~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~ 152 (808)
T KOG0597|consen 76 LWVVTEYAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST 152 (808)
T ss_pred EEEEehhhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc
Confidence 9999999965 999999886 7899999999999999999999999999999999999999999999999999965432
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
. .
T Consensus 153 ~------------------------------------------------------------------------------t 154 (808)
T KOG0597|consen 153 N------------------------------------------------------------------------------T 154 (808)
T ss_pred C------------------------------------------------------------------------------c
Confidence 1 1
Q ss_pred cCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHh
Q 011302 324 ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVV 403 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~ 403 (489)
...+++.|||.|||||++.+++|+..+|+||||||+|||++|++||....-.+....|...+..+|.....
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~--------- 225 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASS--------- 225 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccH---------
Confidence 12345679999999999999999999999999999999999999999999999999999998888863322
Q ss_pred hHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 404 KLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 404 ~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
.+..||..+|.+||..|++.. +++.|||.++
T Consensus 226 ~f~nfl~gLL~kdP~~RltW~----~Ll~HpF~k~ 256 (808)
T KOG0597|consen 226 SFVNFLQGLLIKDPAQRLTWT----DLLGHPFWKG 256 (808)
T ss_pred HHHHHHHHHhhcChhhcccHH----HHhcChHHhh
Confidence 378999999999999999987 9999999976
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-52 Score=416.02 Aligned_cols=267 Identities=38% Similarity=0.715 Sum_probs=234.1
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
...++|.+.+.||+|+||.||+|+++. +++.||+|++.+...........+.+|+.+++.++||||+++++++.+
T Consensus 15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 89 (329)
T PTZ00263 15 WKLSDFEMGETLGTGSFGRVRIAKHKG-----TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD 89 (329)
T ss_pred CCchheEEEEEEEecCCeEEEEEEECC-----CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc
Confidence 345899999999999999999999887 578899999988765555566778889999999999999999999999
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~ 240 (489)
++.+|+||||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus 90 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 167 (329)
T PTZ00263 90 ENRVYFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKK 167 (329)
T ss_pred CCEEEEEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceE
Confidence 99999999999999999988765 5789999999999999999999999999999999999999999999999999743
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
...
T Consensus 168 ~~~----------------------------------------------------------------------------- 170 (329)
T PTZ00263 168 VPD----------------------------------------------------------------------------- 170 (329)
T ss_pred cCC-----------------------------------------------------------------------------
Confidence 210
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHH
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFE 400 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 400 (489)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..+..+...+|....
T Consensus 171 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~------- 239 (329)
T PTZ00263 171 ----RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFD------- 239 (329)
T ss_pred ----CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCC-------
Confidence 112347999999999999999999999999999999999999999998888888888877666654321
Q ss_pred HHhhHHHHHHHHhhcCcccccCCC-CChHHHHcCCCcCCCCcccc
Q 011302 401 EVVKLQDLISKLLVKNPKKRIGSL-KGSVEIKRHEFFKGINWALI 444 (489)
Q Consensus 401 ~~~~l~~li~~~L~~dP~~R~~~~-~~~~~ll~hp~f~~~~~~~~ 444 (489)
..+++||.+||+.||.+|++.. ..+++++.||||++.+|..+
T Consensus 240 --~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~ 282 (329)
T PTZ00263 240 --GRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKL 282 (329)
T ss_pred --HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHHH
Confidence 2489999999999999999853 34679999999999999976
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-53 Score=420.06 Aligned_cols=323 Identities=31% Similarity=0.557 Sum_probs=253.1
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
....-|..++.||-|+||+|.+++..+ +..+||+|.+++.++..++.+..+..|..||...+.+.||+||..|++
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvD-----T~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD 700 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVD-----TRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD 700 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecc-----hhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc
Confidence 445678899999999999999999887 578999999999999999999999999999999999999999999999
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~ 240 (489)
.+++|+||+|++||++..+|.+. +-|.|..+++|+.++.+|++++|..|+|||||||+|||||.+|++||+||||++-
T Consensus 701 kdnLYFVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTG 778 (1034)
T KOG0608|consen 701 KDNLYFVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG 778 (1034)
T ss_pred CCceEEEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeecccccc
Confidence 99999999999999999998876 7899999999999999999999999999999999999999999999999999977
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
+.+.... ..|++.++.-. ..|.+...+ ..-... ++.+.-. ....
T Consensus 779 fRWTHds----------kYYq~gdH~Rq-DSmep~~e~----~d~~~~------lkvL~~r---------------a~~~ 822 (1034)
T KOG0608|consen 779 FRWTHDS----------KYYQEGDHHRQ-DSMEPSPEW----ADISKC------LKVLERR---------------AMRQ 822 (1034)
T ss_pred ceecccc----------ccccCCCcccc-ccCCCchhh----cccccc------chHHHHH---------------HHhh
Confidence 7664332 12222111100 001100000 000000 0000000 0000
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcC--CCCCCCCCCCCchh
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK--PLTFPRIGVSSSKE 398 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~ 398 (489)
-..-...+++||+.|+|||+|...+|+..+|+||.|||||||+.|++||...+..+...+++.. -+.++.-...+
T Consensus 823 h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls--- 899 (1034)
T KOG0608|consen 823 HQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLS--- 899 (1034)
T ss_pred hhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccC---
Confidence 0011246789999999999999999999999999999999999999999998887776666543 23344333332
Q ss_pred HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccccccCCCCCCCCc
Q 011302 399 FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIRSIKPPEVPNN 455 (489)
Q Consensus 399 ~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~~~~~~p~~~~~ 455 (489)
.++.+||.+++ .+++.|++-. +.++|+.||||++|||..++++.+|++|..
T Consensus 900 ----~e~~~li~kLc-~sad~RLGkn-g~d~vKaHpfFkgIDfsslRkq~ApYIP~I 950 (1034)
T KOG0608|consen 900 ----KEALDLIQKLC-CSADSRLGKN-GADQVKAHPFFKGIDFSSLRKQRAPYIPRI 950 (1034)
T ss_pred ----HHHHHHHHHHh-cChhhhhccc-chhhhhcCccccccchHhhhhccCCcCccc
Confidence 25789998864 5789999963 555899999999999999999999998875
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-54 Score=391.81 Aligned_cols=252 Identities=27% Similarity=0.406 Sum_probs=215.0
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccc-eee
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYA-EFE 159 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~-~~~ 159 (489)
..+.+|+++++||.|+||+||+|.+.. +++.+|.|.+.-+.+. ....+....|+.+|+.|+|||||++++ .|.
T Consensus 16 ~~l~~y~Il~~IG~GsFg~vykv~~~~-----~g~l~a~K~i~f~~md-~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~ 89 (375)
T KOG0591|consen 16 KTLADYQILKKIGRGSFGEVYKVQCLL-----DGKLVALKKIQFGMMD-AKARQDCVKEISLLKQLNHPNIVQYYAHSFI 89 (375)
T ss_pred ccHHHHHHHHHHcCCcchheEEeeecc-----Ccchhhhhhcchhhcc-HHHHHHHHHHHHHHHhcCCchHHHHHHHhhh
Confidence 345789999999999999999999987 6889999999865554 345567788999999999999999999 565
Q ss_pred cCce-EEEEEeecCCCchHHHHHhC--CCCCCChhhHHHHHHHHHHHHHHHHh--CC--CeeecCCCCCeEeccCCcEEE
Q 011302 160 ASHY-SCLVMEYCPGGDLYAARQRQ--PGKRFGISSAKFYAAETLLALEYLHM--MG--IVYRDLKPENVLVREDGHIML 232 (489)
Q Consensus 160 ~~~~-~~lV~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~yLH~--~~--iiHrDIKp~NILl~~~~~vkl 232 (489)
.++. ++||||||.+|||.+++++. ..+.+++..++.++.|++.||..||+ .+ |+||||||.||+|+.+|.|||
T Consensus 90 ~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKL 169 (375)
T KOG0591|consen 90 EDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKL 169 (375)
T ss_pred ccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceee
Confidence 5554 99999999999999988753 35789999999999999999999999 45 999999999999999999999
Q ss_pred cccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCcccc
Q 011302 233 SDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELL 312 (489)
Q Consensus 233 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (489)
+|||+++.+...
T Consensus 170 GDfGL~r~l~s~-------------------------------------------------------------------- 181 (375)
T KOG0591|consen 170 GDFGLGRFLSSK-------------------------------------------------------------------- 181 (375)
T ss_pred ccchhHhHhcch--------------------------------------------------------------------
Confidence 999998654310
Q ss_pred CCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCC-CCCC
Q 011302 313 DDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLT-FPRI 391 (489)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~p~~ 391 (489)
.....+++|||+||+||.+.+.+|+.++||||+||++|||+.-++||.|.+-.+...+|..+.+. .|..
T Consensus 182 ----------~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~ 251 (375)
T KOG0591|consen 182 ----------TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDE 251 (375)
T ss_pred ----------hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHH
Confidence 11245789999999999999999999999999999999999999999999888888999888543 2211
Q ss_pred CCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 392 GVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 392 ~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
..+.++..||..|++.||+.||+..
T Consensus 252 --------~YS~~l~~li~~ci~vd~~~RP~t~ 276 (375)
T KOG0591|consen 252 --------HYSTDLRELINMCIAVDPEQRPDTV 276 (375)
T ss_pred --------HhhhHHHHHHHHHccCCcccCCCcc
Confidence 1223589999999999999999864
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-52 Score=408.53 Aligned_cols=265 Identities=40% Similarity=0.723 Sum_probs=230.3
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
++|++++.||+|+||.||+|.++. +++.||+|++.............+.+|+.+++.++||||+++++++.+++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRI-----SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcC-----CCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCe
Confidence 479999999999999999999886 578899999987655444455667889999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
+|+||||+++|+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999999998765 5799999999999999999999999999999999999999999999999999732210
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
T Consensus 154 -------------------------------------------------------------------------------- 153 (291)
T cd05612 154 -------------------------------------------------------------------------------- 153 (291)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHh
Q 011302 324 ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVV 403 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~ 403 (489)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+..+...+|... ..
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~---------~~ 223 (291)
T cd05612 154 -RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHL---------DL 223 (291)
T ss_pred -CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccC---------CH
Confidence 11234699999999999999999999999999999999999999999988888888887776665432 12
Q ss_pred hHHHHHHHHhhcCcccccCCC-CChHHHHcCCCcCCCCccccc
Q 011302 404 KLQDLISKLLVKNPKKRIGSL-KGSVEIKRHEFFKGINWALIR 445 (489)
Q Consensus 404 ~l~~li~~~L~~dP~~R~~~~-~~~~~ll~hp~f~~~~~~~~~ 445 (489)
.+++||.+||+.||.+|++.. ..++++++||||+.++|....
T Consensus 224 ~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~ 266 (291)
T cd05612 224 YAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVP 266 (291)
T ss_pred HHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHHHHh
Confidence 489999999999999999743 345699999999999998653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-54 Score=406.23 Aligned_cols=281 Identities=36% Similarity=0.665 Sum_probs=249.5
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-CCCcccccceee
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-HPFLPTLYAEFE 159 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~ 159 (489)
+...+|.++.+||+|+||+|.+|..++ +.++||||+++++.+......+--+.|.++|.... -|+++.|+.+|+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkg-----tdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQ 420 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKG-----TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQ 420 (683)
T ss_pred eeecccceEEEeccCccceeeeecccC-----cchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhh
Confidence 456799999999999999999999887 67899999999987766666666778999998875 679999999999
Q ss_pred cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 160 ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 160 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
.-+.+|+||||+.||+|.-.+++. ++|.+..+..|+.+|+-||-|||++|||+||||.+|||++.+|++||+|||+++
T Consensus 421 TmDRLyFVMEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcK 498 (683)
T KOG0696|consen 421 TMDRLYFVMEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK 498 (683)
T ss_pred hhhheeeEEEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccc
Confidence 999999999999999998877775 789999999999999999999999999999999999999999999999999973
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
.--
T Consensus 499 Eni----------------------------------------------------------------------------- 501 (683)
T KOG0696|consen 499 ENI----------------------------------------------------------------------------- 501 (683)
T ss_pred ccc-----------------------------------------------------------------------------
Confidence 210
Q ss_pred cccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhH
Q 011302 320 EPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEF 399 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 399 (489)
.....+.++||||.|+|||++..++|+.++|+||+||+||||+.|++||+|.++.+++..|......+|.....
T Consensus 502 -~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSk----- 575 (683)
T KOG0696|consen 502 -FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSK----- 575 (683)
T ss_pred -cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccH-----
Confidence 01224568899999999999999999999999999999999999999999999999999999998888864322
Q ss_pred HHHhhHHHHHHHHhhcCcccccCCCC-ChHHHHcCCCcCCCCcccc--ccCCCCCCCCc
Q 011302 400 EEVVKLQDLISKLLVKNPKKRIGSLK-GSVEIKRHEFFKGINWALI--RSIKPPEVPNN 455 (489)
Q Consensus 400 ~~~~~l~~li~~~L~~dP~~R~~~~~-~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~~ 455 (489)
++.+++..+|.+.|.+|++... +-.+|..||||+.|||+.+ +++.||+-|..
T Consensus 576 ----EAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~ 630 (683)
T KOG0696|consen 576 ----EAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKI 630 (683)
T ss_pred ----HHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCcc
Confidence 5889999999999999999753 3468999999999999988 67889987775
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-53 Score=402.05 Aligned_cols=253 Identities=29% Similarity=0.514 Sum_probs=233.1
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
.+|.+.+.||+|+||+|-+|..+. .++.||||.++++.+...+.+-.+.+|++||+.|+||||+.+|++|++.+.
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~-----sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdK 127 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHK-----SGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDK 127 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhcc-----CCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCce
Confidence 579999999999999999999876 689999999999999888888899999999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
+.|||||..+|+|++++... +.|++.+++.+++||+.|+.|||.++++|||||.+|||+|.|+++||+|||++-.+..
T Consensus 128 IvivMEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEEEEEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 99999999999999999887 7899999999999999999999999999999999999999999999999999733321
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
.
T Consensus 206 -------------------------------------------------------------------------------~ 206 (668)
T KOG0611|consen 206 -------------------------------------------------------------------------------K 206 (668)
T ss_pred -------------------------------------------------------------------------------c
Confidence 1
Q ss_pred cCCccccCCCCccCcchhcCCCC-CCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHH
Q 011302 324 ARSKSFVGTHEYLAPEVISGQGH-GSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEV 402 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~~~~-~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~ 402 (489)
....+|||+|-|.+||+++|.+| ++.+|-|||||+||.|+.|..||+|.+...++.+|..+.+..|....
T Consensus 207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~PS--------- 277 (668)
T KOG0611|consen 207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPETPS--------- 277 (668)
T ss_pred cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCCCc---------
Confidence 23467899999999999999998 89999999999999999999999999999999999999887775432
Q ss_pred hhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 403 VKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 403 ~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
.+.-||+.||..||++|.|+. +|..|.|.
T Consensus 278 -dA~gLIRwmLmVNP~RRATie----DiAsHWWv 306 (668)
T KOG0611|consen 278 -DASGLIRWMLMVNPERRATIE----DIASHWWV 306 (668)
T ss_pred -hHHHHHHHHHhcCcccchhHH----HHhhhhee
Confidence 378999999999999999987 99999885
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-52 Score=404.64 Aligned_cols=277 Identities=35% Similarity=0.569 Sum_probs=227.3
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceE
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYS 164 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 164 (489)
.|++.+.||+|+||+||+|.+.. +++.||+|.+.+...........+.+|+.+++.++|+||+++++++.+++.+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRA-----TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDAL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEec-----CCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeE
Confidence 37889999999999999999887 5789999999877655444445677899999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccC
Q 011302 165 CLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVV 244 (489)
Q Consensus 165 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~ 244 (489)
|+||||+++|+|.+++.......+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~- 154 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE- 154 (285)
T ss_pred EEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC-
Confidence 9999999999998887655445789999999999999999999999999999999999999999999999999733210
Q ss_pred ccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccccc
Q 011302 245 PKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINA 324 (489)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (489)
..
T Consensus 155 ------------------------------------------------------------------------------~~ 156 (285)
T cd05631 155 ------------------------------------------------------------------------------GE 156 (285)
T ss_pred ------------------------------------------------------------------------------CC
Confidence 00
Q ss_pred CCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHH----HHhcCCCCCCCCCCCCchhHH
Q 011302 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLI----NILKKPLTFPRIGVSSSKEFE 400 (489)
Q Consensus 325 ~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~----~i~~~~~~~p~~~~~~~~~~~ 400 (489)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...... .+......++..
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 227 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEK--------- 227 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCcc---------
Confidence 1123468999999999999999999999999999999999999998766532222 222222222211
Q ss_pred HHhhHHHHHHHHhhcCcccccCCCC-ChHHHHcCCCcCCCCcccc--ccCCCCCCCC
Q 011302 401 EVVKLQDLISKLLVKNPKKRIGSLK-GSVEIKRHEFFKGINWALI--RSIKPPEVPN 454 (489)
Q Consensus 401 ~~~~l~~li~~~L~~dP~~R~~~~~-~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~ 454 (489)
....+.+||++||+.||++|+++.+ .++++++||||++++|+.+ +.++||+.|+
T Consensus 228 ~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~ 284 (285)
T cd05631 228 FSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPPFCPD 284 (285)
T ss_pred CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhCcCCcCCCCC
Confidence 1125899999999999999998643 3679999999999999987 4467787775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-51 Score=414.00 Aligned_cols=308 Identities=31% Similarity=0.557 Sum_probs=232.4
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
++|++++.||+|+||+||+|+++. +++.||||++.+...........+..|+.++..++||||+++++++.+...
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKD-----TGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECC-----CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCe
Confidence 479999999999999999999886 578999999988766555566778889999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
+|||||||+||+|.+++.+. +.+++..++.++.||+.||+|||++|||||||||+|||++.+|++||+|||+++.+..
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 99999999999999998775 5799999999999999999999999999999999999999999999999999864432
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
..... .+..... .. +....+.... ... ..........
T Consensus 154 ~~~~~----------~~~~~~~-~~-----~~~~~~~~~~--~~~-------------------------~~~~~~~~~~ 190 (363)
T cd05628 154 AHRTE----------FYRNLNH-SL-----PSDFTFQNMN--SKR-------------------------KAETWKRNRR 190 (363)
T ss_pred ccccc----------ccccccc-cc-----cccccccccc--ccc-------------------------ccchhhhccc
Confidence 10000 0000000 00 0000000000 000 0000000001
Q ss_pred cCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcC--CCCCCCCCCCCchhHHH
Q 011302 324 ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK--PLTFPRIGVSSSKEFEE 401 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~~~~ 401 (489)
....+.+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+.++... ...+|.....
T Consensus 191 ~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~------- 263 (363)
T cd05628 191 QLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPI------- 263 (363)
T ss_pred cccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCC-------
Confidence 1234568999999999999999999999999999999999999999998888888887753 3334432211
Q ss_pred HhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccccccCCCC
Q 011302 402 VVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIRSIKPP 450 (489)
Q Consensus 402 ~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~~~~~~p 450 (489)
..++++||.+|+. +|.+|++. ..+++|++||||++++|+.+....++
T Consensus 264 s~~~~~li~~l~~-~~~~r~~r-~~~~ei~~hp~f~~~~~~~~~~~~~~ 310 (363)
T cd05628 264 SEKAKDLILRFCC-EWEHRIGA-PGVEEIKTNPFFEGVDWEHIRERPAA 310 (363)
T ss_pred CHHHHHHHHHHcC-ChhhcCCC-CCHHHHhCCCCCCCCCHHHHHhCCCC
Confidence 1258999999885 67777543 24459999999999999988654433
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-51 Score=416.69 Aligned_cols=315 Identities=34% Similarity=0.608 Sum_probs=237.7
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
++|++++.||+|+||+||+|++.. +++.||||++.+...........+..|+.+|..++||||++++++|.+++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKD-----TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCe
Confidence 479999999999999999999987 578899999988765555566677889999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
+|||||||+||+|.+++... ..+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.+..
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred EEEEECCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999999998765 5699999999999999999999999999999999999999999999999999854321
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
...... +.... ................... ..........
T Consensus 154 ~~~~~~----------~~~~~-----~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~ 193 (364)
T cd05599 154 SHRTEF----------YRILS-----HALPSNFLDFISKPMSSKR-------------------------KAETWKRNRR 193 (364)
T ss_pred cccccc----------ccccc-----ccccccccccccccccccc-------------------------cccchhhccc
Confidence 100000 00000 0000000000000000000 0000000001
Q ss_pred cCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCC--CCCCCCCCCchhHHH
Q 011302 324 ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL--TFPRIGVSSSKEFEE 401 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--~~p~~~~~~~~~~~~ 401 (489)
....+.+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..+..... .+|.... .
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~-------~ 266 (364)
T cd05599 194 ALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVP-------L 266 (364)
T ss_pred ccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCC-------C
Confidence 122346899999999999999999999999999999999999999999888877777765432 2222111 1
Q ss_pred HhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccccccCCCCCCCC
Q 011302 402 VVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIRSIKPPEVPN 454 (489)
Q Consensus 402 ~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~~~~~~p~~~~ 454 (489)
...+++||.+||. +|.+|++. ..+.++++||||++++|..+....+|.+|.
T Consensus 267 s~~~~~li~~ll~-~p~~R~~~-~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~ 317 (364)
T cd05599 267 SPEAKDLIKRLCC-EAERRLGN-NGVNEIKSHPFFKGVDWEHIRERPAPIIPE 317 (364)
T ss_pred CHHHHHHHHHHcc-CHhhcCCC-CCHHHHhcCCCcCCCCHHHHhhcCCCCCCC
Confidence 2258999999996 99999984 344599999999999999887777776665
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-51 Score=409.97 Aligned_cols=271 Identities=39% Similarity=0.714 Sum_probs=229.4
Q ss_pred eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEEEEEe
Q 011302 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVME 169 (489)
Q Consensus 90 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 169 (489)
+.||+|+||.||+|+++. +++.||||++++..........++..|+.+++.++||||+++++++..++.+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKA-----TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEe
Confidence 369999999999999886 578999999998766555566677889999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCccccC
Q 011302 170 YCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLR 249 (489)
Q Consensus 170 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 249 (489)
|++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 76 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~------ 147 (323)
T cd05571 76 YANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS------ 147 (323)
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc------
Confidence 99999999988765 5799999999999999999999999999999999999999999999999999732100
Q ss_pred CcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCccc
Q 011302 250 PKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSF 329 (489)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (489)
........
T Consensus 148 ------------------------------------------------------------------------~~~~~~~~ 155 (323)
T cd05571 148 ------------------------------------------------------------------------DGATMKTF 155 (323)
T ss_pred ------------------------------------------------------------------------CCCcccce
Confidence 00112345
Q ss_pred cCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHHH
Q 011302 330 VGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLI 409 (489)
Q Consensus 330 ~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li 409 (489)
+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+......+|... ..++.+||
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~---------~~~~~~li 226 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTL---------SPEAKSLL 226 (323)
T ss_pred ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC---------CHHHHHHH
Confidence 799999999999999999999999999999999999999999888777777777766665421 12589999
Q ss_pred HHHhhcCcccccCCCC-ChHHHHcCCCcCCCCcccc--ccCCCCCCCC
Q 011302 410 SKLLVKNPKKRIGSLK-GSVEIKRHEFFKGINWALI--RSIKPPEVPN 454 (489)
Q Consensus 410 ~~~L~~dP~~R~~~~~-~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~ 454 (489)
.+||+.||++|++... .+.++++||||++++|..+ +...||..|.
T Consensus 227 ~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~~~~~~~~~~~~~ 274 (323)
T cd05571 227 AGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEPPFKPQ 274 (323)
T ss_pred HHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCC
Confidence 9999999999996432 4569999999999999876 3455554443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-52 Score=408.12 Aligned_cols=271 Identities=29% Similarity=0.393 Sum_probs=221.1
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
...+.|+.+++||+|+||.||+|++.. +++.||+|.++.+... .....-..+|+.||++|+||||++|.+...+
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~-----tgkivALKKvr~d~~~-~~~~~t~~REI~ILr~l~HpNIikL~eivt~ 187 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLE-----TGKIVALKKVRFDNEK-EGFPITAIREIKILRRLDHPNIIKLEEIVTS 187 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecc-----cCcEEEEEEeecccCC-CcchHHHHHHHHHHHhcCCCcccceeeEEEe
Confidence 345789999999999999999999987 6899999999876533 2344556789999999999999999998876
Q ss_pred C--ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 161 S--HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 161 ~--~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
. ..+|||+|||+ -||..++.. ++-.|++.+++.||.||+.||+|||.+||+|||||..|||||.+|.+||+|||||
T Consensus 188 ~~~~siYlVFeYMd-hDL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLA 265 (560)
T KOG0600|consen 188 KLSGSIYLVFEYMD-HDLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLA 265 (560)
T ss_pred cCCceEEEEEeccc-chhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccce
Confidence 5 78999999995 588777654 4568999999999999999999999999999999999999999999999999999
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
+.+.....
T Consensus 266 r~y~~~~~------------------------------------------------------------------------ 273 (560)
T KOG0600|consen 266 RFYTPSGS------------------------------------------------------------------------ 273 (560)
T ss_pred eeccCCCC------------------------------------------------------------------------
Confidence 65542110
Q ss_pred ccccccCCccccCCCCccCcchhcCCC-CCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhc--CCC---CCCCCC
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQG-HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILK--KPL---TFPRIG 392 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~--~~~---~~p~~~ 392 (489)
...++.+-|.+|+|||+|+|.. |+.++|+||.||||.||++|++.|.|.++.+++..|.+ +.. .|+...
T Consensus 274 -----~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 274 -----APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred -----cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 1234567899999999999975 89999999999999999999999999999999888864 111 111100
Q ss_pred CCC----------c----hhH-HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 393 VSS----------S----KEF-EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 393 ~~~----------~----~~~-~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
.+. . +.+ ..+..+.+|+..||..||.+|.++. ++|+|+||..-.
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~----~aL~seyF~t~p 407 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTAS----SALQSEYFTTEP 407 (560)
T ss_pred CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHH----HHhcCcccccCC
Confidence 000 0 001 1123478999999999999999998 999999995443
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-51 Score=417.50 Aligned_cols=325 Identities=34% Similarity=0.609 Sum_probs=238.0
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
++|.+++.||+|+||+||+|+++. +++.||||++.+...........+.+|+.+++.++||||++++++|.+...
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKD-----TGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECC-----CCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCe
Confidence 479999999999999999999886 578999999987765555666778889999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
+||||||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999999999998765 5799999999999999999999999999999999999999999999999999854321
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
..... .+.......... . .................... ...........
T Consensus 154 ~~~~~----------~~~~~~~~~~~~---------~-----~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~ 202 (377)
T cd05629 154 QHDSA----------YYQKLLQGKSNK---------N-----RIDNRNSVAVDSINLTMSSK-------DQIATWKKNRR 202 (377)
T ss_pred ccccc----------cccccccccccc---------c-----ccccccccccccccccccch-------hhhhhhhhccc
Confidence 10000 000000000000 0 00000000000000000000 00000000000
Q ss_pred cCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcC--CCCCCCCCCCCchhHHH
Q 011302 324 ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK--PLTFPRIGVSSSKEFEE 401 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~~~~ 401 (489)
....+.+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+.+..+... ...+|.... .
T Consensus 203 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~-------~ 275 (377)
T cd05629 203 LMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIH-------L 275 (377)
T ss_pred ccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCC-------C
Confidence 1122468999999999999999999999999999999999999999988877777777653 233332211 1
Q ss_pred HhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccccccCCCCCCCCc
Q 011302 402 VVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIRSIKPPEVPNN 455 (489)
Q Consensus 402 ~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~~~~~~p~~~~~ 455 (489)
..++.+||.+||. +|.+|++. ..+.+++.||||++++|..++.+.+|.+|..
T Consensus 276 s~~~~dli~~lL~-~~~~r~~r-~~~~~~l~hp~~~~~~~~~~~~~~~~~~~~~ 327 (377)
T cd05629 276 SVEAEDLIRRLIT-NAENRLGR-GGAHEIKSHPFFRGVDWDTIRQIRAPFIPQL 327 (377)
T ss_pred CHHHHHHHHHHhc-CHhhcCCC-CCHHHHhcCCCcCCCCHHHHccCCCCcccCC
Confidence 2358999999997 88888743 2345999999999999999998888887764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-51 Score=404.94 Aligned_cols=276 Identities=36% Similarity=0.686 Sum_probs=233.6
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccceeecCce
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAEFEASHY 163 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~ 163 (489)
+|.+++.||+|+||+||+|+++. +++.||||++.+..............|..++..+ +|++|+++++++.+.+.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKG-----TDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCE
Confidence 58999999999999999999886 5788999999987655445555667788888777 58999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
+|+||||++||+|...+... ..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 99999999999999888765 5699999999999999999999999999999999999999999999999999732110
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
. .
T Consensus 154 ~------------------------------------------------------------------------------~ 155 (323)
T cd05616 154 D------------------------------------------------------------------------------G 155 (323)
T ss_pred C------------------------------------------------------------------------------C
Confidence 0 0
Q ss_pred cCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHh
Q 011302 324 ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVV 403 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~ 403 (489)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+....+..+......+|... ..
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~---------s~ 226 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSM---------SK 226 (323)
T ss_pred CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcC---------CH
Confidence 012245799999999999999999999999999999999999999999988888888887766665422 12
Q ss_pred hHHHHHHHHhhcCcccccCCC-CChHHHHcCCCcCCCCcccc--ccCCCCCCCC
Q 011302 404 KLQDLISKLLVKNPKKRIGSL-KGSVEIKRHEFFKGINWALI--RSIKPPEVPN 454 (489)
Q Consensus 404 ~l~~li~~~L~~dP~~R~~~~-~~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~ 454 (489)
++.+||.+||+.||++|++.. ....++++||||+.++|..+ +...||..|.
T Consensus 227 ~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~~~~~~~~~~~~~ 280 (323)
T cd05616 227 EAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEVQPPYKPK 280 (323)
T ss_pred HHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCc
Confidence 589999999999999999974 24569999999999999976 4456666655
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-51 Score=405.79 Aligned_cols=273 Identities=38% Similarity=0.717 Sum_probs=230.1
Q ss_pred eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccceeecCceEEEEE
Q 011302 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAEFEASHYSCLVM 168 (489)
Q Consensus 90 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lV~ 168 (489)
+.||+|+||+||+|+++. +++.||||++.+...........+..|..++..+ +||||+++++++.+.+.+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKE-----SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcC-----CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEE
Confidence 369999999999999886 5788999999887655445566677788888776 6999999999999999999999
Q ss_pred eecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCcccc
Q 011302 169 EYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLL 248 (489)
Q Consensus 169 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 248 (489)
||++||+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 76 Ey~~~g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~---- 149 (320)
T cd05590 76 EFVNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN---- 149 (320)
T ss_pred cCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC----
Confidence 999999999888765 57999999999999999999999999999999999999999999999999997321100
Q ss_pred CCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCcc
Q 011302 249 RPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKS 328 (489)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (489)
......
T Consensus 150 --------------------------------------------------------------------------~~~~~~ 155 (320)
T cd05590 150 --------------------------------------------------------------------------GKTTST 155 (320)
T ss_pred --------------------------------------------------------------------------CCcccc
Confidence 001123
Q ss_pred ccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHH
Q 011302 329 FVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDL 408 (489)
Q Consensus 329 ~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~l 408 (489)
.+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......+|... ..++.+|
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~---------~~~~~~l 226 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWL---------SQDAVDI 226 (320)
T ss_pred cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCC---------CHHHHHH
Confidence 4799999999999999999999999999999999999999999998888888887766555421 1258999
Q ss_pred HHHHhhcCcccccCCCC--ChHHHHcCCCcCCCCcccc--ccCCCCCCCCcc
Q 011302 409 ISKLLVKNPKKRIGSLK--GSVEIKRHEFFKGINWALI--RSIKPPEVPNND 456 (489)
Q Consensus 409 i~~~L~~dP~~R~~~~~--~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~~~ 456 (489)
|.+||+.||++|+++.+ ..+++++||||+.++|..+ +.+.||+.|...
T Consensus 227 i~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~ 278 (320)
T cd05590 227 LKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPRIK 278 (320)
T ss_pred HHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCC
Confidence 99999999999999842 2469999999999999876 456677666653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-53 Score=379.93 Aligned_cols=261 Identities=29% Similarity=0.497 Sum_probs=228.2
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.+.|++.+.||+|.|+.||++.++. +++.||+|+++...+... ..+.+.+|+.|-+.|+|||||+|.+.+....
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~-----tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~ 83 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKT-----TGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEES 83 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhcc-----chHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccc
Confidence 4789999999999999999998876 678899999987766644 5677888999999999999999999999999
Q ss_pred eEEEEEeecCCCchH-HHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccC---CcEEEcccCCC
Q 011302 163 YSCLVMEYCPGGDLY-AARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRED---GHIMLSDFDLS 238 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~-~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~---~~vkl~DFG~a 238 (489)
..|||+|++.|++|. ++.++ .-+++..+-.+++||+++|.|+|.+||||||+||+|+|+... -.+||+|||+|
T Consensus 84 ~~ylvFe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvA 160 (355)
T KOG0033|consen 84 FHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLA 160 (355)
T ss_pred eeEEEEecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceE
Confidence 999999999999996 44444 458999999999999999999999999999999999999643 35999999998
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
..+..
T Consensus 161 i~l~~--------------------------------------------------------------------------- 165 (355)
T KOG0033|consen 161 IEVND--------------------------------------------------------------------------- 165 (355)
T ss_pred EEeCC---------------------------------------------------------------------------
Confidence 43320
Q ss_pred ccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchh
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKE 398 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 398 (489)
.....+++|||+|||||++...+|+..+|||+-|||||-||.|.+||.+.+...+++.|..+.+.+|...+....
T Consensus 166 ----g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is- 240 (355)
T KOG0033|consen 166 ----GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVT- 240 (355)
T ss_pred ----ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCC-
Confidence 112345789999999999999999999999999999999999999999999999999999999988875544433
Q ss_pred HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 399 FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 399 ~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
+.+++||++||..||.+|+++. |+|+|||+..-+
T Consensus 241 ----~~Ak~LvrrML~~dP~kRIta~----EAL~HpWi~~r~ 274 (355)
T KOG0033|consen 241 ----PEAKSLIRRMLTVNPKKRITAD----EALKHPWICNRE 274 (355)
T ss_pred ----HHHHHHHHHHhccChhhhccHH----HHhCCchhcchH
Confidence 3699999999999999999998 999999997654
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-51 Score=415.71 Aligned_cols=324 Identities=32% Similarity=0.550 Sum_probs=236.1
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceE
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYS 164 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 164 (489)
.|.+++.||+|+||+||+|+++. +++.||||++.+...........+.+|+.+++.++||||++++++|.+++.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~-----~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVD-----TKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECC-----CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEE
Confidence 68999999999999999999886 5789999999887665566677888999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccC
Q 011302 165 CLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVV 244 (489)
Q Consensus 165 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~ 244 (489)
|+|||||+||+|.+++.+. +.+++..++.++.||+.||+|||++|||||||||+|||++.+|++||+|||++..+...
T Consensus 77 ~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 9999999999999998765 56899999999999999999999999999999999999999999999999998543221
Q ss_pred ccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccccc
Q 011302 245 PKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINA 324 (489)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (489)
..... +.... ...... ..+.... +...... .+ .................
T Consensus 155 ~~~~~----------~~~~~-----~~~~~~-~~~~~~~-~~~~~~~-----------~~---~~~~~~~~~~~~~~~~~ 203 (382)
T cd05625 155 HDSKY----------YQSGD-----HVRQDS-MDFSNEW-GDPANCR-----------CG---DRLKPLERRAARQHQRC 203 (382)
T ss_pred ccccc----------ccccc-----cccccc-ccccccc-ccccccc-----------cc---ccccchhhhhccccccc
Confidence 11000 00000 000000 0000000 0000000 00 00000000000000111
Q ss_pred CCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCC--CCCCCCCCCCchhHHHH
Q 011302 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP--LTFPRIGVSSSKEFEEV 402 (489)
Q Consensus 325 ~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~~~~~ 402 (489)
...+.+||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+...++.... ..+|..... .
T Consensus 204 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~-------s 276 (382)
T cd05625 204 LAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKL-------S 276 (382)
T ss_pred cccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccC-------C
Confidence 2345789999999999999999999999999999999999999999988877777776533 223322111 2
Q ss_pred hhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccc-cccCCCCCCCCc
Q 011302 403 VKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWAL-IRSIKPPEVPNN 455 (489)
Q Consensus 403 ~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~-~~~~~~p~~~~~ 455 (489)
.++.+||.+|+ .+|++|++. ..+.++++||||++++|.. +....+|.+|..
T Consensus 277 ~~~~~li~~l~-~~p~~R~~~-~~~~ei~~hp~f~~~~~~~~~~~~~~~~~~~~ 328 (382)
T cd05625 277 PEASDLIIKLC-RGPEDRLGK-NGADEIKAHPFFKTIDFSSDLRQQSAPYIPKI 328 (382)
T ss_pred HHHHHHHHHHc-cCHhHcCCC-CCHHHHhcCCCcCCcChHHHHhcCCCCccCcC
Confidence 35889999986 599999984 3456999999999999986 455666666554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-52 Score=384.26 Aligned_cols=319 Identities=35% Similarity=0.627 Sum_probs=267.9
Q ss_pred hcCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCccccc
Q 011302 77 AQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLY 155 (489)
Q Consensus 77 ~~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~ 155 (489)
..+.+++++|.++++||+|+|++|.+++++. +.+.||+|+++++.....+...-++.|..+.... +||++|.|+
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~-----t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglh 317 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKK-----TDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLH 317 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcc-----cceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehh
Confidence 4567889999999999999999999999987 6899999999999888888888888899888775 699999999
Q ss_pred ceeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEccc
Q 011302 156 AEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235 (489)
Q Consensus 156 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DF 235 (489)
.+|+.+..+++|.||++||+|.-.++++ +.|+++.+++|..+|+.||.|||+.|||+||||.+|+||+..|++||+|+
T Consensus 318 scfqtesrlffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdy 395 (593)
T KOG0695|consen 318 SCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDY 395 (593)
T ss_pred hhhcccceEEEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeeccc
Confidence 9999999999999999999998777776 68999999999999999999999999999999999999999999999999
Q ss_pred CCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCc
Q 011302 236 DLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDP 315 (489)
Q Consensus 236 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (489)
|+.+. .++
T Consensus 396 gmcke------~l~------------------------------------------------------------------ 403 (593)
T KOG0695|consen 396 GMCKE------GLG------------------------------------------------------------------ 403 (593)
T ss_pred chhhc------CCC------------------------------------------------------------------
Confidence 99631 110
Q ss_pred cccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCC--C------CcHHHHHHHhcCCCC
Q 011302 316 EVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKG--E------NNEKTLINILKKPLT 387 (489)
Q Consensus 316 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~--~------~~~~~~~~i~~~~~~ 387 (489)
....+.++||||.|+|||++.|..|+..+|+|+|||+++||+.|+.||+- . ++.-.+.-|+..++.
T Consensus 404 ------~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir 477 (593)
T KOG0695|consen 404 ------PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR 477 (593)
T ss_pred ------CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc
Confidence 12245678999999999999999999999999999999999999999962 1 223355667788888
Q ss_pred CCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCC--ChHHHHcCCCcCCCCcccc--ccCCCCCCCCccccccc--
Q 011302 388 FPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLK--GSVEIKRHEFFKGINWALI--RSIKPPEVPNNDLYCKI-- 461 (489)
Q Consensus 388 ~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~--~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~~~~~~~~-- 461 (489)
+|..... .+..+++..|++||.+|++... ++.+++.|+||+.+||+.+ +...||+-|....-...
T Consensus 478 iprslsv---------kas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ppf~p~i~~d~~l~~ 548 (593)
T KOG0695|consen 478 IPRSLSV---------KASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPPFQPQITDDYGLDN 548 (593)
T ss_pred ccceeeh---------hhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCCCCCccccccCccc
Confidence 7764433 3678999999999999999753 5789999999999999987 66788888875433321
Q ss_pred ---ccccccCcCcccccCCCCCCCCCCCCCC
Q 011302 462 ---KKKVYVPKLSKQERDAPYQIPTHHFDYF 489 (489)
Q Consensus 462 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 489 (489)
.-+.-.++++++.+|..-.|-++-||-|
T Consensus 549 fd~qft~e~~qltpdd~d~i~ridqsefegf 579 (593)
T KOG0695|consen 549 FDTQFTSEPVQLTPDDEDAIKRIDQSEFEGF 579 (593)
T ss_pred cccccccCCcccCCCCHHHHHhcchhhcCcc
Confidence 1233455677777777777777777765
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-51 Score=408.81 Aligned_cols=277 Identities=35% Similarity=0.582 Sum_probs=235.7
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
++|++++.||+|+||.||+|++.. +++.||||++.+...........+..|+.++..++||||+++++++.+++.
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKD-----TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECC-----CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCE
Confidence 479999999999999999999886 567899999998766555566778889999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
.||||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 99999999999999998765 5689999999999999999999999999999999999999999999999999832210
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
T Consensus 154 -------------------------------------------------------------------------------- 153 (333)
T cd05600 154 -------------------------------------------------------------------------------- 153 (333)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCC--CCCCCCCCCchhHHH
Q 011302 324 ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL--TFPRIGVSSSKEFEE 401 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--~~p~~~~~~~~~~~~ 401 (489)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..+..... ..|...... ...
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~---~~~ 229 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPR---FNL 229 (333)
T ss_pred -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccc---ccc
Confidence 11234799999999999999999999999999999999999999999888777766654322 222211100 112
Q ss_pred HhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccccccCCCCCCCCc
Q 011302 402 VVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIRSIKPPEVPNN 455 (489)
Q Consensus 402 ~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~~~~~~p~~~~~ 455 (489)
..++.+||.+||..+|.+|+++. ++++||||+.++|..+....||.+|..
T Consensus 230 s~~~~~li~~~l~~~~~rr~s~~----~ll~h~~~~~~~~~~~~~~~~~~~~~~ 279 (333)
T cd05600 230 SDEAWDLITKLINDPSRRFGSLE----DIKNHPFFKEVDWNELRELKPPFVPEL 279 (333)
T ss_pred CHHHHHHHHHHhhChhhhcCCHH----HHHhCcccCCCCHHHHhhCCCCCCCCC
Confidence 23589999999999999999987 999999999999999888888877663
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=403.15 Aligned_cols=275 Identities=39% Similarity=0.715 Sum_probs=230.2
Q ss_pred ceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHH---HhCCCCCcccccceeecCc
Q 011302 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL---TMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 86 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l---~~l~hpnIv~l~~~~~~~~ 162 (489)
|++++.||+|+||.||+|.++. +++.||||++++...........+..|+.++ +.++||||+++++++.+.+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKK-----TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCC
Confidence 7889999999999999999886 5788999999877654445556666676655 4567999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
.+|+||||++||+|...+.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 76 ~~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EEEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 99999999999999887754 469999999999999999999999999999999999999999999999999873211
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
. .
T Consensus 153 ~------------------------------------------------------------------------------~ 154 (324)
T cd05589 153 G------------------------------------------------------------------------------F 154 (324)
T ss_pred C------------------------------------------------------------------------------C
Confidence 0 0
Q ss_pred ccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHH
Q 011302 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEV 402 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~ 402 (489)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..+......+|... .
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~---------~ 225 (324)
T cd05589 155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFL---------S 225 (324)
T ss_pred CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCC---------C
Confidence 0112345799999999999999999999999999999999999999999888888888877666555322 1
Q ss_pred hhHHHHHHHHhhcCcccccCCCC-ChHHHHcCCCcCCCCcccc--ccCCCCCCCCc
Q 011302 403 VKLQDLISKLLVKNPKKRIGSLK-GSVEIKRHEFFKGINWALI--RSIKPPEVPNN 455 (489)
Q Consensus 403 ~~l~~li~~~L~~dP~~R~~~~~-~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~~ 455 (489)
..+.+||.+||+.||.+||+..+ .+.++++||||++++|..+ +...||.+|..
T Consensus 226 ~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~~~~~~~~~~~~~~~ 281 (324)
T cd05589 226 REAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKPPFVPTI 281 (324)
T ss_pred HHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHHHHhCCCCcCccCCC
Confidence 24889999999999999998654 4789999999999999865 44556665543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-53 Score=409.15 Aligned_cols=285 Identities=36% Similarity=0.676 Sum_probs=254.2
Q ss_pred hhcCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccccc
Q 011302 76 RAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLY 155 (489)
Q Consensus 76 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~ 155 (489)
.....+.+.+++.+..||-|+||.|-+++.+. ....+|+|++++..+....+.+.+..|..+|..++.|+||+||
T Consensus 412 ~e~a~v~l~dl~~iaTLGvGgFGRVELV~~~~-----~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLY 486 (732)
T KOG0614|consen 412 EEFAQVKLSDLKRIATLGVGGFGRVELVKVNS-----QKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLY 486 (732)
T ss_pred hhhcccchhhhhhhhhcccCccceEEEEEecc-----cchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHH
Confidence 34456778899999999999999999998876 2335899999999888777788889999999999999999999
Q ss_pred ceeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEccc
Q 011302 156 AEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235 (489)
Q Consensus 156 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DF 235 (489)
..|.+..++|++||-|-||+|+..++.+ +.|.+..+++|+..+++|++|||++|||+|||||+|+|++.+|.+||.||
T Consensus 487 rTfrd~kyvYmLmEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDF 564 (732)
T KOG0614|consen 487 RTFRDSKYVYMLMEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDF 564 (732)
T ss_pred HHhccchhhhhhHHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeeh
Confidence 9999999999999999999999999876 78999999999999999999999999999999999999999999999999
Q ss_pred CCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCc
Q 011302 236 DLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDP 315 (489)
Q Consensus 236 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (489)
|+|+.+..
T Consensus 565 GFAKki~~------------------------------------------------------------------------ 572 (732)
T KOG0614|consen 565 GFAKKIGS------------------------------------------------------------------------ 572 (732)
T ss_pred hhHHHhcc------------------------------------------------------------------------
Confidence 99955421
Q ss_pred cccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCC--CCCCCCCC
Q 011302 316 EVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP--LTFPRIGV 393 (489)
Q Consensus 316 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~ 393 (489)
+.++-++||||.|.|||++.+.+++.++|.||||+++||||+|.+||.+.++..++..|+++. +.+|....
T Consensus 573 -------g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~ 645 (732)
T KOG0614|consen 573 -------GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRIT 645 (732)
T ss_pred -------CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccc
Confidence 345678999999999999999999999999999999999999999999999999999999864 45564433
Q ss_pred CCchhHHHHhhHHHHHHHHhhcCcccccCCC-CChHHHHcCCCcCCCCcccc--ccCCCCCCCCc
Q 011302 394 SSSKEFEEVVKLQDLISKLLVKNPKKRIGSL-KGSVEIKRHEFFKGINWALI--RSIKPPEVPNN 455 (489)
Q Consensus 394 ~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~-~~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~~ 455 (489)
. .+.+||+++...+|.+|++.. .++.+|++|-||.++||+.+ +.+.||++|..
T Consensus 646 k---------~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~v 701 (732)
T KOG0614|consen 646 K---------TATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSV 701 (732)
T ss_pred h---------hHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccC
Confidence 3 378999999999999999965 57889999999999999977 55778877765
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-51 Score=373.11 Aligned_cols=266 Identities=30% Similarity=0.420 Sum_probs=218.8
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
++|..+++||+|.||.||+|++.. +++.||||.++..... ........+|+.+|+.++|+||+.|+++|...+.
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~-----t~~~VAIKKIkl~~~k-dGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~ 75 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTE-----TGKRVAIKKIKLGNAK-DGINRTALREIKLLQELKHPNIIELIDVFPHKSN 75 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecC-----CCcEEEEEEeeccccc-cCccHHHHHHHHHHHHccCcchhhhhhhccCCCc
Confidence 468889999999999999999887 6889999999866332 2233456789999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
+.||+||+ ..+|+..++.. ...|+...++.|+.++++||+|||++.|+||||||.|+||+.+|.+||+|||+|+.+..
T Consensus 76 l~lVfEfm-~tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 76 LSLVFEFM-PTDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGS 153 (318)
T ss_pred eEEEEEec-cccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCC
Confidence 99999999 67999888765 47899999999999999999999999999999999999999999999999999954421
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
. +
T Consensus 154 p------------------------------------------------------------------------------~ 155 (318)
T KOG0659|consen 154 P------------------------------------------------------------------------------N 155 (318)
T ss_pred C------------------------------------------------------------------------------C
Confidence 0 0
Q ss_pred cCCccccCCCCccCcchhcCCC-CCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcC-----CCCCCCCCCC-Cc
Q 011302 324 ARSKSFVGTHEYLAPEVISGQG-HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK-----PLTFPRIGVS-SS 396 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~~~-~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-----~~~~p~~~~~-~~ 396 (489)
.....-+-|.+|+|||.+.|.. |+..+||||.|||+.||+.|.+-|.|.++.+++..|.+. +-.||..... ..
T Consensus 156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 156 RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence 1111226799999999999865 899999999999999999999999999999888887641 1122221100 00
Q ss_pred h------------hH-HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 397 K------------EF-EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 397 ~------------~~-~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
. .| ....++.||+.+||..||.+|+++. |+++|+||++.
T Consensus 236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~----qaL~~~yf~~~ 287 (318)
T KOG0659|consen 236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITAS----QALKHPYFKSL 287 (318)
T ss_pred HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHH----HHhcchhhhcC
Confidence 0 01 1223578999999999999999998 99999999874
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-50 Score=402.58 Aligned_cols=276 Identities=36% Similarity=0.691 Sum_probs=231.9
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCC-CcccccceeecCce
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHP-FLPTLYAEFEASHY 163 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-nIv~l~~~~~~~~~ 163 (489)
+|++++.||+|+||.||+|++++ +++.||||++.+...........+..|..++..++|+ +|+++++++.+.+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKG-----TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCE
Confidence 58999999999999999999887 5678999999987655455566777899999999765 68899999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
+|+||||++||+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 99999999999999888765 5689999999999999999999999999999999999999999999999999732110
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
. .
T Consensus 154 ~------------------------------------------------------------------------------~ 155 (324)
T cd05587 154 G------------------------------------------------------------------------------G 155 (324)
T ss_pred C------------------------------------------------------------------------------C
Confidence 0 0
Q ss_pred cCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHh
Q 011302 324 ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVV 403 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~ 403 (489)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......+|... ..
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~---------~~ 226 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSL---------SK 226 (324)
T ss_pred CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCC---------CH
Confidence 011234799999999999999999999999999999999999999999988888888887766555422 12
Q ss_pred hHHHHHHHHhhcCcccccCCC-CChHHHHcCCCcCCCCcccc--ccCCCCCCCC
Q 011302 404 KLQDLISKLLVKNPKKRIGSL-KGSVEIKRHEFFKGINWALI--RSIKPPEVPN 454 (489)
Q Consensus 404 ~l~~li~~~L~~dP~~R~~~~-~~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~ 454 (489)
.+.+||.+||..||.+|++.. ...+++++||||+.++|..+ +.+.+|..|.
T Consensus 227 ~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~ 280 (324)
T cd05587 227 EAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERREIQPPFKPK 280 (324)
T ss_pred HHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCccCc
Confidence 488999999999999999974 34469999999999999876 3344554444
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=400.60 Aligned_cols=268 Identities=40% Similarity=0.731 Sum_probs=227.6
Q ss_pred eccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEEEEEeec
Q 011302 92 LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYC 171 (489)
Q Consensus 92 lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 171 (489)
||+|+||.||+|++.. +++.||+|++.+...........+..|+.+++.++||||+++++++.+.+.+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~-----~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRD-----TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCC
Confidence 7999999999999886 56789999998776555556667788999999999999999999999999999999999
Q ss_pred CCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCccccCCc
Q 011302 172 PGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPK 251 (489)
Q Consensus 172 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 251 (489)
+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 76 ~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~------- 146 (312)
T cd05585 76 NGGELFHHLQRE--GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD------- 146 (312)
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC-------
Confidence 999999988765 57999999999999999999999999999999999999999999999999997321100
Q ss_pred chhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCccccC
Q 011302 252 LSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVG 331 (489)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 331 (489)
.......+|
T Consensus 147 -----------------------------------------------------------------------~~~~~~~~g 155 (312)
T cd05585 147 -----------------------------------------------------------------------DDKTNTFCG 155 (312)
T ss_pred -----------------------------------------------------------------------CCccccccC
Confidence 011234579
Q ss_pred CCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHHHHH
Q 011302 332 THEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISK 411 (489)
Q Consensus 332 t~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~ 411 (489)
|+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..+......+|.... ..+.+||.+
T Consensus 156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~li~~ 226 (312)
T cd05585 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFD---------RDAKDLLIG 226 (312)
T ss_pred CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCC---------HHHHHHHHH
Confidence 99999999999999999999999999999999999999998888888888887766654321 258999999
Q ss_pred HhhcCcccccCCCCChHHHHcCCCcCCCCcccc--ccCCCCCCCC
Q 011302 412 LLVKNPKKRIGSLKGSVEIKRHEFFKGINWALI--RSIKPPEVPN 454 (489)
Q Consensus 412 ~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~ 454 (489)
||..||.+|++.. .+.+++.||||+..+|..+ +.+.++..|.
T Consensus 227 ~L~~dp~~R~~~~-~~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~ 270 (312)
T cd05585 227 LLSRDPTRRLGYN-GAQEIKNHPFFSQLSWKKLLMKGIQPPFKPA 270 (312)
T ss_pred HcCCCHHHcCCCC-CHHHHHcCCCcCCCCHHHHHhCCCCCCcCCC
Confidence 9999999999863 4569999999999998755 3444544433
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-52 Score=409.49 Aligned_cols=256 Identities=27% Similarity=0.441 Sum_probs=220.7
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
...|....+||+|+.|.||.|+... +++.||||.+....... .+-+.+|+.+|+..+|+|||.+++.|..++
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~-----~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~d 343 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKIS-----TKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGD 343 (550)
T ss_pred hhhhcchhhhccccccceeeeeecc-----CCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccc
Confidence 4678889999999999999999887 56779999998665432 345677999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
.+++||||++||+|.+.+... .++|.++..|+++++.||+|||.+||||||||.+|||++.+|.+||+|||++..+.
T Consensus 344 eLWVVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~ 420 (550)
T KOG0578|consen 344 ELWVVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQIS 420 (550)
T ss_pred eeEEEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccc
Confidence 999999999999999998764 59999999999999999999999999999999999999999999999999973322
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
. .
T Consensus 421 ~------------------------------------------------------------------------------~ 422 (550)
T KOG0578|consen 421 E------------------------------------------------------------------------------E 422 (550)
T ss_pred c------------------------------------------------------------------------------c
Confidence 1 1
Q ss_pred ccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcC-CCCCCCCCCCCchhHHH
Q 011302 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK-PLTFPRIGVSSSKEFEE 401 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~~~~ 401 (489)
..+..+.+|||+|||||++....|++++||||||++++||+-|++||...+....+..|... ...+......+
T Consensus 423 ~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS------ 496 (550)
T KOG0578|consen 423 QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLS------ 496 (550)
T ss_pred cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccC------
Confidence 12456779999999999999999999999999999999999999999998888877777653 33333222222
Q ss_pred HhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 402 VVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 402 ~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
..++|||.+||+.|+++|+++. +||+||||+.
T Consensus 497 -~~~kdFL~~cL~~dv~~RasA~----eLL~HpFl~~ 528 (550)
T KOG0578|consen 497 -PELKDFLDRCLVVDVEQRASAK----ELLEHPFLKM 528 (550)
T ss_pred -HHHHHHHHHHhhcchhcCCCHH----HHhcChhhhh
Confidence 3589999999999999999998 9999999954
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-50 Score=390.14 Aligned_cols=277 Identities=27% Similarity=0.378 Sum_probs=232.7
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccccccee
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEF 158 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 158 (489)
+....++|.+...||.|.-++||+|++.. .+.+||||+++.+.... .+..+.+|+..|+.++||||++++.+|
T Consensus 21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p-----~~e~VAIK~inLEkc~~--~ld~l~kE~~~msl~~HPNIv~~~~sF 93 (516)
T KOG0582|consen 21 FPLNAKDYELQEVIGVGASAVVYLARCIP-----TNEVVAIKIINLEKCNN--DLDALRKEVQTMSLIDHPNIVTYHCSF 93 (516)
T ss_pred CCCCccceeEEEEEeccceeEeeeeeecc-----cCCEEEEEEeehhhhhh--hHHHHHHHHHHhhhcCCCCcceEEEEE
Confidence 45567899999999999999999999987 57899999999887663 377888899999999999999999999
Q ss_pred ecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 159 EASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
..+..+|+||.||.+|++.+++.......|.|..+..|++++++||.|||.+|.||||||+.||||+.+|.|||+|||.+
T Consensus 94 vv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvs 173 (516)
T KOG0582|consen 94 VVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVS 173 (516)
T ss_pred EecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceee
Confidence 99999999999999999999998876667999999999999999999999999999999999999999999999999986
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
..+.. +|. +
T Consensus 174 a~l~~----------------------------------------~G~---------------------R---------- 182 (516)
T KOG0582|consen 174 ASLFD----------------------------------------SGD---------------------R---------- 182 (516)
T ss_pred eeecc----------------------------------------cCc---------------------e----------
Confidence 32211 000 0
Q ss_pred ccccccCCccccCCCCccCcchhcC--CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCc
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISG--QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSS 396 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~--~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 396 (489)
...+..+++|||+|||||++.. .+|+.|+||||||++..||.+|..||....+.+++..-+.+....+.......
T Consensus 183 ---~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~ 259 (516)
T KOG0582|consen 183 ---QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDK 259 (516)
T ss_pred ---eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCCh
Confidence 0012267799999999999764 46899999999999999999999999999988888777776655444222221
Q ss_pred hhH-HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 397 KEF-EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 397 ~~~-~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
+.. .....++.+|..||++||.+||++. ++|+|+||+...
T Consensus 260 d~~k~~~ksf~e~i~~CL~kDP~kRptAs----kLlkh~FFk~~k 300 (516)
T KOG0582|consen 260 DEDKKFSKSFREMIALCLVKDPSKRPTAS----KLLKHAFFKKAK 300 (516)
T ss_pred HHhhhhcHHHHHHHHHHhhcCcccCCCHH----HHhccHHHhhcc
Confidence 111 1123578999999999999999998 999999998753
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=408.63 Aligned_cols=306 Identities=32% Similarity=0.586 Sum_probs=233.3
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
++|++++.||+|+||+||+|+++. +++.||||++.+...........+..|+.++..++||||+++++++.+++.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKD-----TGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 479999999999999999999887 578999999987765555666778889999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
+|||||||+||+|.+++... ..+++..++.++.|++.||+|||++|||||||||+|||++.+|.+||+|||+++.+..
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred EEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 99999999999999998765 5699999999999999999999999999999999999999999999999999854321
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
..... .+.... ...+....+..... .. ..........
T Consensus 154 ~~~~~----------~~~~~~------~~~~~~~~~~~~~~---~~------------------------~~~~~~~~~~ 190 (360)
T cd05627 154 AHRTE----------FYRNLT------HNPPSDFSFQNMNS---KR------------------------KAETWKKNRR 190 (360)
T ss_pred ccccc----------cccccc------cCCccccccccccc---cc------------------------cccccccccc
Confidence 10000 000000 00000000000000 00 0000000111
Q ss_pred cCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCC--CCCCCCCCCCchhHHH
Q 011302 324 ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP--LTFPRIGVSSSKEFEE 401 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~~~~ 401 (489)
....+.+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+....+.++.... ..+|.... .
T Consensus 191 ~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~-------~ 263 (360)
T cd05627 191 QLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVP-------I 263 (360)
T ss_pred ccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCC-------C
Confidence 22345689999999999999999999999999999999999999999988888777776532 33333211 1
Q ss_pred HhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccccccCC
Q 011302 402 VVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIRSIK 448 (489)
Q Consensus 402 ~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~~~~~ 448 (489)
..++++||.+|+. ||.+|++. ..+.++++||||++++|..+....
T Consensus 264 s~~~~~li~~l~~-~p~~R~~~-~~~~ei~~hp~f~~~~~~~~~~~~ 308 (360)
T cd05627 264 SEKAKDLILRFCT-DSENRIGS-NGVEEIKSHPFFEGVDWGHIRERP 308 (360)
T ss_pred CHHHHHHHHHhcc-ChhhcCCC-CCHHHHhcCCCCCCCCHHHHhcCC
Confidence 2258999999874 99999985 356699999999999999885543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-50 Score=411.55 Aligned_cols=321 Identities=31% Similarity=0.520 Sum_probs=232.1
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceE
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYS 164 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 164 (489)
.|++++.||+|+||+||+|+++. +++.||||++.+...........+..|+.+++.++||||+++++++.+.+.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~-----~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVD-----THALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECC-----CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEE
Confidence 68999999999999999999887 5789999999987766566677888999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccC
Q 011302 165 CLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVV 244 (489)
Q Consensus 165 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~ 244 (489)
|+|||||+||+|.+++.+. ..+++..++.++.||+.||+|||++|||||||||+||||+.+|++||+|||+++.+...
T Consensus 77 ~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred EEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 9999999999999998765 56899999999999999999999999999999999999999999999999998543221
Q ss_pred ccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccccc
Q 011302 245 PKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINA 324 (489)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (489)
.... +......-....+.+...+ ..... ....... ..+.. .........
T Consensus 155 ~~~~-----------~~~~~~~~~~~~~~~~~~~-~~~~~-----------~~~~~~~-------~~~~~-~~~~~~~~~ 203 (381)
T cd05626 155 HNSK-----------YYQKGSHIRQDSMEPSDLW-DDVSN-----------CRCGDRL-------KTLEQ-RATKQHQRC 203 (381)
T ss_pred cccc-----------cccccccccccccCccccc-ccccc-----------ccccccc-------chhhc-ccccccccc
Confidence 1000 0000000000000000000 00000 0000000 00000 000001111
Q ss_pred CCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcC--CCCCCCCCCCCchhHHHH
Q 011302 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK--PLTFPRIGVSSSKEFEEV 402 (489)
Q Consensus 325 ~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~~~~~ 402 (489)
...+++||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+...++... ...+|..... .
T Consensus 204 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~-------s 276 (381)
T cd05626 204 LAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKL-------S 276 (381)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCC-------C
Confidence 234678999999999999999999999999999999999999999988877666666542 2333322111 2
Q ss_pred hhHHHHHHHHhhc--CcccccCCCCChHHHHcCCCcCCCCcccc-ccCCCCCCCC
Q 011302 403 VKLQDLISKLLVK--NPKKRIGSLKGSVEIKRHEFFKGINWALI-RSIKPPEVPN 454 (489)
Q Consensus 403 ~~l~~li~~~L~~--dP~~R~~~~~~~~~ll~hp~f~~~~~~~~-~~~~~p~~~~ 454 (489)
.++.+||.+||.. ++..|+++. +++.||||+.++|... +...+|.+|.
T Consensus 277 ~~~~dli~~ll~~~~~~~~R~~~~----~~l~hp~f~~~~~~~~~~~~~~~~~p~ 327 (381)
T cd05626 277 PEAVDLITKLCCSAEERLGRNGAD----DIKAHPFFSEVDFSSDIRTQPAPYVPK 327 (381)
T ss_pred HHHHHHHHHHccCcccccCCCCHH----HHhcCcccCCCChhHHhhcCCCCccCc
Confidence 3589999997654 444588887 9999999999999864 4455555555
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-51 Score=412.92 Aligned_cols=320 Identities=32% Similarity=0.543 Sum_probs=233.2
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
++|++++.||+|+||.||+|++.. +++.||||++.+...........+.+|+.+|+.++||||+++++.|.+++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVD-----TNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC-----CCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCE
Confidence 479999999999999999999886 578999999987766555566778889999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
+|+|||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..+..
T Consensus 76 ~~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 99999999999999998775 5689999999999999999999999999999999999999999999999999854322
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
...... +.... ................... ... ....... .....
T Consensus 154 ~~~~~~----------~~~~~-----~~~~~~~~~~~~~~~~~~~-----~~~--------------~~~~~~~-~~~~~ 198 (376)
T cd05598 154 THDSKY----------YQKGD-----HHRQDSMEPSEEWSEIDRC-----RLK--------------PLERRRK-RQHQR 198 (376)
T ss_pred cccccc----------ccccc-----ccccccccccccccccccc-----ccc--------------chhhhhh-hhccc
Confidence 110000 00000 0000000000000000000 000 0000000 00001
Q ss_pred cCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCC--CCCCCCCCchhHHH
Q 011302 324 ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLT--FPRIGVSSSKEFEE 401 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--~p~~~~~~~~~~~~ 401 (489)
....+++||+.|||||++.+..++.++|||||||++|||++|+.||.+.+..+....+...... +|.... .
T Consensus 199 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~-------~ 271 (376)
T cd05598 199 CLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAK-------L 271 (376)
T ss_pred ccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCC-------C
Confidence 2234578999999999999999999999999999999999999999998877766666543222 222111 1
Q ss_pred HhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcccc-ccCCCCCCCC
Q 011302 402 VVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALI-RSIKPPEVPN 454 (489)
Q Consensus 402 ~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~-~~~~~p~~~~ 454 (489)
...+.+||.+|+ .+|.+|++.. .+.++++||||++++|..+ ....+|.+|.
T Consensus 272 s~~~~~li~~l~-~~p~~R~~~~-t~~ell~h~~~~~~~~~~~~~~~~~~~~~~ 323 (376)
T cd05598 272 SREASDLILRLC-CGAEDRLGKN-GADEIKAHPFFKGIDFASLIRRQKAPYIPK 323 (376)
T ss_pred CHHHHHHHHHHh-cCHhhcCCCC-CHHHHhCCCCcCCCCHHHHhhcCCCCCCCc
Confidence 225789999976 5999999431 2349999999999999877 5555665554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-50 Score=401.77 Aligned_cols=271 Identities=40% Similarity=0.733 Sum_probs=227.5
Q ss_pred eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEEEEEe
Q 011302 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVME 169 (489)
Q Consensus 90 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 169 (489)
+.||+|+||.||+|+++. +++.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKA-----SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEe
Confidence 368999999999999886 578999999988765555566778889999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCccccC
Q 011302 170 YCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLR 249 (489)
Q Consensus 170 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 249 (489)
|+++|+|..++... ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 76 y~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~----- 148 (328)
T cd05593 76 YVNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD----- 148 (328)
T ss_pred CCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc-----
Confidence 99999999888765 57999999999999999999999999999999999999999999999999997321100
Q ss_pred CcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCccc
Q 011302 250 PKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSF 329 (489)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (489)
.......
T Consensus 149 -------------------------------------------------------------------------~~~~~~~ 155 (328)
T cd05593 149 -------------------------------------------------------------------------AATMKTF 155 (328)
T ss_pred -------------------------------------------------------------------------ccccccc
Confidence 0011235
Q ss_pred cCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHHH
Q 011302 330 VGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLI 409 (489)
Q Consensus 330 ~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li 409 (489)
+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+......+|... ..++.+||
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~---------~~~~~~li 226 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTL---------SADAKSLL 226 (328)
T ss_pred cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCC---------CHHHHHHH
Confidence 799999999999999999999999999999999999999998888777777776666555422 12589999
Q ss_pred HHHhhcCcccccCCC-CChHHHHcCCCcCCCCcccc--ccCCCCCCCC
Q 011302 410 SKLLVKNPKKRIGSL-KGSVEIKRHEFFKGINWALI--RSIKPPEVPN 454 (489)
Q Consensus 410 ~~~L~~dP~~R~~~~-~~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~ 454 (489)
.+||+.||++|++.. ..+.++++||||.+++|..+ ..+.+|..|.
T Consensus 227 ~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~ 274 (328)
T cd05593 227 SGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVPPFKPQ 274 (328)
T ss_pred HHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCc
Confidence 999999999998543 34569999999999999866 3344554443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-51 Score=381.30 Aligned_cols=280 Identities=26% Similarity=0.327 Sum_probs=224.0
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE 159 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 159 (489)
.-..++|+.+.+|++|+||.||+|+++. ++..||+|.++-+... ....-...+|+.+|.+++|||||.+-++..
T Consensus 72 Crsv~efe~lnrI~EGtyGiVYRakdk~-----t~eIVALKr~kmekek-~GFPItsLREIniLl~~~H~NIV~vkEVVv 145 (419)
T KOG0663|consen 72 CRSVEEFEKLNRIEEGTYGVVYRAKDKK-----TDEIVALKRLKMEKEK-EGFPITSLREINILLKARHPNIVEVKEVVV 145 (419)
T ss_pred cccHHHHHHHhhcccCcceeEEEeccCC-----cceeEEeeeccccccc-CCCcchhHHHHHHHHhcCCCCeeeeEEEEe
Confidence 3456889999999999999999999998 6899999999865421 222333567999999999999999999875
Q ss_pred --cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCC
Q 011302 160 --ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237 (489)
Q Consensus 160 --~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~ 237 (489)
+-+.+||||||| .-||..++...+ .+|...+++.++.|++.||+|||.+.|+|||||++|+|++..|.+||+|||+
T Consensus 146 G~~~d~iy~VMe~~-EhDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGL 223 (419)
T KOG0663|consen 146 GSNMDKIYIVMEYV-EHDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGL 223 (419)
T ss_pred ccccceeeeeHHHH-HhhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccch
Confidence 445799999999 469999888764 6899999999999999999999999999999999999999999999999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
|+.+....
T Consensus 224 AR~ygsp~------------------------------------------------------------------------ 231 (419)
T KOG0663|consen 224 AREYGSPL------------------------------------------------------------------------ 231 (419)
T ss_pred hhhhcCCc------------------------------------------------------------------------
Confidence 96553211
Q ss_pred cccccccCCccccCCCCccCcchhcCCC-CCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcC--C---CCCCCC
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVISGQG-HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK--P---LTFPRI 391 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~---~~~p~~ 391 (489)
...+..+-|.+|+|||++.|.. |++++|+||+|||+.||+++++.|.|..+.+++.+|... . -.||-.
T Consensus 232 ------k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 232 ------KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred ------ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence 1234567899999999999976 899999999999999999999999999999888888641 0 011111
Q ss_pred CCC---------------CchhHHH---HhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccccccCCC
Q 011302 392 GVS---------------SSKEFEE---VVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIRSIKP 449 (489)
Q Consensus 392 ~~~---------------~~~~~~~---~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~~~~~~ 449 (489)
... -...|.. .....+|+.++|.+||.+|.|+. +.|+|+||.......-+...|
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~----~~L~h~~F~e~P~p~~P~~~P 377 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAE----DGLKHEYFRETPLPIDPSMFP 377 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHH----HhhcccccccCCCCCChhhcC
Confidence 000 0011111 13567999999999999999998 999999998865433333333
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-50 Score=399.03 Aligned_cols=271 Identities=39% Similarity=0.710 Sum_probs=227.6
Q ss_pred eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEEEEEe
Q 011302 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVME 169 (489)
Q Consensus 90 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 169 (489)
+.||+|+||.||+|+++. ++..||+|++.++..........+.+|+.+++.++||||++++++|...+.+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKA-----TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEe
Confidence 469999999999999876 578999999998765555556677789999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCccccC
Q 011302 170 YCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLR 249 (489)
Q Consensus 170 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 249 (489)
|++||+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 76 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~----- 148 (323)
T cd05595 76 YANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD----- 148 (323)
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC-----
Confidence 99999999888765 57999999999999999999999999999999999999999999999999987321000
Q ss_pred CcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCccc
Q 011302 250 PKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSF 329 (489)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (489)
.......
T Consensus 149 -------------------------------------------------------------------------~~~~~~~ 155 (323)
T cd05595 149 -------------------------------------------------------------------------GATMKTF 155 (323)
T ss_pred -------------------------------------------------------------------------CCccccc
Confidence 0011234
Q ss_pred cCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHHH
Q 011302 330 VGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLI 409 (489)
Q Consensus 330 ~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li 409 (489)
+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+......+|... ...+.+||
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~---------~~~~~~li 226 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTL---------SPEAKSLL 226 (323)
T ss_pred cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCC---------CHHHHHHH
Confidence 799999999999999999999999999999999999999998888887777777666555421 12589999
Q ss_pred HHHhhcCcccccCCC-CChHHHHcCCCcCCCCcccc--ccCCCCCCCC
Q 011302 410 SKLLVKNPKKRIGSL-KGSVEIKRHEFFKGINWALI--RSIKPPEVPN 454 (489)
Q Consensus 410 ~~~L~~dP~~R~~~~-~~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~ 454 (489)
.+||+.||++|++.. ..+.++++||||.+++|..+ ..+.||..+.
T Consensus 227 ~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~ 274 (323)
T cd05595 227 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQ 274 (323)
T ss_pred HHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCC
Confidence 999999999999643 24569999999999999875 3344554443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-50 Score=399.10 Aligned_cols=271 Identities=37% Similarity=0.720 Sum_probs=227.6
Q ss_pred eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccceeecCceEEEEE
Q 011302 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAEFEASHYSCLVM 168 (489)
Q Consensus 90 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lV~ 168 (489)
+.||+|+||.||+|+++. +++.||||++.+...........+..|..++..+ +||||+++++++.+++.+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKG-----TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECC-----CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEE
Confidence 369999999999999886 5788999999887655455566677788888865 7999999999999999999999
Q ss_pred eecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCcccc
Q 011302 169 EYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLL 248 (489)
Q Consensus 169 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 248 (489)
||++||+|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 76 E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~---- 149 (321)
T cd05591 76 EYVNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN---- 149 (321)
T ss_pred eCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccC----
Confidence 999999999888765 57999999999999999999999999999999999999999999999999997321100
Q ss_pred CCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCcc
Q 011302 249 RPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKS 328 (489)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (489)
......
T Consensus 150 --------------------------------------------------------------------------~~~~~~ 155 (321)
T cd05591 150 --------------------------------------------------------------------------GVTTTT 155 (321)
T ss_pred --------------------------------------------------------------------------Cccccc
Confidence 001223
Q ss_pred ccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHH
Q 011302 329 FVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDL 408 (489)
Q Consensus 329 ~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~l 408 (489)
.+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......+|.... .++.+|
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~---------~~~~~l 226 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLS---------KEAVSI 226 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC---------HHHHHH
Confidence 57999999999999999999999999999999999999999999988888888887666554321 248999
Q ss_pred HHHHhhcCcccccCCCC---ChHHHHcCCCcCCCCccccc--cCCCCCCCC
Q 011302 409 ISKLLVKNPKKRIGSLK---GSVEIKRHEFFKGINWALIR--SIKPPEVPN 454 (489)
Q Consensus 409 i~~~L~~dP~~R~~~~~---~~~~ll~hp~f~~~~~~~~~--~~~~p~~~~ 454 (489)
|.+||+.||++|++... .++++++||||+.++|..+. ...+|+.|.
T Consensus 227 l~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~ 277 (321)
T cd05591 227 LKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFKPK 277 (321)
T ss_pred HHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHHHHhCCCCCCCCCC
Confidence 99999999999997544 46699999999999998763 344444433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-50 Score=398.59 Aligned_cols=271 Identities=40% Similarity=0.704 Sum_probs=227.0
Q ss_pred eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHH-HHHhCCCCCcccccceeecCceEEEEE
Q 011302 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKV-ILTMLDHPFLPTLYAEFEASHYSCLVM 168 (489)
Q Consensus 90 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~lV~ 168 (489)
+.||+|+||+||+|+++. +++.||||++.+..........++..|.. +++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKA-----DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEE
Confidence 469999999999999886 57889999998776554444455555554 567899999999999999999999999
Q ss_pred eecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCcccc
Q 011302 169 EYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLL 248 (489)
Q Consensus 169 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 248 (489)
||++||+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 76 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~----- 148 (323)
T cd05575 76 DYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE----- 148 (323)
T ss_pred cCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc-----
Confidence 999999999988765 5799999999999999999999999999999999999999999999999999732100
Q ss_pred CCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCcc
Q 011302 249 RPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKS 328 (489)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (489)
.......
T Consensus 149 -------------------------------------------------------------------------~~~~~~~ 155 (323)
T cd05575 149 -------------------------------------------------------------------------HSKTTST 155 (323)
T ss_pred -------------------------------------------------------------------------CCCcccc
Confidence 0011223
Q ss_pred ccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHH
Q 011302 329 FVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDL 408 (489)
Q Consensus 329 ~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~l 408 (489)
.+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..+.......+... ...+.+|
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~---------~~~~~~l 226 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNI---------SVSARHL 226 (323)
T ss_pred ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC---------CHHHHHH
Confidence 4799999999999999999999999999999999999999999888888888877665544321 1248999
Q ss_pred HHHHhhcCcccccCCCCChHHHHcCCCcCCCCcccc--ccCCCCCCCC
Q 011302 409 ISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALI--RSIKPPEVPN 454 (489)
Q Consensus 409 i~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~ 454 (489)
|.+||+.||.+|+++...+.+++.||||..++|..+ ..+.+|..|.
T Consensus 227 i~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (323)
T cd05575 227 LEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITPPFNPN 274 (323)
T ss_pred HHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHHHHhhccCCCCcCCC
Confidence 999999999999999888889999999999999876 3455555444
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-50 Score=406.26 Aligned_cols=304 Identities=39% Similarity=0.657 Sum_probs=239.4
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
++|.+++.||+|+||+||+|++.. +++.||||++.+...........+..|+.++..++||||+++++++.++++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKD-----TGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECC-----CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCe
Confidence 479999999999999999999886 578999999998766555566678889999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
+|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+..
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 99999999999999998876 6799999999999999999999999999999999999999999999999999854432
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
......... ... .... .... ... ........
T Consensus 154 ~~~~~~~~~----------~~~--------~~~~-~~~~-----------------------------~~~-~~~~~~~~ 184 (350)
T cd05573 154 AKDREYYLN----------DSH--------NLLF-RDNV-----------------------------LVR-RRDHKQRR 184 (350)
T ss_pred cCccccccc----------ccc--------cccc-cccc-----------------------------ccc-cccccccc
Confidence 110000000 000 0000 0000 000 00000001
Q ss_pred cCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhc--CCCCCCCCCCCCchhHHH
Q 011302 324 ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILK--KPLTFPRIGVSSSKEFEE 401 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~~~~ 401 (489)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+......++.. ....+|.... .
T Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~-------~ 257 (350)
T cd05573 185 VRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPP-------V 257 (350)
T ss_pred ccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCC-------C
Confidence 123345799999999999999999999999999999999999999999888777777766 3344443322 1
Q ss_pred HhhHHHHHHHHhhcCcccccC-CCCChHHHHcCCCcCCCCccccccCCCCCCCCc
Q 011302 402 VVKLQDLISKLLVKNPKKRIG-SLKGSVEIKRHEFFKGINWALIRSIKPPEVPNN 455 (489)
Q Consensus 402 ~~~l~~li~~~L~~dP~~R~~-~~~~~~~ll~hp~f~~~~~~~~~~~~~p~~~~~ 455 (489)
...+.+||.+||. ||.+|++ +. ++++||||++++|+.+....+|.+|..
T Consensus 258 ~~~~~~li~~ll~-dp~~R~~s~~----~ll~hp~~~~~~~~~~~~~~~~~~~~~ 307 (350)
T cd05573 258 SPEAIDLICRLLC-DPEDRLGSFE----EIKSHPFFKGIDWENLRETKPPFVPEL 307 (350)
T ss_pred CHHHHHHHHHHcc-ChhhcCCCHH----HHhcCCCcCCCCHHHHhhCCCCcCCCC
Confidence 2358999999997 9999999 76 999999999999998887777776654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-50 Score=396.34 Aligned_cols=268 Identities=36% Similarity=0.736 Sum_probs=222.2
Q ss_pred eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHh-CCCCCcccccceeecCceEEEEE
Q 011302 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTM-LDHPFLPTLYAEFEASHYSCLVM 168 (489)
Q Consensus 90 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpnIv~l~~~~~~~~~~~lV~ 168 (489)
+.||+|+||.||+|+++. +++.||+|++++..............|..++.. ++||||+++++++.+.+++|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKG-----KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEE
Confidence 469999999999999886 578899999988755433444556667777765 48999999999999999999999
Q ss_pred eecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCcccc
Q 011302 169 EYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLL 248 (489)
Q Consensus 169 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 248 (489)
||+.||+|..++... ..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 76 E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~----- 148 (316)
T cd05620 76 EFLNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF----- 148 (316)
T ss_pred CCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc-----
Confidence 999999999888764 5689999999999999999999999999999999999999999999999998732100
Q ss_pred CCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCcc
Q 011302 249 RPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKS 328 (489)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (489)
.......
T Consensus 149 -------------------------------------------------------------------------~~~~~~~ 155 (316)
T cd05620 149 -------------------------------------------------------------------------GDNRAST 155 (316)
T ss_pred -------------------------------------------------------------------------CCCceec
Confidence 0011234
Q ss_pred ccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHH
Q 011302 329 FVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDL 408 (489)
Q Consensus 329 ~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~l 408 (489)
.+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..+......+|... ..++++|
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~l 226 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWI---------TKESKDI 226 (316)
T ss_pred cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCC---------CHHHHHH
Confidence 5799999999999999999999999999999999999999999888877777766555444321 1248999
Q ss_pred HHHHhhcCcccccCCCCChHHHHcCCCcCCCCcccc--ccCCCCCCCC
Q 011302 409 ISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALI--RSIKPPEVPN 454 (489)
Q Consensus 409 i~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~ 454 (489)
|.+||+.||++|+++. +++++||||+.++|..+ ....+|..|.
T Consensus 227 i~~~l~~dP~~R~~~~---~~~~~h~~f~~~~~~~~~~~~~~~~~~~~ 271 (316)
T cd05620 227 LEKLFERDPTRRLGVV---GNIRGHPFFKTINWTALEKRELDPPFKPK 271 (316)
T ss_pred HHHHccCCHHHcCCCh---HHHHcCCCcCCCCHHHHHhCCCCCCcCCC
Confidence 9999999999999974 27889999999999875 3444555444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=395.42 Aligned_cols=276 Identities=36% Similarity=0.695 Sum_probs=233.1
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-CCCcccccceeecCce
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-HPFLPTLYAEFEASHY 163 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~ 163 (489)
+|.+.+.||+|+||+||+|+++. +++.||||++.+...........+..|..++..+. |++|+++++++.+.+.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKG-----TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCE
Confidence 47889999999999999999886 57899999999876554455566777888888876 5778899999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
+|+||||++||+|.+++... ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 99999999999999988765 5699999999999999999999999999999999999999999999999999732110
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
. .
T Consensus 154 ~------------------------------------------------------------------------------~ 155 (323)
T cd05615 154 D------------------------------------------------------------------------------G 155 (323)
T ss_pred C------------------------------------------------------------------------------C
Confidence 0 0
Q ss_pred cCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHh
Q 011302 324 ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVV 403 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~ 403 (489)
......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+......+|.... .
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~---------~ 226 (323)
T cd05615 156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLS---------K 226 (323)
T ss_pred ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCC---------H
Confidence 0122346999999999999999999999999999999999999999999888888888877666554221 2
Q ss_pred hHHHHHHHHhhcCcccccCCCC-ChHHHHcCCCcCCCCcccc--ccCCCCCCCC
Q 011302 404 KLQDLISKLLVKNPKKRIGSLK-GSVEIKRHEFFKGINWALI--RSIKPPEVPN 454 (489)
Q Consensus 404 ~l~~li~~~L~~dP~~R~~~~~-~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~ 454 (489)
.+.+|+.+||+.||.+|++..+ ..+++++||||+.++|..+ +.+.+|+.|.
T Consensus 227 ~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~ 280 (323)
T cd05615 227 EAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENREIQPPFKPK 280 (323)
T ss_pred HHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHHHhcCCCCcCccCc
Confidence 4889999999999999999753 4579999999999999877 4455666654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-50 Score=395.75 Aligned_cols=268 Identities=38% Similarity=0.755 Sum_probs=221.6
Q ss_pred eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHh-CCCCCcccccceeecCceEEEEE
Q 011302 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTM-LDHPFLPTLYAEFEASHYSCLVM 168 (489)
Q Consensus 90 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpnIv~l~~~~~~~~~~~lV~ 168 (489)
+.||+|+||.||+|+++. +++.||||+++++.............|..++.. .+||||+++++++..++.+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKG-----TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEE
Confidence 369999999999999887 578899999988765444445555667777765 48999999999999999999999
Q ss_pred eecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCcccc
Q 011302 169 EYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLL 248 (489)
Q Consensus 169 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 248 (489)
||++||+|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 76 e~~~gg~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~---- 149 (316)
T cd05592 76 EYLNGGDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG---- 149 (316)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC----
Confidence 999999999988765 57999999999999999999999999999999999999999999999999997321100
Q ss_pred CCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCcc
Q 011302 249 RPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKS 328 (489)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (489)
......
T Consensus 150 --------------------------------------------------------------------------~~~~~~ 155 (316)
T cd05592 150 --------------------------------------------------------------------------EGKAST 155 (316)
T ss_pred --------------------------------------------------------------------------CCcccc
Confidence 011234
Q ss_pred ccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHH
Q 011302 329 FVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDL 408 (489)
Q Consensus 329 ~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~l 408 (489)
.+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..+......+|... ..++.+|
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~---------~~~~~~l 226 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWI---------SKEAKDC 226 (316)
T ss_pred ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCC---------CHHHHHH
Confidence 5799999999999999999999999999999999999999999888888877776554444321 1248899
Q ss_pred HHHHhhcCcccccCCCCChHHHHcCCCcCCCCccccc--cCCCCCCCC
Q 011302 409 ISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIR--SIKPPEVPN 454 (489)
Q Consensus 409 i~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~~--~~~~p~~~~ 454 (489)
|.+||+.||++|+++. ++++.||||+.++|..+. .+.||+.|.
T Consensus 227 l~~~l~~~P~~R~~~~---~~l~~h~~~~~~~~~~~~~~~~~~~~~~~ 271 (316)
T cd05592 227 LSKLFERDPTKRLGVD---GDIRQHPFFRGIDWERLEKREIPPPFKPK 271 (316)
T ss_pred HHHHccCCHHHcCCCh---HHHHcCcccCCCCHHHHHhCCCCCCcCCC
Confidence 9999999999999874 378899999999998763 344444443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-50 Score=404.43 Aligned_cols=281 Identities=35% Similarity=0.622 Sum_probs=228.0
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccccccee
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEF 158 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 158 (489)
..+..++|++.+.||+|+||.||+|+++. +++.||+|++.+...........+.+|+.+++.++||||+++++++
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~ 112 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKS-----SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF 112 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECC-----CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 44567899999999999999999999987 5788999999876554444455677899999999999999999999
Q ss_pred ecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 159 EASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
.+++.+|+|||||+||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 113 ~~~~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 113 QDDKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred EcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccc
Confidence 9999999999999999999988653 5899999999999999999999999999999999999999999999999998
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
..+...
T Consensus 190 ~~~~~~-------------------------------------------------------------------------- 195 (370)
T cd05621 190 MKMDET-------------------------------------------------------------------------- 195 (370)
T ss_pred eecccC--------------------------------------------------------------------------
Confidence 432100
Q ss_pred ccccccCCccccCCCCccCcchhcCCC----CCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCC--CCCCCCC
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQG----HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP--LTFPRIG 392 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~----~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~ 392 (489)
........+||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.+....+.++.... +.+|...
T Consensus 196 ---~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 272 (370)
T cd05621 196 ---GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDV 272 (370)
T ss_pred ---CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcc
Confidence 000123457999999999997653 7889999999999999999999999988888888877643 3333321
Q ss_pred CCCchhHHHHhhHHHHHHHHhhcCccc--ccCCCCChHHHHcCCCcCCCCcc--ccccCCCCCCCCc
Q 011302 393 VSSSKEFEEVVKLQDLISKLLVKNPKK--RIGSLKGSVEIKRHEFFKGINWA--LIRSIKPPEVPNN 455 (489)
Q Consensus 393 ~~~~~~~~~~~~l~~li~~~L~~dP~~--R~~~~~~~~~ll~hp~f~~~~~~--~~~~~~~p~~~~~ 455 (489)
. ....+++||.+||..++.+ |+++. ++++||||+..+|. .++...+|..|..
T Consensus 273 ~-------~s~~~~~li~~~L~~~~~r~~R~~~~----e~l~hp~~~~~~~~~~~~~~~~~~~~p~~ 328 (370)
T cd05621 273 E-------ISKHAKNLICAFLTDREVRLGRNGVE----EIKQHPFFKNDQWNWDNIRETAAPVVPEL 328 (370)
T ss_pred c-------CCHHHHHHHHHHccCchhccCCCCHH----HHhcCcccCCCCcChHhcCCCCCCcCCCC
Confidence 1 1224899999999844432 55655 99999999986654 4556666766654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-51 Score=391.07 Aligned_cols=262 Identities=31% Similarity=0.473 Sum_probs=213.4
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc-
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH- 162 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~- 162 (489)
.++...+.||+|+||.||++.+.+ ++...|||.+...... ..+.+.+|+.+|..++|||||+++|......
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~-----~g~~~AvK~v~~~~~~---~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~ 88 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKK-----TGELMAVKSVELEDSP---TSESLEREIRILSRLNHPNIVQYYGSSSSREN 88 (313)
T ss_pred chhhhhccccCccceEEEEEEecC-----CCcceeeeeeecccch---hHHHHHHHHHHHHhCCCCCEEeeCCccccccC
Confidence 457778899999999999999987 4678999999866222 1556778999999999999999999754444
Q ss_pred -eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEecc-CCcEEEcccCCCcc
Q 011302 163 -YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRE-DGHIMLSDFDLSFK 240 (489)
Q Consensus 163 -~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~-~~~vkl~DFG~a~~ 240 (489)
.+++.|||++||+|.+++.+..+ .|++..++.+.+||++||+|||++|||||||||+||||+. +|.+||+|||+++.
T Consensus 89 ~~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~ 167 (313)
T KOG0198|consen 89 DEYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKK 167 (313)
T ss_pred eeeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccc
Confidence 69999999999999999998865 8999999999999999999999999999999999999999 79999999999854
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
.....
T Consensus 168 ~~~~~--------------------------------------------------------------------------- 172 (313)
T KOG0198|consen 168 LESKG--------------------------------------------------------------------------- 172 (313)
T ss_pred ccccc---------------------------------------------------------------------------
Confidence 32100
Q ss_pred ccccCCccccCCCCccCcchhcCC-CCCCcccHHHHHHHHHHHhhCCCCCCC-CCcHHHHHHHhcCCCCCCCCCCCCchh
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQ-GHGSAVDWWTLGVFLYEMLYGTTPFKG-ENNEKTLINILKKPLTFPRIGVSSSKE 398 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~p~~~~~~~~~ 398 (489)
........+.||+.|||||++.+. ..+.++|||||||++.||+||.+||.. ....+.+..+.... ..|.+...-+
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~-~~P~ip~~ls-- 249 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED-SLPEIPDSLS-- 249 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC-CCCCCCcccC--
Confidence 001123456899999999999962 234599999999999999999999987 45555555665544 2232222222
Q ss_pred HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 399 FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 399 ~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
.++++||.+||.+||++||++. ++|.|||.+...
T Consensus 250 ----~~a~~Fl~~C~~~~p~~Rpta~----eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 250 ----DEAKDFLRKCFKRDPEKRPTAE----ELLEHPFLKQNS 283 (313)
T ss_pred ----HHHHHHHHHHhhcCcccCcCHH----HHhhChhhhccc
Confidence 2589999999999999999998 999999997744
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=396.56 Aligned_cols=271 Identities=37% Similarity=0.695 Sum_probs=221.5
Q ss_pred eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccceeecCceEEEEE
Q 011302 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAEFEASHYSCLVM 168 (489)
Q Consensus 90 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lV~ 168 (489)
+.||+|+||.||+|+++. +++.||+|+++++..........+..|..++..+ +||||++++++|.+.+.+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~-----~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKK-----TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEE
Confidence 468999999999999887 5788999999987665555566778899999888 6999999999999999999999
Q ss_pred eecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCcccc
Q 011302 169 EYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLL 248 (489)
Q Consensus 169 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 248 (489)
|||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 76 e~~~~g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~----- 148 (329)
T cd05588 76 EFVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR----- 148 (329)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc-----
Confidence 999999999888765 5799999999999999999999999999999999999999999999999999732100
Q ss_pred CCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCcc
Q 011302 249 RPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKS 328 (489)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (489)
.......
T Consensus 149 -------------------------------------------------------------------------~~~~~~~ 155 (329)
T cd05588 149 -------------------------------------------------------------------------PGDTTST 155 (329)
T ss_pred -------------------------------------------------------------------------CCCcccc
Confidence 0011234
Q ss_pred ccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCC---------cHHHHHHHhcCCCCCCCCCCCCchhH
Q 011302 329 FVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGEN---------NEKTLINILKKPLTFPRIGVSSSKEF 399 (489)
Q Consensus 329 ~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~---------~~~~~~~i~~~~~~~p~~~~~~~~~~ 399 (489)
.+||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+......+|...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~------- 228 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSL------- 228 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCC-------
Confidence 579999999999999999999999999999999999999996321 1223444555555555321
Q ss_pred HHHhhHHHHHHHHhhcCcccccCCC--CChHHHHcCCCcCCCCccccc--cCCCCCCCC
Q 011302 400 EEVVKLQDLISKLLVKNPKKRIGSL--KGSVEIKRHEFFKGINWALIR--SIKPPEVPN 454 (489)
Q Consensus 400 ~~~~~l~~li~~~L~~dP~~R~~~~--~~~~~ll~hp~f~~~~~~~~~--~~~~p~~~~ 454 (489)
...+.+||.+||+.||.+|+++. ..++++++||||+.++|..+. ...||..|.
T Consensus 229 --~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~~~~~~~~~~~~~~ 285 (329)
T cd05588 229 --SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPPYKPN 285 (329)
T ss_pred --CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHhCCCCCCcccc
Confidence 12489999999999999999964 246799999999999998763 344444433
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-49 Score=401.03 Aligned_cols=284 Identities=35% Similarity=0.639 Sum_probs=231.9
Q ss_pred cCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccce
Q 011302 78 QGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAE 157 (489)
Q Consensus 78 ~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~ 157 (489)
..++..++|++.+.||+|+||.||+|+++. +++.||+|++.+...........+.+|+.+++.++||||++++++
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~-----~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~ 111 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKS-----TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA 111 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECC-----CCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 345677999999999999999999999887 578999999987655444455567789999999999999999999
Q ss_pred eecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCC
Q 011302 158 FEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237 (489)
Q Consensus 158 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~ 237 (489)
+.+++.+|+|||||+||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+
T Consensus 112 ~~~~~~~~lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 112 FQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred EEcCCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 9999999999999999999998865 3589999999999999999999999999999999999999999999999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
++......
T Consensus 189 a~~~~~~~------------------------------------------------------------------------ 196 (371)
T cd05622 189 CMKMNKEG------------------------------------------------------------------------ 196 (371)
T ss_pred eeEcCcCC------------------------------------------------------------------------
Confidence 84321100
Q ss_pred cccccccCCccccCCCCccCcchhcCCC----CCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCC--CCCCCC
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVISGQG----HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP--LTFPRI 391 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~----~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~ 391 (489)
.......+||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.+....+.+|.... ..+|..
T Consensus 197 -----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 271 (371)
T cd05622 197 -----MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD 271 (371)
T ss_pred -----cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCc
Confidence 00123457999999999997653 7889999999999999999999999988888888887643 333432
Q ss_pred CCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC--ccccccCCCCCCCCc
Q 011302 392 GVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN--WALIRSIKPPEVPNN 455 (489)
Q Consensus 392 ~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~--~~~~~~~~~p~~~~~ 455 (489)
... ...+++||.+||. +|..|++. ..++++++|+||++.+ |..++...+|.+|..
T Consensus 272 ~~~-------s~~~~~li~~~L~-~~~~r~~r-~~~~ei~~h~~~~~~~~~~~~~~~~~~~~~~~~ 328 (371)
T cd05622 272 NDI-------SKEAKNLICAFLT-DREVRLGR-NGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDL 328 (371)
T ss_pred CCC-------CHHHHHHHHHHcC-ChhhhcCC-CCHHHHhcCcccCCCChhHHhcCCCCCCCCCCC
Confidence 111 2258999999998 67766553 2455999999998855 456677777777653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-50 Score=401.32 Aligned_cols=264 Identities=35% Similarity=0.573 Sum_probs=234.6
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-CCCcccccceeecC
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-HPFLPTLYAEFEAS 161 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~ 161 (489)
.+.|.+.+.||.|.||.||+|+.+. +++.||+|++.+...........+.+|+.+|+++. |||||.++++|++.
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~-----tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~ 108 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKS-----TGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP 108 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecC-----CCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence 3689999999999999999999998 57899999999887765555667888999999998 99999999999999
Q ss_pred ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccC----CcEEEcccCC
Q 011302 162 HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRED----GHIMLSDFDL 237 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~----~~vkl~DFG~ 237 (489)
..+|+|||+|.||+|++.+... .+++..+..++.|++.+++|||+.||+||||||+|+|+... +.+|++|||+
T Consensus 109 ~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 109 DSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred CeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 9999999999999999998876 39999999999999999999999999999999999999743 5799999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
|.....
T Consensus 186 a~~~~~-------------------------------------------------------------------------- 191 (382)
T KOG0032|consen 186 AKFIKP-------------------------------------------------------------------------- 191 (382)
T ss_pred ceEccC--------------------------------------------------------------------------
Confidence 854321
Q ss_pred cccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCch
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSK 397 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 397 (489)
..+....+|||.|+|||++.+.+|+..+||||+||++|.|++|.+||.+.+....+.+|..+.+.++........
T Consensus 192 -----~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is 266 (382)
T KOG0032|consen 192 -----GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDIS 266 (382)
T ss_pred -----CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccC
Confidence 123456799999999999999999999999999999999999999999999999999999998877766555433
Q ss_pred hHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcc
Q 011302 398 EFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWA 442 (489)
Q Consensus 398 ~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~ 442 (489)
..+++||++||..||.+|+++. ++|+|||+++..-.
T Consensus 267 -----~~akd~i~~ll~~dp~~R~ta~----~~L~HpWi~~~~~~ 302 (382)
T KOG0032|consen 267 -----ESAKDFIRKLLEFDPRKRLTAA----QALQHPWIKSIGEA 302 (382)
T ss_pred -----HHHHHHHHHhcccCcccCCCHH----HHhcCccccCCccc
Confidence 3599999999999999999998 99999999876433
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-50 Score=398.44 Aligned_cols=277 Identities=38% Similarity=0.637 Sum_probs=232.3
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
++|.+.+.||+|+||+||+|+++. +++.||||++++...........+..|+.+++.++||||+++++++.+.+.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKA-----TGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCe
Confidence 479999999999999999999886 578999999998766545566678889999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
+|+||||++||+|.+++.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..+..
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 999999999999999987752 4699999999999999999999999999999999999999999999999999843211
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
.. .
T Consensus 155 ~~-----------------------------------------------------------------------------~ 157 (330)
T cd05601 155 NK-----------------------------------------------------------------------------M 157 (330)
T ss_pred CC-----------------------------------------------------------------------------c
Confidence 00 0
Q ss_pred cCCccccCCCCccCcchhc------CCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCC--CCCCCCCCCC
Q 011302 324 ARSKSFVGTHEYLAPEVIS------GQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP--LTFPRIGVSS 395 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~------~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~ 395 (489)
......+||+.|+|||++. +..++.++|||||||++|||++|..||.+.+....+.++.... ..+|....
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~-- 235 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPK-- 235 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCC--
Confidence 0012236899999999997 4557899999999999999999999999888877777776532 23332211
Q ss_pred chhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccccccCCCCCCCCc
Q 011302 396 SKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIRSIKPPEVPNN 455 (489)
Q Consensus 396 ~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~~~~~~p~~~~~ 455 (489)
....+.+||.+||. +|.+|+++. ++++||||+.++|..+....||..|..
T Consensus 236 -----~~~~~~~li~~ll~-~p~~R~t~~----~l~~h~~~~~~~~~~~~~~~~~~~~~~ 285 (330)
T cd05601 236 -----VSSDFLDLIQSLLC-GQKERLGYE----GLCCHPFFSKIDWNNIRNSLPPFVPTL 285 (330)
T ss_pred -----CCHHHHHHHHHHcc-ChhhCCCHH----HHhCCCCcCCCCHHHHhhCCCCccCcC
Confidence 11258999999998 999999997 999999999999999887777766654
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-52 Score=375.21 Aligned_cols=271 Identities=29% Similarity=0.457 Sum_probs=229.9
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHH-----HHHHHHHHHHHHHHHHHHhC-CCCCcccccce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREA-----LAIRKKLHRADMEKVILTML-DHPFLPTLYAE 157 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~ 157 (489)
+.|.-.+.||.|..+.|.++.++. +++.+|+|++.... .......+.-..|+.+|+++ .||+|+++.++
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~-----t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ 91 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKE-----TGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV 91 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcc-----cccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence 467778899999999999998887 56778999885321 11334455566799999997 69999999999
Q ss_pred eecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCC
Q 011302 158 FEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237 (489)
Q Consensus 158 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~ 237 (489)
|+.+..+++|+|+|+.|.|+|++... -.+++.+.+.||+|+.+|++|||.++||||||||+|||++++.++||+|||+
T Consensus 92 yes~sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 92 YESDAFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred ccCcchhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccce
Confidence 99999999999999999999999876 6799999999999999999999999999999999999999999999999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
|..+..
T Consensus 170 a~~l~~-------------------------------------------------------------------------- 175 (411)
T KOG0599|consen 170 ACQLEP-------------------------------------------------------------------------- 175 (411)
T ss_pred eeccCC--------------------------------------------------------------------------
Confidence 855432
Q ss_pred cccccccCCccccCCCCccCcchhcC------CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCC
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVISG------QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRI 391 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~ 391 (489)
..+...+||||+|+|||.+.. .+|+..+|+||+|||+|.||.|.+||......-++..|..+.+.|...
T Consensus 176 -----GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~sp 250 (411)
T KOG0599|consen 176 -----GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSP 250 (411)
T ss_pred -----chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCc
Confidence 223456799999999999964 357889999999999999999999999999888999999999888654
Q ss_pred CCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccccccCCC
Q 011302 392 GVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIRSIKP 449 (489)
Q Consensus 392 ~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~~~~~~ 449 (489)
.+. +.....+|||.+||+.||.+|+++. ++|+||||..+-....+.+.|
T Consensus 251 eWa-----dis~~~KdLIsrlLqVdp~~Ritak----e~LaHpff~q~~~~~~r~msP 299 (411)
T KOG0599|consen 251 EWA-----DISATVKDLISRLLQVDPTKRITAK----EALAHPFFIQIAQQQARQMSP 299 (411)
T ss_pred chh-----hccccHHHHHHHHHeeCchhcccHH----HHhcChHHHHHHHhcccccCC
Confidence 333 2334689999999999999999998 999999998765554454443
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=402.92 Aligned_cols=281 Identities=36% Similarity=0.609 Sum_probs=232.6
Q ss_pred cCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccce
Q 011302 78 QGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAE 157 (489)
Q Consensus 78 ~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~ 157 (489)
...+..++|++.+.||+|+||.||+|+++. +++.||+|++.+...........+..|+.+++.++||||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~ 111 (370)
T cd05596 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKS-----SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYA 111 (370)
T ss_pred cCCCCHHHcEEEEEEeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 345677899999999999999999999886 578899999987655544455567789999999999999999999
Q ss_pred eecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCC
Q 011302 158 FEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237 (489)
Q Consensus 158 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~ 237 (489)
+.+++.+|+||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+
T Consensus 112 ~~~~~~~~lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~ 188 (370)
T cd05596 112 FQDDKYLYMVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT 188 (370)
T ss_pred EecCCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccc
Confidence 9999999999999999999998865 3588999999999999999999999999999999999999999999999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
++......
T Consensus 189 ~~~~~~~~------------------------------------------------------------------------ 196 (370)
T cd05596 189 CMKMDANG------------------------------------------------------------------------ 196 (370)
T ss_pred eeeccCCC------------------------------------------------------------------------
Confidence 74321000
Q ss_pred cccccccCCccccCCCCccCcchhcCC----CCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCC--CCCCCC
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVISGQ----GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP--LTFPRI 391 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~----~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~ 391 (489)
.......+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+....+.++.... +.+|..
T Consensus 197 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 271 (370)
T cd05596 197 -----MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDD 271 (370)
T ss_pred -----cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCc
Confidence 0011234799999999999764 37889999999999999999999999988888888887643 333432
Q ss_pred CCCCchhHHHHhhHHHHHHHHhhcCccc--ccCCCCChHHHHcCCCcCCCCccc--cccCCCCCCCC
Q 011302 392 GVSSSKEFEEVVKLQDLISKLLVKNPKK--RIGSLKGSVEIKRHEFFKGINWAL--IRSIKPPEVPN 454 (489)
Q Consensus 392 ~~~~~~~~~~~~~l~~li~~~L~~dP~~--R~~~~~~~~~ll~hp~f~~~~~~~--~~~~~~p~~~~ 454 (489)
... +.++.+||.+||..+|.+ |+++. ++++||||++.+|.. ++...+|.+|.
T Consensus 272 ~~~-------s~~~~~li~~~L~~~p~r~~R~s~~----ell~h~~~~~~~~~~~~~~~~~~~~~p~ 327 (370)
T cd05596 272 IEI-------SKQAKDLICAFLTDREVRLGRNGVD----EIKSHPFFKNDQWTFDNIRETVAPVVPE 327 (370)
T ss_pred CCC-------CHHHHHHHHHHccChhhccCCCCHH----HHhcCcccCCCChhhHHhcCCCcCccCc
Confidence 111 235899999999999987 88876 999999999988874 45666666655
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-49 Score=393.30 Aligned_cols=271 Identities=40% Similarity=0.760 Sum_probs=226.8
Q ss_pred eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccceeecCceEEEEE
Q 011302 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAEFEASHYSCLVM 168 (489)
Q Consensus 90 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lV~ 168 (489)
+.||+|+||+||+|+++. +++.||||++.+...........+..|..++..+ +||||+++++++.+.+.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKG-----TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEE
Confidence 469999999999999886 5778999999987655555566677888888887 6999999999999999999999
Q ss_pred eecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCcccc
Q 011302 169 EYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLL 248 (489)
Q Consensus 169 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 248 (489)
||++||+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 76 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~----- 148 (318)
T cd05570 76 EYVNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL----- 148 (318)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc-----
Confidence 999999999888765 5799999999999999999999999999999999999999999999999998732100
Q ss_pred CCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCcc
Q 011302 249 RPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKS 328 (489)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (489)
.......
T Consensus 149 -------------------------------------------------------------------------~~~~~~~ 155 (318)
T cd05570 149 -------------------------------------------------------------------------GGVTTST 155 (318)
T ss_pred -------------------------------------------------------------------------CCCcccc
Confidence 0001223
Q ss_pred ccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHH
Q 011302 329 FVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDL 408 (489)
Q Consensus 329 ~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~l 408 (489)
.+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+......+|... ...+.+|
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~---------~~~~~~l 226 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWL---------SKEAKSI 226 (318)
T ss_pred eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcC---------CHHHHHH
Confidence 4799999999999999999999999999999999999999999888888888877666555321 1248999
Q ss_pred HHHHhhcCcccccCCC-CChHHHHcCCCcCCCCcccc--ccCCCCCCCC
Q 011302 409 ISKLLVKNPKKRIGSL-KGSVEIKRHEFFKGINWALI--RSIKPPEVPN 454 (489)
Q Consensus 409 i~~~L~~dP~~R~~~~-~~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~ 454 (489)
|.+||+.||++|+++. ....+++.||||+.++|... ....||..+.
T Consensus 227 i~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (318)
T cd05570 227 LKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPK 275 (318)
T ss_pred HHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCC
Confidence 9999999999999983 22359999999999999865 3455554444
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-50 Score=397.83 Aligned_cols=270 Identities=40% Similarity=0.723 Sum_probs=226.2
Q ss_pred eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEEEEEe
Q 011302 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVME 169 (489)
Q Consensus 90 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 169 (489)
+.||+|+||.||+|+++. +++.||+|++.++.........++..|..+++.++||||+++++++...+.+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~-----~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKA-----TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEe
Confidence 469999999999999876 578999999998766555556677789999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHh-CCCeeecCCCCCeEeccCCcEEEcccCCCcccccCcccc
Q 011302 170 YCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHM-MGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLL 248 (489)
Q Consensus 170 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 248 (489)
|++||+|..++... ..+++..++.++.||+.||+|||+ +||+||||||+|||++.+|.+||+|||+++.....
T Consensus 76 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~---- 149 (325)
T cd05594 76 YANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD---- 149 (325)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC----
Confidence 99999999888765 579999999999999999999997 79999999999999999999999999997321100
Q ss_pred CCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCcc
Q 011302 249 RPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKS 328 (489)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (489)
......
T Consensus 150 --------------------------------------------------------------------------~~~~~~ 155 (325)
T cd05594 150 --------------------------------------------------------------------------GATMKT 155 (325)
T ss_pred --------------------------------------------------------------------------Cccccc
Confidence 001123
Q ss_pred ccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHH
Q 011302 329 FVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDL 408 (489)
Q Consensus 329 ~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~l 408 (489)
.+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+......+|... ..++.+|
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~---------~~~~~~l 226 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTL---------SPEAKSL 226 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCC---------CHHHHHH
Confidence 4699999999999999999999999999999999999999999888777777777666655432 1258999
Q ss_pred HHHHhhcCcccccCCC-CChHHHHcCCCcCCCCcccc--ccCCCCCCC
Q 011302 409 ISKLLVKNPKKRIGSL-KGSVEIKRHEFFKGINWALI--RSIKPPEVP 453 (489)
Q Consensus 409 i~~~L~~dP~~R~~~~-~~~~~ll~hp~f~~~~~~~~--~~~~~p~~~ 453 (489)
|.+||+.||++|++.. ..+.++++||||+++.|... ....||+.+
T Consensus 227 i~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~ 274 (325)
T cd05594 227 LSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKP 274 (325)
T ss_pred HHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCC
Confidence 9999999999998543 24569999999999999865 334455443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-49 Score=394.20 Aligned_cols=261 Identities=41% Similarity=0.697 Sum_probs=219.8
Q ss_pred eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHH-HHHHhCCCCCcccccceeecCceEEEEE
Q 011302 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEK-VILTMLDHPFLPTLYAEFEASHYSCLVM 168 (489)
Q Consensus 90 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~-~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 168 (489)
+.||+|+||+||+|+++. .++.||+|++.+...........+..|. .+++.++||||+++++++...+.+|+||
T Consensus 1 ~~lg~G~fg~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKA-----EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEE
Confidence 369999999999999886 5688999999876544333333444444 4567899999999999999999999999
Q ss_pred eecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCcccc
Q 011302 169 EYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLL 248 (489)
Q Consensus 169 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 248 (489)
||++||+|.+++... ..+.+..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 76 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~---- 149 (325)
T cd05602 76 DYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH---- 149 (325)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC----
Confidence 999999999988765 56889999999999999999999999999999999999999999999999997321100
Q ss_pred CCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCcc
Q 011302 249 RPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKS 328 (489)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (489)
......
T Consensus 150 --------------------------------------------------------------------------~~~~~~ 155 (325)
T cd05602 150 --------------------------------------------------------------------------NGTTST 155 (325)
T ss_pred --------------------------------------------------------------------------CCCccc
Confidence 001234
Q ss_pred ccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHH
Q 011302 329 FVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDL 408 (489)
Q Consensus 329 ~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~l 408 (489)
.+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..+......++... ...+.+|
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~---------~~~~~~l 226 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNI---------TNSARHL 226 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCC---------CHHHHHH
Confidence 5799999999999999999999999999999999999999999888888888776655443211 1248999
Q ss_pred HHHHhhcCcccccCCCCChHHHHcCCCcCCCCcccc
Q 011302 409 ISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALI 444 (489)
Q Consensus 409 i~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~ 444 (489)
|.+||+.||.+|+++.+.+.++++|+||..++|..+
T Consensus 227 i~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~~ 262 (325)
T cd05602 227 LEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDL 262 (325)
T ss_pred HHHHcccCHHHCCCCCCCHHHHhcCcccCCCCHHHH
Confidence 999999999999999888889999999999999876
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-49 Score=393.10 Aligned_cols=268 Identities=38% Similarity=0.775 Sum_probs=222.6
Q ss_pred eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHh-CCCCCcccccceeecCceEEEEE
Q 011302 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTM-LDHPFLPTLYAEFEASHYSCLVM 168 (489)
Q Consensus 90 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpnIv~l~~~~~~~~~~~lV~ 168 (489)
+.||+|+||+||+|+++. +++.||||++++..............|..++.. ++||||+++++++.+.+.+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKG-----TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEE
Confidence 469999999999999887 578899999988755444445556667777776 58999999999999999999999
Q ss_pred eecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCcccc
Q 011302 169 EYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLL 248 (489)
Q Consensus 169 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 248 (489)
||++||+|..++... ..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 76 ey~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~---- 149 (316)
T cd05619 76 EYLNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG---- 149 (316)
T ss_pred eCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC----
Confidence 999999999988764 56899999999999999999999999999999999999999999999999997321100
Q ss_pred CCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCcc
Q 011302 249 RPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKS 328 (489)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (489)
......
T Consensus 150 --------------------------------------------------------------------------~~~~~~ 155 (316)
T cd05619 150 --------------------------------------------------------------------------DAKTCT 155 (316)
T ss_pred --------------------------------------------------------------------------CCceee
Confidence 001123
Q ss_pred ccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHH
Q 011302 329 FVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDL 408 (489)
Q Consensus 329 ~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~l 408 (489)
.+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..+......+|... ..++.+|
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~---------~~~~~~l 226 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWL---------TREAKDI 226 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccC---------CHHHHHH
Confidence 4799999999999999999999999999999999999999999888777777765544444321 1248999
Q ss_pred HHHHhhcCcccccCCCCChHHHHcCCCcCCCCcccc--ccCCCCCCCC
Q 011302 409 ISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALI--RSIKPPEVPN 454 (489)
Q Consensus 409 i~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~ 454 (489)
|.+||+.||++|+++. +++++||||+.++|..+ +.+.+|..|.
T Consensus 227 i~~~l~~~P~~R~~~~---~~l~~h~~~~~~~~~~~~~~~~~~~~~~~ 271 (316)
T cd05619 227 LVKLFVREPERRLGVK---GDIRQHPFFREIDWSALEEREIEPPFKPK 271 (316)
T ss_pred HHHHhccCHhhcCCCh---HHHHcCcccCCCCHHHHHhCCCCCCcCCC
Confidence 9999999999999985 38999999999999876 3455665544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-49 Score=395.11 Aligned_cols=270 Identities=38% Similarity=0.676 Sum_probs=224.5
Q ss_pred eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHH-HHHhCCCCCcccccceeecCceEEEEE
Q 011302 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKV-ILTMLDHPFLPTLYAEFEASHYSCLVM 168 (489)
Q Consensus 90 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~lV~ 168 (489)
+.||+|+||+||+|+++. +++.||+|++.+...........+..|.. +++.++||||+++++++..++.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKL-----DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEE
Confidence 469999999999999876 57899999998765544444445555554 567799999999999999999999999
Q ss_pred eecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCcccc
Q 011302 169 EYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLL 248 (489)
Q Consensus 169 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 248 (489)
||++||+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 76 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~----- 148 (325)
T cd05604 76 DFVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA----- 148 (325)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC-----
Confidence 999999999888764 5799999999999999999999999999999999999999999999999999732100
Q ss_pred CCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCcc
Q 011302 249 RPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKS 328 (489)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (489)
.......
T Consensus 149 -------------------------------------------------------------------------~~~~~~~ 155 (325)
T cd05604 149 -------------------------------------------------------------------------QSDTTTT 155 (325)
T ss_pred -------------------------------------------------------------------------CCCCccc
Confidence 0001224
Q ss_pred ccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHH
Q 011302 329 FVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDL 408 (489)
Q Consensus 329 ~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~l 408 (489)
.+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..+.......+.. . ...+.++
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~---~------~~~~~~l 226 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPG---A------SLTAWSI 226 (325)
T ss_pred ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCC---C------CHHHHHH
Confidence 579999999999999999999999999999999999999999988888888887765544321 1 1247899
Q ss_pred HHHHhhcCcccccCCCCChHHHHcCCCcCCCCcccccc--CCCCCCC
Q 011302 409 ISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIRS--IKPPEVP 453 (489)
Q Consensus 409 i~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~~~--~~~p~~~ 453 (489)
|.+||+.||.+|+++.+.+.+++.||||++++|..+.. +.+|..|
T Consensus 227 l~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~ 273 (325)
T cd05604 227 LEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPPFNP 273 (325)
T ss_pred HHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCC
Confidence 99999999999999988889999999999999987643 3444443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-49 Score=393.95 Aligned_cols=281 Identities=33% Similarity=0.611 Sum_probs=227.9
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
++|++++.||+|+||+||+|+++. .++.||+|++.+...........+..|+.++..++|+||+++++++.+.+.
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKN-----ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC-----CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCE
Confidence 479999999999999999999887 567899999987655544555567789999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
+|+||||++||+|.+++.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred EEEEEeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 999999999999999987642 5689999999999999999999999999999999999999999999999999732210
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
.. .
T Consensus 155 ~~-----------------------------------------------------------------------------~ 157 (332)
T cd05623 155 DG-----------------------------------------------------------------------------T 157 (332)
T ss_pred CC-----------------------------------------------------------------------------c
Confidence 00 0
Q ss_pred cCCccccCCCCccCcchhcC-----CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCC--CCCCCCCCc
Q 011302 324 ARSKSFVGTHEYLAPEVISG-----QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLT--FPRIGVSSS 396 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~-----~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--~p~~~~~~~ 396 (489)
......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+.++...... +|.....
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~-- 235 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTD-- 235 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCcccc--
Confidence 01123479999999999863 45789999999999999999999999998888888888765432 2322111
Q ss_pred hhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccccccCCCCCCCCc
Q 011302 397 KEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIRSIKPPEVPNN 455 (489)
Q Consensus 397 ~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~~~~~~p~~~~~ 455 (489)
...++++||++||..++ +|++. ..++++++||||.+++|..+....+|.+|..
T Consensus 236 ----~s~~~~~li~~ll~~~~-~r~~r-~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~ 288 (332)
T cd05623 236 ----VSEDAKDLIRRLICSRE-HRLGQ-NGIEDFKQHPFFTGIDWDNIRNCEAPYIPEV 288 (332)
T ss_pred ----CCHHHHHHHHHHccChh-hhcCC-CCHHHHhCCCCcCCCCHHHHhhCCCCccCCC
Confidence 12358999999997654 44332 1334999999999999999887777766654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-49 Score=392.48 Aligned_cols=270 Identities=40% Similarity=0.706 Sum_probs=225.0
Q ss_pred eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHH-HHHhCCCCCcccccceeecCceEEEEE
Q 011302 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKV-ILTMLDHPFLPTLYAEFEASHYSCLVM 168 (489)
Q Consensus 90 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~lV~ 168 (489)
+.||+|+||.||+|++.. .++.||+|++.+...........+..|.. +++.++||||+++++++.+.+..|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKS-----DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEE
Confidence 369999999999999886 57899999998776544444445555554 678899999999999999999999999
Q ss_pred eecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCcccc
Q 011302 169 EYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLL 248 (489)
Q Consensus 169 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 248 (489)
||++||+|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 76 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~---- 149 (321)
T cd05603 76 DYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP---- 149 (321)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC----
Confidence 999999998888764 56899999999999999999999999999999999999999999999999997321000
Q ss_pred CCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCcc
Q 011302 249 RPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKS 328 (489)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (489)
......
T Consensus 150 --------------------------------------------------------------------------~~~~~~ 155 (321)
T cd05603 150 --------------------------------------------------------------------------EETTST 155 (321)
T ss_pred --------------------------------------------------------------------------CCcccc
Confidence 001123
Q ss_pred ccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHH
Q 011302 329 FVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDL 408 (489)
Q Consensus 329 ~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~l 408 (489)
.+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+......+|... ...+.++
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~---------~~~~~~l 226 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGK---------TVAACDL 226 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCC---------CHHHHHH
Confidence 4799999999999998999999999999999999999999999888888888877766555321 1248899
Q ss_pred HHHHhhcCcccccCCCCChHHHHcCCCcCCCCccccc--cCCCCCCC
Q 011302 409 ISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIR--SIKPPEVP 453 (489)
Q Consensus 409 i~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~~--~~~~p~~~ 453 (489)
|.+||+.||.+|+++...+.++++|+||..++|..+. .+.+|..+
T Consensus 227 i~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (321)
T cd05603 227 LVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDLYHKRITPPYNP 273 (321)
T ss_pred HHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHHHHhcCCCCCCcCC
Confidence 9999999999999988788899999999999998763 34455433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-49 Score=395.13 Aligned_cols=271 Identities=37% Similarity=0.701 Sum_probs=219.9
Q ss_pred eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccceeecCceEEEEE
Q 011302 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAEFEASHYSCLVM 168 (489)
Q Consensus 90 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lV~ 168 (489)
+.||+|+||+||+|+++. +++.||+|++.+...........+..|..++..+ +||||+++++++...+.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKK-----TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECC-----CCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEE
Confidence 469999999999999887 5788999999987655445556677788888776 7999999999999999999999
Q ss_pred eecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCcccc
Q 011302 169 EYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLL 248 (489)
Q Consensus 169 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 248 (489)
||+++|+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 76 E~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~----- 148 (329)
T cd05618 76 EYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR----- 148 (329)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC-----
Confidence 999999998888765 5799999999999999999999999999999999999999999999999999732100
Q ss_pred CCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCcc
Q 011302 249 RPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKS 328 (489)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (489)
.......
T Consensus 149 -------------------------------------------------------------------------~~~~~~~ 155 (329)
T cd05618 149 -------------------------------------------------------------------------PGDTTST 155 (329)
T ss_pred -------------------------------------------------------------------------CCCcccc
Confidence 0001223
Q ss_pred ccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCC---------CcHHHHHHHhcCCCCCCCCCCCCchhH
Q 011302 329 FVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGE---------NNEKTLINILKKPLTFPRIGVSSSKEF 399 (489)
Q Consensus 329 ~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~---------~~~~~~~~i~~~~~~~p~~~~~~~~~~ 399 (489)
.+||+.|+|||++.+..++.++|||||||++|||++|..||... ........+......+|...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~------- 228 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL------- 228 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCC-------
Confidence 57999999999999999999999999999999999999999531 11223344555555555322
Q ss_pred HHHhhHHHHHHHHhhcCcccccCCC--CChHHHHcCCCcCCCCcccc--ccCCCCCCCC
Q 011302 400 EEVVKLQDLISKLLVKNPKKRIGSL--KGSVEIKRHEFFKGINWALI--RSIKPPEVPN 454 (489)
Q Consensus 400 ~~~~~l~~li~~~L~~dP~~R~~~~--~~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~ 454 (489)
...+.+||.+||+.||++|+++. .++.++++||||+.++|..+ +...||..|.
T Consensus 229 --~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~~~~~~ 285 (329)
T cd05618 229 --SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKPN 285 (329)
T ss_pred --CHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHcCCCCcCccCC
Confidence 12488999999999999999964 34579999999999999866 3345555444
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-49 Score=385.59 Aligned_cols=276 Identities=34% Similarity=0.564 Sum_probs=224.0
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceE
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYS 164 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 164 (489)
.|++.+.||+|+||+||+|.+.. +++.||+|++.............+.+|+.+++.++||||+++++++.+++.+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRA-----TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcC-----CCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeE
Confidence 48899999999999999999876 5789999999876655444445567899999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccC
Q 011302 165 CLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVV 244 (489)
Q Consensus 165 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~ 244 (489)
|+||||++||+|.+++.......+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~- 154 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE- 154 (285)
T ss_pred EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC-
Confidence 9999999999999887665445799999999999999999999999999999999999999999999999999743210
Q ss_pred ccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccccc
Q 011302 245 PKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINA 324 (489)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (489)
..
T Consensus 155 ------------------------------------------------------------------------------~~ 156 (285)
T cd05605 155 ------------------------------------------------------------------------------GE 156 (285)
T ss_pred ------------------------------------------------------------------------------CC
Confidence 00
Q ss_pred CCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHH----hcCCCCCCCCCCCCchhHH
Q 011302 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINI----LKKPLTFPRIGVSSSKEFE 400 (489)
Q Consensus 325 ~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i----~~~~~~~p~~~~~~~~~~~ 400 (489)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+ ......++..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 227 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEK--------- 227 (285)
T ss_pred ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcc---------
Confidence 012336899999999999988999999999999999999999999887654333222 2222222211
Q ss_pred HHhhHHHHHHHHhhcCcccccCCC-CChHHHHcCCCcCCCCccccc--cCCCCCCC
Q 011302 401 EVVKLQDLISKLLVKNPKKRIGSL-KGSVEIKRHEFFKGINWALIR--SIKPPEVP 453 (489)
Q Consensus 401 ~~~~l~~li~~~L~~dP~~R~~~~-~~~~~ll~hp~f~~~~~~~~~--~~~~p~~~ 453 (489)
....+.+||.+||..||++|++.. ..++++++||||...+|..+. .+.||+.|
T Consensus 228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (285)
T cd05605 228 FSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPPFCP 283 (285)
T ss_pred cCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhhCCCCCCCCC
Confidence 122488999999999999999643 234599999999999999773 34455544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-49 Score=391.42 Aligned_cols=280 Identities=35% Similarity=0.637 Sum_probs=226.1
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
++|++++.||+|+||+||+|+++. +++.||+|++.+...........+..|+.++..++|+||+++++++.++++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKN-----TGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECC-----CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCe
Confidence 479999999999999999999887 578899999987655555556667889999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
+|+||||++||+|.+++.+. ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..+..
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred EEEEEecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 99999999999999998763 35699999999999999999999999999999999999999999999999999733210
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
.. .
T Consensus 155 ~~-----------------------------------------------------------------------------~ 157 (331)
T cd05597 155 DG-----------------------------------------------------------------------------T 157 (331)
T ss_pred CC-----------------------------------------------------------------------------C
Confidence 00 0
Q ss_pred cCCccccCCCCccCcchhcC-----CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCC--CCCCCCCCCc
Q 011302 324 ARSKSFVGTHEYLAPEVISG-----QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL--TFPRIGVSSS 396 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~-----~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--~~p~~~~~~~ 396 (489)
......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+..... .++.....
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~-- 235 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTD-- 235 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCC--
Confidence 00112369999999999974 3478899999999999999999999998887777777765332 22222111
Q ss_pred hhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccccccCCCCCCCC
Q 011302 397 KEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIRSIKPPEVPN 454 (489)
Q Consensus 397 ~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~~~~~~p~~~~ 454 (489)
....+++||++||.. |.+|++. ..++++++||||++++|..+....+|.+|.
T Consensus 236 ----~~~~~~~li~~ll~~-~~~r~~r-~~~~~~l~hp~~~~~~~~~~~~~~~~~~~~ 287 (331)
T cd05597 236 ----VSEEAKDLIRRLICS-PETRLGR-NGLQDFKDHPFFEGIDWDNIRNSTAPYVPE 287 (331)
T ss_pred ----CCHHHHHHHHHHccC-cccccCC-CCHHHHhcCCCCCCCCHHHHhhCCCCccCc
Confidence 123589999999975 4444432 133499999999999999887777776654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-49 Score=383.55 Aligned_cols=262 Identities=34% Similarity=0.580 Sum_probs=215.2
Q ss_pred eccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEEEEEeec
Q 011302 92 LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYC 171 (489)
Q Consensus 92 lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 171 (489)
||+|+||+||+|.++. +++.||+|.+.+...........+..|+.+++.++||||+++++++..+..+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRA-----TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEcc-----CCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCC
Confidence 7999999999999886 57899999998776655555667788999999999999999999999999999999999
Q ss_pred CCCchHHHHHhC--CCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCccccC
Q 011302 172 PGGDLYAARQRQ--PGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLR 249 (489)
Q Consensus 172 ~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 249 (489)
+||+|..++... ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~----- 150 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG----- 150 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCC-----
Confidence 999998776432 2356899999999999999999999999999999999999999999999999997432110
Q ss_pred CcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCccc
Q 011302 250 PKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSF 329 (489)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (489)
.......
T Consensus 151 -------------------------------------------------------------------------~~~~~~~ 157 (280)
T cd05608 151 -------------------------------------------------------------------------QSKTKGY 157 (280)
T ss_pred -------------------------------------------------------------------------Ccccccc
Confidence 0011234
Q ss_pred cCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcH----HHHHHHhcCCCCCCCCCCCCchhHHHHhhH
Q 011302 330 VGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNE----KTLINILKKPLTFPRIGVSSSKEFEEVVKL 405 (489)
Q Consensus 330 ~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~----~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l 405 (489)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+......++.. ....+
T Consensus 158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~ 228 (280)
T cd05608 158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDK---------FSPAS 228 (280)
T ss_pred CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCccc---------CCHHH
Confidence 6899999999999999999999999999999999999999875432 2223333333222211 12358
Q ss_pred HHHHHHHhhcCcccccCCCC-ChHHHHcCCCcCCCCccccc
Q 011302 406 QDLISKLLVKNPKKRIGSLK-GSVEIKRHEFFKGINWALIR 445 (489)
Q Consensus 406 ~~li~~~L~~dP~~R~~~~~-~~~~ll~hp~f~~~~~~~~~ 445 (489)
.+|+.+||+.||++|++..+ .++++++||||++++|..+.
T Consensus 229 ~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~~ 269 (280)
T cd05608 229 KSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLE 269 (280)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHHh
Confidence 99999999999999998764 56799999999999998763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-49 Score=391.84 Aligned_cols=271 Identities=38% Similarity=0.702 Sum_probs=222.3
Q ss_pred eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccceeecCceEEEEE
Q 011302 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAEFEASHYSCLVM 168 (489)
Q Consensus 90 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lV~ 168 (489)
+.||+|+||+||+|+++. .++.||+|++.++..........+..|+.++..+ +||||+++++++.+.+.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKK-----NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEE
Confidence 469999999999999887 5788999999987666556667788899998887 6999999999999999999999
Q ss_pred eecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCcccc
Q 011302 169 EYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLL 248 (489)
Q Consensus 169 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 248 (489)
||++||+|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 76 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~---- 149 (327)
T cd05617 76 EYVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP---- 149 (327)
T ss_pred eCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC----
Confidence 999999999888765 57999999999999999999999999999999999999999999999999987321000
Q ss_pred CCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCcc
Q 011302 249 RPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKS 328 (489)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (489)
......
T Consensus 150 --------------------------------------------------------------------------~~~~~~ 155 (327)
T cd05617 150 --------------------------------------------------------------------------GDTTST 155 (327)
T ss_pred --------------------------------------------------------------------------CCceec
Confidence 011234
Q ss_pred ccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCC------c-HHHHHHHhcCCCCCCCCCCCCchhHHH
Q 011302 329 FVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGEN------N-EKTLINILKKPLTFPRIGVSSSKEFEE 401 (489)
Q Consensus 329 ~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~------~-~~~~~~i~~~~~~~p~~~~~~~~~~~~ 401 (489)
.+||+.|+|||++.+..++.++|||||||++|||++|..||.... . ......+......+|....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~-------- 227 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLS-------- 227 (327)
T ss_pred ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCC--------
Confidence 579999999999999999999999999999999999999996421 1 2334445555545443211
Q ss_pred HhhHHHHHHHHhhcCcccccCCC--CChHHHHcCCCcCCCCccccc--cCCCCCCCC
Q 011302 402 VVKLQDLISKLLVKNPKKRIGSL--KGSVEIKRHEFFKGINWALIR--SIKPPEVPN 454 (489)
Q Consensus 402 ~~~l~~li~~~L~~dP~~R~~~~--~~~~~ll~hp~f~~~~~~~~~--~~~~p~~~~ 454 (489)
..+.+||.+||+.||.+|+++. ..+++++.||||++++|..+. ...+|+.|.
T Consensus 228 -~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~ 283 (327)
T cd05617 228 -VKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTPPFKPQ 283 (327)
T ss_pred -HHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHHHhCCCCCCccCC
Confidence 2488999999999999999974 356799999999999999773 344454444
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=396.15 Aligned_cols=270 Identities=39% Similarity=0.684 Sum_probs=224.0
Q ss_pred eccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC---CCCCcccccceeecCceEEEEE
Q 011302 92 LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML---DHPFLPTLYAEFEASHYSCLVM 168 (489)
Q Consensus 92 lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~~~~~~lV~ 168 (489)
||+|+||+||+|+++. +++.||||++.+..............|..++..+ +||||+++++++.+...+|+||
T Consensus 1 lG~G~~g~Vy~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKD-----TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECC-----CCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEE
Confidence 7999999999999886 5789999999876555444455555677776655 6999999999999999999999
Q ss_pred eecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCcccc
Q 011302 169 EYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLL 248 (489)
Q Consensus 169 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 248 (489)
||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 76 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~----- 148 (330)
T cd05586 76 DYMSGGELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT----- 148 (330)
T ss_pred cCCCCChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC-----
Confidence 999999999888765 6799999999999999999999999999999999999999999999999999732110
Q ss_pred CCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCcc
Q 011302 249 RPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKS 328 (489)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (489)
.......
T Consensus 149 -------------------------------------------------------------------------~~~~~~~ 155 (330)
T cd05586 149 -------------------------------------------------------------------------DNKTTNT 155 (330)
T ss_pred -------------------------------------------------------------------------CCCCccC
Confidence 0011234
Q ss_pred ccCCCCccCcchhcCC-CCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHH
Q 011302 329 FVGTHEYLAPEVISGQ-GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQD 407 (489)
Q Consensus 329 ~~Gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~ 407 (489)
.+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+.+..+..+...+|.... ...+.+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~--------~~~~~~ 227 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVL--------SDEGRQ 227 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccC--------CHHHHH
Confidence 5799999999999765 4799999999999999999999999998888888888777666654321 124889
Q ss_pred HHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcccc--ccCCCCCCCC
Q 011302 408 LISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALI--RSIKPPEVPN 454 (489)
Q Consensus 408 li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~ 454 (489)
||.+||+.||.+|+++...+.++++||||+.++|..+ ..+.+|..|.
T Consensus 228 li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~ 276 (330)
T cd05586 228 FVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQITPPFKPI 276 (330)
T ss_pred HHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCccCC
Confidence 9999999999999998778889999999999999876 3344454443
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-49 Score=392.65 Aligned_cols=281 Identities=34% Similarity=0.644 Sum_probs=230.3
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
++|++++.||+|+||+||+|+++. +++.||+|++.+...........+.+|..++..++|+||+++++++.+.+.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKH-----TERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 579999999999999999999886 578899999987654444555667789999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
.|+||||++||+|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999999987642 5689999999999999999999999999999999999999999999999999743211
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
.. .
T Consensus 155 ~~-----------------------------------------------------------------------------~ 157 (331)
T cd05624 155 DG-----------------------------------------------------------------------------T 157 (331)
T ss_pred CC-----------------------------------------------------------------------------c
Confidence 00 0
Q ss_pred cCCccccCCCCccCcchhcC-----CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCC--CCCCCCCCc
Q 011302 324 ARSKSFVGTHEYLAPEVISG-----QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLT--FPRIGVSSS 396 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~-----~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--~p~~~~~~~ 396 (489)
......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+.++...... +|.....
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~-- 235 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITD-- 235 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCcccc--
Confidence 01122469999999999976 45788999999999999999999999988887777777654322 2322111
Q ss_pred hhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccccccCCCCCCCCc
Q 011302 397 KEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIRSIKPPEVPNN 455 (489)
Q Consensus 397 ~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~~~~~~p~~~~~ 455 (489)
....+++||.+||..++ +|+.. ..++++++||||++++|..++...+|.+|..
T Consensus 236 ----~~~~~~~li~~ll~~~~-~~~~~-~~~~~~~~h~~f~~~~~~~~~~~~~~~~p~~ 288 (331)
T cd05624 236 ----VSEEAKDLIQRLICSRE-RRLGQ-NGIEDFKKHAFFEGIDWENIRNLEAPYIPDV 288 (331)
T ss_pred ----CCHHHHHHHHHHccCch-hhcCC-CCHHHHhcCCCcCCCCHHHHhhCCCCccCCC
Confidence 12358999999998654 55443 3556999999999999999988888887764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-49 Score=382.44 Aligned_cols=269 Identities=33% Similarity=0.542 Sum_probs=217.5
Q ss_pred eccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEEEEEeec
Q 011302 92 LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYC 171 (489)
Q Consensus 92 lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 171 (489)
||+|+||.||+|+++. +++.||+|.+.............+..|+.+++.++||||+++++++.++.++|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~-----~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKN-----TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEcc-----CCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecC
Confidence 7999999999999887 57899999998765543333445566999999999999999999999999999999999
Q ss_pred CCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCccccCCc
Q 011302 172 PGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPK 251 (489)
Q Consensus 172 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 251 (489)
+||+|.+++.......+++..+..++.||+.||+|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~------- 148 (277)
T cd05607 76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG------- 148 (277)
T ss_pred CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC-------
Confidence 9999998887655556889999999999999999999999999999999999999999999999997332100
Q ss_pred chhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCccccC
Q 011302 252 LSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVG 331 (489)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 331 (489)
.......|
T Consensus 149 ------------------------------------------------------------------------~~~~~~~~ 156 (277)
T cd05607 149 ------------------------------------------------------------------------KTITQRAG 156 (277)
T ss_pred ------------------------------------------------------------------------ceeeccCC
Confidence 00112358
Q ss_pred CCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcH----HHHHHHhcCCCCCCCCCCCCchhHHHHhhHHH
Q 011302 332 THEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNE----KTLINILKKPLTFPRIGVSSSKEFEEVVKLQD 407 (489)
Q Consensus 332 t~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~----~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~ 407 (489)
|+.|+|||++.+..++.++|||||||++|||++|..||.+.... +....+......++... ...++.+
T Consensus 157 ~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~ 228 (277)
T cd05607 157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQN--------FTEESKD 228 (277)
T ss_pred CCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccccccc--------CCHHHHH
Confidence 99999999999988999999999999999999999999765432 23333333322221111 1225899
Q ss_pred HHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccccc--cCCCCCC
Q 011302 408 LISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIR--SIKPPEV 452 (489)
Q Consensus 408 li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~~--~~~~p~~ 452 (489)
||.+||+.||++|+++.+.+++++.||||++++|..+. ...+|++
T Consensus 229 li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~ 275 (277)
T cd05607 229 ICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRLEAGLIPPPFV 275 (277)
T ss_pred HHHHHhccCHhhCCCCccchhhhhcChhhcCCCHHHHhcCcCCCCCC
Confidence 99999999999999998777899999999999998775 3444543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-49 Score=390.16 Aligned_cols=265 Identities=38% Similarity=0.697 Sum_probs=222.0
Q ss_pred eeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHH-HHHHHHHHHHHHHHHhCCCCCcccccceeecCceEEEE
Q 011302 89 LRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAI-RKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLV 167 (489)
Q Consensus 89 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 167 (489)
++.||+|+||.||+|+..... ..++.||+|++.+..... ......+..|+.+|+.++||||++++++|..++.+|+|
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv 78 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGA--DTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLI 78 (323)
T ss_pred CceeeecCCeEEEEEEEcccC--CCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEE
Confidence 367999999999999875321 257899999998765432 23345567899999999999999999999999999999
Q ss_pred EeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCccc
Q 011302 168 MEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKL 247 (489)
Q Consensus 168 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 247 (489)
|||++||+|.+++.+. +.+.+..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---- 152 (323)
T cd05584 79 LEYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH---- 152 (323)
T ss_pred EeCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc----
Confidence 9999999999998765 5688999999999999999999999999999999999999999999999999732110
Q ss_pred cCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCc
Q 011302 248 LRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSK 327 (489)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (489)
......
T Consensus 153 --------------------------------------------------------------------------~~~~~~ 158 (323)
T cd05584 153 --------------------------------------------------------------------------EGTVTH 158 (323)
T ss_pred --------------------------------------------------------------------------CCCccc
Confidence 001122
Q ss_pred cccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHH
Q 011302 328 SFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQD 407 (489)
Q Consensus 328 ~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~ 407 (489)
..+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+....+..+..+...+|.... ..+.+
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~ 229 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLT---------PEARD 229 (323)
T ss_pred ccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC---------HHHHH
Confidence 357999999999999988999999999999999999999999998888888888877665554321 24899
Q ss_pred HHHHHhhcCcccccCCC-CChHHHHcCCCcCCCCcccc
Q 011302 408 LISKLLVKNPKKRIGSL-KGSVEIKRHEFFKGINWALI 444 (489)
Q Consensus 408 li~~~L~~dP~~R~~~~-~~~~~ll~hp~f~~~~~~~~ 444 (489)
||.+||+.||++|++.. ..+++++.||||+..+|..+
T Consensus 230 li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~~~ 267 (323)
T cd05584 230 LLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDL 267 (323)
T ss_pred HHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCHHHH
Confidence 99999999999999643 23569999999999999866
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=388.90 Aligned_cols=280 Identities=41% Similarity=0.755 Sum_probs=222.2
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHH-HHHHHHHHHHHHHHHhC-CCCCcccccceeecCc
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAI-RKKLHRADMEKVILTML-DHPFLPTLYAEFEASH 162 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~ 162 (489)
+|++++.||+|+||.||+|+..... .+++.||+|++.+..... ......+..|+.+++.+ +||||+++++++..++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGH--DTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEA 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccC--CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCC
Confidence 5899999999999999999875321 257899999998765432 23345677899999999 5999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
.+|+||||++||+|.+++... ..+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.+.
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 999999999999999988765 569999999999999999999999999999999999999999999999999984321
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
...
T Consensus 157 ~~~----------------------------------------------------------------------------- 159 (332)
T cd05614 157 SEE----------------------------------------------------------------------------- 159 (332)
T ss_pred ccC-----------------------------------------------------------------------------
Confidence 100
Q ss_pred ccCCccccCCCCccCcchhcCCC-CCCcccHHHHHHHHHHHhhCCCCCCCCCc----HHHHHHHhcCCCCCCCCCCCCch
Q 011302 323 NARSKSFVGTHEYLAPEVISGQG-HGSAVDWWTLGVFLYEMLYGTTPFKGENN----EKTLINILKKPLTFPRIGVSSSK 397 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~-~~~~~DiwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~p~~~~~~~~ 397 (489)
.......+||+.|+|||++.+.. ++.++|||||||++|||++|..||..... ......+......+|...
T Consensus 160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 234 (332)
T cd05614 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFI----- 234 (332)
T ss_pred CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCC-----
Confidence 01123457999999999998764 78999999999999999999999975432 233334444433333211
Q ss_pred hHHHHhhHHHHHHHHhhcCcccccCCC-CChHHHHcCCCcCCCCcccc--ccCCCCCCCC
Q 011302 398 EFEEVVKLQDLISKLLVKNPKKRIGSL-KGSVEIKRHEFFKGINWALI--RSIKPPEVPN 454 (489)
Q Consensus 398 ~~~~~~~l~~li~~~L~~dP~~R~~~~-~~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~ 454 (489)
...+.+||.+||+.||++|+++. ..++++++||||++.+|..+ ....+|+.|.
T Consensus 235 ----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~ 290 (332)
T cd05614 235 ----GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPS 290 (332)
T ss_pred ----CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCC
Confidence 12489999999999999999764 24569999999999999865 3445554443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-49 Score=390.46 Aligned_cols=253 Identities=26% Similarity=0.426 Sum_probs=211.0
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
+..++..+.+.||.|+||+||+|.+++. ..||||++......... ...+.+|+.+|.+++|||||+|+|++.+
T Consensus 38 i~~~~l~~~~~iG~G~~g~V~~~~~~g~------~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~ 110 (362)
T KOG0192|consen 38 IDPDELPIEEVLGSGSFGTVYKGKWRGT------DVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTS 110 (362)
T ss_pred cChHHhhhhhhcccCCceeEEEEEeCCc------eeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 4445666677799999999999999972 33899999876655444 6788899999999999999999999998
Q ss_pred Cc-eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCC-CeeecCCCCCeEeccCC-cEEEcccCC
Q 011302 161 SH-YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMG-IVYRDLKPENVLVREDG-HIMLSDFDL 237 (489)
Q Consensus 161 ~~-~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~-iiHrDIKp~NILl~~~~-~vkl~DFG~ 237 (489)
.. .++|||||+++|+|..++.......+++..+..|+.||+.||.|||+++ ||||||||+|||++.++ ++||+|||+
T Consensus 111 ~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGl 190 (362)
T KOG0192|consen 111 PPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGL 190 (362)
T ss_pred CCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcc
Confidence 87 7999999999999999998744478999999999999999999999999 99999999999999998 999999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
++......
T Consensus 191 sr~~~~~~------------------------------------------------------------------------ 198 (362)
T KOG0192|consen 191 SREKVISK------------------------------------------------------------------------ 198 (362)
T ss_pred ceeecccc------------------------------------------------------------------------
Confidence 85432100
Q ss_pred cccccccCCccccCCCCccCcchhc--CCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCC
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVIS--GQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSS 395 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~--~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 395 (489)
...+...||+.|||||++. ...|+.++||||||+++|||+||+.||.+....+....+..+....+.... .
T Consensus 199 ------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~-~ 271 (362)
T KOG0192|consen 199 ------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKE-C 271 (362)
T ss_pred ------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCcc-C
Confidence 0112247999999999999 568999999999999999999999999999987666666654443332221 2
Q ss_pred chhHHHHhhHHHHHHHHhhcCcccccCCCC
Q 011302 396 SKEFEEVVKLQDLISKLLVKNPKKRIGSLK 425 (489)
Q Consensus 396 ~~~~~~~~~l~~li~~~L~~dP~~R~~~~~ 425 (489)
. ..+..||.+||..||..||++.+
T Consensus 272 ~------~~l~~l~~~CW~~dp~~RP~f~e 295 (362)
T KOG0192|consen 272 P------PHLSSLMERCWLVDPSRRPSFLE 295 (362)
T ss_pred C------HHHHHHHHHhCCCCCCcCCCHHH
Confidence 2 24899999999999999999863
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-49 Score=389.92 Aligned_cols=272 Identities=40% Similarity=0.738 Sum_probs=225.7
Q ss_pred eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEEEEEe
Q 011302 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVME 169 (489)
Q Consensus 90 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 169 (489)
+.||+|+||.||++++.... ..++.||+|++.+..... ....++..|+.+|+.++||||+++++++.+++.+|+|||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~--~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 78 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGP--DAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILD 78 (318)
T ss_pred ceeeeCCCEEEEEEEEeccC--CCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEc
Confidence 57999999999999875321 257899999998765432 233456779999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCccccC
Q 011302 170 YCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLR 249 (489)
Q Consensus 170 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 249 (489)
|++||+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 79 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~----- 151 (318)
T cd05582 79 FLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH----- 151 (318)
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC-----
Confidence 99999999988765 56999999999999999999999999999999999999999999999999997422100
Q ss_pred CcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCccc
Q 011302 250 PKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSF 329 (489)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (489)
.......
T Consensus 152 -------------------------------------------------------------------------~~~~~~~ 158 (318)
T cd05582 152 -------------------------------------------------------------------------EKKAYSF 158 (318)
T ss_pred -------------------------------------------------------------------------CCceecc
Confidence 0112345
Q ss_pred cCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHHH
Q 011302 330 VGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLI 409 (489)
Q Consensus 330 ~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li 409 (489)
+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+......+|... ...+.+||
T Consensus 159 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~---------~~~~~~li 229 (318)
T cd05582 159 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFL---------SPEAQSLL 229 (318)
T ss_pred cCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCC---------CHHHHHHH
Confidence 799999999999998899999999999999999999999999888888888877665555321 12488999
Q ss_pred HHHhhcCcccccCCCC-ChHHHHcCCCcCCCCccccc--cCCCCCCC
Q 011302 410 SKLLVKNPKKRIGSLK-GSVEIKRHEFFKGINWALIR--SIKPPEVP 453 (489)
Q Consensus 410 ~~~L~~dP~~R~~~~~-~~~~ll~hp~f~~~~~~~~~--~~~~p~~~ 453 (489)
++||+.||++|+++.+ .+.+++.||||+.++|..+. ...||..+
T Consensus 230 ~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (318)
T cd05582 230 RALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPPFKP 276 (318)
T ss_pred HHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHHHHHhcCCCCCcCC
Confidence 9999999999999864 36789999999999998763 34444443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-48 Score=383.63 Aligned_cols=311 Identities=56% Similarity=0.970 Sum_probs=246.5
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
++|++.+.||+|+||.||+|.+.. +++.||+|.+.+...........+..|+.+++.++||||+++++.+.++..
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKG-----TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcC-----CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCE
Confidence 479999999999999999999886 578899999987655544566778889999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
.|+||||+.|++|.+++....+..+++..+..++.|++.||+|||+.|++||||||+|||++.++.++|+|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 99999999999999998876667899999999999999999999999999999999999999999999999999854321
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
....... ..... ....... .........+..
T Consensus 156 ~~~~~~~------------------------~~~~~--~~~~~~~-----------------------~~~~~~~~~~~~ 186 (316)
T cd05574 156 EPPPVSK------------------------ALRKG--SRRSSVN-----------------------SIPSETFSEEPS 186 (316)
T ss_pred ccccccc------------------------ccccc--ccccccc-----------------------ccchhhhccccc
Confidence 1000000 00000 0000000 000000011112
Q ss_pred cCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHh
Q 011302 324 ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVV 403 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~ 403 (489)
.....+.||..|+|||++.+..++.++|||||||++|+|++|..||.+.+....+.++......++.... ...
T Consensus 187 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------~~~ 259 (316)
T cd05574 187 FRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPP-------VSS 259 (316)
T ss_pred CCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCCccc-------cCH
Confidence 2334568999999999999988999999999999999999999999998888888877766555543321 223
Q ss_pred hHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccccccCCCCCCCCc
Q 011302 404 KLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIRSIKPPEVPNN 455 (489)
Q Consensus 404 ~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~~~~~~p~~~~~ 455 (489)
.+.+||.+||+.||++||+...++++++.||||++++|..++...||.+|..
T Consensus 260 ~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~ 311 (316)
T cd05574 260 SARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRHTTPPIIPRP 311 (316)
T ss_pred HHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhcccCCCCCCCCc
Confidence 5899999999999999999766677999999999999999988888877653
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-49 Score=373.65 Aligned_cols=268 Identities=28% Similarity=0.366 Sum_probs=217.2
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec---
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA--- 160 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--- 160 (489)
..|..++.||+|+||.|+.|.++. +++.||||.+... ........+..+|+.+|+.++|+||+.+++++..
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~-----t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKR-----TGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR 95 (359)
T ss_pred ceecccccccCcceeeEEEEEEcC-----CCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence 456668999999999999999998 5789999998743 2334566788899999999999999999998864
Q ss_pred --CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 161 --SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 161 --~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
-+.+|+|+|+| +.+|...++.+ ..|++..++.+++||+.||.|+|+.||+||||||.|+|++.+..+||||||+|
T Consensus 96 ~~f~DvYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 96 DKFNDVYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred cccceeEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccce
Confidence 45799999999 89999999875 45999999999999999999999999999999999999999999999999999
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
+.....
T Consensus 173 R~~~~~-------------------------------------------------------------------------- 178 (359)
T KOG0660|consen 173 RYLDKF-------------------------------------------------------------------------- 178 (359)
T ss_pred eecccc--------------------------------------------------------------------------
Confidence 543211
Q ss_pred ccccccCCccccCCCCccCcchhcC-CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCC----------
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLT---------- 387 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------- 387 (489)
......+.++-|.+|+|||++.. ..|+.++||||+|||+.||++|++.|.|.+..+++..|..--..
T Consensus 179 --~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~ 256 (359)
T KOG0660|consen 179 --FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR 256 (359)
T ss_pred --CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence 00112356688999999999864 56999999999999999999999999999877766665431100
Q ss_pred ----------CCCCC-CCCchhH-HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 388 ----------FPRIG-VSSSKEF-EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 388 ----------~p~~~-~~~~~~~-~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
.|... .+....| ...+.+.||+.+||..||.+|+|++ |+|+||||..+.
T Consensus 257 s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~----eAL~hPYl~~~h 317 (359)
T KOG0660|consen 257 SEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAE----EALAHPYLAPYH 317 (359)
T ss_pred cHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHH----HHhcChhhhhhc
Confidence 11100 0001111 2234689999999999999999998 999999998864
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-49 Score=373.19 Aligned_cols=269 Identities=28% Similarity=0.395 Sum_probs=218.3
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCC-cccccceeecC
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPF-LPTLYAEFEAS 161 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~ 161 (489)
...|..+++||+|+||+||+|+.+. +++.||+|.++.+... +.......+|+.+|+.++|+| ||+|++++.+.
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~-----~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~ 83 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKR-----TGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTS 83 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEec-----CCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeec
Confidence 3567888899999999999999997 6789999999866432 223455678999999999999 99999999887
Q ss_pred c------eEEEEEeecCCCchHHHHHhCCC--CCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEc
Q 011302 162 H------YSCLVMEYCPGGDLYAARQRQPG--KRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLS 233 (489)
Q Consensus 162 ~------~~~lV~E~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~ 233 (489)
+ .+|||+||+ .-+|..++...+. ..++...++.+++||+.||+|||+++|+||||||+||||+.+|.+||+
T Consensus 84 ~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKla 162 (323)
T KOG0594|consen 84 NNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLA 162 (323)
T ss_pred ccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeee
Confidence 7 899999999 7899999987643 357778899999999999999999999999999999999999999999
Q ss_pred ccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccC
Q 011302 234 DFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLD 313 (489)
Q Consensus 234 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (489)
|||+|+.+....
T Consensus 163 DFGlAra~~ip~-------------------------------------------------------------------- 174 (323)
T KOG0594|consen 163 DFGLARAFSIPM-------------------------------------------------------------------- 174 (323)
T ss_pred ccchHHHhcCCc--------------------------------------------------------------------
Confidence 999995332100
Q ss_pred CccccccccccCCccccCCCCccCcchhcCC-CCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhc---C--CCC
Q 011302 314 DPEVVAEPINARSKSFVGTHEYLAPEVISGQ-GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILK---K--PLT 387 (489)
Q Consensus 314 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~--~~~ 387 (489)
.....-++|.+|+|||++.|. .|+..+||||+|||++||+++++.|.|..+.+++..|.+ . ...
T Consensus 175 ----------~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 175 ----------RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred ----------ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 112344789999999999997 589999999999999999999999999999888877754 1 111
Q ss_pred CCCCC-----------CCCchhH-----HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 388 FPRIG-----------VSSSKEF-----EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 388 ~p~~~-----------~~~~~~~-----~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
||... ......+ .......+|+.+||+.+|.+|.++. .++.||||....
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~----~al~h~yf~~~~ 309 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAK----GALTHPYFSELP 309 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHH----HHhcChhhcccc
Confidence 22111 0000111 1113578999999999999999998 999999998874
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-49 Score=397.03 Aligned_cols=261 Identities=28% Similarity=0.462 Sum_probs=218.1
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-CC-----Ccccccce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-HP-----FLPTLYAE 157 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp-----nIv~l~~~ 157 (489)
.+|.+++.||+|+||.|.+|.++. +++.||||+++... ....+...|+.+|..|+ |. |||+++++
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~-----T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~ 256 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHK-----TGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDY 256 (586)
T ss_pred EEEEEEEEecccccceeEEEEecC-----CCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeec
Confidence 367899999999999999999998 68999999998764 45567777999999997 43 79999999
Q ss_pred eecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccC--CcEEEccc
Q 011302 158 FEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRED--GHIMLSDF 235 (489)
Q Consensus 158 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~--~~vkl~DF 235 (489)
|...+++|||+|++ +-+|+++++.+....|+...++.|+.||+.||.+||+.||||+|||||||||..- ..|||+||
T Consensus 257 F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDF 335 (586)
T KOG0667|consen 257 FYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDF 335 (586)
T ss_pred cccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEec
Confidence 99999999999999 8999999999888889999999999999999999999999999999999999753 47999999
Q ss_pred CCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCc
Q 011302 236 DLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDP 315 (489)
Q Consensus 236 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (489)
|.|....
T Consensus 336 GSSc~~~------------------------------------------------------------------------- 342 (586)
T KOG0667|consen 336 GSSCFES------------------------------------------------------------------------- 342 (586)
T ss_pred ccccccC-------------------------------------------------------------------------
Confidence 9873211
Q ss_pred cccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCC---------
Q 011302 316 EVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL--------- 386 (489)
Q Consensus 316 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--------- 386 (489)
....+++-+..|+|||+|.|.+|+.+.||||||||++||++|.+.|.|.++.++++.|..-.-
T Consensus 343 --------q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~ 414 (586)
T KOG0667|consen 343 --------QRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT 414 (586)
T ss_pred --------CcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 122366788999999999999999999999999999999999999999999999888853100
Q ss_pred ------------CCCC--------------------------CCCC-CchhH------HHHhhHHHHHHHHhhcCccccc
Q 011302 387 ------------TFPR--------------------------IGVS-SSKEF------EEVVKLQDLISKLLVKNPKKRI 421 (489)
Q Consensus 387 ------------~~p~--------------------------~~~~-~~~~~------~~~~~l~~li~~~L~~dP~~R~ 421 (489)
.++. ...+ ....+ .....+.|||.+||++||.+|+
T Consensus 415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~ 494 (586)
T KOG0667|consen 415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI 494 (586)
T ss_pred ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence 0000 0000 00000 1122468999999999999999
Q ss_pred CCCCChHHHHcCCCcCCC
Q 011302 422 GSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 422 ~~~~~~~~ll~hp~f~~~ 439 (489)
+.. ++|+||||.+.
T Consensus 495 tp~----qal~Hpfl~~~ 508 (586)
T KOG0667|consen 495 TPA----QALNHPFLTGT 508 (586)
T ss_pred CHH----HHhcCcccccc
Confidence 998 99999999854
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=389.02 Aligned_cols=258 Identities=28% Similarity=0.448 Sum_probs=221.0
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
..|..++.||+|+||.||+|.+.. +++.||||++..+... .....++.|+.+|..++++||.++|+.|..+..
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~-----t~k~vAiKii~Le~~~--deIediqqei~~Ls~~~~~~it~yygsyl~g~~ 85 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNK-----TKKVVAIKIIDLEEAE--DEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK 85 (467)
T ss_pred cccccchhccccccceeeeeeecc-----ccceEEEEEechhhcc--hhhHHHHHHHHHHHhcCcchHHhhhhheeeccc
Confidence 568888999999999999999987 6889999999877544 445677789999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
++++||||.||++.++++.. ..+.+.++..++++++.||.|||.++.||||||+.|||+..+|.|||+|||.+-.+..
T Consensus 86 LwiiMey~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 86 LWIIMEYCGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTN 163 (467)
T ss_pred HHHHHHHhcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeec
Confidence 99999999999999998764 4568999999999999999999999999999999999999999999999999732211
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
..
T Consensus 164 ------------------------------------------------------------------------------~~ 165 (467)
T KOG0201|consen 164 ------------------------------------------------------------------------------TV 165 (467)
T ss_pred ------------------------------------------------------------------------------hh
Confidence 01
Q ss_pred cCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHh
Q 011302 324 ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVV 403 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~ 403 (489)
.+..+++|||.|||||++.+..|+.++||||||++.|||++|.+||....+..++..|-+.. .|........
T Consensus 166 ~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~--PP~L~~~~S~------ 237 (467)
T KOG0201|consen 166 KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSA--PPRLDGDFSP------ 237 (467)
T ss_pred hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCC--CCccccccCH------
Confidence 23478899999999999999999999999999999999999999999888865555444432 2222222222
Q ss_pred hHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 404 KLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 404 ~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
.+++||..||++||+.||++. +||+|+|.+...
T Consensus 238 ~~kEFV~~CL~k~P~~RpsA~----~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 238 PFKEFVEACLDKNPEFRPSAK----ELLKHKFIKRAK 270 (467)
T ss_pred HHHHHHHHHhhcCcccCcCHH----HHhhhHHHHhcC
Confidence 489999999999999999998 999999998743
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-48 Score=377.28 Aligned_cols=277 Identities=36% Similarity=0.597 Sum_probs=221.9
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceE
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYS 164 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 164 (489)
.|++.+.||+|+||.||+|.++. +++.||+|.+.+...........+..|+.+++.++|+||+++++.+.+++..
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRA-----TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDAL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcC-----CCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEE
Confidence 37888999999999999999987 5789999999866544334445567799999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccC
Q 011302 165 CLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVV 244 (489)
Q Consensus 165 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~ 244 (489)
|+||||++||+|.+++.......+++.++..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 76 ~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~- 154 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE- 154 (285)
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC-
Confidence 9999999999999988765545699999999999999999999999999999999999999999999999998732110
Q ss_pred ccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccccc
Q 011302 245 PKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINA 324 (489)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (489)
..
T Consensus 155 ------------------------------------------------------------------------------~~ 156 (285)
T cd05630 155 ------------------------------------------------------------------------------GQ 156 (285)
T ss_pred ------------------------------------------------------------------------------Cc
Confidence 00
Q ss_pred CCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcH---HHHHHHhcC-CCCCCCCCCCCchhHH
Q 011302 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNE---KTLINILKK-PLTFPRIGVSSSKEFE 400 (489)
Q Consensus 325 ~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~~~~~i~~~-~~~~p~~~~~~~~~~~ 400 (489)
......||+.|+|||++.+..++.++|||||||++|||++|..||.+.... .....+... ...++..
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 227 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEK--------- 227 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCcc---------
Confidence 011236899999999999989999999999999999999999999875432 222222211 1111110
Q ss_pred HHhhHHHHHHHHhhcCcccccCCCC-ChHHHHcCCCcCCCCcccccc--CCCCCCCC
Q 011302 401 EVVKLQDLISKLLVKNPKKRIGSLK-GSVEIKRHEFFKGINWALIRS--IKPPEVPN 454 (489)
Q Consensus 401 ~~~~l~~li~~~L~~dP~~R~~~~~-~~~~ll~hp~f~~~~~~~~~~--~~~p~~~~ 454 (489)
....+.+||.+||+.||++|++... .++++++||||+.++|..+.. ..||+.|.
T Consensus 228 ~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~ 284 (285)
T cd05630 228 FSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLEPPFKPD 284 (285)
T ss_pred CCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHHHhcCCCCCCCCCC
Confidence 1124899999999999999999431 245999999999999987644 56666554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-49 Score=382.52 Aligned_cols=262 Identities=31% Similarity=0.464 Sum_probs=231.8
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
+-|.+.+.||+|.|+.|-+|++.- ++..||||++.+..+..-.. ..+..|+++|+..+|||||+||++......
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVF-----TGekVAVKviDKTKlD~~st-~hlfqEVRCMKLVQHpNiVRLYEViDTQTK 91 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVF-----TGEKVAVKVIDKTKLDTLST-GHLFQEVRCMKLVQHPNIVRLYEVIDTQTK 91 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhc-----ccceeEEEEecccccchhhh-hHHHHHHHHHHHhcCcCeeeeeehhcccce
Confidence 568899999999999999999886 68999999999887764433 345569999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEec-cCCcEEEcccCCCcccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVR-EDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~-~~~~vkl~DFG~a~~~~ 242 (489)
+|||+|+=++|+|++++.++. ..+.++.++.|++||+.|+.|+|...+|||||||+|+++- .-|-|||.|||++-.+.
T Consensus 92 lyLiLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 92 LYLILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EEEEEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 999999999999999998874 5699999999999999999999999999999999999886 45899999999984332
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
+
T Consensus 171 P------------------------------------------------------------------------------- 171 (864)
T KOG4717|consen 171 P------------------------------------------------------------------------------- 171 (864)
T ss_pred C-------------------------------------------------------------------------------
Confidence 2
Q ss_pred ccCCccccCCCCccCcchhcCCCC-CCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHH
Q 011302 323 NARSKSFVGTHEYLAPEVISGQGH-GSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEE 401 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~~-~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 401 (489)
.....+.||+..|-|||++.|..| .+++||||||||||-|++|++||...+..+.+..|+.+.+..|.-..
T Consensus 172 G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS-------- 243 (864)
T KOG4717|consen 172 GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVS-------- 243 (864)
T ss_pred cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhh--------
Confidence 123456799999999999999998 57899999999999999999999999999999999999998886432
Q ss_pred HhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcccc
Q 011302 402 VVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALI 444 (489)
Q Consensus 402 ~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~ 444 (489)
.+++|||..||.+||.+|.+.+ +|..|+|++.+|....
T Consensus 244 -~eCrdLI~sMLvRdPkkRAslE----eI~s~~Wlq~~D~~~s 281 (864)
T KOG4717|consen 244 -KECRDLIQSMLVRDPKKRASLE----EIVSTSWLQAGDRGLS 281 (864)
T ss_pred -HHHHHHHHHHHhcCchhhccHH----HHhccccccCCCCCcc
Confidence 2589999999999999999886 9999999999986543
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=373.21 Aligned_cols=281 Identities=35% Similarity=0.573 Sum_probs=226.6
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceE
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYS 164 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 164 (489)
.|+..+.||+|+||+||+|.+.. +++.||+|.+.............+.+|+.+|+.++|+||+++++++..++..
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~ 75 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRA-----TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECC-----CCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEE
Confidence 37888999999999999999886 5788999999876555444445567799999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccC
Q 011302 165 CLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVV 244 (489)
Q Consensus 165 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~ 244 (489)
|+||||+++++|.+++.......+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~- 154 (285)
T cd05632 76 CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE- 154 (285)
T ss_pred EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCC-
Confidence 9999999999999888765445799999999999999999999999999999999999999999999999998732210
Q ss_pred ccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccccc
Q 011302 245 PKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINA 324 (489)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (489)
..
T Consensus 155 ------------------------------------------------------------------------------~~ 156 (285)
T cd05632 155 ------------------------------------------------------------------------------GE 156 (285)
T ss_pred ------------------------------------------------------------------------------CC
Confidence 00
Q ss_pred CCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhh
Q 011302 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVK 404 (489)
Q Consensus 325 ~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~ 404 (489)
......|++.|+|||++.+..++.++|||||||++|||++|..||.+.........+.............. ....
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~ 231 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAK-----FSEE 231 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCcc-----CCHH
Confidence 01223689999999999998899999999999999999999999988766544333322111111000000 1124
Q ss_pred HHHHHHHHhhcCcccccCCCCC-hHHHHcCCCcCCCCcccc--ccCCCCCCCC
Q 011302 405 LQDLISKLLVKNPKKRIGSLKG-SVEIKRHEFFKGINWALI--RSIKPPEVPN 454 (489)
Q Consensus 405 l~~li~~~L~~dP~~R~~~~~~-~~~ll~hp~f~~~~~~~~--~~~~~p~~~~ 454 (489)
+.+|+.+||+.||++|+++.+. +.+++.|+||+.++|..+ ..+.||++|.
T Consensus 232 ~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (285)
T cd05632 232 AKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPFVPD 284 (285)
T ss_pred HHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHHhcCcCCCCCCCC
Confidence 7899999999999999997543 679999999999999865 5566777664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-48 Score=378.66 Aligned_cols=263 Identities=29% Similarity=0.390 Sum_probs=207.6
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
+++|++.+.||+|+||.||+|+++. ++..||+|+++..... .....+.+|+.+++.++||||+++++++.+++
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 76 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKL-----TENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTER 76 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECC-----CCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 4789999999999999999999886 5788999998754211 22334567999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
..|+||||++ |+|.+++... +..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 77 ~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 77 CLTLVFEYLD-SDLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKS 154 (288)
T ss_pred eEEEEEeCCC-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence 9999999996 5898887654 2458899999999999999999999999999999999999999999999999973221
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
..
T Consensus 155 ~~------------------------------------------------------------------------------ 156 (288)
T cd07871 155 VP------------------------------------------------------------------------------ 156 (288)
T ss_pred CC------------------------------------------------------------------------------
Confidence 00
Q ss_pred ccCCccccCCCCccCcchhcC-CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCC--------------
Q 011302 323 NARSKSFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLT-------------- 387 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-------------- 387 (489)
........||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+.+..+......
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 157 TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 001122368999999999876 45899999999999999999999999988876665554321100
Q ss_pred -----CCCCCCCCchh--HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 388 -----FPRIGVSSSKE--FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 388 -----~p~~~~~~~~~--~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
+|......... .....+++|||.+||++||.+|+++. ++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~----~~l~hp~f 288 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAE----AALRHSYF 288 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHH----HHhcCCCC
Confidence 11000000000 01123588999999999999999997 99999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=375.14 Aligned_cols=264 Identities=27% Similarity=0.367 Sum_probs=208.4
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
++|++.+.||+|+||+||+|+++. +++.||+|++...... ......+.+|+.+++.++||||+++++++..++.
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 74 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKE-----TKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGK 74 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECC-----CCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCE
Confidence 479999999999999999999986 5788999999754322 2234556779999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
+|+||||++++.|..+.... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 75 ~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 75 LYLVFEYVEKNMLELLEEMP--NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred EEEEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 99999999887776554332 5689999999999999999999999999999999999999999999999999843211
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
.. .
T Consensus 153 ~~-----------------------------------------------------------------------------~ 155 (287)
T cd07848 153 GS-----------------------------------------------------------------------------N 155 (287)
T ss_pred cc-----------------------------------------------------------------------------c
Confidence 00 0
Q ss_pred cCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCC------------------
Q 011302 324 ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP------------------ 385 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------------ 385 (489)
.......||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+....+....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 01123468999999999999889999999999999999999999999877655444332210
Q ss_pred -CCCCCCCCCCchh----HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 386 -LTFPRIGVSSSKE----FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 386 -~~~p~~~~~~~~~----~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
..+|......... ...+..+.+||.+||+.||++||++. ++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~----~~l~hp~f 287 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTE----QCLNHPAF 287 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHH----HHhcCCCC
Confidence 0111110000000 01223589999999999999999997 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-49 Score=373.66 Aligned_cols=259 Identities=32% Similarity=0.496 Sum_probs=209.4
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC---
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS--- 161 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--- 161 (489)
.|...+++|.|+||.||.|.... +.+.||||.+-.+.. .-.+|..+|+.++|||||+|..+|...
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e-----~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~ 92 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRE-----TEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTES 92 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcC-----CCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCC
Confidence 58889999999999999999998 478899999865431 223499999999999999999988522
Q ss_pred --ceEEEEEeecCCCchHHHHHhC--CCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccC-CcEEEcccC
Q 011302 162 --HYSCLVMEYCPGGDLYAARQRQ--PGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRED-GHIMLSDFD 236 (489)
Q Consensus 162 --~~~~lV~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~-~~vkl~DFG 236 (489)
-++.|||||+ ..+|++.++.. .+.+++.-.++.|.+||++||.|||+.||+||||||.|+|+|.+ |.+||||||
T Consensus 93 d~~~lnlVleym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFG 171 (364)
T KOG0658|consen 93 DEVYLNLVLEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFG 171 (364)
T ss_pred chhHHHHHHHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCC
Confidence 2567899999 57998888742 23678999999999999999999999999999999999999965 999999999
Q ss_pred CCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcc
Q 011302 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPE 316 (489)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (489)
.|+.+..
T Consensus 172 SAK~L~~------------------------------------------------------------------------- 178 (364)
T KOG0658|consen 172 SAKVLVK------------------------------------------------------------------------- 178 (364)
T ss_pred cceeecc-------------------------------------------------------------------------
Confidence 9965432
Q ss_pred ccccccccCCccccCCCCccCcchhcCCC-CCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcC-----------
Q 011302 317 VVAEPINARSKSFVGTHEYLAPEVISGQG-HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK----------- 384 (489)
Q Consensus 317 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~----------- 384 (489)
+....++..|..|+|||.+.|.. |+.+.||||.||++.||+-|++.|.|.+..+++..|.+-
T Consensus 179 ------~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 179 ------GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred ------CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 11234567899999999999865 899999999999999999999999999988887777541
Q ss_pred ------CCCCCCCCCCCc---hhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 385 ------PLTFPRIGVSSS---KEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 385 ------~~~~p~~~~~~~---~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
...+|......- ......+++.+|+.++|..+|++|.++. +++.||||..+
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~----~~l~h~fFdel 312 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSAL----EALAHPFFDEL 312 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHH----HHhcchhhHHh
Confidence 112222211110 0112335689999999999999999998 99999999765
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-48 Score=380.02 Aligned_cols=268 Identities=28% Similarity=0.415 Sum_probs=207.4
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.++|++.+.||+|+||.||+|+++. +++.||||++...... .....+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 76 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKV-----NGKLVALKVIRLQEEE--GTPFTAIREASLLKGLKHANIVLLHDIIHTKE 76 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECC-----CCCEEEEEEecccccc--ccchhHHHHHHHHhhCCCCCcCeEEEEEecCC
Confidence 3789999999999999999999876 5788999998754221 12234567999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
..|+||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 77 ~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 77 TLTLVFEYV-HTDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred eEEEEEECC-CcCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 999999999 578887776543 568999999999999999999999999999999999999999999999999973211
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
..
T Consensus 155 ~~------------------------------------------------------------------------------ 156 (303)
T cd07869 155 VP------------------------------------------------------------------------------ 156 (303)
T ss_pred CC------------------------------------------------------------------------------
Confidence 00
Q ss_pred ccCCccccCCCCccCcchhcCC-CCCCcccHHHHHHHHHHHhhCCCCCCCCCcH-HHHHHHhc---CCC--CCCC-----
Q 011302 323 NARSKSFVGTHEYLAPEVISGQ-GHGSAVDWWTLGVFLYEMLYGTTPFKGENNE-KTLINILK---KPL--TFPR----- 390 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~---~~~--~~p~----- 390 (489)
.......+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.... +.+..+.. .+. .++.
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence 0011223689999999998764 4789999999999999999999999876543 22222211 100 0000
Q ss_pred -C-----CCCCchh----H---HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCc
Q 011302 391 -I-----GVSSSKE----F---EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINW 441 (489)
Q Consensus 391 -~-----~~~~~~~----~---~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~ 441 (489)
. ....... + .....+.+||.+||+.||.+|+++. ++++||||+.+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~----~~l~h~~f~~~~~ 296 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQ----AALSHEYFSDLPP 296 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHH----HHhcCcccccCCh
Confidence 0 0000000 0 0123578999999999999999997 9999999998864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-47 Score=387.13 Aligned_cols=263 Identities=23% Similarity=0.381 Sum_probs=207.0
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE 159 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 159 (489)
.+...+|.+++.||+|+||.||+|.+.. +++.||||.... ..+.+|+.+|+.++||||++++++|.
T Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~-----~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~ 153 (391)
T PHA03212 88 GIEKAGFSILETFTPGAEGFAFACIDNK-----TCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFT 153 (391)
T ss_pred ccccCCcEEEEEEcCCCCeEEEEEEECC-----CCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEE
Confidence 3556789999999999999999999987 578899997542 23456999999999999999999999
Q ss_pred cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 160 ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 160 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
.+...|+|||++ +++|..++... ..+++.+++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+
T Consensus 154 ~~~~~~lv~e~~-~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~ 230 (391)
T PHA03212 154 YNKFTCLILPRY-KTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAAC 230 (391)
T ss_pred ECCeeEEEEecC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccc
Confidence 999999999999 57898887665 568999999999999999999999999999999999999999999999999983
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
.....
T Consensus 231 ~~~~~--------------------------------------------------------------------------- 235 (391)
T PHA03212 231 FPVDI--------------------------------------------------------------------------- 235 (391)
T ss_pred ccccc---------------------------------------------------------------------------
Confidence 21100
Q ss_pred cccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCC-------cHHHHHHHhcCC----CCC
Q 011302 320 EPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGEN-------NEKTLINILKKP----LTF 388 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~-------~~~~~~~i~~~~----~~~ 388 (489)
........+||+.|+|||++.+..++.++|||||||++|||++|..||...+ ....+..+.... ..+
T Consensus 236 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~ 313 (391)
T PHA03212 236 --NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313 (391)
T ss_pred --cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence 0011234579999999999999999999999999999999999998875432 112222222110 011
Q ss_pred CC----------------------CCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 389 PR----------------------IGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 389 p~----------------------~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
+. ........+..+.++.+||.+||++||++||++. ++|+||||+.+.
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~----elL~hp~f~~~~ 383 (391)
T PHA03212 314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAE----ALLDFAAFQDIP 383 (391)
T ss_pred CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHH----HHhcChhhccCC
Confidence 10 0000001112234689999999999999999998 999999998753
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-47 Score=369.28 Aligned_cols=265 Identities=42% Similarity=0.771 Sum_probs=228.8
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
++|++.+.||+|+||.||+|.+.. .++.||+|++.+...........+.+|+.++++++||||+++++++.+++.
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKG-----SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCe
Confidence 479999999999999999999886 568899999987766555566778889999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
.|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||.|||++.++.+||+|||++.....
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred EEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 99999999999999998776 5799999999999999999999999999999999999999999999999999732210
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
T Consensus 154 -------------------------------------------------------------------------------- 153 (290)
T cd05580 154 -------------------------------------------------------------------------------- 153 (290)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHh
Q 011302 324 ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVV 403 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~ 403 (489)
.....+|++.|+|||.+.+..++.++|||||||++|+|++|..||...+.......+..+...+|... ..
T Consensus 154 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~ 223 (290)
T cd05580 154 -RTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFF---------SP 223 (290)
T ss_pred -CCCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccC---------CH
Confidence 01234689999999999888889999999999999999999999988887777777776655554322 12
Q ss_pred hHHHHHHHHhhcCcccccCCC-CChHHHHcCCCcCCCCccccc
Q 011302 404 KLQDLISKLLVKNPKKRIGSL-KGSVEIKRHEFFKGINWALIR 445 (489)
Q Consensus 404 ~l~~li~~~L~~dP~~R~~~~-~~~~~ll~hp~f~~~~~~~~~ 445 (489)
.++++|.+||..||.+|++.. ..++++++||||+.++|..+.
T Consensus 224 ~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~ 266 (290)
T cd05580 224 DAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALL 266 (290)
T ss_pred HHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHHHh
Confidence 589999999999999999543 456799999999999998763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-47 Score=396.94 Aligned_cols=261 Identities=24% Similarity=0.345 Sum_probs=201.4
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC------CCCccccc
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD------HPFLPTLY 155 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~------hpnIv~l~ 155 (489)
..++|+++++||+|+||+||+|.+.. .++.||||+++.... .......|+.+++.+. |.+|++++
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~-----~~~~vAvK~i~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~ 197 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRK-----RKEYCAVKIVRNVPK----YTRDAKIEIQFMEKVRQADPADRFPLMKIQ 197 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcC-----CCeEEEEEEEecchh----hHHHHHHHHHHHHHHhhcCcccCcceeeeE
Confidence 45789999999999999999999876 578899999964321 1222334666665554 45688999
Q ss_pred ceeecC-ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHh-CCCeeecCCCCCeEeccCC-----
Q 011302 156 AEFEAS-HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHM-MGIVYRDLKPENVLVREDG----- 228 (489)
Q Consensus 156 ~~~~~~-~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiHrDIKp~NILl~~~~----- 228 (489)
++|..+ .++|+|||++ |++|.+++.+. +.+++..++.|+.||+.||+|||+ .|||||||||+|||++.++
T Consensus 198 ~~~~~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 198 RYFQNETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred EEEEcCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccc
Confidence 988754 5899999999 88998888765 579999999999999999999998 5999999999999998765
Q ss_pred -----------cEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccc
Q 011302 229 -----------HIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTT 297 (489)
Q Consensus 229 -----------~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (489)
.+||+|||++....
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~------------------------------------------------------- 299 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDER------------------------------------------------------- 299 (467)
T ss_pred ccccccCCCCceEEECCCCccccCc-------------------------------------------------------
Confidence 49999999862110
Q ss_pred cccccCCCCCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHH
Q 011302 298 IREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKT 377 (489)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~ 377 (489)
......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.
T Consensus 300 --------------------------~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~ 353 (467)
T PTZ00284 300 --------------------------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH 353 (467)
T ss_pred --------------------------cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 012345799999999999999999999999999999999999999998877665
Q ss_pred HHHHhcCCCCCCCCC---------------------CCCch------------hHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 378 LINILKKPLTFPRIG---------------------VSSSK------------EFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 378 ~~~i~~~~~~~p~~~---------------------~~~~~------------~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
+..+......+|... ..... .......+.|||.+||++||++|+++.
T Consensus 354 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~ 433 (467)
T PTZ00284 354 LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNAR 433 (467)
T ss_pred HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHH
Confidence 554432111111000 00000 001123578999999999999999998
Q ss_pred CChHHHHcCCCcCCC
Q 011302 425 KGSVEIKRHEFFKGI 439 (489)
Q Consensus 425 ~~~~~ll~hp~f~~~ 439 (489)
|+|+||||...
T Consensus 434 ----e~L~Hp~~~~~ 444 (467)
T PTZ00284 434 ----QMTTHPYVLKY 444 (467)
T ss_pred ----HHhcCcccccc
Confidence 99999999864
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-47 Score=377.05 Aligned_cols=267 Identities=26% Similarity=0.353 Sum_probs=213.1
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
+..++|++++.||+|+||.||+|++.. ++..||+|++..+.. .....++.+|+.+|+.++||||+++++++.+
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKP-----SGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECC-----CCcEEEEEEeecccC--HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 445899999999999999999999886 578899999975421 2334567789999999999999999999999
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhC-CCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMM-GIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
++.+|+||||++||+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 152 (331)
T cd06649 75 DGEISICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSG 152 (331)
T ss_pred CCEEEEEeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccc
Confidence 99999999999999999998765 5689999999999999999999986 69999999999999999999999999973
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
....
T Consensus 153 ~~~~---------------------------------------------------------------------------- 156 (331)
T cd06649 153 QLID---------------------------------------------------------------------------- 156 (331)
T ss_pred cccc----------------------------------------------------------------------------
Confidence 2210
Q ss_pred cccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCC-----CCCCC--
Q 011302 320 EPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLT-----FPRIG-- 392 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~-- 392 (489)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+ ..... .+...
T Consensus 157 ----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 231 (331)
T cd06649 157 ----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIF-GRPVVDGEEGEPHSISP 231 (331)
T ss_pred ----cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh-cccccccccCCccccCc
Confidence 0112346899999999999999999999999999999999999999876654433222 11100 00000
Q ss_pred ---------------------------------CCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 393 ---------------------------------VSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 393 ---------------------------------~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
.+.........++++||.+||.+||++||++. +|++||||+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~----ell~h~~~~~~ 307 (331)
T cd06649 232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLK----MLMNHTFIKRS 307 (331)
T ss_pred ccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHH----HHhcChHHhhc
Confidence 00000001123589999999999999999998 99999999765
Q ss_pred Cc
Q 011302 440 NW 441 (489)
Q Consensus 440 ~~ 441 (489)
..
T Consensus 308 ~~ 309 (331)
T cd06649 308 EV 309 (331)
T ss_pred cc
Confidence 43
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-48 Score=381.98 Aligned_cols=260 Identities=30% Similarity=0.495 Sum_probs=227.8
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.++|..++++|+|+||.+++++++. ..+.|++|.+..+....+. .+.+..|+.+++++.|||||.+.+.|..++
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~-----~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~ 76 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKS-----DDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDG 76 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhcc-----CCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCC
Confidence 4789999999999999999999887 5678999999876655333 236777999999999999999999999888
Q ss_pred e-EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccc
Q 011302 163 Y-SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKC 241 (489)
Q Consensus 163 ~-~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~ 241 (489)
. +||||+||+||+|.+.+.+..+..|+++.+..|+.|++.||.|||+++|+|||||+.||+++.++.|||+|||+|+.+
T Consensus 77 ~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l 156 (426)
T KOG0589|consen 77 QLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKIL 156 (426)
T ss_pred ceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhc
Confidence 8 999999999999999999887888999999999999999999999999999999999999999999999999999654
Q ss_pred ccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccc
Q 011302 242 DVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEP 321 (489)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (489)
...
T Consensus 157 ~~~----------------------------------------------------------------------------- 159 (426)
T KOG0589|consen 157 NPE----------------------------------------------------------------------------- 159 (426)
T ss_pred CCc-----------------------------------------------------------------------------
Confidence 321
Q ss_pred cccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHH
Q 011302 322 INARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEE 401 (489)
Q Consensus 322 ~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 401 (489)
.....+.+|||.||+||++.+.+|+.|+|||||||++|||++-+++|.+.+....+.+|....+. |.....+
T Consensus 160 -~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~-Plp~~ys------ 231 (426)
T KOG0589|consen 160 -DSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYS-PLPSMYS------ 231 (426)
T ss_pred -hhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCC-CCCcccc------
Confidence 11345679999999999999999999999999999999999999999999999999999887632 2222222
Q ss_pred HhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 402 VVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 402 ~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
.+++.||..||..+|+.||++. +||.+|....
T Consensus 232 -~el~~lv~~~l~~~P~~RPsa~----~LL~~P~l~~ 263 (426)
T KOG0589|consen 232 -SELRSLVKSMLRKNPEHRPSAL----ELLRRPHLLR 263 (426)
T ss_pred -HHHHHHHHHHhhcCCccCCCHH----HHhhChhhhh
Confidence 2489999999999999999998 9999988763
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-47 Score=377.55 Aligned_cols=271 Identities=24% Similarity=0.301 Sum_probs=207.1
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC---
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS--- 161 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--- 161 (489)
+|++.+.||+|+||.||+|++.. +++.||||++...... .....++.+|+.+++.++||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 74 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTH-----TGEKVAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 74 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECC-----CCCEEEEEEechhhcc-chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCC
Confidence 58999999999999999999886 5788999998753222 22334677899999999999999999987533
Q ss_pred --ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 162 --HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 162 --~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
..+|+||||| +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 75 ~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~ 151 (338)
T cd07859 75 EFKDIYVVFELM-ESDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 151 (338)
T ss_pred CCceEEEEEecC-CCCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccc
Confidence 3589999999 57998888765 569999999999999999999999999999999999999999999999999984
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
.......
T Consensus 152 ~~~~~~~------------------------------------------------------------------------- 158 (338)
T cd07859 152 VAFNDTP------------------------------------------------------------------------- 158 (338)
T ss_pred ccccccC-------------------------------------------------------------------------
Confidence 3210000
Q ss_pred cccccCCccccCCCCccCcchhcC--CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCC--------
Q 011302 320 EPINARSKSFVGTHEYLAPEVISG--QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFP-------- 389 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~--~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p-------- 389 (489)
........+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+....+..+.......+
T Consensus 159 --~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (338)
T cd07859 159 --TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR 236 (338)
T ss_pred --ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 0001123579999999999876 5689999999999999999999999988765443322211000000
Q ss_pred -------------CCCCCCchhH-HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccc
Q 011302 390 -------------RIGVSSSKEF-EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWAL 443 (489)
Q Consensus 390 -------------~~~~~~~~~~-~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~ 443 (489)
.........+ .....+.+||.+||+.||++||++. ++++||||+++....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~----e~l~hp~f~~~~~~~ 300 (338)
T cd07859 237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAE----EALADPYFKGLAKVE 300 (338)
T ss_pred hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHH----HHhcCchhhhcCccc
Confidence 0000000000 1123578999999999999999987 999999999877643
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-47 Score=390.92 Aligned_cols=267 Identities=25% Similarity=0.399 Sum_probs=206.5
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE 159 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 159 (489)
.....+|++++.||+|+||.||+|.+.. +++.||||.+..... ...+|+.+|+.++|||||+++++|.
T Consensus 62 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-----~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~l~~~~~ 129 (440)
T PTZ00036 62 RSPNKSYKLGNIIGNGSFGVVYEAICID-----TSEKVAIKKVLQDPQ-------YKNRELLIMKNLNHINIIFLKDYYY 129 (440)
T ss_pred cCcCCeEEEeEEEEeCCCEEEEEEEECC-----CCCEEEEEEEecCcc-------hHHHHHHHHHhcCCCCCcceeeeEe
Confidence 3455789999999999999999999876 567899998864321 2235999999999999999988764
Q ss_pred c--------CceEEEEEeecCCCchHHHHHh--CCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCC-
Q 011302 160 A--------SHYSCLVMEYCPGGDLYAARQR--QPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDG- 228 (489)
Q Consensus 160 ~--------~~~~~lV~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~- 228 (489)
. ...+|+||||++ ++|.+++.. .....+++..++.|+.||+.||+|||++|||||||||+||||+.++
T Consensus 130 ~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~ 208 (440)
T PTZ00036 130 TECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTH 208 (440)
T ss_pred ecccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCC
Confidence 2 235789999996 577766643 2346799999999999999999999999999999999999999665
Q ss_pred cEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCC
Q 011302 229 HIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHD 308 (489)
Q Consensus 229 ~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (489)
.+||+|||+|+.+..
T Consensus 209 ~vkL~DFGla~~~~~----------------------------------------------------------------- 223 (440)
T PTZ00036 209 TLKLCDFGSAKNLLA----------------------------------------------------------------- 223 (440)
T ss_pred ceeeeccccchhccC-----------------------------------------------------------------
Confidence 699999999843211
Q ss_pred ccccCCccccccccccCCccccCCCCccCcchhcCC-CCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcC---
Q 011302 309 QELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQ-GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK--- 384 (489)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--- 384 (489)
.......+||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+..+.+.++...
T Consensus 224 --------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~ 289 (440)
T PTZ00036 224 --------------GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGT 289 (440)
T ss_pred --------------CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 0011234789999999998765 5899999999999999999999999998877666655431
Q ss_pred --------------CCCCCCCCCCCch-hH--HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcc
Q 011302 385 --------------PLTFPRIGVSSSK-EF--EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWA 442 (489)
Q Consensus 385 --------------~~~~p~~~~~~~~-~~--~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~ 442 (489)
...+|........ .+ ..+.++++||.+||.+||.+|+++. ++++||||+.+...
T Consensus 290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~----e~l~hp~f~~~~~~ 360 (440)
T PTZ00036 290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPI----EALADPFFDDLRDP 360 (440)
T ss_pred CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHH----HHhCChhHHhhhcc
Confidence 1112211100000 00 1224689999999999999999997 99999999887553
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-47 Score=370.28 Aligned_cols=264 Identities=27% Similarity=0.352 Sum_probs=205.0
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC---CCCCcccccceee-
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML---DHPFLPTLYAEFE- 159 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~- 159 (489)
++|++++.||+|+||+||+|++... .+..||+|+++...... .....+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~----~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~ 75 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKN----GGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 75 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCC----CCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEec
Confidence 3799999999999999999998642 35789999987532211 1122334566666655 6999999999875
Q ss_pred ----cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEccc
Q 011302 160 ----ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235 (489)
Q Consensus 160 ----~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DF 235 (489)
....+|+||||++ ++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 76 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 76 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred ccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccc
Confidence 3457899999995 79999887765567899999999999999999999999999999999999999999999999
Q ss_pred CCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCc
Q 011302 236 DLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDP 315 (489)
Q Consensus 236 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (489)
|+++.....
T Consensus 155 g~~~~~~~~----------------------------------------------------------------------- 163 (290)
T cd07862 155 GLARIYSFQ----------------------------------------------------------------------- 163 (290)
T ss_pred cceEeccCC-----------------------------------------------------------------------
Confidence 997432100
Q ss_pred cccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCC-----CCCC
Q 011302 316 EVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL-----TFPR 390 (489)
Q Consensus 316 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-----~~p~ 390 (489)
.......||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+.+.++..... .++.
T Consensus 164 --------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (290)
T cd07862 164 --------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 235 (290)
T ss_pred --------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence 011234689999999999998899999999999999999999999999888777777654211 1110
Q ss_pred CC-----------CCCchh--HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 391 IG-----------VSSSKE--FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 391 ~~-----------~~~~~~--~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
.. ...... ...+..+++||.+||+.||++||++. ++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~----~~l~hp~f 290 (290)
T cd07862 236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY----SALSHPYF 290 (290)
T ss_pred hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHH----HHhcCCCC
Confidence 00 000000 01223578999999999999999997 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=375.57 Aligned_cols=255 Identities=27% Similarity=0.374 Sum_probs=200.1
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS 161 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 161 (489)
..++|+.++.||+|+||.||+|++.. +++.||||++..... ......+.+|+.+++.++|+||+++++++..+
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 144 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRP-----TGRLYALKVIYGNHE--DTVRRQICREIEILRDVNHPNVVKCHDMFDHN 144 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECC-----CCCEEEEEEEecCCc--HHHHHHHHHHHHHHHhCCCCCcceeeeEeccC
Confidence 45678889999999999999999876 567899999864321 12345677899999999999999999999999
Q ss_pred ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccc
Q 011302 162 HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKC 241 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~ 241 (489)
+.+|+||||+++|+|... ..+.+..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+++.+
T Consensus 145 ~~~~lv~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~ 218 (353)
T PLN00034 145 GEIQVLLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL 218 (353)
T ss_pred CeEEEEEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceec
Confidence 999999999999998542 23567788899999999999999999999999999999999999999999998432
Q ss_pred ccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccc
Q 011302 242 DVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEP 321 (489)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (489)
...
T Consensus 219 ~~~----------------------------------------------------------------------------- 221 (353)
T PLN00034 219 AQT----------------------------------------------------------------------------- 221 (353)
T ss_pred ccc-----------------------------------------------------------------------------
Confidence 110
Q ss_pred cccCCccccCCCCccCcchhcC-----CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHH---HHHHHhcCCCCCCCCCC
Q 011302 322 INARSKSFVGTHEYLAPEVISG-----QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEK---TLINILKKPLTFPRIGV 393 (489)
Q Consensus 322 ~~~~~~~~~Gt~~y~aPE~l~~-----~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~---~~~~i~~~~~~~p~~~~ 393 (489)
.......+||..|+|||++.. ...+.++|||||||++|||++|+.||......+ ....+..... +....
T Consensus 222 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~ 298 (353)
T PLN00034 222 -MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP--PEAPA 298 (353)
T ss_pred -cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCC--CCCCC
Confidence 001123469999999999853 224568999999999999999999997443222 2222221111 11111
Q ss_pred CCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 394 SSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 394 ~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
. ...++++||.+||+.||++||++. ++++||||.+-
T Consensus 299 ~------~~~~l~~li~~~l~~~P~~Rpt~~----ell~hp~~~~~ 334 (353)
T PLN00034 299 T------ASREFRHFISCCLQREPAKRWSAM----QLLQHPFILRA 334 (353)
T ss_pred c------cCHHHHHHHHHHccCChhhCcCHH----HHhcCcccccC
Confidence 1 122589999999999999999987 99999999874
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=363.35 Aligned_cols=290 Identities=37% Similarity=0.681 Sum_probs=231.4
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
++|++++.||+|+||.||+|.++. .++.||+|.+.............+..|+.+++.++||||+++++.+..+++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKE-----TRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECC-----CCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCE
Confidence 479999999999999999999886 578899999987765545556677889999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
+|+||||++|++|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred EEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 99999999999999998765 5689999999999999999999999999999999999999999999999998742110
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
.... .. . .+ ........
T Consensus 154 ~~~~-----------------------~~------~----~~------------------------------~~~~~~~~ 170 (305)
T cd05609 154 SLTT-----------------------NL------Y----EG------------------------------HIEKDTRE 170 (305)
T ss_pred Cccc-----------------------cc------c----cc------------------------------ccccchhh
Confidence 0000 00 0 00 00000000
Q ss_pred cCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHh
Q 011302 324 ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVV 403 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~ 403 (489)
.......|+..|+|||.+.+..++.++|||||||++|||++|..||.+.+..+....+.......|....... .
T Consensus 171 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------~ 244 (305)
T cd05609 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALP------A 244 (305)
T ss_pred ccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccccCC------H
Confidence 0112346889999999999888999999999999999999999999988877777777666555544322212 2
Q ss_pred hHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccccccCCCC
Q 011302 404 KLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIRSIKPP 450 (489)
Q Consensus 404 ~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~~~~~~p 450 (489)
.+.+||.+||+.||++||+.. .+.++++||||...+|..+......
T Consensus 245 ~~~~li~~~l~~~P~~R~~~~-~~~~ll~~~~~~~~~~~~~~~~~~~ 290 (305)
T cd05609 245 DAQDLISRLLRQNPLERLGTG-GAFEVKQHRFFLGLDWNGLLRQKAE 290 (305)
T ss_pred HHHHHHHHHhccChhhccCcc-CHHHHHhCccccCCCHHHHhhcCCC
Confidence 489999999999999999973 4459999999999999876544333
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=382.66 Aligned_cols=269 Identities=25% Similarity=0.383 Sum_probs=212.0
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
..+|.+++.||+|+||.||+|...+. ..++.||+|.+.... ...+|+.+|+.++||||+++++++....
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~---~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~ 159 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGD---EQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKS 159 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCC---ccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCC
Confidence 46899999999999999999987642 246788999886532 2345999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
..|+|||++ +++|.+++... ..+++.+++.|+.||+.||.|||++|||||||||+|||++.++.+||+|||++..+.
T Consensus 160 ~~~lv~e~~-~~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 160 TVCMVMPKY-KCDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred EEEEEehhc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 999999999 57888888544 679999999999999999999999999999999999999999999999999984322
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
... .
T Consensus 237 ~~~----------------------------------------------------------------------------~ 240 (392)
T PHA03207 237 AHP----------------------------------------------------------------------------D 240 (392)
T ss_pred ccc----------------------------------------------------------------------------c
Confidence 100 0
Q ss_pred ccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCc---HHHHHHHhc----CCCCCCCCCCC-
Q 011302 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENN---EKTLINILK----KPLTFPRIGVS- 394 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~----~~~~~p~~~~~- 394 (489)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||.+... ...+..+.. .+..++.....
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN 320 (392)
T ss_pred cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence 0112345799999999999999999999999999999999999999987543 222222222 11112211000
Q ss_pred -----------------Cch---hHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccccc
Q 011302 395 -----------------SSK---EFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIR 445 (489)
Q Consensus 395 -----------------~~~---~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~~ 445 (489)
... ......++.+||.+||..||++||++. +++.||||+..+|+.++
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~----e~l~~p~f~~~~~~~~~ 387 (392)
T PHA03207 321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQ----DILSLPLFTKEPINLLN 387 (392)
T ss_pred HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHH----HHhhCchhhccchhhhc
Confidence 000 001123578999999999999999998 99999999999988765
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=376.60 Aligned_cols=254 Identities=25% Similarity=0.354 Sum_probs=212.4
Q ss_pred hhcCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccccc
Q 011302 76 RAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLY 155 (489)
Q Consensus 76 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~ 155 (489)
...|++..+.+++++.||+|.||+||+|.+++. ..||+|.++...+.. +.+.+|+.+|++|+|+|||+|+
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~------~~vavk~ik~~~m~~----~~f~~Ea~iMk~L~H~~lV~l~ 267 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGS------TKVAVKTIKEGSMSP----EAFLREAQIMKKLRHEKLVKLY 267 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCC------CcccceEEeccccCh----hHHHHHHHHHHhCcccCeEEEE
Confidence 345566777888999999999999999999973 457999998754432 3455799999999999999999
Q ss_pred ceeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEccc
Q 011302 156 AEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235 (489)
Q Consensus 156 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DF 235 (489)
+++..++.+|||||||+.|+|.++|+...+..+...+.+.|+.|||+||+||+++++|||||.++||||+++..+||+||
T Consensus 268 gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDF 347 (468)
T KOG0197|consen 268 GVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDF 347 (468)
T ss_pred EEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEccc
Confidence 99999899999999999999999999866788999999999999999999999999999999999999999999999999
Q ss_pred CCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCc
Q 011302 236 DLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDP 315 (489)
Q Consensus 236 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (489)
|+|+..... .|.
T Consensus 348 GLAr~~~d~--------------~Y~------------------------------------------------------ 359 (468)
T KOG0197|consen 348 GLARLIGDD--------------EYT------------------------------------------------------ 359 (468)
T ss_pred ccccccCCC--------------cee------------------------------------------------------
Confidence 999622110 000
Q ss_pred cccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCC
Q 011302 316 EVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVS 394 (489)
Q Consensus 316 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~ 394 (489)
...+.--...|.|||++....++.++|||||||+||||+| |+.||.+.++.+++..+.++..-.....++
T Consensus 360 ---------~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP 430 (468)
T KOG0197|consen 360 ---------ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCP 430 (468)
T ss_pred ---------ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCC
Confidence 0000012347999999999999999999999999999997 999999999999998887764332222222
Q ss_pred CchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 395 SSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 395 ~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
..+.+||..||+.+|++|||+.
T Consensus 431 --------~~vY~lM~~CW~~~P~~RPtF~ 452 (468)
T KOG0197|consen 431 --------DEVYELMKSCWHEDPEDRPTFE 452 (468)
T ss_pred --------HHHHHHHHHHhhCCcccCCCHH
Confidence 2488999999999999999985
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=350.46 Aligned_cols=257 Identities=28% Similarity=0.425 Sum_probs=216.9
Q ss_pred ccCCceee-eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccceee
Q 011302 82 GLDHFRLL-RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAEFE 159 (489)
Q Consensus 82 ~~~~y~~~-~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~ 159 (489)
.+++|++. ++||-|-.|.|..|.++. +++.+|+|++.... .+.+|+++.-+. .|||||.++++|+
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~-----T~ekfALKvL~Ds~--------KARrEVeLHw~~s~h~~iV~IidVye 125 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKR-----TQEKFALKVLLDSP--------KARREVELHWMASGHPHIVSIIDVYE 125 (400)
T ss_pred chhhheehhhhhccccCCceEEEEecc-----chhhhHHHHHhcCH--------HHHhHhhhhhhhcCCCceEEeehhhh
Confidence 35788776 478999999999999987 68889999985332 233477765444 6999999999886
Q ss_pred ----cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEecc---CCcEEE
Q 011302 160 ----ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRE---DGHIML 232 (489)
Q Consensus 160 ----~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~---~~~vkl 232 (489)
...++.+|||.|+||+|+..++.+....|++.++..|+.||+.|+.|||+.+|.||||||||+|... |-.+||
T Consensus 126 Ns~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKL 205 (400)
T KOG0604|consen 126 NSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKL 205 (400)
T ss_pred hhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEe
Confidence 3467899999999999999999988888999999999999999999999999999999999999974 457999
Q ss_pred cccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCcccc
Q 011302 233 SDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELL 312 (489)
Q Consensus 233 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (489)
+|||+|+.-..
T Consensus 206 tDfGFAK~t~~--------------------------------------------------------------------- 216 (400)
T KOG0604|consen 206 TDFGFAKETQE--------------------------------------------------------------------- 216 (400)
T ss_pred cccccccccCC---------------------------------------------------------------------
Confidence 99999953211
Q ss_pred CCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCC----cHHHHHHHhcCCCCC
Q 011302 313 DDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGEN----NEKTLINILKKPLTF 388 (489)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~----~~~~~~~i~~~~~~~ 388 (489)
+....+.|-||+|.|||++..++|+..+|+||+||++|-||+|.+||+... ...+-.+|..+.+.|
T Consensus 217 ----------~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F 286 (400)
T KOG0604|consen 217 ----------PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF 286 (400)
T ss_pred ----------CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence 112234588999999999999999999999999999999999999998654 345677899999999
Q ss_pred CCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 389 PRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 389 p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
|...+.+.+ ..++|+|++||.-+|++|+++. +++.|||..+.
T Consensus 287 P~pEWs~VS-----e~aKdlIR~LLkt~PteRlTI~----~~m~hpwi~~~ 328 (400)
T KOG0604|consen 287 PEPEWSCVS-----EAAKDLIRKLLKTEPTERLTIE----EVMDHPWINQY 328 (400)
T ss_pred CChhHhHHH-----HHHHHHHHHHhcCCchhheeHH----HhhcCchhccc
Confidence 976655444 3689999999999999999998 99999999764
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=373.75 Aligned_cols=261 Identities=21% Similarity=0.270 Sum_probs=202.0
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccce
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAE 157 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~ 157 (489)
|++..++|++.+.||+|+||.||+|.+........+..||+|++...... .....+..|+.+|..+ +||||++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATA--SEHKALMSELKILIHIGNHLNVVNLLGA 79 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccch--HHHHHHHHHHHHHHHhccCcceeeEEeE
Confidence 56777899999999999999999998754333335678999998753221 2345677899999999 89999999998
Q ss_pred eecC-ceEEEEEeecCCCchHHHHHhCC----------------------------------------------------
Q 011302 158 FEAS-HYSCLVMEYCPGGDLYAARQRQP---------------------------------------------------- 184 (489)
Q Consensus 158 ~~~~-~~~~lV~E~~~gg~L~~~l~~~~---------------------------------------------------- 184 (489)
+... ..+|+||||++||+|.+++....
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (338)
T cd05102 80 CTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP 159 (338)
T ss_pred ecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence 8754 46899999999999999886531
Q ss_pred --------CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCccccCCcchhHH
Q 011302 185 --------GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEA 256 (489)
Q Consensus 185 --------~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~ 256 (489)
...+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....+.
T Consensus 160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~---------- 229 (338)
T cd05102 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD---------- 229 (338)
T ss_pred chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcc----------
Confidence 12477888899999999999999999999999999999999999999999999843211000
Q ss_pred HhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCccccCCCCcc
Q 011302 257 IEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYL 336 (489)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~ 336 (489)
........+++.|+
T Consensus 230 ------------------------------------------------------------------~~~~~~~~~~~~y~ 243 (338)
T cd05102 230 ------------------------------------------------------------------YVRKGSARLPLKWM 243 (338)
T ss_pred ------------------------------------------------------------------hhcccCCCCCcccc
Confidence 00112234678899
Q ss_pred CcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhc
Q 011302 337 APEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVK 415 (489)
Q Consensus 337 aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~ 415 (489)
|||++.+..++.++|||||||++|||++ |..||.+....+.+............ ... ....+.+||.+||..
T Consensus 244 aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~------~~~~l~~li~~cl~~ 316 (338)
T cd05102 244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRA-PEN------ATPEIYRIMLACWQG 316 (338)
T ss_pred CcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCC-CCC------CCHHHHHHHHHHccC
Confidence 9999999999999999999999999997 99999886654444333332211111 111 112589999999999
Q ss_pred CcccccCCC
Q 011302 416 NPKKRIGSL 424 (489)
Q Consensus 416 dP~~R~~~~ 424 (489)
||++||++.
T Consensus 317 dp~~RPs~~ 325 (338)
T cd05102 317 DPKERPTFS 325 (338)
T ss_pred ChhhCcCHH
Confidence 999999987
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=380.78 Aligned_cols=262 Identities=29% Similarity=0.487 Sum_probs=219.0
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
+.|.|+..||.|+||+||+|..+. ++.+.|-|++.... ...+..++.|++||..++||+||+|++.|..++.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nke-----t~~lAAaKvIetks---eEELEDylVEIeILa~CdHP~ivkLl~ayy~enk 103 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKE-----TKLLAAAKVIETKS---EEELEDYLVEIEILAECDHPVIVKLLSAYYFENK 103 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhccc-----chhhhhhhhhcccc---hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc
Confidence 557888999999999999999887 45667888885432 3456778889999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
++|+.|||.||-+..++-.- +..|.+.++..+++|++.||.|||+++|||||||..|||++-+|.++|+|||.+....
T Consensus 104 LwiliEFC~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~- 181 (1187)
T KOG0579|consen 104 LWILIEFCGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK- 181 (1187)
T ss_pred eEEEEeecCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccch-
Confidence 99999999999887665443 4789999999999999999999999999999999999999999999999999862110
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
...
T Consensus 182 -----------------------------------------------------------------------------~t~ 184 (1187)
T KOG0579|consen 182 -----------------------------------------------------------------------------STR 184 (1187)
T ss_pred -----------------------------------------------------------------------------hHH
Confidence 001
Q ss_pred cCCccccCCCCccCcchhc-----CCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchh
Q 011302 324 ARSKSFVGTHEYLAPEVIS-----GQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKE 398 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~-----~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 398 (489)
.+..+|+|||+|||||++. ..+|++++||||||++|.||..+.+|....+...++.+|.+... |....++ .
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSeP--PTLlqPS--~ 260 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP--PTLLQPS--H 260 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCC--CcccCcc--h
Confidence 2346789999999999975 46799999999999999999999999999999999988876422 2222221 1
Q ss_pred HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcc
Q 011302 399 FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWA 442 (489)
Q Consensus 399 ~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~ 442 (489)
|. ..+.||+.+||.+||..||++. +|++||||.+++-+
T Consensus 261 Ws--~~F~DfLk~cL~Knp~~Rp~aa----qll~Hpfv~~~~Sn 298 (1187)
T KOG0579|consen 261 WS--RSFSDFLKRCLVKNPRNRPPAA----QLLKHPFVQNAPSN 298 (1187)
T ss_pred hh--hHHHHHHHHHHhcCCccCCCHH----HHhhCcccccCCcc
Confidence 11 1378999999999999999998 99999999977643
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-46 Score=375.44 Aligned_cols=262 Identities=28% Similarity=0.412 Sum_probs=203.6
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.++|++.+.||+|+||.||+|.+.. +++.||+|++...... .....++.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTV-----LGINVAVKKLSRPFQN-QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQK 93 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcC-----CCceeEEEEecccccc-hhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC
Confidence 4789999999999999999999876 5788999999754321 233455667999999999999999999986443
Q ss_pred ------eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccC
Q 011302 163 ------YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFD 236 (489)
Q Consensus 163 ------~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG 236 (489)
.+|+||||++ ++|.+.+.. .+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||
T Consensus 94 ~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 94 SLEEFQDVYLVMELMD-ANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred CccccceeEEEEeCCC-cCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCC
Confidence 5799999995 567666543 48899999999999999999999999999999999999999999999999
Q ss_pred CCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcc
Q 011302 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPE 316 (489)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (489)
+++....
T Consensus 169 ~a~~~~~------------------------------------------------------------------------- 175 (359)
T cd07876 169 LARTACT------------------------------------------------------------------------- 175 (359)
T ss_pred Ccccccc-------------------------------------------------------------------------
Confidence 9732110
Q ss_pred ccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcC------------
Q 011302 317 VVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK------------ 384 (489)
Q Consensus 317 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------ 384 (489)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+...
T Consensus 176 ------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 176 ------NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred ------CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 00112346899999999999999999999999999999999999999887755443332211
Q ss_pred ----------CCCCCCC---------CCCCch--hHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 385 ----------PLTFPRI---------GVSSSK--EFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 385 ----------~~~~p~~---------~~~~~~--~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
...++.. ...... .......+++||.+||..||++||++. ++++||||..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~----e~l~hp~~~~ 320 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVD----EALRHPYITV 320 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHH----HHhcCchhhh
Confidence 0011000 000000 000123588999999999999999987 9999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-46 Score=374.11 Aligned_cols=262 Identities=27% Similarity=0.385 Sum_probs=205.7
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC-
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS- 161 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~- 161 (489)
.++|++.+.||+|+||.||+|.+.. .++.||||++...... ......+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~ 96 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAI-----LERNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK 96 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECC-----CCcEEEEEEeCccccC-chhHHHHHHHHHHHHhcCCCCccccceeecccc
Confidence 4789999999999999999999876 5678999999754321 22334566799999999999999999987543
Q ss_pred -----ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccC
Q 011302 162 -----HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFD 236 (489)
Q Consensus 162 -----~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG 236 (489)
..+|+||||++ ++|.+.+.. .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 97 ~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 97 SLEEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred cccccCeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCC
Confidence 35799999995 577776653 48889999999999999999999999999999999999999999999999
Q ss_pred CCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcc
Q 011302 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPE 316 (489)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (489)
+++....
T Consensus 172 ~a~~~~~------------------------------------------------------------------------- 178 (364)
T cd07875 172 LARTAGT------------------------------------------------------------------------- 178 (364)
T ss_pred CccccCC-------------------------------------------------------------------------
Confidence 9842210
Q ss_pred ccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCC--------
Q 011302 317 VVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTF-------- 388 (489)
Q Consensus 317 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-------- 388 (489)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+.++.......
T Consensus 179 ------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 179 ------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred ------CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 001123468999999999999999999999999999999999999999888766665554311000
Q ss_pred -----------CCCC------------CCC--chhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 389 -----------PRIG------------VSS--SKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 389 -----------p~~~------------~~~--~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
|... ... .........+++||.+||+.||.+||++. ++|+||||..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~----e~L~hp~~~~ 323 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD----EALQHPYINV 323 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHH----HHhcCccccc
Confidence 0000 000 00000123578999999999999999997 9999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=357.39 Aligned_cols=260 Identities=37% Similarity=0.596 Sum_probs=213.6
Q ss_pred eccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEEEEEeec
Q 011302 92 LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYC 171 (489)
Q Consensus 92 lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 171 (489)
||+|+||+||+|.++. +++.||+|++.+...........+..|+.+|+.++||||+++++++...+..|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKA-----TGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcC-----CCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecC
Confidence 6999999999999876 57889999998765544444556678999999999999999999999999999999999
Q ss_pred CCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCccccCCc
Q 011302 172 PGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPK 251 (489)
Q Consensus 172 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 251 (489)
+|++|.+++.......+++.++..++.|++.||.|||++|++||||||+|||++.++.+||+|||++.....
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~-------- 147 (277)
T cd05577 76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG-------- 147 (277)
T ss_pred CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc--------
Confidence 999999988776545799999999999999999999999999999999999999999999999998732210
Q ss_pred chhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCccccC
Q 011302 252 LSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVG 331 (489)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 331 (489)
........|
T Consensus 148 -----------------------------------------------------------------------~~~~~~~~~ 156 (277)
T cd05577 148 -----------------------------------------------------------------------GKKIKGRAG 156 (277)
T ss_pred -----------------------------------------------------------------------CCccccccC
Confidence 000112357
Q ss_pred CCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHH----hcCCCCCCCCCCCCchhHHHHhhHHH
Q 011302 332 THEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINI----LKKPLTFPRIGVSSSKEFEEVVKLQD 407 (489)
Q Consensus 332 t~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i----~~~~~~~p~~~~~~~~~~~~~~~l~~ 407 (489)
+..|+|||++.+..++.++|||||||++|+|++|+.||...........+ .......+.. ....+.+
T Consensus 157 ~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~ 227 (277)
T cd05577 157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDK---------FSPEAKD 227 (277)
T ss_pred CCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCcc---------CCHHHHH
Confidence 88999999999888999999999999999999999999876542222222 2222222211 1235899
Q ss_pred HHHHHhhcCcccccCCCC-ChHHHHcCCCcCCCCcccc
Q 011302 408 LISKLLVKNPKKRIGSLK-GSVEIKRHEFFKGINWALI 444 (489)
Q Consensus 408 li~~~L~~dP~~R~~~~~-~~~~ll~hp~f~~~~~~~~ 444 (489)
||.+||+.||++|++..+ .+.+++.||||+.++|..+
T Consensus 228 li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~ 265 (277)
T cd05577 228 LCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRL 265 (277)
T ss_pred HHHHHccCChhHccCCCcccHHHHHhChhhhcCChhhh
Confidence 999999999999998887 7789999999999999766
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-46 Score=376.99 Aligned_cols=267 Identities=24% Similarity=0.295 Sum_probs=208.5
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc--
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH-- 162 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-- 162 (489)
+|++++.||+|+||.||+|.+.. +++.||||.+...... .....++.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 74 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPR-----DGKRVALKKMPNVFQN-LVSCKRVFRELKMLCFFKHDNVLSALDILQPPHID 74 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECC-----CCCEEEEEeccccccc-hHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCcc
Confidence 57889999999999999999876 5788999998643211 123456778999999999999999999998776
Q ss_pred ---eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 163 ---YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 163 ---~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
.+|+||||+. ++|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 75 ~~~~~~lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~ 151 (372)
T cd07853 75 PFEEIYVVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLAR 151 (372)
T ss_pred ccceEEEEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEecccccee
Confidence 8999999994 6888877654 579999999999999999999999999999999999999999999999999984
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
......
T Consensus 152 ~~~~~~-------------------------------------------------------------------------- 157 (372)
T cd07853 152 VEEPDE-------------------------------------------------------------------------- 157 (372)
T ss_pred ecccCc--------------------------------------------------------------------------
Confidence 321100
Q ss_pred cccccCCccccCCCCccCcchhcCCC-CCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhc---------------
Q 011302 320 EPINARSKSFVGTHEYLAPEVISGQG-HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILK--------------- 383 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~~~-~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~--------------- 383 (489)
........||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+..+.+..+..
T Consensus 158 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 158 ---SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred ---cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 00112236899999999998754 78999999999999999999999998877665554432
Q ss_pred --------CCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCc
Q 011302 384 --------KPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINW 441 (489)
Q Consensus 384 --------~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~ 441 (489)
.....+..............++.+||.+||+.||++||++. ++++||||++..+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~----e~l~hp~~~~~~~ 296 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAA----DALAHPYLDEGRL 296 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHH----HHhcCHhhCCCcc
Confidence 11111110000000001123588999999999999999997 9999999988643
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-46 Score=369.78 Aligned_cols=266 Identities=25% Similarity=0.344 Sum_probs=209.6
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
+..++|++.+.||+|+||.||+|.+.. ++..+|+|++..+.. ......+.+|+.+++.++||||++++++|.+
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~-----~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKP-----SGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECC-----CCcEEEEEEeecccC--HHHHHHHHHHHHHHHHCCCCcccceeEEEEE
Confidence 345899999999999999999999886 567899999875421 1234557789999999999999999999999
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhC-CCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMM-GIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
++.+|+||||++||+|.+++... +.+++..+..++.|++.||.|||++ +|+||||||+|||++.+|.+||+|||++.
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~ 152 (333)
T cd06650 75 DGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 152 (333)
T ss_pred CCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcch
Confidence 99999999999999999998765 5688999999999999999999985 79999999999999999999999999973
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
.+..
T Consensus 153 ~~~~---------------------------------------------------------------------------- 156 (333)
T cd06650 153 QLID---------------------------------------------------------------------------- 156 (333)
T ss_pred hhhh----------------------------------------------------------------------------
Confidence 2210
Q ss_pred cccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhc---CCCCC--------
Q 011302 320 EPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILK---KPLTF-------- 388 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~~~~~-------- 388 (489)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.. +....
T Consensus 157 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (333)
T cd06650 157 ----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPR 232 (333)
T ss_pred ----hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccC
Confidence 001234689999999999998899999999999999999999999986654333211100 00000
Q ss_pred ----------CCCCC----------------CCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 389 ----------PRIGV----------------SSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 389 ----------p~~~~----------------~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
|.... +.........++++||.+||++||++||++. +++.||||+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~----ell~h~~~~~~ 305 (333)
T cd06650 233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLK----QLMVHAFIKRS 305 (333)
T ss_pred CccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHH----HHhhCHHHhcC
Confidence 00000 0000000123588999999999999999987 99999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-46 Score=366.12 Aligned_cols=267 Identities=27% Similarity=0.401 Sum_probs=208.4
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.++|.+++.||+|+||.||+|+++. ++..||+|.++..... .....+.+|+.+++.++||||+++++++..++
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 77 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKL-----TENLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIVHTDK 77 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecC-----CCCeEEEEEeeccccC--CcchhHHHHHHHHHhCCCCCcceEEEEEeeCC
Confidence 4789999999999999999999876 5678999998754321 12234567999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
..|+||||++ ++|.+++... +..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 78 ~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 78 SLTLVFEYLD-KDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (309)
T ss_pred eEEEEEeCCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecC
Confidence 9999999996 5888877654 2458899999999999999999999999999999999999999999999999973221
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
..
T Consensus 156 ~~------------------------------------------------------------------------------ 157 (309)
T cd07872 156 VP------------------------------------------------------------------------------ 157 (309)
T ss_pred CC------------------------------------------------------------------------------
Confidence 00
Q ss_pred ccCCccccCCCCccCcchhcCC-CCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcC---C-------------
Q 011302 323 NARSKSFVGTHEYLAPEVISGQ-GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK---P------------- 385 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~------------- 385 (489)
........||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+... +
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 158 TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 0001123578999999998764 5799999999999999999999999988766554444321 0
Q ss_pred ---CCCCCCCCCC--chhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 386 ---LTFPRIGVSS--SKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 386 ---~~~p~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
..++...... ......+.++++||.+||..||.+|+++. ++++||||+.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~----e~l~h~~~~~~~ 293 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAE----EAMKHAYFRSLG 293 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHH----HHhcChhhhhcc
Confidence 0011100000 00001123588999999999999999987 999999998763
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=393.41 Aligned_cols=152 Identities=36% Similarity=0.616 Sum_probs=138.3
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
+++|.++++||+|+||+||+|.+.. .++.||||++.............+..|+.++..++||||+++++++....
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKN-----NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSAN 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECC-----CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC
Confidence 4789999999999999999999886 57899999998765544455667888999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKC 241 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~ 241 (489)
++||||||+.|++|.+++... +.+++..++.|+.||+.||+|||.+|||||||||+||||+.++.+||+|||+++..
T Consensus 78 ~~~lVmEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~ 154 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCccc
Confidence 999999999999999998765 56899999999999999999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=361.06 Aligned_cols=262 Identities=28% Similarity=0.367 Sum_probs=201.9
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC---CCCCcccccceeec-
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML---DHPFLPTLYAEFEA- 160 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~- 160 (489)
+|++++.||+|+||+||+|+++. +++.||+|.++..... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~-----~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~ 74 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPH-----SGHFVALKSVRVQTNE-DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATS 74 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECC-----CCcEEEEEEeccCcCC-CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccc
Confidence 58999999999999999999987 5788999998753211 11112334466666554 79999999998864
Q ss_pred ----CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccC
Q 011302 161 ----SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFD 236 (489)
Q Consensus 161 ----~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG 236 (489)
...+++||||+. ++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 75 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg 153 (288)
T cd07863 75 RTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFG 153 (288)
T ss_pred cCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccC
Confidence 346899999996 589888877655569999999999999999999999999999999999999999999999999
Q ss_pred CCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcc
Q 011302 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPE 316 (489)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (489)
+++.....
T Consensus 154 ~~~~~~~~------------------------------------------------------------------------ 161 (288)
T cd07863 154 LARIYSCQ------------------------------------------------------------------------ 161 (288)
T ss_pred ccccccCc------------------------------------------------------------------------
Confidence 97432100
Q ss_pred ccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcC-----CCCCCCC
Q 011302 317 VVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK-----PLTFPRI 391 (489)
Q Consensus 317 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-----~~~~p~~ 391 (489)
.......||+.|+|||++.+..++.++|||||||++|||++|.+||.+....+.+.++... ...++..
T Consensus 162 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 162 -------MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred -------ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 0012236899999999999988999999999999999999999999888776665555431 0011100
Q ss_pred CC-----------CCchh--HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 392 GV-----------SSSKE--FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 392 ~~-----------~~~~~--~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
.. ..... ......+.+||.+||+.||++||++. +++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~----~~l~hp~f 288 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAF----RALQHPFF 288 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHH----HHhcCCCC
Confidence 00 00000 01123578999999999999999987 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=371.01 Aligned_cols=262 Identities=27% Similarity=0.396 Sum_probs=203.5
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC-
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS- 161 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~- 161 (489)
.++|++.+.||+|+||.||+|.+.. .++.||||++...... .....++.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 89 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAV-----LDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK 89 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecC-----CCceEEEEEeCCcccC-hHHHHHHHHHHHHHHHhCCCchhceeeeeeccc
Confidence 4789999999999999999999875 5788999999754322 22345566799999999999999999988643
Q ss_pred -----ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccC
Q 011302 162 -----HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFD 236 (489)
Q Consensus 162 -----~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG 236 (489)
...|+||||++ ++|.+.+.. .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 90 ~~~~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 90 SLEEFQDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred cccccceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCc
Confidence 35799999995 567666643 48899999999999999999999999999999999999999999999999
Q ss_pred CCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcc
Q 011302 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPE 316 (489)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (489)
+++....
T Consensus 165 ~~~~~~~------------------------------------------------------------------------- 171 (355)
T cd07874 165 LARTAGT------------------------------------------------------------------------- 171 (355)
T ss_pred ccccCCC-------------------------------------------------------------------------
Confidence 9842210
Q ss_pred ccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCC-----------
Q 011302 317 VVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP----------- 385 (489)
Q Consensus 317 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~----------- 385 (489)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+....
T Consensus 172 ------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 172 ------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred ------ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 001123468999999999999999999999999999999999999999877554443332110
Q ss_pred -----------CC-----CCCC----CCCCch--hHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 386 -----------LT-----FPRI----GVSSSK--EFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 386 -----------~~-----~p~~----~~~~~~--~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
.. ++.. ...... .......+++||.+||..||++||++. ++++||||..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~----ell~hp~~~~ 316 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD----EALQHPYINV 316 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHH----HHhcCcchhc
Confidence 00 0000 000000 000123578999999999999999997 9999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=372.82 Aligned_cols=259 Identities=30% Similarity=0.492 Sum_probs=230.6
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
.....|.+.+.||+|.|++|.+|++.. ++..||||.+.+.......... +.+|+.+|+.++|||||+|+.+.+.
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~-----t~~~VaiK~idkt~ln~~~~~k-~~rev~imk~l~HPnIvkl~~v~~t 126 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHIL-----TGTEVAIKIIDKTQLNPSKRQK-LGREVDIMKSLNHPNIVKLFSVIET 126 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecC-----CCceEEEEEehhcccChHHHHH-HHHHHHHHHhcCCcceeeeeeeeee
Confidence 345789999999999999999999987 5788999999988776544333 7789999999999999999999999
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~ 240 (489)
...+|+||||+.+|++++++.++ +++.+.+++.++.|++.|++|||+++|||||||++||||+.+.++||+|||++..
T Consensus 127 ~~~lylV~eya~~ge~~~yl~~~--gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~ 204 (596)
T KOG0586|consen 127 EATLYLVMEYASGGELFDYLVKH--GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTF 204 (596)
T ss_pred cceeEEEEEeccCchhHHHHHhc--ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeecccccee
Confidence 99999999999999999999987 6788899999999999999999999999999999999999999999999999855
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
+..
T Consensus 205 ~~~----------------------------------------------------------------------------- 207 (596)
T KOG0586|consen 205 FDY----------------------------------------------------------------------------- 207 (596)
T ss_pred ecc-----------------------------------------------------------------------------
Confidence 432
Q ss_pred ccccCCccccCCCCccCcchhcCCCC-CCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhH
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGH-GSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEF 399 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 399 (489)
.....++||++.|.|||++.|..| ++.+|+||+|++||-|+.|..||+|.+-.+.-.+.+.+.+.+|.....
T Consensus 208 --~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~----- 280 (596)
T KOG0586|consen 208 --GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSC----- 280 (596)
T ss_pred --cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeec-----
Confidence 123457799999999999999987 889999999999999999999999999888877888888777765443
Q ss_pred HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 400 EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 400 ~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
++.+||+++|..+|.+|++.. ++..|.|....
T Consensus 281 ----dce~lLrk~lvl~Pskr~~~d----qim~~~W~n~~ 312 (596)
T KOG0586|consen 281 ----DCEDLLRKFLVLNPSKRGPCD----QIMKDRWRNDL 312 (596)
T ss_pred ----hhHHHHHHhhccCccccCCHH----Hhhhhcccchh
Confidence 478999999999999999997 99999998643
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=368.69 Aligned_cols=262 Identities=27% Similarity=0.380 Sum_probs=206.7
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC--
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS-- 161 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-- 161 (489)
++|++++.||+|+||+||+|.+.. +++.||||++.+.... ......+.+|+.+|+.++||||+++++++...
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTR-----LRQKVAVKKLSRPFQS-LIHARRTYRELRLLKHMKHENVIGLLDVFTPATS 88 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECC-----CCCEEEEEEeCchhhh-hHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence 789999999999999999999876 5678999999765332 22344566799999999999999999988543
Q ss_pred ----ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCC
Q 011302 162 ----HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237 (489)
Q Consensus 162 ----~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~ 237 (489)
...|++||++ |++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 89 ~~~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 89 IENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred ccccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCcc
Confidence 4579999998 8999887754 4699999999999999999999999999999999999999999999999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
++....
T Consensus 165 ~~~~~~-------------------------------------------------------------------------- 170 (343)
T cd07878 165 ARQADD-------------------------------------------------------------------------- 170 (343)
T ss_pred ceecCC--------------------------------------------------------------------------
Confidence 742210
Q ss_pred cccccccCCccccCCCCccCcchhcC-CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCC------
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPR------ 390 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~------ 390 (489)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.......+.
T Consensus 171 -------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07878 171 -------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI 243 (343)
T ss_pred -------CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 1123468999999999987 46899999999999999999999999887765555444321100000
Q ss_pred -----------CCCCCchhH-----HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 391 -----------IGVSSSKEF-----EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 391 -----------~~~~~~~~~-----~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
........+ .....+.+||.+||..||++||++. +++.||||....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~----ell~hp~~~~~~ 305 (343)
T cd07878 244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISAS----EALAHPYFSQYH 305 (343)
T ss_pred chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHH----HHhcCcchhccC
Confidence 000000000 0112478999999999999999987 999999998753
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=356.97 Aligned_cols=276 Identities=23% Similarity=0.291 Sum_probs=218.1
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccccccee
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEF 158 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 158 (489)
|++..++|++.+.||+|+||.||+|.+++.........||+|.+...... .....+.+|+.+++.++||||+++++++
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 78 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL--RERIEFLNEASVMKGFTCHHVVRLLGVV 78 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH--HHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 45677899999999999999999998876444445678999998644321 1223466799999999999999999999
Q ss_pred ecCceEEEEEeecCCCchHHHHHhCC--------CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcE
Q 011302 159 EASHYSCLVMEYCPGGDLYAARQRQP--------GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHI 230 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~v 230 (489)
.+....|+||||+++|+|.+++.... ...++...+..++.||+.||.|||+++|+||||||+|||++.++.+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcE
Confidence 99999999999999999999987532 1234566788899999999999999999999999999999999999
Q ss_pred EEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCcc
Q 011302 231 MLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQE 310 (489)
Q Consensus 231 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (489)
||+|||+++.......
T Consensus 159 ~L~Dfg~~~~~~~~~~---------------------------------------------------------------- 174 (288)
T cd05061 159 KIGDFGMTRDIYETDY---------------------------------------------------------------- 174 (288)
T ss_pred EECcCCcccccccccc----------------------------------------------------------------
Confidence 9999999843211000
Q ss_pred ccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCC-CC
Q 011302 311 LLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPL-TF 388 (489)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~-~~ 388 (489)
........++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+....+..+.. ..
T Consensus 175 ------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 242 (288)
T cd05061 175 ------------YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ 242 (288)
T ss_pred ------------ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 000111245678999999998889999999999999999998 8999998877776666654422 11
Q ss_pred CCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHc--CCCcCCCCc
Q 011302 389 PRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKR--HEFFKGINW 441 (489)
Q Consensus 389 p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~--hp~f~~~~~ 441 (489)
+. .. ...+.+||.+||+.||++||++.+.++.+.. ||||++++|
T Consensus 243 ~~---~~------~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 243 PD---NC------PERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred CC---CC------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence 11 11 1258999999999999999999855544444 999999998
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=382.43 Aligned_cols=261 Identities=26% Similarity=0.355 Sum_probs=214.1
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
..|.+.+.||+|+||.||+|..... .+..||+|.+..... .....+.+|+.+|+.++|||||+++++|..++.
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~----~~~~vv~K~~~~~~~---~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~ 139 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSD----PKEKVVAKFVMLNDE---RQAAYARSELHCLAACDHFGIVKHFDDFKSDDK 139 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCC----CCeEEEEEEcccCCH---HHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCE
Confidence 4599999999999999999987652 256788887654322 223456679999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhC--CCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQ--PGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKC 241 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~ 241 (489)
+||||||++||+|.+++... ....+++.++..++.||+.||+|||++|||||||||+|||++.++.+||+|||+++.+
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 99999999999999877542 2356899999999999999999999999999999999999999999999999998432
Q ss_pred ccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccc
Q 011302 242 DVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEP 321 (489)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (489)
....
T Consensus 220 ~~~~---------------------------------------------------------------------------- 223 (478)
T PTZ00267 220 SDSV---------------------------------------------------------------------------- 223 (478)
T ss_pred CCcc----------------------------------------------------------------------------
Confidence 1100
Q ss_pred cccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHH
Q 011302 322 INARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEE 401 (489)
Q Consensus 322 ~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 401 (489)
........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..+..+..... ....
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~------ 295 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF--PCPV------ 295 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--CccC------
Confidence 00112345799999999999999999999999999999999999999999888887777776543211 1111
Q ss_pred HhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 402 VVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 402 ~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
...+.+||.+||..||++||++. +++.|+|++.+
T Consensus 296 s~~~~~li~~~L~~dP~~Rps~~----~~l~~~~~~~~ 329 (478)
T PTZ00267 296 SSGMKALLDPLLSKNPALRPTTQ----QLLHTEFLKYV 329 (478)
T ss_pred CHHHHHHHHHHhccChhhCcCHH----HHHhCHHHHHH
Confidence 12589999999999999999997 99999998643
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-45 Score=354.45 Aligned_cols=258 Identities=34% Similarity=0.665 Sum_probs=199.5
Q ss_pred eeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHH---HhCCCCCcccccceeecCceEEEE
Q 011302 91 RLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL---TMLDHPFLPTLYAEFEASHYSCLV 167 (489)
Q Consensus 91 ~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l---~~l~hpnIv~l~~~~~~~~~~~lV 167 (489)
.||+|+||.||+|.+.. +++.||+|.+.+.............+|..++ ...+||||+.+++++..++..|+|
T Consensus 1 ~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKAD-----TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECC-----CCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEE
Confidence 48999999999999876 5789999999765433222222233344333 345799999999999999999999
Q ss_pred EeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCccc
Q 011302 168 MEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKL 247 (489)
Q Consensus 168 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 247 (489)
|||++||+|.+++... +.+++..+..++.|++.||+|||+++|+||||||+|||++.++.++|+|||++.....
T Consensus 76 ~e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~---- 149 (279)
T cd05633 76 LDLMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK---- 149 (279)
T ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccc----
Confidence 9999999999888765 5699999999999999999999999999999999999999999999999998732110
Q ss_pred cCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCc
Q 011302 248 LRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSK 327 (489)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (489)
....
T Consensus 150 ----------------------------------------------------------------------------~~~~ 153 (279)
T cd05633 150 ----------------------------------------------------------------------------KKPH 153 (279)
T ss_pred ----------------------------------------------------------------------------cCcc
Confidence 0011
Q ss_pred cccCCCCccCcchhc-CCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcH--HHHHHH-hcCCCCCCCCCCCCchhHHHHh
Q 011302 328 SFVGTHEYLAPEVIS-GQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNE--KTLINI-LKKPLTFPRIGVSSSKEFEEVV 403 (489)
Q Consensus 328 ~~~Gt~~y~aPE~l~-~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--~~~~~i-~~~~~~~p~~~~~~~~~~~~~~ 403 (489)
...||+.|+|||.+. +..++.++|||||||++|||++|..||...... ..+... .......|.. ...
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~ 224 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDS---------FSP 224 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccc---------cCH
Confidence 235899999999986 456899999999999999999999999764322 222221 1112222211 112
Q ss_pred hHHHHHHHHhhcCcccccCCC-CChHHHHcCCCcCCCCcccc
Q 011302 404 KLQDLISKLLVKNPKKRIGSL-KGSVEIKRHEFFKGINWALI 444 (489)
Q Consensus 404 ~l~~li~~~L~~dP~~R~~~~-~~~~~ll~hp~f~~~~~~~~ 444 (489)
.+.+||.+||..||.+|++.. ..++++++||||++++|...
T Consensus 225 ~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~ 266 (279)
T cd05633 225 ELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQV 266 (279)
T ss_pred HHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhHH
Confidence 589999999999999999632 34569999999999999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=382.53 Aligned_cols=264 Identities=27% Similarity=0.396 Sum_probs=216.0
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS 161 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 161 (489)
..++|++.+.||+|+||+||+|++.. +++.||||++...... .....++.+|+.++..++|+||++++..+...
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~-----~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVS-----DGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK 103 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcC-----CCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence 44799999999999999999999876 5789999999765332 23345677899999999999999998877533
Q ss_pred c--------eEEEEEeecCCCchHHHHHhC--CCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEE
Q 011302 162 H--------YSCLVMEYCPGGDLYAARQRQ--PGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIM 231 (489)
Q Consensus 162 ~--------~~~lV~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vk 231 (489)
. .+++||||+++|+|.+++... ....+++..+..++.|++.||.|||++|||||||||+|||++.++.+|
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEE
Confidence 2 478999999999999988643 235689999999999999999999999999999999999999999999
Q ss_pred EcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccc
Q 011302 232 LSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQEL 311 (489)
Q Consensus 232 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (489)
|+|||+++.+....
T Consensus 184 L~DFGls~~~~~~~------------------------------------------------------------------ 197 (496)
T PTZ00283 184 LGDFGFSKMYAATV------------------------------------------------------------------ 197 (496)
T ss_pred EEecccCeeccccc------------------------------------------------------------------
Confidence 99999984332100
Q ss_pred cCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCC
Q 011302 312 LDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRI 391 (489)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~ 391 (489)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+..+.....
T Consensus 198 ----------~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~-- 265 (496)
T PTZ00283 198 ----------SDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPL-- 265 (496)
T ss_pred ----------cccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCC--
Confidence 00112345799999999999999999999999999999999999999999888777777766543211
Q ss_pred CCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 392 GVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 392 ~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
... ...++.+||.+||+.||.+||++. ++++|||++..
T Consensus 266 ~~~------~~~~l~~li~~~L~~dP~~RPs~~----ell~~p~~~~~ 303 (496)
T PTZ00283 266 PPS------ISPEMQEIVTALLSSDPKRRPSSS----KLLNMPICKLF 303 (496)
T ss_pred CCC------CCHHHHHHHHHHcccChhhCcCHH----HHHhCHHHHHh
Confidence 111 112589999999999999999997 99999998754
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=347.80 Aligned_cols=258 Identities=38% Similarity=0.684 Sum_probs=212.3
Q ss_pred eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHH-HhCCCCCcccccceeecCceEEEEE
Q 011302 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL-TMLDHPFLPTLYAEFEASHYSCLVM 168 (489)
Q Consensus 90 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l-~~l~hpnIv~l~~~~~~~~~~~lV~ 168 (489)
+.||+|+||.||+|.+.. .++.||+|++.+...........+..|..++ ...+|+||+++++++..++.+|+||
T Consensus 2 ~~l~~g~~~~v~~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRS-----TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecC-----CCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEE
Confidence 569999999999999876 4678999999765544333344444555444 4458999999999999999999999
Q ss_pred eecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCcccc
Q 011302 169 EYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLL 248 (489)
Q Consensus 169 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 248 (489)
||++|++|.+++... ..+++..+..++.|++.||.|||+.||+||||+|+||+++.++.+||+|||+++....
T Consensus 77 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 77 EYLNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred eccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 999999999998765 5689999999999999999999999999999999999999999999999998732110
Q ss_pred CCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCcc
Q 011302 249 RPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKS 328 (489)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (489)
...
T Consensus 150 -----------------------------------------------------------------------------~~~ 152 (260)
T cd05611 150 -----------------------------------------------------------------------------NKK 152 (260)
T ss_pred -----------------------------------------------------------------------------ccc
Confidence 112
Q ss_pred ccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHH
Q 011302 329 FVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDL 408 (489)
Q Consensus 329 ~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~l 408 (489)
..|++.|+|||.+.+..++.++|||||||++|||++|..||...+....+..+......++...... ....+.++
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~ 227 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEF-----CSPEAVDL 227 (260)
T ss_pred CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCccccc-----CCHHHHHH
Confidence 3588899999999988889999999999999999999999998888777777766554443322211 12358999
Q ss_pred HHHHhhcCcccccCCCCChHHHHcCCCcCCCCcc
Q 011302 409 ISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWA 442 (489)
Q Consensus 409 i~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~ 442 (489)
|.+||+.||++||++. .+++++.||||+.++|+
T Consensus 228 i~~~l~~~p~~R~~~~-~~~~~l~~~~~~~~~~~ 260 (260)
T cd05611 228 INRLLCMDPAKRLGAN-GYQEIKSHPFFKSINWD 260 (260)
T ss_pred HHHHccCCHHHccCCC-cHHHHHcChHhhcCCCC
Confidence 9999999999999873 55699999999999995
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-45 Score=365.72 Aligned_cols=258 Identities=22% Similarity=0.366 Sum_probs=198.8
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
..+|++++.||+|+||.||+|++.. .+..||+|+..+.. ...|+.+++.++||||+++++++....
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~ 130 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPG-----QPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGA 130 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECC-----CCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCC
Confidence 4579999999999999999999886 46789999864432 234889999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
..|+||||+ .++|.+++... ...+++..++.|+.||+.||.|||++|||||||||+|||++.++.+||+|||+++...
T Consensus 131 ~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 131 ITCMVLPHY-SSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred eeEEEEEcc-CCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 999999999 57888887654 3579999999999999999999999999999999999999999999999999973210
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
.
T Consensus 209 ~------------------------------------------------------------------------------- 209 (357)
T PHA03209 209 V------------------------------------------------------------------------------- 209 (357)
T ss_pred c-------------------------------------------------------------------------------
Confidence 0
Q ss_pred ccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCC-CCCCCc---------HHHHHHHhc----CCCCC
Q 011302 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTP-FKGENN---------EKTLINILK----KPLTF 388 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~P-f~~~~~---------~~~~~~i~~----~~~~~ 388 (489)
........||+.|+|||++.+..++.++|||||||++|||+++..| |..... ...+..+.. .+..+
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 289 (357)
T PHA03209 210 APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEF 289 (357)
T ss_pred CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhc
Confidence 0011234699999999999999999999999999999999985444 443211 111222221 11112
Q ss_pred CCCCC---------------------CCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 389 PRIGV---------------------SSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 389 p~~~~---------------------~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
+.... ...........+.+||.+||+.||.+||++. ++++||||+.+
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~----e~l~hp~f~~~ 357 (357)
T PHA03209 290 PRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAE----EILNYPMFAQL 357 (357)
T ss_pred CCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHH----HHhcCchhccC
Confidence 20000 0000011123567899999999999999997 99999999864
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-46 Score=341.61 Aligned_cols=263 Identities=30% Similarity=0.443 Sum_probs=215.9
Q ss_pred eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-CCCcccccceeecCceEEEEE
Q 011302 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-HPFLPTLYAEFEASHYSCLVM 168 (489)
Q Consensus 90 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lV~ 168 (489)
+.||+|+|+.|--|.... ++..||||++.+..- ....++.+|++++..++ |+||+.|+++|+++..+||||
T Consensus 84 e~LGeGAyasVqtcv~i~-----t~~EYAVKiidKq~g---HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVf 155 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQ-----TGKEYAVKIIDKQPG---HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVF 155 (463)
T ss_pred HHhcCccceeeeeeeeec-----cchhhhhhhhhcCCc---hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEE
Confidence 579999999999988776 578899999987532 23456778999998875 999999999999999999999
Q ss_pred eecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCC---cEEEcccCCCcccccCc
Q 011302 169 EYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDG---HIMLSDFDLSFKCDVVP 245 (489)
Q Consensus 169 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~---~vkl~DFG~a~~~~~~~ 245 (489)
|-|.||.|...++++ ..|++.++..+..+|+.||.|||.+||.||||||+|||..... -||||||.++.-....
T Consensus 156 EKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~- 232 (463)
T KOG0607|consen 156 EKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLN- 232 (463)
T ss_pred ecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccC-
Confidence 999999999998876 6799999999999999999999999999999999999997654 4899999986211000
Q ss_pred cccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccC
Q 011302 246 KLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINAR 325 (489)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (489)
..| . ......
T Consensus 233 --------------------~~~-----------------------------------------------s---pastP~ 242 (463)
T KOG0607|consen 233 --------------------NDC-----------------------------------------------S---PASTPE 242 (463)
T ss_pred --------------------CCC-----------------------------------------------C---CCCCcc
Confidence 000 0 000123
Q ss_pred CccccCCCCccCcchhc---C--CCCCCcccHHHHHHHHHHHhhCCCCCCCC-------C--------cHHHHHHHhcCC
Q 011302 326 SKSFVGTHEYLAPEVIS---G--QGHGSAVDWWTLGVFLYEMLYGTTPFKGE-------N--------NEKTLINILKKP 385 (489)
Q Consensus 326 ~~~~~Gt~~y~aPE~l~---~--~~~~~~~DiwSlGvil~elltG~~Pf~~~-------~--------~~~~~~~i~~~~ 385 (489)
..+.+|+..|||||++. + ..|+.++|.||||||||-||.|.+||.|. + ....++.|..+.
T Consensus 243 L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGk 322 (463)
T KOG0607|consen 243 LLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGK 322 (463)
T ss_pred ccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccC
Confidence 44568999999999973 3 34899999999999999999999999763 1 346788899999
Q ss_pred CCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcc
Q 011302 386 LTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWA 442 (489)
Q Consensus 386 ~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~ 442 (489)
++||+..+. ....+++|||+.+|.+|+..|+.+. ++++|||++.+..+
T Consensus 323 YeFPdkdWa-----hIS~eakdlisnLlvrda~~rlsa~----~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 323 YEFPDKDWA-----HISSEAKDLISNLLVRDAKQRLSAA----QVLNHPWVQRCAPE 370 (463)
T ss_pred CcCChhhhH-----HhhHHHHHHHHHHHhccHHhhhhhh----hccCCccccccchh
Confidence 999975433 3344789999999999999999998 99999999987654
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=362.12 Aligned_cols=260 Identities=27% Similarity=0.365 Sum_probs=191.4
Q ss_pred eeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee--cCceEEE
Q 011302 89 LRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE--ASHYSCL 166 (489)
Q Consensus 89 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~--~~~~~~l 166 (489)
.++||+|+||+||+|+++.. ..++.||+|.+..... ...+.+|+.+|+.++||||+++++++. .+..+|+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~---~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l 77 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDG---KDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 77 (317)
T ss_pred ccccccCCCeEEEEEEEccC---CCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEE
Confidence 46899999999999997652 2467899999875422 123456999999999999999999885 3567899
Q ss_pred EEeecCCCchHHHHHhC-------CCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEe----ccCCcEEEccc
Q 011302 167 VMEYCPGGDLYAARQRQ-------PGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLV----REDGHIMLSDF 235 (489)
Q Consensus 167 V~E~~~gg~L~~~l~~~-------~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl----~~~~~vkl~DF 235 (489)
||||+ +++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+||
T Consensus 78 v~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 78 LFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred EEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 99999 56888876532 12358899999999999999999999999999999999999 45689999999
Q ss_pred CCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCc
Q 011302 236 DLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDP 315 (489)
Q Consensus 236 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (489)
|+|+.+.....
T Consensus 157 G~a~~~~~~~~--------------------------------------------------------------------- 167 (317)
T cd07868 157 GFARLFNSPLK--------------------------------------------------------------------- 167 (317)
T ss_pred CceeccCCCCc---------------------------------------------------------------------
Confidence 99843321000
Q ss_pred cccccccccCCccccCCCCccCcchhcCC-CCCCcccHHHHHHHHHHHhhCCCCCCCCCc---------HHHHHHHhcC-
Q 011302 316 EVVAEPINARSKSFVGTHEYLAPEVISGQ-GHGSAVDWWTLGVFLYEMLYGTTPFKGENN---------EKTLINILKK- 384 (489)
Q Consensus 316 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~---------~~~~~~i~~~- 384 (489)
........+||+.|+|||++.+. .++.++|||||||++|||++|++||.+... ...+..+...
T Consensus 168 ------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07868 168 ------PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241 (317)
T ss_pred ------cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence 00112235789999999999875 489999999999999999999999975432 1222222110
Q ss_pred --CC--------CCCCC-------------CCCCchh-----HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 385 --PL--------TFPRI-------------GVSSSKE-----FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 385 --~~--------~~p~~-------------~~~~~~~-----~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
+. ..+.. ....... ......+.+||.+||++||.+|+++. ++++||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~----e~l~hp~f 317 (317)
T cd07868 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE----QAMQDPYF 317 (317)
T ss_pred CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHH----HHhcCCCC
Confidence 00 00000 0000000 00122478999999999999999998 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=366.93 Aligned_cols=257 Identities=21% Similarity=0.327 Sum_probs=209.1
Q ss_pred hcCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccc
Q 011302 77 AQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYA 156 (489)
Q Consensus 77 ~~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~ 156 (489)
..|++..+++.+...||+|+||+||+|++.+ .||||+++.+.... +.++.|.+|+.++++-+|.||+-+.|
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--------dVAVK~Lnv~~pt~-~qlqaFKnEVa~lkkTRH~NIlLFMG 455 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--------DVAVKLLNVDDPTP-EQLQAFKNEVAVLKKTRHENILLFMG 455 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc--------ceEEEEEecCCCCH-HHHHHHHHHHHHHhhcchhhheeeeh
Confidence 5677888999999999999999999999997 47999998766553 47888999999999999999999999
Q ss_pred eeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccC
Q 011302 157 EFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFD 236 (489)
Q Consensus 157 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG 236 (489)
++..... .||+-||+|-+|+.+++-.. ..|.....+.|++||++||.|||.++|||||||..||+|.++++|||+|||
T Consensus 456 ~~~~p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFG 533 (678)
T KOG0193|consen 456 ACMNPPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFG 533 (678)
T ss_pred hhcCCce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEeccc
Confidence 9998877 99999999999999987654 679999999999999999999999999999999999999999999999999
Q ss_pred CCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcc
Q 011302 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPE 316 (489)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (489)
++..-..+.
T Consensus 534 Latvk~~w~----------------------------------------------------------------------- 542 (678)
T KOG0193|consen 534 LATVKTRWS----------------------------------------------------------------------- 542 (678)
T ss_pred ceeeeeeec-----------------------------------------------------------------------
Confidence 983211100
Q ss_pred ccccccccCCccccCCCCccCcchhcC---CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCC
Q 011302 317 VVAEPINARSKSFVGTHEYLAPEVISG---QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGV 393 (489)
Q Consensus 317 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~---~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~ 393 (489)
.........|...|||||+++. .+|+..+|||||||++|||++|..||...+..+++-.+-++ +-.|+...
T Consensus 543 -----g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG-~l~pd~s~ 616 (678)
T KOG0193|consen 543 -----GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRG-YLMPDLSK 616 (678)
T ss_pred -----cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEeccc-ccCccchh
Confidence 0011123357889999999975 45899999999999999999999999954444444333333 22232221
Q ss_pred CCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 394 SSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 394 ~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
... ....++++|+..||..++++||...
T Consensus 617 ~~s---~~pk~mk~Ll~~C~~~~~~eRP~F~ 644 (678)
T KOG0193|consen 617 IRS---NCPKAMKRLLSDCWKFDREERPLFP 644 (678)
T ss_pred hhc---cCHHHHHHHHHHHHhcCcccCccHH
Confidence 111 1122589999999999999999987
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=345.98 Aligned_cols=260 Identities=28% Similarity=0.427 Sum_probs=212.1
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHH--HHHHHHHHHHHHHHHHHhCCCCCcccccceeecC
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREAL--AIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS 161 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 161 (489)
++|.+.+.||+|+||.||+|.+.. +++.||+|.+..... ........+.+|+.+++.++||||+++++++.++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~-----~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVD-----TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcC-----CCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC
Confidence 579999999999999999999876 567899999865422 1223445678899999999999999999999999
Q ss_pred ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccc
Q 011302 162 HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKC 241 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~ 241 (489)
+.+|+||||++|++|.+++... ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++..
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9999999999999999988765 56899999999999999999999999999999999999999999999999997432
Q ss_pred ccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccc
Q 011302 242 DVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEP 321 (489)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (489)
......
T Consensus 155 ~~~~~~-------------------------------------------------------------------------- 160 (263)
T cd06625 155 QTICSS-------------------------------------------------------------------------- 160 (263)
T ss_pred cccccc--------------------------------------------------------------------------
Confidence 110000
Q ss_pred cccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHH
Q 011302 322 INARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEE 401 (489)
Q Consensus 322 ~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 401 (489)
........|+..|+|||++.+..++.++|||||||++|||++|+.||...+.......+........ .... .
T Consensus 161 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~------~ 232 (263)
T cd06625 161 -GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQ-LPSH------V 232 (263)
T ss_pred -cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCC-CCcc------C
Confidence 0001233588899999999998899999999999999999999999988766655555544322211 1111 1
Q ss_pred HhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 402 VVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 402 ~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
...+.+||.+||..+|++||++. ++++|+||
T Consensus 233 ~~~~~~li~~~l~~~p~~Rpt~~----~ll~~~~~ 263 (263)
T cd06625 233 SPDARNFLRRTFVENAKKRPSAE----ELLRHFFV 263 (263)
T ss_pred CHHHHHHHHHHhhcCcccCCCHH----HHhhCCCC
Confidence 12489999999999999999987 99999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=382.21 Aligned_cols=274 Identities=29% Similarity=0.373 Sum_probs=215.5
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-CCCcccccce
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-HPFLPTLYAE 157 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~ 157 (489)
..++..++++.+.|.+|||+.||+|++.+. +..||+|++-.. ....++.+.+|+.+|+.|. |+|||.+++.
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~-----~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yids 103 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKG-----GKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDS 103 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCC-----CceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEecc
Confidence 346677899999999999999999999873 378999988644 2355677788999999996 9999999993
Q ss_pred e-e----c--CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCC--CeeecCCCCCeEeccCC
Q 011302 158 F-E----A--SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMG--IVYRDLKPENVLVREDG 228 (489)
Q Consensus 158 ~-~----~--~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDIKp~NILl~~~~ 228 (489)
. . . .-.++|+||||.||.|-+++..+...+|++.+++.|+.|+++||.+||... |||||||-|||||..+|
T Consensus 104 s~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g 183 (738)
T KOG1989|consen 104 SAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADG 183 (738)
T ss_pred ccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCC
Confidence 3 1 1 236789999999999999998776677999999999999999999999998 99999999999999999
Q ss_pred cEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCC
Q 011302 229 HIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHD 308 (489)
Q Consensus 229 ~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (489)
+.||||||.|...-..+. +...+..
T Consensus 184 ~~KLCDFGSatt~~~~~~------~~~e~~~------------------------------------------------- 208 (738)
T KOG1989|consen 184 NYKLCDFGSATTKILSPT------SAQEVNY------------------------------------------------- 208 (738)
T ss_pred CEEeCcccccccccCCCc------cHHHHHH-------------------------------------------------
Confidence 999999999843222111 0000000
Q ss_pred ccccCCccccccccccCCccccCCCCccCcchhc---CCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCC
Q 011302 309 QELLDDPEVVAEPINARSKSFVGTHEYLAPEVIS---GQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP 385 (489)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~ 385 (489)
..+. -...-|+.|+|||+|. +.+.+.|+|||||||+||-|++...||..... .+|+.+.
T Consensus 209 ---------ve~e-----I~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----laIlng~ 270 (738)
T KOG1989|consen 209 ---------VEEE-----IEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----LAILNGN 270 (738)
T ss_pred ---------HHHH-----HHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----eeEEecc
Confidence 0000 0113589999999984 67789999999999999999999999987643 4688999
Q ss_pred CCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHH----cCCCcCCCC
Q 011302 386 LTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIK----RHEFFKGIN 440 (489)
Q Consensus 386 ~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll----~hp~f~~~~ 440 (489)
+.+|.....+ ..+.+||+.||+.||++||++.+.+.++. .+.++..+.
T Consensus 271 Y~~P~~p~ys-------~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~ 322 (738)
T KOG1989|consen 271 YSFPPFPNYS-------DRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY 322 (738)
T ss_pred ccCCCCccHH-------HHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence 9999763332 25899999999999999999985544443 345555544
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=360.29 Aligned_cols=272 Identities=23% Similarity=0.325 Sum_probs=206.7
Q ss_pred eeeeeccC--CceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEE
Q 011302 88 LLRRLGSG--DIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSC 165 (489)
Q Consensus 88 ~~~~lG~G--~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 165 (489)
++++||+| +||+||++.++. +++.||+|.+..+... ......+.+|+.+++.++||||++++++|..++..|
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~ 75 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKP-----TGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 75 (327)
T ss_pred hhhhccccccceEEEEEEeecc-----cCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEE
Confidence 46789999 789999999887 6789999999765432 233455677999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCc
Q 011302 166 LVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVP 245 (489)
Q Consensus 166 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~ 245 (489)
+||||+++|+|.+++.......+++..++.++.||+.||+|||++|||||||||+|||++.++.++++|||.+.......
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 76 VVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred EEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 99999999999999876544568999999999999999999999999999999999999999999999998652211000
Q ss_pred cccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccC
Q 011302 246 KLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINAR 325 (489)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (489)
... ......
T Consensus 156 ~~~-----------------------------------------------------------------------~~~~~~ 164 (327)
T cd08227 156 QRL-----------------------------------------------------------------------RVVHDF 164 (327)
T ss_pred ccc-----------------------------------------------------------------------cccccc
Confidence 000 000000
Q ss_pred CccccCCCCccCcchhcC--CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCC-------C------
Q 011302 326 SKSFVGTHEYLAPEVISG--QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFP-------R------ 390 (489)
Q Consensus 326 ~~~~~Gt~~y~aPE~l~~--~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p-------~------ 390 (489)
.....++..|+|||++.+ ..++.++|||||||++|||++|..||.................... .
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (327)
T cd08227 165 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMK 244 (327)
T ss_pred cccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccC
Confidence 112357788999999976 4589999999999999999999999987655444333332211100 0
Q ss_pred ----------------------CCCCC--chhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 391 ----------------------IGVSS--SKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 391 ----------------------~~~~~--~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
..... .........+.+||.+||+.||++||++. ++++||||+.+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~----ell~~p~f~~~~ 314 (327)
T cd08227 245 PSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSAS----TLLNHSFFKQIK 314 (327)
T ss_pred CcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHH----HHhcChhhhhcc
Confidence 00000 00001224688999999999999999998 999999998764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=367.56 Aligned_cols=250 Identities=28% Similarity=0.430 Sum_probs=211.8
Q ss_pred HhhcCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccc
Q 011302 75 RRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTL 154 (489)
Q Consensus 75 ~~~~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l 154 (489)
+...|++.++...-++-||+|+-|.||+|+.++ +.||||.++.-.. .++.-|++|+||||+.|
T Consensus 115 q~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~n-------etVAVKKV~elkE----------TdIKHLRkLkH~NII~F 177 (904)
T KOG4721|consen 115 QEELWEIPFEEISELEWLGSGAQGAVFLGRLHN-------ETVAVKKVRELKE----------TDIKHLRKLKHPNIITF 177 (904)
T ss_pred hhhhccCCHHHhhhhhhhccCcccceeeeeccC-------ceehhHHHhhhhh----------hhHHHHHhccCcceeeE
Confidence 446678888888889999999999999999886 6789998853321 26777999999999999
Q ss_pred cceeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcc
Q 011302 155 YAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSD 234 (489)
Q Consensus 155 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~D 234 (489)
.|+|....++|||||||..|-|+.+|+.. ..+.......+..+|+.||.|||.++|||||||.-||||..+..|||+|
T Consensus 178 kGVCtqsPcyCIiMEfCa~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsD 255 (904)
T KOG4721|consen 178 KGVCTQSPCYCIIMEFCAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISD 255 (904)
T ss_pred eeeecCCceeEEeeeccccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEecc
Confidence 99999999999999999999999999875 6788899999999999999999999999999999999999999999999
Q ss_pred cCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCC
Q 011302 235 FDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDD 314 (489)
Q Consensus 235 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (489)
||.++.....
T Consensus 256 FGTS~e~~~~---------------------------------------------------------------------- 265 (904)
T KOG4721|consen 256 FGTSKELSDK---------------------------------------------------------------------- 265 (904)
T ss_pred ccchHhhhhh----------------------------------------------------------------------
Confidence 9987433211
Q ss_pred ccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCC
Q 011302 315 PEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVS 394 (489)
Q Consensus 315 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~ 394 (489)
...-+|+||..|||||+|.+++.+.|+|||||||+|||||||+.||...+...++--+-.+.+.+|....
T Consensus 266 ---------STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPst- 335 (904)
T KOG4721|consen 266 ---------STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPST- 335 (904)
T ss_pred ---------hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCccc-
Confidence 1234679999999999999999999999999999999999999999887766555444444444443321
Q ss_pred CchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 395 SSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 395 ~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
++. .++=||+.||...|.+||++. +||.|
T Consensus 336 cP~------GfklL~Kqcw~sKpRNRPSFr----qil~H 364 (904)
T KOG4721|consen 336 CPD------GFKLLLKQCWNSKPRNRPSFR----QILLH 364 (904)
T ss_pred Cch------HHHHHHHHHHhcCCCCCccHH----HHHHH
Confidence 222 377899999999999999998 89888
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=391.56 Aligned_cols=267 Identities=27% Similarity=0.443 Sum_probs=213.3
Q ss_pred cCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccce
Q 011302 78 QGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAE 157 (489)
Q Consensus 78 ~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~ 157 (489)
.+.+..++|.+++.||+|+||+||+|++.. .+..||+|++...... ......+..|+.+|+.++|||||+++++
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~-----tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~HPNIVrl~d~ 80 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKR-----TQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYIDR 80 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECC-----CCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHcCCCCcCeEEEE
Confidence 345667899999999999999999999986 5789999998754332 2234567789999999999999999998
Q ss_pred eec--CceEEEEEeecCCCchHHHHHhC--CCCCCChhhHHHHHHHHHHHHHHHHhC-------CCeeecCCCCCeEecc
Q 011302 158 FEA--SHYSCLVMEYCPGGDLYAARQRQ--PGKRFGISSAKFYAAETLLALEYLHMM-------GIVYRDLKPENVLVRE 226 (489)
Q Consensus 158 ~~~--~~~~~lV~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~yLH~~-------~iiHrDIKp~NILl~~ 226 (489)
|.+ ...+||||||+++|+|.+++... ....+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 81 f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s 160 (1021)
T PTZ00266 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST 160 (1021)
T ss_pred EEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeec
Confidence 854 46799999999999999988653 225699999999999999999999984 4999999999999964
Q ss_pred -----------------CCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccc
Q 011302 227 -----------------DGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNK 289 (489)
Q Consensus 227 -----------------~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (489)
.+.+||+|||++..+..
T Consensus 161 ~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~---------------------------------------------- 194 (1021)
T PTZ00266 161 GIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI---------------------------------------------- 194 (1021)
T ss_pred CccccccccccccccCCCCceEEccCCccccccc----------------------------------------------
Confidence 23589999999843210
Q ss_pred cccccccccccccCCCCCCccccCCccccccccccCCccccCCCCccCcchhcC--CCCCCcccHHHHHHHHHHHhhCCC
Q 011302 290 KKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISG--QGHGSAVDWWTLGVFLYEMLYGTT 367 (489)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--~~~~~~~DiwSlGvil~elltG~~ 367 (489)
.......+||+.|+|||++.+ ..++.++||||||||||||++|..
T Consensus 195 ---------------------------------~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~ 241 (1021)
T PTZ00266 195 ---------------------------------ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241 (1021)
T ss_pred ---------------------------------cccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCC
Confidence 001123479999999999965 347899999999999999999999
Q ss_pred CCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCc
Q 011302 368 PFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINW 441 (489)
Q Consensus 368 Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~ 441 (489)
||...+....+...+.....+|.... ..++.+||.+||..+|.+||++. ++|.|+||+.+..
T Consensus 242 PF~~~~~~~qli~~lk~~p~lpi~~~--------S~eL~dLI~~~L~~dPeeRPSa~----QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 242 PFHKANNFSQLISELKRGPDLPIKGK--------SKELNILIKNLLNLSAKERPSAL----QCLGYQIIKNVGP 303 (1021)
T ss_pred CCCcCCcHHHHHHHHhcCCCCCcCCC--------CHHHHHHHHHHhcCChhHCcCHH----HHhccHHHhhcCC
Confidence 99877766555554443333332111 12589999999999999999997 9999999987654
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=346.89 Aligned_cols=256 Identities=39% Similarity=0.724 Sum_probs=215.0
Q ss_pred eccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEEEEEeec
Q 011302 92 LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYC 171 (489)
Q Consensus 92 lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 171 (489)
||.|+||.||+|++.. .++.||+|++.+...........+..|+.+++.++||||+++++++.++..+|+||||+
T Consensus 1 lg~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKS-----KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECC-----CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecC
Confidence 6999999999999886 56789999998765544445567888999999999999999999999999999999999
Q ss_pred CCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCccccCCc
Q 011302 172 PGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPK 251 (489)
Q Consensus 172 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 251 (489)
++++|.+++.+. ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 76 ~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~------- 146 (262)
T cd05572 76 LGGELWTILRDR--GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG------- 146 (262)
T ss_pred CCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc-------
Confidence 999999998775 45899999999999999999999999999999999999999999999999997432110
Q ss_pred chhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCccccC
Q 011302 252 LSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVG 331 (489)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 331 (489)
.......|
T Consensus 147 ------------------------------------------------------------------------~~~~~~~~ 154 (262)
T cd05572 147 ------------------------------------------------------------------------QKTWTFCG 154 (262)
T ss_pred ------------------------------------------------------------------------cccccccC
Confidence 01123468
Q ss_pred CCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCC--cHHHHHHHhc--CCCCCCCCCCCCchhHHHHhhHHH
Q 011302 332 THEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGEN--NEKTLINILK--KPLTFPRIGVSSSKEFEEVVKLQD 407 (489)
Q Consensus 332 t~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~--~~~~~~~i~~--~~~~~p~~~~~~~~~~~~~~~l~~ 407 (489)
++.|+|||.+.+..++.++|+|||||++|+|++|..||.... ..+...++.. ....+|... ...+.+
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~ 225 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYI---------DKAAKD 225 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCccc---------CHHHHH
Confidence 899999999988889999999999999999999999998776 5566666663 233333221 125899
Q ss_pred HHHHHhhcCcccccCCC-CChHHHHcCCCcCCCCcc
Q 011302 408 LISKLLVKNPKKRIGSL-KGSVEIKRHEFFKGINWA 442 (489)
Q Consensus 408 li~~~L~~dP~~R~~~~-~~~~~ll~hp~f~~~~~~ 442 (489)
||.+||..||++|++.. ..++++++||||++.+|+
T Consensus 226 ~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 261 (262)
T cd05572 226 LIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE 261 (262)
T ss_pred HHHHHccCChhhCcCCcccCHHHHhcChhhhCCCCC
Confidence 99999999999999943 345799999999999996
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=351.35 Aligned_cols=265 Identities=29% Similarity=0.463 Sum_probs=214.6
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.+.|+++++||.|+||.||+|++.. .+..|++|++.... ......+..|+.+++.++||||+++++++..++
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~-----~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 82 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKE-----TGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFYWDG 82 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECC-----CCceEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC
Confidence 4679999999999999999999886 56789999987542 233456677999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
.+|+||||++|++|..++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 83 ~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 161 (292)
T cd06644 83 KLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNV 161 (292)
T ss_pred eEEEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecc
Confidence 9999999999999988775532 568999999999999999999999999999999999999999999999999873211
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
..
T Consensus 162 ~~------------------------------------------------------------------------------ 163 (292)
T cd06644 162 KT------------------------------------------------------------------------------ 163 (292)
T ss_pred cc------------------------------------------------------------------------------
Confidence 00
Q ss_pred ccCCccccCCCCccCcchhc-----CCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCch
Q 011302 323 NARSKSFVGTHEYLAPEVIS-----GQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSK 397 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~-----~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 397 (489)
........|++.|+|||++. ...++.++|||||||++|||++|..||...+......++..... +......
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~-- 239 (292)
T cd06644 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP--PTLSQPS-- 239 (292)
T ss_pred ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCC--ccCCCCc--
Confidence 00112345889999999985 34468899999999999999999999988776666555544322 1111100
Q ss_pred hHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcccc
Q 011302 398 EFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALI 444 (489)
Q Consensus 398 ~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~ 444 (489)
.....+.+||.+||..||++||++. ++++||||..++|...
T Consensus 240 --~~~~~~~~li~~~l~~~p~~Rp~~~----~il~~~~~~~~~~~~~ 280 (292)
T cd06644 240 --KWSMEFRDFLKTALDKHPETRPSAA----QLLEHPFVSSVTSNRP 280 (292)
T ss_pred --ccCHHHHHHHHHHhcCCcccCcCHH----HHhcCccccccccchh
Confidence 1112488999999999999999987 9999999999998764
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=355.33 Aligned_cols=268 Identities=27% Similarity=0.398 Sum_probs=208.9
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS 161 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 161 (489)
..++|++.+.||+|+||.||+|+++. ++..||+|.+...... .....+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~-----~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~ 76 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKL-----TDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTE 76 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcC-----CCcEEEEEEEeccccc--CchhHHHHHHHHHHhcCCCCcceEEEEEecC
Confidence 35789999999999999999999876 5678999998754321 1223456799999999999999999999999
Q ss_pred ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccc
Q 011302 162 HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKC 241 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~ 241 (489)
+.+|+||||++ ++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 77 ~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 154 (301)
T cd07873 77 KSLTLVFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAK 154 (301)
T ss_pred CeEEEEEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhcc
Confidence 99999999995 6898887654 346889999999999999999999999999999999999999999999999997321
Q ss_pred ccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccc
Q 011302 242 DVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEP 321 (489)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (489)
...
T Consensus 155 ~~~----------------------------------------------------------------------------- 157 (301)
T cd07873 155 SIP----------------------------------------------------------------------------- 157 (301)
T ss_pred CCC-----------------------------------------------------------------------------
Confidence 100
Q ss_pred cccCCccccCCCCccCcchhcCC-CCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcC---C------------
Q 011302 322 INARSKSFVGTHEYLAPEVISGQ-GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK---P------------ 385 (489)
Q Consensus 322 ~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~------------ 385 (489)
........+++.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+....+... +
T Consensus 158 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 158 -TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred -CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence 0001122578899999998764 4788999999999999999999999988766554443321 0
Q ss_pred ----CCCCCCCCCCchh--HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 386 ----LTFPRIGVSSSKE--FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 386 ----~~~p~~~~~~~~~--~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
..+|......... ...+..+++||.+||+.||.+||++. ++++||||+.+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~----eil~h~~f~~~~ 293 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAE----EAMKHPYFHCLG 293 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHH----HHhcCccccccc
Confidence 0011100000000 01123578999999999999999987 999999998765
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=349.44 Aligned_cols=261 Identities=31% Similarity=0.601 Sum_probs=202.1
Q ss_pred eeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHH---HHHHhCCCCCcccccceeecCceEEEE
Q 011302 91 RLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEK---VILTMLDHPFLPTLYAEFEASHYSCLV 167 (489)
Q Consensus 91 ~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~---~~l~~l~hpnIv~l~~~~~~~~~~~lV 167 (489)
.||+|+||.||+|.+.. +++.||||.+.+...........+..|. .+++..+||||+++++++.+.+..|+|
T Consensus 1 ~ig~g~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKAD-----TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEec-----CCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEE
Confidence 48999999999999876 5789999998764332212111222233 345556899999999999999999999
Q ss_pred EeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCccc
Q 011302 168 MEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKL 247 (489)
Q Consensus 168 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 247 (489)
|||++||+|.+++... ..+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||++..+..
T Consensus 76 ~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~---- 149 (278)
T cd05606 76 LDLMNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK---- 149 (278)
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCc----
Confidence 9999999999888764 5799999999999999999999999999999999999999999999999998732210
Q ss_pred cCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCc
Q 011302 248 LRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSK 327 (489)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (489)
....
T Consensus 150 ----------------------------------------------------------------------------~~~~ 153 (278)
T cd05606 150 ----------------------------------------------------------------------------KKPH 153 (278)
T ss_pred ----------------------------------------------------------------------------cCCc
Confidence 0011
Q ss_pred cccCCCCccCcchhcCC-CCCCcccHHHHHHHHHHHhhCCCCCCCCC---cHHHHHHHhcCCCCCCCCCCCCchhHHHHh
Q 011302 328 SFVGTHEYLAPEVISGQ-GHGSAVDWWTLGVFLYEMLYGTTPFKGEN---NEKTLINILKKPLTFPRIGVSSSKEFEEVV 403 (489)
Q Consensus 328 ~~~Gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~ 403 (489)
..+|+..|+|||++.+. .++.++||||+||++|||++|..||.+.. .......+......+|... +.
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---------s~ 224 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF---------SP 224 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcC---------CH
Confidence 23689999999999754 58999999999999999999999998763 2222222322223333211 12
Q ss_pred hHHHHHHHHhhcCcccccCCC-CChHHHHcCCCcCCCCccccccC
Q 011302 404 KLQDLISKLLVKNPKKRIGSL-KGSVEIKRHEFFKGINWALIRSI 447 (489)
Q Consensus 404 ~l~~li~~~L~~dP~~R~~~~-~~~~~ll~hp~f~~~~~~~~~~~ 447 (489)
.+.++|.+||..+|.+|+... ..+.++++||||+.++|+.+...
T Consensus 225 ~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~~~~ 269 (278)
T cd05606 225 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQ 269 (278)
T ss_pred HHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchHhhhc
Confidence 589999999999999999432 23459999999999999876433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-45 Score=348.65 Aligned_cols=256 Identities=38% Similarity=0.629 Sum_probs=208.3
Q ss_pred ceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEE
Q 011302 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSC 165 (489)
Q Consensus 86 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 165 (489)
|++++.||+|+||+||+|++.. .++.||+|++......... ......|..+++.++||||+++++++.+...+|
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~-----~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~ 74 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKK-----NGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLY 74 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETT-----TTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECC-----CCeEEEEEEeccccccccc-cchhhhhhhcccccccccccccccccccccccc
Confidence 7899999999999999999997 5778999999876544332 223344999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCc
Q 011302 166 LVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVP 245 (489)
Q Consensus 166 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~ 245 (489)
+||||+++++|.+++... ..+++..+..++.||+.||++||++||+||||||+|||++.++.++|+|||.+.....
T Consensus 75 ~v~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-- 150 (260)
T PF00069_consen 75 IVMEYCPGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-- 150 (260)
T ss_dssp EEEEEETTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS--
T ss_pred cccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--
Confidence 999999999999999843 6799999999999999999999999999999999999999999999999999732200
Q ss_pred cccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccC
Q 011302 246 KLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINAR 325 (489)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (489)
....
T Consensus 151 ----------------------------------------------------------------------------~~~~ 154 (260)
T PF00069_consen 151 ----------------------------------------------------------------------------NNEN 154 (260)
T ss_dssp ----------------------------------------------------------------------------TTSE
T ss_pred ----------------------------------------------------------------------------cccc
Confidence 0112
Q ss_pred CccccCCCCccCcchhc-CCCCCCcccHHHHHHHHHHHhhCCCCCCCCC---cHHHHHHHhcCCCCCCCCCCCCchhHHH
Q 011302 326 SKSFVGTHEYLAPEVIS-GQGHGSAVDWWTLGVFLYEMLYGTTPFKGEN---NEKTLINILKKPLTFPRIGVSSSKEFEE 401 (489)
Q Consensus 326 ~~~~~Gt~~y~aPE~l~-~~~~~~~~DiwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 401 (489)
.....||+.|+|||++. +..++.++||||||+++|+|++|..||.... ....+.+........+..... ..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~ 229 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSR-----EK 229 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHT-----TS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccc-----hh
Confidence 23447899999999998 7778999999999999999999999999873 333333333322111111100 00
Q ss_pred HhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 402 VVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 402 ~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
...+.+||.+||+.||++||++. ++++||||
T Consensus 230 ~~~l~~li~~~l~~~p~~R~~~~----~l~~~~~~ 260 (260)
T PF00069_consen 230 SEELRDLIKKMLSKDPEQRPSAE----ELLKHPWF 260 (260)
T ss_dssp HHHHHHHHHHHSSSSGGGSTTHH----HHHTSGGG
T ss_pred HHHHHHHHHHHccCChhHCcCHH----HHhcCCCC
Confidence 13589999999999999999987 99999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=354.06 Aligned_cols=263 Identities=27% Similarity=0.346 Sum_probs=208.8
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
++|++.+.||+|+||.||+|.+.. ++..||+|.+..+.. .....++.+|+.+++.++||||+++++++.+++.
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~-----~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 73 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRP-----SGLIMARKLIHLEIK--PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGE 73 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcC-----CCeEEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCE
Confidence 479999999999999999999876 567899999865421 2334567789999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHh-CCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHM-MGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
+|+||||++|++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++....
T Consensus 74 ~~lv~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (308)
T cd06615 74 ISICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 151 (308)
T ss_pred EEEEeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccc
Confidence 99999999999999998765 568999999999999999999997 599999999999999999999999999873211
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
.
T Consensus 152 ~------------------------------------------------------------------------------- 152 (308)
T cd06615 152 D------------------------------------------------------------------------------- 152 (308)
T ss_pred c-------------------------------------------------------------------------------
Confidence 0
Q ss_pred ccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCC----------
Q 011302 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIG---------- 392 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~---------- 392 (489)
......+|++.|+|||++.+..++.++|||||||++|||++|..||...+.......+.......+...
T Consensus 153 -~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 153 -SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred -cccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence 011234689999999999888899999999999999999999999987654333222211110000000
Q ss_pred -------------------CCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 393 -------------------VSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 393 -------------------~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
.+.........++.+||.+||..||++||++. ++++||||...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~----~ll~~~~~~~~ 293 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLK----ELTKHPFIKRA 293 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHH----HHhcChhhhhc
Confidence 00000001123588999999999999999987 99999999763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=370.72 Aligned_cols=260 Identities=23% Similarity=0.334 Sum_probs=201.6
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
...|.+.+.||+|+||.||+|.+.. .++.||||.... ..+.+|+.+|++++|+|||++++++..++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~-----~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~ 233 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPD-----YPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGG 233 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECC-----CCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECC
Confidence 4579999999999999999999887 467899996432 23456999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
..|||||++ .++|..++.... ..+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+.
T Consensus 234 ~~~lv~e~~-~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~ 311 (461)
T PHA03211 234 LTCLVLPKY-RSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFAR 311 (461)
T ss_pred EEEEEEEcc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecc
Confidence 999999999 578988876542 469999999999999999999999999999999999999999999999999984321
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
....
T Consensus 312 ~~~~---------------------------------------------------------------------------- 315 (461)
T PHA03211 312 GSWS---------------------------------------------------------------------------- 315 (461)
T ss_pred cccc----------------------------------------------------------------------------
Confidence 1000
Q ss_pred ccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCC-------cHHHHHHHhc-CCC---CCCCC
Q 011302 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGEN-------NEKTLINILK-KPL---TFPRI 391 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~-------~~~~~~~i~~-~~~---~~p~~ 391 (489)
.......+||+.|+|||++.+..++.++|||||||+||||++|..|+.... ....+.+++. ... .++..
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 001123579999999999999999999999999999999999887654321 1122233322 111 11110
Q ss_pred CC------------------CCchhH----HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 392 GV------------------SSSKEF----EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 392 ~~------------------~~~~~~----~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
.. .....| .....+.+||.+||..||.+||++. |+|+||||++
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~----elL~hp~f~~ 460 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAA----ELLRLPLFQS 460 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHH----HHhhCcccCC
Confidence 00 000001 1123588999999999999999998 9999999975
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-44 Score=341.48 Aligned_cols=256 Identities=27% Similarity=0.450 Sum_probs=211.2
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec-Cce
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA-SHY 163 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~ 163 (489)
+|++++.||+|+||.||+|.++. .++.||+|.+..+... ......+..|+.+++.++|+||+++++.+.. +..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRT-----DGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGL 74 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcC-----CCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCE
Confidence 58999999999999999999876 4678999999765432 2234556779999999999999999998864 456
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
+|+||||+++++|.+++.......+++.+++.++.|++.||+|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 75 ~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 75 LYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred EEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 89999999999999998775556799999999999999999999999999999999999999999999999999733210
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
. .
T Consensus 155 ~------------------------------------------------------------------------------~ 156 (257)
T cd08223 155 Q------------------------------------------------------------------------------C 156 (257)
T ss_pred c------------------------------------------------------------------------------C
Confidence 0 0
Q ss_pred cCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHh
Q 011302 324 ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVV 403 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~ 403 (489)
.......|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+..+... .... ....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~--~~~~------~~~~ 228 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP--PMPK------DYSP 228 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC--CCcc------ccCH
Confidence 0112346889999999999998999999999999999999999999988776666666554331 1111 1223
Q ss_pred hHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 404 KLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 404 ~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
.+.+||.+||+.||++||++. ++++||||
T Consensus 229 ~~~~li~~~l~~~p~~Rp~~~----~~l~~~~~ 257 (257)
T cd08223 229 ELGELIATMLSKRPEKRPSVK----SILRQPYI 257 (257)
T ss_pred HHHHHHHHHhccCcccCCCHH----HHhcCCCC
Confidence 589999999999999999987 99999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-47 Score=347.11 Aligned_cols=258 Identities=26% Similarity=0.438 Sum_probs=216.9
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
+-|.++.+||+|+||.||+|.++. +++.+|||.+..+ ..++++..|+.+|+++..|+||++|+.|.....
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~E-----sG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD 102 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRE-----SGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD 102 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhc-----cCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCc
Confidence 347788999999999999999998 6899999999765 345677789999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
+++|||||..|++.++++.+ .++|++.++..+++..+.||+|||...=||||||..|||++.+|+.||+|||.|-.+..
T Consensus 103 LWIVMEYCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD 181 (502)
T KOG0574|consen 103 LWIVMEYCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD 181 (502)
T ss_pred eEeehhhcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhh
Confidence 99999999999999988765 47899999999999999999999999999999999999999999999999999832211
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
.-
T Consensus 182 ------------------------------------------------------------------------------TM 183 (502)
T KOG0574|consen 182 ------------------------------------------------------------------------------TM 183 (502)
T ss_pred ------------------------------------------------------------------------------hH
Confidence 01
Q ss_pred cCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHh
Q 011302 324 ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVV 403 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~ 403 (489)
....+++|||.|||||++...+|+.++||||||++..||..|++||....+...+.-|-.. .|.. -..++.|. .
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~---PPPT-F~KPE~WS--~ 257 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTK---PPPT-FKKPEEWS--S 257 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCC---CCCC-CCChHhhh--h
Confidence 2346779999999999999999999999999999999999999999887665443333222 1111 11122222 2
Q ss_pred hHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 404 KLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 404 ~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
++.|||++||.+.|++|-++. ++++|||.++-.
T Consensus 258 ~F~DFi~~CLiK~PE~R~TA~----~L~~H~FiknA~ 290 (502)
T KOG0574|consen 258 EFNDFIRSCLIKKPEERKTAL----RLCEHTFIKNAP 290 (502)
T ss_pred HHHHHHHHHhcCCHHHHHHHH----HHhhhhhhcCCC
Confidence 478999999999999999998 999999998653
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=340.58 Aligned_cols=256 Identities=26% Similarity=0.417 Sum_probs=214.6
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceE
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYS 164 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 164 (489)
+|.+.+.||+|+||.||+|.++. +++.|++|.+...... ......+..|+.+++.++||||+++++++.+.+..
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKA-----DKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKL 74 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcC-----CCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEE
Confidence 58899999999999999999886 5688999998765433 23345677899999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccC
Q 011302 165 CLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVV 244 (489)
Q Consensus 165 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~ 244 (489)
|+||||++|++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++.+...
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 75 NIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred EEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 99999999999999988765567999999999999999999999999999999999999999999999999987432210
Q ss_pred ccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccccc
Q 011302 245 PKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINA 324 (489)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (489)
. .
T Consensus 155 ~------------------------------------------------------------------------------~ 156 (256)
T cd08529 155 T------------------------------------------------------------------------------N 156 (256)
T ss_pred c------------------------------------------------------------------------------c
Confidence 0 0
Q ss_pred CCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhh
Q 011302 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVK 404 (489)
Q Consensus 325 ~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~ 404 (489)
......|++.|+|||++.+..++.++|||||||++|||++|..||...+.......+..+.... .... ....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~------~~~~ 228 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPP--VSQM------YSQQ 228 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC--Cccc------cCHH
Confidence 0122368899999999999889999999999999999999999999888777666666543221 1111 1235
Q ss_pred HHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 405 LQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 405 l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
+.++|.+||+.+|++||++. ++++|||+
T Consensus 229 ~~~~i~~~l~~~p~~Rp~~~----~ll~~~~~ 256 (256)
T cd08529 229 LAQLIDQCLTKDYRQRPDTF----QLLRNPSL 256 (256)
T ss_pred HHHHHHHHccCCcccCcCHH----HHhhCCCC
Confidence 89999999999999999998 99999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=378.31 Aligned_cols=259 Identities=24% Similarity=0.350 Sum_probs=219.6
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE 159 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 159 (489)
.+...+.+..+.||+|.||+||+|+..+.........||||.++..... +...+|.+|+++|..++|||||+|+|+|.
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~--~~~~dF~REaeLla~l~H~nIVrLlGVC~ 559 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAEN--QARQDFRREAELLAELQHPNIVRLLGVCR 559 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccH--HHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence 4567788999999999999999999998877778899999999876544 35567888999999999999999999999
Q ss_pred cCceEEEEEeecCCCchHHHHHhCC--------C----CCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccC
Q 011302 160 ASHYSCLVMEYCPGGDLYAARQRQP--------G----KRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRED 227 (489)
Q Consensus 160 ~~~~~~lV~E~~~gg~L~~~l~~~~--------~----~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~ 227 (489)
.++.+|||+|||..|||.++|.-.. + ..|+..+.+.|+.||+.||+||-++.+|||||..+|+||+++
T Consensus 560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGEN 639 (774)
T ss_pred cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccc
Confidence 9999999999999999999987542 1 238888999999999999999999999999999999999999
Q ss_pred CcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCC
Q 011302 228 GHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHH 307 (489)
Q Consensus 228 ~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (489)
..|||+|||+++..... +.|+
T Consensus 640 l~VKIsDfGLsRdiYss-------------DYYk---------------------------------------------- 660 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSS-------------DYYK---------------------------------------------- 660 (774)
T ss_pred eEEEecccccchhhhhh-------------hhhc----------------------------------------------
Confidence 99999999998543210 0000
Q ss_pred CccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCC
Q 011302 308 DQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPL 386 (489)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~ 386 (489)
......-...|||||.|...+|+.++|||||||+|||+++ |..||.+..+.++++.|..+..
T Consensus 661 -----------------~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l 723 (774)
T KOG1026|consen 661 -----------------VRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL 723 (774)
T ss_pred -----------------ccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc
Confidence 0001123458999999999999999999999999999996 9999999999999999998876
Q ss_pred CCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 387 TFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 387 ~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
++..... + .++.+||..||+.+|.+||++.
T Consensus 724 -L~~Pe~C-P------~~vY~LM~~CW~~~P~~RPsF~ 753 (774)
T KOG1026|consen 724 -LSCPENC-P------TEVYSLMLECWNENPKRRPSFK 753 (774)
T ss_pred -ccCCCCC-C------HHHHHHHHHHhhcCcccCCCHH
Confidence 4333222 1 2489999999999999999996
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=342.62 Aligned_cols=262 Identities=26% Similarity=0.376 Sum_probs=210.2
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHH---HHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREA---LAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS 161 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 161 (489)
+|++.+.||+|+||+||+|... ++..+|+|.+.... .........+.+|+.+++.++|+||+++++++.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~------~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN------QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD 74 (265)
T ss_pred CccccceEeccCCeEEEEEEEc------CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC
Confidence 5788999999999999999864 35789999886431 22234456688899999999999999999999999
Q ss_pred ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccc
Q 011302 162 HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKC 241 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~ 241 (489)
+..|+||||++|++|.+++.+. ..+++..+..++.|++.||+|||+.+|+|+||||+||+++.++.++|+|||++...
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 9999999999999999998765 46889999999999999999999999999999999999999999999999987432
Q ss_pred ccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccc
Q 011302 242 DVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEP 321 (489)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (489)
...... ..
T Consensus 153 ~~~~~~------------------------------------------------------------------------~~ 160 (265)
T cd06631 153 AWVGLH------------------------------------------------------------------------GT 160 (265)
T ss_pred hhcccc------------------------------------------------------------------------cc
Confidence 110000 00
Q ss_pred cccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHH
Q 011302 322 INARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEE 401 (489)
Q Consensus 322 ~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 401 (489)
.........|+..|+|||++.+..++.++|||||||++|+|++|..||...+.......+.......+......
T Consensus 161 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 234 (265)
T cd06631 161 HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSF------ 234 (265)
T ss_pred ccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCC------
Confidence 00111234689999999999998899999999999999999999999988766555444443322222222211
Q ss_pred HhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 402 VVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 402 ~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
...+.+||.+||..+|++||++. ++++||||
T Consensus 235 ~~~~~~~i~~~l~~~p~~Rp~~~----~~l~~~~~ 265 (265)
T cd06631 235 SAAAIDFVTSCLTRDQHERPSAL----QLLRHDFL 265 (265)
T ss_pred CHHHHHHHHHHhcCCcccCCCHH----HHhcCCCC
Confidence 22489999999999999999987 99999998
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=364.08 Aligned_cols=253 Identities=28% Similarity=0.393 Sum_probs=217.4
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceE
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYS 164 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 164 (489)
.|.-++.||.|+||.||.|++.. +...||||.+.-..-....+...+..|+..|+.+.|||+|.+.|+|-.+...
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~-----n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~Ta 101 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVR-----NSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTA 101 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccC-----ccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchH
Confidence 47778899999999999999987 6789999999766555567788899999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccC
Q 011302 165 CLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVV 244 (489)
Q Consensus 165 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~ 244 (489)
+|||||| -|+-.|++.-.. +++.+.++..|+.+.+.||+|||+.+.||||||..|||+++.|.|||+|||.|...
T Consensus 102 WLVMEYC-lGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~--- 176 (948)
T KOG0577|consen 102 WLVMEYC-LGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIM--- 176 (948)
T ss_pred HHHHHHH-hccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhc---
Confidence 9999999 677777776543 67999999999999999999999999999999999999999999999999987322
Q ss_pred ccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccccc
Q 011302 245 PKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINA 324 (489)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (489)
.
T Consensus 177 -------------------------------------------------------------------------------~ 177 (948)
T KOG0577|consen 177 -------------------------------------------------------------------------------A 177 (948)
T ss_pred -------------------------------------------------------------------------------C
Confidence 1
Q ss_pred CCccccCCCCccCcchhcC---CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHH
Q 011302 325 RSKSFVGTHEYLAPEVISG---QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEE 401 (489)
Q Consensus 325 ~~~~~~Gt~~y~aPE~l~~---~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 401 (489)
...+|+|||+|||||+|.. ..|+-++||||||+++.||.-.++|+...+....+..|..+.. |. ....+|..
T Consensus 178 PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNes--Pt---Lqs~eWS~ 252 (948)
T KOG0577|consen 178 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--PT---LQSNEWSD 252 (948)
T ss_pred chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCC--CC---CCCchhHH
Confidence 2467899999999999864 3489999999999999999999999999998888888866422 11 11223322
Q ss_pred HhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcC
Q 011302 402 VVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437 (489)
Q Consensus 402 ~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~ 437 (489)
.++.||..||.+-|.+||+.. ++++|+|..
T Consensus 253 --~F~~Fvd~CLqKipqeRptse----~ll~H~fv~ 282 (948)
T KOG0577|consen 253 --YFRNFVDSCLQKIPQERPTSE----ELLKHRFVL 282 (948)
T ss_pred --HHHHHHHHHHhhCcccCCcHH----HHhhcchhc
Confidence 378999999999999999997 999999974
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=348.63 Aligned_cols=262 Identities=27% Similarity=0.437 Sum_probs=213.8
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.++|++++.||.|+||.||+|.+.. ++..||+|++..... .....+..|+.+++.++||||+++++++..+.
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKE-----TGLFAAAKIIQIESE---EELEDFMVEIDILSECKHPNIVGLYEAYFYEN 75 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcC-----CCcEEEEEEEeeCCH---HHHHHHHHHHHHHHhCCCCceeEEEEEEecCC
Confidence 3679999999999999999999876 467899999865422 23456777999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
..|+||||+++++|.+++... ...+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~ 154 (280)
T cd06611 76 KLWILIEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNK 154 (280)
T ss_pred eEEEEeeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhc
Confidence 999999999999999988764 2569999999999999999999999999999999999999999999999999873211
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
..
T Consensus 155 ~~------------------------------------------------------------------------------ 156 (280)
T cd06611 155 ST------------------------------------------------------------------------------ 156 (280)
T ss_pred cc------------------------------------------------------------------------------
Confidence 00
Q ss_pred ccCCccccCCCCccCcchhc-----CCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCch
Q 011302 323 NARSKSFVGTHEYLAPEVIS-----GQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSK 397 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~-----~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 397 (489)
........||+.|+|||++. ...++.++|||||||++|||++|..||.+.+....+.++..............
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 234 (280)
T cd06611 157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKW-- 234 (280)
T ss_pred ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccC--
Confidence 00112346899999999985 34467899999999999999999999998877776666655432111111111
Q ss_pred hHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCc
Q 011302 398 EFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINW 441 (489)
Q Consensus 398 ~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~ 441 (489)
...+.+||.+||..+|.+||++. ++++||||....+
T Consensus 235 ----~~~~~~li~~~l~~~p~~Rps~~----~il~~~~~~~~~~ 270 (280)
T cd06611 235 ----SSSFNDFLKSCLVKDPDDRPTAA----ELLKHPFVSDQSD 270 (280)
T ss_pred ----CHHHHHHHHHHhccChhhCcCHH----HHhcChhhcccch
Confidence 12488999999999999999987 9999999988643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=341.35 Aligned_cols=265 Identities=42% Similarity=0.721 Sum_probs=219.8
Q ss_pred eccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEEEEEeec
Q 011302 92 LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYC 171 (489)
Q Consensus 92 lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 171 (489)
||.|+||.||+|++.. +++.|++|++.............+.+|..+++.++||||+++++.+..+...|+||||+
T Consensus 1 lg~g~~~~vy~~~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKS-----TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECC-----CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecC
Confidence 6899999999999886 46889999998776655566677888999999999999999999999999999999999
Q ss_pred CCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCccccCCc
Q 011302 172 PGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPK 251 (489)
Q Consensus 172 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 251 (489)
+|++|.+++.+. ..+++..+..++.||+.||+|||++|++||||+|+||+++.++.++|+|||++..........
T Consensus 76 ~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~--- 150 (265)
T cd05579 76 PGGDLASLLENV--GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQIN--- 150 (265)
T ss_pred CCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccc---
Confidence 999999998775 478999999999999999999999999999999999999999999999999974321100000
Q ss_pred chhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCccccC
Q 011302 252 LSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVG 331 (489)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 331 (489)
............+
T Consensus 151 -------------------------------------------------------------------~~~~~~~~~~~~~ 163 (265)
T cd05579 151 -------------------------------------------------------------------LNDDEKEDKRIVG 163 (265)
T ss_pred -------------------------------------------------------------------cccccccccCccc
Confidence 0000011233468
Q ss_pred CCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHHHHH
Q 011302 332 THEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISK 411 (489)
Q Consensus 332 t~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~ 411 (489)
+..|+|||.+.+..++.++|||||||++|+|++|..||........+..+..+...++.... ....+.+||.+
T Consensus 164 ~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~i~~ 236 (265)
T cd05579 164 TPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVE-------VSDEAIDLISK 236 (265)
T ss_pred CccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCcccc-------CCHHHHHHHHH
Confidence 88999999999888999999999999999999999999988888777777765555443321 12358999999
Q ss_pred HhhcCcccccCCCCChHHHHcCCCcCCCCc
Q 011302 412 LLVKNPKKRIGSLKGSVEIKRHEFFKGINW 441 (489)
Q Consensus 412 ~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~ 441 (489)
||+.+|.+||++ ..+.++++||||+.++|
T Consensus 237 ~l~~~p~~Rpt~-~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 237 LLVPDPEKRLGA-KSIEEIKNHPFFKGIDW 265 (265)
T ss_pred HhcCCHhhcCCC-ccHHHHhcCccccCCCC
Confidence 999999999998 24449999999999998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=365.27 Aligned_cols=261 Identities=18% Similarity=0.234 Sum_probs=205.4
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccce
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAE 157 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~ 157 (489)
|.+..++|++.+.||+|+||.||+|++...........||||++...... .....+.+|+.+++.+ +|+|||+++++
T Consensus 33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~~h~nIv~~~~~ 110 (374)
T cd05106 33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT--DEREALMSELKILSHLGQHKNIVNLLGA 110 (374)
T ss_pred ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH--HHHHHHHHHHHHHHhhccCCceeeEeeE
Confidence 44566789999999999999999999765433345668999999754322 2345677899999999 89999999999
Q ss_pred eecCceEEEEEeecCCCchHHHHHhCC-----------------------------------------------------
Q 011302 158 FEASHYSCLVMEYCPGGDLYAARQRQP----------------------------------------------------- 184 (489)
Q Consensus 158 ~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------------------------------------------- 184 (489)
+...+.+|+|||||++|+|.+++....
T Consensus 111 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 111 CTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred ecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 999999999999999999999886421
Q ss_pred ---------------CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCccccC
Q 011302 185 ---------------GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLR 249 (489)
Q Consensus 185 ---------------~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 249 (489)
..++++.++..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~--- 267 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN--- 267 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc---
Confidence 12478888999999999999999999999999999999999999999999999843211000
Q ss_pred CcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCccc
Q 011302 250 PKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSF 329 (489)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (489)
.......
T Consensus 268 -------------------------------------------------------------------------~~~~~~~ 274 (374)
T cd05106 268 -------------------------------------------------------------------------YVVKGNA 274 (374)
T ss_pred -------------------------------------------------------------------------eeeccCC
Confidence 0001122
Q ss_pred cCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHH
Q 011302 330 VGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDL 408 (489)
Q Consensus 330 ~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~l 408 (489)
.+++.|||||++.+..++.++|||||||++|||++ |..||........+..+.......+.... .+.++.+|
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~l~~l 347 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDF-------APPEIYSI 347 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCC-------CCHHHHHH
Confidence 35678999999998889999999999999999997 99999887655544454443322221111 11358999
Q ss_pred HHHHhhcCcccccCCC
Q 011302 409 ISKLLVKNPKKRIGSL 424 (489)
Q Consensus 409 i~~~L~~dP~~R~~~~ 424 (489)
|.+||+.||++||++.
T Consensus 348 i~~cl~~dp~~RPs~~ 363 (374)
T cd05106 348 MKMCWNLEPTERPTFS 363 (374)
T ss_pred HHHHcCCChhhCcCHH
Confidence 9999999999999997
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=348.86 Aligned_cols=240 Identities=15% Similarity=0.165 Sum_probs=199.1
Q ss_pred eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec----CceEE
Q 011302 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA----SHYSC 165 (489)
Q Consensus 90 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~~ 165 (489)
..||+|++|.||+|.+. ++.||||++.............+.+|+.+|++++||||+++++++.+ ...+|
T Consensus 26 ~~i~~g~~~~v~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~ 98 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN-------NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLS 98 (283)
T ss_pred eEEeeCCceEEEEEEEC-------CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceE
Confidence 57999999999999875 46899999987654444445677889999999999999999999876 45789
Q ss_pred EEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHh-CCCeeecCCCCCeEeccCCcEEEcccCCCcccccC
Q 011302 166 LVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHM-MGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVV 244 (489)
Q Consensus 166 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~ 244 (489)
+||||++||+|.+++... ..+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++.+..
T Consensus 99 lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~- 175 (283)
T PHA02988 99 LILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS- 175 (283)
T ss_pred EEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcc-
Confidence 999999999999998765 568899999999999999999998 4999999999999999999999999999743210
Q ss_pred ccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccccc
Q 011302 245 PKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINA 324 (489)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (489)
T Consensus 176 -------------------------------------------------------------------------------- 175 (283)
T PHA02988 176 -------------------------------------------------------------------------------- 175 (283)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCccccCCCCccCcchhcC--CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHH
Q 011302 325 RSKSFVGTHEYLAPEVISG--QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEV 402 (489)
Q Consensus 325 ~~~~~~Gt~~y~aPE~l~~--~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~ 402 (489)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+..+....+......++... .. +
T Consensus 176 ~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~-~~------~ 248 (283)
T PHA02988 176 PPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPL-DC------P 248 (283)
T ss_pred ccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCC-cC------c
Confidence 0012358899999999976 6789999999999999999999999999888777777765443333211 11 1
Q ss_pred hhHHHHHHHHhhcCcccccCCCCC
Q 011302 403 VKLQDLISKLLVKNPKKRIGSLKG 426 (489)
Q Consensus 403 ~~l~~li~~~L~~dP~~R~~~~~~ 426 (489)
..+++||.+||+.||++||++.+.
T Consensus 249 ~~l~~li~~cl~~dp~~Rps~~el 272 (283)
T PHA02988 249 LEIKCIVEACTSHDSIKRPNIKEI 272 (283)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHH
Confidence 258999999999999999999733
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=345.87 Aligned_cols=256 Identities=28% Similarity=0.408 Sum_probs=204.9
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccceeec-
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAEFEA- 160 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~- 160 (489)
.+.|++.+.||+|+||+||+|.+.. .++.||+|++..... ....+..|+.+++.+ +||||+++++++..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~-----~~~~~aik~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 75 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVK-----TGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKK 75 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcC-----CCcEEEEEEEEcCCc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEeec
Confidence 3678999999999999999999886 578899999875421 123456688888888 69999999999864
Q ss_pred -----CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEccc
Q 011302 161 -----SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235 (489)
Q Consensus 161 -----~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DF 235 (489)
...+|+||||+++|+|.+++.......+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+||
T Consensus 76 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Df 155 (272)
T cd06637 76 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDF 155 (272)
T ss_pred CCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccC
Confidence 246899999999999999988765567999999999999999999999999999999999999999999999999
Q ss_pred CCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCc
Q 011302 236 DLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDP 315 (489)
Q Consensus 236 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (489)
|+++.....
T Consensus 156 g~~~~~~~~----------------------------------------------------------------------- 164 (272)
T cd06637 156 GVSAQLDRT----------------------------------------------------------------------- 164 (272)
T ss_pred CCceecccc-----------------------------------------------------------------------
Confidence 997432110
Q ss_pred cccccccccCCccccCCCCccCcchhcC-----CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCC
Q 011302 316 EVVAEPINARSKSFVGTHEYLAPEVISG-----QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPR 390 (489)
Q Consensus 316 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~ 390 (489)
........|++.|+|||++.+ ..++.++|||||||++|||++|..||...........+.........
T Consensus 165 -------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd06637 165 -------VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLK 237 (272)
T ss_pred -------cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCC
Confidence 001223468999999999863 35788999999999999999999999876655444444332211111
Q ss_pred CCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 391 IGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 391 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
.. . ....+.+||.+||..||.+||++. +++.||||
T Consensus 238 ~~-~------~~~~~~~li~~~l~~~p~~Rpt~~----~il~~~~~ 272 (272)
T cd06637 238 SK-K------WSKKFQSFIESCLVKNHSQRPTTE----QLMKHPFI 272 (272)
T ss_pred CC-C------cCHHHHHHHHHHcCCChhhCCCHH----HHhhCCCC
Confidence 00 1 112589999999999999999987 99999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=363.02 Aligned_cols=261 Identities=18% Similarity=0.243 Sum_probs=203.9
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccce
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAE 157 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~ 157 (489)
+.+..++|++.+.||+|+||.||+|++.......+...||+|+++..... .....+.+|+.+|+.+ +||||++++++
T Consensus 30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~Ei~il~~l~~HpnIv~l~~~ 107 (375)
T cd05104 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHINIVNLLGA 107 (375)
T ss_pred cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc--HHHHHHHHHHHHHHHhcCCcceeeeeee
Confidence 34556789999999999999999998654322335678999999754322 2334677899999999 89999999999
Q ss_pred eecCceEEEEEeecCCCchHHHHHhCC-----------------------------------------------------
Q 011302 158 FEASHYSCLVMEYCPGGDLYAARQRQP----------------------------------------------------- 184 (489)
Q Consensus 158 ~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------------------------------------------- 184 (489)
+.++...|+|||||+||+|.+++....
T Consensus 108 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 187 (375)
T cd05104 108 CTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR 187 (375)
T ss_pred eccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence 999999999999999999998886431
Q ss_pred --------------------CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccC
Q 011302 185 --------------------GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVV 244 (489)
Q Consensus 185 --------------------~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~ 244 (489)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 124778889999999999999999999999999999999999999999999998432110
Q ss_pred ccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccccc
Q 011302 245 PKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINA 324 (489)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (489)
.. ..
T Consensus 268 ~~----------------------------------------------------------------------------~~ 271 (375)
T cd05104 268 SN----------------------------------------------------------------------------YV 271 (375)
T ss_pred cc----------------------------------------------------------------------------cc
Confidence 00 00
Q ss_pred CCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHh
Q 011302 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVV 403 (489)
Q Consensus 325 ~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~ 403 (489)
......++..|+|||++.+..++.++|||||||++|||++ |..||.+......+.++........... .. +.
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~------~~ 344 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPE-CA------PS 344 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCC-CC------CH
Confidence 0112235678999999999999999999999999999997 9999988765554444444332221111 11 12
Q ss_pred hHHHHHHHHhhcCcccccCCC
Q 011302 404 KLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 404 ~l~~li~~~L~~dP~~R~~~~ 424 (489)
++.+||.+||..||++||++.
T Consensus 345 ~l~~li~~cl~~dP~~RPs~~ 365 (375)
T cd05104 345 EMYDIMKSCWDADPLKRPTFK 365 (375)
T ss_pred HHHHHHHHHccCChhHCcCHH
Confidence 589999999999999999997
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=350.52 Aligned_cols=254 Identities=27% Similarity=0.411 Sum_probs=203.9
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
++|++++.||+|+||.||+|.+.. +++.||+|++..+.. ......+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 73 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLL-----TRRILAVKVIPLDIT--VELQKQIMSELEILYKCDSPYIIGFYGAFFVENR 73 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcC-----CCcEEEEEEEecCCC--hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCE
Confidence 478899999999999999999876 578899999875421 1233457789999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
.++||||+++++|..+ ..+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++.....
T Consensus 74 ~~lv~e~~~~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 74 ISICTEFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred EEEEEecCCCCChHHh------hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence 9999999999999543 2478888999999999999999999999999999999999999999999999732210
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
T Consensus 148 -------------------------------------------------------------------------------- 147 (279)
T cd06619 148 -------------------------------------------------------------------------------- 147 (279)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcH-------HHHHHHhcCCCCCCCCCCCCc
Q 011302 324 ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNE-------KTLINILKKPLTFPRIGVSSS 396 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-------~~~~~i~~~~~~~p~~~~~~~ 396 (489)
......+||..|+|||++.+..++.++|||||||++|+|++|..||...... .....+..... +.....
T Consensus 148 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~-- 223 (279)
T cd06619 148 SIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP--PVLPVG-- 223 (279)
T ss_pred ccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC--CCCCCC--
Confidence 0112347899999999999988999999999999999999999999653221 22222222111 111000
Q ss_pred hhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCc
Q 011302 397 KEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINW 441 (489)
Q Consensus 397 ~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~ 441 (489)
....++.+||.+||..||++||++. +++.||||...+-
T Consensus 224 ---~~~~~~~~li~~~l~~~P~~Rp~~~----eil~~~~~~~~~~ 261 (279)
T cd06619 224 ---QFSEKFVHFITQCMRKQPKERPAPE----NLMDHPFIVQYND 261 (279)
T ss_pred ---cCCHHHHHHHHHHhhCChhhCCCHH----HHhcCcccccccC
Confidence 1123589999999999999999987 9999999987654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=347.47 Aligned_cols=263 Identities=27% Similarity=0.372 Sum_probs=203.5
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceE
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYS 164 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 164 (489)
+|++++.||+|+||.||+|+++. ++..||||.+...... ......+..|+.+++.++||||+++++++.+++.+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKK-----TGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRL 74 (285)
T ss_pred CceEeeEecccCceEEEEEEECC-----CCcEEEEEEecccccc-CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeE
Confidence 58899999999999999999876 4678999998654221 12234566799999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhCC-CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 165 CLVMEYCPGGDLYAARQRQP-GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 165 ~lV~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
|+||||++ ++|.+++.... +..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+..
T Consensus 75 ~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 153 (285)
T cd07861 75 YLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI 153 (285)
T ss_pred EEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCC
Confidence 99999996 68888876543 35789999999999999999999999999999999999999999999999999732210
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
. .
T Consensus 154 ~------------------------------------------------------------------------------~ 155 (285)
T cd07861 154 P------------------------------------------------------------------------------V 155 (285)
T ss_pred C------------------------------------------------------------------------------c
Confidence 0 0
Q ss_pred cCCccccCCCCccCcchhcCC-CCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCC-----C---------
Q 011302 324 ARSKSFVGTHEYLAPEVISGQ-GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLT-----F--------- 388 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-----~--------- 388 (489)
.......|++.|+|||++.+. .++.++|||||||++|||++|++||.+.+.......+...... +
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence 001122578899999998764 4788999999999999999999999887665444333211000 0
Q ss_pred ----CCCCCCC--chhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 389 ----PRIGVSS--SKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 389 ----p~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
+...... ......+.++.+||.+||+.||.+||++. +|+.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~----~ll~~~~~ 285 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAK----KALNHPYF 285 (285)
T ss_pred HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHH----HHhcCCCC
Confidence 0000000 00001223578999999999999999987 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=373.38 Aligned_cols=277 Identities=22% Similarity=0.330 Sum_probs=199.2
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEE--------------eeehHHHHHHHHHHHHHHHHHHHHhCC
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMK--------------VVDREALAIRKKLHRADMEKVILTMLD 147 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK--------------~~~~~~~~~~~~~~~~~~E~~~l~~l~ 147 (489)
..++|++++.||+|+||+||+|..+... ...+++| ++.+...........+.+|+.+|+.++
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~ 221 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRAST----EEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLN 221 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccc----hhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCC
Confidence 3578999999999999999999876421 1111111 111111112233456778999999999
Q ss_pred CCCcccccceeecCceEEEEEeecCCCchHHHHHhCC---CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEe
Q 011302 148 HPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQP---GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLV 224 (489)
Q Consensus 148 hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl 224 (489)
|||||++++++.+.+..|+|||++ +++|..++.... ........++.|+.||+.||+|||++|||||||||+||||
T Consensus 222 HpnIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl 300 (501)
T PHA03210 222 HENILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL 300 (501)
T ss_pred CCCcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 999999999999999999999999 677877765421 1233456788899999999999999999999999999999
Q ss_pred ccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCC
Q 011302 225 REDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDG 304 (489)
Q Consensus 225 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (489)
+.+|.+||+|||+++.+...
T Consensus 301 ~~~~~vkL~DFGla~~~~~~------------------------------------------------------------ 320 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKE------------------------------------------------------------ 320 (501)
T ss_pred CCCCCEEEEeCCCceecCcc------------------------------------------------------------
Confidence 99999999999998433110
Q ss_pred CCCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCC-CCC--CcHHHHHHH
Q 011302 305 DHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPF-KGE--NNEKTLINI 381 (489)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf-~~~--~~~~~~~~i 381 (489)
........+||+.|+|||++.+..++.++|||||||++|||++|..++ .+. .....+.++
T Consensus 321 -----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~ 383 (501)
T PHA03210 321 -----------------REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383 (501)
T ss_pred -----------------cccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence 001123457999999999999999999999999999999999987654 322 222333333
Q ss_pred hcC----CCCCCCCCC----------------CCchh---HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 382 LKK----PLTFPRIGV----------------SSSKE---FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 382 ~~~----~~~~p~~~~----------------~~~~~---~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
... ...+|.... ..... ......+.++|.+||.+||.+||++. |+|.||||..
T Consensus 384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~----elL~hp~f~~ 459 (501)
T PHA03210 384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAA----ELLALPLFSA 459 (501)
T ss_pred HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHH----HHhhChhhhc
Confidence 221 111121100 00000 01122467889999999999999998 9999999998
Q ss_pred CCcccc
Q 011302 439 INWALI 444 (489)
Q Consensus 439 ~~~~~~ 444 (489)
..+..+
T Consensus 460 ~~~~~~ 465 (501)
T PHA03210 460 EEEEEI 465 (501)
T ss_pred CCchHH
Confidence 776654
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=339.81 Aligned_cols=255 Identities=36% Similarity=0.660 Sum_probs=212.4
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceE
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYS 164 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 164 (489)
+|++.+.||.|+||.||+|.+.. ++..||+|++.+...........+..|+.+++.++||||+++++++.++...
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRD-----TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEcc-----CCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeE
Confidence 58999999999999999999876 5678999999877655445667788899999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccC
Q 011302 165 CLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVV 244 (489)
Q Consensus 165 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~ 244 (489)
|+||||+.|++|.+++... ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred EEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 9999999999999988765 57999999999999999999999999999999999999999999999999987322100
Q ss_pred ccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccccc
Q 011302 245 PKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINA 324 (489)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (489)
.
T Consensus 154 -------------------------------------------------------------------------------~ 154 (258)
T cd05578 154 -------------------------------------------------------------------------------T 154 (258)
T ss_pred -------------------------------------------------------------------------------c
Confidence 0
Q ss_pred CCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCc--HHHHHHHhc-CCCCCCCCCCCCchhHHH
Q 011302 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENN--EKTLINILK-KPLTFPRIGVSSSKEFEE 401 (489)
Q Consensus 325 ~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~--~~~~~~i~~-~~~~~p~~~~~~~~~~~~ 401 (489)
......|+..|+|||++.+..++.++|+|||||++|+|++|..||...+. ...+..... .....|.. .
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~------ 225 (258)
T cd05578 155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPAT---W------ 225 (258)
T ss_pred cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCccc---C------
Confidence 01123578899999999998899999999999999999999999988764 222223222 22222221 1
Q ss_pred HhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 402 VVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 402 ~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
...+.++|.+||..||.+|+++. ++++++||||
T Consensus 226 ~~~~~~~i~~~l~~~p~~R~~~~--~~~l~~~~~~ 258 (258)
T cd05578 226 STEAIDAINKLLERDPQKRLGDN--LKDLKNHPYF 258 (258)
T ss_pred cHHHHHHHHHHccCChhHcCCcc--HHHHhcCCCC
Confidence 13589999999999999999992 3499999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=353.70 Aligned_cols=261 Identities=30% Similarity=0.414 Sum_probs=208.3
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-CCCcccccceee
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-HPFLPTLYAEFE 159 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~ 159 (489)
+....|+++++||+||-++||++..-+ ...||+|.+..... ....+.-+..|+.+|.+|. |.+||+|+++-.
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~------~~iyalkkv~~~~~-D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv 430 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSD------KQIYALKKVVLLEA-DNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV 430 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCC------CcchhhhHHHHhhc-CHHHHHHHHHHHHHHHHhcCCceEEEEeeeec
Confidence 345679999999999999999998664 46778777754433 3456777888999999995 999999999999
Q ss_pred cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 160 ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 160 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
.++.+||||||= ..||..+|++.... +..-.++.|..||+.|+.++|..||||.||||.|+|+- .|.+||+|||+|.
T Consensus 431 ~d~~lYmvmE~G-d~DL~kiL~k~~~~-~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~ 507 (677)
T KOG0596|consen 431 TDGYLYMVMECG-DIDLNKILKKKKSI-DPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIAN 507 (677)
T ss_pred cCceEEEEeecc-cccHHHHHHhccCC-CchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhc
Confidence 999999999975 78999999876433 33238899999999999999999999999999999986 7899999999995
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
.+..-..
T Consensus 508 aI~~DTT------------------------------------------------------------------------- 514 (677)
T KOG0596|consen 508 AIQPDTT------------------------------------------------------------------------- 514 (677)
T ss_pred ccCcccc-------------------------------------------------------------------------
Confidence 4332110
Q ss_pred cccccCCccccCCCCccCcchhcCCC-----------CCCcccHHHHHHHHHHHhhCCCCCCCCC-cHHHHHHHhcCC--
Q 011302 320 EPINARSKSFVGTHEYLAPEVISGQG-----------HGSAVDWWTLGVFLYEMLYGTTPFKGEN-NEKTLINILKKP-- 385 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~~~-----------~~~~~DiwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~~~-- 385 (489)
+-...+-+||+.||+||.+.... .+.++||||||||||+|+.|++||.... ...-+..|....
T Consensus 515 ---sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~ 591 (677)
T KOG0596|consen 515 ---SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHE 591 (677)
T ss_pred ---ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcc
Confidence 11123448999999999996543 3578999999999999999999997654 344455555543
Q ss_pred CCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 386 LTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 386 ~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
++||...... ++.++++.||.+||.+||++- +||+|||+..+
T Consensus 592 Iefp~~~~~~--------~li~~mK~CL~rdPkkR~si~----eLLqhpFl~~~ 633 (677)
T KOG0596|consen 592 IEFPDIPEND--------ELIDVMKCCLARDPKKRWSIP----ELLQHPFLQIQ 633 (677)
T ss_pred ccccCCCCch--------HHHHHHHHHHhcCcccCCCcH----HHhcCcccccc
Confidence 3566544332 389999999999999999998 99999999874
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-44 Score=343.50 Aligned_cols=258 Identities=27% Similarity=0.444 Sum_probs=207.5
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS 161 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 161 (489)
..++|.+.+.||+|+||.||+|++.. +++.||+|+++.... .....+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~---~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~ 78 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVN-----TGELAAIKVIKLEPG---EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR 78 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcC-----CCcEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Confidence 34689999999999999999999876 567899999875432 2233456799999999999999999999999
Q ss_pred ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccc
Q 011302 162 HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKC 241 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~ 241 (489)
+..|+||||+++++|.+++... +.+++.++..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..+
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd06645 79 DKLWICMEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQI 156 (267)
T ss_pred CEEEEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEc
Confidence 9999999999999999988765 57999999999999999999999999999999999999999999999999997332
Q ss_pred ccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccc
Q 011302 242 DVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEP 321 (489)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (489)
...
T Consensus 157 ~~~----------------------------------------------------------------------------- 159 (267)
T cd06645 157 TAT----------------------------------------------------------------------------- 159 (267)
T ss_pred cCc-----------------------------------------------------------------------------
Confidence 100
Q ss_pred cccCCccccCCCCccCcchhc---CCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchh
Q 011302 322 INARSKSFVGTHEYLAPEVIS---GQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKE 398 (489)
Q Consensus 322 ~~~~~~~~~Gt~~y~aPE~l~---~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 398 (489)
........||+.|+|||++. ...++.++|||||||++|||++|..||...........+.......+..... .
T Consensus 160 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~- 235 (267)
T cd06645 160 -IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDK--M- 235 (267)
T ss_pred -ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCccccc--C-
Confidence 00112346899999999985 4457889999999999999999999997766554444443333322221110 0
Q ss_pred HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCC
Q 011302 399 FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEF 435 (489)
Q Consensus 399 ~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~ 435 (489)
.....+.+||.+||..+|++||++. ++++|||
T Consensus 236 -~~~~~~~~li~~~l~~~P~~R~~~~----~ll~~~~ 267 (267)
T cd06645 236 -KWSNSFHHFVKMALTKNPKKRPTAE----KLLQHPF 267 (267)
T ss_pred -CCCHHHHHHHHHHccCCchhCcCHH----HHhcCCC
Confidence 0112488999999999999999987 9999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=361.78 Aligned_cols=264 Identities=22% Similarity=0.322 Sum_probs=220.6
Q ss_pred HHhhcCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccc
Q 011302 74 LRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPT 153 (489)
Q Consensus 74 ~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~ 153 (489)
+....|++..++..+.++||+|+||+||+|+.+...... ...||||..+.+....+....++.+|+++|+.++|||||+
T Consensus 147 I~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~-~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr 225 (474)
T KOG0194|consen 147 IPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFK-VVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVR 225 (474)
T ss_pred ccccccEEeccCccccceeecccccEEEEEEEEecCCce-eeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEE
Confidence 455667888899999999999999999999988643211 1228999998755555677889999999999999999999
Q ss_pred ccceeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEc
Q 011302 154 LYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLS 233 (489)
Q Consensus 154 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~ 233 (489)
+||+......+|||||+|.||+|.++|++.+ ..++..+...++.+.+.||+|||++++|||||..+|+|++.++.+||+
T Consensus 226 ~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~-~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKIS 304 (474)
T KOG0194|consen 226 FYGVAVLEEPLMLVMELCNGGSLDDYLKKNK-KSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKIS 304 (474)
T ss_pred EEEEEcCCCccEEEEEecCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeC
Confidence 9999999999999999999999999999875 369999999999999999999999999999999999999999999999
Q ss_pred ccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccC
Q 011302 234 DFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLD 313 (489)
Q Consensus 234 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (489)
|||+++.......
T Consensus 305 DFGLs~~~~~~~~------------------------------------------------------------------- 317 (474)
T KOG0194|consen 305 DFGLSRAGSQYVM------------------------------------------------------------------- 317 (474)
T ss_pred ccccccCCcceee-------------------------------------------------------------------
Confidence 9999843220000
Q ss_pred CccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCC
Q 011302 314 DPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIG 392 (489)
Q Consensus 314 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 392 (489)
......-...|+|||.+....|+.++|||||||++||+++ |..||.+....++..+|....+..+...
T Consensus 318 -----------~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~ 386 (474)
T KOG0194|consen 318 -----------KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPS 386 (474)
T ss_pred -----------ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCC
Confidence 0000012357999999999999999999999999999998 8999999999999999966555544332
Q ss_pred CCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 393 VSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 393 ~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
.. +..+..++.+||..||++|+++.
T Consensus 387 ~~-------p~~~~~~~~~c~~~~p~~R~tm~ 411 (474)
T KOG0194|consen 387 KT-------PKELAKVMKQCWKKDPEDRPTMS 411 (474)
T ss_pred CC-------HHHHHHHHHHhccCChhhccCHH
Confidence 11 12488999999999999999986
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=346.04 Aligned_cols=258 Identities=24% Similarity=0.398 Sum_probs=209.9
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
..+|++.+.||+|+||.||+|.+.. .++.||+|.+...... ....+.+|+.+++.++||||+++++.+..+.
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~ 90 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVA-----TGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGD 90 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECC-----CCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC
Confidence 4689999999999999999999876 5678999998754332 2345667999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
..|+||||++|++|.+++.. ..+++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~ 167 (296)
T cd06654 91 ELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (296)
T ss_pred EEEEeecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence 99999999999999998865 358899999999999999999999999999999999999999999999999873221
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
..
T Consensus 168 ~~------------------------------------------------------------------------------ 169 (296)
T cd06654 168 PE------------------------------------------------------------------------------ 169 (296)
T ss_pred cc------------------------------------------------------------------------------
Confidence 00
Q ss_pred ccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHH
Q 011302 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEV 402 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~ 402 (489)
........|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+..... +..... . ...
T Consensus 170 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~--~--~~~ 243 (296)
T cd06654 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT--PELQNP--E--KLS 243 (296)
T ss_pred ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCC--CCCCCc--c--ccC
Confidence 0011223688999999999988889999999999999999999999988776544443332211 111000 0 112
Q ss_pred hhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 403 VKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 403 ~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
..+.+||.+||..||++||++. ++++||||...
T Consensus 244 ~~l~~li~~~l~~~p~~Rpt~~----eil~~~~~~~~ 276 (296)
T cd06654 244 AIFRDFLNRCLDMDVEKRGSAK----ELLQHQFLKIA 276 (296)
T ss_pred HHHHHHHHHHCcCCcccCcCHH----HHhhChhhhcc
Confidence 3588999999999999999987 99999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=343.76 Aligned_cols=257 Identities=28% Similarity=0.425 Sum_probs=205.3
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccceee-
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAEFE- 159 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~- 159 (489)
..+.|++.+.||.|+||.||+|++.. .++.||+|++..... ....+..|+.+++++ +||||+++++++.
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVK-----TGQLAAIKVMDVTED----EEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcC-----CCcEEEEEEEecChH----HHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 45789999999999999999999876 567899999875432 223456688888888 6999999999884
Q ss_pred -----cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcc
Q 011302 160 -----ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSD 234 (489)
Q Consensus 160 -----~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~D 234 (489)
....+|+||||+++|+|.+++.......+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~d 164 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVD 164 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEee
Confidence 356889999999999999998876556788888999999999999999999999999999999999999999999
Q ss_pred cCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCC
Q 011302 235 FDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDD 314 (489)
Q Consensus 235 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (489)
||++......
T Consensus 165 fg~~~~~~~~---------------------------------------------------------------------- 174 (282)
T cd06636 165 FGVSAQLDRT---------------------------------------------------------------------- 174 (282)
T ss_pred Ccchhhhhcc----------------------------------------------------------------------
Confidence 9997322100
Q ss_pred ccccccccccCCccccCCCCccCcchhc-----CCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCC
Q 011302 315 PEVVAEPINARSKSFVGTHEYLAPEVIS-----GQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFP 389 (489)
Q Consensus 315 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p 389 (489)
........|++.|+|||++. +..++.++|||||||++|||++|..||...........+..... +
T Consensus 175 --------~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--~ 244 (282)
T cd06636 175 --------VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP--P 244 (282)
T ss_pred --------ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCC--C
Confidence 00112346899999999986 34578899999999999999999999987665544443333211 1
Q ss_pred CCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 390 RIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 390 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
..... .....+.+||.+||..||.+||++. +|++||||
T Consensus 245 ~~~~~-----~~~~~~~~li~~cl~~~p~~Rp~~~----ell~~~~~ 282 (282)
T cd06636 245 KLKSK-----KWSKKFIDFIEGCLVKNYLSRPSTE----QLLKHPFI 282 (282)
T ss_pred CCccc-----ccCHHHHHHHHHHhCCChhhCcCHH----HHhcCCCC
Confidence 11100 1123589999999999999999987 99999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=337.87 Aligned_cols=261 Identities=27% Similarity=0.401 Sum_probs=210.1
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHH------HHHHHHHHHHHHHHHHHhCCCCCccccccee
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREAL------AIRKKLHRADMEKVILTMLDHPFLPTLYAEF 158 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 158 (489)
+|.+...||+|+||.||+|.+.. .++.||+|.+..... ........+.+|+.+++.++||||+++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 75 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNAS-----SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSS 75 (267)
T ss_pred CccccceeecCCCeEEEEEEecC-----CCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 36778899999999999999876 467899998864321 1223446678899999999999999999999
Q ss_pred ecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 159 EASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
...+..|+||||+++++|.+++... +.+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 76 LDADHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred EeCCccEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCC
Confidence 9999999999999999999998765 56899999999999999999999999999999999999999999999999998
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
+.+.....
T Consensus 154 ~~~~~~~~------------------------------------------------------------------------ 161 (267)
T cd06628 154 KKLEANSL------------------------------------------------------------------------ 161 (267)
T ss_pred cccccccc------------------------------------------------------------------------
Confidence 43321000
Q ss_pred ccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchh
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKE 398 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 398 (489)
............|+..|+|||.+.+..++.++|||||||++|+|++|..||.+.+....+.++.... .+......
T Consensus 162 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~--- 236 (267)
T cd06628 162 STKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA--SPEIPSNI--- 236 (267)
T ss_pred cCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC--CCcCCccc---
Confidence 0000001123468899999999998889999999999999999999999998877665555544421 11111111
Q ss_pred HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 399 FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 399 ~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
...+.+||.+||+.||.+||++. ++++||||
T Consensus 237 ---~~~~~~li~~~l~~~p~~Rp~~~----~il~~~~~ 267 (267)
T cd06628 237 ---SSEAIDFLEKTFEIDHNKRPTAA----ELLKHPFL 267 (267)
T ss_pred ---CHHHHHHHHHHccCCchhCcCHH----HHhhCCCC
Confidence 12589999999999999999987 99999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=342.53 Aligned_cols=259 Identities=29% Similarity=0.422 Sum_probs=208.9
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceE
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYS 164 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 164 (489)
-|++.+.||+|+||.||+|.+.. ++..+++|.+..... .....+.+|+.+++.++||||+++++++...+..
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~-----~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~ 77 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKE-----TGVLAAAKVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNL 77 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECC-----CCeEEEEEEeCCCCH---HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEE
Confidence 46888999999999999999886 567889999864322 2344567799999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccC
Q 011302 165 CLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVV 244 (489)
Q Consensus 165 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~ 244 (489)
|+||||+++++|..++... ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 78 ~~v~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~ 156 (282)
T cd06643 78 WILIEFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 156 (282)
T ss_pred EEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc
Confidence 9999999999998877653 256899999999999999999999999999999999999999999999999997332100
Q ss_pred ccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccccc
Q 011302 245 PKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINA 324 (489)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (489)
..
T Consensus 157 ------------------------------------------------------------------------------~~ 158 (282)
T cd06643 157 ------------------------------------------------------------------------------IQ 158 (282)
T ss_pred ------------------------------------------------------------------------------cc
Confidence 00
Q ss_pred CCccccCCCCccCcchhc-----CCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhH
Q 011302 325 RSKSFVGTHEYLAPEVIS-----GQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEF 399 (489)
Q Consensus 325 ~~~~~~Gt~~y~aPE~l~-----~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 399 (489)
......||+.|+|||++. +..++.++|||||||++|||++|.+||...+..+....+.............
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----- 233 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSR----- 233 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccc-----
Confidence 112346899999999984 3457789999999999999999999999887766666655432211110111
Q ss_pred HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 400 EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 400 ~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
....+.+||.+||+.||++||++. ++++||||+...
T Consensus 234 -~~~~~~~li~~~l~~~p~~Rp~~~----~il~~~~~~~~~ 269 (282)
T cd06643 234 -WSSEFKDFLKKCLEKNVDARWTTT----QLLQHPFVTVNS 269 (282)
T ss_pred -cCHHHHHHHHHHccCChhhCcCHH----HHhcCCCEeccC
Confidence 112589999999999999999987 999999997643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=344.31 Aligned_cols=263 Identities=24% Similarity=0.337 Sum_probs=211.4
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
+..++|++.+.||+|+||.||+|.+...........||+|.+..... ......+.+|+.+++.++||||+++++++.+
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 79 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE--PKVQQEFRQEAELMSDLQHPNIVCLLGVCTK 79 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC--HHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence 34578999999999999999999987654334557899999874422 2334567789999999999999999999999
Q ss_pred CceEEEEEeecCCCchHHHHHhCCC--------------CCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEecc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPG--------------KRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRE 226 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~ 226 (489)
.+..|++|||+++|+|.+++..... ..+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE 159 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence 9999999999999999999876421 45788889999999999999999999999999999999999
Q ss_pred CCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCC
Q 011302 227 DGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDH 306 (489)
Q Consensus 227 ~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (489)
++.+||+|||+++......
T Consensus 160 ~~~~~L~dfg~~~~~~~~~------------------------------------------------------------- 178 (283)
T cd05048 160 GLTVKISDFGLSRDIYSAD------------------------------------------------------------- 178 (283)
T ss_pred CCcEEECCCcceeeccccc-------------------------------------------------------------
Confidence 9999999999974321000
Q ss_pred CCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCC
Q 011302 307 HDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKP 385 (489)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~ 385 (489)
.........+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+....+..+.
T Consensus 179 ---------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~ 243 (283)
T cd05048 179 ---------------YYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQ 243 (283)
T ss_pred ---------------cccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 0001122357889999999998889999999999999999998 999999988877777666543
Q ss_pred CCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 386 LTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 386 ~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
... ..... +..+.+|+.+||+.||.+||++. +|+++
T Consensus 244 ~~~--~~~~~------~~~~~~l~~~c~~~~p~~Rp~~~----~i~~~ 279 (283)
T cd05048 244 LLP--CPEDC------PARVYALMIECWNEIPARRPRFK----DIHTR 279 (283)
T ss_pred cCC--CcccC------CHHHHHHHHHHccCChhhCcCHH----HHHHH
Confidence 221 11111 13589999999999999999997 66654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=335.85 Aligned_cols=254 Identities=29% Similarity=0.466 Sum_probs=209.7
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
++|++.+.||+|+||.||+|..+. .++.|++|.+..... ...+.+|+.+++.++||||+++++++.+...
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~ 72 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKE-----TGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTD 72 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcC-----CCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCc
Confidence 689999999999999999999886 467899999976532 4567789999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
+|+||||+++++|.+++... ...+++..+..++.|++.||.|||+.+|+||||+|+||+++.++.+||+|||++.....
T Consensus 73 ~~l~~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 73 LWIVMEYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred EEEEEecCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence 99999999999999988654 25789999999999999999999999999999999999999999999999999743211
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
. .
T Consensus 152 ~------------------------------------------------------------------------------~ 153 (256)
T cd06612 152 T------------------------------------------------------------------------------M 153 (256)
T ss_pred C------------------------------------------------------------------------------c
Confidence 0 0
Q ss_pred cCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHh
Q 011302 324 ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVV 403 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~ 403 (489)
.......|+..|+|||++.+..++.++|||||||++|+|++|..||...+.......+...... ..... .....
T Consensus 154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~----~~~~~ 227 (256)
T cd06612 154 AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPP--TLSDP----EKWSP 227 (256)
T ss_pred cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCC--CCCch----hhcCH
Confidence 0112235788999999999998999999999999999999999999887665544443322111 10000 01123
Q ss_pred hHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 404 KLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 404 ~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
.+.+||.+||+.||++||++. ++++||||
T Consensus 228 ~~~~~i~~~l~~~P~~Rps~~----~il~~~~~ 256 (256)
T cd06612 228 EFNDFVKKCLVKDPEERPSAI----QLLQHPFI 256 (256)
T ss_pred HHHHHHHHHHhcChhhCcCHH----HHhcCCCC
Confidence 589999999999999999997 99999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=344.50 Aligned_cols=257 Identities=25% Similarity=0.383 Sum_probs=211.1
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
.+|++.+.||.|+||.||+|.+.. .++.||+|.+...... ....+.+|+.+++.++||||+++++++..++.
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~-----~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 90 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVA-----TGQEVAIKQINLQKQP---KKELIINEILVMKELKNPNIVNFLDSFLVGDE 90 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcC-----CCcEEEEEEEecccCc---hHHHHHHHHHHHHhcCCCceeeeeeeEecCce
Confidence 579999999999999999999876 5788999998654322 23456779999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
+|+||||+++++|..++.. ..+++.++..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 91 ~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 91 LFVVMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred EEEEEEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 9999999999999998865 3589999999999999999999999999999999999999999999999998732210
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
. .
T Consensus 168 ~------------------------------------------------------------------------------~ 169 (296)
T cd06655 168 E------------------------------------------------------------------------------Q 169 (296)
T ss_pred c------------------------------------------------------------------------------c
Confidence 0 0
Q ss_pred cCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHh
Q 011302 324 ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVV 403 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~ 403 (489)
.......|++.|+|||.+.+..++.++|||||||++|+|++|..||.+.+.......+............ ....
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~~~~ 243 (296)
T cd06655 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPE------KLSP 243 (296)
T ss_pred ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcc------cCCH
Confidence 0112236889999999999888999999999999999999999999988776555554432211111111 1122
Q ss_pred hHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 404 KLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 404 ~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
.+.+||.+||..||++||++. +++.||||+..
T Consensus 244 ~~~~li~~~l~~dp~~Rpt~~----~il~~~~~~~~ 275 (296)
T cd06655 244 IFRDFLNRCLEMDVEKRGSAK----ELLQHPFLKLA 275 (296)
T ss_pred HHHHHHHHHhhcChhhCCCHH----HHhhChHhhhc
Confidence 588999999999999999987 99999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=335.36 Aligned_cols=274 Identities=27% Similarity=0.360 Sum_probs=207.9
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec-Cc
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA-SH 162 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~ 162 (489)
..|.++..||+|+||.||+|...++.. .-.+.||||.++.+... ......+-+|+.+++.++||||+.|..+|-. +.
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~-kr~k~yAiKkfk~~kd~-tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTND-KRTKEYAIKKFKGEKDG-TGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCc-ccchhhHHHHHhccCCC-CCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 579999999999999999997665431 12458999999765221 1223345679999999999999999999977 88
Q ss_pred eEEEEEeecCCCchHHHHHhC---CCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccC----CcEEEccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQ---PGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRED----GHIMLSDF 235 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~----~~vkl~DF 235 (489)
.++|++||++ -+|+.+++.+ ..+.++...++.|+.||+.|+.|||++.|+||||||.|||+..+ |.|||+||
T Consensus 102 ~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 9999999995 5888877653 23568888999999999999999999999999999999999977 99999999
Q ss_pred CCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCc
Q 011302 236 DLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDP 315 (489)
Q Consensus 236 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (489)
|+|+.+...-.-+
T Consensus 181 GlaR~~~~plkpl------------------------------------------------------------------- 193 (438)
T KOG0666|consen 181 GLARLFNNPLKPL------------------------------------------------------------------- 193 (438)
T ss_pred cHHHHhhcccccc-------------------------------------------------------------------
Confidence 9997764311000
Q ss_pred cccccccccCCccccCCCCccCcchhcCCC-CCCcccHHHHHHHHHHHhhCCCCCCCCCc---------HHHHHHHhc--
Q 011302 316 EVVAEPINARSKSFVGTHEYLAPEVISGQG-HGSAVDWWTLGVFLYEMLYGTTPFKGENN---------EKTLINILK-- 383 (489)
Q Consensus 316 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~~~~~DiwSlGvil~elltG~~Pf~~~~~---------~~~~~~i~~-- 383 (489)
.....++-|.+|+|||.+.|.. |+.++||||+|||+.||++-++.|.+... .+++.+|.+
T Consensus 194 --------~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vL 265 (438)
T KOG0666|consen 194 --------ASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVL 265 (438)
T ss_pred --------ccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHc
Confidence 0122346799999999999976 79999999999999999999999987531 234444432
Q ss_pred -CC--CCCCCCCCCC------------------chhHH-----HHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcC
Q 011302 384 -KP--LTFPRIGVSS------------------SKEFE-----EVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437 (489)
Q Consensus 384 -~~--~~~p~~~~~~------------------~~~~~-----~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~ 437 (489)
.+ -.+|...... ...|. .++.+.+|+.+||..||.+|+++. ++++|+||.
T Consensus 266 G~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~----qAleh~yF~ 341 (438)
T KOG0666|consen 266 GTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAE----QALEHPYFT 341 (438)
T ss_pred CCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHH----HHhcccccc
Confidence 11 1122111000 00000 112367999999999999999998 999999997
Q ss_pred CC
Q 011302 438 GI 439 (489)
Q Consensus 438 ~~ 439 (489)
.-
T Consensus 342 ~d 343 (438)
T KOG0666|consen 342 ED 343 (438)
T ss_pred cC
Confidence 64
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=339.26 Aligned_cols=253 Identities=19% Similarity=0.213 Sum_probs=203.6
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS 161 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 161 (489)
..++|++.+.||+|+||.||+|.++... .....||+|.++..... .....+.+|+.+++.++||||+++++++..+
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~--~~~~~vaik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 78 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPS--KRELPVAIHTLRAGCSD--KQRRGFLAEALTLGQFDHSNIVRLEGVITRG 78 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCC--CceeeEEEEecCCCCCH--HHHHHHHHHHHHHhcCCCCCcCeEEEEEecC
Confidence 4568999999999999999999876422 24678999998754221 2234677899999999999999999999999
Q ss_pred ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccc
Q 011302 162 HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKC 241 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~ 241 (489)
+..|+||||+++|+|.+++.... ..+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||.+...
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 99999999999999999887643 57899999999999999999999999999999999999999999999999986221
Q ss_pred ccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccc
Q 011302 242 DVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEP 321 (489)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (489)
....
T Consensus 158 ~~~~---------------------------------------------------------------------------- 161 (266)
T cd05064 158 KSEA---------------------------------------------------------------------------- 161 (266)
T ss_pred cccc----------------------------------------------------------------------------
Confidence 0000
Q ss_pred cccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHH
Q 011302 322 INARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFE 400 (489)
Q Consensus 322 ~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 400 (489)
........++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+....+..+. ..|... ..
T Consensus 162 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~-~~----- 233 (266)
T cd05064 162 -IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF-RLPAPR-NC----- 233 (266)
T ss_pred -hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC-CCCCCC-CC-----
Confidence 000011235678999999999999999999999999999775 999999888777766665542 222211 11
Q ss_pred HHhhHHHHHHHHhhcCcccccCCC
Q 011302 401 EVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 401 ~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
+..+.+++.+||+.+|++||++.
T Consensus 234 -~~~~~~li~~c~~~~p~~RP~~~ 256 (266)
T cd05064 234 -PNLLHQLMLDCWQKERGERPRFS 256 (266)
T ss_pred -CHHHHHHHHHHcCCCchhCCCHH
Confidence 12489999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=358.73 Aligned_cols=261 Identities=23% Similarity=0.280 Sum_probs=205.0
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-CCCcccccce
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-HPFLPTLYAE 157 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~ 157 (489)
+.+..++|++++.||+|+||.||+|++.......+...||||++...... .....+.+|+.+|+.+. ||||++++++
T Consensus 32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~Ei~~l~~l~~HpnIv~l~~~ 109 (400)
T cd05105 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARS--SEKQALMSELKIMTHLGPHLNIVNLLGA 109 (400)
T ss_pred eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCCh--HHHHHHHHHHHHHHhcCCCCCeeeEEEE
Confidence 45667899999999999999999999865433334568999999653221 23356788999999996 9999999999
Q ss_pred eecCceEEEEEeecCCCchHHHHHhCC-----------------------------------------------------
Q 011302 158 FEASHYSCLVMEYCPGGDLYAARQRQP----------------------------------------------------- 184 (489)
Q Consensus 158 ~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------------------------------------------- 184 (489)
+.+.+.+|||||||++|+|.+++....
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 110 CTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred EccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 999999999999999999998876431
Q ss_pred -----------------------------------------CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeE
Q 011302 185 -----------------------------------------GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVL 223 (489)
Q Consensus 185 -----------------------------------------~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIL 223 (489)
...+++.++..++.||+.||+|||+++|+||||||+|||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nil 269 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEE
Confidence 124778888999999999999999999999999999999
Q ss_pred eccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccC
Q 011302 224 VREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVD 303 (489)
Q Consensus 224 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (489)
++.++.+||+|||+++.+.....
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~--------------------------------------------------------- 292 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSN--------------------------------------------------------- 292 (400)
T ss_pred EeCCCEEEEEeCCcceecccccc---------------------------------------------------------
Confidence 99999999999999843211000
Q ss_pred CCCCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHh
Q 011302 304 GDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINIL 382 (489)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~ 382 (489)
........|++.|+|||++.+..++.++|||||||++|||++ |..||.+......+....
T Consensus 293 -------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~ 353 (400)
T cd05105 293 -------------------YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKI 353 (400)
T ss_pred -------------------ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHH
Confidence 001122357789999999999889999999999999999997 999998765544444433
Q ss_pred cCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 383 KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 383 ~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
......+... . ....+.+||.+||+.||++||++.
T Consensus 354 ~~~~~~~~~~-~------~~~~l~~li~~cl~~dP~~RPt~~ 388 (400)
T cd05105 354 KSGYRMAKPD-H------ATQEVYDIMVKCWNSEPEKRPSFL 388 (400)
T ss_pred hcCCCCCCCc-c------CCHHHHHHHHHHCccCHhHCcCHH
Confidence 3332222111 1 122589999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=346.49 Aligned_cols=257 Identities=24% Similarity=0.394 Sum_probs=208.6
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
.+|++++.||+|+||.||+|.+.. .++.||+|.+...... ....+.+|+.+++.++||||+++++++..++.
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 90 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIA-----TGQEVAIKQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDE 90 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECC-----CCCEEEEEEEecCccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCE
Confidence 789999999999999999999876 5678999999754322 22446679999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
.|+||||++|++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 91 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 91 LWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred EEEeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence 9999999999999998865 3588999999999999999999999999999999999999999999999998732211
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
. .
T Consensus 168 ~------------------------------------------------------------------------------~ 169 (297)
T cd06656 168 E------------------------------------------------------------------------------Q 169 (297)
T ss_pred C------------------------------------------------------------------------------c
Confidence 0 0
Q ss_pred cCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHh
Q 011302 324 ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVV 403 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~ 403 (489)
.......|++.|+|||.+.+..++.++|||||||++|+|++|..||.+.+.......+..... +....+. ....
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~--~~~~~~~----~~~~ 243 (297)
T cd06656 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT--PELQNPE----RLSA 243 (297)
T ss_pred cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCC--CCCCCcc----ccCH
Confidence 001223688999999999998899999999999999999999999987765443332222111 1110000 1123
Q ss_pred hHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 404 KLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 404 ~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
.+.+||.+||..||++||++. ++++||||+..
T Consensus 244 ~~~~li~~~l~~~p~~Rps~~----~il~~~~~~~~ 275 (297)
T cd06656 244 VFRDFLNRCLEMDVDRRGSAK----ELLQHPFLKLA 275 (297)
T ss_pred HHHHHHHHHccCChhhCcCHH----HHhcCchhccc
Confidence 478999999999999999987 99999999763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=337.86 Aligned_cols=264 Identities=27% Similarity=0.377 Sum_probs=213.1
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
++|++.+.||.|+||+||+|.+.. ++..+|+|++....... ....+.+|+.+++.++|+||+++++.+...+.
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLP-----NNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDE 73 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcC-----CCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCE
Confidence 479999999999999999999876 46789999987543332 44567789999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCC-CCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPG-KRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
.|+||||++|++|.+++..... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++..+.
T Consensus 74 ~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~ 153 (267)
T cd06610 74 LWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLA 153 (267)
T ss_pred EEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhc
Confidence 9999999999999999876432 568999999999999999999999999999999999999999999999999974322
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
..... .
T Consensus 154 ~~~~~--------------------------------------------------------------------------~ 159 (267)
T cd06610 154 DGGDR--------------------------------------------------------------------------T 159 (267)
T ss_pred cCccc--------------------------------------------------------------------------c
Confidence 10000 0
Q ss_pred ccCCccccCCCCccCcchhcCC-CCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCC-CCCCCCCCchhHH
Q 011302 323 NARSKSFVGTHEYLAPEVISGQ-GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLT-FPRIGVSSSKEFE 400 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~p~~~~~~~~~~~ 400 (489)
.......+|+..|+|||++... .++.++|+|||||++|||++|+.||...+....+.++...... ++.... .-.
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~ 235 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGAD----YKK 235 (267)
T ss_pred ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccc----ccc
Confidence 0012334689999999999877 6899999999999999999999999888776666665554221 111110 001
Q ss_pred HHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 401 EVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 401 ~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
....+.+||.+||..||++||++. +|++||||
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~----~ll~~p~~ 267 (267)
T cd06610 236 YSKSFRKMISLCLQKDPSKRPTAE----ELLKHKFF 267 (267)
T ss_pred ccHHHHHHHHHHcCCChhhCcCHH----HHhhCCCC
Confidence 123578999999999999999987 99999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=334.43 Aligned_cols=256 Identities=29% Similarity=0.441 Sum_probs=215.3
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceE
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYS 164 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 164 (489)
+|++++.||.|+||.||.++... .++.+++|.+....... ....++.+|+.+++.++|+||+++++++.+.+.+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~-----~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 74 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTE-----DDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTL 74 (256)
T ss_pred CceEeeEecccCCceEEEEEEcC-----CCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeE
Confidence 58999999999999999999876 56789999987543322 2344567899999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccC
Q 011302 165 CLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVV 244 (489)
Q Consensus 165 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~ 244 (489)
++||||+++|+|.+++.......+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 75 ~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 75 LIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred EEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 99999999999999998765567899999999999999999999999999999999999999999999999997432110
Q ss_pred ccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccccc
Q 011302 245 PKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINA 324 (489)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (489)
. .
T Consensus 155 ~------------------------------------------------------------------------------~ 156 (256)
T cd08221 155 Y------------------------------------------------------------------------------S 156 (256)
T ss_pred c------------------------------------------------------------------------------c
Confidence 0 0
Q ss_pred CCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhh
Q 011302 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVK 404 (489)
Q Consensus 325 ~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~ 404 (489)
......|++.|+|||.+.+..++.++|||||||++|||++|..||.+.+..+....+..+...... . ....+
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~--~------~~~~~ 228 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVV--S------VYSSE 228 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc--c------ccCHH
Confidence 112346899999999999888899999999999999999999999988888877777665433211 1 11235
Q ss_pred HHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 405 LQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 405 l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
+.+||.+||..+|.+||++. ++++|+|+
T Consensus 229 ~~~~i~~~l~~~p~~R~s~~----~ll~~~~l 256 (256)
T cd08221 229 LISLVHSLLQQDPEKRPTAD----EVLDQPLL 256 (256)
T ss_pred HHHHHHHHcccCcccCCCHH----HHhhCcCC
Confidence 89999999999999999987 99999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=335.68 Aligned_cols=256 Identities=26% Similarity=0.464 Sum_probs=214.0
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceE
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYS 164 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 164 (489)
+|++.+.||+|+||.||+++... .++.||+|.+....... .....+.+|+.+++.++||||+++++++...+..
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~-----~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKE-----DGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHPNIVQYQESFEENGNL 74 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcC-----CCCEEEEEEEEhHhCCh-HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeE
Confidence 58999999999999999999876 46789999997654332 2335677899999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccC
Q 011302 165 CLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVV 244 (489)
Q Consensus 165 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~ 244 (489)
|+||||+.+++|.+++.......+++..+..++.|++.||.|||++|++|+||+|+|||++.++.++|+|||++......
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~ 154 (256)
T cd08218 75 YIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154 (256)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence 99999999999999887654456889999999999999999999999999999999999999999999999997432110
Q ss_pred ccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccccc
Q 011302 245 PKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINA 324 (489)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (489)
..
T Consensus 155 ------------------------------------------------------------------------------~~ 156 (256)
T cd08218 155 ------------------------------------------------------------------------------VE 156 (256)
T ss_pred ------------------------------------------------------------------------------hh
Confidence 00
Q ss_pred CCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhh
Q 011302 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVK 404 (489)
Q Consensus 325 ~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~ 404 (489)
......|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..+...++..+.... ..... ...
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~--~~~~~------~~~ 228 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPP--VSSHY------SYD 228 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCC--CcccC------CHH
Confidence 0112358889999999999889999999999999999999999999888777777776554321 11111 224
Q ss_pred HHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 405 LQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 405 l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
+.++|.+||+.+|++||++. ++++||||
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~----~vl~~~~~ 256 (256)
T cd08218 229 LRNLVSQLFKRNPRDRPSVN----SILEKNFI 256 (256)
T ss_pred HHHHHHHHhhCChhhCcCHH----HHhhCcCC
Confidence 89999999999999999998 99999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=344.92 Aligned_cols=259 Identities=23% Similarity=0.275 Sum_probs=199.3
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCC-----------CCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCC
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPM-----------VGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPF 150 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~-----------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn 150 (489)
..++|++.++||+|+||.||+|.++... ....+..||+|++..... ......+.+|+.+|..++|||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN--KNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC--HHHHHHHHHHHHHHhhcCCCC
Confidence 4478999999999999999999875432 112345799999875421 223456778999999999999
Q ss_pred cccccceeecCceEEEEEeecCCCchHHHHHhCC-----------------CCCCChhhHHHHHHHHHHHHHHHHhCCCe
Q 011302 151 LPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQP-----------------GKRFGISSAKFYAAETLLALEYLHMMGIV 213 (489)
Q Consensus 151 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-----------------~~~l~~~~~~~i~~qi~~~L~yLH~~~ii 213 (489)
|+++++++.+.+..|+||||+++|+|.+++.... ...+++..+..++.||+.||.|||++||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 9999999999999999999999999999886532 12467788899999999999999999999
Q ss_pred eecCCCCCeEeccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccc
Q 011302 214 YRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAV 293 (489)
Q Consensus 214 HrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (489)
||||||+|||++.++.+||+|||+++.+.....
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~----------------------------------------------- 193 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDY----------------------------------------------- 193 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCce-----------------------------------------------
Confidence 999999999999999999999999843211000
Q ss_pred cccccccccCCCCCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh--CCCCCCC
Q 011302 294 TVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY--GTTPFKG 371 (489)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt--G~~Pf~~ 371 (489)
........++..|+|||++.+..++.++|||||||++|||++ +..||.+
T Consensus 194 -----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 244 (304)
T cd05096 194 -----------------------------YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGE 244 (304)
T ss_pred -----------------------------eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCc
Confidence 001122356789999999998889999999999999999986 6788887
Q ss_pred CCcHHHHHHHhc---CC--CCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 372 ENNEKTLINILK---KP--LTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 372 ~~~~~~~~~i~~---~~--~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
.+..+.+..+.. .. ...+...... +..+.+||.+||..||++||++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~li~~cl~~~p~~RPs~~ 296 (304)
T cd05096 245 LTDEQVIENAGEFFRDQGRQVYLFRPPPC------PQGLYELMLQCWSRDCRERPSFS 296 (304)
T ss_pred CCHHHHHHHHHHHhhhccccccccCCCCC------CHHHHHHHHHHccCCchhCcCHH
Confidence 766555443321 10 0011111111 12489999999999999999996
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=339.96 Aligned_cols=258 Identities=26% Similarity=0.415 Sum_probs=206.0
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS 161 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 161 (489)
..++|++.+.||+|+||.||+|++.. .++.||+|++..... .....+.+|+.+++.++||||+++++++..+
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~-----~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~ 78 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLH-----TGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGSYLSR 78 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECC-----CCeEEEEEEEecCcc---chHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Confidence 34689999999999999999999876 567899999874322 1223466799999999999999999999999
Q ss_pred ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccc
Q 011302 162 HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKC 241 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~ 241 (489)
+..|+||||+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.+
T Consensus 79 ~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 156 (267)
T cd06646 79 EKLWICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKI 156 (267)
T ss_pred CEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceee
Confidence 9999999999999999988764 56899999999999999999999999999999999999999999999999998432
Q ss_pred ccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccc
Q 011302 242 DVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEP 321 (489)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (489)
...
T Consensus 157 ~~~----------------------------------------------------------------------------- 159 (267)
T cd06646 157 TAT----------------------------------------------------------------------------- 159 (267)
T ss_pred ccc-----------------------------------------------------------------------------
Confidence 100
Q ss_pred cccCCccccCCCCccCcchhcC---CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchh
Q 011302 322 INARSKSFVGTHEYLAPEVISG---QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKE 398 (489)
Q Consensus 322 ~~~~~~~~~Gt~~y~aPE~l~~---~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 398 (489)
........|++.|+|||.+.+ ..++.++|||||||++|||++|..||...+.......+.......+......
T Consensus 160 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 235 (267)
T cd06646 160 -IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKT--- 235 (267)
T ss_pred -ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCcccc---
Confidence 001123468899999999853 4468899999999999999999999976654443333333322222211110
Q ss_pred HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCC
Q 011302 399 FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEF 435 (489)
Q Consensus 399 ~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~ 435 (489)
..+..+.+||++||..||++||++. ++++|+|
T Consensus 236 -~~~~~~~~li~~~l~~~P~~Rp~~~----~il~~l~ 267 (267)
T cd06646 236 -KWSSTFHNFVKISLTKNPKKRPTAE----RLLTHLF 267 (267)
T ss_pred -ccCHHHHHHHHHHhhCChhhCcCHH----HHhcCCC
Confidence 1123589999999999999999987 9999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=352.70 Aligned_cols=266 Identities=20% Similarity=0.278 Sum_probs=205.8
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccce
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAE 157 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~ 157 (489)
|+++.++|++.+.||+|+||.||+|.+.+.....+++.||+|+++..... .....+..|+.++.++ +|+||++++++
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~E~~~~~~l~~h~niv~~~~~ 79 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATA--SEYKALMTELKILIHIGHHLNVVNLLGA 79 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCH--HHHHHHHHHHHHHHhhccCcchhheeee
Confidence 56677899999999999999999998765433345688999998643221 2334566799999999 79999999998
Q ss_pred ee-cCceEEEEEeecCCCchHHHHHhCCC---------------------------------------------------
Q 011302 158 FE-ASHYSCLVMEYCPGGDLYAARQRQPG--------------------------------------------------- 185 (489)
Q Consensus 158 ~~-~~~~~~lV~E~~~gg~L~~~l~~~~~--------------------------------------------------- 185 (489)
+. .+..+|+||||+++|+|.+++.....
T Consensus 80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 75 45678999999999999988864321
Q ss_pred --------CCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCccccCCcchhHHH
Q 011302 186 --------KRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAI 257 (489)
Q Consensus 186 --------~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~ 257 (489)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+...+.
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~----------- 228 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD----------- 228 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcc-----------
Confidence 2578889999999999999999999999999999999999999999999999844321100
Q ss_pred hhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCccccCCCCccC
Q 011302 258 EKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLA 337 (489)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~a 337 (489)
........++..|+|
T Consensus 229 -----------------------------------------------------------------~~~~~~~~~~~~y~a 243 (337)
T cd05054 229 -----------------------------------------------------------------YVRKGDARLPLKWMA 243 (337)
T ss_pred -----------------------------------------------------------------hhhccCCCCCccccC
Confidence 001123356778999
Q ss_pred cchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcC
Q 011302 338 PEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKN 416 (489)
Q Consensus 338 PE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~d 416 (489)
||++.+..++.++|||||||++|||++ |..||.+....+.+............ .... ...+.+|+.+||+.+
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~------~~~~~~l~~~cl~~~ 316 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRA-PEYA------TPEIYSIMLDCWHNN 316 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCC-CccC------CHHHHHHHHHHccCC
Confidence 999999999999999999999999997 99999876554444443332221111 1111 125899999999999
Q ss_pred cccccCCCCChHHHHcC
Q 011302 417 PKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 417 P~~R~~~~~~~~~ll~h 433 (489)
|++||++. ++++|
T Consensus 317 p~~RPs~~----ell~~ 329 (337)
T cd05054 317 PEDRPTFS----ELVEI 329 (337)
T ss_pred hhhCcCHH----HHHHH
Confidence 99999997 66654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=339.66 Aligned_cols=269 Identities=40% Similarity=0.720 Sum_probs=214.2
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHH-HHHHHHHHHHHHHHHhC-CCCCcccccceeecCc
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAI-RKKLHRADMEKVILTML-DHPFLPTLYAEFEASH 162 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~ 162 (489)
+|++.+.||+|+||.||+|++.... ..+..||||++++..... .....++..|+.++..+ +||||+++++++..+.
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~--~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGH--DAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDT 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccc--cCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCC
Confidence 4889999999999999999876432 146789999998654432 23345677899999999 5999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
..|+||||+++|+|.+.+... ..+++..++.++.|++.||.|||+.|++||||||.||+++.++.++|+|||+++.+.
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 999999999999999988764 568999999999999999999999999999999999999999999999999874321
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
...
T Consensus 157 ~~~----------------------------------------------------------------------------- 159 (288)
T cd05583 157 AEE----------------------------------------------------------------------------- 159 (288)
T ss_pred ccc-----------------------------------------------------------------------------
Confidence 100
Q ss_pred ccCCccccCCCCccCcchhcCCC--CCCcccHHHHHHHHHHHhhCCCCCCCCCc----HHHHHHHhcCCCCCCCCCCCCc
Q 011302 323 NARSKSFVGTHEYLAPEVISGQG--HGSAVDWWTLGVFLYEMLYGTTPFKGENN----EKTLINILKKPLTFPRIGVSSS 396 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~--~~~~~DiwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~p~~~~~~~ 396 (489)
........|++.|+|||.+.+.. .+.++||||||+++|||++|..||..... .+....+.......|..
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 234 (288)
T cd05583 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKT----- 234 (288)
T ss_pred ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcc-----
Confidence 00112346889999999987765 68899999999999999999999965432 22233333332222221
Q ss_pred hhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcccc
Q 011302 397 KEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALI 444 (489)
Q Consensus 397 ~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~ 444 (489)
....+.+||.+||+.||++||++. .+.++++||||+.++|+.+
T Consensus 235 ----~~~~l~~li~~~l~~~p~~R~t~~-~~~~~l~~~~~~~~~~~~~ 277 (288)
T cd05583 235 ----MSAEARDFIQKLLEKDPKKRLGAN-GADEIKNHPFFQGIDWDDL 277 (288)
T ss_pred ----cCHHHHHHHHHHhcCCHhhccCcc-hHHHHhcCcccccCCHHHH
Confidence 112488999999999999999974 5568999999999999876
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=337.74 Aligned_cols=279 Identities=37% Similarity=0.604 Sum_probs=223.4
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-CCCcccccceeecCc
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-HPFLPTLYAEFEASH 162 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~ 162 (489)
++|.+.+.||+|+||.||+|..+. +++.||+|++.+...........+.+|..+++.++ ||||+++++++.+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKE-----TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcC-----CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCc
Confidence 479999999999999999999886 57889999998765544444567788999999998 999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
..|+||||+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++....
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 999999999999999998875 479999999999999999999999999999999999999999999999999984432
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
........ ..... .........
T Consensus 154 ~~~~~~~~-----------------------~~~~~-----------------------------------~~~~~~~~~ 175 (280)
T cd05581 154 PNSSPESN-----------------------KGDAT-----------------------------------NIDSQIEKN 175 (280)
T ss_pred CccccccC-----------------------CCCCc-----------------------------------ccccccccc
Confidence 11000000 00000 000000001
Q ss_pred ccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHH
Q 011302 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEV 402 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~ 402 (489)
......+.|+..|+|||++.+..++.++|||||||++|+|++|..||...+....+..+......+|... .
T Consensus 176 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~ 246 (280)
T cd05581 176 RRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFPPNF---------P 246 (280)
T ss_pred ccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCCCCCcc---------C
Confidence 1223455789999999999988899999999999999999999999998887777777665554444322 1
Q ss_pred hhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 403 VKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 403 ~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
..+.+||.+||..+|++||++.+..+++++||||
T Consensus 247 ~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 247 PDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 2489999999999999999995555599999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=341.85 Aligned_cols=263 Identities=27% Similarity=0.403 Sum_probs=205.8
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
++|++.+.||+|+||.||+|+++. .++.||+|++...... ......+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 74 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRE-----TGQIVAIKKFVESEDD-PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRK 74 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECC-----CCcEEEEEEEeecccC-ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCE
Confidence 479999999999999999999886 5788999998644211 1122346679999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
.|+||||++++.|..++... ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 75 ~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07847 75 LHLVFEYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTG 152 (286)
T ss_pred EEEEEeccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCC
Confidence 99999999998887776543 4689999999999999999999999999999999999999999999999999743211
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
. .
T Consensus 153 ~------------------------------------------------------------------------------~ 154 (286)
T cd07847 153 P------------------------------------------------------------------------------G 154 (286)
T ss_pred C------------------------------------------------------------------------------c
Confidence 0 0
Q ss_pred cCCccccCCCCccCcchhcC-CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcC------------------
Q 011302 324 ARSKSFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK------------------ 384 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------------ 384 (489)
.......|+..|+|||++.+ ..++.++|||||||++|||++|..||.+.+..+....+...
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 155 DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence 01122357889999999876 45789999999999999999999999987765544433210
Q ss_pred -CCCCCCCCCCCchh--H-HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 385 -PLTFPRIGVSSSKE--F-EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 385 -~~~~p~~~~~~~~~--~-~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
....|......... + .....+.+||.+||..||++||++. +++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~----eil~~~~f 286 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCE----ELLEHPYF 286 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHH----HHhcCCCC
Confidence 00111110000000 0 1123588999999999999999997 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=348.79 Aligned_cols=260 Identities=27% Similarity=0.375 Sum_probs=190.1
Q ss_pred eeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee--cCceEEE
Q 011302 89 LRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE--ASHYSCL 166 (489)
Q Consensus 89 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~--~~~~~~l 166 (489)
.++||+|+||+||+|+.++. .....||+|.+..... ...+.+|+.+++.++||||+++++++. .+..+|+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~---~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l 77 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDG---KDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWL 77 (317)
T ss_pred ceEeccCCCeeEEEEEecCC---CccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEE
Confidence 36899999999999997653 2457899999875422 123556999999999999999999884 4568899
Q ss_pred EEeecCCCchHHHHHhC-------CCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEe----ccCCcEEEccc
Q 011302 167 VMEYCPGGDLYAARQRQ-------PGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLV----REDGHIMLSDF 235 (489)
Q Consensus 167 V~E~~~gg~L~~~l~~~-------~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl----~~~~~vkl~DF 235 (489)
||||+ +++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 78 v~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 78 LFDYA-EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred EEeee-CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 99999 46887776432 12358888999999999999999999999999999999999 46689999999
Q ss_pred CCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCc
Q 011302 236 DLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDP 315 (489)
Q Consensus 236 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (489)
|+++.......
T Consensus 157 G~a~~~~~~~~--------------------------------------------------------------------- 167 (317)
T cd07867 157 GFARLFNSPLK--------------------------------------------------------------------- 167 (317)
T ss_pred cceeccCCCcc---------------------------------------------------------------------
Confidence 99843321000
Q ss_pred cccccccccCCccccCCCCccCcchhcCC-CCCCcccHHHHHHHHHHHhhCCCCCCCCCcH---------HHHHHHhcC-
Q 011302 316 EVVAEPINARSKSFVGTHEYLAPEVISGQ-GHGSAVDWWTLGVFLYEMLYGTTPFKGENNE---------KTLINILKK- 384 (489)
Q Consensus 316 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---------~~~~~i~~~- 384 (489)
........+||+.|+|||++.+. .++.++|||||||++|||++|.+||...... ..+..+...
T Consensus 168 ------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07867 168 ------PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM 241 (317)
T ss_pred ------cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence 00011234689999999999874 4799999999999999999999999754321 111111110
Q ss_pred --C-----------CCCCCCC---------CCCch------hHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 385 --P-----------LTFPRIG---------VSSSK------EFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 385 --~-----------~~~p~~~---------~~~~~------~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
+ ..++... ..... .......+.+||.+||+.||.+||++. |+++||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~----e~l~hp~f 317 (317)
T cd07867 242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSE----QALQDPYF 317 (317)
T ss_pred CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHH----HHhcCCCC
Confidence 0 0000000 00000 001122478999999999999999998 99999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=333.92 Aligned_cols=254 Identities=26% Similarity=0.415 Sum_probs=212.3
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceE
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYS 164 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 164 (489)
+|++.+.||+|+||.||+|.... ++..||+|.+....... .....+..|+.+++.++||||+++++.+..++..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 74 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKA-----DQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYENFLEDKAL 74 (256)
T ss_pred CceEEEEecccCceEEEEEEEcC-----CCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEE
Confidence 58999999999999999999876 57889999997654332 2345677899999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccC-CcEEEcccCCCccccc
Q 011302 165 CLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRED-GHIMLSDFDLSFKCDV 243 (489)
Q Consensus 165 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~-~~vkl~DFG~a~~~~~ 243 (489)
|+||||++|++|.+++....+..+++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++.....
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 75 MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 999999999999999987655668999999999999999999999999999999999999865 4689999999743210
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
.
T Consensus 155 -------------------------------------------------------------------------------~ 155 (256)
T cd08220 155 -------------------------------------------------------------------------------K 155 (256)
T ss_pred -------------------------------------------------------------------------------C
Confidence 0
Q ss_pred cCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCC-CCCCCCCCchhHHHH
Q 011302 324 ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLT-FPRIGVSSSKEFEEV 402 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~p~~~~~~~~~~~~~ 402 (489)
.......|++.|+|||.+.+..++.++|||||||++|+|++|..||.+.+.......+...... ++.. ..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~ 226 (256)
T cd08220 156 SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDR---------YS 226 (256)
T ss_pred ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCC---------cC
Confidence 0112236889999999999888899999999999999999999999988877766666554322 1211 11
Q ss_pred hhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 403 VKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 403 ~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
..+.+||.+||..||++||++. ++++||||
T Consensus 227 ~~l~~li~~~l~~~p~~Rpt~~----~ll~~p~~ 256 (256)
T cd08220 227 PDLRQLILSMLNLDPSKRPQLS----QIMAQPIC 256 (256)
T ss_pred HHHHHHHHHHccCChhhCCCHH----HHhhCCCC
Confidence 2589999999999999999998 99999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=336.67 Aligned_cols=260 Identities=27% Similarity=0.418 Sum_probs=206.6
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHH--HHHHHHHHHHHHHHHHHhCCCCCcccccceeec-
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREAL--AIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA- 160 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~- 160 (489)
.+|++.+.||+|+||.||+|.+.. ++..||+|.+..... ........+.+|+.+++.++||||+++++++.+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 76 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVD-----TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR 76 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcC-----CCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC
Confidence 478999999999999999999876 567899999864321 122344567789999999999999999998865
Q ss_pred -CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 161 -SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 161 -~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
...+|+||||+++++|.+++... ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||++.
T Consensus 77 ~~~~~~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 77 AEKTLTIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 46789999999999999988765 468999999999999999999999999999999999999999999999999984
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
........
T Consensus 155 ~~~~~~~~------------------------------------------------------------------------ 162 (266)
T cd06651 155 RLQTICMS------------------------------------------------------------------------ 162 (266)
T ss_pred cccccccc------------------------------------------------------------------------
Confidence 33210000
Q ss_pred cccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhH
Q 011302 320 EPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEF 399 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 399 (489)
........|+..|+|||.+.+..++.++|||||||++|||++|+.||...+....+..+...... |.....
T Consensus 163 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~----- 233 (266)
T cd06651 163 ---GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTN-PQLPSH----- 233 (266)
T ss_pred ---CCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCC-CCCchh-----
Confidence 00011235889999999999988999999999999999999999999887666555554432211 111111
Q ss_pred HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcC
Q 011302 400 EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437 (489)
Q Consensus 400 ~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~ 437 (489)
....+++|| +||..+|++||++. ++++||||+
T Consensus 234 -~~~~~~~li-~~~~~~p~~Rp~~~----eil~hp~~~ 265 (266)
T cd06651 234 -ISEHARDFL-GCIFVEARHRPSAE----ELLRHPFAQ 265 (266)
T ss_pred -cCHHHHHHH-HHhcCChhhCcCHH----HHhcCcccc
Confidence 122478888 57778999999987 999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=335.69 Aligned_cols=260 Identities=27% Similarity=0.421 Sum_probs=207.4
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHH--HHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREA--LAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS 161 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 161 (489)
.+|++.+.||+|+||.||+|.+.. +++.||||.+..+. .........+.+|+.+++.++||||+++++++.+.
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~-----~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 76 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDAD-----TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP 76 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcC-----CCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC
Confidence 579999999999999999999876 57889999886422 11123456677899999999999999999998763
Q ss_pred --ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 162 --HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 162 --~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
..+|+||||++|++|.+++... ..+++..+..++.|++.||+|||+++|+|+||||+|||++.++.++|+|||++.
T Consensus 77 ~~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 77 MERTLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred CCceEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 5789999999999999988765 458899999999999999999999999999999999999999999999999974
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
.......
T Consensus 155 ~~~~~~~------------------------------------------------------------------------- 161 (265)
T cd06652 155 RLQTICL------------------------------------------------------------------------- 161 (265)
T ss_pred ccccccc-------------------------------------------------------------------------
Confidence 3211000
Q ss_pred cccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhH
Q 011302 320 EPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEF 399 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 399 (489)
.........|+..|+|||++.+..++.++|||||||++|||++|+.||........+.++...... +....
T Consensus 162 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~------ 232 (265)
T cd06652 162 --SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN-PVLPP------ 232 (265)
T ss_pred --cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCC-CCCch------
Confidence 000112235889999999999888999999999999999999999999877665555554433211 11110
Q ss_pred HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcC
Q 011302 400 EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437 (489)
Q Consensus 400 ~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~ 437 (489)
.....+.++|++||. +|++||++. ++++|||++
T Consensus 233 ~~~~~~~~~i~~~l~-~p~~Rp~~~----~il~~~~~~ 265 (265)
T cd06652 233 HVSDHCRDFLKRIFV-EAKLRPSAD----ELLRHTFVH 265 (265)
T ss_pred hhCHHHHHHHHHHhc-ChhhCCCHH----HHhcCcccC
Confidence 112358899999994 999999987 999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=343.41 Aligned_cols=262 Identities=26% Similarity=0.389 Sum_probs=200.3
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceE
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYS 164 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 164 (489)
+|++.+.||+|+||.||+|+++. ++..||+|.+...... ......+.+|+.+++.++||||+++++++.+...+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~-----~g~~~~~k~~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 74 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRE-----THEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKL 74 (284)
T ss_pred CceeEEEecccCCeEEEEEEECC-----CCcEEEEEEeeccccc-ccCccchhHHHHHHHhcCCCCeeeHHHHhccCCce
Confidence 48899999999999999999886 5678999998754221 12234456799999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccC
Q 011302 165 CLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVV 244 (489)
Q Consensus 165 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~ 244 (489)
|+||||++ ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 75 ~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 152 (284)
T cd07839 75 TLVFEYCD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 152 (284)
T ss_pred EEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence 99999995 6887777653 256999999999999999999999999999999999999999999999999997422100
Q ss_pred ccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccccc
Q 011302 245 PKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINA 324 (489)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (489)
..
T Consensus 153 ------------------------------------------------------------------------------~~ 154 (284)
T cd07839 153 ------------------------------------------------------------------------------VR 154 (284)
T ss_pred ------------------------------------------------------------------------------CC
Confidence 00
Q ss_pred CCccccCCCCccCcchhcCCC-CCCcccHHHHHHHHHHHhhCCCCC-CCCCcHHHHHHHhcCC-----------------
Q 011302 325 RSKSFVGTHEYLAPEVISGQG-HGSAVDWWTLGVFLYEMLYGTTPF-KGENNEKTLINILKKP----------------- 385 (489)
Q Consensus 325 ~~~~~~Gt~~y~aPE~l~~~~-~~~~~DiwSlGvil~elltG~~Pf-~~~~~~~~~~~i~~~~----------------- 385 (489)
......+++.|+|||++.+.. ++.++|||||||++|||++|..|| .+.+..+.+..+....
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 011235788999999987754 689999999999999999988885 4444444333332100
Q ss_pred CCCCCCCCCCc---hhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 386 LTFPRIGVSSS---KEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 386 ~~~p~~~~~~~---~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
..++....... ........+.+||.+||..||.+||++. +++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~----~il~h~~f 284 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAE----EALQHPYF 284 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHH----HHhcCCCC
Confidence 00000000000 0001123588999999999999999987 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=339.45 Aligned_cols=264 Identities=22% Similarity=0.269 Sum_probs=208.1
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE 159 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 159 (489)
.+..++|++.+.||+|+||.||+|.+++.........||||++...... ....++.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASM--RERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 4556889999999999999999999876443345678999998643211 22345778999999999999999999999
Q ss_pred cCceEEEEEeecCCCchHHHHHhCC--------CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEE
Q 011302 160 ASHYSCLVMEYCPGGDLYAARQRQP--------GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIM 231 (489)
Q Consensus 160 ~~~~~~lV~E~~~gg~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vk 231 (489)
.+...|+||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.|++||||||+|||++.++.++
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEE
Confidence 9999999999999999999886532 12356778889999999999999999999999999999999999999
Q ss_pred EcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccc
Q 011302 232 LSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQEL 311 (489)
Q Consensus 232 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (489)
|+|||+++.+.....
T Consensus 160 l~dfg~~~~~~~~~~----------------------------------------------------------------- 174 (277)
T cd05062 160 IGDFGMTRDIYETDY----------------------------------------------------------------- 174 (277)
T ss_pred ECCCCCccccCCcce-----------------------------------------------------------------
Confidence 999999843221000
Q ss_pred cCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCC
Q 011302 312 LDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPR 390 (489)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~ 390 (489)
........+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+.........
T Consensus 175 -----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (277)
T cd05062 175 -----------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKP 243 (277)
T ss_pred -----------eecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCC
Confidence 000011246788999999998889999999999999999998 79999988877766666554322111
Q ss_pred CCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 391 IGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 391 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
.... ..+.+||.+||+.||++||++. +++++
T Consensus 244 --~~~~------~~~~~li~~~l~~~p~~Rps~~----e~l~~ 274 (277)
T cd05062 244 --DNCP------DMLFELMRMCWQYNPKMRPSFL----EIISS 274 (277)
T ss_pred --CCCC------HHHHHHHHHHcCCChhhCcCHH----HHHHH
Confidence 1111 2489999999999999999987 66553
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=338.81 Aligned_cols=258 Identities=30% Similarity=0.508 Sum_probs=213.4
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
++|++.+.||.|+||.||+|++.. ++..||+|++..+.. ......+..|+.+++.++|+||+++++++.++..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKR-----TNQVVAIKVIDLEEA--EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSK 73 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECC-----CCeEEEEEEeecccc--chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCe
Confidence 468899999999999999999876 578899999975431 2334456779999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
+|+|+||+++++|.+++... .+++..+..++.|++.||.|||+++++||||+|+||+++.++.++|+|||+++....
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 150 (274)
T cd06609 74 LWIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTS 150 (274)
T ss_pred EEEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence 99999999999999988763 689999999999999999999999999999999999999999999999999844321
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
..
T Consensus 151 ~~------------------------------------------------------------------------------ 152 (274)
T cd06609 151 TM------------------------------------------------------------------------------ 152 (274)
T ss_pred cc------------------------------------------------------------------------------
Confidence 00
Q ss_pred cCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHh
Q 011302 324 ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVV 403 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~ 403 (489)
.......|++.|+|||.+.+..++.++|||||||++|+|++|..||...+.......+..... +..... ....
T Consensus 153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~-----~~~~ 225 (274)
T cd06609 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNP--PSLEGN-----KFSK 225 (274)
T ss_pred cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCC--CCCccc-----ccCH
Confidence 011234688999999999998899999999999999999999999988776655555444321 111111 0122
Q ss_pred hHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 404 KLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 404 ~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
.+.++|.+||..+|++||++. ++++||||+...
T Consensus 226 ~~~~~l~~~l~~~p~~Rpt~~----~il~~~~~~~~~ 258 (274)
T cd06609 226 PFKDFVSLCLNKDPKERPSAK----ELLKHKFIKKAK 258 (274)
T ss_pred HHHHHHHHHhhCChhhCcCHH----HHhhChhhcCCC
Confidence 488999999999999999987 999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=341.79 Aligned_cols=257 Identities=27% Similarity=0.389 Sum_probs=206.1
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
++|++++.||+|+||.||+|.+.. .+..||+|.+..... ......+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~-----~~~~~a~k~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 73 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRP-----TGVTMAMKEIRLELD--ESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGA 73 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcC-----CCcEEEEEEeecccC--HHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCe
Confidence 478999999999999999999876 568899998865321 1234567789999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCC-CCCCChhhHHHHHHHHHHHHHHHHh-CCCeeecCCCCCeEeccCCcEEEcccCCCccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQP-GKRFGISSAKFYAAETLLALEYLHM-MGIVYRDLKPENVLVREDGHIMLSDFDLSFKC 241 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~ 241 (489)
+|+||||++|++|..++.... ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++..+
T Consensus 74 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 153 (286)
T cd06622 74 VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL 153 (286)
T ss_pred EEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999999999999988876531 2368999999999999999999997 59999999999999999999999999987322
Q ss_pred ccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccc
Q 011302 242 DVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEP 321 (489)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (489)
..
T Consensus 154 ~~------------------------------------------------------------------------------ 155 (286)
T cd06622 154 VA------------------------------------------------------------------------------ 155 (286)
T ss_pred cC------------------------------------------------------------------------------
Confidence 10
Q ss_pred cccCCccccCCCCccCcchhcCC------CCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHH---HHhcCC-CCCCCC
Q 011302 322 INARSKSFVGTHEYLAPEVISGQ------GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLI---NILKKP-LTFPRI 391 (489)
Q Consensus 322 ~~~~~~~~~Gt~~y~aPE~l~~~------~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~---~i~~~~-~~~p~~ 391 (489)
.......|++.|+|||.+.+. .++.++|||||||++|+|++|..||.......... .+.... ...+.
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~- 232 (286)
T cd06622 156 --SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPS- 232 (286)
T ss_pred --CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCc-
Confidence 011223588899999998654 34789999999999999999999997765444333 233221 11111
Q ss_pred CCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 392 GVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 392 ~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
. ....+.+||.+||..+|++||++. +++.||||....
T Consensus 233 --~------~~~~~~~li~~~l~~~p~~Rp~~~----~l~~~~~~~~~~ 269 (286)
T cd06622 233 --G------YSDDAQDFVAKCLNKIPNRRPTYA----QLLEHPWLVKYK 269 (286)
T ss_pred --c------cCHHHHHHHHHHcccCcccCCCHH----HHhcChhhhhcc
Confidence 1 123589999999999999999987 999999997653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=333.31 Aligned_cols=257 Identities=30% Similarity=0.464 Sum_probs=211.7
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
++|++.+.||+|+||.||+|.+.. +++.+++|++...... ....+..|+.+++.++||||+++++++.++..
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 74 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIA-----TGELVAIKVIKLEPGD---DFEIIQQEISMLKECRHPNIVAYFGSYLRRDK 74 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecC-----CCCEEEEEEEEcCchh---hHHHHHHHHHHHHhCCCCChhceEEEEEeCCE
Confidence 689999999999999999999876 4678999999754322 34567779999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
+|+||||+++++|.+++... ...+++.++..++.|++.||.|||++||+|+||||+||+++.++.+||+|||++..+..
T Consensus 75 ~~l~~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 75 LWIVMEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153 (262)
T ss_pred EEEEEeCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhh
Confidence 99999999999999988664 25689999999999999999999999999999999999999999999999999743210
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
. .
T Consensus 154 ~------------------------------------------------------------------------------~ 155 (262)
T cd06613 154 T------------------------------------------------------------------------------I 155 (262)
T ss_pred h------------------------------------------------------------------------------h
Confidence 0 0
Q ss_pred cCCccccCCCCccCcchhcCC---CCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHH
Q 011302 324 ARSKSFVGTHEYLAPEVISGQ---GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFE 400 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~~---~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 400 (489)
.......|+..|+|||.+.+. .++.++|||||||++|||++|..||.+.+.......+.......+.... ...
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~ 231 (262)
T cd06613 156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKD----KEK 231 (262)
T ss_pred hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccc----hhh
Confidence 011234688899999999877 7889999999999999999999999887766655555444332222111 112
Q ss_pred HHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCC
Q 011302 401 EVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEF 435 (489)
Q Consensus 401 ~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~ 435 (489)
....+.+||.+||..+|.+||++. +++.|+|
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rpt~~----~il~~~~ 262 (262)
T cd06613 232 WSPVFHDFIKKCLTKDPKKRPTAT----KLLQHPF 262 (262)
T ss_pred hhHHHHHHHHHHcCCChhhCCCHH----HHhcCCC
Confidence 234589999999999999999997 9999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=341.27 Aligned_cols=263 Identities=27% Similarity=0.412 Sum_probs=212.9
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-C-CC----ccccc
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-H-PF----LPTLY 155 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-pn----Iv~l~ 155 (489)
..++|.++..||+|+||.|..+.++. .+..||||+++.-. ...+....|+++|.++. + |+ +|.+.
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~-----~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~ 157 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRE-----TKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQMR 157 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecC-----CCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence 35789999999999999999999997 46889999997432 33445667999999984 2 33 88999
Q ss_pred ceeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEecc---------
Q 011302 156 AEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRE--------- 226 (489)
Q Consensus 156 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~--------- 226 (489)
++|.-.++.|||+|.+ |-++++++..+...+|+...++.|++|++++|+|||+.+++|.||||||||+..
T Consensus 158 ~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~ 236 (415)
T KOG0671|consen 158 DWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNP 236 (415)
T ss_pred hhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEecc
Confidence 9999999999999999 889999999988889999999999999999999999999999999999999942
Q ss_pred -----------CCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccc
Q 011302 227 -----------DGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTV 295 (489)
Q Consensus 227 -----------~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (489)
+-.++|+|||-|+.-.
T Consensus 237 k~~~~~~r~~ks~~I~vIDFGsAtf~~----------------------------------------------------- 263 (415)
T KOG0671|consen 237 KKKVCFIRPLKSTAIKVIDFGSATFDH----------------------------------------------------- 263 (415)
T ss_pred CCccceeccCCCcceEEEecCCcceec-----------------------------------------------------
Confidence 2348999999873221
Q ss_pred cccccccCCCCCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcH
Q 011302 296 TTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNE 375 (489)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~ 375 (489)
.-...++-|..|+|||++++-+|++.+||||+||||+||++|...|.+.++.
T Consensus 264 ----------------------------e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 264 ----------------------------EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred ----------------------------cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 1124567899999999999999999999999999999999999999988766
Q ss_pred H---HHHHHhc------------------CCCCCCCCCCCC--------ch--------hHHHHhhHHHHHHHHhhcCcc
Q 011302 376 K---TLINILK------------------KPLTFPRIGVSS--------SK--------EFEEVVKLQDLISKLLVKNPK 418 (489)
Q Consensus 376 ~---~~~~i~~------------------~~~~~p~~~~~~--------~~--------~~~~~~~l~~li~~~L~~dP~ 418 (489)
+ +++.|+. +.+.+|...... .. ...+..++.|||++||..||.
T Consensus 316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 6 3444432 111222211111 00 013445689999999999999
Q ss_pred cccCCCCChHHHHcCCCcCCC
Q 011302 419 KRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 419 ~R~~~~~~~~~ll~hp~f~~~ 439 (489)
+|+|+. |+|.||||+..
T Consensus 396 ~RiTl~----EAL~HpFF~~~ 412 (415)
T KOG0671|consen 396 RRITLR----EALSHPFFARL 412 (415)
T ss_pred ccccHH----HHhcCHHhhcC
Confidence 999998 99999999874
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=375.60 Aligned_cols=271 Identities=22% Similarity=0.302 Sum_probs=203.2
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
++|++.++||+|+||.||+|.+.. +++.||||++..+.........++.+|+.+++.++||||+++++++.+++.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~-----tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPV-----CSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECC-----CCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCE
Confidence 689999999999999999999876 578899999976543333445678889999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCC---------CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcc
Q 011302 164 SCLVMEYCPGGDLYAARQRQP---------GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSD 234 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~---------~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~D 234 (489)
.|+||||++||+|.+++.... ...++...+..++.||+.||+|||++|||||||||+|||++.+|.+||+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiD 156 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILD 156 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEe
Confidence 999999999999999886421 12355667788999999999999999999999999999999999999999
Q ss_pred cCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCC
Q 011302 235 FDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDD 314 (489)
Q Consensus 235 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (489)
||+++.......... ... ... .+
T Consensus 157 FGLAk~i~~~~~~~~-----------------~l~---------~~~---------------------~~---------- 179 (932)
T PRK13184 157 WGAAIFKKLEEEDLL-----------------DID---------VDE---------------------RN---------- 179 (932)
T ss_pred cCcceeccccccccc-----------------ccc---------ccc---------------------cc----------
Confidence 999854321000000 000 000 00
Q ss_pred ccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHH-hcCCCCCCCCCC
Q 011302 315 PEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINI-LKKPLTFPRIGV 393 (489)
Q Consensus 315 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i-~~~~~~~p~~~~ 393 (489)
............+||+.|||||++.+..++.++|||||||++|||++|..||.+.+........ ...+......
T Consensus 180 ---s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~-- 254 (932)
T PRK13184 180 ---ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPY-- 254 (932)
T ss_pred ---ccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhccChhhcccc--
Confidence 0000001123457999999999999999999999999999999999999999876554332221 1111111100
Q ss_pred CCchhHHHHhhHHHHHHHHhhcCcccccCCCCC
Q 011302 394 SSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKG 426 (489)
Q Consensus 394 ~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~ 426 (489)
...+..+.+++.+||..||++|++..++
T Consensus 255 -----~~iP~~L~~LI~rcL~~DP~kR~ss~ee 282 (932)
T PRK13184 255 -----REIPPFLSQIAMKALAVDPAERYSSVQE 282 (932)
T ss_pred -----ccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 0112358899999999999999987643
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=338.30 Aligned_cols=270 Identities=38% Similarity=0.711 Sum_probs=213.6
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHH-HHHHHHHHHHHHHHHhC-CCCCcccccceeecCc
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAI-RKKLHRADMEKVILTML-DHPFLPTLYAEFEASH 162 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~ 162 (489)
+|++.+.||+|+||.||+|+..... .++..||+|++....... .....++..|+.++..+ +|+||++++++++.+.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~--~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGH--DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDT 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCC--CCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCC
Confidence 4889999999999999999876421 146789999998654332 22345567799999999 5999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
.+|+||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred eEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 999999999999999988765 568899999999999999999999999999999999999999999999999974321
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
...
T Consensus 157 ~~~----------------------------------------------------------------------------- 159 (290)
T cd05613 157 EDE----------------------------------------------------------------------------- 159 (290)
T ss_pred ccc-----------------------------------------------------------------------------
Confidence 000
Q ss_pred ccCCccccCCCCccCcchhcCC--CCCCcccHHHHHHHHHHHhhCCCCCCCCCc----HHHHHHHhcCCCCCCCCCCCCc
Q 011302 323 NARSKSFVGTHEYLAPEVISGQ--GHGSAVDWWTLGVFLYEMLYGTTPFKGENN----EKTLINILKKPLTFPRIGVSSS 396 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~--~~~~~~DiwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~p~~~~~~~ 396 (489)
........|+..|+|||.+.+. .++.++|||||||++|+|++|..||..... .+....+......+|..
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 234 (290)
T cd05613 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE----- 234 (290)
T ss_pred ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCcc-----
Confidence 0011234688999999998753 467899999999999999999999975432 22223333332222221
Q ss_pred hhHHHHhhHHHHHHHHhhcCcccccCCC-CChHHHHcCCCcCCCCcccc
Q 011302 397 KEFEEVVKLQDLISKLLVKNPKKRIGSL-KGSVEIKRHEFFKGINWALI 444 (489)
Q Consensus 397 ~~~~~~~~l~~li~~~L~~dP~~R~~~~-~~~~~ll~hp~f~~~~~~~~ 444 (489)
....+.+|+.+||..||++|++.. ..+++++.||||+.++|+.+
T Consensus 235 ----~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~ 279 (290)
T cd05613 235 ----MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDL 279 (290)
T ss_pred ----CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHH
Confidence 112488999999999999999653 45679999999999999876
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=335.97 Aligned_cols=261 Identities=23% Similarity=0.362 Sum_probs=206.6
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHH---HHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREA---LAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS 161 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 161 (489)
+|+..+.||+|+||.||+|.+.. +++.||+|++.... .........+..|+.+++.++|+||+++++++.+.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVK-----TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcC-----CCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC
Confidence 47788999999999999999866 56789999987432 12223456778899999999999999999999999
Q ss_pred ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCC-cEEEcccCCCcc
Q 011302 162 HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDG-HIMLSDFDLSFK 240 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~-~vkl~DFG~a~~ 240 (489)
+..++||||++|++|.+++... +.+++..+..++.||+.||.|||++|++||||||+||+++.++ .+||+|||++..
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 9999999999999999998765 5689999999999999999999999999999999999998776 599999999743
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
......
T Consensus 154 ~~~~~~-------------------------------------------------------------------------- 159 (268)
T cd06630 154 LAAKGT-------------------------------------------------------------------------- 159 (268)
T ss_pred cccccc--------------------------------------------------------------------------
Confidence 321000
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHH---HHhcCCCCCCCCCCCCch
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLI---NILKKPLTFPRIGVSSSK 397 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~---~i~~~~~~~p~~~~~~~~ 397 (489)
..........||..|+|||.+.+..++.++|||||||++|+|++|..||.......... ++...... +....
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~---- 234 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA-PSIPE---- 234 (268)
T ss_pred cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCC-CCCch----
Confidence 00001123468999999999998889999999999999999999999997554332222 22211111 11110
Q ss_pred hHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcC
Q 011302 398 EFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437 (489)
Q Consensus 398 ~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~ 437 (489)
....++.++|.+||..+|++||++. ++++||||+
T Consensus 235 --~~~~~~~~~i~~~l~~~p~~R~~~~----~ll~~~~~~ 268 (268)
T cd06630 235 --HLSPGLRDVTLRCLELQPEDRPPSR----ELLKHPVFR 268 (268)
T ss_pred --hhCHHHHHHHHHHcCCCcccCcCHH----HHhcCcccC
Confidence 1223589999999999999999997 999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=355.41 Aligned_cols=251 Identities=27% Similarity=0.429 Sum_probs=206.9
Q ss_pred eeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEEEEEee
Q 011302 91 RLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEY 170 (489)
Q Consensus 91 ~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 170 (489)
+||+|+||+||.|+++. ++...|||-+.... .+..+-+.+|+.+.+.|.|.|||+++|++..++++-|.||-
T Consensus 582 VLGKGTYG~VYA~RD~~-----tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEq 653 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMD-----TQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQ 653 (1226)
T ss_pred EeecCceeEEEeecccc-----ceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeec
Confidence 69999999999999998 57788999986543 23445577799999999999999999999999999999999
Q ss_pred cCCCchHHHHHhCCCCCC--ChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEec-cCCcEEEcccCCCcccccCccc
Q 011302 171 CPGGDLYAARQRQPGKRF--GISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVR-EDGHIMLSDFDLSFKCDVVPKL 247 (489)
Q Consensus 171 ~~gg~L~~~l~~~~~~~l--~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~-~~~~vkl~DFG~a~~~~~~~~~ 247 (489)
++||+|.++++... +++ .+..+-+|..||++||.|||++.|||||||-+|+||+ -.|.+||+|||.++++.-.
T Consensus 654 VPGGSLSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--- 729 (1226)
T KOG4279|consen 654 VPGGSLSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--- 729 (1226)
T ss_pred CCCCcHHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccC---
Confidence 99999999998765 566 7788899999999999999999999999999999997 5799999999998654321
Q ss_pred cCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCc
Q 011302 248 LRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSK 327 (489)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (489)
+.-+.
T Consensus 730 ---------------------------------------------------------------------------nP~TE 734 (1226)
T KOG4279|consen 730 ---------------------------------------------------------------------------NPCTE 734 (1226)
T ss_pred ---------------------------------------------------------------------------Ccccc
Confidence 23356
Q ss_pred cccCCCCccCcchhcCC--CCCCcccHHHHHHHHHHHhhCCCCCCCCCcHH-HHHHHhcCCCCCCCCCCCCchhHHHHhh
Q 011302 328 SFVGTHEYLAPEVISGQ--GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEK-TLINILKKPLTFPRIGVSSSKEFEEVVK 404 (489)
Q Consensus 328 ~~~Gt~~y~aPE~l~~~--~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~-~~~~i~~~~~~~p~~~~~~~~~~~~~~~ 404 (489)
++.||..|||||+|... +|+.++|||||||++.||.||++||......+ .+.++-.-....| +.. +...+
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~-iPe------elsae 807 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPP-IPE------ELSAE 807 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCC-CcH------HHHHH
Confidence 78899999999999754 48999999999999999999999997655433 3333322111111 111 12236
Q ss_pred HHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 405 LQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 405 l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
++.||.+|++.||.+||++. ++|++||++.-
T Consensus 808 ak~FilrcFepd~~~R~sA~----~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 808 AKNFILRCFEPDPCDRPSAK----DLLQDPFLQHN 838 (1226)
T ss_pred HHHHHHHHcCCCcccCccHH----HhccCcccccC
Confidence 89999999999999999998 99999999754
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=323.50 Aligned_cols=262 Identities=24% Similarity=0.337 Sum_probs=210.8
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-CCCcccccceee
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-HPFLPTLYAEFE 159 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~ 159 (489)
...++.+++..||.|+.|.||+++.+. ++...|||.+.+.... +...++.+.+.++.+.+ +|+||+.+|+|.
T Consensus 89 ~dindl~~l~dlGsGtcG~V~k~~~rs-----~~~iiAVK~M~rt~Nk--ee~kRILmDldvv~~s~dcpyIV~c~GyFi 161 (391)
T KOG0983|consen 89 ADINDLENLGDLGSGTCGQVWKMRFRS-----TGHIIAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVQCFGYFI 161 (391)
T ss_pred cChHHhhhHHhhcCCCccceEEEEEcc-----cceEEEEEeecccCCH--HHHHHHHHhhhHHhhccCCCeeeeeeeEEe
Confidence 345677888999999999999999998 6789999999876543 44566777777666554 899999999999
Q ss_pred cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHh-CCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 160 ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHM-MGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 160 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
.+..+++.||.| +..+..++++.. ++++|..+-.+...++.||.||-+ +||||||+||.|||+|+.|++||||||++
T Consensus 162 ~n~dV~IcMelM-s~C~ekLlkrik-~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIs 239 (391)
T KOG0983|consen 162 TNTDVFICMELM-STCAEKLLKRIK-GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGIS 239 (391)
T ss_pred eCchHHHHHHHH-HHHHHHHHHHhc-CCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeeccccc
Confidence 999999999999 566666666653 679998889999999999999996 48999999999999999999999999998
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
-++....
T Consensus 240 GrlvdSk------------------------------------------------------------------------- 246 (391)
T KOG0983|consen 240 GRLVDSK------------------------------------------------------------------------- 246 (391)
T ss_pred ceeeccc-------------------------------------------------------------------------
Confidence 4332110
Q ss_pred ccccccCCccccCCCCccCcchhcCC---CCCCcccHHHHHHHHHHHhhCCCCCCCC-CcHHHHHHHhcCCCCCCCCCCC
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQ---GHGSAVDWWTLGVFLYEMLYGTTPFKGE-NNEKTLINILKKPLTFPRIGVS 394 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~---~~~~~~DiwSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~~~~~p~~~~~ 394 (489)
-.+...|.+.|||||.+.-. .|+.++||||||+.|+||.||+.||.+. .+.+++.++++... |.....
T Consensus 247 ------AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP--P~L~~~ 318 (391)
T KOG0983|consen 247 ------AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP--PLLPGH 318 (391)
T ss_pred ------ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC--CCCCcc
Confidence 01223689999999999643 5899999999999999999999999985 45677778877433 222111
Q ss_pred CchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 395 SSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 395 ~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
. . ..+++++|+..||.+|+.+||... +||+|||+..++
T Consensus 319 ~--g--FSp~F~~fv~~CL~kd~r~RP~Y~----~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 319 M--G--FSPDFQSFVKDCLTKDHRKRPKYN----KLLEHPFIKRYE 356 (391)
T ss_pred c--C--cCHHHHHHHHHHhhcCcccCcchH----HHhcCcceeecc
Confidence 0 0 223589999999999999999998 999999997653
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=338.34 Aligned_cols=259 Identities=27% Similarity=0.413 Sum_probs=205.4
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccceeec
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAEFEA 160 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~ 160 (489)
..++|.+.+.||+|+||.||+|.... .++.||+|++..... ....+..|+.+++.+ +||||+++++++..
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~-----~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKK-----DGSLAAVKILDPISD----VDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECC-----CCCEEEEEEeccccc----HHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 45889999999999999999999876 577899999865321 123455688888888 79999999999864
Q ss_pred C-----ceEEEEEeecCCCchHHHHHhC--CCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEc
Q 011302 161 S-----HYSCLVMEYCPGGDLYAARQRQ--PGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLS 233 (489)
Q Consensus 161 ~-----~~~~lV~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~ 233 (489)
. ...|+||||++||+|.++++.. ....+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~ 170 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLV 170 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEe
Confidence 3 4689999999999999887642 23578999999999999999999999999999999999999999999999
Q ss_pred ccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccC
Q 011302 234 DFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLD 313 (489)
Q Consensus 234 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (489)
|||++......
T Consensus 171 dfg~~~~~~~~--------------------------------------------------------------------- 181 (291)
T cd06639 171 DFGVSAQLTST--------------------------------------------------------------------- 181 (291)
T ss_pred ecccchhcccc---------------------------------------------------------------------
Confidence 99987332100
Q ss_pred CccccccccccCCccccCCCCccCcchhcCC-----CCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCC
Q 011302 314 DPEVVAEPINARSKSFVGTHEYLAPEVISGQ-----GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTF 388 (489)
Q Consensus 314 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-----~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~ 388 (489)
........|+..|+|||++... .++.++|||||||++|||++|+.||...+....+..+.......
T Consensus 182 ---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 252 (291)
T cd06639 182 ---------RLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPT 252 (291)
T ss_pred ---------cccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCC
Confidence 0001123588999999998653 26789999999999999999999998877666666655432211
Q ss_pred CCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcC
Q 011302 389 PRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437 (489)
Q Consensus 389 p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~ 437 (489)
.... . .....+.+||.+||..+|++||++. ++++||||+
T Consensus 253 --~~~~--~--~~~~~l~~li~~~l~~~p~~Rps~~----~il~~~~~~ 291 (291)
T cd06639 253 --LLHP--E--KWCRSFNHFISQCLIKDFEARPSVT----HLLEHPFIK 291 (291)
T ss_pred --CCcc--c--ccCHHHHHHHHHHhhcChhhCcCHH----HHhcCcccC
Confidence 0000 0 1112589999999999999999987 999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=341.17 Aligned_cols=263 Identities=27% Similarity=0.383 Sum_probs=206.4
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceE
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYS 164 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 164 (489)
+|++++.||.|+||.||+|++.. ++..||||.+..+... ......+..|+.+++.++||||+++++++.+++..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKL-----TGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL 74 (284)
T ss_pred CceeeeeecCCCceEEEEEEECC-----CCCEEEEEEccccccc-cccchHHHHHHHHHHhcCCCCCcchhhhcccCCcE
Confidence 48899999999999999999876 5678999988654321 12234567799999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccC
Q 011302 165 CLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVV 244 (489)
Q Consensus 165 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~ 244 (489)
|+||||+. ++|..++.......+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus 75 ~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 75 YLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 153 (284)
T ss_pred EEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 99999995 68988887766677999999999999999999999999999999999999999999999999987322100
Q ss_pred ccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccccc
Q 011302 245 PKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINA 324 (489)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (489)
..
T Consensus 154 ------------------------------------------------------------------------------~~ 155 (284)
T cd07860 154 ------------------------------------------------------------------------------VR 155 (284)
T ss_pred ------------------------------------------------------------------------------cc
Confidence 00
Q ss_pred CCccccCCCCccCcchhcCCC-CCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCC-----------------
Q 011302 325 RSKSFVGTHEYLAPEVISGQG-HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL----------------- 386 (489)
Q Consensus 325 ~~~~~~Gt~~y~aPE~l~~~~-~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~----------------- 386 (489)
......+++.|+|||++.+.. ++.++|||||||++|||++|..||.+.+..+...++.....
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK 235 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence 011224688999999987755 58899999999999999999999988776655544432110
Q ss_pred -CCCCCCCCCchh--HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 387 -TFPRIGVSSSKE--FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 387 -~~p~~~~~~~~~--~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
.++......... ......+++||.+||+.||.+||++. ++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~----~~l~~~~f 284 (284)
T cd07860 236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAK----AALAHPFF 284 (284)
T ss_pred hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHH----HHhcCCCC
Confidence 011110000000 01123578999999999999999987 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=343.10 Aligned_cols=256 Identities=27% Similarity=0.416 Sum_probs=208.0
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
+.|.....||+|+||.||+|.+.. ++..||||.+..... .....+.+|+.+++.++||||+++++.+..++.
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~ 93 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKH-----TGKQVAVKKMDLRKQ---QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDE 93 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECC-----CCCEEEEEEEecchH---HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCe
Confidence 345556779999999999999875 567899999865432 233456779999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
.|+||||+++++|.+++.. ..+++.++..++.||+.||+|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 94 ~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (292)
T cd06658 94 LWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK 170 (292)
T ss_pred EEEEEeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccc
Confidence 9999999999999988754 4589999999999999999999999999999999999999999999999998732110
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
. .
T Consensus 171 ~------------------------------------------------------------------------------~ 172 (292)
T cd06658 171 E------------------------------------------------------------------------------V 172 (292)
T ss_pred c------------------------------------------------------------------------------c
Confidence 0 0
Q ss_pred cCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCC-CCCCCCCCCchhHHHH
Q 011302 324 ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL-TFPRIGVSSSKEFEEV 402 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~~~~~ 402 (489)
.......|++.|+|||.+.+..++.++|||||||++|||++|..||.+.+....+..+..... ..+... ...
T Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~ 245 (292)
T cd06658 173 PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSH-------KVS 245 (292)
T ss_pred ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCcccccc-------ccC
Confidence 011234689999999999988899999999999999999999999988776665555443211 111100 112
Q ss_pred hhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 403 VKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 403 ~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
..+.+||.+||..||.+||++. ++++||||+..
T Consensus 246 ~~~~~li~~~l~~~P~~Rpt~~----~il~~~~~~~~ 278 (292)
T cd06658 246 SVLRGFLDLMLVREPSQRATAQ----ELLQHPFLKLA 278 (292)
T ss_pred HHHHHHHHHHccCChhHCcCHH----HHhhChhhhcc
Confidence 2588999999999999999987 99999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=333.02 Aligned_cols=251 Identities=26% Similarity=0.448 Sum_probs=207.6
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceE
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYS 164 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 164 (489)
+|++.+.||+|+||.||+|++.. +++.||+|.++..... .....+..|+.+++.++||||+++++++.+++.+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~-----~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 73 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVN-----SDQKYAMKEIRLPKSS--SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHL 73 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcC-----CCceEEEEEEEcCcch--HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEE
Confidence 58899999999999999999876 5678999998643221 2345666799999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccC
Q 011302 165 CLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVV 244 (489)
Q Consensus 165 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~ 244 (489)
|+||||+++|+|.+++....+..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||+++.....
T Consensus 74 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 153 (255)
T cd08219 74 YIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP 153 (255)
T ss_pred EEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence 99999999999999887655567899999999999999999999999999999999999999999999999987432110
Q ss_pred ccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccccc
Q 011302 245 PKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINA 324 (489)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (489)
..
T Consensus 154 ------------------------------------------------------------------------------~~ 155 (255)
T cd08219 154 ------------------------------------------------------------------------------GA 155 (255)
T ss_pred ------------------------------------------------------------------------------cc
Confidence 00
Q ss_pred CCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhh
Q 011302 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVK 404 (489)
Q Consensus 325 ~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~ 404 (489)
......|++.|+|||++.+..++.++|+|||||++|+|++|..||...+.......+..+....... .. ...
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~------~~~ 227 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPS--HY------SYE 227 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCc--cc------CHH
Confidence 1123468899999999999889999999999999999999999999887766666665543321111 11 124
Q ss_pred HHHHHHHHhhcCcccccCCCCChHHHHc
Q 011302 405 LQDLISKLLVKNPKKRIGSLKGSVEIKR 432 (489)
Q Consensus 405 l~~li~~~L~~dP~~R~~~~~~~~~ll~ 432 (489)
+.+||.+||+.||++||++. +++.
T Consensus 228 ~~~li~~~l~~~P~~Rp~~~----~il~ 251 (255)
T cd08219 228 LRSLIKQMFKRNPRSRPSAT----TILS 251 (255)
T ss_pred HHHHHHHHHhCCcccCCCHH----HHhh
Confidence 88999999999999999987 7665
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=342.09 Aligned_cols=263 Identities=27% Similarity=0.370 Sum_probs=206.2
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
++|++.+.||+|+||.||+|.+++ .++.||+|++.+..... .....+.+|+.+++.++||||+++++++.+++.
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 74 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKE-----TGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKR 74 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECC-----CCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCe
Confidence 479999999999999999999876 46789999986543221 233456679999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
.|+||||++++.|..+.... ..+++.+++.++.||+.||+|||+.||+||||+|+||+++.++.++|+|||++.....
T Consensus 75 ~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 75 LYLVFEFVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred EEEEEecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 99999999999888776543 4589999999999999999999999999999999999999999999999999743211
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
. .
T Consensus 153 ~------------------------------------------------------------------------------~ 154 (286)
T cd07846 153 P------------------------------------------------------------------------------G 154 (286)
T ss_pred C------------------------------------------------------------------------------c
Confidence 0 0
Q ss_pred cCCccccCCCCccCcchhcCC-CCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCC----------------
Q 011302 324 ARSKSFVGTHEYLAPEVISGQ-GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL---------------- 386 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------------- 386 (489)
.......|+..|+|||++.+. .++.++|||||||++|||++|.+||.+....+.+..+.....
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence 011224578999999998764 468899999999999999999999987776554444432100
Q ss_pred ---CCCCCCCCCch---hHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 387 ---TFPRIGVSSSK---EFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 387 ---~~p~~~~~~~~---~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
..+........ .......+.+||.+||..+|++||++. ++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~----~il~~~~~ 286 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSS----QLLHHEFF 286 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHH----HHhcCCCC
Confidence 11110000000 001123588999999999999999997 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=304.86 Aligned_cols=265 Identities=24% Similarity=0.394 Sum_probs=213.8
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceE
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYS 164 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 164 (489)
.|.-.++||+|+||+||+|+.++ +.+.||+|.++.+... +.......+|+.+|+.+.|.|||+++++...++.+
T Consensus 3 ~ydkmekigegtygtvfkarn~~-----t~eivalkrvrldddd-egvpssalreicllkelkhknivrl~dvlhsdkkl 76 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRE-----THEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKL 76 (292)
T ss_pred chHHHHhhcCCcceeeEecccCC-----ccceEEEEEEeccCCC-CCCcHHHHHHHHHHHHhhhcceeehhhhhccCcee
Confidence 46667899999999999999988 6789999999865432 23445677899999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccC
Q 011302 165 CLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVV 244 (489)
Q Consensus 165 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~ 244 (489)
-+|+||| ..+|..+.... .+.++.+.++.++.|++.||.|+|++++.||||||.|+||+.+|.+||+|||+|+.+...
T Consensus 77 tlvfe~c-dqdlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgip 154 (292)
T KOG0662|consen 77 TLVFEFC-DQDLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP 154 (292)
T ss_pred EEeHHHh-hHHHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence 9999999 67887776654 367999999999999999999999999999999999999999999999999998654321
Q ss_pred ccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccccc
Q 011302 245 PKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINA 324 (489)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (489)
-.
T Consensus 155 vr------------------------------------------------------------------------------ 156 (292)
T KOG0662|consen 155 VR------------------------------------------------------------------------------ 156 (292)
T ss_pred eE------------------------------------------------------------------------------
Confidence 00
Q ss_pred CCccccCCCCccCcchhcCCC-CCCcccHHHHHHHHHHHh-hCCCCCCCCCcHHHHHHHhcC-----CCCCCCCCC----
Q 011302 325 RSKSFVGTHEYLAPEVISGQG-HGSAVDWWTLGVFLYEML-YGTTPFKGENNEKTLINILKK-----PLTFPRIGV---- 393 (489)
Q Consensus 325 ~~~~~~Gt~~y~aPE~l~~~~-~~~~~DiwSlGvil~ell-tG~~Pf~~~~~~~~~~~i~~~-----~~~~p~~~~---- 393 (489)
-...-+-|.+|++|.++.|.. |++..|+||.|||+.|+. .|++.|.|.+..+++.+|... .-.+|....
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy 236 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY 236 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence 011225789999999999987 799999999999999999 599999999998888887541 112221110
Q ss_pred ------CCchhHHH-Hh----hHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 394 ------SSSKEFEE-VV----KLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 394 ------~~~~~~~~-~~----~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
+....|.. .+ .-+||++++|..+|..|++++ ++++||||...
T Consensus 237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisae----aalqhpyf~d~ 289 (292)
T KOG0662|consen 237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAE----AALQHPYFSDF 289 (292)
T ss_pred cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHH----HHhcCcccccc
Confidence 00011111 11 347999999999999999997 99999999764
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=344.33 Aligned_cols=269 Identities=28% Similarity=0.355 Sum_probs=208.1
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS 161 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 161 (489)
..++|++.+.||+|+||.||+|.++. ++..||+|.+..+... ........+|+.+++.++|+||+++++++...
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTT-----SGEIVALKKVRMDNER-DGIPISSLREITLLLNLRHPNIVELKEVVVGK 78 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECC-----CCcEEEEEEEEeccCC-CCCcchhhHHHHHHHhCCCCCCcceEEEEecC
Confidence 45789999999999999999999886 5788999998754321 11122345699999999999999999998754
Q ss_pred --ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 162 --HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 162 --~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
+.+|+||||+. ++|.+++.... ..+++.++..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.
T Consensus 79 ~~~~~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~ 156 (309)
T cd07845 79 HLDSIFLVMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLAR 156 (309)
T ss_pred CCCeEEEEEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceee
Confidence 57899999995 58888876542 568999999999999999999999999999999999999999999999999974
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
......
T Consensus 157 ~~~~~~-------------------------------------------------------------------------- 162 (309)
T cd07845 157 TYGLPA-------------------------------------------------------------------------- 162 (309)
T ss_pred ecCCcc--------------------------------------------------------------------------
Confidence 321100
Q ss_pred cccccCCccccCCCCccCcchhcC-CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCC------------
Q 011302 320 EPINARSKSFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL------------ 386 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~------------ 386 (489)
.......+++.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+..+.+..+.....
T Consensus 163 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07845 163 ----KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD 238 (309)
T ss_pred ----CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhc
Confidence 00111245788999999876 4578999999999999999999999998887777666543110
Q ss_pred -------CCCCCCCCCch-hH-HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 387 -------TFPRIGVSSSK-EF-EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 387 -------~~p~~~~~~~~-~~-~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
..+........ .+ .....+.+||.+||..||++||++. +++.||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~----~il~h~~f~~~~ 297 (309)
T cd07845 239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAE----EALESSYFKEKP 297 (309)
T ss_pred ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHH----HHhcChhhccCC
Confidence 00000000000 00 0134578999999999999999987 999999998644
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=338.75 Aligned_cols=256 Identities=23% Similarity=0.287 Sum_probs=207.9
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.++|.+.+.||+|+||.||+|.+.+.........||||.+...... .....+.+|+.+|+.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN--DARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCH--HHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 4679999999999999999999876433345688999998754222 23456778999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCC------------CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcE
Q 011302 163 YSCLVMEYCPGGDLYAARQRQP------------GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHI 230 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~------------~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~v 230 (489)
..|+||||++||+|.+++.... ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 9999999999999999987542 2457888999999999999999999999999999999999999999
Q ss_pred EEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCcc
Q 011302 231 MLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQE 310 (489)
Q Consensus 231 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (489)
||+|||+++.......
T Consensus 162 kl~d~g~~~~~~~~~~---------------------------------------------------------------- 177 (280)
T cd05049 162 KIGDFGMSRDVYTTDY---------------------------------------------------------------- 177 (280)
T ss_pred EECCcccceecccCcc----------------------------------------------------------------
Confidence 9999999743210000
Q ss_pred ccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCC
Q 011302 311 LLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFP 389 (489)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p 389 (489)
........+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+..+....+
T Consensus 178 ------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 245 (280)
T cd05049 178 ------------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQR 245 (280)
T ss_pred ------------eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence 000112246788999999999999999999999999999998 9999998888777777765543332
Q ss_pred CCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 390 RIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 390 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
... . ...+.+||.+||..||++||++.
T Consensus 246 ~~~--~------~~~~~~li~~~l~~~p~~Rp~~~ 272 (280)
T cd05049 246 PRT--C------PSEVYDIMLGCWKRDPQQRINIK 272 (280)
T ss_pred CCC--C------CHHHHHHHHHHcCCCcccCCCHH
Confidence 211 1 12589999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=337.78 Aligned_cols=258 Identities=26% Similarity=0.412 Sum_probs=202.5
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccceee-
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAEFE- 159 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~- 159 (489)
..++|++.+.||+|+||.||+|.+.. .++.||+|++...... ...+..|+.+++.+ +||||+++++++.
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~-----~~~~~~ik~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKK-----NGSKAAVKILDPIHDI----DEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECC-----CCceeEEEeeccccch----HHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 45899999999999999999999876 4678999998653211 23456688889998 6999999999873
Q ss_pred ----cCceEEEEEeecCCCchHHHHHhC--CCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEc
Q 011302 160 ----ASHYSCLVMEYCPGGDLYAARQRQ--PGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLS 233 (489)
Q Consensus 160 ----~~~~~~lV~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~ 233 (489)
.++..|+||||++|++|.+++... ....+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEc
Confidence 456799999999999999887532 23568889999999999999999999999999999999999999999999
Q ss_pred ccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccC
Q 011302 234 DFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLD 313 (489)
Q Consensus 234 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (489)
|||+++.....
T Consensus 167 dfg~~~~~~~~--------------------------------------------------------------------- 177 (286)
T cd06638 167 DFGVSAQLTST--------------------------------------------------------------------- 177 (286)
T ss_pred cCCceeecccC---------------------------------------------------------------------
Confidence 99997432110
Q ss_pred CccccccccccCCccccCCCCccCcchhcC-----CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCC
Q 011302 314 DPEVVAEPINARSKSFVGTHEYLAPEVISG-----QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTF 388 (489)
Q Consensus 314 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~ 388 (489)
........|++.|+|||++.. ..++.++|||||||++|||++|+.||........+..+.....
T Consensus 178 ---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~-- 246 (286)
T cd06638 178 ---------RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPP-- 246 (286)
T ss_pred ---------CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCC--
Confidence 000122358999999999853 4478899999999999999999999987766554444333211
Q ss_pred CCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 389 PRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 389 p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
+....+. .....+.+||.+||+.||++||++. +|++|+||
T Consensus 247 ~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~----ell~~~~~ 286 (286)
T cd06638 247 PTLHQPE----LWSNEFNDFIRKCLTKDYEKRPTVS----DLLQHVFI 286 (286)
T ss_pred CcccCCC----CcCHHHHHHHHHHccCCcccCCCHH----HHhhcccC
Confidence 1111110 0112489999999999999999987 99999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=339.71 Aligned_cols=266 Identities=28% Similarity=0.359 Sum_probs=208.7
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHH--HHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALA--IRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
+|.+.+.||+|+||.||+|.+.. .++.||||.+...... .......+..|+.+++.++|+||+++++++.+.+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKE-----TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECC-----CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCC
Confidence 48889999999999999999876 4678999999765432 1122344567999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
..|+||||+ +|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.+.
T Consensus 76 ~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 76 NINLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred EEEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 999999999 999999987653 369999999999999999999999999999999999999999999999999974322
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
...
T Consensus 154 ~~~----------------------------------------------------------------------------- 156 (298)
T cd07841 154 SPN----------------------------------------------------------------------------- 156 (298)
T ss_pred CCC-----------------------------------------------------------------------------
Confidence 100
Q ss_pred ccCCccccCCCCccCcchhcC-CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCC-----CCCC-----
Q 011302 323 NARSKSFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLT-----FPRI----- 391 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-----~p~~----- 391 (489)
.......+++.|+|||.+.+ ..++.++|||||||++|||++|.+||.+.+..+.+.++...... ++..
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (298)
T cd07841 157 -RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD 235 (298)
T ss_pred -ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence 00112246788999999865 45789999999999999999999999887766655554321000 0000
Q ss_pred -------CCCCch--hHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 392 -------GVSSSK--EFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 392 -------~~~~~~--~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
...... .......+.+||.+||.+||++||++. +++.|+||++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~----e~l~~~~~~~~ 288 (298)
T cd07841 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITAR----QALEHPYFSND 288 (298)
T ss_pred cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHH----HHhhCccccCC
Confidence 000000 001234588999999999999999987 99999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=340.24 Aligned_cols=263 Identities=28% Similarity=0.427 Sum_probs=201.9
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.++|++.+.||+|+||.||+|.++. .++.||||.+...... .....+.+|+.+++.++||||+++++++.+++
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 76 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKL-----TGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKK 76 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcC-----CCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCC
Confidence 4789999999999999999999875 4678999998754321 12234557999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
..|+||||+. ++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 77 ~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 154 (291)
T cd07844 77 TLTLVFEYLD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKS 154 (291)
T ss_pred eEEEEEecCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccC
Confidence 9999999996 59998887653 468999999999999999999999999999999999999999999999999873211
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
...
T Consensus 155 ~~~----------------------------------------------------------------------------- 157 (291)
T cd07844 155 VPS----------------------------------------------------------------------------- 157 (291)
T ss_pred CCC-----------------------------------------------------------------------------
Confidence 000
Q ss_pred ccCCccccCCCCccCcchhcC-CCCCCcccHHHHHHHHHHHhhCCCCCCCCC-cHHHHHHHhc---CC------------
Q 011302 323 NARSKSFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGEN-NEKTLINILK---KP------------ 385 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~---~~------------ 385 (489)
.......++..|+|||++.+ ..++.++|||||||++|||++|..||.+.. ..+.+..+.. .+
T Consensus 158 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 158 -KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred -ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence 00011246789999999876 457899999999999999999999997765 2222222211 00
Q ss_pred ----CCCCCCCCCC----chhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 386 ----LTFPRIGVSS----SKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 386 ----~~~p~~~~~~----~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
..++...... .........+.+||.+||+.+|++||++. +++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~----e~l~~~~f 291 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAA----EAMKHPYF 291 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHH----HHhcCCCC
Confidence 0000000000 00001113578999999999999999987 99999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=334.93 Aligned_cols=257 Identities=30% Similarity=0.461 Sum_probs=206.5
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccceeecC
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAEFEAS 161 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~ 161 (489)
.++|++.+.||+|+||.||+|.++. .++.|++|++..... ....+.+|+.+++++ +|+||+++++++...
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 75 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKK-----TGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKK 75 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECC-----CCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEec
Confidence 4789999999999999999999876 467899999876532 224567799999998 699999999999654
Q ss_pred c------eEEEEEeecCCCchHHHHHhCC--CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEc
Q 011302 162 H------YSCLVMEYCPGGDLYAARQRQP--GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLS 233 (489)
Q Consensus 162 ~------~~~lV~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~ 233 (489)
. .+|+||||+++++|.+++.... ...+++..+..++.|++.||.|||++||+|+||+|+||+++.++.+||+
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~ 155 (275)
T cd06608 76 NPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLV 155 (275)
T ss_pred CCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEEC
Confidence 4 5899999999999999886543 4679999999999999999999999999999999999999999999999
Q ss_pred ccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccC
Q 011302 234 DFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLD 313 (489)
Q Consensus 234 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (489)
|||++......
T Consensus 156 d~~~~~~~~~~--------------------------------------------------------------------- 166 (275)
T cd06608 156 DFGVSAQLDST--------------------------------------------------------------------- 166 (275)
T ss_pred CCccceecccc---------------------------------------------------------------------
Confidence 99987322100
Q ss_pred CccccccccccCCccccCCCCccCcchhcC-----CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCC
Q 011302 314 DPEVVAEPINARSKSFVGTHEYLAPEVISG-----QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTF 388 (489)
Q Consensus 314 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~ 388 (489)
........|++.|+|||++.. ..++.++|||||||++|+|++|..||...........+......
T Consensus 167 ---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~- 236 (275)
T cd06608 167 ---------LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPP- 236 (275)
T ss_pred ---------hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCC-
Confidence 001123368999999999864 33678999999999999999999999877666666665544221
Q ss_pred CCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 389 PRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 389 p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
... ... .....+++||.+||..||++||++. ++++|||+
T Consensus 237 -~~~--~~~--~~~~~~~~li~~~l~~dp~~Rpt~~----~ll~~~~~ 275 (275)
T cd06608 237 -TLK--SPE--NWSKKFNDFISECLIKNYEQRPFME----ELLEHPFI 275 (275)
T ss_pred -CCC--chh--hcCHHHHHHHHHHhhcChhhCcCHH----HHhcCCCC
Confidence 111 111 1123589999999999999999997 99999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=350.14 Aligned_cols=261 Identities=32% Similarity=0.457 Sum_probs=220.5
Q ss_pred eeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEEEEE
Q 011302 89 LRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVM 168 (489)
Q Consensus 89 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 168 (489)
.+.||+|.||+||-|+++. +++.||||++.+.....++ ..++.+|+.||+.++||.||.|-..|+..+.+++||
T Consensus 569 devLGSGQFG~VYgg~hRk-----tGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVM 642 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRK-----TGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVM 642 (888)
T ss_pred HhhccCCcceeeecceecc-----cCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEe
Confidence 4689999999999999998 6889999999887665333 366778999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccC---CcEEEcccCCCcccccCc
Q 011302 169 EYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRED---GHIMLSDFDLSFKCDVVP 245 (489)
Q Consensus 169 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~---~~vkl~DFG~a~~~~~~~ 245 (489)
|-+ .|++.+.+-....++|++...++++.||+.||+|||-+||+|.||||||||+... -.+||||||+|+....
T Consensus 643 EKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE-- 719 (888)
T KOG4236|consen 643 EKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE-- 719 (888)
T ss_pred hhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch--
Confidence 999 6777777666666899999999999999999999999999999999999999754 3699999999964321
Q ss_pred cccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccC
Q 011302 246 KLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINAR 325 (489)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (489)
...
T Consensus 720 -----------------------------------------------------------------------------ksF 722 (888)
T KOG4236|consen 720 -----------------------------------------------------------------------------KSF 722 (888)
T ss_pred -----------------------------------------------------------------------------hhh
Confidence 123
Q ss_pred CccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhH
Q 011302 326 SKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKL 405 (489)
Q Consensus 326 ~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l 405 (489)
..+.+|||.|+|||++.+++|+..-|+||+|||+|.-|.|..||..+.+ +-.+|.+..+.+|...+. +...++
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQNAaFMyPp~PW~-----eis~~A 795 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQNAAFMYPPNPWS-----EISPEA 795 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc--hhHHhhccccccCCCchh-----hcCHHH
Confidence 4577999999999999999999999999999999999999999975543 344555666666654433 334579
Q ss_pred HHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC-cccccc
Q 011302 406 QDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN-WALIRS 446 (489)
Q Consensus 406 ~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~-~~~~~~ 446 (489)
.|||..+|+..-.+|++.. ..+.|||++++. |..|+.
T Consensus 796 idlIn~LLqVkm~kRysvd----k~lsh~Wlq~yq~w~DLRe 833 (888)
T KOG4236|consen 796 IDLINNLLQVKMRKRYSVD----KSLSHPWLQDYQTWLDLRE 833 (888)
T ss_pred HHHHHHHHHHHHHHhcchH----hhccchhhhcchHHHHHHH
Confidence 9999999999999999997 899999999874 665544
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=332.85 Aligned_cols=250 Identities=21% Similarity=0.339 Sum_probs=205.5
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE 159 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 159 (489)
.+..++|+++++||+|+||.||+|...+ ...||+|.+...... ...+.+|+.+++.++|+||+++++++.
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~------~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYNN------STKVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKLVRLYAVVT 71 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEecC------CceEEEEEccCCchh----HHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 4567899999999999999999998764 356899988754322 345677999999999999999999999
Q ss_pred cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 160 ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 160 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
+.+..|+||||+++|+|.+++.......+++..+..++.|++.||+|||+++++||||||+||+++.++.+||+|||++.
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 151 (261)
T cd05072 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLAR 151 (261)
T ss_pred CCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccce
Confidence 99999999999999999999987666778999999999999999999999999999999999999999999999999984
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
......
T Consensus 152 ~~~~~~-------------------------------------------------------------------------- 157 (261)
T cd05072 152 VIEDNE-------------------------------------------------------------------------- 157 (261)
T ss_pred ecCCCc--------------------------------------------------------------------------
Confidence 321100
Q ss_pred cccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchh
Q 011302 320 EPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKE 398 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 398 (489)
........++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+.......+... ...+....
T Consensus 158 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~----- 228 (261)
T cd05072 158 ---YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG-YRMPRMEN----- 228 (261)
T ss_pred ---eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-CCCCCCCC-----
Confidence 000112245678999999998889999999999999999998 99999988777766666543 22222111
Q ss_pred HHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 399 FEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 399 ~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
.+..+.+||.+||..+|++||++.
T Consensus 229 --~~~~~~~li~~~l~~~p~~Rp~~~ 252 (261)
T cd05072 229 --CPDELYDIMKTCWKEKAEERPTFD 252 (261)
T ss_pred --CCHHHHHHHHHHccCCcccCcCHH
Confidence 112588999999999999999996
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=337.11 Aligned_cols=264 Identities=30% Similarity=0.438 Sum_probs=208.6
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceE
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYS 164 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 164 (489)
+|++.+.||+|+||.||+|++.. .+..||+|++...... ......+..|+.+++.++||||+++++++..+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 74 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRE-----TGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGF 74 (286)
T ss_pred CceEEeecccCCCcEEEEEEECC-----CCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCee
Confidence 58999999999999999999876 4678999998764322 12345677899999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccC
Q 011302 165 CLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVV 244 (489)
Q Consensus 165 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~ 244 (489)
|+||||+ +++|.+++.... ..+++.+++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 75 ~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 75 VLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred EEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 9999999 999999887643 56999999999999999999999999999999999999999999999999997432110
Q ss_pred ccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccccc
Q 011302 245 PKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINA 324 (489)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (489)
. ..
T Consensus 153 ~-----------------------------------------------------------------------------~~ 155 (286)
T cd07832 153 E-----------------------------------------------------------------------------PR 155 (286)
T ss_pred C-----------------------------------------------------------------------------CC
Confidence 0 00
Q ss_pred CCccccCCCCccCcchhcCCC-CCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCC-----------------
Q 011302 325 RSKSFVGTHEYLAPEVISGQG-HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL----------------- 386 (489)
Q Consensus 325 ~~~~~~Gt~~y~aPE~l~~~~-~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~----------------- 386 (489)
......|+..|+|||++.+.. ++.++|||||||++|||++|.+||.+.+....+..+.....
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhh
Confidence 012236899999999987654 68999999999999999999999988776665554433100
Q ss_pred --CCCCCCCCCchh--HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcC
Q 011302 387 --TFPRIGVSSSKE--FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437 (489)
Q Consensus 387 --~~p~~~~~~~~~--~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~ 437 (489)
.++......... ......+.+||.+||..||++||++. ++++||||.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~----~~l~h~~~~ 286 (286)
T cd07832 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAA----EALRHPYFT 286 (286)
T ss_pred cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHH----HHhhCcCcC
Confidence 011000000000 01224689999999999999999997 999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=349.43 Aligned_cols=262 Identities=28% Similarity=0.396 Sum_probs=204.0
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC-
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS- 161 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~- 161 (489)
.++|++.+.||+|+||.||+|.+.. +++.||||++.+.... .....++.+|+.+++.++||||++++++|...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTV-----TGQNVAIKKLSRPFQN-VTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQK 88 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECC-----CCCEEEEEecCccccC-hhHHHHHHHHHHHHHhcCCCCCcceeeeeccCC
Confidence 4789999999999999999999886 5778999998653221 12334566799999999999999999988643
Q ss_pred -----ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccC
Q 011302 162 -----HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFD 236 (489)
Q Consensus 162 -----~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG 236 (489)
...|+||||+ +++|.+.+... +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~~~~~lv~e~~-~~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 89 SLEEFQDVYLVMELM-DANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CccccCcEEEEEecc-CCCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCc
Confidence 3579999999 56888877542 8899999999999999999999999999999999999999999999999
Q ss_pred CCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcc
Q 011302 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPE 316 (489)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (489)
+++.....
T Consensus 164 ~~~~~~~~------------------------------------------------------------------------ 171 (353)
T cd07850 164 LARTAGTS------------------------------------------------------------------------ 171 (353)
T ss_pred cceeCCCC------------------------------------------------------------------------
Confidence 98432100
Q ss_pred ccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCC--------
Q 011302 317 VVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTF-------- 388 (489)
Q Consensus 317 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-------- 388 (489)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+.++...-...
T Consensus 172 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T cd07850 172 -------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL 244 (353)
T ss_pred -------CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 00122358899999999999999999999999999999999999998877655444443210000
Q ss_pred -----------------------CCCCCCCch---hHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 389 -----------------------PRIGVSSSK---EFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 389 -----------------------p~~~~~~~~---~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
+........ .-.....+++||.+||..||.+||++. ++|.||||+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~----eiL~~~~~~~ 316 (353)
T cd07850 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVD----DALQHPYINV 316 (353)
T ss_pred hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHH----HHhcChhHhh
Confidence 000000000 001123578999999999999999997 9999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=331.72 Aligned_cols=251 Identities=20% Similarity=0.272 Sum_probs=205.1
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE 159 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 159 (489)
.+...+|.+.+.||+|+||.||+|.+++ .++.||+|++..+... ...+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~ 72 (263)
T cd05052 2 EMERTDITMKHKLGGGQYGEVYEGVWKK-----YSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCT 72 (263)
T ss_pred CCchHHeEEeeecCCcccceEEEEEEec-----CCceEEEEEecCCchH----HHHHHHHHHHHHhCCCCChhheEEEEc
Confidence 3556789999999999999999999886 5678999998754322 345677999999999999999999999
Q ss_pred cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 160 ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 160 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
.+..+|+||||+++++|.+++.......+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||++.
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~ 152 (263)
T cd05052 73 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 152 (263)
T ss_pred CCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccc
Confidence 99999999999999999999876555668999999999999999999999999999999999999999999999999974
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
......
T Consensus 153 ~~~~~~-------------------------------------------------------------------------- 158 (263)
T cd05052 153 LMTGDT-------------------------------------------------------------------------- 158 (263)
T ss_pred ccccce--------------------------------------------------------------------------
Confidence 321100
Q ss_pred cccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchh
Q 011302 320 EPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKE 398 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 398 (489)
........++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+....+.... ..+. ....
T Consensus 159 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~-~~~~--- 230 (263)
T cd05052 159 ---YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY-RMER-PEGC--- 230 (263)
T ss_pred ---eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-CCCC-CCCC---
Confidence 000011234678999999999999999999999999999998 999999887776666655431 1111 1111
Q ss_pred HHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 399 FEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 399 ~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
+..+.+||.+||..||++||++.
T Consensus 231 ---~~~~~~li~~cl~~~p~~Rp~~~ 253 (263)
T cd05052 231 ---PPKVYELMRACWQWNPSDRPSFA 253 (263)
T ss_pred ---CHHHHHHHHHHccCCcccCCCHH
Confidence 13589999999999999999997
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=340.92 Aligned_cols=257 Identities=25% Similarity=0.419 Sum_probs=209.1
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
..|.....||+|+||.||+|.+.. .++.||+|++...... ....+.+|+.+++.++||||+++++++..++.
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~ 92 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKH-----SGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEE 92 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcC-----CCCEEEEEEEEecccc---hHHHHHHHHHHHHhCCCCchhhhhhheeeCCe
Confidence 445666789999999999999875 5678999998654322 23446679999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
.|+||||+++++|..++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 93 ~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~ 169 (297)
T cd06659 93 LWVLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 169 (297)
T ss_pred EEEEEecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccc
Confidence 9999999999999887754 4689999999999999999999999999999999999999999999999998732210
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
. .
T Consensus 170 ~------------------------------------------------------------------------------~ 171 (297)
T cd06659 170 D------------------------------------------------------------------------------V 171 (297)
T ss_pred c------------------------------------------------------------------------------c
Confidence 0 0
Q ss_pred cCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHh
Q 011302 324 ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVV 403 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~ 403 (489)
......+|++.|+|||++.+..++.++|||||||++|||++|+.||...+..+.+..+............ ....
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~ 245 (297)
T cd06659 172 PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAH------KISP 245 (297)
T ss_pred ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccC------CCCH
Confidence 0112346899999999999888999999999999999999999999887776666555443222111111 1123
Q ss_pred hHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 404 KLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 404 ~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
.+.++|.+||+.+|++||++. ++++||||...
T Consensus 246 ~l~~~i~~~l~~~P~~Rps~~----~ll~~~~~~~~ 277 (297)
T cd06659 246 VLRDFLERMLTREPQERATAQ----ELLDHPFLLQT 277 (297)
T ss_pred HHHHHHHHHhcCCcccCcCHH----HHhhChhhccC
Confidence 488999999999999999987 99999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=329.11 Aligned_cols=256 Identities=27% Similarity=0.500 Sum_probs=211.3
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceE
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYS 164 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 164 (489)
+|.+.+.||+|+||.||+|.++. .+..||+|.+....... .....+.+|+.+++.++|+||+++++.+......
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~ 74 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKS-----DSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRL 74 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcC-----CCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeE
Confidence 58899999999999999999987 46779999998754332 2234566799999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCc-EEEcccCCCccccc
Q 011302 165 CLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGH-IMLSDFDLSFKCDV 243 (489)
Q Consensus 165 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~-vkl~DFG~a~~~~~ 243 (489)
|+|+||+++++|.+++....+..+++..+..++.|++.||.|||+++|+|+||||+||+++.++. +||+|||.+.....
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 75 FIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 99999999999999988765556899999999999999999999999999999999999998864 69999998733211
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
. .
T Consensus 155 ~------------------------------------------------------------------------------~ 156 (257)
T cd08225 155 S------------------------------------------------------------------------------M 156 (257)
T ss_pred C------------------------------------------------------------------------------c
Confidence 0 0
Q ss_pred cCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHh
Q 011302 324 ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVV 403 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~ 403 (489)
.......|++.|+|||++.+..++.++|+|||||++|||++|..||...+..+....+....... ..... ..
T Consensus 157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~------~~ 228 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAP--ISPNF------SR 228 (257)
T ss_pred ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCC--CCCCC------CH
Confidence 00112358899999999988889999999999999999999999998877766666665543221 11111 12
Q ss_pred hHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 404 KLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 404 ~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
.+.++|.+||..+|++||++. ++++||||
T Consensus 229 ~~~~~i~~~l~~~p~~Rpt~~----~ll~~~~~ 257 (257)
T cd08225 229 DLRSLISQLFKVSPRDRPSIT----SILKRPFL 257 (257)
T ss_pred HHHHHHHHHhccChhhCcCHH----HHhhCCCC
Confidence 589999999999999999987 99999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=339.00 Aligned_cols=261 Identities=18% Similarity=0.240 Sum_probs=208.8
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccce
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAE 157 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~ 157 (489)
+.+..++|.+.+.||+|+||.||+|.+...........||+|+++..... .....+.+|+.+++++ +||||++++++
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHS--SEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCCh--HHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 45666889999999999999999998754333345678999998754321 2345677899999999 79999999999
Q ss_pred eecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCC
Q 011302 158 FEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237 (489)
Q Consensus 158 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~ 237 (489)
+...+..|+||||+++|+|.+++.......+++.++..++.|++.||+|||+++|+|+||||+|||++.++.+||+|||+
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 99999999999999999999998765445589999999999999999999999999999999999999999999999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
++.......
T Consensus 188 ~~~~~~~~~----------------------------------------------------------------------- 196 (302)
T cd05055 188 ARDIMNDSN----------------------------------------------------------------------- 196 (302)
T ss_pred cccccCCCc-----------------------------------------------------------------------
Confidence 743211000
Q ss_pred cccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCc
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSS 396 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 396 (489)
........+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....+.+.+........+....
T Consensus 197 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 268 (302)
T cd05055 197 -----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEH--- 268 (302)
T ss_pred -----eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCC---
Confidence 000112246788999999999889999999999999999998 99999887766665555543322221111
Q ss_pred hhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 397 KEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 397 ~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
...++.+||.+||..+|++||++.
T Consensus 269 ----~~~~~~~li~~cl~~~p~~Rpt~~ 292 (302)
T cd05055 269 ----APAEIYDIMKTCWDADPLKRPTFK 292 (302)
T ss_pred ----CCHHHHHHHHHHcCCCchhCcCHH
Confidence 112589999999999999999997
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=338.20 Aligned_cols=256 Identities=26% Similarity=0.386 Sum_probs=208.4
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS 161 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 161 (489)
..++|++++.||+|+||+||+|.+.. .++.||+|++..... ......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~-----~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIP-----TGTVMAKKVVHIGAK--SSVRKQILRELQIMHECRSPYIVSFYGAFLNE 75 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcC-----CCcEEEEEEEEecCc--chHHHHHHHHHHHHHHcCCCCcceEeeeEecC
Confidence 34689999999999999999999876 467899998865421 22345677899999999999999999999999
Q ss_pred ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHh-CCCeeecCCCCCeEeccCCcEEEcccCCCcc
Q 011302 162 HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHM-MGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~ 240 (489)
..+|+||||+++++|.+++... +.+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++..
T Consensus 76 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~ 153 (284)
T cd06620 76 NNICMCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGE 153 (284)
T ss_pred CEEEEEEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccc
Confidence 9999999999999999888764 568999999999999999999997 6899999999999999999999999998732
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
...
T Consensus 154 ~~~----------------------------------------------------------------------------- 156 (284)
T cd06620 154 LIN----------------------------------------------------------------------------- 156 (284)
T ss_pred hhh-----------------------------------------------------------------------------
Confidence 110
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcH-----------HHHHHHhcCC-CCC
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNE-----------KTLINILKKP-LTF 388 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-----------~~~~~i~~~~-~~~ 388 (489)
......+|+..|+|||++.+..++.++|||||||++|+|++|..||...... +.+..+.... ..+
T Consensus 157 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd06620 157 ---SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRL 233 (284)
T ss_pred ---hccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCC
Confidence 0011346899999999998888999999999999999999999999865442 2223333221 111
Q ss_pred CCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 389 PRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 389 p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
+.. .....+.+||.+||..||++||++. ++++|+||..
T Consensus 234 ~~~--------~~~~~~~~li~~~l~~dp~~Rpt~~----e~~~~~~~~~ 271 (284)
T cd06620 234 PSS--------DFPEDLRDFVDACLLKDPTERPTPQ----QLCAMPPFIQ 271 (284)
T ss_pred Cch--------hcCHHHHHHHHHHhcCCcccCcCHH----HHhcCccccc
Confidence 111 1123589999999999999999997 9999999955
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=333.53 Aligned_cols=245 Identities=27% Similarity=0.492 Sum_probs=194.4
Q ss_pred CCceeeeee--ccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHh-CCCCCcccccceeec
Q 011302 84 DHFRLLRRL--GSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTM-LDHPFLPTLYAEFEA 160 (489)
Q Consensus 84 ~~y~~~~~l--G~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpnIv~l~~~~~~ 160 (489)
++|.+.+.+ |+|+||.||++..+. ++..||+|++........ |..+... .+||||++++++|..
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~k~~~~~~~~~~--------e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKP-----TQKLFVQKIIKAKNFNAI--------EPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcC-----CCcEEEEEEEehhhcchh--------hHHHHHHhhcCCCEEEEEEEEec
Confidence 466666666 999999999999876 577899999976532211 2222222 279999999999999
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCC-cEEEcccCCCc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDG-HIMLSDFDLSF 239 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~-~vkl~DFG~a~ 239 (489)
.+..|+||||++||+|.+++... ..+++.++..++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++.
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK 158 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence 99999999999999999998775 4799999999999999999999999999999999999999988 99999999873
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
....
T Consensus 159 ~~~~---------------------------------------------------------------------------- 162 (267)
T PHA03390 159 IIGT---------------------------------------------------------------------------- 162 (267)
T ss_pred ecCC----------------------------------------------------------------------------
Confidence 2110
Q ss_pred cccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHH-HHHHh---cCCCCCCCCCCCC
Q 011302 320 EPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKT-LINIL---KKPLTFPRIGVSS 395 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~-~~~i~---~~~~~~p~~~~~~ 395 (489)
.....|+..|+|||++.+..++.++|||||||++|||++|..||........ ...+. ......+.
T Consensus 163 ------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----- 231 (267)
T PHA03390 163 ------PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIK----- 231 (267)
T ss_pred ------CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCccc-----
Confidence 0123578999999999998899999999999999999999999986543321 11111 11111111
Q ss_pred chhHHHHhhHHHHHHHHhhcCcccccCC-CCChHHHHcCCCcCC
Q 011302 396 SKEFEEVVKLQDLISKLLVKNPKKRIGS-LKGSVEIKRHEFFKG 438 (489)
Q Consensus 396 ~~~~~~~~~l~~li~~~L~~dP~~R~~~-~~~~~~ll~hp~f~~ 438 (489)
..+..+.+||.+||+.||.+|++. . ++|+||||+.
T Consensus 232 ----~~~~~~~~li~~~l~~~p~~R~~~~~----~~l~h~~~~~ 267 (267)
T PHA03390 232 ----NVSKNANDFVQSMLKYNINYRLTNYN----EIIKHPFLKI 267 (267)
T ss_pred ----ccCHHHHHHHHHHhccChhhCCchHH----HHhcCCcccC
Confidence 122358999999999999999975 5 9999999974
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=333.47 Aligned_cols=258 Identities=24% Similarity=0.305 Sum_probs=207.2
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE 159 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 159 (489)
++..++|++.+.||+|+||.||+|.++..........||+|.+...... .....+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM--RERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCH--HHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 4566899999999999999999999886543445688999998644321 22345667999999999999999999999
Q ss_pred cCceEEEEEeecCCCchHHHHHhCC--------CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEE
Q 011302 160 ASHYSCLVMEYCPGGDLYAARQRQP--------GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIM 231 (489)
Q Consensus 160 ~~~~~~lV~E~~~gg~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vk 231 (489)
.....|+||||+++|+|.+++.... ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+|
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence 9999999999999999999886532 12467888999999999999999999999999999999999999999
Q ss_pred EcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccc
Q 011302 232 LSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQEL 311 (489)
Q Consensus 232 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (489)
|+|||+++.+.....
T Consensus 160 l~dfg~~~~~~~~~~----------------------------------------------------------------- 174 (277)
T cd05032 160 IGDFGMTRDIYETDY----------------------------------------------------------------- 174 (277)
T ss_pred ECCcccchhhccCcc-----------------------------------------------------------------
Confidence 999999743211000
Q ss_pred cCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCC-CCC
Q 011302 312 LDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPL-TFP 389 (489)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~-~~p 389 (489)
........++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+....+..... ..|
T Consensus 175 -----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (277)
T cd05032 175 -----------YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLP 243 (277)
T ss_pred -----------cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCCCC
Confidence 001122356788999999988889999999999999999998 9999998877766666553321 222
Q ss_pred CCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 390 RIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 390 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
. .. ...+.+||.+||..+|++||++.
T Consensus 244 ~---~~------~~~~~~li~~~l~~~p~~Rpt~~ 269 (277)
T cd05032 244 E---NC------PDKLLELMRMCWQYNPKMRPTFL 269 (277)
T ss_pred C---CC------CHHHHHHHHHHcCCChhhCCCHH
Confidence 1 11 22589999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=345.35 Aligned_cols=267 Identities=25% Similarity=0.343 Sum_probs=202.8
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC--
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS-- 161 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-- 161 (489)
++|++.+.||+|+||.||+|.+.. +++.||||++.... ......++.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~-----~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 77 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKP-----TGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSF 77 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcC-----CCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccc
Confidence 689999999999999999999876 56789999986421 122344566799999999999999999987543
Q ss_pred ---ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 162 ---HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 162 ---~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
...|+||||+. ++|.+++.. ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 78 ~~~~~~~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 78 ESFNDVYIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred cccceEEEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccce
Confidence 35899999994 688877754 46999999999999999999999999999999999999999999999999997
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
+.......
T Consensus 154 ~~~~~~~~------------------------------------------------------------------------ 161 (336)
T cd07849 154 RIADPEHD------------------------------------------------------------------------ 161 (336)
T ss_pred eecccccc------------------------------------------------------------------------
Confidence 43211000
Q ss_pred ccccccCCccccCCCCccCcchhcC-CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhc---CCCC-------
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILK---KPLT------- 387 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~~~~------- 387 (489)
.........||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+....+..+.. .+..
T Consensus 162 ---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (336)
T cd07849 162 ---HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII 238 (336)
T ss_pred ---ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 0001123468999999998765 4589999999999999999999999987665443332211 0000
Q ss_pred ----------CCCCCCCCch--hHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 388 ----------FPRIGVSSSK--EFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 388 ----------~p~~~~~~~~--~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
.+........ ......++.+||.+||+.||++||++. ++++||||+.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~----e~l~hp~~~~~~ 299 (336)
T cd07849 239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVE----EALAHPYLEQYH 299 (336)
T ss_pred chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHH----HHhcCccccccC
Confidence 0000000000 001134588999999999999999987 999999998763
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=330.72 Aligned_cols=246 Identities=22% Similarity=0.294 Sum_probs=201.7
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.++|++.+.||+|+||.||+|+++. ...+|+|.+...... ...+..|+.+|+.++||||+++++++...+
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~------~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRA------QIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQK 72 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEecc------CceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCC
Confidence 4679999999999999999998765 356899988654322 234667999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
..|+||||++||+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 73 ~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~ 151 (256)
T cd05114 73 PLYIVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVL 151 (256)
T ss_pred CEEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccC
Confidence 9999999999999999887543 468899999999999999999999999999999999999999999999999874321
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
...
T Consensus 152 ~~~----------------------------------------------------------------------------- 154 (256)
T cd05114 152 DDE----------------------------------------------------------------------------- 154 (256)
T ss_pred CCc-----------------------------------------------------------------------------
Confidence 000
Q ss_pred ccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHH
Q 011302 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEE 401 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 401 (489)
........++..|+|||++.+..++.++|||||||++|||++ |+.||...+..+.+..+..+...... ...
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~--~~~------ 226 (256)
T cd05114 155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP--KLA------ 226 (256)
T ss_pred eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCC--CCC------
Confidence 000011235678999999998889999999999999999999 99999998888877777664322111 111
Q ss_pred HhhHHHHHHHHhhcCcccccCCC
Q 011302 402 VVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 402 ~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
...+.+||.+||..||++||++.
T Consensus 227 ~~~~~~li~~c~~~~p~~Rps~~ 249 (256)
T cd05114 227 SMTVYEVMYSCWHEKPEGRPTFA 249 (256)
T ss_pred CHHHHHHHHHHccCCcccCcCHH
Confidence 12589999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=346.76 Aligned_cols=271 Identities=20% Similarity=0.308 Sum_probs=205.7
Q ss_pred eeeccC--CceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEEEE
Q 011302 90 RRLGSG--DIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLV 167 (489)
Q Consensus 90 ~~lG~G--~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 167 (489)
..||.| +||+||+|++.. +++.||+|++....... ...+.+.+|+.+++.++||||++++++|..++..|+|
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~-----~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v 77 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTP-----TGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVI 77 (328)
T ss_pred HHhCCcccCceeEEEEEEcC-----CCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEE
Confidence 356666 999999999876 57899999987543221 3346777899999999999999999999999999999
Q ss_pred EeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCccc
Q 011302 168 MEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKL 247 (489)
Q Consensus 168 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 247 (489)
|||+.+|+|.+++.+.....+++..+..++.||+.||+|||++||+||||||+|||++.++.++++|||.+........
T Consensus 78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~- 156 (328)
T cd08226 78 SPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ- 156 (328)
T ss_pred EecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc-
Confidence 9999999999998876445689999999999999999999999999999999999999999999999986521110000
Q ss_pred cCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCc
Q 011302 248 LRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSK 327 (489)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (489)
. .........
T Consensus 157 ---------------------------------------~-------------------------------~~~~~~~~~ 166 (328)
T cd08226 157 ---------------------------------------K-------------------------------AKVVYDFPQ 166 (328)
T ss_pred ---------------------------------------c-------------------------------ccccccccc
Confidence 0 000000001
Q ss_pred cccCCCCccCcchhcCC--CCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCC-------------
Q 011302 328 SFVGTHEYLAPEVISGQ--GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIG------------- 392 (489)
Q Consensus 328 ~~~Gt~~y~aPE~l~~~--~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~------------- 392 (489)
...++..|+|||++.+. .++.++|||||||++|||++|..||.+.........+.......|...
T Consensus 167 ~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (328)
T cd08226 167 FSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNS 246 (328)
T ss_pred cccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccc
Confidence 12356779999999774 478999999999999999999999988776665555544322211100
Q ss_pred -------------------------CCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCc
Q 011302 393 -------------------------VSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINW 441 (489)
Q Consensus 393 -------------------------~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~ 441 (489)
............+.+||++||..||++||++. ++++||||+.+.-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~----e~l~~~~~~~~~~ 316 (328)
T cd08226 247 QSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSAS----SLLSHAFFKQVKE 316 (328)
T ss_pred hhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHH----HHhhCHHHHHHHH
Confidence 00001112334689999999999999999997 9999999977543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=331.46 Aligned_cols=260 Identities=28% Similarity=0.410 Sum_probs=207.2
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHH-------HHHHHHHHHHHHHHHHhCCCCCcccccce
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALA-------IRKKLHRADMEKVILTMLDHPFLPTLYAE 157 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~~~E~~~l~~l~hpnIv~l~~~ 157 (489)
+|.+.+.||+|+||.||+|.... +++.||+|.++..... .....+.+..|+.+++.++||||++++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~-----~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 76 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVT-----TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGF 76 (272)
T ss_pred ceeecceecccCceEEEEEeecC-----CCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Confidence 47888999999999999999876 4678999988642211 12234567789999999999999999999
Q ss_pred eecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCC
Q 011302 158 FEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237 (489)
Q Consensus 158 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~ 237 (489)
+...+..|+||||++||+|.+++... ..+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||+
T Consensus 77 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 77 ETTEEYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred eccCCceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccc
Confidence 99999999999999999999998775 5789999999999999999999999999999999999999999999999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
++......
T Consensus 155 ~~~~~~~~------------------------------------------------------------------------ 162 (272)
T cd06629 155 SKKSDDIY------------------------------------------------------------------------ 162 (272)
T ss_pred cccccccc------------------------------------------------------------------------
Confidence 73321000
Q ss_pred cccccccCCccccCCCCccCcchhcCCC--CCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCC--CCCCCCCC
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVISGQG--HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP--LTFPRIGV 393 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~--~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~ 393 (489)
.........|+..|+|||.+.... ++.++|+|||||++|||++|..||...+......++.... ..++....
T Consensus 163 ----~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd06629 163 ----DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVS 238 (272)
T ss_pred ----cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccc
Confidence 000112345889999999998755 7899999999999999999999997666554444443322 12222111
Q ss_pred CCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 394 SSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 394 ~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
. .....+.+||.+||..+|++||++. ++++||||
T Consensus 239 ~-----~~~~~~~~li~~~l~~~p~~Rps~~----~il~~~~~ 272 (272)
T cd06629 239 M-----NLSPVALDFLNACFTINPDNRPTAR----ELLQHPFI 272 (272)
T ss_pred c-----cCCHHHHHHHHHHhcCChhhCCCHH----HHhhCCCC
Confidence 1 1123589999999999999999987 99999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=336.10 Aligned_cols=258 Identities=27% Similarity=0.415 Sum_probs=211.6
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
..|+.++.||+|+||.||+|.+.. .+..||||++...... .....+..|+.+++.++||||+++++++.++..
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNR-----TQQVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTK 76 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEcc-----CCEEEEEEEEeccccH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE
Confidence 468888999999999999999876 4678999998754322 334567789999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
.|+||||++||+|.+++.. ..+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++..+..
T Consensus 77 ~~lv~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 77 LWIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred EEEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 9999999999999998865 4688999999999999999999999999999999999999999999999999733210
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
. .
T Consensus 154 ~------------------------------------------------------------------------------~ 155 (277)
T cd06640 154 T------------------------------------------------------------------------------Q 155 (277)
T ss_pred C------------------------------------------------------------------------------c
Confidence 0 0
Q ss_pred cCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHh
Q 011302 324 ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVV 403 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~ 403 (489)
.......|+..|+|||++.+..++.++|+|||||++|||++|..||...+.......+.... .+... ...+.
T Consensus 156 ~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~--~~~~~------~~~~~ 227 (277)
T cd06640 156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN--PPTLT------GEFSK 227 (277)
T ss_pred cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCC--CCCCc------hhhhH
Confidence 01122357889999999998889999999999999999999999998877655544432221 11111 11233
Q ss_pred hHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCc
Q 011302 404 KLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINW 441 (489)
Q Consensus 404 ~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~ 441 (489)
.+.+||.+||..+|++||++. ++++|+||.....
T Consensus 228 ~~~~li~~~l~~~p~~Rp~~~----~il~~~~~~~~~~ 261 (277)
T cd06640 228 PFKEFIDACLNKDPSFRPTAK----ELLKHKFIVKNAK 261 (277)
T ss_pred HHHHHHHHHcccCcccCcCHH----HHHhChHhhhcch
Confidence 588999999999999999997 9999999976543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=353.87 Aligned_cols=253 Identities=23% Similarity=0.364 Sum_probs=204.8
Q ss_pred eeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehH-HHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce--
Q 011302 87 RLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDRE-ALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY-- 163 (489)
Q Consensus 87 ~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~-- 163 (489)
+...+||+|+|-+||+|.+... +..||=-.++.. .......++++..|+.+|+.|+|||||++|.+|.+...
T Consensus 43 k~~evLGrGafKtVYka~De~~-----giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~ 117 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEE-----GIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKT 117 (632)
T ss_pred ehhhhcccccceeeeecccccc-----chhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCce
Confidence 4556899999999999999764 333443333322 22334567889999999999999999999999986654
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCC--CeeecCCCCCeEecc-CCcEEEcccCCCcc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMG--IVYRDLKPENVLVRE-DGHIMLSDFDLSFK 240 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDIKp~NILl~~-~~~vkl~DFG~a~~ 240 (489)
+.+|+|++..|+|..++++. ++.....++.|++||+.||.|||++. |||||||++||+|+. -|.|||+|+|+|+.
T Consensus 118 in~iTEL~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl 195 (632)
T KOG0584|consen 118 INFITELFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL 195 (632)
T ss_pred eeeeeecccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHH
Confidence 89999999999999999887 67899999999999999999999986 999999999999985 59999999999954
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
...
T Consensus 196 ~r~----------------------------------------------------------------------------- 198 (632)
T KOG0584|consen 196 LRK----------------------------------------------------------------------------- 198 (632)
T ss_pred hhc-----------------------------------------------------------------------------
Confidence 321
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHH-HHHhcCCCCCCCCCCCCchhH
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTL-INILKKPLTFPRIGVSSSKEF 399 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~-~~i~~~~~~~p~~~~~~~~~~ 399 (489)
....+.+|||.|||||++- ..|+..+||||||.++.||+|+..||....+...+ .++..+. ........
T Consensus 199 ---s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGi-KP~sl~kV----- 268 (632)
T KOG0584|consen 199 ---SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGI-KPAALSKV----- 268 (632)
T ss_pred ---cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCC-CHHHhhcc-----
Confidence 1234568999999999998 66999999999999999999999999887766554 4454442 21111111
Q ss_pred HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 400 EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 400 ~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
..+++++||.+||.. ..+|+++. |||.||||..-
T Consensus 269 -~dPevr~fIekCl~~-~~~R~sa~----eLL~d~Ff~~d 302 (632)
T KOG0584|consen 269 -KDPEVREFIEKCLAT-KSERLSAK----ELLKDPFFDED 302 (632)
T ss_pred -CCHHHHHHHHHHhcC-chhccCHH----HHhhChhhccc
Confidence 123699999999999 99999998 99999999764
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=339.47 Aligned_cols=258 Identities=26% Similarity=0.416 Sum_probs=209.9
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
+.|+..+.||+|+||.||+|.+.. .+..||+|.+...... .....+.+|+.+++.++||||+++++++..+..
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~-----~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNR-----TKEVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTK 76 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcC-----CCeEEEEEEeccccch--HHHHHHHHHHHHHHcCCCCccHhhhcccccCCc
Confidence 457788899999999999999876 4678999998754322 234567789999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
.|+||||+++++|.+++.. ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++..+..
T Consensus 77 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 77 LWIIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred eEEEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccC
Confidence 9999999999999988764 4689999999999999999999999999999999999999999999999999743211
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
. .
T Consensus 154 ~------------------------------------------------------------------------------~ 155 (277)
T cd06642 154 T------------------------------------------------------------------------------Q 155 (277)
T ss_pred c------------------------------------------------------------------------------c
Confidence 0 0
Q ss_pred cCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHh
Q 011302 324 ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVV 403 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~ 403 (489)
.......|+..|+|||++.+..++.++|||||||++|||++|..||...........+.... .+.... ....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~------~~~~ 227 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS--PPTLEG------QYSK 227 (277)
T ss_pred hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCC--CCCCCc------ccCH
Confidence 00112357889999999999889999999999999999999999998766555444333221 111111 1123
Q ss_pred hHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCc
Q 011302 404 KLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINW 441 (489)
Q Consensus 404 ~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~ 441 (489)
.+.+||.+||..+|++||++. ++++||||+...+
T Consensus 228 ~~~~li~~~l~~~p~~Rp~~~----~il~~~~~~~~~~ 261 (277)
T cd06642 228 PFKEFVEACLNKDPRFRPTAK----ELLKHKFITRYTK 261 (277)
T ss_pred HHHHHHHHHccCCcccCcCHH----HHHHhHHHHHHhh
Confidence 588999999999999999987 9999999977554
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=334.74 Aligned_cols=261 Identities=21% Similarity=0.322 Sum_probs=205.3
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS 161 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 161 (489)
..++|++.+.||+|+||+||+|....... .....||+|.+..... ......+.+|+.+++.++||||+++++++..+
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~-~~~~~~~ik~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 79 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGM-DHAQLVAIKTLKDINN--PQQWGEFQQEASLMAELHHPNIVCLLGVVTQE 79 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCC-CCcceEEEEeccCCCC--HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence 45789999999999999999998753221 1457899999974322 23345677899999999999999999999999
Q ss_pred ceEEEEEeecCCCchHHHHHhCC---------------CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEecc
Q 011302 162 HYSCLVMEYCPGGDLYAARQRQP---------------GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRE 226 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~~~---------------~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~ 226 (489)
...|+||||+++|+|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~ 159 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE 159 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence 99999999999999999885431 124788888999999999999999999999999999999999
Q ss_pred CCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCC
Q 011302 227 DGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDH 306 (489)
Q Consensus 227 ~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (489)
++.+||+|||+++.......
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~------------------------------------------------------------ 179 (283)
T cd05090 160 QLHVKISDLGLSREIYSADY------------------------------------------------------------ 179 (283)
T ss_pred CCcEEeccccccccccCCcc------------------------------------------------------------
Confidence 99999999999843311000
Q ss_pred CCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCC
Q 011302 307 HDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKP 385 (489)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~ 385 (489)
........++..|+|||++.+..++.++|||||||++|||++ |..||.+.+.......+....
T Consensus 180 ----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 243 (283)
T cd05090 180 ----------------YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQ 243 (283)
T ss_pred ----------------eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 001122346778999999998889999999999999999998 999998877666655554433
Q ss_pred CCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 386 LTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 386 ~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
. .+... .. ...+.+||.+||+.||++||++. +|+++
T Consensus 244 ~-~~~~~-~~------~~~~~~li~~cl~~~p~~Rp~~~----~i~~~ 279 (283)
T cd05090 244 L-LPCSE-DC------PPRMYSLMTECWQEGPSRRPRFK----DIHTR 279 (283)
T ss_pred c-CCCCC-CC------CHHHHHHHHHHcccCcccCcCHH----HHHHH
Confidence 2 11111 11 12589999999999999999987 66554
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=337.54 Aligned_cols=265 Identities=26% Similarity=0.355 Sum_probs=203.3
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-CCCcccccceeecCc
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-HPFLPTLYAEFEASH 162 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~ 162 (489)
++|++.+.||+|+||.||+|.+.. +++.||+|.+...... ......+.+|+.+++.+. ||||+++++++...+
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~-----~~~~v~lK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 74 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKN-----TGKLVALKKTRLEMDE-EGIPPTALREISLLQMLSESIYIVRLLDVEHVEE 74 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECC-----CCcEEEEEeehhhccc-cCCchHHHHHHHHHHHccCCCCccceeeeEeecC
Confidence 479999999999999999999886 5788999998654321 122345677999999995 699999999987666
Q ss_pred e-----EEEEEeecCCCchHHHHHhCC---CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEecc-CCcEEEc
Q 011302 163 Y-----SCLVMEYCPGGDLYAARQRQP---GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRE-DGHIMLS 233 (489)
Q Consensus 163 ~-----~~lV~E~~~gg~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~-~~~vkl~ 233 (489)
. .|+||||+++ +|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+
T Consensus 75 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~ 153 (295)
T cd07837 75 KNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIA 153 (295)
T ss_pred CCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEe
Confidence 5 8999999975 8888776532 246899999999999999999999999999999999999998 8999999
Q ss_pred ccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccC
Q 011302 234 DFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLD 313 (489)
Q Consensus 234 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (489)
|||++..+....
T Consensus 154 dfg~~~~~~~~~-------------------------------------------------------------------- 165 (295)
T cd07837 154 DLGLGRAFSIPV-------------------------------------------------------------------- 165 (295)
T ss_pred ecccceecCCCc--------------------------------------------------------------------
Confidence 999974321100
Q ss_pred CccccccccccCCccccCCCCccCcchhcCC-CCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCC-----C
Q 011302 314 DPEVVAEPINARSKSFVGTHEYLAPEVISGQ-GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL-----T 387 (489)
Q Consensus 314 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-----~ 387 (489)
.......+++.|+|||++.+. .++.++|||||||++|+|++|..||.+.+......++..... .
T Consensus 166 ----------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (295)
T cd07837 166 ----------KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV 235 (295)
T ss_pred ----------cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 001122468899999998764 478999999999999999999999998877665554432100 0
Q ss_pred C------------CCCCCCCchh--HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcC
Q 011302 388 F------------PRIGVSSSKE--FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437 (489)
Q Consensus 388 ~------------p~~~~~~~~~--~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~ 437 (489)
+ +......... ......+.+||.+||..||.+||++. +++.||||+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~----eil~~~~~~ 295 (295)
T cd07837 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAK----AALTHPYFD 295 (295)
T ss_pred CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHH----HHhcCCCcC
Confidence 0 0000000000 01234589999999999999999987 999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=337.00 Aligned_cols=265 Identities=20% Similarity=0.273 Sum_probs=210.4
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccce
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAE 157 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~ 157 (489)
+.+..++|++.+.||+|+||.||+|.+++.........+|+|.+...... ....++.+|+.+++++ +||||++++++
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHKNIINLLGV 84 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCH--HHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 45667899999999999999999999876433335678999998754222 2335577899999999 79999999999
Q ss_pred eecCceEEEEEeecCCCchHHHHHhC--------------CCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeE
Q 011302 158 FEASHYSCLVMEYCPGGDLYAARQRQ--------------PGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVL 223 (489)
Q Consensus 158 ~~~~~~~~lV~E~~~gg~L~~~l~~~--------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIL 223 (489)
+..++.+|+||||+++|+|..++... ....+++..+..++.|++.||+|||++||+||||||+|||
T Consensus 85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil 164 (293)
T cd05053 85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL 164 (293)
T ss_pred EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence 99999999999999999999998642 2356889999999999999999999999999999999999
Q ss_pred eccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccC
Q 011302 224 VREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVD 303 (489)
Q Consensus 224 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (489)
++.++.+||+|||+++.+.....
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~--------------------------------------------------------- 187 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDY--------------------------------------------------------- 187 (293)
T ss_pred EcCCCeEEeCccccccccccccc---------------------------------------------------------
Confidence 99999999999999843321000
Q ss_pred CCCCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHh
Q 011302 304 GDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINIL 382 (489)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~ 382 (489)
........++..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+.
T Consensus 188 -------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 248 (293)
T cd05053 188 -------------------YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK 248 (293)
T ss_pred -------------------eeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence 000111235678999999999889999999999999999997 999999887776666555
Q ss_pred cCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 383 KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 383 ~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
.+. ..+. .... ...+.+|+.+||..||++||++. +++++
T Consensus 249 ~~~-~~~~-~~~~------~~~~~~li~~~l~~~p~~Rps~~----eil~~ 287 (293)
T cd05053 249 EGY-RMEK-PQNC------TQELYHLMRDCWHEVPSQRPTFK----QLVED 287 (293)
T ss_pred cCC-cCCC-CCCC------CHHHHHHHHHHcccCcccCcCHH----HHHHH
Confidence 432 1111 1111 22588999999999999999997 66543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=336.88 Aligned_cols=262 Identities=19% Similarity=0.258 Sum_probs=208.8
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
+...+|++.+.||+|+||.||+|.+..+.....+..||||++..... ......+.+|+.++..++||||+++++++..
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~ 79 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE--GPLREEFKHEAMMRSRLQHPNIVCLLGVVTK 79 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence 34567899999999999999999987643334567899999974421 1234557779999999999999999999999
Q ss_pred CceEEEEEeecCCCchHHHHHhCC--------------CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEecc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQP--------------GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRE 226 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~ 226 (489)
....++++||+.+++|.+++.... ...+++..+..++.|++.||.|||++||+||||||+|||++.
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD 159 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC
Confidence 999999999999999999875321 235788889999999999999999999999999999999999
Q ss_pred CCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCC
Q 011302 227 DGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDH 306 (489)
Q Consensus 227 ~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (489)
++.+||+|||+++.......
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~------------------------------------------------------------ 179 (283)
T cd05091 160 KLNVKISDLGLFREVYAADY------------------------------------------------------------ 179 (283)
T ss_pred CCceEecccccccccccchh------------------------------------------------------------
Confidence 99999999999743211000
Q ss_pred CCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCC
Q 011302 307 HDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKP 385 (489)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~ 385 (489)
........+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+....
T Consensus 180 ----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~ 243 (283)
T cd05091 180 ----------------YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQ 243 (283)
T ss_pred ----------------eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 001122346789999999988889999999999999999998 999999888877777776654
Q ss_pred CCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHc
Q 011302 386 LTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKR 432 (489)
Q Consensus 386 ~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~ 432 (489)
..... .... ..+.+|+.+||+.+|++||++. +|++
T Consensus 244 ~~~~~--~~~~------~~~~~li~~cl~~~p~~RP~~~----~i~~ 278 (283)
T cd05091 244 VLPCP--DDCP------AWVYTLMLECWNEFPSRRPRFK----DIHS 278 (283)
T ss_pred cCCCC--CCCC------HHHHHHHHHHhCCCcccCCCHH----HHHH
Confidence 32111 1111 2488999999999999999987 6665
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=333.03 Aligned_cols=263 Identities=28% Similarity=0.442 Sum_probs=207.0
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec--C
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA--S 161 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~ 161 (489)
++|...+.||.|+||.||+|.+.. .++.||+|.+...... ....++.+|+.+++.++||||++++++|.+ .
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 73 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKN-----TGMIFALKTITTDPNP--DLQKQILRELEINKSCKSPYIVKYYGAFLDESS 73 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECC-----CCeEEEEEEEecCCch--HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCC
Confidence 478999999999999999999986 5788999998754322 334567779999999999999999998854 4
Q ss_pred ceEEEEEeecCCCchHHHHHh--CCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 162 HYSCLVMEYCPGGDLYAARQR--QPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
+.+|+||||++|++|.+++.. .....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~ 153 (287)
T cd06621 74 SSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSG 153 (287)
T ss_pred CeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccc
Confidence 478999999999999887654 223568899999999999999999999999999999999999999999999999973
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
....
T Consensus 154 ~~~~---------------------------------------------------------------------------- 157 (287)
T cd06621 154 ELVN---------------------------------------------------------------------------- 157 (287)
T ss_pred cccc----------------------------------------------------------------------------
Confidence 2110
Q ss_pred cccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCC-----cHHHHHHHhcCCC-CCCCCCC
Q 011302 320 EPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGEN-----NEKTLINILKKPL-TFPRIGV 393 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~-----~~~~~~~i~~~~~-~~p~~~~ 393 (489)
.......++..|+|||.+.+..++.++|||||||++|+|++|..||.... ..+....+..... ..+....
T Consensus 158 ----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd06621 158 ----SLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233 (287)
T ss_pred ----cccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence 00012357888999999999889999999999999999999999998662 2333333333111 1111111
Q ss_pred CCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 394 SSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 394 ~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
. .. .....+.+||.+||..+|.+||++. ++++||||+...
T Consensus 234 ~-~~--~~~~~~~~li~~~l~~~p~~Rpt~~----eil~~~~~~~~~ 273 (287)
T cd06621 234 N-GI--KWSEEFKDFIKQCLEKDPTRRPTPW----DMLEHPWIKAQM 273 (287)
T ss_pred C-CC--chHHHHHHHHHHHcCCCcccCCCHH----HHHhCccccccc
Confidence 0 00 1123589999999999999999997 999999997654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=333.29 Aligned_cols=256 Identities=31% Similarity=0.431 Sum_probs=209.7
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
++|++.+.||+|+||.||+|.++. .++.||+|.+...... ....++.+|+.+++.++||||+++++++...+.
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 73 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRP-----TGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGFYGAFYNNGD 73 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcC-----CCcEEEEEEEecccCh--HHHHHHHHHHHHHHHCCCCchhhhheeeecCCE
Confidence 468888999999999999999886 5788999998765322 334567789999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHh-CCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHM-MGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
+|+||||+++++|.+++.... ..+++..+..++.|++.||+|||+ .|++||||||+||+++.++.++|+|||++....
T Consensus 74 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 74 ISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence 999999999999999987653 578999999999999999999999 999999999999999999999999999873221
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
.
T Consensus 153 ~------------------------------------------------------------------------------- 153 (265)
T cd06605 153 N------------------------------------------------------------------------------- 153 (265)
T ss_pred H-------------------------------------------------------------------------------
Confidence 0
Q ss_pred ccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCC-----cHHHHHHHhcCCC-CCCCCCCCCc
Q 011302 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGEN-----NEKTLINILKKPL-TFPRIGVSSS 396 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~-----~~~~~~~i~~~~~-~~p~~~~~~~ 396 (489)
.......|+..|+|||.+.+..++.++|||||||++|+|++|..||...+ ..+.+..+..... ..+...
T Consensus 154 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 228 (265)
T cd06605 154 -SLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGK---- 228 (265)
T ss_pred -HHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhh----
Confidence 00011468889999999999999999999999999999999999997652 2233333433211 111110
Q ss_pred hhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 397 KEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 397 ~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
...++.+||.+||..||++||++. +++.||||+..
T Consensus 229 ----~~~~~~~li~~~l~~~p~~Rpt~~----~ll~~~~~~~~ 263 (265)
T cd06605 229 ----FSPDFQDFVNLCLIKDPRERPSYK----ELLEHPFIKKY 263 (265)
T ss_pred ----cCHHHHHHHHHHcCCCchhCcCHH----HHhhCchhhcc
Confidence 123589999999999999999987 99999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=335.42 Aligned_cols=260 Identities=25% Similarity=0.340 Sum_probs=202.0
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHH-HHHhCCCCCcccccceeecCc
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKV-ILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~ 162 (489)
++|++.+.||+|+||.||+|+++. +++.||||+++...... . ..++..|.. .++.++||||+++++++..++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~~-~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~ 73 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVP-----TGTIMAVKRIRATVNSQ-E-QKRLLMDLDISMRSVDCPYTVTFYGALFREG 73 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcC-----CCcEEEEEEEecCCCcH-H-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCC
Confidence 479999999999999999999886 57899999987543221 1 122333444 466789999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhC--CCCCCChhhHHHHHHHHHHHHHHHHhC-CCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQ--PGKRFGISSAKFYAAETLLALEYLHMM-GIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~yLH~~-~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
..|+||||++ |+|.+++... ....+++..+..++.||+.||+|||++ +++||||||+|||++.++.+||+|||++.
T Consensus 74 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~ 152 (283)
T cd06617 74 DVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISG 152 (283)
T ss_pred cEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 9999999995 7887776542 235689999999999999999999997 99999999999999999999999999973
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
.....
T Consensus 153 ~~~~~--------------------------------------------------------------------------- 157 (283)
T cd06617 153 YLVDS--------------------------------------------------------------------------- 157 (283)
T ss_pred ccccc---------------------------------------------------------------------------
Confidence 22100
Q ss_pred cccccCCccccCCCCccCcchhcC----CCCCCcccHHHHHHHHHHHhhCCCCCCCCC-cHHHHHHHhcCC-CCCCCCCC
Q 011302 320 EPINARSKSFVGTHEYLAPEVISG----QGHGSAVDWWTLGVFLYEMLYGTTPFKGEN-NEKTLINILKKP-LTFPRIGV 393 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~----~~~~~~~DiwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~~~-~~~p~~~~ 393 (489)
.......|+..|+|||++.+ ..++.++|+|||||++|||++|+.||.... ..+.+..+.... ..++...
T Consensus 158 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 232 (283)
T cd06617 158 ----VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEK- 232 (283)
T ss_pred ----cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccc-
Confidence 00112357889999999865 456889999999999999999999997533 334444443321 2222111
Q ss_pred CCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcc
Q 011302 394 SSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWA 442 (489)
Q Consensus 394 ~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~ 442 (489)
.+.++.+||.+||..+|++||++. +++.||||+...+.
T Consensus 233 -------~~~~l~~li~~~l~~~p~~Rp~~~----~il~~~~~~~~~~~ 270 (283)
T cd06617 233 -------FSPEFQDFVNKCLKKNYKERPNYP----ELLQHPFFELHLSK 270 (283)
T ss_pred -------cCHHHHHHHHHHccCChhhCcCHH----HHhcCchhhhcccc
Confidence 123589999999999999999997 99999999987654
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=333.07 Aligned_cols=256 Identities=27% Similarity=0.422 Sum_probs=209.5
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceE
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYS 164 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 164 (489)
.|...+.||+|+||.||+|.+.. .++.+++|++...... ....+.+|+.+++.++||||+++++++...+..
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~iK~~~~~~~~---~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~ 91 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKS-----TGRQVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDEL 91 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECC-----CCCEEEEEEEeccchh---HHHHHHHHHHHHHHcCCCChheEEEEEEcCCeE
Confidence 45566799999999999999876 4678999988643322 234467799999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccC
Q 011302 165 CLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVV 244 (489)
Q Consensus 165 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~ 244 (489)
|+|+||++|++|.+++.. .++++.++..++.|++.||+|||++||+||||||+||+++.++.++|+|||++......
T Consensus 92 ~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~ 168 (285)
T cd06648 92 WVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE 168 (285)
T ss_pred EEEEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccC
Confidence 999999999999998876 46899999999999999999999999999999999999999999999999986321100
Q ss_pred ccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccccc
Q 011302 245 PKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINA 324 (489)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (489)
..
T Consensus 169 ------------------------------------------------------------------------------~~ 170 (285)
T cd06648 169 ------------------------------------------------------------------------------VP 170 (285)
T ss_pred ------------------------------------------------------------------------------Cc
Confidence 00
Q ss_pred CCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhh
Q 011302 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVK 404 (489)
Q Consensus 325 ~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~ 404 (489)
......|++.|+|||.+.+..++.++|||||||++|||++|..||...+.......+............ .....
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~ 244 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLH------KVSPR 244 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccc------cCCHH
Confidence 112346899999999999888999999999999999999999999887776666666554221111111 11235
Q ss_pred HHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 405 LQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 405 l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
+.+||.+||..+|++||++. ++++||||+..
T Consensus 245 l~~li~~~l~~~p~~Rpt~~----~il~~~~~~~~ 275 (285)
T cd06648 245 LRSFLDRMLVRDPAQRATAA----ELLNHPFLAKA 275 (285)
T ss_pred HHHHHHHHcccChhhCcCHH----HHccCcccccC
Confidence 89999999999999999987 99999999774
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=339.21 Aligned_cols=265 Identities=25% Similarity=0.314 Sum_probs=204.7
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-CCCcccccceeecCc
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-HPFLPTLYAEFEASH 162 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~ 162 (489)
++|...+.||+|+||.||++.++. .++.||+|.+...... .....+..|+.++.++. ||||+++++++..+.
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~-----~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~ 76 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKP-----SGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG 76 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECC-----CCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC
Confidence 567788899999999999999886 5788999998754332 23445677998999986 999999999999999
Q ss_pred eEEEEEeecCCCchHHHH---HhCCCCCCChhhHHHHHHHHHHHHHHHHhC-CCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 163 YSCLVMEYCPGGDLYAAR---QRQPGKRFGISSAKFYAAETLLALEYLHMM-GIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l---~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
..++||||+. ++|.++. .......+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 77 ~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 155 (288)
T cd06616 77 DCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS 155 (288)
T ss_pred cEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchh
Confidence 9999999994 5655433 222336799999999999999999999975 9999999999999999999999999997
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
..+...
T Consensus 156 ~~~~~~-------------------------------------------------------------------------- 161 (288)
T cd06616 156 GQLVDS-------------------------------------------------------------------------- 161 (288)
T ss_pred HHhccC--------------------------------------------------------------------------
Confidence 322100
Q ss_pred ccccccCCccccCCCCccCcchhcCC---CCCCcccHHHHHHHHHHHhhCCCCCCCCCcH-HHHHHHhcCCCCCCCCCCC
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQ---GHGSAVDWWTLGVFLYEMLYGTTPFKGENNE-KTLINILKKPLTFPRIGVS 394 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~---~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~p~~~~~ 394 (489)
.......|++.|+|||++.+. .++.++|||||||++|||++|+.||...... +.+.++..... |.....
T Consensus 162 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~ 234 (288)
T cd06616 162 -----IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDP--PILSNS 234 (288)
T ss_pred -----CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCC--CcCCCc
Confidence 001122588999999999876 6899999999999999999999999765521 22333332211 111111
Q ss_pred CchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccc
Q 011302 395 SSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWAL 443 (489)
Q Consensus 395 ~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~ 443 (489)
........+.+||.+||..||++||++. ++++||||+...|..
T Consensus 235 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~----~i~~~~~~~~~~~~~ 277 (288)
T cd06616 235 --EEREFSPSFVNFINLCLIKDESKRPKYK----ELLEHPFIKDYEERN 277 (288)
T ss_pred --CCCccCHHHHHHHHHHccCChhhCcCHH----HHhcChhhhchhhcc
Confidence 0012233589999999999999999997 999999999876643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=339.12 Aligned_cols=268 Identities=28% Similarity=0.404 Sum_probs=201.3
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.++|++.+.||+|+||.||+|+++. +++.||||.+...... ......+.+|+.+++.++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~aik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKK-----TKQIVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKA 84 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECC-----CCcEEEEEEEeccCCc-CCchhHHHHHHHHHHhCCCCCccceEEEEeccc
Confidence 4689999999999999999999886 5789999998643211 111223456999999999999999999886543
Q ss_pred --------eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcc
Q 011302 163 --------YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSD 234 (489)
Q Consensus 163 --------~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~D 234 (489)
..|+||||+ +++|.+++... ...+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~d 162 (310)
T cd07865 85 TPYNRYKGSFYLVFEFC-EHDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLAD 162 (310)
T ss_pred ccccCCCceEEEEEcCC-CcCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECc
Confidence 459999999 46888777654 24689999999999999999999999999999999999999999999999
Q ss_pred cCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCC
Q 011302 235 FDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDD 314 (489)
Q Consensus 235 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (489)
||++.........
T Consensus 163 fg~~~~~~~~~~~------------------------------------------------------------------- 175 (310)
T cd07865 163 FGLARAFSLSKNS------------------------------------------------------------------- 175 (310)
T ss_pred CCCcccccCCccc-------------------------------------------------------------------
Confidence 9998433210000
Q ss_pred ccccccccccCCccccCCCCccCcchhcCCC-CCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhc--CCCC---C
Q 011302 315 PEVVAEPINARSKSFVGTHEYLAPEVISGQG-HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILK--KPLT---F 388 (489)
Q Consensus 315 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~--~~~~---~ 388 (489)
.........++..|+|||.+.+.. ++.++|||||||++|||++|..||.+.+.......+.. +... +
T Consensus 176 -------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (310)
T cd07865 176 -------KPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVW 248 (310)
T ss_pred -------CCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 000112335788999999987654 68899999999999999999999988776544333222 1000 0
Q ss_pred CCCC---------CCC-----ch----hHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 389 PRIG---------VSS-----SK----EFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 389 p~~~---------~~~-----~~----~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
|... ... .. .......+.+||.+||..||++||++. ++++||||
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~----e~l~h~~f 310 (310)
T cd07865 249 PGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDAD----TALNHDFF 310 (310)
T ss_pred ccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHH----HHhcCCCC
Confidence 0000 000 00 000123578999999999999999997 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=334.07 Aligned_cols=256 Identities=22% Similarity=0.294 Sum_probs=206.9
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
..+|.+.+.||+|+||.||+|++...........+++|.+....... ...+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA---RKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHH---HHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 46799999999999999999997654444466789999987554332 245667999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCC--------------CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCC
Q 011302 163 YSCLVMEYCPGGDLYAARQRQP--------------GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDG 228 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~ 228 (489)
..++||||+++++|.+++.... ...+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 9999999999999999987542 23488899999999999999999999999999999999999999
Q ss_pred cEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCC
Q 011302 229 HIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHD 308 (489)
Q Consensus 229 ~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (489)
.++|+|||++........
T Consensus 161 ~~~l~dfg~a~~~~~~~~-------------------------------------------------------------- 178 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDY-------------------------------------------------------------- 178 (291)
T ss_pred cEEECCCCcccccCCCce--------------------------------------------------------------
Confidence 999999999843211000
Q ss_pred ccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCC
Q 011302 309 QELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLT 387 (489)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~ 387 (489)
........|+..|+|||++.+..++.++|||||||++|||++ |..||...+..+.+..+..+...
T Consensus 179 --------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 244 (291)
T cd05094 179 --------------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVL 244 (291)
T ss_pred --------------eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCCCC
Confidence 001122357889999999999989999999999999999998 99999888877776666554332
Q ss_pred CCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCC
Q 011302 388 FPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLK 425 (489)
Q Consensus 388 ~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~ 425 (489)
... ... +..+.+||.+||+.||++||++.+
T Consensus 245 ~~~--~~~------~~~~~~li~~~l~~~P~~Rpt~~~ 274 (291)
T cd05094 245 ERP--RVC------PKEVYDIMLGCWQREPQQRLNIKE 274 (291)
T ss_pred CCC--ccC------CHHHHHHHHHHcccChhhCcCHHH
Confidence 111 111 125899999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=333.77 Aligned_cols=255 Identities=22% Similarity=0.279 Sum_probs=206.2
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.++|.+.+.||+|+||+||+|.+........+..||+|.+..... .....+.+|+.+++.++||||+++++++...+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD---NARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCH---HHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 368999999999999999999875533333567799999875422 23455777999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCC-----------CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEE
Q 011302 163 YSCLVMEYCPGGDLYAARQRQP-----------GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIM 231 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~-----------~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vk 231 (489)
..|+||||+++++|.+++.... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 9999999999999999887542 13489999999999999999999999999999999999999999999
Q ss_pred EcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccc
Q 011302 232 LSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQEL 311 (489)
Q Consensus 232 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (489)
|+|||+++.+.....
T Consensus 161 l~dfg~~~~~~~~~~----------------------------------------------------------------- 175 (288)
T cd05093 161 IGDFGMSRDVYSTDY----------------------------------------------------------------- 175 (288)
T ss_pred eccCCccccccCCce-----------------------------------------------------------------
Confidence 999999743211000
Q ss_pred cCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCC
Q 011302 312 LDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPR 390 (489)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~ 390 (489)
........+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+..+......
T Consensus 176 -----------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~~~~ 244 (288)
T cd05093 176 -----------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRP 244 (288)
T ss_pred -----------eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcCCCC
Confidence 000112246788999999999889999999999999999998 99999988877777777665432111
Q ss_pred CCCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 391 IGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 391 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
... +..+.+|+.+||+.||.+||++.
T Consensus 245 --~~~------~~~l~~li~~~l~~~p~~Rpt~~ 270 (288)
T cd05093 245 --RTC------PKEVYDLMLGCWQREPHMRLNIK 270 (288)
T ss_pred --CCC------CHHHHHHHHHHccCChhhCCCHH
Confidence 111 12489999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=336.80 Aligned_cols=268 Identities=26% Similarity=0.358 Sum_probs=207.6
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
++|++.+.||+|+||.||+|+++. +++.||+|.+...... ......+..|+.+++.++||||+++++++.++..
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 75 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRV-----TNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKR 75 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecC-----CCcEEEEEehhhcccc-ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCe
Confidence 689999999999999999999876 5678999998654321 1233456679999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEecc-CCcEEEcccCCCcccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRE-DGHIMLSDFDLSFKCD 242 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~-~~~vkl~DFG~a~~~~ 242 (489)
.|+||||++ ++|.+.+.......+++..+..++.||+.||+|||++||+||||||+||+++. ++.+||+|||++....
T Consensus 76 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 76 LYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred EEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 999999994 68888876655455788888999999999999999999999999999999985 5679999999974321
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
..
T Consensus 155 ~~------------------------------------------------------------------------------ 156 (294)
T PLN00009 155 IP------------------------------------------------------------------------------ 156 (294)
T ss_pred CC------------------------------------------------------------------------------
Confidence 10
Q ss_pred ccCCccccCCCCccCcchhcCC-CCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhc---CCCC-----------
Q 011302 323 NARSKSFVGTHEYLAPEVISGQ-GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILK---KPLT----------- 387 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~~~~----------- 387 (489)
........|++.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+.++.. .+..
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 0001123578899999998764 478999999999999999999999988776665554432 1100
Q ss_pred ----CCCCCCCCchh--HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 388 ----FPRIGVSSSKE--FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 388 ----~p~~~~~~~~~--~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
.+......... ......+.++|.+||+.+|++||++. ++++||||++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~----~~l~~~~~~~~~ 291 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITAR----AALEHEYFKDLG 291 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHH----HHhcCchHhHHh
Confidence 00000000000 01123588999999999999999987 999999998865
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=336.85 Aligned_cols=257 Identities=25% Similarity=0.390 Sum_probs=208.7
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.++|.+.+.||+|+||.||+|.... ++..||+|.+...... ....+.+|+.+++.++||||+++++++...+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~ 89 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVA-----TGQEVAIKQMNLQQQP---KKELIINEILVMRENKHPNIVNYLDSYLVGD 89 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcC-----CCCEEEEEEeccccch---HHHHHHHHHHHHhhcCCCCeeehhheeeeCC
Confidence 3689999999999999999998765 4678999998644322 2345677999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
..|+|+||+++++|.+++.. ..+++.++..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~ 166 (293)
T cd06647 90 ELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (293)
T ss_pred cEEEEEecCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccc
Confidence 99999999999999998865 358899999999999999999999999999999999999999999999999873221
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
..
T Consensus 167 ~~------------------------------------------------------------------------------ 168 (293)
T cd06647 167 PE------------------------------------------------------------------------------ 168 (293)
T ss_pred cc------------------------------------------------------------------------------
Confidence 10
Q ss_pred ccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcC-CCCCCCCCCCCchhHHH
Q 011302 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK-PLTFPRIGVSSSKEFEE 401 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~~~~ 401 (489)
........|++.|+|||.+.+..++.++|||||||++|+|++|..||...+.......+... ...++... ..
T Consensus 169 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------~~ 241 (293)
T cd06647 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPE-------KL 241 (293)
T ss_pred ccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCcc-------cc
Confidence 00112236889999999998888999999999999999999999999877655443333221 11111100 11
Q ss_pred HhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 402 VVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 402 ~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
...+++||++||..+|++||++. +++.|+||+..
T Consensus 242 ~~~l~~li~~~l~~~p~~Rp~~~----~il~h~~~~~~ 275 (293)
T cd06647 242 SAIFRDFLNRCLEMDVEKRGSAK----ELLQHPFLKIA 275 (293)
T ss_pred CHHHHHHHHHHccCChhhCcCHH----HHhcCHHHhcC
Confidence 23588999999999999999987 99999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=326.27 Aligned_cols=259 Identities=29% Similarity=0.477 Sum_probs=209.0
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceE
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYS 164 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 164 (489)
+|.+.+.||+|+||.||+|.+.. .++.|++|.+...... ......+..|+.+++.++|+||+++++.+.+.+.+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 74 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLD-----TGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKV 74 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECC-----CCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEE
Confidence 58899999999999999999876 4678999999866443 34567788899999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccC
Q 011302 165 CLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVV 244 (489)
Q Consensus 165 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~ 244 (489)
++|+||+++++|.+++... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||++......
T Consensus 75 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 75 YIFMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred EEEEecCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence 9999999999999998764 45889999999999999999999999999999999999999999999999997433210
Q ss_pred ccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccccc
Q 011302 245 PKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINA 324 (489)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (489)
... ...
T Consensus 153 ~~~--------------------------------------------------------------------------~~~ 158 (264)
T cd06626 153 TTT--------------------------------------------------------------------------MGE 158 (264)
T ss_pred CCc--------------------------------------------------------------------------ccc
Confidence 000 000
Q ss_pred CCccccCCCCccCcchhcCCC---CCCcccHHHHHHHHHHHhhCCCCCCCCCcH-HHHHHHhcC-CCCCCCCCCCCchhH
Q 011302 325 RSKSFVGTHEYLAPEVISGQG---HGSAVDWWTLGVFLYEMLYGTTPFKGENNE-KTLINILKK-PLTFPRIGVSSSKEF 399 (489)
Q Consensus 325 ~~~~~~Gt~~y~aPE~l~~~~---~~~~~DiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~-~~~~p~~~~~~~~~~ 399 (489)
......|++.|+|||++.+.. ++.++|||||||++|||++|..||...+.. .....+... ...+|....
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------ 232 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQ------ 232 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccc------
Confidence 012246889999999998776 789999999999999999999999766433 333333322 122222211
Q ss_pred HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 400 EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 400 ~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
....+.+||.+||+.+|.+||++. +++.|||+
T Consensus 233 -~~~~~~~li~~~l~~~p~~R~~~~----~i~~~~~~ 264 (264)
T cd06626 233 -LSPEGKDFLDRCLESDPKKRPTAS----ELLQHPFV 264 (264)
T ss_pred -cCHHHHHHHHHHccCCcccCCCHH----HHhcCCCC
Confidence 123578999999999999999987 99999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=328.22 Aligned_cols=250 Identities=24% Similarity=0.293 Sum_probs=204.3
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE 159 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 159 (489)
++..++|++.+.||+|+||.||+|.+.. .+.||+|.++..... ...+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~------~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNN------TTPVAVKTLKPGTMD----PKDFLAEAQIMKKLRHPKLIQLYAVCT 71 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEecC------CeEEEEEeeCCCccc----HHHHHHHHHHHHHCCCCCccceeEEEe
Confidence 4566889999999999999999998754 357999998754322 234667999999999999999999999
Q ss_pred cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 160 ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 160 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
..+..|+||||+++++|.+++....+..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~ 151 (261)
T cd05068 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLAR 151 (261)
T ss_pred cCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEE
Confidence 99999999999999999999887655679999999999999999999999999999999999999999999999999984
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
.+....
T Consensus 152 ~~~~~~-------------------------------------------------------------------------- 157 (261)
T cd05068 152 VIKEDI-------------------------------------------------------------------------- 157 (261)
T ss_pred EccCCc--------------------------------------------------------------------------
Confidence 332000
Q ss_pred cccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchh
Q 011302 320 EPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKE 398 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 398 (489)
........++..|+|||++.+..++.++|||||||++|||++ |+.||.+.+....+..+.... ..+... .
T Consensus 158 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~-~---- 228 (261)
T cd05068 158 ---YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGY-RMPCPP-G---- 228 (261)
T ss_pred ---ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCC-c----
Confidence 000011123457999999999889999999999999999999 999999888777776665432 222111 1
Q ss_pred HHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 399 FEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 399 ~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
....+.+||.+||+.+|++||++.
T Consensus 229 --~~~~~~~li~~~l~~~P~~Rp~~~ 252 (261)
T cd05068 229 --CPKELYDIMLDCWKEDPDDRPTFE 252 (261)
T ss_pred --CCHHHHHHHHHHhhcCcccCCCHH
Confidence 112589999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=343.69 Aligned_cols=266 Identities=20% Similarity=0.265 Sum_probs=203.4
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccce
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAE 157 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~ 157 (489)
|.+..++|++.+.||+|+||+||+|.+.+......++.||||+++..... .....+.+|+.+|..+ +||||++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGA 79 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCCh--HHHHHHHHHHHHHHhccCCccHhhhcce
Confidence 45667899999999999999999999765433346789999999753221 2345677799999999 68999999998
Q ss_pred eec-CceEEEEEeecCCCchHHHHHhCC----------------------------------------------------
Q 011302 158 FEA-SHYSCLVMEYCPGGDLYAARQRQP---------------------------------------------------- 184 (489)
Q Consensus 158 ~~~-~~~~~lV~E~~~gg~L~~~l~~~~---------------------------------------------------- 184 (489)
+.. +..+|+|||||++|+|.+++....
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (343)
T cd05103 80 CTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS 159 (343)
T ss_pred eecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence 754 457899999999999999886531
Q ss_pred -------------CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCccccCCc
Q 011302 185 -------------GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPK 251 (489)
Q Consensus 185 -------------~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 251 (489)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~----- 234 (343)
T cd05103 160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD----- 234 (343)
T ss_pred cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcc-----
Confidence 12367778889999999999999999999999999999999999999999999743211000
Q ss_pred chhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCccccC
Q 011302 252 LSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVG 331 (489)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 331 (489)
........+
T Consensus 235 -----------------------------------------------------------------------~~~~~~~~~ 243 (343)
T cd05103 235 -----------------------------------------------------------------------YVRKGDARL 243 (343)
T ss_pred -----------------------------------------------------------------------hhhcCCCCC
Confidence 000112245
Q ss_pred CCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHHHH
Q 011302 332 THEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLIS 410 (489)
Q Consensus 332 t~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li~ 410 (489)
++.|+|||++.+..++.++|||||||++|||++ |..||.+......+..........+.... . ...+.+++.
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~------~~~~~~~~~ 316 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDY-T------TPEMYQTML 316 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCC-C------CHHHHHHHH
Confidence 678999999999889999999999999999996 99999876544333333322222111111 1 124889999
Q ss_pred HHhhcCcccccCCCCChHHHHcC
Q 011302 411 KLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 411 ~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
+||+.||++||++. +|++|
T Consensus 317 ~cl~~~p~~Rps~~----eil~~ 335 (343)
T cd05103 317 DCWHGEPSQRPTFS----ELVEH 335 (343)
T ss_pred HHccCChhhCcCHH----HHHHH
Confidence 99999999999997 77765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=334.91 Aligned_cols=263 Identities=28% Similarity=0.363 Sum_probs=200.3
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.++|++.+.||+|+||.||+|.++. ++..||+|++...... .....+.+|+.+++.++|+||+++++++.+++
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 76 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRI-----NGQLVALKVISMKTEE--GVPFTAIREASLLKGLKHANIVLLHDIIHTKE 76 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcC-----CCcEEEEEEecccCcC--CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCC
Confidence 3689999999999999999999886 5678999998654211 11224556999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
..|+||||+. ++|.+.+.... ..+.+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 77 ~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 77 TLTFVFEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKS 154 (291)
T ss_pred eEEEEEeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence 9999999994 77777665542 457888999999999999999999999999999999999999999999999973211
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
..
T Consensus 155 ~~------------------------------------------------------------------------------ 156 (291)
T cd07870 155 IP------------------------------------------------------------------------------ 156 (291)
T ss_pred CC------------------------------------------------------------------------------
Confidence 00
Q ss_pred ccCCccccCCCCccCcchhcCC-CCCCcccHHHHHHHHHHHhhCCCCCCCCCcH-HHHHHHhcC---C------------
Q 011302 323 NARSKSFVGTHEYLAPEVISGQ-GHGSAVDWWTLGVFLYEMLYGTTPFKGENNE-KTLINILKK---P------------ 385 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~---~------------ 385 (489)
........+++.|+|||++.+. .++.++|||||||++|||++|..||.+.+.. +.+.++... +
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 157 SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence 0001123578899999998764 4788999999999999999999999876542 222222110 0
Q ss_pred ----CCCCCCCCCCc----hhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 386 ----LTFPRIGVSSS----KEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 386 ----~~~p~~~~~~~----~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
..++....... ........+.+||.+||+.||.+||++. +++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~----~~l~h~~~ 291 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQ----DALLHPYF 291 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHH----HHhcCCCC
Confidence 00000000000 0011123588999999999999999997 99999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=328.68 Aligned_cols=256 Identities=27% Similarity=0.393 Sum_probs=200.4
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
...+.+.....||+|+||.||+|.++. ++..||+|.+...... ....+.+|+.+++.++|+||+++++++..
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~v~~k~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 76 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLS-----TQVRIAIKEIPERDSR---YVQPLHEEIALHSYLKHRNIVQYLGSDSE 76 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecC-----CCcEEEEEEecCCCHH---HHHHHHHHHHHHHhcCCCCeeeeeeeecc
Confidence 344566666789999999999999876 5678999988654322 33466779999999999999999999999
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCC--ChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEecc-CCcEEEcccCC
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRF--GISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRE-DGHIMLSDFDL 237 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l--~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~-~~~vkl~DFG~ 237 (489)
++..|+||||+++++|.+++.... ..+ ++..+..++.||+.||+|||++||+||||||+||+++. ++.++|+|||+
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~ 155 (268)
T cd06624 77 NGFFKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGT 155 (268)
T ss_pred CCEEEEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchh
Confidence 999999999999999999887642 335 78888999999999999999999999999999999986 67999999998
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
+......
T Consensus 156 ~~~~~~~------------------------------------------------------------------------- 162 (268)
T cd06624 156 SKRLAGI------------------------------------------------------------------------- 162 (268)
T ss_pred heecccC-------------------------------------------------------------------------
Confidence 7322100
Q ss_pred cccccccCCccccCCCCccCcchhcCCC--CCCcccHHHHHHHHHHHhhCCCCCCCCCcHHH-HHHHh--cCCCCCCCCC
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVISGQG--HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKT-LINIL--KKPLTFPRIG 392 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~--~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~-~~~i~--~~~~~~p~~~ 392 (489)
+.......|++.|+|||.+.+.. ++.++|||||||++|+|++|..||........ ...+. .....+|.
T Consensus 163 -----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 235 (268)
T cd06624 163 -----NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPE-- 235 (268)
T ss_pred -----CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCc--
Confidence 00011235789999999987643 78899999999999999999999976543221 11111 11111221
Q ss_pred CCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 393 VSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 393 ~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
. ...++.+||.+||..+|++||++. +++.||||
T Consensus 236 -~------~~~~~~~li~~~l~~~p~~Rpt~~----~ll~~~~~ 268 (268)
T cd06624 236 -S------LSAEAKNFILRCFEPDPDKRASAH----DLLQDPFL 268 (268)
T ss_pred -c------cCHHHHHHHHHHcCCCchhCCCHH----HHHhCCCC
Confidence 1 112589999999999999999997 99999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=326.12 Aligned_cols=255 Identities=29% Similarity=0.446 Sum_probs=207.8
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHH--HHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREAL--AIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
+|+..+.||+|+||+||+|.... ++..|++|.+..... ........+.+|+.+++.++|+||+++++++.++.
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLD-----DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcC-----CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCC
Confidence 47778899999999999999875 467899999865331 12234556778999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
.+|+||||++|++|.+++.+. ..+++..+..++.||+.||+|||+.||+|+||||+||+++.++.+||+|||++....
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999999999998765 468899999999999999999999999999999999999999999999999873321
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
..
T Consensus 154 ~~------------------------------------------------------------------------------ 155 (258)
T cd06632 154 EF------------------------------------------------------------------------------ 155 (258)
T ss_pred cc------------------------------------------------------------------------------
Confidence 10
Q ss_pred ccCCccccCCCCccCcchhcCCC-CCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHH
Q 011302 323 NARSKSFVGTHEYLAPEVISGQG-HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEE 401 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~-~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 401 (489)
.......|++.|+|||.+.... ++.++|+|||||++|+|++|+.||...........+.... ..+..... .
T Consensus 156 -~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~------~ 227 (258)
T cd06632 156 -SFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK-ELPPIPDH------L 227 (258)
T ss_pred -ccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc-cCCCcCCC------c
Confidence 0012345889999999998776 8999999999999999999999998776555554444311 11211111 1
Q ss_pred HhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 402 VVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 402 ~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
...+.+||.+||..+|.+||++. +++.|||+
T Consensus 228 ~~~~~~li~~~l~~~p~~Rp~~~----~~l~~~~~ 258 (258)
T cd06632 228 SDEAKDFILKCLQRDPSLRPTAA----ELLEHPFV 258 (258)
T ss_pred CHHHHHHHHHHhhcCcccCcCHH----HHhcCCCC
Confidence 13589999999999999999987 99999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=330.01 Aligned_cols=255 Identities=24% Similarity=0.337 Sum_probs=202.9
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
++|++.+.||+|+||.||+|++.. +++.||||.+.............+..|+.+++.++||||+++++++.+.+.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLL-----DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeC-----CCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCe
Confidence 689999999999999999999876 568899998865333223444567789999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhC--CCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQ--PGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKC 241 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~ 241 (489)
.|+||||+++|+|.+++... ....+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~ 156 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence 99999999999999887542 2245788999999999999999999999999999999999999999999999987432
Q ss_pred ccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccc
Q 011302 242 DVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEP 321 (489)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (489)
....
T Consensus 157 ~~~~---------------------------------------------------------------------------- 160 (267)
T cd08228 157 SSKT---------------------------------------------------------------------------- 160 (267)
T ss_pred cchh----------------------------------------------------------------------------
Confidence 1100
Q ss_pred cccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCc--HHHHHHHhcCCCCCCCCCCCCchhH
Q 011302 322 INARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENN--EKTLINILKKPLTFPRIGVSSSKEF 399 (489)
Q Consensus 322 ~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~--~~~~~~i~~~~~~~p~~~~~~~~~~ 399 (489)
.......|++.|+|||.+.+..++.++|||||||++|||++|..||..... ......+.... ++.....
T Consensus 161 --~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~----- 231 (267)
T cd08228 161 --TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD--YPPLPTE----- 231 (267)
T ss_pred --HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCC--CCCCChh-----
Confidence 001123588999999999988899999999999999999999999976532 23333333221 2221111
Q ss_pred HHHhhHHHHHHHHhhcCcccccCCCCChHHHHc
Q 011302 400 EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKR 432 (489)
Q Consensus 400 ~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~ 432 (489)
.....+.+||.+||..+|++||++. ++++
T Consensus 232 ~~~~~~~~li~~cl~~~p~~Rp~~~----~vl~ 260 (267)
T cd08228 232 HYSEKLRELVSMCIYPDPDQRPDIG----YVHQ 260 (267)
T ss_pred hcCHHHHHHHHHHCCCCcccCcCHH----HHHH
Confidence 1123589999999999999999997 6665
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=327.46 Aligned_cols=259 Identities=27% Similarity=0.443 Sum_probs=213.4
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
++|++.+.||+|+||.||+|++.. +++.|++|++...... .....+..|+.++..++|+||+++++++...+.
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~-----~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKP-----TGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGE 73 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcC-----CCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCe
Confidence 478999999999999999999987 5788999998765432 334567789999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHh-CCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHM-MGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
.|+||||+++++|.+++... ..+++..+..++.|++.||+|||+ +|++||||+|+||+++.++.++|+|||++....
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~ 151 (264)
T cd06623 74 ISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLE 151 (264)
T ss_pred EEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 99999999999999998765 579999999999999999999999 999999999999999999999999999873321
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
...
T Consensus 152 ~~~----------------------------------------------------------------------------- 154 (264)
T cd06623 152 NTL----------------------------------------------------------------------------- 154 (264)
T ss_pred cCC-----------------------------------------------------------------------------
Confidence 100
Q ss_pred ccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCC---cHHHHHHHhcCCCCCCCCCCCCchhH
Q 011302 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGEN---NEKTLINILKKPLTFPRIGVSSSKEF 399 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~p~~~~~~~~~~ 399 (489)
.......|+..|+|||.+.+..++.++|||||||++|+|++|..||.... ..+....+...... + .....
T Consensus 155 -~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~---- 227 (264)
T cd06623 155 -DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPP-S-LPAEE---- 227 (264)
T ss_pred -CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCC-C-CCccc----
Confidence 00112357889999999999889999999999999999999999998774 34444444432211 1 11110
Q ss_pred HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 400 EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 400 ~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
.+..+.++|.+||..+|++||++. ++++||||+.++
T Consensus 228 -~~~~l~~li~~~l~~~p~~R~~~~----~ll~~~~~~~~~ 263 (264)
T cd06623 228 -FSPEFRDFISACLQKDPKKRPSAA----ELLQHPFIKKAD 263 (264)
T ss_pred -CCHHHHHHHHHHccCChhhCCCHH----HHHhCHHHHhcc
Confidence 112589999999999999999997 999999998764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=339.28 Aligned_cols=255 Identities=21% Similarity=0.260 Sum_probs=199.6
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
+...+|++.+.||+|+||.||+|++..... .....||+|+++.... .....++..|+.+++.++||||+++++++..
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~ 80 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGE-KVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLT 80 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCC-ccceeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC
Confidence 345789999999999999999999865322 1244589999864321 1234567779999999999999999998876
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~ 240 (489)
. ..++|+||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~-~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 81 S-TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred C-CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccc
Confidence 5 5789999999999999987653 4688889999999999999999999999999999999999999999999999854
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
+......
T Consensus 159 ~~~~~~~------------------------------------------------------------------------- 165 (316)
T cd05108 159 LGADEKE------------------------------------------------------------------------- 165 (316)
T ss_pred ccCCCcc-------------------------------------------------------------------------
Confidence 3210000
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhH
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEF 399 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 399 (489)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.+....+. ..+......+|..... .
T Consensus 166 ---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~-~--- 237 (316)
T cd05108 166 ---YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGERLPQPPIC-T--- 237 (316)
T ss_pred ---eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHhCCCCCCCCCCC-C---
Confidence 00011234678999999999999999999999999999997 9999988765544 3444433333322211 1
Q ss_pred HHHhhHHHHHHHHhhcCcccccCCC
Q 011302 400 EEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 400 ~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
..+.++|.+||..||++||++.
T Consensus 238 ---~~~~~li~~cl~~~p~~Rps~~ 259 (316)
T cd05108 238 ---IDVYMIMVKCWMIDADSRPKFR 259 (316)
T ss_pred ---HHHHHHHHHHccCChhhCcCHH
Confidence 2478999999999999999997
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=328.47 Aligned_cols=258 Identities=21% Similarity=0.257 Sum_probs=206.6
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.++|++.+.||+|+||.||+|++.... .....||||.+..... ......+..|+.+++.++||||+++++++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~--~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPG--KKEIDVAIKTLKAGSS--DKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSR 78 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCC--CCcceEEEEEcCCCCC--hHHHHHHHHHHHHHHhCCCCCcceEeEEEecCC
Confidence 468999999999999999999987531 1356899999875432 223345677999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
..|+||||+++++|.+++.... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.++|+|||+++.+.
T Consensus 79 ~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 79 PVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred ceEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999999999987653 478999999999999999999999999999999999999999999999999985432
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
.....
T Consensus 158 ~~~~~--------------------------------------------------------------------------- 162 (266)
T cd05033 158 DSEAT--------------------------------------------------------------------------- 162 (266)
T ss_pred ccccc---------------------------------------------------------------------------
Confidence 00000
Q ss_pred ccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHH
Q 011302 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEE 401 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 401 (489)
.......+++.|+|||.+.+..++.++|||||||++|||++ |..||......+....+.... ..+.... .
T Consensus 163 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~-~------ 233 (266)
T cd05033 163 -YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY-RLPPPMD-C------ 233 (266)
T ss_pred -eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC-CCCCCCC-C------
Confidence 00011235678999999999889999999999999999997 999998877777666665432 2222111 1
Q ss_pred HhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 402 VVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 402 ~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
+..+.+|+.+||+.+|++||++. +++++
T Consensus 234 ~~~l~~li~~cl~~~p~~Rp~~~----ei~~~ 261 (266)
T cd05033 234 PSALYQLMLDCWQKDRNERPTFS----QIVST 261 (266)
T ss_pred CHHHHHHHHHHcCCCcccCcCHH----HHHHH
Confidence 12589999999999999999987 55543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=337.07 Aligned_cols=264 Identities=27% Similarity=0.347 Sum_probs=206.1
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC-
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS- 161 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~- 161 (489)
.++|++.+.||+|+||.||+|.++. +++.+|+|.++..... ......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 77 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKK-----TGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSN 77 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECC-----CCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC
Confidence 3679999999999999999999886 4678999999755333 22333456799999999999999999998877
Q ss_pred -ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcc
Q 011302 162 -HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240 (489)
Q Consensus 162 -~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~ 240 (489)
...|+||||+. ++|.+++.... ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 78 ~~~~~lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~ 155 (293)
T cd07843 78 LDKIYMVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLARE 155 (293)
T ss_pred CCcEEEEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceee
Confidence 89999999996 59988887653 4689999999999999999999999999999999999999999999999998743
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
+....
T Consensus 156 ~~~~~--------------------------------------------------------------------------- 160 (293)
T cd07843 156 YGSPL--------------------------------------------------------------------------- 160 (293)
T ss_pred ccCCc---------------------------------------------------------------------------
Confidence 22100
Q ss_pred ccccCCccccCCCCccCcchhcCCC-CCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCC-----------CC
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQG-HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL-----------TF 388 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~-~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-----------~~ 388 (489)
.......+++.|+|||.+.+.. ++.++|||||||++|||++|.+||.+.+..+.+.++...-. ..
T Consensus 161 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 161 ---KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred ---cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence 0011235788999999987654 68899999999999999999999998876665554432100 00
Q ss_pred CCCCC-----CC----chhHH---HHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 389 PRIGV-----SS----SKEFE---EVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 389 p~~~~-----~~----~~~~~---~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
+.... .. ...+. ....+.+||.+||+.||++||++. |++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~----ell~~~~f 293 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAE----DALKHPYF 293 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHH----HHhcCCCC
Confidence 00000 00 00000 133588999999999999999987 99999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=332.46 Aligned_cols=264 Identities=27% Similarity=0.403 Sum_probs=207.4
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
++|++.+.||+|+||.||+|.++. +++.||+|+++..... ......+.+|+.+++.++|+||+++++++..++.
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~-----~~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 74 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKA-----TGEIVAIKKFKESEDD-EDVKKTALREVKVLRQLRHENIVNLKEAFRRKGR 74 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCC-----CCcEEEEehhhhhccc-ccchhHHHHHHHHHHhcCCCCeeehhheEEECCE
Confidence 479999999999999999999886 4678999998754322 2334567789999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
.|+||||++++.|..+.... ..+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 75 ~~iv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 75 LYLVFEYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRA 152 (288)
T ss_pred EEEEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence 99999999887776655443 4589999999999999999999999999999999999999999999999999743221
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
.. .
T Consensus 153 ~~-----------------------------------------------------------------------------~ 155 (288)
T cd07833 153 RP-----------------------------------------------------------------------------A 155 (288)
T ss_pred Cc-----------------------------------------------------------------------------c
Confidence 00 0
Q ss_pred cCCccccCCCCccCcchhcCC-CCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCC----------------
Q 011302 324 ARSKSFVGTHEYLAPEVISGQ-GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL---------------- 386 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------------- 386 (489)
.......|+..|+|||++.+. .++.++|||||||++|+|++|.+||.+....+.+..+.....
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 011234688999999999888 789999999999999999999999987766544433321000
Q ss_pred ---CCCCCCCCCch--hH--HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 387 ---TFPRIGVSSSK--EF--EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 387 ---~~p~~~~~~~~--~~--~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
.++........ .+ ....++.+||.+||..+|++||++. ++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~----~il~~~~f 288 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCD----ELLQHPYF 288 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHH----HHhcCCCC
Confidence 01110000000 00 0134689999999999999999987 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=347.81 Aligned_cols=261 Identities=21% Similarity=0.254 Sum_probs=205.4
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-CCCcccccce
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-HPFLPTLYAE 157 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~ 157 (489)
+++..++|.+.+.||+|+||.||+|++++.......+.||+|+++..... .....+..|+.+|..+. ||||++++++
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS--SEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh--hHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 55666789999999999999999999875333335678999999754222 22345778999999997 9999999999
Q ss_pred eecCceEEEEEeecCCCchHHHHHhCCC----------------------------------------------------
Q 011302 158 FEASHYSCLVMEYCPGGDLYAARQRQPG---------------------------------------------------- 185 (489)
Q Consensus 158 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~---------------------------------------------------- 185 (489)
+...+..|+|||||++|+|.+++.+...
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 9999999999999999999999875321
Q ss_pred --------------------------------------------CCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCC
Q 011302 186 --------------------------------------------KRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPEN 221 (489)
Q Consensus 186 --------------------------------------------~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~N 221 (489)
..+++..+..|+.||+.||+|||+++|+||||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N 269 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN 269 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence 235667788899999999999999999999999999
Q ss_pred eEeccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccc
Q 011302 222 VLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQ 301 (489)
Q Consensus 222 ILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (489)
||++.++.+||+|||+++.+.....
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~------------------------------------------------------- 294 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSN------------------------------------------------------- 294 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccc-------------------------------------------------------
Confidence 9999999999999999843210000
Q ss_pred cCCCCCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHH
Q 011302 302 VDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLIN 380 (489)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~ 380 (489)
........|++.|+|||.+.+..++.++|||||||++|||++ |..||......+...+
T Consensus 295 ---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~ 353 (401)
T cd05107 295 ---------------------YISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYN 353 (401)
T ss_pred ---------------------cccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHH
Confidence 000122357889999999998889999999999999999998 8999987766555444
Q ss_pred HhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 381 ILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 381 i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
........+... .. ..++.+||.+||..+|++||++.
T Consensus 354 ~~~~~~~~~~p~-~~------~~~l~~li~~cl~~~P~~RPs~~ 390 (401)
T cd05107 354 AIKRGYRMAKPA-HA------SDEIYEIMQKCWEEKFEIRPDFS 390 (401)
T ss_pred HHHcCCCCCCCC-CC------CHHHHHHHHHHcCCChhHCcCHH
Confidence 443332222111 11 13589999999999999999997
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=326.94 Aligned_cols=256 Identities=26% Similarity=0.399 Sum_probs=209.2
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee--cCc
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE--ASH 162 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~--~~~ 162 (489)
+|++++.||.|+||.||+|.+.. ++..||+|++...... .....++..|+.+++.++||||+++++++. .+.
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKS-----DGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQ 74 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecC-----CCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCC
Confidence 58899999999999999999886 5678999998754332 233456778999999999999999999775 456
Q ss_pred eEEEEEeecCCCchHHHHHhC--CCCCCChhhHHHHHHHHHHHHHHHH-----hCCCeeecCCCCCeEeccCCcEEEccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQ--PGKRFGISSAKFYAAETLLALEYLH-----MMGIVYRDLKPENVLVREDGHIMLSDF 235 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~yLH-----~~~iiHrDIKp~NILl~~~~~vkl~DF 235 (489)
.+|+||||+++++|.+++... ....+++..+..++.||+.||+||| +.+|+|+||||+||+++.++.+||+||
T Consensus 75 ~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~ 154 (265)
T cd08217 75 TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDF 154 (265)
T ss_pred EEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecc
Confidence 789999999999999888653 2357899999999999999999999 899999999999999999999999999
Q ss_pred CCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCc
Q 011302 236 DLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDP 315 (489)
Q Consensus 236 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (489)
|++......
T Consensus 155 g~~~~~~~~----------------------------------------------------------------------- 163 (265)
T cd08217 155 GLAKILGHD----------------------------------------------------------------------- 163 (265)
T ss_pred cccccccCC-----------------------------------------------------------------------
Confidence 997432110
Q ss_pred cccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCC
Q 011302 316 EVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSS 395 (489)
Q Consensus 316 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 395 (489)
........|++.|+|||++.+..++.++|+|||||++|+|++|..||...+.......+..+... .....
T Consensus 164 -------~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~- 233 (265)
T cd08217 164 -------SSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFR--RIPYR- 233 (265)
T ss_pred -------cccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCC--CCccc-
Confidence 00012336899999999999988999999999999999999999999988766666666554321 11111
Q ss_pred chhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 396 SKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 396 ~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
....+.+|+.+||..+|++||++. +|++|||+
T Consensus 234 -----~~~~~~~l~~~~l~~~p~~Rp~~~----~il~~~~~ 265 (265)
T cd08217 234 -----YSSELNEVIKSMLNVDPDKRPSTE----ELLQLPLI 265 (265)
T ss_pred -----cCHHHHHHHHHHccCCcccCCCHH----HHhhCCCC
Confidence 113589999999999999999998 99999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=327.81 Aligned_cols=251 Identities=26% Similarity=0.366 Sum_probs=202.1
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
++|++.+.||+|+||.||+|++.. .+..||||.+............++.+|+.+++.++||||+++++++..++.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~-----~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLL-----DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecC-----CCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCe
Confidence 579999999999999999999876 467899998876544434455677889999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhC--CCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQ--PGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKC 241 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~ 241 (489)
.|+||||++|++|.+++... ....+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++...
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence 99999999999999988642 2356899999999999999999999999999999999999999999999999987332
Q ss_pred ccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccc
Q 011302 242 DVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEP 321 (489)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (489)
...
T Consensus 157 ~~~----------------------------------------------------------------------------- 159 (267)
T cd08229 157 SSK----------------------------------------------------------------------------- 159 (267)
T ss_pred ccC-----------------------------------------------------------------------------
Confidence 100
Q ss_pred cccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcH--HHHHHHhcCCCCCCCCCCCCchhH
Q 011302 322 INARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNE--KTLINILKKPLTFPRIGVSSSKEF 399 (489)
Q Consensus 322 ~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--~~~~~i~~~~~~~p~~~~~~~~~~ 399 (489)
........|++.|+|||.+.+..++.++|||||||++|+|++|..||.+.... .....+.... ++.....
T Consensus 160 -~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~----- 231 (267)
T cd08229 160 -TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--YPPLPSD----- 231 (267)
T ss_pred -CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCC--CCCCCcc-----
Confidence 00012346889999999999988999999999999999999999999765432 2333333221 1211111
Q ss_pred HHHhhHHHHHHHHhhcCcccccCCC
Q 011302 400 EEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 400 ~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
.....+.+||.+||..||++||++.
T Consensus 232 ~~~~~~~~li~~~l~~~p~~Rpt~~ 256 (267)
T cd08229 232 HYSEELRQLVNMCINPDPEKRPDIT 256 (267)
T ss_pred cccHHHHHHHHHhcCCCcccCCCHH
Confidence 1123589999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=335.51 Aligned_cols=257 Identities=27% Similarity=0.366 Sum_probs=207.8
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS 161 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 161 (489)
....|.+.+.||+|+||+||+|.... .++.||+|.+.............+.+|+.+++.++||||+++++++.++
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~ 87 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVR-----TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE 87 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcC-----CCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC
Confidence 44679999999999999999999876 4678999998654333334445677899999999999999999999999
Q ss_pred ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccc
Q 011302 162 HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKC 241 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~ 241 (489)
+..|+||||+. |+|.+++.... ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.+||+|||++...
T Consensus 88 ~~~~lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~ 165 (307)
T cd06607 88 HTAWLVMEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLV 165 (307)
T ss_pred CeEEEEHHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceec
Confidence 99999999995 67777665432 46899999999999999999999999999999999999999999999999987321
Q ss_pred ccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccc
Q 011302 242 DVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEP 321 (489)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (489)
..
T Consensus 166 ~~------------------------------------------------------------------------------ 167 (307)
T cd06607 166 SP------------------------------------------------------------------------------ 167 (307)
T ss_pred CC------------------------------------------------------------------------------
Confidence 10
Q ss_pred cccCCccccCCCCccCcchhc---CCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchh
Q 011302 322 INARSKSFVGTHEYLAPEVIS---GQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKE 398 (489)
Q Consensus 322 ~~~~~~~~~Gt~~y~aPE~l~---~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 398 (489)
.....|++.|+|||++. ...++.++|||||||++|||++|..||.+.+.......+..... +.... .
T Consensus 168 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~---~- 237 (307)
T cd06607 168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PTLSS---N- 237 (307)
T ss_pred ----CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC--CCCCc---h-
Confidence 11235788999999985 34578899999999999999999999988776655554443211 11110 0
Q ss_pred HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 399 FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 399 ~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
.....+.+||.+||..||++||++. +++.||||..
T Consensus 238 -~~~~~~~~li~~~l~~~p~~Rp~~~----~il~~~~~~~ 272 (307)
T cd06607 238 -DWSDYFRNFVDSCLQKIPQDRPSSE----ELLKHRFVLR 272 (307)
T ss_pred -hhCHHHHHHHHHHhcCChhhCcCHH----HHhcChhhcc
Confidence 1123589999999999999999987 9999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=336.67 Aligned_cols=257 Identities=21% Similarity=0.303 Sum_probs=201.6
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccceee
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAEFE 159 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~ 159 (489)
+..++|++.+.||+|+||.||+|.++... ....+|+|.+.... .......+.+|+.++.++ +||||+++++++.
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~---~~~~~~ik~~~~~~--~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~ 78 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDG---LRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACE 78 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCC---ceeeEEEEEecccC--CHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC
Confidence 45679999999999999999999987521 22356777765321 123345667799999999 8999999999999
Q ss_pred cCceEEEEEeecCCCchHHHHHhCC--------------CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEec
Q 011302 160 ASHYSCLVMEYCPGGDLYAARQRQP--------------GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVR 225 (489)
Q Consensus 160 ~~~~~~lV~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~ 225 (489)
.++..|+||||+++|+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~ 158 (303)
T cd05088 79 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 158 (303)
T ss_pred CCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEec
Confidence 9999999999999999999987542 23578999999999999999999999999999999999999
Q ss_pred cCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCC
Q 011302 226 EDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGD 305 (489)
Q Consensus 226 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (489)
.++.+||+|||++......
T Consensus 159 ~~~~~kl~dfg~~~~~~~~------------------------------------------------------------- 177 (303)
T cd05088 159 ENYVAKIADFGLSRGQEVY------------------------------------------------------------- 177 (303)
T ss_pred CCCcEEeCccccCcccchh-------------------------------------------------------------
Confidence 9999999999987311000
Q ss_pred CCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcC
Q 011302 306 HHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKK 384 (489)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~ 384 (489)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+...
T Consensus 178 ------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 239 (303)
T cd05088 178 ------------------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 239 (303)
T ss_pred ------------------hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC
Confidence 00011134667999999988889999999999999999998 99999888777666655432
Q ss_pred CCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 385 PLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 385 ~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
. ..+.. .. ....+.+||.+||+.+|++||++. +++++
T Consensus 240 ~-~~~~~-~~------~~~~~~~li~~~l~~~p~~Rp~~~----~il~~ 276 (303)
T cd05088 240 Y-RLEKP-LN------CDDEVYDLMRQCWREKPYERPSFA----QILVS 276 (303)
T ss_pred C-cCCCC-CC------CCHHHHHHHHHHcCCChhhCcCHH----HHHHH
Confidence 1 11111 11 112588999999999999999997 55554
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=321.73 Aligned_cols=250 Identities=48% Similarity=0.839 Sum_probs=212.3
Q ss_pred eccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEEEEEeec
Q 011302 92 LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYC 171 (489)
Q Consensus 92 lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 171 (489)
||.|+||.||+|.+.. .++.||+|++.+...........+..|+.+++.++||||+++++.+..+...|+||||+
T Consensus 1 lg~G~~~~v~~~~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKD-----TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECC-----CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecC
Confidence 6999999999999876 46789999998876554456667888999999999999999999999999999999999
Q ss_pred CCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCccccCCc
Q 011302 172 PGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPK 251 (489)
Q Consensus 172 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 251 (489)
++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++.......
T Consensus 76 ~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~------ 147 (250)
T cd05123 76 PGGELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG------ 147 (250)
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC------
Confidence 999999998775 468999999999999999999999999999999999999999999999999873321100
Q ss_pred chhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCccccC
Q 011302 252 LSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVG 331 (489)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 331 (489)
.......|
T Consensus 148 ------------------------------------------------------------------------~~~~~~~~ 155 (250)
T cd05123 148 ------------------------------------------------------------------------SRTNTFCG 155 (250)
T ss_pred ------------------------------------------------------------------------CcccCCcC
Confidence 01123468
Q ss_pred CCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHHHHH
Q 011302 332 THEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISK 411 (489)
Q Consensus 332 t~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~ 411 (489)
+..|+|||.+.+...+.++|+|||||++|+|++|..||...+.......+......+|... ...+.+||.+
T Consensus 156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~~l~~~i~~ 226 (250)
T cd05123 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFL---------SPEARDLISG 226 (250)
T ss_pred CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCC---------CHHHHHHHHH
Confidence 8899999999988889999999999999999999999988877666677666544444332 1248999999
Q ss_pred HhhcCcccccCCCCChHHHHcCCCc
Q 011302 412 LLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 412 ~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
||..||++||++.. +++++.||||
T Consensus 227 ~l~~~p~~R~~~~~-~~~l~~~~~f 250 (250)
T cd05123 227 LLQKDPTKRLGSGG-AEEIKAHPFF 250 (250)
T ss_pred HhcCCHhhCCCccc-HHHHHhCCCC
Confidence 99999999999943 4499999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=327.02 Aligned_cols=251 Identities=22% Similarity=0.282 Sum_probs=204.0
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.++|++++.||+|+||+||+|++.+ ...+|+|.+...... ...+..|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~------~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG------QYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQR 72 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC------CCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 4679999999999999999998765 245899988754332 234667999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
.+|+||||+.+|+|.+++.... ..+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||+++.+.
T Consensus 73 ~~~lv~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~ 151 (256)
T cd05113 73 PIYIVTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVL 151 (256)
T ss_pred CcEEEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecC
Confidence 9999999999999999987653 368999999999999999999999999999999999999999999999999874321
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
...
T Consensus 152 ~~~----------------------------------------------------------------------------- 154 (256)
T cd05113 152 DDE----------------------------------------------------------------------------- 154 (256)
T ss_pred CCc-----------------------------------------------------------------------------
Confidence 000
Q ss_pred ccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHH
Q 011302 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEE 401 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 401 (489)
........++..|+|||.+.+..++.++|||||||++|||++ |..||...+..+....+..+....... ..
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~------ 226 (256)
T cd05113 155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPH--LA------ 226 (256)
T ss_pred eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCC--CC------
Confidence 000111235678999999998889999999999999999998 999998888777777776543322111 11
Q ss_pred HhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 402 VVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 402 ~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
...+.+++.+||+.||++||++. +|+.+
T Consensus 227 ~~~~~~li~~cl~~~p~~Rp~~~----~ll~~ 254 (256)
T cd05113 227 SEKVYAIMYSCWHEKAEERPTFQ----QLLSS 254 (256)
T ss_pred CHHHHHHHHHHcCCCcccCCCHH----HHHHh
Confidence 12589999999999999999997 77653
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=336.64 Aligned_cols=264 Identities=20% Similarity=0.310 Sum_probs=197.4
Q ss_pred CceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEEEEEeecCCCc
Q 011302 96 DIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGD 175 (489)
Q Consensus 96 ~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 175 (489)
++|.||+++.+. +++.||||++...... ......+..|+.+++.++||||+++++++.+.+..|++|||+++|+
T Consensus 12 ~~~~v~~~~~~~-----~~~~~avK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 12 DLMIVHLAKHKP-----TNTLVAVKKINLDSCS-KEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred CCceEEEEEecC-----CCCEEEEEEEeccccc-hhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 445555555554 4688999999765322 2345678889999999999999999999999999999999999999
Q ss_pred hHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCccccCCcchhH
Q 011302 176 LYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFE 255 (489)
Q Consensus 176 L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~ 255 (489)
|.+++.......+++..+..++.|++.||+|||+++|+||||||+|||++.+|.+||+|||.+..+.......
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~------- 158 (314)
T cd08216 86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ------- 158 (314)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccc-------
Confidence 9999887555678999999999999999999999999999999999999999999999999874321100000
Q ss_pred HHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCccccCCCCc
Q 011302 256 AIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEY 335 (489)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y 335 (489)
...........++..|
T Consensus 159 ----------------------------------------------------------------~~~~~~~~~~~~~~~y 174 (314)
T cd08216 159 ----------------------------------------------------------------RVVHDFPKSSVKNLPW 174 (314)
T ss_pred ----------------------------------------------------------------cccccccccccccccc
Confidence 0000011233578899
Q ss_pred cCcchhcCC--CCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCC-------CCCCC--------------
Q 011302 336 LAPEVISGQ--GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLT-------FPRIG-------------- 392 (489)
Q Consensus 336 ~aPE~l~~~--~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-------~p~~~-------------- 392 (489)
+|||++.+. .++.++|||||||++|||++|..||..........+...+... .+...
T Consensus 175 ~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (314)
T cd08216 175 LSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPN 254 (314)
T ss_pred cCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccc
Confidence 999999764 5789999999999999999999999876654433222221100 00000
Q ss_pred ----CCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 393 ----VSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 393 ----~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
...........++.+||.+||.+||++||++. ++++||||+.+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~----~ll~~p~~~~~~ 302 (314)
T cd08216 255 NRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSAS----QLLNHSFFKQCK 302 (314)
T ss_pred hhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHH----HHhcCchHhhhc
Confidence 00000011224688999999999999999987 999999998763
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=329.70 Aligned_cols=258 Identities=25% Similarity=0.394 Sum_probs=198.3
Q ss_pred ceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-CCCcccccceeecC--c
Q 011302 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-HPFLPTLYAEFEAS--H 162 (489)
Q Consensus 86 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~--~ 162 (489)
|++++.||+|+||.||+|.+.. +++.||+|.++....... . .....|+.++.++. |+||+++++++.++ +
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~-----~~~~~aik~~~~~~~~~~-~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 73 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRK-----TGKYYAIKCMKKHFKSLE-Q-VNNLREIQALRRLSPHPNILRLIEVLFDRKTG 73 (282)
T ss_pred CceEeeccccccceEEEEEEcC-----CCcEEEEEEehhccCCch-h-hhHHHHHHHHhhcCCCCCccceEEEEecCCCC
Confidence 6789999999999999999876 568899999875422111 1 12345888888885 99999999999987 8
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
.+|+||||++ |+|.+.+.... ..+++.++..++.|++.||+|||++||+||||||+||+++. +.+||+|||+++...
T Consensus 74 ~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~ 150 (282)
T cd07831 74 RLALVFELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIY 150 (282)
T ss_pred cEEEEEecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccc
Confidence 9999999996 58877776542 46899999999999999999999999999999999999999 999999999974321
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
..
T Consensus 151 ~~------------------------------------------------------------------------------ 152 (282)
T cd07831 151 SK------------------------------------------------------------------------------ 152 (282)
T ss_pred cC------------------------------------------------------------------------------
Confidence 00
Q ss_pred ccCCccccCCCCccCcchhcC-CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcC-----------------
Q 011302 323 NARSKSFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK----------------- 384 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~----------------- 384 (489)
.......+++.|+|||++.. ..++.++|||||||++|||++|.+||.+.+..+.+..+...
T Consensus 153 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 153 -PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred -CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence 00112357889999998754 44688999999999999999999999988766554444321
Q ss_pred -CCCCCCCCCCCchh--HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 385 -PLTFPRIGVSSSKE--FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 385 -~~~~p~~~~~~~~~--~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
...+|......... ...+..+.+||.+||..||++||++. ++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~----~~l~~~~~ 282 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAK----QALRHPYF 282 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHH----HHhhCCCC
Confidence 01111110000000 01234689999999999999999997 99999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=329.85 Aligned_cols=261 Identities=20% Similarity=0.283 Sum_probs=204.6
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS 161 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 161 (489)
..++|.+.+.||+|+||.||+|.+...........||+|.+...... .....+..|+.+++.++|+||+++++++.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE--QDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 44789999999999999999999876322224678999988643211 2234567799999999999999999999999
Q ss_pred ceEEEEEeecCCCchHHHHHhCCC-----CCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCC---cEEEc
Q 011302 162 HYSCLVMEYCPGGDLYAARQRQPG-----KRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDG---HIMLS 233 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~---~vkl~ 233 (489)
...|+||||++|++|.+++..... ..+++..+..++.||+.||+|||+++++||||||+|||++.++ .+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 999999999999999999876421 2588899999999999999999999999999999999998765 59999
Q ss_pred ccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccC
Q 011302 234 DFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLD 313 (489)
Q Consensus 234 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (489)
|||+++.+.....
T Consensus 162 dfg~~~~~~~~~~------------------------------------------------------------------- 174 (277)
T cd05036 162 DFGMARDIYRASY------------------------------------------------------------------- 174 (277)
T ss_pred cCccccccCCccc-------------------------------------------------------------------
Confidence 9999843311000
Q ss_pred CccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCC-CCCCCC
Q 011302 314 DPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKP-LTFPRI 391 (489)
Q Consensus 314 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~ 391 (489)
........++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+.... ..+|.
T Consensus 175 ---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~- 244 (277)
T cd05036 175 ---------YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPK- 244 (277)
T ss_pred ---------eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCC-
Confidence 000111234567999999998889999999999999999996 999999887776665554432 11111
Q ss_pred CCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 392 GVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 392 ~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
.. +..+.+||.+||+.+|++||++. ++++|
T Consensus 245 --~~------~~~~~~~i~~cl~~~p~~Rps~~----~vl~~ 274 (277)
T cd05036 245 --GC------PGPVYRIMTDCWQHTPEDRPNFA----TILER 274 (277)
T ss_pred --CC------CHHHHHHHHHHcCCCcccCcCHH----HHHHH
Confidence 11 12588999999999999999997 78776
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=338.57 Aligned_cols=269 Identities=26% Similarity=0.320 Sum_probs=201.3
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC--c
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS--H 162 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~ 162 (489)
.|++.+.||+|+||.||+|.+... ..+..||+|.+.............+.+|+.+++.++||||+++++++.+. .
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~---~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNG---KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCC---CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCc
Confidence 488999999999999999998752 14678999999874322223344566799999999999999999999988 8
Q ss_pred eEEEEEeecCCCchHHHHHhCC---CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEecc----CCcEEEccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQP---GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRE----DGHIMLSDF 235 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~----~~~vkl~DF 235 (489)
.+|+||||++ ++|.+++.... ...+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+||
T Consensus 78 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 78 SVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred eEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 8999999995 57766664321 236889999999999999999999999999999999999999 999999999
Q ss_pred CCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCc
Q 011302 236 DLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDP 315 (489)
Q Consensus 236 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (489)
|+++.+......
T Consensus 157 g~~~~~~~~~~~-------------------------------------------------------------------- 168 (316)
T cd07842 157 GLARLFNAPLKP-------------------------------------------------------------------- 168 (316)
T ss_pred ccccccCCCccc--------------------------------------------------------------------
Confidence 998443210000
Q ss_pred cccccccccCCccccCCCCccCcchhcCC-CCCCcccHHHHHHHHHHHhhCCCCCCCCCcHH---------HHHHHhcC-
Q 011302 316 EVVAEPINARSKSFVGTHEYLAPEVISGQ-GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEK---------TLINILKK- 384 (489)
Q Consensus 316 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~---------~~~~i~~~- 384 (489)
.......+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+..... .+.++...
T Consensus 169 -------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (316)
T cd07842 169 -------LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVL 241 (316)
T ss_pred -------ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHh
Confidence 0011234688999999998774 47899999999999999999999998654321 11111110
Q ss_pred ----------------------CCCCCCCCCCCchhH-----HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 385 ----------------------PLTFPRIGVSSSKEF-----EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 385 ----------------------~~~~p~~~~~~~~~~-----~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
..............+ .....+.++|.+||+.||++||++. +++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~----eil~~~~f 316 (316)
T cd07842 242 GTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAE----EALEHPYF 316 (316)
T ss_pred CCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHH----HHhcCCCC
Confidence 000000000000000 1223588999999999999999987 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=330.57 Aligned_cols=255 Identities=27% Similarity=0.426 Sum_probs=209.3
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceE
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYS 164 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 164 (489)
-|++++.||+|+||.||+|.+.. .+..||||++...... .....+.+|+.+++.++||||+++++++..+...
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~-----~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 77 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNR-----TQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL 77 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECC-----CCcEEEEEEeccccch--HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeE
Confidence 47888999999999999998876 4678999998644322 3345677899999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccC
Q 011302 165 CLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVV 244 (489)
Q Consensus 165 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~ 244 (489)
|+||||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..+...
T Consensus 78 ~lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06641 78 WIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 154 (277)
T ss_pred EEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccc
Confidence 999999999999988864 46899999999999999999999999999999999999999999999999987432110
Q ss_pred ccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccccc
Q 011302 245 PKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINA 324 (489)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (489)
..
T Consensus 155 ------------------------------------------------------------------------------~~ 156 (277)
T cd06641 155 ------------------------------------------------------------------------------QI 156 (277)
T ss_pred ------------------------------------------------------------------------------hh
Confidence 00
Q ss_pred CCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhh
Q 011302 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVK 404 (489)
Q Consensus 325 ~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~ 404 (489)
......|+..|+|||.+.+..++.++|+|||||++|+|++|..||...........+..... +..... ....
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~------~~~~ 228 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP--PTLEGN------YSKP 228 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCC--CCCCcc------cCHH
Confidence 01223588899999999888889999999999999999999999987776655555433321 111111 1235
Q ss_pred HHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 405 LQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 405 l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
+.++|.+||..+|.+||++. ++++||||...
T Consensus 229 ~~~~i~~~l~~~p~~Rp~~~----~~l~~~~~~~~ 259 (277)
T cd06641 229 LKEFVEACLNKEPSFRPTAK----ELLKHKFIVRF 259 (277)
T ss_pred HHHHHHHHccCChhhCcCHH----HHHhCHHHhhh
Confidence 88999999999999999987 99999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=327.89 Aligned_cols=249 Identities=25% Similarity=0.328 Sum_probs=205.5
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
.+..+|++.+.||.|+||.||+|.+.. +..+|+|++...... ....+..|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~------~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 73 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKN------RVRVAIKILKSDDLL---KQQDFQKEVQALKRLRHKHLISLFAVCSV 73 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecC------CCcEEEEeccccchh---hHHHHHHHHHHHhcCCCcchhheeeeEec
Confidence 445789999999999999999999875 467899998765432 23356679999999999999999999999
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~ 240 (489)
....|+||||+++|+|.+++....+..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~ 153 (261)
T cd05148 74 GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARL 153 (261)
T ss_pred CCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhh
Confidence 99999999999999999999876667799999999999999999999999999999999999999999999999999743
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
.....
T Consensus 154 ~~~~~--------------------------------------------------------------------------- 158 (261)
T cd05148 154 IKEDV--------------------------------------------------------------------------- 158 (261)
T ss_pred cCCcc---------------------------------------------------------------------------
Confidence 21000
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhH
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEF 399 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 399 (489)
.......++..|+|||.+.+..++.++|||||||++|+|++ |+.||.+.+..+.+..+... ...+... ..
T Consensus 159 ---~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~-~~---- 229 (261)
T cd05148 159 ---YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG-YRMPCPA-KC---- 229 (261)
T ss_pred ---ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhC-CcCCCCC-CC----
Confidence 00012235678999999998889999999999999999998 89999988877777766643 2222111 11
Q ss_pred HHHhhHHHHHHHHhhcCcccccCCC
Q 011302 400 EEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 400 ~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
+..+.++|.+||..||.+||++.
T Consensus 230 --~~~~~~~i~~~l~~~p~~Rpt~~ 252 (261)
T cd05148 230 --PQEIYKIMLECWAAEPEDRPSFK 252 (261)
T ss_pred --CHHHHHHHHHHcCCCchhCcCHH
Confidence 12488999999999999999997
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=329.46 Aligned_cols=254 Identities=20% Similarity=0.295 Sum_probs=203.9
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
..+|++.++||+|+||.||+|..........+..+|+|.+..... .....+.+|+.+++.++|+||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE---SARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCH---HHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 467899999999999999999876433334567899998865332 23346777999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCC-------------CCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPG-------------KRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGH 229 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~-------------~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~ 229 (489)
..|+||||+++|+|.+++..... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence 99999999999999998876421 35888999999999999999999999999999999999999999
Q ss_pred EEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCc
Q 011302 230 IMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQ 309 (489)
Q Consensus 230 vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (489)
+||+|||++..+.....
T Consensus 161 ~kL~dfg~~~~~~~~~~--------------------------------------------------------------- 177 (280)
T cd05092 161 VKIGDFGMSRDIYSTDY--------------------------------------------------------------- 177 (280)
T ss_pred EEECCCCceeEcCCCce---------------------------------------------------------------
Confidence 99999999743211000
Q ss_pred cccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCC-C
Q 011302 310 ELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPL-T 387 (489)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~-~ 387 (489)
........+++.|+|||.+.+..++.++|||||||++|||++ |.+||......+....+..+.. .
T Consensus 178 -------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 244 (280)
T cd05092 178 -------------YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELE 244 (280)
T ss_pred -------------eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCccCC
Confidence 000112246788999999999999999999999999999998 9999988777776666655422 1
Q ss_pred CCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 388 FPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 388 ~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
.+. .. +..+.+||.+||..||.+||++.
T Consensus 245 ~~~---~~------~~~~~~li~~cl~~~P~~Rp~~~ 272 (280)
T cd05092 245 RPR---TC------PPEVYAIMQGCWQREPQQRMVIK 272 (280)
T ss_pred CCC---CC------CHHHHHHHHHHccCChhhCCCHH
Confidence 111 11 12488999999999999999997
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=342.47 Aligned_cols=263 Identities=30% Similarity=0.410 Sum_probs=207.0
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.++|++++.||+|+||.||+|.+.. ++..||||++.+... .......+..|+.+|+.++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRR-----TGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL 87 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECC-----CCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence 4789999999999999999999876 578899999865321 1223345677999999999999999999987654
Q ss_pred ------eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccC
Q 011302 163 ------YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFD 236 (489)
Q Consensus 163 ------~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG 236 (489)
.+|+||||+ |++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 88 ~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 88 SLDRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred cccccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecc
Confidence 469999999 8899888764 468999999999999999999999999999999999999999999999999
Q ss_pred CCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcc
Q 011302 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPE 316 (489)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (489)
++.....
T Consensus 164 ~~~~~~~------------------------------------------------------------------------- 170 (343)
T cd07880 164 LARQTDS------------------------------------------------------------------------- 170 (343)
T ss_pred ccccccc-------------------------------------------------------------------------
Confidence 9732210
Q ss_pred ccccccccCCccccCCCCccCcchhcC-CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCC----
Q 011302 317 VVAEPINARSKSFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRI---- 391 (489)
Q Consensus 317 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~---- 391 (489)
......|++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+......++.......+..
T Consensus 171 --------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07880 171 --------EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK 242 (343)
T ss_pred --------CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 0112357889999999876 357899999999999999999999999877665555544321111100
Q ss_pred -------------CCCCchhH-----HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 392 -------------GVSSSKEF-----EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 392 -------------~~~~~~~~-----~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
.......+ .....+.+||.+||+.||++||++. +++.||||+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~----~~l~~~~~~~~~ 305 (343)
T cd07880 243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAA----EALAHPYFEEFH 305 (343)
T ss_pred hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHH----HHhcCccHhhhc
Confidence 00000000 1123588999999999999999987 999999998764
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=323.92 Aligned_cols=259 Identities=27% Similarity=0.419 Sum_probs=207.5
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHH--HHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREA--LAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS 161 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 161 (489)
.+|++.+.||+|+||.||+|.+.. +++.||+|.+..+. .........+.+|+.+++.++||||+++++++.+.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 76 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDAD-----TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP 76 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcC-----CCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC
Confidence 579999999999999999999876 57889999875321 11234456778899999999999999999998764
Q ss_pred --ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 162 --HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 162 --~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
..+++||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||+++
T Consensus 77 ~~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 77 EEKKLSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 5689999999999999988765 458899999999999999999999999999999999999999999999999984
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
.......
T Consensus 155 ~~~~~~~------------------------------------------------------------------------- 161 (264)
T cd06653 155 RIQTICM------------------------------------------------------------------------- 161 (264)
T ss_pred ccccccc-------------------------------------------------------------------------
Confidence 3211000
Q ss_pred cccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhH
Q 011302 320 EPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEF 399 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 399 (489)
.........|+..|+|||.+.+..++.++|||||||++|+|++|+.||........+.++...+.. +.....
T Consensus 162 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~p~~----- 233 (264)
T cd06653 162 --SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTK-PMLPDG----- 233 (264)
T ss_pred --cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCC-CCCCcc-----
Confidence 000112346889999999999988999999999999999999999999887766666555443221 111111
Q ss_pred HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 400 EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 400 ~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
....+.++|.+||. +|..||++. +++.|||.
T Consensus 234 -~~~~~~~~i~~~l~-~~~~r~~~~----~~~~~~~~ 264 (264)
T cd06653 234 -VSDACRDFLKQIFV-EEKRRPTAE----FLLRHPFV 264 (264)
T ss_pred -cCHHHHHHHHHHhc-CcccCccHH----HHhcCCCC
Confidence 11258999999999 579999997 99999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=342.76 Aligned_cols=258 Identities=26% Similarity=0.302 Sum_probs=200.5
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS 161 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 161 (489)
++++|.-...||+|+||.||+|...+ +..||||.+....... ..+|..|+.+|.+++|||+|+|+|+|.+.
T Consensus 73 AT~~Fs~~~~ig~Ggfg~VYkG~l~~------~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~ 143 (361)
T KOG1187|consen 73 ATNNFSESNLIGEGGFGTVYKGVLSD------GTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEG 143 (361)
T ss_pred HHhCCchhcceecCCCeEEEEEEECC------CCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecC
Confidence 45899999999999999999999886 3789999887654321 34488899999999999999999999988
Q ss_pred c-eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCC---CeeecCCCCCeEeccCCcEEEcccCC
Q 011302 162 H-YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMG---IVYRDLKPENVLVREDGHIMLSDFDL 237 (489)
Q Consensus 162 ~-~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDIKp~NILl~~~~~vkl~DFG~ 237 (489)
+ +.+||+|||++|+|.+++.......++|.....|+.+++.||+|||+.. |||||||+.|||||+++.+||+|||+
T Consensus 144 ~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGL 223 (361)
T KOG1187|consen 144 GEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGL 223 (361)
T ss_pred CceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccC
Confidence 8 5999999999999999998764338999999999999999999999854 99999999999999999999999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
|+..+...
T Consensus 224 a~~~~~~~------------------------------------------------------------------------ 231 (361)
T KOG1187|consen 224 AKLGPEGD------------------------------------------------------------------------ 231 (361)
T ss_pred cccCCccc------------------------------------------------------------------------
Confidence 84322100
Q ss_pred cccccccCCccc-cCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCC---cH--HHH-HHHhcCCCCCCC
Q 011302 318 VAEPINARSKSF-VGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGEN---NE--KTL-INILKKPLTFPR 390 (489)
Q Consensus 318 ~~~~~~~~~~~~-~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~---~~--~~~-~~i~~~~~~~p~ 390 (489)
...... .||.+|+|||.+.....+.++|||||||+|.||++|+.+.+... .. ..+ ....... ....
T Consensus 232 ------~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~-~~~e 304 (361)
T KOG1187|consen 232 ------TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG-KLRE 304 (361)
T ss_pred ------cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc-chhh
Confidence 000111 69999999999988888999999999999999999999887532 11 111 1111111 1111
Q ss_pred CCCCCc--hhH---HHHhhHHHHHHHHhhcCcccccCCCCCh
Q 011302 391 IGVSSS--KEF---EEVVKLQDLISKLLVKNPKKRIGSLKGS 427 (489)
Q Consensus 391 ~~~~~~--~~~---~~~~~l~~li~~~L~~dP~~R~~~~~~~ 427 (489)
+..+.. ..+ .....+..+..+|++.+|.+||++.+.+
T Consensus 305 iiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv 346 (361)
T KOG1187|consen 305 IVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVV 346 (361)
T ss_pred eeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHH
Confidence 111110 111 3455688999999999999999997433
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=340.86 Aligned_cols=270 Identities=23% Similarity=0.319 Sum_probs=207.1
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee----
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE---- 159 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~---- 159 (489)
++|.+.+.||+|+||.||+|.+.. +++.||+|++...... ......+.+|+.+|+.++||||+++++++.
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 78 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTR-----SGKKVAIKKIPHAFDV-PTLAKRTLRELKILRHFKHDNIIAIRDILRPPGA 78 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcC-----CCCEEEEEEecccccc-ccchHHHHHHHHHHHhcCCCCccCHHHhccccCC
Confidence 689999999999999999999887 5778999998754321 123455667999999999999999999886
Q ss_pred cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 160 ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 160 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
....+|+||||+ +|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.
T Consensus 79 ~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 79 DFKDVYVVMDLM-ESDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred CCceEEEEEehh-hhhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccce
Confidence 345789999999 57898888654 559999999999999999999999999999999999999999999999999974
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
.......
T Consensus 156 ~~~~~~~------------------------------------------------------------------------- 162 (334)
T cd07855 156 GLSSSPT------------------------------------------------------------------------- 162 (334)
T ss_pred eecccCc-------------------------------------------------------------------------
Confidence 3211000
Q ss_pred cccccCCccccCCCCccCcchhcC-CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCC------------
Q 011302 320 EPINARSKSFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL------------ 386 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~------------ 386 (489)
..........|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.+.+....+..+.....
T Consensus 163 -~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~ 241 (334)
T cd07855 163 -EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS 241 (334)
T ss_pred -CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence 00011123478999999999876 4579999999999999999999999988765444333222100
Q ss_pred --------CCCCCCCCCchh--HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 387 --------TFPRIGVSSSKE--FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 387 --------~~p~~~~~~~~~--~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
.++......... ......+.+||.+||+.+|++||++. +++.||||++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~----~~l~~~~~~~~~ 301 (334)
T cd07855 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVE----QALQHPFLAQYH 301 (334)
T ss_pred hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHH----HHHhChhhhhcc
Confidence 001000000000 01234689999999999999999987 999999998754
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=332.44 Aligned_cols=260 Identities=19% Similarity=0.258 Sum_probs=205.9
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCC--CCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCccccc
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPM--VGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLY 155 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~--~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~ 155 (489)
+.+..++|.+.+.||+|+||.||+|++.... .......||+|.+..... ......+.+|+.+++.+ +||||++++
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc--hHHHHHHHHHHHHHHhhccCCCchhee
Confidence 4566789999999999999999999865321 112456899999875422 23345677899999999 899999999
Q ss_pred ceeecCceEEEEEeecCCCchHHHHHhCC--------------CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCC
Q 011302 156 AEFEASHYSCLVMEYCPGGDLYAARQRQP--------------GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPEN 221 (489)
Q Consensus 156 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~N 221 (489)
+++......|+||||+++|+|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 167 (304)
T cd05101 88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN 167 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence 99999999999999999999999987642 2357778889999999999999999999999999999
Q ss_pred eEeccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccc
Q 011302 222 VLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQ 301 (489)
Q Consensus 222 ILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (489)
||++.++.+||+|||+++.+.....
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~------------------------------------------------------- 192 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDY------------------------------------------------------- 192 (304)
T ss_pred EEEcCCCcEEECCCccceecccccc-------------------------------------------------------
Confidence 9999999999999999854321000
Q ss_pred cCCCCCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHH
Q 011302 302 VDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLIN 380 (489)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~ 380 (489)
........+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....
T Consensus 193 ---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~ 251 (304)
T cd05101 193 ---------------------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 251 (304)
T ss_pred ---------------------cccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH
Confidence 000112246678999999999889999999999999999998 8999998877777666
Q ss_pred HhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 381 ILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 381 i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
+..... .... .. ....+.+||.+||..+|.+||++.
T Consensus 252 ~~~~~~-~~~~-~~------~~~~~~~li~~cl~~~p~~Rps~~ 287 (304)
T cd05101 252 LKEGHR-MDKP-AN------CTNELYMMMRDCWHAIPSHRPTFK 287 (304)
T ss_pred HHcCCc-CCCC-CC------CCHHHHHHHHHHcccChhhCCCHH
Confidence 654322 1111 11 123589999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=326.35 Aligned_cols=248 Identities=24% Similarity=0.301 Sum_probs=200.2
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
+..++|++.++||+|+||.||+|++.+ ...||+|.+...... ..++.+|+.+++.++||||+++++.+..
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~------~~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~~ 72 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNG------TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE 72 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecC------CceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEECC
Confidence 456789999999999999999998765 235899999754322 2356779999999999999999998754
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~ 240 (489)
...|+||||+++|+|.+++....+..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus 73 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~ 151 (262)
T cd05071 73 -EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 151 (262)
T ss_pred -CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceee
Confidence 5689999999999999999875556689999999999999999999999999999999999999999999999999843
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
+....
T Consensus 152 ~~~~~--------------------------------------------------------------------------- 156 (262)
T cd05071 152 IEDNE--------------------------------------------------------------------------- 156 (262)
T ss_pred ccccc---------------------------------------------------------------------------
Confidence 32100
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhH
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEF 399 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 399 (489)
........++..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+.... ..+...
T Consensus 157 --~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~~~------- 226 (262)
T cd05071 157 --YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-RMPCPP------- 226 (262)
T ss_pred --cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCC-CCCCcc-------
Confidence 000012246778999999998889999999999999999999 899998887777766665432 111111
Q ss_pred HHHhhHHHHHHHHhhcCcccccCCC
Q 011302 400 EEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 400 ~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
..+..+.+||.+||+.||++||++.
T Consensus 227 ~~~~~l~~li~~~l~~~p~~Rp~~~ 251 (262)
T cd05071 227 ECPESLHDLMCQCWRKEPEERPTFE 251 (262)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHH
Confidence 1123588999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=327.98 Aligned_cols=261 Identities=20% Similarity=0.287 Sum_probs=211.5
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.++|++++.||+|+||.||+|+.+........+.|++|.+..... ......+.+|+.++++++|+||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD--ENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc--hHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 468999999999999999999987655455677899999865432 124456777999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCC-------CCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPG-------KRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~-------~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DF 235 (489)
..|+||||+++|+|.+++..... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999999876531 16899999999999999999999999999999999999999999999999
Q ss_pred CCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCc
Q 011302 236 DLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDP 315 (489)
Q Consensus 236 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (489)
|+++......
T Consensus 162 ~~~~~~~~~~---------------------------------------------------------------------- 171 (275)
T cd05046 162 SLSKDVYNSE---------------------------------------------------------------------- 171 (275)
T ss_pred ccccccCccc----------------------------------------------------------------------
Confidence 9873211000
Q ss_pred cccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCC
Q 011302 316 EVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVS 394 (489)
Q Consensus 316 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~ 394 (489)
........++..|+|||.+.+..++.++|||||||++|+|++ |..||.+......+..+..+...++....
T Consensus 172 -------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 243 (275)
T cd05046 172 -------YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEG- 243 (275)
T ss_pred -------ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCCCC-
Confidence 001112246778999999988888999999999999999998 89999887777777776655544432211
Q ss_pred CchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 395 SSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 395 ~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
. +..+.++|.+||..||++||++. +++.+
T Consensus 244 ~------~~~l~~~i~~~l~~~p~~Rp~~~----~~l~~ 272 (275)
T cd05046 244 C------PSRLYKLMTRCWAVNPKDRPSFS----ELVSA 272 (275)
T ss_pred C------CHHHHHHHHHHcCCCcccCCCHH----HHHHH
Confidence 1 12589999999999999999987 66653
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=334.03 Aligned_cols=258 Identities=21% Similarity=0.273 Sum_probs=202.5
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCC--CCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccc
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVG--LPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYA 156 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~ 156 (489)
++..++|.+.+.||+|+||.||+|++.+.... .....||+|.+..+.. .....++..|+.+++.+ +||||+++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLG 91 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC--hHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 44557899999999999999999987643221 2345799999975421 12345677799999999 7999999999
Q ss_pred eeecCceEEEEEeecCCCchHHHHHhCC--------------CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCe
Q 011302 157 EFEASHYSCLVMEYCPGGDLYAARQRQP--------------GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENV 222 (489)
Q Consensus 157 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NI 222 (489)
++...+..|+||||+++|+|.+++.... ...+++.++..++.||+.||+|||++|++||||||+||
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 171 (307)
T cd05098 92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171 (307)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence 9999999999999999999999987642 13588889999999999999999999999999999999
Q ss_pred EeccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCcccccccccccccccccccccccccccc
Q 011302 223 LVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQV 302 (489)
Q Consensus 223 Ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (489)
|++.++.+||+|||+++.+.....
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~-------------------------------------------------------- 195 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDY-------------------------------------------------------- 195 (307)
T ss_pred EEcCCCcEEECCCcccccccccch--------------------------------------------------------
Confidence 999999999999999743211000
Q ss_pred CCCCCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHH
Q 011302 303 DGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINI 381 (489)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i 381 (489)
........+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+
T Consensus 196 --------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~ 255 (307)
T cd05098 196 --------------------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 255 (307)
T ss_pred --------------------hhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence 000011134578999999999889999999999999999998 89999887766655555
Q ss_pred hcCCC-CCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 382 LKKPL-TFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 382 ~~~~~-~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
..... ..+. .. ..++.+||.+||..+|++||++.
T Consensus 256 ~~~~~~~~~~---~~------~~~~~~li~~~l~~~p~~Rps~~ 290 (307)
T cd05098 256 KEGHRMDKPS---NC------TNELYMMMRDCWHAVPSQRPTFK 290 (307)
T ss_pred HcCCCCCCCC---cC------CHHHHHHHHHHcccChhhCcCHH
Confidence 44321 1111 11 12588999999999999999997
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=330.11 Aligned_cols=257 Identities=25% Similarity=0.463 Sum_probs=206.5
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC---CCCcccccceeecC
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD---HPFLPTLYAEFEAS 161 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~ 161 (489)
.|++++.||+|+||.||+|.+.. .++.||+|.+..... .....++.+|+.+++.++ ||||+++++++..+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~-----~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~ 74 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVP-----TGRVVALKIINLDTP--DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG 74 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcC-----CCcEEEEEEecCCCC--chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC
Confidence 47888999999999999999876 568899999864321 123345667888888886 99999999999999
Q ss_pred ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccc
Q 011302 162 HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKC 241 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~ 241 (489)
...|+||||++|++|.+++.. ..+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++..+
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06917 75 PRLWIIMEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALL 151 (277)
T ss_pred CEEEEEEecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence 999999999999999998865 36899999999999999999999999999999999999999999999999987432
Q ss_pred ccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccc
Q 011302 242 DVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEP 321 (489)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (489)
...
T Consensus 152 ~~~----------------------------------------------------------------------------- 154 (277)
T cd06917 152 NQN----------------------------------------------------------------------------- 154 (277)
T ss_pred CCC-----------------------------------------------------------------------------
Confidence 110
Q ss_pred cccCCccccCCCCccCcchhcC-CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHH
Q 011302 322 INARSKSFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFE 400 (489)
Q Consensus 322 ~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 400 (489)
........|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+.......+... ..+..... .
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~-----~ 226 (277)
T cd06917 155 -SSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KPPRLEDN-----G 226 (277)
T ss_pred -ccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC--CCCCCCcc-----c
Confidence 001122368899999999875 44689999999999999999999999887665544333222 11111111 0
Q ss_pred HHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 401 EVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 401 ~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
...++.+||.+||..||++||++. +++.|+||+...
T Consensus 227 ~~~~~~~~i~~~l~~~p~~R~~~~----~il~~~~~~~~~ 262 (277)
T cd06917 227 YSKLLREFVAACLDEEPKERLSAE----ELLKSKWIKAHS 262 (277)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHH----HHhhChHhhccc
Confidence 123589999999999999999987 999999997754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=331.42 Aligned_cols=262 Identities=27% Similarity=0.411 Sum_probs=204.5
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceE
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYS 164 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 164 (489)
+|++.+.||.|+||.||+|++.. ++..||||++...... .....+.+|+.+++.++||||+++++++.+.+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 73 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRT-----TGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKL 73 (284)
T ss_pred CceEeeeeccCCceEEEEEEECC-----CCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcE
Confidence 58999999999999999999876 5788999998754321 1234456699999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhCC-CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 165 CLVMEYCPGGDLYAARQRQP-GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 165 ~lV~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
|+||||++ ++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 74 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~ 152 (284)
T cd07836 74 MLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGI 152 (284)
T ss_pred EEEEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcC
Confidence 99999996 58888776542 24689999999999999999999999999999999999999999999999998732211
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
..
T Consensus 153 ~~------------------------------------------------------------------------------ 154 (284)
T cd07836 153 PV------------------------------------------------------------------------------ 154 (284)
T ss_pred Cc------------------------------------------------------------------------------
Confidence 00
Q ss_pred cCCccccCCCCccCcchhcCC-CCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcC---CC-------------
Q 011302 324 ARSKSFVGTHEYLAPEVISGQ-GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK---PL------------- 386 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~~------------- 386 (489)
.......+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+...++... +.
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence 001122578899999998764 4688999999999999999999999988776655544321 00
Q ss_pred --CCCCCCCCCchh--HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 387 --TFPRIGVSSSKE--FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 387 --~~p~~~~~~~~~--~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
.+|......... ......+.++|.+||+.||.+||++. ++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~----~~l~~~~f 284 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAH----DALQHPWF 284 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHH----HHhcCCCC
Confidence 000000000000 01234688999999999999999987 99999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=309.46 Aligned_cols=266 Identities=22% Similarity=0.295 Sum_probs=205.8
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE 159 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 159 (489)
.+..++|++.+.||+|||+-||+++.-. +.+.||+|.+..... +..+.+++|++..++++||||++++++..
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s-----~~~~YAlKkI~c~~~---~~~e~~~rEid~~rkf~s~~vl~l~dh~l 88 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLS-----TGHLYALKKILCHSQ---EDIEEALREIDNHRKFNSPNVLRLVDHQL 88 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccC-----cccchhhheeeccch---HHHHHHHHHHHHHHhhCCcchHHHHHHHH
Confidence 3566899999999999999999999665 678999999986652 34567778999999999999999999875
Q ss_pred cCc-----eEEEEEeecCCCchHHHHHhC--CCCCCChhhHHHHHHHHHHHHHHHHhCC--CeeecCCCCCeEeccCCcE
Q 011302 160 ASH-----YSCLVMEYCPGGDLYAARQRQ--PGKRFGISSAKFYAAETLLALEYLHMMG--IVYRDLKPENVLVREDGHI 230 (489)
Q Consensus 160 ~~~-----~~~lV~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDIKp~NILl~~~~~v 230 (489)
.+. ..||+++|...|+|.+.+++. ++..+++.++..|+.+|++||++||+.. ++||||||.|||+...+.+
T Consensus 89 ~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~ 168 (302)
T KOG2345|consen 89 REEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLP 168 (302)
T ss_pred HhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCce
Confidence 333 589999999999999887754 4457999999999999999999999998 9999999999999999999
Q ss_pred EEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCcc
Q 011302 231 MLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQE 310 (489)
Q Consensus 231 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (489)
+|.|||.++.....-. .... .. ++
T Consensus 169 vl~D~GS~~~a~i~i~---~~~~---a~--------------------------------------~l------------ 192 (302)
T KOG2345|consen 169 VLMDLGSATQAPIQIE---GSRQ---AL--------------------------------------RL------------ 192 (302)
T ss_pred EEEeccCccccceEee---chHH---HH--------------------------------------HH------------
Confidence 9999998743321000 0000 00 00
Q ss_pred ccCCccccccccccCCccccCCCCccCcchhcCCC---CCCcccHHHHHHHHHHHhhCCCCCCCCCcH--HHHHHHhcCC
Q 011302 311 LLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQG---HGSAVDWWTLGVFLYEMLYGTTPFKGENNE--KTLINILKKP 385 (489)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~---~~~~~DiwSlGvil~elltG~~Pf~~~~~~--~~~~~i~~~~ 385 (489)
.++ ..-..|..|+|||.+.-+. .+.++|||||||+||+|+.|..||...... .+...+...+
T Consensus 193 --------Qe~-----a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q 259 (302)
T KOG2345|consen 193 --------QEW-----AEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQ 259 (302)
T ss_pred --------HHH-----HHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccc
Confidence 000 0113578899999986543 588999999999999999999999643221 1222345566
Q ss_pred CCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 386 LTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 386 ~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
+.+|.....+ ..+.+||..||+.||.+||++. +++.+
T Consensus 260 ~s~P~~~~ys-------e~l~~lik~mlqvdP~qRP~i~----~ll~~ 296 (302)
T KOG2345|consen 260 ISIPNSSRYS-------EALHQLIKSMLQVDPNQRPTIP----ELLSK 296 (302)
T ss_pred cccCCCCCcc-------HHHHHHHHHHhcCCcccCCCHH----HHHHH
Confidence 7777654422 2489999999999999999997 66654
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=329.75 Aligned_cols=263 Identities=28% Similarity=0.433 Sum_probs=215.7
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS 161 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 161 (489)
..+.|.+...||+|+||.||+|.+.. .+..|++|++..... ....+..|+.+++.++|+||+++++++...
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 87 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRA-----TGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVG 87 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEcc-----CCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC
Confidence 34679999999999999999999885 467899999975432 344566799999999999999999999999
Q ss_pred ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccc
Q 011302 162 HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKC 241 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~ 241 (489)
...|+|+||++|++|.+++.... ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++...
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 166 (286)
T cd06614 88 DELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166 (286)
T ss_pred CEEEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence 99999999999999999998753 37999999999999999999999999999999999999999999999999986321
Q ss_pred ccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccc
Q 011302 242 DVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEP 321 (489)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (489)
...
T Consensus 167 ~~~----------------------------------------------------------------------------- 169 (286)
T cd06614 167 TKE----------------------------------------------------------------------------- 169 (286)
T ss_pred ccc-----------------------------------------------------------------------------
Confidence 100
Q ss_pred cccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHH
Q 011302 322 INARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEE 401 (489)
Q Consensus 322 ~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 401 (489)
........|++.|+|||++.+..++.++|+|||||++|+|++|..||...+.......+....... ..... ..
T Consensus 170 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~----~~ 242 (286)
T cd06614 170 -KSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPP--LKNPE----KW 242 (286)
T ss_pred -hhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--Ccchh----hC
Confidence 000122357889999999998889999999999999999999999998877666555554432211 11000 01
Q ss_pred HhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcc
Q 011302 402 VVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWA 442 (489)
Q Consensus 402 ~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~ 442 (489)
...+.+||.+||+.+|.+||++. +++.|+||+...|.
T Consensus 243 ~~~l~~li~~~l~~~p~~Rpt~~----~il~~~~~~~~~~~ 279 (286)
T cd06614 243 SPEFKDFLNKCLVKDPEKRPSAE----ELLQHPFLKKACPK 279 (286)
T ss_pred CHHHHHHHHHHhccChhhCcCHH----HHhhChHhhccCch
Confidence 23589999999999999999997 99999999997664
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=339.21 Aligned_cols=266 Identities=23% Similarity=0.316 Sum_probs=204.2
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC--
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS-- 161 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-- 161 (489)
.+|.+.+.||+|+||+||+|++.. +++.||||.+...... .....++.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~ 78 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSE-----TNEKVAIKKIANAFDN-RIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHR 78 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecC-----CCCeEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCccchHHheecccc
Confidence 579999999999999999999876 5789999998753221 22234566799999999999999999988644
Q ss_pred ---ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 162 ---HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 162 ---~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
...|+||||+ +++|.+++... ..+++..+..++.||+.||.|||+++++||||||+|||++.++.+||+|||++
T Consensus 79 ~~~~~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 79 EAFNDVYIVYELM-DTDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred cccCcEEEEEeCC-CCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 3589999999 57898888764 57999999999999999999999999999999999999999999999999998
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
+......
T Consensus 156 ~~~~~~~------------------------------------------------------------------------- 162 (337)
T cd07858 156 RTTSEKG------------------------------------------------------------------------- 162 (337)
T ss_pred cccCCCc-------------------------------------------------------------------------
Confidence 4321100
Q ss_pred ccccccCCccccCCCCccCcchhcC-CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhc---CCCC-------
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILK---KPLT------- 387 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~~~~------- 387 (489)
.......|+..|+|||.+.+ ..++.++|||||||++|+|++|++||.+.+.......+.. .+..
T Consensus 163 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07858 163 -----DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237 (337)
T ss_pred -----ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence 01123357889999999875 4588999999999999999999999987654333322211 0000
Q ss_pred ----------CCCCCCCCch--hHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 388 ----------FPRIGVSSSK--EFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 388 ----------~p~~~~~~~~--~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
.+........ .......+.+||.+||+.+|++||++. ++++||||+.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~----ell~h~~~~~~~ 298 (337)
T cd07858 238 NEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVE----EALAHPYLASLH 298 (337)
T ss_pred chhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHH----HHHcCcchhhhc
Confidence 0000000000 001234588999999999999999987 999999998753
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=365.37 Aligned_cols=258 Identities=24% Similarity=0.352 Sum_probs=212.1
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
+..+...+.+.||+|.||.||.|...+.........||||.+++.. ..+....|.+|..+|+.++|||||+++|++-+
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~--~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS--SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 4467888999999999999999999874333335568999987643 23566788999999999999999999999999
Q ss_pred CceEEEEEeecCCCchHHHHHhCC-----CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEccc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQP-----GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~-----~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DF 235 (489)
....+|++|||.||||..+++... ...++..+...++.||++|+.||+++++|||||.++|+||+....|||+||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence 999999999999999999998751 356888999999999999999999999999999999999999999999999
Q ss_pred CCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCc
Q 011302 236 DLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDP 315 (489)
Q Consensus 236 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (489)
|+|+.... ...|++.
T Consensus 847 GlArDiy~-------------~~yyr~~---------------------------------------------------- 861 (1025)
T KOG1095|consen 847 GLARDIYD-------------KDYYRKH---------------------------------------------------- 861 (1025)
T ss_pred chhHhhhh-------------chheecc----------------------------------------------------
Confidence 99953211 1111110
Q ss_pred cccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCC
Q 011302 316 EVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVS 394 (489)
Q Consensus 316 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~ 394 (489)
..-.-...|||||.+....++.++|||||||+|||+++ |..||.+.++.+++...+.+..-.+...++
T Consensus 862 -----------~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~CP 930 (1025)
T KOG1095|consen 862 -----------GEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSYCP 930 (1025)
T ss_pred -----------CccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCCCC
Confidence 00112357999999999999999999999999999997 999999999999998777665222222232
Q ss_pred CchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 395 SSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 395 ~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
. .+.+||..||+.+|++||++.
T Consensus 931 ~--------~ly~lM~~CW~~~pe~RP~F~ 952 (1025)
T KOG1095|consen 931 E--------KLYQLMLQCWKHDPEDRPSFR 952 (1025)
T ss_pred h--------HHHHHHHHHccCChhhCccHH
Confidence 2 377999999999999999987
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=325.53 Aligned_cols=250 Identities=22% Similarity=0.325 Sum_probs=201.5
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccccccee
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEF 158 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 158 (489)
|++..++|++.+.||+|+||.||+|.+.. +..+|+|.+...... ...+.+|+.++++++|+||+++++++
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~------~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~ 70 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNG------NTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVV 70 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEecC------CceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEE
Confidence 34566899999999999999999998764 356899998754322 23467799999999999999999987
Q ss_pred ecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 159 EASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
.. ...|+||||+++++|.+++.......+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++
T Consensus 71 ~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~ 149 (260)
T cd05070 71 SE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLA 149 (260)
T ss_pred CC-CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceee
Confidence 54 56899999999999999987765567899999999999999999999999999999999999999999999999998
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
..+....
T Consensus 150 ~~~~~~~------------------------------------------------------------------------- 156 (260)
T cd05070 150 RLIEDNE------------------------------------------------------------------------- 156 (260)
T ss_pred eeccCcc-------------------------------------------------------------------------
Confidence 4321100
Q ss_pred ccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCch
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSK 397 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 397 (489)
........++..|+|||.+.+..++.++|||||||++|||++ |.+||.+.+..+....+.... ..+... .
T Consensus 157 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~-~--- 227 (260)
T cd05070 157 ----YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY-RMPCPQ-D--- 227 (260)
T ss_pred ----cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCC-c---
Confidence 000011235668999999998889999999999999999999 999999888777777665431 222111 1
Q ss_pred hHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 398 EFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 398 ~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
....+.+||.+||..+|++||++.
T Consensus 228 ---~~~~~~~li~~~l~~~p~~Rpt~~ 251 (260)
T cd05070 228 ---CPISLHELMLQCWKKDPEERPTFE 251 (260)
T ss_pred ---CCHHHHHHHHHHcccCcccCcCHH
Confidence 112589999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=320.90 Aligned_cols=256 Identities=33% Similarity=0.540 Sum_probs=213.2
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceE
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYS 164 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 164 (489)
+|.+.+.||.|+||.||+|.+.. +++.|++|++...... ......+..|+.+++.++|||++++++.+..+...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 74 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKS-----DGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKL 74 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcC-----CCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEE
Confidence 58899999999999999999876 4678999999765432 23344567799999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhCC--CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 165 CLVMEYCPGGDLYAARQRQP--GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 165 ~lV~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
++||||+++++|.+++.... +..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 154 (258)
T cd08215 75 CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS 154 (258)
T ss_pred EEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecc
Confidence 99999999999999887643 4679999999999999999999999999999999999999999999999999973321
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
..
T Consensus 155 ~~------------------------------------------------------------------------------ 156 (258)
T cd08215 155 ST------------------------------------------------------------------------------ 156 (258)
T ss_pred cC------------------------------------------------------------------------------
Confidence 10
Q ss_pred ccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHH
Q 011302 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEV 402 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~ 402 (489)
........|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+....... ..... .
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~------~ 228 (258)
T cd08215 157 VDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP--IPSQY------S 228 (258)
T ss_pred cceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCC--CCCCC------C
Confidence 001123368899999999999889999999999999999999999998887776666665543211 11111 1
Q ss_pred hhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 403 VKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 403 ~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
..+.++|.+||..+|++||++. ++++||||
T Consensus 229 ~~~~~~i~~~l~~~p~~Rp~~~----~ll~~~~~ 258 (258)
T cd08215 229 SELRNLVSSLLQKDPEERPSIA----QILQSPFI 258 (258)
T ss_pred HHHHHHHHHHcCCChhhCcCHH----HHhcCCCC
Confidence 2489999999999999999998 99999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=338.93 Aligned_cols=262 Identities=26% Similarity=0.359 Sum_probs=204.2
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC-
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS- 161 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~- 161 (489)
.++|.+.+.||+|+||.||+|.+.. +++.||+|++.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTK-----TGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcC-----CCeEEEEEEecCcchh-hHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 3789999999999999999999876 5788999999754322 12334566799999999999999999988543
Q ss_pred -----ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccC
Q 011302 162 -----HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFD 236 (489)
Q Consensus 162 -----~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG 236 (489)
...|+|++++ |++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg 165 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFG 165 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccc
Confidence 3578999988 8899887764 358999999999999999999999999999999999999999999999999
Q ss_pred CCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcc
Q 011302 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPE 316 (489)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (489)
+++...
T Consensus 166 ~~~~~~-------------------------------------------------------------------------- 171 (345)
T cd07877 166 LARHTD-------------------------------------------------------------------------- 171 (345)
T ss_pred cccccc--------------------------------------------------------------------------
Confidence 873210
Q ss_pred ccccccccCCccccCCCCccCcchhcC-CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCC------
Q 011302 317 VVAEPINARSKSFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFP------ 389 (489)
Q Consensus 317 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p------ 389 (489)
.......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.+.+....+..+.......+
T Consensus 172 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T cd07877 172 -------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 244 (345)
T ss_pred -------ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 00122358899999999877 4578999999999999999999999987766554444332111000
Q ss_pred --------------CCCCCCchh--HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 390 --------------RIGVSSSKE--FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 390 --------------~~~~~~~~~--~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
......... ......+.+||.+||..||.+|+++. +++.||||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~----e~l~h~~f~~~ 306 (345)
T cd07877 245 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA----QALAHAYFAQY 306 (345)
T ss_pred cccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHH----HHhcChhhhhc
Confidence 000000000 01123588999999999999999987 99999999863
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=324.74 Aligned_cols=249 Identities=22% Similarity=0.337 Sum_probs=202.1
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE 159 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 159 (489)
++..++|+++++||+|+||.||+|..++ ++.||+|.+...... ...+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~------~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~ 71 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNG------HTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT 71 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCC------CceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc
Confidence 4566899999999999999999998654 467999998754432 235667999999999999999999875
Q ss_pred cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 160 ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 160 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
.+..|+||||+.+|+|.+++....+..+++.++..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.
T Consensus 72 -~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 150 (260)
T cd05067 72 -QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLAR 150 (260)
T ss_pred -cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCccee
Confidence 4578999999999999999877666779999999999999999999999999999999999999999999999999973
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
......
T Consensus 151 ~~~~~~-------------------------------------------------------------------------- 156 (260)
T cd05067 151 LIEDNE-------------------------------------------------------------------------- 156 (260)
T ss_pred ecCCCC--------------------------------------------------------------------------
Confidence 321000
Q ss_pred cccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchh
Q 011302 320 EPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKE 398 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 398 (489)
........++..|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+....+.... ..+.... .
T Consensus 157 ---~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~-~--- 228 (260)
T cd05067 157 ---YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGY-RMPRPDN-C--- 228 (260)
T ss_pred ---cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC-CCCCCCC-C---
Confidence 000112245678999999998889999999999999999998 999999888777666654432 2221111 1
Q ss_pred HHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 399 FEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 399 ~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
..++.+||.+||+.+|++||++.
T Consensus 229 ---~~~~~~li~~~l~~~p~~Rp~~~ 251 (260)
T cd05067 229 ---PEELYELMRLCWKEKPEERPTFE 251 (260)
T ss_pred ---CHHHHHHHHHHccCChhhCCCHH
Confidence 12589999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=329.29 Aligned_cols=262 Identities=27% Similarity=0.381 Sum_probs=204.5
Q ss_pred ceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEE
Q 011302 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSC 165 (489)
Q Consensus 86 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 165 (489)
|++.+.||.|++|.||+|.++. ++..||+|++..+... ......+.+|+.+++.++||||+++++++.+++..|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~-----~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~ 74 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKL-----TGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLY 74 (283)
T ss_pred CchheEecCCCCeEEEEEEEcC-----CCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEE
Confidence 6778999999999999999876 5678999998754322 122345667999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCc
Q 011302 166 LVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVP 245 (489)
Q Consensus 166 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~ 245 (489)
+||||+ +++|.+++.......+++..+..++.|++.||+|||+++++||||+|+||+++.++.++|+|||++.......
T Consensus 75 iv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 75 LVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV 153 (283)
T ss_pred EEEecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence 999999 5789998877654579999999999999999999999999999999999999999999999999974321100
Q ss_pred cccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccC
Q 011302 246 KLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINAR 325 (489)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (489)
..
T Consensus 154 ------------------------------------------------------------------------------~~ 155 (283)
T cd07835 154 ------------------------------------------------------------------------------RT 155 (283)
T ss_pred ------------------------------------------------------------------------------cc
Confidence 00
Q ss_pred CccccCCCCccCcchhcCC-CCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCC------------------
Q 011302 326 SKSFVGTHEYLAPEVISGQ-GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL------------------ 386 (489)
Q Consensus 326 ~~~~~Gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~------------------ 386 (489)
.....+++.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+......++.....
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP 235 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence 0112468899999998765 468899999999999999999999988776554444332110
Q ss_pred CCCCCCCCCchh--HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 387 TFPRIGVSSSKE--FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 387 ~~p~~~~~~~~~--~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
.++......... ......+.+||.+||+.||.+||++. +++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~----~il~~~~~ 283 (283)
T cd07835 236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAK----AALQHPYF 283 (283)
T ss_pred hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHH----HHhcCCCC
Confidence 011100000000 01123588999999999999999987 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=332.09 Aligned_cols=260 Identities=19% Similarity=0.239 Sum_probs=203.7
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCC--CCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCccccc
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMV--GLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLY 155 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~ 155 (489)
+.+..++|.+.+.||+|+||.||+|++.+... ......||+|++..... ......+..|+.+++.+ +||||++++
T Consensus 7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (314)
T cd05099 7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--DKDLADLISEMELMKLIGKHKNIINLL 84 (314)
T ss_pred ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC--hHHHHHHHHHHHHHHhccCCCCeeeEE
Confidence 34556789999999999999999998754221 12456789999874321 23345577799999999 699999999
Q ss_pred ceeecCceEEEEEeecCCCchHHHHHhCC--------------CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCC
Q 011302 156 AEFEASHYSCLVMEYCPGGDLYAARQRQP--------------GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPEN 221 (489)
Q Consensus 156 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~N 221 (489)
+++.+...+|+||||+++|+|.+++.... ...+++.++..++.||+.||.|||++||+||||||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 164 (314)
T cd05099 85 GVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN 164 (314)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccccee
Confidence 99999999999999999999999987632 2358888999999999999999999999999999999
Q ss_pred eEeccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccc
Q 011302 222 VLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQ 301 (489)
Q Consensus 222 ILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (489)
||++.++.+||+|||+++.+......
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~------------------------------------------------------ 190 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYY------------------------------------------------------ 190 (314)
T ss_pred EEEcCCCcEEEccccccccccccccc------------------------------------------------------
Confidence 99999999999999998533210000
Q ss_pred cCCCCCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHH
Q 011302 302 VDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLIN 380 (489)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~ 380 (489)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.+....+.+..
T Consensus 191 ----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~ 248 (314)
T cd05099 191 ----------------------KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248 (314)
T ss_pred ----------------------cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 00011124567999999999889999999999999999998 9999988877776666
Q ss_pred HhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 381 ILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 381 i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
+..+... . ..... ..++.+||.+||..||++||++.
T Consensus 249 ~~~~~~~-~-~~~~~------~~~l~~li~~cl~~~p~~Rps~~ 284 (314)
T cd05099 249 LREGHRM-D-KPSNC------THELYMLMRECWHAVPTQRPTFK 284 (314)
T ss_pred HHcCCCC-C-CCCCC------CHHHHHHHHHHcCCCcccCcCHH
Confidence 6544211 1 11111 12488999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=324.01 Aligned_cols=250 Identities=23% Similarity=0.316 Sum_probs=200.6
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
..+|++.+.||+|+||.||+|+++. ...+|+|++.+.... ...+.+|+.+++.++||||+++++++...+
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~~------~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWRG------KIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQR 72 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEecC------CccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 3578999999999999999998764 456899998653322 234566999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
..|+||||++|++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~ 151 (256)
T cd05059 73 PIFIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVL 151 (256)
T ss_pred ceEEEEecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecc
Confidence 9999999999999999987653 468999999999999999999999999999999999999999999999999874221
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
...
T Consensus 152 ~~~----------------------------------------------------------------------------- 154 (256)
T cd05059 152 DDQ----------------------------------------------------------------------------- 154 (256)
T ss_pred ccc-----------------------------------------------------------------------------
Confidence 000
Q ss_pred ccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHH
Q 011302 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEE 401 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 401 (489)
........++..|+|||.+.+..++.++|||||||++|||++ |..||...+..+....+.... ..+... ..
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~-~~------ 226 (256)
T cd05059 155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY-RLYRPK-LA------ 226 (256)
T ss_pred ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCC-cCCCCC-CC------
Confidence 000011124567999999999889999999999999999998 899998877776666665432 111111 11
Q ss_pred HhhHHHHHHHHhhcCcccccCCCCChHHHHc
Q 011302 402 VVKLQDLISKLLVKNPKKRIGSLKGSVEIKR 432 (489)
Q Consensus 402 ~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~ 432 (489)
+..+.+|+.+||..+|++||++. ++++
T Consensus 227 ~~~~~~li~~cl~~~p~~Rpt~~----~~l~ 253 (256)
T cd05059 227 PTEVYTIMYSCWHEKPEDRPAFK----KLLS 253 (256)
T ss_pred CHHHHHHHHHHhcCChhhCcCHH----HHHH
Confidence 12589999999999999999987 6654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=326.93 Aligned_cols=261 Identities=29% Similarity=0.390 Sum_probs=204.2
Q ss_pred ceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC---CCCCcccccceeecCc
Q 011302 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML---DHPFLPTLYAEFEASH 162 (489)
Q Consensus 86 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~~~ 162 (489)
|++.+.||+|+||.||+|+++. +++.||+|+++..... ......+..|+.+++++ +||||+++++++...+
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~-----~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 74 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLN-----TGRFVALKKVRVPLSE-EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPR 74 (287)
T ss_pred CeEEEEecccCceEEEEEEECC-----CCCEEEEEEecccccc-chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeecc
Confidence 6789999999999999999886 4678999999743221 11223344577666655 6999999999998777
Q ss_pred e-----EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCC
Q 011302 163 Y-----SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237 (489)
Q Consensus 163 ~-----~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~ 237 (489)
. .|+||||+. ++|.+++.......+++..+..++.|++.||.|||+++++|+||||+|||++.++.+||+|||+
T Consensus 75 ~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~ 153 (287)
T cd07838 75 TDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGL 153 (287)
T ss_pred CCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCc
Confidence 6 999999995 5898888776545699999999999999999999999999999999999999999999999998
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
+......
T Consensus 154 ~~~~~~~------------------------------------------------------------------------- 160 (287)
T cd07838 154 ARIYSFE------------------------------------------------------------------------- 160 (287)
T ss_pred ceeccCC-------------------------------------------------------------------------
Confidence 7432110
Q ss_pred cccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCC-----CCCCC--
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP-----LTFPR-- 390 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-----~~~p~-- 390 (489)
.......|+..|+|||++.+..++.++|||||||++|||++|.+||.+.+..+.+.++.... ..++.
T Consensus 161 ------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 161 ------MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred ------cccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 00112247889999999999889999999999999999999999999888777666664311 11110
Q ss_pred ---------CCCCCchh--HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 391 ---------IGVSSSKE--FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 391 ---------~~~~~~~~--~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
........ ......+.+||.+||..||.+||++. +++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~----~il~~~~~ 287 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAF----EALQHPYF 287 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHH----HHhcCcCC
Confidence 00000000 01234678999999999999999987 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=325.03 Aligned_cols=255 Identities=21% Similarity=0.286 Sum_probs=200.2
Q ss_pred ceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce--
Q 011302 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY-- 163 (489)
Q Consensus 86 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~-- 163 (489)
|++.+.||+|+||.||+|.+.... .....||+|.+..+... ......+..|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~--~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 77 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDD--GSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQ 77 (273)
T ss_pred CccccccCcCCCceEEEEEEecCC--CCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccc
Confidence 577899999999999999986532 13578999998754322 2334567789999999999999999998765443
Q ss_pred ----EEEEEeecCCCchHHHHHhC----CCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEccc
Q 011302 164 ----SCLVMEYCPGGDLYAARQRQ----PGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235 (489)
Q Consensus 164 ----~~lV~E~~~gg~L~~~l~~~----~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DF 235 (489)
.++||||+++|+|..++... ....+++..+..++.|++.||+|||+++|+||||||+|||+++++.+||+||
T Consensus 78 ~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 78 KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred cCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCc
Confidence 79999999999998887543 2246889999999999999999999999999999999999999999999999
Q ss_pred CCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCc
Q 011302 236 DLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDP 315 (489)
Q Consensus 236 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (489)
|+++.+.....
T Consensus 158 g~~~~~~~~~~--------------------------------------------------------------------- 168 (273)
T cd05035 158 GLSKKIYSGDY--------------------------------------------------------------------- 168 (273)
T ss_pred cceeecccccc---------------------------------------------------------------------
Confidence 99843321000
Q ss_pred cccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCC-CCCCCCC
Q 011302 316 EVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPL-TFPRIGV 393 (489)
Q Consensus 316 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~ 393 (489)
........++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+.+..+..+.. ..|.
T Consensus 169 -------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--- 238 (273)
T cd05035 169 -------YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPE--- 238 (273)
T ss_pred -------ccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc---
Confidence 000111235678999999988889999999999999999999 9999988887777666655421 1111
Q ss_pred CCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHc
Q 011302 394 SSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKR 432 (489)
Q Consensus 394 ~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~ 432 (489)
. ....+.++|.+||+.||++||++. ++++
T Consensus 239 ~------~~~~~~~li~~~l~~~p~~Rp~~~----e~~~ 267 (273)
T cd05035 239 D------CLDELYDLMYSCWRADPKDRPTFT----KLRE 267 (273)
T ss_pred C------CCHHHHHHHHHHcCCChhhCcCHH----HHHH
Confidence 1 122589999999999999999987 5554
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=327.97 Aligned_cols=258 Identities=22% Similarity=0.303 Sum_probs=204.9
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
+..++|++.+.||+|+||.||+|.+.+.....+...||+|++...... .....+.+|+.+++.++||||+++++++.+
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~ 79 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA--DMQADFQREAALMAEFDHPNIVKLLGVCAV 79 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCH--HHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence 345789999999999999999999865333346788999998754321 233557779999999999999999999999
Q ss_pred CceEEEEEeecCCCchHHHHHhCC--------------------CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCC
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQP--------------------GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPE 220 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~--------------------~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~ 220 (489)
+...|+||||+++|+|.+++.... ...+++..+..++.||+.||+|||+++++||||||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ 159 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR 159 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence 999999999999999999887431 124778888999999999999999999999999999
Q ss_pred CeEeccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCcccccccccccccccccccccccccc
Q 011302 221 NVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIRE 300 (489)
Q Consensus 221 NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (489)
|||++.++.++|+|||++..+.....
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~------------------------------------------------------ 185 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADY------------------------------------------------------ 185 (288)
T ss_pred heEecCCCceEECccccceecccCcc------------------------------------------------------
Confidence 99999999999999998743211000
Q ss_pred ccCCCCCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHH
Q 011302 301 QVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLI 379 (489)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~ 379 (489)
........++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+...
T Consensus 186 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~ 243 (288)
T cd05050 186 ----------------------YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIY 243 (288)
T ss_pred ----------------------ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 000111234567999999998889999999999999999997 889998888777777
Q ss_pred HHhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 380 NILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 380 ~i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
.+..+... +... . ....+.+||.+||..||++||++.
T Consensus 244 ~~~~~~~~-~~~~-~------~~~~l~~li~~~l~~~p~~Rpt~~ 280 (288)
T cd05050 244 YVRDGNVL-SCPD-N------CPLELYNLMRLCWSKLPSDRPSFA 280 (288)
T ss_pred HHhcCCCC-CCCC-C------CCHHHHHHHHHHcccCcccCCCHH
Confidence 66654332 1111 1 112589999999999999999997
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=316.99 Aligned_cols=269 Identities=27% Similarity=0.374 Sum_probs=209.9
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee----
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE---- 159 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~---- 159 (489)
+.|.-..+||+|.||+||+|+.++ +++.||+|++--+... ........+|+.+|..|.|+||+.+++.|.
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n-----~~kkvalkkvlmeneK-eGfpitalreikiL~~lkHenv~nliEic~tk~T 90 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKN-----TGKKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKAT 90 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcC-----ccchhHHHHHHHhccc-cCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccC
Confidence 456677889999999999999988 4566888876432211 123344667999999999999999999884
Q ss_pred ----cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEccc
Q 011302 160 ----ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235 (489)
Q Consensus 160 ----~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DF 235 (489)
+...+||||.+| .-+|..++... ..+|+..+++.++.++..||.|+|.+.|+|||+|++|+||+.+|.+||+||
T Consensus 91 p~~r~r~t~ylVf~~c-ehDLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 91 PTNRDRATFYLVFDFC-EHDLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred CcccccceeeeeHHHh-hhhHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecc
Confidence 233589999999 46888887654 367999999999999999999999999999999999999999999999999
Q ss_pred CCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCc
Q 011302 236 DLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDP 315 (489)
Q Consensus 236 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (489)
|+|+.+....+..
T Consensus 169 Glar~fs~~~n~~------------------------------------------------------------------- 181 (376)
T KOG0669|consen 169 GLARAFSTSKNVV------------------------------------------------------------------- 181 (376)
T ss_pred ccccceecccccC-------------------------------------------------------------------
Confidence 9996654322211
Q ss_pred cccccccccCCccccCCCCccCcchhcCCC-CCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhc--CC---CCCC
Q 011302 316 EVVAEPINARSKSFVGTHEYLAPEVISGQG-HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILK--KP---LTFP 389 (489)
Q Consensus 316 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~--~~---~~~p 389 (489)
..+.+..+-|.+|++||.+.|.. |+++.|||..|||+.||++|.+.|.+.++.+++..|.. +. -.||
T Consensus 182 -------kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP 254 (376)
T KOG0669|consen 182 -------KPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWP 254 (376)
T ss_pred -------CCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCC
Confidence 12344557799999999999865 89999999999999999999999999998887776642 11 1122
Q ss_pred CCCC------C---------------CchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 390 RIGV------S---------------SSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 390 ~~~~------~---------------~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
.... . ..+.|-.+.++.||+.+||..||.+|+.+. +++.|.||..
T Consensus 255 ~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad----~alnh~~F~k 320 (376)
T KOG0669|consen 255 NVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDAD----QALNHDFFWK 320 (376)
T ss_pred CcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchH----hhhchhhhhc
Confidence 1100 0 000111223578999999999999999998 9999999965
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=330.29 Aligned_cols=257 Identities=27% Similarity=0.392 Sum_probs=207.5
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
+-|...+.||+|+||+||+|++.. .+..|++|++.............+..|+.+++.++||||+++++++.+...
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 95 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSH-----TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHT 95 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECC-----CCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCE
Confidence 347777889999999999999876 568899999875443333444567779999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
.|+||||+. |+|.+++... ...+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 96 ~~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~- 172 (313)
T cd06633 96 AWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS- 172 (313)
T ss_pred EEEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC-
Confidence 999999995 6787777654 2568999999999999999999999999999999999999999999999999862110
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
T Consensus 173 -------------------------------------------------------------------------------- 172 (313)
T cd06633 173 -------------------------------------------------------------------------------- 172 (313)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCccccCCCCccCcchhc---CCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHH
Q 011302 324 ARSKSFVGTHEYLAPEVIS---GQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFE 400 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~---~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 400 (489)
......|+..|+|||++. +..++.++|||||||++|||++|..||...+.......+..... +......
T Consensus 173 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~----- 244 (313)
T cd06633 173 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PTLQSNE----- 244 (313)
T ss_pred -CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--CCCCccc-----
Confidence 011236889999999984 34578899999999999999999999988776665555544321 1111111
Q ss_pred HHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 401 EVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 401 ~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
....+++||.+||+.+|++||++. +++.||||+..+
T Consensus 245 ~~~~l~~li~~~l~~~P~~Rp~~~----~~l~~~~~~~~~ 280 (313)
T cd06633 245 WTDSFRGFVDYCLQKIPQERPASA----ELLRHDFVRRDR 280 (313)
T ss_pred cCHHHHHHHHHHccCChhhCcCHH----HHhcCcccCCCc
Confidence 112488999999999999999987 999999998744
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=333.33 Aligned_cols=275 Identities=26% Similarity=0.324 Sum_probs=203.9
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec--
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA-- 160 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-- 160 (489)
.++|++.+.||+|+||.||+|+++. +++.||||++....... .....+.+|+.+++.++||||+++++++..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIK-----TGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERP 80 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECC-----CCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheeccc
Confidence 5899999999999999999999876 56789999986543211 112244569999999999999999998743
Q ss_pred ------CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcc
Q 011302 161 ------SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSD 234 (489)
Q Consensus 161 ------~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~D 234 (489)
...+|+||||+. ++|...+... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 81 ~~~~~~~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~d 158 (311)
T cd07866 81 DKSKRKRGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIAD 158 (311)
T ss_pred ccccccCceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECc
Confidence 335799999995 5777766543 35799999999999999999999999999999999999999999999999
Q ss_pred cCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCC
Q 011302 235 FDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDD 314 (489)
Q Consensus 235 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (489)
||+++...........
T Consensus 159 fg~~~~~~~~~~~~~~---------------------------------------------------------------- 174 (311)
T cd07866 159 FGLARPYDGPPPNPKG---------------------------------------------------------------- 174 (311)
T ss_pred CccchhccCCCccccc----------------------------------------------------------------
Confidence 9998433211000000
Q ss_pred ccccccccccCCccccCCCCccCcchhcCC-CCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCC-----C
Q 011302 315 PEVVAEPINARSKSFVGTHEYLAPEVISGQ-GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLT-----F 388 (489)
Q Consensus 315 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-----~ 388 (489)
. ............|++.|+|||.+.+. .++.++|||||||++|||++|.+||.+.+.......+...... +
T Consensus 175 ~---~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (311)
T cd07866 175 G---GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETW 251 (311)
T ss_pred C---CcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 0 00001122345789999999998764 4789999999999999999999999988776655554321000 0
Q ss_pred C------CCC-----CCCch----h-HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 389 P------RIG-----VSSSK----E-FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 389 p------~~~-----~~~~~----~-~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
+ ... ..... . ......+.+||.+||..||++||++. +++.||||
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~----ell~~~~f 311 (311)
T cd07866 252 PGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTAS----DALEHPYF 311 (311)
T ss_pred hhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHH----HHhcCCCC
Confidence 0 000 00000 0 01123578999999999999999987 99999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=338.16 Aligned_cols=262 Identities=28% Similarity=0.384 Sum_probs=207.8
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.++|.+.+.||+|+||.||+|++.. +++.||||++...... ......+.+|+.+++.++||||+++++++...+
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~-----~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTK-----TGRKVAIKKLSRPFQS-AIHAKRTYRELRLLKHMDHENVIGLLDVFTPAS 87 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECC-----CCcEEEEEecccccch-hhHHHHHHHHHHHHHhccCCCHHHHHHHhhccc
Confidence 4689999999999999999999986 5678999998654222 223355667999999999999999999887665
Q ss_pred e------EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccC
Q 011302 163 Y------SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFD 236 (489)
Q Consensus 163 ~------~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG 236 (489)
. +|+|+||+ |++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||
T Consensus 88 ~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 88 SLEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccc
Confidence 4 89999999 7899998865 469999999999999999999999999999999999999999999999999
Q ss_pred CCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcc
Q 011302 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPE 316 (489)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (489)
++.....
T Consensus 164 ~~~~~~~------------------------------------------------------------------------- 170 (343)
T cd07851 164 LARHTDD------------------------------------------------------------------------- 170 (343)
T ss_pred ccccccc-------------------------------------------------------------------------
Confidence 9732210
Q ss_pred ccccccccCCccccCCCCccCcchhcCC-CCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCC------
Q 011302 317 VVAEPINARSKSFVGTHEYLAPEVISGQ-GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFP------ 389 (489)
Q Consensus 317 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p------ 389 (489)
......+|..|+|||.+.+. .++.++|||||||++|||++|+.||.+.+..+.+..+.......+
T Consensus 171 --------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (343)
T cd07851 171 --------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQK 242 (343)
T ss_pred --------cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Confidence 01223578899999998764 578999999999999999999999988877666555543211000
Q ss_pred --------------CCCCCCchh--HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 390 --------------RIGVSSSKE--FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 390 --------------~~~~~~~~~--~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
......... ......+.+||.+||..||++||++. +|++||||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~----ell~h~~~~~~ 304 (343)
T cd07851 243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAA----EALAHPYLAEY 304 (343)
T ss_pred ccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHH----HHhcCCCcccc
Confidence 000000000 01134689999999999999999987 99999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=322.12 Aligned_cols=244 Identities=23% Similarity=0.323 Sum_probs=197.8
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccccccee-
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEF- 158 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~- 158 (489)
.+...+|++.+.||+|+||.||+|...+ ..||+|.+..+. ....+.+|+.+++.++|+||+++++++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~-------~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 69 (256)
T cd05082 2 ALNMKELKLLQTIGKGEFGDVMLGDYRG-------NKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIV 69 (256)
T ss_pred CccHHhCeeeeeecccCCCeEEEEEEcC-------CcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence 3456789999999999999999997653 568999986542 234567799999999999999999975
Q ss_pred ecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 159 EASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
..++..|+||||+++++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 70 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~ 149 (256)
T cd05082 70 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLT 149 (256)
T ss_pred cCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccc
Confidence 45678999999999999999988765556889999999999999999999999999999999999999999999999987
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
.....
T Consensus 150 ~~~~~--------------------------------------------------------------------------- 154 (256)
T cd05082 150 KEASS--------------------------------------------------------------------------- 154 (256)
T ss_pred eeccc---------------------------------------------------------------------------
Confidence 32110
Q ss_pred ccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCch
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSK 397 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 397 (489)
......++..|+|||++.+..++.++|||||||++|||++ |+.||...+..+....+..+.. .. .....
T Consensus 155 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~-~~~~~-- 224 (256)
T cd05082 155 ------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-MD-APDGC-- 224 (256)
T ss_pred ------cCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC-CC-CCCCC--
Confidence 0011234567999999998889999999999999999997 9999988776666655544311 11 11111
Q ss_pred hHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 398 EFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 398 ~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
+..+.+||.+||..+|++||++.
T Consensus 225 ----~~~~~~li~~~l~~~p~~Rpt~~ 247 (256)
T cd05082 225 ----PPVVYDVMKQCWHLDAATRPSFL 247 (256)
T ss_pred ----CHHHHHHHHHHhcCChhhCcCHH
Confidence 23589999999999999999987
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=325.54 Aligned_cols=255 Identities=20% Similarity=0.254 Sum_probs=198.6
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
+..++|++++.||+|+||+||+|++...... ....||+|++...... .....+..|+.+++.++||||+++++++..
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~-~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGEN-VKIPVAIKVLRENTSP--KANKEILDEAYVMAGVGSPYVCRLLGICLT 80 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCc-cceEEEEEEecCCCCH--HHHHHHHHHHHHHHhcCCCCCceEEEEEcC
Confidence 3457899999999999999999997653221 2345899998643222 223456779999999999999999998875
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~ 240 (489)
...+++|||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 81 -~~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 81 -STVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred -CCcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceee
Confidence 45789999999999999887642 5689999999999999999999999999999999999999999999999999854
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
+......
T Consensus 159 ~~~~~~~------------------------------------------------------------------------- 165 (279)
T cd05109 159 LDIDETE------------------------------------------------------------------------- 165 (279)
T ss_pred cccccce-------------------------------------------------------------------------
Confidence 3210000
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhH
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEF 399 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 399 (489)
.......+++.|+|||.+.+..++.++|||||||++|||++ |..||...........+.... ..+.. ...
T Consensus 166 ---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~-~~~---- 236 (279)
T cd05109 166 ---YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE-RLPQP-PIC---- 236 (279)
T ss_pred ---eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-cCCCC-ccC----
Confidence 00011135678999999999889999999999999999998 999998776655544443322 22211 111
Q ss_pred HHHhhHHHHHHHHhhcCcccccCCC
Q 011302 400 EEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 400 ~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
...+.++|.+||..||++||++.
T Consensus 237 --~~~~~~li~~~l~~dp~~Rp~~~ 259 (279)
T cd05109 237 --TIDVYMIMVKCWMIDSECRPRFR 259 (279)
T ss_pred --CHHHHHHHHHHcCCChhhCcCHH
Confidence 12488999999999999999997
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=328.28 Aligned_cols=258 Identities=22% Similarity=0.289 Sum_probs=203.8
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCC-----------CCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCC
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVG-----------LPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPF 150 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn 150 (489)
..++|++++.||+|+||.||+|.+...... .....||+|.+...... .....+.+|+.+++.++|||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD--NAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH--HHHHHHHHHHHHHHhcCCCC
Confidence 346899999999999999999987653211 13467899998765322 33456778999999999999
Q ss_pred cccccceeecCceEEEEEeecCCCchHHHHHhCC---------CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCC
Q 011302 151 LPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQP---------GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPEN 221 (489)
Q Consensus 151 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~---------~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~N 221 (489)
|+++++++..++..++||||+++++|.+++.... ...+++..+..++.|++.||+|||++||+||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999999999999999999999987653 1268999999999999999999999999999999999
Q ss_pred eEeccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccc
Q 011302 222 VLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQ 301 (489)
Q Consensus 222 ILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (489)
||++.++.++|+|||+++......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~-------------------------------------------------------- 184 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSD-------------------------------------------------------- 184 (296)
T ss_pred eeecCCCceEEccccceeecccCc--------------------------------------------------------
Confidence 999999999999999974321100
Q ss_pred cCCCCCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh--CCCCCCCCCcHHHHH
Q 011302 302 VDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY--GTTPFKGENNEKTLI 379 (489)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt--G~~Pf~~~~~~~~~~ 379 (489)
.........+++.|+|||.+.+..++.++|||||||++|||++ |..||...+..+.+.
T Consensus 185 --------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~ 244 (296)
T cd05051 185 --------------------YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIE 244 (296)
T ss_pred --------------------ceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHH
Confidence 0001123356789999999998889999999999999999998 788998877666655
Q ss_pred HHhcC------CCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 380 NILKK------PLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 380 ~i~~~------~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
.+... ....+.. . ..+.++.+||.+||+.||++||++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~-~------~~~~~l~~li~~cl~~~p~~Rpt~~ 288 (296)
T cd05051 245 NAGHFFRDDGRQIYLPRP-P------NCPKDIYELMLECWRRDEEDRPTFR 288 (296)
T ss_pred HHHhccccccccccCCCc-c------CCCHHHHHHHHHHhccChhcCCCHH
Confidence 55432 1111110 0 1113589999999999999999997
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=322.03 Aligned_cols=251 Identities=24% Similarity=0.314 Sum_probs=205.6
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccccccee
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEF 158 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 158 (489)
|++..++|.+.+.||+|+||.||+|.+.+ .+.||||.+...... ...+.+|+.+++.++||||+++++++
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~------~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~ 70 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNG------TTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVC 70 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcC------CceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeee
Confidence 34667899999999999999999998764 356899998754332 23566799999999999999999999
Q ss_pred ecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 159 EASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
......|+||||+++++|.+++....+..+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++
T Consensus 71 ~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~ 150 (261)
T cd05034 71 SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLA 150 (261)
T ss_pred ecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccc
Confidence 99899999999999999999998765567999999999999999999999999999999999999999999999999997
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
+.+....
T Consensus 151 ~~~~~~~------------------------------------------------------------------------- 157 (261)
T cd05034 151 RLIEDDE------------------------------------------------------------------------- 157 (261)
T ss_pred eeccchh-------------------------------------------------------------------------
Confidence 4332100
Q ss_pred ccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCch
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSK 397 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 397 (489)
........++..|+|||.+.+..++.++|||||||++|||++ |+.||.+.+....+.++.... ..+.... .
T Consensus 158 ----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~-~-- 229 (261)
T cd05034 158 ----YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY-RMPRPPN-C-- 229 (261)
T ss_pred ----hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCCC-C--
Confidence 000011124568999999998889999999999999999998 999999888777777765532 1111111 1
Q ss_pred hHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 398 EFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 398 ~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
+..+.+++.+||..+|++||++.
T Consensus 230 ----~~~~~~~i~~~l~~~p~~Rp~~~ 252 (261)
T cd05034 230 ----PEELYDLMLQCWDKDPEERPTFE 252 (261)
T ss_pred ----CHHHHHHHHHHcccCcccCCCHH
Confidence 12589999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=325.49 Aligned_cols=255 Identities=18% Similarity=0.202 Sum_probs=197.6
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
+..++|++++.||+|+||+||+|.+...... ....+++|.+.... ......++..|..+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~ 80 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDS-IKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG 80 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCc-eeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEECC
Confidence 3457899999999999999999998653211 22357888875322 12334566778888999999999999998754
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~ 240 (489)
...++|+||+++|+|.+++.... ..+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||+++.
T Consensus 81 -~~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 81 -ASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred -CccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCcccee
Confidence 56789999999999999987643 5689999999999999999999999999999999999999999999999999843
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
+.....
T Consensus 159 ~~~~~~-------------------------------------------------------------------------- 164 (279)
T cd05111 159 LYPDDK-------------------------------------------------------------------------- 164 (279)
T ss_pred ccCCCc--------------------------------------------------------------------------
Confidence 211000
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhH
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEF 399 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 399 (489)
........|+..|+|||.+.+..++.++|||||||++|||++ |..||.+.........+..+.. .+.. ....
T Consensus 165 --~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~~~-~~~~--- 237 (279)
T cd05111 165 --KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGER-LAQP-QICT--- 237 (279)
T ss_pred --ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCc-CCCC-CCCC---
Confidence 000122357778999999998889999999999999999998 9999988776554444433321 1111 1111
Q ss_pred HHHhhHHHHHHHHhhcCcccccCCC
Q 011302 400 EEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 400 ~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
..+.+++.+||..||++||++.
T Consensus 238 ---~~~~~li~~c~~~~p~~Rps~~ 259 (279)
T cd05111 238 ---IDVYMVMVKCWMIDENVRPTFK 259 (279)
T ss_pred ---HHHHHHHHHHcCCCcccCcCHH
Confidence 2478999999999999999997
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=327.92 Aligned_cols=254 Identities=22% Similarity=0.284 Sum_probs=199.9
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceE
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYS 164 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 164 (489)
+|++.+.||+|+||.||+|.............+|+|.+...... ....++..|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS--SELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCH--HHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 47889999999999999999765332223467899988654322 2345677899999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhCC----------------------CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCe
Q 011302 165 CLVMEYCPGGDLYAARQRQP----------------------GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENV 222 (489)
Q Consensus 165 ~lV~E~~~gg~L~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NI 222 (489)
|+||||+.+|+|.+++.... ...+++..+..++.|++.||+|||+++|+||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 99999999999999876421 13578888999999999999999999999999999999
Q ss_pred EeccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCcccccccccccccccccccccccccccc
Q 011302 223 LVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQV 302 (489)
Q Consensus 223 Ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (489)
|++.++.+||+|||+++.......
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~-------------------------------------------------------- 182 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDS-------------------------------------------------------- 182 (290)
T ss_pred EEcCCCcEEeccccccccccCccc--------------------------------------------------------
Confidence 999999999999999843211000
Q ss_pred CCCCCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHH
Q 011302 303 DGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINI 381 (489)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i 381 (489)
........++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+
T Consensus 183 --------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~ 242 (290)
T cd05045 183 --------------------YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLL 242 (290)
T ss_pred --------------------hhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 000112245678999999998889999999999999999998 99999888776655544
Q ss_pred hcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 382 LKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 382 ~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
... ...+... .. ...+.+||.+||+.+|++||++.
T Consensus 243 ~~~-~~~~~~~-~~------~~~~~~~i~~cl~~~P~~Rp~~~ 277 (290)
T cd05045 243 KTG-YRMERPE-NC------SEEMYNLMLTCWKQEPDKRPTFA 277 (290)
T ss_pred hCC-CCCCCCC-CC------CHHHHHHHHHHccCCcccCCCHH
Confidence 432 2222111 11 12588999999999999999987
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=320.68 Aligned_cols=242 Identities=23% Similarity=0.313 Sum_probs=192.3
Q ss_pred eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEEEEEe
Q 011302 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVME 169 (489)
Q Consensus 90 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 169 (489)
+.||+|+||.||+|.++. +++.||+|.+..... ......+.+|+.+++.++||||+++++++......|+|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~-----~~~~~a~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 73 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRA-----DNTPVAVKSCRETLP--PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 73 (252)
T ss_pred CccCcccCccEEEEEEec-----CCceEEEEecCccCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEe
Confidence 368999999999999876 467899998764321 1233567779999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCccccC
Q 011302 170 YCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLR 249 (489)
Q Consensus 170 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 249 (489)
|+++++|.+++... +..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 74 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~--~- 149 (252)
T cd05084 74 LVQGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGV--Y- 149 (252)
T ss_pred eccCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCccccccc--c-
Confidence 99999999988654 2468999999999999999999999999999999999999999999999999973211000 0
Q ss_pred CcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCccc
Q 011302 250 PKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSF 329 (489)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (489)
.......
T Consensus 150 -------------------------------------------------------------------------~~~~~~~ 156 (252)
T cd05084 150 -------------------------------------------------------------------------ASTGGMK 156 (252)
T ss_pred -------------------------------------------------------------------------cccCCCC
Confidence 0000011
Q ss_pred cCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCC-CCCCCCCCCCchhHHHHhhHHH
Q 011302 330 VGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKP-LTFPRIGVSSSKEFEEVVKLQD 407 (489)
Q Consensus 330 ~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~~~~~~~l~~ 407 (489)
.++..|+|||.+.+..++.++|||||||++|||++ |..||...........+.... ...+. .. +..+.+
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---~~------~~~~~~ 227 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPE---LC------PDAVYR 227 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcc---cC------CHHHHH
Confidence 23457999999998889999999999999999997 999998777665555554321 11111 11 125899
Q ss_pred HHHHHhhcCcccccCCC
Q 011302 408 LISKLLVKNPKKRIGSL 424 (489)
Q Consensus 408 li~~~L~~dP~~R~~~~ 424 (489)
|+.+||+.+|++||++.
T Consensus 228 li~~~l~~~p~~Rps~~ 244 (252)
T cd05084 228 LMERCWEYDPGQRPSFS 244 (252)
T ss_pred HHHHHcCCChhhCcCHH
Confidence 99999999999999997
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=337.30 Aligned_cols=267 Identities=28% Similarity=0.399 Sum_probs=205.3
Q ss_pred cCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccce
Q 011302 78 QGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAE 157 (489)
Q Consensus 78 ~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~ 157 (489)
.|++. ++|.+.+.||+|+||.||+|++.. ++..||||++.+.... ......+.+|+.+++.++||||++++++
T Consensus 10 ~~~~~-~~y~~~~~ig~g~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~ 82 (342)
T cd07879 10 VWELP-ERYTSLKQVGSGAYGSVCSAIDKR-----TGEKVAIKKLSRPFQS-EIFAKRAYRELTLLKHMQHENVIGLLDV 82 (342)
T ss_pred hhccc-cceEEEEEeeecCCeEEEEEEeCC-----CCcEEEEEEecCcccc-ccchhHHHHHHHHHHhcCCCCccchhhe
Confidence 34443 689999999999999999999876 5678999998753211 1223456779999999999999999999
Q ss_pred eecC------ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEE
Q 011302 158 FEAS------HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIM 231 (489)
Q Consensus 158 ~~~~------~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vk 231 (489)
+... ..+|+||||+. .+|..++. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~k 157 (342)
T cd07879 83 FTSAVSGDEFQDFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELK 157 (342)
T ss_pred ecccccCCCCceEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEE
Confidence 8754 35699999994 57766542 3589999999999999999999999999999999999999999999
Q ss_pred EcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccc
Q 011302 232 LSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQEL 311 (489)
Q Consensus 232 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (489)
|+|||+++....
T Consensus 158 L~dfg~~~~~~~-------------------------------------------------------------------- 169 (342)
T cd07879 158 ILDFGLARHADA-------------------------------------------------------------------- 169 (342)
T ss_pred EeeCCCCcCCCC--------------------------------------------------------------------
Confidence 999999732110
Q ss_pred cCCccccccccccCCccccCCCCccCcchhcC-CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCC-C--
Q 011302 312 LDDPEVVAEPINARSKSFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL-T-- 387 (489)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~-- 387 (489)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..+..... .
T Consensus 170 -------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (342)
T cd07879 170 -------------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGP 236 (342)
T ss_pred -------------CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 0112357889999999876 4578999999999999999999999998776555544433100 0
Q ss_pred -----------------CCCCCCCCc-hhH-HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCc
Q 011302 388 -----------------FPRIGVSSS-KEF-EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINW 441 (489)
Q Consensus 388 -----------------~p~~~~~~~-~~~-~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~ 441 (489)
.+....... ..+ .....+.+||.+||+.||++||++. +++.||||+.+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~----e~l~h~~f~~~~~ 305 (342)
T cd07879 237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTAT----EALEHPYFDSFRD 305 (342)
T ss_pred HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHH----HHhcCcchhhccc
Confidence 000000000 000 1123588999999999999999987 9999999998765
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=331.34 Aligned_cols=255 Identities=26% Similarity=0.353 Sum_probs=207.9
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
..|...+.||+|+||.||+|++.. .+..||+|.+.............+..|+.+++.++||||+++++++.++..
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVR-----TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHT 99 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcC-----CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCe
Confidence 458889999999999999999876 467899999875433333445567789999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
.|+||||+. |+|.+++... ...+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 100 ~~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~- 176 (317)
T cd06635 100 AWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS- 176 (317)
T ss_pred EEEEEeCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccC-
Confidence 999999996 5787776543 3568999999999999999999999999999999999999999999999999863211
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
T Consensus 177 -------------------------------------------------------------------------------- 176 (317)
T cd06635 177 -------------------------------------------------------------------------------- 176 (317)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCccccCCCCccCcchhc---CCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHH
Q 011302 324 ARSKSFVGTHEYLAPEVIS---GQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFE 400 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~---~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 400 (489)
......|++.|+|||.+. ...++.++|||||||++|||++|..||...+.......+............
T Consensus 177 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~------- 248 (317)
T cd06635 177 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNE------- 248 (317)
T ss_pred -CcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCcc-------
Confidence 011235888999999984 345788999999999999999999999887766666666554322111111
Q ss_pred HHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 401 EVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 401 ~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
....+++||.+||..+|.+||++. ++++|+|+..
T Consensus 249 ~~~~l~~li~~~l~~~p~~Rpt~~----~il~~~~~~~ 282 (317)
T cd06635 249 WSDYFRNFVDSCLQKIPQDRPTSE----ELLKHMFVLR 282 (317)
T ss_pred ccHHHHHHHHHHccCCcccCcCHH----HHHhChhhhc
Confidence 112489999999999999999987 9999999955
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=322.69 Aligned_cols=254 Identities=23% Similarity=0.282 Sum_probs=202.6
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.++|++.+.||+|+||.||+|+++.... ....+|+|.++..... .....+..|+.+++.++||||+++++++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~--~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGK--REIPVAIKTLKAGYTE--KQRRDFLSEASIMGQFDHPNIIHLEGVVTKSK 78 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCC--CceEEEEEECCCCCCH--HHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 4689999999999999999999864311 3457899998653221 23456777999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
..|+||||++|++|.+++.... ..+++.++..++.|++.||+|||++|++||||||+|||++.++.++|+|||++..+.
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred ccEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 9999999999999999987653 568999999999999999999999999999999999999999999999999974322
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
.....
T Consensus 158 ~~~~~--------------------------------------------------------------------------- 162 (267)
T cd05066 158 DDPEA--------------------------------------------------------------------------- 162 (267)
T ss_pred cccce---------------------------------------------------------------------------
Confidence 10000
Q ss_pred ccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHH
Q 011302 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEE 401 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 401 (489)
........++..|+|||.+.+..++.++|+|||||++||+++ |..||.+.+..+....+... ...|.... .
T Consensus 163 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~-------~ 234 (267)
T cd05066 163 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-YRLPAPMD-------C 234 (267)
T ss_pred eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC-CcCCCCCC-------C
Confidence 000011234568999999998889999999999999999886 99999888776666666544 22232211 1
Q ss_pred HhhHHHHHHHHhhcCcccccCCC
Q 011302 402 VVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 402 ~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
+..+.+|+.+||+.+|++||++.
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~ 257 (267)
T cd05066 235 PAALHQLMLDCWQKDRNERPKFE 257 (267)
T ss_pred CHHHHHHHHHHcccCchhCCCHH
Confidence 12488999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=328.75 Aligned_cols=249 Identities=21% Similarity=0.285 Sum_probs=197.6
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccceeecCc
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAEFEASH 162 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~ 162 (489)
++|++.+.||+|+||.||+|..+... ....+++|.++.... ......+..|+.++.++ +||||+++++++....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~---~~~~~~ik~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDG---LKMNAAIKMLKEFAS--ENDHRDFAGELEVLCKLGHHPNIINLLGACENRG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCC---CcceeEEEEccccCC--HHHHHHHHHHHHHHHhhcCCCchhheEEEEccCC
Confidence 68999999999999999999987632 123468887763211 12345577799999998 7999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCC--------------CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCC
Q 011302 163 YSCLVMEYCPGGDLYAARQRQP--------------GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDG 228 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~ 228 (489)
..|+||||+++|+|.+++.... ...+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~ 156 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL 156 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC
Confidence 9999999999999999986532 13588899999999999999999999999999999999999999
Q ss_pred cEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCC
Q 011302 229 HIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHD 308 (489)
Q Consensus 229 ~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (489)
.+||+|||++......
T Consensus 157 ~~kl~dfg~~~~~~~~---------------------------------------------------------------- 172 (297)
T cd05089 157 ASKIADFGLSRGEEVY---------------------------------------------------------------- 172 (297)
T ss_pred eEEECCcCCCccccce----------------------------------------------------------------
Confidence 9999999987321000
Q ss_pred ccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCC
Q 011302 309 QELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLT 387 (489)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~ 387 (489)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+..+..
T Consensus 173 ---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~- 236 (297)
T cd05089 173 ---------------VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR- 236 (297)
T ss_pred ---------------eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC-
Confidence 00001123457999999999889999999999999999997 9999999888777777655421
Q ss_pred CCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 388 FPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 388 ~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
.+.. ... ...+.+||.+||..+|.+||++.
T Consensus 237 ~~~~-~~~------~~~~~~li~~~l~~~p~~Rp~~~ 266 (297)
T cd05089 237 MEKP-RNC------DDEVYELMRQCWRDRPYERPPFA 266 (297)
T ss_pred CCCC-CCC------CHHHHHHHHHHcCCChhhCcCHH
Confidence 1111 111 12488999999999999999997
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=328.78 Aligned_cols=251 Identities=27% Similarity=0.442 Sum_probs=204.0
Q ss_pred eeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEEEEE
Q 011302 89 LRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVM 168 (489)
Q Consensus 89 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 168 (489)
...||+|+||.||+|..+. +++.||||.+..... .....+.+|+.+++.++|+||+++++++..++..|+||
T Consensus 25 ~~~lg~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKS-----SGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 96 (292)
T ss_pred HHHcCCCCCeEEEEEEEcC-----CCeEEEEEEecccch---hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEE
Confidence 4579999999999999876 578999998854321 23345777999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCcccc
Q 011302 169 EYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLL 248 (489)
Q Consensus 169 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 248 (489)
||+++++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++......
T Consensus 97 e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~---- 169 (292)
T cd06657 97 EFLEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE---- 169 (292)
T ss_pred ecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccc----
Confidence 99999999987754 45899999999999999999999999999999999999999999999999986321100
Q ss_pred CCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCcc
Q 011302 249 RPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKS 328 (489)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (489)
......
T Consensus 170 --------------------------------------------------------------------------~~~~~~ 175 (292)
T cd06657 170 --------------------------------------------------------------------------VPRRKS 175 (292)
T ss_pred --------------------------------------------------------------------------cccccc
Confidence 000122
Q ss_pred ccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCC-CCCCCCCCCchhHHHHhhHHH
Q 011302 329 FVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL-TFPRIGVSSSKEFEEVVKLQD 407 (489)
Q Consensus 329 ~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~~~~~~~l~~ 407 (489)
..|++.|+|||.+.+..++.++|+|||||++|+|++|..||.+....+....+..... .++.... ....+.+
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~l~~ 248 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHK-------VSPSLKG 248 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCccc-------CCHHHHH
Confidence 4688999999999888889999999999999999999999988776655554433211 1111111 1224889
Q ss_pred HHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 408 LISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 408 li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
+|.+||..||.+||++. +++.||||...
T Consensus 249 li~~~l~~~P~~R~~~~----~ll~~~~~~~~ 276 (292)
T cd06657 249 FLDRLLVRDPAQRATAA----ELLKHPFLAKA 276 (292)
T ss_pred HHHHHHhCCcccCcCHH----HHhcChHHhcc
Confidence 99999999999999997 99999999763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=336.80 Aligned_cols=268 Identities=24% Similarity=0.312 Sum_probs=211.4
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc--
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH-- 162 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-- 162 (489)
+|++.+.||.|+||.||+|++.. .+..||||.+..... .......+.+|+.+++.++||||+++++++....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKR-----TGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPE 74 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCC-----CCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcc
Confidence 58899999999999999999876 478899999875432 1233456777999999999999999999998775
Q ss_pred ---eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 163 ---YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 163 ---~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
.+|+||||++ ++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.
T Consensus 75 ~~~~~~lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~ 151 (330)
T cd07834 75 DFNDVYIVTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLAR 151 (330)
T ss_pred cccceEEEecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceE
Confidence 8899999996 6898888764 479999999999999999999999999999999999999999999999999984
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
........
T Consensus 152 ~~~~~~~~------------------------------------------------------------------------ 159 (330)
T cd07834 152 GVDPDEDE------------------------------------------------------------------------ 159 (330)
T ss_pred eecccccc------------------------------------------------------------------------
Confidence 33210000
Q ss_pred cccccCCccccCCCCccCcchhcCC-CCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCC-----CC
Q 011302 320 EPINARSKSFVGTHEYLAPEVISGQ-GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRI-----GV 393 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~-----~~ 393 (489)
........||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+.......+.. ..
T Consensus 160 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (330)
T cd07834 160 ---KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS 236 (330)
T ss_pred ---cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence 0011234688999999999888 78999999999999999999999999988776666554421111100 00
Q ss_pred CCch------------hH-----HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 394 SSSK------------EF-----EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 394 ~~~~------------~~-----~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
.... .+ .....+.+||.+||+++|++||++. +++.||||+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~----~ll~~~~~~~~~ 296 (330)
T cd07834 237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITAD----EALAHPYLAQLH 296 (330)
T ss_pred cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHH----HHHhCccHHhhc
Confidence 0000 00 1234588999999999999999987 999999998753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=334.19 Aligned_cols=266 Identities=19% Similarity=0.264 Sum_probs=207.3
Q ss_pred cCccccCCceeeeeeccCCceeEEEEEEccCCCC--CCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccc
Q 011302 78 QGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVG--LPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTL 154 (489)
Q Consensus 78 ~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l 154 (489)
.+++...+|++.+.||+|+||.||+|++.+..+. .....||+|++..... ......+..|+.+++++ +||||+++
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDAT--DKDLSDLVSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccC--HHHHHHHHHHHHHHHhhcCCCCeeee
Confidence 3556667899999999999999999987542221 2335789998875321 13345677899999999 79999999
Q ss_pred cceeecCceEEEEEeecCCCchHHHHHhCC--------------CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCC
Q 011302 155 YAEFEASHYSCLVMEYCPGGDLYAARQRQP--------------GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPE 220 (489)
Q Consensus 155 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~ 220 (489)
++++...+.+|+||||+++|+|.+++.... ...+++..+..++.||+.||+|||++||+||||||+
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 163 (334)
T cd05100 84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR 163 (334)
T ss_pred eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence 999999999999999999999999987532 234778888999999999999999999999999999
Q ss_pred CeEeccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCcccccccccccccccccccccccccc
Q 011302 221 NVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIRE 300 (489)
Q Consensus 221 NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (489)
|||++.++.+||+|||+++.......
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~------------------------------------------------------ 189 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDY------------------------------------------------------ 189 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccc------------------------------------------------------
Confidence 99999999999999999843211000
Q ss_pred ccCCCCCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHH
Q 011302 301 QVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLI 379 (489)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~ 379 (489)
........++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+.+.
T Consensus 190 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 247 (334)
T cd05100 190 ----------------------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 247 (334)
T ss_pred ----------------------cccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 000111234567999999999999999999999999999998 899999888777666
Q ss_pred HHhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 380 NILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 380 ~i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
.+..... .+.. ... ..++.+||.+||+.+|++||++. +++.+
T Consensus 248 ~~~~~~~-~~~~-~~~------~~~l~~li~~cl~~~p~~Rps~~----ell~~ 289 (334)
T cd05100 248 LLKEGHR-MDKP-ANC------THELYMIMRECWHAVPSQRPTFK----QLVED 289 (334)
T ss_pred HHHcCCC-CCCC-CCC------CHHHHHHHHHHcccChhhCcCHH----HHHHH
Confidence 6654321 1111 111 12488999999999999999987 55554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=320.58 Aligned_cols=244 Identities=22% Similarity=0.260 Sum_probs=193.6
Q ss_pred eeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEEEEEee
Q 011302 91 RLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEY 170 (489)
Q Consensus 91 ~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 170 (489)
.||+|+||.||+|.++.. .++..||+|+++..... ......+..|+.+++.++||||+++++++. .+..++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~---~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~ 76 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMK---KSEKTVAVKILKNDNND-PALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMEL 76 (257)
T ss_pred cCCCcCCcceEEeEEecC---CCceEEEEEEccCCCCc-HHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEec
Confidence 589999999999987542 14678999998654322 234456778999999999999999999876 4567999999
Q ss_pred cCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCccccCC
Q 011302 171 CPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRP 250 (489)
Q Consensus 171 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 250 (489)
+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||.|||++.++.+||+|||++..+......
T Consensus 77 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~--- 151 (257)
T cd05116 77 AELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY--- 151 (257)
T ss_pred CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCe---
Confidence 9999999998764 56899999999999999999999999999999999999999999999999998432110000
Q ss_pred cchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCcccc
Q 011302 251 KLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFV 330 (489)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (489)
........
T Consensus 152 ------------------------------------------------------------------------~~~~~~~~ 159 (257)
T cd05116 152 ------------------------------------------------------------------------YKAKTHGK 159 (257)
T ss_pred ------------------------------------------------------------------------eeecCCCC
Confidence 00001123
Q ss_pred CCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHHH
Q 011302 331 GTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLI 409 (489)
Q Consensus 331 Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li 409 (489)
+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+....+..+.. .+ ..... +.++.+||
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~-~~-~~~~~------~~~l~~li 231 (257)
T cd05116 160 WPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER-ME-CPQRC------PPEMYDLM 231 (257)
T ss_pred CCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC-CC-CCCCC------CHHHHHHH
Confidence 5678999999988889999999999999999998 9999998877777666655432 11 11111 12589999
Q ss_pred HHHhhcCcccccCCC
Q 011302 410 SKLLVKNPKKRIGSL 424 (489)
Q Consensus 410 ~~~L~~dP~~R~~~~ 424 (489)
.+||+.||++||++.
T Consensus 232 ~~~~~~~p~~Rp~~~ 246 (257)
T cd05116 232 KLCWTYGVDERPGFA 246 (257)
T ss_pred HHHhccCchhCcCHH
Confidence 999999999999996
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=318.89 Aligned_cols=243 Identities=23% Similarity=0.297 Sum_probs=201.9
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
+..++|++.+.||+|+||.||+|... ++.||+|.+..... ...++..|+.+++.++|+||+++++++.+
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~-------~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 71 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYR-------GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEec-------CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcC
Confidence 45678999999999999999999865 36789999976643 34567779999999999999999999999
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~ 240 (489)
....|+||||+++++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.
T Consensus 72 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~ 151 (256)
T cd05039 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKE 151 (256)
T ss_pred CCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccc
Confidence 99999999999999999999876545799999999999999999999999999999999999999999999999999743
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
....
T Consensus 152 ~~~~---------------------------------------------------------------------------- 155 (256)
T cd05039 152 ASQG---------------------------------------------------------------------------- 155 (256)
T ss_pred cccc----------------------------------------------------------------------------
Confidence 2100
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCC-CCCCCCCCCchh
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPL-TFPRIGVSSSKE 398 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~ 398 (489)
.....++..|+|||.+.+..++.++|||||||++|||++ |..||...+..+....+..+.. ..+. .
T Consensus 156 -----~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~---- 223 (256)
T cd05039 156 -----QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPE---G---- 223 (256)
T ss_pred -----cccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCcc---C----
Confidence 001124567999999988889999999999999999997 9999988876666555544321 1111 1
Q ss_pred HHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 399 FEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 399 ~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
.+..+.+||.+||..+|++||++.
T Consensus 224 --~~~~~~~li~~~l~~~p~~Rp~~~ 247 (256)
T cd05039 224 --CPPEVYKVMKDCWELDPAKRPTFK 247 (256)
T ss_pred --CCHHHHHHHHHHhccChhhCcCHH
Confidence 123589999999999999999997
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=321.65 Aligned_cols=249 Identities=22% Similarity=0.283 Sum_probs=199.8
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE 159 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 159 (489)
++..++|.+.+.||+|+||.||+|.+.. ...+|+|.+..... ....+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~------~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 71 (260)
T cd05069 2 EIPRESLRLDVKLGQGCFGEVWMGTWNG------TTKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS 71 (260)
T ss_pred cCChHHeeeeeeecCcCCCeEEEEEEcC------CceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 3455789999999999999999998765 23589998865432 1234667999999999999999999875
Q ss_pred cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 160 ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 160 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
. +..|+||||+++|+|.+++.......+++..+..++.|++.||+|||+.||+||||||+|||++.++.++|+|||+++
T Consensus 72 ~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~ 150 (260)
T cd05069 72 E-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLAR 150 (260)
T ss_pred C-CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccce
Confidence 4 568999999999999999987655568899999999999999999999999999999999999999999999999984
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
......
T Consensus 151 ~~~~~~-------------------------------------------------------------------------- 156 (260)
T cd05069 151 LIEDNE-------------------------------------------------------------------------- 156 (260)
T ss_pred EccCCc--------------------------------------------------------------------------
Confidence 321100
Q ss_pred cccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchh
Q 011302 320 EPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKE 398 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 398 (489)
........++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+.... ..+...
T Consensus 157 ---~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~------ 226 (260)
T cd05069 157 ---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY-RMPCPQ------ 226 (260)
T ss_pred ---ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCc------
Confidence 000011235678999999998889999999999999999999 999999888777766665532 111111
Q ss_pred HHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 399 FEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 399 ~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
..+..+.+||.+||+.||++||++.
T Consensus 227 -~~~~~~~~li~~~l~~~p~~Rp~~~ 251 (260)
T cd05069 227 -GCPESLHELMKLCWKKDPDERPTFE 251 (260)
T ss_pred -ccCHHHHHHHHHHccCCcccCcCHH
Confidence 1123589999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=317.37 Aligned_cols=254 Identities=28% Similarity=0.456 Sum_probs=210.9
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceE
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYS 164 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 164 (489)
+|++.+.||+|+||.||+|.+.. .++.|++|.+...... ......+.+|+.++++++||||+++++++.+.+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLE-----TGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSL 74 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcC-----CCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Confidence 58899999999999999999876 4678999999766542 23446778899999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccC
Q 011302 165 CLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVV 244 (489)
Q Consensus 165 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~ 244 (489)
|+||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 75 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 75 YIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred EEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 9999999999999998775 57999999999999999999999999999999999999999999999999998432210
Q ss_pred ccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccccc
Q 011302 245 PKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINA 324 (489)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (489)
. .
T Consensus 153 ~------------------------------------------------------------------------------~ 154 (254)
T cd06627 153 S------------------------------------------------------------------------------K 154 (254)
T ss_pred c------------------------------------------------------------------------------c
Confidence 0 0
Q ss_pred CCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhh
Q 011302 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVK 404 (489)
Q Consensus 325 ~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~ 404 (489)
......|+..|+|||.+.+..++.++||||||+++|+|++|..||...+......++..... +...... ...
T Consensus 155 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~------~~~ 226 (254)
T cd06627 155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDH--PPLPEGI------SPE 226 (254)
T ss_pred cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCC--CCCCCCC------CHH
Confidence 01233588899999999888889999999999999999999999987766555555443221 1111111 124
Q ss_pred HHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 405 LQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 405 l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
+.++|.+||..+|++||++. +++.||||
T Consensus 227 ~~~~i~~~l~~~p~~R~~~~----~~l~~~~~ 254 (254)
T cd06627 227 LKDFLMQCFQKDPNLRPTAK----QLLKHPWI 254 (254)
T ss_pred HHHHHHHHHhCChhhCcCHH----HHhcCCCC
Confidence 89999999999999999987 99999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=320.55 Aligned_cols=251 Identities=27% Similarity=0.358 Sum_probs=201.5
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
++|++.+.||+|+||.||+|.+.. +++.||+|.++...........++.+|+.+++.++|+||+++++++...+.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLL-----DGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcC-----CCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe
Confidence 689999999999999999999885 567899999875433333445667789999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhC--CCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQ--PGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKC 241 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~ 241 (489)
.++||||+++|+|..++... ....+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++..
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~ 156 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeec
Confidence 99999999999999888642 2356899999999999999999999999999999999999999999999999987432
Q ss_pred ccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccc
Q 011302 242 DVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEP 321 (489)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (489)
...
T Consensus 157 ~~~----------------------------------------------------------------------------- 159 (267)
T cd08224 157 SSK----------------------------------------------------------------------------- 159 (267)
T ss_pred cCC-----------------------------------------------------------------------------
Confidence 100
Q ss_pred cccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCc--HHHHHHHhcCCCCCCCCCCCCchhH
Q 011302 322 INARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENN--EKTLINILKKPLTFPRIGVSSSKEF 399 (489)
Q Consensus 322 ~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~--~~~~~~i~~~~~~~p~~~~~~~~~~ 399 (489)
........|++.|+|||.+.+..++.++|||||||++|+|++|..||..... .+....+..+.. +.....
T Consensus 160 -~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~----- 231 (267)
T cd08224 160 -TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDY--PPLPAD----- 231 (267)
T ss_pred -CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCC--CCCChh-----
Confidence 0001223588899999999998899999999999999999999999965532 233333333221 111110
Q ss_pred HHHhhHHHHHHHHhhcCcccccCCC
Q 011302 400 EEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 400 ~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
.....+.++|.+||..+|++||++.
T Consensus 232 ~~~~~~~~~i~~cl~~~p~~Rp~~~ 256 (267)
T cd08224 232 HYSEELRDLVSRCINPDPEKRPDIS 256 (267)
T ss_pred hcCHHHHHHHHHHcCCCcccCCCHH
Confidence 1123588999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=336.37 Aligned_cols=266 Identities=23% Similarity=0.309 Sum_probs=202.0
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC--
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS-- 161 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-- 161 (489)
.+|.+.+.||.|+||.||+|.++. +++.||+|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~-----~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~ 76 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSD-----CDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGS 76 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECC-----CCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhccccc
Confidence 689999999999999999999886 578899999865432 2334566799999999999999999877644
Q ss_pred ------------ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEec-cCC
Q 011302 162 ------------HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVR-EDG 228 (489)
Q Consensus 162 ------------~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~-~~~ 228 (489)
...|+||||++ ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++ .++
T Consensus 77 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~ 152 (342)
T cd07854 77 DLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDL 152 (342)
T ss_pred ccccccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCc
Confidence 35899999995 689887754 4689999999999999999999999999999999999998 456
Q ss_pred cEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCC
Q 011302 229 HIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHD 308 (489)
Q Consensus 229 ~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (489)
.+||+|||+++.+...-.
T Consensus 153 ~~kl~dfg~~~~~~~~~~-------------------------------------------------------------- 170 (342)
T cd07854 153 VLKIGDFGLARIVDPHYS-------------------------------------------------------------- 170 (342)
T ss_pred eEEECCcccceecCCccc--------------------------------------------------------------
Confidence 789999999743211000
Q ss_pred ccccCCccccccccccCCccccCCCCccCcchhcC-CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCC
Q 011302 309 QELLDDPEVVAEPINARSKSFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLT 387 (489)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~ 387 (489)
.........|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.+.+..+....+......
T Consensus 171 -------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 171 -------------HKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred -------------cccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 0000011257889999998765 45788999999999999999999999887765555444332100
Q ss_pred -CC-----------------CCCC-CCchhH--HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 388 -FP-----------------RIGV-SSSKEF--EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 388 -~p-----------------~~~~-~~~~~~--~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
.+ .... .....+ ....++.+||.+||..||++||++. +++.||||+.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~----ell~h~~~~~~~ 307 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAE----EALMHPYMSCYS 307 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHH----HHhCCCcccccc
Confidence 00 0000 000000 1123588999999999999999987 999999998653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=325.98 Aligned_cols=262 Identities=24% Similarity=0.343 Sum_probs=203.6
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccce
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAE 157 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~ 157 (489)
+.+..++|.+.+.||+|+||+||+|.+.. +++.||||.+.+.... .....+..|..++..+ +||||++++++
T Consensus 10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~ 82 (296)
T cd06618 10 YPADLNDLENLGEIGSGTCGQVYKMRFKK-----TGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGY 82 (296)
T ss_pred ccCCcchheeeeEeeccCCeEEEEEEECC-----CCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhhee
Confidence 34567899999999999999999999886 4688999999754322 2233444566656555 59999999999
Q ss_pred eecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHh-CCCeeecCCCCCeEeccCCcEEEcccC
Q 011302 158 FEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHM-MGIVYRDLKPENVLVREDGHIMLSDFD 236 (489)
Q Consensus 158 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiHrDIKp~NILl~~~~~vkl~DFG 236 (489)
+.+....|+||||+ +++|..++.... ..+++..+..++.|++.||+|||+ .||+||||+|+||+++.++.+||+|||
T Consensus 83 ~~~~~~~~~v~e~~-~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg 160 (296)
T cd06618 83 FITDSDVFICMELM-STCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFG 160 (296)
T ss_pred eecCCeEEEEeecc-CcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccc
Confidence 99999999999999 567777766533 478999999999999999999997 599999999999999999999999999
Q ss_pred CCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcc
Q 011302 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPE 316 (489)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (489)
++..+...
T Consensus 161 ~~~~~~~~------------------------------------------------------------------------ 168 (296)
T cd06618 161 ISGRLVDS------------------------------------------------------------------------ 168 (296)
T ss_pred cchhccCC------------------------------------------------------------------------
Confidence 87322100
Q ss_pred ccccccccCCccccCCCCccCcchhcCCC----CCCcccHHHHHHHHHHHhhCCCCCCCCCc-HHHHHHHhcCCC-CCCC
Q 011302 317 VVAEPINARSKSFVGTHEYLAPEVISGQG----HGSAVDWWTLGVFLYEMLYGTTPFKGENN-EKTLINILKKPL-TFPR 390 (489)
Q Consensus 317 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~----~~~~~DiwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~-~~p~ 390 (489)
.......|++.|+|||.+.+.. ++.++|||||||++|||++|+.||..... .+.+..+..... ..+.
T Consensus 169 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T cd06618 169 -------KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPP 241 (296)
T ss_pred -------CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCC
Confidence 0001124788999999997654 78899999999999999999999976433 344444444321 2221
Q ss_pred CCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 391 IGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 391 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
.. .....+.+||.+||..||.+||++. ++++||||+..
T Consensus 242 ~~-------~~~~~l~~li~~~l~~~p~~Rp~~~----~il~~~~~~~~ 279 (296)
T cd06618 242 NE-------GFSPDFCSFVDLCLTKDHRKRPKYR----ELLQHPFIRRY 279 (296)
T ss_pred CC-------CCCHHHHHHHHHHccCChhhCCCHH----HHhcChhhhcc
Confidence 11 0122589999999999999999997 99999999753
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=319.01 Aligned_cols=250 Identities=18% Similarity=0.297 Sum_probs=202.2
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccccccee
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEF 158 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 158 (489)
|++..++|++.+.||+|+||.||+|.+.. ...+|+|.+..... ....+.+|+.+++.++|+||+++++++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~------~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~ 70 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNK------HTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVV 70 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecC------CccEEEEecCCChh----HHHHHHHHHHHHHhcCCCCcceEEEEE
Confidence 34667899999999999999999998654 34589998875432 234567799999999999999999998
Q ss_pred ecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 159 EASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
.. ...|+||||+++|+|.+++....+..+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++
T Consensus 71 ~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~ 149 (260)
T cd05073 71 TK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLA 149 (260)
T ss_pred cC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcce
Confidence 87 78899999999999999998765667888999999999999999999999999999999999999999999999987
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
..+....
T Consensus 150 ~~~~~~~------------------------------------------------------------------------- 156 (260)
T cd05073 150 RVIEDNE------------------------------------------------------------------------- 156 (260)
T ss_pred eeccCCC-------------------------------------------------------------------------
Confidence 4321100
Q ss_pred ccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCch
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSK 397 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 397 (489)
........++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+..+. ..+...
T Consensus 157 ----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~----- 226 (260)
T cd05073 157 ----YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY-RMPRPE----- 226 (260)
T ss_pred ----cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC-CCCCcc-----
Confidence 000011235677999999998889999999999999999998 999999887776666655432 222111
Q ss_pred hHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 398 EFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 398 ~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
....++.+++.+||+.+|++||++.
T Consensus 227 --~~~~~~~~~i~~~l~~~p~~Rp~~~ 251 (260)
T cd05073 227 --NCPEELYNIMMRCWKNRPEERPTFE 251 (260)
T ss_pred --cCCHHHHHHHHHHcccCcccCcCHH
Confidence 1123589999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=322.95 Aligned_cols=255 Identities=20% Similarity=0.251 Sum_probs=196.2
Q ss_pred ceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec-----
Q 011302 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA----- 160 (489)
Q Consensus 86 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----- 160 (489)
|.+.+.||+|+||.||+|++.... ....||+|.++..... ......+..|..+++.++||||+++++++..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~---~~~~~a~k~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 76 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDD---SILKVAVKTMKIAICT-RSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESE 76 (272)
T ss_pred CccccccCcccCceEEEeEEccCC---CeeeEEEEecccCcCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCccc
Confidence 356789999999999999987631 1246899988654221 2335567789999999999999999997642
Q ss_pred -CceEEEEEeecCCCchHHHHHhC----CCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEccc
Q 011302 161 -SHYSCLVMEYCPGGDLYAARQRQ----PGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235 (489)
Q Consensus 161 -~~~~~lV~E~~~gg~L~~~l~~~----~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DF 235 (489)
....++||||+++|+|.+++... ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 77 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Df 156 (272)
T cd05075 77 GYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADF 156 (272)
T ss_pred CCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCC
Confidence 23578999999999998876432 1245889999999999999999999999999999999999999999999999
Q ss_pred CCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCc
Q 011302 236 DLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDP 315 (489)
Q Consensus 236 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (489)
|+++.+.....
T Consensus 157 g~~~~~~~~~~--------------------------------------------------------------------- 167 (272)
T cd05075 157 GLSKKIYNGDY--------------------------------------------------------------------- 167 (272)
T ss_pred CcccccCcccc---------------------------------------------------------------------
Confidence 99843211000
Q ss_pred cccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCC
Q 011302 316 EVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVS 394 (489)
Q Consensus 316 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~ 394 (489)
........+++.|+|||.+.+..++.++|||||||++|||++ |+.||.+....+....+..+... +... .
T Consensus 168 -------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~-~ 238 (272)
T cd05075 168 -------YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRL-KQPP-D 238 (272)
T ss_pred -------eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC-CCCC-C
Confidence 000111246678999999999989999999999999999999 89999888777666666554321 1111 1
Q ss_pred CchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHc
Q 011302 395 SSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKR 432 (489)
Q Consensus 395 ~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~ 432 (489)
. ...+.+||.+||+.||++||++. +|++
T Consensus 239 ~------~~~~~~li~~~l~~~p~~Rps~~----~l~~ 266 (272)
T cd05075 239 C------LDGLYSLMSSCWLLNPKDRPSFE----TLRC 266 (272)
T ss_pred C------CHHHHHHHHHHcCCCcccCcCHH----HHHH
Confidence 1 12489999999999999999987 5554
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=343.20 Aligned_cols=244 Identities=32% Similarity=0.489 Sum_probs=200.6
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHh-CCCCCcccccceeec
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTM-LDHPFLPTLYAEFEA 160 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpnIv~l~~~~~~ 160 (489)
..+.|.+...+|.|+|+.|-.+.+.. +.+.+++|++.+.. .....|+.++.. -+||||+++++++.+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~-----t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~ 387 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSP-----TDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYED 387 (612)
T ss_pred cchhhccccccCCCCccceeeeeccc-----cccchhheeccccc-------cccccccchhhhhcCCCcceeecceecC
Confidence 45789999999999999999999887 56788999998662 122236655444 479999999999999
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEe-ccCCcEEEcccCCCc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLV-REDGHIMLSDFDLSF 239 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl-~~~~~vkl~DFG~a~ 239 (489)
+.+.|+|||++.|+.|.+.+... ..+. .++..|++||+.||.|||++|||||||||+|||+ +..|+++|+|||.++
T Consensus 388 ~~~~~~v~e~l~g~ell~ri~~~--~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~ 464 (612)
T KOG0603|consen 388 GKEIYLVMELLDGGELLRRIRSK--PEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWS 464 (612)
T ss_pred CceeeeeehhccccHHHHHHHhc--chhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhh
Confidence 99999999999999998877665 2233 7888899999999999999999999999999999 699999999999984
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
..+.
T Consensus 465 ~~~~---------------------------------------------------------------------------- 468 (612)
T KOG0603|consen 465 ELER---------------------------------------------------------------------------- 468 (612)
T ss_pred hCch----------------------------------------------------------------------------
Confidence 3321
Q ss_pred cccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcH-HHHHHHhcCCCCCCCCCCCCchh
Q 011302 320 EPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNE-KTLINILKKPLTFPRIGVSSSKE 398 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~p~~~~~~~~~ 398 (489)
...+-|-|..|.|||++....|+.++||||||++||+||+|+.||...... ++..+|..+... .+
T Consensus 469 -----~~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s----~~----- 534 (612)
T KOG0603|consen 469 -----SCDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS----EC----- 534 (612)
T ss_pred -----hhcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc----cc-----
Confidence 012235688999999999999999999999999999999999999876665 444444443322 11
Q ss_pred HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 399 FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 399 ~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
.+..++|||++||+.||.+|+++. +++.||||
T Consensus 535 --vS~~AKdLl~~LL~~dP~~Rl~~~----~i~~h~w~ 566 (612)
T KOG0603|consen 535 --VSDEAKDLLQQLLQVDPALRLGAD----EIGAHPWF 566 (612)
T ss_pred --cCHHHHHHHHHhccCChhhCcChh----hhccCcch
Confidence 122599999999999999999998 99999999
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=315.93 Aligned_cols=257 Identities=30% Similarity=0.445 Sum_probs=209.0
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC--c
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS--H 162 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~ 162 (489)
+|++.+.||+|+||.||+|.+.. ++..|++|++...... ......+.+|+.++++++||||+++++.+... .
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKD-----TGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKN 74 (260)
T ss_pred CceeeeEeeecCceEEEEEEECC-----CCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCC
Confidence 47889999999999999999886 5678999998765432 34456778899999999999999999999988 8
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
..|+||||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 152 (260)
T cd06606 75 TLNIFLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLG 152 (260)
T ss_pred eEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence 999999999999999998876 379999999999999999999999999999999999999999999999999974332
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
.....
T Consensus 153 ~~~~~--------------------------------------------------------------------------- 157 (260)
T cd06606 153 DIETG--------------------------------------------------------------------------- 157 (260)
T ss_pred ccccc---------------------------------------------------------------------------
Confidence 10000
Q ss_pred ccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCc-HHHHHHHhcCCCCCCCCCCCCchhHHH
Q 011302 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENN-EKTLINILKKPLTFPRIGVSSSKEFEE 401 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~~p~~~~~~~~~~~~ 401 (489)
.......++..|+|||.+.+...+.++|||||||++|+|++|..||...+. ......+.... ..+......
T Consensus 158 -~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~------ 229 (260)
T cd06606 158 -EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSG-EPPEIPEHL------ 229 (260)
T ss_pred -ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccC-CCcCCCccc------
Confidence 001223688899999999988899999999999999999999999987762 23333333211 111111111
Q ss_pred HhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 402 VVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 402 ~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
...+.+||.+||+.||++||++. ++++||||
T Consensus 230 ~~~l~~~i~~~l~~~p~~Rp~~~----~ll~~~~~ 260 (260)
T cd06606 230 SEEAKDFLRKCLRRDPKKRPTAD----ELLQHPFL 260 (260)
T ss_pred CHHHHHHHHHhCcCChhhCCCHH----HHhhCCCC
Confidence 23589999999999999999997 99999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=314.41 Aligned_cols=253 Identities=30% Similarity=0.489 Sum_probs=208.3
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceE
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYS 164 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 164 (489)
+|.+.+.||+|+||.||+|.+.. .++.|++|++..... .....+.+|+.+++.++|+||+++++++......
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 72 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKR-----TGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDEL 72 (253)
T ss_pred CceeeeeeccCCceEEEEEEECC-----CCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE
Confidence 58889999999999999999886 467899999976543 2345677799999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccC
Q 011302 165 CLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVV 244 (489)
Q Consensus 165 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~ 244 (489)
|+|+||++|++|.+++.... ..+++..+..++.|++.||.|||.+|++||||+|+||+++.++.++|+|||++......
T Consensus 73 ~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 73 WIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred EEEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 99999999999999887653 57899999999999999999999999999999999999999999999999987332110
Q ss_pred ccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccccc
Q 011302 245 PKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINA 324 (489)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (489)
.
T Consensus 152 ~------------------------------------------------------------------------------- 152 (253)
T cd05122 152 K------------------------------------------------------------------------------- 152 (253)
T ss_pred c-------------------------------------------------------------------------------
Confidence 0
Q ss_pred CCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhh
Q 011302 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVK 404 (489)
Q Consensus 325 ~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~ 404 (489)
......|+..|+|||.+.+..++.++|||||||++|+|++|..||...+.......+.... .+...... .....
T Consensus 153 ~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~----~~~~~ 226 (253)
T cd05122 153 ARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNG--PPGLRNPE----KWSDE 226 (253)
T ss_pred cccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcC--CCCcCccc----ccCHH
Confidence 0123468889999999998888999999999999999999999998876555444443321 11111111 00125
Q ss_pred HHHHHHHHhhcCcccccCCCCChHHHHcCCC
Q 011302 405 LQDLISKLLVKNPKKRIGSLKGSVEIKRHEF 435 (489)
Q Consensus 405 l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~ 435 (489)
+.++|.+||..||++||++. ++++|||
T Consensus 227 ~~~~i~~~l~~~p~~R~t~~----~~l~~~~ 253 (253)
T cd05122 227 FKDFLKKCLQKNPEKRPTAE----QLLKHPF 253 (253)
T ss_pred HHHHHHHHccCChhhCCCHH----HHhcCCC
Confidence 89999999999999999997 9999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=320.06 Aligned_cols=256 Identities=20% Similarity=0.250 Sum_probs=203.5
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
+..++|+..+.||+|+||.||+|++..... ....+|+|.+...... .....+..|+.+++.++||||+++++++.+
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~--~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 77 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGR--KEVAVAIKTLKPGYTE--KQRQDFLSEASIMGQFSHHNIIRLEGVVTK 77 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCC--CceEEEEEeccccCCH--HHHHHHHHHHHHHhcCCCCCeeEEEEEEcc
Confidence 345689999999999999999999875321 3457999998654221 223456779999999999999999999999
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~ 240 (489)
.+..|+||||+++++|.+++.... ..+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 78 FKPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred CCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCcccee
Confidence 999999999999999999887643 5689999999999999999999999999999999999999999999999999743
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
+......
T Consensus 157 ~~~~~~~------------------------------------------------------------------------- 163 (268)
T cd05063 157 LEDDPEG------------------------------------------------------------------------- 163 (268)
T ss_pred ccccccc-------------------------------------------------------------------------
Confidence 2210000
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhH
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEF 399 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 399 (489)
.........++.|+|||++.+..++.++|||||||++|||++ |..||...+..+....+... ...|.... .
T Consensus 164 --~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~-~---- 235 (268)
T cd05063 164 --TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG-FRLPAPMD-C---- 235 (268)
T ss_pred --ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcC-CCCCCCCC-C----
Confidence 000011123467999999998889999999999999999997 99999888877777766543 22222211 1
Q ss_pred HHHhhHHHHHHHHhhcCcccccCCC
Q 011302 400 EEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 400 ~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
...+.+|+.+||..+|++||++.
T Consensus 236 --~~~~~~li~~c~~~~p~~Rp~~~ 258 (268)
T cd05063 236 --PSAVYQLMLQCWQQDRARRPRFV 258 (268)
T ss_pred --CHHHHHHHHHHcCCCcccCcCHH
Confidence 12488999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=317.75 Aligned_cols=248 Identities=24% Similarity=0.306 Sum_probs=200.4
Q ss_pred eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEEEEEe
Q 011302 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVME 169 (489)
Q Consensus 90 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 169 (489)
+.||+|+||.||+|.+.... .....||||.+...... .....+..|+.++++++||||+++++.+.+ ...++|||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~--~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e 75 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSG--GKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTE 75 (257)
T ss_pred CcCCccCcccEEeeeEecCC--CCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEE
Confidence 36899999999999987531 23457999999876654 455677889999999999999999999988 89999999
Q ss_pred ecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCccccC
Q 011302 170 YCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLR 249 (489)
Q Consensus 170 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 249 (489)
|+++|+|.+++.......+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++..+......
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-- 153 (257)
T cd05040 76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH-- 153 (257)
T ss_pred ecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccc--
Confidence 999999999987754356899999999999999999999999999999999999999999999999998433210000
Q ss_pred CcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCccc
Q 011302 250 PKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSF 329 (489)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (489)
.......
T Consensus 154 -------------------------------------------------------------------------~~~~~~~ 160 (257)
T cd05040 154 -------------------------------------------------------------------------YVMEEHL 160 (257)
T ss_pred -------------------------------------------------------------------------eecccCC
Confidence 0001123
Q ss_pred cCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHH
Q 011302 330 VGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDL 408 (489)
Q Consensus 330 ~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~l 408 (489)
.++..|+|||.+.+..++.++|||||||++|||++ |..||...+..+....+.......+.... .+..+.+|
T Consensus 161 ~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l 233 (257)
T cd05040 161 KVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEA-------CPQDIYNV 233 (257)
T ss_pred CCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCcc-------CCHHHHHH
Confidence 57788999999999889999999999999999998 99999888777766666543222221111 12358999
Q ss_pred HHHHhhcCcccccCCC
Q 011302 409 ISKLLVKNPKKRIGSL 424 (489)
Q Consensus 409 i~~~L~~dP~~R~~~~ 424 (489)
+.+||..+|++||++.
T Consensus 234 i~~~l~~~p~~Rps~~ 249 (257)
T cd05040 234 MLQCWAHNPADRPTFA 249 (257)
T ss_pred HHHHCCCCcccCCCHH
Confidence 9999999999999987
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=317.64 Aligned_cols=252 Identities=25% Similarity=0.333 Sum_probs=205.1
Q ss_pred eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEEEEEe
Q 011302 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVME 169 (489)
Q Consensus 90 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 169 (489)
+.||+|+||.||+|.+.... ..+..|++|++....... ....+..|+.+++.++|+||+++++++.+...+|+|||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~--~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 76 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKD--GKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLE 76 (262)
T ss_pred CccccCCceEEEEEEEecCC--CCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEE
Confidence 46899999999999988621 136789999998664432 45667789999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhCC-------CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 170 YCPGGDLYAARQRQP-------GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 170 ~~~gg~L~~~l~~~~-------~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
|+++++|.+++.... ...+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||.+....
T Consensus 77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccc
Confidence 999999999987642 3679999999999999999999999999999999999999999999999999984332
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
....
T Consensus 157 ~~~~---------------------------------------------------------------------------- 160 (262)
T cd00192 157 DDDY---------------------------------------------------------------------------- 160 (262)
T ss_pred cccc----------------------------------------------------------------------------
Confidence 1000
Q ss_pred ccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHH
Q 011302 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEE 401 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 401 (489)
........+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+..+.. .+... ..
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~-~~------ 232 (262)
T cd00192 161 YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYR-LPKPE-YC------ 232 (262)
T ss_pred cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCCCc-cC------
Confidence 001123357889999999998889999999999999999998 6999999887777777665321 11111 11
Q ss_pred HhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 402 VVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 402 ~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
+.++.++|.+||..+|.+||++. +++.+
T Consensus 233 ~~~~~~li~~~l~~~p~~Rps~~----~l~~~ 260 (262)
T cd00192 233 PDELYELMLSCWQLDPEDRPTFS----ELVER 260 (262)
T ss_pred ChHHHHHHHHHccCCcccCcCHH----HHHHh
Confidence 22589999999999999999997 77764
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=325.97 Aligned_cols=259 Identities=21% Similarity=0.256 Sum_probs=199.1
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCC---------CCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcc
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMV---------GLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLP 152 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv 152 (489)
..++|++.+.||+|+||.||+|++.+... ......||+|.+..... ......+.+|+.+++.++||||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT--KTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC--HHHHHHHHHHHHHHHhCCCCCcC
Confidence 34689999999999999999998764211 11234689999875421 12344577899999999999999
Q ss_pred cccceeecCceEEEEEeecCCCchHHHHHhCC----------CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCe
Q 011302 153 TLYAEFEASHYSCLVMEYCPGGDLYAARQRQP----------GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENV 222 (489)
Q Consensus 153 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~----------~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NI 222 (489)
++++++...+..|+||||+++++|.+++.... ...+++..+..++.|++.||+|||++|++||||||+||
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 99999999999999999999999999886531 12367888899999999999999999999999999999
Q ss_pred EeccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCcccccccccccccccccccccccccccc
Q 011302 223 LVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQV 302 (489)
Q Consensus 223 Ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (489)
|++.++.+||+|||++..+....
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~--------------------------------------------------------- 183 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGD--------------------------------------------------------- 183 (295)
T ss_pred EEcCCCcEEecccccccccccCc---------------------------------------------------------
Confidence 99999999999999974321000
Q ss_pred CCCCCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh--CCCCCCCCCcHHHHHH
Q 011302 303 DGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY--GTTPFKGENNEKTLIN 380 (489)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt--G~~Pf~~~~~~~~~~~ 380 (489)
.........++..|+|||++.+..++.++|||||||++|||++ |..||...+..+.+..
T Consensus 184 -------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~ 244 (295)
T cd05097 184 -------------------YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIEN 244 (295)
T ss_pred -------------------ceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHH
Confidence 0001122346778999999998889999999999999999987 7789988776665544
Q ss_pred Hhc-----CCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 381 ILK-----KPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 381 i~~-----~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
+.. ....+...... .+..+.+||.+||..||++||++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~------~~~~l~~li~~~l~~~p~~RPs~~ 287 (295)
T cd05097 245 TGEFFRNQGRQIYLSQTPL------CPSPVFKLMMRCWSRDIKDRPTFN 287 (295)
T ss_pred HHHhhhhccccccCCCCCC------CCHHHHHHHHHHcCCCchhCcCHH
Confidence 422 11111111111 123589999999999999999996
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=331.92 Aligned_cols=270 Identities=26% Similarity=0.296 Sum_probs=202.0
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccceee----
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAEFE---- 159 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~---- 159 (489)
+|.+.+.||+|+||.||+|++.... .+..||||.+..... .......+..|+.+++++ +||||+++++.+.
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~---~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 76 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETS---EEETVAIKKITNVFS-KKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPG 76 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCC---cCceEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccc
Confidence 4889999999999999999987621 267899999864321 122344566799999998 5999999998653
Q ss_pred cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 160 ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 160 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
....+|++|||+ +++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 77 ~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 77 NFNELYLYEELM-EADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred cCCcEEEEEecc-cCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 235689999999 57898888654 579999999999999999999999999999999999999999999999999984
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
.+......
T Consensus 154 ~~~~~~~~------------------------------------------------------------------------ 161 (332)
T cd07857 154 GFSENPGE------------------------------------------------------------------------ 161 (332)
T ss_pred eccccccc------------------------------------------------------------------------
Confidence 33210000
Q ss_pred cccccCCccccCCCCccCcchhcC-CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCC---------
Q 011302 320 EPINARSKSFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFP--------- 389 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p--------- 389 (489)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+....+..+.......+
T Consensus 162 --~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd07857 162 --NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS 239 (332)
T ss_pred --ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhh
Confidence 0011223578999999998866 4689999999999999999999999988765544443322100000
Q ss_pred -----------CCCCCCchh--HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 390 -----------RIGVSSSKE--FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 390 -----------~~~~~~~~~--~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
......... ......+.+||.+||+.||++||++. +++.||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~----~ll~~~~~~~~ 298 (332)
T cd07857 240 PKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVE----EALEHPYLAIW 298 (332)
T ss_pred hhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHH----HHhcChhhhhh
Confidence 000000000 01123589999999999999999987 99999999643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=333.65 Aligned_cols=281 Identities=26% Similarity=0.334 Sum_probs=208.0
Q ss_pred CCcee-eeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHH-----------HHHHHHHHHHHHHhCCCCCc
Q 011302 84 DHFRL-LRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRK-----------KLHRADMEKVILTMLDHPFL 151 (489)
Q Consensus 84 ~~y~~-~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~hpnI 151 (489)
++|.. .+.||+|+||+||+|.+.. .++.||||.+......... ....+.+|+.+++.++||||
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 82 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTL-----TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENI 82 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECC-----CCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcce
Confidence 46654 5779999999999999876 5688999998754322100 01245679999999999999
Q ss_pred ccccceeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEE
Q 011302 152 PTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIM 231 (489)
Q Consensus 152 v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vk 231 (489)
+++++++..++..|+||||+. |+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus 83 v~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 83 MGLVDVYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred eeeeEEEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEE
Confidence 999999999999999999995 6999888764 5689999999999999999999999999999999999999999999
Q ss_pred EcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccc
Q 011302 232 LSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQEL 311 (489)
Q Consensus 232 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (489)
|+|||++.......... ......
T Consensus 160 l~dfg~~~~~~~~~~~~--------------------------------~~~~~~------------------------- 182 (335)
T PTZ00024 160 IADFGLARRYGYPPYSD--------------------------------TLSKDE------------------------- 182 (335)
T ss_pred ECCccceeecccccccc--------------------------------cccccc-------------------------
Confidence 99999984432100000 000000
Q ss_pred cCCccccccccccCCccccCCCCccCcchhcCCC-CCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhc---CCC-
Q 011302 312 LDDPEVVAEPINARSKSFVGTHEYLAPEVISGQG-HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILK---KPL- 386 (489)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~~~- 386 (489)
............+++.|+|||.+.+.. ++.++|||||||++|||++|.+||.+.+..+.+..+.. .+.
T Consensus 183 -------~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~ 255 (335)
T PTZ00024 183 -------TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNE 255 (335)
T ss_pred -------cccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCch
Confidence 000001112235788999999997754 68999999999999999999999998887766555432 111
Q ss_pred -CCCCCC---------CCCchhH-----HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 387 -TFPRIG---------VSSSKEF-----EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 387 -~~p~~~---------~~~~~~~-----~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
.++... ......+ .....+.+||.+||+.+|++||++. +++.||||++..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~----~~l~~~~~~~~~ 320 (335)
T PTZ00024 256 DNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAK----EALKHEYFKSDP 320 (335)
T ss_pred hhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHH----HHhcCcccCCCC
Confidence 011100 0000000 1123588999999999999999987 999999998643
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=315.79 Aligned_cols=254 Identities=30% Similarity=0.418 Sum_probs=210.7
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceE
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYS 164 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 164 (489)
+|++.+.||+|+||.||+|+++. +++.||+|.+....... .....+..|+.+++.++|+||+++++++.+....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLS-----DNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKL 74 (256)
T ss_pred CceEeeeecCCCceeEEEEEECC-----CCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEE
Confidence 58899999999999999999876 56789999998654432 3345667799999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhC--CCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 165 CLVMEYCPGGDLYAARQRQ--PGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 165 ~lV~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
|+||||+++++|.+++.+. ....+++..+..++.|++.||+|||++|++||||+|.||+++.++.+||+|||+++...
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~ 154 (256)
T cd08530 75 CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLK 154 (256)
T ss_pred EEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhc
Confidence 9999999999999887652 23568899999999999999999999999999999999999999999999999974321
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
..
T Consensus 155 ~~------------------------------------------------------------------------------ 156 (256)
T cd08530 155 KN------------------------------------------------------------------------------ 156 (256)
T ss_pred cC------------------------------------------------------------------------------
Confidence 10
Q ss_pred ccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHH
Q 011302 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEV 402 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~ 402 (489)
......|++.|+|||.+.+..++.++|+||||+++|||++|..||...+..+....+..... +.... ...
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~------~~~ 226 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKY--PPIPP------IYS 226 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC--CCCch------hhC
Confidence 01112578899999999998899999999999999999999999998887666555554332 21111 112
Q ss_pred hhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 403 VKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 403 ~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
.+++++|.+||..+|++||++. ++++||++
T Consensus 227 ~~~~~li~~~l~~~p~~Rp~~~----~~l~~p~~ 256 (256)
T cd08530 227 QDLQNFIRSMLQVKPKLRPNCD----KILASPAV 256 (256)
T ss_pred HHHHHHHHHHcCCCcccCCCHH----HHhcCCCC
Confidence 3589999999999999999997 99999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=320.08 Aligned_cols=256 Identities=29% Similarity=0.496 Sum_probs=201.9
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHH--HHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALA--IRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
+|.+.+.||+|+||.||+|++... ...+++|+++..... ......++..|+.+++.++||||+++++++.+..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKA-----VAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCC-----CCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC
Confidence 588999999999999999998763 333455555432111 0122334566889999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHh--CCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcc
Q 011302 163 YSCLVMEYCPGGDLYAARQR--QPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~ 240 (489)
..|+||||+++++|.+++.. .....+++..++.++.|++.||.|||++|++|+||||+||+++. +.++|+|||++..
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~ 154 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRL 154 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceee
Confidence 99999999999999988764 23357999999999999999999999999999999999999974 6799999998743
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
....
T Consensus 155 ~~~~---------------------------------------------------------------------------- 158 (260)
T cd08222 155 LMGS---------------------------------------------------------------------------- 158 (260)
T ss_pred cCCC----------------------------------------------------------------------------
Confidence 2110
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHH
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFE 400 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 400 (489)
........|++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.........+..+.. +.... .
T Consensus 159 --~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~------~ 228 (260)
T cd08222 159 --CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPT--PSLPE------T 228 (260)
T ss_pred --cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCC--CCCcc------h
Confidence 0011223578899999999888889999999999999999999999988776666666654322 11111 1
Q ss_pred HHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 401 EVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 401 ~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
....+.++|.+||..||++||++. ++++||||
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rp~~~----~il~~~~~ 260 (260)
T cd08222 229 YSRQLNSIMQSMLNKDPSLRPSAA----EILRNPFI 260 (260)
T ss_pred hcHHHHHHHHHHhcCChhhCcCHH----HHhhCCCC
Confidence 123588999999999999999997 99999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=317.55 Aligned_cols=244 Identities=23% Similarity=0.261 Sum_probs=192.2
Q ss_pred eeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEEEEEee
Q 011302 91 RLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEY 170 (489)
Q Consensus 91 ~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 170 (489)
.||+|+||.||+|.++... .+..||+|++..... ......+.+|+.+++.++||||+++++++.. ...|+||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~---~~~~vavk~~~~~~~--~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRK---KQIDVAIKVLKNENE--KSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCC---CceeEEEEEcccccC--hHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEe
Confidence 4899999999999876421 345799999875422 2334567789999999999999999998864 578999999
Q ss_pred cCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCccccCC
Q 011302 171 CPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRP 250 (489)
Q Consensus 171 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 250 (489)
+++|+|.+++... ...+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||++.........
T Consensus 76 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~--- 151 (257)
T cd05115 76 ASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY--- 151 (257)
T ss_pred CCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccc---
Confidence 9999999988754 257899999999999999999999999999999999999999999999999997432110000
Q ss_pred cchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCcccc
Q 011302 251 KLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFV 330 (489)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (489)
........
T Consensus 152 ------------------------------------------------------------------------~~~~~~~~ 159 (257)
T cd05115 152 ------------------------------------------------------------------------YKARSAGK 159 (257)
T ss_pred ------------------------------------------------------------------------eeccCCCC
Confidence 00001112
Q ss_pred CCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHHH
Q 011302 331 GTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLI 409 (489)
Q Consensus 331 Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li 409 (489)
+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+..+... + ..... ..++.+||
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~-~~~~~------~~~l~~li 231 (257)
T cd05115 160 WPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRL-D-CPAEC------PPEMYALM 231 (257)
T ss_pred CCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC-C-CCCCC------CHHHHHHH
Confidence 4678999999998889999999999999999996 99999988877766665554321 1 11111 12588999
Q ss_pred HHHhhcCcccccCCC
Q 011302 410 SKLLVKNPKKRIGSL 424 (489)
Q Consensus 410 ~~~L~~dP~~R~~~~ 424 (489)
.+||..||++||++.
T Consensus 232 ~~c~~~~~~~Rp~~~ 246 (257)
T cd05115 232 KDCWIYKWEDRPNFA 246 (257)
T ss_pred HHHcCCChhhCcCHH
Confidence 999999999999986
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=328.37 Aligned_cols=268 Identities=25% Similarity=0.335 Sum_probs=204.5
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE 159 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 159 (489)
+...++|++.+.||+|+||.||+|.++. +++.||+|+++..... ......+.+|+.+++.++||||+++++++.
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~ 76 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKD-----TGELVALKKVRLDNEK-EGFPITAIREIKILRQLNHRNIVNLKEIVT 76 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECC-----CCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCCCCCeeeeeheec
Confidence 3456899999999999999999999986 4678999999754321 112234556999999999999999999887
Q ss_pred cCc----------eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCc
Q 011302 160 ASH----------YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGH 229 (489)
Q Consensus 160 ~~~----------~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~ 229 (489)
+.. .+|+||||+++ +|...+... ...+++..+..++.||+.||+|||++||+||||||+||+++.++.
T Consensus 77 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~ 154 (302)
T cd07864 77 DKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ 154 (302)
T ss_pred CcchhhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCc
Confidence 654 89999999965 777766654 346899999999999999999999999999999999999999999
Q ss_pred EEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCc
Q 011302 230 IMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQ 309 (489)
Q Consensus 230 vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (489)
+||+|||++.......
T Consensus 155 ~kl~dfg~~~~~~~~~---------------------------------------------------------------- 170 (302)
T cd07864 155 IKLADFGLARLYNSEE---------------------------------------------------------------- 170 (302)
T ss_pred EEeCcccccccccCCc----------------------------------------------------------------
Confidence 9999999974321100
Q ss_pred cccCCccccccccccCCccccCCCCccCcchhcCC-CCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhc---CC
Q 011302 310 ELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQ-GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILK---KP 385 (489)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~~ 385 (489)
........++..|+|||.+.+. .++.++|||||||++|||++|++||...+..+.+..+.. .+
T Consensus 171 -------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 237 (302)
T cd07864 171 -------------SRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP 237 (302)
T ss_pred -------------ccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 0001112467889999998754 478999999999999999999999988776655544433 11
Q ss_pred C--CCCCCCCCC---------------chhH-HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 386 L--TFPRIGVSS---------------SKEF-EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 386 ~--~~p~~~~~~---------------~~~~-~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
. .+|...... ...+ ..+..+.+||.+||..||.+||++. +++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~----~il~~~~~ 302 (302)
T cd07864 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAE----EALNSPWL 302 (302)
T ss_pred ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHH----HHhcCCCC
Confidence 1 111110000 0000 1134689999999999999999987 99999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=317.84 Aligned_cols=245 Identities=22% Similarity=0.285 Sum_probs=194.5
Q ss_pred eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEEEEEe
Q 011302 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVME 169 (489)
Q Consensus 90 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 169 (489)
++||+|+||.||+|.+..... ....||+|.+...... .....+..|+.+++.++||||+++++++. .+..++|||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~--~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e 75 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSG--KEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVME 75 (257)
T ss_pred CccCccCceeEEEeEeeccCC--CcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEE
Confidence 469999999999998765321 3478999999866543 33456777999999999999999999876 456899999
Q ss_pred ecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCccccC
Q 011302 170 YCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLR 249 (489)
Q Consensus 170 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 249 (489)
|+++|+|.+++... ..+++..+..++.|++.||+|||.++++||||||+|||++.++.+||+|||+++.+......
T Consensus 76 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~-- 151 (257)
T cd05060 76 LAPLGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY-- 151 (257)
T ss_pred eCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcc--
Confidence 99999999999875 36899999999999999999999999999999999999999999999999998433210000
Q ss_pred CcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCccc
Q 011302 250 PKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSF 329 (489)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (489)
.......
T Consensus 152 -------------------------------------------------------------------------~~~~~~~ 158 (257)
T cd05060 152 -------------------------------------------------------------------------YRATTAG 158 (257)
T ss_pred -------------------------------------------------------------------------cccccCc
Confidence 0000111
Q ss_pred cCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHH
Q 011302 330 VGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDL 408 (489)
Q Consensus 330 ~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~l 408 (489)
.++..|+|||.+.+..++.++|||||||++|||++ |..||...+..+....+..... .+... . .+..+.+|
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~-~------~~~~l~~l 230 (257)
T cd05060 159 RWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGER-LPRPE-E------CPQEIYSI 230 (257)
T ss_pred cccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc-CCCCC-C------CCHHHHHH
Confidence 24568999999998889999999999999999997 9999988877666666554321 11111 1 11258899
Q ss_pred HHHHhhcCcccccCCC
Q 011302 409 ISKLLVKNPKKRIGSL 424 (489)
Q Consensus 409 i~~~L~~dP~~R~~~~ 424 (489)
|.+||..+|++||++.
T Consensus 231 i~~cl~~~p~~Rp~~~ 246 (257)
T cd05060 231 MLSCWKYRPEDRPTFS 246 (257)
T ss_pred HHHHhcCChhhCcCHH
Confidence 9999999999999987
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=323.82 Aligned_cols=258 Identities=24% Similarity=0.309 Sum_probs=198.5
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCC-----------CCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCC
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPM-----------VGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPF 150 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~-----------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn 150 (489)
..++|++.+.||+|+||.||+|.+.+.. .......||+|++..... ......+.+|+.+++.++|+|
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~E~~~l~~l~~~~ 80 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN--KNARNDFLKEIKIMSRLKDPN 80 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCC
Confidence 3468999999999999999999765421 112345789999875421 233456778999999999999
Q ss_pred cccccceeecCceEEEEEeecCCCchHHHHHhCCC---------CCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCC
Q 011302 151 LPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPG---------KRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPEN 221 (489)
Q Consensus 151 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~---------~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~N 221 (489)
|+++++++...+..|+||||+++|+|.+++..... ..+++..+..++.||+.||+|||++||+||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N 160 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN 160 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence 99999999999999999999999999998876421 246677899999999999999999999999999999
Q ss_pred eEeccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccc
Q 011302 222 VLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQ 301 (489)
Q Consensus 222 ILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (489)
||++.++.++|+|||+++.+....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~-------------------------------------------------------- 184 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGD-------------------------------------------------------- 184 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCc--------------------------------------------------------
Confidence 999999999999999984321100
Q ss_pred cCCCCCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh--CCCCCCCCCcHHHHH
Q 011302 302 VDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY--GTTPFKGENNEKTLI 379 (489)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt--G~~Pf~~~~~~~~~~ 379 (489)
.........+++.|+|||.+.+..++.++|||||||++|||++ |..||...+..+.+.
T Consensus 185 --------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~ 244 (296)
T cd05095 185 --------------------YYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIE 244 (296)
T ss_pred --------------------ceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 0000112245678999999988889999999999999999998 789998776655544
Q ss_pred HHhc------CCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 380 NILK------KPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 380 ~i~~------~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
.... .....+... .. ...+.+||.+||..||++||++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~-~~------~~~~~~li~~cl~~~p~~Rp~~~ 288 (296)
T cd05095 245 NTGEFFRDQGRQVYLPKPA-LC------PDSLYKLMLSCWRRNAKERPSFQ 288 (296)
T ss_pred HHHHHHhhccccccCCCCC-CC------CHHHHHHHHHHcCCCcccCCCHH
Confidence 3311 111111111 11 12588999999999999999997
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=327.99 Aligned_cols=256 Identities=26% Similarity=0.344 Sum_probs=206.1
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
..|...+.||+|+||.||+|+++. .+..+|+|.+............++..|+.+++.++|+||+++++++.....
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 89 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVR-----NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT 89 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcC-----CCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCe
Confidence 458888999999999999999876 467899999875433223344567779999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
.|+||||+. |+|.+++... ...+++..+..++.|++.||.|||+++++||||||+|||++.++.+||+|||++.....
T Consensus 90 ~~lv~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 90 AWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred eEEEEEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 999999995 6887776543 25689999999999999999999999999999999999999999999999998732110
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
T Consensus 168 -------------------------------------------------------------------------------- 167 (308)
T cd06634 168 -------------------------------------------------------------------------------- 167 (308)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCccccCCCCccCcchhcC---CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHH
Q 011302 324 ARSKSFVGTHEYLAPEVISG---QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFE 400 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~---~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 400 (489)
.....|++.|+|||.+.+ ..++.++|||||||++|+|++|..||...+.......+...... ..... .
T Consensus 168 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~-----~ 238 (308)
T cd06634 168 --ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP--ALQSG-----H 238 (308)
T ss_pred --cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCC--CcCcc-----c
Confidence 112358889999999853 45788999999999999999999999887665555555443221 11111 1
Q ss_pred HHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 401 EVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 401 ~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
....+.+||.+||..+|++||++. +++.||||...
T Consensus 239 ~~~~~~~li~~cl~~~P~~Rp~~~----~ll~~~~~~~~ 273 (308)
T cd06634 239 WSEYFRNFVDSCLQKIPQDRPTSE----VLLKHRFVLRE 273 (308)
T ss_pred ccHHHHHHHHHHhhCCcccCCCHH----HHhhCcccccc
Confidence 112488999999999999999987 99999999773
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=319.78 Aligned_cols=256 Identities=22% Similarity=0.268 Sum_probs=202.1
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
..+|++.+.||+|+||.||+|.++.... ....||||++..... .....++..|+.+++.++||||+++++++.++.
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~--~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 78 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGK--REIFVAIKTLKSGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR 78 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCC--CceeEEEEEcCCCCC--HHHHHHHHHHHHHHHhCCCcCcceEEEEECCCC
Confidence 4579999999999999999999876422 245799999875421 233456778999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
..|+||||+++|+|.+++.... +.+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++..+.
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred ceEEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccc
Confidence 9999999999999999887643 568999999999999999999999999999999999999999999999999874321
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
..... +.
T Consensus 158 ~~~~~-------------------------------------------------------------------------~~ 164 (269)
T cd05065 158 DDTSD-------------------------------------------------------------------------PT 164 (269)
T ss_pred cCccc-------------------------------------------------------------------------cc
Confidence 10000 00
Q ss_pred ccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHH
Q 011302 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEE 401 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 401 (489)
........++..|+|||.+.+..++.++|||||||++|||++ |..||...+..+....+... ...|.... .
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~-------~ 236 (269)
T cd05065 165 YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD-YRLPPPMD-------C 236 (269)
T ss_pred cccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-CcCCCccc-------C
Confidence 000001123457999999998889999999999999999886 99999888777666666432 22222111 1
Q ss_pred HhhHHHHHHHHhhcCcccccCCC
Q 011302 402 VVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 402 ~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
+..+.+++.+||..+|++||++.
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~ 259 (269)
T cd05065 237 PTALHQLMLDCWQKDRNARPKFG 259 (269)
T ss_pred CHHHHHHHHHHcCCChhhCcCHH
Confidence 12488999999999999999997
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=323.84 Aligned_cols=262 Identities=29% Similarity=0.418 Sum_probs=205.3
Q ss_pred ceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC--ce
Q 011302 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS--HY 163 (489)
Q Consensus 86 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~ 163 (489)
|.+.+.||+|+||.||+|.+.. .++.||+|++.... ........+.+|+.+++.++||||+++++++.+. +.
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~-----~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 74 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKK-----TGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGS 74 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECC-----CCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCc
Confidence 6789999999999999999886 56889999998653 1122334566799999999999999999999888 89
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
.|+||||++ ++|..++.... ..+++..+..++.||+.||+|||++|++|+||||+|||++.++.+||+|||++.....
T Consensus 75 ~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 75 IYMVFEYMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTK 152 (287)
T ss_pred EEEEecccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence 999999996 58988876542 4799999999999999999999999999999999999999999999999999743211
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
.. .
T Consensus 153 ~~-----------------------------------------------------------------------------~ 155 (287)
T cd07840 153 RN-----------------------------------------------------------------------------S 155 (287)
T ss_pred CC-----------------------------------------------------------------------------c
Confidence 00 0
Q ss_pred cCCccccCCCCccCcchhcCC-CCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCC-----CCCCCCCCC---
Q 011302 324 ARSKSFVGTHEYLAPEVISGQ-GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP-----LTFPRIGVS--- 394 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-----~~~p~~~~~--- 394 (489)
.......++..|+|||.+.+. .++.++|||||||++|||++|+.||...+....+..+.... ..++.....
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence 001122567889999988764 57899999999999999999999999888766655554311 011110000
Q ss_pred --------Cc----hhHH--HHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 395 --------SS----KEFE--EVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 395 --------~~----~~~~--~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
.. ..+. ....+.++|.+||..+|.+||++. +++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~----~~l~~~~~ 287 (287)
T cd07840 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISAD----QALQHEYF 287 (287)
T ss_pred hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHH----HHhhCcCC
Confidence 00 0001 134688999999999999999997 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=321.90 Aligned_cols=260 Identities=28% Similarity=0.444 Sum_probs=203.4
Q ss_pred ceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-CCCcccccceeecCceE
Q 011302 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-HPFLPTLYAEFEASHYS 164 (489)
Q Consensus 86 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~ 164 (489)
|++.+.||+|+||+||+|.... +++.|+||.+....... ......+|+..++.++ ||||+++++++.+++..
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~-----~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 73 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKE-----TGELVAIKKMKKKFYSW--EECMNLREVKSLRKLNEHPNIVKLKEVFRENDEL 73 (283)
T ss_pred CeeheeeccCCceEEEEEEECC-----CCcEEEEEEehhhccch--hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcE
Confidence 6788999999999999999876 46789999987553221 1122345888899999 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccC
Q 011302 165 CLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVV 244 (489)
Q Consensus 165 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~ 244 (489)
|+||||+ +|+|.+.+.......+++..+..++.|++.+|.|||++|++|+||||+||+++.++.++|+|||+++.....
T Consensus 74 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (283)
T cd07830 74 YFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR 152 (283)
T ss_pred EEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence 9999999 889999887764457899999999999999999999999999999999999999999999999987322100
Q ss_pred ccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccccc
Q 011302 245 PKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINA 324 (489)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (489)
.
T Consensus 153 -------------------------------------------------------------------------------~ 153 (283)
T cd07830 153 -------------------------------------------------------------------------------P 153 (283)
T ss_pred -------------------------------------------------------------------------------C
Confidence 0
Q ss_pred CCccccCCCCccCcchhcC-CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcC---CC--------------
Q 011302 325 RSKSFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK---PL-------------- 386 (489)
Q Consensus 325 ~~~~~~Gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~~-------------- 386 (489)
......|+..|+|||++.+ ..++.++|+|||||++|||++|++||.+....+.+.++... +.
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 154 PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 1122358889999998854 44789999999999999999999999887766555443321 00
Q ss_pred --CCCCCCCCCchhH--HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 387 --TFPRIGVSSSKEF--EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 387 --~~p~~~~~~~~~~--~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
.++.......... .....+.+||++||..||++||++. +++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~----ei~~~~~~ 283 (283)
T cd07830 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTAS----QALQHPYF 283 (283)
T ss_pred cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHH----HHhhCCCC
Confidence 0000000000000 1124689999999999999999987 99999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=322.68 Aligned_cols=261 Identities=28% Similarity=0.410 Sum_probs=205.7
Q ss_pred ceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEE
Q 011302 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSC 165 (489)
Q Consensus 86 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 165 (489)
|.+.+.||+|++|.||+|.+.. .++.+++|.+...... ......+..|+.+++.++|+||+++++++.++...|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 74 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKL-----TGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLY 74 (283)
T ss_pred CccceeeecCCCceEEEEEcCC-----CCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEE
Confidence 6678899999999999999875 5688999998755332 123456677999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCc
Q 011302 166 LVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVP 245 (489)
Q Consensus 166 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~ 245 (489)
+||||++ ++|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||.+.......
T Consensus 75 ~v~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 75 LVFEFMD-TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152 (283)
T ss_pred EEEeccC-CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence 9999996 58888776643 578999999999999999999999999999999999999999999999999873321100
Q ss_pred cccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccC
Q 011302 246 KLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINAR 325 (489)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (489)
..
T Consensus 153 ------------------------------------------------------------------------------~~ 154 (283)
T cd05118 153 ------------------------------------------------------------------------------RP 154 (283)
T ss_pred ------------------------------------------------------------------------------cc
Confidence 00
Q ss_pred CccccCCCCccCcchhcCC-CCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCC------------------
Q 011302 326 SKSFVGTHEYLAPEVISGQ-GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL------------------ 386 (489)
Q Consensus 326 ~~~~~Gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~------------------ 386 (489)
.....++..|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 1123578899999999877 689999999999999999999999988877665544432100
Q ss_pred -CCCCCCCCCch--hHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 387 -TFPRIGVSSSK--EFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 387 -~~p~~~~~~~~--~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
.++........ ....+.++.+||.+||..||.+||++. +++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~----~ll~~~~~ 283 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAE----QALAHPYF 283 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHH----HHhhCCCC
Confidence 01100000000 011234689999999999999999998 99999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=329.72 Aligned_cols=262 Identities=27% Similarity=0.381 Sum_probs=202.1
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec-
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA- 160 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~- 160 (489)
..++|++.+.||.|+||.||+|.+.. +++.||||++.+.... ......+..|+.+++.++||||++++++|..
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 81 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQL-----TGQNVAIKKIMKPFST-PVLAKRTYRELKLLKHLRHENIISLSDIFISP 81 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECC-----CCCEEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCeeeEeeeEecC
Confidence 45789999999999999999999886 5788999988653221 1233456679999999999999999999865
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~ 240 (489)
....|+||||+ +++|..++.. ..+++..+..++.||+.||.|||++||+||||||.|||++.++.+||+|||+++.
T Consensus 82 ~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 82 LEDIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred CCcEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccc
Confidence 56899999999 6789887764 4588888999999999999999999999999999999999999999999998732
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
..
T Consensus 158 ~~------------------------------------------------------------------------------ 159 (328)
T cd07856 158 QD------------------------------------------------------------------------------ 159 (328)
T ss_pred cC------------------------------------------------------------------------------
Confidence 11
Q ss_pred ccccCCccccCCCCccCcchhcC-CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhc---CCC----------
Q 011302 321 PINARSKSFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILK---KPL---------- 386 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~~~---------- 386 (489)
.......|++.|+|||.+.+ ..++.++|||||||++|+|++|.+||.+.+.......+.+ .+.
T Consensus 160 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd07856 160 ---PQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSE 236 (328)
T ss_pred ---CCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccch
Confidence 01122357889999999876 5689999999999999999999999987765332222111 000
Q ss_pred -------CCCCCCCCC-chhH-HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 387 -------TFPRIGVSS-SKEF-EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 387 -------~~p~~~~~~-~~~~-~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
..+...... .... .....+.++|.+||+.+|++||++. +++.||||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~----ell~~~~~~~ 293 (328)
T cd07856 237 NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAA----EALAHPYLAP 293 (328)
T ss_pred hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHH----HHhcCCcccc
Confidence 000000000 0000 1123589999999999999999987 9999999964
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=322.69 Aligned_cols=251 Identities=28% Similarity=0.412 Sum_probs=195.6
Q ss_pred eeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEEE
Q 011302 87 RLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCL 166 (489)
Q Consensus 87 ~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 166 (489)
.+.+.||.|.||.||+|.++. .....+..|+||.++.... ......+.+|+.+++.++||||+++++++...+..++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~-~~~~~~~~V~vk~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQ-KDNDKNQPVAVKILKPSSS--EEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEES-TTTSSEEEEEEEEESTTSS--HHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEE
T ss_pred EEeeEEccCCCcEEEEEEEEc-ccCCCCEEEEEEEeccccc--cccceeeeecccccccccccccccccccccccccccc
Confidence 467899999999999999993 1223578899999964221 1235667779999999999999999999998888999
Q ss_pred EEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCcc
Q 011302 167 VMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPK 246 (489)
Q Consensus 167 V~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 246 (489)
|||||++|+|.+++.......+++..+..|+.||+.||.|||+++|+|+||+++|||++.++.+||+|||++........
T Consensus 79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999887556799999999999999999999999999999999999999999999999999743210000
Q ss_pred ccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCC
Q 011302 247 LLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARS 326 (489)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (489)
....
T Consensus 159 ----------------------------------------------------------------------------~~~~ 162 (259)
T PF07714_consen 159 ----------------------------------------------------------------------------YKND 162 (259)
T ss_dssp ----------------------------------------------------------------------------EEES
T ss_pred ----------------------------------------------------------------------------cccc
Confidence 0001
Q ss_pred ccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhH
Q 011302 327 KSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKL 405 (489)
Q Consensus 327 ~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l 405 (489)
....+...|+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+..+.. .+ ....... .+
T Consensus 163 ~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~-~~-~~~~~~~------~~ 234 (259)
T PF07714_consen 163 SSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR-LP-IPDNCPK------DI 234 (259)
T ss_dssp TTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE-TT-SBTTSBH------HH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ce-eccchhH------HH
Confidence 12235678999999998889999999999999999999 7899998888777777755432 21 1111122 48
Q ss_pred HHHHHHHhhcCcccccCCC
Q 011302 406 QDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 406 ~~li~~~L~~dP~~R~~~~ 424 (489)
.+||.+||..||++||++.
T Consensus 235 ~~li~~C~~~~p~~RPs~~ 253 (259)
T PF07714_consen 235 YSLIQQCWSHDPEKRPSFQ 253 (259)
T ss_dssp HHHHHHHT-SSGGGS--HH
T ss_pred HHHHHHHcCCChhhCcCHH
Confidence 8999999999999999987
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=357.73 Aligned_cols=275 Identities=29% Similarity=0.363 Sum_probs=207.0
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC-
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS- 161 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~- 161 (489)
..+|+.++.||+||||.||+|+.+- +++.||||.+.... .......+.+|+.+|++|+|||||++|..|...
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKl-----DGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~ 550 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKL-----DGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVEST 550 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecc-----cchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccC
Confidence 3688999999999999999999885 78999999998665 356677888999999999999999998766100
Q ss_pred --------------------------------------------------------------------------------
Q 011302 162 -------------------------------------------------------------------------------- 161 (489)
Q Consensus 162 -------------------------------------------------------------------------------- 161 (489)
T Consensus 551 ~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~ 630 (1351)
T KOG1035|consen 551 AELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNL 630 (1351)
T ss_pred CccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccc
Confidence
Q ss_pred --------------------------------------ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHH
Q 011302 162 --------------------------------------HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLA 203 (489)
Q Consensus 162 --------------------------------------~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~ 203 (489)
..+||-||||+...|.+++.++.... ....+..+++||++|
T Consensus 631 S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEG 709 (1351)
T KOG1035|consen 631 SNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEG 709 (1351)
T ss_pred ccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHH
Confidence 12689999999988888888763211 467889999999999
Q ss_pred HHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccc
Q 011302 204 LEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVS 283 (489)
Q Consensus 204 L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (489)
|.|+|++|||||||||.||+++.++.|||+|||+|+.........
T Consensus 710 LaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~----------------------------------- 754 (1351)
T KOG1035|consen 710 LAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESI----------------------------------- 754 (1351)
T ss_pred HHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhH-----------------------------------
Confidence 999999999999999999999999999999999995422100000
Q ss_pred cccccccccccccccccccCCCCCCccccCCccccccccccCCccccCCCCccCcchhcCCC---CCCcccHHHHHHHHH
Q 011302 284 HGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQG---HGSAVDWWTLGVFLY 360 (489)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~---~~~~~DiwSlGvil~ 360 (489)
++.+. .............++.+||.-|+|||++.+.. |+.|+|+|||||||+
T Consensus 755 ----------------d~~~~---------~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlF 809 (1351)
T KOG1035|consen 755 ----------------DQDLS---------FSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLF 809 (1351)
T ss_pred ----------------hhccC---------ccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHH
Confidence 00000 00000111122345679999999999998765 999999999999999
Q ss_pred HHhhCCCCCCCCCcH-HHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcC
Q 011302 361 EMLYGTTPFKGENNE-KTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437 (489)
Q Consensus 361 elltG~~Pf~~~~~~-~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~ 437 (489)
||+. ||...-+. .++..+.++.+..|.. -..+..+.-..+|+.||+.||.+|||+. +||++.||-
T Consensus 810 EM~y---PF~TsMERa~iL~~LR~g~iP~~~~-----f~~~~~~~e~slI~~Ll~hdP~kRPtA~----eLL~s~llp 875 (1351)
T KOG1035|consen 810 EMLY---PFGTSMERASILTNLRKGSIPEPAD-----FFDPEHPEEASLIRWLLSHDPSKRPTAT----ELLNSELLP 875 (1351)
T ss_pred HHhc---cCCchHHHHHHHHhcccCCCCCCcc-----cccccchHHHHHHHHHhcCCCccCCCHH----HHhhccCCC
Confidence 9995 47554443 3444555444444410 0112223467999999999999999998 999999986
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=370.01 Aligned_cols=259 Identities=29% Similarity=0.447 Sum_probs=211.4
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceE
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYS 164 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 164 (489)
+++-...||.|.||.||-|...+ ++...|+|-++..... ......+.+|..++..++|||+|++||+=.+.+.+
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~-----tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLD-----TGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred eeccccccCCcceeeeEEeecCC-----ccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 34556679999999999999888 6788899988755443 45566777899999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccC
Q 011302 165 CLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVV 244 (489)
Q Consensus 165 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~ 244 (489)
||.||||.||+|.++++.. +..++...+.|-.|++.||.|||++|||||||||+||+|+.+|-+|++|||.|..+...
T Consensus 1310 ~IFMEyC~~GsLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHHHHHhccCcHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 9999999999999998874 56788888999999999999999999999999999999999999999999998554321
Q ss_pred ccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccccc
Q 011302 245 PKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINA 324 (489)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (489)
-.. ...
T Consensus 1388 ~~~--------------------------------------------------------------------------~~~ 1393 (1509)
T KOG4645|consen 1388 AQT--------------------------------------------------------------------------MPG 1393 (1509)
T ss_pred hhc--------------------------------------------------------------------------CCH
Confidence 000 001
Q ss_pred CCccccCCCCccCcchhcCC---CCCCcccHHHHHHHHHHHhhCCCCCCCCCc-HHHHHHHhcCC-CCCCCCCCCCchhH
Q 011302 325 RSKSFVGTHEYLAPEVISGQ---GHGSAVDWWTLGVFLYEMLYGTTPFKGENN-EKTLINILKKP-LTFPRIGVSSSKEF 399 (489)
Q Consensus 325 ~~~~~~Gt~~y~aPE~l~~~---~~~~~~DiwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~-~~~p~~~~~~~~~~ 399 (489)
.....+|||.|||||++.+. +...+.|||||||++.||+||+.||...++ .+++..+..+. +.+|.. .
T Consensus 1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~--l----- 1466 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPER--L----- 1466 (1509)
T ss_pred HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchh--h-----
Confidence 22356899999999999864 467899999999999999999999987654 45555555443 233433 1
Q ss_pred HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 400 EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 400 ~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
..+.+|||..||+.||++|+++. ||+.|-|=+.
T Consensus 1467 --s~~g~dFle~Cl~~dP~~Rw~~~----qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1467 --SSEGRDFLEHCLEQDPKMRWTAS----QLLEHAFGKS 1499 (1509)
T ss_pred --hHhHHHHHHHHHhcCchhhhHHH----HHHHhhcccc
Confidence 12479999999999999999987 9999977543
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=316.14 Aligned_cols=241 Identities=22% Similarity=0.271 Sum_probs=195.9
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS 161 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 161 (489)
..++|++.+.||+|+||.||++... ++.||+|.+..+.. ...+.+|+.+++.++||||+++++++..+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~-------~~~~~iK~~~~~~~-----~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEYT-------GQKVAVKNIKCDVT-----AQAFLEETAVMTKLHHKNLVRLLGVILHN 71 (254)
T ss_pred cHHHceeeeeeccCCCCceEecccC-------CCceEEEeecCcch-----HHHHHHHHHHHHhCCCCCcCeEEEEEcCC
Confidence 4578999999999999999998643 46789999865422 24567799999999999999999998765
Q ss_pred ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccc
Q 011302 162 HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKC 241 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~ 241 (489)
..|+||||+++++|.+++.......+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++..
T Consensus 72 -~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~ 150 (254)
T cd05083 72 -GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVG 150 (254)
T ss_pred -CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceec
Confidence 4799999999999999998765556899999999999999999999999999999999999999999999999987321
Q ss_pred ccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccc
Q 011302 242 DVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEP 321 (489)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (489)
..
T Consensus 151 ~~------------------------------------------------------------------------------ 152 (254)
T cd05083 151 SM------------------------------------------------------------------------------ 152 (254)
T ss_pred cc------------------------------------------------------------------------------
Confidence 10
Q ss_pred cccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHH
Q 011302 322 INARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFE 400 (489)
Q Consensus 322 ~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 400 (489)
......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+....+..+. ..+.. ..
T Consensus 153 ---~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~-~~------ 221 (254)
T cd05083 153 ---GVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY-RMEPP-EG------ 221 (254)
T ss_pred ---cCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC-CCCCC-Cc------
Confidence 0001123467999999998889999999999999999997 999999887776666555432 21111 11
Q ss_pred HHhhHHHHHHHHhhcCcccccCCC
Q 011302 401 EVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 401 ~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
.+..+.+||.+||..+|++||++.
T Consensus 222 ~~~~~~~li~~~l~~~p~~Rp~~~ 245 (254)
T cd05083 222 CPADVYVLMTSCWETEPKKRPSFH 245 (254)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHH
Confidence 113588999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=317.56 Aligned_cols=249 Identities=19% Similarity=0.278 Sum_probs=188.1
Q ss_pred eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEEEEEe
Q 011302 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVME 169 (489)
Q Consensus 90 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 169 (489)
+.||+|+||+||+|..... .....+|+|.+..... ......+.+|+.+++.++||||+++++.+.....+|+|||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~---~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e 75 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRG---MSKARVVVKELRASAT--PDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLE 75 (269)
T ss_pred CcCCccCCceEEEEEEecC---CCCeEEEEeecCccCC--hHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEE
Confidence 3689999999999976542 2456789998764321 2233456779999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhCCC---CCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCcc
Q 011302 170 YCPGGDLYAARQRQPG---KRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPK 246 (489)
Q Consensus 170 ~~~gg~L~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 246 (489)
|+++|+|.+++..... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 155 (269)
T cd05042 76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY 155 (269)
T ss_pred eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchh
Confidence 9999999999876432 2346778889999999999999999999999999999999999999999998732110000
Q ss_pred ccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCC
Q 011302 247 LLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARS 326 (489)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (489)
....
T Consensus 156 ----------------------------------------------------------------------------~~~~ 159 (269)
T cd05042 156 ----------------------------------------------------------------------------YITK 159 (269)
T ss_pred ----------------------------------------------------------------------------eecc
Confidence 0001
Q ss_pred ccccCCCCccCcchhcC-------CCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcC-CCCCCCCCCCCch
Q 011302 327 KSFVGTHEYLAPEVISG-------QGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKK-PLTFPRIGVSSSK 397 (489)
Q Consensus 327 ~~~~Gt~~y~aPE~l~~-------~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~~ 397 (489)
....+++.|+|||++.. ..++.++|||||||++|||++ |..||....+.+.+..+... ...++......
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 237 (269)
T cd05042 160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDL-- 237 (269)
T ss_pred CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccc--
Confidence 12246778999999753 346889999999999999998 88999887776666555443 22222221110
Q ss_pred hHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 398 EFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 398 ~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
.....+.+++..|+ .||++||++.
T Consensus 238 --~~~~~~~~~~~~~~-~dp~~Rpt~~ 261 (269)
T cd05042 238 --KYSDRWYEVMQFCW-LDPETRPTAE 261 (269)
T ss_pred --cCCHHHHHHHHHHh-cCcccccCHH
Confidence 11224678898888 5999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=319.40 Aligned_cols=253 Identities=22% Similarity=0.258 Sum_probs=190.6
Q ss_pred CCc-eeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec--
Q 011302 84 DHF-RLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA-- 160 (489)
Q Consensus 84 ~~y-~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-- 160 (489)
++| ++++.||+|+||+||++...... ...++.||+|++...... .....+.+|+.+|+.++||||+++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPAN-DGTGEMVAVKTLKRECGQ--QNTSGWKKEINILKTLYHENIVKYKGCCSEQG 79 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEcccc-CCCCceEEEEEeccccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 345 89999999999999998754321 225678999999754221 223456679999999999999999998764
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~ 240 (489)
...+|+||||+++|+|.+++... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccc
Confidence 34689999999999999988763 599999999999999999999999999999999999999999999999999843
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
+......
T Consensus 157 ~~~~~~~------------------------------------------------------------------------- 163 (283)
T cd05080 157 VPEGHEY------------------------------------------------------------------------- 163 (283)
T ss_pred cCCcchh-------------------------------------------------------------------------
Confidence 3210000
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHH--------------HHHHHhcCCC
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEK--------------TLINILKKPL 386 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~--------------~~~~i~~~~~ 386 (489)
........++..|+|||.+.+..++.++|||||||++|||++|..||....... .+........
T Consensus 164 --~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (283)
T cd05080 164 --YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGM 241 (283)
T ss_pred --hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCC
Confidence 000011235667999999998889999999999999999999999986533210 0011111111
Q ss_pred CCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 387 TFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 387 ~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
..+.. . .....+.+|+.+||+.+|++||++.
T Consensus 242 ~~~~~-~------~~~~~~~~li~~cl~~~p~~Rps~~ 272 (283)
T cd05080 242 RLPCP-K------NCPQEVYILMKNCWETEAKFRPTFR 272 (283)
T ss_pred CCCCC-C------CCCHHHHHHHHHHhccChhhCCCHH
Confidence 11110 0 1123589999999999999999997
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=318.10 Aligned_cols=255 Identities=21% Similarity=0.259 Sum_probs=202.9
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
+..++|++.+.||+|+||.||+|.++.... .....||+|.+..... ......+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~-~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGE-KVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS 80 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCC-CcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 345789999999999999999999875322 2345789998875532 2344567779999999999999999999887
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~ 240 (489)
...++||||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred -CceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccc
Confidence 78999999999999999987653 4589999999999999999999999999999999999999999999999999844
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
+.......
T Consensus 159 ~~~~~~~~------------------------------------------------------------------------ 166 (279)
T cd05057 159 LDVDEKEY------------------------------------------------------------------------ 166 (279)
T ss_pred ccCcccce------------------------------------------------------------------------
Confidence 32100000
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhH
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEF 399 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 399 (489)
......++..|+|||.+....++.++|||||||++|||++ |..||.+....+....+..+. ..+.... ..
T Consensus 167 ----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~-~~--- 237 (279)
T cd05057 167 ----HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE-RLPQPPI-CT--- 237 (279)
T ss_pred ----ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC-CCCCCCC-CC---
Confidence 0001124568999999988889999999999999999998 999999887766666655432 1222111 11
Q ss_pred HHHhhHHHHHHHHhhcCcccccCCC
Q 011302 400 EEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 400 ~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
..+.+++.+||..||++||++.
T Consensus 238 ---~~~~~~~~~~l~~~p~~Rp~~~ 259 (279)
T cd05057 238 ---IDVYMVLVKCWMIDAESRPTFK 259 (279)
T ss_pred ---HHHHHHHHHHcCCChhhCCCHH
Confidence 2488999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=315.89 Aligned_cols=249 Identities=20% Similarity=0.280 Sum_probs=187.3
Q ss_pred eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEEEEEe
Q 011302 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVME 169 (489)
Q Consensus 90 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 169 (489)
+.||+|+||.||+|.+.+. .+...+|+|.++..... .....+.+|+.+++.++||||+++++++.+....|+|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~---~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSG---YTPAQVVVKELRVSASV--QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCC---CCceEEEEEecCCCCCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEE
Confidence 3689999999999987642 24567899988654321 222356779999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhCC---CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCcc
Q 011302 170 YCPGGDLYAARQRQP---GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPK 246 (489)
Q Consensus 170 ~~~gg~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 246 (489)
|+++|+|.+++.... ...+++..++.++.|++.||+|||+++++||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~- 154 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED- 154 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcc-
Confidence 999999999887532 1245667788899999999999999999999999999999999999999999873211000
Q ss_pred ccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCC
Q 011302 247 LLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARS 326 (489)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (489)
.....
T Consensus 155 ---------------------------------------------------------------------------~~~~~ 159 (269)
T cd05087 155 ---------------------------------------------------------------------------YYVTP 159 (269)
T ss_pred ---------------------------------------------------------------------------eeecC
Confidence 00011
Q ss_pred ccccCCCCccCcchhcCC-------CCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhc-CCCCCCCCCCCCch
Q 011302 327 KSFVGTHEYLAPEVISGQ-------GHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILK-KPLTFPRIGVSSSK 397 (489)
Q Consensus 327 ~~~~Gt~~y~aPE~l~~~-------~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~-~~~~~p~~~~~~~~ 397 (489)
....|++.|+|||++.+. .++.++|||||||++|||++ |..||...+..+....... ....++......
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 237 (269)
T cd05087 160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKL-- 237 (269)
T ss_pred CCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCC--
Confidence 223578899999998643 35789999999999999996 9999987766554433322 222222211110
Q ss_pred hHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 398 EFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 398 ~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
.....+.+||.+|+ .+|++||++.
T Consensus 238 --~~~~~~~~l~~~c~-~~P~~Rpt~~ 261 (269)
T cd05087 238 --PLSDRWYEVMQFCW-LQPEQRPSAE 261 (269)
T ss_pred --CCChHHHHHHHHHh-cCcccCCCHH
Confidence 01124789999998 6899999997
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=331.37 Aligned_cols=270 Identities=29% Similarity=0.396 Sum_probs=204.8
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccceeec-
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAEFEA- 160 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~- 160 (489)
.++|.+.+.||+|+||.||+|.+.. +++.||+|.+.+.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~vK~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~ 79 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRR-----TKEVVALKKIFDAFRN-ATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE 79 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcC-----CCeEEEEEeeccccCc-chhhhhhhHHHHHHHHhcCCCCccceeeeeccC
Confidence 4689999999999999999999875 4678999988543211 12234566799999999 99999999998864
Q ss_pred -CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 161 -SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 161 -~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
...+|+||||++ ++|..++... .+.+..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.
T Consensus 80 ~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 80 NDKDIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred CCceEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 347899999995 6998887653 68888999999999999999999999999999999999999999999999984
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
.+......
T Consensus 156 ~~~~~~~~------------------------------------------------------------------------ 163 (337)
T cd07852 156 SLSELEEN------------------------------------------------------------------------ 163 (337)
T ss_pred cccccccc------------------------------------------------------------------------
Confidence 33210000
Q ss_pred cccccCCccccCCCCccCcchhcC-CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCC---------
Q 011302 320 EPINARSKSFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFP--------- 389 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p--------- 389 (489)
........+.||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+...++.......+
T Consensus 164 -~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (337)
T cd07852 164 -PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKS 242 (337)
T ss_pred -ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHh
Confidence 00011223468999999998865 4478899999999999999999999988766555444332110000
Q ss_pred -----------CCCCCCchh--HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 390 -----------RIGVSSSKE--FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 390 -----------~~~~~~~~~--~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
......... .....++.+||.+||+.||++||++. ++++||||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~----~il~~~~~~~~ 301 (337)
T cd07852 243 PFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAE----EALEHPYVAQF 301 (337)
T ss_pred hhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHH----HHhhChhhhhh
Confidence 000000000 01123589999999999999999987 99999999876
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=314.27 Aligned_cols=250 Identities=23% Similarity=0.298 Sum_probs=201.6
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
..+|++.+.||+|+||.||+|.+.. +..+|+|.+...... ...+..|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~------~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLE------KRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERS 72 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeC------CCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCC
Confidence 4689999999999999999998763 356899988754322 124567999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
..|+||||+++++|.+++.... ..+++..+..++.|++.||+|||+++++||||||+||+++.++.+||+|||++....
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 151 (256)
T cd05112 73 PICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVL 151 (256)
T ss_pred ceEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecc
Confidence 9999999999999999887643 468899999999999999999999999999999999999999999999999873221
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
.. .
T Consensus 152 ~~-----------------------------------------------------------------------------~ 154 (256)
T cd05112 152 DD-----------------------------------------------------------------------------Q 154 (256)
T ss_pred cC-----------------------------------------------------------------------------c
Confidence 00 0
Q ss_pred ccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHH
Q 011302 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEE 401 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 401 (489)
........++..|+|||.+.+..++.++|||||||++|||++ |..||...........+..+...+.... ..
T Consensus 155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~----- 227 (256)
T cd05112 155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRL--AS----- 227 (256)
T ss_pred ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCC--CC-----
Confidence 000112235678999999998889999999999999999998 9999988877777766654422111111 11
Q ss_pred HhhHHHHHHHHhhcCcccccCCCCChHHHHc
Q 011302 402 VVKLQDLISKLLVKNPKKRIGSLKGSVEIKR 432 (489)
Q Consensus 402 ~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~ 432 (489)
..+.+|+.+||+.+|++||++. ++++
T Consensus 228 -~~~~~l~~~~l~~~p~~Rp~~~----~~l~ 253 (256)
T cd05112 228 -QSVYELMQHCWKERPEDRPSFS----LLLH 253 (256)
T ss_pred -HHHHHHHHHHcccChhhCCCHH----HHHH
Confidence 2589999999999999999987 6665
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=317.98 Aligned_cols=243 Identities=23% Similarity=0.287 Sum_probs=189.3
Q ss_pred eeeccCCceeEEEEEEccCCC--CCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEEEE
Q 011302 90 RRLGSGDIGNVYLCQIRNPMV--GLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLV 167 (489)
Q Consensus 90 ~~lG~G~fg~Vy~a~~~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV 167 (489)
+.||+|+||.||+|.++.... ......||+|.+.... ......+..|..+++.++||||+++++++..+...++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 368999999999999865321 1234557888876543 23344567799999999999999999999999999999
Q ss_pred EeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCc--------EEEcccCCCc
Q 011302 168 MEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGH--------IMLSDFDLSF 239 (489)
Q Consensus 168 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~--------vkl~DFG~a~ 239 (489)
|||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++. ++++|||++.
T Consensus 78 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 78 QEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999999987653 36889999999999999999999999999999999999987765 6899999863
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
...
T Consensus 157 ~~~----------------------------------------------------------------------------- 159 (258)
T cd05078 157 TVL----------------------------------------------------------------------------- 159 (258)
T ss_pred ccC-----------------------------------------------------------------------------
Confidence 211
Q ss_pred cccccCCccccCCCCccCcchhcCC-CCCCcccHHHHHHHHHHHhhC-CCCCCCCCcHHHHHHHhcCCCCCCCCCCCCch
Q 011302 320 EPINARSKSFVGTHEYLAPEVISGQ-GHGSAVDWWTLGVFLYEMLYG-TTPFKGENNEKTLINILKKPLTFPRIGVSSSK 397 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 397 (489)
......|++.|+|||++.+. .++.++|||||||++|||++| ..||...+...... +......+|....
T Consensus 160 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~~---- 229 (258)
T cd05078 160 -----PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRHQLPAPKW---- 229 (258)
T ss_pred -----CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHccccCCCCCc----
Confidence 01123578899999999874 478999999999999999998 56766655544332 3333333332211
Q ss_pred hHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHc
Q 011302 398 EFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKR 432 (489)
Q Consensus 398 ~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~ 432 (489)
.++.+||.+||+.||++||++. ++++
T Consensus 230 -----~~~~~li~~~l~~~p~~Rps~~----~il~ 255 (258)
T cd05078 230 -----TELANLINQCMDYEPDFRPSFR----AIIR 255 (258)
T ss_pred -----HHHHHHHHHHhccChhhCCCHH----HHHH
Confidence 2488999999999999999997 6665
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=319.18 Aligned_cols=258 Identities=23% Similarity=0.288 Sum_probs=195.5
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC--c
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS--H 162 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~ 162 (489)
-|++++.||+|+||.||+|++.... ..++..||+|.++.... ......+.+|+.+++.++||||+++++++... .
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEG-DNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCC-CCccceEEEEEcCcccc--HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 4789999999999999999865321 12578899999875432 23345677899999999999999999988765 6
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
..|+||||++|++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 7899999999999999987643 468999999999999999999999999999999999999999999999999984321
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
.....
T Consensus 161 ~~~~~--------------------------------------------------------------------------- 165 (284)
T cd05079 161 TDKEY--------------------------------------------------------------------------- 165 (284)
T ss_pred cCccc---------------------------------------------------------------------------
Confidence 10000
Q ss_pred ccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCC--------------cHHHHHHHhcCCCCC
Q 011302 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGEN--------------NEKTLINILKKPLTF 388 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~--------------~~~~~~~i~~~~~~~ 388 (489)
........|+..|+|||++.+..++.++|||||||++|||+++..|+.... ...............
T Consensus 166 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (284)
T cd05079 166 YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRL 245 (284)
T ss_pred eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCccC
Confidence 000122357778999999998889999999999999999999877653211 111111222222222
Q ss_pred CCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHc
Q 011302 389 PRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKR 432 (489)
Q Consensus 389 p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~ 432 (489)
+.... ....+.+||.+||+.||++||++. ++++
T Consensus 246 ~~~~~-------~~~~~~~li~~~l~~~p~~Rpt~~----~il~ 278 (284)
T cd05079 246 PRPPN-------CPEEVYQLMRKCWEFQPSKRTTFQ----NLIE 278 (284)
T ss_pred CCCCC-------CCHHHHHHHHHHccCCcccCcCHH----HHHH
Confidence 21111 123589999999999999999987 6654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=313.36 Aligned_cols=233 Identities=29% Similarity=0.414 Sum_probs=186.1
Q ss_pred CCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEEEEEeecCCC
Q 011302 95 GDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGG 174 (489)
Q Consensus 95 G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 174 (489)
|.||.||+|+++. +++.||+|.+.+.... ..|...+....||||+++++++.+.+..|+||||++||
T Consensus 4 g~~~~v~~~~~~~-----~~~~~~~K~i~~~~~~--------~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 70 (237)
T cd05576 4 GVIDKVLLVMDTR-----TQQTFILKGLRKSSEY--------SRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGG 70 (237)
T ss_pred cccceEEEEEEcc-----CCcEEEEEeecchhhh--------hhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCC
Confidence 8999999999987 5788999999765321 12444455567999999999999999999999999999
Q ss_pred chHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCccccCCcchh
Q 011302 175 DLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSF 254 (489)
Q Consensus 175 ~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~ 254 (489)
+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++..+..
T Consensus 71 ~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~----------- 137 (237)
T cd05576 71 KLWSHISKF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED----------- 137 (237)
T ss_pred CHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccc-----------
Confidence 999988765 4589999999999999999999999999999999999999999999999998632210
Q ss_pred HHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCccccCCCC
Q 011302 255 EAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHE 334 (489)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~ 334 (489)
......++..
T Consensus 138 ----------------------------------------------------------------------~~~~~~~~~~ 147 (237)
T cd05576 138 ----------------------------------------------------------------------SCDGEAVENM 147 (237)
T ss_pred ----------------------------------------------------------------------ccccCCcCcc
Confidence 0011245678
Q ss_pred ccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhh
Q 011302 335 YLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLV 414 (489)
Q Consensus 335 y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~ 414 (489)
|+|||.+.+..++.++||||+||++|||++|..||....... . ......+|.. ....+++||.+||+
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~--~--~~~~~~~~~~---------~~~~~~~li~~~l~ 214 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI--N--THTTLNIPEW---------VSEEARSLLQQLLQ 214 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc--c--cccccCCccc---------CCHHHHHHHHHHcc
Confidence 999999988889999999999999999999999886432110 0 0011112211 12358999999999
Q ss_pred cCcccccCCCC-ChHHHHcCCCc
Q 011302 415 KNPKKRIGSLK-GSVEIKRHEFF 436 (489)
Q Consensus 415 ~dP~~R~~~~~-~~~~ll~hp~f 436 (489)
.||++|+++.. .++++++||||
T Consensus 215 ~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 215 FNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred CCHHHhcCCCccchHHHHcCCCC
Confidence 99999999743 36799999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=319.65 Aligned_cols=261 Identities=30% Similarity=0.433 Sum_probs=205.6
Q ss_pred ceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEE
Q 011302 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSC 165 (489)
Q Consensus 86 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 165 (489)
|++.+.||+|+||.||+|+... +++.||+|++...... ......+..|+.+++.++|+||+++++++.+.+..|
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~-----~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 74 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKK-----TGEIVALKKIRLDNEE-EGIPSTALREISLLKELKHPNIVKLLDVIHTERKLY 74 (282)
T ss_pred CeeehcccccCcceEEEeeecC-----CCcEEEEEEecccccc-ccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceE
Confidence 6678899999999999999886 5788999999865311 223345667999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCc
Q 011302 166 LVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVP 245 (489)
Q Consensus 166 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~ 245 (489)
+||||++ ++|.+++.... ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.+||+|||+++......
T Consensus 75 ~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 152 (282)
T cd07829 75 LVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL 152 (282)
T ss_pred EEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence 9999996 69999887653 469999999999999999999999999999999999999999999999999874321100
Q ss_pred cccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccC
Q 011302 246 KLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINAR 325 (489)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (489)
..
T Consensus 153 ------------------------------------------------------------------------------~~ 154 (282)
T cd07829 153 ------------------------------------------------------------------------------RT 154 (282)
T ss_pred ------------------------------------------------------------------------------cc
Confidence 00
Q ss_pred CccccCCCCccCcchhcCC-CCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcC------------------CC
Q 011302 326 SKSFVGTHEYLAPEVISGQ-GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK------------------PL 386 (489)
Q Consensus 326 ~~~~~Gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------------~~ 386 (489)
.....++..|+|||.+.+. .++.++|||||||++|||++|..||.+.+..+.+.++... ..
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 1122467789999999876 7899999999999999999999999888766555444321 00
Q ss_pred CCCCCCCCCc-hhH-HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 387 TFPRIGVSSS-KEF-EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 387 ~~p~~~~~~~-~~~-~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
.++....... ..+ .....+.++|.+||..||++||++. +++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~----~~l~~p~~ 282 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAK----EALKHPYF 282 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHH----HHhhCcCC
Confidence 1111100000 000 1134689999999999999999987 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=315.59 Aligned_cols=244 Identities=20% Similarity=0.235 Sum_probs=188.4
Q ss_pred eeeccCCceeEEEEEEccCCC-------CCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 90 RRLGSGDIGNVYLCQIRNPMV-------GLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 90 ~~lG~G~fg~Vy~a~~~~~~~-------~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
+.||+|+||.||+|+...... ......+++|++..... .....+.+|+.+++.++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR---DISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh---hHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 368999999999998643211 11234688998865432 23345667889999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCc-------EEEccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGH-------IMLSDF 235 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~-------vkl~DF 235 (489)
..++||||+++|+|..++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++. +|++||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCEEEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 999999999999998877654 256899999999999999999999999999999999999987664 899999
Q ss_pred CCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCc
Q 011302 236 DLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDP 315 (489)
Q Consensus 236 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (489)
|++....
T Consensus 157 g~~~~~~------------------------------------------------------------------------- 163 (262)
T cd05077 157 GIPITVL------------------------------------------------------------------------- 163 (262)
T ss_pred CCCcccc-------------------------------------------------------------------------
Confidence 9873211
Q ss_pred cccccccccCCccccCCCCccCcchhc-CCCCCCcccHHHHHHHHHHHh-hCCCCCCCCCcHHHHHHHhcCCCCCCCCCC
Q 011302 316 EVVAEPINARSKSFVGTHEYLAPEVIS-GQGHGSAVDWWTLGVFLYEML-YGTTPFKGENNEKTLINILKKPLTFPRIGV 393 (489)
Q Consensus 316 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~-~~~~~~~~DiwSlGvil~ell-tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~ 393 (489)
......|+..|+|||.+. +..++.++|||||||++|||+ .|..||......+. ............
T Consensus 164 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~~~~~~~~~~~--- 230 (262)
T cd05077 164 ---------SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-ERFYEGQCMLVT--- 230 (262)
T ss_pred ---------CcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-HHHHhcCccCCC---
Confidence 011235788899999987 466899999999999999998 58999877654332 222222221111
Q ss_pred CCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 394 SSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 394 ~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
+. ..++.+||.+||+.||++||++. +|+++
T Consensus 231 ~~------~~~~~~li~~cl~~dp~~Rp~~~----~il~~ 260 (262)
T cd05077 231 PS------CKELADLMTHCMNYDPNQRPFFR----AIMRD 260 (262)
T ss_pred CC------hHHHHHHHHHHcCCChhhCcCHH----HHHHh
Confidence 11 12588999999999999999997 77765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=311.31 Aligned_cols=240 Identities=23% Similarity=0.320 Sum_probs=192.3
Q ss_pred eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEEEEEe
Q 011302 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVME 169 (489)
Q Consensus 90 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 169 (489)
+.||+|+||.||+|...+ +..||+|++...... .....+..|+.+++.++||||+++++++...+..|+|||
T Consensus 1 ~~ig~g~~g~vy~~~~~~------~~~~a~K~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 72 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKD------KTPVAVKTCKEDLPQ--ELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVME 72 (250)
T ss_pred CccCCCCCceEEEEEecC------CcEEEEEecCCcCCH--HHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEE
Confidence 368999999999998653 567899998654321 222356779999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCccccC
Q 011302 170 YCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLR 249 (489)
Q Consensus 170 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 249 (489)
|+++++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 73 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~---- 147 (250)
T cd05085 73 LVPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI---- 147 (250)
T ss_pred CCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccc----
Confidence 999999999886543 468899999999999999999999999999999999999999999999999873211000
Q ss_pred CcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCccc
Q 011302 250 PKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSF 329 (489)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (489)
.......
T Consensus 148 -------------------------------------------------------------------------~~~~~~~ 154 (250)
T cd05085 148 -------------------------------------------------------------------------YSSSGLK 154 (250)
T ss_pred -------------------------------------------------------------------------cccCCCC
Confidence 0000111
Q ss_pred cCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCC-CCCCCCCCCchhHHHHhhHHH
Q 011302 330 VGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPL-TFPRIGVSSSKEFEEVVKLQD 407 (489)
Q Consensus 330 ~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~~~~~~~l~~ 407 (489)
.++..|+|||++.+..++.++|||||||++|||++ |..||.+.........+..... ..+. . ....+.+
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~------~~~~~~~ 225 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQ---K------CPDDVYK 225 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCC---C------CCHHHHH
Confidence 34567999999998889999999999999999998 9999998877666666554321 1111 1 1235899
Q ss_pred HHHHHhhcCcccccCCC
Q 011302 408 LISKLLVKNPKKRIGSL 424 (489)
Q Consensus 408 li~~~L~~dP~~R~~~~ 424 (489)
|+.+||..+|++||++.
T Consensus 226 li~~~l~~~p~~Rp~~~ 242 (250)
T cd05085 226 VMQRCWDYKPENRPKFS 242 (250)
T ss_pred HHHHHcccCcccCCCHH
Confidence 99999999999999987
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=314.71 Aligned_cols=253 Identities=26% Similarity=0.335 Sum_probs=200.6
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
+..++|.+.+.||+|+||.||+|.+.+.. .....||||....... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~--~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 78 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPE--NEKIAVAVKTCKNCTS--PSVREKFLQEAYIMRQFDHPHIVKLIGVITE 78 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCC--CCCcceEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCchhceeEEEcC
Confidence 34568999999999999999999976531 1345789998865431 1234567789999999999999999998876
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~ 240 (489)
...|+||||+++|+|.+++.... ..+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||+++.
T Consensus 79 -~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 79 -NPVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred -CCcEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeee
Confidence 45789999999999999987643 4689999999999999999999999999999999999999999999999999743
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
+.....
T Consensus 157 ~~~~~~-------------------------------------------------------------------------- 162 (270)
T cd05056 157 LEDESY-------------------------------------------------------------------------- 162 (270)
T ss_pred cccccc--------------------------------------------------------------------------
Confidence 211000
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhH
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEF 399 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 399 (489)
.......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+....+..+... +... ..
T Consensus 163 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~-~~---- 233 (270)
T cd05056 163 ---YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL-PMPP-NC---- 233 (270)
T ss_pred ---eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC-CCCC-CC----
Confidence 00011234568999999988889999999999999999996 99999988877766666554321 1111 11
Q ss_pred HHHhhHHHHHHHHhhcCcccccCCC
Q 011302 400 EEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 400 ~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
+..+.+||.+||..+|++||++.
T Consensus 234 --~~~~~~li~~~l~~~P~~Rpt~~ 256 (270)
T cd05056 234 --PPTLYSLMTKCWAYDPSKRPRFT 256 (270)
T ss_pred --CHHHHHHHHHHcCCChhhCcCHH
Confidence 12589999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=336.37 Aligned_cols=248 Identities=33% Similarity=0.484 Sum_probs=194.6
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc--
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH-- 162 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-- 162 (489)
-+...+.||+|+||.||+++++. +++.||||.+++... ....++..+|+++|++++|+|||+++++=++..
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnke-----tG~~vAvK~~~~~~~--~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~ 86 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKE-----TGRLVAVKTFNKESS--LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLG 86 (732)
T ss_pred ceeehhhhcCCccceeeeecccc-----cccchhHHhhhhhcc--cchHHHHHHHHHHHHHcCchhhhhhcccCCccccC
Confidence 34556789999999999999887 789999999987652 234566778999999999999999999766544
Q ss_pred ----eEEEEEeecCCCchHHHHHhCC-CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEec--cCCc--EEEc
Q 011302 163 ----YSCLVMEYCPGGDLYAARQRQP-GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVR--EDGH--IMLS 233 (489)
Q Consensus 163 ----~~~lV~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~--~~~~--vkl~ 233 (489)
...+|||||.||+|+..+++-. ...|++.+.+.++..++.||.|||++|||||||||.||++- .+|. -||+
T Consensus 87 ~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLt 166 (732)
T KOG4250|consen 87 LVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLT 166 (732)
T ss_pred cccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeee
Confidence 4689999999999999987642 25699999999999999999999999999999999999985 4454 5999
Q ss_pred ccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccC
Q 011302 234 DFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLD 313 (489)
Q Consensus 234 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (489)
|||.|+.++.
T Consensus 167 DfG~Arel~d---------------------------------------------------------------------- 176 (732)
T KOG4250|consen 167 DFGAARELDD---------------------------------------------------------------------- 176 (732)
T ss_pred cccccccCCC----------------------------------------------------------------------
Confidence 9999965542
Q ss_pred CccccccccccCCccccCCCCccCcchhcC-CCCCCcccHHHHHHHHHHHhhCCCCCCCCC----cHHHHHHHhcC----
Q 011302 314 DPEVVAEPINARSKSFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGEN----NEKTLINILKK---- 384 (489)
Q Consensus 314 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~----~~~~~~~i~~~---- 384 (489)
+....+++||+.|++||++-. ..|+.-+|.|||||++|+++||..||.... +.+....+..+
T Consensus 177 ---------~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 177 ---------NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG 247 (732)
T ss_pred ---------CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence 224567899999999999985 778999999999999999999999995432 33344444321
Q ss_pred -----------CCC----CCCCCCCCchhHHHHhhHHHHHHHHhhcCccccc
Q 011302 385 -----------PLT----FPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRI 421 (489)
Q Consensus 385 -----------~~~----~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~ 421 (489)
++. +|.....+. .....+..++..+|.++|.+|.
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~---~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSR---GLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccH---HHHhhhhHHHHHHHhhhHHHhC
Confidence 111 111111111 1122466889999999999999
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=315.85 Aligned_cols=242 Identities=22% Similarity=0.310 Sum_probs=190.6
Q ss_pred eeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccceeecCceEEEEEe
Q 011302 91 RLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAEFEASHYSCLVME 169 (489)
Q Consensus 91 ~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lV~E 169 (489)
.||+|+||.||+|++.++. ....+|+|.++.... ......+..|+.++.++ +||||+++++++...+..|+|||
T Consensus 2 ~lg~g~~g~v~~~~~~~~~---~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 76 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDG---LRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 76 (270)
T ss_pred cCCCCCCceEEEEEEcCCC---CeeEEEEEEccccCC--HHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEE
Confidence 5899999999999987632 124578888864221 12334566799999999 79999999999999999999999
Q ss_pred ecCCCchHHHHHhCC--------------CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEccc
Q 011302 170 YCPGGDLYAARQRQP--------------GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235 (489)
Q Consensus 170 ~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DF 235 (489)
|+++|+|.+++.... ...+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+||
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCC
Confidence 999999999987532 134788999999999999999999999999999999999999999999999
Q ss_pred CCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCc
Q 011302 236 DLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDP 315 (489)
Q Consensus 236 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (489)
|++......
T Consensus 157 gl~~~~~~~----------------------------------------------------------------------- 165 (270)
T cd05047 157 GLSRGQEVY----------------------------------------------------------------------- 165 (270)
T ss_pred CCccccchh-----------------------------------------------------------------------
Confidence 987311000
Q ss_pred cccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCC
Q 011302 316 EVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVS 394 (489)
Q Consensus 316 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~ 394 (489)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+.+..+.... ..+.. ..
T Consensus 166 --------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-~~~~~-~~ 235 (270)
T cd05047 166 --------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-RLEKP-LN 235 (270)
T ss_pred --------hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC-CCCCC-Cc
Confidence 00001124567999999998889999999999999999996 999998887777666664431 11111 11
Q ss_pred CchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 395 SSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 395 ~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
....+.+|+.+||..||.+||++.
T Consensus 236 ------~~~~~~~li~~~l~~~p~~Rps~~ 259 (270)
T cd05047 236 ------CDDEVYDLMRQCWREKPYERPSFA 259 (270)
T ss_pred ------CCHHHHHHHHHHcccChhhCCCHH
Confidence 112588999999999999999997
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=316.38 Aligned_cols=243 Identities=23% Similarity=0.281 Sum_probs=188.3
Q ss_pred eeccCCceeEEEEEEccCC-------------------CCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCc
Q 011302 91 RLGSGDIGNVYLCQIRNPM-------------------VGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFL 151 (489)
Q Consensus 91 ~lG~G~fg~Vy~a~~~~~~-------------------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI 151 (489)
+||+|+||.||+|...... .......+++|++..... .....+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR---DIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH---HHHHHHHHHHHHHhcCCCCCe
Confidence 6999999999999864211 011234689999876532 233456778899999999999
Q ss_pred ccccceeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCC---
Q 011302 152 PTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDG--- 228 (489)
Q Consensus 152 v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~--- 228 (489)
+++++++.++...|+||||+++|+|..++... .+.+++..+..++.||+.||+|||++||+||||||+|||++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999998888653 35789999999999999999999999999999999999998654
Q ss_pred ----cEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCC
Q 011302 229 ----HIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDG 304 (489)
Q Consensus 229 ----~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (489)
.+||+|||++.....
T Consensus 158 ~~~~~~kl~d~g~~~~~~~------------------------------------------------------------- 176 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALS------------------------------------------------------------- 176 (274)
T ss_pred CccceeeecCCcccccccc-------------------------------------------------------------
Confidence 489999998622100
Q ss_pred CCCCccccCCccccccccccCCccccCCCCccCcchhcC-CCCCCcccHHHHHHHHHHHh-hCCCCCCCCCcHHHHHHHh
Q 011302 305 DHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEML-YGTTPFKGENNEKTLINIL 382 (489)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell-tG~~Pf~~~~~~~~~~~i~ 382 (489)
.....|+..|+|||.+.+ ..++.++|||||||++|||+ +|..||.+....+... ..
T Consensus 177 ---------------------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-~~ 234 (274)
T cd05076 177 ---------------------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-FY 234 (274)
T ss_pred ---------------------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-HH
Confidence 011246788999999876 45799999999999999995 7999998776554322 22
Q ss_pred cCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 383 KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 383 ~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
......|... ...+.+||.+||+.+|++||++. +++++
T Consensus 235 ~~~~~~~~~~---------~~~~~~li~~cl~~~p~~Rps~~----~il~~ 272 (274)
T cd05076 235 EKKHRLPEPS---------CKELATLISQCLTYEPTQRPSFR----TILRD 272 (274)
T ss_pred HhccCCCCCC---------ChHHHHHHHHHcccChhhCcCHH----HHHHh
Confidence 2222233211 12488999999999999999987 77654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=316.16 Aligned_cols=257 Identities=17% Similarity=0.206 Sum_probs=202.1
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
+..++|++.+.||+|+||.||+|.+.... ......|++|.+..... ......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~-~~~~~~v~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 79 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEK-PGKEEEVFVKTVKDHAS--EIQVTLLLQESCLLYGLSHQNILPILHVCIE 79 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCC-CCceeEEEEEEccCCCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 34578999999999999999999987632 12367899998864321 2334567779999999999999999998665
Q ss_pred -CceEEEEEeecCCCchHHHHHhCCC------CCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEc
Q 011302 161 -SHYSCLVMEYCPGGDLYAARQRQPG------KRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLS 233 (489)
Q Consensus 161 -~~~~~lV~E~~~gg~L~~~l~~~~~------~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~ 233 (489)
+...++++||+++|+|.+++..... ..+++..+..++.|++.||+|||+++++||||||+|||++.++.+||+
T Consensus 80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEEC
Confidence 5788999999999999998876422 458899999999999999999999999999999999999999999999
Q ss_pred ccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccC
Q 011302 234 DFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLD 313 (489)
Q Consensus 234 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (489)
|||+++.+......
T Consensus 160 d~g~~~~~~~~~~~------------------------------------------------------------------ 173 (280)
T cd05043 160 DNALSRDLFPMDYH------------------------------------------------------------------ 173 (280)
T ss_pred CCCCcccccCCceE------------------------------------------------------------------
Confidence 99998543210000
Q ss_pred CccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCC
Q 011302 314 DPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIG 392 (489)
Q Consensus 314 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 392 (489)
.......++..|+|||++.+..++.++|||||||++||+++ |+.||...+..+....+..+ ..++..
T Consensus 174 ----------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~- 241 (280)
T cd05043 174 ----------CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG-YRLAQP- 241 (280)
T ss_pred ----------EeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC-CCCCCC-
Confidence 00011235678999999999889999999999999999998 99999888776655554443 222211
Q ss_pred CCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 393 VSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 393 ~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
.... ..+.+++.+||..||++||++.
T Consensus 242 ~~~~------~~~~~li~~~l~~~p~~Rps~~ 267 (280)
T cd05043 242 INCP------DELFAVMACCWALDPEERPSFS 267 (280)
T ss_pred CcCC------HHHHHHHHHHcCCChhhCCCHH
Confidence 1111 2489999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=312.22 Aligned_cols=248 Identities=19% Similarity=0.236 Sum_probs=189.7
Q ss_pred eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee-cCceEEEEE
Q 011302 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE-ASHYSCLVM 168 (489)
Q Consensus 90 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-~~~~~~lV~ 168 (489)
+.||+|+||.||+|.+.... .....+|||.+..... ......+.+|+.+++.++||||+++++++. .++..|+||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~--~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSD--GQKIHCAVKSLNRITD--LEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCC--CceEEEEEEecCccCC--HHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEE
Confidence 36899999999999976432 2456799998854211 123456677999999999999999999765 556789999
Q ss_pred eecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCcccc
Q 011302 169 EYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLL 248 (489)
Q Consensus 169 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 248 (489)
||+.+|+|.+++.... ..+++..+..++.||+.||+|||+.+|+||||||+|||++.++.+||+|||+++.+......
T Consensus 77 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~- 154 (262)
T cd05058 77 PYMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY- 154 (262)
T ss_pred ecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcce-
Confidence 9999999999987643 44677788889999999999999999999999999999999999999999998432110000
Q ss_pred CCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCcc
Q 011302 249 RPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKS 328 (489)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (489)
.......
T Consensus 155 -------------------------------------------------------------------------~~~~~~~ 161 (262)
T cd05058 155 -------------------------------------------------------------------------SVHNHTG 161 (262)
T ss_pred -------------------------------------------------------------------------eeccccc
Confidence 0000112
Q ss_pred ccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHH
Q 011302 329 FVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQD 407 (489)
Q Consensus 329 ~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~ 407 (489)
..+++.|+|||.+.+..++.++|||||||++|||++ |.+||...+..+....+..+... +. .... +..+.+
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~------~~~~~~ 233 (262)
T cd05058 162 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRL-LQ-PEYC------PDPLYE 233 (262)
T ss_pred CcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCC-CC-CCcC------CHHHHH
Confidence 246778999999998889999999999999999999 57778777766665555443211 11 1111 124889
Q ss_pred HHHHHhhcCcccccCCC
Q 011302 408 LISKLLVKNPKKRIGSL 424 (489)
Q Consensus 408 li~~~L~~dP~~R~~~~ 424 (489)
++.+||..+|++||++.
T Consensus 234 li~~cl~~~p~~Rp~~~ 250 (262)
T cd05058 234 VMLSCWHPKPEMRPTFS 250 (262)
T ss_pred HHHHHcCCChhhCCCHH
Confidence 99999999999999997
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=320.01 Aligned_cols=255 Identities=21% Similarity=0.273 Sum_probs=197.8
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS 161 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 161 (489)
..++|+..+.||+|+||.||+|.+..+... ....||+|.+...... .....+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~ 81 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGET-VKIPVAIKILNETTGP--KANVEFMDEALIMASMDHPHLVRLLGVCLSP 81 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCc-ceeeEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence 457899999999999999999998754322 2346899988754322 2233567799999999999999999988754
Q ss_pred ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccc
Q 011302 162 HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKC 241 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~ 241 (489)
..++|+||+++|+|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccc
Confidence 4689999999999999887642 46889999999999999999999999999999999999999999999999998433
Q ss_pred ccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccc
Q 011302 242 DVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEP 321 (489)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (489)
.....
T Consensus 160 ~~~~~--------------------------------------------------------------------------- 164 (303)
T cd05110 160 EGDEK--------------------------------------------------------------------------- 164 (303)
T ss_pred cCccc---------------------------------------------------------------------------
Confidence 21000
Q ss_pred cccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHH
Q 011302 322 INARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFE 400 (489)
Q Consensus 322 ~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 400 (489)
........++..|+|||.+.+..++.++|||||||++|||++ |..||.+........ +......++.... .
T Consensus 165 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~-~----- 236 (303)
T cd05110 165 -EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD-LLEKGERLPQPPI-C----- 236 (303)
T ss_pred -ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHCCCCCCCCCC-C-----
Confidence 000112245778999999999989999999999999999997 999998876554433 3333222222111 1
Q ss_pred HHhhHHHHHHHHhhcCcccccCCCC
Q 011302 401 EVVKLQDLISKLLVKNPKKRIGSLK 425 (489)
Q Consensus 401 ~~~~l~~li~~~L~~dP~~R~~~~~ 425 (489)
...+.++|.+||..+|++||++.+
T Consensus 237 -~~~~~~li~~c~~~~p~~Rp~~~~ 260 (303)
T cd05110 237 -TIDVYMVMVKCWMIDADSRPKFKE 260 (303)
T ss_pred -CHHHHHHHHHHcCCChhhCcCHHH
Confidence 124889999999999999999973
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=310.57 Aligned_cols=255 Identities=25% Similarity=0.345 Sum_probs=204.6
Q ss_pred ceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEE
Q 011302 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSC 165 (489)
Q Consensus 86 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 165 (489)
+++.+.||.|+||.||+|++..... .....||+|++...... .....+..|+.+++.++|+||+++++++.+.+..|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~-~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSG-EKEVEVAVKTLKEDADE--QQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCC-CCCceEEEEEccCCCCh--HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeE
Confidence 4577899999999999999886321 23478999999755322 13456777999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCc
Q 011302 166 LVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVP 245 (489)
Q Consensus 166 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~ 245 (489)
+||||+++++|.+++.......+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||+++......
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 99999999999999876543338999999999999999999999999999999999999999999999999974332100
Q ss_pred cccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccC
Q 011302 246 KLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINAR 325 (489)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (489)
. ..
T Consensus 158 ~-----------------------------------------------------------------------------~~ 160 (258)
T smart00219 158 Y-----------------------------------------------------------------------------YK 160 (258)
T ss_pred c-----------------------------------------------------------------------------cc
Confidence 0 00
Q ss_pred CccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhh
Q 011302 326 SKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVK 404 (489)
Q Consensus 326 ~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~ 404 (489)
.....+++.|+|||.+.+..++.++|||||||++|+|++ |.+||...+.......+......... ... ...
T Consensus 161 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~------~~~ 232 (258)
T smart00219 161 KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKP--ENC------PPE 232 (258)
T ss_pred cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC--CcC------CHH
Confidence 001126789999999988889999999999999999998 89999888777777776654322111 111 225
Q ss_pred HHHHHHHHhhcCcccccCCCCChHHHHc
Q 011302 405 LQDLISKLLVKNPKKRIGSLKGSVEIKR 432 (489)
Q Consensus 405 l~~li~~~L~~dP~~R~~~~~~~~~ll~ 432 (489)
+.+++.+||..||++||++. ++++
T Consensus 233 ~~~~i~~~l~~~p~~Rpt~~----~ll~ 256 (258)
T smart00219 233 IYKLMLQCWAEDPEDRPTFS----ELVE 256 (258)
T ss_pred HHHHHHHHCcCChhhCcCHH----HHHh
Confidence 89999999999999999987 6654
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=315.33 Aligned_cols=248 Identities=22% Similarity=0.314 Sum_probs=194.5
Q ss_pred eeeccCCceeEEEEEEccCC-CCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEEEEE
Q 011302 90 RRLGSGDIGNVYLCQIRNPM-VGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVM 168 (489)
Q Consensus 90 ~~lG~G~fg~Vy~a~~~~~~-~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~ 168 (489)
+.||+|+||.||+|++.... ....++.+|||.+.+... ......+.+|+.+++.++||||+++++++...+..|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 36899999999999987532 112346889998865421 123446777999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhCC-----CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCC-----cEEEcccCCC
Q 011302 169 EYCPGGDLYAARQRQP-----GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDG-----HIMLSDFDLS 238 (489)
Q Consensus 169 E~~~gg~L~~~l~~~~-----~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~-----~vkl~DFG~a 238 (489)
||+++|+|.+++.... ...+++.++..++.|++.||+|||+++++|+||||+|||++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9999999999887532 23478899999999999999999999999999999999999887 8999999997
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
..+.....
T Consensus 159 ~~~~~~~~------------------------------------------------------------------------ 166 (269)
T cd05044 159 RDIYKSDY------------------------------------------------------------------------ 166 (269)
T ss_pred cccccccc------------------------------------------------------------------------
Confidence 43211000
Q ss_pred ccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCC-CCCCCCCCCCc
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKP-LTFPRIGVSSS 396 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~ 396 (489)
........++..|+|||.+.+..++.++|||||||++|||++ |..||...+..+....+..+. ...+. .
T Consensus 167 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~-- 237 (269)
T cd05044 167 ----YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPE---N-- 237 (269)
T ss_pred ----cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcc---c--
Confidence 000112245778999999998889999999999999999998 999998887776666554432 11111 1
Q ss_pred hhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 397 KEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 397 ~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
.+..+.+||.+||..+|.+||++.
T Consensus 238 ----~~~~~~~li~~~l~~~p~~Rp~~~ 261 (269)
T cd05044 238 ----CPDKIYQLMTNCWAQDPSERPTFD 261 (269)
T ss_pred ----chHHHHHHHHHHcCCCcccCCCHH
Confidence 123588999999999999999986
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=311.68 Aligned_cols=248 Identities=18% Similarity=0.246 Sum_probs=186.9
Q ss_pred eeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEEEEEee
Q 011302 91 RLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEY 170 (489)
Q Consensus 91 ~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~ 170 (489)
.||+|+||+||+|+..... ....+++|.+...... .....+.+|+.+++.++||||+++++.+.+....|+||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~---~~~~~~~k~~~~~~~~--~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDT---GVARVVVKELKANASS--KEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEY 76 (268)
T ss_pred cCCCCcCceEEEEEEEcCC---CcceEEEEEecCCCCh--HHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEec
Confidence 5999999999999865421 2455677777643221 2345677899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhCC--CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCcccc
Q 011302 171 CPGGDLYAARQRQP--GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLL 248 (489)
Q Consensus 171 ~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 248 (489)
+++|+|.+++.... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~--- 153 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED--- 153 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcch---
Confidence 99999999887642 2346677788999999999999999999999999999999999999999999873210000
Q ss_pred CCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCcc
Q 011302 249 RPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKS 328 (489)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (489)
.......
T Consensus 154 -------------------------------------------------------------------------~~~~~~~ 160 (268)
T cd05086 154 -------------------------------------------------------------------------YIETEDD 160 (268)
T ss_pred -------------------------------------------------------------------------hhhcccC
Confidence 0001123
Q ss_pred ccCCCCccCcchhcC-------CCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCC-CCCCCCCCCCchhH
Q 011302 329 FVGTHEYLAPEVISG-------QGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKP-LTFPRIGVSSSKEF 399 (489)
Q Consensus 329 ~~Gt~~y~aPE~l~~-------~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~~ 399 (489)
.+|+..|+|||++.. ..++.++|||||||++|||++ |..||...+..+.+..+..+. ...+......
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 236 (268)
T cd05086 161 KCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLEL---- 236 (268)
T ss_pred CcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCC----
Confidence 468899999999853 235789999999999999996 678998877777666655432 2221111110
Q ss_pred HHHhhHHHHHHHHhhcCcccccCCC
Q 011302 400 EEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 400 ~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
.....+.+++..|| .+|++||++.
T Consensus 237 ~~~~~~~~l~~~c~-~~P~~Rp~~~ 260 (268)
T cd05086 237 PYSERWYEVLQFCW-LSPEKRATAE 260 (268)
T ss_pred CCcHHHHHHHHHHh-hCcccCCCHH
Confidence 01124788999999 6899999997
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=327.81 Aligned_cols=255 Identities=26% Similarity=0.355 Sum_probs=208.4
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE 159 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 159 (489)
++..+...+.+.||.|.||.||.|.+....++ ..--||||..+.+... +..+.|..|..+|+.++|||||+|+|++.
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kg-e~iaVAvKtCK~d~t~--d~tekflqEa~iMrnfdHphIikLIGv~~ 461 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKG-ERIAVAVKTCKTDCTP--DDTEKFLQEASIMRNFDHPHIIKLIGVCV 461 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccC-cceeeeeehhccCCCh--hhHHHHHHHHHHHHhCCCcchhheeeeee
Confidence 34456667788999999999999999876443 4556899998764333 23567888999999999999999999988
Q ss_pred cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 160 ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 160 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
+ ...+||||+++-|.|..+++.+. ..|+......|+.||+.||.|||+.++|||||..+|||+.....|||+|||+++
T Consensus 462 e-~P~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 462 E-QPMWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred c-cceeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhh
Confidence 6 56899999999999999999875 568888899999999999999999999999999999999999999999999997
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
.+....-. +
T Consensus 540 ~~ed~~yY--------------k--------------------------------------------------------- 548 (974)
T KOG4257|consen 540 YLEDDAYY--------------K--------------------------------------------------------- 548 (974)
T ss_pred hccccchh--------------h---------------------------------------------------------
Confidence 65431100 0
Q ss_pred cccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchh
Q 011302 320 EPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKE 398 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 398 (489)
.....-...|||||.++...++.++|||.|||++||++. |..||.|-.+.+++-.|.++.. .|.... ++
T Consensus 549 ------aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeR-lP~P~n-CP-- 618 (974)
T KOG4257|consen 549 ------ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGER-LPCPPN-CP-- 618 (974)
T ss_pred ------ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCC-CCCCCC-CC--
Confidence 001123457999999999999999999999999999995 9999999998888877766542 222211 11
Q ss_pred HHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 399 FEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 399 ~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
+.+..|+.+||+++|.+||.+.
T Consensus 619 ----p~LYslmskcWayeP~kRPrft 640 (974)
T KOG4257|consen 619 ----PALYSLMSKCWAYEPSKRPRFT 640 (974)
T ss_pred ----hHHHHHHHHHhccCcccCCcHH
Confidence 2478999999999999999985
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=310.60 Aligned_cols=241 Identities=23% Similarity=0.254 Sum_probs=188.8
Q ss_pred eeeccCCceeEEEEEEccCCC-----CCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceE
Q 011302 90 RRLGSGDIGNVYLCQIRNPMV-----GLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYS 164 (489)
Q Consensus 90 ~~lG~G~fg~Vy~a~~~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 164 (489)
+.||+|+||.||+|.+..... ......+++|++...... ...+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD----SLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh----HHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 368999999999999986431 122346788887654322 4566779999999999999999999888 778
Q ss_pred EEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCC-------cEEEcccCC
Q 011302 165 CLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDG-------HIMLSDFDL 237 (489)
Q Consensus 165 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~-------~vkl~DFG~ 237 (489)
|+||||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 99999999999999988753 3689999999999999999999999999999999999999888 799999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
+.....
T Consensus 155 a~~~~~-------------------------------------------------------------------------- 160 (259)
T cd05037 155 PITVLS-------------------------------------------------------------------------- 160 (259)
T ss_pred cccccc--------------------------------------------------------------------------
Confidence 732210
Q ss_pred cccccccCCccccCCCCccCcchhcCC--CCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCC
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVISGQ--GHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVS 394 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~--~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~ 394 (489)
.....++..|+|||++.+. .++.++|||||||++|||++ |..||...+......... .....+....
T Consensus 161 --------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~- 230 (259)
T cd05037 161 --------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMPDC- 230 (259)
T ss_pred --------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCCCc-
Confidence 0112466789999999877 68999999999999999999 688887765443332222 1111121111
Q ss_pred CchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHc
Q 011302 395 SSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKR 432 (489)
Q Consensus 395 ~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~ 432 (489)
..+.+||.+||..+|++||++. ++++
T Consensus 231 --------~~~~~li~~~l~~~p~~Rpt~~----~il~ 256 (259)
T cd05037 231 --------AELANLINQCWTYDPTKRPSFR----AILR 256 (259)
T ss_pred --------hHHHHHHHHHhccChhhCCCHH----HHHH
Confidence 2588999999999999999987 6654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=315.38 Aligned_cols=258 Identities=17% Similarity=0.174 Sum_probs=183.8
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHH--HHHHH------HHHHHHHHHHHHHhCCCCCcc
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREA--LAIRK------KLHRADMEKVILTMLDHPFLP 152 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~--~~~~~------~~~~~~~E~~~l~~l~hpnIv 152 (489)
+..++|++.+.||+|+||+||+|.+.+... ....+|+|+..... ..... .......+...+..++|+||+
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~--~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~ 86 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHC--INNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP 86 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcc--cccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence 344789999999999999999999876311 24566777643211 10000 001122233445567899999
Q ss_pred cccceeecCc----eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCC
Q 011302 153 TLYAEFEASH----YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDG 228 (489)
Q Consensus 153 ~l~~~~~~~~----~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~ 228 (489)
++++++.... ..|++||++ ..++.+++... ..+++..++.++.|++.||+|||+++|+||||||+|||++.++
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNN 163 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC
Confidence 9998765443 457889988 55777766553 3467888999999999999999999999999999999999999
Q ss_pred cEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCC
Q 011302 229 HIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHD 308 (489)
Q Consensus 229 ~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (489)
.++|+|||+|+.+.......
T Consensus 164 ~~~l~DFGla~~~~~~~~~~------------------------------------------------------------ 183 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHI------------------------------------------------------------ 183 (294)
T ss_pred cEEEEEcCCceeeccCCccc------------------------------------------------------------
Confidence 99999999985432100000
Q ss_pred ccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcH-HH--------HH
Q 011302 309 QELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNE-KT--------LI 379 (489)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-~~--------~~ 379 (489)
...........||+.|+|||++.+..++.++|||||||++|||++|..||.+.... .. +.
T Consensus 184 -----------~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~ 252 (294)
T PHA02882 184 -----------EYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIK 252 (294)
T ss_pred -----------ccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHH
Confidence 00001112346999999999999999999999999999999999999999877432 21 22
Q ss_pred HHhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 380 NILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 380 ~i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
++..+....+. . +..+.+++..|+..+|++||+..
T Consensus 253 ~~~~~~~~~~~----~------~~~~~~~~~~~~~~~~~~rp~~~ 287 (294)
T PHA02882 253 RLHEGKIKIKN----A------NKFIYDFIECVTKLSYEEKPDYD 287 (294)
T ss_pred HhhhhhhccCC----C------CHHHHHHHHHHHhCCCCCCCCHH
Confidence 22222222221 1 12488999999999999999986
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=337.28 Aligned_cols=261 Identities=29% Similarity=0.460 Sum_probs=216.0
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCccccccee
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAEF 158 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~ 158 (489)
....+-|.+...||.|.+|.||+++.+. .++..|+|+...... .-+++..|.++|+.+ +|||++.++++|
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~-----~~~~aa~kI~~~~~d----~deEiE~eynil~~~~~hpnv~~fyg~~ 85 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVK-----TGQLAAIKIMDPTED----EEEEIELEYNMLKKYSHHPNVATFYGAF 85 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeee-----cCceeeeEeecCCcc----ccHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 3456789999999999999999999887 567788888764421 123455578888876 699999999998
Q ss_pred e-----cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEc
Q 011302 159 E-----ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLS 233 (489)
Q Consensus 159 ~-----~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~ 233 (489)
. .++.++||||||.||+.-|+++...+.++.|..+..|++.++.||.+||.+.+||||||-.|||++.+|.|||+
T Consensus 86 ~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 86 IKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred EEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEe
Confidence 4 56789999999999999999998888999999999999999999999999999999999999999999999999
Q ss_pred ccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccC
Q 011302 234 DFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLD 313 (489)
Q Consensus 234 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (489)
|||++..++.
T Consensus 166 DFGvSaQlds---------------------------------------------------------------------- 175 (953)
T KOG0587|consen 166 DFGVSAQLDS---------------------------------------------------------------------- 175 (953)
T ss_pred eeeeeeeeec----------------------------------------------------------------------
Confidence 9999733210
Q ss_pred CccccccccccCCccccCCCCccCcchhcCC-----CCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCC
Q 011302 314 DPEVVAEPINARSKSFVGTHEYLAPEVISGQ-----GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTF 388 (489)
Q Consensus 314 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-----~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~ 388 (489)
.-.+..+++|||.|||||++... .|+..+|+||||++..||--|.+|+-+.-+...+..|-+.+.
T Consensus 176 --------T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPP-- 245 (953)
T KOG0587|consen 176 --------TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP-- 245 (953)
T ss_pred --------ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCC--
Confidence 01356678999999999999754 368899999999999999999999988887777666655432
Q ss_pred CCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcC
Q 011302 389 PRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437 (489)
Q Consensus 389 p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~ 437 (489)
......+.|. .++.+||..||.+|-++||+.. ++++|||..
T Consensus 246 --PkLkrp~kWs--~~FndFIs~cL~Kd~e~RP~~~----~ll~hpFi~ 286 (953)
T KOG0587|consen 246 --PKLKRPKKWS--KKFNDFISTCLVKDYEQRPSTE----ELLKHPFIT 286 (953)
T ss_pred --ccccchhhHH--HHHHHHHHHHHhhccccCcchh----hhccCCccc
Confidence 1112222222 3578999999999999999998 999999996
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=307.21 Aligned_cols=246 Identities=24% Similarity=0.322 Sum_probs=195.5
Q ss_pred eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEEEEEe
Q 011302 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVME 169 (489)
Q Consensus 90 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 169 (489)
++||+|+||.||+|.+.. ++.||+|.+...... .....+..|+.+++.++||||+++++++.+....|+|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~------~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 72 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG------NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVME 72 (251)
T ss_pred CccccCCCceEEEEEEeC------CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEE
Confidence 469999999999999764 467899988754332 234567779999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCccccC
Q 011302 170 YCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLR 249 (489)
Q Consensus 170 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 249 (489)
|++|++|.+++.... ..+++..+..++.|++.||+|||+++++||||||+|||++.++.+||+|||++........
T Consensus 73 ~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~--- 148 (251)
T cd05041 73 LVPGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY--- 148 (251)
T ss_pred cCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcc---
Confidence 999999999886643 4688899999999999999999999999999999999999999999999999743210000
Q ss_pred CcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCccc
Q 011302 250 PKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSF 329 (489)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (489)
.......
T Consensus 149 -------------------------------------------------------------------------~~~~~~~ 155 (251)
T cd05041 149 -------------------------------------------------------------------------TVSDGLK 155 (251)
T ss_pred -------------------------------------------------------------------------eeccccC
Confidence 0000111
Q ss_pred cCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHH
Q 011302 330 VGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDL 408 (489)
Q Consensus 330 ~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~l 408 (489)
.++..|+|||.+.+..++.++|||||||++|||++ |..||.+.........+.... ..+... . ...++.+|
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~-~~~~~~-~------~~~~~~~l 227 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY-RMPAPQ-L------CPEEIYRL 227 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC-CCCCCc-c------CCHHHHHH
Confidence 24567999999998889999999999999999998 899998887666555554331 111111 1 11258999
Q ss_pred HHHHhhcCcccccCCCCChHHHHc
Q 011302 409 ISKLLVKNPKKRIGSLKGSVEIKR 432 (489)
Q Consensus 409 i~~~L~~dP~~R~~~~~~~~~ll~ 432 (489)
|.+||..+|.+||++. ++++
T Consensus 228 i~~~l~~~p~~Rp~~~----ell~ 247 (251)
T cd05041 228 MLQCWAYDPENRPSFS----EIYN 247 (251)
T ss_pred HHHHhccChhhCcCHH----HHHH
Confidence 9999999999999987 6654
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=311.63 Aligned_cols=254 Identities=24% Similarity=0.324 Sum_probs=191.1
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee--cC
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE--AS 161 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~--~~ 161 (489)
.+|++++.||+|+||.||+|...... ...+..||+|.+..... .....+.+|+.+++.++||||+++++++. +.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQ-DNTGEVVAVKKLQHSTA---EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCc-CCCCcEEEEEEeccCCH---HHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 57999999999999999999864211 12567899999865432 23456778999999999999999999764 34
Q ss_pred ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccc
Q 011302 162 HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKC 241 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~ 241 (489)
..+|+||||+++|+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..+
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 57899999999999999987642 46899999999999999999999999999999999999999999999999998433
Q ss_pred ccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccc
Q 011302 242 DVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEP 321 (489)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (489)
.......
T Consensus 159 ~~~~~~~------------------------------------------------------------------------- 165 (284)
T cd05081 159 PQDKEYY------------------------------------------------------------------------- 165 (284)
T ss_pred cCCCcce-------------------------------------------------------------------------
Confidence 2100000
Q ss_pred cccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcH---------------HHHHHHhcCCC
Q 011302 322 INARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNE---------------KTLINILKKPL 386 (489)
Q Consensus 322 ~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---------------~~~~~i~~~~~ 386 (489)
.......++..|+|||++.+..++.++|||||||++|||++|..|+...... ..+.++.....
T Consensus 166 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (284)
T cd05081 166 --KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNG 243 (284)
T ss_pred --eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCC
Confidence 0000112445699999999888999999999999999999988776433211 01111222222
Q ss_pred CCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 387 TFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 387 ~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
.++... .....+.+||.+||..+|++||++.
T Consensus 244 ~~~~~~-------~~~~~~~~li~~cl~~~p~~Rpt~~ 274 (284)
T cd05081 244 RLPAPP-------GCPAEIYAIMKECWNNDPSQRPSFS 274 (284)
T ss_pred cCCCCC-------CCCHHHHHHHHHHccCChhhCCCHH
Confidence 222111 1123589999999999999999997
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=309.54 Aligned_cols=274 Identities=27% Similarity=0.381 Sum_probs=215.7
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC-
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS- 161 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~- 161 (489)
..+|..++.+|.|.- .|..|.+.- .++.||+|.+... ........++.+|..++..+.|+||++++.+|.-.
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v-----~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~ 88 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQV-----LGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQK 88 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhh-----ccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccc
Confidence 357888899999988 777776653 5788999988766 33345567788999999999999999999999533
Q ss_pred -----ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccC
Q 011302 162 -----HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFD 236 (489)
Q Consensus 162 -----~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG 236 (489)
..+|+||||| .++|...+.. .++-..+..++.|++.|++|||+.||+||||||+||++..++.+||.|||
T Consensus 89 ~l~~~~e~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg 163 (369)
T KOG0665|consen 89 TLEEFQEVYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFG 163 (369)
T ss_pred cHHHHHhHHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccch
Confidence 4689999999 7899888763 47888999999999999999999999999999999999999999999999
Q ss_pred CCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcc
Q 011302 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPE 316 (489)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (489)
+|+....
T Consensus 164 ~ar~e~~------------------------------------------------------------------------- 170 (369)
T KOG0665|consen 164 LARTEDT------------------------------------------------------------------------- 170 (369)
T ss_pred hhcccCc-------------------------------------------------------------------------
Confidence 9843211
Q ss_pred ccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcC------------
Q 011302 317 VVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK------------ 384 (489)
Q Consensus 317 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------ 384 (489)
.-+.+.++.|..|+|||++.+..|...+||||+||++.||++|...|.|.+..+.+.++...
T Consensus 171 ------~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL 244 (369)
T KOG0665|consen 171 ------DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL 244 (369)
T ss_pred ------ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence 01345568999999999999999999999999999999999999999998877666665321
Q ss_pred -------------------CCCCCCCCCCCchhH--HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccc
Q 011302 385 -------------------PLTFPRIGVSSSKEF--EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWAL 443 (489)
Q Consensus 385 -------------------~~~~p~~~~~~~~~~--~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~ 443 (489)
.-.+|+.......+. .....++||+.+||..||++|.++. ++|+||||+ -|-.
T Consensus 245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~----daL~HPY~~--vw~~ 318 (369)
T KOG0665|consen 245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVD----DALRHPYIK--VWYD 318 (369)
T ss_pred hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHH----HHhcCCeee--eecc
Confidence 001122111111111 1223589999999999999999997 999999999 5744
Q ss_pred cccCCCCCCC
Q 011302 444 IRSIKPPEVP 453 (489)
Q Consensus 444 ~~~~~~p~~~ 453 (489)
-..+..|.++
T Consensus 319 ~~ev~ap~pe 328 (369)
T KOG0665|consen 319 PDEVEAPPPE 328 (369)
T ss_pred cccccCCCCc
Confidence 4444444433
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=322.37 Aligned_cols=266 Identities=25% Similarity=0.371 Sum_probs=212.2
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC------CCCcc
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD------HPFLP 152 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~------hpnIv 152 (489)
+++--.+|.+....|+|-||+|.+|.+.. .+..||||+|.....-.. .-..|+++|++|+ --|++
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~-----r~~~vAiKIIRnNE~M~K----tGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQA-----RGQEVAIKIIRNNEVMHK----TGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccC-----CCCeeEEEEeecchHHhh----hhhHHHHHHHHhhccCchhhhHHH
Confidence 34556889999999999999999999887 456899999986543322 3345999999995 34899
Q ss_pred cccceeecCceEEEEEeecCCCchHHHHHhCC-CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccC-CcE
Q 011302 153 TLYAEFEASHYSCLVMEYCPGGDLYAARQRQP-GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRED-GHI 230 (489)
Q Consensus 153 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~-~~v 230 (489)
+|+-.|...+++|||+|-+ ..+|.++|++.. .-.|....++.|+.|+..||..|-..||+|.||||+|||+++. ..+
T Consensus 498 rl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iL 576 (752)
T KOG0670|consen 498 RLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNIL 576 (752)
T ss_pred HHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCccee
Confidence 9999999999999999999 789999998753 2458889999999999999999999999999999999999965 568
Q ss_pred EEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCcc
Q 011302 231 MLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQE 310 (489)
Q Consensus 231 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (489)
||||||.|-....
T Consensus 577 KLCDfGSA~~~~e------------------------------------------------------------------- 589 (752)
T KOG0670|consen 577 KLCDFGSASFASE------------------------------------------------------------------- 589 (752)
T ss_pred eeccCcccccccc-------------------------------------------------------------------
Confidence 9999998722110
Q ss_pred ccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCC
Q 011302 311 LLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPR 390 (489)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~ 390 (489)
...+.+.-+..|.|||+|.|.+|+...|+||+||+||||+||+..|.|.++.+++.-.+...-.||.
T Consensus 590 -------------neitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~ 656 (752)
T KOG0670|consen 590 -------------NEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPN 656 (752)
T ss_pred -------------ccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcH
Confidence 0112223456899999999999999999999999999999999999999888776544332222221
Q ss_pred CC---------------------------------------------------CCCchhHHHHhhHHHHHHHHhhcCccc
Q 011302 391 IG---------------------------------------------------VSSSKEFEEVVKLQDLISKLLVKNPKK 419 (489)
Q Consensus 391 ~~---------------------------------------------------~~~~~~~~~~~~l~~li~~~L~~dP~~ 419 (489)
.. ...........++++||.+||..||++
T Consensus 657 KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~K 736 (752)
T KOG0670|consen 657 KMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEK 736 (752)
T ss_pred HHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhh
Confidence 10 011112234457899999999999999
Q ss_pred ccCCCCChHHHHcCCCcCC
Q 011302 420 RIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 420 R~~~~~~~~~ll~hp~f~~ 438 (489)
|++.. ++|+||||.+
T Consensus 737 Rit~n----qAL~HpFi~~ 751 (752)
T KOG0670|consen 737 RITVN----QALKHPFITE 751 (752)
T ss_pred cCCHH----HHhcCCcccC
Confidence 99998 9999999975
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=317.93 Aligned_cols=268 Identities=29% Similarity=0.404 Sum_probs=213.8
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeee--hH--HHHHHHHHHHHHHHHHHHHhCCCCCcccccce
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVD--RE--ALAIRKKLHRADMEKVILTMLDHPFLPTLYAE 157 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~--~~--~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~ 157 (489)
-.++|.++.+||+|||++||+|.+.. .+++||+|+-. +. .....+....+.+|..|.+.|+||.||++|++
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~-----EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDy 535 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLT-----EQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDY 535 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccc-----hhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeee
Confidence 35789999999999999999999876 57899999863 22 12234456668899999999999999999999
Q ss_pred ee-cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCC--CeeecCCCCCeEecc---CCcEE
Q 011302 158 FE-ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMG--IVYRDLKPENVLVRE---DGHIM 231 (489)
Q Consensus 158 ~~-~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDIKp~NILl~~---~~~vk 231 (489)
|. +...+|-|+|||+|.+|.-+++.+ +.+++.+++.|+.||+.||.||.+.. |||-||||.||||-. -|.+|
T Consensus 536 fslDtdsFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIK 613 (775)
T KOG1151|consen 536 FSLDTDSFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIK 613 (775)
T ss_pred eeeccccceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeE
Confidence 96 667899999999999998888876 67999999999999999999999875 999999999999953 47899
Q ss_pred EcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccc
Q 011302 232 LSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQEL 311 (489)
Q Consensus 232 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (489)
|+|||+++.++.....
T Consensus 614 ITDFGLSKIMdddSy~---------------------------------------------------------------- 629 (775)
T KOG1151|consen 614 ITDFGLSKIMDDDSYN---------------------------------------------------------------- 629 (775)
T ss_pred eeecchhhhccCCccC----------------------------------------------------------------
Confidence 9999998665421100
Q ss_pred cCCccccccccccCCccccCCCCccCcchhcCC----CCCCcccHHHHHHHHHHHhhCCCCCCCCCcH-HHHHH--Hh-c
Q 011302 312 LDDPEVVAEPINARSKSFVGTHEYLAPEVISGQ----GHGSAVDWWTLGVFLYEMLYGTTPFKGENNE-KTLIN--IL-K 383 (489)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~----~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-~~~~~--i~-~ 383 (489)
....-..+....||.+|++||.+.-. ..+.++||||+|||+|++++|+.||...-.. +++.. |+ .
T Consensus 630 -------~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkA 702 (775)
T KOG1151|consen 630 -------SVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKA 702 (775)
T ss_pred -------cccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcc
Confidence 00011234566899999999997532 3588999999999999999999999765433 33222 22 3
Q ss_pred CCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 384 KPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 384 ~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
..+.||.....++ ++++||++||++--++|.... +|..||||..
T Consensus 703 tEVqFP~KPvVss-------eAkaFIRRCLaYRKeDR~DV~----qLA~dpyllP 746 (775)
T KOG1151|consen 703 TEVQFPPKPVVSS-------EAKAFIRRCLAYRKEDRIDVQ----QLACDPYLLP 746 (775)
T ss_pred eeccCCCCCccCH-------HHHHHHHHHHHhhhhhhhhHH----HHccCccccc
Confidence 5567776655544 489999999999999999876 9999999965
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=321.78 Aligned_cols=255 Identities=21% Similarity=0.264 Sum_probs=206.8
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE 159 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 159 (489)
+++.+...+.++||+|.||+|.+|...+ ...||+|.++.+... +....|..|+.+|.+|.|||||.|+++|.
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg------~lkVAVK~Lr~~a~~--~~r~~F~kEIkiLsqLkhPNIveLvGVC~ 605 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEG------PLKVAVKILRPDATK--NARNDFLKEIKILSRLKHPNIVELLGVCV 605 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecC------ceEEEEeecCcccch--hHHHHHHHHHHHHhccCCCCeeEEEeeee
Confidence 4555778899999999999999999775 468999999877544 34567888999999999999999999999
Q ss_pred cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 160 ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 160 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
.++.+|+||||++.|+|.+++..+....+.......|+.||+.||+||.+.++|||||.+.|+|++.++++||+|||+++
T Consensus 606 ~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR 685 (807)
T KOG1094|consen 606 QDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSR 685 (807)
T ss_pred cCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCccccc
Confidence 99999999999999999999988743334555667799999999999999999999999999999999999999999985
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
.+.-.+-
T Consensus 686 ~lysg~y------------------------------------------------------------------------- 692 (807)
T KOG1094|consen 686 NLYSGDY------------------------------------------------------------------------- 692 (807)
T ss_pred ccccCCc-------------------------------------------------------------------------
Confidence 4321100
Q ss_pred cccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHh--hCCCCCCCCCcHHHHHHHhc---C--CCCCCCCC
Q 011302 320 EPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEML--YGTTPFKGENNEKTLINILK---K--PLTFPRIG 392 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell--tG~~Pf~~~~~~~~~~~i~~---~--~~~~p~~~ 392 (489)
.+.-+..+-...|||||.|...++++++|+|+|||++||++ +.+.||......+..++... . ....+...
T Consensus 693 ---y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P 769 (807)
T KOG1094|consen 693 ---YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRP 769 (807)
T ss_pred ---eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCC
Confidence 11112335567899999999999999999999999999987 58999998888777665532 1 11122222
Q ss_pred CCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 393 VSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 393 ~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
..+.. .+.+||.+||.++-++||+++
T Consensus 770 ~~cp~------~lyelml~Cw~~es~~RPsFe 795 (807)
T KOG1094|consen 770 PACPQ------GLYELMLRCWRRESEQRPSFE 795 (807)
T ss_pred CcCcH------HHHHHHHHHhchhhhcCCCHH
Confidence 22222 477999999999999999986
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=309.17 Aligned_cols=250 Identities=27% Similarity=0.393 Sum_probs=199.2
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHH-------HHHHHHHHHHHHHHHHHh-CCCCCcccccc
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREAL-------AIRKKLHRADMEKVILTM-LDHPFLPTLYA 156 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~~~E~~~l~~-l~hpnIv~l~~ 156 (489)
+|++.+.||+|+||.||+|.+... +++.+|+|.+..... .......++..|..++.. ++||||+++++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~----~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~ 76 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNN----GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYK 76 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCC----CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEe
Confidence 478889999999999999998762 457899998864321 112334556678887765 79999999999
Q ss_pred eeecCceEEEEEeecCCCchHHHHHh--CCCCCCChhhHHHHHHHHHHHHHHHHh-CCCeeecCCCCCeEeccCCcEEEc
Q 011302 157 EFEASHYSCLVMEYCPGGDLYAARQR--QPGKRFGISSAKFYAAETLLALEYLHM-MGIVYRDLKPENVLVREDGHIMLS 233 (489)
Q Consensus 157 ~~~~~~~~~lV~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiHrDIKp~NILl~~~~~vkl~ 233 (489)
++..++..|+||||++|++|.+++.. .....+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+
T Consensus 77 ~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~ 156 (269)
T cd08528 77 TFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTIT 156 (269)
T ss_pred eEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEe
Confidence 99999999999999999999988753 223568999999999999999999996 789999999999999999999999
Q ss_pred ccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccC
Q 011302 234 DFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLD 313 (489)
Q Consensus 234 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (489)
|||++......
T Consensus 157 dfg~~~~~~~~--------------------------------------------------------------------- 167 (269)
T cd08528 157 DFGLAKQKQPE--------------------------------------------------------------------- 167 (269)
T ss_pred cccceeecccc---------------------------------------------------------------------
Confidence 99997332110
Q ss_pred CccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCC
Q 011302 314 DPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGV 393 (489)
Q Consensus 314 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~ 393 (489)
.......|+..|+|||.+.+..++.++|||||||++|||++|..||...+.......+...........
T Consensus 168 ----------~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~- 236 (269)
T cd08528 168 ----------SKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEG- 236 (269)
T ss_pred ----------cccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcc-
Confidence 011234588899999999988899999999999999999999999987776666666655433211110
Q ss_pred CCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 394 SSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 394 ~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
. ....+.+||.+||..||++||++.
T Consensus 237 ~------~~~~l~~li~~cl~~~p~~Rp~~~ 261 (269)
T cd08528 237 M------YSEDVTDVITSCLTPDAEARPDII 261 (269)
T ss_pred c------CCHHHHHHHHHHCCCCCccCCCHH
Confidence 1 113589999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=310.07 Aligned_cols=251 Identities=21% Similarity=0.279 Sum_probs=195.0
Q ss_pred ceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc---
Q 011302 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH--- 162 (489)
Q Consensus 86 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--- 162 (489)
|.+.+.||+|+||.||+|.++... .+++.||||++..+... .....++.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~--~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSED--GSFQKVAVKMLKADIFS-SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKG 77 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccC--CCceEEEEEEeccccCC-hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCC
Confidence 567889999999999999876421 24688999998754322 223456778999999999999999999886432
Q ss_pred ---eEEEEEeecCCCchHHHHHhCC----CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEccc
Q 011302 163 ---YSCLVMEYCPGGDLYAARQRQP----GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235 (489)
Q Consensus 163 ---~~~lV~E~~~gg~L~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DF 235 (489)
..++++||+.+|+|.+++.... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 78 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 78 RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcc
Confidence 3478999999999988764321 125788889999999999999999999999999999999999999999999
Q ss_pred CCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCc
Q 011302 236 DLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDP 315 (489)
Q Consensus 236 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (489)
|+++.......
T Consensus 158 g~~~~~~~~~~--------------------------------------------------------------------- 168 (273)
T cd05074 158 GLSKKIYSGDY--------------------------------------------------------------------- 168 (273)
T ss_pred cccccccCCcc---------------------------------------------------------------------
Confidence 99843211000
Q ss_pred cccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCC-CCCCCCC
Q 011302 316 EVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPL-TFPRIGV 393 (489)
Q Consensus 316 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~ 393 (489)
........+++.|++||.+.+..++.++|||||||++|||++ |.+||.+.+..+....+..... ..+.
T Consensus 169 -------~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--- 238 (273)
T cd05074 169 -------YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP--- 238 (273)
T ss_pred -------eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCC---
Confidence 000112245678999999998889999999999999999999 9999988877666666554321 1111
Q ss_pred CCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 394 SSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 394 ~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
. ....+.+|+.+||..+|++||++.
T Consensus 239 ~------~~~~~~~l~~~~l~~~p~~Rps~~ 263 (273)
T cd05074 239 D------CLEDVYELMCQCWSPEPKCRPSFQ 263 (273)
T ss_pred C------CCHHHHHHHHHHcCCChhhCcCHH
Confidence 1 112589999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=330.53 Aligned_cols=256 Identities=23% Similarity=0.307 Sum_probs=212.0
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
+..++..+.++||+|.||.|++|.|.... .+...||||+++.+.... ....|.+|+.+|.+|+|||+|+|||+..+
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~ps--gk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~ 182 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQPS--GKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD 182 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCCC--CcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc
Confidence 34567788899999999999999999743 256688999998765542 56788899999999999999999999888
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~ 240 (489)
..+.||||+++.|+|.+.|++.....|-......|+.||+.||.||.++++|||||..+|+||-....|||+|||+.+.
T Consensus 183 -qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRa 261 (1039)
T KOG0199|consen 183 -QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRA 261 (1039)
T ss_pred -chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceec
Confidence 7889999999999999999886667788888999999999999999999999999999999999999999999999865
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
+...+...
T Consensus 262 Lg~ned~Y------------------------------------------------------------------------ 269 (1039)
T KOG0199|consen 262 LGENEDMY------------------------------------------------------------------------ 269 (1039)
T ss_pred cCCCCcce------------------------------------------------------------------------
Confidence 43211110
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhH
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEF 399 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 399 (489)
.......-...|.|||.|....++.++|||+|||+||||++ |+.||.|....+++.+|-.+. .++... .+..
T Consensus 270 ---vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~e-rLpRPk-~cse-- 342 (1039)
T KOG0199|consen 270 ---VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGE-RLPRPK-YCSE-- 342 (1039)
T ss_pred ---EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccc-cCCCCC-CChH--
Confidence 00111123457999999999999999999999999999996 999999999999998887443 233221 2222
Q ss_pred HHHhhHHHHHHHHhhcCcccccCCC
Q 011302 400 EEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 400 ~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
.+.+++..||..+|++||++.
T Consensus 343 ----dIY~imk~cWah~paDRptFs 363 (1039)
T KOG0199|consen 343 ----DIYQIMKNCWAHNPADRPTFS 363 (1039)
T ss_pred ----HHHHHHHHhccCCccccccHH
Confidence 489999999999999999985
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=320.95 Aligned_cols=253 Identities=20% Similarity=0.257 Sum_probs=209.0
Q ss_pred hcCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccc
Q 011302 77 AQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYA 156 (489)
Q Consensus 77 ~~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~ 156 (489)
..|++...+..+..+||-|.||.||.|.|+. -...||||.++.+.+. +++|..|..+|+.+.|||+|+|++
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKk-----yslTvAVKtLKEDtMe----veEFLkEAAvMKeikHpNLVqLLG 330 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKK-----YSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLG 330 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeec-----cceeeehhhhhhcchh----HHHHHHHHHHHHhhcCccHHHHhh
Confidence 4456666788889999999999999999997 4678899999887654 567777999999999999999999
Q ss_pred eeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccC
Q 011302 157 EFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFD 236 (489)
Q Consensus 157 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG 236 (489)
+|..+..+|||+|||..|+|.++|+......++.-....|+.||..||+||..+++|||||..+|+|+.++..||++|||
T Consensus 331 VCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFG 410 (1157)
T KOG4278|consen 331 VCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFG 410 (1157)
T ss_pred hhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccc
Confidence 99999999999999999999999998766667777778889999999999999999999999999999999999999999
Q ss_pred CCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcc
Q 011302 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPE 316 (489)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (489)
+++.+... +...+
T Consensus 411 LsRlMtgD-------------------------------------------------------------TYTAH------ 423 (1157)
T KOG4278|consen 411 LSRLMTGD-------------------------------------------------------------TYTAH------ 423 (1157)
T ss_pred hhhhhcCC-------------------------------------------------------------ceecc------
Confidence 99654310 00000
Q ss_pred ccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCC-CCCC
Q 011302 317 VVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPR-IGVS 394 (489)
Q Consensus 317 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~-~~~~ 394 (489)
.+..-...|.|||-|....++.++|||+|||+|||+.| |-.||.|.+-.+++.-+.+ .+.... .+++
T Consensus 424 ----------AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEk-gyRM~~PeGCP 492 (1157)
T KOG4278|consen 424 ----------AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEK-GYRMDGPEGCP 492 (1157)
T ss_pred ----------cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhc-cccccCCCCCC
Confidence 00012357999999999999999999999999999996 9999999987766654443 333222 2222
Q ss_pred CchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 395 SSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 395 ~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
+.+.+||+.||+|+|.+||++.
T Consensus 493 --------pkVYeLMraCW~WsPsDRPsFa 514 (1157)
T KOG4278|consen 493 --------PKVYELMRACWNWSPSDRPSFA 514 (1157)
T ss_pred --------HHHHHHHHHHhcCCcccCccHH
Confidence 1478999999999999999986
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=309.25 Aligned_cols=255 Identities=24% Similarity=0.335 Sum_probs=198.3
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec--C
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA--S 161 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~ 161 (489)
.+|++.+.||+|+||.||+|++.... ...+..||+|++...... .....+..|+.+++.++||||+++++++.. .
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLG-DNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCC-CCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 57889999999999999999976422 125788999999765433 345567889999999999999999998877 6
Q ss_pred ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccc
Q 011302 162 HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKC 241 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~ 241 (489)
...|+||||+++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++...
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 68999999999999999987653 35899999999999999999999999999999999999999999999999998433
Q ss_pred ccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccc
Q 011302 242 DVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEP 321 (489)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (489)
......
T Consensus 160 ~~~~~~-------------------------------------------------------------------------- 165 (284)
T cd05038 160 PEDKDY-------------------------------------------------------------------------- 165 (284)
T ss_pred ccCCcc--------------------------------------------------------------------------
Confidence 210000
Q ss_pred cccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcH--------------HHHHHHhcCCCC
Q 011302 322 INARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNE--------------KTLINILKKPLT 387 (489)
Q Consensus 322 ~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--------------~~~~~i~~~~~~ 387 (489)
........++..|+|||.+.+..++.++|||||||++|||++|..||...... ..+..+......
T Consensus 166 -~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (284)
T cd05038 166 -YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGER 244 (284)
T ss_pred -eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCCc
Confidence 00001123456799999999888999999999999999999999998654321 122223333222
Q ss_pred CCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 388 FPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 388 ~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
.+.... ....+.+|+.+||..+|++||++.
T Consensus 245 ~~~~~~-------~~~~~~~li~~cl~~~p~~Rpt~~ 274 (284)
T cd05038 245 LPRPPS-------CPDEVYDLMKLCWEAEPQDRPSFA 274 (284)
T ss_pred CCCCcc-------CCHHHHHHHHHHhccChhhCCCHH
Confidence 222111 113588999999999999999997
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=337.87 Aligned_cols=274 Identities=20% Similarity=0.195 Sum_probs=181.7
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccce-
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAE- 157 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~- 157 (489)
.....++|.+.+.||+|+||.||+|++..+.. ..+..||+|.+...... +....| .+....+.++..++..
T Consensus 127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~-~~~~~vAvK~~~~~~~~-----e~~~~e--~l~~~~~~~~~~~~~~~ 198 (566)
T PLN03225 127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQS-KKEGKYVLKKATEYGAV-----EIWMNE--RVRRACPNSCADFVYGF 198 (566)
T ss_pred CCCccCCeEEeEEEeeCCCeEEEEEEEcCCcc-ccCcEEEEEEecccchh-----HHHHHH--HHHhhchhhHHHHHHhh
Confidence 34567899999999999999999999986321 23678999988643211 001111 1122223333333322
Q ss_pred -----eecCceEEEEEeecCCCchHHHHHhCCC------------------CCCChhhHHHHHHHHHHHHHHHHhCCCee
Q 011302 158 -----FEASHYSCLVMEYCPGGDLYAARQRQPG------------------KRFGISSAKFYAAETLLALEYLHMMGIVY 214 (489)
Q Consensus 158 -----~~~~~~~~lV~E~~~gg~L~~~l~~~~~------------------~~l~~~~~~~i~~qi~~~L~yLH~~~iiH 214 (489)
...+..++|||||+.+++|.+++..... .......+..|+.||+.||+|||++||||
T Consensus 199 ~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiH 278 (566)
T PLN03225 199 LEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVH 278 (566)
T ss_pred hcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence 2456789999999999999998865321 01123346679999999999999999999
Q ss_pred ecCCCCCeEecc-CCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccc
Q 011302 215 RDLKPENVLVRE-DGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAV 293 (489)
Q Consensus 215 rDIKp~NILl~~-~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (489)
|||||+|||++. ++.+||+|||+|+.+....
T Consensus 279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~------------------------------------------------ 310 (566)
T PLN03225 279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGI------------------------------------------------ 310 (566)
T ss_pred CcCCHHHEEEeCCCCcEEEEeCCCcccccccc------------------------------------------------
Confidence 999999999985 6899999999984321100
Q ss_pred cccccccccCCCCCCccccCCccccccccccCCccccCCCCccCcchhcCC----------------------CCCCccc
Q 011302 294 TVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQ----------------------GHGSAVD 351 (489)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~----------------------~~~~~~D 351 (489)
+.....++||+.|||||.+... .++.++|
T Consensus 311 -----------------------------~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 311 -----------------------------NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred -----------------------------ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 0112345789999999976432 2345679
Q ss_pred HHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhc-CCCCC-------CCCCCCC-chhHH----HHhhHHHHHHHHhhcCcc
Q 011302 352 WWTLGVFLYEMLYGTTPFKGENNEKTLINILK-KPLTF-------PRIGVSS-SKEFE----EVVKLQDLISKLLVKNPK 418 (489)
Q Consensus 352 iwSlGvil~elltG~~Pf~~~~~~~~~~~i~~-~~~~~-------p~~~~~~-~~~~~----~~~~l~~li~~~L~~dP~ 418 (489)
||||||+||||+++..++. +....+..++. ....+ +...... ...++ ......+||.+||+.||+
T Consensus 362 VwSlGviL~el~~~~~~~~--~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSD--SNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred cHHHHHHHHHHHhCcCCCc--hHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 9999999999999776653 22222222221 11100 0000000 00000 111355899999999999
Q ss_pred cccCCCCChHHHHcCCCcCCCCccc
Q 011302 419 KRIGSLKGSVEIKRHEFFKGINWAL 443 (489)
Q Consensus 419 ~R~~~~~~~~~ll~hp~f~~~~~~~ 443 (489)
+||++. ++|+||||++.++..
T Consensus 440 kR~ta~----e~L~Hpff~~~~~~~ 460 (566)
T PLN03225 440 QRISAK----AALAHPYFDREGLLG 460 (566)
T ss_pred cCCCHH----HHhCCcCcCCCCccc
Confidence 999998 999999999988753
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=302.54 Aligned_cols=135 Identities=27% Similarity=0.391 Sum_probs=117.9
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-----C---CCcccc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-----H---PFLPTL 154 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---pnIv~l 154 (489)
..+|.++++||-|.|++||+|.+.. ..++||+|+++..... .+..+.|+.+|++++ | .+||+|
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq-----~~r~VAlKVvKSAqhY----tEaAlDEIklL~~v~~~Dp~~~~~~~VV~L 147 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQ-----NKRYVALKVVKSAQHY----TEAALDEIKLLQQVREGDPNDPGKKCVVQL 147 (590)
T ss_pred CceEEEEEeccccccceeEEEeecc-----CCeEEEEEEEehhhHH----HHHHHHHHHHHHHHHhcCCCCCCCceeeee
Confidence 4899999999999999999999997 6789999999866433 334556899998873 3 369999
Q ss_pred cceee----cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHh-CCCeeecCCCCCeEeccC
Q 011302 155 YAEFE----ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHM-MGIVYRDLKPENVLVRED 227 (489)
Q Consensus 155 ~~~~~----~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiHrDIKp~NILl~~~ 227 (489)
++.|. ++.++|||+|++ |.+|..++.+...+.++...++.|++||+.||.|||. .||||.||||+|||+..+
T Consensus 148 lD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 148 LDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCST 224 (590)
T ss_pred eccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeecc
Confidence 99995 667999999999 9999999998888889999999999999999999996 599999999999999654
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=331.34 Aligned_cols=261 Identities=22% Similarity=0.310 Sum_probs=220.3
Q ss_pred HHhhcCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccc
Q 011302 74 LRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPT 153 (489)
Q Consensus 74 ~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~ 153 (489)
++....++......+.++||.|.||+||+|+.+-+.+ ....||||.++...-. +....|..|+.||.+++||||++
T Consensus 619 vreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgk--re~~VAIKTLK~Gyte--kqrrdFL~EAsIMGQFdHPNIIr 694 (996)
T KOG0196|consen 619 VREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGK--REITVAIKTLKAGYTE--KQRRDFLSEASIMGQFDHPNIIR 694 (996)
T ss_pred HHHhhhhcChhheEEEEEEecccccceecccccCCCC--cceeEEEeeeccCccH--HHHhhhhhhhhhcccCCCCcEEE
Confidence 3444556777889999999999999999999987654 5678999999865432 45667889999999999999999
Q ss_pred ccceeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEc
Q 011302 154 LYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLS 233 (489)
Q Consensus 154 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~ 233 (489)
|.|+....+.+.||+|||++|+|..+|+.+. +.|+.-+...|++.|+.||.||-+.|.|||||..+|||++.+-.+|++
T Consensus 695 LEGVVTks~PvMIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVs 773 (996)
T KOG0196|consen 695 LEGVVTKSKPVMIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVS 773 (996)
T ss_pred EEEEEecCceeEEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEec
Confidence 9999999999999999999999999998875 569999999999999999999999999999999999999999999999
Q ss_pred ccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccC
Q 011302 234 DFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLD 313 (489)
Q Consensus 234 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (489)
|||+++.+...+..
T Consensus 774 DFGLSRvledd~~~------------------------------------------------------------------ 787 (996)
T KOG0196|consen 774 DFGLSRVLEDDPEA------------------------------------------------------------------ 787 (996)
T ss_pred cccceeecccCCCc------------------------------------------------------------------
Confidence 99999755432110
Q ss_pred CccccccccccCCccccC--CCCccCcchhcCCCCCCcccHHHHHHHHHHHh-hCCCCCCCCCcHHHHHHHhcCCCCCCC
Q 011302 314 DPEVVAEPINARSKSFVG--THEYLAPEVISGQGHGSAVDWWTLGVFLYEML-YGTTPFKGENNEKTLINILKKPLTFPR 390 (489)
Q Consensus 314 ~~~~~~~~~~~~~~~~~G--t~~y~aPE~l~~~~~~~~~DiwSlGvil~ell-tG~~Pf~~~~~~~~~~~i~~~~~~~p~ 390 (489)
..++..| ...|.|||.|...+++.++||||+|+++||.+ +|+.||...++++++..|..+-.-.|.
T Consensus 788 -----------~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP 856 (996)
T KOG0196|consen 788 -----------AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP 856 (996)
T ss_pred -----------cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC
Confidence 0011111 35799999999999999999999999999987 699999999999999988776433333
Q ss_pred CCCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 391 IGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 391 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
..++. .|.+|+..||++|-.+||.+.
T Consensus 857 mDCP~--------aL~qLMldCWqkdR~~RP~F~ 882 (996)
T KOG0196|consen 857 MDCPA--------ALYQLMLDCWQKDRNRRPKFA 882 (996)
T ss_pred CCCcH--------HHHHHHHHHHHHHhhcCCCHH
Confidence 33332 488999999999999999987
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=298.99 Aligned_cols=266 Identities=22% Similarity=0.316 Sum_probs=204.1
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHH-HHhCCCCCcccccceee
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVI-LTMLDHPFLPTLYAEFE 159 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~-l~~l~hpnIv~l~~~~~ 159 (489)
+..++.+-+..||.|+||+|++-.++. .++..|||.++..... ....++.+|.+. ++.-+.||||++||+.-
T Consensus 61 F~~~~Lqdlg~iG~G~fG~V~KM~hk~-----sg~~mAVKrIr~~n~~--keq~rll~e~d~~mks~~cp~IVkfyGa~F 133 (361)
T KOG1006|consen 61 FTSDNLQDLGEIGNGAFGTVNKMLHKP-----SGKLMAVKRIRSNNIE--KEQKRLLMEHDTVMKSSNCPNIVKFYGALF 133 (361)
T ss_pred cccchHHHHHHhcCCcchhhhhhhcCc-----cCcEEEEEEeeeccch--HHHHHHHHHHHHHHhhcCCcHHHHHhhhhh
Confidence 444566677889999999999999887 6889999999865442 334456666664 44557999999999999
Q ss_pred cCceEEEEEeecCCCchHHHHH---hCCCCCCChhhHHHHHHHHHHHHHHHHh-CCCeeecCCCCCeEeccCCcEEEccc
Q 011302 160 ASHYSCLVMEYCPGGDLYAARQ---RQPGKRFGISSAKFYAAETLLALEYLHM-MGIVYRDLKPENVLVREDGHIMLSDF 235 (489)
Q Consensus 160 ~~~~~~lV~E~~~gg~L~~~l~---~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiHrDIKp~NILl~~~~~vkl~DF 235 (489)
.++..++.||+| ..+|..+.+ ......++++-+-.|..-.+.||.||-+ .+||||||||+||||+..|.+|||||
T Consensus 134 ~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDF 212 (361)
T KOG1006|consen 134 SEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDF 212 (361)
T ss_pred cCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecc
Confidence 999999999999 677743322 2233678998888899999999999985 58999999999999999999999999
Q ss_pred CCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCc
Q 011302 236 DLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDP 315 (489)
Q Consensus 236 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (489)
|++-.+.. .+
T Consensus 213 GIcGqLv~---------------Si------------------------------------------------------- 222 (361)
T KOG1006|consen 213 GICGQLVD---------------SI------------------------------------------------------- 222 (361)
T ss_pred cchHhHHH---------------HH-------------------------------------------------------
Confidence 99722210 00
Q ss_pred cccccccccCCccccCCCCccCcchhcC--CCCCCcccHHHHHHHHHHHhhCCCCCCCCCc-HHHHHHHhcCCCCCCCCC
Q 011302 316 EVVAEPINARSKSFVGTHEYLAPEVISG--QGHGSAVDWWTLGVFLYEMLYGTTPFKGENN-EKTLINILKKPLTFPRIG 392 (489)
Q Consensus 316 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~~p~~~ 392 (489)
-.+.-+|...|||||.+.. .+|+-++|+||||++|||+.||..||.+.+. .+++..+..+.. ...
T Consensus 223 ---------AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdp---p~l 290 (361)
T KOG1006|consen 223 ---------AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDP---PIL 290 (361)
T ss_pred ---------HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCC---Cee
Confidence 0011268899999999964 4589999999999999999999999998765 344555555432 222
Q ss_pred CCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 393 VSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 393 ~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
.......+....+..||.-||.+|-..||... +|+++||++-..
T Consensus 291 ~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~----~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 291 LFDKECVHYSFSMVRFINTCLIKDRSDRPKYD----DLKKFPFYRMYA 334 (361)
T ss_pred cCcccccccCHHHHHHHHHHhhcccccCcchh----hhhcCchhhhhh
Confidence 22222233344689999999999999999997 999999997653
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=317.56 Aligned_cols=272 Identities=22% Similarity=0.244 Sum_probs=189.7
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCC-----------CCCCCeeEEEEeeehHHHHHHH-----------HHHHH
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPM-----------VGLPQCFYAMKVVDREALAIRK-----------KLHRA 136 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~-----------~~~~~~~~aiK~~~~~~~~~~~-----------~~~~~ 136 (489)
.++..++|.+.++||+|+||+||+|.+.... ....++.||||.+......... ..+..
T Consensus 140 ~r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~ 219 (507)
T PLN03224 140 SRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETG 219 (507)
T ss_pred CCccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchh
Confidence 3456789999999999999999999763211 1124567999998643211111 12234
Q ss_pred HHHHHHHHhCCCCCc-----ccccceeec--------CceEEEEEeecCCCchHHHHHhCCC------------------
Q 011302 137 DMEKVILTMLDHPFL-----PTLYAEFEA--------SHYSCLVMEYCPGGDLYAARQRQPG------------------ 185 (489)
Q Consensus 137 ~~E~~~l~~l~hpnI-----v~l~~~~~~--------~~~~~lV~E~~~gg~L~~~l~~~~~------------------ 185 (489)
..|+.++.+++|.++ ++++++|.. .+..||||||+++|+|.+++....+
T Consensus 220 ~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~ 299 (507)
T PLN03224 220 MVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD 299 (507)
T ss_pred HHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence 457777777766554 677777643 3568999999999999998864211
Q ss_pred ----CCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCccccCCcchhHHHhhhh
Q 011302 186 ----KRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYE 261 (489)
Q Consensus 186 ----~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~ 261 (489)
..+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||++.......
T Consensus 300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~---------------- 363 (507)
T PLN03224 300 NMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI---------------- 363 (507)
T ss_pred hcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC----------------
Confidence 124567788999999999999999999999999999999999999999999983221000
Q ss_pred ccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCccccCCCCccCcchh
Q 011302 262 KCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVI 341 (489)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l 341 (489)
........+|+.|+|||++
T Consensus 364 -------------------------------------------------------------~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 364 -------------------------------------------------------------NFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred -------------------------------------------------------------ccCccccCCCcceeChhhh
Confidence 0000112358999999998
Q ss_pred cCCC--------------------C--CCcccHHHHHHHHHHHhhCCC-CCCCCCcH-----------HHHHHHhcCCCC
Q 011302 342 SGQG--------------------H--GSAVDWWTLGVFLYEMLYGTT-PFKGENNE-----------KTLINILKKPLT 387 (489)
Q Consensus 342 ~~~~--------------------~--~~~~DiwSlGvil~elltG~~-Pf~~~~~~-----------~~~~~i~~~~~~ 387 (489)
.... | ..+.||||+||++|||++|.. ||.+.... ..+..+....+.
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~ 462 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYD 462 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCC
Confidence 6432 1 124799999999999999986 77543211 111222223333
Q ss_pred CCCCCCCCchhHHHHhhHHHHHHHHhhcCc---ccccCCCCChHHHHcCCCcCC
Q 011302 388 FPRIGVSSSKEFEEVVKLQDLISKLLVKNP---KKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 388 ~p~~~~~~~~~~~~~~~l~~li~~~L~~dP---~~R~~~~~~~~~ll~hp~f~~ 438 (489)
++..... ...++|||.+||..+| .+|+++. |+|+||||..
T Consensus 463 ~~~~d~~-------s~~~~dLi~~LL~~~~~~~~~RlSa~----eaL~Hp~f~~ 505 (507)
T PLN03224 463 FSLLDRN-------KEAGWDLACKLITKRDQANRGRLSVG----QALSHRFFLP 505 (507)
T ss_pred ccccccc-------ChHHHHHHHHHhccCCCCcccCCCHH----HHhCCCCcCC
Confidence 3322111 2358999999999876 6899998 9999999954
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=282.31 Aligned_cols=260 Identities=24% Similarity=0.390 Sum_probs=202.9
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-CCCcccccceeec
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-HPFLPTLYAEFEA 160 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~ 160 (489)
..++|++++++|+|-|++||.|.... ++..+.||+++.-. ...+.+|+.+|..|. ||||++|+++..+
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~-----~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~D 104 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINIT-----NNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKD 104 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccC-----CCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcC
Confidence 45899999999999999999998765 45677899987543 234556999999996 9999999999976
Q ss_pred C--ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEecc-CCcEEEcccCC
Q 011302 161 S--HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRE-DGHIMLSDFDL 237 (489)
Q Consensus 161 ~--~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~-~~~vkl~DFG~ 237 (489)
. ....||+||+++.+...+. ..|+...++.++.|++.||.|||+.||+|||+||.|+||+. ...++|+|+|+
T Consensus 105 p~SktpaLiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGL 179 (338)
T KOG0668|consen 105 PESKTPSLIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGL 179 (338)
T ss_pred ccccCchhHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecch
Confidence 4 4678999999998886654 35888999999999999999999999999999999999994 56799999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
|..+.+..
T Consensus 180 AEFYHp~~------------------------------------------------------------------------ 187 (338)
T KOG0668|consen 180 AEFYHPGK------------------------------------------------------------------------ 187 (338)
T ss_pred HhhcCCCc------------------------------------------------------------------------
Confidence 95543211
Q ss_pred cccccccCCccccCCCCccCcchhcCC-CCCCcccHHHHHHHHHHHhhCCCCC-CCCCcHHHHHHHhc------------
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVISGQ-GHGSAVDWWTLGVFLYEMLYGTTPF-KGENNEKTLINILK------------ 383 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltG~~Pf-~~~~~~~~~~~i~~------------ 383 (489)
...-.+.+..|--||.+..- .|+..-|+|||||+|..|+..+.|| .|.++.+++.+|.+
T Consensus 188 -------eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 188 -------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred -------eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence 11223567889999998764 4899999999999999999988886 56777766665532
Q ss_pred -CCCCCC----C-CCCCCchhHH----------HHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 384 -KPLTFP----R-IGVSSSKEFE----------EVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 384 -~~~~~p----~-~~~~~~~~~~----------~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
-.+..+ . .+......|. ..+++.|||.++|..|-.+|+|+. |++.||||..+-
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTak----Eam~HpyF~~~~ 329 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAK----EAMAHPYFAPVR 329 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchH----HHhcCchHHHHH
Confidence 011111 1 0111111121 124689999999999999999998 999999998753
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=289.35 Aligned_cols=266 Identities=24% Similarity=0.294 Sum_probs=206.1
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC--
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS-- 161 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-- 161 (489)
.+.+-.+.||.|+||.||.+.+-. .++.+|+|.+..-. ..-....++.+|..+|..+.|.||+..++..+-.
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPR-----dgrrvalkK~pnvf-q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~ 126 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPR-----SGKRVALKKMPNVF-QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANP 126 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCC-----CccchhHhhcchHH-HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCc
Confidence 356667899999999999998876 67889999886432 2233456788899999999999999999977643
Q ss_pred ---ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 162 ---HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 162 ---~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
+.+|+|+|+| ..+|..++-.- ..++.+.++.+++||+.||+|||+.||.||||||.|+|++.|..+||||||+|
T Consensus 127 dfFqEiYV~TELm-QSDLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLA 203 (449)
T KOG0664|consen 127 SFFQELYVLTELM-QSDLHKIIVSP--QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLA 203 (449)
T ss_pred hHHHHHHHHHHHH-HhhhhheeccC--CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccc
Confidence 2578999999 67887776543 67999999999999999999999999999999999999999999999999999
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
+..+....
T Consensus 204 Rvee~d~~------------------------------------------------------------------------ 211 (449)
T KOG0664|consen 204 RTWDQRDR------------------------------------------------------------------------ 211 (449)
T ss_pred cccchhhh------------------------------------------------------------------------
Confidence 54322110
Q ss_pred ccccccCCccccCCCCccCcchhcCCC-CCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHh---------------
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQG-HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINIL--------------- 382 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~--------------- 382 (489)
...+.-+-|-+|+|||+++|.. |+.++||||+|||+.||+..+..|...++.+.+.-|.
T Consensus 212 -----~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 212 -----LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC 286 (449)
T ss_pred -----hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence 0112235688999999999976 7999999999999999999999999887766555442
Q ss_pred --------cCCCCCCCCCCCCc--hhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 383 --------KKPLTFPRIGVSSS--KEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 383 --------~~~~~~p~~~~~~~--~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
++....|....... .......+..+++.+||..||++|.+.. +++.|+|....
T Consensus 287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~----~A~~~~~~~e~ 349 (449)
T KOG0664|consen 287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVE----EALQHRYLEEG 349 (449)
T ss_pred hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHh----hhccccccccc
Confidence 22333333221110 0001223567999999999999999987 89999998654
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=322.60 Aligned_cols=250 Identities=27% Similarity=0.339 Sum_probs=198.3
Q ss_pred ceeeeeeccCCcee-EEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-CCCcccccceeecCce
Q 011302 86 FRLLRRLGSGDIGN-VYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-HPFLPTLYAEFEASHY 163 (489)
Q Consensus 86 y~~~~~lG~G~fg~-Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~ 163 (489)
|.--+.+|.|+-|+ ||+|...+ +.||||++-.+. ...+.+|+.+|+.-+ |||||++|+.-.+.++
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~-------R~VAVKrll~e~------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF 577 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEG-------REVAVKRLLEEF------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQF 577 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCC-------ceehHHHHhhHh------HHHHHHHHHHHHhccCCCceEEEEeeccCCce
Confidence 34446789999986 79998875 688999986553 335667999998875 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhC--CCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEecc---C--CcEEEcccC
Q 011302 164 SCLVMEYCPGGDLYAARQRQ--PGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRE---D--GHIMLSDFD 236 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~---~--~~vkl~DFG 236 (489)
.||..|+| ..+|.+++... ..........+.++.|++.||++||+.+||||||||.||||+. + ..++|+|||
T Consensus 578 ~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfg 656 (903)
T KOG1027|consen 578 LYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFG 656 (903)
T ss_pred EEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccc
Confidence 99999999 78999999874 1111111345778999999999999999999999999999986 3 468999999
Q ss_pred CCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcc
Q 011302 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPE 316 (489)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (489)
+++++..-+..+
T Consensus 657 lsKkl~~~~sS~-------------------------------------------------------------------- 668 (903)
T KOG1027|consen 657 LSKKLAGGKSSF-------------------------------------------------------------------- 668 (903)
T ss_pred cccccCCCcchh--------------------------------------------------------------------
Confidence 997665322211
Q ss_pred ccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhC-CCCCCCCCcHHHHHHHhcCCCCCCCCCCCC
Q 011302 317 VVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYG-TTPFKGENNEKTLINILKKPLTFPRIGVSS 395 (489)
Q Consensus 317 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 395 (489)
++..+..||-+|+|||++....-+.++|||||||++|+.++| ..||...- +...+|+.+....-......
T Consensus 669 -------~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~--~R~~NIl~~~~~L~~L~~~~ 739 (903)
T KOG1027|consen 669 -------SRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL--ERQANILTGNYTLVHLEPLP 739 (903)
T ss_pred -------hcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH--HhhhhhhcCccceeeeccCc
Confidence 123455799999999999999888999999999999999985 99996544 34457777766544333221
Q ss_pred chhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 396 SKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 396 ~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
.. ++.|||.+||+.+|..||++. ++|.||||
T Consensus 740 d~------eA~dLI~~ml~~dP~~RPsa~----~VL~HPlF 770 (903)
T KOG1027|consen 740 DC------EAKDLISRMLNPDPQLRPSAT----DVLNHPLF 770 (903)
T ss_pred hH------HHHHHHHHhcCCCcccCCCHH----HHhCCCcc
Confidence 11 589999999999999999998 99999999
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=281.83 Aligned_cols=243 Identities=44% Similarity=0.709 Sum_probs=197.4
Q ss_pred CceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEEEEEeecCCCc
Q 011302 96 DIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGD 175 (489)
Q Consensus 96 ~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 175 (489)
+||.||+|.+.+ .++.+|+|++........ ...+..|+..++.++|+||+++++.+......++||||+++++
T Consensus 1 ~~g~v~~~~~~~-----~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~ 73 (244)
T smart00220 1 SFGKVYLARDKK-----TGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGD 73 (244)
T ss_pred CceEEEEEEECC-----CCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCC
Confidence 689999999886 467899999976543321 4567779999999999999999999999999999999999999
Q ss_pred hHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCccccCCcchhH
Q 011302 176 LYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFE 255 (489)
Q Consensus 176 L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~ 255 (489)
|..++... ..+++..+..++.+++.+|.|||+.+|+|+||+|.||+++.++.++|+|||.+......
T Consensus 74 L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~----------- 140 (244)
T smart00220 74 LFDLLKKR--GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPG----------- 140 (244)
T ss_pred HHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccc-----------
Confidence 99988765 23889999999999999999999999999999999999999999999999997432210
Q ss_pred HHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCccccCCCCc
Q 011302 256 AIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEY 335 (489)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y 335 (489)
.......|+..|
T Consensus 141 --------------------------------------------------------------------~~~~~~~~~~~~ 152 (244)
T smart00220 141 --------------------------------------------------------------------GLLTTFVGTPEY 152 (244)
T ss_pred --------------------------------------------------------------------cccccccCCcCC
Confidence 011233578899
Q ss_pred cCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCC-CCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhh
Q 011302 336 LAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKG-ENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLV 414 (489)
Q Consensus 336 ~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~ 414 (489)
++||.+.+..++.++||||||+++|+|++|..||.. .+.......+............. ....+.+++.+||.
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~i~~~l~ 226 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWK------ISPEAKDLIRKLLV 226 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcccccc------CCHHHHHHHHHHcc
Confidence 999999988889999999999999999999999988 44444444444333332221110 11248899999999
Q ss_pred cCcccccCCCCChHHHHcCCCc
Q 011302 415 KNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 415 ~dP~~R~~~~~~~~~ll~hp~f 436 (489)
.+|++||++. ++++||||
T Consensus 227 ~~p~~Rp~~~----~~~~~~~~ 244 (244)
T smart00220 227 KDPEKRLTAE----EALQHPFF 244 (244)
T ss_pred CCchhccCHH----HHhhCCCC
Confidence 9999999997 99999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=304.53 Aligned_cols=202 Identities=31% Similarity=0.504 Sum_probs=178.2
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHH-----HHHHHHHHHHHHHhCC---CCCcccc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRK-----KLHRADMEKVILTMLD---HPFLPTL 154 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~---hpnIv~l 154 (489)
..+|..++.||+|+||.|++|.++. ....|.||.+.++.+-.+. ++-.+-.|+.||..++ |+||+++
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~-----n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKl 634 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKE-----NNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKL 634 (772)
T ss_pred cccceeeeeccccccceEEEeeecc-----cceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhh
Confidence 4679999999999999999999998 4678999999988655333 3344567999999998 9999999
Q ss_pred cceeecCceEEEEEeec-CCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEc
Q 011302 155 YAEFEASHYSCLVMEYC-PGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLS 233 (489)
Q Consensus 155 ~~~~~~~~~~~lV~E~~-~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~ 233 (489)
+++|++++++||+||-- +|.+|++++... .+++|.+++.|++|++.|+++||++||||||||-+|+.++.+|.+||+
T Consensus 635 LdfFEddd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~kli 712 (772)
T KOG1152|consen 635 LDFFEDDDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLI 712 (772)
T ss_pred hheeecCCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEe
Confidence 99999999999999985 467999999987 579999999999999999999999999999999999999999999999
Q ss_pred ccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccC
Q 011302 234 DFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLD 313 (489)
Q Consensus 234 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (489)
|||.|....
T Consensus 713 dfgsaa~~k----------------------------------------------------------------------- 721 (772)
T KOG1152|consen 713 DFGSAAYTK----------------------------------------------------------------------- 721 (772)
T ss_pred eccchhhhc-----------------------------------------------------------------------
Confidence 999872110
Q ss_pred CccccccccccCCccccCCCCccCcchhcCCCC-CCcccHHHHHHHHHHHhhCCCCCCC
Q 011302 314 DPEVVAEPINARSKSFVGTHEYLAPEVISGQGH-GSAVDWWTLGVFLYEMLYGTTPFKG 371 (489)
Q Consensus 314 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~~DiwSlGvil~elltG~~Pf~~ 371 (489)
+.....++||..|.|||++.|.+| +..-||||||++||.+++.+.||+.
T Consensus 722 ---------sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 722 ---------SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred ---------CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 123346799999999999999998 8899999999999999999999974
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=294.15 Aligned_cols=300 Identities=24% Similarity=0.364 Sum_probs=210.0
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-CCCcccccceeecC
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-HPFLPTLYAEFEAS 161 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~ 161 (489)
.+.|.++.+||+|+|++||+|.+... ....++||+|.+.... ...++..|.++|..+. +.||+++.+++..+
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~--~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQ--DTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhh--ccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 36899999999999999999998763 2357899999997542 3445777999999985 89999999999999
Q ss_pred ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEec-cCCcEEEcccCCCcc
Q 011302 162 HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVR-EDGHIMLSDFDLSFK 240 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~-~~~~vkl~DFG~a~~ 240 (489)
+..++||||++..+..++... ++..+++.|++.++.||.++|.+|||||||||.|+|.+ ..+.-.|+|||+|..
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred CeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHH
Confidence 999999999999999888753 77899999999999999999999999999999999998 457889999999842
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCC-----CCC-CCCccccccccccccccccccccccccccccCCCCCCccccCC
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSC-----ATP-MQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDD 314 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (489)
. +.|+......+ .++ +.....+..-.+ .....
T Consensus 183 ~----------------d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~--------------------------~~~p~ 220 (418)
T KOG1167|consen 183 Y----------------DGYQQTEHSRSYSGRHATPAMGKDVHCQSVAT--------------------------ASKPA 220 (418)
T ss_pred H----------------HhhhhhhhhhhhhcccCCccccCccccccccc--------------------------ccCCC
Confidence 1 11111111000 000 000000000000 00000
Q ss_pred cccc--ccccccCCccccCCCCccCcchhcCCC-CCCcccHHHHHHHHHHHhhCCCCCCCC-CcHHHHHHHh--------
Q 011302 315 PEVV--AEPINARSKSFVGTHEYLAPEVISGQG-HGSAVDWWTLGVFLYEMLYGTTPFKGE-NNEKTLINIL-------- 382 (489)
Q Consensus 315 ~~~~--~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~~~~~DiwSlGvil~elltG~~Pf~~~-~~~~~~~~i~-------- 382 (489)
+.+. ............||++|+|||++...+ .++++||||.|||+.-++++..||... +....+.+|.
T Consensus 221 g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~m 300 (418)
T KOG1167|consen 221 GYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEM 300 (418)
T ss_pred CceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHH
Confidence 0111 122233455679999999999998766 589999999999999999999998543 2222222221
Q ss_pred ------cCC--CC----CC----------CCC---CC-------CchhHHH--HhhHHHHHHHHhhcCcccccCCCCChH
Q 011302 383 ------KKP--LT----FP----------RIG---VS-------SSKEFEE--VVKLQDLISKLLVKNPKKRIGSLKGSV 428 (489)
Q Consensus 383 ------~~~--~~----~p----------~~~---~~-------~~~~~~~--~~~l~~li~~~L~~dP~~R~~~~~~~~ 428 (489)
.+. +. ++ ... +. ....+.+ +..+.||+.+||+.||.+|.+++
T Consensus 301 rk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAE---- 376 (418)
T KOG1167|consen 301 RKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAE---- 376 (418)
T ss_pred HHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHH----
Confidence 011 00 00 000 00 0011111 12578999999999999999998
Q ss_pred HHHcCCCcCCCC
Q 011302 429 EIKRHEFFKGIN 440 (489)
Q Consensus 429 ~ll~hp~f~~~~ 440 (489)
++|+||||...+
T Consensus 377 eALkHpFF~~~~ 388 (418)
T KOG1167|consen 377 DALKHPFFDEAD 388 (418)
T ss_pred HHhcCcCCcchh
Confidence 999999998554
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=306.34 Aligned_cols=261 Identities=28% Similarity=0.436 Sum_probs=216.8
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.++|.++.++|.|+||.||+|+++. ++++.|+|+++.+.-. .+.-++.|+-+++.++|||||.+++.+-...
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~-----s~elaavkvVkLep~d---d~~~iqqei~~~~dc~h~nivay~gsylr~d 85 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKR-----SGELAAVKVVKLEPGD---DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD 85 (829)
T ss_pred ccchhheeeecCCcccchhhhcccc-----cCchhhheeeeccCCc---cccccccceeeeecCCCcChHHHHhhhhhhc
Confidence 4799999999999999999999987 6788999999865433 2333445888999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
.++++||||.||+|.+..+-. +.+++.++..++++.+.||+|||++|=+|||||-.|||+++.|.+|++|||.+-.+.
T Consensus 86 klwicMEycgggslQdiy~~T--gplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqit 163 (829)
T KOG0576|consen 86 KLWICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQIT 163 (829)
T ss_pred CcEEEEEecCCCcccceeeec--ccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhh
Confidence 999999999999998876554 789999999999999999999999999999999999999999999999999872110
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
..
T Consensus 164 ------------------------------------------------------------------------------at 165 (829)
T KOG0576|consen 164 ------------------------------------------------------------------------------AT 165 (829)
T ss_pred ------------------------------------------------------------------------------hh
Confidence 00
Q ss_pred ccCCccccCCCCccCcchhc---CCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhH
Q 011302 323 NARSKSFVGTHEYLAPEVIS---GQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEF 399 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~---~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 399 (489)
-.+..++.|||+|||||+-. ...|...+|||++|+...||---++|....-+...+.-..+..+..|....+...
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kw-- 243 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKW-- 243 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccc--
Confidence 12456789999999999963 4569999999999999999999999987777766666555655555554433321
Q ss_pred HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 400 EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 400 ~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
. ..+-+|++.+|.++|.+||++. .+|+|||...-
T Consensus 244 s--~~fh~fvK~altknpKkRptae----klL~h~fvs~~ 277 (829)
T KOG0576|consen 244 S--EFFHNFVKGALTKNPKKRPTAE----KLLQHPFVSQT 277 (829)
T ss_pred h--HHHHHHHHHHhcCCCccCCChh----hheeceeeccc
Confidence 1 2378999999999999999998 88999998543
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=311.61 Aligned_cols=262 Identities=23% Similarity=0.318 Sum_probs=207.7
Q ss_pred cCccccCCceeeeeeccCCceeEEEEEEccCCCCC--CCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-CCCcccc
Q 011302 78 QGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGL--PQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-HPFLPTL 154 (489)
Q Consensus 78 ~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l 154 (489)
.+++..++..+.+.||+|.||.|++|...+..... ....||||.++..... .....+..|..+|+.+. ||||+.+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~l 367 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNL 367 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhh
Confidence 45666677778889999999999999977544331 3678999999866544 45567788999999985 9999999
Q ss_pred cceeecCceEEEEEeecCCCchHHHHHhCC------C--------CCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCC
Q 011302 155 YAEFEASHYSCLVMEYCPGGDLYAARQRQP------G--------KRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPE 220 (489)
Q Consensus 155 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~------~--------~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~ 220 (489)
++++...+.+++|+|||..|+|..+++... . ..++..+...++.||+.|++||++.++|||||..+
T Consensus 368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaR 447 (609)
T KOG0200|consen 368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAAR 447 (609)
T ss_pred eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhh
Confidence 999999999999999999999999998763 0 13888899999999999999999999999999999
Q ss_pred CeEeccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCcccccccccccccccccccccccccc
Q 011302 221 NVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIRE 300 (489)
Q Consensus 221 NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (489)
|||+..+..+||+|||+|+.........
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~---------------------------------------------------- 475 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYR---------------------------------------------------- 475 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceE----------------------------------------------------
Confidence 9999999999999999996432211100
Q ss_pred ccCCCCCCccccCCccccccccccCCccccC--CCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCC-cHH
Q 011302 301 QVDGDHHDQELLDDPEVVAEPINARSKSFVG--THEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGEN-NEK 376 (489)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G--t~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~-~~~ 376 (489)
...-.| ...|||||.+....|+.++|||||||+||||++ |..||.+.. ..+
T Consensus 476 -------------------------~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~ 530 (609)
T KOG0200|consen 476 -------------------------TKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEE 530 (609)
T ss_pred -------------------------ecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHH
Confidence 000012 235999999999999999999999999999997 999999866 555
Q ss_pred HHHHHhcCCC-CCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCCh
Q 011302 377 TLINILKKPL-TFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGS 427 (489)
Q Consensus 377 ~~~~i~~~~~-~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~ 427 (489)
.+..+..+.. ..|.. +. .++.+|++.||+.+|++||++.+-.
T Consensus 531 l~~~l~~G~r~~~P~~---c~------~eiY~iM~~CW~~~p~~RP~F~~~~ 573 (609)
T KOG0200|consen 531 LLEFLKEGNRMEQPEH---CS------DEIYDLMKSCWNADPEDRPTFSECV 573 (609)
T ss_pred HHHHHhcCCCCCCCCC---CC------HHHHHHHHHHhCCCcccCCCHHHHH
Confidence 5554544432 22221 12 2478999999999999999997433
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=335.62 Aligned_cols=241 Identities=19% Similarity=0.225 Sum_probs=183.2
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
..|.....||+|+||.||+|+++. .+..||||.+..... ....|+.++++++|||||++++++.+.+.
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~ 757 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIK-----NGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKG 757 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECC-----CCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCC
Confidence 345667789999999999999875 467899999864321 11236788999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHH---hCCCeeecCCCCCeEeccCCcEEEcccCCCcc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLH---MMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~ 240 (489)
.|+||||+++|+|.++++ .+++..+..|+.|++.||+||| +.+|+||||||+|||++.++..++. ||.+..
T Consensus 758 ~~lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~ 831 (968)
T PLN00113 758 AYLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL 831 (968)
T ss_pred CEEEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccc
Confidence 999999999999999985 3789999999999999999999 6699999999999999998888775 655311
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
..
T Consensus 832 ~~------------------------------------------------------------------------------ 833 (968)
T PLN00113 832 LC------------------------------------------------------------------------------ 833 (968)
T ss_pred cc------------------------------------------------------------------------------
Confidence 00
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCc----HHHHHHHhcCC-----CCCCCC
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENN----EKTLINILKKP-----LTFPRI 391 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~-----~~~p~~ 391 (489)
......||+.|||||++.+..++.++|||||||++|||++|+.||+.... ...+.+..... +..|..
T Consensus 834 ----~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (968)
T PLN00113 834 ----TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSI 909 (968)
T ss_pred ----cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccc
Confidence 00122588999999999999999999999999999999999999964321 11111111100 001111
Q ss_pred CCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 392 GVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 392 ~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
.........+..++.+++.+||+.||++||++.
T Consensus 910 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~ 942 (968)
T PLN00113 910 RGDVSVNQNEIVEVMNLALHCTATDPTARPCAN 942 (968)
T ss_pred cCCCCccHHHHHHHHHHHHhhCcCCchhCcCHH
Confidence 111111223445678999999999999999997
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=281.11 Aligned_cols=248 Identities=24% Similarity=0.319 Sum_probs=185.1
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHH--HHhCCCCCcccccceeec
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVI--LTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~--l~~l~hpnIv~l~~~~~~ 160 (489)
..+.++++.||+|.||+||+|.+++ ..||||++...... ...+|.++ ...|+|+||+.+++.=..
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wrG-------e~VAVKiF~srdE~------SWfrEtEIYqTvmLRHENILgFIaaD~~ 276 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWRG-------EDVAVKIFSSRDER------SWFRETEIYQTVMLRHENILGFIAADNK 276 (513)
T ss_pred hheeEEEEEecCccccceeeccccC-------CceEEEEecccchh------hhhhHHHHHHHHHhccchhhhhhhcccc
Confidence 3578999999999999999999996 67899999754322 22234444 445799999999986543
Q ss_pred C----ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHh-----C---CCeeecCCCCCeEeccCC
Q 011302 161 S----HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHM-----M---GIVYRDLKPENVLVREDG 228 (489)
Q Consensus 161 ~----~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-----~---~iiHrDIKp~NILl~~~~ 228 (489)
+ .+++||++|.+.|+|+|+|.++ .++.+....++..++.||+|||. + .|.|||||..|||+..+|
T Consensus 277 ~~gs~TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~ 353 (513)
T KOG2052|consen 277 DNGSWTQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 353 (513)
T ss_pred CCCceEEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC
Confidence 3 2689999999999999999884 69999999999999999999994 2 399999999999999999
Q ss_pred cEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCC
Q 011302 229 HIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHD 308 (489)
Q Consensus 229 ~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (489)
.+-|+|+|+|-.......
T Consensus 354 ~C~IADLGLAv~h~~~t~-------------------------------------------------------------- 371 (513)
T KOG2052|consen 354 TCCIADLGLAVRHDSDTD-------------------------------------------------------------- 371 (513)
T ss_pred cEEEeeceeeEEecccCC--------------------------------------------------------------
Confidence 999999999843321110
Q ss_pred ccccCCccccccccccCCccccCCCCccCcchhcCCC----C--CCcccHHHHHHHHHHHhhC----------CCCCCCC
Q 011302 309 QELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQG----H--GSAVDWWTLGVFLYEMLYG----------TTPFKGE 372 (489)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~----~--~~~~DiwSlGvil~elltG----------~~Pf~~~ 372 (489)
..+......+||..|||||+|...- + -..+||||||.++||++-. ++||.+.
T Consensus 372 ------------~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 372 ------------TIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred ------------cccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 0111234458999999999996532 1 2468999999999999832 5788653
Q ss_pred ----CcHHHHHHHhc-CCC--CCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 373 ----NNEKTLINILK-KPL--TFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 373 ----~~~~~~~~i~~-~~~--~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
...+.+.++.- ..+ .+|.... ..+....+..||+.||..||..|+++.
T Consensus 440 Vp~DPs~eeMrkVVCv~~~RP~ipnrW~----s~~~l~~m~klMkeCW~~Np~aRltAL 494 (513)
T KOG2052|consen 440 VPSDPSFEEMRKVVCVQKLRPNIPNRWK----SDPALRVMAKLMKECWYANPAARLTAL 494 (513)
T ss_pred CCCCCCHHHHhcceeecccCCCCCcccc----cCHHHHHHHHHHHHhhcCCchhhhHHH
Confidence 23344444432 222 2222111 123344677999999999999999986
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=283.55 Aligned_cols=247 Identities=24% Similarity=0.348 Sum_probs=186.6
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHh--CCCCCcccccceee
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTM--LDHPFLPTLYAEFE 159 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l~~~~~ 159 (489)
.+...+++++||+|.||.||+|+..+ +.||||++.... ...+..|.+|.+. +.|+||++++++-+
T Consensus 208 ~l~pl~l~eli~~Grfg~V~KaqL~~-------~~VAVKifp~~~------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ek 274 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQLDN-------RLVAVKIFPEQE------KQSFQNEKNIYSLPGMKHENILQFIGAEK 274 (534)
T ss_pred cCCchhhHHHhhcCccceeehhhccC-------ceeEEEecCHHH------HHHHHhHHHHHhccCccchhHHHhhchhc
Confidence 35667888999999999999999875 789999998654 3345667777765 57999999999776
Q ss_pred cCc----eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhC---------CCeeecCCCCCeEecc
Q 011302 160 ASH----YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMM---------GIVYRDLKPENVLVRE 226 (489)
Q Consensus 160 ~~~----~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~---------~iiHrDIKp~NILl~~ 226 (489)
... .++||+||.+.|+|.++|..+ ..++.+...|+..|++||+|||+- .|+|||||..||||..
T Consensus 275 r~t~~~~eywLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~ 351 (534)
T KOG3653|consen 275 RGTADRMEYWLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKN 351 (534)
T ss_pred cCCccccceeEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEcc
Confidence 544 889999999999999999885 699999999999999999999963 4999999999999999
Q ss_pred CCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCC
Q 011302 227 DGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDH 306 (489)
Q Consensus 227 ~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (489)
|+++.|+|||+|.++.+-.. .
T Consensus 352 DlTccIaDFGLAl~~~p~~~--------------------------------------------------------~--- 372 (534)
T KOG3653|consen 352 DLTCCIADFGLALRLEPGKP--------------------------------------------------------Q--- 372 (534)
T ss_pred CCcEEeeccceeEEecCCCC--------------------------------------------------------C---
Confidence 99999999999966542100 0
Q ss_pred CCccccCCccccccccccCCccccCCCCccCcchhcCCCC-C-----CcccHHHHHHHHHHHhhCCCCCC-C--------
Q 011302 307 HDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGH-G-----SAVDWWTLGVFLYEMLYGTTPFK-G-------- 371 (489)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~-----~~~DiwSlGvil~elltG~~Pf~-~-------- 371 (489)
.....-+||..|||||+|.|..- . .+.||||+|.+||||++...-++ +
T Consensus 373 -----------------~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlp 435 (534)
T KOG3653|consen 373 -----------------GDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLP 435 (534)
T ss_pred -----------------cchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCc
Confidence 01122489999999999977532 2 36899999999999997543332 1
Q ss_pred ------C-CcHHHHHH-Hhc--CCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 372 ------E-NNEKTLIN-ILK--KPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 372 ------~-~~~~~~~~-i~~--~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
. ...+.+.. +.+ ....+|...... .....+++.|..||..|++.|+|+.
T Consensus 436 fe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h----~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 436 FEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKH----AGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred hhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcC----ccHHHHHHHHHHHcCCchhhhhhhH
Confidence 1 11122222 222 223333322211 2233588999999999999999985
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=255.42 Aligned_cols=218 Identities=25% Similarity=0.356 Sum_probs=174.5
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHh-CCCCCccccccee
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTM-LDHPFLPTLYAEF 158 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpnIv~l~~~~ 158 (489)
++..++..-+..||+|++|.|-+.++.. ++...|+|.+...... +...+..+|+.+..+ ..+|++|.+||.+
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~~-----sg~imAvKri~~tvn~--q~q~r~L~dldi~~r~~~CPf~V~FyGa~ 114 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHIQ-----SGTIMAVKRIRATVNS--QEQKRLLMDLDIIMRTVDCPFTVHFYGAL 114 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeecc-----CCeEEEEeeehhhcCh--HHHHHHHHhhhhhccCCCCCeEEEeehhh
Confidence 3455667778899999999998888876 6789999999765432 344566677776554 5799999999999
Q ss_pred ecCceEEEEEeecCCCchHHHHHh--CCCCCCChhhHHHHHHHHHHHHHHHHhC-CCeeecCCCCCeEeccCCcEEEccc
Q 011302 159 EASHYSCLVMEYCPGGDLYAARQR--QPGKRFGISSAKFYAAETLLALEYLHMM-GIVYRDLKPENVLVREDGHIMLSDF 235 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~iiHrDIKp~NILl~~~~~vkl~DF 235 (489)
.....+++.||.| .-+|..+... ..++..+|.-+-.|+..++.||.|||++ .|||||+||.||||+.+|+||||||
T Consensus 115 ~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDF 193 (282)
T KOG0984|consen 115 FREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDF 193 (282)
T ss_pred hccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccc
Confidence 9999999999999 6777554332 2457899999999999999999999986 8999999999999999999999999
Q ss_pred CCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCc
Q 011302 236 DLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDP 315 (489)
Q Consensus 236 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (489)
|++-.+..
T Consensus 194 GIsG~L~d------------------------------------------------------------------------ 201 (282)
T KOG0984|consen 194 GISGYLVD------------------------------------------------------------------------ 201 (282)
T ss_pred ccceeehh------------------------------------------------------------------------
Confidence 99733211
Q ss_pred cccccccccCCcc-ccCCCCccCcchhcC----CCCCCcccHHHHHHHHHHHhhCCCCCCCC-CcHHHHHHHhcCC
Q 011302 316 EVVAEPINARSKS-FVGTHEYLAPEVISG----QGHGSAVDWWTLGVFLYEMLYGTTPFKGE-NNEKTLINILKKP 385 (489)
Q Consensus 316 ~~~~~~~~~~~~~-~~Gt~~y~aPE~l~~----~~~~~~~DiwSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~~ 385 (489)
+...+ -.|.-.|||||.+.. ..|+-++||||||+++.||.+++.||+.. ++.+++.++...+
T Consensus 202 --------SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep 269 (282)
T KOG0984|consen 202 --------SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEP 269 (282)
T ss_pred --------hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCC
Confidence 00011 257889999999864 36899999999999999999999999765 5667777776654
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=298.56 Aligned_cols=252 Identities=22% Similarity=0.235 Sum_probs=201.2
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceE
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYS 164 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 164 (489)
..+..++||+|+||+||+|.+--.. +.-+..||||++...... +...++..|+.+|..++|||+++|++++.... +
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Peg-e~vKipVaiKvl~~~t~~--~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ 772 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEG-ENVKIPVAIKVLIEFTSP--KASIELLDEALRMASLDHPNLLRLLGVCMLST-L 772 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCC-ceecceeEEEEeeccCCc--hhhHHHHHHHHHHhcCCCchHHHHhhhcccch-H
Confidence 3455678999999999999986432 224668999998754332 44567788999999999999999999998766 8
Q ss_pred EEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccC
Q 011302 165 CLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVV 244 (489)
Q Consensus 165 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~ 244 (489)
-||++|+++|.|.++++.+. ..+.....+.|..||++||.|||++++|||||..+|||+....++||.|||+|+.+...
T Consensus 773 qlvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HHHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 89999999999999998764 67899999999999999999999999999999999999999999999999999665432
Q ss_pred ccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccccc
Q 011302 245 PKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINA 324 (489)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (489)
.....
T Consensus 852 ~~ey~--------------------------------------------------------------------------- 856 (1177)
T KOG1025|consen 852 EKEYS--------------------------------------------------------------------------- 856 (1177)
T ss_pred ccccc---------------------------------------------------------------------------
Confidence 21110
Q ss_pred CCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHh
Q 011302 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVV 403 (489)
Q Consensus 325 ~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~ 403 (489)
.....-.+.|||-|.+....|+.++|||||||++|||+| |..||.+....++-.-+..+. ..+....-. .
T Consensus 857 -~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ge-RLsqPpiCt-------i 927 (1177)
T KOG1025|consen 857 -APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGE-RLSQPPICT-------I 927 (1177)
T ss_pred -ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccc-cCCCCCCcc-------H
Confidence 001112357999999999999999999999999999997 999999998776654443332 233222211 1
Q ss_pred hHHHHHHHHhhcCcccccCCCC
Q 011302 404 KLQDLISKLLVKNPKKRIGSLK 425 (489)
Q Consensus 404 ~l~~li~~~L~~dP~~R~~~~~ 425 (489)
++.-++.+||..|+..||++.+
T Consensus 928 DVy~~mvkCwmid~~~rp~fke 949 (1177)
T KOG1025|consen 928 DVYMVMVKCWMIDADSRPTFKE 949 (1177)
T ss_pred HHHHHHHHHhccCcccCccHHH
Confidence 3678999999999999999864
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-32 Score=255.53 Aligned_cols=259 Identities=19% Similarity=0.190 Sum_probs=200.0
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE 159 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 159 (489)
.+..+++++...+-+|.||+||+|.+++...--..+.|-+|.++... ...++..+..|.-++..+.|||+..+.++..
T Consensus 280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 34557799999999999999999988864333334455566665433 2345667778888888899999999999774
Q ss_pred -cCceEEEEEeecCCCchHHHHHhCC------CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEE
Q 011302 160 -ASHYSCLVMEYCPGGDLYAARQRQP------GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIML 232 (489)
Q Consensus 160 -~~~~~~lV~E~~~gg~L~~~l~~~~------~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl 232 (489)
+....++++.++.-|+|..++.... ...++..+...++.|++.|++|||.+||||.||..+|++|++.-.|||
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkl 437 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKL 437 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEe
Confidence 5567788999999999999987321 234666777889999999999999999999999999999999999999
Q ss_pred cccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCcccc
Q 011302 233 SDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELL 312 (489)
Q Consensus 233 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (489)
+|=.+++.+-+ ++. +.+
T Consensus 438 tDsaLSRDLFP------------------------------------------------------------~DY---hcL 454 (563)
T KOG1024|consen 438 TDSALSRDLFP------------------------------------------------------------GDY---HCL 454 (563)
T ss_pred ccchhccccCc------------------------------------------------------------ccc---ccc
Confidence 99999854321 000 000
Q ss_pred CCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCC
Q 011302 313 DDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRI 391 (489)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~ 391 (489)
.+.+ --...||+||.+.+..|+.++|+|||||+||||+| |+.||...++.++..-+.++..--...
T Consensus 455 GDnE-------------nRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP~ 521 (563)
T KOG1024|consen 455 GDNE-------------NRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQPF 521 (563)
T ss_pred CCCC-------------CCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCCC
Confidence 0000 12357999999999999999999999999999997 999999999998877776643211111
Q ss_pred CCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 392 GVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 392 ~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
.++ .++..++..||+.+|++||+..
T Consensus 522 NCP--------DeLf~vMacCWallpeeRPsf~ 546 (563)
T KOG1024|consen 522 NCP--------DELFTVMACCWALLPEERPSFS 546 (563)
T ss_pred CCc--------HHHHHHHHHHHhcCcccCCCHH
Confidence 222 2589999999999999999986
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=287.70 Aligned_cols=264 Identities=41% Similarity=0.699 Sum_probs=221.7
Q ss_pred eeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-CCCcccccceeecCceEEEEEe
Q 011302 91 RLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-HPFLPTLYAEFEASHYSCLVME 169 (489)
Q Consensus 91 ~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lV~E 169 (489)
.+|+|+||.|++++...... .+..||+|++++.....+... ....|..++...+ ||++|++...|+.+..+|++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~d--a~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld 77 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGAD--AGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILD 77 (612)
T ss_pred CCCcCCCcchHHHHHhcccc--ccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhh
Confidence 37999999999987654332 578899999987766544443 4556888888887 9999999999999999999999
Q ss_pred ecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCccccC
Q 011302 170 YCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLR 249 (489)
Q Consensus 170 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 249 (489)
|..||+|+..+... ..+.+...+.+..+++.+++++|+.+|||||+|++||+++.+|++|+.|||+++....
T Consensus 78 ~~rgg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~------ 149 (612)
T KOG0603|consen 78 FLRGGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK------ 149 (612)
T ss_pred hcccchhhhccccC--CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHh------
Confidence 99999998877654 5688889999999999999999999999999999999999999999999999743210
Q ss_pred CcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCccc
Q 011302 250 PKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSF 329 (489)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (489)
....
T Consensus 150 ----------------------------------------------------------------------------~~~~ 153 (612)
T KOG0603|consen 150 ----------------------------------------------------------------------------EKIA 153 (612)
T ss_pred ----------------------------------------------------------------------------hhhc
Confidence 0011
Q ss_pred cCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHHH
Q 011302 330 VGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLI 409 (489)
Q Consensus 330 ~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li 409 (489)
|||..|||||+++ ++..++|+||||++.+||++|..||.+ ++...|.+....+|..... .+++++
T Consensus 154 cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~---------~a~~~~ 218 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSA---------EARSLF 218 (612)
T ss_pred ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhH---------HHHHHH
Confidence 8999999999999 678899999999999999999999988 6777888766666653322 489999
Q ss_pred HHHhhcCcccccCCC-CChHHHHcCCCcCCCCcccc--ccCCCCCCCCcc
Q 011302 410 SKLLVKNPKKRIGSL-KGSVEIKRHEFFKGINWALI--RSIKPPEVPNND 456 (489)
Q Consensus 410 ~~~L~~dP~~R~~~~-~~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~~~ 456 (489)
..++.++|.+|+... +...++++|+||.+++|+.+ +...||+.|...
T Consensus 219 ~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~~ 268 (612)
T KOG0603|consen 219 RQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPGSI 268 (612)
T ss_pred HHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCccc
Confidence 999999999999985 56789999999999999965 667777776653
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-32 Score=302.52 Aligned_cols=235 Identities=15% Similarity=0.166 Sum_probs=156.9
Q ss_pred CCC-CCccccccee-------ecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecC
Q 011302 146 LDH-PFLPTLYAEF-------EASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDL 217 (489)
Q Consensus 146 l~h-pnIv~l~~~~-------~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDI 217 (489)
++| +||++++++| .....++++|||+ +++|++++... ...+++.+++.|+.||+.||+|||++|||||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 445 5888888887 3345788899988 78999999753 356999999999999999999999999999999
Q ss_pred CCCCeEeccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccc
Q 011302 218 KPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTT 297 (489)
Q Consensus 218 Kp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (489)
||+||||+..|.+|++|||++....... ........|+........... ..+.
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~-------------------------~~~~ki~DfG~a~~~~~~~~~--~~~~ 159 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDE-------------------------DATTKSREIGSSRREEILSER--RIEK 159 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccc-------------------------cCccccccccccccccccccc--chhh
Confidence 9999999998999999999873211000 000001111111000000000 0000
Q ss_pred cccccCCCCCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHH
Q 011302 298 IREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKT 377 (489)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~ 377 (489)
.......+........+||++|||||++.+..|+.++|||||||+||||++|.+||..... .
T Consensus 160 ----------------~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~ 221 (793)
T PLN00181 160 ----------------LEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--T 221 (793)
T ss_pred ----------------hhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--H
Confidence 0000000001112335799999999999999999999999999999999999998764321 2
Q ss_pred HHHHhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 378 LINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 378 ~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
+..+.... .|... ......+.+++.+||+.||.+||++. ++++||||...
T Consensus 222 ~~~~~~~~--~~~~~------~~~~~~~~~~~~~~L~~~P~~Rps~~----eil~h~~~~~~ 271 (793)
T PLN00181 222 MSSLRHRV--LPPQI------LLNWPKEASFCLWLLHPEPSCRPSMS----ELLQSEFINEP 271 (793)
T ss_pred HHHHHHhh--cChhh------hhcCHHHHHHHHHhCCCChhhCcChH----HHhhchhhhhh
Confidence 22222211 11110 01112467899999999999999998 99999999764
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=243.67 Aligned_cols=215 Identities=41% Similarity=0.641 Sum_probs=177.2
Q ss_pred ceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEE
Q 011302 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSC 165 (489)
Q Consensus 86 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 165 (489)
|.+.+.||+|+||.||+|...+ .++.+|+|.+...... .....+..|+..++.++|+||+++++++......|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~ 73 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKG-----TGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLY 73 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcC-----CCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceE
Confidence 5678899999999999999886 4678999999865433 23456777999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCc
Q 011302 166 LVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVP 245 (489)
Q Consensus 166 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~ 245 (489)
+++||+++++|.+++..... .+++..+..++.+++.+|.|||+++++|+||+|.||+++.++.++|+|||++.......
T Consensus 74 ~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~ 152 (225)
T smart00221 74 LVMEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL 152 (225)
T ss_pred EEEeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence 99999999999999877521 18899999999999999999999999999999999999999999999999874322100
Q ss_pred cccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccC
Q 011302 246 KLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINAR 325 (489)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (489)
...
T Consensus 153 -----------------------------------------------------------------------------~~~ 155 (225)
T smart00221 153 -----------------------------------------------------------------------------AAL 155 (225)
T ss_pred -----------------------------------------------------------------------------ccc
Confidence 001
Q ss_pred CccccCCCCccCcchh-cCCCCCCcccHHHHHHHHHHHhhCCCCCCC-CCcH-HHHHHHhcCC
Q 011302 326 SKSFVGTHEYLAPEVI-SGQGHGSAVDWWTLGVFLYEMLYGTTPFKG-ENNE-KTLINILKKP 385 (489)
Q Consensus 326 ~~~~~Gt~~y~aPE~l-~~~~~~~~~DiwSlGvil~elltG~~Pf~~-~~~~-~~~~~i~~~~ 385 (489)
.....++..|++||.+ ....++.++|||+||+++|||++|+.||.+ .+.. .+...|..+.
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 218 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV 218 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence 1233578899999999 666788899999999999999999999987 4444 5555555544
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=237.04 Aligned_cols=213 Identities=39% Similarity=0.592 Sum_probs=180.5
Q ss_pred eccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEEEEEeec
Q 011302 92 LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYC 171 (489)
Q Consensus 92 lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 171 (489)
||+|++|.||+|.... .++.+++|++....... ....+.+|+.+++.+.|++|+++++++......++||||+
T Consensus 1 l~~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~ 73 (215)
T cd00180 1 LGEGGFGTVYLARDKK-----TGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYC 73 (215)
T ss_pred CCcCCceEEEEEEecC-----CCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecC
Confidence 6899999999999875 46789999998664331 3456777999999999999999999999999999999999
Q ss_pred CCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEecc-CCcEEEcccCCCcccccCccccCC
Q 011302 172 PGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRE-DGHIMLSDFDLSFKCDVVPKLLRP 250 (489)
Q Consensus 172 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~-~~~vkl~DFG~a~~~~~~~~~~~~ 250 (489)
+|++|.+++.... ..+++..+..++.+++.+|.+||++|++|+||+|.||+++. ++.++|+|||.+........
T Consensus 74 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---- 148 (215)
T cd00180 74 EGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---- 148 (215)
T ss_pred CCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc----
Confidence 9999999887642 35889999999999999999999999999999999999999 89999999998743221000
Q ss_pred cchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCcccc
Q 011302 251 KLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFV 330 (489)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (489)
......
T Consensus 149 --------------------------------------------------------------------------~~~~~~ 154 (215)
T cd00180 149 --------------------------------------------------------------------------LLKTIV 154 (215)
T ss_pred --------------------------------------------------------------------------hhhccc
Confidence 012235
Q ss_pred CCCCccCcchhcCC-CCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHHH
Q 011302 331 GTHEYLAPEVISGQ-GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLI 409 (489)
Q Consensus 331 Gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li 409 (489)
+...|++||.+... .++.+.|+|+||+++++| ..+.+++
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------~~~~~~l 194 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------PELKDLI 194 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------HHHHHHH
Confidence 77889999999887 788999999999999999 1378999
Q ss_pred HHHhhcCcccccCCCCChHHHHcCC
Q 011302 410 SKLLVKNPKKRIGSLKGSVEIKRHE 434 (489)
Q Consensus 410 ~~~L~~dP~~R~~~~~~~~~ll~hp 434 (489)
.+||..||++||++. ++++|+
T Consensus 195 ~~~l~~~p~~R~~~~----~l~~~~ 215 (215)
T cd00180 195 RKMLQKDPEKRPSAK----EILEHL 215 (215)
T ss_pred HHHhhCCcccCcCHH----HHhhCC
Confidence 999999999999987 888774
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=242.48 Aligned_cols=238 Identities=27% Similarity=0.375 Sum_probs=181.1
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccc-eeecC
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYA-EFEAS 161 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~-~~~~~ 161 (489)
+.|.+.+.||+|.||.+-+|++++ ++..+++|.+.+...... .|.+|...--.| .|.||+.-|+ .|+..
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~-----s~t~ivlKavp~p~tt~~----dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~ 94 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQ-----SKTRIVLKAVPRPQTTQA----DFVREFHYSFFLSPHQHIIDTYEVAFQTS 94 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccC-----CceEEEeeccCcchhhHH----HHHHHhccceeeccchhhhHHHHHHhhcC
Confidence 789999999999999999999998 678899999988765544 445565544344 4889998887 57888
Q ss_pred ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEec--cCCcEEEcccCCCc
Q 011302 162 HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVR--EDGHIMLSDFDLSF 239 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~--~~~~vkl~DFG~a~ 239 (489)
+.++++|||++-|+|..-+.. ..+.+...+.++.|++.||.|||++++||||||.+||||- +..+|||||||+.+
T Consensus 95 d~YvF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~ 171 (378)
T KOG1345|consen 95 DAYVFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTR 171 (378)
T ss_pred ceEEEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccc
Confidence 899999999999999776544 4588999999999999999999999999999999999995 34589999999974
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
.....-
T Consensus 172 k~g~tV-------------------------------------------------------------------------- 177 (378)
T KOG1345|consen 172 KVGTTV-------------------------------------------------------------------------- 177 (378)
T ss_pred ccCcee--------------------------------------------------------------------------
Confidence 321100
Q ss_pred cccccCCccccCCCCccCcchhcC---CC--CCCcccHHHHHHHHHHHhhCCCCCCCCC----cHHHHHHHhc-CCCCCC
Q 011302 320 EPINARSKSFVGTHEYLAPEVISG---QG--HGSAVDWWTLGVFLYEMLYGTTPFKGEN----NEKTLINILK-KPLTFP 389 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~---~~--~~~~~DiwSlGvil~elltG~~Pf~~~~----~~~~~~~i~~-~~~~~p 389 (489)
...--+..|.+||++.. .. ..+.+|||.||+++|.++||.+||.... ..-.+.++.. .....|
T Consensus 178 -------~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P 250 (378)
T KOG1345|consen 178 -------KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALP 250 (378)
T ss_pred -------hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCc
Confidence 01123456899998643 22 3778999999999999999999997432 1222333333 223444
Q ss_pred CCCCCCchhHHHHhhHHHHHHHHhhcCcccc
Q 011302 390 RIGVSSSKEFEEVVKLQDLISKLLVKNPKKR 420 (489)
Q Consensus 390 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 420 (489)
.....-.+ .+..+.++-|..++++|
T Consensus 251 ~~F~~fs~------~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 251 KKFNPFSE------KALRLFKKSLTPRFKDR 275 (378)
T ss_pred hhhcccCH------HHHHHHHHhcCCccccc
Confidence 43333332 48899999999999999
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=281.68 Aligned_cols=256 Identities=36% Similarity=0.659 Sum_probs=196.7
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.++|..++.|..|+||.||+++++. +.+.+|+| +++..+..++ ++.....|++|
T Consensus 82 e~df~~IklisngAygavylvrh~~-----trqrfa~k-iNkq~lilRn----------ilt~a~npfvv---------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKE-----TRQRFAMK-INKQNLILRN----------ILTFAGNPFVV---------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccc-----cccchhhc-ccccchhhhc----------cccccCCccee----------
Confidence 4789999999999999999999987 56788994 4544333222 44455566655
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
||-..+++.. +.++. +++.+++|||+.||+|||+||+|.||+.-|++|+.|||+++.--
T Consensus 136 -----------gDc~tllk~~--g~lPv--------dmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GL 194 (1205)
T KOG0606|consen 136 -----------GDCATLLKNI--GPLPV--------DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGL 194 (1205)
T ss_pred -----------chhhhhcccC--CCCcc--------hhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhh
Confidence 5555555543 33443 33889999999999999999999999999999999999973211
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
. ..++. +.++.......
T Consensus 195 m--------------------------------------------------s~atn-------------l~eg~I~k~t~ 211 (1205)
T KOG0606|consen 195 M--------------------------------------------------SLATN-------------LKEGHIEKDTH 211 (1205)
T ss_pred h--------------------------------------------------hccch-------------hhhcchHHHHH
Confidence 0 00000 00000000000
Q ss_pred ccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHH
Q 011302 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEV 402 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~ 402 (489)
.-....+||||.|+|||++..++|+..+|||++|+|+||.+.|..||.|++..+++...+...+.+|+.......
T Consensus 212 Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~----- 286 (1205)
T KOG0606|consen 212 EFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPP----- 286 (1205)
T ss_pred HhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCH-----
Confidence 112356799999999999999999999999999999999999999999999999999999988888876544443
Q ss_pred hhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccccccCCCCCCCCc
Q 011302 403 VKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIRSIKPPEVPNN 455 (489)
Q Consensus 403 ~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~~~~~~p~~~~~ 455 (489)
+++++|.++|+.+|..|.... +.-++++|+||+.+||.-|..++.+++|..
T Consensus 287 -Ea~dli~~LL~qnp~~Rlgt~-ga~evk~h~ff~~LDw~~llRqkaefvpql 337 (1205)
T KOG0606|consen 287 -EAQDLIEQLLRQNPLCRLGTG-GALEVKQHGFFQLLDWKSLLRQKAEFVPQL 337 (1205)
T ss_pred -HHHHHHHHHHHhChHhhcccc-hhhhhhhccceeecccchhhhhhccccccc
Confidence 599999999999999999986 445999999999999998878888877765
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-30 Score=272.24 Aligned_cols=274 Identities=26% Similarity=0.333 Sum_probs=199.3
Q ss_pred eeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEEE
Q 011302 87 RLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCL 166 (489)
Q Consensus 87 ~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 166 (489)
...+.+|.|++|.|+.+...........+.+++| .. ...........+..|..+-..+.|||++..+..+.+....+-
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~-~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~ 398 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VK-PTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQ 398 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcc-cC-CcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchh
Confidence 4567899999998888887764333333444443 21 111112222236668888888999999999888887777777
Q ss_pred EEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCcc
Q 011302 167 VMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPK 246 (489)
Q Consensus 167 V~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 246 (489)
+||||++ +|+.++... +.++..++..++.|++.||+|||+.||.|||||++|+|+..+|.+||+|||.+..+...-+
T Consensus 399 ~mE~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 399 SMEYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hhhcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 7999999 999998875 5799999999999999999999999999999999999999999999999999744321100
Q ss_pred ccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCC
Q 011302 247 LLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARS 326 (489)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (489)
. .....
T Consensus 476 ~--------------------------------------------------------------------------~~~~~ 481 (601)
T KOG0590|consen 476 K--------------------------------------------------------------------------NIHES 481 (601)
T ss_pred h--------------------------------------------------------------------------hhhhh
Confidence 0 00123
Q ss_pred ccccCCCCccCcchhcCCCCC-CcccHHHHHHHHHHHhhCCCCCCCCCcHHHH-HHHhcCCCCCCCCCCCCchhHHHHhh
Q 011302 327 KSFVGTHEYLAPEVISGQGHG-SAVDWWTLGVFLYEMLYGTTPFKGENNEKTL-INILKKPLTFPRIGVSSSKEFEEVVK 404 (489)
Q Consensus 327 ~~~~Gt~~y~aPE~l~~~~~~-~~~DiwSlGvil~elltG~~Pf~~~~~~~~~-~~i~~~~~~~p~~~~~~~~~~~~~~~ 404 (489)
..++|+..|+|||++.+..|+ ..+||||.|++++.|++|+.||.-....+.. ...... -.+.....+....-.....
T Consensus 482 ~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~-~~~~~~~~~~~~~~~lp~~ 560 (601)
T KOG0590|consen 482 SGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYS-DQRNIFEGPNRLLSLLPRE 560 (601)
T ss_pred cCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccc-cccccccChHHHHHhchhh
Confidence 567899999999999999985 5789999999999999999999754433221 111110 0000101111111112234
Q ss_pred HHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcccc
Q 011302 405 LQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALI 444 (489)
Q Consensus 405 l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~ 444 (489)
.+.+|.+||+.||.+|.++. +|++.+||+.++-+..
T Consensus 561 ~~~~~~~~l~~~P~~R~ti~----~i~~d~W~~~i~~c~v 596 (601)
T KOG0590|consen 561 TRIIIYRMLQLDPTKRITIE----QILNDEWIRSIECCHV 596 (601)
T ss_pred HHHHHHHHccCChhheecHH----HHhhChHhhhcceEEe
Confidence 68999999999999999998 9999999999876543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=224.85 Aligned_cols=168 Identities=21% Similarity=0.181 Sum_probs=128.3
Q ss_pred CchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCccccCCcch
Q 011302 174 GDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLS 253 (489)
Q Consensus 174 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~ 253 (489)
|+|.+++... +..+++.+++.|+.||+.||.|||+++ ||+|||++.++.+|+ ||++.....
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~---------- 61 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP---------- 61 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc----------
Confidence 7899998764 356999999999999999999999998 999999999999999 998732110
Q ss_pred hHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCccccCCC
Q 011302 254 FEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTH 333 (489)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~ 333 (489)
....||+
T Consensus 62 -------------------------------------------------------------------------~~~~g~~ 68 (176)
T smart00750 62 -------------------------------------------------------------------------EQSRVDP 68 (176)
T ss_pred -------------------------------------------------------------------------ccCCCcc
Confidence 0115889
Q ss_pred CccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcH-HHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHHHHHH
Q 011302 334 EYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNE-KTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKL 412 (489)
Q Consensus 334 ~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~ 412 (489)
.|||||++.+..++.++|||||||++|||++|+.||...... ..+..+.................+.....+.+||.+|
T Consensus 69 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~c 148 (176)
T smart00750 69 YFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVC 148 (176)
T ss_pred cccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHH
Confidence 999999999999999999999999999999999999765443 2333333322111111111111111112589999999
Q ss_pred hhcCcccccCCCCChHHHHcCCCcC
Q 011302 413 LVKNPKKRIGSLKGSVEIKRHEFFK 437 (489)
Q Consensus 413 L~~dP~~R~~~~~~~~~ll~hp~f~ 437 (489)
|..||.+||++. ++++|+|+.
T Consensus 149 l~~~p~~Rp~~~----~ll~~~~~~ 169 (176)
T smart00750 149 ASRLPQRREAAN----HYLAHCRAL 169 (176)
T ss_pred HhcccccccCHH----HHHHHHHHH
Confidence 999999999997 999999874
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=227.27 Aligned_cols=218 Identities=23% Similarity=0.380 Sum_probs=180.4
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-CCCcccccceeecCc
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-HPFLPTLYAEFEASH 162 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~ 162 (489)
-.|++.++||+|+||+.+.|+..- .++.||||.-.... ..-++..|-...+.|. .++|...|.+...+.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~-----nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~ 97 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLY-----NNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGK 97 (449)
T ss_pred ccceeccccccCcceeeecccccc-----cCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccc
Confidence 379999999999999999998764 67899999865432 2233444777777775 799999998888998
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCC-----cEEEcccCC
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDG-----HIMLSDFDL 237 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~-----~vkl~DFG~ 237 (489)
+-.||||++ |.+|+|+..-. +++|+...+..++.|++.-++|+|++.+|.|||||+|+||+..+ .+.|+|||+
T Consensus 98 ~NiLVidLL-GPSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm 175 (449)
T KOG1165|consen 98 YNILVIDLL-GPSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGM 175 (449)
T ss_pred hhhhhhhhh-CcCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccc
Confidence 999999999 99999998876 47899999999999999999999999999999999999998544 489999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
|+.+... .+
T Consensus 176 AK~YrDp-----------------------------------------------------------------------~T 184 (449)
T KOG1165|consen 176 AKEYRDP-----------------------------------------------------------------------KT 184 (449)
T ss_pred hhhhcCc-----------------------------------------------------------------------cc
Confidence 9665432 12
Q ss_pred cccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCC---CcHHHHHHHhcC
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGE---NNEKTLINILKK 384 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~---~~~~~~~~i~~~ 384 (489)
..++..+...++.||..||+-...+|...+.+-|+=|||-++++.|-|..||.|. +..+-+++|-..
T Consensus 185 kqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~ 254 (449)
T KOG1165|consen 185 KQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGET 254 (449)
T ss_pred cccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccc
Confidence 2333445667789999999999999999999999999999999999999999875 445556666543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-26 Score=226.96 Aligned_cols=268 Identities=38% Similarity=0.542 Sum_probs=203.8
Q ss_pred ceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCC-CcccccceeecCceE
Q 011302 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHP-FLPTLYAEFEASHYS 164 (489)
Q Consensus 86 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-nIv~l~~~~~~~~~~ 164 (489)
|.+.+.||.|+||.||++.+. ..+++|.+.............+.+|..++..+.|+ +|+++++.+......
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEE
Confidence 788899999999999999977 46799999877655434566788899999999988 799999999888889
Q ss_pred EEEEeecCCCchHHHHHhCCC-CCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCC-cEEEcccCCCcccc
Q 011302 165 CLVMEYCPGGDLYAARQRQPG-KRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDG-HIMLSDFDLSFKCD 242 (489)
Q Consensus 165 ~lV~E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~-~vkl~DFG~a~~~~ 242 (489)
+++++++.+++|.+++..... ..+....+..++.|++.++.|+|+.+++||||||+|||++..+ .++++|||++..+.
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~ 153 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence 999999999999976665421 2689999999999999999999999999999999999999988 79999999984221
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
....... .
T Consensus 154 ~~~~~~~------------------------------------------------------------------------~ 161 (384)
T COG0515 154 DPGSTSS------------------------------------------------------------------------I 161 (384)
T ss_pred CCCcccc------------------------------------------------------------------------c
Confidence 1000000 0
Q ss_pred ccCCccccCCCCccCcchhcC---CCCCCcccHHHHHHHHHHHhhCCCCCCCCCc----HHHHHHHhcCCCC-CCCCCCC
Q 011302 323 NARSKSFVGTHEYLAPEVISG---QGHGSAVDWWTLGVFLYEMLYGTTPFKGENN----EKTLINILKKPLT-FPRIGVS 394 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~---~~~~~~~DiwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~-~p~~~~~ 394 (489)
.......+||..|+|||.+.+ ..+....|+||+|++++++++|..||..... ......+...... .......
T Consensus 162 ~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (384)
T COG0515 162 PALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSP 241 (384)
T ss_pred cccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCc
Confidence 012345689999999999998 5688999999999999999999999887764 3444444333322 1111111
Q ss_pred CchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 395 SSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 395 ~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
... ......+.+++.+++..+|..|.+.. +...++|...
T Consensus 242 ~~~-~~~~~~~~~~~~~~~~~~~~~r~~~~----~~~~~~~~~~ 280 (384)
T COG0515 242 SNP-ELISKAASDLLKKLLAKDPKNRLSSS----SDLSHDLLAH 280 (384)
T ss_pred ccc-chhhHHHHHHHHHHHhcCchhcCCHH----HHhhchHhhC
Confidence 100 11112478999999999999999987 5555555433
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-26 Score=229.99 Aligned_cols=258 Identities=24% Similarity=0.331 Sum_probs=190.7
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCC----CCccccccee-e
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDH----PFLPTLYAEF-E 159 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----pnIv~l~~~~-~ 159 (489)
+|.+.+.||+|+||.||+|.+.... ...+|+|+........ ...+..|..++..+.. .++..+++.. .
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~----~~~~a~K~e~~~~~~~---~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~ 91 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK----NKEYAKKLEKKELGSK---PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRS 91 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC----CeeEEEEEEEecccCC---CccchhHHHHHHHHhhhcCCCCCCEEEEeccC
Confidence 8999999999999999999988632 4678999987643221 1145568888888863 6899999999 5
Q ss_pred cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccC-----CcEEEcc
Q 011302 160 ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRED-----GHIMLSD 234 (489)
Q Consensus 160 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~-----~~vkl~D 234 (489)
.+..-|+||+++ |.+|.++....+.+.|+...+..|+.|++.+|++||+.|+|||||||+|++++.. ..+.|.|
T Consensus 92 ~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 92 TEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred CCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEe
Confidence 888899999999 9999999877767889999999999999999999999999999999999999865 4699999
Q ss_pred cCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCC
Q 011302 235 FDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDD 314 (489)
Q Consensus 235 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (489)
||+|+.+.......
T Consensus 171 fGlar~~~~~~~~~------------------------------------------------------------------ 184 (322)
T KOG1164|consen 171 FGLARRFKYVGDSG------------------------------------------------------------------ 184 (322)
T ss_pred cCCCccccccCCCC------------------------------------------------------------------
Confidence 99997433211100
Q ss_pred ccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCC--CC
Q 011302 315 PEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPR--IG 392 (489)
Q Consensus 315 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~ 392 (489)
.. ..+.......+.||..|+++.+..+...+.+.|+||++-++.||+.|..||.+........++......... ..
T Consensus 185 -~~-~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (322)
T KOG1164|consen 185 -GN-LRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDRFG 262 (322)
T ss_pred -cc-cccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhcccccc
Confidence 00 000000123457999999999999999999999999999999999999999776643322222221111110 01
Q ss_pred CCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 393 VSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 393 ~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
.... ..+.++...+-..+...+|...
T Consensus 263 ~~~~------~~~~~~~~~~~~~~~~~~Pdy~ 288 (322)
T KOG1164|consen 263 DLKP------EEFAKILEYIDSLDYEDKPDYE 288 (322)
T ss_pred CCCh------HHHHHHHHHhhccCCcCCCCHH
Confidence 1111 1355666666667778888764
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-27 Score=211.10 Aligned_cols=224 Identities=22% Similarity=0.336 Sum_probs=182.8
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCC-CCcccccceee
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDH-PFLPTLYAEFE 159 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~ 159 (489)
+..+.|+++++||+|+||.+|+|.... .+..||||+-... ....++..|..+.+.|++ ..|..+..++.
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~-----~ge~VAiK~Es~~-----a~hpqL~yEskvY~iL~~g~GiP~i~~y~~ 81 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISIT-----SGEEVAIKLESSK-----AKHPQLLYESKVYRILQGGVGIPHIRHYGT 81 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeecc-----CCceEEEEeeccc-----CCCcchhHHHHHHHHhccCCCCchhhhhcc
Confidence 445799999999999999999999886 6789999987543 223345668888888875 67888888888
Q ss_pred cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccC---CcEEEcccC
Q 011302 160 ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRED---GHIMLSDFD 236 (489)
Q Consensus 160 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~---~~vkl~DFG 236 (489)
+..+-.|||+++ |.+|.++..... ++|+..++..++-|++.-|+|+|.+++|||||||+|+|.+-+ ..+.|+|||
T Consensus 82 e~~ynvlVMdLL-GPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFG 159 (341)
T KOG1163|consen 82 EKDYNVLVMDLL-GPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFG 159 (341)
T ss_pred ccccceeeeecc-CccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEecc
Confidence 888999999999 999999988663 679999999999999999999999999999999999999754 458999999
Q ss_pred CCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcc
Q 011302 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPE 316 (489)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (489)
+|+++.....
T Consensus 160 LaKky~d~~t---------------------------------------------------------------------- 169 (341)
T KOG1163|consen 160 LAKKYRDIRT---------------------------------------------------------------------- 169 (341)
T ss_pred chhhhccccc----------------------------------------------------------------------
Confidence 9976543211
Q ss_pred ccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcH---HHHHHHhcCCCC
Q 011302 317 VVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNE---KTLINILKKPLT 387 (489)
Q Consensus 317 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~~~~~i~~~~~~ 387 (489)
..+...+....+.||..|.+-....+...+..-|+=|+|-+|.++.-|..||.|.... +-.++|......
T Consensus 170 -~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s 242 (341)
T KOG1163|consen 170 -RQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMS 242 (341)
T ss_pred -cccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcC
Confidence 1122334556778999999999988888899999999999999999999999986543 445556554443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-27 Score=232.72 Aligned_cols=144 Identities=24% Similarity=0.164 Sum_probs=113.8
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHH--HHHHHHHHHHHHHHHHHhCCCCCccc-ccce
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREAL--AIRKKLHRADMEKVILTMLDHPFLPT-LYAE 157 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~-l~~~ 157 (489)
...++|.+.+.||+|+||+||+|.++.. ++..||||++..... ........+.+|+.+|+.++|+||++ +++.
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~----~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~ 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGD----PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCC----CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc
Confidence 4457899999999999999999987742 356689998753211 11223455788999999999999985 4432
Q ss_pred eecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecC-CCCCeEeccCCcEEEcccC
Q 011302 158 FEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDL-KPENVLVREDGHIMLSDFD 236 (489)
Q Consensus 158 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDI-Kp~NILl~~~~~vkl~DFG 236 (489)
+..|||||||+|++|... .. .. ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||
T Consensus 91 ----~~~~LVmE~~~G~~L~~~-~~-----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 ----GKDGLVRGWTEGVPLHLA-RP-----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred ----CCcEEEEEccCCCCHHHh-Cc-----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 457999999999999632 11 11 1467899999999999999999999 9999999999999999999
Q ss_pred CCccc
Q 011302 237 LSFKC 241 (489)
Q Consensus 237 ~a~~~ 241 (489)
+|+.+
T Consensus 158 lA~~~ 162 (365)
T PRK09188 158 LASVF 162 (365)
T ss_pred cceec
Confidence 98554
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-24 Score=199.45 Aligned_cols=139 Identities=19% Similarity=0.176 Sum_probs=113.3
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHH------HHHHHHHHHhCCCCCccccc
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHR------ADMEKVILTMLDHPFLPTLY 155 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~------~~~E~~~l~~l~hpnIv~l~ 155 (489)
-.++|++++.||.|+||.||++... ...+|||++..+.........+ +.+|+..+.++.|++|..+.
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~~-------~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~ 101 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDTD-------YGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLN 101 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEecC-------CCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcce
Confidence 3479999999999999999997653 2458999997655443343333 57898899999999999999
Q ss_pred ceeecC--------ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccC
Q 011302 156 AEFEAS--------HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRED 227 (489)
Q Consensus 156 ~~~~~~--------~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~ 227 (489)
+++... ...||||||++|.+|.++.. +++ ..+.+++.+|..||..|++||||||.|||++.+
T Consensus 102 d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~ 171 (232)
T PRK10359 102 DFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKN 171 (232)
T ss_pred EeeeecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCC
Confidence 886533 35899999999999977632 332 246699999999999999999999999999999
Q ss_pred CcEEEcccCCC
Q 011302 228 GHIMLSDFDLS 238 (489)
Q Consensus 228 ~~vkl~DFG~a 238 (489)
| ++|+|||..
T Consensus 172 g-i~liDfg~~ 181 (232)
T PRK10359 172 G-LRIIDLSGK 181 (232)
T ss_pred C-EEEEECCCc
Confidence 8 999999986
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-24 Score=196.43 Aligned_cols=141 Identities=21% Similarity=0.200 Sum_probs=108.0
Q ss_pred eeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHH-----------------------HHHHHHHHHHHHHh
Q 011302 89 LRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRK-----------------------KLHRADMEKVILTM 145 (489)
Q Consensus 89 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~-----------------------~~~~~~~E~~~l~~ 145 (489)
...||+|+||.||+|.+. +++.||||+++........ .......|..+|..
T Consensus 2 ~~~ig~G~~~~Vy~a~~~------~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 75 (190)
T cd05147 2 NGCISTGKEANVYHATTA------NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKR 75 (190)
T ss_pred CCccccccceEEEEEECC------CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHH
Confidence 467999999999999875 3678999999764321100 01123458899999
Q ss_pred CCCCCcccccceeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHH-HhCCCeeecCCCCCeEe
Q 011302 146 LDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYL-HMMGIVYRDLKPENVLV 224 (489)
Q Consensus 146 l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yL-H~~~iiHrDIKp~NILl 224 (489)
+.+++|.....+ .... .||||||++|++|...+... ..+++..+..++.|++.+|.|| |+.||+||||||+|||+
T Consensus 76 l~~~~v~~p~~~-~~~~-~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli 151 (190)
T cd05147 76 LVTAGIPCPEPI-LLKS-HVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLY 151 (190)
T ss_pred HHHCCCCCCcEE-EecC-CEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE
Confidence 988877443332 2222 38999999888776543332 5689999999999999999999 79999999999999999
Q ss_pred ccCCcEEEcccCCCcc
Q 011302 225 REDGHIMLSDFDLSFK 240 (489)
Q Consensus 225 ~~~~~vkl~DFG~a~~ 240 (489)
+ ++.++|+|||+|..
T Consensus 152 ~-~~~v~LiDFG~a~~ 166 (190)
T cd05147 152 H-DGKLYIIDVSQSVE 166 (190)
T ss_pred E-CCcEEEEEcccccc
Confidence 8 58899999999854
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-25 Score=234.00 Aligned_cols=243 Identities=22% Similarity=0.330 Sum_probs=178.4
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHH--HHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREA--LAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
+|...+.||++.|=+|.+|++++ ..|.||++-+.. ...+...+++. |+. ...++|||++++.-+-..+.
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-------G~vVvKVFvk~~p~~sL~~~~qrL~-~ik-~~l~~~pn~lPfqk~~~t~k 94 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-------GLVVVKVFVKQDPTISLRPFKQRLE-EIK-FALMKAPNCLPFQKVLVTDK 94 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-------ceEEEEEEeccCCCCCchHHHHHHH-HHH-HHhhcCCcccchHHHHHhhH
Confidence 78889999999999999999886 348899986543 33334444443 333 55678999999999888888
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
..|||-+|. .-+|+|.+..++ -+...+.+.|+.||+.||.-+|..||+|+|||.|||||+.-..+.|+||.--+..
T Consensus 95 AAylvRqyv-khnLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPt- 170 (1431)
T KOG1240|consen 95 AAYLVRQYV-KHNLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPT- 170 (1431)
T ss_pred HHHHHHHHH-hhhhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCc-
Confidence 999999999 679999987763 4777888999999999999999999999999999999999999999999853211
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
..|+..+.+.+ .+| .
T Consensus 171 YLPeDNPadf~-----------------------fFF-D----------------------------------------- 185 (1431)
T KOG1240|consen 171 YLPEDNPADFT-----------------------FFF-D----------------------------------------- 185 (1431)
T ss_pred cCCCCCcccce-----------------------EEE-e-----------------------------------------
Confidence 11111111000 000 0
Q ss_pred ccCCccccCCCCccCcchhcCC----------C-CCCcccHHHHHHHHHHHhh-CCCCCCC----------C-CcHHHHH
Q 011302 323 NARSKSFVGTHEYLAPEVISGQ----------G-HGSAVDWWTLGVFLYEMLY-GTTPFKG----------E-NNEKTLI 379 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~----------~-~~~~~DiwSlGvil~ellt-G~~Pf~~----------~-~~~~~~~ 379 (489)
.. .--.+|+|||.+... + .+++.||||+||+++||++ |++||.- . +....++
T Consensus 186 -TS----rRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~Le 260 (1431)
T KOG1240|consen 186 -TS----RRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLLE 260 (1431)
T ss_pred -cC----CceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHHHH
Confidence 00 112369999998542 2 4678999999999999997 7999842 1 1122222
Q ss_pred HHhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 380 NILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 380 ~i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
+|.. ..++.||..|+++||.+|+++. +.|+-
T Consensus 261 ~Ied-------------------~~~Rnlil~Mi~rdPs~RlSAe----dyL~~ 291 (1431)
T KOG1240|consen 261 KIED-------------------VSLRNLILSMIQRDPSKRLSAE----DYLQK 291 (1431)
T ss_pred hCcC-------------------ccHHHHHHHHHccCchhccCHH----HHHHh
Confidence 2211 1388999999999999999997 66654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=188.57 Aligned_cols=203 Identities=21% Similarity=0.239 Sum_probs=140.2
Q ss_pred eeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHH-HHHHHHHHHHHHHhCC-CCCcccccceeecCceE
Q 011302 87 RLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRK-KLHRADMEKVILTMLD-HPFLPTLYAEFEASHYS 164 (489)
Q Consensus 87 ~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~-~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~ 164 (489)
.+...|++|+||+||++... ...++.+.+.....-.+. ....+.+|+.+|++|+ |++|++++++ +..
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~-------~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~ 73 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGG-------ERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGR 73 (218)
T ss_pred ccceeecCCCcceEEEeecC-------CceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCE
Confidence 35678999999999977642 345565655544332221 2235778999999995 5889999885 346
Q ss_pred EEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecC-CCCCeEeccCCcEEEcccCCCccccc
Q 011302 165 CLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDL-KPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 165 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDI-Kp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
|++|||+.|.+|.+.+.. ....++.|++.+|++||++||||||| ||+|||++.+|.++|+|||+|.....
T Consensus 74 ~lvmeyI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 74 HLDRSYLAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred EEEEeeecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 999999999999654321 11357889999999999999999999 79999999999999999999853322
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
..... .-+-..++...
T Consensus 145 ~~~~~-r~L~~rDl~~l--------------------------------------------------------------- 160 (218)
T PRK12274 145 RARWM-RLLAREDLRHL--------------------------------------------------------------- 160 (218)
T ss_pred cchHH-HHHHHHHHHHH---------------------------------------------------------------
Confidence 11000 00000000000
Q ss_pred cCCccccCCCCccCcchhcCC-CCC-CcccHHHHHHHHHHHhhCCCCCCCCCc
Q 011302 324 ARSKSFVGTHEYLAPEVISGQ-GHG-SAVDWWTLGVFLYEMLYGTTPFKGENN 374 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~~-~~~-~~~DiwSlGvil~elltG~~Pf~~~~~ 374 (489)
...-...++.|+.|+.-.-. ..+ ...++++.|+.+|.++|+..++.++++
T Consensus 161 -lk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 161 -LKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred -HHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 00111367889999875432 223 578999999999999999999876653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-24 Score=226.46 Aligned_cols=314 Identities=29% Similarity=0.446 Sum_probs=239.5
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
...+++.+++-+-+|+|+.++.+.-.. .+...++|+.........+..+....+..++-...+|.++.....+..
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~-----sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~ 875 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAG-----SGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPC 875 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccc-----cccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCC
Confidence 455788888899999999999887665 455667777765544444445555556666655677889988888888
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~ 240 (489)
....+|||+|+.|++|...++.. +..+.+-++.++..++.+++|||...++|||+||.|+|+..+|+.++.|||....
T Consensus 876 rsP~~L~~~~~~~~~~~Skl~~~--~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 876 RSPLPLVGHYLNGGDLPSKLHNS--GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSK 953 (1205)
T ss_pred CCCcchhhHHhccCCchhhhhcC--CCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccc
Confidence 88999999999999999988776 4678888899999999999999999999999999999999999999999997543
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
....+...... .+....+... ...+.. +.+ ...
T Consensus 954 vg~~~p~~~~s---------------------g~~~~~~~~~-~~~~~~---------~~~----------------l~~ 986 (1205)
T KOG0606|consen 954 VGLIPPTTDLS---------------------GPSSSGTPRR-LSRSER---------RPQ----------------LSA 986 (1205)
T ss_pred cccccCcCCcc---------------------cccccCcccc-cccccc---------ccc----------------ccc
Confidence 32221111000 0000000000 000000 000 000
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHH
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFE 400 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 400 (489)
....+.....||+.|.+||.+.+...+..+|+|++|++++|.++|.+||......+.+..|......+|........
T Consensus 987 ~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~--- 1063 (1205)
T KOG0606|consen 987 DEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSY--- 1063 (1205)
T ss_pred chhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccCh---
Confidence 01234567789999999999999999999999999999999999999999999999999999998888876555443
Q ss_pred HHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccccccCCCCCCCCc
Q 011302 401 EVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIRSIKPPEVPNN 455 (489)
Q Consensus 401 ~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~~~~~~p~~~~~ 455 (489)
.+++++.++|..+|.+|.++. +..++..|+||+.++|+.+...+.+++|..
T Consensus 1064 ---~aq~~~~~ll~~~~~qr~~a~-~~~e~k~~~~~~~~~~~~l~~q~~~~~p~~ 1114 (1205)
T KOG0606|consen 1064 ---EAQDLINRLLTEEPTQRLGAK-GAAEVKGHPFFQDVDWENLALQKAEFVPQP 1114 (1205)
T ss_pred ---hhhhhhhhhhccCchhccCcc-cccccccCCccCCCCccccccccCccCCCC
Confidence 489999999999999999985 455899999999999999988887777664
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.8e-23 Score=188.71 Aligned_cols=143 Identities=21% Similarity=0.203 Sum_probs=109.9
Q ss_pred eeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHH-----------------------HHHHHHHHHHHHHHHh
Q 011302 89 LRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAI-----------------------RKKLHRADMEKVILTM 145 (489)
Q Consensus 89 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~-----------------------~~~~~~~~~E~~~l~~ 145 (489)
.+.||+|+||.||+|.+. +++.||||+++...... .........|...+.+
T Consensus 2 ~~~ig~G~~~~Vy~a~~~------~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 75 (190)
T cd05145 2 NGCISTGKEANVYHARTG------DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKR 75 (190)
T ss_pred CceeecCCCcEEEEEEcC------CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 568999999999999865 36789999998642110 0011234578899999
Q ss_pred CCCCCcccccceeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHh-CCCeeecCCCCCeEe
Q 011302 146 LDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHM-MGIVYRDLKPENVLV 224 (489)
Q Consensus 146 l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiHrDIKp~NILl 224 (489)
+.|++|.....+.... .||||||++|+++....... ..++..++..++.|++.+|.+||+ +||+||||||+|||+
T Consensus 76 l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll 151 (190)
T cd05145 76 LYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILY 151 (190)
T ss_pred HHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEE
Confidence 9999875444433332 48999999888654332222 467888999999999999999999 999999999999999
Q ss_pred ccCCcEEEcccCCCcccc
Q 011302 225 REDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 225 ~~~~~vkl~DFG~a~~~~ 242 (489)
+ ++.++|+|||+|....
T Consensus 152 ~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 152 H-DGKPYIIDVSQAVELD 168 (190)
T ss_pred E-CCCEEEEEcccceecC
Confidence 9 8999999999996554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-23 Score=198.30 Aligned_cols=236 Identities=24% Similarity=0.301 Sum_probs=144.4
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCC----------CCcccc
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDH----------PFLPTL 154 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----------pnIv~l 154 (489)
.+...+.||.|+|+.||.+++.. +++.+|+|++........+..+.+.+|......+.+ -.++.-
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~-----t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P 87 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVE-----TGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVP 87 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETT-----TTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---
T ss_pred EEEEccccccCCceEEEEEEEcc-----CCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEee
Confidence 45677899999999999999998 689999999854333333444555555533333221 111111
Q ss_pred cc---------eeecC---c-----eEEEEEeecCCCchHHHHHh---CCCC--CCChhhHHHHHHHHHHHHHHHHhCCC
Q 011302 155 YA---------EFEAS---H-----YSCLVMEYCPGGDLYAARQR---QPGK--RFGISSAKFYAAETLLALEYLHMMGI 212 (489)
Q Consensus 155 ~~---------~~~~~---~-----~~~lV~E~~~gg~L~~~l~~---~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~i 212 (489)
++ ++... . +.+++|+-+ -++|.+++.- .... .+.......+..|++..+++||..||
T Consensus 88 ~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~Gl 166 (288)
T PF14531_consen 88 LDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGL 166 (288)
T ss_dssp SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred eEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcce
Confidence 11 11111 1 347888888 7888776542 2111 12222234455899999999999999
Q ss_pred eeecCCCCCeEeccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCcccccccccccccccccc
Q 011302 213 VYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKA 292 (489)
Q Consensus 213 iHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (489)
||+||||+|++++.+|.+.|+||+.......
T Consensus 167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~------------------------------------------------- 197 (288)
T PF14531_consen 167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGT------------------------------------------------- 197 (288)
T ss_dssp EEST-SGGGEEE-TTS-EEE--GGGEEETTE-------------------------------------------------
T ss_pred EecccceeeEEEcCCCCEEEcChHHHeecCc-------------------------------------------------
Confidence 9999999999999999999999987522100
Q ss_pred ccccccccccCCCCCCccccCCccccccccccCCccccCCCCccCcchhcC--------CCCCCcccHHHHHHHHHHHhh
Q 011302 293 VTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISG--------QGHGSAVDWWTLGVFLYEMLY 364 (489)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--------~~~~~~~DiwSlGvil~ellt 364 (489)
.......+..|.+||.... ..++.+.|.|+||+++|.|++
T Consensus 198 --------------------------------~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 198 --------------------------------RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp --------------------------------EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred --------------------------------eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 0000134577999998744 246889999999999999999
Q ss_pred CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccc
Q 011302 365 GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKR 420 (489)
Q Consensus 365 G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 420 (489)
|..||........... .|. .|. +.+..+++||++||++||++|
T Consensus 246 ~~lPf~~~~~~~~~~~------~f~--~C~-----~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW------DFS--RCR-----DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG------GGT--TSS--------HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc------cch--hcC-----CcCHHHHHHHHHHccCCcccC
Confidence 9999986643211110 111 111 112358999999999999998
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-23 Score=198.90 Aligned_cols=203 Identities=21% Similarity=0.322 Sum_probs=142.5
Q ss_pred CCCCcccccceeec---------------------------CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHH
Q 011302 147 DHPFLPTLYAEFEA---------------------------SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAE 199 (489)
Q Consensus 147 ~hpnIv~l~~~~~~---------------------------~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~q 199 (489)
.|||||+++++|.+ +..+|+||... ..+|.+++-.+ ..+....+.|+.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~---~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR---HRSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC---CCchHHHHHHHHH
Confidence 59999999998732 23589999988 57998888664 4667778899999
Q ss_pred HHHHHHHHHhCCCeeecCCCCCeEec--cCC--cEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCc
Q 011302 200 TLLALEYLHMMGIVYRDLKPENVLVR--EDG--HIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPV 275 (489)
Q Consensus 200 i~~~L~yLH~~~iiHrDIKp~NILl~--~~~--~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (489)
+++|+.|||.+||.|||+|.+||||. +|+ .+.|+|||.+-...... +
T Consensus 350 lLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hG--l--------------------------- 400 (598)
T KOG4158|consen 350 LLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHG--L--------------------------- 400 (598)
T ss_pred HHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccc--c---------------------------
Confidence 99999999999999999999999994 444 47899999863221100 0
Q ss_pred cccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCccccCCCCccCcchhcCCC------CCCc
Q 011302 276 LSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQG------HGSA 349 (489)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~------~~~~ 349 (489)
.-+..+-.-...|.-.-||||+....+ --.+
T Consensus 401 -------------------------------------------qlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~k 437 (598)
T KOG4158|consen 401 -------------------------------------------QLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEK 437 (598)
T ss_pred -------------------------------------------ccccccccccCCCcceecchhhhhcCCCCceeeccch
Confidence 000011112335777899999986543 1358
Q ss_pred ccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHH
Q 011302 350 VDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVE 429 (489)
Q Consensus 350 ~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ 429 (489)
+|.|+.|.+.||+++...||++..+...-.+- ...-..|....... +.+++|+..+|+.||.+|++.. .++.
T Consensus 438 AD~WA~GalaYEIfg~~NPFY~rGem~L~~r~-Yqe~qLPalp~~vp------p~~rqlV~~lL~r~pskRvsp~-iAAN 509 (598)
T KOG4158|consen 438 ADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT-YQESQLPALPSRVP------PVARQLVFDLLKRDPSKRVSPN-IAAN 509 (598)
T ss_pred hhhhhhhhhHHHHhccCCcccccchheechhh-hhhhhCCCCcccCC------hHHHHHHHHHhcCCccccCCcc-HHHh
Confidence 99999999999999999999885432211111 11223333322222 2489999999999999999974 3335
Q ss_pred HHcC
Q 011302 430 IKRH 433 (489)
Q Consensus 430 ll~h 433 (489)
+++-
T Consensus 510 vl~L 513 (598)
T KOG4158|consen 510 VLNL 513 (598)
T ss_pred HHHH
Confidence 5543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.9e-23 Score=187.50 Aligned_cols=241 Identities=17% Similarity=0.284 Sum_probs=188.5
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS 161 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 161 (489)
...+..++.+|.+..-|+.|+|++.+. -++.|+++...... ...+.|..|.-.|+.+.||||+.+++.|...
T Consensus 188 d~~~lnl~tkl~e~hsgelwrgrwqgn-------divakil~vr~~t~-risrdfneefp~lrifshpnilpvlgacnsp 259 (448)
T KOG0195|consen 188 DVSSLNLITKLAESHSGELWRGRWQGN-------DIVAKILNVREVTA-RISRDFNEEFPALRIFSHPNILPVLGACNSP 259 (448)
T ss_pred chhhhhhhhhhccCCCcccccccccCc-------chhhhhhhhhhcch-hhcchhhhhCcceeeecCCchhhhhhhccCC
Confidence 345556777899999999999999873 23567766554432 3456678888889999999999999999999
Q ss_pred ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCC-C-eeecCCCCCeEeccCCcEEE--cccCC
Q 011302 162 HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMG-I-VYRDLKPENVLVREDGHIML--SDFDL 237 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~-i-iHrDIKp~NILl~~~~~vkl--~DFG~ 237 (489)
.++.++..||+.|+|+.+++...+-..+..++..++.+|+.|++|||+.. + ----|....++||++.+.+| +|--+
T Consensus 260 pnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kf 339 (448)
T KOG0195|consen 260 PNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKF 339 (448)
T ss_pred CCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheeccccee
Confidence 99999999999999999998876666778899999999999999999875 3 34468889999999987665 34333
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
++.+
T Consensus 340 sfqe---------------------------------------------------------------------------- 343 (448)
T KOG0195|consen 340 SFQE---------------------------------------------------------------------------- 343 (448)
T ss_pred eeec----------------------------------------------------------------------------
Confidence 2110
Q ss_pred cccccccCCccccCCCCccCcchhcCCCCC---CcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCC--CCCCC
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVISGQGHG---SAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLT--FPRIG 392 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~---~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--~p~~~ 392 (489)
.+..-.|.||+||.+...+-+ .++|+|||+++||||.|.+.||....+.+.-.+|.-..+. +|...
T Consensus 344 ---------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgi 414 (448)
T KOG0195|consen 344 ---------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGI 414 (448)
T ss_pred ---------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCc
Confidence 111346889999999887643 4799999999999999999999999888876666544433 33222
Q ss_pred CCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 393 VSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 393 ~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
. ..+..|+.-|++.||.+||.+.
T Consensus 415 s---------~hm~klm~icmnedpgkrpkfd 437 (448)
T KOG0195|consen 415 S---------RHMNKLMNICMNEDPGKRPKFD 437 (448)
T ss_pred c---------HHHHHHHHHHhcCCCCcCCCcc
Confidence 1 1478999999999999999985
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=181.04 Aligned_cols=135 Identities=21% Similarity=0.208 Sum_probs=103.8
Q ss_pred eeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-----CCCCcccccceeecCc-
Q 011302 89 LRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-----DHPFLPTLYAEFEASH- 162 (489)
Q Consensus 89 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~l~~~~~~~~- 162 (489)
.+.||+|+||.||. +.. ... .+||++...... ..+.+.+|+.+++.+ +||||++++++++++.
T Consensus 7 ~~~LG~G~~~~Vy~--hp~-----~~~-k~IKv~~~~~~~---~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g 75 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPE-----DAQ-RCIKIVYHRGDG---GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG 75 (210)
T ss_pred cceecCCCceEEEE--CCC-----CcC-eEEEEEeccccc---hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCC
Confidence 46899999999995 333 222 368988654221 234577899999999 6799999999998763
Q ss_pred --eEE-EEEee--cCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHH-HHHHhCCCeeecCCCCCeEeccC----CcEEE
Q 011302 163 --YSC-LVMEY--CPGGDLYAARQRQPGKRFGISSAKFYAAETLLAL-EYLHMMGIVYRDLKPENVLVRED----GHIML 232 (489)
Q Consensus 163 --~~~-lV~E~--~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L-~yLH~~~iiHrDIKp~NILl~~~----~~vkl 232 (489)
.+| +|||| +.+|+|.+++.+. .+++. ..++.|++.++ +|||+++||||||||+|||++.. +.++|
T Consensus 76 ~g~v~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~L 150 (210)
T PRK10345 76 TGYVYDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVV 150 (210)
T ss_pred CeEEEEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEE
Confidence 434 78999 5579999999653 36655 45688888888 99999999999999999999743 47999
Q ss_pred cccCCCc
Q 011302 233 SDFDLSF 239 (489)
Q Consensus 233 ~DFG~a~ 239 (489)
+||+.+.
T Consensus 151 iDg~G~~ 157 (210)
T PRK10345 151 CDNIGES 157 (210)
T ss_pred EECCCCc
Confidence 9955443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.2e-21 Score=207.74 Aligned_cols=198 Identities=26% Similarity=0.372 Sum_probs=155.9
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC---CCCcccccc
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD---HPFLPTLYA 156 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~ 156 (489)
++..+.|.|.+.||+|+||+||+|...+ ++.||+|+-+....- ++..=..++.+|. -+.|..+..
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~------~~~~alK~e~P~~~W------EfYI~~q~~~RLk~~~~~~~~~~~~ 761 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN------GKLVALKVEKPPNPW------EFYICLQVMERLKPQMLPSIMHISS 761 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC------CcEEEEEeecCCCce------eeeehHHHHHhhchhhhcchHHHHH
Confidence 4567889999999999999999999875 689999997542100 0000111222222 245666667
Q ss_pred eeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEecc-------CCc
Q 011302 157 EFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRE-------DGH 229 (489)
Q Consensus 157 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~-------~~~ 229 (489)
++.-.+..+||+||.+.|+|.++++.. +.+++..+..++.||+.-|+.||..+|||+||||+|+||.. ..-
T Consensus 762 a~~~~~~S~lv~ey~~~Gtlld~~N~~--~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 762 AHVFQNASVLVSEYSPYGTLLDLINTN--KVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred HHccCCcceeeeeccccccHHHhhccC--CCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccc
Confidence 666677789999999999999999854 67999999999999999999999999999999999999963 235
Q ss_pred EEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCc
Q 011302 230 IMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQ 309 (489)
Q Consensus 230 vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (489)
++|+|||-+..+...+..
T Consensus 840 l~lIDfG~siDm~lfp~~-------------------------------------------------------------- 857 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFPDG-------------------------------------------------------------- 857 (974)
T ss_pred eEEEecccceeeeEcCCC--------------------------------------------------------------
Confidence 899999998555433321
Q ss_pred cccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCC
Q 011302 310 ELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTT 367 (489)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~ 367 (489)
.+....++|-.+-++|++.|++|++.+|.|.|+.+++.||.|+.
T Consensus 858 --------------~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 858 --------------TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred --------------cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 12345578899999999999999999999999999999999864
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1e-20 Score=178.67 Aligned_cols=146 Identities=24% Similarity=0.200 Sum_probs=110.9
Q ss_pred CceeeeeeccCCceeEEEEE-EccCCCCCCCeeEEEEeeehHHHH---------------------HHHHHHHHHHHHHH
Q 011302 85 HFRLLRRLGSGDIGNVYLCQ-IRNPMVGLPQCFYAMKVVDREALA---------------------IRKKLHRADMEKVI 142 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~-~~~~~~~~~~~~~aiK~~~~~~~~---------------------~~~~~~~~~~E~~~ 142 (489)
.|.+.+.||+|+||.||+|. +.. +++.||||+++..... .......+..|..+
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 103 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDG-----SGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRN 103 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCC-----CCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHH
Confidence 58899999999999999998 333 4688999998753210 00011235679999
Q ss_pred HHhCCCCC--cccccceeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCC-CeeecCCC
Q 011302 143 LTMLDHPF--LPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMG-IVYRDLKP 219 (489)
Q Consensus 143 l~~l~hpn--Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~-iiHrDIKp 219 (489)
+.++.+.+ +.++++ .. ..||||||++|++|....... ..+...++..++.||+.+|.+||.+| |+||||||
T Consensus 104 L~~L~~~~i~~p~~~~---~~-~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp 177 (237)
T smart00090 104 LQRLYEAGVPVPKPIA---WR-RNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSE 177 (237)
T ss_pred HHHHHhcCCCCCeeeE---ec-CceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCCh
Confidence 99997533 334443 22 358999999988886654222 34666677899999999999999999 99999999
Q ss_pred CCeEeccCCcEEEcccCCCcccc
Q 011302 220 ENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 220 ~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
+|||++ ++.++|+|||.|....
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccC
Confidence 999999 8899999999986443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.6e-22 Score=195.53 Aligned_cols=185 Identities=30% Similarity=0.446 Sum_probs=137.8
Q ss_pred ceEEEEEeecCCCchHHHHHhC-CCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcc
Q 011302 162 HYSCLVMEYCPGGDLYAARQRQ-PGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~ 240 (489)
.++|+.|++|...+|.+++.+. .+...+....+.++.|++.|++| +|.+|||+||.||....+..+||.|||+.+.
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 3689999999999999999743 44567778899999999999999 9999999999999999999999999999754
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
...++...
T Consensus 406 ~~~~~~~~------------------------------------------------------------------------ 413 (516)
T KOG1033|consen 406 QDKDETVA------------------------------------------------------------------------ 413 (516)
T ss_pred cccCCccc------------------------------------------------------------------------
Confidence 43322000
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhH
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEF 399 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 399 (489)
+...+.+.-+||..||+||.|.++.|+.++||||||+||+||+. -...|.. ...+..+..+.+. |....
T Consensus 414 ~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~r~g~ip-~~~~~------ 483 (516)
T KOG1033|consen 414 PAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER---IATLTDIRDGIIP-PEFLQ------ 483 (516)
T ss_pred chhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH---HHhhhhhhcCCCC-hHHhh------
Confidence 01122344589999999999999999999999999999999997 4444422 2233344444322 11111
Q ss_pred HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 400 EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 400 ~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
..++-.+|+..||...|.+||++. +.-.|+|.
T Consensus 484 -d~p~e~~ll~~lls~~p~~RP~~~----~~~~~~~~ 515 (516)
T KOG1033|consen 484 -DYPEEYTLLQQLLSPSPEERPSAI----EVALHEFL 515 (516)
T ss_pred -cCcHHHHHHHHhcCCCcccCchHH----HHhhhhhc
Confidence 112356999999999999999654 55556554
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=168.81 Aligned_cols=136 Identities=22% Similarity=0.229 Sum_probs=112.3
Q ss_pred eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehH-----HHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceE
Q 011302 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDRE-----ALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYS 164 (489)
Q Consensus 90 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~-----~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 164 (489)
+.||+|++|.||+|.+.+ ..+++|+.... .........++.+|..++..+.|++|+....++.+....
T Consensus 2 ~~l~~G~~~~vy~~~~~~-------~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLG-------IKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENF 74 (211)
T ss_pred cccccCceEEEEEEeeCC-------CceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCC
Confidence 579999999999998743 45788875432 122222345677899999999999988777777777889
Q ss_pred EEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 165 CLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 165 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
++||||++|++|.+++.... . ....++.+++.+|.+||+.|++|||++|.|||++ ++.++|+|||++.
T Consensus 75 ~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~ 142 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAE 142 (211)
T ss_pred EEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCccc
Confidence 99999999999999886531 2 7788999999999999999999999999999999 8899999999984
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.5e-22 Score=207.81 Aligned_cols=264 Identities=25% Similarity=0.365 Sum_probs=197.5
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-CCCcccccceeecCc
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-HPFLPTLYAEFEASH 162 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~ 162 (489)
..|.+.+.||+|+|+.|-++..... +...+|+|.+.... .......+...|..+-..+. |.|++.+++...+.+
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~----~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~ 94 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRD----PESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPR 94 (601)
T ss_pred ccccccccccccccchhhhhhhcCC----CcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCc
Confidence 4678888899999999988876542 45566777765432 11223334445777777776 999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHH-hCCCeeecCCCCCeEeccCC-cEEEcccCCCcc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLH-MMGIVYRDLKPENVLVREDG-HIMLSDFDLSFK 240 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH-~~~iiHrDIKp~NILl~~~~-~vkl~DFG~a~~ 240 (489)
..++++||..|++++..+........+...+..++.|+..++.|+| ..++.||||||+|.+++..+ .+++.|||+|..
T Consensus 95 ~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 95 SYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 9999999999999988773222225778889999999999999999 99999999999999999999 999999999854
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
+.....
T Consensus 175 ~~~~~g-------------------------------------------------------------------------- 180 (601)
T KOG0590|consen 175 YRNKNG-------------------------------------------------------------------------- 180 (601)
T ss_pred ccccCC--------------------------------------------------------------------------
Confidence 432100
Q ss_pred ccccCCccccC-CCCccCcchhcCCCC-CCcccHHHHHHHHHHHhhCCCCCCCCCcHHH-HHHHhcCCC--CCCCCCCCC
Q 011302 321 PINARSKSFVG-THEYLAPEVISGQGH-GSAVDWWTLGVFLYEMLYGTTPFKGENNEKT-LINILKKPL--TFPRIGVSS 395 (489)
Q Consensus 321 ~~~~~~~~~~G-t~~y~aPE~l~~~~~-~~~~DiwSlGvil~elltG~~Pf~~~~~~~~-~~~i~~~~~--~~p~~~~~~ 395 (489)
........+| ++.|+|||...+..| ....|+||.|+++.-+++|..|+........ +........ ....+..
T Consensus 181 -~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 257 (601)
T KOG0590|consen 181 -AERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS-- 257 (601)
T ss_pred -cceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc--
Confidence 0112233467 999999999998654 7899999999999999999999976543321 111111110 1111111
Q ss_pred chhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 396 SKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 396 ~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
......+++.++|..+|.+|.+.. ++..++|+..
T Consensus 258 -----~~~~~~~~l~k~l~~~~~~r~s~~----~~~~d~~~~~ 291 (601)
T KOG0590|consen 258 -----ISDQAHDLLHKILKENPSNRLSIE----ELKLDNWLSS 291 (601)
T ss_pred -----CChhhhhcccccccCCchhccccc----cccccccccc
Confidence 112478999999999999999998 9999999988
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.8e-19 Score=164.96 Aligned_cols=133 Identities=24% Similarity=0.207 Sum_probs=105.6
Q ss_pred eeccCCceeEEEEEEccCCCCCCCeeEEEEeeehH-----HHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEE
Q 011302 91 RLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDRE-----ALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSC 165 (489)
Q Consensus 91 ~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~-----~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 165 (489)
.||+|+||.||+|.+.+ ..+++|+.... .........++.+|..++..+.|+++.....++......+
T Consensus 1 ~ig~G~~~~vy~~~~~~-------~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLG-------LKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKT 73 (199)
T ss_pred CCCCCceEEEEEeecCC-------ccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCE
Confidence 48999999999998543 56788875432 1222233466778999999999887655554555666779
Q ss_pred EEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcc
Q 011302 166 LVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240 (489)
Q Consensus 166 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~ 240 (489)
+||||++|++|.+++.... . .++.+++.+|.+||+.|++|||++|.|||++ ++.++++|||++..
T Consensus 74 lv~e~~~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEGN---D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEEEECCccHHHHHhhcH---H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999999988775431 1 7899999999999999999999999999999 89999999999843
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.80 E-value=3e-19 Score=189.10 Aligned_cols=139 Identities=22% Similarity=0.193 Sum_probs=111.2
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEee-----ehHHHHHHHHHHHHHHHHHHHHhCCCCCccccccee
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVV-----DREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEF 158 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~-----~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 158 (489)
..|...+.||+|+||+||+|.+.+.. +++|+. ............++.+|+.+++.++|++|+....++
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~-------~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~ 405 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRD-------AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYD 405 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCcc-------ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEE
Confidence 44567889999999999999876521 223322 111222223345678899999999999998887777
Q ss_pred ecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 159 EASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
.+....++||||++|++|.+++. ....++.|++.+|.|||+.||+||||||+|||+ .++.++|+|||++
T Consensus 406 ~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 406 VDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred EeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccc
Confidence 77778899999999999988775 346789999999999999999999999999999 6889999999998
Q ss_pred cc
Q 011302 239 FK 240 (489)
Q Consensus 239 ~~ 240 (489)
+.
T Consensus 475 ~~ 476 (535)
T PRK09605 475 KY 476 (535)
T ss_pred cc
Confidence 54
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.2e-19 Score=165.58 Aligned_cols=140 Identities=24% Similarity=0.228 Sum_probs=107.3
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHH-------------------HHHHHHHHHHHHHHHh
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAI-------------------RKKLHRADMEKVILTM 145 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~-------------------~~~~~~~~~E~~~l~~ 145 (489)
.|.+.+.||+|+||.||+|... +++.||||++....... .........|..++..
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP------DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC------CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 3788899999999999999864 36789999876432000 0011235678888888
Q ss_pred CCCCC--cccccceeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeE
Q 011302 146 LDHPF--LPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVL 223 (489)
Q Consensus 146 l~hpn--Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIL 223 (489)
+.|++ ++..++ ....|+||||++|++|..+.. ......++.+++.++.++|+.||+||||||+||+
T Consensus 90 l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~--------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nil 157 (198)
T cd05144 90 LYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV--------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNIL 157 (198)
T ss_pred HHHcCCCCCceee----cCCceEEEEEeCCcchhhccc--------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEE
Confidence 88774 444443 234589999999999865432 1345678899999999999999999999999999
Q ss_pred eccCCcEEEcccCCCcccc
Q 011302 224 VREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 224 l~~~~~vkl~DFG~a~~~~ 242 (489)
++.++.++|+|||++..+.
T Consensus 158 l~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 158 VDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred EcCCCcEEEEECCccccCC
Confidence 9999999999999996554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.6e-18 Score=172.98 Aligned_cols=201 Identities=22% Similarity=0.306 Sum_probs=149.7
Q ss_pred HHhCCCCCcccccceeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCC-eeecCCCCC
Q 011302 143 LTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGI-VYRDLKPEN 221 (489)
Q Consensus 143 l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~i-iHrDIKp~N 221 (489)
|+.+.|.|+.+++|.+.++..+++|.+||.-|+|.+.+... ...+++.-...++++|+.||.|||..-| .|+.++..|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence 35688999999999999999999999999999999998773 3557777778889999999999998765 999999999
Q ss_pred eEeccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccc
Q 011302 222 VLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQ 301 (489)
Q Consensus 222 ILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (489)
++++..+.+||+|||+.........
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~~~~~------------------------------------------------------- 104 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLEETAE------------------------------------------------------- 104 (484)
T ss_pred ceeeeeEEEEechhhhccccccccc-------------------------------------------------------
Confidence 9999999999999999632210000
Q ss_pred cCCCCCCccccCCccccccccccCCccccCCCCccCcchhcCCC-------CCCcccHHHHHHHHHHHhhCCCCCCCCC-
Q 011302 302 VDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQG-------HGSAVDWWTLGVFLYEMLYGTTPFKGEN- 373 (489)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-------~~~~~DiwSlGvil~elltG~~Pf~~~~- 373 (489)
........-..-|.|||.+.+.. -+.+.||||||++++|+++...||....
T Consensus 105 ---------------------~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~ 163 (484)
T KOG1023|consen 105 ---------------------PEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNL 163 (484)
T ss_pred ---------------------ccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccc
Confidence 00000001124599999998742 3667999999999999999999997632
Q ss_pred ---cHHHHHHHhcCCCC--CCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 374 ---NEKTLINILKKPLT--FPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 374 ---~~~~~~~i~~~~~~--~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
..+.+..+.++... .|...... +....+..++..||..+|.+||++.
T Consensus 164 ~~~~~eii~~~~~~~~~~~rP~i~~~~----e~~~~l~~l~~~cw~e~P~~rPs~~ 215 (484)
T KOG1023|consen 164 VEDPDEIILRVKKGGSNPFRPSIELLN----ELPPELLLLVARCWEEIPEKRPSIE 215 (484)
T ss_pred cCChHHHHHHHHhcCCCCcCcchhhhh----hcchHHHHHHHHhcccChhhCccHH
Confidence 23455555442221 12211110 2223588999999999999999986
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.2e-18 Score=155.51 Aligned_cols=139 Identities=24% Similarity=0.265 Sum_probs=97.1
Q ss_pred eeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHH---------------------HHHHHHHHHHhCC
Q 011302 89 LRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLH---------------------RADMEKVILTMLD 147 (489)
Q Consensus 89 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~---------------------~~~~E~~~l~~l~ 147 (489)
.+.||+|+||+||+|.+. .+..||||++............ ....|...+..+.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~------~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 75 (187)
T cd05119 2 GGPIGTGKEADVYLALDG------DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLY 75 (187)
T ss_pred CcccccccceeEEEEECC------CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHH
Confidence 467999999999999866 2578999998753221111110 1134555555554
Q ss_pred CCC--cccccceeecCceEEEEEeecCCCchHH-HHHhCCCCCCChhhHHHHHHHHHHHHHHHHh-CCCeeecCCCCCeE
Q 011302 148 HPF--LPTLYAEFEASHYSCLVMEYCPGGDLYA-ARQRQPGKRFGISSAKFYAAETLLALEYLHM-MGIVYRDLKPENVL 223 (489)
Q Consensus 148 hpn--Iv~l~~~~~~~~~~~lV~E~~~gg~L~~-~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiHrDIKp~NIL 223 (489)
+.+ +.+.+++ ...++||||++|+.+.. .+... .. ..++..++.+++.++.++|. .||+||||||+|||
T Consensus 76 ~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~---~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nil 147 (187)
T cd05119 76 EAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV---RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNIL 147 (187)
T ss_pred HcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhh---hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEE
Confidence 432 4444433 23589999999865421 11111 01 16688899999999999999 99999999999999
Q ss_pred eccCCcEEEcccCCCcccc
Q 011302 224 VREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 224 l~~~~~vkl~DFG~a~~~~ 242 (489)
++ ++.++|+|||.+....
T Consensus 148 i~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 148 VD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred EE-CCcEEEEECccccccc
Confidence 99 9999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.4e-17 Score=156.07 Aligned_cols=137 Identities=23% Similarity=0.229 Sum_probs=102.5
Q ss_pred eeec-cCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHH----------HHHHHHHHHHHHHHHhCCCCCc--ccccc
Q 011302 90 RRLG-SGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAI----------RKKLHRADMEKVILTMLDHPFL--PTLYA 156 (489)
Q Consensus 90 ~~lG-~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~----------~~~~~~~~~E~~~l~~l~hpnI--v~l~~ 156 (489)
..|| .|+.|+||.+... +..++||.+....... .....++.+|..++..+.|++| +..++
T Consensus 37 ~~lg~~~g~gtv~~v~~~-------~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~ 109 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-------GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIA 109 (239)
T ss_pred ceeecCCCCccEEEEEeC-------CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEe
Confidence 4577 7888888888764 3567888885432110 1223567789999999998875 66776
Q ss_pred eeecC-ce---EEEEEeecCC-CchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEE
Q 011302 157 EFEAS-HY---SCLVMEYCPG-GDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIM 231 (489)
Q Consensus 157 ~~~~~-~~---~~lV~E~~~g-g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vk 231 (489)
+.... .. .++||||++| .+|.+++.. ..+++. .+.||+.+|.+||++||+||||||+|||++.++.++
T Consensus 110 ~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 110 ARVVRHGLFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred eeeeecCcceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEE
Confidence 54332 22 3599999997 689888754 245543 367899999999999999999999999999999999
Q ss_pred EcccCCCcc
Q 011302 232 LSDFDLSFK 240 (489)
Q Consensus 232 l~DFG~a~~ 240 (489)
|+|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999999843
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.69 E-value=8.1e-17 Score=140.74 Aligned_cols=133 Identities=23% Similarity=0.278 Sum_probs=110.5
Q ss_pred eeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCC--CCcccccceeecCceEE
Q 011302 88 LLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDH--PFLPTLYAEFEASHYSC 165 (489)
Q Consensus 88 ~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~~~~~ 165 (489)
+++.||+|.++.||++...+ ..+++|....... ...+..|..+++.+.| .++++++.++...+..|
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-------~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~ 69 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-------EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSY 69 (155)
T ss_pred cceecccccccceEEEEecC-------CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccE
Confidence 45789999999999999754 4689999865432 2356668899999976 58999999888888999
Q ss_pred EEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhC---CCeeecCCCCCeEeccCCcEEEcccCCCccc
Q 011302 166 LVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMM---GIVYRDLKPENVLVREDGHIMLSDFDLSFKC 241 (489)
Q Consensus 166 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~ 241 (489)
++|||++|+.+..+ +......++.+++.+|++||.. +++|+||||+|||++..+.++++|||.+...
T Consensus 70 ~v~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 70 LLMEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred EEEEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 99999988877543 4456677889999999999985 6999999999999999899999999998543
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=5.4e-15 Score=153.68 Aligned_cols=144 Identities=18% Similarity=0.240 Sum_probs=94.5
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHH-------------------------------HHH
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAI-------------------------------RKK 132 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~-------------------------------~~~ 132 (489)
.+|.. +.||+|++|.||+|+.++ +++.||||++++..... .+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~-----~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~ 193 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKD-----NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEF 193 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECC-----CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHH
Confidence 45676 789999999999999986 46889999997542110 011
Q ss_pred HHHHHHHHHHHHhCCCCCcccccceeecC-------------ceEEEEEeecCCCchHHHHHhCCCC----CCChhhHHH
Q 011302 133 LHRADMEKVILTMLDHPFLPTLYAEFEAS-------------HYSCLVMEYCPGGDLYAARQRQPGK----RFGISSAKF 195 (489)
Q Consensus 133 ~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-------------~~~~lV~E~~~gg~L~~~l~~~~~~----~l~~~~~~~ 195 (489)
...+..|...+... .|+.++...|.+. ..-+|||||+.|+.|.++......+ .+.+..+..
T Consensus 194 ~~~l~~ElD~~~Ea--~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~ 271 (537)
T PRK04750 194 EKTLHDELDLMREA--ANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEV 271 (537)
T ss_pred HHHHHHhhCHHHHH--HHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHH
Confidence 12223333333322 2444444443333 3346999999999997643211111 244444455
Q ss_pred HHHHHHHHHHHHHhCCCeeecCCCCCeEeccCC----cEEEcccCCCcccc
Q 011302 196 YAAETLLALEYLHMMGIVYRDLKPENVLVREDG----HIMLSDFDLSFKCD 242 (489)
Q Consensus 196 i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~----~vkl~DFG~a~~~~ 242 (489)
++.|++ ..|++|+|+||.||+++.+| .++++|||++..++
T Consensus 272 ~~~Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 272 FFTQVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HHHHHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 555554 58999999999999999888 99999999986554
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.1e-14 Score=146.30 Aligned_cols=141 Identities=21% Similarity=0.236 Sum_probs=96.3
Q ss_pred eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHH-------------------------------HHHHH----
Q 011302 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAI-------------------------------RKKLH---- 134 (489)
Q Consensus 90 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~-------------------------------~~~~~---- 134 (489)
+.||+|++|.||+|+.++ ++.||||+.+...... .+...
T Consensus 123 ~plasaSigQVh~A~l~~------G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~ 196 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVD------GKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR 196 (437)
T ss_pred cceeeeehhheEEEEecC------CCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence 579999999999999874 5789999986431100 00000
Q ss_pred --HHHHHHHHHHhC----C-CCCc--ccccceeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHH-HH
Q 011302 135 --RADMEKVILTML----D-HPFL--PTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLL-AL 204 (489)
Q Consensus 135 --~~~~E~~~l~~l----~-hpnI--v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~-~L 204 (489)
.+.+|...+.++ . +++| .+++. ......+|||||++|++|.++..... ..+ ....++.+++. .+
T Consensus 197 Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~--~~~~~~vLvmE~i~G~~L~~~~~~~~-~~~---~~~~ia~~~~~~~l 270 (437)
T TIGR01982 197 ELDLRREAANASELGENFKNDPGVYVPEVYW--DRTSERVLTMEWIDGIPLSDIAALDE-AGL---DRKALAENLARSFL 270 (437)
T ss_pred HHCHHHHHHHHHHHHHhcCCCCCEEeCCEeh--hhcCCceEEEEeECCcccccHHHHHh-cCC---CHHHHHHHHHHHHH
Confidence 133455555544 2 3432 23332 22344689999999999987765321 112 23455666665 47
Q ss_pred HHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 205 EYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 205 ~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
..+|..|++|+|+||.||+++.+|.++|+|||++..+.
T Consensus 271 ~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 271 NQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 88999999999999999999999999999999986554
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=6.8e-15 Score=149.35 Aligned_cols=262 Identities=23% Similarity=0.212 Sum_probs=183.3
Q ss_pred CCceeeeeecc--CCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-CCCcccccceeec
Q 011302 84 DHFRLLRRLGS--GDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-HPFLPTLYAEFEA 160 (489)
Q Consensus 84 ~~y~~~~~lG~--G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~ 160 (489)
..|.+...+|. |.+|.||.+.+... .....+|+|.-+...-. .....+-.+|.....+++ |+|.++.+..|+.
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~---~s~~~~a~k~s~~p~s~-p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNS---ESPHKFAVKKSKIPFSP-PLDSKRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcc---cCCcccccccccCCCCC-ccccccccchhhcccccCccccccccCccccc
Confidence 45778889999 99999999988321 14667888873211100 001111223555555554 9999999999999
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHH----HHHHHHhCCCeeecCCCCCeEeccC-CcEEEccc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLL----ALEYLHMMGIVYRDLKPENVLVRED-GHIMLSDF 235 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~----~L~yLH~~~iiHrDIKp~NILl~~~-~~vkl~DF 235 (489)
.+.+|+-+|+| |.+|.++.... ..-++...+..++.++.. ||.++|+.+++|-|+||+||++..+ ...+++||
T Consensus 190 ~~~lfiqtE~~-~~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 190 SGILFIQTELC-GESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred CCcceeeeccc-cchhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCc
Confidence 99999999999 67887765443 345888889999999999 9999999999999999999999999 88999999
Q ss_pred CCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCc
Q 011302 236 DLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDP 315 (489)
Q Consensus 236 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (489)
|+...+....- .+.
T Consensus 268 ~~v~~i~~~~~---------------------------------~~~--------------------------------- 281 (524)
T KOG0601|consen 268 GLVSKISDGNF---------------------------------SSV--------------------------------- 281 (524)
T ss_pred ceeEEccCCcc---------------------------------ccc---------------------------------
Confidence 99744321100 000
Q ss_pred cccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCC--CcHHHHHHHhcCCCCCCCCCC
Q 011302 316 EVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGE--NNEKTLINILKKPLTFPRIGV 393 (489)
Q Consensus 316 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~--~~~~~~~~i~~~~~~~p~~~~ 393 (489)
.......-|...|++||.+.+. ++...||++||-++.+-.+|..++... +....+..+. .|...+
T Consensus 282 -------~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-----ip~e~~ 348 (524)
T KOG0601|consen 282 -------FKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-----IPLEFC 348 (524)
T ss_pred -------eeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-----Cchhhh
Confidence 0000111366789999999876 788999999999999999888776544 2222222111 222111
Q ss_pred CCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 394 SSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 394 ~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
.... ..+...+..|+..+|-.|++.+ .++.|++.+..
T Consensus 349 ~~~s-----~~l~~~~~~~~d~~~~~~~~~q----~~~~l~~i~s~ 385 (524)
T KOG0601|consen 349 EGGS-----SSLRSVTSQMLDEDPRLRLTAQ----ILTALNVIHSK 385 (524)
T ss_pred cCcc-----hhhhhHHHHhcCcchhhhhHHH----HHhccccccch
Confidence 1111 1355689999999999999987 88889887644
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=7.7e-15 Score=148.96 Aligned_cols=251 Identities=21% Similarity=0.293 Sum_probs=179.3
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccceeec
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAEFEA 160 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~ 160 (489)
...+|.++..||.|.|+.|+.+..+. ...+.|++|-+.+.......... -..|+.+...+ .|.++++.+..|..
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~----~~~~~Y~~ke~~~~l~~~~~di~-sl~ev~l~~~l~~~~~~~g~~~~W~~ 337 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRP----EGDCIYAAKELLNGLATFASDIF-SLGEVILEAILGSHLPSVGKNSSWSQ 337 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecC----CCCceEeChhhhccccchHhhhc-chhhhhHhhHhhcccccCCCCCCccc
Confidence 35789999999999999999988552 25788999988654333222211 22355555555 49999999999999
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccC-CcEEEcccCCCc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRED-GHIMLSDFDLSF 239 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~-~~vkl~DFG~a~ 239 (489)
..+.|+-.|||.++++...+.-. ..+.+...+.+..|++.++.++|+..++|+|+||.||++..+ +..++.|||.++
T Consensus 338 ~r~~~ip~e~~~~~s~~l~~~~~--~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 338 LRQGYIPLEFCEGGSSSLRSVTS--QMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred cccccCchhhhcCcchhhhhHHH--HhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccc
Confidence 99999999999999986654222 457888899999999999999999999999999999999976 788999999874
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
.+...
T Consensus 416 ~~~~~--------------------------------------------------------------------------- 420 (524)
T KOG0601|consen 416 RLAFS--------------------------------------------------------------------------- 420 (524)
T ss_pred cccee---------------------------------------------------------------------------
Confidence 32210
Q ss_pred cccccCCccccC-CCCc-cCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCch
Q 011302 320 EPINARSKSFVG-THEY-LAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSK 397 (489)
Q Consensus 320 ~~~~~~~~~~~G-t~~y-~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 397 (489)
.....+ +..| .+++......+..+.|++|||.-++|.++|...-..... ...|..+.. |......
T Consensus 421 ------~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i~~~~~--p~~~~~~-- 487 (524)
T KOG0601|consen 421 ------SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTIRSGDT--PNLPGLK-- 487 (524)
T ss_pred ------cccccccccccccchhhccccccccccccccccccccccccCcccCccccc---ceeeecccc--cCCCchH--
Confidence 001112 2334 355555566689999999999999999998765332222 223333322 1111111
Q ss_pred hHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 398 EFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 398 ~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
.+++.+...++..++..|+.+. ++..|.=|
T Consensus 488 -----~~~q~~~kv~~~~~~~~~~l~~----~l~~~~~~ 517 (524)
T KOG0601|consen 488 -----LQLQVLLKVMINPDRKRRPSAV----ELSLHSEF 517 (524)
T ss_pred -----HhhhhhhhhhcCCccccchhhh----hhcccchh
Confidence 2478899999999999999886 66666444
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=6.5e-14 Score=131.69 Aligned_cols=208 Identities=19% Similarity=0.212 Sum_probs=145.1
Q ss_pred HHhCCCCCcccccceeecCc-----eEEEEEeecCCCchHHHHHhC--CCCCCChhhHHHHHHHHHHHHHHHHhCC--Ce
Q 011302 143 LTMLDHPFLPTLYAEFEASH-----YSCLVMEYCPGGDLYAARQRQ--PGKRFGISSAKFYAAETLLALEYLHMMG--IV 213 (489)
Q Consensus 143 l~~l~hpnIv~l~~~~~~~~-----~~~lV~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~yLH~~~--ii 213 (489)
|-.+.|.|||+++.+|.+.+ ...+++||+.-|+|.++|++. ....+.....++|+-||+.||.|||+.. ||
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 44567999999999997554 478999999999999988763 2356788888999999999999999875 99
Q ss_pred eecCCCCCeEeccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccc
Q 011302 214 YRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAV 293 (489)
Q Consensus 214 HrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (489)
|+.+.++-|++..+|.+|+.--.....-. .
T Consensus 201 hgnlTc~tifiq~ngLIkig~~ap~s~h~----s---------------------------------------------- 230 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHNGLIKIGSVAPDSTHP----S---------------------------------------------- 230 (458)
T ss_pred cCCcchhheeecCCceEEecccCccccch----h----------------------------------------------
Confidence 99999999999999998875332210000 0
Q ss_pred cccccccccCCCCCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCC-CCC
Q 011302 294 TVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPF-KGE 372 (489)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf-~~~ 372 (489)
+.+. .......-.|-++|.|||.=.-...+.++|||+||.+..||..|+.-- .+.
T Consensus 231 -~~~~-----------------------~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnse 286 (458)
T KOG1266|consen 231 -VNST-----------------------REAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSE 286 (458)
T ss_pred -hhhh-----------------------hHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCc
Confidence 0000 000001113567899998766666678999999999999999887653 222
Q ss_pred CcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 373 NNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 373 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
.....-..|..-.+.. ... .-+++|.+||+-.|..||++. +++.||-+=.+.
T Consensus 287 S~~~~ee~ia~~i~~l-----en~-------lqr~~i~kcl~~eP~~rp~ar----~llfHpllfeVh 338 (458)
T KOG1266|consen 287 SKVEVEENIANVIIGL-----ENG-------LQRGSITKCLEGEPNGRPDAR----LLLFHPLLFEVH 338 (458)
T ss_pred ceeehhhhhhhheeec-----cCc-------cccCcCcccccCCCCCCcchh----hhhcCceeeecc
Confidence 2222222222211111 000 125789999999999999998 999999875543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.2e-13 Score=123.76 Aligned_cols=127 Identities=20% Similarity=0.246 Sum_probs=94.4
Q ss_pred eeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCc-ccccceeecCceEEEE
Q 011302 89 LRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFL-PTLYAEFEASHYSCLV 167 (489)
Q Consensus 89 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lV 167 (489)
++.|+.|.++.||+++.. +..|++|+...... ....+..|..+++.+.+.++ .+++.... ...++|
T Consensus 3 ~~~l~~G~~~~vy~~~~~-------~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv 69 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-------NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLI 69 (170)
T ss_pred eeecCCcccCceEEEEEC-------CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEE
Confidence 467899999999999865 35799999865421 11234568888888865554 44554432 345899
Q ss_pred EeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCC-----eeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 168 MEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGI-----VYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 168 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~i-----iHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
|||++|.++... ......++.+++.+|+.||..++ +|+|++|.|||++ ++.++|+|||.+.
T Consensus 70 ~e~i~G~~l~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 70 TEFIEGSELLTE----------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred EEecCCCccccc----------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 999999888542 01123457899999999999985 9999999999999 7789999999984
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.45 E-value=8.6e-13 Score=135.41 Aligned_cols=116 Identities=21% Similarity=0.179 Sum_probs=91.0
Q ss_pred CCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEEEEEeecCCCchHHHHHhCCCCCCChhh
Q 011302 113 PQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISS 192 (489)
Q Consensus 113 ~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~ 192 (489)
.+..+.|.+.+.... .....+.+-+.-|+.++||||+++++.++..+.+|||+|-+ --|..++.. ++...
T Consensus 36 ~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~-----l~~~~ 105 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE-----LGKEE 105 (690)
T ss_pred cCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH-----hHHHH
Confidence 344555555543322 12223334556688899999999999999999999999998 466666654 44677
Q ss_pred HHHHHHHHHHHHHHHH-hCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 193 AKFYAAETLLALEYLH-MMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 193 ~~~i~~qi~~~L~yLH-~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
+...+.||+.||.||| ..+++|++|.-.-|+++..|..||++|.++
T Consensus 106 v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v 152 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELV 152 (690)
T ss_pred HHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEE
Confidence 7888999999999998 678999999999999999999999999886
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.36 E-value=8.6e-12 Score=113.26 Aligned_cols=143 Identities=18% Similarity=0.147 Sum_probs=98.6
Q ss_pred eeeccCCceeEEEEEEccCC-CCCCCeeEEEEeeehHHHH-------H--H----------HHHH----HHHHHHHHHHh
Q 011302 90 RRLGSGDIGNVYLCQIRNPM-VGLPQCFYAMKVVDREALA-------I--R----------KKLH----RADMEKVILTM 145 (489)
Q Consensus 90 ~~lG~G~fg~Vy~a~~~~~~-~~~~~~~~aiK~~~~~~~~-------~--~----------~~~~----~~~~E~~~l~~ 145 (489)
..||.|-=+.||.|...+.. .......+|||+.+..... . + +... -...|...|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46899999999999754310 0112467899998531100 0 0 0011 13478888888
Q ss_pred CCC--CCcccccceeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHH-HhCCCeeecCCCCCe
Q 011302 146 LDH--PFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYL-HMMGIVYRDLKPENV 222 (489)
Q Consensus 146 l~h--pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yL-H~~~iiHrDIKp~NI 222 (489)
+.. -++.+.+++ ..-+|||||+.++.+..-.-+. ..++..+...++.+++.+|..| |..||||+||++.||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 853 456666654 3457999999665453221111 2355666778889999999999 899999999999999
Q ss_pred EeccCCcEEEcccCCCc
Q 011302 223 LVREDGHIMLSDFDLSF 239 (489)
Q Consensus 223 Ll~~~~~vkl~DFG~a~ 239 (489)
|+. ++.+.|+|||.|-
T Consensus 157 L~~-~~~v~iIDF~qav 172 (197)
T cd05146 157 LWH-DGKVWFIDVSQSV 172 (197)
T ss_pred EEE-CCcEEEEECCCce
Confidence 997 5789999999874
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=3.1e-11 Score=106.00 Aligned_cols=132 Identities=23% Similarity=0.202 Sum_probs=98.5
Q ss_pred eeccCCceeEEEEEEccCCCCCCCeeEEEEe-----eehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEE
Q 011302 91 RLGSGDIGNVYLCQIRNPMVGLPQCFYAMKV-----VDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSC 165 (489)
Q Consensus 91 ~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~-----~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 165 (489)
.+++|+=+.+|.+.+.+. .+.+|. .+...+..+-...+..+|+.++..+.--.|..-+-++.+.....
T Consensus 3 ~i~~GAEa~i~~~~~~g~-------~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~ 75 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGL-------PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGL 75 (204)
T ss_pred hhhCCcceeEEeeeccCc-------ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCE
Confidence 578899999999876541 133332 23344555555667788999999886545444343456667778
Q ss_pred EEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 166 LVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 166 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
|+|||++|-.|.+.+... ...++..+-.-+.-||..||||+||.+.||++..++ +.++|||++.
T Consensus 76 I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~ 139 (204)
T COG3642 76 IVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGE 139 (204)
T ss_pred EEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccc
Confidence 999999988888888654 145677888888899999999999999999998654 9999999984
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=6.2e-11 Score=103.65 Aligned_cols=144 Identities=21% Similarity=0.144 Sum_probs=105.1
Q ss_pred eeeeeccCCceeEEEEEEccCCCCCCCeeEEE-----EeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 88 LLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAM-----KVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 88 ~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~ai-----K~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.+..|-+|+-+.|+++.+.+ +.+.| |..+-..+..+-...+...|..+|.++.--.|.--.-+|.+..
T Consensus 11 ~l~likQGAEArv~~~~~~G-------e~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~ 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSG-------EAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY 83 (229)
T ss_pred cceeeeccceeeEeeeccCC-------ceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC
Confidence 56778899999999998775 23333 3444455555555677888999999886444443333466666
Q ss_pred eEEEEEeecCC-CchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCC---cEEEcccCCC
Q 011302 163 YSCLVMEYCPG-GDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDG---HIMLSDFDLS 238 (489)
Q Consensus 163 ~~~lV~E~~~g-g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~---~vkl~DFG~a 238 (489)
.-.|+|||++| .++.+++...-...........++.+|-+.|.-||.++|||+||..+||||..+| .+.|+|||++
T Consensus 84 ~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 84 GGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred CCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecch
Confidence 67899999966 3777777654333333333367899999999999999999999999999998665 3589999997
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.21 E-value=4.2e-11 Score=111.99 Aligned_cols=139 Identities=23% Similarity=0.220 Sum_probs=102.8
Q ss_pred eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCC--CCcccccceeecC---ceE
Q 011302 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDH--PFLPTLYAEFEAS---HYS 164 (489)
Q Consensus 90 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~---~~~ 164 (489)
+.||.|.++.||++...+ ++.|++|+....... .....+..|..+++.+.+ ..+.+++.+.... +..
T Consensus 4 ~~l~~G~~n~~~~v~~~~------g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~ 75 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG------GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTP 75 (223)
T ss_pred eecCCCccceEEEEEecC------CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCc
Confidence 578999999999998653 357899998654321 123456679999999875 3467777766653 367
Q ss_pred EEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHh-----------------------------------
Q 011302 165 CLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHM----------------------------------- 209 (489)
Q Consensus 165 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~----------------------------------- 209 (489)
|+||||++|.+|...+.. ..+++.....++.+++.+|..||+
T Consensus 76 ~~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (223)
T cd05154 76 FYVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTD 152 (223)
T ss_pred eEEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhccc
Confidence 899999999988654321 235666667777777777777773
Q ss_pred ---------------------CCCeeecCCCCCeEecc--CCcEEEcccCCCc
Q 011302 210 ---------------------MGIVYRDLKPENVLVRE--DGHIMLSDFDLSF 239 (489)
Q Consensus 210 ---------------------~~iiHrDIKp~NILl~~--~~~vkl~DFG~a~ 239 (489)
..+||+|+.+.|||++. ++.+.|+||+.+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 153 EPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred ccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 23699999999999998 6778999999873
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.14 E-value=7.5e-10 Score=106.16 Aligned_cols=135 Identities=15% Similarity=0.015 Sum_probs=94.0
Q ss_pred eeEEEEEEccCCCCCCCeeEEEEeeehHHHH--HHH------HHHHHHHHHHHHHhCCCCC--cccccceeec-----Cc
Q 011302 98 GNVYLCQIRNPMVGLPQCFYAMKVVDREALA--IRK------KLHRADMEKVILTMLDHPF--LPTLYAEFEA-----SH 162 (489)
Q Consensus 98 g~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~--~~~------~~~~~~~E~~~l~~l~hpn--Iv~l~~~~~~-----~~ 162 (489)
..|+++... ++.|.||........ .+. -...+.+|...+.+|..-+ ++..+++++. ..
T Consensus 36 rrvvr~~~~-------g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 36 RRTLRFELA-------GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred ceEEEEEEC-------CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 346665543 356888876432211 011 0113667888887775333 3444555543 23
Q ss_pred eEEEEEeecCCC-chHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEecc-------CCcEEEcc
Q 011302 163 YSCLVMEYCPGG-DLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRE-------DGHIMLSD 234 (489)
Q Consensus 163 ~~~lV~E~~~gg-~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~-------~~~vkl~D 234 (489)
..+||||++++. +|.+++........+......++.+++..+.-||..||+|+|+++.|||++. ++.+.|+|
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LID 188 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVID 188 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEE
Confidence 578999999875 7888875422244566778899999999999999999999999999999985 46899999
Q ss_pred cCCCc
Q 011302 235 FDLSF 239 (489)
Q Consensus 235 FG~a~ 239 (489)
|+.+.
T Consensus 189 l~r~~ 193 (268)
T PRK15123 189 LHRAQ 193 (268)
T ss_pred CCccc
Confidence 99873
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.7e-10 Score=119.29 Aligned_cols=174 Identities=20% Similarity=0.273 Sum_probs=115.6
Q ss_pred HHHHHHHHHHHHh-CCCeeecCCCCCeEeccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCc
Q 011302 197 AAETLLALEYLHM-MGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPV 275 (489)
Q Consensus 197 ~~qi~~~L~yLH~-~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (489)
+.+++.||.|+|. .++||+.|.|++|.++.+|..||+.|+++-......+
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~----------------------------- 155 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTE----------------------------- 155 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCc-----------------------------
Confidence 3455599999996 4899999999999999999999999998622111000
Q ss_pred cccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHH
Q 011302 276 LSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTL 355 (489)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSl 355 (489)
..|.. ..........-...|.|||.+.+...+.++|+|||
T Consensus 156 -~p~~~---------------------------------------yd~~lp~~~~~~~~f~apE~~~~~~~~~~sd~fSl 195 (700)
T KOG2137|consen 156 -YPFSE---------------------------------------YDPPLPLLLQPHLNFLAPEYLLGTTNTPASDVFSL 195 (700)
T ss_pred -ccccc---------------------------------------CCCCCChhhccCcccccchhhccccccccccceee
Confidence 00000 00000111223467999999999888999999999
Q ss_pred HHHHHHHh-hCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCC
Q 011302 356 GVFLYEML-YGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHE 434 (489)
Q Consensus 356 Gvil~ell-tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp 434 (489)
||++|-+. .|+..+.+........ .............. -+.+.++++=|.++|..++.-||++. .++.-|
T Consensus 196 G~li~~i~~~gk~i~~a~~~~~~~~-~~~~~~~~~~~~~s----~~~p~el~~~l~k~l~~~~~~rp~~~----~l~~~~ 266 (700)
T KOG2137|consen 196 GVLIYTIYNGGKSIIAANGGLLSYS-FSRNLLNAGAFGYS----NNLPSELRESLKKLLNGDSAVRPTLD----LLLSIP 266 (700)
T ss_pred eeEEEEEecCCcchhhccCCcchhh-hhhccccccccccc----ccCcHHHHHHHHHHhcCCcccCcchh----hhhccc
Confidence 99999999 6777776554332221 11111111111111 01223588999999999999999776 889999
Q ss_pred CcCCCCccccccCC
Q 011302 435 FFKGINWALIRSIK 448 (489)
Q Consensus 435 ~f~~~~~~~~~~~~ 448 (489)
||.+..-..|+.+.
T Consensus 267 ff~D~~~~aLrfLD 280 (700)
T KOG2137|consen 267 FFSDPGLKALRFLD 280 (700)
T ss_pred ccCCchhhhhhhcc
Confidence 99987766665544
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.2e-09 Score=98.87 Aligned_cols=127 Identities=24% Similarity=0.199 Sum_probs=82.5
Q ss_pred eEEEEEEccCCCCCCCeeEEEEeeehHHH-----------------------HHHHHHHHHHHHHHHHHhCCCC--Cccc
Q 011302 99 NVYLCQIRNPMVGLPQCFYAMKVVDREAL-----------------------AIRKKLHRADMEKVILTMLDHP--FLPT 153 (489)
Q Consensus 99 ~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~-----------------------~~~~~~~~~~~E~~~l~~l~hp--nIv~ 153 (489)
.||.|...+ +..+|+|+.+.... ...........|...|.++..- ++.+
T Consensus 1 ~Vy~~~~~~------~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~ 74 (188)
T PF01163_consen 1 DVYHAIDPD------GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPK 74 (188)
T ss_dssp EEEEEEECT------TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--
T ss_pred CEEEEECCC------CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCc
Confidence 378887654 56789998753210 0111223467899999999765 4666
Q ss_pred ccceeecCceEEEEEeecC--CCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHH-HHhCCCeeecCCCCCeEeccCCcE
Q 011302 154 LYAEFEASHYSCLVMEYCP--GGDLYAARQRQPGKRFGISSAKFYAAETLLALEY-LHMMGIVYRDLKPENVLVREDGHI 230 (489)
Q Consensus 154 l~~~~~~~~~~~lV~E~~~--gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~y-LH~~~iiHrDIKp~NILl~~~~~v 230 (489)
.+++. .-+|||||++ |..+..+... .++..+...++.+++..+.. +|..||||+||.+.|||++.+ .+
T Consensus 75 p~~~~----~~~ivME~I~~~G~~~~~l~~~----~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 75 PYDYN----RNVIVMEYIGEDGVPLPRLKDV----DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp EEEEE----TTEEEEE--EETTEEGGCHHHC----GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CE
T ss_pred EEEEe----CCEEEEEecCCCccchhhHHhc----cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eE
Confidence 66542 2369999998 6666544332 23356677888899986666 579999999999999999977 99
Q ss_pred EEcccCCCcc
Q 011302 231 MLSDFDLSFK 240 (489)
Q Consensus 231 kl~DFG~a~~ 240 (489)
.|+|||.|..
T Consensus 146 ~iIDf~qav~ 155 (188)
T PF01163_consen 146 YIIDFGQAVD 155 (188)
T ss_dssp EE--GTTEEE
T ss_pred EEEecCccee
Confidence 9999998743
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.2e-08 Score=102.35 Aligned_cols=133 Identities=17% Similarity=0.144 Sum_probs=103.2
Q ss_pred eeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee----cCceEEEEEeecCC
Q 011302 98 GNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE----ASHYSCLVMEYCPG 173 (489)
Q Consensus 98 g~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~----~~~~~~lV~E~~~g 173 (489)
.+.|+|...- ++..|.+|++........++ ...-+++++++.|+|||+|.++|. .+.-++||++|.++
T Consensus 290 ~Ttyk~~s~~-----DG~~YvLkRlhg~r~~~~nk---~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~ 361 (655)
T KOG3741|consen 290 ITTYKATSNV-----DGNAYVLKRLHGDRDQSTNK---DTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPS 361 (655)
T ss_pred ceeEeeeecc-----CCceeeeeeeccccccCccc---chHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCC
Confidence 4678888765 67889999995443322211 222567899999999999999987 34568999999875
Q ss_pred -CchHHHHHhC-------------CCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 174 -GDLYAARQRQ-------------PGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 174 -g~L~~~l~~~-------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
++|+++.-.. .+...++..++.|+.|+..||.++|+.|+.-+-|.|.+||++.+.+++|..-|+.
T Consensus 362 s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~ 440 (655)
T KOG3741|consen 362 SPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIM 440 (655)
T ss_pred CchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccce
Confidence 5777653221 2345778889999999999999999999999999999999998888998877764
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.88 E-value=3.1e-08 Score=91.73 Aligned_cols=125 Identities=27% Similarity=0.198 Sum_probs=90.6
Q ss_pred CCeeEEEEeeehHH----HHHHHHHHHHHHHHHHHHhCCCC--CcccccceeecC----ceEEEEEeecCCC-chHHHHH
Q 011302 113 PQCFYAMKVVDREA----LAIRKKLHRADMEKVILTMLDHP--FLPTLYAEFEAS----HYSCLVMEYCPGG-DLYAARQ 181 (489)
Q Consensus 113 ~~~~~aiK~~~~~~----~~~~~~~~~~~~E~~~l~~l~hp--nIv~l~~~~~~~----~~~~lV~E~~~gg-~L~~~l~ 181 (489)
..+.|-+|...... ....-...+..+|...+..|..- .+++.+++.+.. ...|||||+++|. +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 34566666543321 11112234566788877776533 345666655542 2458999999874 7988887
Q ss_pred hCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCC---cEEEcccCCCc
Q 011302 182 RQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDG---HIMLSDFDLSF 239 (489)
Q Consensus 182 ~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~---~vkl~DFG~a~ 239 (489)
... .++......++.+++..+.-||.+||+|+|+++.|||++.++ .+.|+||+-++
T Consensus 111 ~~~--~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~ 169 (206)
T PF06293_consen 111 QWE--QLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR 169 (206)
T ss_pred hhc--ccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence 642 266777889999999999999999999999999999999887 89999999863
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=7.1e-08 Score=90.05 Aligned_cols=136 Identities=26% Similarity=0.271 Sum_probs=99.1
Q ss_pred ceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHH------H-------------HHHHHHHHHHHHHHhC
Q 011302 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAI------R-------------KKLHRADMEKVILTML 146 (489)
Q Consensus 86 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~------~-------------~~~~~~~~E~~~l~~l 146 (489)
+.+...||-|-=|.||.|.... +..+|||.-+....+- + -....+.+|..+|.+|
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~------g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L 166 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPK------GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRL 166 (304)
T ss_pred HhhccccccCccceEEEEECCC------CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHh
Confidence 3466889999999999998763 5778999754211110 0 0122356788899988
Q ss_pred CCC--CcccccceeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEe
Q 011302 147 DHP--FLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLV 224 (489)
Q Consensus 147 ~hp--nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl 224 (489)
... .|.+-+++ +.-.+||||++|-.|+... +.......++..|++-+.-+-..||||+|+.+=|||+
T Consensus 167 ~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV 235 (304)
T COG0478 167 YPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILV 235 (304)
T ss_pred hhcCCCCCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEE
Confidence 755 56666654 4457999999998885432 2344556667777777776668999999999999999
Q ss_pred ccCCcEEEcccCCC
Q 011302 225 REDGHIMLSDFDLS 238 (489)
Q Consensus 225 ~~~~~vkl~DFG~a 238 (489)
++||.+.++||--+
T Consensus 236 ~~dg~~~vIDwPQ~ 249 (304)
T COG0478 236 TEDGDIVVIDWPQA 249 (304)
T ss_pred ecCCCEEEEeCccc
Confidence 99999999999754
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.1e-07 Score=86.83 Aligned_cols=138 Identities=12% Similarity=0.058 Sum_probs=98.1
Q ss_pred ccCCceeEEEEEEccCCCCCCCeeEEEEeeehHH---HHHHHHHHHHHHHHHHHHhCCCCC--cccccceee-c----Cc
Q 011302 93 GSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREA---LAIRKKLHRADMEKVILTMLDHPF--LPTLYAEFE-A----SH 162 (489)
Q Consensus 93 G~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~~~-~----~~ 162 (489)
|.||.+-|+.....+ +.|-+|.-.... +....-...+.+|...|..|..-+ +.+.. ++. . .-
T Consensus 27 ~rgG~SgV~r~~~~g-------~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~ 98 (216)
T PRK09902 27 RRNGMSGVQCVERNG-------KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEW 98 (216)
T ss_pred CCCCcceEEEEEeCC-------cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCce
Confidence 568999999877664 246677654111 000112334677888888875322 45554 332 1 12
Q ss_pred eEEEEEeecCC-CchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCc--EEEcccCCC
Q 011302 163 YSCLVMEYCPG-GDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGH--IMLSDFDLS 238 (489)
Q Consensus 163 ~~~lV~E~~~g-g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~--vkl~DFG~a 238 (489)
.-+||+|-+.| -+|.+++....-.+.+......++.+|+..|+-||..|+.|+|+-+.|||++.+|. ++++||.-+
T Consensus 99 rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~ 177 (216)
T PRK09902 99 RALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKS 177 (216)
T ss_pred EEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence 46899998743 68888876643345677778899999999999999999999999999999987777 999999865
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.66 E-value=7.6e-07 Score=81.60 Aligned_cols=140 Identities=19% Similarity=0.198 Sum_probs=92.9
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHH------HHHHHHHHhC---CCCCc
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRA------DMEKVILTML---DHPFL 151 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~------~~E~~~l~~l---~hpnI 151 (489)
+...+|.+++.+-......|.+-... ++.|.+|..+.+.......+..+ .++...+..+ +--.+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~-------~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~ 100 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEID-------GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEP 100 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEEC-------CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccc
Confidence 34578999999988888888776644 46789999876543322222222 2233323333 23333
Q ss_pred ccccceee-----cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEecc
Q 011302 152 PTLYAEFE-----ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRE 226 (489)
Q Consensus 152 v~l~~~~~-----~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~ 226 (489)
..++.+.+ -....+|||||++|..|.++.. +++ .+...++++|.-||+.|+.|+|..|.|++++.
T Consensus 101 ~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~ 170 (229)
T PF06176_consen 101 ADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSN 170 (229)
T ss_pred ccceeeeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEEC
Confidence 34333332 2234568999999998866432 222 24456778899999999999999999999995
Q ss_pred CCcEEEcccCCC
Q 011302 227 DGHIMLSDFDLS 238 (489)
Q Consensus 227 ~~~vkl~DFG~a 238 (489)
++ ++++||+..
T Consensus 171 ~~-i~iID~~~k 181 (229)
T PF06176_consen 171 NG-IRIIDTQGK 181 (229)
T ss_pred Cc-EEEEECccc
Confidence 54 999999975
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.63 E-value=4.6e-07 Score=88.99 Aligned_cols=193 Identities=22% Similarity=0.257 Sum_probs=124.5
Q ss_pred ceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHH-HhCCCCCccc--------ccc
Q 011302 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL-TMLDHPFLPT--------LYA 156 (489)
Q Consensus 86 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l-~~l~hpnIv~--------l~~ 156 (489)
....+.||+|+-+.+|-.-.-.. . +-|+..+.......+ .+..| +.-.||-+-. |+|
T Consensus 13 i~~gr~LgqGgea~ly~l~e~~d-------~-VAKIYh~Pppa~~aq------k~a~la~~p~~p~~~~rvaWPqa~L~G 78 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGEVRD-------Q-VAKIYHAPPPAAQAQ------KVAELAATPDAPLLNYRVAWPQATLHG 78 (637)
T ss_pred cCCCccccCCccceeeecchhhc-------h-hheeecCCCchHHHH------HHHHhccCCCCcchhhhhcccHHHhhC
Confidence 34567899999999996432221 1 235554322221111 11122 2235664432 122
Q ss_pred eeecCceEEEEEeecCCCch-HHHH----HhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEE
Q 011302 157 EFEASHYSCLVMEYCPGGDL-YAAR----QRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIM 231 (489)
Q Consensus 157 ~~~~~~~~~lV~E~~~gg~L-~~~l----~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vk 231 (489)
- ..+...-++|..++|..= ..++ +++....+.+.-....++.|+.+.+-||+.|.+-+|+.++|+|+++++.|.
T Consensus 79 ~-~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~ 157 (637)
T COG4248 79 G-RRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVV 157 (637)
T ss_pred C-CccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEE
Confidence 1 122337788998877532 1221 122223467888899999999999999999999999999999999999999
Q ss_pred EcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccc
Q 011302 232 LSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQEL 311 (489)
Q Consensus 232 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (489)
|.|=..--.+
T Consensus 158 LVdsDsfqi~---------------------------------------------------------------------- 167 (637)
T COG4248 158 LVDSDSFQIN---------------------------------------------------------------------- 167 (637)
T ss_pred EEcccceeec----------------------------------------------------------------------
Confidence 9874311000
Q ss_pred cCCccccccccccCCccccCCCCccCcchhc-----CCCCCCcccHHHHHHHHHHHhhC-CCCCCCC
Q 011302 312 LDDPEVVAEPINARSKSFVGTHEYLAPEVIS-----GQGHGSAVDWWTLGVFLYEMLYG-TTPFKGE 372 (489)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~~~~~DiwSlGvil~elltG-~~Pf~~~ 372 (489)
........-+|.+.|.+||.-. +..-+...|.|.|||++++||.| +.||.|.
T Consensus 168 ---------~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 168 ---------ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred ---------cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 0011123347999999999865 33446789999999999999986 9999874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=6e-09 Score=106.79 Aligned_cols=246 Identities=18% Similarity=0.190 Sum_probs=158.9
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCC-cccccceeecCce
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPF-LPTLYAEFEASHY 163 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~~ 163 (489)
.+.....+++|+++++++.+... .+....+.+... .....++++|.+++||| .+..++-++.+..
T Consensus 243 ws~~fh~fvK~altknpKkRpta------eklL~h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~ 308 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTA------EKLLQHPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDY 308 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCCh------hhheeceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccc
Confidence 45555668899999999987553 222335555443 11223788999999999 8888888888889
Q ss_pred EEEEEeecCCC-chHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 164 SCLVMEYCPGG-DLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 164 ~~lV~E~~~gg-~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
..++|+++.+| +-...+... .-.|...+...+.+.-+++|++||+.-=+||| |||..+ +.+|..||+.+..+.
T Consensus 309 ~~i~~~i~s~~rs~~~~~~~s-e~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~ 382 (829)
T KOG0576|consen 309 LWIPMRICSTGRSSALEMTVS-EIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLT 382 (829)
T ss_pred cchhhhhhcCCccccccCChh-hHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccC
Confidence 99999999877 222111110 12244444555677778899999998778999 777664 788999999863221
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
..
T Consensus 383 ~~------------------------------------------------------------------------------ 384 (829)
T KOG0576|consen 383 RT------------------------------------------------------------------------------ 384 (829)
T ss_pred cc------------------------------------------------------------------------------
Confidence 10
Q ss_pred ccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHH
Q 011302 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEV 402 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~ 402 (489)
-...++.+|+.|+|||++....+....|.|++|+--.+|--|.+|-.. +......+-.++-. +..... ..|. .
T Consensus 385 -~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~--P~~~~~~~g~~p~s-~~L~~~--~aw~-~ 457 (829)
T KOG0576|consen 385 -MKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS--PPAVLPMIGNGPNS-PMLTDK--SAWS-P 457 (829)
T ss_pred -cccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC--CccccCCCCCCCCc-cccchh--hhcC-c
Confidence 023456799999999999999999999999999987788877777533 11111111111000 000000 0000 0
Q ss_pred hhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 403 VKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 403 ~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
..=.++...|+..-|..|.... .++.|.+|++-
T Consensus 458 ~~~~~~~~~~~~g~P~~pkv~m----gacfsKvfngC 490 (829)
T KOG0576|consen 458 VFHRDFPAPCLNGLPPTPKVHM----GACFSKVFNGC 490 (829)
T ss_pred ccccCCcccccCCCCCCCcchh----hHHHHHHhccC
Confidence 0012466778888888888776 77778888753
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.1e-06 Score=89.40 Aligned_cols=143 Identities=23% Similarity=0.209 Sum_probs=89.3
Q ss_pred eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHH-------------------------------HHHHHH---
Q 011302 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAI-------------------------------RKKLHR--- 135 (489)
Q Consensus 90 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~-------------------------------~~~~~~--- 135 (489)
..|+.++-|.||+|+.++ ++.||||+.+...... .+..+.
T Consensus 131 ~PiAsASIaQVH~A~L~s------G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ 204 (517)
T COG0661 131 EPIASASIAQVHRAVLKS------GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE 204 (517)
T ss_pred CchhhhhHhhheeEEecC------CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence 578999999999999985 6889999986421110 001111
Q ss_pred ---HHHHHHHHHhC-----CCCCcccccceeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHH-HHH
Q 011302 136 ---ADMEKVILTML-----DHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLA-LEY 206 (489)
Q Consensus 136 ---~~~E~~~l~~l-----~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~-L~y 206 (489)
+.+|..-+.++ +.++|.--.=+++-...-.|+|||++|..+.+...... ..++... ++..++.+ +.-
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~---ia~~~~~~f~~q 280 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKE---LAELLVRAFLRQ 280 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHH---HHHHHHHHHHHH
Confidence 12344444433 23443211112333455679999999999877643221 2344333 23322222 233
Q ss_pred HHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 207 LHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 207 LH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
+=..|++|.|..|.||+++.+|.+.+.|||+...+.
T Consensus 281 ~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 281 LLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred HHhcCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 334899999999999999999999999999975543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.9e-06 Score=80.97 Aligned_cols=134 Identities=13% Similarity=0.065 Sum_probs=80.8
Q ss_pred eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCC--cccccceeecCceEEEE
Q 011302 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPF--LPTLYAEFEASHYSCLV 167 (489)
Q Consensus 90 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~~~~~~~~~lV 167 (489)
..||+|..+.||+.. +..+++|...... ....+.+|..+++.+..-+ +.+.+++..+.+..++|
T Consensus 7 ~~i~~G~t~~~y~~~---------~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv 72 (226)
T TIGR02172 7 TQTGEGGNGESYTHK---------TGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLI 72 (226)
T ss_pred eeecCCCCcceeEec---------CCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeee
Confidence 578999999999832 2235778875422 1123456888888876433 56778877788888999
Q ss_pred EeecCCCc-hH--------------H----H---HHhCCCCCCChhhH-HHHHH----------HHHH-HHHHHH----h
Q 011302 168 MEYCPGGD-LY--------------A----A---RQRQPGKRFGISSA-KFYAA----------ETLL-ALEYLH----M 209 (489)
Q Consensus 168 ~E~~~gg~-L~--------------~----~---l~~~~~~~l~~~~~-~~i~~----------qi~~-~L~yLH----~ 209 (489)
||+++|.+ +. . + ++..+......... ..+.. .+.. ...+|. .
T Consensus 73 ~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~ 152 (226)
T TIGR02172 73 YELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDT 152 (226)
T ss_pred eeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCC
Confidence 99998863 11 1 0 11110011111110 01100 0111 122222 1
Q ss_pred CCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 210 MGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 210 ~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
..++|+|+.|.||+++.++ +.|+||+.+
T Consensus 153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a 180 (226)
T TIGR02172 153 STCLHGDFQIGNLITSGKG-TYWIDLGDF 180 (226)
T ss_pred CceEecCCCCCcEEEcCCC-cEEEechhc
Confidence 2478999999999999888 999999987
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.1e-06 Score=81.29 Aligned_cols=135 Identities=21% Similarity=0.212 Sum_probs=87.4
Q ss_pred eeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHH---------------------HHHHHHHHHHHhCC--
Q 011302 91 RLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKL---------------------HRADMEKVILTMLD-- 147 (489)
Q Consensus 91 ~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~---------------------~~~~~E~~~l~~l~-- 147 (489)
.|..|--+.||+|... .+..+|+|+.+.....-+... .-...|..-|+++.
T Consensus 55 ~istGKEA~Vy~a~~~------~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eA 128 (268)
T COG1718 55 CISTGKEANVYLAETG------DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEA 128 (268)
T ss_pred eecCCcceEEEeeccC------CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHc
Confidence 5666777789999864 367899999975443322210 01223444444442
Q ss_pred CCCcccccceeecCceEEEEEeecCCCchH-HHHHhCCCCCCChhhHHHHHHHHHHHHHHHHh-CCCeeecCCCCCeEec
Q 011302 148 HPFLPTLYAEFEASHYSCLVMEYCPGGDLY-AARQRQPGKRFGISSAKFYAAETLLALEYLHM-MGIVYRDLKPENVLVR 225 (489)
Q Consensus 148 hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~-~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiHrDIKp~NILl~ 225 (489)
+-.+.+-+++. +-.|||||+....+- =.|. .-.+...++..+..++++.+.-|-. .++||+||..=|||+.
T Consensus 129 GVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk---Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~ 201 (268)
T COG1718 129 GVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK---DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH 201 (268)
T ss_pred CCCCCCceeec----CCeEEEEeccCCCCCCCCcc---cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE
Confidence 22333333332 236999999443110 0111 1233444688888999999998887 8999999999999999
Q ss_pred cCCcEEEcccCCCc
Q 011302 226 EDGHIMLSDFDLSF 239 (489)
Q Consensus 226 ~~~~vkl~DFG~a~ 239 (489)
++.+.|+|||-|.
T Consensus 202 -~~~p~iID~~QaV 214 (268)
T COG1718 202 -DGEPYIIDVSQAV 214 (268)
T ss_pred -CCeEEEEECcccc
Confidence 8999999999874
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.35 E-value=5e-06 Score=78.05 Aligned_cols=139 Identities=27% Similarity=0.331 Sum_probs=80.5
Q ss_pred eeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCC--Cccccccee---ecCce
Q 011302 89 LRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHP--FLPTLYAEF---EASHY 163 (489)
Q Consensus 89 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~l~~~~---~~~~~ 163 (489)
++.|+.|..+.||++...+ ..|++|..... .....+..|..+++.+... .+.+++... .....
T Consensus 2 i~~l~~G~~n~~~~v~~~~-------~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~ 69 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-------GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGF 69 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-------SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSE
T ss_pred CccCCCCCeeeEEEEEECC-------cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeeccccccccc
Confidence 5689999999999998764 47899998765 1223444577777777533 355666533 23345
Q ss_pred EEEEEeecCCCchHH----------------HH---HhC--CCCCCChhh------HHH---H------------HHHHH
Q 011302 164 SCLVMEYCPGGDLYA----------------AR---QRQ--PGKRFGISS------AKF---Y------------AAETL 201 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~----------------~l---~~~--~~~~l~~~~------~~~---i------------~~qi~ 201 (489)
.+++|++++|..+.. .+ +.. ....+.... ... . ...+.
T Consensus 70 ~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (239)
T PF01636_consen 70 PYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELE 149 (239)
T ss_dssp EEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHH
T ss_pred ceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHH
Confidence 799999999987766 11 111 111111100 000 0 11122
Q ss_pred H-HHHHHHh-------CCCeeecCCCCCeEec-cCCcEEEcccCCCc
Q 011302 202 L-ALEYLHM-------MGIVYRDLKPENVLVR-EDGHIMLSDFDLSF 239 (489)
Q Consensus 202 ~-~L~yLH~-------~~iiHrDIKp~NILl~-~~~~vkl~DFG~a~ 239 (489)
. .+..+++ ..+||+|+.|.|||++ .++.+-|+||+.+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 150 ERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2 3333332 3599999999999999 66777899999873
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.31 E-value=4.3e-06 Score=91.71 Aligned_cols=206 Identities=20% Similarity=0.239 Sum_probs=141.7
Q ss_pred HHHHHHHHHHHhCCCCCcccccceeecCc----eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHh
Q 011302 134 HRADMEKVILTMLDHPFLPTLYAEFEASH----YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHM 209 (489)
Q Consensus 134 ~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~ 209 (489)
.....|...+..+.|+|++.++.+-.... .+.+..|+|.+-++...++.. ...+....+.+..++++||+|+|+
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHHHHHH
Confidence 34455777888899999999998765433 234566889999998888775 678889999999999999999999
Q ss_pred CCCeeecCCCC---CeEeccCCcEEEc--ccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCcccccccccc
Q 011302 210 MGIVYRDLKPE---NVLVREDGHIMLS--DFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSH 284 (489)
Q Consensus 210 ~~iiHrDIKp~---NILl~~~~~vkl~--DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (489)
....|.-+-.. +--.+..+.+.++ ||+....+....
T Consensus 305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~--------------------------------------- 345 (1351)
T KOG1035|consen 305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE--------------------------------------- 345 (1351)
T ss_pred hccceeEEecccccccccCccceeecchhhhcccccCCCcc---------------------------------------
Confidence 96666655544 4444555666666 777653332111
Q ss_pred ccccccccccccccccccCCCCCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCc--ccHHHHHHHHHHH
Q 011302 285 GKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSA--VDWWTLGVFLYEM 362 (489)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~--~DiwSlGvil~el 362 (489)
......-+..|.++|......+..+ .|+|.+|..+..+
T Consensus 346 ----------------------------------------~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~ 385 (1351)
T KOG1035|consen 346 ----------------------------------------KSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQL 385 (1351)
T ss_pred ----------------------------------------cchhhcCccccccccccccccchhhhhhHHHHHHHHHhhh
Confidence 1111233456888888877766544 6999999999999
Q ss_pred hhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcc
Q 011302 363 LYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWA 442 (489)
Q Consensus 363 ltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~ 442 (489)
..|..+-.... ....++.. .... ...+++.+|+..++++|+++. +++.|+|.+.-.-.
T Consensus 386 ~~~~~i~~~~~---~~~~~l~~---------~~~~------~~~d~~~~~~~~~~~~Rl~~~----~ll~~~f~~~~~~~ 443 (1351)
T KOG1035|consen 386 SQGEDISEKSA---VPVSLLDV---------LSTS------ELLDALPKCLDEDSEERLSAL----ELLTHPFLRFPTDN 443 (1351)
T ss_pred hhcCccccccc---chhhhhcc---------ccch------hhhhhhhhhcchhhhhccchh----hhhhchhccccccc
Confidence 98765522111 11111110 0000 267899999999999999998 99999998765433
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.27 E-value=8.3e-06 Score=73.96 Aligned_cols=128 Identities=27% Similarity=0.333 Sum_probs=91.3
Q ss_pred CCceeeeeeccCCc-eeEEEEEEccCCCCCCCeeEEEEeeeh----------HHHH--------HHHHHHHHHHHHHHHH
Q 011302 84 DHFRLLRRLGSGDI-GNVYLCQIRNPMVGLPQCFYAMKVVDR----------EALA--------IRKKLHRADMEKVILT 144 (489)
Q Consensus 84 ~~y~~~~~lG~G~f-g~Vy~a~~~~~~~~~~~~~~aiK~~~~----------~~~~--------~~~~~~~~~~E~~~l~ 144 (489)
.+++.++.||.|.- |.||+++..+ +.||+|+++. +... ......-+..|.+...
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g-------~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfg 109 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDG-------RIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFG 109 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECC-------eEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhH
Confidence 68999999999999 9999999875 6899999321 0000 0123345677888776
Q ss_pred hCC---CCCc--ccccceeecC------------------ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHH
Q 011302 145 MLD---HPFL--PTLYAEFEAS------------------HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETL 201 (489)
Q Consensus 145 ~l~---hpnI--v~l~~~~~~~------------------~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~ 201 (489)
+|+ +.++ |+.+|+..-. ....||.||++... .+... -+.+|.
T Consensus 110 RLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~----~~~~~~ 174 (207)
T PF13095_consen 110 RLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQIR----DIPQML 174 (207)
T ss_pred HHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccchh----HHHHHH
Confidence 664 5566 8888877211 12467888876543 12222 256788
Q ss_pred HHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 202 LALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 202 ~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
+-|..+|..||+-+|+|+.|.. .-||+|||.+
T Consensus 175 ~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 175 RDLKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence 8889999999999999999997 4589999964
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.26 E-value=6.9e-06 Score=78.13 Aligned_cols=136 Identities=18% Similarity=0.070 Sum_probs=80.5
Q ss_pred eeccCCc-eeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-CCCcccccceeecCceEEEEE
Q 011302 91 RLGSGDI-GNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-HPFLPTLYAEFEASHYSCLVM 168 (489)
Q Consensus 91 ~lG~G~f-g~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lV~ 168 (489)
.|-.|.. ..||++...+ ..+.+|+..... ...+..|+.+++.+. +--+.+++++...++..++||
T Consensus 5 ~~~~g~~~~~v~~~~~~~-------~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 71 (244)
T cd05150 5 RVTEGQSGATVYRLDGKN-------PGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLT 71 (244)
T ss_pred ecCCCCCcCeEEEEcCCC-------CcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEE
Confidence 3445555 7899986432 356788776432 123445888887774 344667787777667789999
Q ss_pred eecCCCchHHHH-------------------HhCCC--CCCChh--hHHHH-----------------------HHHHHH
Q 011302 169 EYCPGGDLYAAR-------------------QRQPG--KRFGIS--SAKFY-----------------------AAETLL 202 (489)
Q Consensus 169 E~~~gg~L~~~l-------------------~~~~~--~~l~~~--~~~~i-----------------------~~qi~~ 202 (489)
|+++|.+|.... +..+. ..+... ..... ..++..
T Consensus 72 e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (244)
T cd05150 72 SAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYA 151 (244)
T ss_pred EeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHH
Confidence 999987765321 11111 011100 00000 111111
Q ss_pred HHHHH----HhCCCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 203 ALEYL----HMMGIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 203 ~L~yL----H~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
.|... ....++|+|+.|.|||++.++.+.|+||+.|.
T Consensus 152 ~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 152 ELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred HHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 11111 12348999999999999998888999999873
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.17 E-value=9.6e-06 Score=90.61 Aligned_cols=83 Identities=20% Similarity=0.318 Sum_probs=55.9
Q ss_pred eeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-CCCc--ccccceeecC---
Q 011302 88 LLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-HPFL--PTLYAEFEAS--- 161 (489)
Q Consensus 88 ~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnI--v~l~~~~~~~--- 161 (489)
-++.|+.|.+..+|+....... ....|++|+....... .....+.+|..+|+.+. |.+| .+++.++.+.
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~---~~~~~VLR~~p~~~~~--~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~ 116 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGG---SVKRYVLRKKPPGKLL--QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVI 116 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCC---cceeEEEEeCCCCccC--ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcC
Confidence 3678899999999998765421 1235677765432211 11234567999999985 6664 7778777664
Q ss_pred ceEEEEEeecCCCc
Q 011302 162 HYSCLVMEYCPGGD 175 (489)
Q Consensus 162 ~~~~lV~E~~~gg~ 175 (489)
+..|+||||++|..
T Consensus 117 G~~flVME~v~G~~ 130 (822)
T PLN02876 117 GTAFYIMEYLEGRI 130 (822)
T ss_pred CCceEEEEecCCcc
Confidence 46789999998764
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.10 E-value=1.8e-05 Score=82.24 Aligned_cols=140 Identities=20% Similarity=0.215 Sum_probs=85.6
Q ss_pred eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHH----------------------------HHHHHH------
Q 011302 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAI----------------------------RKKLHR------ 135 (489)
Q Consensus 90 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~----------------------------~~~~~~------ 135 (489)
+.||..+.|.||+|+.++ ++.||||+-+...... ++....
T Consensus 167 ~piaaASlaQVhrA~L~~------G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELD 240 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN------GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELD 240 (538)
T ss_pred chhhhcchhheEEEEecC------CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcc
Confidence 579999999999999986 6789999975321110 000111
Q ss_pred HHHHHH----HHHhCCCCC------cccccceeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHH
Q 011302 136 ADMEKV----ILTMLDHPF------LPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALE 205 (489)
Q Consensus 136 ~~~E~~----~l~~l~hpn------Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~ 205 (489)
+..|.. +.+.+.|-+ |.++|..+ ...-.|+||||+|.-+.++..-.. ..++...+..-+.++..-
T Consensus 241 F~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~l~~~~~~-- 315 (538)
T KOG1235|consen 241 FTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDK-RGISPHDILNKLVEAYLE-- 315 (538)
T ss_pred hHHHHHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHH-cCCCHHHHHHHHHHHHHH--
Confidence 122222 222334444 45554333 234679999999988765432211 235555433333322222
Q ss_pred HHHhCCCeeecCCCCCeEecc----CCcEEEcccCCCcc
Q 011302 206 YLHMMGIVYRDLKPENVLVRE----DGHIMLSDFDLSFK 240 (489)
Q Consensus 206 yLH~~~iiHrDIKp~NILl~~----~~~vkl~DFG~a~~ 240 (489)
-|=..|++|.|=.|.||+++. ++.+.+-|||+...
T Consensus 316 qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~ 354 (538)
T KOG1235|consen 316 QIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV 354 (538)
T ss_pred HHHhcCCccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence 222468999999999999994 57899999999743
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.09 E-value=5.7e-05 Score=69.05 Aligned_cols=134 Identities=19% Similarity=0.199 Sum_probs=90.4
Q ss_pred eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHH-------------HHHHHHHHHHHHHHHHhCC------CCC
Q 011302 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALA-------------IRKKLHRADMEKVILTMLD------HPF 150 (489)
Q Consensus 90 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~-------------~~~~~~~~~~E~~~l~~l~------hpn 150 (489)
..||+|+.=.||.--.. ....||+....... ......+..+|+.....+. +.+
T Consensus 7 ~~i~~G~~R~cy~HP~d--------p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~ 78 (199)
T PF10707_consen 7 DLIAQGGERDCYQHPDD--------PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSH 78 (199)
T ss_pred cccccCCCceEEECCCC--------CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccc
Confidence 46899999999963322 23478888765500 0011233444554444443 789
Q ss_pred cccccceeecCceEEEEEeecCC------CchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEe
Q 011302 151 LPTLYAEFEASHYSCLVMEYCPG------GDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLV 224 (489)
Q Consensus 151 Iv~l~~~~~~~~~~~lV~E~~~g------g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl 224 (489)
|.+++|+.+++.-.-+|+|.+.+ -+|.+++.. ..+++ .. ...+-.-.+||-+++|+.+||+|.||++
T Consensus 79 i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 79 IPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE---GGLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVV 151 (199)
T ss_pred cccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc---CCccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEE
Confidence 99999999999999999999754 256777754 34554 22 3334455578889999999999999999
Q ss_pred ccC--C--cEEEcc-cCCC
Q 011302 225 RED--G--HIMLSD-FDLS 238 (489)
Q Consensus 225 ~~~--~--~vkl~D-FG~a 238 (489)
... + .+.|+| ||-.
T Consensus 152 ~~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 152 QRRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred EecCCCceEEEEEeCCCCc
Confidence 743 2 588888 7764
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.00 E-value=3.8e-05 Score=72.64 Aligned_cols=29 Identities=28% Similarity=0.252 Sum_probs=25.2
Q ss_pred CCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 211 GIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 211 ~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
++||+|+.+.|||++.++..-|+||+.+.
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 48999999999999876656799999873
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.96 E-value=2.3e-05 Score=71.18 Aligned_cols=96 Identities=27% Similarity=0.314 Sum_probs=78.1
Q ss_pred HHHHHHHhCCC-CCcccccceeecCceEEEEEeecCCCchHHH---HHhCCCCCCChhhHHHHHHHHHHHHHHHHh---C
Q 011302 138 MEKVILTMLDH-PFLPTLYAEFEASHYSCLVMEYCPGGDLYAA---RQRQPGKRFGISSAKFYAAETLLALEYLHM---M 210 (489)
Q Consensus 138 ~E~~~l~~l~h-pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~---l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~---~ 210 (489)
.|..+|+.+++ +++++++|+|-. ++|+||...+++... +.. ....++..+..|+.+++..+++|+. .
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~--~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQ--FLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccccccc--ccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 48888888876 699999999843 578999987776421 111 1246789999999999999999997 3
Q ss_pred CCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 211 GIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 211 ~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
.+.-.|++++|+-++.+|++|++|...+.
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVF 110 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcc
Confidence 58889999999999999999999998763
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.92 E-value=2.9e-05 Score=68.25 Aligned_cols=129 Identities=26% Similarity=0.282 Sum_probs=89.6
Q ss_pred ceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCc-ccccceeecCceE
Q 011302 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFL-PTLYAEFEASHYS 164 (489)
Q Consensus 86 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~ 164 (489)
.++.+.||+|++|.||+|.+++ ..+|+|+-+.+. ....+..|+.+|..+.--++ .++|.+-.+
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~~-------~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg~~---- 87 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWRG-------GEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYGED---- 87 (201)
T ss_pred hhhhhhhhcccccEEEEeeccC-------ceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEechh----
Confidence 3456789999999999999886 467899876543 23445669999988876665 345544333
Q ss_pred EEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCC-CCCeEeccCCcEEEcccCCCc
Q 011302 165 CLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLK-PENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 165 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIK-p~NILl~~~~~vkl~DFG~a~ 239 (489)
++.|||+.|-.|.++-.. .+ +.-+..+++.---|-..||-|..|. |...+|..++.+.|+||.-|+
T Consensus 88 ~i~me~i~G~~L~~~~~~-----~~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 88 FIRMEYIDGRPLGKLEIG-----GD----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred hhhhhhhcCcchhhhhhc-----cc----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchh
Confidence 355999988888654431 11 2224456666556677899999885 455555556699999999884
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.81 E-value=4.9e-06 Score=93.16 Aligned_cols=156 Identities=13% Similarity=0.013 Sum_probs=116.1
Q ss_pred HHHHHHHHhCCCCCcccccceee--cCceEEEEEeecCCCchHHHHHhCCC--CCCChhhHHHHHHHHHHHHHHHHhCC-
Q 011302 137 DMEKVILTMLDHPFLPTLYAEFE--ASHYSCLVMEYCPGGDLYAARQRQPG--KRFGISSAKFYAAETLLALEYLHMMG- 211 (489)
Q Consensus 137 ~~E~~~l~~l~hpnIv~l~~~~~--~~~~~~lV~E~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~- 211 (489)
..|+..++...|+++...+.-.. .....|.+++|+.+|.++..+.+.-. ..+...-+.....+.+.+..-+|+..
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 34555666678999887666443 34467899999999999998876421 22333333344444477778877642
Q ss_pred ----CeeecCCCCCeEeccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccc
Q 011302 212 ----IVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKK 287 (489)
Q Consensus 212 ----iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (489)
.+|++||+-|.+|..+..+|+.++|+++...+
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp-------------------------------------------- 1392 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP-------------------------------------------- 1392 (2724)
T ss_pred CCccchhhhhhhhccceecCCcccccccccccccCc--------------------------------------------
Confidence 79999999999999999999999999852111
Q ss_pred cccccccccccccccCCCCCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCC
Q 011302 288 NKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTT 367 (489)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~ 367 (489)
.....+..++++.|+.|++.....++.++|+|..|+-+|++.-|..
T Consensus 1393 ----------------------------------~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~ 1438 (2724)
T KOG1826|consen 1393 ----------------------------------VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNA 1438 (2724)
T ss_pred ----------------------------------hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccH
Confidence 0112345578999999999998889988999999999999999988
Q ss_pred CCC
Q 011302 368 PFK 370 (489)
Q Consensus 368 Pf~ 370 (489)
+|.
T Consensus 1439 ~fi 1441 (2724)
T KOG1826|consen 1439 YFI 1441 (2724)
T ss_pred HHH
Confidence 874
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00022 Score=67.35 Aligned_cols=76 Identities=22% Similarity=0.356 Sum_probs=47.0
Q ss_pred eeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCC-CcccccceeecCceEEEE
Q 011302 89 LRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHP-FLPTLYAEFEASHYSCLV 167 (489)
Q Consensus 89 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-nIv~l~~~~~~~~~~~lV 167 (489)
++.|..|-...||++...+. .++.|.+|+...... ......+|..+++.+... .++++++.+.. .+|
T Consensus 3 i~~l~gG~tN~~~~v~~~~~----~~~~~vlR~~~~~~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l 70 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKED----NQDAVLVRVYGNKTE----LIIDRERELRIHKLLSKHGLAPKLYATFQN----GLI 70 (235)
T ss_pred EEEcCCcccceEEEEEcCCC----CCCeEEEEEccCCcc----ceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEE
Confidence 45788888889999875420 135678887754211 112233588888887533 34555544332 389
Q ss_pred EeecCCCch
Q 011302 168 MEYCPGGDL 176 (489)
Q Consensus 168 ~E~~~gg~L 176 (489)
|||++|.++
T Consensus 71 ~e~i~G~~l 79 (235)
T cd05157 71 YEFIPGRTL 79 (235)
T ss_pred EEeeCCCcC
Confidence 999998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00027 Score=69.23 Aligned_cols=80 Identities=14% Similarity=0.084 Sum_probs=54.6
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCC---CCcccccceeec-
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDH---PFLPTLYAEFEA- 160 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h---pnIv~l~~~~~~- 160 (489)
...-.+.||.|..+.||+....+ ..+.+|..+.. .....+..|...|+.+.- -.|.++++++..
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~-------~~~~~k~~~~~-----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~ 82 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQ-------GNPMPLMARSF-----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHE 82 (297)
T ss_pred hhheeeecCCccceeEEEEEcCC-------CCEEEEEeccc-----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccC
Confidence 34446789999999999986543 23566764321 011345568888888753 357788877654
Q ss_pred --CceEEEEEeecCCCch
Q 011302 161 --SHYSCLVMEYCPGGDL 176 (489)
Q Consensus 161 --~~~~~lV~E~~~gg~L 176 (489)
.+..|||||+++|+++
T Consensus 83 ~~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 83 QSPGPDVLLLERLRGVSV 100 (297)
T ss_pred CcCCCeEEEEeccCCEec
Confidence 3668999999998754
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00019 Score=70.24 Aligned_cols=141 Identities=17% Similarity=0.188 Sum_probs=82.2
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCC--Ccccccce-----
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHP--FLPTLYAE----- 157 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~l~~~----- 157 (489)
+..-++.|..|....+|++...+ ..+++|+..... ...+..|..++..+.+- .+.+.+..
T Consensus 15 ~~~~i~~i~~G~~n~~y~v~~~~-------~~~vLr~~~~~~------~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~ 81 (296)
T cd05153 15 ELLSFEGISAGIENTNYFVTTDS-------GRYVLTLFEKVS------AEELPFFLALLDHLAERGLPVPRPIADRDGEY 81 (296)
T ss_pred chhheecccCccccceEEEEeCC-------CcEEEEEcCCCC------hHhccHHHHHHHHHHHCCCCCCccccCCCCcE
Confidence 44446778888888999986543 357889876411 12344477777776432 24454442
Q ss_pred -eecCceEEEEEeecCCCchHH--------------HHHhC----CCC-----CCChhhH----------HHHHHHHHHH
Q 011302 158 -FEASHYSCLVMEYCPGGDLYA--------------ARQRQ----PGK-----RFGISSA----------KFYAAETLLA 203 (489)
Q Consensus 158 -~~~~~~~~lV~E~~~gg~L~~--------------~l~~~----~~~-----~l~~~~~----------~~i~~qi~~~ 203 (489)
...++..++|++|++|..+.. .++.. ... ...+... ......+..+
T Consensus 82 ~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 161 (296)
T cd05153 82 LSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADE 161 (296)
T ss_pred eeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHH
Confidence 123456789999999866421 01110 000 0000000 0011112334
Q ss_pred HHHHHh-------CCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 204 LEYLHM-------MGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 204 L~yLH~-------~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
+.++.. .++||+|+.|.|||++.++.+.|+||+.+
T Consensus 162 ~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a 203 (296)
T cd05153 162 LARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFA 203 (296)
T ss_pred HHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhh
Confidence 444443 46999999999999998877899999987
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00056 Score=69.28 Aligned_cols=81 Identities=19% Similarity=0.185 Sum_probs=52.8
Q ss_pred eeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHH--H--HHHHHHHHHHHHHHHhCC---CCCcccccceeec
Q 011302 88 LLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALA--I--RKKLHRADMEKVILTMLD---HPFLPTLYAEFEA 160 (489)
Q Consensus 88 ~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~--~--~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~ 160 (489)
-.+.||.|.+..||++...++ .+.|.||.-...... . .-...+...|.+.|..+. ..++++++.+ +
T Consensus 30 ~~~elggGn~N~VyrV~~~~g-----~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D 102 (401)
T PRK09550 30 TAREIGDGNLNLVFRVSDTEG-----GKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--D 102 (401)
T ss_pred eeeEcCCCceEEEEEEEeCCC-----CeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--C
Confidence 457899999999999997641 246788874311100 0 012345566777777753 3457777765 4
Q ss_pred CceEEEEEeecCCCc
Q 011302 161 SHYSCLVMEYCPGGD 175 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~ 175 (489)
.+..++||||+++..
T Consensus 103 ~~~~~lVME~L~~~~ 117 (401)
T PRK09550 103 EELAVTVMEDLSDHK 117 (401)
T ss_pred CCCCEEEEecCCCcc
Confidence 456789999998643
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00076 Score=66.51 Aligned_cols=143 Identities=20% Similarity=0.228 Sum_probs=81.9
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCC--ccccccee--
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPF--LPTLYAEF-- 158 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~~-- 158 (489)
++....++.++.|.-..||++...+ ..|.+|+..... ....+..|..++..|...+ |.+.+...
T Consensus 21 ~~~~~~i~~~~~G~~n~~y~v~t~~-------~~~vLK~~~~~~-----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g 88 (307)
T TIGR00938 21 LGELLSLKGIAEGVENSNYLLTTDV-------GRYILTLYEKRV-----KAEELPFFLALTTHLAARGLPVPKPVKSRDG 88 (307)
T ss_pred CCCceeccccCCccccceEEEEeCC-------CcEEEEEecCCC-----CHHHHHHHHHHHHHHHHCCCCCCccccCCCC
Confidence 3445567788888888999986442 247788765421 0112233556666663212 34444321
Q ss_pred ----ecCceEEEEEeecCCCchH-----------H---HHHhCCCCCCC--------hh---h--HH----------HHH
Q 011302 159 ----EASHYSCLVMEYCPGGDLY-----------A---ARQRQPGKRFG--------IS---S--AK----------FYA 197 (489)
Q Consensus 159 ----~~~~~~~lV~E~~~gg~L~-----------~---~l~~~~~~~l~--------~~---~--~~----------~i~ 197 (489)
..++..++||||++|..+. . .++... ..++ .. . .. ...
T Consensus 89 ~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~-~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~ 167 (307)
T TIGR00938 89 RQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAG-AHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMG 167 (307)
T ss_pred CeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhh-ccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHH
Confidence 2345678999999885431 0 111110 0010 00 0 00 011
Q ss_pred HHHHHHHHHHHh-------CCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 198 AETLLALEYLHM-------MGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 198 ~qi~~~L~yLH~-------~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
..+...++++.. .++||+|+.+.||+++.++.+.|+||+.+
T Consensus 168 ~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~ 215 (307)
T TIGR00938 168 AELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFA 215 (307)
T ss_pred HHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccc
Confidence 223345555542 57999999999999998887789999987
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00029 Score=67.48 Aligned_cols=134 Identities=18% Similarity=0.179 Sum_probs=74.9
Q ss_pred eeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCc-ccccceeecCceEEEEEe
Q 011302 91 RLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFL-PTLYAEFEASHYSCLVME 169 (489)
Q Consensus 91 ~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lV~E 169 (489)
.+..|-...+|+.... +..|.+|+....... ..-....|..+++.+..-++ .+++.... -++|||
T Consensus 3 ~~~~G~tn~~y~~~~~-------~~~~vlR~~~~~~~~---~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e 68 (256)
T TIGR02721 3 TLSGGLTNRSWRIEHP-------GISFVWRPQSPVCKA---LGVDRQREYQILQALSALGLAPKPILVNE----HWLLVE 68 (256)
T ss_pred cCCCcCcCCeEEEEeC-------CccEEEeeCCccccc---ccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEE
Confidence 3556777889988632 346778876543211 00123458888888764333 44444332 268999
Q ss_pred ecCCCchHH--------------HHH---hCC--CCCCChh-hHHHHHHHH---------HHHHHHHHh--------CCC
Q 011302 170 YCPGGDLYA--------------ARQ---RQP--GKRFGIS-SAKFYAAET---------LLALEYLHM--------MGI 212 (489)
Q Consensus 170 ~~~gg~L~~--------------~l~---~~~--~~~l~~~-~~~~i~~qi---------~~~L~yLH~--------~~i 212 (489)
|++|..+.. .+. ..+ +.+++.. .+..+..++ ...+..+-. ..+
T Consensus 69 ~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 148 (256)
T TIGR02721 69 WLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAP 148 (256)
T ss_pred eccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCee
Confidence 999866521 111 111 1112211 112222122 111222221 248
Q ss_pred eeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 213 VYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 213 iHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
+|+|+.|.|||++.++ +.|+||+.|.
T Consensus 149 ~H~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 149 LHMDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred ecCCCCcCcEEEeCCC-CEEEeccccC
Confidence 9999999999999877 7899999874
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00016 Score=69.54 Aligned_cols=134 Identities=20% Similarity=0.289 Sum_probs=91.6
Q ss_pred ceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHH-----------------HHH--HHHHHHHHHHhC
Q 011302 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRK-----------------KLH--RADMEKVILTML 146 (489)
Q Consensus 86 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~-----------------~~~--~~~~E~~~l~~l 146 (489)
+.++..||=|--+-||.+-+.. +..+++|.-+.....-++ .+. .+..|...|+.|
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~------G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL 167 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEE------GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKAL 167 (465)
T ss_pred hhhccccccccccceEEEecCC------CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHH
Confidence 4567889999999999998774 456677765322211111 111 235677777777
Q ss_pred C-CCC-cccccceeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEe
Q 011302 147 D-HPF-LPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLV 224 (489)
Q Consensus 147 ~-hpn-Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl 224 (489)
. |-+ |.+.++ .+.-|+|||++.|-.|.+..+- ..+..+...+..-+.-|-.+|+||+|..-=||++
T Consensus 168 ~e~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v--------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv 235 (465)
T KOG2268|consen 168 YERGFPVPKPID----HNRHCVVMELVDGYPLRQVRHV--------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMV 235 (465)
T ss_pred HHcCCCCCCccc----ccceeeHHHhhcccceeeeeec--------CChHHHHHHHHHHHHHHHHcCceecccchheeEE
Confidence 4 333 444444 3456899999999888654322 1233344555666677889999999999999999
Q ss_pred ccCCcEEEcccCC
Q 011302 225 REDGHIMLSDFDL 237 (489)
Q Consensus 225 ~~~~~vkl~DFG~ 237 (489)
.+++.++++||--
T Consensus 236 ~dd~~i~vIDFPQ 248 (465)
T KOG2268|consen 236 KDDDKIVVIDFPQ 248 (465)
T ss_pred ecCCCEEEeechH
Confidence 9999999999953
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.00092 Score=65.68 Aligned_cols=80 Identities=19% Similarity=0.255 Sum_probs=47.2
Q ss_pred eeeeccCCceeEEEEEEccCC-CCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCC-cccccceeecCceEEE
Q 011302 89 LRRLGSGDIGNVYLCQIRNPM-VGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPF-LPTLYAEFEASHYSCL 166 (489)
Q Consensus 89 ~~~lG~G~fg~Vy~a~~~~~~-~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~~~~l 166 (489)
++.|..|-...||++...... ....++.|.+|+...... .......|..++..+...+ ..++++++.. .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE----LLIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc----ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 355666777789988754310 011246788898764321 1223445877787775333 3455655542 36
Q ss_pred EEeecCCCch
Q 011302 167 VMEYCPGGDL 176 (489)
Q Consensus 167 V~E~~~gg~L 176 (489)
|+||++|..+
T Consensus 75 v~e~i~G~~l 84 (302)
T cd05156 75 IEEFIPSRTL 84 (302)
T ss_pred hhheeCCCcC
Confidence 8999988766
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0048 Score=61.12 Aligned_cols=29 Identities=31% Similarity=0.405 Sum_probs=25.5
Q ss_pred CCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 210 MGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 210 ~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
.++||+|+.|.|||++.+...-|+||+.+
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~ 215 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFA 215 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccc
Confidence 37999999999999996655689999987
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0045 Score=62.01 Aligned_cols=145 Identities=14% Similarity=0.116 Sum_probs=81.2
Q ss_pred ceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCC-cccccceeecCceE
Q 011302 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPF-LPTLYAEFEASHYS 164 (489)
Q Consensus 86 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~~~ 164 (489)
..-+..|-.|-.-.+|++...+... ...+.|.+|+..... ..... ...|..+++.+..-+ -.++++.+..+
T Consensus 38 ~~~i~~l~gGlTN~~y~v~~~~~~~-~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g--- 109 (344)
T PLN02236 38 ALQVIPLKGAMTNEVFQIKWPTKEG-NLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG--- 109 (344)
T ss_pred cEEEEEcCCcccceeEEEEeCCCCC-CCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc---
Confidence 3334456568888999987543111 124678888876432 11112 245888888775433 34566666443
Q ss_pred EEEEeecCCCchHH--------------HHH---hCC--CC--CCChhhHHHHHHHH-----------------HHHHHH
Q 011302 165 CLVMEYCPGGDLYA--------------ARQ---RQP--GK--RFGISSAKFYAAET-----------------LLALEY 206 (489)
Q Consensus 165 ~lV~E~~~gg~L~~--------------~l~---~~~--~~--~l~~~~~~~i~~qi-----------------~~~L~y 206 (489)
.|+||++|.+|.. .+. ... +. .....++..++.++ ...+..
T Consensus 110 -~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~ 188 (344)
T PLN02236 110 -RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINL 188 (344)
T ss_pred -eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHH
Confidence 5899998876631 111 110 01 01122232332111 111112
Q ss_pred H----H----hCCCeeecCCCCCeEecc-CCcEEEcccCCCc
Q 011302 207 L----H----MMGIVYRDLKPENVLVRE-DGHIMLSDFDLSF 239 (489)
Q Consensus 207 L----H----~~~iiHrDIKp~NILl~~-~~~vkl~DFG~a~ 239 (489)
| . ...++|+|+++.|||+++ ++.+.|+||..|.
T Consensus 189 L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 189 LEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 2 2 225899999999999986 5789999999884
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0066 Score=58.81 Aligned_cols=29 Identities=31% Similarity=0.434 Sum_probs=24.8
Q ss_pred CCeeecCCCCCeEeccCCc-EEEcccCCCc
Q 011302 211 GIVYRDLKPENVLVREDGH-IMLSDFDLSF 239 (489)
Q Consensus 211 ~iiHrDIKp~NILl~~~~~-vkl~DFG~a~ 239 (489)
.+||+|+.|.|||++.++. +-|+||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 3899999999999997565 5699999974
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.00098 Score=67.92 Aligned_cols=88 Identities=19% Similarity=0.215 Sum_probs=58.4
Q ss_pred CcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCC---CCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 348 SAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLT---FPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 348 ~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
+|+|||++|.++.|+..|...+......+....|.+-... .........-.+..+....+++.+|+-..|..||...
T Consensus 110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~ 189 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPM 189 (725)
T ss_pred cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchh
Confidence 3999999999999999999988777666665555432111 0000000011123334567899999999999999765
Q ss_pred CChHHHHcCCCcCCC
Q 011302 425 KGSVEIKRHEFFKGI 439 (489)
Q Consensus 425 ~~~~~ll~hp~f~~~ 439 (489)
++.+|+-|..+
T Consensus 190 ----~~~k~~i~~ev 200 (725)
T KOG1093|consen 190 ----ELSKRCSFTEV 200 (725)
T ss_pred ----HHhcCccHHHH
Confidence 77788777543
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.01 Score=58.40 Aligned_cols=28 Identities=25% Similarity=0.538 Sum_probs=25.1
Q ss_pred CCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 210 MGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 210 ~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
.++||+|+.+.|||++. +.+.|+||+.+
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence 47899999999999987 67899999975
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.011 Score=58.33 Aligned_cols=138 Identities=24% Similarity=0.262 Sum_probs=88.8
Q ss_pred eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHH----------------------HH-HHHHHHHHHHHHHhC
Q 011302 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAI----------------------RK-KLHRADMEKVILTML 146 (489)
Q Consensus 90 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~----------------------~~-~~~~~~~E~~~l~~l 146 (489)
..|..|--+.||.|...+ +..+|||+++...+.- +. ..--+..|.+-|.++
T Consensus 150 GCiSTGKEANVYHat~~d------G~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl 223 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEED------GSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRL 223 (520)
T ss_pred cccccCccceeEeeecCC------CceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHH
Confidence 456667777899987664 5679999985321110 00 111234466667776
Q ss_pred CCCCcccccceeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHH-hCCCeeecCCCCCeEec
Q 011302 147 DHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLH-MMGIVYRDLKPENVLVR 225 (489)
Q Consensus 147 ~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH-~~~iiHrDIKp~NILl~ 225 (489)
+.-.|..---... ..-.|||+|+. .+=+..-.. ....++...+..+-.|++.-|.-|- ..++||.||.-=|+|+-
T Consensus 224 ~~aGIP~PePIlL--k~hVLVM~FlG-rdgw~aPkL-Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 224 NNAGIPCPEPILL--KNHVLVMEFLG-RDGWAAPKL-KDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH 299 (520)
T ss_pred HhcCCCCCCceee--ecceEeeeecc-CCCCcCccc-ccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE
Confidence 6544331111111 22469999994 433221111 1245778888888889998888875 56999999999999986
Q ss_pred cCCcEEEcccCCC
Q 011302 226 EDGHIMLSDFDLS 238 (489)
Q Consensus 226 ~~~~vkl~DFG~a 238 (489)
+|.+.|+|.+-+
T Consensus 300 -dG~lyiIDVSQS 311 (520)
T KOG2270|consen 300 -DGKLYIIDVSQS 311 (520)
T ss_pred -CCEEEEEEcccc
Confidence 789999999875
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.0035 Score=61.49 Aligned_cols=72 Identities=22% Similarity=0.268 Sum_probs=57.4
Q ss_pred cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhC-CCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 160 ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMM-GIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 160 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
...+.|++|++- |+.|.-+ ..-..+++..++++++.-++-+..+ ..=|||+.-.||||+ +|+|.|+||-++
T Consensus 297 e~~y~yl~~kdh-gt~is~i------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISII------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred CceEEEEEEecC-Cceeeee------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeee
Confidence 344678889987 7777422 2244678888999988887777754 689999999999999 999999999998
Q ss_pred c
Q 011302 239 F 239 (489)
Q Consensus 239 ~ 239 (489)
+
T Consensus 369 R 369 (488)
T COG5072 369 R 369 (488)
T ss_pred e
Confidence 6
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.014 Score=58.19 Aligned_cols=76 Identities=18% Similarity=0.224 Sum_probs=47.4
Q ss_pred eeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHH----HHHHHHHHHHHHHHHhCC--CC-CcccccceeecCce
Q 011302 91 RLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAI----RKKLHRADMEKVILTMLD--HP-FLPTLYAEFEASHY 163 (489)
Q Consensus 91 ~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~~E~~~l~~l~--hp-nIv~l~~~~~~~~~ 163 (489)
.||.|...-||++...+ ..+.+.||.-..-.... .-...+...|...|+... -| .++++|. .+.+.
T Consensus 2 EigdGnlN~VfrV~~~~-----g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~ 74 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQE-----GDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEM 74 (370)
T ss_pred cCCCCceEEEEEEEcCC-----CCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--Ecccc
Confidence 57999999999999643 12467888754322111 112345556888887664 34 4555553 45556
Q ss_pred EEEEEeecCC
Q 011302 164 SCLVMEYCPG 173 (489)
Q Consensus 164 ~~lV~E~~~g 173 (489)
..+|||+++.
T Consensus 75 ~~~vMEdL~~ 84 (370)
T TIGR01767 75 AVTVMEDLSH 84 (370)
T ss_pred ceehHhhCcc
Confidence 6799999955
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.016 Score=58.66 Aligned_cols=77 Identities=18% Similarity=0.225 Sum_probs=49.1
Q ss_pred eeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHH----HHHHHHHHHHHHHHhCC---CCCcccccceeec
Q 011302 88 LLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIR----KKLHRADMEKVILTMLD---HPFLPTLYAEFEA 160 (489)
Q Consensus 88 ~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~ 160 (489)
..+.||.|.-..||+....+ ..|.||.-........ -...+...|...|+.+. ..+|.+++.++.
T Consensus 36 ~~~eiggGn~N~VyrV~~~~-------~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de- 107 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSSS-------GSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR- 107 (418)
T ss_pred eEEEcCCCceeeEEEEEcCC-------ccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC-
Confidence 47789999999999987632 3477887542111000 12334444666666553 247888888776
Q ss_pred CceEEEEEeecCC
Q 011302 161 SHYSCLVMEYCPG 173 (489)
Q Consensus 161 ~~~~~lV~E~~~g 173 (489)
+..++||||+++
T Consensus 108 -d~~vlvME~L~~ 119 (418)
T PLN02756 108 -TMALIGMRYLEP 119 (418)
T ss_pred -CCCEEEEeecCC
Confidence 446789999976
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.014 Score=58.11 Aligned_cols=144 Identities=11% Similarity=0.152 Sum_probs=79.3
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCc-ccccceeecCc
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFL-PTLYAEFEASH 162 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~ 162 (489)
+.+.+. .|..|-.-.+|++...+... ....|.+|+...... ..-....|..+++.+..-++ .++++++..+
T Consensus 15 ~~i~i~-~l~gGlTN~~~~v~~~~~~~--~~~~~v~Ri~g~~t~----~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G- 86 (330)
T PLN02421 15 SDFSVE-RISGGITNLLLKVSVKEENG--NEVSVTVRLFGPNTD----YVIDRERELQAIKYLSAAGFGAKLLGVFGNG- 86 (330)
T ss_pred CceEEE-EeCCcccceEEEEEecCCCC--CCceEEEEEecCCcC----eEechHHHHHHHHHHHhcCCCCceeEEeCCc-
Confidence 344544 45457778899987654211 123678888754321 11223448888888764444 4566655432
Q ss_pred eEEEEEeecCCCchHH--------------HHHhCCCCC------C-ChhhHHHHHHHH---------------------
Q 011302 163 YSCLVMEYCPGGDLYA--------------ARQRQPGKR------F-GISSAKFYAAET--------------------- 200 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~--------------~l~~~~~~~------l-~~~~~~~i~~qi--------------------- 200 (489)
+|.+|++|..|.. .+++-.... + -+..+..+..++
T Consensus 87 ---~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (330)
T PLN02421 87 ---MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEE 163 (330)
T ss_pred ---EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHH
Confidence 5899998766521 111110011 1 122222222221
Q ss_pred -HHHHHH---HH-hCC----CeeecCCCCCeEecc-CCcEEEcccCCC
Q 011302 201 -LLALEY---LH-MMG----IVYRDLKPENVLVRE-DGHIMLSDFDLS 238 (489)
Q Consensus 201 -~~~L~y---LH-~~~----iiHrDIKp~NILl~~-~~~vkl~DFG~a 238 (489)
..-+.. +. ..+ ++|.|+-+.|||+++ ++.++++||..|
T Consensus 164 l~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYa 211 (330)
T PLN02421 164 LRDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYG 211 (330)
T ss_pred HHHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEccccc
Confidence 111222 22 222 799999999999975 578999999987
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.28 E-value=0.0073 Score=55.96 Aligned_cols=29 Identities=34% Similarity=0.615 Sum_probs=21.0
Q ss_pred CCeeecCCCCCeEe-ccCCcEEEcccCCCc
Q 011302 211 GIVYRDLKPENVLV-REDGHIMLSDFDLSF 239 (489)
Q Consensus 211 ~iiHrDIKp~NILl-~~~~~vkl~DFG~a~ 239 (489)
.++|.||.+.|||+ +.++.++|+||..|.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 48999999999999 889999999999873
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.03 E-value=0.029 Score=56.62 Aligned_cols=79 Identities=20% Similarity=0.316 Sum_probs=50.1
Q ss_pred eeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHH---HHHHHHHHHHHHHHHhCC--CC-CcccccceeecC
Q 011302 88 LLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAI---RKKLHRADMEKVILTMLD--HP-FLPTLYAEFEAS 161 (489)
Q Consensus 88 ~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~E~~~l~~l~--hp-nIv~l~~~~~~~ 161 (489)
.++.||.|.-.-||++.+.. .++.+.||.-..-.... .-...+...|..+|+.+. .| +++++|. .+.
T Consensus 33 ~~~eigdGnlN~VfrV~~~~-----~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~ 105 (409)
T PRK12396 33 QCKEIGDGNLNYVFRVWDEQ-----KNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDS 105 (409)
T ss_pred eeeEcCCCceEEEEEEeeCC-----CCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECc
Confidence 37789999999999998742 12456777643221110 112455566888887764 34 4556653 455
Q ss_pred ceEEEEEeecCC
Q 011302 162 HYSCLVMEYCPG 173 (489)
Q Consensus 162 ~~~~lV~E~~~g 173 (489)
+...+|||+++.
T Consensus 106 e~~~~vMEdL~~ 117 (409)
T PRK12396 106 VMNCCVMEDLSD 117 (409)
T ss_pred HHhhHHHHhCcc
Confidence 666799999865
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.81 E-value=0.083 Score=52.06 Aligned_cols=29 Identities=17% Similarity=0.127 Sum_probs=26.9
Q ss_pred CCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 211 GIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 211 ~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
++||+|+.+.|+|++.++.+.|+||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 69999999999999999999999999873
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.70 E-value=0.036 Score=56.26 Aligned_cols=84 Identities=15% Similarity=0.292 Sum_probs=47.1
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCC-CCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCC-CcccccceeecC
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMV-GLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHP-FLPTLYAEFEAS 161 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-nIv~l~~~~~~~ 161 (489)
++.. ++.|..|-...+|++...+... ....+.|.+.+.... ....-...+|..+++.+... .-.++++.+..
T Consensus 51 ~~i~-i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~----~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~- 124 (383)
T PTZ00384 51 EFIE-IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY----NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD- 124 (383)
T ss_pred ccEE-EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCC----CceEeccHHHHHHHHHHHhCCCCCeEEEecCC-
Confidence 3444 4466668889999997543210 011122333332111 11111224488888888644 44566776653
Q ss_pred ceEEEEEeecCCCch
Q 011302 162 HYSCLVMEYCPGGDL 176 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L 176 (489)
++|.||++|-.|
T Consensus 125 ---g~l~efIeGr~l 136 (383)
T PTZ00384 125 ---FTIQEWVEGNTM 136 (383)
T ss_pred ---EEEEEEeccccC
Confidence 599999998776
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.15 E-value=0.14 Score=50.26 Aligned_cols=31 Identities=19% Similarity=0.303 Sum_probs=27.8
Q ss_pred CCeeecCCCCCeEeccCCcEEEcccCCCccc
Q 011302 211 GIVYRDLKPENVLVREDGHIMLSDFDLSFKC 241 (489)
Q Consensus 211 ~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~ 241 (489)
.++|+|+.+.||+++.++-+-++||+++..-
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 3899999999999999988999999998543
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=94.95 E-value=0.045 Score=53.20 Aligned_cols=76 Identities=21% Similarity=0.192 Sum_probs=45.6
Q ss_pred ceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC---CCCcccccceeecCc
Q 011302 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD---HPFLPTLYAEFEASH 162 (489)
Q Consensus 86 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~ 162 (489)
.+-.+.|+.|....+|+... .++.|.+|+-.... ...+..|..-|+.|. --.|++.+++....+
T Consensus 19 i~~~~~v~GG~i~~a~~~~~-------~~~~~FvK~~~~~~------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~ 85 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLDT-------DGGSYFVKVNSESG------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDD 85 (288)
T ss_dssp --EEEEE--SSSSEEEEEET-------TS-EEEEEEEEGGG------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SS
T ss_pred eeeeEecCCCChhheEEEEC-------CCccEEEEecChhh------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecC
Confidence 44567789999999999872 35678899876321 233455777777773 345778888887777
Q ss_pred eEEEEEeecCCC
Q 011302 163 YSCLVMEYCPGG 174 (489)
Q Consensus 163 ~~~lV~E~~~gg 174 (489)
.-||||||++.+
T Consensus 86 ~~fLlle~l~~~ 97 (288)
T PF03881_consen 86 DAFLLLEFLEMG 97 (288)
T ss_dssp CCEEEEE-----
T ss_pred CceEEEEeecCC
Confidence 779999999776
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.88 E-value=0.33 Score=55.79 Aligned_cols=30 Identities=30% Similarity=0.409 Sum_probs=25.6
Q ss_pred CCCeeecCCCCCeEeccCC--cEE-EcccCCCc
Q 011302 210 MGIVYRDLKPENVLVREDG--HIM-LSDFDLSF 239 (489)
Q Consensus 210 ~~iiHrDIKp~NILl~~~~--~vk-l~DFG~a~ 239 (489)
.++||.|+.+.|||++.++ .+. |+|||.+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 4799999999999999775 555 99999864
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.86 E-value=0.26 Score=51.05 Aligned_cols=86 Identities=13% Similarity=0.153 Sum_probs=50.2
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCC---CCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCc-ccccce
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMV---GLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFL-PTLYAE 157 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~---~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~ 157 (489)
..++. -++.|..|-.-.+|++...+... ...++.|.+++....... +-....|..+++.+..-+| .++++.
T Consensus 104 ~~~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~----lIdR~~E~~v~~~ls~~gi~P~l~~~ 178 (442)
T PTZ00296 104 TEDDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDE----LYNPISEFEVYKTMSKYRIAPQLLNT 178 (442)
T ss_pred CcccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccc----eeCHHHHHHHHHHHHHCCCCCceEEE
Confidence 34455 56777778888899997653211 112457888887543211 1122347777776654343 355565
Q ss_pred eecCceEEEEEeecCCCch
Q 011302 158 FEASHYSCLVMEYCPGGDL 176 (489)
Q Consensus 158 ~~~~~~~~lV~E~~~gg~L 176 (489)
+.. +.|.||++|-.|
T Consensus 179 f~g----g~I~efi~g~~l 193 (442)
T PTZ00296 179 FSG----GRIEEWLYGDPL 193 (442)
T ss_pred eCC----CEEEEeeCCccC
Confidence 542 468999988744
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.32 E-value=0.13 Score=47.41 Aligned_cols=82 Identities=13% Similarity=0.122 Sum_probs=55.1
Q ss_pred HHHHHHHHhCCCCCcccccceeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHh--CCCee
Q 011302 137 DMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHM--MGIVY 214 (489)
Q Consensus 137 ~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~--~~iiH 214 (489)
..+.+++.+++ .|++|.. .++-.+-+++|+|-.... .. .- ++.-=+.+|.-.|+ .+.+|
T Consensus 106 ~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~~i-----------~~---~N-~i~agi~~L~~fH~~~~~~lH 166 (308)
T PF07387_consen 106 FNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKIKI-----------NF---SN-FITAGIKDLMDFHSENQHCLH 166 (308)
T ss_pred hhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCccc-----------ch---hH-HHHHhHHHHHHhhccCCCeec
Confidence 34566666654 5777773 244456789999932211 11 11 11222466777884 47999
Q ss_pred ecCCCCCeEeccCCcEEEcccCC
Q 011302 215 RDLKPENVLVREDGHIMLSDFDL 237 (489)
Q Consensus 215 rDIKp~NILl~~~~~vkl~DFG~ 237 (489)
+|-.|+|||.|..|.+||.|=+.
T Consensus 167 GD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 167 GDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred CCCChhheeecCCCCEEecChhh
Confidence 99999999999999999999875
|
The function of this family is unknown. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=93.97 E-value=1.2 Score=41.53 Aligned_cols=79 Identities=25% Similarity=0.295 Sum_probs=50.4
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC---CCCCcccccceeecC
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML---DHPFLPTLYAEFEAS 161 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~~ 161 (489)
+.+..+.+.-|.--+.|...+- ...|-+|+-.++.. ..+..|+.-|..+ +--.|.+.+.+-.+.
T Consensus 17 ~i~er~~v~gG~inea~~v~dg-------~~~~FvK~n~~~~~------~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~ 83 (286)
T COG3001 17 EIKEREEVSGGDINEAWRLRDG-------TDPFFVKCNQREQL------SMFTAEADGLELLARSNTITVPKVIAVGASR 83 (286)
T ss_pred hhhcccccCCccccceeEeecC-------CcceEEEecchhhH------HHHHHHHHHHHHHHhcCCccccceEEecCCC
Confidence 3344445555554555555443 35677887665433 3344466555544 445678888888899
Q ss_pred ceEEEEEeecCCCch
Q 011302 162 HYSCLVMEYCPGGDL 176 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L 176 (489)
.+.||||||++-|.+
T Consensus 84 ~~sylVle~L~~~~~ 98 (286)
T COG3001 84 DHSYLVLEYLPTGPL 98 (286)
T ss_pred CeeEEEEeeccCCCC
Confidence 999999999987655
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=93.56 E-value=0.018 Score=58.77 Aligned_cols=96 Identities=20% Similarity=0.238 Sum_probs=66.3
Q ss_pred cCCCCCCccHHHHHHHHHHHhhcCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHH
Q 011302 56 NSHKPHKANQAAWEAMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHR 135 (489)
Q Consensus 56 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~ 135 (489)
....+..++...+...++.. .....++|..+..+|.|+||+|+.+.... ....||||.+...... ....+
T Consensus 24 ~~e~s~~~~~~~~~~~~~~~---~sr~a~~~e~~~~~~~~g~~~~~~~~n~~-----d~~~~avkritlkn~e--~s~~r 93 (516)
T KOG1033|consen 24 AREDSFPANKSKVRHNKRVI---TSREANDFEPGQCLGRGGFGVVFSAQNKA-----DENKYAVKRITLKNRE--ESRSR 93 (516)
T ss_pred cccccccccccchhhhhhhh---hhhhhccccccccccccCccccCCccccc-----cchhhHHHHhcccchh--hhhhh
Confidence 33444444444444444332 22345789999999999999999998775 4567899988643222 33445
Q ss_pred HHHHHHHHHhCCCCCcccccceeecC
Q 011302 136 ADMEKVILTMLDHPFLPTLYAEFEAS 161 (489)
Q Consensus 136 ~~~E~~~l~~l~hpnIv~l~~~~~~~ 161 (489)
..+|+.-+..+.|++|++++..|...
T Consensus 94 vl~~~~s~a~feh~g~~~~~ha~~~~ 119 (516)
T KOG1033|consen 94 VLREVSSLAEFEHPGIKRYFHAWYER 119 (516)
T ss_pred hhccccchhhhcccchhhheeceecC
Confidence 66788889999999999998877543
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.35 E-value=0.18 Score=50.70 Aligned_cols=62 Identities=26% Similarity=0.160 Sum_probs=45.1
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHH-hCCCeeecCCCCCeEeccC
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLH-MMGIVYRDLKPENVLVRED 227 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH-~~~iiHrDIKp~NILl~~~ 227 (489)
...||-+|..|.++..++... ..+++..+.++.-.+.||--|- -.+++|.|+.|.||++..+
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~---~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWK---SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred cceeeeeccccccHHhhhhcc---cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 346788899999998887653 3455566666666666654443 5689999999999999744
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 489 | ||||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-23 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-23 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-22 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-22 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-22 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-22 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-21 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-21 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-19 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-21 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-21 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-20 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-20 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-20 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-20 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-20 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-20 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-20 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-20 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-20 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-19 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-19 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-19 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-19 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-19 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-19 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-19 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-19 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-17 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-19 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-17 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-19 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-16 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-19 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-17 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-19 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-17 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-19 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-19 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-16 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-19 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-17 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-19 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-17 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-19 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-17 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-19 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-17 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-19 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-17 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-19 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 9e-17 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-19 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-17 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-19 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-17 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-19 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-16 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-19 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-17 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-19 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-17 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-19 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-17 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-19 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 9e-17 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-19 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-17 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-19 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 9e-17 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-19 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-17 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-19 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-17 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-19 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-16 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-19 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-17 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-19 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-16 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-19 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-17 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-19 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-17 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 9e-19 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 8e-17 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-18 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-17 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-18 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 8e-17 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-18 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 8e-17 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-18 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-16 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-18 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-17 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-18 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-17 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-18 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-17 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-18 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-16 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-18 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-16 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-18 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 9e-16 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-18 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-17 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-18 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-17 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-18 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-17 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-18 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-17 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-18 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-16 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-18 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-16 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-18 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-16 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-18 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-17 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-18 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-17 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-18 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-17 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-18 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-17 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 9e-18 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 9e-18 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-17 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 9e-18 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-17 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-17 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-17 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-17 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-17 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-17 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-16 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-16 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-16 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 7e-16 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-14 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-14 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-14 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-14 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 7e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-04 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-12 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-06 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-06 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-07 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-07 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-04 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 8e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-06 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-09 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-06 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-06 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 8e-07 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 8e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 7e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-05 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-08 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-08 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-07 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-05 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 8e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 8e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 8e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 8e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 8e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 9e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 9e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 9e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-07 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-06 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-07 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-07 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-07 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-06 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-06 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 7e-07 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-06 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-06 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-05 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-06 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-06 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-06 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-06 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-06 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 7e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-06 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 8e-06 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-05 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-05 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-05 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-05 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-05 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-05 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-05 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-05 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-05 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-05 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-05 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-05 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-04 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-05 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-05 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-04 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-05 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-05 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-05 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-04 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 8e-05 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-05 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-04 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-04 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-04 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-04 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-04 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-04 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 1e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-04 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-04 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-04 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-04 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-04 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-04 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-04 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-04 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-04 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-04 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-04 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-04 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-04 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-04 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-04 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-04 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-04 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-04 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-04 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-04 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-04 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 8e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-04 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 9e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-04 |
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-50
Identities = 49/161 (30%), Positives = 80/161 (49%), Gaps = 7/161 (4%)
Query: 78 QGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRAD 137
+ + F+ + LG G V L + YA+K++++ + K+
Sbjct: 24 PRKKRPEDFKFGKILGEGSFSTVVLARELAT-----SREYAIKILEKRHIIKENKVPYVT 78
Query: 138 MEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYA 197
E+ +++ LDHPF LY F+ + Y G+L ++ F + +FY
Sbjct: 79 RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYT 136
Query: 198 AETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
AE + ALEYLH GI++RDLKPEN+L+ ED HI ++DF +
Sbjct: 137 AEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA 177
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 9e-50
Identities = 42/140 (30%), Positives = 71/140 (50%), Gaps = 11/140 (7%)
Query: 316 EVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNE 375
+ E AR+ SFVGT +Y++PE+++ + + D W LG +Y+++ G PF+ N
Sbjct: 179 VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY 238
Query: 376 KTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGS--LKGSVEIKRH 433
I+K FP +F + DL+ KLLV + KR+G ++G +K H
Sbjct: 239 LIFQKIIKLEYDFPE-------KFFPKAR--DLVEKLLVLDATKRLGCEEMEGYGPLKAH 289
Query: 434 EFFKGINWALIRSIKPPEVP 453
FF+ + W + PP++
Sbjct: 290 PFFESVTWENLHQQTPPKLT 309
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 1e-49
Identities = 50/182 (27%), Positives = 90/182 (49%), Gaps = 8/182 (4%)
Query: 61 HKANQAAWEAMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMK 120
+ N + + R+ + + +++ +G G G V L + ++ + YAMK
Sbjct: 46 NIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKST-----RKVYAMK 100
Query: 121 VVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAAR 180
++ + + R E+ I+ + P++ L+ F+ Y +VMEY PGGDL
Sbjct: 101 LLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM 160
Query: 181 QRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240
A+FY AE +LAL+ +H MG ++RD+KP+N+L+ + GH+ L+DF K
Sbjct: 161 SNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 217
Query: 241 CD 242
+
Sbjct: 218 MN 219
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 4e-43
Identities = 56/140 (40%), Positives = 74/140 (52%), Gaps = 17/140 (12%)
Query: 323 NARSKSFVGTHEYLAPEVISGQG----HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTL 378
R + VGT +Y++PEV+ QG +G DWW++GVFLYEML G TPF ++ T
Sbjct: 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY 282
Query: 379 INIL--KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436
I+ K LTFP SKE ++LI L + + R+G G EIKRH FF
Sbjct: 283 SKIMNHKNSLTFPD-DNDISKE------AKNLICAFL-TDREVRLGR-NGVEEIKRHLFF 333
Query: 437 KGINWA--LIRSIKPPEVPN 454
K WA +R P VP+
Sbjct: 334 KNDQWAWETLRDTVAPVVPD 353
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-49
Identities = 53/182 (29%), Positives = 95/182 (52%), Gaps = 6/182 (3%)
Query: 57 SHKPHKANQAAWEAMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCF 116
+ + A+ W +R + R+ D F +L+ +G G V + +++
Sbjct: 34 AQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQT-----GQV 88
Query: 117 YAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDL 176
YAMK++++ + R ++ E+ +L D ++ L+ F+ +Y LVMEY GGDL
Sbjct: 89 YAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDL 148
Query: 177 YAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFD 236
+ G+R A+FY AE ++A++ +H +G V+RD+KP+N+L+ GHI L+DF
Sbjct: 149 LTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFG 207
Query: 237 LS 238
Sbjct: 208 SC 209
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 1e-44
Identities = 49/141 (34%), Positives = 73/141 (51%), Gaps = 17/141 (12%)
Query: 323 NARSKSFVGTHEYLAPEVISGQG-------HGSAVDWWTLGVFLYEMLYGTTPFKGENNE 375
RS VGT +YL+PE++ G +G DWW LGVF YEM YG TPF ++
Sbjct: 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA 276
Query: 376 KTLINIL--KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433
+T I+ K+ L+ P + +E +D I +LL P+ R+G G+ + + H
Sbjct: 277 ETYGKIVHYKEHLSLPLVDEGVPEEA------RDFIQRLL-CPPETRLGR-GGAGDFRTH 328
Query: 434 EFFKGINWALIRSIKPPEVPN 454
FF G++W +R PP P+
Sbjct: 329 PFFFGLDWDGLRDSVPPFTPD 349
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 4e-48
Identities = 50/171 (29%), Positives = 87/171 (50%), Gaps = 33/171 (19%)
Query: 322 INARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINI 381
+ + + GT +Y+APEV+S + + ++DWW+ G+ +YEML G TPF N KT I
Sbjct: 156 VPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI 215
Query: 382 LKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLK-GSVEIKRHEFFKGIN 440
L L FP + ++DL+S+L+ ++ +R+G+L+ G+ ++K H +FK +
Sbjct: 216 LNAELRFPP-FFNED--------VKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 266
Query: 441 WALI--RSIKPPEVPNNDLYCKIKKKVYVPKLSKQERDAPYQIPTHHFDYF 489
W + R+I+ P Y P + + + D T FD +
Sbjct: 267 WEKLLSRNIETP---------------YEPPIQQGQGD------TSQFDKY 296
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 5e-47
Identities = 60/159 (37%), Positives = 102/159 (64%), Gaps = 7/159 (4%)
Query: 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADME 139
+ L F++LR LG+G G V+L + R+ +YAMKV+ +E + K++ + E
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHN-----GRYYAMKVLKKEIVVRLKQVEHTNDE 56
Query: 140 KVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAE 199
+++L+++ HPF+ ++ F+ + ++M+Y GG+L++ ++ +RF AKFYAAE
Sbjct: 57 RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAE 114
Query: 200 TLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
LALEYLH I+YRDLKPEN+L+ ++GHI ++DF +
Sbjct: 115 VCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFA 153
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 4e-48
Identities = 55/135 (40%), Positives = 78/135 (57%), Gaps = 12/135 (8%)
Query: 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINIL 382
++ SF GT EY+APEV++ +GH + DWW+ GV ++EML GT PF+G++ ++T+ IL
Sbjct: 180 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL 239
Query: 383 KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGS-LKGSVEIKRHEFFKGINW 441
K L P+ S E Q L+ L +NP R+G+ G EIKRH FF I+W
Sbjct: 240 KAKLGMPQ---FLSPE------AQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDW 290
Query: 442 ALI--RSIKPPEVPN 454
+ R I PP P
Sbjct: 291 NKLYRREIHPPFKPA 305
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 166 bits (424), Expect = 8e-48
Identities = 61/164 (37%), Positives = 93/164 (56%), Gaps = 5/164 (3%)
Query: 75 RRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLH 134
+ + F LL+ LG G G V+L + + YAMKV+ + L +R ++
Sbjct: 15 KEGHEKADPSQFELLKVLGQGSFGKVFLV--KKISGSDARQLYAMKVLKKATLKVRDRVR 72
Query: 135 RADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAK 194
ME+ IL ++HPF+ L+ F+ L++++ GGDL+ ++ F K
Sbjct: 73 -TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVK 129
Query: 195 FYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
FY AE LAL++LH +GI+YRDLKPEN+L+ E+GHI L+DF LS
Sbjct: 130 FYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS 173
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 1e-47
Identities = 55/134 (41%), Positives = 71/134 (52%), Gaps = 11/134 (8%)
Query: 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINIL 382
N+ + +F GT EYLAPEV+ Q + VDWW LG LYEMLYG PF N + NIL
Sbjct: 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 252
Query: 383 KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWA 442
KPL + + + L+ LL K+ KR+G+ +EIK H FF INW
Sbjct: 253 NKPLQLKP---NITNS------ARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWD 303
Query: 443 LI--RSIKPPEVPN 454
+ + I PP PN
Sbjct: 304 DLINKKITPPFNPN 317
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-44
Identities = 59/163 (36%), Positives = 90/163 (55%), Gaps = 8/163 (4%)
Query: 77 AQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRA 136
+ F L+ +G G G V L + + + FYA+KV+ ++A+ +K+
Sbjct: 31 SNPHAKPSDFHFLKVIGKGSFGKVLLARHKAE-----EVFYAVKVLQKKAILKKKEEKHI 85
Query: 137 DMEKVILTM-LDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKF 195
E+ +L + HPFL L+ F+ + V++Y GG+L+ QR+ + F A+F
Sbjct: 86 MSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARF 143
Query: 196 YAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
YAAE AL YLH + IVYRDLKPEN+L+ GHI+L+DF L
Sbjct: 144 YAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLC 186
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-47
Identities = 53/135 (39%), Positives = 77/135 (57%), Gaps = 12/135 (8%)
Query: 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINIL 382
+ +F GT EY+APE++ GH AVDWW+LG +Y+ML G PF GEN +KT+ IL
Sbjct: 175 GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL 234
Query: 383 KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGS-LKGSVEIKRHEFFKGINW 441
K L P ++E +DL+ KLL +N R+G+ + E++ H FF+ INW
Sbjct: 235 KCKLNLPP---YLTQE------ARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINW 285
Query: 442 ALI--RSIKPPEVPN 454
+ R ++PP P
Sbjct: 286 EELLARKVEPPFKPL 300
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 161 bits (411), Expect = 7e-46
Identities = 57/166 (34%), Positives = 85/166 (51%), Gaps = 5/166 (3%)
Query: 74 LRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKK- 132
+ R ++ + F LLR LG G G V+ R +AMKV+ + + K
Sbjct: 7 VNRGPEKIRPECFELLRVLGKGGYGKVFQV--RKVTGANTGKIFAMKVLKKAMIVRNAKD 64
Query: 133 LHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISS 192
E+ IL + HPF+ L F+ L++EY GG+L+ +R+ F +
Sbjct: 65 TAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLERE--GIFMEDT 122
Query: 193 AKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
A FY AE +AL +LH GI+YRDLKPEN+++ GH+ L+DF L
Sbjct: 123 ACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC 168
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-47
Identities = 64/194 (32%), Positives = 104/194 (53%), Gaps = 7/194 (3%)
Query: 45 SSSAADQTSLYNSHKPHKANQAAWEAMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQ 104
+++AA + S S K A K +Q LD F ++ LG+G G V L +
Sbjct: 2 NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61
Query: 105 IRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYS 164
+ YAMK++D++ + K++ EK IL ++ PFL L F+ +
Sbjct: 62 HKES-----GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116
Query: 165 CLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLV 224
+VMEY GG++++ +R RF A+FYAA+ +L EYLH + ++YRDLKPEN+L+
Sbjct: 117 YMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI 174
Query: 225 REDGHIMLSDFDLS 238
+ G+I ++DF +
Sbjct: 175 DQQGYIQVTDFGFA 188
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 3e-46
Identities = 50/139 (35%), Positives = 73/139 (52%), Gaps = 12/139 (8%)
Query: 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTL 378
A+ + R+ + GT E LAPE+I +G+ AVDWW LGV +YEM G PF + +
Sbjct: 188 AKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 379 INILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLK-GSVEIKRHEFFK 437
I+ + FP SS L+DL+ LL + KR G+LK G +IK H++F
Sbjct: 248 EKIVSGKVRFPS-HFSSD--------LKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298
Query: 438 GINWALI--RSIKPPEVPN 454
+W I R ++ P +P
Sbjct: 299 TTDWIAIYQRKVEAPFIPK 317
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-46
Identities = 50/161 (31%), Positives = 86/161 (53%), Gaps = 7/161 (4%)
Query: 78 QGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRAD 137
V DHF +LR +G G G V + Q + + YAMK ++++ R ++
Sbjct: 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDT-----KKMYAMKYMNKQKCVERNEVRNVF 63
Query: 138 MEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYA 197
E I+ L+HPFL L+ F+ +V++ GGDL Q+ F + K +
Sbjct: 64 KELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFI 121
Query: 198 AETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
E ++AL+YL I++RD+KP+N+L+ E GH+ ++DF+++
Sbjct: 122 CELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIA 162
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-41
Identities = 39/142 (27%), Positives = 65/142 (45%), Gaps = 20/142 (14%)
Query: 323 NARSKSFVGTHEYLAPEVIS---GQGHGSAVDWWTLGVFLYEMLYGTTPFKG---ENNEK 376
+ + GT Y+APE+ S G G+ AVDWW+LGV YE+L G P+ ++++
Sbjct: 168 ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKE 227
Query: 377 TLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436
+ +T+P S + L+ KLL NP +R L +++ +
Sbjct: 228 IVHTFETTVVTYPS-AWSQE--------MVSLLKKLLEPNPDQRFSQLS---DVQNFPYM 275
Query: 437 KGINWALI--RSIKPPEVPNND 456
INW + + + P +PN
Sbjct: 276 NDINWDAVFQKRLIPGFIPNKG 297
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-46
Identities = 57/159 (35%), Positives = 87/159 (54%), Gaps = 7/159 (4%)
Query: 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADME 139
+V ++ F L+ LG G G V L + + +YAMK++ +E + + ++ E
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKAT-----GRYYAMKILRKEVIIAKDEVAHTVTE 55
Query: 140 KVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAE 199
+L HPFL L F+ C VMEY GG+L+ R+ + F A+FY AE
Sbjct: 56 SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAE 113
Query: 200 TLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ ALEYLH +VYRD+K EN+++ +DGHI ++DF L
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC 152
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 3e-45
Identities = 53/135 (39%), Positives = 76/135 (56%), Gaps = 12/135 (8%)
Query: 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINIL 382
A K+F GT EYLAPEV+ +G AVDWW LGV +YEM+ G PF +++E+ IL
Sbjct: 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL 218
Query: 383 KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGS-LKGSVEIKRHEFFKGINW 441
+ + FPR + S E + L++ LL K+PK+R+G + E+ H FF INW
Sbjct: 219 MEEIRFPR---TLSPE------AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269
Query: 442 ALI--RSIKPPEVPN 454
+ + + PP P
Sbjct: 270 QDVVQKKLLPPFKPQ 284
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 3e-46
Identities = 48/161 (29%), Positives = 87/161 (54%), Gaps = 6/161 (3%)
Query: 78 QGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRAD 137
Q R+ + F +L+ +G G G V + +++N +AMK++++ + R +
Sbjct: 68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNA-----DKVFAMKILNKWEMLKRAETACFR 122
Query: 138 MEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYA 197
E+ +L D ++ TL+ F+ + LVM+Y GGDL + R A+FY
Sbjct: 123 EERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFED-RLPEEMARFYL 181
Query: 198 AETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
AE ++A++ +H + V+RD+KP+N+L+ +GHI L+DF
Sbjct: 182 AEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSC 222
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 4e-43
Identities = 48/139 (34%), Positives = 74/139 (53%), Gaps = 15/139 (10%)
Query: 323 NARSKSFVGTHEYLAPEVISGQ-----GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKT 377
+S VGT +Y++PE++ +G DWW+LGV +YEMLYG TPF E+ +T
Sbjct: 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET 289
Query: 378 LINIL--KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEF 435
I+ K+ FP S+ +DLI +L+ + + R+G G + K+H F
Sbjct: 290 YGKIMNHKERFQFPTQVTDVSEN------AKDLIRRLI-CSREHRLGQ-NGIEDFKKHPF 341
Query: 436 FKGINWALIRSIKPPEVPN 454
F GI+W IR+ + P +P
Sbjct: 342 FSGIDWDNIRNCEAPYIPE 360
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-45
Identities = 62/163 (38%), Positives = 88/163 (53%), Gaps = 8/163 (4%)
Query: 77 AQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRA 136
A +GL F LLR +G G V L +++ YAMKVV +E + + +
Sbjct: 2 AMDPLGLQDFDLLRVIGRGSYAKVLLVRLKKT-----DRIYAMKVVKKELVNDDEDIDWV 56
Query: 137 DMEKVILTM-LDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKF 195
EK + +HPFL L++ F+ V+EY GGDL QRQ ++ A+F
Sbjct: 57 QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARF 114
Query: 196 YAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
Y+AE LAL YLH GI+YRDLK +NVL+ +GHI L+D+ +
Sbjct: 115 YSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 157
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-41
Identities = 44/145 (30%), Positives = 74/145 (51%), Gaps = 22/145 (15%)
Query: 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPF---------KGEN 373
+ +F GT Y+APE++ G+ +G +VDWW LGV ++EM+ G +PF
Sbjct: 164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT 223
Query: 374 NEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGS--LKGSVEIK 431
+ IL+K + PR S S + ++ L K+PK+R+G G +I+
Sbjct: 224 EDYLFQVILEKQIRIPR---SLSVK------AASVLKSFLNKDPKERLGCHPQTGFADIQ 274
Query: 432 RHEFFKGINWALI--RSIKPPEVPN 454
H FF+ ++W ++ + + PP PN
Sbjct: 275 GHPFFRNVDWDMMEQKQVVPPFKPN 299
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 2e-45
Identities = 60/163 (36%), Positives = 84/163 (51%), Gaps = 11/163 (6%)
Query: 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADME 139
+G D F R LG G G V+ CQ++ YA K ++++ L RK A +E
Sbjct: 181 PMGEDWFLDFRVLGRGGFGEVFACQMKAT-----GKLYACKKLNKKRLKKRKGYQGAMVE 235
Query: 140 KVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDL----YAARQRQPGKRFGISSAKF 195
K IL + F+ +L FE CLVM GGD+ Y + P F A F
Sbjct: 236 KKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNP--GFQEPRAIF 293
Query: 196 YAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
Y A+ + LE+LH I+YRDLKPENVL+ +DG++ +SD L+
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLA 336
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-41
Identities = 41/146 (28%), Positives = 74/146 (50%), Gaps = 17/146 (11%)
Query: 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGEN----NEKTL 378
++K + GT ++APE++ G+ + +VD++ LGV LYEM+ PF+ N++
Sbjct: 343 QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402
Query: 379 INILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL-KGSVEIKRHEFFK 437
+L++ +T+P S +D LL K+P+KR+G ++ H F+
Sbjct: 403 QRVLEQAVTYPD---KFSPA------SKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR 453
Query: 438 GINWALI--RSIKPPEVPN-NDLYCK 460
I+W + + PP VP+ +Y K
Sbjct: 454 DISWRQLEAGMLTPPFVPDSRTVYAK 479
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 4e-45
Identities = 60/159 (37%), Positives = 79/159 (49%), Gaps = 5/159 (3%)
Query: 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADME 139
V + FR R LG G G V CQ+R YA K ++++ + RK A E
Sbjct: 180 PVTKNTFRQYRVLGKGGFGEVCACQVRAT-----GKMYACKKLEKKRIKKRKGEAMALNE 234
Query: 140 KVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAE 199
K IL ++ F+ +L +E CLV+ GGDL F + A FYAAE
Sbjct: 235 KQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE 294
Query: 200 TLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
LE LH IVYRDLKPEN+L+ + GHI +SD L+
Sbjct: 295 ICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA 333
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-40
Identities = 44/146 (30%), Positives = 71/146 (48%), Gaps = 17/146 (11%)
Query: 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGEN----NEKTL 378
K VGT Y+APEV+ + + + DWW LG LYEM+ G +PF+ E+
Sbjct: 339 GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE 398
Query: 379 INILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL-KGSVEIKRHEFFK 437
+ + P + S + + L S+LL K+P +R+G + E+K H FK
Sbjct: 399 RLVKEVPEEYSE---RFSPQ------ARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK 449
Query: 438 GINWALI--RSIKPPEVPN-NDLYCK 460
+N+ + ++PP P+ +YCK
Sbjct: 450 KLNFKRLGAGMLEPPFKPDPQAIYCK 475
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 5e-45
Identities = 51/135 (37%), Positives = 80/135 (59%), Gaps = 12/135 (8%)
Query: 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINIL 382
+K+F GT +Y+APE+I+ Q +G +VDWW GV LYEML G PF+GE+ ++ +I+
Sbjct: 175 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 234
Query: 383 KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGS-LKGSVEIKRHEFFKGINW 441
+ + +P+ S SKE + L+ K+P KR+G +G +IK H FF+ I+W
Sbjct: 235 EHNVAYPK---SMSKE------AVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 285
Query: 442 ALI--RSIKPPEVPN 454
+ + I+PP P
Sbjct: 286 EKLERKEIQPPYKPK 300
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 5e-44
Identities = 54/164 (32%), Positives = 82/164 (50%), Gaps = 8/164 (4%)
Query: 76 RAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHR 135
+ R+ L F L LG G G V L + + YA+K++ ++ + +
Sbjct: 12 GNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGT-----DELYAVKILKKDVVIQDDDVEC 66
Query: 136 ADMEKVILTMLD-HPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAK 194
+EK +L + PFL L++ F+ VMEY GGDL Q+ RF A
Sbjct: 67 TMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAV 124
Query: 195 FYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
FYAAE + L +L GI+YRDLK +NV++ +GHI ++DF +
Sbjct: 125 FYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC 168
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 6e-45
Identities = 50/136 (36%), Positives = 71/136 (52%), Gaps = 13/136 (9%)
Query: 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINIL 382
+ +F GT +Y+APE++ +G AVDWW +GV LYEML G PF+ EN + IL
Sbjct: 178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL 237
Query: 383 KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLK--GSVEIKRHEFFKGIN 440
+ +P ++ ++ + KNP R+GSL G I RH FFK I+
Sbjct: 238 NDEVVYPT---WLHED------ATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEID 288
Query: 441 WALI--RSIKPPEVPN 454
WA + R I+PP P
Sbjct: 289 WAQLNHRQIEPPFRPR 304
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-44
Identities = 61/171 (35%), Positives = 93/171 (54%), Gaps = 8/171 (4%)
Query: 69 EAMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALA 128
E + R+G+D+F +R LG G G V L +++ YA+KV+ ++ +
Sbjct: 8 EGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKET-----GDLYAVKVLKKDVIL 62
Query: 129 IRKKLHRADMEKVILTM-LDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKR 187
+ EK IL++ +HPFL L+ F+ VME+ GGDL Q+ +R
Sbjct: 63 QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKS--RR 120
Query: 188 FGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
F + A+FYAAE + AL +LH GI+YRDLK +NVL+ +GH L+DF +
Sbjct: 121 FDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMC 171
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 6e-45
Identities = 61/164 (37%), Positives = 89/164 (54%), Gaps = 8/164 (4%)
Query: 76 RAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHR 135
+A +GL F LLR +G G V L +++ YAM+VV +E + + +
Sbjct: 44 KASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKT-----DRIYAMRVVKKELVNDDEDIDW 98
Query: 136 ADMEKVILTM-LDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAK 194
EK + +HPFL L++ F+ V+EY GGDL QRQ ++ A+
Sbjct: 99 VQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHAR 156
Query: 195 FYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
FY+AE LAL YLH GI+YRDLK +NVL+ +GHI L+D+ +
Sbjct: 157 FYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 200
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 8e-41
Identities = 44/145 (30%), Positives = 74/145 (51%), Gaps = 22/145 (15%)
Query: 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPF---------KGEN 373
+ +F GT Y+APE++ G+ +G +VDWW LGV ++EM+ G +PF
Sbjct: 207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT 266
Query: 374 NEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGS--LKGSVEIK 431
+ IL+K + PR S S + ++ L K+PK+R+G G +I+
Sbjct: 267 EDYLFQVILEKQIRIPR---SLSVK------AASVLKSFLNKDPKERLGCHPQTGFADIQ 317
Query: 432 RHEFFKGINWALI--RSIKPPEVPN 454
H FF+ ++W ++ + + PP PN
Sbjct: 318 GHPFFRNVDWDMMEQKQVVPPFKPN 342
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 7e-45
Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 6/204 (2%)
Query: 37 RRSSISLCSSSAADQTSLYNSHKPHKANQAAWEAMKRLRRAQGRVGLDHFRLLRRLGSGD 96
S AA ++ L +VG+++F LL+ LG+G
Sbjct: 7 HHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGA 66
Query: 97 IGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKK-LHRADMEKVILTMLDH-PFLPTL 154
G V+L R YAMKV+ + + + K E+ +L + PFL TL
Sbjct: 67 YGKVFLV--RKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTL 124
Query: 155 YAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVY 214
+ F+ L+++Y GG+L+ ++ +RF + Y E +LALE+LH +GI+Y
Sbjct: 125 HYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIY 182
Query: 215 RDLKPENVLVREDGHIMLSDFDLS 238
RD+K EN+L+ +GH++L+DF LS
Sbjct: 183 RDIKLENILLDSNGHVVLTDFGLS 206
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 5e-43
Identities = 52/141 (36%), Positives = 76/141 (53%), Gaps = 18/141 (12%)
Query: 323 NARSKSFVGTHEYLAPEVISG--QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLI- 379
R+ F GT EY+AP+++ G GH AVDWW+LGV +YE+L G +PF + + +
Sbjct: 214 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE 273
Query: 380 ---NILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLK-GSVEIKRHEF 435
ILK +P+ S +DLI +LL+K+PKKR+G + EIK H F
Sbjct: 274 ISRRILKSEPPYPQ---EMSAL------AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324
Query: 436 FKGINWALI--RSIKPPEVPN 454
F+ INW + + + P P
Sbjct: 325 FQKINWDDLAAKKVPAPFKPV 345
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 1e-44
Identities = 59/171 (34%), Positives = 95/171 (55%), Gaps = 8/171 (4%)
Query: 69 EAMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALA 128
E K Q ++ ++ F L + LG G G V+L + + F+A+K + ++ +
Sbjct: 2 ELNKERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKT-----NQFFAIKALKKDVVL 56
Query: 129 IRKKLHRADMEKVILTM-LDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKR 187
+ + +EK +L++ +HPFL ++ F+ VMEY GGDL Q +
Sbjct: 57 MDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HK 114
Query: 188 FGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
F +S A FYAAE +L L++LH GIVYRDLK +N+L+ +DGHI ++DF +
Sbjct: 115 FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC 165
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 4e-43
Identities = 50/134 (37%), Positives = 78/134 (58%), Gaps = 14/134 (10%)
Query: 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINIL 382
+A++ +F GT +Y+APE++ GQ + +VDWW+ GV LYEML G +PF G++ E+ +I
Sbjct: 172 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR 231
Query: 383 KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWA 442
+PR KE +DL+ KL V+ P+KR+G +I++H F+ INW
Sbjct: 232 MDNPFYPR---WLEKE------AKDLLVKLFVREPEKRLGVRG---DIRQHPLFREINWE 279
Query: 443 LI--RSIKPPEVPN 454
+ + I PP P
Sbjct: 280 ELERKEIDPPFRPK 293
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 1e-43
Identities = 49/164 (29%), Positives = 87/164 (53%), Gaps = 10/164 (6%)
Query: 78 QGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRAD 137
+ ++ F + R +G G G VY C+ + YAMK +D++ + +++ A
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADT-----GKMYAMKCLDKKRIKMKQGETLAL 237
Query: 138 MEKVILTML---DHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAK 194
E+++L+++ D PF+ + F +++ GGDL+ + F + +
Sbjct: 238 NERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMR 295
Query: 195 FYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
FYAAE +L LE++H +VYRDLKP N+L+ E GH+ +SD L+
Sbjct: 296 FYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 339
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-39
Identities = 41/141 (29%), Positives = 73/141 (51%), Gaps = 16/141 (11%)
Query: 320 EPINARSKSFVGTHEYLAPEVIS-GQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTL 378
+ + + VGTH Y+APEV+ G + S+ DW++LG L+++L G +PF+ +
Sbjct: 341 DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 400
Query: 379 I---NILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL-KGSVEIKRHE 434
L + P S S E L+ L+ LL ++ +R+G L +G+ E+K
Sbjct: 401 EIDRMTLTMAVELPD---SFSPE------LRSLLEGLLQRDVNRRLGCLGRGAQEVKESP 451
Query: 435 FFKGINWALI--RSIKPPEVP 453
FF+ ++W ++ + PP +P
Sbjct: 452 FFRSLDWQMVFLQKYPPPLIP 472
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-43
Identities = 55/135 (40%), Positives = 77/135 (57%), Gaps = 12/135 (8%)
Query: 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINIL 382
A K+F GT EYLAPEV+ +G AVDWW LGV +YEM+ G PF +++EK IL
Sbjct: 303 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 362
Query: 383 KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL-KGSVEIKRHEFFKGINW 441
+ + FPR + E + L+S LL K+PK+R+G + + EI +H FF GI W
Sbjct: 363 MEEIRFPR---TLGPE------AKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVW 413
Query: 442 ALI--RSIKPPEVPN 454
+ + + PP P
Sbjct: 414 QHVYEKKLSPPFKPQ 428
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 7e-43
Identities = 59/167 (35%), Positives = 90/167 (53%), Gaps = 8/167 (4%)
Query: 73 RLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKK 132
L + + RV ++ F L+ LG G G V L + + +YAMK++ +E + + +
Sbjct: 137 SLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKAT-----GRYYAMKILKKEVIVAKDE 191
Query: 133 LHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISS 192
+ E +L HPFL L F+ C VMEY GG+L+ R+ + F
Sbjct: 192 VAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDR 249
Query: 193 AKFYAAETLLALEYLHM-MGIVYRDLKPENVLVREDGHIMLSDFDLS 238
A+FY AE + AL+YLH +VYRDLK EN+++ +DGHI ++DF L
Sbjct: 250 ARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC 296
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 5e-42
Identities = 59/233 (25%), Positives = 95/233 (40%), Gaps = 8/233 (3%)
Query: 7 TNESDYDSSSSSITVPDSSRSFMSNLSFGSRRSSISLCSSSAADQTSLYNSHKPHKANQA 66
+E + N+ S + ++ + K + A
Sbjct: 264 ISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTA 323
Query: 67 AWEAMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREA 126
+ + R+ L F L LG G G V L + + YA+K++ ++
Sbjct: 324 NTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGT-----DELYAVKILKKDV 378
Query: 127 LAIRKKLHRADMEKVIL-TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPG 185
+ + +EK +L PFL L++ F+ VMEY GGDL Q+
Sbjct: 379 VIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-- 436
Query: 186 KRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
RF A FYAAE + L +L GI+YRDLK +NV++ +GHI ++DF +
Sbjct: 437 GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC 489
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 7e-42
Identities = 51/135 (37%), Positives = 80/135 (59%), Gaps = 12/135 (8%)
Query: 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINIL 382
+K+F GT +Y+APE+I+ Q +G +VDWW GV LYEML G PF+GE+ ++ +I+
Sbjct: 496 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 555
Query: 383 KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGS-LKGSVEIKRHEFFKGINW 441
+ + +P+ S SKE + L+ K+P KR+G +G +IK H FF+ I+W
Sbjct: 556 EHNVAYPK---SMSKE------AVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 606
Query: 442 ALI--RSIKPPEVPN 454
+ + I+PP P
Sbjct: 607 EKLERKEIQPPYKPK 621
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-40
Identities = 91/388 (23%), Positives = 135/388 (34%), Gaps = 119/388 (30%)
Query: 75 RRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLH 134
+ V L+ + L +G G G V L N YAMKV+ ++ L +
Sbjct: 4 GSSGDCVQLNQYTLKDEIGKGSYGVVKLA--YNENDNTY---YAMKVLSKKKLIRQAGFP 58
Query: 135 RAD------------------MEKV-----ILTMLDHPFLPTLY--AEFEASHYSCLVME 169
R +E+V IL LDHP + L + + +V E
Sbjct: 59 RRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFE 118
Query: 170 YCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGH 229
G + K A+FY + + +EYLH I++RD+KP N+LV EDGH
Sbjct: 119 LVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGH 175
Query: 230 IMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNK 289
I ++DF +S + LL + TP F +
Sbjct: 176 IKIADFGVSNEFKGSDALLS----------------NTVGTP------AFMA-------- 205
Query: 290 KKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSA 349
PE ++ K F G A
Sbjct: 206 -------------------------PES----LSETRKIFSG----------------KA 220
Query: 350 VDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLI 409
+D W +GV LY ++G PF E I + L FP + L+DLI
Sbjct: 221 LDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAE-------DLKDLI 273
Query: 410 SKLLVKNPKKRIGSLKGSVEIKRHEFFK 437
+++L KNP+ RI + EIK H +
Sbjct: 274 TRMLDKNPESRI-VVP---EIKLHPWVT 297
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 7e-40
Identities = 62/348 (17%), Positives = 116/348 (33%), Gaps = 88/348 (25%)
Query: 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEK 140
+ H+ +++LG G V L + + FYA+K + ++ A E
Sbjct: 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHD-----GHFYALKRIL---CHEQQDREEAQREA 77
Query: 141 VILTMLDHPFLPTLYAEF----EASHYSCLVMEYCPGGDLYAA--RQRQPGKRFGISSAK 194
+ + +HP + L A A H + L++ + G L+ R + G
Sbjct: 78 DMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL 137
Query: 195 FYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSF 254
+ LE +H G +RDLKP N+L+ ++G +L D + + + R L+
Sbjct: 138 WLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197
Query: 255 EAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDD 314
+ + + S P E H
Sbjct: 198 Q--DWAAQRCTISYRAP----------------------------ELFSVQSHC------ 221
Query: 315 PEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGEN- 373
I+ R+ D W+LG LY M++G P+
Sbjct: 222 ------VIDERT------------------------DVWSLGCVLYAMMFGEGPYDMVFQ 251
Query: 374 NEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRI 421
++ ++ L+ P+ SS L L++ ++ +P +R
Sbjct: 252 KGDSVALAVQNQLSIPQSPRHSS-------ALWQLLNSMMTVDPHQRP 292
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-39
Identities = 48/164 (29%), Positives = 78/164 (47%), Gaps = 7/164 (4%)
Query: 75 RRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLH 134
+ + +D F + R LG G GNVYL + + + A+KV+ + L H
Sbjct: 5 EMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQN-----KFIMALKVLFKSQLEKEGVEH 59
Query: 135 RADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAK 194
+ E I + L HP + +Y F L++E+ P G+LY Q+ RF +
Sbjct: 60 QLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH--GRFDEQRSA 117
Query: 195 FYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ E AL Y H +++RD+KPEN+L+ G + ++DF S
Sbjct: 118 TFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS 161
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-33
Identities = 42/138 (30%), Positives = 61/138 (44%), Gaps = 17/138 (12%)
Query: 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTL 378
+ R ++ GT +YL PE+I G+ H VD W GV YE L G PF ++ +T
Sbjct: 162 VHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH 221
Query: 379 INILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438
I+ L FP +S +DLISKLL +P +R+ + H + K
Sbjct: 222 RRIVNVDLKFPP-FLSDG--------SKDLISKLLRYHPPQRL----PLKGVMEHPWVK- 267
Query: 439 INWALIRSIKPPEVPNND 456
A R + PP +
Sbjct: 268 ---ANSRRVLPPVYQSTQ 282
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 8e-39
Identities = 50/161 (31%), Positives = 75/161 (46%), Gaps = 7/161 (4%)
Query: 78 QGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRAD 137
+ + L+ F + R LG G GNVYL R A+KV+ + L H+
Sbjct: 3 KRQWALEDFEIGRPLGKGKFGNVYLA--REKQSKF---ILALKVLFKAQLEKAGVEHQLR 57
Query: 138 MEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYA 197
E I + L HP + LY F + L++EY P G +Y Q+ +F Y
Sbjct: 58 REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYI 115
Query: 198 AETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
E AL Y H +++RD+KPEN+L+ G + ++DF S
Sbjct: 116 TELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 156
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-32
Identities = 39/119 (32%), Positives = 55/119 (46%), Gaps = 13/119 (10%)
Query: 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTL 378
++R GT +YL PE+I G+ H VD W+LGV YE L G PF+ ++T
Sbjct: 157 VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY 216
Query: 379 INILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437
I + TFP V+ +DLIS+LL NP +R E+ H +
Sbjct: 217 KRISRVEFTFPD-FVTEG--------ARDLISRLLKHNPSQRP----MLREVLEHPWIT 262
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 51/227 (22%), Positives = 78/227 (34%), Gaps = 26/227 (11%)
Query: 12 YDSSSSSITVPDSSRSFMSNLSFGSRRSSISLCSSSAADQTSLYNSHKPHKANQAAWEAM 71
+ SS + + + F S RR S +S Q+ Y+ +P
Sbjct: 4 HHHHSSGVDLGTENLYFQSMHQLQPRRVSFRG-EASETLQSPGYDPSRPES--------- 53
Query: 72 KRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRK 131
F+ L RLG G G V+ + + YA+K +
Sbjct: 54 ---------FFQQSFQRLSRLGHGSYGEVFKVRSK-----EDGRLYAVKRSMSPFRGPKD 99
Query: 132 KLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGIS 191
+ + + HP L +E L E C G L + G +
Sbjct: 100 RARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAW-GASLPEA 157
Query: 192 SAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
Y +TLLAL +LH G+V+ D+KP N+ + G L DF L
Sbjct: 158 QVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLL 204
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 8e-20
Identities = 21/115 (18%), Positives = 42/115 (36%), Gaps = 15/115 (13%)
Query: 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINIL 382
+ G Y+APE++ G +G+A D ++LG+ + E+ G + L
Sbjct: 210 AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGY 268
Query: 383 KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437
P + S E + ++ +L +PK R + + +
Sbjct: 269 LPPEFTAGL----SSEL------RSVLVMMLEPDPKLRA----TAEALLALPVLR 309
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 8e-35
Identities = 36/185 (19%), Positives = 71/185 (38%), Gaps = 28/185 (15%)
Query: 75 RRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLH 134
+ ++ +R++R L G + LC+ N FYA+K ++ L ++
Sbjct: 22 YVKEKDKYINDYRIIRTLNQGKFNKIILCEKDNK-------FYALKKYEKSLLEKKRDFT 74
Query: 135 RADMEKV--------------ILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLY--- 177
+++ +K+ I+T + + + T ++ EY +
Sbjct: 75 KSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFD 134
Query: 178 ---AARQRQPGKRFGISSAKFYAAETLLALEYLHM-MGIVYRDLKPENVLVREDGHIMLS 233
+ I K L + Y+H I +RD+KP N+L+ ++G + LS
Sbjct: 135 EYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLS 194
Query: 234 DFDLS 238
DF S
Sbjct: 195 DFGES 199
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 36/139 (25%), Positives = 56/139 (40%), Gaps = 17/139 (12%)
Query: 323 NARSKSFVGTHEYLAPEVISGQG--HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLI- 379
+ + K GT+E++ PE S + +G+ VD W+LG+ LY M Y PF + + L
Sbjct: 204 DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN 263
Query: 380 NILKKPLTFPRIGVSSSKEFEEVVK----------LQDLISKLLVKNPKKRIGSLKGSVE 429
NI K + +P D + L KNP +RI S +
Sbjct: 264 NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI----TSED 319
Query: 430 IKRHEFFKGINWALIRSIK 448
+HE+ N +R
Sbjct: 320 ALKHEWLADTNIEDLREFS 338
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-32
Identities = 42/169 (24%), Positives = 67/169 (39%), Gaps = 23/169 (13%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVI 142
F + LG G G V + L +YA+K + +KL E ++
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNA-----LDSRYYAIKKIRHT----EEKLSTILSEVML 55
Query: 143 LTMLDHPFLPTLYAEF-------------EASHYSCLVMEYCPGGDLYAARQRQPGKRFG 189
L L+H ++ YA + + + MEYC G LY +
Sbjct: 56 LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQ 114
Query: 190 ISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ L AL Y+H GI++RDLKP N+ + E ++ + DF L+
Sbjct: 115 RDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLA 163
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-26
Identities = 29/134 (21%), Positives = 51/134 (38%), Gaps = 14/134 (10%)
Query: 306 HHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGH-GSAVDWWTLGVFLYEMLY 364
H ++L + S +GT Y+A EV+ G GH +D ++LG+ +EM+Y
Sbjct: 167 HRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226
Query: 365 GTTPFKGENNEKTLINILKKPLTFP-RIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGS 423
G L + + FP + K + +I L+ +P KR
Sbjct: 227 P--FSTGMERVNILKKLRSVSIEFPPDFDDNKMKVE------KKIIRLLIDHDPNKRP-- 276
Query: 424 LKGSVEIKRHEFFK 437
G+ + +
Sbjct: 277 --GARTLLNSGWLP 288
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 6e-32
Identities = 39/170 (22%), Positives = 76/170 (44%), Gaps = 6/170 (3%)
Query: 69 EAMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALA 128
+ ++ + L+++G G G L + Y +K ++ ++
Sbjct: 9 SGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTED-----GRQYVIKEINISRMS 63
Query: 129 IRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRF 188
K+ + E +L + HP + FE + +VM+YC GGDL+ Q G F
Sbjct: 64 -SKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLF 122
Query: 189 GISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ + LAL+++H I++RD+K +N+ + +DG + L DF ++
Sbjct: 123 QEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIA 172
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-20
Identities = 32/152 (21%), Positives = 62/152 (40%), Gaps = 16/152 (10%)
Query: 327 KSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL 386
++ +GT YL+PE+ + + + D W LG LYE+ F+ + + ++ I+
Sbjct: 183 RACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS- 241
Query: 387 TFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIRS 446
FP + + S + L+ L+S+L +NP+ R S+ I F I
Sbjct: 242 -FPPVSLHYSYD------LRSLVSQLFKRNPRDRP-SVN---SILEKGFIA----KRIEK 286
Query: 447 IKPPEVPNNDLYCKIKKKVYVPKLSKQERDAP 478
P++ + K K + + +
Sbjct: 287 FLSPQLIAEEFCLKTFSKFGSQPIPAKRPASG 318
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 122 bits (306), Expect = 7e-31
Identities = 31/181 (17%), Positives = 55/181 (30%), Gaps = 17/181 (9%)
Query: 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADME 139
++G + LG G VY + + + +KV + +
Sbjct: 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQL 117
Query: 140 KVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGG---DLYAARQRQPGKRFGISSAKFY 196
L Y+ + S LV E G + + P K +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 197 AAETLLALEYLHMMGIVYRDLKPENVLVR-----------EDGHIMLSDFDLSFKCDVVP 245
A L +E +H I++ D+KP+N ++ + L D S + P
Sbjct: 178 AMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP 237
Query: 246 K 246
K
Sbjct: 238 K 238
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 16/119 (13%), Positives = 42/119 (35%), Gaps = 9/119 (7%)
Query: 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLIN 380
P + T + E++S + +D++ + +Y ML+GT +
Sbjct: 237 PKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPE 296
Query: 381 ILKKPLTFPRI---------GVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEI 430
L + L + + + L+ + K+ ++ +I +L+ + +
Sbjct: 297 GLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIV 355
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-30
Identities = 44/172 (25%), Positives = 70/172 (40%), Gaps = 7/172 (4%)
Query: 69 EAMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALA 128
+ K LR G L +FR+ +++G G VY A+K V L
Sbjct: 17 QPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLD-----GVPVALKKVQIFDLM 71
Query: 129 IRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAA--RQRQPGK 186
K E +L L+HP + YA F + +V+E GDL ++ +
Sbjct: 72 DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKR 131
Query: 187 RFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ Y + ALE++H +++RD+KP NV + G + L D L
Sbjct: 132 LIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG 183
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 31/97 (31%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 327 KSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGEN-NEKTLIN-ILKK 384
S VGT Y++PE I G+ D W+LG LYEM +PF G+ N +L I +
Sbjct: 194 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC 253
Query: 385 PLTFPRIGVSS-SKEFEEVVKLQDLISKLLVKNPKKR 420
+P + S+E L+ L++ + +P+KR
Sbjct: 254 D--YPPLPSDHYSEE------LRQLVNMCINPDPEKR 282
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 54/382 (14%), Positives = 113/382 (29%), Gaps = 96/382 (25%)
Query: 70 AMKRLRRAQGRVGLDH----FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDRE 125
A+KR+R + + + L +L I + + P + + + D
Sbjct: 35 AIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDES 94
Query: 126 A---LAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAA-RQ 181
L+ + ++ + Y + M+ C +L +
Sbjct: 95 TDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNR 154
Query: 182 RQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKC 241
R + + A+E+LH G+++RDLKP N+ D + + DF L
Sbjct: 155 RCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGL---- 210
Query: 242 DVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIR-- 299
T M + ++ V T
Sbjct: 211 ---------------------------VTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243
Query: 300 --EQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGV 357
EQ+ G+++ + VD ++LG+
Sbjct: 244 SPEQIHGNNYSHK---------------------------------------VDIFSLGL 264
Query: 358 FLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNP 417
L+E+LY F + +I ++ FP + + ++ +L +P
Sbjct: 265 ILFELLY---SFSTQMERVRIITDVRNL-KFPLLFTQKYPQ------EHMMVQDMLSPSP 314
Query: 418 KKRIGSLKGSVEIKRHEFFKGI 439
+R + +I + F+ +
Sbjct: 315 TERP----EATDIIENAIFENL 332
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 2e-04
Identities = 17/89 (19%), Positives = 34/89 (38%), Gaps = 7/89 (7%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVI 142
L F ++ +G G G V+ +N + C YA+K + + ++ + E
Sbjct: 5 LTDFEPIQCMGRGGFGVVFEA--KNKVDD---CNYAIKRIRLPNRELARE--KVMREVKA 57
Query: 143 LTMLDHPFLPTLYAEFEASHYSCLVMEYC 171
L L+HP + + + + E
Sbjct: 58 LAKLEHPGIVRYFNAWLETPPEKWQEEMD 86
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-29
Identities = 36/165 (21%), Positives = 65/165 (39%), Gaps = 15/165 (9%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVI 142
+ + +L +G+G G + ++ K +D ++ + E +
Sbjct: 5 AEDYEVLYTIGTGSYGRCQKIRRKSD-----GKILVWKELDYGSMT-EAEKQMLVSEVNL 58
Query: 143 LTMLDHPFLPTLYAEF--EASHYSCLVMEYCPGGDLYAA--RQRQPGKRFGISSAKFYAA 198
L L HP + Y + +VMEYC GGDL + + + +
Sbjct: 59 LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 199 ETLLALEYLH-----MMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ LAL+ H +++RDLKP NV + ++ L DF L+
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 4e-18
Identities = 31/112 (27%), Positives = 49/112 (43%), Gaps = 14/112 (12%)
Query: 327 KSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL 386
K+FVGT Y++PE ++ + D W+LG LYE+ PF + ++ I +
Sbjct: 174 KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK- 232
Query: 387 TFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSV-EIKRHEFFK 437
F RI S E L ++I+++L R SV EI +
Sbjct: 233 -FRRIPYRYSDE------LNEIITRMLNLKDYHRP-----SVEEILENPLIL 272
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 8e-29
Identities = 53/166 (31%), Positives = 79/166 (47%), Gaps = 22/166 (13%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKV-- 141
D + + + LGSG G V L R A++++ + AI V
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKT--CKK---VAIRIISKRKFAIGSAREADPALNVET 189
Query: 142 ---ILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLY---AARQRQPGKRFGISSAKF 195
IL L+HP + + F+A Y +V+E GG+L+ KR ++ K
Sbjct: 190 EIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGN-----KRLKEATCKL 243
Query: 196 YAAETLLALEYLHMMGIVYRDLKPENVLVR---EDGHIMLSDFDLS 238
Y + LLA++YLH GI++RDLKPENVL+ ED I ++DF S
Sbjct: 244 YFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 38/117 (32%), Positives = 56/117 (47%), Gaps = 15/117 (12%)
Query: 327 KSFVGTHEYLAPEVISG---QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLIN-IL 382
++ GT YLAPEV+ G+ AVD W+LGV L+ L G PF + +L + I
Sbjct: 299 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 358
Query: 383 KKPLTFPRIGVSSSKEFEEVVKL-QDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438
F + + EV + DL+ KLLV +PK R + + E RH + +
Sbjct: 359 SGKYNFI------PEVWAEVSEKALDLVKKLLVVDPKARF-TTE---EALRHPWLQD 405
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 48/170 (28%), Positives = 74/170 (43%), Gaps = 24/170 (14%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKV-- 141
D F R+LGSG G+V+L + R+ +K I K + ME++
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSS-----GLERVIKT-------INKDRSQVPMEQIEA 69
Query: 142 ---ILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLY---AARQRQPGKRFGISSAKF 195
+L LDHP + ++ FE H +VME C GG+L + Q +
Sbjct: 70 EIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGK-ALSEGYVAE 128
Query: 196 YAAETLLALEYLHMMGIVYRDLKPENVLVR---EDGHIMLSDFDLSFKCD 242
+ + AL Y H +V++DLKPEN+L + I + DF L+
Sbjct: 129 LMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 25/97 (25%), Positives = 41/97 (42%), Gaps = 11/97 (11%)
Query: 327 KSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL 386
+ GT Y+APEV D W+ GV +Y +L G PF G + E+ K
Sbjct: 184 TNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP 242
Query: 387 TFPRI--GVSSSKEFEEVVKLQDLISKLLVKNPKKRI 421
+ ++ DL+ ++L K+P++R
Sbjct: 243 NYAVECRPLTPQ------AV--DLLKQMLTKDPERRP 271
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 53/166 (31%), Positives = 79/166 (47%), Gaps = 22/166 (13%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKV-- 141
D + + + LGSG G V L R A+K++ + AI V
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKT-----CKKVAIKIISKRKFAIGSAREADPALNVET 64
Query: 142 ---ILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLY---AARQRQPGKRFGISSAKF 195
IL L+HP + + F+A Y +V+E GG+L+ +R ++ K
Sbjct: 65 EIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR-----LKEATCKL 118
Query: 196 YAAETLLALEYLHMMGIVYRDLKPENVLVR---EDGHIMLSDFDLS 238
Y + LLA++YLH GI++RDLKPENVL+ ED I ++DF S
Sbjct: 119 YFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 5e-20
Identities = 41/158 (25%), Positives = 64/158 (40%), Gaps = 19/158 (12%)
Query: 327 KSFVGTHEYLAPEVISG---QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLI-NIL 382
++ GT YLAPEV+ G+ AVD W+LGV L+ L G PF + +L I
Sbjct: 174 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 233
Query: 383 KKPLTFPRIGVSSSKEFEEV---VKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439
F + + EV DL+ KLLV +PK R + E RH + +
Sbjct: 234 SGKYNFI------PEVWAEVSEKAL--DLVKKLLVVDPKARF----TTEEALRHPWLQDE 281
Query: 440 NWALIRSIKPPEVPNNDLYCKIKKKVYVPKLSKQERDA 477
+ E + ++ + + +E +A
Sbjct: 282 DMKRKFQDLLSEENESTALPQVLAQPSTSRKRPREGEA 319
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 46/156 (29%), Positives = 80/156 (51%), Gaps = 6/156 (3%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVI 142
++ F++ LG G VY + GL A+K++D++A+ + R E I
Sbjct: 10 IEDFKVGNLLGKGSFAGVYR--AESIHTGLE---VAIKMIDKKAMYKAGMVQRVQNEVKI 64
Query: 143 LTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLL 202
L HP + LY FE S+Y LV+E C G++ + + K F + A+ + + +
Sbjct: 65 HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIIT 123
Query: 203 ALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ YLH GI++RDL N+L+ + +I ++DF L+
Sbjct: 124 GMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLA 159
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 32/121 (26%), Positives = 52/121 (42%), Gaps = 13/121 (10%)
Query: 317 VVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEK 376
+ + + + GT Y++PE+ + HG D W+LG Y +L G PF + +
Sbjct: 160 TQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN 219
Query: 377 TLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436
TL ++ P +S +DLI +LL +NP R+ SL + H F
Sbjct: 220 TLNKVVLADYEMPS-FLSIE--------AKDLIHQLLRRNPADRL-SLS---SVLDHPFM 266
Query: 437 K 437
Sbjct: 267 S 267
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 36/172 (20%), Positives = 65/172 (37%), Gaps = 28/172 (16%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVI 142
F+ + +GSG G V+ + R + Y +K V +K R E
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHR-----IDGKTYVIKRVKYN----NEKAER---EVKA 57
Query: 143 LTMLDHPFLPTLYAEFEASHYS----------------CLVMEYCPGGDLYAARQRQPGK 186
L LDH + ++ Y + ME+C G L +++ G+
Sbjct: 58 LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 117
Query: 187 RFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ A + ++Y+H ++ RDLKP N+ + + + + DF L
Sbjct: 118 KLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLV 169
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 29/111 (26%), Positives = 43/111 (38%), Gaps = 17/111 (15%)
Query: 327 KSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL 386
GT Y++PE IS Q +G VD + LG+ L E+L+ + T +
Sbjct: 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISD 238
Query: 387 TFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437
F + K + L+ KLL K P+ R + EI R
Sbjct: 239 IFDK-------------KEKTLLQKLLSKKPEDRP-NTS---EILRTLTVW 272
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 7e-28
Identities = 49/166 (29%), Positives = 74/166 (44%), Gaps = 29/166 (17%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
F + LGSG V+L + R +A+K + + L E +L
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLT-----GKLFALKCIKKSPAFRDSSLEN---EIAVL 60
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFY----AAE 199
+ H + TL +E++ + LVM+ GG+L+ I Y A+
Sbjct: 61 KKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDR----------ILERGVYTEKDASL 110
Query: 200 T----LLALEYLHMMGIVYRDLKPENVLVR---EDGHIMLSDFDLS 238
L A++YLH GIV+RDLKPEN+L E+ IM++DF LS
Sbjct: 111 VIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLS 156
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 1e-20
Identities = 30/96 (31%), Positives = 48/96 (50%), Gaps = 7/96 (7%)
Query: 327 KSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL 386
+ GT Y+APEV++ + + AVD W++GV Y +L G PF E K I +
Sbjct: 165 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYY 224
Query: 387 TFPRIGVSSSKEFEEVVKL-QDLISKLLVKNPKKRI 421
F S ++++ + +D I LL K+P +R
Sbjct: 225 EFE------SPFWDDISESAKDFICHLLEKDPNERY 254
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 9e-28
Identities = 39/163 (23%), Positives = 70/163 (42%), Gaps = 16/163 (9%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
+ L LG G NV+ R+ G +A+KV + + + + E +L
Sbjct: 9 HLWLLSDILGQGATANVFRG--RHKKTGDL---FAIKVFNNISF--LRPVDVQMREFEVL 61
Query: 144 TMLDHPFLPTLYA--EFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGIS--SAKFYAAE 199
L+H + L+A E + + L+ME+CP G LY +P +G+ +
Sbjct: 62 KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYT-VLEEPSNAYGLPESEFLIVLRD 120
Query: 200 TLLALEYLHMMGIVYRDLKPENVLVR----EDGHIMLSDFDLS 238
+ + +L GIV+R++KP N++ L+DF +
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 8e-17
Identities = 25/124 (20%), Positives = 46/124 (37%), Gaps = 28/124 (22%)
Query: 327 KSFVGTHEYLAPEVISG--------QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTL 378
S GT EYL P++ + +G+ VD W++GV Y G+ PF+ +
Sbjct: 173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232
Query: 379 INILKKPLTFPRIGVSSSKEFEEVVKLQ--------------------DLISKLLVKNPK 418
++ K +T G S + E + +++ +L + +
Sbjct: 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE 292
Query: 419 KRIG 422
K G
Sbjct: 293 KCWG 296
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 42/203 (20%)
Query: 60 PHKANQAAWEAMKR----LRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQC 115
PH A+ + M R + A + D++ + LG G V C +
Sbjct: 2 PHMASMTGGQQMGRGSEFMMNASTKFS-DNYDVKEELGKGAFSVVRRCVHKTT-----GL 55
Query: 116 FYAMKVVDREALAIRKKLHRADMEKV-----ILTMLDHPFLPTLYAEFEASHYSCLVMEY 170
+A K+++ KKL D +K+ I L HP + L+ + + LV +
Sbjct: 56 EFAAKIINT------KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 109
Query: 171 CPGGDLYAARQRQPGKRFGISSAKFY----AAET----LLALEYLHMMGIVYRDLKPENV 222
GG+L+ I + +FY A+ L ++ Y H GIV+R+LKPEN+
Sbjct: 110 VTGGELFED----------IVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENL 159
Query: 223 LVR---EDGHIMLSDFDLSFKCD 242
L+ + + L+DF L+ + +
Sbjct: 160 LLASKAKGAAVKLADFGLAIEVN 182
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 35/98 (35%), Positives = 45/98 (45%), Gaps = 11/98 (11%)
Query: 327 KSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL 386
F GT YL+PEV+ + VD W GV LY +L G PF E+ + I
Sbjct: 188 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 247
Query: 387 TFPRIGVSSSKEFEEV---VKLQDLISKLLVKNPKKRI 421
+P S E++ V K LI +L NPKKRI
Sbjct: 248 DYP------SPEWDTVTPEAK--SLIDSMLTVNPKKRI 277
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 42/163 (25%), Positives = 65/163 (39%), Gaps = 14/163 (8%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEK--V 141
D + L +G G V C R +A+K+VD L D+++
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRET-----GQQFAVKIVDVAKFTSSPGLSTEDLKREAS 78
Query: 142 ILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLY---AARQRQPGKRFGISSAKFYAA 198
I ML HP + L + + +V E+ G DL R G + + A Y
Sbjct: 79 ICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRAD-AGFVYSEAVASHYMR 137
Query: 199 ETLLALEYLHMMGIVYRDLKPENVLVR---EDGHIMLSDFDLS 238
+ L AL Y H I++RD+KP VL+ + L F ++
Sbjct: 138 QILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 6e-19
Identities = 29/98 (29%), Positives = 48/98 (48%), Gaps = 12/98 (12%)
Query: 327 KSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL 386
VGT ++APEV+ + +G VD W GV L+ +L G PF G E+ I+K
Sbjct: 191 GGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKY 249
Query: 387 TFPRIGVSSSKEFEEV---VKLQDLISKLLVKNPKKRI 421
+++ + K DL+ ++L+ +P +RI
Sbjct: 250 KMN------PRQWSHISESAK--DLVRRMLMLDPAERI 279
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-27
Identities = 44/175 (25%), Positives = 76/175 (43%), Gaps = 37/175 (21%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKV-- 141
D++ + LG G V C + +A K+++ KKL D +K+
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTT-----GLEFAAKIINT------KKLSARDFQKLER 54
Query: 142 ---ILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFY-- 196
I L HP + L+ + + LV + GG+L+ I + +FY
Sbjct: 55 EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFED----------IVAREFYSE 104
Query: 197 --AAET----LLALEYLHMMGIVYRDLKPENVLVR---EDGHIMLSDFDLSFKCD 242
A+ L ++ Y H GIV+R+LKPEN+L+ + + L+DF L+ + +
Sbjct: 105 ADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 3e-21
Identities = 34/96 (35%), Positives = 45/96 (46%), Gaps = 7/96 (7%)
Query: 327 KSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL 386
F GT YL+PEV+ + VD W GV LY +L G PF E+ + I
Sbjct: 165 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 224
Query: 387 TFPRIGVSSSKEFEEVVKL-QDLISKLLVKNPKKRI 421
+P S E++ V + LI +L NPKKRI
Sbjct: 225 DYP------SPEWDTVTPEAKSLIDSMLTVNPKKRI 254
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 52/162 (32%), Positives = 76/162 (46%), Gaps = 10/162 (6%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
D ++ R LG G G V LC+ + A+KV+ + + + E +L
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKIT-----GQECAVKVISKRQVKQKTDKESLLREVQLL 80
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLA 203
LDHP + LY FE Y LV E GG+L+ + KRF A + L
Sbjct: 81 KQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSG 138
Query: 204 LEYLHMMGIVYRDLKPENVLVR---EDGHIMLSDFDLSFKCD 242
+ Y+H IV+RDLKPEN+L+ +D +I + DF LS +
Sbjct: 139 ITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-19
Identities = 36/98 (36%), Positives = 45/98 (45%), Gaps = 12/98 (12%)
Query: 327 KSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL 386
K +GT Y+APEV+ G + D W+ GV LY +L G PF G N L + K
Sbjct: 186 KDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKY 244
Query: 387 TFPR---IGVSSSKEFEEVVKLQDLISKLLVKNPKKRI 421
TF VS S +DLI K+L P RI
Sbjct: 245 TFELPQWKKVSES--------AKDLIRKMLTYVPSMRI 274
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 49/170 (28%), Positives = 73/170 (42%), Gaps = 27/170 (15%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKV-- 141
+ + ++ LG G G V C+ R Q YA+KV+++ D +
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRIT-----QQEYAVKVINK------ASAKNKDTSTILR 70
Query: 142 ---ILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLY---AARQRQPGKRFGISSAKF 195
+L LDHP + L+ E S +V E GG+L+ R KRF A
Sbjct: 71 EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR-----KRFSEHDAAR 125
Query: 196 YAAETLLALEYLHMMGIVYRDLKPENVLVR---EDGHIMLSDFDLSFKCD 242
+ + Y+H IV+RDLKPEN+L+ +D I + DF LS
Sbjct: 126 IIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 8e-19
Identities = 33/98 (33%), Positives = 46/98 (46%), Gaps = 12/98 (12%)
Query: 327 KSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL 386
K +GT Y+APEV+ G + D W+ GV LY +L GT PF G+N L +
Sbjct: 181 KDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY 239
Query: 387 TFPRIGVSSSKEFEEV---VKLQDLISKLLVKNPKKRI 421
F ++ + K DLI K+L +P RI
Sbjct: 240 AFD------LPQWRTISDDAK--DLIRKMLTFHPSLRI 269
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 50/247 (20%), Positives = 83/247 (33%), Gaps = 39/247 (15%)
Query: 16 SSSITVPDSSRSFMSNLSFGSRRSSISLCSSSAADQTSLYNSHKPHKANQAAWEAMKRLR 75
+ + NL+ RR+ I + +L K Q +
Sbjct: 16 NKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQ 75
Query: 76 RAQGRVGL----------DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDRE 125
L + +G G V C R +A+K+++
Sbjct: 76 SMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRAT-----GHEFAVKIMEVT 130
Query: 126 ALAIRKKLHRADMEKV-----ILTML-DHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAA 179
A + + E IL + HP + TL +E+S + LV + G+L+
Sbjct: 131 AERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDY 190
Query: 180 RQRQPGKRFGISSAKFY----AAET----LLALEYLHMMGIVYRDLKPENVLVREDGHIM 231
++ L A+ +LH IV+RDLKPEN+L+ ++ I
Sbjct: 191 ----------LTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIR 240
Query: 232 LSDFDLS 238
LSDF S
Sbjct: 241 LSDFGFS 247
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 37/120 (30%), Positives = 57/120 (47%), Gaps = 21/120 (17%)
Query: 327 KSFVGTHEYLAPEVISG------QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLIN 380
+ GT YLAPE++ G+G VD W GV L+ +L G+ PF L
Sbjct: 257 RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM 316
Query: 381 ILKKPLTFPRIGVSSSKEFEEV---VKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437
I++ F S E+++ VK DLIS+LL +P+ R+ + + +H FF+
Sbjct: 317 IMEGQYQFS------SPEWDDRSSTVK--DLISRLLQVDPEARL----TAEQALQHPFFE 364
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 39/166 (23%), Positives = 70/166 (42%), Gaps = 16/166 (9%)
Query: 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEK 140
+ L LG G NV+ R+ G +A+KV + + + + E
Sbjct: 6 TSNHLWLLSDILGQGATANVFRG--RHKKTGDL---FAIKVFNNISF--LRPVDVQMREF 58
Query: 141 VILTMLDHPFLPTLYA--EFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGIS--SAKFY 196
+L L+H + L+A E + + L+ME+CP G LY +P +G+
Sbjct: 59 EVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYT-VLEEPSNAYGLPESEFLIV 117
Query: 197 AAETLLALEYLHMMGIVYRDLKPENVLVR----EDGHIMLSDFDLS 238
+ + + +L GIV+R++KP N++ L+DF +
Sbjct: 118 LRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 31/149 (20%), Positives = 54/149 (36%), Gaps = 37/149 (24%)
Query: 327 KSFVGTHEYLAPEVISG--------QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTL 378
S GT EYL P++ + +G+ VD W++GV Y G+ PF+ +
Sbjct: 173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232
Query: 379 INILKKPLTFPRIGVSSSKEFEEV--------------------VKLQDLISKLLVKNPK 418
++ K +T G S + E V L +++ +L + +
Sbjct: 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE 292
Query: 419 KRIGSLKGSVEIKRHEFFKGINWALIRSI 447
K G +FF + L R +
Sbjct: 293 KCWG---------FDQFFAETSDILHRMV 312
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-27
Identities = 48/167 (28%), Positives = 74/167 (44%), Gaps = 21/167 (12%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKV-- 141
+ + ++ LG G G V C+ R Q YA+KV+++ D +
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRIT-----QQEYAVKVINK------ASAKNKDTSTILR 70
Query: 142 ---ILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAA 198
+L LDHP + L+ E S +V E GG+L+ ++ KRF A
Sbjct: 71 EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIK 128
Query: 199 ETLLALEYLHMMGIVYRDLKPENVLVR---EDGHIMLSDFDLSFKCD 242
+ + Y+H IV+RDLKPEN+L+ +D I + DF LS
Sbjct: 129 QVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 33/98 (33%), Positives = 45/98 (45%), Gaps = 12/98 (12%)
Query: 327 KSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL 386
K +GT Y+APEV+ G + D W+ GV LY +L GT PF G+N L +
Sbjct: 181 KDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY 239
Query: 387 TFPR---IGVSSSKEFEEVVKLQDLISKLLVKNPKKRI 421
F +S +DLI K+L +P RI
Sbjct: 240 AFDLPQWRTISDD--------AKDLIRKMLTFHPSLRI 269
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-27
Identities = 49/167 (29%), Positives = 79/167 (47%), Gaps = 21/167 (12%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKV-- 141
+ ++ +++LGSG G V LC+ + A+K++ + + + K+
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVT-----HVERAIKIIRK------TSVSTSSNSKLLE 85
Query: 142 ---ILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAA 198
+L +LDHP + LY FE LVME GG+L+ + +F A
Sbjct: 86 EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIK 143
Query: 199 ETLLALEYLHMMGIVYRDLKPENVLVR---EDGHIMLSDFDLSFKCD 242
+ L + YLH IV+RDLKPEN+L+ +D I + DF LS +
Sbjct: 144 QVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-19
Identities = 30/98 (30%), Positives = 50/98 (51%), Gaps = 12/98 (12%)
Query: 327 KSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL 386
K +GT Y+APEV+ + + D W++GV L+ +L G PF G+ +++ L + K
Sbjct: 196 KERLGTAYYIAPEVLRKK-YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKY 254
Query: 387 TFPR---IGVSSSKEFEEVVKLQDLISKLLVKNPKKRI 421
TF VS +DLI ++L + ++RI
Sbjct: 255 TFDSPEWKNVSEG--------AKDLIKQMLQFDSQRRI 284
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-27
Identities = 45/165 (27%), Positives = 71/165 (43%), Gaps = 19/165 (11%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
++ L +G G G V + + + A K + + + + + E I+
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGT-----RIRRAAKKIPKYFVEDVDRFKQ---EIEIM 60
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLY---AARQRQPGKRFGISSAKFYAAET 200
LDHP + LY FE + LVME C GG+L+ + + F S A +
Sbjct: 61 KSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHK-----RVFRESDAARIMKDV 115
Query: 201 LLALEYLHMMGIVYRDLKPENVLVR---EDGHIMLSDFDLSFKCD 242
L A+ Y H + + +RDLKPEN L D + L DF L+ +
Sbjct: 116 LSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 1e-19
Identities = 36/115 (31%), Positives = 61/115 (53%), Gaps = 16/115 (13%)
Query: 327 KSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL 386
++ VGT Y++P+V+ G +G D W+ GV +Y +L G PF + + ++ I +
Sbjct: 166 RTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTF 224
Query: 387 TFPRIGVSSSKEFEEV---VKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438
TFP K++ V + LI +LL K+PK+RI S++ HE+F+
Sbjct: 225 TFP------EKDWLNVSPQAE--SLIRRLLTKSPKQRI----TSLQALEHEWFEK 267
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-27
Identities = 42/175 (24%), Positives = 75/175 (42%), Gaps = 37/175 (21%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKV-- 141
+ ++L LG G V C YA +++ KKL D +K+
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLA-----GQEYAAMIINT------KKLSARDHQKLER 59
Query: 142 ---ILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFY-- 196
I +L HP + L+ + L+ + GG+L+ I + ++Y
Sbjct: 60 EARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFED----------IVAREYYSE 109
Query: 197 --AAET----LLALEYLHMMGIVYRDLKPENVLVR---EDGHIMLSDFDLSFKCD 242
A+ L A+ + H MG+V+R+LKPEN+L+ + + L+DF L+ + +
Sbjct: 110 ADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 38/98 (38%), Positives = 48/98 (48%), Gaps = 11/98 (11%)
Query: 327 KSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL 386
F GT YL+PEV+ +G VD W GV LY +L G PF E+ + I
Sbjct: 171 FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAY 230
Query: 387 TFPRIGVSSSKEFEEV---VKLQDLISKLLVKNPKKRI 421
FP S E++ V K DLI+K+L NP KRI
Sbjct: 231 DFP------SPEWDTVTPEAK--DLINKMLTINPSKRI 260
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 9e-27
Identities = 38/156 (24%), Positives = 67/156 (42%), Gaps = 7/156 (4%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVI 142
+ R LG G + I + +A K+V + L + + ME I
Sbjct: 14 RRRYVRGRFLGKGGFAKCFE--ISDADTKEV---FAGKIVPKSLLLKPHQREKMSMEISI 68
Query: 143 LTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLL 202
L H + + FE + + +V+E C L +R+ K A++Y + +L
Sbjct: 69 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVL 126
Query: 203 ALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+YLH +++RDLK N+ + ED + + DF L+
Sbjct: 127 GCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 162
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-24
Identities = 33/107 (30%), Positives = 53/107 (49%), Gaps = 13/107 (12%)
Query: 331 GTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPR 390
GT Y+APEV+S +GH VD W++G +Y +L G PF+ ++T + I K + P+
Sbjct: 177 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK 236
Query: 391 IGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437
++ LI K+L +P R ++ E+ EFF
Sbjct: 237 -HINPV--------AASLIQKMLQTDPTARP-TIN---ELLNDEFFT 270
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 44/171 (25%), Positives = 72/171 (42%), Gaps = 24/171 (14%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKV-- 141
DH+ + LGSG V C+ + YA K + + L E++
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGT-----GKEYAAKFIKKRRL--SSSRRGVSREEIER 57
Query: 142 ---ILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLY---AARQRQPGKRFGISSAKF 195
IL + HP + TL+ FE L++E GG+L+ A + + A
Sbjct: 58 EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK-----ESLTEDEATQ 112
Query: 196 YAAETLLALEYLHMMGIVYRDLKPENVLV----REDGHIMLSDFDLSFKCD 242
+ + L + YLH I + DLKPEN+++ + I L DF ++ K +
Sbjct: 113 FLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-22
Identities = 35/96 (36%), Positives = 55/96 (57%), Gaps = 7/96 (7%)
Query: 327 KSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL 386
K+ GT E++APE+++ + G D W++GV Y +L G +PF GE ++TL NI
Sbjct: 169 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNY 228
Query: 387 TFPRIGVSSSKEFEEVVKL-QDLISKLLVKNPKKRI 421
F + F +L +D I +LLVK+PK+R+
Sbjct: 229 DFD------EEYFSNTSELAKDFIRRLLVKDPKRRM 258
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 42/182 (23%), Positives = 72/182 (39%), Gaps = 7/182 (3%)
Query: 57 SHKPHKANQAAWEAMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCF 116
A AA A + + R LG G + I +
Sbjct: 14 GVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFE--ISDADTKEV--- 68
Query: 117 YAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDL 176
+A K+V + L + + ME I L H + + FE + + +V+E C L
Sbjct: 69 FAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSL 128
Query: 177 YAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFD 236
+R+ K A++Y + +L +YLH +++RDLK N+ + ED + + DF
Sbjct: 129 LELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFG 186
Query: 237 LS 238
L+
Sbjct: 187 LA 188
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 33/107 (30%), Positives = 53/107 (49%), Gaps = 13/107 (12%)
Query: 331 GTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPR 390
GT Y+APEV+S +GH VD W++G +Y +L G PF+ ++T + I K + P+
Sbjct: 203 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK 262
Query: 391 IGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437
++ LI K+L +P R ++ E+ EFF
Sbjct: 263 -HINPV--------AASLIQKMLQTDPTARP-TIN---ELLNDEFFT 296
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 49/242 (20%), Positives = 77/242 (31%), Gaps = 52/242 (21%)
Query: 54 LYNSHKPHKANQAAWEAMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLP 113
+++ H + + L Q + L +G G G V +
Sbjct: 1 MHHHHHHSSGRENLYFQGGSLLELQ-----KKYHLKGAIGQGSYGVVRVAIENQT----- 50
Query: 114 QCFYAMKVVDREALAIRKKLHRADM--EKVILTMLDHPFLPTLYAEFEASHYSCLVMEYC 171
+ A+K++++ + + E ++ L HP + LY +E Y CLVME C
Sbjct: 51 RAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELC 110
Query: 172 PGGDLY------------------------------AARQRQPGKRFGISSAKFY----A 197
GG L F S
Sbjct: 111 HGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLI 170
Query: 198 AET----LLALEYLHMMGIVYRDLKPENVLV--REDGHIMLSDFDLSFKCDVVPKLLRPK 251
+ AL YLH GI +RD+KPEN L + I L DF LS + +
Sbjct: 171 SNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYG 230
Query: 252 LS 253
++
Sbjct: 231 MT 232
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 4e-22
Identities = 31/114 (27%), Positives = 53/114 (46%), Gaps = 13/114 (11%)
Query: 327 KSFVGTHEYLAPEVISGQGH--GSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK 384
+ GT ++APEV++ G D W+ GV L+ +L G PF G N+ T+ +L K
Sbjct: 232 TTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNK 291
Query: 385 PLTFPRIGVSSSKEFEEV-VKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437
L F + + + +DL+S LL +N +R ++ +H +
Sbjct: 292 KLCFE------NPNYNVLSPLARDLLSNLLNRNVDERF----DAMRALQHPWIS 335
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 38/170 (22%), Positives = 67/170 (39%), Gaps = 30/170 (17%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKV-- 141
+++ LG G V C + YA+K++D ++ +
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPT-----CKEYAVKIIDVTGGGSFSAEEVQELREATL 71
Query: 142 ----ILTMLD-HPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFY 196
IL + HP + L +E + + LV + G+L+ ++
Sbjct: 72 KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDY----------LTEKVTL 121
Query: 197 ----AAET----LLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ L + LH + IV+RDLKPEN+L+ +D +I L+DF S
Sbjct: 122 SEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 171
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 3e-19
Identities = 40/128 (31%), Positives = 57/128 (44%), Gaps = 21/128 (16%)
Query: 327 KSFVGTHEYLAPEVISG------QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLIN 380
+ GT YLAPE+I G+G VD W+ GV +Y +L G+ PF L
Sbjct: 181 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM 240
Query: 381 ILKKPLTFPRIGVSSSKEFEEV---VKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437
I+ F S E+++ VK DL+S+ LV P+KR + E H FF+
Sbjct: 241 IMSGNYQFG------SPEWDDYSDTVK--DLVSRFLVVQPQKRY----TAEEALAHPFFQ 288
Query: 438 GINWALIR 445
+R
Sbjct: 289 QYVVEEVR 296
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 44/237 (18%), Positives = 89/237 (37%), Gaps = 23/237 (9%)
Query: 10 SDYDSSSSSITVPDSSRSFMSNLSFGSRRSSISLCSSSAADQTSLYNSHKPHKANQAAWE 69
S ++ + +P R + + + +++ + Q
Sbjct: 91 SKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEI 150
Query: 70 AMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAI 129
+ DH+ + LG+G G V+ R +A K V +
Sbjct: 151 KHDHVL--------DHYDIHEELGTGAFGVVHRVTERAT-----GNNFAAKFVMTPHESD 197
Query: 130 RKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFG 189
++ + + E +++L HP L L+ FE + ++ E+ GG+L+ ++ +
Sbjct: 198 KETVRK---EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELF---EKVADEHNK 251
Query: 190 IS--SAKFYAAETLLALEYLHMMGIVYRDLKPENVLV--REDGHIMLSDFDLSFKCD 242
+S A Y + L ++H V+ DLKPEN++ + + L DF L+ D
Sbjct: 252 MSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 2e-21
Identities = 33/96 (34%), Positives = 49/96 (51%), Gaps = 7/96 (7%)
Query: 327 KSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL 386
K GT E+ APEV G+ G D W++GV Y +L G +PF GEN+++TL N+
Sbjct: 314 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW 373
Query: 387 TFPRIGVSSSKEFEEVVKL-QDLISKLLVKNPKKRI 421
F + + +D I KLL+ +P R+
Sbjct: 374 NMD------DSAFSGISEDGKDFIRKLLLADPNTRM 403
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 78/412 (18%), Positives = 133/412 (32%), Gaps = 100/412 (24%)
Query: 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADM 138
G + + ++R+LG G V+L + F AMKVV + A
Sbjct: 32 GDLFNGRYHVIRKLGWGHFSTVWLSWDIQG-----KKFVAMKVV----KSAEHYTETALD 82
Query: 139 EKVILTML-----DHP---FLPTLYAEFEAS-----HYSCLVMEYCPGGDLYAARQRQPG 185
E +L + + P + L +F+ S H C+V E G L +
Sbjct: 83 EIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHI-CMVFEVL-GHHLLKWIIKSNY 140
Query: 186 KRFGISSAKFYAAETLLALEYLHM-MGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVV 244
+ + K + L L+YLH I++ D+KPEN+L+ + + + +
Sbjct: 141 QGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRS 200
Query: 245 PKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDG 304
P S A+ + P++P K +K V + +
Sbjct: 201 G---APPPSGSAVSTAPATAGNFLVNPLEP-----------KNAEKLKVKIADLGNACWV 246
Query: 305 DHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY 364
H E + T +Y + EV+ G G+ + D W+ +E+
Sbjct: 247 HKHFTED------------------IQTRQYRSLEVLIGSGYNTPADIWSTACMAFELAT 288
Query: 365 GTTPFKGENNEKTL---------INILKK-PLTFPRIGVSSSKEF--------------- 399
G F+ + E+ I +L K P G S + F
Sbjct: 289 GDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPW 348
Query: 400 --------------EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437
EE D + +L P+KR + E RH +
Sbjct: 349 GLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRA-TAA---ECLRHPWLN 396
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 38/169 (22%), Positives = 65/169 (38%), Gaps = 9/169 (5%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADME-KV 141
F L ++GSG+ G+V+ C R L C YA+K + LA A E
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKR-----LDGCIYAIKRSKKP-LAGSVDEQNALREVYA 63
Query: 142 ILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAA--RQRQPGKRFGISSAKFYAAE 199
+ H + ++ + + + EYC GG L A + F + K +
Sbjct: 64 HAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ 123
Query: 200 TLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLL 248
L Y+H M +V+ D+KP N+ + + + K++
Sbjct: 124 VGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVM 172
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 20/112 (17%), Positives = 39/112 (34%), Gaps = 16/112 (14%)
Query: 327 KSFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP 385
+ G +LA EV+ H D + L + + N I +
Sbjct: 188 QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP---RNGDQWHEIRQGR 244
Query: 386 LTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437
PRI S+EF +L+ ++ +P++R ++ + +H
Sbjct: 245 --LPRIPQVLSQEF------TELLKVMIHPDPERRP----SAMALVKHSVLL 284
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 3e-26
Identities = 39/161 (24%), Positives = 73/161 (45%), Gaps = 11/161 (6%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
D++ +L LGSG G V+ C + + K ++ + + E I+
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKAT-----GRVFVAKFINTPYPLDKYTVKN---EISIM 102
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLA 203
L HP L L+ FE + L++E+ GG+L+ R + + Y +
Sbjct: 103 NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELF-DRIAAEDYKMSEAEVINYMRQACEG 161
Query: 204 LEYLHMMGIVYRDLKPENVLV--REDGHIMLSDFDLSFKCD 242
L+++H IV+ D+KPEN++ ++ + + DF L+ K +
Sbjct: 162 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 6e-22
Identities = 32/96 (33%), Positives = 47/96 (48%), Gaps = 7/96 (7%)
Query: 327 KSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL 386
K T E+ APE++ + G D W +GV Y +L G +PF GE++ +TL N+ +
Sbjct: 208 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW 267
Query: 387 TFPRIGVSSSKEFEEVVKL-QDLISKLLVKNPKKRI 421
F F V +D I LL K P+KR+
Sbjct: 268 EFD------EDAFSSVSPEAKDFIKNLLQKEPRKRL 297
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-26
Identities = 37/169 (21%), Positives = 63/169 (37%), Gaps = 20/169 (11%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVI 142
L F ++ LG G G V+ + + + C YA+K + + E
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNK-----VDDCNYAIKRIRLPNRE--LAREKVMREVKA 56
Query: 143 LTMLDHPFLPTLYAEFE------------ASHYSCLVMEYCPGGDLYAA-RQRQPGKRFG 189
L L+HP + + + Y + M+ C +L R +
Sbjct: 57 LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE 116
Query: 190 ISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
S + A+E+LH G+++RDLKP N+ D + + DF L
Sbjct: 117 RSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLV 165
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 4e-20
Identities = 28/124 (22%), Positives = 51/124 (41%), Gaps = 14/124 (11%)
Query: 317 VVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEK 376
+ P AR VGT Y++PE I G + VD ++LG+ L+E+LY PF +
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERV 234
Query: 377 TLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436
+ ++ FP + ++ +L +P +R I + F
Sbjct: 235 RTLTDVRNL-KFPPLFTQKYPC------EYVMVQDMLSPSPMERP-EAI---NIIENAVF 283
Query: 437 KGIN 440
+ ++
Sbjct: 284 EDLD 287
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 8e-26
Identities = 33/166 (19%), Positives = 64/166 (38%), Gaps = 22/166 (13%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEK--V 141
+ + + LG G+ G V+ C + + Y K V K + ++K
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSS-----KKTYMAKFVKV------KGTDQVLVKKEIS 53
Query: 142 ILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLY---AARQRQPGKRFGISSAKFYAA 198
IL + H + L+ FE+ ++ E+ G D++ Y
Sbjct: 54 ILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTS----AFELNEREIVSYVH 109
Query: 199 ETLLALEYLHMMGIVYRDLKPENVLV--REDGHIMLSDFDLSFKCD 242
+ AL++LH I + D++PEN++ R I + +F + +
Sbjct: 110 QVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 31/96 (32%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 327 KSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL 386
+ EY APEV +A D W+LG +Y +L G PF E N++ + NI+
Sbjct: 161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY 220
Query: 387 TFPRIGVSSSKEFEEVVKL-QDLISKLLVKNPKKRI 421
TF + F+E+ D + +LLVK K R+
Sbjct: 221 TFD------EEAFKEISIEAMDFVDRLLVKERKSRM 250
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 42/176 (23%), Positives = 70/176 (39%), Gaps = 34/176 (19%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKV-- 141
D++ LGSG V C+ ++ YA K + + + E +
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKST-----GLQYAAKFIKKRRT--KSSRRGVSREDIER 63
Query: 142 ---ILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFY-- 196
IL + HP + TL+ +E L++E GG+L+ ++ +
Sbjct: 64 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDF----------LAEKESLTE 113
Query: 197 --AAET----LLALEYLHMMGIVYRDLKPENVLVR----EDGHIMLSDFDLSFKCD 242
A E L + YLH + I + DLKPEN+++ I + DF L+ K D
Sbjct: 114 EEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 7/96 (7%)
Query: 327 KSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL 386
K+ GT E++APE+++ + G D W++GV Y +L G +PF G+ ++TL N+
Sbjct: 175 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY 234
Query: 387 TFPRIGVSSSKEFEEVVKL-QDLISKLLVKNPKKRI 421
F + F L +D I +LLVK+PKKR+
Sbjct: 235 EFE------DEYFSNTSALAKDFIRRLLVKDPKKRM 264
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 43/171 (25%), Positives = 72/171 (42%), Gaps = 24/171 (14%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKV-- 141
D + + LGSG V C+ ++ YA K + + R E++
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKST-----GLEYAAKFIKKRQS--RASRRGVCREEIER 64
Query: 142 ---ILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLY---AARQRQPGKRFGISSAKF 195
IL + HP + TL+ +E L++E GG+L+ A ++ A
Sbjct: 65 EVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE-----SLSEEEATS 119
Query: 196 YAAETLLALEYLHMMGIVYRDLKPENVLVR----EDGHIMLSDFDLSFKCD 242
+ + L + YLH I + DLKPEN+++ HI L DF L+ + +
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 7/96 (7%)
Query: 327 KSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL 386
K+ GT E++APE+++ + G D W++GV Y +L G +PF G+ ++TL NI
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSY 235
Query: 387 TFPRIGVSSSKEFEEVVKL-QDLISKLLVKNPKKRI 421
F + F + +L +D I KLLVK +KR+
Sbjct: 236 DFD------EEFFSQTSELAKDFIRKLLVKETRKRL 265
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 42/171 (24%), Positives = 71/171 (41%), Gaps = 24/171 (14%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKV-- 141
D + + LGSG V C+ ++ YA K + + R E++
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKST-----GLEYAAKFIKKRQS--RASRRGVSREEIER 64
Query: 142 ---ILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLY---AARQRQPGKRFGISSAKF 195
IL + H + TL+ +E L++E GG+L+ A ++ A
Sbjct: 65 EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-----SLSEEEATS 119
Query: 196 YAAETLLALEYLHMMGIVYRDLKPENVLVR----EDGHIMLSDFDLSFKCD 242
+ + L + YLH I + DLKPEN+++ HI L DF L+ + +
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 34/96 (35%), Positives = 53/96 (55%), Gaps = 7/96 (7%)
Query: 327 KSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL 386
K+ GT E++APE+++ + G D W++GV Y +L G +PF G+ ++TL NI
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSY 235
Query: 387 TFPRIGVSSSKEFEEVVKL-QDLISKLLVKNPKKRI 421
F + F +L +D I KLLVK +KR+
Sbjct: 236 DFD------EEFFSHTSELAKDFIRKLLVKETRKRL 265
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 54/185 (29%), Positives = 85/185 (45%), Gaps = 27/185 (14%)
Query: 74 LRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALA----- 128
+R+ +G++G + + +R+LGSG G V LC+ +N A+KV+ +
Sbjct: 27 VRKKEGKIG-ESYFKVRKLGSGAYGEVLLCKEKNG-----HSEKAIKVIKKSQFDKGRYS 80
Query: 129 IRKKLHRADMEKV-----ILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLY---AAR 180
K E++ +L LDHP + L+ FE Y LV E+ GG+L+ R
Sbjct: 81 DDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR 140
Query: 181 QRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVR---EDGHIMLSDFDL 237
+F A + L + YLH IV+RD+KPEN+L+ +I + DF L
Sbjct: 141 -----HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGL 195
Query: 238 SFKCD 242
S
Sbjct: 196 SSFFS 200
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 2e-19
Identities = 26/98 (26%), Positives = 45/98 (45%), Gaps = 12/98 (12%)
Query: 327 KSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL 386
+ +GT Y+APEV+ + + D W+ GV +Y +L G PF G+N++ + + K
Sbjct: 206 RDRLGTAYYIAPEVLKKK-YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKY 264
Query: 387 TFPR---IGVSSSKEFEEVVKLQDLISKLLVKNPKKRI 421
F +S ++LI +L + KR
Sbjct: 265 YFDFNDWKNISDE--------AKELIKLMLTYDYNKRC 294
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 53/170 (31%), Positives = 73/170 (42%), Gaps = 31/170 (18%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
D F + LG G VY C+ + Q YA+KV+ + E +L
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGT-----QKPYALKVLKK-----TVDKKIVRTEIGVL 102
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFY----AAE 199
L HP + L FE LV+E GG+L+ R I +Y AA+
Sbjct: 103 LRLSHPNIIKLKEIFETPTEISLVLELVTGGELF---DR-------IVEKGYYSERDAAD 152
Query: 200 T----LLALEYLHMMGIVYRDLKPENVLVR---EDGHIMLSDFDLSFKCD 242
L A+ YLH GIV+RDLKPEN+L D + ++DF LS +
Sbjct: 153 AVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 6e-20
Identities = 34/97 (35%), Positives = 52/97 (53%), Gaps = 8/97 (8%)
Query: 327 KSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLIN-ILKKP 385
K+ GT Y APE++ G +G VD W++G+ Y +L G PF E ++ + IL
Sbjct: 208 KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCE 267
Query: 386 LTFPRIGVSSSKEFEEVVKL-QDLISKLLVKNPKKRI 421
F S ++EV +DL+ KL+V +PKKR+
Sbjct: 268 YYFI------SPWWDEVSLNAKDLVRKLIVLDPKKRL 298
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 43/188 (22%), Positives = 70/188 (37%), Gaps = 23/188 (12%)
Query: 58 HKPHKANQAAWEAMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFY 117
H H + + L V + +L+++GSG V+ + Y
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK------KQIY 55
Query: 118 AMKVVDREALAIRKKLHRADMEKV-----ILTMLDHPFLP--TLYAEFEASHYSCLVMEY 170
A+K V+ ++ ++ L L LY Y +VME
Sbjct: 56 AIKYVNL------EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC 109
Query: 171 CPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHI 230
DL + +++ K K Y L A+ +H GIV+ DLKP N L+ DG +
Sbjct: 110 G-NIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGML 165
Query: 231 MLSDFDLS 238
L DF ++
Sbjct: 166 KLIDFGIA 173
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 6e-21
Identities = 37/129 (28%), Positives = 52/129 (40%), Gaps = 27/129 (20%)
Query: 323 NARSKSFVGTHEYLAPEVISGQG-----------HGSAVDWWTLGVFLYEMLYGTTPFKG 371
+ S VGT Y+ PE I D W+LG LY M YG TPF+
Sbjct: 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241
Query: 372 -ENNEKTLINILKK--PLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSV 428
N L I+ + FP I LQD++ L ++PK+RI S+
Sbjct: 242 IINQISKLHAIIDPNHEIEFPDI-PEKD--------LQDVLKCCLKRDPKQRI-SIP--- 288
Query: 429 EIKRHEFFK 437
E+ H + +
Sbjct: 289 ELLAHPYVQ 297
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 41/163 (25%), Positives = 71/163 (43%), Gaps = 13/163 (7%)
Query: 84 DHFRLLRR--LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKV 141
+ + + LG G G V+ C+ A K++ + ++++ E
Sbjct: 87 SFYTVSKTEILGGGRFGQVHKCEETAT-----GLKLAAKIIKTRGMKDKEEVKN---EIS 138
Query: 142 ILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETL 201
++ LDH L LY FE+ + LVMEY GG+L+ R + +
Sbjct: 139 VMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF-DRIIDESYNLTELDTILFMKQIC 197
Query: 202 LALEYLHMMGIVYRDLKPENVLV--REDGHIMLSDFDLSFKCD 242
+ ++H M I++ DLKPEN+L R+ I + DF L+ +
Sbjct: 198 EGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK 240
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 5e-22
Identities = 35/96 (36%), Positives = 53/96 (55%), Gaps = 7/96 (7%)
Query: 327 KSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL 386
K GT E+LAPEV++ D W++GV Y +L G +PF G+N+ +TL NIL
Sbjct: 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRW 305
Query: 387 TFPRIGVSSSKEFEEVVKL-QDLISKLLVKNPKKRI 421
+EF+++ + ++ ISKLL+K RI
Sbjct: 306 DLE------DEEFQDISEEAKEFISKLLIKEKSWRI 335
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-24
Identities = 42/183 (22%), Positives = 70/183 (38%), Gaps = 30/183 (16%)
Query: 72 KRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRK 131
R + + + RLG+G G V + G A+K R+
Sbjct: 3 GRSPSLPTQT-CGPWEMKERLGTGGFGYVLRW--IHQDTGEQ---VAIKQ-------CRQ 49
Query: 132 KLHRADMEKV-----ILTMLDHPFLPTLYAEFE------ASHYSCLVMEYCPGGDLYAAR 180
+L + E+ I+ L+HP + + + + L MEYC GGDL
Sbjct: 50 ELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRK-Y 108
Query: 181 QRQPGKRFGIS--SAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGH---IMLSDF 235
Q G+ + ++ AL YLH I++RDLKPEN++++ + D
Sbjct: 109 LNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDL 168
Query: 236 DLS 238
+
Sbjct: 169 GYA 171
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 87.0 bits (215), Expect = 3e-18
Identities = 25/136 (18%), Positives = 52/136 (38%), Gaps = 19/136 (13%)
Query: 327 KSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL 386
FVGT +YLAPE++ + + VD+W+ G +E + G PF +++
Sbjct: 181 TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKS 240
Query: 387 TFPRIGVSSSK---EFEEVV------------KLQDLISKLLVKNPKKRIGSLKGSVEIK 431
+ +F V+ KL+ + +L+ + ++R +
Sbjct: 241 NEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDP----QNP 296
Query: 432 RHEFFKGINWALIRSI 447
F+ ++ L +
Sbjct: 297 NVGCFQALDSILSLKL 312
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-24
Identities = 48/165 (29%), Positives = 77/165 (46%), Gaps = 11/165 (6%)
Query: 76 RAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHR 135
+ GRV + H+ L LG G G V + + + G A+K+++R+ + + +
Sbjct: 3 KHDGRVKIGHYVLGDTLGVGTFGKVKIG--EHQLTGHK---VAVKILNRQKIRSLDVVGK 57
Query: 136 ADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDL--YAARQRQPGKRFGISSA 193
E L + HP + LY +VMEY GG+L Y + R A
Sbjct: 58 IKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKH----GRVEEMEA 113
Query: 194 KFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ + L A++Y H +V+RDLKPENVL+ + ++DF LS
Sbjct: 114 RRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS 158
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-18
Identities = 37/112 (33%), Positives = 55/112 (49%), Gaps = 14/112 (12%)
Query: 327 KSFVGTHEYLAPEVISGQG-HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP 385
++ G+ Y APEVISG+ G VD W+ GV LY +L GT PF E+ I
Sbjct: 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV 227
Query: 386 LTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437
P ++ S + L+ +L +P KR ++K +I+ HE+FK
Sbjct: 228 FYIPEY-LNRS--------VATLLMHMLQVDPLKRA-TIK---DIREHEWFK 266
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 9e-24
Identities = 39/198 (19%), Positives = 76/198 (38%), Gaps = 28/198 (14%)
Query: 58 HKPHKANQAAWEAMKRLRRAQGRVGLDHFRLLRR-LGSGDIGNVYLCQIRNPMVGLPQCF 116
H H ++ ++ + + L + LG G V C ++
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMENFN-NFYILTSKELGRGKFAVVRQCISKST-----GQE 56
Query: 117 YAMKVVDREALAIRKKLHRADMEKV-----ILTMLDH-PFLPTLYAEFEASHYSCLVMEY 170
YA K + + ++ + ++ +L + P + L+ +E + L++EY
Sbjct: 57 YAAKFLKK------RRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEY 110
Query: 171 CPGGDLYAARQRQPGKRFGISS---AKFYAAETLLALEYLHMMGIVYRDLKPENVLV--- 224
GG+++ + + S + L + YLH IV+ DLKP+N+L+
Sbjct: 111 AAGGEIF---SLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSI 167
Query: 225 REDGHIMLSDFDLSFKCD 242
G I + DF +S K
Sbjct: 168 YPLGDIKIVDFGMSRKIG 185
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 36/96 (37%), Positives = 56/96 (58%), Gaps = 7/96 (7%)
Query: 327 KSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL 386
+ +GT EYLAPE+++ +A D W +G+ Y +L T+PF GE+N++T +NI + +
Sbjct: 191 REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNV 250
Query: 387 TFPRIGVSSSKEFEEVVKL-QDLISKLLVKNPKKRI 421
+ + F V +L D I LLVKNP+KR
Sbjct: 251 DYS------EETFSSVSQLATDFIQSLLVKNPEKRP 280
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 38/161 (23%), Positives = 69/161 (42%), Gaps = 33/161 (20%)
Query: 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-H 148
+ LG G C + +A+K++ + + E L + + H
Sbjct: 17 KPLGEGSFSICRKCVHKKS-----NQAFAVKIISK------RMEANTQKEITALKLCEGH 65
Query: 149 PFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFY----AAET---- 200
P + L+ F ++ LVME GG+L+ +R I K + A+
Sbjct: 66 PNIVKLHEVFHDQLHTFLVMELLNGGELF---ER-------IKKKKHFSETEASYIMRKL 115
Query: 201 LLALEYLHMMGIVYRDLKPENVLVR---EDGHIMLSDFDLS 238
+ A+ ++H +G+V+RDLKPEN+L ++ I + DF +
Sbjct: 116 VSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFA 156
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 38/150 (25%), Positives = 62/150 (41%), Gaps = 22/150 (14%)
Query: 317 VVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEK 376
+ P N K+ T Y APE+++ G+ + D W+LGV LY ML G PF+ +
Sbjct: 157 RLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSL 216
Query: 377 TLIN-------ILKKPLTFPR---IGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKG 426
T + I K +F VS K DLI LL +P KR+
Sbjct: 217 TCTSAVEIMKKIKKGDFSFEGEAWKNVSQE------AK--DLIQGLLTVDPNKRL----K 264
Query: 427 SVEIKRHEFFKGINWALIRSIKPPEVPNND 456
++ +E+ + + + P++ +
Sbjct: 265 MSGLRYNEWLQDGSQLSSNPLMTPDILGSS 294
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 40/166 (24%), Positives = 65/166 (39%), Gaps = 23/166 (13%)
Query: 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADME 139
V + +L+++GSG V+ + YA+K V+ ++ ++
Sbjct: 5 SVKGRIYSILKQIGSGGSSKVFQVLNEK------KQIYAIKYVNL------EEADNQTLD 52
Query: 140 KV-----ILTMLDHPFLP--TLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISS 192
L L LY Y +VME DL + +++ K
Sbjct: 53 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKK--KSIDPWE 109
Query: 193 AKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
K Y L A+ +H GIV+ DLKP N L+ DG + L DF ++
Sbjct: 110 RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIA 154
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-20
Identities = 36/125 (28%), Positives = 51/125 (40%), Gaps = 27/125 (21%)
Query: 327 KSFVGTHEYLAPEVISGQG-----------HGSAVDWWTLGVFLYEMLYGTTPFKGENNE 375
S VGT Y+ PE I D W+LG LY M YG TPF+ N+
Sbjct: 167 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 226
Query: 376 -KTLINILKK--PLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKR 432
L I+ + FP LQD++ L ++PK+RI S+ E+
Sbjct: 227 ISKLHAIIDPNHEIEFPD-IPEKD--------LQDVLKCCLKRDPKQRI-SIP---ELLA 273
Query: 433 HEFFK 437
H + +
Sbjct: 274 HPYVQ 278
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 17/140 (12%), Positives = 39/140 (27%), Gaps = 33/140 (23%)
Query: 325 RSKSFVGTHEYLAPEVISGQG-----------HGSAVDWWTLGVFLYEMLYGTTPFKGEN 373
+ + PE+ + + + D W LG+ +Y + P +
Sbjct: 258 ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDA 317
Query: 374 NEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433
I + P + V + L+ L + R+ L +
Sbjct: 318 ALGGSEWIFRSCKNIP----------QPV---RALLEGFLRYPKEDRLLPL----QAMET 360
Query: 434 EFFKGINWALIRSIKPPEVP 453
++ +R+ +P
Sbjct: 361 PEYEQ-----LRTELSAALP 375
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 95.1 bits (236), Expect = 2e-21
Identities = 20/188 (10%), Positives = 49/188 (26%), Gaps = 38/188 (20%)
Query: 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILT 144
LG D + G + + V + + E + L
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQET--GES---FEVHVPYFTERPPSNAIKQMKEEVLRLR 128
Query: 145 ML-------------------------DHPFLPTLYAEFEASHYS--CLVMEYCPG---- 173
+L + + + +
Sbjct: 129 LLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQT 188
Query: 174 -GDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIML 232
G++ + K + + + L LH G+V+ L+P ++++ + G + L
Sbjct: 189 FGEVLLSHSST-HKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFL 247
Query: 233 SDFDLSFK 240
+ F+ +
Sbjct: 248 TGFEHLVR 255
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 49/177 (27%), Positives = 88/177 (49%), Gaps = 26/177 (14%)
Query: 70 AMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAI 129
++ Q +G ++RLL+ +G G+ V L R+ + G A+K++D+
Sbjct: 3 SIASCADEQPHIG--NYRLLKTIGKGNFAKVKLA--RHILTGRE---VAIKIIDKT---- 51
Query: 130 RKKLHRADMEKV-----ILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLY---AARQ 181
+L+ ++K+ I+ +L+HP + L+ E L+MEY GG+++ A
Sbjct: 52 --QLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG 109
Query: 182 RQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
R K A+ + + A++Y H IV+RDLK EN+L+ D +I ++DF S
Sbjct: 110 RMKEKE-----ARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFS 161
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 4e-20
Identities = 37/132 (28%), Positives = 64/132 (48%), Gaps = 15/132 (11%)
Query: 327 KSFVGTHEYLAPEVISGQG-HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP 385
+F G Y APE+ G+ G VD W+LGV LY ++ G+ PF G+N ++ +L+
Sbjct: 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 230
Query: 386 LTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK-GINWALI 444
P +S+ ++L+ + LV NP KR +L+ +I + + G +
Sbjct: 231 YRIPF-YMSTD--------CENLLKRFLVLNPIKRG-TLE---QIMKDRWINAGHEEDEL 277
Query: 445 RSIKPPEVPNND 456
+ PE+ +D
Sbjct: 278 KPFVEPELDISD 289
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 4e-23
Identities = 42/162 (25%), Positives = 72/162 (44%), Gaps = 13/162 (8%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKV- 141
+ + LGSG G V+ + +K + +E + + + KV
Sbjct: 23 SQKYSTMSPLGSGAFGFVWTA--VDKEKNKE---VVVKFIKKEKVLEDCWIEDPKLGKVT 77
Query: 142 ----ILTMLDHPFLPTLYAEFEASHYSCLVME-YCPGGDLYAARQRQPGKRFGISSAKFY 196
IL+ ++H + + FE + LVME + G DL+A R P R A +
Sbjct: 78 LEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYI 135
Query: 197 AAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ + A+ YL + I++RD+K EN+++ ED I L DF +
Sbjct: 136 FRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 9e-17
Identities = 34/135 (25%), Positives = 60/135 (44%), Gaps = 23/135 (17%)
Query: 327 KSFVGTHEYLAPEVISGQG-HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP 385
+F GT EY APEV+ G G ++ W+LGV LY +++ PF E+ ++
Sbjct: 187 YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF--CELEE----TVEAA 240
Query: 386 LTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF-KGINWA-- 442
+ P + VS L L+S LL P++R +L+ ++ + + +N A
Sbjct: 241 IHPPYL-VSKE--------LMSLVSGLLQPVPERRT-TLE---KLVTDPWVTQPVNLADY 287
Query: 443 LIRSIKPPEVPNNDL 457
+ P + +
Sbjct: 288 TWEEVFRVNKPESGV 302
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 4e-23
Identities = 40/182 (21%), Positives = 74/182 (40%), Gaps = 34/182 (18%)
Query: 69 EAMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALA 128
+++L R + D + + +G G C + +A+K++D+
Sbjct: 8 SIVQQLHRNSIQF-TDGYEVKEDIGVGSYSVCKRCIHKAT-----NMEFAVKIIDKSKRD 61
Query: 129 IRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRF 188
++ +++L HP + TL ++ Y +V E GG+L +
Sbjct: 62 PTEE------IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELL---DK------ 106
Query: 189 GISSAKFY----AAET----LLALEYLHMMGIVYRDLKPENVLVREDGH----IMLSDFD 236
I KF+ A+ +EYLH G+V+RDLKP N+L ++ I + DF
Sbjct: 107 -ILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFG 165
Query: 237 LS 238
+
Sbjct: 166 FA 167
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 37/141 (26%), Positives = 60/141 (42%), Gaps = 18/141 (12%)
Query: 320 EPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPF---KGENNEK 376
N + T ++APEV+ QG+ +A D W+LGV LY ML G TPF + E+
Sbjct: 171 RAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEE 230
Query: 377 TLINILKKPLTFPRIGVSSSKEFEEV---VKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433
L I + + V K DL+SK+L +P +R+ + + RH
Sbjct: 231 ILARIGSGKFSLS------GGYWNSVSDTAK--DLVSKMLHVDPHQRL----TAALVLRH 278
Query: 434 EFFKGINWALIRSIKPPEVPN 454
+ + + + P+
Sbjct: 279 PWIVHWDQLPQYQLNRQDAPH 299
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 5e-23
Identities = 46/172 (26%), Positives = 80/172 (46%), Gaps = 17/172 (9%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALA-IRKKLHRADMEKV 141
++ + L++ LG G G V L N + A+K+VD + + + + E
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLA--VNRVTEEA---VAVKIVDMKRAVDCPENIKK---EIC 57
Query: 142 ILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDL--YAARQRQPGKRFGISSAKFYAAE 199
I ML+H + Y + L +EYC GG+L A+ + +
Sbjct: 58 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQ 113
Query: 200 TLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS--FKCDVVPKLLR 249
+ + YLH +GI +RD+KPEN+L+ E ++ +SDF L+ F+ + +LL
Sbjct: 114 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 5e-19
Identities = 28/113 (24%), Positives = 49/113 (43%), Gaps = 13/113 (11%)
Query: 327 KSFVGTHEYLAPEVISGQG-HGSAVDWWTLGVFLYEMLYGTTPFKGE-NNEKTLINILKK 384
GT Y+APE++ + H VD W+ G+ L ML G P+ ++ + + +K
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK 224
Query: 385 PLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437
S L+ K+LV+NP RI ++ +IK+ ++
Sbjct: 225 KTYLNPWKKIDS-------APLALLHKILVENPSARI-TIP---DIKKDRWYN 266
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 99.0 bits (246), Expect = 8e-23
Identities = 33/186 (17%), Positives = 53/186 (28%), Gaps = 35/186 (18%)
Query: 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILT 144
+L+ L GD V+L R+ +A+KV A R +L R
Sbjct: 63 KLKLVEPLRVGDRSVVFLV--RDVERLED---FALKVFTMGAENSRSELERLHEATFAAA 117
Query: 145 MLDHPFLPTLYAEF--------------------------EASHYSCLVMEYCPG--GDL 176
L A L+M L
Sbjct: 118 RLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELL 177
Query: 177 YAARQRQP--GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSD 234
++ GI + A+ + L G+V+ P+N+ + DG +ML D
Sbjct: 178 FSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGD 237
Query: 235 FDLSFK 240
+K
Sbjct: 238 VSALWK 243
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 94.0 bits (233), Expect = 3e-21
Identities = 34/284 (11%), Positives = 75/284 (26%), Gaps = 28/284 (9%)
Query: 177 YAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFD 236
+ R + + F + A + LE LH L E+ D +L D
Sbjct: 79 FLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSD 138
Query: 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSI-PSCATPMQPVLSCFSSVSHGKKNKKKAVTV 295
P + + + P+ + ++ + S V + ++
Sbjct: 139 A-VAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALH 197
Query: 296 TTIREQVDGDHHDQE-------------LLDDPEVV-------AEPINARSKSFVGTHEY 335
+ + + Q + + + R + Y
Sbjct: 198 ILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTY 257
Query: 336 LAPEVISGQG--HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGV 393
E ++ A++ W LG+ +Y + PF +
Sbjct: 258 APREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSL 317
Query: 394 SSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437
+ ++ LI + L + ++R+ L E F
Sbjct: 318 AFGSCTPLPDFVKTLIGRFLNFDRRRRLLPL----EAMETPEFL 357
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-22
Identities = 44/168 (26%), Positives = 68/168 (40%), Gaps = 31/168 (18%)
Query: 84 DHFRLLRR-LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVI 142
D ++L LG G V C YA+K+++++ IR ++ R E +
Sbjct: 12 DVYQLQEDVLGEGAHARVQTCINLIT-----SQEYAVKIIEKQPGHIRSRVFR---EVEM 63
Query: 143 LTML-DHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFY----A 197
L H + L FE LV E GG + + I + + A
Sbjct: 64 LYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSH----------IHKRRHFNELEA 113
Query: 198 AET----LLALEYLHMMGIVYRDLKPENVLVR---EDGHIMLSDFDLS 238
+ AL++LH GI +RDLKPEN+L + + + DFDL
Sbjct: 114 SVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLG 161
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 5e-15
Identities = 34/133 (25%), Positives = 52/133 (39%), Gaps = 31/133 (23%)
Query: 312 LDDPEVVAEPINARSKSFVGTHEYLAPEVISGQ-----GHGSAVDWWTLGVFLYEMLYGT 366
+ + + G+ EY+APEV+ + D W+LGV LY +L G
Sbjct: 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGY 223
Query: 367 TPFKGENNEKTLIN---------------ILKKPLTFPRIGVSSSKEFEEV---VKLQDL 408
PF G + I + FP K++ + K DL
Sbjct: 224 PPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFP------DKDWAHISCAAK--DL 275
Query: 409 ISKLLVKNPKKRI 421
ISKLLV++ K+R+
Sbjct: 276 ISKLLVRDAKQRL 288
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 1e-22
Identities = 46/172 (26%), Positives = 80/172 (46%), Gaps = 17/172 (9%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALA-IRKKLHRADMEKV 141
++ + L++ LG G G V L N + A+K+VD + + + + E
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLA--VNRVTEEA---VAVKIVDMKRAVDCPENIKK---EIC 57
Query: 142 ILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDL--YAARQRQPGKRFGISSAKFYAAE 199
I ML+H + Y + L +EYC GG+L A+ + +
Sbjct: 58 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQ 113
Query: 200 TLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS--FKCDVVPKLLR 249
+ + YLH +GI +RD+KPEN+L+ E ++ +SDF L+ F+ + +LL
Sbjct: 114 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 5e-19
Identities = 30/133 (22%), Positives = 54/133 (40%), Gaps = 14/133 (10%)
Query: 327 KSFVGTHEYLAPEVISGQG-HGSAVDWWTLGVFLYEMLYGTTPF-KGENNEKTLINILKK 384
GT Y+APE++ + H VD W+ G+ L ML G P+ + ++ + + +K
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK 224
Query: 385 PLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF-KGINWAL 443
S L+ K+LV+NP RI ++ +IK+ ++ K +
Sbjct: 225 KTYLNPWKKIDS-------APLALLHKILVENPSARI-TIP---DIKKDRWYNKPLKKGA 273
Query: 444 IRSIKPPEVPNND 456
R +
Sbjct: 274 KRPRVTSGGVSES 286
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-22
Identities = 42/169 (24%), Positives = 68/169 (40%), Gaps = 25/169 (14%)
Query: 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALA----IRKKLHR 135
+G + + LG G G V + C A+K++ ++ L + +
Sbjct: 3 LIG--KYLMGDLLGEGSYGKVKEV--LDSETL---CRRAVKILKKKKLRRIPNGEANVKK 55
Query: 136 ADMEKVILTMLDHPFLPTLY--AEFEASHYSCLVMEYCPGGDL----YAARQRQPGKRFG 189
E +L L H + L E +VMEYC G KRF
Sbjct: 56 ---EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-----KRFP 107
Query: 190 ISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ A Y + + LEYLH GIV++D+KP N+L+ G + +S ++
Sbjct: 108 VCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVA 156
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-20
Identities = 38/134 (28%), Positives = 56/134 (41%), Gaps = 16/134 (11%)
Query: 331 GTHEYLAPEVISGQG--HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTF 388
G+ + PE+ +G G VD W+ GV LY + G PF+G+N K NI K
Sbjct: 173 GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAI 232
Query: 389 PRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF-KGINWALIRSI 447
P L DL+ +L P KR S++ +I++H +F K A
Sbjct: 233 PG-DCGPP--------LSDLLKGMLEYEPAKRF-SIR---QIRQHSWFRKKHPPAEAPVP 279
Query: 448 KPPEVPNNDLYCKI 461
PP D + +
Sbjct: 280 IPPSPDTKDRWRSM 293
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 40/190 (21%), Positives = 75/190 (39%), Gaps = 24/190 (12%)
Query: 60 PHKANQAAWEAMKRLRRAQGRVG--LDHFRLLRR-LGSGDIGNVYLCQIRNPMVGLPQCF 116
H + + + + + D ++L ++ LG G G V C R
Sbjct: 2 AHHHHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRT-----GQK 56
Query: 117 YAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAEFEASHYSC----LVMEYC 171
A+K++ A + E P + + +E H+ ++ME
Sbjct: 57 CALKLLYDSPKARQ--------EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECM 108
Query: 172 PGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLV---REDG 228
GG+L++ Q + + F A + A+++LH I +RD+KPEN+L +D
Sbjct: 109 EGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDA 168
Query: 229 HIMLSDFDLS 238
+ L+DF +
Sbjct: 169 VLKLTDFGFA 178
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 28/102 (27%), Positives = 47/102 (46%), Gaps = 15/102 (14%)
Query: 327 KSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK-- 384
++ T Y+APEV+ + + + D W+LGV +Y +L G PF + + ++
Sbjct: 187 QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIR 246
Query: 385 --PLTFPRIGVSSSKEFEEV---VKLQDLISKLLVKNPKKRI 421
FP + E+ EV K LI LL +P +R+
Sbjct: 247 LGQYGFP------NPEWSEVSEDAK--QLIRLLLKTDPTERL 280
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 3e-22
Identities = 47/170 (27%), Positives = 79/170 (46%), Gaps = 11/170 (6%)
Query: 71 MKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIR 130
M ++ GRV + H+ L LG G G V + ++ + G A+K+++R+ +
Sbjct: 3 MAEKQKHDGRVKIGHYILGDTLGVGTFGKVKVG--KHELTGHK---VAVKILNRQKIRSL 57
Query: 131 KKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDL--YAARQRQPGKRF 188
+ + E L + HP + LY +VMEY GG+L Y + R
Sbjct: 58 DVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKN----GRL 113
Query: 189 GISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
++ + L ++Y H +V+RDLKPENVL+ + ++DF LS
Sbjct: 114 DEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS 163
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 3e-17
Identities = 36/112 (32%), Positives = 56/112 (50%), Gaps = 14/112 (12%)
Query: 327 KSFVGTHEYLAPEVISGQG-HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP 385
++ G+ Y APEVISG+ G VD W+ GV LY +L GT PF ++ I
Sbjct: 173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI 232
Query: 386 LTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437
P+ ++ S + L+ +L +P KR ++K +I+ HE+FK
Sbjct: 233 FYTPQ-YLNPS--------VISLLKHMLQVDPMKRA-TIK---DIREHEWFK 271
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 3e-22
Identities = 40/166 (24%), Positives = 65/166 (39%), Gaps = 23/166 (13%)
Query: 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADME 139
V + +L+++GSG V+ + YA+K V+ ++ ++
Sbjct: 52 SVKGRIYSILKQIGSGGSSKVFQVLNEK------KQIYAIKYVNL------EEADNQTLD 99
Query: 140 KV-----ILTMLDHPFLP--TLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISS 192
L L LY Y +VME DL + +++ K
Sbjct: 100 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKK--KSIDPWE 156
Query: 193 AKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
K Y L A+ +H GIV+ DLKP N L+ DG + L DF ++
Sbjct: 157 RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIA 201
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 36/125 (28%), Positives = 51/125 (40%), Gaps = 27/125 (21%)
Query: 327 KSFVGTHEYLAPEVISGQG-----------HGSAVDWWTLGVFLYEMLYGTTPFKGENNE 375
S VG Y+ PE I D W+LG LY M YG TPF+ N+
Sbjct: 214 DSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 273
Query: 376 -KTLINILKK--PLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKR 432
L I+ + FP I LQD++ L ++PK+RI S+ E+
Sbjct: 274 ISKLHAIIDPNHEIEFPDI-PEKD--------LQDVLKCCLKRDPKQRI-SIP---ELLA 320
Query: 433 HEFFK 437
H + +
Sbjct: 321 HPYVQ 325
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 4e-22
Identities = 48/209 (22%), Positives = 78/209 (37%), Gaps = 21/209 (10%)
Query: 31 NLSFGSRRSSISLCSSSAADQTSLYNSHKPHKANQAAWEAMKRLRRAQG--RVGLDHFRL 88
++S G S SL + ++ L P + ++L+ R +
Sbjct: 4 SVSSGQAHSLASLAKTWSSGSAKLQ-RLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTH 62
Query: 89 LRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKV-ILTMLD 147
R+G G G V+ ++ G A+K V L +E++ L
Sbjct: 63 QPRVGRGSFGEVHRM--KDKQTGF---QCAVKKVR---------LEVFRVEELVACAGLS 108
Query: 148 HPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYL 207
P + LY + + ME GG L + + A +Y + L LEYL
Sbjct: 109 SPRIVPLYGAVREGPWVNIFMELLEGGSL--GQLIKQMGCLPEDRALYYLGQALEGLEYL 166
Query: 208 HMMGIVYRDLKPENVLVREDG-HIMLSDF 235
H I++ D+K +NVL+ DG L DF
Sbjct: 167 HTRRILHGDVKADNVLLSSDGSRAALCDF 195
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 23/97 (23%), Positives = 35/97 (36%), Gaps = 6/97 (6%)
Query: 324 ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILK 383
GT ++APEV+ G+ + VD W+ + ML G P+ + I
Sbjct: 211 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS 270
Query: 384 KPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKR 420
+P I S + I + L K P R
Sbjct: 271 EPPPIREIPPSCAPLT------AQAIQEGLRKEPVHR 301
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 42/160 (26%), Positives = 68/160 (42%), Gaps = 17/160 (10%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVI 142
D + ++ +GSG+ G L R+ + A+K ++R A I + + R E +
Sbjct: 19 SDRYDFVKDIGSGNFGVARLM--RDKLTKEL---VAVKYIERGAA-IDENVQR---EIIN 69
Query: 143 LTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDL--YAARQRQPGKRFGISSAKFYAAET 200
L HP + + ++MEY GG+L RF A+F+ +
Sbjct: 70 HRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNA----GRFSEDEARFFFQQL 125
Query: 201 LLALEYLHMMGIVYRDLKPENVLVRED--GHIMLSDFDLS 238
L + Y H M I +RDLK EN L+ + + DF S
Sbjct: 126 LSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS 165
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 42/116 (36%), Positives = 54/116 (46%), Gaps = 16/116 (13%)
Query: 327 KSFVGTHEYLAPEVISGQG-HGSAVDWWTLGVFLYEMLYGTTPFKGENNE----KTLINI 381
KS VGT Y+APEV+ Q G D W+ GV LY ML G PF+ KT+ I
Sbjct: 175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRI 234
Query: 382 LKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437
L + P S + LIS++ V +P RI S+ EIK H +F
Sbjct: 235 LSVKYSIPDDIRISP-------ECCHLISRIFVADPATRI-SIP---EIKTHSWFL 279
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 2e-21
Identities = 44/166 (26%), Positives = 73/166 (43%), Gaps = 24/166 (14%)
Query: 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVV----DREALAIRKKLH 134
G + + + + G +G +YL RN + +K + D EA A
Sbjct: 75 GDIVAGQYEVKGCIAHGGLGWIYLALDRN----VNGRPVVLKGLVHSGDAEAQA------ 124
Query: 135 RADMEKVILTMLDHPFLPTLY-----AEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFG 189
A E+ L + HP + ++ + +VMEY G L ++ + +
Sbjct: 125 MAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLP 180
Query: 190 ISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235
++ A Y E L AL YLH +G+VY DLKPEN+++ E+ + L D
Sbjct: 181 VAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDL 225
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 18/96 (18%), Positives = 33/96 (34%), Gaps = 16/96 (16%)
Query: 328 SFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLT 387
GT + APE++ G A D +T+G L + G + P
Sbjct: 236 YLYGTPGFQAPEIVRT-GPTVATDIYTVGRTLAALTLDLPTRNGRYVDGL-------PED 287
Query: 388 FPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGS 423
P + S L+ + + +P++R +
Sbjct: 288 DPVLKTYDS--------YGRLLRRAIDPDPRQRFTT 315
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 4e-21
Identities = 42/177 (23%), Positives = 67/177 (37%), Gaps = 30/177 (16%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
+ + LG G G V G P A+K + + A ME +L
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQ---GRP---VAVKRMLID------FCDIALMEIKLL 62
Query: 144 TMLD-HPFLPTLYAEFEASHYSCLVMEYCPGG--DLYAARQ--RQPGKRFGISSAKFYAA 198
T D HP + Y + + +E C DL ++ + K +
Sbjct: 63 TESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLR 122
Query: 199 ETLLALEYLHMMGIVYRDLKPENVLV-------------REDGHIMLSDFDLSFKCD 242
+ + +LH + I++RDLKP+N+LV E+ I++SDF L K D
Sbjct: 123 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 24/123 (19%), Positives = 52/123 (42%), Gaps = 16/123 (13%)
Query: 324 ARSKSFVGTHEYLAPEVISGQGH-------GSAVDWWTLGVFLYEML-YGTTPFKGENNE 375
+ GT + APE++ + ++D +++G Y +L G PF + +
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246
Query: 376 KTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEF 435
++ NI++ + + + DLIS+++ +P KR ++++ RH
Sbjct: 247 ES--NIIRGIFSLDEMKCLHDRSLIAEAT--DLISQMIDHDPLKRP----TAMKVLRHPL 298
Query: 436 FKG 438
F
Sbjct: 299 FWP 301
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 6e-21
Identities = 41/190 (21%), Positives = 72/190 (37%), Gaps = 21/190 (11%)
Query: 57 SHKPHKANQAAWEAMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCF 116
P + L+ + + D+ + LG G G V + Q
Sbjct: 35 PPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRT-----QEK 89
Query: 117 YAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAEFE----ASHYSCLVMEYC 171
+A+K++ A R E + P + + +E +VME
Sbjct: 90 FALKMLQDCPKARR--------EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 141
Query: 172 PGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLV---REDG 228
GG+L++ Q + + F A A++YLH + I +RD+KPEN+L R +
Sbjct: 142 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNA 201
Query: 229 HIMLSDFDLS 238
+ L+DF +
Sbjct: 202 ILKLTDFGFA 211
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 30/102 (29%), Positives = 44/102 (43%), Gaps = 15/102 (14%)
Query: 327 KSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKT----LINIL 382
+ T Y+APEV+ + + + D W+LGV +Y +L G PF + I
Sbjct: 221 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 280
Query: 383 KKPLTFPRIGVSSSKEFEEV---VKLQDLISKLLVKNPKKRI 421
FP + E+ EV VK LI LL P +R+
Sbjct: 281 MGQYEFP------NPEWSEVSEEVK--MLIRNLLKTEPTQRM 314
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 9e-21
Identities = 48/205 (23%), Positives = 77/205 (37%), Gaps = 22/205 (10%)
Query: 45 SSSAADQTSLYNSHKPHKANQAAWEAMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQ 104
S +S H A A K + +++ LGSG G+VY
Sbjct: 4 SHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG- 62
Query: 105 IRNPMVGLPQCFYAMKVVDREAL---AIRKKLHRADMEKVILTMLDHPFLP---TLYAEF 158
LP A+K V+++ + R ME V+L + F L F
Sbjct: 63 -IRVSDNLP---VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF-SGVIRLLDWF 117
Query: 159 EASHYSCLVMEYC-PGGDLY---AARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVY 214
E L++E P DL+ R + A+ + + L A+ + H G+++
Sbjct: 118 ERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARSFFWQVLEAVRHCHNCGVLH 172
Query: 215 RDLKPENVLV-REDGHIMLSDFDLS 238
RD+K EN+L+ G + L DF
Sbjct: 173 RDIKDENILIDLNRGELKLIDFGSG 197
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 5e-20
Identities = 35/133 (26%), Positives = 53/133 (39%), Gaps = 27/133 (20%)
Query: 327 KSFVGTHEYLAPEVISGQG-HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP 385
F GT Y PE I HG + W+LG+ LY+M+ G PF+ + I++
Sbjct: 206 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQ 259
Query: 386 LTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIR 445
+ F + VSS Q LI L P R + + EI+ H + + +
Sbjct: 260 VFFRQ-RVSSE--------CQHLIRWCLALRPSDRP-TFE---EIQNHPWMQDVL----- 301
Query: 446 SIKPPEVPNNDLY 458
P E L+
Sbjct: 302 --LPQETAEIHLH 312
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 44/162 (27%), Positives = 67/162 (41%), Gaps = 21/162 (12%)
Query: 84 DHFRLLRRLGSGDIGNVY--LCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKV 141
D + L +GSG V C + V A+K ++ E ++ K
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKV-------AIKRINLEKCQTSMD----ELLKE 63
Query: 142 ILTM--LDHPFLPTLYAEFEASHYSCLVMEYCPGG---DLYAARQRQPGKRFGISSAKFY 196
I M HP + + Y F LVM+ GG D+ + + G+
Sbjct: 64 IQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTI 123
Query: 197 AA---ETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235
A E L LEYLH G ++RD+K N+L+ EDG + ++DF
Sbjct: 124 ATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADF 165
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 5e-12
Identities = 34/121 (28%), Positives = 57/121 (47%), Gaps = 10/121 (8%)
Query: 321 PINARSKSFVGTHEYLAPEVIS-GQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLI 379
N K+FVGT ++APEV+ +G+ D W+ G+ E+ G P+ K L+
Sbjct: 178 TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM 237
Query: 380 NILKKP---LTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436
L+ L K++ + + +IS L K+P+KR + E+ RH+FF
Sbjct: 238 LTLQNDPPSLETGVQDKEMLKKYGKSFR--KMISLCLQKDPEKR----PTAAELLRHKFF 291
Query: 437 K 437
+
Sbjct: 292 Q 292
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-20
Identities = 43/149 (28%), Positives = 65/149 (43%), Gaps = 10/149 (6%)
Query: 92 LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFL 151
LG G G VY R+ + A+K + + LH E + L H +
Sbjct: 30 LGKGTYGIVYAG--RDLSNQV---RIAIKEIPERDSRYSQPLHE---EIALHKHLKHKNI 81
Query: 152 PTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGK-RFGISSAKFYAAETLLALEYLHMM 210
F + + + ME PGG L A + + G + + FY + L L+YLH
Sbjct: 82 VQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN 141
Query: 211 GIVYRDLKPENVLV-REDGHIMLSDFDLS 238
IV+RD+K +NVL+ G + +SDF S
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTS 170
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 32/102 (31%), Positives = 47/102 (46%), Gaps = 10/102 (9%)
Query: 322 INARSKSFVGTHEYLAPEVISG--QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNE-KTL 378
IN +++F GT +Y+APE+I +G+G A D W+LG + EM G PF +
Sbjct: 176 INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM 235
Query: 379 INILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKR 420
+ + P I S S E + I K +P KR
Sbjct: 236 FKVGMFKVH-PEIPESMSAEA------KAFILKCFEPDPDKR 270
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-20
Identities = 41/187 (21%), Positives = 71/187 (37%), Gaps = 30/187 (16%)
Query: 74 LRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKL 133
L+ + + D+ + LG G G V + Q +A+K++ A R
Sbjct: 8 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRT-----QEKFALKMLQDCPKARR--- 59
Query: 134 HRADMEKVILT-MLDHPFLPTLYAEFE----ASHYSCLVMEYCPGGDLYAARQRQPGKRF 188
E + P + + +E +VME GG+L++ Q + + F
Sbjct: 60 -----EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 114
Query: 189 GISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVR---EDGHIMLSDFDL-------- 237
A A++YLH + I +RD+KPEN+L + + L+DF
Sbjct: 115 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEK 174
Query: 238 -SFKCDV 243
CD+
Sbjct: 175 YDKSCDM 181
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 5e-14
Identities = 26/93 (27%), Positives = 35/93 (37%), Gaps = 16/93 (17%)
Query: 336 LAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKT----LINILKKPLTFPR- 390
A E G+ + + D W+LGV +Y +L G PF + I FP
Sbjct: 166 FAKETT-GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 224
Query: 391 --IGVSSSKEFEEVVKLQDLISKLLVKNPKKRI 421
VS VK LI LL P +R+
Sbjct: 225 EWSEVSEE------VK--MLIRNLLKTEPTQRM 249
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 46/167 (27%), Positives = 77/167 (46%), Gaps = 14/167 (8%)
Query: 74 LRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKL 133
+ ++ +G + + LG G G V L + A+K + R+ L
Sbjct: 1 MAISKRHIG--PYIIRETLGEGSFGKVKLA--THYKTQQK---VALKFISRQLLKKSDMH 53
Query: 134 HRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDL--YAARQRQPGKRFGIS 191
R + E L +L HP + LY +V+EY GG+L Y + KR
Sbjct: 54 MRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEK----KRMTED 108
Query: 192 SAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ + + + A+EY H IV+RDLKPEN+L+ ++ ++ ++DF LS
Sbjct: 109 EGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLS 155
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 7e-18
Identities = 35/112 (31%), Positives = 53/112 (47%), Gaps = 14/112 (12%)
Query: 327 KSFVGTHEYLAPEVISGQG-HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP 385
K+ G+ Y APEVI+G+ G VD W+ G+ LY ML G PF E +
Sbjct: 165 KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCV 224
Query: 386 LTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437
P +S Q LI +++V +P +RI +++ EI+R +F
Sbjct: 225 YVMPDF-LSPG--------AQSLIRRMIVADPMQRI-TIQ---EIRRDPWFN 263
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 92.0 bits (228), Expect = 3e-20
Identities = 23/185 (12%), Positives = 48/185 (25%), Gaps = 38/185 (20%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVD--------------REALAIR- 130
LG D + G + + V E L +R
Sbjct: 80 LVRGTVLGQEDPYAYLEA--TDQETGES---FEVHVPYFTERPPSNAIKQMKEEVLRLRL 134
Query: 131 ----KKLHRADMEKVILTMLDHPFLPTLYAEFEASHYS--------CLVMEYCPG----- 173
K +A + + D P +
Sbjct: 135 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 194
Query: 174 GDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLS 233
G++ + + + + L LH G+V+ L+P ++++ + G + L+
Sbjct: 195 GEVLLSHSSTHK-SLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLT 253
Query: 234 DFDLS 238
F+
Sbjct: 254 GFEHL 258
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 90.9 bits (225), Expect = 6e-20
Identities = 18/134 (13%), Positives = 38/134 (28%), Gaps = 22/134 (16%)
Query: 325 RSKSFVGTHEYLAPEVISGQGHG-----SAVDWWTLGVFLYEMLYGTTPFKGENNEKTLI 379
E A ++ H A D WTLG+ +Y + P +
Sbjct: 268 PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSE 327
Query: 380 NILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439
I + P+ ++ L+ L + R+ L + ++ +
Sbjct: 328 WIFRSCKNIPQP-------------VRALLEGFLRYPKEDRLLPL----QAMETPEYEQL 370
Query: 440 NWALIRSIKPPEVP 453
L ++ +
Sbjct: 371 RTELSAALPLYQTD 384
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 3e-20
Identities = 29/159 (18%), Positives = 48/159 (30%), Gaps = 13/159 (8%)
Query: 79 GRVGLDHFRLLRRLGSGDIGNVYLC--QIRNPMVGLPQCFYAMKVVDREALAIRKKLHRA 136
R+ +RLL G + + V A+ VD + + L
Sbjct: 26 ARIANGRYRLLIFHGGVPPLQFWQALDTALDRQV-------ALTFVDPQGVLPDDVLQET 78
Query: 137 DMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFY 196
+ L+ +D P + + +V E+ GG L P A
Sbjct: 79 LSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPV----GAIRA 134
Query: 197 AAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235
A + H G+ P V V DG ++L+
Sbjct: 135 MQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYP 173
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 9/92 (9%), Positives = 25/92 (27%), Gaps = 11/92 (11%)
Query: 330 VGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFP 389
+ + D +G LY +L P L + P
Sbjct: 170 LAYPATMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQP 222
Query: 390 RIGVSSSKEFEEV-VKLQDLISKLLVKNPKKR 420
+ + ++ ++ + ++ + + R
Sbjct: 223 ---IEPADIDRDIPFQISAVAARSVQGDGGIR 251
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 3e-20
Identities = 42/204 (20%), Positives = 68/204 (33%), Gaps = 23/204 (11%)
Query: 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADME 139
+G R+ R L G VY Q YA+K + +K E
Sbjct: 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGS-----GREYALKRLLSNE---EEKNRAIIQE 75
Query: 140 KVILTML-DHPFLPTLYAEFEASHYS--------CLVMEYCPGGDLYAARQRQPGKRFGI 190
+ L HP + + L+ E C G + ++ +
Sbjct: 76 VCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSC 135
Query: 191 SSAKFYAAETLLALEYLHMMG--IVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLL 248
+ +T A++++H I++RDLK EN+L+ G I L DF + P
Sbjct: 136 DTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYS 195
Query: 249 RPKLSFEAIEKYEKCSIPSCATPM 272
+E+ I TPM
Sbjct: 196 WSAQRRALVEE----EITRNTTPM 215
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 3e-15
Identities = 23/96 (23%), Positives = 35/96 (36%), Gaps = 14/96 (14%)
Query: 329 FVGTHEYLAPEVI---SGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP 385
T Y PE+I S G D W LG LY + + PF+ + I+
Sbjct: 210 RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR----IVNGK 265
Query: 386 LTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRI 421
+ P + LI +L NP++R+
Sbjct: 266 YSIPPHDTQYT-------VFHSLIRAMLQVNPEERL 294
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 5e-20
Identities = 51/188 (27%), Positives = 77/188 (40%), Gaps = 25/188 (13%)
Query: 58 HKPHKANQAAWEAMKRLRRAQGRVG--LDHFRLLRRLGSGDIGNVYL--CQIRNPMVGLP 113
H H ++ A+ R G +RL R +G G +G+VY +R +V
Sbjct: 6 HHHHHSSGLVPRGSHMDGTAESREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIV--- 62
Query: 114 QCFYAMKVVDREALA----IRKKLHRADMEKVILTMLDHPFLPTLY--AEFEASHYSCLV 167
A+K++ E L+ R ++ R E L P + ++ E + Y +
Sbjct: 63 ----ALKLM-SETLSSDPVFRTRMQR---EARTAGRLQEPHVVPIHDFGEIDGQLY--VD 112
Query: 168 MEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRED 227
M G DL AA R+ G A + AL+ H G +RD+KPEN+LV D
Sbjct: 113 MRLINGVDL-AAMLRRQG-PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSAD 170
Query: 228 GHIMLSDF 235
L DF
Sbjct: 171 DFAYLVDF 178
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 5e-09
Identities = 25/98 (25%), Positives = 43/98 (43%), Gaps = 16/98 (16%)
Query: 328 SFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLT 387
+ VGT Y+APE S D + L LYE L G+ P++G+ ++++ +
Sbjct: 194 NTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ-----LSVMGAHIN 248
Query: 388 FPRIGVSS-----SKEFEEVVKLQDLISKLLVKNPKKR 420
S+ F+ V I++ + KNP+ R
Sbjct: 249 QAIPRPSTVRPGIPVAFDAV------IARGMAKNPEDR 280
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 7e-20
Identities = 40/169 (23%), Positives = 59/169 (34%), Gaps = 20/169 (11%)
Query: 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADME 139
VG F LG G G + + + A+K + E AD E
Sbjct: 20 IVGKISFCPKDVLGHGAEGTIVYRGMFD---NRD---VAVKRILPE------CFSFADRE 67
Query: 140 KVILTMLD-HPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAA 198
+L D HP + + + + + +E C L Q
Sbjct: 68 VQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATL-QEYVEQKDFAHLGLEPITLLQ 125
Query: 199 ETLLALEYLHMMGIVYRDLKPENVLVREDGH-----IMLSDFDLSFKCD 242
+T L +LH + IV+RDLKP N+L+ M+SDF L K
Sbjct: 126 QTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 3e-17
Identities = 25/119 (21%), Positives = 47/119 (39%), Gaps = 14/119 (11%)
Query: 324 ARSKSFVGTHEYLAPEVISG---QGHGSAVDWWTLGVFLYEML-YGTTPFKGENNEKTLI 379
+R GT ++APE++S + VD ++ G Y ++ G+ PF + I
Sbjct: 181 SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI 240
Query: 380 NILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438
+ L ++LI K++ +P+KR + + +H FF
Sbjct: 241 LLGACSLDCLHPEKHEDVIA------RELIEKMIAMDPQKRP----SAKHVLKHPFFWS 289
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 8e-20
Identities = 34/112 (30%), Positives = 45/112 (40%), Gaps = 20/112 (17%)
Query: 327 KSFVGTHEYLAPEVISGQG-HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP 385
F GT Y PE IS H W+LG+ LY+M+ G PF+ + IL+
Sbjct: 196 TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAE 249
Query: 386 LTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437
L FP VS LI + L P R SL+ EI + +
Sbjct: 250 LHFPA-HVSPD--------CCALIRRCLAPKPSSRP-SLE---EILLDPWMQ 288
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 39/168 (23%), Positives = 65/168 (38%), Gaps = 22/168 (13%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREAL---AIRKKLHRADME 139
+RL LG G G V+ L A+KV+ R + + +E
Sbjct: 30 EAEYRLGPLLGKGGFGTVFAG--HRLTDRLQ---VAIKVIPRNRVLGWSPLSDSVTCPLE 84
Query: 140 KVILTMLD----HPFLPTLYAEFEASHYSCLVMEY-CPGGDLY---AARQRQPGKRFGIS 191
+L + HP + L FE LV+E P DL+ +
Sbjct: 85 VALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGP---- 140
Query: 192 SAKFYAAETLLALEYLHMMGIVYRDLKPENVLV-REDGHIMLSDFDLS 238
++ + + + A+++ H G+V+RD+K EN+L+ G L DF
Sbjct: 141 -SRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 4e-19
Identities = 33/161 (20%), Positives = 57/161 (35%), Gaps = 13/161 (8%)
Query: 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDRE-ALAIRKKLHRADM 138
+ + L +G G G+V + A+K + +K+L M
Sbjct: 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPS-----GQIMAVKRIRSTVDEKEQKQLL---M 69
Query: 139 E-KVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGG--DLYAARQRQPGKRFGISSAKF 195
+ V++ D P++ Y + ME Y
Sbjct: 70 DLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGK 129
Query: 196 YAAETLLALEYLH-MMGIVYRDLKPENVLVREDGHIMLSDF 235
T+ AL +L + I++RD+KP N+L+ G+I L DF
Sbjct: 130 ITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDF 170
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 30/127 (23%), Positives = 55/127 (43%), Gaps = 14/127 (11%)
Query: 317 VVAEPINARSKS-FVGTHEYLAPEVISGQGHGSA----VDWWTLGVFLYEMLYGTTPFKG 371
+ + +++ +K+ G Y+APE I D W+LG+ LYE+ G P+
Sbjct: 172 ISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK 231
Query: 372 ENNEKTLIN-ILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEI 430
N+ + ++K P++ S +EF + ++ L K+ KR K E+
Sbjct: 232 WNSVFDQLTQVVKGDP--PQLSNSEEREFSP--SFINFVNLCLTKDESKR-PKYK---EL 283
Query: 431 KRHEFFK 437
+H F
Sbjct: 284 LKHPFIL 290
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 6e-19
Identities = 40/162 (24%), Positives = 65/162 (40%), Gaps = 18/162 (11%)
Query: 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREA-LAIRKKLHRAD 137
G + D F + LG+G+ G V+ + A K++ E AIR ++
Sbjct: 28 GELKDDDFEKISELGAGNGGVVFKVSHKPS-----GLVMARKLIHLEIKPAIRNQII--- 79
Query: 138 MEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGG---DLYAARQRQPGKRFGISSAK 194
E +L + P++ Y F + + ME+ GG + + R
Sbjct: 80 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-----KKAGRIPEQILG 134
Query: 195 FYAAETLLALEYLHMMG-IVYRDLKPENVLVREDGHIMLSDF 235
+ + L YL I++RD+KP N+LV G I L DF
Sbjct: 135 KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDF 176
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 6e-09
Identities = 19/91 (20%), Positives = 37/91 (40%)
Query: 317 VVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEK 376
V + I++ + SFVGT Y++PE + G + D W++G+ L EM G P + ++
Sbjct: 178 VSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 237
Query: 377 TLINILKKPLTFPRIGVSSSKEFEEVVKLQD 407
+ + + +
Sbjct: 238 LELMFGCQVEGDAAETPPRPRTPGRPLNKFG 268
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 87.3 bits (216), Expect = 7e-19
Identities = 35/159 (22%), Positives = 63/159 (39%), Gaps = 18/159 (11%)
Query: 84 DHFRLLRRLGSG--DIGNVY--LCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADME 139
+ LL +G G D+ V + V ++ ++ EA + + + E
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYV-------TVRRINLEACS-NEMVTFLQGE 76
Query: 140 KVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGG---DLYAARQRQPGKRFGISSAKFY 196
+ + +HP + A F A + +V + G DL I+ +
Sbjct: 77 LHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIA---YI 133
Query: 197 AAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235
L AL+Y+H MG V+R +K ++L+ DG + LS
Sbjct: 134 LQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGL 172
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 30/159 (18%), Positives = 55/159 (34%), Gaps = 47/159 (29%)
Query: 322 INARSKSFVGTHEYLAPEVI--SGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLI 379
++ K V +L+PEV+ + QG+ + D +++G+ E+ G PFK + L+
Sbjct: 188 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL 247
Query: 380 NILKKPLTFPRIGVSSSKEFEEVV------------------------------------ 403
L + P + +S+ EE+
Sbjct: 248 EKLNGTV--PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRT 305
Query: 404 ---KLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439
+ + L +NP R + + H FFK I
Sbjct: 306 FSPHFHHFVEQCLQRNPDAR----PSASTLLNHSFFKQI 340
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 8e-19
Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 19/161 (11%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVI 142
+ +G G G V + R V A+K ++ E+ RK E
Sbjct: 7 YKEIEVEEVVGRGAFGVVCKAKWRAKDV-------AIKQIESESE--RKAFIV---ELRQ 54
Query: 143 LTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAA-RQRQPGKRFGISSAKFYAAETL 201
L+ ++HP + LY + CLVMEY GG LY +P + + A + +
Sbjct: 55 LSRVNHPNIVKLYG-ACLNPV-CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112
Query: 202 LALEYLHMM---GIVYRDLKPENVLVREDGHIM-LSDFDLS 238
+ YLH M +++RDLKP N+L+ G ++ + DF +
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 153
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 13/50 (26%), Positives = 24/50 (48%)
Query: 322 INARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKG 371
I + G+ ++APEV G + D ++ G+ L+E++ PF
Sbjct: 156 IQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDE 205
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-18
Identities = 42/157 (26%), Positives = 69/157 (43%), Gaps = 20/157 (12%)
Query: 84 DHFRLLRRLGSGDIGNVY--LCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKV 141
+ F L ++G G G V+ + +V A+K++D E + + E
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVV-------AIKIIDLEEAEDEIEDIQQ--EIT 72
Query: 142 ILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGG---DLYAARQRQPGKRFGISSAKFYAA 198
+L+ D P++ Y + ++MEY GG DL +PG +
Sbjct: 73 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-----EPGP-LDETQIATILR 126
Query: 199 ETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235
E L L+YLH ++RD+K NVL+ E G + L+DF
Sbjct: 127 EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADF 163
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 31/114 (27%), Positives = 49/114 (42%), Gaps = 12/114 (10%)
Query: 324 ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILK 383
+ +FVGT ++APEVI + S D W+LG+ E+ G P + K L I K
Sbjct: 174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK 233
Query: 384 KPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437
P + + SK ++ + L K P R + E+ +H+F
Sbjct: 234 NNP--PTLEGNYSKPL------KEFVEACLNKEPSFR----PTAKELLKHKFIL 275
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 37/160 (23%), Positives = 61/160 (38%), Gaps = 12/160 (7%)
Query: 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDRE-ALAIRKKLHRADM 138
V D + LG G G V + A+K + +K+L M
Sbjct: 3 EVKADDLEPIMELGRGAYGVVEKMRHVPS-----GQIMAVKRIRATVNSQEQKRLL---M 54
Query: 139 E-KVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGG-DLYAARQRQPGKRFGISSAKFY 196
+ + + +D PF T Y + ME D + + G+
Sbjct: 55 DLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKI 114
Query: 197 AAETLLALEYLHM-MGIVYRDLKPENVLVREDGHIMLSDF 235
A + ALE+LH + +++RD+KP NVL+ G + + DF
Sbjct: 115 AVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDF 154
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 2e-09
Identities = 29/116 (25%), Positives = 50/116 (43%), Gaps = 18/116 (15%)
Query: 328 SFVGTHEYLAPEVISGQGHGSA----VDWWTLGVFLYEMLYGTTPFKGENNE-KTLINIL 382
G Y+APE I+ + + D W+LG+ + E+ P+ + L ++
Sbjct: 168 IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV 227
Query: 383 KKPLTFPRIGVSS-SKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437
++P P++ S EF D S+ L KN K+R + E+ +H FF
Sbjct: 228 EEPS--PQLPADKFSAEF------VDFTSQCLKKNSKER-PTYP---ELMQHPFFT 271
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 3e-18
Identities = 42/155 (27%), Positives = 70/155 (45%), Gaps = 15/155 (9%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
+ + ++ LG G G VY + + A KV++ ++ ++L +E IL
Sbjct: 19 EVWEIVGELGDGAFGKVYKAKNKET-----GALAAAKVIETKS---EEELEDYIVEIEIL 70
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGG---DLYAARQRQPGKRFGISSAKFYAAET 200
DHP++ L + +++E+CPGG + R I +
Sbjct: 71 ATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR-GLTEPQIQ---VVCRQM 126
Query: 201 LLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235
L AL +LH I++RDLK NVL+ +G I L+DF
Sbjct: 127 LEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADF 161
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 33/123 (26%), Positives = 50/123 (40%), Gaps = 19/123 (15%)
Query: 322 INARSKSFVGTHEYLAPEVI-----SGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEK 376
+ SF+GT ++APEV+ + D W+LG+ L EM P N +
Sbjct: 170 TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR 229
Query: 377 TLINILKKPLTFPRIGVSS--SKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHE 434
L+ I K P + S S EF +D + L KNP+ R + ++ H
Sbjct: 230 VLLKIAKSDP--PTLLTPSKWSVEF------RDFLKIALDKNPETR----PSAAQLLEHP 277
Query: 435 FFK 437
F
Sbjct: 278 FVS 280
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-17
Identities = 39/200 (19%), Positives = 71/200 (35%), Gaps = 28/200 (14%)
Query: 45 SSSAADQTSLYNSHKPHKANQAAWEAMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQ 104
S D + N + + + + + ++G+G G V+ +
Sbjct: 9 PMSDYDIPTTENLYFQGAMDGDDMD-----------IPWCDLNIKEKIGAGSFGTVHRAE 57
Query: 105 IRNPMVGLPQCFYAMKVVDREAL--AIRKKLHRADMEKVILTMLDHPFLPTLY-AEFEAS 161
V A+K++ + + R E I+ L HP + A +
Sbjct: 58 WHGSDV-------AVKILMEQDFHAERVNEFLR---EVAIMKRLRHPNIVLFMGAVTQPP 107
Query: 162 HYSCLVMEYCPGGDLYAA-RQRQPGKRFGISSAKFYAAETLLALEYLHMMG--IVYRDLK 218
+ +V EY G LY + ++ A + + YLH IV+R+LK
Sbjct: 108 NL-SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLK 166
Query: 219 PENVLVREDGHIMLSDFDLS 238
N+LV + + + DF LS
Sbjct: 167 SPNLLVDKKYTVKVCDFGLS 186
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 6e-07
Identities = 23/95 (24%), Positives = 40/95 (42%), Gaps = 7/95 (7%)
Query: 326 SKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP 385
SKS GT E++APEV+ + D ++ GV L+E+ P+ N + + + K
Sbjct: 196 SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC 255
Query: 386 LTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKR 420
I + + + + +I P KR
Sbjct: 256 KR-LEIPRNLNPQ------VAAIIEGCWTNEPWKR 283
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 36/159 (22%), Positives = 63/159 (39%), Gaps = 13/159 (8%)
Query: 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDRE-ALAIRKKLHRADM 138
+ ++ L +GSG G V+ + R A+K + R K++ M
Sbjct: 21 QAEINDLENLGEMGSGTCGQVWKMRFRKT-----GHVIAVKQMRRSGNKEENKRIL---M 72
Query: 139 E-KVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYA 197
+ V+L D P++ + F + + ME +++
Sbjct: 73 DLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAE--KLKKRMQGPIPERILGKMT 130
Query: 198 AETLLALEYLH-MMGIVYRDLKPENVLVREDGHIMLSDF 235
+ AL YL G+++RD+KP N+L+ E G I L DF
Sbjct: 131 VAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDF 169
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 32/164 (19%), Positives = 61/164 (37%), Gaps = 25/164 (15%)
Query: 317 VVAEPINARSK-SFVGTHEYLAPEVI-----SGQGHGSAVDWWTLGVFLYEMLYGTTPFK 370
+ ++ ++K G Y+APE I + + D W+LG+ L E+ G P+K
Sbjct: 171 ISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYK 230
Query: 371 GENNE-KTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVE 429
+ + L +L++ + S +F Q + L K+ +KR +
Sbjct: 231 NCKTDFEVLTKVLQEEPPLLPGHMGFSGDF------QSFVKDCLTKDHRKR----PKYNK 280
Query: 430 IKRHEFFKGINWALIRSIKPPEVPNNDLYCKIKKKVYVPKLSKQ 473
+ H F I+ + EV + + K P+
Sbjct: 281 LLEHSF--------IKRYETLEVDVASWFKDVMAKTESPRSGPS 316
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 44/160 (27%), Positives = 68/160 (42%), Gaps = 27/160 (16%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKV-- 141
+ F +L +LG G G+VY + A+K V E+ D++++
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKET-----GQIVAIKQVPVES----------DLQEIIK 73
Query: 142 ---ILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGG---DLYAARQRQPGKRFGISSAKF 195
I+ D P + Y + + +VMEYC G D+ R K
Sbjct: 74 EISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR----NKTLTEDEIAT 129
Query: 196 YAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235
TL LEYLH M ++RD+K N+L+ +GH L+DF
Sbjct: 130 ILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADF 169
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 30/119 (25%), Positives = 52/119 (43%), Gaps = 14/119 (11%)
Query: 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLIN 380
A+ + +GT ++APEVI G+ D W+LG+ EM G P+ + + +
Sbjct: 177 DTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFM 236
Query: 381 ILKKPLTFPRIGVSS--SKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437
I P P S F D + + LVK+P++R + ++ +H F +
Sbjct: 237 IPTNPP--PTFRKPELWSDNF------TDFVKQCLVKSPEQR----ATATQLLQHPFVR 283
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 42/167 (25%), Positives = 69/167 (41%), Gaps = 26/167 (15%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
F L+ +G+G G VY + A+KV+D ++++ I
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKT-----GQLAAIKVMDVTGDEEE------EIKQEIN 72
Query: 144 TML---DHPFLPTLYAEFEASHYSC------LVMEYCPGG---DLYAARQRQPGKRFGIS 191
+ H + T Y F + LVME+C G DL + K I+
Sbjct: 73 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA 132
Query: 192 SAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ E L L +LH +++RD+K +NVL+ E+ + L DF +S
Sbjct: 133 ---YICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 41/163 (25%), Positives = 65/163 (39%), Gaps = 27/163 (16%)
Query: 323 NARSKSFVGTHEYLAPEVI-----SGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKT 377
R +F+GT ++APEVI + D W+LG+ EM G P + +
Sbjct: 183 VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA 242
Query: 378 LINILKKPLTFPRI-GVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436
L I + P PR+ SK+F Q I LVKN +R + ++ +H F
Sbjct: 243 LFLIPRNP--APRLKSKKWSKKF------QSFIESCLVKNHSQR----PATEQLMKHPFI 290
Query: 437 KGINWALIRSIKPPEVPNNDLYCKIKKKVYVPKLSKQERDAPY 479
+ + + + D + KKK + K E + Y
Sbjct: 291 RD-----QPNERQVRIQLKDHIDRTKKK----RGEKDETEYEY 324
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 35/154 (22%), Positives = 63/154 (40%), Gaps = 15/154 (9%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
+ ++G G G VY A++ ++ ++++ + + IL
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVAT-----GQEVAIRQMN-----LQQQPKKELIINEIL 69
Query: 144 TM--LDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETL 201
M +P + + +VMEY GG L I+ E L
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA---AVCRECL 126
Query: 202 LALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235
ALE+LH +++RD+K +N+L+ DG + L+DF
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDF 160
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 33/119 (27%), Positives = 58/119 (48%), Gaps = 14/119 (11%)
Query: 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLIN 380
P ++ + VGT ++APEV++ + +G VD W+LG+ EM+ G P+ EN + L
Sbjct: 168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL 227
Query: 381 ILKKPLTFPRIGVSS--SKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437
I P + S F +D +++ L + +KR + E+ +H+F K
Sbjct: 228 IATNGT--PELQNPEKLSAIF------RDFLNRCLEMDVEKR----GSAKELLQHQFLK 274
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 3e-17
Identities = 29/164 (17%), Positives = 54/164 (32%), Gaps = 18/164 (10%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREAL--AIRKKLHRADMEK 140
L +L G ++ + + + +KV+ + + E
Sbjct: 9 FKQLNFLTKLNENHSGELWKGRWQGNDI-------VVKVLKVRDWSTRKSRDFNE---EC 58
Query: 141 VILTMLDHPFLPTLYA---EFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYA 197
L + HP + + A H L+ + P G LY S A +A
Sbjct: 59 PRLRIFSHPNVLPVLGACQSPPAPHP-TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFA 117
Query: 198 AETLLALEYLHMMG--IVYRDLKPENVLVREDGHIMLSDFDLSF 239
+ + +LH + I L +V++ ED +S D+ F
Sbjct: 118 LDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF 161
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 4e-06
Identities = 20/98 (20%), Positives = 41/98 (41%), Gaps = 10/98 (10%)
Query: 326 SKSFVGTHEYLAPEVISGQGHGS---AVDWWTLGVFLYEMLYGTTPFKGENNEKTLINIL 382
S + ++APE + + + + D W+ V L+E++ PF +N + + +
Sbjct: 165 SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVA 224
Query: 383 KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKR 420
+ L P I S + L+ + ++P KR
Sbjct: 225 LEGLR-PTIPPGISPH------VSKLMKICMNEDPAKR 255
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 43/154 (27%), Positives = 61/154 (39%), Gaps = 11/154 (7%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
F LR +G G G VY + A+K + +K E L
Sbjct: 54 KLFSDLREIGHGSFGAVYFARDVRN-----SEVVAIKKMSYSGKQSNEKWQDIIKEVRFL 108
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGG--DLYAARQRQPGKRFGISSAKFYAAETL 201
L HP + H + LVMEYC G DL ++ P + I+ L
Sbjct: 109 QKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIA---AVTHGAL 164
Query: 202 LALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235
L YLH +++RD+K N+L+ E G + L DF
Sbjct: 165 QGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDF 198
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 31/118 (26%), Positives = 48/118 (40%), Gaps = 16/118 (13%)
Query: 324 ARSKSFVGTHEYLAPEVISGQ---GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLIN 380
A + SFVGT ++APEVI + VD W+LG+ E+ P N L +
Sbjct: 205 APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 264
Query: 381 ILKKPLTFPRIGVSS-SKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437
I + P + S+ F ++ + L K P+ R S + +H F
Sbjct: 265 IAQNES--PALQSGHWSEYF------RNFVDSCLQKIPQDR----PTSEVLLKHRFVL 310
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 5e-17
Identities = 39/154 (25%), Positives = 66/154 (42%), Gaps = 15/154 (9%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIR--NPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKV 141
++G G G V L + + V A+K++D R++L E V
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQV-------AVKMMDLRK-QQRRELLFN--EVV 94
Query: 142 ILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETL 201
I+ H + +Y + ++ME+ GG L + I+ L
Sbjct: 95 IMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIA---TVCEAVL 151
Query: 202 LALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235
AL YLH G+++RD+K +++L+ DG + LSDF
Sbjct: 152 QALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDF 185
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 32/119 (26%), Positives = 59/119 (49%), Gaps = 14/119 (11%)
Query: 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLIN 380
+ KS VGT ++APEVIS + + VD W+LG+ + EM+ G P+ ++ + +
Sbjct: 193 KDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR 252
Query: 381 ILKKPLTFPRIGVSS--SKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437
+ P P++ S S +D + ++LV++P++R + E+ H F
Sbjct: 253 LRDSPP--PKLKNSHKVSPVL------RDFLERMLVRDPQER----ATAQELLDHPFLL 299
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 6e-17
Identities = 40/162 (24%), Positives = 76/162 (46%), Gaps = 17/162 (10%)
Query: 79 GRVGLDHFRLLRRLGSGDIGNVYL--CQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRA 136
G++ + ++++ +LG G + VYL I N V A+K + + L R
Sbjct: 6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKV-------AIKAIFIPPREKEETLKRF 58
Query: 137 DMEKVILTMLDHPFLPTLY--AEFEASHYSCLVMEYCPGGDLYAARQR-QPGKRFGISSA 193
+ E + L H + ++ E + +Y LVMEY G L + + + +A
Sbjct: 59 EREVHNSSQLSHQNIVSMIDVDEEDDCYY--LVMEYIEGPTL---SEYIESHGPLSVDTA 113
Query: 194 KFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235
+ + L +++ H M IV+RD+KP+N+L+ + + + DF
Sbjct: 114 INFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDF 155
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 1e-08
Identities = 26/93 (27%), Positives = 44/93 (47%), Gaps = 4/93 (4%)
Query: 328 SFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLT 387
+GT +Y +PE G+ D +++G+ LYEML G PF GE T ++I K +
Sbjct: 171 HVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE----TAVSIAIKHIQ 226
Query: 388 FPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKR 420
V++ + L ++I + K+ R
Sbjct: 227 DSVPNVTTDVRKDIPQSLSNVILRATEKDKANR 259
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 34/160 (21%), Positives = 58/160 (36%), Gaps = 15/160 (9%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTM 145
+ +G G VY + A + L + + R E +L
Sbjct: 28 LKFDIEIGRGSFKTVYKG-----LDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKG 81
Query: 146 LDHP----FLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETL 201
L HP F + + + LV E G L +R K I + + + L
Sbjct: 82 LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQIL 139
Query: 202 LALEYLHMMG--IVYRDLKPENVLV-REDGHIMLSDFDLS 238
L++LH I++RDLK +N+ + G + + D L+
Sbjct: 140 KGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 24/118 (20%), Positives = 53/118 (44%), Gaps = 17/118 (14%)
Query: 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINIL 382
+ +K+ +GT E++APE+ + + +VD + G+ + EM P+ N + +
Sbjct: 184 ASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV 242
Query: 383 ---KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437
KP +F ++ + E +++I + +N +R ++ H FF+
Sbjct: 243 TSGVKPASFDKV---AIPEV------KEIIEGCIRQNKDERY----SIKDLLNHAFFQ 287
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 5e-16
Identities = 36/157 (22%), Positives = 63/157 (40%), Gaps = 15/157 (9%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREAL--AIRKKLHRADMEKV 141
+ +R+GSG G VY + + A+K+++ A + E
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKWHGDV--------AVKMLNVTAPTPQQLQAFKN---EVG 72
Query: 142 ILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETL 201
+L H + A +V ++C G LY +F + A +T
Sbjct: 73 VLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHA-SETKFEMKKLIDIARQTA 130
Query: 202 LALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
++YLH I++RDLK N+ + ED + + DF L+
Sbjct: 131 RGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLA 167
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 22/104 (21%), Positives = 46/104 (44%), Gaps = 12/104 (11%)
Query: 323 NARSKSFVGTHEYLAPEVISGQGHG---SAVDWWTLGVFLYEMLYGTTPFKGENNEKTLI 379
+ + + G+ ++APEVI Q D + G+ LYE++ G P+ NN +I
Sbjct: 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII 235
Query: 380 NILKK---PLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKR 420
++ + ++ + K ++ L+++ L K +R
Sbjct: 236 EMVGRGSLSPDLSKVRSNCPKR------MKRLMAECLKKKRDER 273
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 5e-16
Identities = 43/218 (19%), Positives = 75/218 (34%), Gaps = 55/218 (25%)
Query: 88 LLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD 147
LL +G G G V+ + V A+K+ +K + E ML
Sbjct: 12 LLECVGKGRYGEVWRGSWQGENV-------AVKIFSSRD----EKSWFRETELYNTVMLR 60
Query: 148 HPFLPTLY-AEFEASHYS---CLVMEYCPGGDLYAARQRQPGK-----RFGISSAKFYAA 198
H + ++ + H S L+ Y G LY Q R +S A
Sbjct: 61 HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIAS---- 116
Query: 199 ETLLALEYLHM--------MGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVV------ 244
L +LH+ I +RDLK +N+LV+++G ++D L+
Sbjct: 117 ----GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDV 172
Query: 245 -------------PKLLRPKLSFEAIEKYEKCSIPSCA 269
P++L + + + Y++ I +
Sbjct: 173 GNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFG 210
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 7e-16
Identities = 39/173 (22%), Positives = 68/173 (39%), Gaps = 31/173 (17%)
Query: 83 LDHFRLLRRLGSGDIGNVYL--CQIRNPMVGLPQCFYAMKVV-------DREALAIRKKL 133
+ +++G G G V+ +V A+K + + E + ++
Sbjct: 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVV-------AIKSLILGDSEGETEMIEKFQEF 70
Query: 134 HRADMEKVILTMLDHPFLPTLYAEFEASHYS-CLVMEYCPGGDLYAARQRQPGKRFGISS 192
R E I++ L+HP + LY H +VME+ P GDLY + S
Sbjct: 71 QR---EVFIMSNLNHPNIVKLYG---LMHNPPRMVMEFVPCGDLYHRLLDKA-HPIKWSV 123
Query: 193 AKFYAAETLLALEYLHMMG--IVYRDLKPENVLVREDG-----HIMLSDFDLS 238
+ L +EY+ IV+RDL+ N+ ++ ++DF LS
Sbjct: 124 KLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS 176
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 8e-06
Identities = 12/51 (23%), Positives = 23/51 (45%), Gaps = 2/51 (3%)
Query: 326 SKSFVGTHEYLAPEVISGQG--HGSAVDWWTLGVFLYEMLYGTTPFKGENN 374
+G +++APE I + + D ++ + LY +L G PF +
Sbjct: 183 VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY 233
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 9e-16
Identities = 35/155 (22%), Positives = 60/155 (38%), Gaps = 9/155 (5%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
LG G G R + MK + R ++ + E ++
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVM-----VMKELIRFDEETQRTFLK---EVKVM 61
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLA 203
L+HP + + EY GG L + ++ S +A +
Sbjct: 62 RCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRG-IIKSMDSQYPWSQRVSFAKDIASG 120
Query: 204 LEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ YLH M I++RDL N LVRE+ +++++DF L+
Sbjct: 121 MAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLA 155
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 7e-05
Identities = 13/67 (19%), Positives = 31/67 (46%)
Query: 307 HDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGT 366
++ + + +P + + VG ++APE+I+G+ + VD ++ G+ L E++
Sbjct: 160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRV 219
Query: 367 TPFKGEN 373
Sbjct: 220 NADPDYL 226
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 38/172 (22%), Positives = 59/172 (34%), Gaps = 47/172 (27%)
Query: 86 FRLLRRLGSGDIGNVYL--CQIRNPMVGLPQCFYAMKVVD--------------REALAI 129
+ L LG G + V+L + V A+KV+ REA
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDV-------AVKVLRADLARDPSFYLRFRREAQNA 66
Query: 130 RKKLHRADMEKVILTMLDHPFLPTLY------AEFEASHYSCLVMEYCPGGDLYAARQRQ 183
L+HP + +Y Y +VMEY G L +
Sbjct: 67 --------------AALNHPAIVAVYDTGEAETPAGPLPY--IVMEYVDGVTLRDIVHTE 110
Query: 184 PGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235
A A+ AL + H GI++RD+KP N+++ + + DF
Sbjct: 111 --GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDF 160
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 5e-09
Identities = 28/97 (28%), Positives = 46/97 (47%), Gaps = 7/97 (7%)
Query: 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK 384
++ + +GT +YL+PE G + D ++LG LYE+L G PF G++ +++
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE 234
Query: 385 PLTFPRIGVSS-SKEFEEVVKLQDLISKLLVKNPKKR 420
P S + + VV K L KNP+ R
Sbjct: 235 DPIPPSARHEGLSADLDAVV------LKALAKNPENR 265
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 39/159 (24%), Positives = 66/159 (41%), Gaps = 11/159 (6%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
H + L++LG G+ G+V +C+ +P+ A+K + + R E IL
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRY-DPLQDNTGEVVAVKKLQHSTEEHLRDFER---EIEIL 96
Query: 144 TMLDHPFLPTLYA--EFEASHYSCLVMEYCPGGDLYAARQ--RQPGKRFGISSAKFYAAE 199
L H + L+MEY P G L R ++ +R Y ++
Sbjct: 97 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL---RDYLQKHKERIDHIKLLQYTSQ 153
Query: 200 TLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+EYL ++RDL N+LV + + + DF L+
Sbjct: 154 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 3e-15
Identities = 43/158 (27%), Positives = 64/158 (40%), Gaps = 10/158 (6%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREA-LAIRKKLHRADMEKVI 142
+ + +R LG G G V L G + A+K + +A R + E I
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMV-AVKALKADAGPQHRSGWKQ---EIDI 86
Query: 143 LTMLDHPFLPTLYA--EFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAET 200
L L H + E + LVMEY P G L R P G++ +A +
Sbjct: 87 LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSL---RDYLPRHSIGLAQLLLFAQQI 143
Query: 201 LLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ YLH ++RDL NVL+ D + + DF L+
Sbjct: 144 CEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA 181
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 3e-15
Identities = 40/169 (23%), Positives = 60/169 (35%), Gaps = 24/169 (14%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRA-DMEKV 141
L +G G G VY V A+K + + E
Sbjct: 6 FAELTLEEIIGIGGFGKVYRAFWIGDEV-------AVKAARHDPDEDISQTIENVRQEAK 58
Query: 142 ILTMLDHPFLPTLY-AEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAET 200
+ ML HP + L + + CLVME+ GG L GKR +A +
Sbjct: 59 LFAMLKHPNIIALRGVCLKEPNL-CLVMEFARGGPLNRVLS---GKRIPPDILVNWAVQI 114
Query: 201 LLALEYLHMMG---IVYRDLKPENVLVREDGHIM--------LSDFDLS 238
+ YLH I++RDLK N+L+ + ++DF L+
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 24/95 (25%), Positives = 38/95 (40%), Gaps = 7/95 (7%)
Query: 326 SKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP 385
S G + ++APEVI D W+ GV L+E+L G PF+G + +
Sbjct: 171 KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK 230
Query: 386 LTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKR 420
L I + + F + L+ +P R
Sbjct: 231 LA-LPIPSTCPEPFAK------LMEDCWNPDPHSR 258
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 3e-15
Identities = 34/158 (21%), Positives = 64/158 (40%), Gaps = 15/158 (9%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREAL--AIRKKLHRADMEK 140
+ + +G G G VY + V A++++D E K R E
Sbjct: 32 FEQLEIGELIGKGRFGQVYHGRWHGE-V-------AIRLIDIERDNEDQLKAFKR---EV 80
Query: 141 VILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAET 200
+ H + + + ++ C G LY+ R ++ + A E
Sbjct: 81 MAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSV-VRDAKIVLDVNKTRQIAQEI 139
Query: 201 LLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ + YLH GI+++DLK +NV ++G ++++DF L
Sbjct: 140 VKGMGYLHAKGILHKDLKSKNVFY-DNGKVVITDFGLF 176
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 4e-05
Identities = 21/105 (20%), Positives = 37/105 (35%), Gaps = 20/105 (19%)
Query: 327 KSFVGTHEYLAPEVISGQGHGS---------AVDWWTLGVFLYEMLYGTTPFKGENNEKT 377
+ G +LAPE+I + D + LG YE+ PFK + E
Sbjct: 192 RIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI 251
Query: 378 LINILK--KPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKR 420
+ + KP +IG+ + D++ ++R
Sbjct: 252 IWQMGTGMKPN-LSQIGMGKE--------ISDILLFCWAFEQEER 287
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 6e-15
Identities = 31/170 (18%), Positives = 67/170 (39%), Gaps = 16/170 (9%)
Query: 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREA------LAIRKKLHRADM 138
+++ +G G G +YL + + +KV + L ++ + +
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 139 EKVILTM--LDHPFLPTLYA----EFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISS 192
+ + L + +P + + Y ++M+ G DL + KRF +
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKT 153
Query: 193 AKFYAAETLLALEYLHMMGIVYRDLKPENVLV--REDGHIMLSDFDLSFK 240
+ L LEY+H V+ D+K N+L+ + + L D+ L+++
Sbjct: 154 VLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 39/159 (24%), Positives = 66/159 (41%), Gaps = 11/159 (6%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
H + L++LG G+ G+V +C+ +P+ A+K + + R E IL
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRY-DPLQDNTGEVVAVKKLQHSTEEHLRDFER---EIEIL 65
Query: 144 TMLDHPFLPTLYA--EFEASHYSCLVMEYCPGGDLYAARQ--RQPGKRFGISSAKFYAAE 199
L H + L+MEY P G L R ++ +R Y ++
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL---RDYLQKHKERIDHIKLLQYTSQ 122
Query: 200 TLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+EYL ++RDL N+LV + + + DF L+
Sbjct: 123 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 35/174 (20%), Positives = 62/174 (35%), Gaps = 38/174 (21%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
+LL G G V+ Q+ N V A+K+ + K+ + + E L
Sbjct: 24 MPLQLLEVKARGRFGCVWKAQLLNEYV-------AVKIFPIQD----KQSWQNEYEVYSL 72
Query: 144 TMLDHPFLPTLY-AEFEASHYS---CLVMEYCPGGDLYAARQRQP---GKRFGI--SSAK 194
+ H + AE + L+ + G L + + I + A+
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMAR 132
Query: 195 FYAAETLLALEYLHMM----------GIVYRDLKPENVLVREDGHIMLSDFDLS 238
L YLH I +RD+K +NVL++ + ++DF L+
Sbjct: 133 --------GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 47/179 (26%), Positives = 66/179 (36%), Gaps = 46/179 (25%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADM--EK 140
LD+ +LL +G G G VY + V A+KV +R + EK
Sbjct: 12 LDNLKLLELIGRGRYGAVYKGSLDERPV-------AVKVFSFA--------NRQNFINEK 56
Query: 141 VI--LTMLDHPFLPTLY-AEFEASHYS----CLVMEYCPGGDLYAARQRQPGK-----RF 188
I + +++H + + + LVMEY P G L R
Sbjct: 57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL 116
Query: 189 GISSAKFYAAETLLALEYLHMM---------GIVYRDLKPENVLVREDGHIMLSDFDLS 238
S + L YLH I +RDL NVLV+ DG ++SDF LS
Sbjct: 117 AHSVTR--------GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 40.6 bits (95), Expect = 7e-04
Identities = 25/134 (18%), Positives = 48/134 (35%), Gaps = 24/134 (17%)
Query: 311 LLDDPEVVAEPINARSKSFVGTHEYLAPEVISG-------QGHGSAVDWWTLGVFLYEML 363
L + V + + S VGT Y+APEV+ G + VD + LG+ +E+
Sbjct: 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229
Query: 364 YGTT-------------PFKGENNEKTLINILKKPLTF----PRIGVSSSKEFEEVVKLQ 406
T F+ E ++ ++ P+ + + V L+
Sbjct: 230 MRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLK 289
Query: 407 DLISKLLVKNPKKR 420
+ I ++ + R
Sbjct: 290 ETIEDCWDQDAEAR 303
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 38/173 (21%), Positives = 64/173 (36%), Gaps = 38/173 (21%)
Query: 88 LLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD 147
L +G G G V+ + R V A+K+ ++ + E ML
Sbjct: 46 LQESIGKGRFGEVWRGKWRGEEV-------AVKIFSSR----EERSWFREAEIYQTVMLR 94
Query: 148 HPFLPTLYA-----EFEASHYSCLVMEYCPGGDLYAARQRQP-----GKRFGISSAKFYA 197
H + A + LV +Y G L+ R + +S+A
Sbjct: 95 HENILGFIAADNKDNGTWTQL-WLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTAS--- 150
Query: 198 AETLLALEYLHM--------MGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242
L +LHM I +RDLK +N+LV+++G ++D L+ + D
Sbjct: 151 -----GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 198
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 31/169 (18%), Positives = 58/169 (34%), Gaps = 14/169 (8%)
Query: 85 HFRLLRRLGSGDIGNVYL---CQIRNPMVGLPQCFYAMKV------VDREALAIRKKLHR 135
++L + G +Y G + +++K+ + E ++
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKP 102
Query: 136 ADMEK-VILTMLDHPFLPTLYAE-FEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSA 193
+ K L +PT Y LV+ G L +A P S
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSV 161
Query: 194 KFYAAETLLALEYLHMMGIVYRDLKPENVLV--REDGHIMLSDFDLSFK 240
A L ALE+LH V+ ++ EN+ V + + L+ + +F+
Sbjct: 162 LQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 3e-14
Identities = 40/168 (23%), Positives = 73/168 (43%), Gaps = 27/168 (16%)
Query: 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRAD-- 137
RVG + +RL R++GSG G++YL + E +AI+ + +
Sbjct: 6 RVG-NRYRLGRKIGSGSFGDIYL---------------GTDIAAGEEVAIKLECVKTKHP 49
Query: 138 ---MEKVILTMLDH-PFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSA 193
+E I M+ +PT+ Y+ +VME G L ++F + +
Sbjct: 50 QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFC-SRKFSLKTV 107
Query: 194 KFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGH---IMLSDFDLS 238
A + + +EY+H ++RD+KP+N L+ + + DF L+
Sbjct: 108 LLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 34/177 (19%), Positives = 64/177 (36%), Gaps = 38/177 (21%)
Query: 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADME 139
R ++++++G G G V++ + R V A+KV + + E
Sbjct: 33 RTIAKQIQMVKQIGKGRYGEVWMGKWRGEKV-------AVKVFFTTE----EASWFRETE 81
Query: 140 KVILTMLDHPFLPTLYA-----EFEASHYSCLVMEYCPGGDLYAARQRQPGK-----RFG 189
++ H + A + L+ +Y G LY + +
Sbjct: 82 IYQTVLMRHENILGFIAADIKGTGSWTQL-YLITDYHENGSLYDYLKSTTLDAKSMLKLA 140
Query: 190 ISSAKFYAAETLLALEYLHM--------MGIVYRDLKPENVLVREDGHIMLSDFDLS 238
SS L +LH I +RDLK +N+LV+++G ++D L+
Sbjct: 141 YSSVS--------GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 189
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 5e-14
Identities = 43/159 (27%), Positives = 68/159 (42%), Gaps = 11/159 (6%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
H + + +LG G+ G+V LC +P+ A+K + ++ R E IL
Sbjct: 23 RHLKYISQLGKGNFGSVELC-RYDPLGDNTGALVAVKQLQHSGPDQQRDFQR---EIQIL 78
Query: 144 TMLDHPFLPTLYA--EFEASHYSCLVMEYCPGGDLYAARQ--RQPGKRFGISSAKFYAAE 199
L F+ LVMEY P G L R ++ R S Y+++
Sbjct: 79 KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCL---RDFLQRHRARLDASRLLLYSSQ 135
Query: 200 TLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+EYL V+RDL N+LV + H+ ++DF L+
Sbjct: 136 ICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA 174
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 8e-14
Identities = 41/168 (24%), Positives = 65/168 (38%), Gaps = 28/168 (16%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKL-------HRA 136
+ +R LG G G V LC+ E +A+ K L H A
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDN-----------TGEQVAV-KSLKPESGGNHIA 68
Query: 137 DM--EKVILTMLDHPFLPTLYA--EFEASHYSCLVMEYCPGGDLYAARQ--RQPGKRFGI 190
D+ E IL L H + + + L+ME+ P G L ++ + + +
Sbjct: 69 DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSL---KEYLPKNKNKINL 125
Query: 191 SSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
YA + ++YL V+RDL NVLV + + + DF L+
Sbjct: 126 KQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 9e-14
Identities = 36/165 (21%), Positives = 68/165 (41%), Gaps = 19/165 (11%)
Query: 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADME 139
VG H+++ RR+G G G ++ N + A+K R + + E
Sbjct: 7 VVG-VHYKVGRRIGEGSFGVIFEG--TNLLNNQQ---VAIKFEPRRS-----DAPQLRDE 55
Query: 140 KVILTMLDH-PFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAA 198
+L +P +Y + ++ LV++ G L G++F + + A
Sbjct: 56 YRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAK 113
Query: 199 ETLLALEYLHMMGIVYRDLKPENVLVREDGH-----IMLSDFDLS 238
+ L ++ +H +VYRD+KP+N L+ I + DF +
Sbjct: 114 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 2e-13
Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 25/165 (15%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIR--NPMVGLPQCFYAMKVV----DREAL---AIRKKL 133
+++F+ + ++G G G VY + + +V A+K + + E + AIR
Sbjct: 2 MENFQKVEKIGEGTYGVVYKARNKLTGEVV-------ALKKIRLDTETEGVPSTAIR--- 51
Query: 134 HRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSA 193
E +L L+HP + L + LV E+ DL +
Sbjct: 52 -----EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLI 105
Query: 194 KFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
K Y + L L + H +++RDLKP+N+L+ +G I L+DF L+
Sbjct: 106 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 150
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 41/170 (24%), Positives = 72/170 (42%), Gaps = 19/170 (11%)
Query: 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREA------LAIRKKLHRADM 138
+ L +++GSG G +YL + +KV +E L +++ + D
Sbjct: 38 QWVLGKKIGSGGFGLIYLA--FPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDC 95
Query: 139 --EKVILTMLDHPFLPTLY----AEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISS 192
+ + LD+ +P Y EF+ Y +VME G DL + F S+
Sbjct: 96 IKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKST 152
Query: 193 AKFYAAETLLALEYLHMMGIVYRDLKPENVLV--REDGHIMLSDFDLSFK 240
L LEY+H V+ D+K N+L+ + + L+D+ LS++
Sbjct: 153 VLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYR 202
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 5e-13
Identities = 43/189 (22%), Positives = 70/189 (37%), Gaps = 39/189 (20%)
Query: 62 KANQAAWEAMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKV 121
NQA +K F+ ++ LGSG G VY + + V
Sbjct: 3 APNQALLRILKE----------TEFKKIKVLGSGAFGTVYKGLWIPEGEKVK-----IPV 47
Query: 122 VDREALAIRKKLHRADMEKV---------ILTMLDHPFLPTLYAE-FEASHYSCLVMEYC 171
AI K+L A K ++ +D+P + L ++ L+ +
Sbjct: 48 ------AI-KELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ--LITQLM 98
Query: 172 PGGDL--YAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGH 229
P G L Y R+ G + + + YL +V+RDL NVLV+ H
Sbjct: 99 PFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH 155
Query: 230 IMLSDFDLS 238
+ ++DF L+
Sbjct: 156 VKITDFGLA 164
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 6e-13
Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 25/164 (15%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIR-NPMVGLPQCFYAMKVV----DREAL---AIRKKLH 134
++ + L ++G G G VY Q A+K + + E + IR
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNNYGETF-------ALKKIRLEKEDEGIPSTTIR---- 49
Query: 135 RADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAK 194
E IL L H + LY LV E+ DL G +AK
Sbjct: 50 ----EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGG-LESVTAK 103
Query: 195 FYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ + L + Y H +++RDLKP+N+L+ +G + ++DF L+
Sbjct: 104 SFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLA 147
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 49.0 bits (118), Expect = 1e-06
Identities = 36/137 (26%), Positives = 57/137 (41%), Gaps = 34/137 (24%)
Query: 332 THE-----YLAPEVISGQGH-GSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILK-- 383
THE Y AP+V+ G + +D W++G EM+ GT F G + L+ I +
Sbjct: 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRIL 217
Query: 384 ---KPLTFPRIGVSS------------SKEFEEVVK-----LQDLISKLLVKNPKKRIGS 423
+P V+ +E +K DL+SK+L +P +RI +
Sbjct: 218 GTPNSKNWP--NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI-T 274
Query: 424 LKGSVEIKRHEFFKGIN 440
K + H +FK N
Sbjct: 275 AK---QALEHAYFKENN 288
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 8e-13
Identities = 42/162 (25%), Positives = 63/162 (38%), Gaps = 25/162 (15%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADM----- 138
+ RL +LG G G V++ +V AI K L M
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTT----------RV------AI-KTLKPGTMSPEAF 226
Query: 139 --EKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFY 196
E ++ L H L LYA +V EY G L + + GK +
Sbjct: 227 LQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 285
Query: 197 AAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
AA+ + Y+ M V+RDL+ N+LV E+ ++DF L+
Sbjct: 286 AAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 327
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 1e-12
Identities = 44/164 (26%), Positives = 71/164 (43%), Gaps = 25/164 (15%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIR--NPMVGLPQCFYAMKVV--DRE----ALAIRKKLH 134
++ + L +LG G VY + + + +V A+K + + E AIR
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLV-------ALKEIRLEHEEGAPCTAIR---- 49
Query: 135 RADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAK 194
E +L L H + TL+ LV EY DL G + + K
Sbjct: 50 ----EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DL-KQYLDDCGNIINMHNVK 103
Query: 195 FYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ + L L Y H +++RDLKP+N+L+ E G + L+DF L+
Sbjct: 104 LFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLA 147
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 2e-07
Identities = 29/136 (21%), Positives = 48/136 (35%), Gaps = 37/136 (27%)
Query: 332 THE-----YLAPEVISGQGH-GSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILK-- 383
+E Y P+++ G + +D W +G YEM G F G E+ L I +
Sbjct: 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRIL 217
Query: 384 -----------------KPLTFPRIGVSSSKEFEEVVKL-----QDLISKLLVKNPKKRI 421
K +P+ ++ DL++KLL + RI
Sbjct: 218 GTPTEETWPGILSNEEFKTYNYPK---YRAEALLSHAPRLDSDGADLLTKLLQFEGRNRI 274
Query: 422 GSLKGSVEIKRHEFFK 437
S + + +H FF
Sbjct: 275 -SAE---DAMKHPFFL 286
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 42/162 (25%), Positives = 63/162 (38%), Gaps = 25/162 (15%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADM----- 138
+ RL +LG G G V++ +V AI K L M
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTT----------RV------AI-KTLKPGTMSPEAF 309
Query: 139 --EKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFY 196
E ++ L H L LYA +V EY G L + + GK +
Sbjct: 310 LQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 368
Query: 197 AAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
AA+ + Y+ M V+RDL+ N+LV E+ ++DF L+
Sbjct: 369 AAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 410
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 1e-12
Identities = 43/164 (26%), Positives = 72/164 (43%), Gaps = 25/164 (15%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIR-NPMVGLPQCFYAMKVV----DREAL---AIRKKLH 134
++ ++ L ++G G G VY + +V A+K + + E + AIR
Sbjct: 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIV-------ALKRIRLDAEDEGIPSTAIR---- 68
Query: 135 RADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAK 194
E +L L HP + +L + LV E+ DL + S K
Sbjct: 69 ----EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DL-KKVLDENKTGLQDSQIK 122
Query: 195 FYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
Y + L + + H I++RDLKP+N+L+ DG + L+DF L+
Sbjct: 123 IYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLA 166
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 52.9 bits (128), Expect = 8e-08
Identities = 35/139 (25%), Positives = 55/139 (39%), Gaps = 37/139 (26%)
Query: 332 THE-----YLAPEVISGQGH-GSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILK-- 383
THE Y AP+V+ G ++VD W++G EM+ G F G ++ L I
Sbjct: 177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSIL 236
Query: 384 -----------------KPLTFPRIGVSSSKEFEEVVK-----LQDLISKLLVKNPKKRI 421
K TF K + ++ DL+S +L +P KRI
Sbjct: 237 GTPNPREWPQVQELPLWKQRTFQV---FEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRI 293
Query: 422 GSLKGSVEIKRHEFFKGIN 440
S + + H +FK ++
Sbjct: 294 -SAR---DAMNHPYFKDLD 308
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 34/162 (20%), Positives = 58/162 (35%), Gaps = 23/162 (14%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEK--- 140
+ +LG G G VY + + V A+ K L ME
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSL---------TV------AV-KTLKEDTMEVEEF 263
Query: 141 ----VILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFY 196
++ + HP L L ++ E+ G+L + + +
Sbjct: 264 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 323
Query: 197 AAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
A + A+EYL ++R+L N LV E+ + ++DF LS
Sbjct: 324 ATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLS 365
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 2e-12
Identities = 43/167 (25%), Positives = 70/167 (41%), Gaps = 28/167 (16%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIR--NPMVGLPQCFYAMKVV--DRE----ALAIRKKLHR 135
F+ L +LG+G VY + V A+K V D E + AIR
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYV-------ALKEVKLDSEEGTPSTAIR----- 52
Query: 136 ADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLY----AARQRQPGKRFGIS 191
E ++ L H + LY + LV E+ DL + + ++
Sbjct: 53 ---EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELN 108
Query: 192 SAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
K++ + L L + H I++RDLKP+N+L+ + G + L DF L+
Sbjct: 109 LVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 7e-06
Identities = 31/139 (22%), Positives = 52/139 (37%), Gaps = 39/139 (28%)
Query: 332 THE-----YLAPEVISGQGH-GSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILK-- 383
+ E Y AP+V+ G +++D W+ G L EM+ G F G N+E+ L I
Sbjct: 166 SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIM 225
Query: 384 ---KPLTFPRIGVSSSKEFEEVVKLQ----------------------DLISKLLVKNPK 418
+P V+ ++ ++ + D + LL NP
Sbjct: 226 GTPNESLWP--SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPD 283
Query: 419 KRIGSLKGSVEIKRHEFFK 437
R+ S K + H +F
Sbjct: 284 MRL-SAK---QALHHPWFA 298
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-12
Identities = 35/162 (21%), Positives = 59/162 (36%), Gaps = 23/162 (14%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEK--- 140
+ +LG G G VY + ++ V A+ K L ME
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKY---------SLTV------AV-KTLKEDTMEVEEF 56
Query: 141 ----VILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFY 196
++ + HP L L ++ E+ G+L + + +
Sbjct: 57 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 116
Query: 197 AAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
A + A+EYL ++RDL N LV E+ + ++DF LS
Sbjct: 117 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS 158
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 37/166 (22%), Positives = 73/166 (43%), Gaps = 21/166 (12%)
Query: 80 RVGLDHFRLLRRLGSGDIGNVYLCQ-IRNPMVGLPQCFYAMKVVDREALAIRKKLHRADM 138
VG +FR+ +++G G+ G + L + + + A+K+ ++ + + +
Sbjct: 6 MVG-PNFRVGKKIGCGNFGELRLGKNLYTNE------YVAIKLEPMKS-----RAPQLHL 53
Query: 139 EKVILTMLDH-PFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYA 197
E L +P +Y Y+ +V+E G L + F + + A
Sbjct: 54 EYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIA 111
Query: 198 AETLLALEYLHMMGIVYRDLKPENVLVREDGH-----IMLSDFDLS 238
+ + +EY+H ++YRD+KPEN L+ G+ I + DF L+
Sbjct: 112 IQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 38/168 (22%), Positives = 69/168 (41%), Gaps = 27/168 (16%)
Query: 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRAD-- 137
RVG + FRL R++GSG G +YL + E +AI+ + +
Sbjct: 4 RVG-NKFRLGRKIGSGSFGEIYL---------------GTNIQTNEEVAIKLENVKTKHP 47
Query: 138 ---MEKVILTML-DHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSA 193
E I +L +P + Y+ LVM+ G L ++ + +
Sbjct: 48 QLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTV 105
Query: 194 KFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGH---IMLSDFDLS 238
A + + +E++H ++RD+KP+N L+ + + DF L+
Sbjct: 106 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 38/157 (24%), Positives = 58/157 (36%), Gaps = 12/157 (7%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADM--EKV 141
+ L ++G G+ G V+ ++R A+K +A E
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTL-----VAVKSCRETLP----PDLKAKFLQEAR 164
Query: 142 ILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETL 201
IL HP + L +VME GGD R G R + + +
Sbjct: 165 ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLT-FLRTEGARLRVKTLLQMVGDAA 223
Query: 202 LALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+EYL ++RDL N LV E + +SDF +S
Sbjct: 224 AGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMS 260
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 3e-12
Identities = 41/162 (25%), Positives = 61/162 (37%), Gaps = 25/162 (15%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEK--- 140
+LL+ +G G+ G+V L R V A+ K + +
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYRGNKV-----------------AV-KCIKNDATAQAFL 62
Query: 141 ---VILTMLDHPFLPTLYAE-FEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFY 196
++T L H L L E +V EY G L + + G +
Sbjct: 63 AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 122
Query: 197 AAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ + A+EYL V+RDL NVLV ED +SDF L+
Sbjct: 123 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 164
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 39/199 (19%), Positives = 63/199 (31%), Gaps = 33/199 (16%)
Query: 51 QTSLYNSHKPHKANQAAWEAMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMV 110
+ + NQA + + + +G+G+ G VY ++
Sbjct: 18 ENLYFQGAMGSDPNQAVLKFTTEIHP-------SCVTRQKVIGAGEFGEVYKGMLKTS-- 68
Query: 111 GLPQCFYAMKVVDREALAIRKKLHRADMEKV---------ILTMLDHPFLPTLYAEFEAS 161
+ V AI K L EK I+ H + L
Sbjct: 69 ---SGKKEVPV------AI-KTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 118
Query: 162 HYSCLVMEYCPGGDL--YAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKP 219
++ EY G L + R+ F + ++YL M V+RDL
Sbjct: 119 KPMMIITEYMENGALDKFL---REKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAA 175
Query: 220 ENVLVREDGHIMLSDFDLS 238
N+LV + +SDF LS
Sbjct: 176 RNILVNSNLVCKVSDFGLS 194
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 3e-12
Identities = 41/164 (25%), Positives = 60/164 (36%), Gaps = 29/164 (17%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEK--- 140
++ +GSG G V+L N KV AI K + M +
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKD----------KV------AI-KTIREGAMSEEDF 50
Query: 141 ----VILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDL--YAARQRQPGKRFGISSAK 194
++ L HP L LY CLV E+ G L Y R F +
Sbjct: 51 IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYL---RTQRGLFAAETLL 107
Query: 195 FYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ + YL +++RDL N LV E+ I +SDF ++
Sbjct: 108 GMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT 151
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 47/213 (22%), Positives = 71/213 (33%), Gaps = 35/213 (16%)
Query: 38 RSSISLCSSSAADQTSLYNS-HKPHKANQAAWEAMKRLRRAQGRVGLDHFRLLRRLGSGD 96
+L + Y H + +A + + + + +GSGD
Sbjct: 9 SGRENLYFQGKLPEPQFYAEPHTYEEPGRAGRSFTREIEA-------SRIHIEKIIGSGD 61
Query: 97 IGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKV---------ILTMLD 147
G V ++R P + V AI K L E+ I+ D
Sbjct: 62 SGEVCYGRLRVPGQR------DVPV------AI-KALKAGYTERQRRDFLSEASIMGQFD 108
Query: 148 HPFLPTLYAEFEASHYSCLVMEYCPGGDL--YAARQRQPGKRFGISSAKFYAAETLLALE 205
HP + L + +V EY G L + R +F I +
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL---RTHDGQFTIMQLVGMLRGVGAGMR 165
Query: 206 YLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
YL +G V+RDL NVLV + +SDF LS
Sbjct: 166 YLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLS 198
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 4e-12
Identities = 40/165 (24%), Positives = 70/165 (42%), Gaps = 26/165 (15%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIR--NPMVGLPQCFYAMKVV----DREAL---AIRKKL 133
+ + L ++G G G V+ + R + +V A+K V D E + A+R
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIV-------ALKRVRLDDDDEGVPSSALR--- 50
Query: 134 HRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSA 193
E +L L H + L+ + LV E+C DL
Sbjct: 51 -----EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DL-KKYFDSCNGDLDPEIV 103
Query: 194 KFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
K + + L L + H +++RDLKP+N+L+ +G + L++F L+
Sbjct: 104 KSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLA 148
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 2e-06
Identities = 27/135 (20%), Positives = 49/135 (36%), Gaps = 35/135 (25%)
Query: 332 THE-----YLAPEVISGQGH-GSAVDWWTLGVFLYEMLYGTTP-FKGENNEKTLINILK- 383
+ E Y P+V+ G +++D W+ G E+ P F G + + L I +
Sbjct: 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 218
Query: 384 ----KPLTFPRIGVSSSKEFEEVVKLQ-----------------DLISKLLVKNPKKRIG 422
+P ++ +++ DL+ LL NP +RI
Sbjct: 219 LGTPTEEQWP--SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI- 275
Query: 423 SLKGSVEIKRHEFFK 437
S + E +H +F
Sbjct: 276 SAE---EALQHPYFS 287
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 30/156 (19%), Positives = 65/156 (41%), Gaps = 13/156 (8%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPM-VGLPQCFYAMKVVDREALAIRKKLHRADMEKVI 142
+ +L ++LG+G G V++ V A+K + ++++ L E +
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKV-------AVKTMKPGSMSVEAFLA----EANV 236
Query: 143 LTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLL 202
+ L H L L+A ++ E+ G L + G + + ++A+
Sbjct: 237 MKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAE 295
Query: 203 ALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ ++ ++RDL+ N+LV ++DF L+
Sbjct: 296 GMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLA 331
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 35/167 (20%), Positives = 64/167 (38%), Gaps = 17/167 (10%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRAD--MEKV 141
F L R LG G+ G+V Q++ + A+K++ + +A + E
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKV--AVKMLKADIIASSD---IEEFLREAA 77
Query: 142 ILTMLDHPFLPTLYA------EFEASHYSCLVMEYCPGGDL--YAARQRQPGKRFGISSA 193
+ DHP + L +++ + GDL + R F +
Sbjct: 78 CMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQ 137
Query: 194 KF--YAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ + +EYL ++RDL N ++ ED + ++DF LS
Sbjct: 138 TLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS 184
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 6e-12
Identities = 36/162 (22%), Positives = 63/162 (38%), Gaps = 25/162 (15%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEK--- 140
+ +L+ RLG+G G V++ KV A+ K L + M
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHT----------KV------AV-KSLKQGSMSPDAF 55
Query: 141 ----VILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFY 196
++ L H L LYA ++ EY G L + G + I+
Sbjct: 56 LAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDM 114
Query: 197 AAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
AA+ + ++ ++RDL+ N+LV + ++DF L+
Sbjct: 115 AAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA 156
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 7e-12
Identities = 44/170 (25%), Positives = 61/170 (35%), Gaps = 19/170 (11%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
L R LG G G V+L + N + A+K + LA RK R E +L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR---EAELL 71
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDL--YAARQRQPGKRFGISSAKFYAAETL 201
T L H + Y +V EY GDL + R P + A L
Sbjct: 72 TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFL-RAHGPDAMILVDGQPRQAKGEL 130
Query: 202 LALEYLHM-------------MGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ LH+ V+RDL N LV + + + DF +S
Sbjct: 131 GLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 8e-12
Identities = 48/222 (21%), Positives = 73/222 (32%), Gaps = 34/222 (15%)
Query: 33 SFGSRRSSISLCSSSAADQTSLYNSHKPHKANQA-AWEAMKRLRRAQGRVGLDHFRLLRR 91
+ GS S + Q + + P + A + L
Sbjct: 2 AMGSGSSLSPTEGKGSGLQGHIIEN--PQYFSDACVHH-----------IKRRDIVLKWE 48
Query: 92 LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRAD--MEKVILTMLDHP 149
LG G G V+L + N + + A+K + +EA + R D E +LTML H
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEA----SESARQDFQREAELLTMLQHQ 103
Query: 150 FLPTLYAEFEASHYSCLVMEYCPGGDLYA-ARQRQPGKRFGISSAKFYAAE-TLLAL--- 204
+ + +V EY GDL R P + L L
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 205 --------EYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
YL + V+RDL N LV + + + DF +S
Sbjct: 164 ASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 9e-12
Identities = 42/187 (22%), Positives = 69/187 (36%), Gaps = 35/187 (18%)
Query: 62 KANQAAWEAMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKV 121
NQA +K F+ ++ LGSG G VY + + V
Sbjct: 3 APNQALLRILKE----------TEFKKIKVLGSGAFGTVYKGLWIPEGEKVK-----IPV 47
Query: 122 VDREALAIRKKLHRADMEKV---------ILTMLDHPFLPTLYAE-FEASHYSCLVMEYC 171
AI K+L A K ++ +D+P + L ++ L+ +
Sbjct: 48 ------AI-KELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ--LITQLM 98
Query: 172 PGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIM 231
P G L R+ G + + + YL +V+RDL NVLV+ H+
Sbjct: 99 PFGCLLD-YVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVK 157
Query: 232 LSDFDLS 238
++DF L+
Sbjct: 158 ITDFGLA 164
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 9e-12
Identities = 46/174 (26%), Positives = 77/174 (44%), Gaps = 36/174 (20%)
Query: 86 FRLLRRLGSGDIGNVYLCQ-IRNPMVGLPQCFYAMKVV-----DREA----LAIRKKLHR 135
+ L+R+LG G V+L + + N AMK+V EA + + ++++
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVN------NTHVAMKIVRGDKVYTEAAEDEIKLLQRVND 74
Query: 136 ADMEKV-------ILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRF 188
AD K IL +LDH F + H +V E G +L A ++ +
Sbjct: 75 ADNTKEDSMGANHILKLLDH-FN---HKGPNGVHV-VMVFEVL-GENLLALIKKYEHRGI 128
Query: 189 GISSAKFYAAETLLALEYLH-MMGIVYRDLKPENVLVRE------DGHIMLSDF 235
+ K + + LL L+Y+H GI++ D+KPENVL+ I ++D
Sbjct: 129 PLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADL 182
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 7e-09
Identities = 27/150 (18%), Positives = 51/150 (34%), Gaps = 43/150 (28%)
Query: 328 SFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLIN------- 380
+ + T EY +PEV+ G G D W+ ++E++ G F+ + +
Sbjct: 194 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 253
Query: 381 --ILKK-PLTFPRIGVSSSKEF-----------------------------EEVVKLQDL 408
+L + P R G + F +E ++ D
Sbjct: 254 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 313
Query: 409 ISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438
+S +L +P+KR + H + K
Sbjct: 314 LSPMLQLDPRKRA-DAG---GLVNHPWLKD 339
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 37/164 (22%), Positives = 63/164 (38%), Gaps = 12/164 (7%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREA-LAIRKKLHRADMEKVI 142
+ + R LG G G VY + + P+ A+K V+ A + R + E +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN---EASV 81
Query: 143 LTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAA-RQRQPGKRFGISSAKF------ 195
+ + + L + ++ME GDL + R +P A
Sbjct: 82 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 196 -YAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
A E + YL+ V+RDL N +V ED + + DF ++
Sbjct: 142 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT 185
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 1e-11
Identities = 37/170 (21%), Positives = 63/170 (37%), Gaps = 18/170 (10%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREA-LAIRKKLHRADMEKVI 142
R + LG G VY + P G A+K + +A +R++ E ++
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRH---EAML 65
Query: 143 LTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYA-ARQRQPGKRFGISSAKFYAAETL 201
L HP + L ++ YC GDL+ R P G + L
Sbjct: 66 RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125
Query: 202 LALEYLHM-------------MGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+++H+ +V++DL NVLV + ++ +SD L
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF 175
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 1e-11
Identities = 42/164 (25%), Positives = 65/164 (39%), Gaps = 26/164 (15%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIR--NPMVGLPQCFYAMKVV----DREAL---AIRKKL 133
++ + + ++G G G V+ C+ R +V A+K D + A+R
Sbjct: 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIV-------AIKKFLESEDDPVIKKIALR--- 51
Query: 134 HRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSA 193
E +L L HP L L F LV EYC + R
Sbjct: 52 -----EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRG-VPEHLV 104
Query: 194 KFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237
K +TL A+ + H ++RD+KPEN+L+ + I L DF
Sbjct: 105 KSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGF 148
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 50.6 bits (122), Expect = 5e-07
Identities = 30/157 (19%), Positives = 54/157 (34%), Gaps = 37/157 (23%)
Query: 332 THE-----YLAPEVISGQGH-GSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILK-- 383
E Y +PE++ G G VD W +G E+L G + G+++ L I K
Sbjct: 160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTL 219
Query: 384 -----------------KPLTFPRIGVSSSKEFEEVV-----KLQDLISKLLVKNPKKRI 421
+ P + E L+ L +P +R+
Sbjct: 220 GDLIPRHQQVFSTNQYFSGVKIPD--PEDMEPLELKFPNISYPALGLLKGCLHMDPTERL 277
Query: 422 GSLKGSVEIKRHEFFKGINWALIRSIKPPEVPNNDLY 458
+ + ++ H +F+ I + K + P +LY
Sbjct: 278 -TCE---QLLHHPYFENIR-EIEDLAKEHDKPAENLY 309
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 1e-11
Identities = 39/155 (25%), Positives = 60/155 (38%), Gaps = 4/155 (2%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
RLL +LG G G V + P A+K + + L+ + + E +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSV--AVKCLKPDVLSQPEAMDDFIREVNAM 75
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLA 203
LDH L LY +V E P G L R R+ F + + YA +
Sbjct: 76 HSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLD-RLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 204 LEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ YL ++RDL N+L+ + + DF L
Sbjct: 134 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM 168
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 46/163 (28%), Positives = 70/163 (42%), Gaps = 30/163 (18%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKV-- 141
D ++L+R+LG G V F A+ + + E + + K L +K+
Sbjct: 36 DDYQLVRKLGRGKYSEV---------------FEAINITNNEKVVV-KILKPVKKKKIKR 79
Query: 142 ---ILTML-DHPFLPTLYAEF--EASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKF 195
IL L P + TL S LV E+ D +Q + +F
Sbjct: 80 EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF-----KQLYQTLTDYDIRF 134
Query: 196 YAAETLLALEYLHMMGIVYRDLKPENVLV-REDGHIMLSDFDL 237
Y E L AL+Y H MGI++RD+KP NV++ E + L D+ L
Sbjct: 135 YMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 177
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 7e-06
Identities = 29/122 (23%), Positives = 47/122 (38%), Gaps = 30/122 (24%)
Query: 330 VGTHEYLAPEVI-SGQGHGSAVDWWTLGVFLYEMLYGTTP-FKGENNEKTLINILK---- 383
V + + PE++ Q + ++D W+LG L M++ P F G +N L+ I K
Sbjct: 191 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 250
Query: 384 -------------KPLTFPRI-GVSSSKEFEEVVKLQ----------DLISKLLVKNPKK 419
F I G S K +E V + D + KLL + +
Sbjct: 251 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQS 310
Query: 420 RI 421
R+
Sbjct: 311 RL 312
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 43/158 (27%), Positives = 62/158 (39%), Gaps = 17/158 (10%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRAD--MEKV 141
+LL+ +G G+ G+V L R V A+K I+ E
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYRGNKV-------AVKC-------IKNDATAQAFLAEAS 238
Query: 142 ILTMLDHPFLPTLYAE-FEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAET 200
++T L H L L E +V EY G L + + G ++ +
Sbjct: 239 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 298
Query: 201 LLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
A+EYL V+RDL NVLV ED +SDF L+
Sbjct: 299 CEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 336
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 44/194 (22%), Positives = 69/194 (35%), Gaps = 34/194 (17%)
Query: 56 NSHKPHKANQAAWEAMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQC 115
+ H Q E K L + + + +G+G+ G V +++ P
Sbjct: 24 DPHTFEDPTQTVHEFAKELDA-------TNISIDKVVGAGEFGEVCSGRLKLPSKK---- 72
Query: 116 FYAMKVVDREALAIRKKLHRADMEKV---------ILTMLDHPFLPTLYAEFEASHYSCL 166
+ V AI K L EK I+ DHP + L S +
Sbjct: 73 --EISV------AI-KTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123
Query: 167 VMEYCPGGDL--YAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLV 224
V EY G L + R+ +F + ++YL MG V+RDL N+L+
Sbjct: 124 VTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI 180
Query: 225 REDGHIMLSDFDLS 238
+ +SDF L
Sbjct: 181 NSNLVCKVSDFGLG 194
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 44/199 (22%), Positives = 74/199 (37%), Gaps = 32/199 (16%)
Query: 53 SLYNSHKPHKANQAAWEAMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIR--NPMV 110
++ H Q + A +D +R + +LG G G VY N V
Sbjct: 3 HHHHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETV 62
Query: 111 GLPQCFYAMKVV----DREAL---AIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163
A+K + + E + AIR E +L L H + L + +H
Sbjct: 63 -------AIKRIRLEHEEEGVPGTAIR--------EVSLLKELQHRNIIELKSVIHHNHR 107
Query: 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVL 223
L+ EY DL + P + K + + + + + H ++RDLKP+N+L
Sbjct: 108 LHLIFEYAEN-DLKKYMDKNPD--VSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLL 164
Query: 224 V-----REDGHIMLSDFDL 237
+ E + + DF L
Sbjct: 165 LSVSDASETPVLKIGDFGL 183
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 34/135 (25%), Positives = 55/135 (40%), Gaps = 35/135 (25%)
Query: 332 THE-----YLAPEVISGQGH-GSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK- 384
THE Y PE++ G H ++VD W++ EML T F G++ L I +
Sbjct: 195 THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVL 254
Query: 385 ----PLTFPRIGVSSSKEFEEVVKLQ------------------DLISKLLVKNPKKRIG 422
T+P GV++ ++++ DL++ +L +P KRI
Sbjct: 255 GLPDDTTWP--GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRI- 311
Query: 423 SLKGSVEIKRHEFFK 437
S K H +F
Sbjct: 312 SAK---NALEHPYFS 323
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 2e-11
Identities = 42/172 (24%), Positives = 65/172 (37%), Gaps = 30/172 (17%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIR--NPMVGLPQCFYAMKVV----DREAL------AIR 130
+ + +G G G VY + V A+K V +R
Sbjct: 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFV-------ALKSVRVPNGGGGGGGLPISTVR 60
Query: 131 -----KKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPG 185
++L + V+ ++D T + E LV E+ DL + P
Sbjct: 61 EVALLRRLEAFEHPNVV-RLMD--VCATSRTDREIKVT--LVFEHVDQ-DLRTYLDKAPP 114
Query: 186 KRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237
+ K + L L++LH IV+RDLKPEN+LV G + L+DF L
Sbjct: 115 PGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL 166
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 1e-06
Identities = 30/133 (22%), Positives = 44/133 (33%), Gaps = 35/133 (26%)
Query: 332 THE-----YLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINI----- 381
T Y APEV+ + + VD W++G EM F G + L I
Sbjct: 177 TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 236
Query: 382 ------------LKKPLTFPRIGVSSSKEFEEVVKLQ-----DLISKLLVKNPKKRIGSL 424
L + FP + + VV L+ ++L NP KRI S
Sbjct: 237 LPPEDDWPRDVSLPRG-AFPP---RGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRI-SA 291
Query: 425 KGSVEIKRHEFFK 437
+H +
Sbjct: 292 F---RALQHSYLH 301
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 48/218 (22%), Positives = 84/218 (38%), Gaps = 36/218 (16%)
Query: 35 GSRRSSISLCSSSAADQTSLYNSHKPHKANQAAW--EAMKRLRRAQGRVGLDHFRLLRRL 92
G R++ S Q S + S K + + + + R + + +
Sbjct: 3 GRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVI 62
Query: 93 GSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKV----ILTMLDH 148
G+G G VY ++ + E +AI KK+ + K I+ LDH
Sbjct: 63 GNGSFGVVYQAKLCD---------------SGELVAI-KKVLQDKRFKNRELQIMRKLDH 106
Query: 149 P--------FLPTLYAEFEASHYSCLVMEYCPGGDLY--AARQRQPGKRFGISSAKFYAA 198
F + + E LV++Y P +Y A + + + K Y
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLN--LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 199 ETLLALEYLHMMGIVYRDLKPENVLVREDGHIM-LSDF 235
+ +L Y+H GI +RD+KP+N+L+ D ++ L DF
Sbjct: 164 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDF 201
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 5e-07
Identities = 36/127 (28%), Positives = 50/127 (39%), Gaps = 31/127 (24%)
Query: 335 YLAPEVISGQGH-GSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILK---------- 383
Y APE+I G S++D W+ G L E+L G F G++ L+ I+K
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 281
Query: 384 -------KPLTFPRI-GVSSSKEF-----EEVVKLQDLISKLLVKNPKKRIGSLKGSVEI 430
FP+I +K F E + L S+LL P R+ L E
Sbjct: 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAI---ALCSRLLEYTPTARLTPL----EA 334
Query: 431 KRHEFFK 437
H FF
Sbjct: 335 CAHSFFD 341
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 2e-11
Identities = 40/158 (25%), Positives = 63/158 (39%), Gaps = 17/158 (10%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPM-VGLPQCFYAMKVVDREALAIRKKLHRADMEKVI 142
L+ LG+G G V + R V A+K++ +++ + + E +
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDV-------AIKMIKEGSMSEDEFI----EEAKV 72
Query: 143 LTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDL--YAARQRQPGKRFGISSAKFYAAET 200
+ L H L LY ++ EY G L Y R+ RF +
Sbjct: 73 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDV 129
Query: 201 LLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
A+EYL ++RDL N LV + G + +SDF LS
Sbjct: 130 CEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS 167
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 3e-11
Identities = 39/158 (24%), Positives = 62/158 (39%), Gaps = 17/158 (10%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPM-VGLPQCFYAMKVVDREALAIRKKLHRADMEKVI 142
+ LL+ LGSG G V L + + V A+K++ +++ + E
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDV-------AVKMIKEGSMSEDEFF----QEAQT 56
Query: 143 LTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDL--YAARQRQPGKRFGISSAKFYAAET 200
+ L HP L Y + +V EY G L Y R GK S +
Sbjct: 57 MMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYL---RSHGKGLEPSQLLEMCYDV 113
Query: 201 LLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ +L ++RDL N LV D + +SDF ++
Sbjct: 114 CEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMT 151
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 3e-11
Identities = 27/167 (16%), Positives = 54/167 (32%), Gaps = 18/167 (10%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFY--AMKVVDREALAIRKKLHRADMEKV 141
+ LG G ++ R +KV+D+ +
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE---AAS 64
Query: 142 ILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDL--YAARQRQPGKRFGISSAKFYAAE 199
+++ L H L Y + LV E+ G L Y ++ I A +
Sbjct: 65 MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL---KKNKNCINILWKLEVAKQ 121
Query: 200 TLLALEYLHMMGIVYRDLKPENVLVREDGHIM--------LSDFDLS 238
A+ +L +++ ++ +N+L+ + LSD +S
Sbjct: 122 LAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS 168
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 4e-11
Identities = 47/167 (28%), Positives = 63/167 (37%), Gaps = 29/167 (17%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRK-KLHRADMEKV 141
+ L LG G VY A + +AI+K KL K
Sbjct: 9 AKRYEKLDFLGEGQFATVYK---------------ARDKNTNQIVAIKKIKLGHRSEAKD 53
Query: 142 -----------ILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGI 190
+L L HP + L F LV ++ DL +
Sbjct: 54 GINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DL-EVIIKDNSLVLTP 111
Query: 191 SSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237
S K Y TL LEYLH I++RDLKP N+L+ E+G + L+DF L
Sbjct: 112 SHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGL 158
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 4e-05
Identities = 29/133 (21%), Positives = 48/133 (36%), Gaps = 33/133 (24%)
Query: 332 THE-----YLAPEVISGQGH-GSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILK-- 383
TH+ Y APE++ G G VD W +G L E+L G+++ L I +
Sbjct: 170 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETL 229
Query: 384 ---KPLTFPRIGVSSSKEFEEVVKLQ----------------DLISKLLVKNPKKRIGSL 424
+P + S ++ DLI L + NP RI
Sbjct: 230 GTPTEEQWP--DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI--- 284
Query: 425 KGSVEIKRHEFFK 437
+ + + ++F
Sbjct: 285 -TATQALKMKYFS 296
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 7e-11
Identities = 37/165 (22%), Positives = 65/165 (39%), Gaps = 26/165 (15%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIR--NPMVGLPQCFYAMKVV----DREAL---AIRKKL 133
++ + L +G G G V C+ + +V A+K D + + A+R
Sbjct: 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIV-------AIKKFLESDDDKMVKKIAMR--- 73
Query: 134 HRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSA 193
E +L L H L L + LV E+ + + P
Sbjct: 74 -----EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNG-LDYQVV 126
Query: 194 KFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ Y + + + + H I++RD+KPEN+LV + G + L DF +
Sbjct: 127 QKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFA 171
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 37/162 (22%), Positives = 57/162 (35%), Gaps = 44/162 (27%)
Query: 332 THE-----YLAPEVISGQGH-GSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILK-- 383
E Y APE++ G G AVD W +G + EM G F G+++ L +I+
Sbjct: 182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCL 241
Query: 384 -----------------KPLTFPRIGVSSSKEFEEVVK-----LQDLISKLLVKNPKKRI 421
+ P I + E + DL K L +P KR
Sbjct: 242 GNLIPRHQELFNKNPVFAGVRLPEI--KEREPLERRYPKLSEVVIDLAKKCLHIDPDKRP 299
Query: 422 GSLKGSVEIKRHEFFKGINWALIRSIKPPEVPNNDLYCKIKK 463
E+ H+FF + E + +L K++K
Sbjct: 300 ----FCAELLHHDFF--------QMDGFAERFSQELQLKVQK 329
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 7e-11
Identities = 46/174 (26%), Positives = 70/174 (40%), Gaps = 38/174 (21%)
Query: 83 LDHFRLLRRLGSGDIGNVY--LCQIRNPMVGLPQCFYAMKVV----DREAL---AIRKKL 133
+ + L ++G G G V+ + V A+K V ++E A+R
Sbjct: 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKV-------ALKKVLMENEKEGFPITALR--- 65
Query: 134 HRADMEKVILTMLDHPFLPTLY----------AEFEASHYSCLVMEYCPGGDLYAARQRQ 183
E IL +L H + L + S Y LV ++C DL A
Sbjct: 66 -----EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIY--LVFDFCEH-DL-AGLLSN 116
Query: 184 PGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237
+F +S K L L Y+H I++RD+K NVL+ DG + L+DF L
Sbjct: 117 VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 170
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 31/149 (20%), Positives = 55/149 (36%), Gaps = 41/149 (27%)
Query: 321 PINARSKSFVGTHE-----YLAPEVISGQGH-GSAVDWWTLGVFLYEMLYGTTPFKGENN 374
N++ + T+ Y PE++ G+ G +D W G + EM + +G
Sbjct: 177 AKNSQPNRY--TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 234
Query: 375 EKTLINILK-------------------KPLTFPRIGVSSSKEFEEVVKLQ-------DL 408
+ L I + + L + ++ ++ +K DL
Sbjct: 235 QHQLALISQLCGSITPEVWPNVDNYELYEKLELVK---GQKRKVKDRLKAYVRDPYALDL 291
Query: 409 ISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437
I KLLV +P +RI S + H+FF
Sbjct: 292 IDKLLVLDPAQRI----DSDDALNHDFFW 316
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 33/166 (19%), Positives = 64/166 (38%), Gaps = 16/166 (9%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRAD--MEKV 141
+ L + LG G+ G+V ++ + A+K + + + R+ + E
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKV--AVKTMKLDNSSQRE---IEEFLSEAA 88
Query: 142 ILTMLDHPFLPTLYA-----EFEASHYSCLVMEYCPGGDL--YAARQRQPGKRFGISSAK 194
+ HP + L + +++ + GDL Y R I
Sbjct: 89 CMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQT 148
Query: 195 F--YAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ + L +EYL ++RDL N ++R+D + ++DF LS
Sbjct: 149 LLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLS 194
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 32/157 (20%), Positives = 58/157 (36%), Gaps = 14/157 (8%)
Query: 87 RLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRAD--MEKVILT 144
+G G G VY + + C A+K ++R + E +I+
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHC--AVKSLNRIT----DIGEVSQFLTEGIIMK 81
Query: 145 MLDHPFLPTLYAE-FEASHYSCLVMEYCPGGDLYAARQ--RQPGKRFGISSAKFYAAETL 201
HP + +L + +V+ Y GDL R R + + +
Sbjct: 82 DFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL---RNFIRNETHNPTVKDLIGFGLQVA 138
Query: 202 LALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
++YL V+RDL N ++ E + ++DF L+
Sbjct: 139 KGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 175
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 1e-10
Identities = 41/159 (25%), Positives = 63/159 (39%), Gaps = 14/159 (8%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRAD--MEKV 141
+ L R LG G G VY N A+K ++ ++ E V
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINV--AVKTCKKDCT----LDNKEKFMSEAV 65
Query: 142 ILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDL--YAARQRQPGKRFGISSAKFYAAE 199
I+ LDHP + L E ++ME P G+L Y + + + Y+ +
Sbjct: 66 IMKNLDHPHIVKLIGIIEEEPT-WIIMELYPYGELGHYL---ERNKNSLKVLTLVLYSLQ 121
Query: 200 TLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
A+ YL + V+RD+ N+LV + L DF LS
Sbjct: 122 ICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS 160
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 37/167 (22%), Positives = 68/167 (40%), Gaps = 28/167 (16%)
Query: 87 RLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREAL---AIRKKLHRADMEKVIL 143
++G G G+VY + ++ YA+K ++ + A R E +L
Sbjct: 24 YEGCKVGRGTYGHVYKAKRKDGKDD---KDYALKQIEGTGISMSACR--------EIALL 72
Query: 144 TMLDHPFLPTLYAEFEASHYSC--LVMEYCPGGDLY-------AARQRQPGKRFGISSAK 194
L HP + +L F + L+ +Y DL+ A++ + + K
Sbjct: 73 RELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVK 131
Query: 195 FYAAETLLALEYLHMMGIVYRDLKPENVLVRED----GHIMLSDFDL 237
+ L + YLH +++RDLKP N+LV + G + ++D
Sbjct: 132 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 178
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 41/169 (24%), Positives = 64/169 (37%), Gaps = 28/169 (16%)
Query: 84 DHFRLLRRLGSGDIGNVYL---CQIRNPMVGLPQCFYAMKVV----DREAL---AIR--- 130
+ + +G G G V+ + V A+K V E + IR
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFV-------ALKRVRVQTGEEGMPLSTIREVA 63
Query: 131 --KKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRF 188
+ L + V+ + D + E LV E+ DL + P
Sbjct: 64 VLRHLETFEHPNVV-RLFD--VCTVSRTDRETKLT--LVFEHVDQ-DLTTYLDKVPEPGV 117
Query: 189 GISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237
+ K + L L++LH +V+RDLKP+N+LV G I L+DF L
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 166
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 1e-06
Identities = 32/131 (24%), Positives = 48/131 (36%), Gaps = 31/131 (23%)
Query: 332 THE-----YLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILK--- 383
T Y APEV+ + + VD W++G EM F+G ++ L IL
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236
Query: 384 --KPLTFPRIGVSS----------SKEFEEVVKLQ-----DLISKLLVKNPKKRIGSLKG 426
+P + ++ E+ V DL+ K L NP KRI S
Sbjct: 237 LPGEEDWP--RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI-SAY- 292
Query: 427 SVEIKRHEFFK 437
H +F+
Sbjct: 293 --SALSHPYFQ 301
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 41/164 (25%), Positives = 72/164 (43%), Gaps = 29/164 (17%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIR-NPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVI 142
+ + +G+G G V+ ++ + V A+K V ++ R K R E I
Sbjct: 40 IAYTNCKVIGNGSFGVVFQAKLVESDEV-------AIKKVLQDK---RFKN-R---ELQI 85
Query: 143 LTMLDHP--------FLPTLYAEFEASHYSCLVMEYCPGGDLY--AARQRQPGKRFGISS 192
+ ++ HP F + E LV+EY P +Y + + + +
Sbjct: 86 MRIVKHPNVVDLKAFFYSNGDKKDEVFLN--LVLEYVPE-TVYRASRHYAKLKQTMPMLL 142
Query: 193 AKFYAAETLLALEYLHMMGIVYRDLKPENVLV-REDGHIMLSDF 235
K Y + L +L Y+H +GI +RD+KP+N+L+ G + L DF
Sbjct: 143 IKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDF 186
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 34/129 (26%), Positives = 54/129 (41%), Gaps = 31/129 (24%)
Query: 335 YLAPEVISGQGH-GSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILK---------- 383
Y APE+I G + + +D W+ G + E++ G F GE+ L+ I+K
Sbjct: 207 YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266
Query: 384 -------KPLTFPRIGVSSSKEFEEVVKLQ------DLISKLLVKNPKKRIGSLKGSVEI 430
FP+I F +V + + DLIS+LL P R+ ++ E
Sbjct: 267 KTMNPNYMEHKFPQI---RPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAI----EA 319
Query: 431 KRHEFFKGI 439
H FF +
Sbjct: 320 LCHPFFDEL 328
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 44/236 (18%), Positives = 84/236 (35%), Gaps = 21/236 (8%)
Query: 11 DYDSSSSSITVPDSSRSFMSNLSFGSRRSSISLCSSSAADQTSLYNSHKPHKA--NQAAW 68
S ++ I VP S S +S+ + S N+ + N
Sbjct: 17 RRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELV 76
Query: 69 EAMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREA-L 127
+A++ + + + +G G G VY + + C A+K ++R +
Sbjct: 77 QAVQHVVIGPSSLIV---HFNEVIGRGHFGCVYHGTLLDNDGKKIHC--AVKSLNRITDI 131
Query: 128 AIRKKLHRADMEKVILTMLDHPFLPTLYA---EFEASHYSCLVMEYCPGGDLYAARQ--R 182
+ E +I+ HP + +L E S +V+ Y GDL R R
Sbjct: 132 GEVSQFLT---EGIIMKDFSHPNVLSLLGICLRSEGSPL--VVLPYMKHGDL---RNFIR 183
Query: 183 QPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ + + +++L V+RDL N ++ E + ++DF L+
Sbjct: 184 NETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 239
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 42/166 (25%), Positives = 63/166 (37%), Gaps = 28/166 (16%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKV-- 141
+ L R +G G G+V+ +P AM V AI K + V
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENP------AMAV------AI-KTCKNCTSDSVRE 436
Query: 142 -------ILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDL--YAARQRQPGKRFGISS 192
+ DHP + L + ++ME C G+L + + ++S
Sbjct: 437 KFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFL---QVRKFSLDLAS 492
Query: 193 AKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
YA + AL YL V+RD+ NVLV + + L DF LS
Sbjct: 493 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 538
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 2e-10
Identities = 41/166 (24%), Positives = 63/166 (37%), Gaps = 28/166 (16%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKV-- 141
+ L R +G G G+V+ +P A+ V AI K + V
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENP------ALAV------AI-KTCKNCTSDSVRE 61
Query: 142 -------ILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDL--YAARQRQPGKRFGISS 192
+ DHP + L + ++ME C G+L + + ++S
Sbjct: 62 KFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFL---QVRKYSLDLAS 117
Query: 193 AKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
YA + AL YL V+RD+ NVLV + + L DF LS
Sbjct: 118 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 163
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 39/178 (21%), Positives = 64/178 (35%), Gaps = 26/178 (14%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREA-LAIRKKLHRADMEKVI 142
++ +R +G G G V+ + + P A+K++ EA ++ R E +
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR---EAAL 103
Query: 143 LTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYA-ARQRQPGKRFGISSAKFYAAE-- 199
+ D+P + L CL+ EY GDL R P +S +
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 200 --------TLLAL-----------EYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ YL V+RDL N LV E+ + ++DF LS
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 221
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 5e-10
Identities = 36/159 (22%), Positives = 63/159 (39%), Gaps = 18/159 (11%)
Query: 87 RLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRAD--MEKVILT 144
R +G G G VY + + QC A+K + R + E +++
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQC--AIKSLSRIT----EMQQVEAFLREGLLMR 77
Query: 145 MLDHPFLPTLYA---EFEASHYSCLVMEYCPGGDLYAARQ--RQPGKRFGISSAKFYAAE 199
L+HP + L E + +++ Y GDL Q R P + + + +
Sbjct: 78 GLNHPNVLALIGIMLPPEGLPH--VLLPYMCHGDL---LQFIRSPQRNPTVKDLISFGLQ 132
Query: 200 TLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+EYL V+RDL N ++ E + ++DF L+
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLA 171
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 6e-10
Identities = 38/151 (25%), Positives = 65/151 (43%), Gaps = 11/151 (7%)
Query: 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADM--EKVILTMLD 147
+ LGSG+ G V + V A+K++ EA + ++ E ++ LD
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKT---VAVKILKNEAND---PALKDELLAEANVMQQLD 76
Query: 148 HPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYL 207
+P++ + EA + LVME G L Q+ + + + + ++YL
Sbjct: 77 NPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYL 133
Query: 208 HMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
V+RDL NVL+ + +SDF LS
Sbjct: 134 EESNFVHRDLAARNVLLVTQHYAKISDFGLS 164
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 7e-10
Identities = 36/174 (20%), Positives = 59/174 (33%), Gaps = 23/174 (13%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRAD--MEKV 141
+ + LG+G G V + A+K++ A R E
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA----HLTEREALMSELK 78
Query: 142 ILTML-DHPFLPTLYAEFEASHYSCLVMEYCPGGDL--YAARQRQPGKRFGISSAKFYAA 198
+L+ L +H + L + ++ EYC GDL + R+R S A
Sbjct: 79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 199 ETLLAL--------------EYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
E L L +L ++RDL N+L+ + DF L+
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 7e-10
Identities = 36/163 (22%), Positives = 68/163 (41%), Gaps = 28/163 (17%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVV-----DREA----LAIRKKLHRA 136
+ +L+ +G G G V A+K+V + I + L +
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKV-----HQHVALKMVRNEKRFHRQAAEEIRILEHLRKQ 153
Query: 137 DME--KVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAK 194
D + ++ ML++ F ++ C+ E +LY ++ + F + +
Sbjct: 154 DKDNTMNVIHMLEN---------FTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVR 203
Query: 195 FYAAETLLALEYLHMMGIVYRDLKPENVLVREDGH--IMLSDF 235
+A L L+ LH I++ DLKPEN+L+++ G I + DF
Sbjct: 204 KFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF 246
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 28/154 (18%), Positives = 49/154 (31%), Gaps = 54/154 (35%)
Query: 335 YLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENN-------------------- 374
Y APEVI G +G +D W+LG L E+L G GE+
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324
Query: 375 ------------------------EKTLINILKKPLTFPRIGVSSSKEFEEVVK------ 404
+ +++ + G S+E+ +K
Sbjct: 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPL 384
Query: 405 LQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438
D + + L +P R+ + + RH + +
Sbjct: 385 FLDFLKQCLEWDPAVRM-TPG---QALRHPWLRR 414
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 37/172 (21%), Positives = 64/172 (37%), Gaps = 20/172 (11%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREA-LAIRKKLHRADMEKVI 142
D +L + LG G G V A+K++ A + + L E I
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS---ELKI 83
Query: 143 LTMLD-HPFLPTLYAE-FEASHYSCLVMEYCPGGDL--YAARQRQPGKRFGISSAKFYAA 198
L + H + L + +++E+C G+L Y +R + ++ Y
Sbjct: 84 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143
Query: 199 E-TLLAL-----------EYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
TL L E+L ++RDL N+L+ E + + DF L+
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 195
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 35/166 (21%), Positives = 58/166 (34%), Gaps = 27/166 (16%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRK-KLHRADMEKV- 141
R L+ LGSG G V+ + + V I+ +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIK-----IPV------CIKVIEDKSGRQSFQA 61
Query: 142 ------ILTMLDHPFLPTLYAE-FEASHYSCLVMEYCPGGDLYAARQ--RQPGKRFGISS 192
+ LDH + L +S LV +Y P G L RQ G
Sbjct: 62 VTDHMLAIGSLDHAHIVRLLGLCPGSSLQ--LVTQYLPLGSL---LDHVRQHRGALGPQL 116
Query: 193 AKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ + + YL G+V+R+L NVL++ + ++DF ++
Sbjct: 117 LLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVA 162
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 38/166 (22%), Positives = 64/166 (38%), Gaps = 24/166 (14%)
Query: 83 LDHFRLLRRLGSGDIGNVY--LCQIRNPMVGLPQCFYAMK-VVDREALAIR-----KKLH 134
+D F++ R G G G V + V A+K V+ R + L
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSV-------AIKKVIQDPRFRNRELQIMQDLA 74
Query: 135 RADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSA- 193
++ L F + Y +VMEY P L+ + ++
Sbjct: 75 VLHHPNIV--QLQSYFYTLGERDRRDI-YLNVVMEYVPD-TLHRCCRNYYRRQVAPPPIL 130
Query: 194 -KFYAAETLLALEYLHM--MGIVYRDLKPENVLV-REDGHIMLSDF 235
K + + + ++ LH+ + + +RD+KP NVLV DG + L DF
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF 176
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 33/129 (25%), Positives = 52/129 (40%), Gaps = 28/129 (21%)
Query: 335 YLAPEVISGQGH-GSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILK---------- 383
Y APE+I G H +AVD W++G EM+ G F+G+N+ L I++
Sbjct: 197 YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL 256
Query: 384 -------KPLTFPRI-GVSSSKEFEEVVKLQ-----DLISKLLVKNPKKRIGSLKGSVEI 430
+ G+ S F + DL+S LL P++R+ E
Sbjct: 257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPY----EA 312
Query: 431 KRHEFFKGI 439
H +F +
Sbjct: 313 LCHPYFDEL 321
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 33/165 (20%), Positives = 62/165 (37%), Gaps = 14/165 (8%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRAD--MEKV 141
+ L+R LG G G VY Q+ A+K + + D ME +
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC----SEQDELDFLMEAL 126
Query: 142 ILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYA---ARQRQPGKRFGISSAKF--Y 196
I++ +H + S +++E GGDL + + +P + ++
Sbjct: 127 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186
Query: 197 AAETLLALEYLHMMGIVYRDLKPENVLVREDGHIML---SDFDLS 238
A + +YL ++RD+ N L+ G + DF ++
Sbjct: 187 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 3e-09
Identities = 34/165 (20%), Positives = 62/165 (37%), Gaps = 14/165 (8%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRAD--MEKV 141
+ L+R LG G G VY Q+ A+K + + D ME +
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC----SEQDELDFLMEAL 85
Query: 142 ILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYA---ARQRQPGKRFGISSAKF--Y 196
I++ +H + S ++ME GGDL + + +P + ++
Sbjct: 86 IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145
Query: 197 AAETLLALEYLHMMGIVYRDLKPENVLVREDGHIML---SDFDLS 238
A + +YL ++RD+ N L+ G + DF ++
Sbjct: 146 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 4e-09
Identities = 41/179 (22%), Positives = 65/179 (36%), Gaps = 38/179 (21%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKL-------HRA 136
+ + +G G+ G V +I+ M AI K++
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDG-------LRMDA------AI-KRMKEYASKDDHR 70
Query: 137 D--MEKVILTML-DHPFLPTLYAEFEASHYSCLVMEYCPGGDLYA-ARQRQPGKRFGISS 192
D E +L L HP + L E Y L +EY P G+L R+ + + +
Sbjct: 71 DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 130
Query: 193 AKFYAAETLLAL-------------EYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
A TL + +YL ++RDL N+LV E+ ++DF LS
Sbjct: 131 IANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 189
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 4e-09
Identities = 39/150 (26%), Positives = 65/150 (43%), Gaps = 11/150 (7%)
Query: 91 RLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADM--EKVILTMLDH 148
LG G+ G+V R + A+KV+ + +K +M E I+ LD+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQID---VAIKVLKQGT----EKADTEEMMREAQIMHQLDN 395
Query: 149 PFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLH 208
P++ L +A LVME GG L+ + +S+ + + ++YL
Sbjct: 396 PYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLE 453
Query: 209 MMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
V+R+L NVL+ + +SDF LS
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLS 483
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 5e-09
Identities = 40/178 (22%), Positives = 67/178 (37%), Gaps = 26/178 (14%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREA-LAIRKKLHRADMEKVI 142
+ L + LG G+ G V + A+K++ A + + L E +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLS---EFNV 79
Query: 143 LTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDL--YAARQRQPGKRFGISSAKFYAAET 200
L ++HP + LY L++EY G L + R+ G + S ++
Sbjct: 80 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 201 LLA--------------------LEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
++YL M +V+RDL N+LV E + +SDF LS
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS 197
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 5e-09
Identities = 41/158 (25%), Positives = 68/158 (43%), Gaps = 12/158 (7%)
Query: 84 DHFRLLR-RLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADM--EK 140
D+ + LG G+ G+V R + A+KV+ + +K +M E
Sbjct: 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQID---VAIKVLKQGT----EKADTEEMMREA 61
Query: 141 VILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAET 200
I+ LD+P++ L +A LVME GG L+ + +S+ +
Sbjct: 62 QIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHK-FLVGKREEIPVSNVAELLHQV 119
Query: 201 LLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ ++YL V+RDL NVL+ + +SDF LS
Sbjct: 120 SMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLS 157
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 36/167 (21%), Positives = 71/167 (42%), Gaps = 30/167 (17%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVV-DREA--------LAIRKKLH 134
D + + +G G G V R Q + A+K++ +++A + + + ++
Sbjct: 54 DRYEIDSLIGKGSFGQVVKAYDRVE-----QEWVAIKIIKNKKAFLNQAQIEVRLLELMN 108
Query: 135 RADME--KVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISS 192
+ D E I+ + H F ++ CLV E +LY + + ++
Sbjct: 109 KHDTEMKYYIVHLKRH---------FMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNL 158
Query: 193 AKFYAAETLLALEYLHM--MGIVYRDLKPENVLVREDGH--IMLSDF 235
+ +A + AL +L + I++ DLKPEN+L+ I + DF
Sbjct: 159 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF 205
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 5e-07
Identities = 36/158 (22%), Positives = 50/158 (31%), Gaps = 59/158 (37%)
Query: 335 YLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGE-NNE------------------ 375
Y +PEV+ G + A+D W+LG L EM G F G +
Sbjct: 224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD 283
Query: 376 ----------------------------------KTLINILKKPLTFP--RIGVSSSKEF 399
+ L NIL P R S
Sbjct: 284 QAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTV 343
Query: 400 EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437
+ +K +DLI ++L +PK RI +H FFK
Sbjct: 344 ADYLKFKDLILRMLDYDPKTRI-QPY---YALQHSFFK 377
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 47/178 (26%), Positives = 69/178 (38%), Gaps = 25/178 (14%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVD-----REA----LAIRKKLHRA 136
F ++R++G G G V LCQ + + +YA+KVV + I KK+
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDN-----KKYYAVKVVRNIKKYTRSAKIEADILKKIQND 91
Query: 137 DM-EKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKF 195
D+ I+ F + CL+ E G LY R F I K
Sbjct: 92 DINNNNIVKYHGK---------FMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKL 141
Query: 196 YAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLS 253
Y E L AL YL M + + DLKPEN+L+ + ++ R K +
Sbjct: 142 YCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 28/140 (20%), Positives = 49/140 (35%), Gaps = 41/140 (29%)
Query: 335 YLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTL---INILKKP------ 385
Y APEVI G + D W+ G L E+ G+ F+ + + L +I++
Sbjct: 225 YRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLY 284
Query: 386 -----------------LTFP--------RIGVSSSKEFEEVVK---LQDLISKLLVKNP 417
L +P V +++K D + +L +P
Sbjct: 285 EATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDP 344
Query: 418 KKRIGSLKGSVEIKRHEFFK 437
R S E+ +H+F +
Sbjct: 345 TLRP-SPA---ELLKHKFLE 360
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 43/224 (19%), Positives = 79/224 (35%), Gaps = 43/224 (19%)
Query: 35 GSRRSSISLCSSSAADQTSLYNSHKPHKANQAAWEAMKRLRRAQGRVGLD-HFRLLRRLG 93
++ +S S + + + + R + + + +G
Sbjct: 3 SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIG 62
Query: 94 SGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKV----------IL 143
+G G+V A +++ +AI KK+ R + + IL
Sbjct: 63 TGSYGHVCE---------------AYDKLEKRVVAI-KKILRVFEDLIDCKRILREIAIL 106
Query: 144 TMLDHP--------FLPTLYAEFEASHYSCLVMEYCPGGDLYAA-RQRQPGKRFGISSAK 194
L+H +P +F+ Y +V+E D R I K
Sbjct: 107 NRLNHDHVVKVLDIVIPKDVEKFD-ELY--VVLEIA-DSDFKKLFRTPVYLTELHI---K 159
Query: 195 FYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
L+ ++Y+H GI++RDLKP N LV +D + + DF L+
Sbjct: 160 TLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 47/173 (27%), Positives = 68/173 (39%), Gaps = 40/173 (23%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLH--------- 134
+R L+ +GSG G V A+ +AI KKL+
Sbjct: 25 AVYRDLQPVGSGAYGAVCS---------------AVDGRTGAKVAI-KKLYRPFQSELFA 68
Query: 135 -RADMEKVILTMLDHP--------FLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPG 185
RA E +L + H F P + Y LVM + G DL + +
Sbjct: 69 KRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY--LVMPFM-GTDLGKLMKHEKL 125
Query: 186 KRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
I +F + L L Y+H GI++RDLKP N+ V ED + + DF L+
Sbjct: 126 GEDRI---QFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 175
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 34/144 (23%), Positives = 59/144 (40%), Gaps = 34/144 (23%)
Query: 324 ARSKS-----FVGTHEYLAPEVI-SGQGHGSAVDWWTLGVFLYEMLYGTTPFKGEN--NE 375
AR +V T Y APEVI + + VD W++G + EM+ G T FKG + ++
Sbjct: 175 ARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ 234
Query: 376 KTLI-NILKKPL--TFPRIGVSSSKE------------FEEVVK-----LQDLISKLLVK 415
I + P R+ +K F ++ +L+ K+LV
Sbjct: 235 LKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVL 294
Query: 416 NPKKRIGSLKGSV-EIKRHEFFKG 438
+ ++R+ + E H +F+
Sbjct: 295 DAEQRV-----TAGEALAHPYFES 313
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 43/173 (24%), Positives = 64/173 (36%), Gaps = 40/173 (23%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLH--------- 134
+ ++ L +GSG G+V A +A+ KKL
Sbjct: 29 ERYQNLSPVGSGAYGSVC---------------AAFDTKTGLRVAV-KKLSRPFQSIIHA 72
Query: 135 -RADMEKVILTMLDHP--------FLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPG 185
R E +L + H F P E Y LV G DL + Q
Sbjct: 73 KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLM-GADLNNIVKCQKL 129
Query: 186 KRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ +F + L L+Y+H I++RDLKP N+ V ED + + DF L+
Sbjct: 130 TDDHV---QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 179
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 34/145 (23%), Positives = 60/145 (41%), Gaps = 38/145 (26%)
Query: 324 ARSKS-----FVGTHEYLAPEVI-SGQGHGSAVDWWTLGVFLYEMLYGTTPFKGEN--NE 375
AR + +V T Y APE++ + + VD W++G + E+L G T F G + ++
Sbjct: 179 ARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 238
Query: 376 KTLI-NILKKPL--TFPRIGVSSSKEFEEVVKLQ-------------------DLISKLL 413
LI ++ P +I S++ + + L DL+ K+L
Sbjct: 239 LKLILRLVGTPGAELLKKISSESARNY--IQSLTQMPKMNFANVFIGANPLAVDLLEKML 296
Query: 414 VKNPKKRIGSLKGSV-EIKRHEFFK 437
V + KRI + + H +F
Sbjct: 297 VLDSDKRI-----TAAQALAHAYFA 316
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 5e-08
Identities = 43/174 (24%), Positives = 66/174 (37%), Gaps = 43/174 (24%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLH--------- 134
+ +GSG G+V A+ E +AI KKL
Sbjct: 24 KTYVSPTHVGSGAYGSVC---------------SAIDKRSGEKVAI-KKLSRPFQSEIFA 67
Query: 135 -RADMEKVILTMLDHP--------FLPTLYAEFEASHYSCLVMEYCPGGDLYAA-RQRQP 184
RA E ++L + H F P Y LVM + DL +
Sbjct: 68 KRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY--LVMPFM-QTDLQKIMGLKFS 124
Query: 185 GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
++ ++ + L L+Y+H G+V+RDLKP N+ V ED + + DF L+
Sbjct: 125 EEKI-----QYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA 173
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 37/144 (25%), Positives = 61/144 (42%), Gaps = 34/144 (23%)
Query: 324 ARSKS-----FVGTHEYLAPEVI-SGQGHGSAVDWWTLGVFLYEMLYGTTPFKGEN--NE 375
AR +V T Y APEVI S + VD W++G + EML G T FKG++ ++
Sbjct: 173 ARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ 232
Query: 376 KTLI-NILKKPL--TFPRIGVSSSKE------------FEEVV-----KLQDLISKLLVK 415
T I + P ++ ++K F ++ + DL+ K+L
Sbjct: 233 LTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLEL 292
Query: 416 NPKKRIGSLKGSV-EIKRHEFFKG 438
+ KR+ + + H FF+
Sbjct: 293 DVDKRL-----TAAQALTHPFFEP 311
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 6e-08
Identities = 42/179 (23%), Positives = 68/179 (37%), Gaps = 33/179 (18%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLH-------RA 136
D L + LG G G V + + P+ A+ V A+ K L +
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPK--EAVTV------AV-KMLKDDATEKDLS 85
Query: 137 D--MEKVILTML-DHPFLPTLYAEFEASHYSCLVMEYCPGGDL--YAARQRQPGKRFGIS 191
D E ++ M+ H + L +++EY G+L Y +R PG +
Sbjct: 86 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 145
Query: 192 SAKFYAAE-TLLAL-----------EYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ + T L EYL ++RDL NVLV E+ + ++DF L+
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 33/160 (20%), Positives = 61/160 (38%), Gaps = 25/160 (15%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVD-----REA----LAIRKKLHRA 136
+ ++ LG G G V C + A+K++ REA + + KK+
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARG----KSQVALKIIRNVGKYREAARLEINVLKKIKEK 76
Query: 137 D--MEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAK 194
D + + + M D F + C+ E G + + + + + + +
Sbjct: 77 DKENKFLCVLMSDW---------FNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVR 126
Query: 195 FYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSD 234
A + AL +LH + + DLKPEN+L L +
Sbjct: 127 HMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYN 166
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 35/141 (24%), Positives = 50/141 (35%), Gaps = 41/141 (29%)
Query: 335 YLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTL---INILKKP------ 385
Y PEVI G D W++G L+E G T F+ N + L IL
Sbjct: 205 YRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIH 264
Query: 386 ------------LTFPRIGVSSSKEFEEVVK---------------LQDLISKLLVKNPK 418
L + S + +E K L DL+ ++L +P
Sbjct: 265 RTRKQKYFYKGGLVWD-ENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA 323
Query: 419 KRIGSLKGSVEIKRHEFFKGI 439
+RI +L E H FF G+
Sbjct: 324 QRI-TLA---EALLHPFFAGL 340
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 43/175 (24%), Positives = 70/175 (40%), Gaps = 43/175 (24%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLH-------- 134
L ++ L+ +GSG G V A + +AI KKL
Sbjct: 24 LKRYQNLKPIGSGAQGIVC---------------AAYDAILERNVAI-KKLSRPFQNQTH 67
Query: 135 --RADMEKVILTMLDHP--------FLPTLYAEFEASHYSCLVMEYCPGGDLYAA-RQRQ 183
RA E V++ ++H F P E Y +VME +L +
Sbjct: 68 AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY--IVMELM-DANLCQVIQMEL 124
Query: 184 PGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+R + + L +++LH GI++RDLKP N++V+ D + + DF L+
Sbjct: 125 DHERM-----SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 174
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 32/126 (25%), Positives = 49/126 (38%), Gaps = 33/126 (26%)
Query: 329 FVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINIL------ 382
+V T Y APEVI G G+ VD W++G + EM+ G F G ++ ++
Sbjct: 186 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP 245
Query: 383 -----------------------KKPLT--FPRIGVSSSKEFEEVVKLQ--DLISKLLVK 415
FP + + E ++ Q DL+SK+LV
Sbjct: 246 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVI 305
Query: 416 NPKKRI 421
+ KRI
Sbjct: 306 DASKRI 311
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 8e-08
Identities = 42/173 (24%), Positives = 64/173 (36%), Gaps = 40/173 (23%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLH-------- 134
F+L LG G G V C A E +AI KK+
Sbjct: 10 SSDFQLKSLLGEGAYGVV--CS-------------ATHKPTGEIVAI-KKIEPFDKPLFA 53
Query: 135 -RADMEKVILTMLDHP--------FLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPG 185
R E IL H P + F Y ++ E DL+ Q
Sbjct: 54 LRTLREIKILKHFKHENIITIFNIQRPDSFENFN-EVY--IIQELM-QTDLHRVISTQML 109
Query: 186 KRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
I +++ +TL A++ LH +++RDLKP N+L+ + + + DF L+
Sbjct: 110 SDDHI---QYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLA 159
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 32/134 (23%), Positives = 52/134 (38%), Gaps = 30/134 (22%)
Query: 330 VGTHEYLAPEVI-SGQGHGSAVDWWTLGVFLYEMLYGTTPFKGEN--NEKTLI-NILKKP 385
V T Y APEV+ + + A+D W+ G L E+ F G + ++ LI I+ P
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242
Query: 386 LTFPRIGVSSSKEFEEVVKLQ--------------------DLISKLLVKNPKKRIGSLK 425
+ + S E +K DL+ ++LV +P KRI
Sbjct: 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRI---- 298
Query: 426 GSV-EIKRHEFFKG 438
+ E H + +
Sbjct: 299 -TAKEALEHPYLQT 311
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 9e-08
Identities = 40/179 (22%), Positives = 65/179 (36%), Gaps = 33/179 (18%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLH-------RA 136
D L + LG G G V + + P+ A+ V A+ K L +
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPK--EAVTV------AV-KMLKDDATEKDLS 131
Query: 137 D--MEKVILTML-DHPFLPTLYAEFEASHYSCLVMEYCPGGDLYA-ARQRQPGKRFGISS 192
D E ++ M+ H + L +++EY G+L R R+P
Sbjct: 132 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 191
Query: 193 AKFYAAETLL-------------ALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
E + +EYL ++RDL NVLV E+ + ++DF L+
Sbjct: 192 INRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 250
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 26/129 (20%), Positives = 52/129 (40%), Gaps = 8/129 (6%)
Query: 110 VGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVME 169
+ L FY + + ++ + + + Y ++ME
Sbjct: 63 IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQN----KYLNVIME 118
Query: 170 YCPGGDLYAA--RQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLV-RE 226
Y P L+ + G+ ++ Y + A+ ++H +GI +RD+KP+N+LV +
Sbjct: 119 YVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSK 177
Query: 227 DGHIMLSDF 235
D + L DF
Sbjct: 178 DNTLKLCDF 186
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 28/133 (21%), Positives = 55/133 (41%), Gaps = 31/133 (23%)
Query: 328 SFVGTHEYLAPEVISGQGH-GSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILK--- 383
+++ + Y APE++ G ++D W++G E++ G F GE + L+ I++
Sbjct: 200 AYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMG 259
Query: 384 --------------KPLTFPRIGVSSSKEFEEVVK------LQDLISKLLVKNPKKRIGS 423
+ FP + +K++ +++ DL+ ++L P RI
Sbjct: 260 TPTKEQMIRMNPHYTEVRFPTL---KAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINP 316
Query: 424 LKGSVEIKRHEFF 436
E H FF
Sbjct: 317 Y----EAMAHPFF 325
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 43/175 (24%), Positives = 67/175 (38%), Gaps = 42/175 (24%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRA--DM-- 138
D++ + +G G G VYL A + +AI KK++R D+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYL---------------AYDKNTEKNVAI-KKVNRMFEDLID 68
Query: 139 ------EKVILTMLDHP--------FLPTLYAEFEASHYSCLVMEYCPGGDLYAA-RQRQ 183
E IL L +P +F+ Y +V+E DL +
Sbjct: 69 CKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL-Y--IVLEIA-DSDLKKLFKTPI 124
Query: 184 PGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
I K LL ++H GI++RDLKP N L+ +D + + DF L+
Sbjct: 125 FLTEEHI---KTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLA 176
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 32/126 (25%), Positives = 47/126 (37%), Gaps = 33/126 (26%)
Query: 329 FVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINIL------ 382
+V T Y APEVI G G+ VD W++G + EM+ F G + ++
Sbjct: 223 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 282
Query: 383 -----------------------KKPLT--FPRIGVSSSKEFEEVVKLQ--DLISKLLVK 415
FP + E ++ Q DL+SK+LV
Sbjct: 283 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 342
Query: 416 NPKKRI 421
+P KRI
Sbjct: 343 DPAKRI 348
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 45/175 (25%), Positives = 70/175 (40%), Gaps = 43/175 (24%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLH-------- 134
L ++ L+ +GSG G V A V +AI KKL
Sbjct: 61 LKRYQNLKPIGSGAQGIVC---------------AAYDAVLDRNVAI-KKLSRPFQNQTH 104
Query: 135 --RADMEKVILTMLDHP--------FLPTLYAEFEASHYSCLVMEYCPGGDLYAA-RQRQ 183
RA E V++ ++H F P E Y LVME +L +
Sbjct: 105 AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY--LVMELM-DANLCQVIQMEL 161
Query: 184 PGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+R + + L +++LH GI++RDLKP N++V+ D + + DF L+
Sbjct: 162 DHERM-----SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 43/179 (24%), Positives = 67/179 (37%), Gaps = 33/179 (18%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLH-------RA 136
D L + LG G G V L + P KV A+ K L +
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPN--RVTKV------AV-KMLKSDATEKDLS 119
Query: 137 D--MEKVILTML-DHPFLPTLYAEFEASHYSCLVMEYCPGGDL--YAARQRQPGKRFGIS 191
D E ++ M+ H + L +++EY G+L Y +R PG + +
Sbjct: 120 DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 179
Query: 192 SAKF------------YAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ A + +EYL ++RDL NVLV ED + ++DF L+
Sbjct: 180 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 238
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 43/184 (23%), Positives = 61/184 (33%), Gaps = 38/184 (20%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVV-------DREALAIRKKLHRA 136
++ + LGSG G V A+K++ +REAL
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALM-------- 96
Query: 137 DMEKVILTML-DHPFLPTLYAEFEASHYSCLVMEYCPGGDL--YAARQRQPGKRFGISSA 193
E ++T L H + L S L+ EYC GDL Y +R+ I
Sbjct: 97 -SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYE 155
Query: 194 KFYAAETLLAL-------------------EYLHMMGIVYRDLKPENVLVREDGHIMLSD 234
E L E+L V+RDL NVLV + + D
Sbjct: 156 NQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICD 215
Query: 235 FDLS 238
F L+
Sbjct: 216 FGLA 219
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 34/163 (20%), Positives = 61/163 (37%), Gaps = 31/163 (19%)
Query: 86 FRLLRRLGSGDIGNVYLC---QIRNPMVGLPQCFYAMKVVD-----REA----LAIRKKL 133
+ ++ LG G G V C + V A+K+V EA + + + L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHV-------AVKIVKNVDRYCEAARSEIQVLEHL 68
Query: 134 HRAD--MEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGIS 191
+ D + ML+ FE + C+V E G Y + F +
Sbjct: 69 NTTDPNSTFRCVQMLEW---------FEHHGHICIVFELL-GLSTYDFIKENGFLPFRLD 118
Query: 192 SAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSD 234
+ A + ++ +LH + + DLKPEN+L + + +
Sbjct: 119 HIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYN 161
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 7e-07
Identities = 37/140 (26%), Positives = 53/140 (37%), Gaps = 39/140 (27%)
Query: 335 YLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTL---INILKKP------ 385
Y APEVI G D W++G L E G T F ++++ L IL
Sbjct: 200 YRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQ 259
Query: 386 ------------LTFP------RIGVSSSKEFEEVVKLQ--------DLISKLLVKNPKK 419
L + R + K +E + Q DLI K+L +P K
Sbjct: 260 KTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319
Query: 420 RIGSLKGSVEIKRHEFFKGI 439
RI +L+ E +H FF +
Sbjct: 320 RI-TLR---EALKHPFFDLL 335
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 43/198 (21%), Positives = 70/198 (35%), Gaps = 41/198 (20%)
Query: 58 HKPHKANQAAWEAMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFY 117
H H AA + +R VG + L +G G G V
Sbjct: 2 HHHHHMAAAAAAGPEMVRGQVFDVG-PRYTNLSYIGEGAYGMVCS--------------- 45
Query: 118 AMKVVDREALAIRKKLH---------RADMEKVILTMLDHP--------FLPTLYAEFEA 160
A +++ +AI KK+ R E IL H + +
Sbjct: 46 AYDNLNKVRVAI-KKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK- 103
Query: 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPE 220
Y +V + DLY + Q I ++ + L L+Y+H +++RDLKP
Sbjct: 104 DVY--IVQDLM-ETDLYKLLKTQHLSNDHI---CYFLYQILRGLKYIHSANVLHRDLKPS 157
Query: 221 NVLVREDGHIMLSDFDLS 238
N+L+ + + DF L+
Sbjct: 158 NLLLNTTCDLKICDFGLA 175
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 8e-06
Identities = 31/117 (26%), Positives = 51/117 (43%), Gaps = 27/117 (23%)
Query: 330 VGTHEYLAPEVI-SGQGHGSAVDWWTLGVFLYEMLYGTTPFKGEN--NEKTLI-NILKKP 385
V T Y APE++ + +G+ ++D W++G L EML F G++ ++ I IL P
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 251
Query: 386 L--TFPRIGVSSSKEFEEVVKLQ-------------------DLISKLLVKNPKKRI 421
I ++ + ++ L DL+ K+L NP KRI
Sbjct: 252 SQEDLNCIINLKARNY--LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI 306
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 4e-07
Identities = 38/171 (22%), Positives = 63/171 (36%), Gaps = 43/171 (25%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADM------- 138
F +G G G VY +R+ KV A+ K+
Sbjct: 41 FDHKFLIGHGVFGKVYKGVLRD----------GAKV------AL-KRRTPESSQGIEEFE 83
Query: 139 -EKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLY-----AARQRQP---GKRFG 189
E L+ HP L +L + + L+ +Y G+L + +R
Sbjct: 84 TEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE 143
Query: 190 IS--SAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
I +A+ L YLH I++RD+K N+L+ E+ ++DF +S
Sbjct: 144 ICIGAAR--------GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGIS 186
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 7e-07
Identities = 32/175 (18%), Positives = 59/175 (33%), Gaps = 29/175 (16%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVV-------DREALAIRKKLHRA 136
++ + + LG+G G V A+K++ ++EAL
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM-------- 97
Query: 137 DMEKVILTMLD-HPFLPTLYAEFEASHYSCLVMEYCPGGDL--Y--AARQRQPGKRFGIS 191
E I++ L H + L ++ EYC GDL + +
Sbjct: 98 -SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAI 156
Query: 192 SAKFYAAETLLA--------LEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ + LL + +L ++RD+ NVL+ + DF L+
Sbjct: 157 ANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 42/186 (22%), Positives = 62/186 (33%), Gaps = 57/186 (30%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDR--EALAIRKKLHRADM--- 138
+ + R + SG G V C VD +AI K++
Sbjct: 22 SPYTVQRFISSGSYGAV--------------C----AGVDSEGIPVAI-KRVFNTVSDGR 62
Query: 139 ----------------EKVILTMLDHP--------FLPTLYAEFEASHYSCLVMEYCPGG 174
E +L HP F+ Y LV E
Sbjct: 63 TVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMH-KLY--LVTELM-RT 118
Query: 175 DLYA--ARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIML 232
DL QR I +++ LL L LH G+V+RDL P N+L+ ++ I +
Sbjct: 119 DLAQVIHDQRIVISPQHI---QYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITI 175
Query: 233 SDFDLS 238
DF+L+
Sbjct: 176 CDFNLA 181
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 31/135 (22%), Positives = 50/135 (37%), Gaps = 30/135 (22%)
Query: 329 FVGTHEYLAPEVI-SGQGHGSAVDWWTLGVFLYEMLYGTTPFKGEN--NEKTLI-NILKK 384
+V Y APE++ +G VD W+ G + EM F+G N+ I ++
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT 252
Query: 385 PL--TFPRIG-------VSSSKEFEEVVKLQ-----------DLISKLLVKNPKKRIGSL 424
P + +S DLI+K+L NP++RI
Sbjct: 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRI--- 309
Query: 425 KGSV-EIKRHEFFKG 438
S + RH +F+
Sbjct: 310 --STEQALRHPYFES 322
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 36/170 (21%), Positives = 70/170 (41%), Gaps = 35/170 (20%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVI 142
L + L+++LG G G V + ++ E +A+ KK+ A +
Sbjct: 8 LRKYELVKKLGKGAYGIV--WK-------------SIDRRTGEVVAV-KKIFDA-FQNST 50
Query: 143 LT------------MLDHPFLPTLYAEFEASHYSC--LVMEYCPGGDLYAARQRQPGKRF 188
+ H + L A + LV +Y DL+A + +
Sbjct: 51 DAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRANILEPV 109
Query: 189 GISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
++ + + ++YLH G+++RD+KP N+L+ + H+ ++DF LS
Sbjct: 110 HK---QYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLS 156
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 48.0 bits (113), Expect = 4e-06
Identities = 30/205 (14%), Positives = 61/205 (29%), Gaps = 55/205 (26%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVV-----DREALAIRKKLHRADM 138
+ + ++G G G V+ + V A+K++ D + +K
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTIADHTPV-------AIKIIAIEGPDLVNGSHQKTFEEILP 72
Query: 139 EKVILTMLDH--------------------------PFLPTLYAEFEASHYSC------- 165
E +I L P L + + ++ S
Sbjct: 73 EIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFF 132
Query: 166 ------LVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLH-MMGIVYRDLK 218
+V+E+ GG + K +++AK + +L + +RDL
Sbjct: 133 KDDQLFIVLEFEFGGIDLE---QMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLH 189
Query: 219 PENVLVREDGHIMLSDFDLSFKCDV 243
NVL+++ L +
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGKSSTI 214
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 6e-06
Identities = 38/160 (23%), Positives = 60/160 (37%), Gaps = 31/160 (19%)
Query: 91 RLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRA-DMEKVILTMLDHP 149
++G G G VY + N V A+K + ++L + D E ++ H
Sbjct: 38 KMGEGGFGVVYKGYVNNTTV-------AVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90
Query: 150 FLPTLY---AEFEASHYSCLVMEYCPGGD----LYAARQRQP---GKRFGIS--SAKFYA 197
L L ++ CLV Y P G L P R I+ +A
Sbjct: 91 NLVELLGFSSD---GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN--- 144
Query: 198 AETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237
+ +LH ++RD+K N+L+ E +SDF L
Sbjct: 145 -----GINFLHENHHIHRDIKSANILLDEAFTAKISDFGL 179
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 8e-06
Identities = 23/114 (20%), Positives = 42/114 (36%), Gaps = 22/114 (19%)
Query: 330 VGTHEYLAPEVI-SGQGHGSAVDWWTLGVFLYEMLYGTTPFKGEN--------------- 373
+ T Y +P ++ S + A+D W G EML G T F G +
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244
Query: 374 NEKTLINILKKPLTFPR-IGVSSSKEFEEVVKLQ-----DLISKLLVKNPKKRI 421
+E+ +L + R K +++ D + ++L +P R+
Sbjct: 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRL 298
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 39/181 (21%), Positives = 65/181 (35%), Gaps = 47/181 (25%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLH-------- 134
+ L+ LG G G V A+ + +AI KK+
Sbjct: 10 GSRYMDLKPLGCGGNGLV--FS-------------AVDNDCDKRVAI-KKIVLTDPQSVK 53
Query: 135 RADMEKVILTMLDHP--------FLPTLYAEFEASHYSC------LVMEYCPGGDLYAAR 180
A E I+ LDH P+ + +V EY DL
Sbjct: 54 HALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVL 112
Query: 181 QRQPGKRFGISSA--KFYAAETLLALEYLHMMGIVYRDLKPENVLV-REDGHIMLSDFDL 237
++ P + + + + L L+Y+H +++RDLKP N+ + ED + + DF L
Sbjct: 113 EQGP-----LLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGL 167
Query: 238 S 238
+
Sbjct: 168 A 168
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 2e-05
Identities = 64/414 (15%), Positives = 125/414 (30%), Gaps = 116/414 (28%)
Query: 101 YLCQIRNPMVGLPQCFYAMKVVDREA-LAIRKKLHRADMEKVILT--MLDHPFLPTLYAE 157
Y+ Q R+ + Q F V + L +R+ L K +L +L
Sbjct: 112 YIEQ-RDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVL----------- 159
Query: 158 FEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDL 217
S + + ++ C Y + + K F ++ + ET+L M+ + +
Sbjct: 160 --GSGKTWVALDVC---LSYKVQCKMDFKIFWLNLKNCNSPETVLE-----MLQKLLYQI 209
Query: 218 KPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVL- 276
P N R D ++ + + LR + YE C + VL
Sbjct: 210 DP-NWTSRSD-----HSSNIKLRIHSIQAELR---RLLKSKPYENCLL---------VLL 251
Query: 277 -----SCFSSVSHGKKNKKKAVTVTT----IREQVDGDHHDQELLDDPEVVAEPINARS- 326
+++ + K + +TT + + + LD + P +S
Sbjct: 252 NVQNAKAWNAFNLSCK-----ILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSL 306
Query: 327 -KSFVGTH-EYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK 384
++ + L EV+ + + + + + L +K N +K L I++
Sbjct: 307 LLKYLDCRPQDLPREVL--TTNPRRLS--IIAESIRDGLATWDNWKHVNCDK-LTTIIES 361
Query: 385 PLT----------FPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHE 434
L F R+ V F + P + +
Sbjct: 362 SLNVLEPAEYRKMFDRLSV-----FPPSAHI-----------PTILLSLI---------- 395
Query: 435 FFKGINWALIRSIKPPEVPNNDLYCKIKKKVYVPKLSKQERDAPYQIPTHHFDY 488
W + V N K+ K V K K+ IP+ + +
Sbjct: 396 ------WFDVIKSDVMVVVN-----KLHKYSLVEKQPKEST---ISIPSIYLEL 435
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.5 bits (104), Expect = 8e-05
Identities = 53/303 (17%), Positives = 106/303 (34%), Gaps = 89/303 (29%)
Query: 208 HM------MGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYE 261
HM Y+D+ + F +F C V + + LS E I+
Sbjct: 6 HMDFETGEHQYQYKDILS----------VFEDAFVDNFDCKDVQDMPKSILSKEEIDH-- 53
Query: 262 KCSIPSCATPMQPVLSCFSSV-SHGKKNKKKAVT----------VTTIREQVDG------ 304
I + L F ++ S ++ +K V ++ I+ +
Sbjct: 54 ---IIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTR 110
Query: 305 ---DHHDQELLDDPEVVAEPIN-ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLY 360
+ D+ L +D +V A N +R + ++ + L E+ + V +
Sbjct: 111 MYIEQRDR-LYNDNQVFA-KYNVSRLQPYLKLRQALL-ELRPAK-----------NVLID 156
Query: 361 EMLYGTTPFKGENNEKT-L-INILKKP---LTFPR----IGVSSSKEFEEVVK-LQDLIS 410
+L G+ G KT + +++ + + + E V++ LQ L+
Sbjct: 157 GVL-GS----G----KTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLY 207
Query: 411 KL---------LVKNPKKRIGSLKGSVEIKRHEFFKGINWALI--RSIKPPEVPNN-DLY 458
++ N K RI S++ E++R K L+ +++ + N +L
Sbjct: 208 QIDPNWTSRSDHSSNIKLRIHSIQA--ELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLS 265
Query: 459 CKI 461
CKI
Sbjct: 266 CKI 268
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 40/167 (23%), Positives = 68/167 (40%), Gaps = 29/167 (17%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
D+F LG G G VY ++ + + A+K + E + + ++E ++
Sbjct: 30 DNFSNKNILGRGGFGKVYKGRLADGTL------VAVKRLKEERTQGGELQFQTEVE--MI 81
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAA-RQRQPGK-------RFGIS--SA 193
+M H L L LV Y G + + R+R + R I+ SA
Sbjct: 82 SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSA 141
Query: 194 KFYAAETLLALEYLH---MMGIVYRDLKPENVLVREDGHIMLSDFDL 237
+ L YLH I++RD+K N+L+ E+ ++ DF L
Sbjct: 142 R--------GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 489 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.87 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.78 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.46 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.36 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.28 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.12 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.89 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.69 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.65 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.59 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.34 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.29 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.23 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.21 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.82 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.68 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.66 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.62 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.39 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.37 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.36 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.32 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.16 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.13 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.1 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.02 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.99 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.78 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.25 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.44 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 87.2 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 83.12 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 80.42 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-72 Score=544.00 Aligned_cols=280 Identities=32% Similarity=0.580 Sum_probs=250.0
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
...++|++++.||+|+||+||+|+++. +++.||||++.+......+....+.+|+.+|+.++|||||+++++|++
T Consensus 29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~-----~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 103 (311)
T 4aw0_A 29 KRPEDFKFGKILGEGSFSTVVLARELA-----TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD 103 (311)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCccccEEEEEEecccCeEEEEEEECC-----CCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence 445799999999999999999999987 678999999998877666667788999999999999999999999999
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~ 240 (489)
++.+|||||||+||+|.+++.+. +.+++.+++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.
T Consensus 104 ~~~~yivmEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~ 181 (311)
T 4aw0_A 104 DEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKV 181 (311)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCEEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCcee
Confidence 99999999999999999999875 6799999999999999999999999999999999999999999999999999954
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
+....
T Consensus 182 ~~~~~--------------------------------------------------------------------------- 186 (311)
T 4aw0_A 182 LSPES--------------------------------------------------------------------------- 186 (311)
T ss_dssp CCTTT---------------------------------------------------------------------------
T ss_pred cCCCC---------------------------------------------------------------------------
Confidence 42100
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHH
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFE 400 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 400 (489)
......+++||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+++.+|....+.+|....
T Consensus 187 -~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s------- 258 (311)
T 4aw0_A 187 -KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFF------- 258 (311)
T ss_dssp -TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCC-------
T ss_pred -CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccC-------
Confidence 012345679999999999999999999999999999999999999999999999999999998888775321
Q ss_pred HHhhHHHHHHHHhhcCcccccCCCCC--hHHHHcCCCcCCCCccccccCCCCCC
Q 011302 401 EVVKLQDLISKLLVKNPKKRIGSLKG--SVEIKRHEFFKGINWALIRSIKPPEV 452 (489)
Q Consensus 401 ~~~~l~~li~~~L~~dP~~R~~~~~~--~~~ll~hp~f~~~~~~~~~~~~~p~~ 452 (489)
.++++||.+||++||++|+++.+. ..+|++||||+++||+.++...||.+
T Consensus 259 --~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~~~pP~l 310 (311)
T 4aw0_A 259 --PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 310 (311)
T ss_dssp --HHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCC
T ss_pred --HHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhcCCCCCCC
Confidence 258999999999999999999742 34689999999999999998888865
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-69 Score=528.05 Aligned_cols=281 Identities=41% Similarity=0.742 Sum_probs=236.9
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
+..++|++++.||+|+||+||+|++.... .+++.||||++++..... ....++.+|+.+|+.++|||||+++++|++
T Consensus 21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~--~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 97 (304)
T 3ubd_A 21 ADPSQFELLKVLGQGSFGKVFLVKKISGS--DARQLYAMKVLKKATLKV-RDRVRTKMERDILVEVNHPFIVKLHYAFQT 97 (304)
T ss_dssp CCGGGEEEEEEEECGGGCEEEEEEECSST--TTTCEEEEEEEESEEEEE-EECC------CCCCCCCCTTEECEEEEEEE
T ss_pred CCccccEEEEEEecCCCeEEEEEEEccCC--CCCEEEEEEEEehHHcCh-HHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 44578999999999999999999975421 257899999997543211 112356679999999999999999999999
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~ 240 (489)
++.+|||||||+||+|.+++.+. +.+++.+++.|+.||+.||+|||++|||||||||+|||++.+|++||+|||+|+.
T Consensus 98 ~~~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 98 EGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp TTEEEEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred CCEEEEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 99999999999999999999876 6799999999999999999999999999999999999999999999999999843
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
...
T Consensus 176 ~~~----------------------------------------------------------------------------- 178 (304)
T 3ubd_A 176 SID----------------------------------------------------------------------------- 178 (304)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccC-----------------------------------------------------------------------------
Confidence 211
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHH
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFE 400 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 400 (489)
......+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+++.+|.+..+.+|...
T Consensus 179 -~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~-------- 249 (304)
T 3ubd_A 179 -HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFL-------- 249 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTS--------
T ss_pred -CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcC--------
Confidence 01123457899999999999999999999999999999999999999999999999999998887776432
Q ss_pred HHhhHHHHHHHHhhcCcccccCCC-CChHHHHcCCCcCCCCcccc--ccCCCCCCC
Q 011302 401 EVVKLQDLISKLLVKNPKKRIGSL-KGSVEIKRHEFFKGINWALI--RSIKPPEVP 453 (489)
Q Consensus 401 ~~~~l~~li~~~L~~dP~~R~~~~-~~~~~ll~hp~f~~~~~~~~--~~~~~p~~~ 453 (489)
+.++++||.+||++||++||++. ..++|+++||||+++||+.+ +.+.||++|
T Consensus 250 -s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~~~~~~pP~~P 304 (304)
T 3ubd_A 250 -SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKP 304 (304)
T ss_dssp -CHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSSCC
T ss_pred -CHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHHHhCCCCcCcCC
Confidence 12589999999999999999985 35789999999999999987 667888776
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-66 Score=510.81 Aligned_cols=260 Identities=24% Similarity=0.442 Sum_probs=221.2
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
+++|++++.||+|+||+||+|+++. +++.||||++.+..... ....++.+|+.+|+.++|||||+++++|++++
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~-----~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~ 96 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTE-----DGRQYVIKEINISRMSS-KEREESRREVAVLANMKHPNIVQYRESFEENG 96 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETT-----TCCEEEEEEEECTTSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ccceEEeEEEecCCCeEEEEEEECC-----CCCEEEEEEEehHHCCH-HHHHHHHHHHHHHHHCCCCCCCcEEEEEEECC
Confidence 5799999999999999999999987 67899999997654332 33567888999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
.+|||||||+||+|.+++....+..+++.+++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+.
T Consensus 97 ~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 176 (350)
T 4b9d_A 97 SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeec
Confidence 99999999999999999987766778999999999999999999999999999999999999999999999999985432
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
..
T Consensus 177 ~~------------------------------------------------------------------------------ 178 (350)
T 4b9d_A 177 ST------------------------------------------------------------------------------ 178 (350)
T ss_dssp HH------------------------------------------------------------------------------
T ss_pred CC------------------------------------------------------------------------------
Confidence 10
Q ss_pred ccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHH
Q 011302 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEV 402 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~ 402 (489)
.....+.+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+++.+|..+.+... .... +
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~--~~~~------s 250 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPV--SLHY------S 250 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC--CTTS------C
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC--CccC------C
Confidence 0112346899999999999999999999999999999999999999999999999999988754321 1111 1
Q ss_pred hhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 403 VKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 403 ~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
.++++||.+||++||++||++. |+|+||||+.
T Consensus 251 ~~~~~li~~~L~~dP~~R~s~~----e~l~hp~~~~ 282 (350)
T 4b9d_A 251 YDLRSLVSQLFKRNPRDRPSVN----SILEKGFIAK 282 (350)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHH----HHHTSHHHHT
T ss_pred HHHHHHHHHHccCChhHCcCHH----HHhcCHHhhc
Confidence 2589999999999999999987 9999999975
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-65 Score=492.43 Aligned_cols=256 Identities=32% Similarity=0.502 Sum_probs=213.2
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
+++|++++.||+|+||+||+|+++. +++.||||++.+..........++.+|+.+|+.++|||||+++++|++++
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 86 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTT-----TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD 86 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTT-----TCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred eeCeEEEEEEecCcCeEEEEEEECC-----CCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 4789999999999999999999886 67899999998766555555667889999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
.+||||||| +|+|.+++... +.+++.+++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 87 ~~~ivmEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 87 EIIMVIEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp EEEEEEECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred EEEEEEeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence 999999999 78999998876 679999999999999999999999999999999999999999999999999984321
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
.
T Consensus 164 ~------------------------------------------------------------------------------- 164 (275)
T 3hyh_A 164 D------------------------------------------------------------------------------- 164 (275)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred C-------------------------------------------------------------------------------
Confidence 1
Q ss_pred ccCCccccCCCCccCcchhcCCCC-CCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHH
Q 011302 323 NARSKSFVGTHEYLAPEVISGQGH-GSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEE 401 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~~-~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 401 (489)
.....+.+||+.|||||++.+..| +.++|||||||++|||++|+.||.+.+..+.+..|..+.+.+|...
T Consensus 165 ~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~--------- 235 (275)
T 3hyh_A 165 GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFL--------- 235 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTS---------
T ss_pred CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCC---------
Confidence 011234689999999999999886 6899999999999999999999999998888999988877776432
Q ss_pred HhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 402 VVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 402 ~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
+.++++||.+||+.||++||++. |+++||||+.
T Consensus 236 s~~~~~li~~~L~~dP~~R~s~~----eil~hpw~k~ 268 (275)
T 3hyh_A 236 SPGAAGLIKRMLIVNPLNRISIH----EIMQDDWFKV 268 (275)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHH----HHHHCHHHHT
T ss_pred CHHHHHHHHHHccCChhHCcCHH----HHHcCccccc
Confidence 12589999999999999999987 9999999964
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-65 Score=502.95 Aligned_cols=257 Identities=27% Similarity=0.432 Sum_probs=222.6
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.+.|+++++||+|+||+||+|+++. +++.||||++..... ...+.+.+|+.+|+.++|||||+++++|.+++
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~-----tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~ 144 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRS-----SGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGD 144 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEGGGC---SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hHhcEEeEEeecCcCeEEEEEEECC-----CCCEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 4679999999999999999999987 678999999976532 23456778999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
.+|||||||+||+|.+++.+ +.+++.+++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+.
T Consensus 145 ~~~ivmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 221 (346)
T 4fih_A 145 ELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 221 (346)
T ss_dssp EEEEEECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecC
Confidence 99999999999999999876 469999999999999999999999999999999999999999999999999985432
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
..
T Consensus 222 ~~------------------------------------------------------------------------------ 223 (346)
T 4fih_A 222 KE------------------------------------------------------------------------------ 223 (346)
T ss_dssp SS------------------------------------------------------------------------------
T ss_pred CC------------------------------------------------------------------------------
Confidence 10
Q ss_pred ccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCC-CCCCCCCCchhHHH
Q 011302 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLT-FPRIGVSSSKEFEE 401 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~p~~~~~~~~~~~~ 401 (489)
.....+++||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+.+..|...... ++... ..
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~-------~~ 296 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLH-------KV 296 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGG-------GS
T ss_pred CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccc-------cC
Confidence 11234679999999999999999999999999999999999999999999988888888764321 11111 12
Q ss_pred HhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 402 VVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 402 ~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
+.++++||.+||+.||++||++. |+|+||||+..
T Consensus 297 s~~~~dli~~~L~~dP~~R~ta~----e~l~Hp~~~~~ 330 (346)
T 4fih_A 297 SPSLKGFLDRLLVRDPAQRATAA----ELLKHPFLAKA 330 (346)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHH----HHTTCGGGGGC
T ss_pred CHHHHHHHHHHcCCChhHCcCHH----HHhcCHhhcCC
Confidence 23589999999999999999987 99999999753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-64 Score=509.79 Aligned_cols=257 Identities=27% Similarity=0.429 Sum_probs=222.6
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.+.|+++++||+|+||+||+|+++. +++.||||++..... ...+.+.+|+.+|+.++|||||+++++|.+++
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~-----tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~ 221 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRS-----SGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGD 221 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEESTTC---SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hHhcEeeeEeccCcCcEEEEEEECC-----CCCEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCCCceEEEEEECC
Confidence 4679999999999999999999987 678999999975432 23456788999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
.+|||||||+||+|.+++.. +.+++.+++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+.
T Consensus 222 ~~~iVmEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~ 298 (423)
T 4fie_A 222 ELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 298 (423)
T ss_dssp EEEEEEECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEEeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECC
Confidence 99999999999999999876 469999999999999999999999999999999999999999999999999985432
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
..
T Consensus 299 ~~------------------------------------------------------------------------------ 300 (423)
T 4fie_A 299 KE------------------------------------------------------------------------------ 300 (423)
T ss_dssp SS------------------------------------------------------------------------------
T ss_pred CC------------------------------------------------------------------------------
Confidence 10
Q ss_pred ccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCC-CCCCCCCCchhHHH
Q 011302 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLT-FPRIGVSSSKEFEE 401 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~p~~~~~~~~~~~~ 401 (489)
.....+++||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+.+..|...... ++.... .
T Consensus 301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~-~------ 373 (423)
T 4fie_A 301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHK-V------ 373 (423)
T ss_dssp CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTS-S------
T ss_pred CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCccccc-C------
Confidence 11234679999999999999999999999999999999999999999999998888888765322 211111 1
Q ss_pred HhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 402 VVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 402 ~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
..++++||.+||+.||++|+++. |+|+||||+..
T Consensus 374 s~~~~dli~~~L~~dP~~R~ta~----ell~Hp~~~~~ 407 (423)
T 4fie_A 374 SPSLKGFLDRLLVRDPAQRATAA----ELLKHPFLAKA 407 (423)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHH----HHTTCGGGGGC
T ss_pred CHHHHHHHHHHcCCChhHCcCHH----HHhcCHHhcCC
Confidence 13589999999999999999987 99999999763
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-63 Score=528.14 Aligned_cols=282 Identities=30% Similarity=0.608 Sum_probs=240.5
Q ss_pred cCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHH---HHHHHhCCCCCcccc
Q 011302 78 QGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADME---KVILTMLDHPFLPTL 154 (489)
Q Consensus 78 ~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E---~~~l~~l~hpnIv~l 154 (489)
...+.+++|++++.||+|+||+||+|+++. +++.||||++.+..+........+.+| +.+++.++|||||++
T Consensus 183 ~~~~slddf~i~k~LG~G~fG~V~la~~~~-----tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l 257 (689)
T 3v5w_A 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKAD-----TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM 257 (689)
T ss_dssp TCCCCGGGEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCE
T ss_pred CCCCchHHeEEEEEEecccCeEEEEEEECC-----CCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEE
Confidence 346788999999999999999999999987 689999999998776544444444445 455667789999999
Q ss_pred cceeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcc
Q 011302 155 YAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSD 234 (489)
Q Consensus 155 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~D 234 (489)
+++|++.+.+|||||||+||+|.+++.+. +.|++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|
T Consensus 258 ~~~f~~~~~lylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~D 335 (689)
T 3v5w_A 258 SYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISD 335 (689)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECC
T ss_pred EEEEEECCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecc
Confidence 99999999999999999999999999876 6799999999999999999999999999999999999999999999999
Q ss_pred cCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCC
Q 011302 235 FDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDD 314 (489)
Q Consensus 235 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (489)
||+|+.+.
T Consensus 336 FGlA~~~~------------------------------------------------------------------------ 343 (689)
T 3v5w_A 336 LGLACDFS------------------------------------------------------------------------ 343 (689)
T ss_dssp CTTCEECS------------------------------------------------------------------------
T ss_pred cceeeecC------------------------------------------------------------------------
Confidence 99984321
Q ss_pred ccccccccccCCccccCCCCccCcchhc-CCCCCCcccHHHHHHHHHHHhhCCCCCCCCC---cHHHHHHHhcCCCCCCC
Q 011302 315 PEVVAEPINARSKSFVGTHEYLAPEVIS-GQGHGSAVDWWTLGVFLYEMLYGTTPFKGEN---NEKTLINILKKPLTFPR 390 (489)
Q Consensus 315 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-~~~~~~~~DiwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~p~ 390 (489)
.....++|||+.|||||++. +..|+.++||||||||||||++|.+||.+.+ ..++...+....+.+|.
T Consensus 344 --------~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~ 415 (689)
T 3v5w_A 344 --------KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 415 (689)
T ss_dssp --------SCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCT
T ss_pred --------CCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCc
Confidence 11234569999999999997 4679999999999999999999999997643 34556677777776664
Q ss_pred CCCCCchhHHHHhhHHHHHHHHhhcCcccccCCC-CChHHHHcCCCcCCCCcccc--ccCCCCCCCCc
Q 011302 391 IGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL-KGSVEIKRHEFFKGINWALI--RSIKPPEVPNN 455 (489)
Q Consensus 391 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~-~~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~~ 455 (489)
... .++++||.+||++||.+|++.. .++++|++||||+++||+.+ +.+.||++|..
T Consensus 416 ~~S---------~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~~P~~ 474 (689)
T 3v5w_A 416 SFS---------PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPR 474 (689)
T ss_dssp TSC---------HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCSCCCCT
T ss_pred cCC---------HHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcCccCCC
Confidence 321 2589999999999999999963 45779999999999999987 67889998864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-63 Score=479.65 Aligned_cols=256 Identities=22% Similarity=0.365 Sum_probs=210.4
Q ss_pred CCc-eeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec--
Q 011302 84 DHF-RLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA-- 160 (489)
Q Consensus 84 ~~y-~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-- 160 (489)
++| ++.++||+|+||+||+|.++. ++..||+|++...... .....++.+|+.+|+.++|||||+++++|++
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~ 98 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTE-----TTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 98 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECC-----CCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc
Confidence 455 788899999999999999987 5788999999765433 2335678889999999999999999999865
Q ss_pred --CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCC--CeeecCCCCCeEec-cCCcEEEccc
Q 011302 161 --SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMG--IVYRDLKPENVLVR-EDGHIMLSDF 235 (489)
Q Consensus 161 --~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDIKp~NILl~-~~~~vkl~DF 235 (489)
++.+|||||||+||+|.+++.+. +.+++..++.|+.||+.||+|||++| ||||||||+||||+ .+|.+||+||
T Consensus 99 ~~~~~~~lvmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DF 176 (290)
T 3fpq_A 99 KGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL 176 (290)
T ss_dssp TTEEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCT
T ss_pred CCCcEEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeC
Confidence 46789999999999999999875 67999999999999999999999998 99999999999998 4899999999
Q ss_pred CCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCc
Q 011302 236 DLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDP 315 (489)
Q Consensus 236 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (489)
|+|+...
T Consensus 177 Gla~~~~------------------------------------------------------------------------- 183 (290)
T 3fpq_A 177 GLATLKR------------------------------------------------------------------------- 183 (290)
T ss_dssp TGGGGCC-------------------------------------------------------------------------
T ss_pred cCCEeCC-------------------------------------------------------------------------
Confidence 9984211
Q ss_pred cccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCC
Q 011302 316 EVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSS 395 (489)
Q Consensus 316 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 395 (489)
.....+.+||+.|||||++.+ .|+.++|||||||+||||+||+.||.+.+....+.+........+......
T Consensus 184 -------~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~ 255 (290)
T 3fpq_A 184 -------ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA 255 (290)
T ss_dssp -------TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCC
T ss_pred -------CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccC
Confidence 012245689999999999876 599999999999999999999999987766554444433322211111111
Q ss_pred chhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 396 SKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 396 ~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
.+++++||.+||+.||++||++. ++|+||||+.
T Consensus 256 ------~~~~~~li~~~L~~dP~~R~s~~----e~l~Hp~~~~ 288 (290)
T 3fpq_A 256 ------IPEVKEIIEGCIRQNKDERYSIK----DLLNHAFFQE 288 (290)
T ss_dssp ------CHHHHHHHHHHSCSSGGGSCCHH----HHHTSGGGC-
T ss_pred ------CHHHHHHHHHHccCChhHCcCHH----HHhcCccccC
Confidence 13589999999999999999987 9999999975
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-63 Score=488.14 Aligned_cols=266 Identities=23% Similarity=0.286 Sum_probs=218.9
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
...+.|++.++||+|+||+||+|+++. +++.||||+++.+.. ..+|+.+|+.++|||||+++++|.+
T Consensus 55 ~~~~~~~~~~~lG~G~fG~Vy~a~~~~-----~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~ 121 (336)
T 4g3f_A 55 EEVHWMTHQPRVGRGSFGEVHRMKDKQ-----TGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVRE 121 (336)
T ss_dssp BTTTEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEE
T ss_pred cchhheEeCcEeccCCCeEEEEEEECC-----CCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 345789999999999999999999987 678999999986432 2359999999999999999999999
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCC-cEEEcccCCCc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDG-HIMLSDFDLSF 239 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~-~vkl~DFG~a~ 239 (489)
++.+|||||||+||+|.++++.. +.|++.+++.|+.||+.||+|||++|||||||||+||||+.+| ++||+|||+|+
T Consensus 122 ~~~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~ 199 (336)
T 4g3f_A 122 GPWVNIFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHAL 199 (336)
T ss_dssp TTEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCE
T ss_pred CCEEEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCe
Confidence 99999999999999999999876 6799999999999999999999999999999999999999988 69999999995
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
.+......
T Consensus 200 ~~~~~~~~------------------------------------------------------------------------ 207 (336)
T 4g3f_A 200 CLQPDGLG------------------------------------------------------------------------ 207 (336)
T ss_dssp EC------------------------------------------------------------------------------
T ss_pred EccCCCcc------------------------------------------------------------------------
Confidence 44210000
Q ss_pred cccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhH
Q 011302 320 EPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEF 399 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 399 (489)
........++||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+++.+|......++......+
T Consensus 208 -~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s--- 283 (336)
T 4g3f_A 208 -KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCA--- 283 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSC---
T ss_pred -cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCC---
Confidence 0001123468999999999999999999999999999999999999999998888888888876654332222222
Q ss_pred HHHhhHHHHHHHHhhcCcccccCCCCChHH---------HHcCCCcCCCC
Q 011302 400 EEVVKLQDLISKLLVKNPKKRIGSLKGSVE---------IKRHEFFKGIN 440 (489)
Q Consensus 400 ~~~~~l~~li~~~L~~dP~~R~~~~~~~~~---------ll~hp~f~~~~ 440 (489)
..+.+||.+||++||++||++.+.++. .++|||+..+.
T Consensus 284 ---~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~ 330 (336)
T 4g3f_A 284 ---PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK 330 (336)
T ss_dssp ---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred ---HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence 258999999999999999998621111 15789987653
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-60 Score=482.88 Aligned_cols=272 Identities=22% Similarity=0.304 Sum_probs=219.6
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee----
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE---- 159 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~---- 159 (489)
++|++++.||+|+||+||+|+++. +++.||||++++.... .....++.+|+.+|+.++|||||++++++.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~-----t~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 127 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRL-----TGQQVAIKKIPNAFDV-VTNAKRTLRELKILKHFKHDNIIAIKDILRPTVP 127 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEETTTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSC
T ss_pred CCeEEEEEEecccCeEEEEEEECC-----CCCEEEEEEECccccc-hHHHHHHHHHHHHHHhcCCCCcceEeeeeecccc
Confidence 689999999999999999999987 6789999999754322 233456778999999999999999999875
Q ss_pred --cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCC
Q 011302 160 --ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237 (489)
Q Consensus 160 --~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~ 237 (489)
+.+.+||||||| +|+|.+++... +.+++.+++.|++||+.||+|||++|||||||||+|||++.+|.+||+|||+
T Consensus 128 ~~~~~~~~ivmE~~-~g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 128 YGEFKSVYVVLDLM-ESDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp TTTCCCEEEEEECC-SEEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred cccCCEEEEEEeCC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecce
Confidence 346899999999 57899998765 6799999999999999999999999999999999999999999999999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
|+.+.....
T Consensus 205 a~~~~~~~~----------------------------------------------------------------------- 213 (398)
T 4b99_A 205 ARGLCTSPA----------------------------------------------------------------------- 213 (398)
T ss_dssp CBCC----------------------------------------------------------------------------
T ss_pred eeecccCcc-----------------------------------------------------------------------
Confidence 854321000
Q ss_pred cccccccCCccccCCCCccCcchhcCCC-CCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCC---
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVISGQG-HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGV--- 393 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~--- 393 (489)
.......+++||+.|||||++.+.. |+.++||||||||+|||++|++||.+.+..+++..|......++....
T Consensus 214 ---~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~ 290 (398)
T 4b99_A 214 ---EHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAV 290 (398)
T ss_dssp -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC--
T ss_pred ---ccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhh
Confidence 0012345679999999999998865 699999999999999999999999999998888887653222111000
Q ss_pred --------------CCchhH-----HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcc
Q 011302 394 --------------SSSKEF-----EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWA 442 (489)
Q Consensus 394 --------------~~~~~~-----~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~ 442 (489)
.....+ ..+.+++|||.+||++||++|+|+. |+|+||||+.+...
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~----e~L~Hp~f~~~~~p 354 (398)
T 4b99_A 291 GAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAA----AALRHPFLAKYHDP 354 (398)
T ss_dssp ---CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHH----HHTTSGGGTTTCCG
T ss_pred hhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHH----HHhcCHhhCcCCCC
Confidence 000001 1134689999999999999999987 99999999987543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-60 Score=467.10 Aligned_cols=271 Identities=24% Similarity=0.398 Sum_probs=199.5
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc-
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH- 162 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~- 162 (489)
++|++++.||+|+||+||+|+++. +++.||||+++.... ....+++.+|+.+|+.++|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~-----~~~~vAiK~i~~~~~--~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~ 77 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKV-----DDCNYAIKRIRLPNR--ELAREKVMREVKALAKLEHPGIVRYFNAWLEKNT 77 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETT-----TCCEEEEEEEEECSS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-
T ss_pred hhCEEeeEEecCCCeEEEEEEECC-----CCCEEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCc
Confidence 579999999999999999999987 578999999975321 123456788999999999999999999987543
Q ss_pred -----------eEEEEEeecCCCchHHHHHhCCC-CCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcE
Q 011302 163 -----------YSCLVMEYCPGGDLYAARQRQPG-KRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHI 230 (489)
Q Consensus 163 -----------~~~lV~E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~v 230 (489)
++|||||||+||+|.+++..... ....+..++.|+.||+.||+|||++|||||||||+||||+.+|.+
T Consensus 78 ~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~v 157 (299)
T 4g31_A 78 TEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVV 157 (299)
T ss_dssp ---------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE
T ss_pred cccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcE
Confidence 47999999999999999986521 223445688999999999999999999999999999999999999
Q ss_pred EEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCcc
Q 011302 231 MLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQE 310 (489)
Q Consensus 231 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (489)
||+|||+|+.+........
T Consensus 158 Kl~DFGla~~~~~~~~~~~------------------------------------------------------------- 176 (299)
T 4g31_A 158 KVGDFGLVTAMDQDEEEQT------------------------------------------------------------- 176 (299)
T ss_dssp EECCCCCC------------------------------------------------------------------------
T ss_pred EEccCccceecCCCccccc-------------------------------------------------------------
Confidence 9999999965432110000
Q ss_pred ccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcH-HHHHHHhcCCCCCC
Q 011302 311 LLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNE-KTLINILKKPLTFP 389 (489)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~p 389 (489)
.....+...+..+.+||+.|||||++.+..|+.++|||||||++|||++ ||.+..+. ..+..+... .+|
T Consensus 177 -----~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~~--~~p 246 (299)
T 4g31_A 177 -----VLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNL--KFP 246 (299)
T ss_dssp --------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHTT--CCC
T ss_pred -----cccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhcC--CCC
Confidence 0000011123456789999999999999999999999999999999996 88654332 233333332 222
Q ss_pred CCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcc
Q 011302 390 RIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWA 442 (489)
Q Consensus 390 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~ 442 (489)
. ......+.+.+||.+||+.||++||++. ++++||||++++|.
T Consensus 247 ~------~~~~~~~~~~~li~~~L~~dP~~Rps~~----eil~h~~~~~~~~p 289 (299)
T 4g31_A 247 P------LFTQKYPCEYVMVQDMLSPSPMERPEAI----NIIENAVFEDLDFP 289 (299)
T ss_dssp H------HHHHHCHHHHHHHHHHTCSSGGGSCCHH----HHHTSGGGCCC---
T ss_pred C------CCcccCHHHHHHHHHHcCCChhHCcCHH----HHhcCHhhCCCCCC
Confidence 1 1112234578999999999999999987 99999999999984
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-59 Score=456.09 Aligned_cols=270 Identities=21% Similarity=0.304 Sum_probs=212.4
Q ss_pred hhcCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccccc
Q 011302 76 RAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLY 155 (489)
Q Consensus 76 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~ 155 (489)
...|++..++|++.++||+|+||+||+|++++ .||||+++..... ....+.+.+|+.+|++++|||||+++
T Consensus 28 ~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~--------~vAvK~~~~~~~~-~~~~~~f~~E~~il~~l~HpNIV~l~ 98 (307)
T 3omv_A 28 SYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG--------DVAVKILKVVDPT-PEQFQAFRNEVAVLRKTRHVNILLFM 98 (307)
T ss_dssp -CCCBCCTTSCCEEEECCCCSSSEEEEEESSS--------EEEEEECCCSSCC-HHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred CcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC--------cEEEEEEEecCCC-HHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 34578899999999999999999999998654 4799998643221 23456788899999999999999999
Q ss_pred ceeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEccc
Q 011302 156 AEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235 (489)
Q Consensus 156 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DF 235 (489)
+++.+ +.+|||||||+||+|.+++.... ..+++.++..|+.||+.||+|||+++||||||||+||||+.++.+||+||
T Consensus 99 g~~~~-~~~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DF 176 (307)
T 3omv_A 99 GYMTK-DNLAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDF 176 (307)
T ss_dssp EEECS-SSCEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCC
T ss_pred EEEEC-CeEEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeec
Confidence 98765 56899999999999999997653 57999999999999999999999999999999999999999999999999
Q ss_pred CCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCc
Q 011302 236 DLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDP 315 (489)
Q Consensus 236 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (489)
|+|+......
T Consensus 177 Gla~~~~~~~---------------------------------------------------------------------- 186 (307)
T 3omv_A 177 GLATVKSRWS---------------------------------------------------------------------- 186 (307)
T ss_dssp SSCBC---------------------------------------------------------------------------
T ss_pred cCceecccCC----------------------------------------------------------------------
Confidence 9985432100
Q ss_pred cccccccccCCccccCCCCccCcchhcCC---CCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCC
Q 011302 316 EVVAEPINARSKSFVGTHEYLAPEVISGQ---GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIG 392 (489)
Q Consensus 316 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~---~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 392 (489)
......+.+||+.|||||++.+. .|+.++|||||||+||||+||+.||.+.+....+..+.......|...
T Consensus 187 ------~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~ 260 (307)
T 3omv_A 187 ------GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLS 260 (307)
T ss_dssp -------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCST
T ss_pred ------cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcc
Confidence 01123456899999999999753 589999999999999999999999999887776666655444443321
Q ss_pred CCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChH--HHHcCCC
Q 011302 393 VSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSV--EIKRHEF 435 (489)
Q Consensus 393 ~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~--~ll~hp~ 435 (489)
.... ..+..+.+||.+||+.||++||++.+.++ ++++|++
T Consensus 261 ~~~~---~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 261 KLYK---NCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp TSCT---TSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred cccc---cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 1100 11235899999999999999999873322 3456654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-59 Score=457.65 Aligned_cols=257 Identities=23% Similarity=0.310 Sum_probs=213.1
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE 159 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 159 (489)
.+..++|.+.+.||+|+||+||+|++++.....++..||||+++.... +..+++.+|+.+|++++|||||+++++|.
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~---~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 85 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD---NARKDFHREAELLTNLQHEHIVKFYGVCV 85 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCCh---HHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence 456689999999999999999999987644444678999999975432 33456888999999999999999999999
Q ss_pred cCceEEEEEeecCCCchHHHHHhC-----------CCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCC
Q 011302 160 ASHYSCLVMEYCPGGDLYAARQRQ-----------PGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDG 228 (489)
Q Consensus 160 ~~~~~~lV~E~~~gg~L~~~l~~~-----------~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~ 228 (489)
+++.+|||||||+||+|.++++.. ....+++.++..|+.||+.||+|||+++||||||||+||||+.++
T Consensus 86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 165 (299)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence 999999999999999999999764 235799999999999999999999999999999999999999999
Q ss_pred cEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCC
Q 011302 229 HIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHD 308 (489)
Q Consensus 229 ~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (489)
.+||+|||+|+......
T Consensus 166 ~~Ki~DFGla~~~~~~~--------------------------------------------------------------- 182 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTD--------------------------------------------------------------- 182 (299)
T ss_dssp CEEECCCSCHHHHTGGG---------------------------------------------------------------
T ss_pred cEEECCcccceecCCCC---------------------------------------------------------------
Confidence 99999999985322100
Q ss_pred ccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCC-
Q 011302 309 QELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPL- 386 (489)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~- 386 (489)
........+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+++..+..+..
T Consensus 183 -------------~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~ 249 (299)
T 4asz_A 183 -------------YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL 249 (299)
T ss_dssp -------------CEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCC
T ss_pred -------------ceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 0011233479999999999999999999999999999999998 9999999999888888877643
Q ss_pred CCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 387 TFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 387 ~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
..|. ..+ .++.+||.+||+.||++||++.
T Consensus 250 ~~p~---~~~------~~~~~li~~cl~~dP~~RPs~~ 278 (299)
T 4asz_A 250 QRPR---TCP------QEVYELMLGCWQREPHMRKNIK 278 (299)
T ss_dssp CCCT---TCC------HHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCc---cch------HHHHHHHHHHcCCChhHCcCHH
Confidence 2221 122 2589999999999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-59 Score=466.40 Aligned_cols=292 Identities=23% Similarity=0.322 Sum_probs=208.2
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccceeecC
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAEFEAS 161 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~ 161 (489)
.++|+++++||+|+||+||+|+++... .+++.||||.+.+... ..++.+|+.+|+.+ +|||||+++++|++.
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~--~~~~~vAiK~i~~~~~-----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQV--GPEEKIALKHLIPTSH-----PIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTT--SCEEEEEEEEECTTSC-----HHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccC--CCCCEEEEEEEccccC-----HHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 378999999999999999999986321 2578999999875432 23466799999988 699999999999999
Q ss_pred ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccC-CcEEEcccCCCcc
Q 011302 162 HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRED-GHIMLSDFDLSFK 240 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~-~~vkl~DFG~a~~ 240 (489)
+++|||||||+||+|.+++. .+++.+++.|+.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+.
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 99999999999999999883 48999999999999999999999999999999999999876 8999999999965
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
.......... +..... ..............
T Consensus 168 ~~~~~~~~~~----------------------------~~~~~~----------------------~~~~~~~~~~~~~~ 197 (361)
T 4f9c_A 168 THDTKIELLK----------------------------FVQSEA----------------------QQERCSQNKCSICL 197 (361)
T ss_dssp CTTCSCGGGG----------------------------GC----------------------------------------
T ss_pred cCCccccccc----------------------------cccccc----------------------cccccccccccccc
Confidence 4322111000 000000 00000000000000
Q ss_pred ccccCCccccCCCCccCcchhcCCC-CCCcccHHHHHHHHHHHhhCCCCCCC-CCcHHHHHHHhcC--------------
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQG-HGSAVDWWTLGVFLYEMLYGTTPFKG-ENNEKTLINILKK-------------- 384 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~-~~~~~DiwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~-------------- 384 (489)
.......+.+||+.|||||++.+.. |+.++||||+||++|||++|+.||.+ .++.+++..|...
T Consensus 198 ~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~ 277 (361)
T 4f9c_A 198 SRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFG 277 (361)
T ss_dssp --------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred cccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhcc
Confidence 0112345679999999999998865 89999999999999999999999965 4444444444220
Q ss_pred ------------------------CCCCCCCCCC------Cchh-HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 385 ------------------------PLTFPRIGVS------SSKE-FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 385 ------------------------~~~~p~~~~~------~~~~-~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
....|..... .... ...+.+++|||.+||++||++|+|+. |+|+|
T Consensus 278 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~----eaL~H 353 (361)
T 4f9c_A 278 KSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAE----EALLH 353 (361)
T ss_dssp EEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHH----HHHTS
T ss_pred ccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHH----HHhcC
Confidence 0000100000 0000 01224689999999999999999987 99999
Q ss_pred CCcCCCC
Q 011302 434 EFFKGIN 440 (489)
Q Consensus 434 p~f~~~~ 440 (489)
|||++++
T Consensus 354 p~f~~i~ 360 (361)
T 4f9c_A 354 PFFKDMS 360 (361)
T ss_dssp GGGTTC-
T ss_pred cccCCCC
Confidence 9999875
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-58 Score=462.91 Aligned_cols=282 Identities=39% Similarity=0.734 Sum_probs=242.3
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCccccccee
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAEF 158 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~ 158 (489)
.+..++|++++.||+|+||+||+|+++. +++.||||++.+...........+..|..+|+.+ +||||++++++|
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~ 93 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKE-----TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF 93 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcC-----CCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE
Confidence 3567899999999999999999999986 5789999999988766666667788899999988 699999999999
Q ss_pred ecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 159 EASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
.+.+.+|||||||+||+|.+++... +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|
T Consensus 94 ~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a 171 (353)
T 3txo_A 94 QTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMC 171 (353)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccce
Confidence 9999999999999999999998875 57999999999999999999999999999999999999999999999999998
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
+....
T Consensus 172 ~~~~~--------------------------------------------------------------------------- 176 (353)
T 3txo_A 172 KEGIC--------------------------------------------------------------------------- 176 (353)
T ss_dssp BCSCC---------------------------------------------------------------------------
T ss_pred eeccc---------------------------------------------------------------------------
Confidence 42110
Q ss_pred ccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchh
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKE 398 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 398 (489)
........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+.+|......+|....
T Consensus 177 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~----- 248 (353)
T 3txo_A 177 ---NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLH----- 248 (353)
T ss_dssp ------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSC-----
T ss_pred ---CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCC-----
Confidence 011234568999999999999999999999999999999999999999999999999999988877775321
Q ss_pred HHHHhhHHHHHHHHhhcCcccccCCC--CChHHHHcCCCcCCCCcccc--ccCCCCCCCCc
Q 011302 399 FEEVVKLQDLISKLLVKNPKKRIGSL--KGSVEIKRHEFFKGINWALI--RSIKPPEVPNN 455 (489)
Q Consensus 399 ~~~~~~l~~li~~~L~~dP~~R~~~~--~~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~~ 455 (489)
..+.+||.+||++||++|+++. .+.+++++||||++++|..+ +.+.||+.|..
T Consensus 249 ----~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~p~~p~~ 305 (353)
T 3txo_A 249 ----EDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRI 305 (353)
T ss_dssp ----HHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCC
T ss_pred ----HHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCCCCccCCC
Confidence 2489999999999999999982 34469999999999999987 66888888875
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-59 Score=456.07 Aligned_cols=265 Identities=21% Similarity=0.292 Sum_probs=215.4
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccccccee
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEF 158 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 158 (489)
.++..++++++++||+|+||+||+|++.+......++.||||+++.... ....+++.+|+.+|++++|||||++++++
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~--~~~~~~f~~E~~il~~l~HpNIV~l~g~~ 98 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE--GPLREEFRHEAMLRARLQHPNVVCLLGVV 98 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC--C-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC--hHHHHHHHHHHHHHHhCCCCCCCCcceEE
Confidence 4577789999999999999999999987543334678999999975421 12335678899999999999999999999
Q ss_pred ecCceEEEEEeecCCCchHHHHHhCC--------------CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEe
Q 011302 159 EASHYSCLVMEYCPGGDLYAARQRQP--------------GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLV 224 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl 224 (489)
.+++.+|||||||++|+|.+++.... ...+++.++..|+.||+.||+|||+++||||||||+||||
T Consensus 99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV 178 (308)
T ss_dssp CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE
Confidence 99999999999999999999996532 2458999999999999999999999999999999999999
Q ss_pred ccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCC
Q 011302 225 REDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDG 304 (489)
Q Consensus 225 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (489)
+.++.+||+|||+|+.+....
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~----------------------------------------------------------- 199 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAAD----------------------------------------------------------- 199 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGG-----------------------------------------------------------
T ss_pred CCCCCEEECCcccceeccCCC-----------------------------------------------------------
Confidence 999999999999985432100
Q ss_pred CCCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhc
Q 011302 305 DHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILK 383 (489)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~ 383 (489)
........+||+.|||||++.+..|+.++|||||||+||||+| |..||.+.+..+++..+..
T Consensus 200 -----------------~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~ 262 (308)
T 4gt4_A 200 -----------------YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN 262 (308)
T ss_dssp -----------------CBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHT
T ss_pred -----------------ceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 0112334579999999999999999999999999999999998 8999999999888888876
Q ss_pred CCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 384 KPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 384 ~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
+... |. ....+ ..+.+||.+||+.||++||++. +|+++
T Consensus 263 ~~~~-~~-p~~~~------~~~~~li~~C~~~dP~~RPs~~----ei~~~ 300 (308)
T 4gt4_A 263 RQVL-PC-PDDCP------AWVYALMIECWNEFPSRRPRFK----DIHSR 300 (308)
T ss_dssp TCCC-CC-CTTCC------HHHHHHHHHHTCSSGGGSCCHH----HHHHH
T ss_pred CCCC-CC-cccch------HHHHHHHHHHcCCChhHCcCHH----HHHHH
Confidence 5432 21 11122 2589999999999999999987 55543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-59 Score=492.27 Aligned_cols=264 Identities=28% Similarity=0.420 Sum_probs=229.8
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
+++|++++.||+|+||+||+|+++. +++.||||++.+.... ....+.+|+.+|+.++|||||+|+++|++.+
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~-----tg~~~AiK~i~~~~~~---~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 227 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERA-----TGNNFAAKFVMTPHES---DKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 227 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECCSHH---HHHHHHHHHHHHHHTCCTTBCCEEEEEECSS
T ss_pred ccccEEEEEEeeccCeEEEEEEECC-----CCCEEEEEEEeccchh---hHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 5789999999999999999999987 6789999999765433 2345677999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccC--CcEEEcccCCCcc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRED--GHIMLSDFDLSFK 240 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~--~~vkl~DFG~a~~ 240 (489)
.+|||||||+||+|++++... .+.|++.+++.|++||+.||+|||++|||||||||+|||++.+ |.+||+|||+|+.
T Consensus 228 ~~~iv~E~~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~ 306 (573)
T 3uto_A 228 EMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 306 (573)
T ss_dssp EEEEEEECCCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred EEEEEEeecCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence 999999999999999988654 3579999999999999999999999999999999999999854 8999999999854
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
+..
T Consensus 307 ~~~----------------------------------------------------------------------------- 309 (573)
T 3uto_A 307 LDP----------------------------------------------------------------------------- 309 (573)
T ss_dssp CCT-----------------------------------------------------------------------------
T ss_pred ccC-----------------------------------------------------------------------------
Confidence 321
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHH
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFE 400 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 400 (489)
.......+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+..+++..|....+.++.......
T Consensus 310 --~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~---- 383 (573)
T 3uto_A 310 --KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI---- 383 (573)
T ss_dssp --TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTS----
T ss_pred --CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCC----
Confidence 01123458999999999999999999999999999999999999999999999999999988776654332221
Q ss_pred HHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccc
Q 011302 401 EVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWAL 443 (489)
Q Consensus 401 ~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~ 443 (489)
..++++||.+||+.||.+||++. |+|+||||+..+|..
T Consensus 384 -s~~~~dli~~~L~~dp~~R~t~~----e~l~Hpw~~~~~~~~ 421 (573)
T 3uto_A 384 -SEDGKDFIRKLLLADPNTRMTIH----QALEHPWLTPGNAPG 421 (573)
T ss_dssp -CHHHHHHHHTTSCSSGGGSCCHH----HHHHSTTTSCCCCTT
T ss_pred -CHHHHHHHHHHccCChhHCcCHH----HHhcCcCcCCCCCCC
Confidence 23589999999999999999987 999999999988854
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-58 Score=456.33 Aligned_cols=262 Identities=21% Similarity=0.309 Sum_probs=212.8
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE 159 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 159 (489)
.+..++|.+.++||+|+||+||+|++++.....+++.||||+++.... ...+++.+|+.+|++++|||||+++++|.
T Consensus 37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~---~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 113 (329)
T 4aoj_A 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE---SARQDFQREAELLTMLQHQHIVRFFGVCT 113 (329)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCH---HHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 456689999999999999999999987643344678999999975432 33456888999999999999999999999
Q ss_pred cCceEEEEEeecCCCchHHHHHhCC-------------CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEecc
Q 011302 160 ASHYSCLVMEYCPGGDLYAARQRQP-------------GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRE 226 (489)
Q Consensus 160 ~~~~~~lV~E~~~gg~L~~~l~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~ 226 (489)
+.+.+|||||||+||+|.++++... ..++++.++..|+.||+.||+|||+++||||||||+||||+.
T Consensus 114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ 193 (329)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECC
Confidence 9999999999999999999987642 246999999999999999999999999999999999999999
Q ss_pred CCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCC
Q 011302 227 DGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDH 306 (489)
Q Consensus 227 ~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (489)
++.+||+|||+|+.+.....
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~------------------------------------------------------------ 213 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDY------------------------------------------------------------ 213 (329)
T ss_dssp TTEEEECCCC----------------------------------------------------------------------
T ss_pred CCcEEEcccccceeccCCCc------------------------------------------------------------
Confidence 99999999999854321000
Q ss_pred CCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCC
Q 011302 307 HDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKP 385 (489)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~ 385 (489)
.......+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+.+..+..+.
T Consensus 214 ----------------~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~ 277 (329)
T 4aoj_A 214 ----------------YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR 277 (329)
T ss_dssp ----------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTC
T ss_pred ----------------ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 011234579999999999999999999999999999999998 999999999888888887653
Q ss_pred -CCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 386 -LTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 386 -~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
...|. ..+ .++.+||.+||+.||++||++. +|+++
T Consensus 278 ~~~~p~---~~~------~~~~~li~~cl~~dP~~RPs~~----ei~~~ 313 (329)
T 4aoj_A 278 ELERPR---ACP------PEVYAIMRGCWQREPQQRHSIK----DVHAR 313 (329)
T ss_dssp CCCCCT---TCC------HHHHHHHHHHCCSSTTTSCCHH----HHHHH
T ss_pred CCCCcc---ccc------HHHHHHHHHHcCcChhHCcCHH----HHHHH
Confidence 22232 112 2589999999999999999987 66553
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-57 Score=448.74 Aligned_cols=278 Identities=38% Similarity=0.749 Sum_probs=244.5
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
+..++|++++.||+|+||+||+|+++. +++.||||++.+...........+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~ 77 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRH-----NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD 77 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe
Confidence 456899999999999999999999886 578999999998766544556677889999999999999999999999
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~ 240 (489)
.+.+|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.
T Consensus 78 ~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~ 155 (318)
T 1fot_A 78 AQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKY 155 (318)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred CCEEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCccee
Confidence 99999999999999999999875 5799999999999999999999999999999999999999999999999999843
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
..
T Consensus 156 ~~------------------------------------------------------------------------------ 157 (318)
T 1fot_A 156 VP------------------------------------------------------------------------------ 157 (318)
T ss_dssp CS------------------------------------------------------------------------------
T ss_pred cC------------------------------------------------------------------------------
Confidence 21
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHH
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFE 400 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 400 (489)
....+.+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+.++......+|....
T Consensus 158 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~------- 227 (318)
T 1fot_A 158 ---DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFN------- 227 (318)
T ss_dssp ---SCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSC-------
T ss_pred ---CccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCC-------
Confidence 0123457999999999999999999999999999999999999999999988889999888776664221
Q ss_pred HHhhHHHHHHHHhhcCcccccCCCC-ChHHHHcCCCcCCCCcccc--ccCCCCCCCCc
Q 011302 401 EVVKLQDLISKLLVKNPKKRIGSLK-GSVEIKRHEFFKGINWALI--RSIKPPEVPNN 455 (489)
Q Consensus 401 ~~~~l~~li~~~L~~dP~~R~~~~~-~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~~ 455 (489)
.++.+||.+||..||++|++..+ .++++++||||++++|+.+ +.+.||++|..
T Consensus 228 --~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~p~~p~~ 283 (318)
T 1fot_A 228 --EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPI 283 (318)
T ss_dssp --HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC
T ss_pred --HHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHHHhCCCCCCCCCCc
Confidence 25899999999999999996543 4669999999999999987 56778888765
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-57 Score=451.77 Aligned_cols=281 Identities=38% Similarity=0.703 Sum_probs=244.9
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
+..++|++++.||+|+||+||+|+++. +++.||||++.+...........+.+|+.+|+.++||||++++++|.+
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 76 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKA-----TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT 76 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECC-----CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe
Confidence 456899999999999999999999886 578999999998766555556678889999999999999999999999
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~ 240 (489)
.+.+|+||||++||+|..++... +.+++..++.++.||+.||+|||++|||||||||+|||++.+|++||+|||+++.
T Consensus 77 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 154 (337)
T 1o6l_A 77 HDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKE 154 (337)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred CCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhh
Confidence 99999999999999999998765 5799999999999999999999999999999999999999999999999999842
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
...
T Consensus 155 ~~~----------------------------------------------------------------------------- 157 (337)
T 1o6l_A 155 GIS----------------------------------------------------------------------------- 157 (337)
T ss_dssp SCC-----------------------------------------------------------------------------
T ss_pred ccc-----------------------------------------------------------------------------
Confidence 110
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHH
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFE 400 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 400 (489)
........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+....+..+......+|...
T Consensus 158 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~-------- 228 (337)
T 1o6l_A 158 -DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTL-------- 228 (337)
T ss_dssp -TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTS--------
T ss_pred -CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC--------
Confidence 00122456899999999999999999999999999999999999999999998888888888777766422
Q ss_pred HHhhHHHHHHHHhhcCcccccCCC-CChHHHHcCCCcCCCCcccc--ccCCCCCCCCc
Q 011302 401 EVVKLQDLISKLLVKNPKKRIGSL-KGSVEIKRHEFFKGINWALI--RSIKPPEVPNN 455 (489)
Q Consensus 401 ~~~~l~~li~~~L~~dP~~R~~~~-~~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~~ 455 (489)
..++.+||.+||+.||++|++.. ..++++++||||++++|..+ +.+.||+.|..
T Consensus 229 -s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~~~pp~~p~~ 285 (337)
T 1o6l_A 229 -SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQV 285 (337)
T ss_dssp -CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCC
T ss_pred -CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCCCCCC
Confidence 12589999999999999999643 24569999999999999987 56788888765
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-57 Score=460.14 Aligned_cols=283 Identities=37% Similarity=0.699 Sum_probs=239.4
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCccccccee
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAEF 158 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~ 158 (489)
.+..++|++++.||+|+||+||+|+++. +++.||||++++...........+..|..+|..+ +||||++++++|
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~-----~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~ 122 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKK-----TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF 122 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE
Confidence 4677899999999999999999999987 6789999999887655555666788899999876 899999999999
Q ss_pred ecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 159 EASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
.+.+.+|||||||+||+|..++.+. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|
T Consensus 123 ~~~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla 200 (396)
T 4dc2_A 123 QTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 200 (396)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EECCEEEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeeccee
Confidence 9999999999999999999998875 57999999999999999999999999999999999999999999999999998
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
+....
T Consensus 201 ~~~~~--------------------------------------------------------------------------- 205 (396)
T 4dc2_A 201 KEGLR--------------------------------------------------------------------------- 205 (396)
T ss_dssp BCCCC---------------------------------------------------------------------------
T ss_pred eeccc---------------------------------------------------------------------------
Confidence 42110
Q ss_pred ccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCC---------CcHHHHHHHhcCCCCCC
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGE---------NNEKTLINILKKPLTFP 389 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~---------~~~~~~~~i~~~~~~~p 389 (489)
......+.+||+.|+|||++.+..++.++|||||||++|||++|+.||.+. ........+......+|
T Consensus 206 ---~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p 282 (396)
T 4dc2_A 206 ---PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 282 (396)
T ss_dssp ---TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCC
T ss_pred ---CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCC
Confidence 011234568999999999999999999999999999999999999999643 22345566777777666
Q ss_pred CCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCC--CChHHHHcCCCcCCCCcccc--ccCCCCCCCCcc
Q 011302 390 RIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL--KGSVEIKRHEFFKGINWALI--RSIKPPEVPNND 456 (489)
Q Consensus 390 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~--~~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~~~ 456 (489)
.... .++++||.+||+.||.+|+++. .++++|++||||++++|+.+ +.+.||++|...
T Consensus 283 ~~~s---------~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~pp~~p~~~ 344 (396)
T 4dc2_A 283 RSLS---------VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNIS 344 (396)
T ss_dssp TTSC---------HHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSCCSCCCCCC
T ss_pred CcCC---------HHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCCCCcCCCC
Confidence 4321 2589999999999999999984 24679999999999999987 567889888753
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-57 Score=450.89 Aligned_cols=279 Identities=37% Similarity=0.756 Sum_probs=237.4
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCccccccee
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAEF 158 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~ 158 (489)
.+..++|.+++.||+|+||+||+|+++. +++.||||++++...........+..|..++..+ +||||+++++++
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~ 87 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKK-----TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF 87 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETT-----TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE
Confidence 4567899999999999999999999987 5789999999987665445556677899998876 899999999999
Q ss_pred ecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 159 EASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
.+.+.+|+||||++||+|.+++... ..+++..++.++.||+.||+|||++|||||||||+|||++.+|++||+|||++
T Consensus 88 ~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 88 QTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhh
Confidence 9999999999999999999998875 57999999999999999999999999999999999999999999999999998
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
+....
T Consensus 166 ~~~~~--------------------------------------------------------------------------- 170 (345)
T 1xjd_A 166 KENML--------------------------------------------------------------------------- 170 (345)
T ss_dssp BCCCC---------------------------------------------------------------------------
T ss_pred hhccc---------------------------------------------------------------------------
Confidence 42110
Q ss_pred ccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchh
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKE 398 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 398 (489)
........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..|......+|...
T Consensus 171 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~------ 241 (345)
T 1xjd_A 171 ---GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWL------ 241 (345)
T ss_dssp ---TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTS------
T ss_pred ---CCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCccc------
Confidence 01123456899999999999999999999999999999999999999999999888888888776666431
Q ss_pred HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcccc--ccCCCCCCCCc
Q 011302 399 FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALI--RSIKPPEVPNN 455 (489)
Q Consensus 399 ~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~~ 455 (489)
..++.+||.+||+.||++||++.+ ++++||||++++|+.+ +.+.||++|..
T Consensus 242 ---s~~~~~li~~lL~~dp~~R~~~~~---~i~~hp~f~~~~w~~l~~~~~~~p~~p~~ 294 (345)
T 1xjd_A 242 ---EKEAKDLLVKLFVREPEKRLGVRG---DIRQHPLFREINWEELERKEIDPPFRPKV 294 (345)
T ss_dssp ---CHHHHHHHHHHSCSSGGGSBTTBS---CGGGSGGGTTCCHHHHHTTCSCC------
T ss_pred ---CHHHHHHHHHHhcCCHhHcCCChH---HHHcCccccCCCHHHHhhCCCCCCcCCCC
Confidence 125899999999999999999852 8999999999999987 56788888764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-58 Score=457.65 Aligned_cols=266 Identities=20% Similarity=0.259 Sum_probs=216.9
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCC-CCcccccce
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDH-PFLPTLYAE 157 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~ 157 (489)
|++..++|++++.||+|+||+||+|++++.......+.||||++...... .....+.+|+.+|+.+.| ||||+++++
T Consensus 59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~--~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccCh--HHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 57888999999999999999999999987665567789999999764322 234567889999999965 899999999
Q ss_pred eec-CceEEEEEeecCCCchHHHHHhCC--------------CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCe
Q 011302 158 FEA-SHYSCLVMEYCPGGDLYAARQRQP--------------GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENV 222 (489)
Q Consensus 158 ~~~-~~~~~lV~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NI 222 (489)
|.+ ++.+|||||||++|+|.++++... ...+++.++..|+.||+.||+|||+++||||||||+||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NI 216 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 216 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccce
Confidence 865 567999999999999999997632 24589999999999999999999999999999999999
Q ss_pred EeccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCcccccccccccccccccccccccccccc
Q 011302 223 LVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQV 302 (489)
Q Consensus 223 Ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (489)
||+.++.+||+|||+|+.+.....
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~~-------------------------------------------------------- 240 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDPD-------------------------------------------------------- 240 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTT--------------------------------------------------------
T ss_pred eeCCCCCEEECcchhhhhcccCCC--------------------------------------------------------
Confidence 999999999999999954321100
Q ss_pred CCCCCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHH
Q 011302 303 DGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINI 381 (489)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i 381 (489)
.....+.+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+.+.++
T Consensus 241 --------------------~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~ 300 (353)
T 4ase_A 241 --------------------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 300 (353)
T ss_dssp --------------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHH
T ss_pred --------------------ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 012234579999999999999999999999999999999998 99999987765555444
Q ss_pred hcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 382 LKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 382 ~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
+......+... ..+ .++.+||.+||+.||++||++. +|++|
T Consensus 301 i~~g~~~~~p~-~~~------~~~~~li~~c~~~dP~~RPt~~----eil~~ 341 (353)
T 4ase_A 301 LKEGTRMRAPD-YTT------PEMYQTMLDCWHGEPSQRPTFS----ELVEH 341 (353)
T ss_dssp HHHTCCCCCCT-TCC------HHHHHHHHHHTCSSGGGSCCHH----HHHHH
T ss_pred HHcCCCCCCCc-cCC------HHHHHHHHHHcCcChhHCcCHH----HHHHH
Confidence 43322222211 112 2589999999999999999987 77776
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-57 Score=451.19 Aligned_cols=279 Identities=37% Similarity=0.689 Sum_probs=246.2
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE 159 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 159 (489)
....++|++++.||+|+||.||+|+++. +++.||||++.+...........+.+|+.+|+.++||||+++++++.
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 111 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKE-----SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECC-----CCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 4567899999999999999999999886 57899999999876655555677888999999999999999999999
Q ss_pred cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 160 ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 160 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
+.+.+|+||||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++
T Consensus 112 ~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~ 189 (350)
T 1rdq_E 112 DNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189 (350)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccce
Confidence 999999999999999999999875 569999999999999999999999999999999999999999999999999984
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
...
T Consensus 190 ~~~----------------------------------------------------------------------------- 192 (350)
T 1rdq_E 190 RVK----------------------------------------------------------------------------- 192 (350)
T ss_dssp ECS-----------------------------------------------------------------------------
T ss_pred ecc-----------------------------------------------------------------------------
Confidence 321
Q ss_pred cccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhH
Q 011302 320 EPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEF 399 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 399 (489)
......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..|..+...+|... .
T Consensus 193 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~---~--- 262 (350)
T 1rdq_E 193 ----GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF---S--- 262 (350)
T ss_dssp ----SCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTC---C---
T ss_pred ----CCcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCC---C---
Confidence 012345799999999999999999999999999999999999999999999899999988877666421 1
Q ss_pred HHHhhHHHHHHHHhhcCcccccCCC-CChHHHHcCCCcCCCCcccc--ccCCCCCCCCc
Q 011302 400 EEVVKLQDLISKLLVKNPKKRIGSL-KGSVEIKRHEFFKGINWALI--RSIKPPEVPNN 455 (489)
Q Consensus 400 ~~~~~l~~li~~~L~~dP~~R~~~~-~~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~~ 455 (489)
..+.+||.+||+.||.+|++.. ..+++|++||||++++|..+ +.+.||++|..
T Consensus 263 ---~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~~~~~~p~~p~~ 318 (350)
T 1rdq_E 263 ---SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKF 318 (350)
T ss_dssp ---HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCC
T ss_pred ---HHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHHhhccCCCCCCCCC
Confidence 2589999999999999999843 34679999999999999987 56888888864
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-57 Score=451.97 Aligned_cols=282 Identities=36% Similarity=0.671 Sum_probs=245.4
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCccccccee
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAEF 158 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~ 158 (489)
++..++|++++.||+|+||+||+|+++. +++.||||++.+...........+..|..+|..+ +||||++++++|
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~ 90 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKG-----TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF 90 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETT-----EEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE
Confidence 3567899999999999999999999986 5789999999987665555566778899999887 799999999999
Q ss_pred ecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 159 EASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
.+.+.+||||||++||+|.+++... +.+++..++.|+.||+.||+|||++|||||||||+|||++.+|++||+|||++
T Consensus 91 ~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a 168 (353)
T 2i0e_A 91 QTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC 168 (353)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcc
Confidence 9999999999999999999998875 56999999999999999999999999999999999999999999999999998
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
+....
T Consensus 169 ~~~~~--------------------------------------------------------------------------- 173 (353)
T 2i0e_A 169 KENIW--------------------------------------------------------------------------- 173 (353)
T ss_dssp BCCCC---------------------------------------------------------------------------
T ss_pred ccccc---------------------------------------------------------------------------
Confidence 42110
Q ss_pred ccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchh
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKE 398 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 398 (489)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..|......+|...
T Consensus 174 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~------ 244 (353)
T 2i0e_A 174 ---DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSM------ 244 (353)
T ss_dssp ---TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTS------
T ss_pred ---CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCC------
Confidence 00123456899999999999999999999999999999999999999999999999999998877776421
Q ss_pred HHHHhhHHHHHHHHhhcCcccccCCCC-ChHHHHcCCCcCCCCcccc--ccCCCCCCCCc
Q 011302 399 FEEVVKLQDLISKLLVKNPKKRIGSLK-GSVEIKRHEFFKGINWALI--RSIKPPEVPNN 455 (489)
Q Consensus 399 ~~~~~~l~~li~~~L~~dP~~R~~~~~-~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~~ 455 (489)
..++.+||.+||..||.+|+++.. .++++++||||++++|+.+ +.+.||++|..
T Consensus 245 ---s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~~p~~p~~ 301 (353)
T 2i0e_A 245 ---SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKA 301 (353)
T ss_dssp ---CHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCC
T ss_pred ---CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCcCCCC
Confidence 125899999999999999998743 4679999999999999987 67889988875
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-57 Score=456.45 Aligned_cols=281 Identities=41% Similarity=0.687 Sum_probs=236.6
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHH-HHhCCCCCcccccceee
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVI-LTMLDHPFLPTLYAEFE 159 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~-l~~l~hpnIv~l~~~~~ 159 (489)
+..++|++++.||+|+||+||+|+++. +++.||||++.+...........+..|..+ ++.++||||++++++|.
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~ 109 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKA-----EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ 109 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETT-----TCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcC-----CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEE
Confidence 456899999999999999999999987 578999999987654434444556667766 56789999999999999
Q ss_pred cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 160 ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 160 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
+.+.+||||||++||+|.+++.+. +.+++..++.|+.||+.||+|||++|||||||||+|||++.+|++||+|||+++
T Consensus 110 ~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~ 187 (373)
T 2r5t_A 110 TADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK 187 (373)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCG
T ss_pred eCCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccc
Confidence 999999999999999999998875 579999999999999999999999999999999999999999999999999984
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
....
T Consensus 188 ~~~~---------------------------------------------------------------------------- 191 (373)
T 2r5t_A 188 ENIE---------------------------------------------------------------------------- 191 (373)
T ss_dssp GGBC----------------------------------------------------------------------------
T ss_pred cccc----------------------------------------------------------------------------
Confidence 2110
Q ss_pred cccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhH
Q 011302 320 EPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEF 399 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 399 (489)
........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..|......++... .
T Consensus 192 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~---~--- 263 (373)
T 2r5t_A 192 --HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNI---T--- 263 (373)
T ss_dssp --CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSS---C---
T ss_pred --CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCC---C---
Confidence 01123456899999999999999999999999999999999999999999999999999988776665321 1
Q ss_pred HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcccc--ccCCCCCCCCc
Q 011302 400 EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALI--RSIKPPEVPNN 455 (489)
Q Consensus 400 ~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~~ 455 (489)
..+++||.+||+.||.+|+++.+++.++++||||++++|..+ +.+.||++|..
T Consensus 264 ---~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~pp~~p~~ 318 (373)
T 2r5t_A 264 ---NSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPPFNPNV 318 (373)
T ss_dssp ---HHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSC
T ss_pred ---HHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHHHhCCCCCCCCCCC
Confidence 248999999999999999999888899999999999999987 66889988864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-56 Score=460.08 Aligned_cols=287 Identities=33% Similarity=0.593 Sum_probs=244.3
Q ss_pred hcCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccc
Q 011302 77 AQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYA 156 (489)
Q Consensus 77 ~~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~ 156 (489)
...++..++|+++++||+|+||+||+|+++. +++.||||++.+...........+.+|+.++..++||||+++++
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~ 141 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKN-----ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEE
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcC-----CCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 3446778999999999999999999999987 57899999999876655455556888999999999999999999
Q ss_pred eeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccC
Q 011302 157 EFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFD 236 (489)
Q Consensus 157 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG 236 (489)
+|.+.+.+|||||||+||+|.+++... ...+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||
T Consensus 142 ~~~~~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 142 AFQDDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp EEECSSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred EEeeCCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchh
Confidence 999999999999999999999999764 3579999999999999999999999999999999999999999999999999
Q ss_pred CCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcc
Q 011302 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPE 316 (489)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (489)
+|+......
T Consensus 221 la~~~~~~~----------------------------------------------------------------------- 229 (437)
T 4aw2_A 221 SCLKLMEDG----------------------------------------------------------------------- 229 (437)
T ss_dssp TCEECCTTS-----------------------------------------------------------------------
T ss_pred hhhhcccCC-----------------------------------------------------------------------
Confidence 984332100
Q ss_pred ccccccccCCccccCCCCccCcchhc-----CCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCC--CCCC
Q 011302 317 VVAEPINARSKSFVGTHEYLAPEVIS-----GQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP--LTFP 389 (489)
Q Consensus 317 ~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p 389 (489)
.......+||+.|+|||++. +..++.++|||||||++|||++|+.||.+.+..+.+.+|.... +.+|
T Consensus 230 ------~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p 303 (437)
T 4aw2_A 230 ------TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP 303 (437)
T ss_dssp ------CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC
T ss_pred ------CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCC
Confidence 01123458999999999997 4568999999999999999999999999999888888887532 3444
Q ss_pred CCCCCCchhHHHHhhHHHHHHHHhhcCccc--ccCCCCChHHHHcCCCcCCCCccccccCCCCCCCCcc
Q 011302 390 RIGVSSSKEFEEVVKLQDLISKLLVKNPKK--RIGSLKGSVEIKRHEFFKGINWALIRSIKPPEVPNND 456 (489)
Q Consensus 390 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~--R~~~~~~~~~ll~hp~f~~~~~~~~~~~~~p~~~~~~ 456 (489)
......+ .++++||++||..+|++ |+++. ++++||||++++|+.++.+.||++|...
T Consensus 304 ~~~~~~s------~~~~dLi~~lL~~~~~r~~r~~~~----eil~Hpff~~i~w~~l~~~~~p~~P~~~ 362 (437)
T 4aw2_A 304 TQVTDVS------ENAKDLIRRLICSREHRLGQNGIE----DFKKHPFFSGIDWDNIRNCEAPYIPEVS 362 (437)
T ss_dssp SSCCCSC------HHHHHHHHTTSSCGGGCTTTTTTH----HHHTSGGGTTCCTTTGGGSCCSCCCCCS
T ss_pred cccccCC------HHHHHHHHHHhcccccccCCCCHH----HHhCCCccCCCCHHHHhhCCCCCCCcCC
Confidence 4322222 25899999999998877 77776 9999999999999999999999988753
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-56 Score=454.98 Aligned_cols=290 Identities=33% Similarity=0.630 Sum_probs=243.5
Q ss_pred hhcCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccccc
Q 011302 76 RAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLY 155 (489)
Q Consensus 76 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~ 155 (489)
....++..++|++++.||+|+||+||+|+++. +++.||||++.+...........+.+|+.++..++||||++++
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~-----~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~ 127 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ-----TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEE
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEE
Confidence 34456778999999999999999999999986 5789999999987666555666788899999999999999999
Q ss_pred ceeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEccc
Q 011302 156 AEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235 (489)
Q Consensus 156 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DF 235 (489)
++|.+.+.+|||||||+||+|.+++.+. +..+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+||
T Consensus 128 ~~~~~~~~~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 128 FAFQDENYLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred EEEeeCCEEEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeec
Confidence 9999999999999999999999999764 247999999999999999999999999999999999999999999999999
Q ss_pred CCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCc
Q 011302 236 DLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDP 315 (489)
Q Consensus 236 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (489)
|+++......
T Consensus 207 Gla~~~~~~~---------------------------------------------------------------------- 216 (412)
T 2vd5_A 207 GSCLKLRADG---------------------------------------------------------------------- 216 (412)
T ss_dssp TTCEECCTTS----------------------------------------------------------------------
T ss_pred hhheeccCCC----------------------------------------------------------------------
Confidence 9984332100
Q ss_pred cccccccccCCccccCCCCccCcchhc-------CCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCC--C
Q 011302 316 EVVAEPINARSKSFVGTHEYLAPEVIS-------GQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP--L 386 (489)
Q Consensus 316 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~-------~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~ 386 (489)
.......+||+.|+|||++. +..++.++|||||||++|||++|+.||.+.+..+.+.+|.... .
T Consensus 217 -------~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~ 289 (412)
T 2vd5_A 217 -------TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL 289 (412)
T ss_dssp -------CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC
T ss_pred -------ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCc
Confidence 00123458999999999997 3568999999999999999999999999999888888887532 3
Q ss_pred CCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccccccCCCCCCCCcc
Q 011302 387 TFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIRSIKPPEVPNND 456 (489)
Q Consensus 387 ~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~~~~~~p~~~~~~ 456 (489)
.+|......+ .++++||++||. +|.+|++. ..++++++||||++++|+.++...||++|...
T Consensus 290 ~~p~~~~~~s------~~~~dli~~lL~-~p~~Rlgr-~~~~ei~~Hpff~~i~w~~l~~~~~p~~p~~~ 351 (412)
T 2vd5_A 290 SLPLVDEGVP------EEARDFIQRLLC-PPETRLGR-GGAGDFRTHPFFFGLDWDGLRDSVPPFTPDFE 351 (412)
T ss_dssp CCC----CCC------HHHHHHHHTTSS-CGGGCTTT-TTHHHHHTSGGGTTCCSTTSTTSCCSCCCC--
T ss_pred CCCccccCCC------HHHHHHHHHHcC-ChhhcCCC-CCHHHHhcCCCcCCCCHHHHhhcCCCCCCcCC
Confidence 3443211112 258999999999 99999864 35569999999999999999999999988753
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-56 Score=445.13 Aligned_cols=282 Identities=37% Similarity=0.701 Sum_probs=239.0
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCccccccee
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAEF 158 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~ 158 (489)
.+..++|++++.||+|+||+||+|+++. +++.||||++.+...........+.+|+.++..+ +||||++++++|
T Consensus 5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~ 79 (345)
T 3a8x_A 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKK-----TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF 79 (345)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred CCchhheEEEEEEEecCCeEEEEEEECC-----CCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE
Confidence 4567899999999999999999999986 5789999999876544445566777899999887 899999999999
Q ss_pred ecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 159 EASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
.+.+.+|+||||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++
T Consensus 80 ~~~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a 157 (345)
T 3a8x_A 80 QTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 157 (345)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGC
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEecccc
Confidence 9999999999999999999998775 57999999999999999999999999999999999999999999999999998
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
+....
T Consensus 158 ~~~~~--------------------------------------------------------------------------- 162 (345)
T 3a8x_A 158 KEGLR--------------------------------------------------------------------------- 162 (345)
T ss_dssp BCSCC---------------------------------------------------------------------------
T ss_pred ccccC---------------------------------------------------------------------------
Confidence 42110
Q ss_pred ccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCC---------CcHHHHHHHhcCCCCCC
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGE---------NNEKTLINILKKPLTFP 389 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~---------~~~~~~~~i~~~~~~~p 389 (489)
........+||+.|+|||++.+..++.++|||||||++|||++|..||... ........+......+|
T Consensus 163 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p 239 (345)
T 3a8x_A 163 ---PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 239 (345)
T ss_dssp ---TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCC
T ss_pred ---CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCC
Confidence 001234568999999999999999999999999999999999999999752 33345566666666665
Q ss_pred CCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCC--CChHHHHcCCCcCCCCcccc--ccCCCCCCCCc
Q 011302 390 RIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL--KGSVEIKRHEFFKGINWALI--RSIKPPEVPNN 455 (489)
Q Consensus 390 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~--~~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~~ 455 (489)
... ...+++||.+||+.||.+|+++. .+++++++||||++++|+.+ +.+.||+.|..
T Consensus 240 ~~~---------s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~~~~~~~p~~p~~ 300 (345)
T 3a8x_A 240 RSL---------SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNI 300 (345)
T ss_dssp TTS---------CHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCC
T ss_pred CCC---------CHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHHhCCCCCCcCCCC
Confidence 421 12589999999999999999984 24579999999999999987 56778887765
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-56 Score=455.87 Aligned_cols=283 Identities=36% Similarity=0.634 Sum_probs=241.2
Q ss_pred cCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccce
Q 011302 78 QGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAE 157 (489)
Q Consensus 78 ~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~ 157 (489)
..++..++|++++.||+|+||+||+|+++. +++.||||++.+...........+.+|+.+++.++||||++++++
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~-----~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 137 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKS-----TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA 137 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECC-----CCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 345678999999999999999999999987 578999999998766555555667889999999999999999999
Q ss_pred eecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCC
Q 011302 158 FEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237 (489)
Q Consensus 158 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~ 237 (489)
|.+.+.+|||||||+||+|.+++.. ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+
T Consensus 138 ~~~~~~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 138 FQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp EECSSEEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEECCEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccce
Confidence 9999999999999999999999876 3599999999999999999999999999999999999999999999999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
|+.+....
T Consensus 215 a~~~~~~~------------------------------------------------------------------------ 222 (410)
T 3v8s_A 215 CMKMNKEG------------------------------------------------------------------------ 222 (410)
T ss_dssp CEECCTTS------------------------------------------------------------------------
T ss_pred eEeeccCC------------------------------------------------------------------------
Confidence 84332100
Q ss_pred cccccccCCccccCCCCccCcchhcCCC----CCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCC--CCCCCC
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVISGQG----HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP--LTFPRI 391 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~----~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~ 391 (489)
.....+.+||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.+..+.+.+|.... +.+|..
T Consensus 223 -----~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 297 (410)
T 3v8s_A 223 -----MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD 297 (410)
T ss_dssp -----EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTT
T ss_pred -----cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCc
Confidence 01223568999999999998766 7899999999999999999999999999988888887643 344432
Q ss_pred CCCCchhHHHHhhHHHHHHHHhhcCccc--ccCCCCChHHHHcCCCcCCCCccc--cccCCCCCCCCcc
Q 011302 392 GVSSSKEFEEVVKLQDLISKLLVKNPKK--RIGSLKGSVEIKRHEFFKGINWAL--IRSIKPPEVPNND 456 (489)
Q Consensus 392 ~~~~~~~~~~~~~l~~li~~~L~~dP~~--R~~~~~~~~~ll~hp~f~~~~~~~--~~~~~~p~~~~~~ 456 (489)
...+ .++++||.+||..+|.+ |+++. +|++||||++++|.. ++.+.||++|...
T Consensus 298 ~~~s-------~~~~~li~~lL~~~~~rlgR~~~~----ei~~Hp~f~~~~w~~~~~~~~~~p~~p~~~ 355 (410)
T 3v8s_A 298 NDIS-------KEAKNLICAFLTDREVRLGRNGVE----EIKRHLFFKNDQWAWETLRDTVAPVVPDLS 355 (410)
T ss_dssp CCCC-------HHHHHHHHHHSSCGGGCTTSSCHH----HHHTSGGGCCSSCCSTTGGGSCCSCCCCCS
T ss_pred cccc-------HHHHHHHHHHccChhhhCCCCCHH----HHhcCccccCCCHHHHhhcccCCCCCCcCC
Confidence 2221 25899999999988877 87776 999999999999874 5888999988753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-55 Score=444.43 Aligned_cols=280 Identities=31% Similarity=0.605 Sum_probs=239.2
Q ss_pred cCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccce
Q 011302 78 QGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAE 157 (489)
Q Consensus 78 ~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~ 157 (489)
.+.+..++|++++.||+|+||.||+|+++. +++.||||++.+...........+.+|+.+|+.++|||||+++++
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~-----~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 83 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKND-----TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYS 83 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 356778999999999999999999999887 578999999998776655666778889999999999999999999
Q ss_pred eecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCC
Q 011302 158 FEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237 (489)
Q Consensus 158 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~ 237 (489)
|.+.+.+|+||||+.||+|..++... ..+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+
T Consensus 84 ~~~~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~ 161 (384)
T 4fr4_A 84 FQDEEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNI 161 (384)
T ss_dssp EECSSEEEEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEeCCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccce
Confidence 99999999999999999999999875 5799999999999999999999999999999999999999999999999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
|+.+..
T Consensus 162 a~~~~~-------------------------------------------------------------------------- 167 (384)
T 4fr4_A 162 AAMLPR-------------------------------------------------------------------------- 167 (384)
T ss_dssp CEECCT--------------------------------------------------------------------------
T ss_pred eeeccC--------------------------------------------------------------------------
Confidence 843211
Q ss_pred cccccccCCccccCCCCccCcchhcC---CCCCCcccHHHHHHHHHHHhhCCCCCCCCC---cHHHHHHHhcCCCCCCCC
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVISG---QGHGSAVDWWTLGVFLYEMLYGTTPFKGEN---NEKTLINILKKPLTFPRI 391 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~~---~~~~~~~DiwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~p~~ 391 (489)
.......+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.. ..+.+..+......+|..
T Consensus 168 -----~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~ 242 (384)
T 4fr4_A 168 -----ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSA 242 (384)
T ss_dssp -----TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTT
T ss_pred -----CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCc
Confidence 112345689999999999974 458999999999999999999999997543 344555555555555532
Q ss_pred CCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcccc--ccCCCCCCCCc
Q 011302 392 GVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALI--RSIKPPEVPNN 455 (489)
Q Consensus 392 ~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~~ 455 (489)
. ...+.+||.+||+.||.+||+. ++++++||||++++|..+ +.+.||++|..
T Consensus 243 ~---------s~~~~~li~~lL~~dP~~R~s~---~~~l~~hp~f~~~~w~~~~~~~~~p~~~p~~ 296 (384)
T 4fr4_A 243 W---------SQEMVSLLKKLLEPNPDQRFSQ---LSDVQNFPYMNDINWDAVFQKRLIPGFIPNK 296 (384)
T ss_dssp S---------CHHHHHHHHHHSCSSGGGSCCS---HHHHHTSGGGTTCCHHHHHTTCSCCCCCCSC
T ss_pred C---------CHHHHHHHHHHhcCCHhHhccc---HHHHHcChhhhcCCHHHHHhCCCCCCCCCCC
Confidence 1 1258999999999999999984 349999999999999976 66888888774
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-55 Score=475.36 Aligned_cols=284 Identities=36% Similarity=0.669 Sum_probs=248.0
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccce
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAE 157 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~ 157 (489)
.++..++|++++.||+|+||+||+|+++. +++.||||++++...........+..|..+|..+ +||||++++++
T Consensus 336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~-----~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~ 410 (674)
T 3pfq_A 336 DRMKLTDFNFLMVLGKGSFGKVMLSERKG-----TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC 410 (674)
T ss_dssp ----CTTEEEEEESSBTTTBCEEEEEESS-----SCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEE
T ss_pred ccccccceEEEEEEccCCCEEEEEEEECC-----CCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence 34567899999999999999999999987 6789999999987766556667788899999887 69999999999
Q ss_pred eecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCC
Q 011302 158 FEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237 (489)
Q Consensus 158 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~ 237 (489)
|++.+.+||||||++||+|.+++... +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+
T Consensus 411 ~~~~~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGl 488 (674)
T 3pfq_A 411 FQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM 488 (674)
T ss_dssp CBCSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTT
T ss_pred EEeCCEEEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecce
Confidence 99999999999999999999999875 5799999999999999999999999999999999999999999999999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
|+....
T Consensus 489 a~~~~~-------------------------------------------------------------------------- 494 (674)
T 3pfq_A 489 CKENIW-------------------------------------------------------------------------- 494 (674)
T ss_dssp CEECCC--------------------------------------------------------------------------
T ss_pred eecccc--------------------------------------------------------------------------
Confidence 843110
Q ss_pred cccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCch
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSK 397 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 397 (489)
......+++||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+++..|....+.+|....
T Consensus 495 ----~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s---- 566 (674)
T 3pfq_A 495 ----DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMS---- 566 (674)
T ss_dssp ----TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSC----
T ss_pred ----CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCC----
Confidence 011234568999999999999999999999999999999999999999999999999999998887775321
Q ss_pred hHHHHhhHHHHHHHHhhcCcccccCCC-CChHHHHcCCCcCCCCcccc--ccCCCCCCCCcc
Q 011302 398 EFEEVVKLQDLISKLLVKNPKKRIGSL-KGSVEIKRHEFFKGINWALI--RSIKPPEVPNND 456 (489)
Q Consensus 398 ~~~~~~~l~~li~~~L~~dP~~R~~~~-~~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~~~ 456 (489)
.++.+||.+||++||++|+++. .++++|++||||++++|+.+ +.+.||++|...
T Consensus 567 -----~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p~~~ 623 (674)
T 3pfq_A 567 -----KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKAS 623 (674)
T ss_dssp -----HHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCCBCC
T ss_pred -----HHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCCcCC
Confidence 2589999999999999999983 34569999999999999987 668899988764
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-54 Score=455.37 Aligned_cols=285 Identities=34% Similarity=0.593 Sum_probs=244.3
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccccccee
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEF 158 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 158 (489)
..+..++|.+++.||+|+||+||+|+++. +++.||||++.+...........+.+|+.+|+.++||||++++++|
T Consensus 180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 254 (543)
T 3c4z_A 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKA-----TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF 254 (543)
T ss_dssp SCCCGGGEEEEEEEEECSSSEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCChhheEEEEEEeeCCCeEEEEEEECC-----CCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 45677999999999999999999999986 5789999999987766555566788899999999999999999999
Q ss_pred ecCceEEEEEeecCCCchHHHHHhCC--CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccC
Q 011302 159 EASHYSCLVMEYCPGGDLYAARQRQP--GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFD 236 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG 236 (489)
.+...+||||||++||+|.+++.... ...+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||
T Consensus 255 ~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFG 334 (543)
T 3c4z_A 255 ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLG 334 (543)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred eeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecc
Confidence 99999999999999999999987643 3569999999999999999999999999999999999999999999999999
Q ss_pred CCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcc
Q 011302 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPE 316 (489)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (489)
+++.+...
T Consensus 335 la~~~~~~------------------------------------------------------------------------ 342 (543)
T 3c4z_A 335 LAVELKAG------------------------------------------------------------------------ 342 (543)
T ss_dssp TCEECCTT------------------------------------------------------------------------
T ss_pred eeeeccCC------------------------------------------------------------------------
Confidence 98432110
Q ss_pred ccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCC----cHHHHHHHhcCCCCCCCCC
Q 011302 317 VVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGEN----NEKTLINILKKPLTFPRIG 392 (489)
Q Consensus 317 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~----~~~~~~~i~~~~~~~p~~~ 392 (489)
.......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+ ..+....+......+|...
T Consensus 343 ------~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~ 416 (543)
T 3c4z_A 343 ------QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKF 416 (543)
T ss_dssp ------CCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTS
T ss_pred ------CcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCccc
Confidence 011234589999999999999999999999999999999999999998763 3556667777666665321
Q ss_pred CCCchhHHHHhhHHHHHHHHhhcCcccccCCCC-ChHHHHcCCCcCCCCcccc--ccCCCCCCCCc
Q 011302 393 VSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLK-GSVEIKRHEFFKGINWALI--RSIKPPEVPNN 455 (489)
Q Consensus 393 ~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~-~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~~ 455 (489)
...+++||.+||+.||++||++.+ .+++|++||||++++|..+ +.+.||++|..
T Consensus 417 ---------s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l~~~~~~pp~~P~~ 473 (543)
T 3c4z_A 417 ---------SPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDS 473 (543)
T ss_dssp ---------CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHHHTTCSCCSCCCCS
T ss_pred ---------CHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHHHcCCCCCCCCCCc
Confidence 125899999999999999999864 4679999999999999987 45788988875
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-54 Score=455.69 Aligned_cols=285 Identities=35% Similarity=0.560 Sum_probs=242.4
Q ss_pred cCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccce
Q 011302 78 QGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAE 157 (489)
Q Consensus 78 ~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~ 157 (489)
...+..++|++++.||+|+||.||+|+++. +++.||||++.+...........+.+|+.+|+.++||||++++++
T Consensus 178 ~~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 252 (576)
T 2acx_A 178 RQPVTKNTFRQYRVLGKGGFGEVCACQVRA-----TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYA 252 (576)
T ss_dssp TSCCCGGGEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hcCccccceEEEEEEeeCCCEEEEEEEECC-----CCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEE
Confidence 445778999999999999999999999986 578999999998776655555667889999999999999999999
Q ss_pred eecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCC
Q 011302 158 FEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237 (489)
Q Consensus 158 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~ 237 (489)
|.+.+.+||||||++||+|.+++.......+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+
T Consensus 253 ~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGl 332 (576)
T 2acx_A 253 YETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGL 332 (576)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred EeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEeccc
Confidence 99999999999999999999999876555699999999999999999999999999999999999999999999999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
|+.+..
T Consensus 333 a~~~~~-------------------------------------------------------------------------- 338 (576)
T 2acx_A 333 AVHVPE-------------------------------------------------------------------------- 338 (576)
T ss_dssp CEECCT--------------------------------------------------------------------------
T ss_pred ceeccc--------------------------------------------------------------------------
Confidence 843211
Q ss_pred cccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCC----cHHHHHHHhcCCCCCCCCCC
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGEN----NEKTLINILKKPLTFPRIGV 393 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~----~~~~~~~i~~~~~~~p~~~~ 393 (489)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+ ...+...+...+..+|...
T Consensus 339 -----~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~- 412 (576)
T 2acx_A 339 -----GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERF- 412 (576)
T ss_dssp -----TCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTS-
T ss_pred -----CccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccC-
Confidence 001123489999999999999999999999999999999999999998764 2445555665555555321
Q ss_pred CCchhHHHHhhHHHHHHHHhhcCcccccCCCC-ChHHHHcCCCcCCCCcccc--ccCCCCCCCCc
Q 011302 394 SSSKEFEEVVKLQDLISKLLVKNPKKRIGSLK-GSVEIKRHEFFKGINWALI--RSIKPPEVPNN 455 (489)
Q Consensus 394 ~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~-~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~~ 455 (489)
..++++||.+||+.||.+|++... .++++++||||++++|..+ +.+.||++|..
T Consensus 413 --------s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~~~~~~pp~~p~~ 469 (576)
T 2acx_A 413 --------SPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDP 469 (576)
T ss_dssp --------CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCC
T ss_pred --------CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHhcCCCCCCCCCCc
Confidence 125899999999999999997643 4579999999999999987 45778888764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-54 Score=426.84 Aligned_cols=285 Identities=38% Similarity=0.669 Sum_probs=232.5
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHH-HHHHHHHHHHHHHHHHhCCCCCccccccee
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALA-IRKKLHRADMEKVILTMLDHPFLPTLYAEF 158 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 158 (489)
.+..++|++++.||+|+||.||+|++.... .+++.||||++++.... .......+.+|+.+|+.++||||+++++++
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 90 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGA--NTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF 90 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSST--TTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccC--CCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE
Confidence 456789999999999999999999985311 25789999999865432 123345567899999999999999999999
Q ss_pred ecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 159 EASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
.+.+.+|+||||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 91 QTGGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp ECSSCEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 9999999999999999999998765 56999999999999999999999999999999999999999999999999997
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
+.....
T Consensus 169 ~~~~~~-------------------------------------------------------------------------- 174 (327)
T 3a62_A 169 KESIHD-------------------------------------------------------------------------- 174 (327)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cccccC--------------------------------------------------------------------------
Confidence 321100
Q ss_pred ccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchh
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKE 398 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 398 (489)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..+......+|...
T Consensus 175 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~------ 244 (327)
T 3a62_A 175 ----GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYL------ 244 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTS------
T ss_pred ----CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCC------
Confidence 0112345799999999999999999999999999999999999999999998888888888766665421
Q ss_pred HHHHhhHHHHHHHHhhcCcccccCCC-CChHHHHcCCCcCCCCcccc--ccCCCCCCCCc
Q 011302 399 FEEVVKLQDLISKLLVKNPKKRIGSL-KGSVEIKRHEFFKGINWALI--RSIKPPEVPNN 455 (489)
Q Consensus 399 ~~~~~~l~~li~~~L~~dP~~R~~~~-~~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~~ 455 (489)
...+.+||.+||..||++||++. ..++++++||||++++|+.+ +.+.||+.|..
T Consensus 245 ---~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~~~~~~~~p~~p~~ 301 (327)
T 3a62_A 245 ---TQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLL 301 (327)
T ss_dssp ---CHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHHHTTCSCCSCCCC-
T ss_pred ---CHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHHhhccCCCCCCCCc
Confidence 12589999999999999999875 25679999999999999876 55677777664
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-54 Score=449.63 Aligned_cols=284 Identities=39% Similarity=0.716 Sum_probs=233.0
Q ss_pred cCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccce
Q 011302 78 QGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAE 157 (489)
Q Consensus 78 ~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~ 157 (489)
..++..++|++++.||+|+||.||+|+++. +++.||||++.++..........+.+|+.+|+.++||||++++++
T Consensus 142 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~ 216 (446)
T 4ejn_A 142 KHRVTMNEFEYLKLLGKGTFGKVILVKEKA-----TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS 216 (446)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEE
T ss_pred ccCCChHHcEEeEEEeeCcCEEEEEEEEcC-----CCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEE
Confidence 345677899999999999999999999887 578999999998766555566677889999999999999999999
Q ss_pred eecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHh-CCCeeecCCCCCeEeccCCcEEEcccC
Q 011302 158 FEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHM-MGIVYRDLKPENVLVREDGHIMLSDFD 236 (489)
Q Consensus 158 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiHrDIKp~NILl~~~~~vkl~DFG 236 (489)
|.+.+.+|||||||+||+|.+++... ..+++..++.++.||+.||+|||+ +|||||||||+||||+.+|.+||+|||
T Consensus 217 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG 294 (446)
T 4ejn_A 217 FQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFG 294 (446)
T ss_dssp EEETTEEEEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCC
T ss_pred EeeCCEEEEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCC
Confidence 99999999999999999999988775 579999999999999999999998 999999999999999999999999999
Q ss_pred CCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcc
Q 011302 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPE 316 (489)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (489)
+|+.....
T Consensus 295 ~a~~~~~~------------------------------------------------------------------------ 302 (446)
T 4ejn_A 295 LCKEGIKD------------------------------------------------------------------------ 302 (446)
T ss_dssp CCCTTCC-------------------------------------------------------------------------
T ss_pred CceeccCC------------------------------------------------------------------------
Confidence 98421100
Q ss_pred ccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCc
Q 011302 317 VVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSS 396 (489)
Q Consensus 317 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 396 (489)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+....+..+......+|....
T Consensus 303 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~--- 373 (446)
T 4ejn_A 303 ------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLG--- 373 (446)
T ss_dssp ----------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSC---
T ss_pred ------CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCC---
Confidence 01123468999999999999999999999999999999999999999999998888888887776664321
Q ss_pred hhHHHHhhHHHHHHHHhhcCcccccCCC-CChHHHHcCCCcCCCCcccc--ccCCCCCCCCc
Q 011302 397 KEFEEVVKLQDLISKLLVKNPKKRIGSL-KGSVEIKRHEFFKGINWALI--RSIKPPEVPNN 455 (489)
Q Consensus 397 ~~~~~~~~l~~li~~~L~~dP~~R~~~~-~~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~~ 455 (489)
.++.+||.+||+.||.+||+.. ..++++++||||++++|..+ +.+.||+.|..
T Consensus 374 ------~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~~~pp~~p~~ 429 (446)
T 4ejn_A 374 ------PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQV 429 (446)
T ss_dssp ------HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSC
T ss_pred ------HHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhhCcCCCCccCCC
Confidence 2589999999999999999432 24569999999999999976 55667766653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-53 Score=422.36 Aligned_cols=261 Identities=29% Similarity=0.480 Sum_probs=227.1
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
...++|++++.||+|+||.||+|++.. +++.||||++.+.... .....++.+|+.+|+.++||||+++++++.+
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 85 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHIL-----TGREVAIKIIDKTQLN-PTSLQKLFREVRIMKILNHPNIVKLFEVIET 85 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECC-----CCCEEEEEEEEhhcCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 346899999999999999999999876 5789999999765432 2344567789999999999999999999999
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~ 240 (489)
.+.+|+||||++||+|.+++... +.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 163 (328)
T 3fe3_A 86 EKTLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNE 163 (328)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGG
T ss_pred CCEEEEEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCcee
Confidence 99999999999999999998775 5699999999999999999999999999999999999999999999999999843
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
+..
T Consensus 164 ~~~----------------------------------------------------------------------------- 166 (328)
T 3fe3_A 164 FTV----------------------------------------------------------------------------- 166 (328)
T ss_dssp GSS-----------------------------------------------------------------------------
T ss_pred cCC-----------------------------------------------------------------------------
Confidence 211
Q ss_pred ccccCCccccCCCCccCcchhcCCCCC-CcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhH
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHG-SAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEF 399 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~-~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 399 (489)
.......+||+.|+|||++.+..+. .++|||||||++|||++|+.||.+.+..+....+..+...+|...
T Consensus 167 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~------- 237 (328)
T 3fe3_A 167 --GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYM------- 237 (328)
T ss_dssp --SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTS-------
T ss_pred --CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCC-------
Confidence 0112345799999999999998874 799999999999999999999999999888888888877666432
Q ss_pred HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCc
Q 011302 400 EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINW 441 (489)
Q Consensus 400 ~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~ 441 (489)
..++.+||.+||+.||.+||++. ++++||||+...+
T Consensus 238 --s~~~~~li~~~L~~dP~~R~t~~----eil~h~~~~~~~~ 273 (328)
T 3fe3_A 238 --STDCENLLKRFLVLNPIKRGTLE----QIMKDRWINAGHE 273 (328)
T ss_dssp --CHHHHHHHHHHCCSSTTTSCCHH----HHTTCTTTTTTCT
T ss_pred --CHHHHHHHHHHCCCChhHCcCHH----HHhcCHhhcCCCc
Confidence 12589999999999999999987 9999999987554
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-54 Score=419.76 Aligned_cols=251 Identities=22% Similarity=0.300 Sum_probs=187.9
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc-
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH- 162 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~- 162 (489)
.+|.+.++||+|+||+||+|+++ ++.||||+++...... .....|+..+..++|||||++++++.+++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-------g~~VAvK~l~~~~~~~----~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~ 71 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-------GEEVAVKIFSSREERS----WFREAEIYQTVMLRHENILGFIAADNKDNG 71 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-------TEEEEEEEECGGGHHH----HHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-------CEEEEEEEECccchhh----HHHHHHHHHHhcCCCCCCCcEEEEEEecCC
Confidence 46899999999999999999875 3789999997653221 12334666667889999999999997553
Q ss_pred ---eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhC--------CCeeecCCCCCeEeccCCcEE
Q 011302 163 ---YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMM--------GIVYRDLKPENVLVREDGHIM 231 (489)
Q Consensus 163 ---~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~--------~iiHrDIKp~NILl~~~~~vk 231 (489)
.+|||||||+||+|.++++.. .+++..+..|+.|++.||+|||++ +||||||||+||||+.++++|
T Consensus 72 ~~~~~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~K 148 (303)
T 3hmm_A 72 TWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 148 (303)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred CceEEEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEE
Confidence 689999999999999999874 599999999999999999999987 999999999999999999999
Q ss_pred EcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccc
Q 011302 232 LSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQEL 311 (489)
Q Consensus 232 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (489)
|+|||+|+........
T Consensus 149 i~DFGla~~~~~~~~~---------------------------------------------------------------- 164 (303)
T 3hmm_A 149 IADLGLAVRHDSATDT---------------------------------------------------------------- 164 (303)
T ss_dssp ECCCTTCEEEETTTTE----------------------------------------------------------------
T ss_pred EEeCCCCccccCCCCc----------------------------------------------------------------
Confidence 9999998543211000
Q ss_pred cCCccccccccccCCccccCCCCccCcchhcCC------CCCCcccHHHHHHHHHHHhhCCCCCCCCC------------
Q 011302 312 LDDPEVVAEPINARSKSFVGTHEYLAPEVISGQ------GHGSAVDWWTLGVFLYEMLYGTTPFKGEN------------ 373 (489)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~------~~~~~~DiwSlGvil~elltG~~Pf~~~~------------ 373 (489)
......+.+||+.|||||++.+. .++.++|||||||+||||+||.+||....
T Consensus 165 ----------~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~ 234 (303)
T 3hmm_A 165 ----------IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp ----------ESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred ----------eeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence 00112345899999999999875 35779999999999999999987664221
Q ss_pred --cHHHHH-HHhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 374 --NEKTLI-NILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 374 --~~~~~~-~i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
..+.+. .+...... |.... .....+....+.+||.+||+.||++||++.
T Consensus 235 ~~~~~~~~~~~~~~~~r-p~~p~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 286 (303)
T 3hmm_A 235 DPSVEEMRKVVCEQKLR-PNIPN-RWQSCEALRVMAKIMRECWYANGAARLTAL 286 (303)
T ss_dssp SCCHHHHHHHHTTSCCC-CCCCG-GGGSSHHHHHHHHHHHTTCCSSGGGSCCHH
T ss_pred cchHHHHHHHHhcccCC-CCCCc-cccchHHHHHHHHHHHHHcccCHhHCcCHH
Confidence 122233 33333222 11110 001112334588999999999999999987
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=429.08 Aligned_cols=267 Identities=29% Similarity=0.456 Sum_probs=227.4
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHH---HHHHHHHHHHHHHHhCCCCCcccccceee
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIR---KKLHRADMEKVILTMLDHPFLPTLYAEFE 159 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 159 (489)
.++|++++.||+|+||+||+|+++. +++.||+|++.+...... .....+.+|+.+|+.++||||++++++|.
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 85 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKS-----TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYE 85 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECC-----CCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEE
Confidence 4789999999999999999999986 578999999976432110 01245677999999999999999999999
Q ss_pred cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCC----cEEEccc
Q 011302 160 ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDG----HIMLSDF 235 (489)
Q Consensus 160 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~----~vkl~DF 235 (489)
+...+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 86 NRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp CSSEEEEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 999999999999999999998764 5799999999999999999999999999999999999998877 7999999
Q ss_pred CCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCc
Q 011302 236 DLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDP 315 (489)
Q Consensus 236 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (489)
|+++.+..
T Consensus 164 G~a~~~~~------------------------------------------------------------------------ 171 (361)
T 2yab_A 164 GLAHEIED------------------------------------------------------------------------ 171 (361)
T ss_dssp SSCEECCT------------------------------------------------------------------------
T ss_pred CCceEcCC------------------------------------------------------------------------
Confidence 99843221
Q ss_pred cccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCC
Q 011302 316 EVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSS 395 (489)
Q Consensus 316 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 395 (489)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..|....+.++.....
T Consensus 172 -------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~- 243 (361)
T 2yab_A 172 -------GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFS- 243 (361)
T ss_dssp -------TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT-
T ss_pred -------CCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhcc-
Confidence 011234579999999999999999999999999999999999999999999999999998876665432111
Q ss_pred chhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcccc
Q 011302 396 SKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALI 444 (489)
Q Consensus 396 ~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~ 444 (489)
.....+++||.+||..||.+||++. ++++||||++++|...
T Consensus 244 ----~~s~~~~~li~~~L~~dP~~R~t~~----e~l~hp~~~~~~~~~~ 284 (361)
T 2yab_A 244 ----QTSELAKDFIRKLLVKETRKRLTIQ----EALRHPWITPVDTQQA 284 (361)
T ss_dssp ----TSCHHHHHHHHHHSCSSTTTSCCHH----HHHTSTTTSCSSHHHH
T ss_pred ----CCCHHHHHHHHHHCCCChhHCcCHH----HHhcCcCcCCCchhhh
Confidence 1123589999999999999999987 9999999999998643
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=425.39 Aligned_cols=261 Identities=28% Similarity=0.472 Sum_probs=223.4
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.++|++++.||+|+||+||+|.++. +++.||+|++....... .....+.+|+.+|+.++||||+++++++.+.+
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~-----~~~~~a~K~i~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 83 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVL-----AGQEYAAMIINTKKLSA-RDHQKLEREARICRLLKHPNIVRLHDSISEEG 83 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETT-----TTEEEEEEEEESCSCHH-HHHHHHHHHHHHHHHCCBTTBCCEEEEEECSS
T ss_pred cCCeEEEEEeccCCCeEEEEEEECC-----CCcEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCcCCCeEEEEEEECC
Confidence 3689999999999999999999886 67899999997644332 23456778999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEec---cCCcEEEcccCCCc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVR---EDGHIMLSDFDLSF 239 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~---~~~~vkl~DFG~a~ 239 (489)
..|+|||||.||+|.+.+... ..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|+
T Consensus 84 ~~~lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 84 HHYLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EEEEEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 999999999999999988876 5699999999999999999999999999999999999998 46889999999984
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
.....
T Consensus 162 ~~~~~--------------------------------------------------------------------------- 166 (444)
T 3soa_A 162 EVEGE--------------------------------------------------------------------------- 166 (444)
T ss_dssp CCCTT---------------------------------------------------------------------------
T ss_pred EecCC---------------------------------------------------------------------------
Confidence 32210
Q ss_pred cccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhH
Q 011302 320 EPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEF 399 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 399 (489)
.......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+..+...++.......
T Consensus 167 ---~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~--- 240 (444)
T 3soa_A 167 ---QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTV--- 240 (444)
T ss_dssp ---CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTS---
T ss_pred ---CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccC---
Confidence 01123457999999999999999999999999999999999999999999999999999888777665433222
Q ss_pred HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 400 EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 400 ~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
...+.+||.+||+.||++||++. ++++||||+.
T Consensus 241 --s~~~~~li~~~L~~dP~~Rpta~----e~L~hp~~~~ 273 (444)
T 3soa_A 241 --TPEAKDLINKMLTINPSKRITAA----EALKHPWISH 273 (444)
T ss_dssp --CHHHHHHHHHHSCSSTTTSCCHH----HHHHSCTTHH
T ss_pred --CHHHHHHHHHHcCCChhHCCCHH----HHhcCccccC
Confidence 23589999999999999999997 9999999964
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-52 Score=415.83 Aligned_cols=259 Identities=31% Similarity=0.472 Sum_probs=219.4
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
...++|++.+.||+|+||+||+|++.. +++.||||++.+..........++.+|+.+|+.++||||+++++++.+
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 80 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYK-----TQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT 80 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECC-----CCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence 345899999999999999999999876 578999999988765544445678889999999999999999999999
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~ 240 (489)
.+.+|+||||+ +|+|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 81 ~~~~~lv~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~ 157 (336)
T 3h4j_B 81 PTDIVMVIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNI 157 (336)
T ss_dssp SSEEEEEECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBT
T ss_pred CCEEEEEEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEecccee
Confidence 99999999999 88999988765 5799999999999999999999999999999999999999999999999999843
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
...
T Consensus 158 ~~~----------------------------------------------------------------------------- 160 (336)
T 3h4j_B 158 MTD----------------------------------------------------------------------------- 160 (336)
T ss_dssp TTT-----------------------------------------------------------------------------
T ss_pred ccC-----------------------------------------------------------------------------
Confidence 211
Q ss_pred ccccCCccccCCCCccCcchhcCCCC-CCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhH
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGH-GSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEF 399 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 399 (489)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.........+......+|...
T Consensus 161 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~------- 231 (336)
T 3h4j_B 161 --GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFL------- 231 (336)
T ss_dssp --SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTS-------
T ss_pred --CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccC-------
Confidence 011234579999999999998876 7899999999999999999999988765554444444444333321
Q ss_pred HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 400 EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 400 ~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
+..+.+||.+||+.||.+||++. ++++||||+.-
T Consensus 232 --s~~~~~li~~~L~~dP~~Rpt~~----eil~hp~~~~~ 265 (336)
T 3h4j_B 232 --SPGAQSLIRRMIVADPMQRITIQ----EIRRDPWFNVN 265 (336)
T ss_dssp --CHHHHHHHHTTSCSSGGGSCCHH----HHTTCHHHHTT
T ss_pred --CHHHHHHHHHHcCCChhHCcCHH----HHHhChhhccC
Confidence 12589999999999999999987 99999999763
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-52 Score=405.63 Aligned_cols=258 Identities=24% Similarity=0.383 Sum_probs=217.2
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS 161 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 161 (489)
..++|++++.||+|+||+||+|.+.. +++.||||++...... ....+.+|+.+++.++||||+++++++..+
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVA-----TGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVG 89 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTT-----TCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hhhceeeeeeeccCCCeEEEEEEECC-----CCcEEEEEEeeccccc---HHHHHHHHHHHHhcCCCCCCCeEeEEEEEC
Confidence 45789999999999999999999876 5789999999754322 224466799999999999999999999999
Q ss_pred ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccc
Q 011302 162 HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKC 241 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~ 241 (489)
+.+|+||||++||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (297)
T 3fxz_A 90 DELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (297)
T ss_dssp TEEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CEEEEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceec
Confidence 9999999999999999999774 5999999999999999999999999999999999999999999999999998432
Q ss_pred ccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccc
Q 011302 242 DVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEP 321 (489)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (489)
...
T Consensus 167 ~~~----------------------------------------------------------------------------- 169 (297)
T 3fxz_A 167 TPE----------------------------------------------------------------------------- 169 (297)
T ss_dssp CST-----------------------------------------------------------------------------
T ss_pred CCc-----------------------------------------------------------------------------
Confidence 210
Q ss_pred cccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCC-CCCCCCCCCchhHH
Q 011302 322 INARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL-TFPRIGVSSSKEFE 400 (489)
Q Consensus 322 ~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~~~ 400 (489)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+..... ...... .
T Consensus 170 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------~ 241 (297)
T 3fxz_A 170 -QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE-------K 241 (297)
T ss_dssp -TCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGG-------G
T ss_pred -ccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCcc-------c
Confidence 0112345799999999999999999999999999999999999999999887776666554322 111111 1
Q ss_pred HHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 401 EVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 401 ~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
....+.+||.+||+.||++||++. ++++||||+..
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~----ell~h~~~~~~ 276 (297)
T 3fxz_A 242 LSAIFRDFLNRCLEMDVEKRGSAK----ELLQHQFLKIA 276 (297)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHH----HHTTCGGGGGC
T ss_pred cCHHHHHHHHHHccCChhHCcCHH----HHhhChhhccc
Confidence 123589999999999999999987 99999999864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-52 Score=416.88 Aligned_cols=259 Identities=27% Similarity=0.475 Sum_probs=222.4
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
++|++.+.||+|+||.||+|.++. +++.||+|++...... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 102 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKT-----TGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESF 102 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cCeEEeeEEecCCCeEEEEEEECC-----CCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence 689999999999999999999886 5789999999765332 2334567789999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccC---CcEEEcccCCCcc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRED---GHIMLSDFDLSFK 240 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~---~~vkl~DFG~a~~ 240 (489)
.|+|||||+||+|.+.+... ..+++.++..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++..
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp EEEEECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 99999999999999988765 579999999999999999999999999999999999999865 4599999999843
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
+..
T Consensus 181 ~~~----------------------------------------------------------------------------- 183 (362)
T 2bdw_A 181 VND----------------------------------------------------------------------------- 183 (362)
T ss_dssp CTT-----------------------------------------------------------------------------
T ss_pred ecC-----------------------------------------------------------------------------
Confidence 221
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHH
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFE 400 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 400 (489)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+..+.+.+|..... .
T Consensus 184 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~-----~ 256 (362)
T 2bdw_A 184 --SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWD-----T 256 (362)
T ss_dssp --CCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGG-----G
T ss_pred --CcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCccccc-----C
Confidence 001234579999999999999999999999999999999999999999999888888888877666543221 1
Q ss_pred HHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 401 EVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 401 ~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
...++++||.+||+.||++||++. ++++||||..
T Consensus 257 ~~~~~~~li~~~L~~dP~~R~t~~----e~l~hp~~~~ 290 (362)
T 2bdw_A 257 VTPEAKSLIDSMLTVNPKKRITAD----QALKVPWICN 290 (362)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHH----HHTTSHHHHT
T ss_pred CCHHHHHHHHHHcCCChhhCcCHH----HHhcCcccCC
Confidence 123589999999999999999987 9999999975
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=406.42 Aligned_cols=271 Identities=27% Similarity=0.398 Sum_probs=213.5
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
...++|++++.||+|+||+||+|++.. ++.||+|++...... ......+.+|+.+++.++||||+++++++.+
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 90 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQ------GRIVALKRIRLDAED-EGIPSTAIREISLLKELHHPNIVSLIDVIHS 90 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETT------SCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECC------CCEEEEEEEeccccc-chhhHHHHHHHHHHHHcCCCCEeeeeeEEcc
Confidence 345899999999999999999999853 678999999765432 2334567789999999999999999999999
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~ 240 (489)
++.+|+||||++ |+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 168 (311)
T 3niz_A 91 ERCLTLVFEFME-KDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARA 168 (311)
T ss_dssp SSCEEEEEECCS-EEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred CCEEEEEEcCCC-CCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCcee
Confidence 999999999996 58888876643 5699999999999999999999999999999999999999999999999999843
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
+...
T Consensus 169 ~~~~---------------------------------------------------------------------------- 172 (311)
T 3niz_A 169 FGIP---------------------------------------------------------------------------- 172 (311)
T ss_dssp TTSC----------------------------------------------------------------------------
T ss_pred cCCC----------------------------------------------------------------------------
Confidence 2110
Q ss_pred ccccCCccccCCCCccCcchhcC-CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhc---CCC--CCCCCCC-
Q 011302 321 PINARSKSFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILK---KPL--TFPRIGV- 393 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~~~--~~p~~~~- 393 (489)
.......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+.. .+. .++....
T Consensus 173 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 173 --VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250 (311)
T ss_dssp --CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred --cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence 001123468999999999987 4589999999999999999999999998877666555543 111 0110000
Q ss_pred ----------CCchhH-----HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcc
Q 011302 394 ----------SSSKEF-----EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWA 442 (489)
Q Consensus 394 ----------~~~~~~-----~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~ 442 (489)
.....+ ....++.+||.+||+.||++||++. ++++||||+++++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~----ell~hp~f~~~~~~ 310 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISAR----DAMNHPYFKDLDPQ 310 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHH----HHHTSGGGTTSCTT
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHH----HHhcCcccccCCcc
Confidence 000000 1123588999999999999999987 99999999998864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-52 Score=411.15 Aligned_cols=266 Identities=29% Similarity=0.453 Sum_probs=223.9
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHH---HHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIR---KKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
++|.+.+.||+|+||.||+|+++. +++.||+|++.+...... .....+.+|+.+|+.++||||+++++++.+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 85 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKS-----TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN 85 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETT-----TCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred cceEeceEEeeCCCeEEEEEEECC-----CCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 679999999999999999999886 578999999975422110 013456779999999999999999999999
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCC----cEEEcccC
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDG----HIMLSDFD 236 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~----~vkl~DFG 236 (489)
...+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred CCEEEEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 99999999999999999998764 5799999999999999999999999999999999999999887 89999999
Q ss_pred CCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcc
Q 011302 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPE 316 (489)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (489)
+++.+...
T Consensus 164 ~a~~~~~~------------------------------------------------------------------------ 171 (326)
T 2y0a_A 164 LAHKIDFG------------------------------------------------------------------------ 171 (326)
T ss_dssp TCEECCTT------------------------------------------------------------------------
T ss_pred CCeECCCC------------------------------------------------------------------------
Confidence 98433210
Q ss_pred ccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCc
Q 011302 317 VVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSS 396 (489)
Q Consensus 317 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 396 (489)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+......++.....
T Consensus 172 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-- 242 (326)
T 2y0a_A 172 -------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS-- 242 (326)
T ss_dssp -------SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHT--
T ss_pred -------CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccc--
Confidence 01123479999999999999999999999999999999999999999998888888877665544421111
Q ss_pred hhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcccc
Q 011302 397 KEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALI 444 (489)
Q Consensus 397 ~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~ 444 (489)
.....+.+||.+||+.||++||++. ++++||||+..+|...
T Consensus 243 ---~~~~~~~~li~~~L~~dP~~Rpt~~----e~l~hp~~~~~~~~~~ 283 (326)
T 2y0a_A 243 ---NTSALAKDFIRRLLVKDPKKRMTIQ----DSLQHPWIKPKDTQQA 283 (326)
T ss_dssp ---TSCHHHHHHHHHHSCSSGGGSCCHH----HHHHSTTTSCCSHHHH
T ss_pred ---cCCHHHHHHHHHHccCChhhCCCHH----HHhcCCCccCCcchhh
Confidence 1123589999999999999999987 9999999999887543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-52 Score=410.75 Aligned_cols=259 Identities=25% Similarity=0.397 Sum_probs=221.6
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.++|++.+.||+|+||+||+|+++. +++.||+|++..... ....+.+|+.+|+.++||||+++++++.+.+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 74 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETS-----SKKTYMAKFVKVKGT----DQVLVKKEISILNIARHRNILHLHESFESME 74 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECCCTH----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETT
T ss_pred hhceEeeeEEecCCCeEEEEEEECC-----CCcEEEEEEEecCcc----cHHHHHHHHHHHHhCCCCCCCeEeEEEecCC
Confidence 4789999999999999999999886 678999999875432 2234667999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEecc--CCcEEEcccCCCcc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRE--DGHIMLSDFDLSFK 240 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~--~~~vkl~DFG~a~~ 240 (489)
.+|+|||||+||+|.+++... ...+++.++..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~ 153 (321)
T 1tki_A 75 ELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred EEEEEEEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence 999999999999999998654 246999999999999999999999999999999999999997 78999999999843
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
+...
T Consensus 154 ~~~~---------------------------------------------------------------------------- 157 (321)
T 1tki_A 154 LKPG---------------------------------------------------------------------------- 157 (321)
T ss_dssp CCTT----------------------------------------------------------------------------
T ss_pred CCCC----------------------------------------------------------------------------
Confidence 3210
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHH
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFE 400 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 400 (489)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+......++..... .
T Consensus 158 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~-----~ 229 (321)
T 1tki_A 158 ---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFK-----E 229 (321)
T ss_dssp ---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHT-----T
T ss_pred ---CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhc-----c
Confidence 01123479999999999999889999999999999999999999999999988888888876655432111 1
Q ss_pred HHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 401 EVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 401 ~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
.+.++.+||.+||..||.+||++. ++++||||+..
T Consensus 230 ~s~~~~~li~~~L~~dp~~Rpt~~----e~l~hp~~~~~ 264 (321)
T 1tki_A 230 ISIEAMDFVDRLLVKERKSRMTAS----EALQHPWLKQK 264 (321)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHH----HHHHSHHHHSC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHH----HHhcChhhccC
Confidence 123589999999999999999987 99999999764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-51 Score=424.88 Aligned_cols=263 Identities=30% Similarity=0.458 Sum_probs=229.4
Q ss_pred cCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccce
Q 011302 78 QGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAE 157 (489)
Q Consensus 78 ~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~ 157 (489)
.+.+..++|.+.+.||+|+||.||+|++.. +++.||||++.+...........+.+|+.+|+.++||||++++++
T Consensus 10 ~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~-----~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~ 84 (476)
T 2y94_A 10 DGRVKIGHYILGDTLGVGTFGKVKVGKHEL-----TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQV 84 (476)
T ss_dssp CSCCEETTEEEEEEEECCSSSCEEEEEETT-----TCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CCCceecCEEEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 455677999999999999999999999886 578999999988765544455678889999999999999999999
Q ss_pred eecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCC
Q 011302 158 FEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237 (489)
Q Consensus 158 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~ 237 (489)
+.+.+.+|+|||||+||+|.+++... +.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 85 ~~~~~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~ 162 (476)
T 2y94_A 85 ISTPSDIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGL 162 (476)
T ss_dssp EECSSEEEEEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSS
T ss_pred EEECCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccc
Confidence 99999999999999999999998764 6799999999999999999999999999999999999999999999999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
+.....
T Consensus 163 a~~~~~-------------------------------------------------------------------------- 168 (476)
T 2y94_A 163 SNMMSD-------------------------------------------------------------------------- 168 (476)
T ss_dssp CEECCT--------------------------------------------------------------------------
T ss_pred hhhccc--------------------------------------------------------------------------
Confidence 843211
Q ss_pred cccccccCCccccCCCCccCcchhcCCCC-CCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCc
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVISGQGH-GSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSS 396 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 396 (489)
.......+||+.|+|||++.+..+ +.++|||||||++|||++|..||.+.+....+.++..+....|...
T Consensus 169 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~---- 239 (476)
T 2y94_A 169 -----GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYL---- 239 (476)
T ss_dssp -----TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTC----
T ss_pred -----cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccC----
Confidence 011234579999999999998876 7899999999999999999999999998888888888766555321
Q ss_pred hhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 397 KEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 397 ~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
...+.+||.+||+.||.+||++. ++++||||+..
T Consensus 240 -----s~~~~~Li~~~L~~dP~~Rpt~~----eil~hp~~~~~ 273 (476)
T 2y94_A 240 -----NPSVISLLKHMLQVDPMKRATIK----DIREHEWFKQD 273 (476)
T ss_dssp -----CHHHHHHHHHHTCSSTTTSCCHH----HHHTCHHHHTT
T ss_pred -----CHHHHHHHHHHcCCCchhCcCHH----HHHhCHHhhhc
Confidence 12589999999999999999987 99999999763
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=418.99 Aligned_cols=281 Identities=21% Similarity=0.300 Sum_probs=219.9
Q ss_pred ccCCceeeeeeccC--CceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 011302 82 GLDHFRLLRRLGSG--DIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE 159 (489)
Q Consensus 82 ~~~~y~~~~~lG~G--~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 159 (489)
..++|++++.||+| +||+||+|+++. +++.||||++...... ......+.+|+.+++.++|||||+++++|.
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 96 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKP-----TGEYVTVRRINLEACS-NEMVTFLQGELHVSKLFNHPNIVPYRATFI 96 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETT-----TCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcC-----CCCEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCCCcEeEEEE
Confidence 45789999999999 999999999986 5789999999865432 234566778999999999999999999999
Q ss_pred cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 160 ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 160 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
+++.+|+|||||+||+|.+++.......+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||++.
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~ 176 (389)
T 3gni_B 97 ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNL 176 (389)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred ECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccce
Confidence 99999999999999999999988766779999999999999999999999999999999999999999999999999874
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
........ .
T Consensus 177 ~~~~~~~~-----------------------------------------------------------------------~ 185 (389)
T 3gni_B 177 SMISHGQR-----------------------------------------------------------------------Q 185 (389)
T ss_dssp ECEETTEE-----------------------------------------------------------------------C
T ss_pred eecccccc-----------------------------------------------------------------------c
Confidence 32110000 0
Q ss_pred cccccCCccccCCCCccCcchhcC--CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCC------
Q 011302 320 EPINARSKSFVGTHEYLAPEVISG--QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRI------ 391 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~--~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~------ 391 (489)
..........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+..+.......
T Consensus 186 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (389)
T 3gni_B 186 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPA 265 (389)
T ss_dssp SCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------------
T ss_pred cccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccccccc
Confidence 000111233479999999999988 578999999999999999999999999877666655544322110000
Q ss_pred -----------------------------CC--CCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 392 -----------------------------GV--SSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 392 -----------------------------~~--~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
.. ...........+.+||.+||+.||++||++. ++++||||+.+.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~----ell~hp~f~~~~ 341 (389)
T 3gni_B 266 EELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAS----TLLNHSFFKQIK 341 (389)
T ss_dssp ----------------------------------------CCHHHHHHHHHHTCSCTTTSCCHH----HHTTSGGGGGC-
T ss_pred ccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHH----HHhcCHHHHHHh
Confidence 00 0000001223589999999999999999987 999999999988
Q ss_pred ccc
Q 011302 441 WAL 443 (489)
Q Consensus 441 ~~~ 443 (489)
|..
T Consensus 342 ~~~ 344 (389)
T 3gni_B 342 RRA 344 (389)
T ss_dssp --C
T ss_pred hcc
Confidence 754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-51 Score=394.48 Aligned_cols=260 Identities=33% Similarity=0.566 Sum_probs=226.1
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE 159 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 159 (489)
.+..++|++.+.||+|+||.||+|++.. .+..||+|++.+...........+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 79 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQ-----SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 79 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEcc-----CCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe
Confidence 4567899999999999999999999887 57789999998876665555667888999999999999999999999
Q ss_pred cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 160 ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 160 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
+.+..|+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 80 ~~~~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~ 157 (279)
T 3fdn_A 80 DATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV 157 (279)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEES
T ss_pred cCCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccc
Confidence 999999999999999999988765 569999999999999999999999999999999999999999999999999873
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
....
T Consensus 158 ~~~~---------------------------------------------------------------------------- 161 (279)
T 3fdn_A 158 HAPS---------------------------------------------------------------------------- 161 (279)
T ss_dssp CC------------------------------------------------------------------------------
T ss_pred cCCc----------------------------------------------------------------------------
Confidence 2110
Q ss_pred cccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhH
Q 011302 320 EPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEF 399 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 399 (489)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......+|....
T Consensus 162 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~------ 231 (279)
T 3fdn_A 162 ----SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT------ 231 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSC------
T ss_pred ----ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCC------
Confidence 0112347899999999999999999999999999999999999999999888888888776666554321
Q ss_pred HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 400 EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 400 ~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
..+.+||.+||+.||.+||++. ++++||||+..
T Consensus 232 ---~~~~~li~~~l~~~p~~Rps~~----e~l~h~~~~~~ 264 (279)
T 3fdn_A 232 ---EGARDLISRLLKHNPSQRPMLR----EVLEHPWITAN 264 (279)
T ss_dssp ---HHHHHHHHHHCCSSGGGSCCHH----HHHHCHHHHHH
T ss_pred ---HHHHHHHHHHhccChhhCCCHH----HHhhCccccCC
Confidence 2489999999999999999987 99999999764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=406.10 Aligned_cols=261 Identities=31% Similarity=0.481 Sum_probs=208.2
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS 161 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 161 (489)
..++|++.+.||+|+||+||+|+++. +++.||||++.... ....+.+|+.+|+.++||||+++++++.+.
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 120 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKG-----TQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETP 120 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECS
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECC-----CCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecC
Confidence 34789999999999999999999986 56889999998653 123466799999999999999999999999
Q ss_pred ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEecc---CCcEEEcccCCC
Q 011302 162 HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRE---DGHIMLSDFDLS 238 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~---~~~vkl~DFG~a 238 (489)
+.+|+||||++||+|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 121 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a 198 (349)
T 2w4o_A 121 TEISLVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLS 198 (349)
T ss_dssp SEEEEEECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--
T ss_pred CeEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccc
Confidence 9999999999999999988765 56999999999999999999999999999999999999975 899999999998
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
+....
T Consensus 199 ~~~~~--------------------------------------------------------------------------- 203 (349)
T 2w4o_A 199 KIVEH--------------------------------------------------------------------------- 203 (349)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cccCc---------------------------------------------------------------------------
Confidence 43211
Q ss_pred ccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHH-HHHHHhcCCCCCCCCCCCCch
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEK-TLINILKKPLTFPRIGVSSSK 397 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~-~~~~i~~~~~~~p~~~~~~~~ 397 (489)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||.+..... .+..+......++......
T Consensus 204 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~-- 277 (349)
T 2w4o_A 204 ----QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDE-- 277 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTT--
T ss_pred ----ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhh--
Confidence 001123479999999999999999999999999999999999999998776654 5666766655443322111
Q ss_pred hHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcc
Q 011302 398 EFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWA 442 (489)
Q Consensus 398 ~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~ 442 (489)
....+.+||.+||..||++||++. ++++||||.+..++
T Consensus 278 ---~~~~~~~li~~~L~~dP~~Rpt~~----e~l~hp~~~~~~~~ 315 (349)
T 2w4o_A 278 ---VSLNAKDLVRKLIVLDPKKRLTTF----QALQHPWVTGKAAN 315 (349)
T ss_dssp ---SCHHHHHHHHTTSCSSGGGSCCHH----HHHHSTTTTSTTCC
T ss_pred ---CCHHHHHHHHHHccCChhhCcCHH----HHhcCcccCCCccc
Confidence 123589999999999999999987 99999999986653
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=411.87 Aligned_cols=266 Identities=27% Similarity=0.431 Sum_probs=218.1
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHH--HHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRK--KLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
.++|++.+.||+|+||+||+|.++. +++.||||++......... ....+.+|+.+++.++||||+++++++.+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 97 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRE-----TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS 97 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECC-----CCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 3679999999999999999999886 5789999999876543211 23557789999999999999999999999
Q ss_pred CceEEEEEeecCCCchHHHHHhC--CCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCc---EEEccc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQ--PGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGH---IMLSDF 235 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~---vkl~DF 235 (489)
.+.+|+|||||+||+|.+.+... .+..+++..+..++.||+.||+|||++|||||||||+|||++.++. +||+||
T Consensus 98 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecC
Confidence 99999999999999998776543 2345899999999999999999999999999999999999986654 999999
Q ss_pred CCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCc
Q 011302 236 DLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDP 315 (489)
Q Consensus 236 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (489)
|+++.+...
T Consensus 178 g~a~~~~~~----------------------------------------------------------------------- 186 (351)
T 3c0i_A 178 GVAIQLGES----------------------------------------------------------------------- 186 (351)
T ss_dssp TTCEECCTT-----------------------------------------------------------------------
T ss_pred cceeEecCC-----------------------------------------------------------------------
Confidence 998433210
Q ss_pred cccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCC
Q 011302 316 EVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSS 395 (489)
Q Consensus 316 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 395 (489)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.. .+.+..+..+...++.....
T Consensus 187 -------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~- 257 (351)
T 3c0i_A 187 -------GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWS- 257 (351)
T ss_dssp -------SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHT-
T ss_pred -------CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccc-
Confidence 001233479999999999999999999999999999999999999998753 45566666655443321100
Q ss_pred chhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCc
Q 011302 396 SKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINW 441 (489)
Q Consensus 396 ~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~ 441 (489)
.....+++||.+||+.||++||++. ++++||||+..++
T Consensus 258 ----~~s~~~~~li~~~L~~dP~~R~s~~----e~l~hp~~~~~~~ 295 (351)
T 3c0i_A 258 ----HISESAKDLVRRMLMLDPAERITVY----EALNHPWLKERDR 295 (351)
T ss_dssp ----TSCHHHHHHHHHHTCSSTTTSCCHH----HHHTSHHHHTHHH
T ss_pred ----cCCHHHHHHHHHHCCCChhHCcCHH----HHhcChhhcCCcc
Confidence 1123589999999999999999987 9999999987654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-51 Score=406.98 Aligned_cols=271 Identities=23% Similarity=0.327 Sum_probs=211.2
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
...++|++++.||+|+||+||+|++.. +++.||||++...... ......+.+|+.+|+.++||||+++++++.+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTV-----TNETVAIKRIRLEHEE-EGVPGTAIREVSLLKELQHRNIIELKSVIHH 104 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETT-----TTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECC-----CCceEEEEEEcccccc-cccchhHHHHHHHHHHcCCCCcceEEEEEec
Confidence 346899999999999999999999886 5789999999754322 2334456679999999999999999999999
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEec-----cCCcEEEccc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVR-----EDGHIMLSDF 235 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~-----~~~~vkl~DF 235 (489)
++.+|+||||++ |+|.+++... ..+++..++.|+.||+.||+|||++|||||||||+|||++ .++.+||+||
T Consensus 105 ~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Df 181 (329)
T 3gbz_A 105 NHRLHLIFEYAE-NDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDF 181 (329)
T ss_dssp TTEEEEEEECCS-EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred CCEEEEEEecCC-CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcC
Confidence 999999999996 6999999876 5699999999999999999999999999999999999994 4556999999
Q ss_pred CCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCc
Q 011302 236 DLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDP 315 (489)
Q Consensus 236 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (489)
|+++.+...
T Consensus 182 g~a~~~~~~----------------------------------------------------------------------- 190 (329)
T 3gbz_A 182 GLARAFGIP----------------------------------------------------------------------- 190 (329)
T ss_dssp THHHHHC-------------------------------------------------------------------------
T ss_pred CCccccCCc-----------------------------------------------------------------------
Confidence 998432110
Q ss_pred cccccccccCCccccCCCCccCcchhcCCC-CCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCC-----C-
Q 011302 316 EVVAEPINARSKSFVGTHEYLAPEVISGQG-HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLT-----F- 388 (489)
Q Consensus 316 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-----~- 388 (489)
.......+||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.+..+.+..+...... +
T Consensus 191 -------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (329)
T 3gbz_A 191 -------IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP 263 (329)
T ss_dssp ----------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred -------ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhh
Confidence 00122346899999999998754 899999999999999999999999999888777766532110 0
Q ss_pred ------------CCCCCCCchhH---HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcc
Q 011302 389 ------------PRIGVSSSKEF---EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWA 442 (489)
Q Consensus 389 ------------p~~~~~~~~~~---~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~ 442 (489)
+.......... ....++.+||.+||+.||++||++. ++++||||++++|+
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~----e~l~hp~f~~~~~~ 328 (329)
T 3gbz_A 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAK----NALEHPYFSHNDFD 328 (329)
T ss_dssp TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHH----HHHTSGGGSSSCSC
T ss_pred hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHH----HHhCCcccCCCCCC
Confidence 00000000000 0224688999999999999999987 99999999999996
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=410.84 Aligned_cols=263 Identities=28% Similarity=0.436 Sum_probs=222.6
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.++|++++.||+|+||.||+|.++. +++.||+|++...... ....+.+|+.+|+.++||||+++++++.+..
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~-----~~~~~a~K~~~~~~~~---~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 121 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKA-----TGRVFVAKFINTPYPL---DKYTVKNEISIMNQLHHPKLINLHDAFEDKY 121 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred ccceEEEEEEecCCCEEEEEEEECC-----CCCEEEEEEecccchh---hHHHHHHHHHHHHhCCCcCCCeEEEEEEeCC
Confidence 4789999999999999999999886 5789999999754322 1235677999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEecc--CCcEEEcccCCCcc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRE--DGHIMLSDFDLSFK 240 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~--~~~vkl~DFG~a~~ 240 (489)
.+|+|||||+||+|.+++... ...+++.++..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.
T Consensus 122 ~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~ 200 (387)
T 1kob_A 122 EMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATK 200 (387)
T ss_dssp EEEEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEeccccee
Confidence 999999999999999988654 346999999999999999999999999999999999999974 57899999999843
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
+...
T Consensus 201 ~~~~---------------------------------------------------------------------------- 204 (387)
T 1kob_A 201 LNPD---------------------------------------------------------------------------- 204 (387)
T ss_dssp CCTT----------------------------------------------------------------------------
T ss_pred cCCC----------------------------------------------------------------------------
Confidence 3210
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHH
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFE 400 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 400 (489)
......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..+....+.++.......
T Consensus 205 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~---- 277 (387)
T 1kob_A 205 ---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV---- 277 (387)
T ss_dssp ---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTS----
T ss_pred ---cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccC----
Confidence 0112336999999999999999999999999999999999999999999888888888776665543322211
Q ss_pred HHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcc
Q 011302 401 EVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWA 442 (489)
Q Consensus 401 ~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~ 442 (489)
..++.+||.+||+.||++||++. ++++||||++..+.
T Consensus 278 -s~~~~~li~~~L~~dP~~Rpt~~----ell~hp~~~~~~~~ 314 (387)
T 1kob_A 278 -SPEAKDFIKNLLQKEPRKRLTVH----DALEHPWLKGDHSN 314 (387)
T ss_dssp -CHHHHHHHHTTSCSSGGGSCCHH----HHHTSTTTSSCCTT
T ss_pred -CHHHHHHHHHHcCCChhHCcCHH----HHhhCccccCCccc
Confidence 23589999999999999999987 99999999886543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=410.57 Aligned_cols=267 Identities=29% Similarity=0.455 Sum_probs=218.1
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccceeecC
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAEFEAS 161 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~ 161 (489)
.++|++.+.||+|+||+||+|+++. +++.||||++.+... ...+|+.++.++ +||||+++++++.++
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~ 88 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKA-----TNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDG 88 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred cccEEEEEEEeeCCCEEEEEEEECC-----CCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcC
Confidence 3689999999999999999999987 578999999976531 233477778777 799999999999999
Q ss_pred ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccC----CcEEEcccCC
Q 011302 162 HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRED----GHIMLSDFDL 237 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~----~~vkl~DFG~ 237 (489)
+.+|+|||||+||+|.+++... +.+++.++..++.||+.||+|||++||+||||||+|||+..+ +.+||+|||+
T Consensus 89 ~~~~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~ 166 (342)
T 2qr7_A 89 KYVYVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGF 166 (342)
T ss_dssp SEEEEEECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCC
Confidence 9999999999999999998775 579999999999999999999999999999999999998533 3599999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
++.....
T Consensus 167 a~~~~~~------------------------------------------------------------------------- 173 (342)
T 2qr7_A 167 AKQLRAE------------------------------------------------------------------------- 173 (342)
T ss_dssp CEECBCT-------------------------------------------------------------------------
T ss_pred cccCcCC-------------------------------------------------------------------------
Confidence 8432110
Q ss_pred cccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCC---CCcHHHHHHHhcCCCCCCCCCCC
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKG---ENNEKTLINILKKPLTFPRIGVS 394 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~---~~~~~~~~~i~~~~~~~p~~~~~ 394 (489)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||.+ .+..+.+..+..+.+.++.....
T Consensus 174 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 248 (342)
T 2qr7_A 174 -----NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWN 248 (342)
T ss_dssp -----TCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTT
T ss_pred -----CCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccc
Confidence 0112345799999999999988899999999999999999999999986 34556777777776655433222
Q ss_pred CchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccccc--cCCCCCC
Q 011302 395 SSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIR--SIKPPEV 452 (489)
Q Consensus 395 ~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~~--~~~~p~~ 452 (489)
.. ...+++||.+||..||++||++. ++++||||. +|..+. .+.+|..
T Consensus 249 ~~-----s~~~~~li~~~L~~dP~~R~t~~----~il~hp~~~--~~~~~~~~~~~~~~~ 297 (342)
T 2qr7_A 249 SV-----SDTAKDLVSKMLHVDPHQRLTAA----LVLRHPWIV--HWDQLPQYQLNRQDA 297 (342)
T ss_dssp TS-----CHHHHHHHHHHTCSSTTTSCCHH----HHTTSHHHH--TGGGSCCSCCCCCCC
T ss_pred cC-----CHHHHHHHHHHCCCChhHCcCHH----HHhcCCeec--CccccccccCCCccc
Confidence 11 12589999999999999999987 999999994 576553 3344443
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-51 Score=396.99 Aligned_cols=267 Identities=24% Similarity=0.338 Sum_probs=209.1
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
+++|++++.||+|+||+||+|+++. +++.||||++...... ......+.+|+.+++.++||||+++++++.+++
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 74 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRE-----THEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDK 74 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETT-----TCCEEEEEEEESSCSS-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCCceeeeEecCCCCeEEEEEEECC-----CCceEEEEeeeccCCc-CCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCC
Confidence 3689999999999999999999987 5789999999754321 123345667999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
.+|+||||+++ +|.+.+... .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 75 ~~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 152 (292)
T 3o0g_A 75 KLTLVFEFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFG 152 (292)
T ss_dssp EEEEEEECCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecC
Confidence 99999999964 666655543 2679999999999999999999999999999999999999999999999999984321
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
..
T Consensus 153 ~~------------------------------------------------------------------------------ 154 (292)
T 3o0g_A 153 IP------------------------------------------------------------------------------ 154 (292)
T ss_dssp SC------------------------------------------------------------------------------
T ss_pred Cc------------------------------------------------------------------------------
Confidence 10
Q ss_pred ccCCccccCCCCccCcchhcCCC-CCCcccHHHHHHHHHHHhhCCCC-CCCCCcHHHHHHHhcCCCCCCCCC--------
Q 011302 323 NARSKSFVGTHEYLAPEVISGQG-HGSAVDWWTLGVFLYEMLYGTTP-FKGENNEKTLINILKKPLTFPRIG-------- 392 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~-~~~~~DiwSlGvil~elltG~~P-f~~~~~~~~~~~i~~~~~~~p~~~-------- 392 (489)
.......+||+.|+|||++.+.. ++.++|||||||++|||++|..| |.+.+..+.+..+.......+...
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence 01123347899999999998876 79999999999999999987777 556666666555543100000000
Q ss_pred ------------CCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 393 ------------VSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 393 ------------~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
............+++||.+||+.||++||++. ++++||||+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~----e~l~hp~f~~~ 289 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAE----EALQHPYFSDF 289 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHH----HHHTSGGGTTC
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHH----HHhcCcccccC
Confidence 00000001223588999999999999999987 99999999875
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-51 Score=403.69 Aligned_cols=263 Identities=26% Similarity=0.421 Sum_probs=213.0
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.++|++++.||+|+||+||+|+++. +++.||||++...... .....+.+|+.+++.++||||+++++++.+++
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 78 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRV-----TEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGN 78 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhceeeeEEecCCCEEEEEEEECC-----CCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 4799999999999999999999886 5789999999654322 22355778999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
..|+|||||+||+|.+++... ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 156 (323)
T 3tki_A 79 IQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (323)
T ss_dssp EEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred eEEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceec
Confidence 999999999999999988654 579999999999999999999999999999999999999999999999999984332
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
... .
T Consensus 157 ~~~----------------------------------------------------------------------------~ 160 (323)
T 3tki_A 157 YNN----------------------------------------------------------------------------R 160 (323)
T ss_dssp ETT----------------------------------------------------------------------------E
T ss_pred cCC----------------------------------------------------------------------------c
Confidence 100 0
Q ss_pred ccCCccccCCCCccCcchhcCCCC-CCcccHHHHHHHHHHHhhCCCCCCCCCcH-HHHHHHhcCCCCCCCCCCCCchhHH
Q 011302 323 NARSKSFVGTHEYLAPEVISGQGH-GSAVDWWTLGVFLYEMLYGTTPFKGENNE-KTLINILKKPLTFPRIGVSSSKEFE 400 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~~-~~~~DiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~p~~~~~~~~~~~ 400 (489)
.......+||+.|+|||++.+..+ +.++|||||||++|||++|..||.+.+.. ..+..+.......+... .
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------~ 233 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK-------K 233 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGG-------G
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccc-------c
Confidence 011234579999999999988775 77999999999999999999999876554 33333333322222211 1
Q ss_pred HHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCc
Q 011302 401 EVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINW 441 (489)
Q Consensus 401 ~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~ 441 (489)
....+.+||.+||+.||++||++. ++++||||+..-.
T Consensus 234 ~~~~~~~li~~~L~~dP~~R~t~~----eil~h~~~~~~~~ 270 (323)
T 3tki_A 234 IDSAPLALLHKILVENPSARITIP----DIKKDRWYNKPLK 270 (323)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHH----HHTTCTTTTCCCC
T ss_pred CCHHHHHHHHHHccCChhhCcCHH----HHhhChhhccccc
Confidence 123588999999999999999987 9999999987543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-51 Score=398.79 Aligned_cols=260 Identities=34% Similarity=0.539 Sum_probs=212.7
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHH-----------------------HHHHHHHH
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAI-----------------------RKKLHRAD 137 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~-----------------------~~~~~~~~ 137 (489)
+..++|++.+.||+|+||.||+|++.. +++.||||++....... ......+.
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNEN-----DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVY 84 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETT-----TTEEEEEEEEECC-------------------------------CHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECC-----CCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHH
Confidence 446899999999999999999999886 57899999997543221 12345678
Q ss_pred HHHHHHHhCCCCCcccccceeec--CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeee
Q 011302 138 MEKVILTMLDHPFLPTLYAEFEA--SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYR 215 (489)
Q Consensus 138 ~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHr 215 (489)
+|+.+|+.++||||+++++++.+ ...+|+||||+++|+|.+++.. ..+++.+++.++.||+.||+|||++||+||
T Consensus 85 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~ 161 (298)
T 2zv2_A 85 QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQKIIHR 161 (298)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 89999999999999999999986 6789999999999999775432 579999999999999999999999999999
Q ss_pred cCCCCCeEeccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccc
Q 011302 216 DLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTV 295 (489)
Q Consensus 216 DIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (489)
||||+|||++.++.+||+|||+++.....
T Consensus 162 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--------------------------------------------------- 190 (298)
T 2zv2_A 162 DIKPSNLLVGEDGHIKIADFGVSNEFKGS--------------------------------------------------- 190 (298)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEECSSS---------------------------------------------------
T ss_pred CCCHHHEEECCCCCEEEecCCCccccccc---------------------------------------------------
Confidence 99999999999999999999998432210
Q ss_pred cccccccCCCCCCccccCCccccccccccCCccccCCCCccCcchhcCCC---CCCcccHHHHHHHHHHHhhCCCCCCCC
Q 011302 296 TTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQG---HGSAVDWWTLGVFLYEMLYGTTPFKGE 372 (489)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~---~~~~~DiwSlGvil~elltG~~Pf~~~ 372 (489)
.......+||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.
T Consensus 191 ---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 191 ---------------------------DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp ---------------------------SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ---------------------------cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 00112347999999999998765 378899999999999999999999998
Q ss_pred CcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcC
Q 011302 373 NNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437 (489)
Q Consensus 373 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~ 437 (489)
+.......+......+|...... ..+.+||.+||+.||++||++. ++++||||+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~-------~~l~~li~~~l~~dp~~R~s~~----e~l~hp~~~ 297 (298)
T 2zv2_A 244 RIMCLHSKIKSQALEFPDQPDIA-------EDLKDLITRMLDKNPESRIVVP----EIKLHPWVT 297 (298)
T ss_dssp SHHHHHHHHHHCCCCCCSSSCCC-------HHHHHHHHHHTCSCTTTSCCHH----HHTTCHHHH
T ss_pred cHHHHHHHHhcccCCCCCccccC-------HHHHHHHHHHhhcChhhCCCHH----HHhcCcccc
Confidence 87777777777666555432221 2589999999999999999987 999999995
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=392.35 Aligned_cols=261 Identities=33% Similarity=0.551 Sum_probs=226.6
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE 159 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 159 (489)
.+..++|++.+.||+|+||.||+|++.. .+..||||++.............+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 84 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQ-----NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH 84 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcC-----CCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE
Confidence 4567899999999999999999999886 57899999998776554444566788999999999999999999999
Q ss_pred cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 160 ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 160 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
+.+..|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~ 162 (284)
T 2vgo_A 85 DRKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSV 162 (284)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred cCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccc
Confidence 999999999999999999998775 569999999999999999999999999999999999999999999999999873
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
....
T Consensus 163 ~~~~---------------------------------------------------------------------------- 166 (284)
T 2vgo_A 163 HAPS---------------------------------------------------------------------------- 166 (284)
T ss_dssp ECSS----------------------------------------------------------------------------
T ss_pred cCcc----------------------------------------------------------------------------
Confidence 2210
Q ss_pred cccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhH
Q 011302 320 EPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEF 399 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 399 (489)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+......+|...
T Consensus 167 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------- 235 (284)
T 2vgo_A 167 ----LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFL------- 235 (284)
T ss_dssp ----SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTS-------
T ss_pred ----cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcC-------
Confidence 011234699999999999999999999999999999999999999999888888888877665555321
Q ss_pred HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 400 EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 400 ~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
...+.+||.+||+.||.+||++. ++++||||+...
T Consensus 236 --~~~~~~li~~~l~~~p~~Rps~~----~ll~h~~~~~~~ 270 (284)
T 2vgo_A 236 --SDGSKDLISKLLRYHPPQRLPLK----GVMEHPWVKANS 270 (284)
T ss_dssp --CHHHHHHHHHHSCSSGGGSCCHH----HHHTCHHHHHHC
T ss_pred --CHHHHHHHHHHhhcCHhhCCCHH----HHhhCHHHHhhc
Confidence 12589999999999999999987 999999998643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=420.29 Aligned_cols=262 Identities=27% Similarity=0.383 Sum_probs=208.0
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC-
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS- 161 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~- 161 (489)
.++|++++.||+|+||+||+|.+.. +++.||||++.+.... .....++.+|+.+|+.++||||++++++|...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~-----~~~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 134 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAV-----LDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK 134 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETT-----TTEEEEEEEEESGGGS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECC-----CCCEEEEEEECccccC-hHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCC
Confidence 4789999999999999999999887 5789999999754221 23455677899999999999999999999654
Q ss_pred -----ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccC
Q 011302 162 -----HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFD 236 (489)
Q Consensus 162 -----~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG 236 (489)
..+||||||++ ++|.+.+.. .+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||
T Consensus 135 ~~~~~~~~~lv~E~~~-~~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG 209 (464)
T 3ttj_A 135 TLEEFQDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 209 (464)
T ss_dssp STTTCCEEEEEEECCS-EEHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred ccccCCeEEEEEeCCC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEE
Confidence 46799999995 557666643 48999999999999999999999999999999999999999999999999
Q ss_pred CCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcc
Q 011302 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPE 316 (489)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (489)
+|+....
T Consensus 210 ~a~~~~~------------------------------------------------------------------------- 216 (464)
T 3ttj_A 210 LARTAGT------------------------------------------------------------------------- 216 (464)
T ss_dssp CC------------------------------------------------------------------------------
T ss_pred eeeecCC-------------------------------------------------------------------------
Confidence 9843210
Q ss_pred ccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCC---------
Q 011302 317 VVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLT--------- 387 (489)
Q Consensus 317 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--------- 387 (489)
.......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.+.+|......
T Consensus 217 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 217 ------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp ------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred ------CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 01123458999999999999999999999999999999999999999999887777766541000
Q ss_pred ----------CCCCCC------------CCchh--HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 388 ----------FPRIGV------------SSSKE--FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 388 ----------~p~~~~------------~~~~~--~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
.|.... ..... -....++++||.+||+.||++||++. |+|+||||+.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~----e~L~Hp~~~~ 361 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD----DALQHPYINV 361 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHH----HHHTSTTTGG
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHH----HHhcChhhhh
Confidence 000000 00000 01134689999999999999999987 9999999985
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=413.37 Aligned_cols=256 Identities=25% Similarity=0.378 Sum_probs=204.1
Q ss_pred ccCCceee-eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHH-HhCCCCCcccccceee
Q 011302 82 GLDHFRLL-RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL-TMLDHPFLPTLYAEFE 159 (489)
Q Consensus 82 ~~~~y~~~-~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l-~~l~hpnIv~l~~~~~ 159 (489)
..++|.+. +.||+|+||+||+|.++. +++.||||++.... .+.+|+.++ +..+||||++++++|.
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~-----~~~~vAiK~~~~~~--------~~~~E~~~~~~~~~hp~iv~l~~~~~ 125 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKR-----TQEKFALKMLQDCP--------KARREVELHWRASQCPHIVRIVDVYE 125 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECSH--------HHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECC-----CCCEEEEEEeCcch--------hHHHHHHHHHHhcCCCCcceEeEEEe
Confidence 34678887 789999999999999886 57899999997432 234577766 4568999999999987
Q ss_pred c----CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEecc---CCcEEE
Q 011302 160 A----SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRE---DGHIML 232 (489)
Q Consensus 160 ~----~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~---~~~vkl 232 (489)
. ..++|||||||+||+|.+++.......+++.+++.|+.||+.||+|||++|||||||||+|||++. ++.+||
T Consensus 126 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl 205 (400)
T 1nxk_A 126 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKL 205 (400)
T ss_dssp EEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEE
T ss_pred ecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEE
Confidence 5 678999999999999999998765567999999999999999999999999999999999999997 789999
Q ss_pred cccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCcccc
Q 011302 233 SDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELL 312 (489)
Q Consensus 233 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (489)
+|||+++....
T Consensus 206 ~DFG~a~~~~~--------------------------------------------------------------------- 216 (400)
T 1nxk_A 206 TDFGFAKETTS--------------------------------------------------------------------- 216 (400)
T ss_dssp CCCTTCEECC----------------------------------------------------------------------
T ss_pred EecccccccCC---------------------------------------------------------------------
Confidence 99999843210
Q ss_pred CCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcH----HHHHHHhcCCCCC
Q 011302 313 DDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNE----KTLINILKKPLTF 388 (489)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~----~~~~~i~~~~~~~ 388 (489)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.. .....+..+.+.+
T Consensus 217 ----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~ 286 (400)
T 1nxk_A 217 ----------HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 286 (400)
T ss_dssp --------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCC
T ss_pred ----------CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccC
Confidence 01123457999999999999999999999999999999999999999876532 2445566666555
Q ss_pred CCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 389 PRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 389 p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
+....... ..++.+||.+||+.||++||++. ++++||||..
T Consensus 287 ~~~~~~~~-----s~~~~~li~~~L~~dP~~Rpt~~----eil~hp~~~~ 327 (400)
T 1nxk_A 287 PNPEWSEV-----SEEVKMLIRNLLKTEPTQRMTIT----EFMNHPWIMQ 327 (400)
T ss_dssp CTTTTTTS-----CHHHHHHHHTTSCSSGGGSCCHH----HHHHSHHHHT
T ss_pred CCcccccC-----CHHHHHHHHHHCCCChhHCcCHH----HHhcCccccC
Confidence 54322111 23589999999999999999987 9999999965
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=409.18 Aligned_cols=286 Identities=26% Similarity=0.398 Sum_probs=206.2
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-CCCcccccceeecC
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-HPFLPTLYAEFEAS 161 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~ 161 (489)
.++|++++.||+|+||.||+|.++. +++.||||++.+.... .....++.+|+.+|+.+. ||||+++++++...
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 81 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRR-----TGEVVAVKKIFDAFQN-STDAQRTFREIMILTELSGHENIVNLLNVLRAD 81 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETT-----TCCEEEEEEECC--CC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT
T ss_pred cCceEEEEEeeeCCCeEEEEEEECC-----CCCEEEEEEecccccC-hHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC
Confidence 4789999999999999999999887 5789999998654221 233456678999999997 99999999999744
Q ss_pred --ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 162 --HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 162 --~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
..+|+|||||+ |+|..++.. ..+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+
T Consensus 82 ~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 82 NDRDVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp TSSCEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred CCCEEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 47999999995 799998876 469999999999999999999999999999999999999999999999999986
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
.+......... .+ .. ........
T Consensus 158 ~~~~~~~~~~~----------------------~~------------------~~-----------------~~~~~~~~ 180 (388)
T 3oz6_A 158 SFVNIRRVTNN----------------------IP------------------LS-----------------INENTENF 180 (388)
T ss_dssp ESSSCCCCCCC----------------------GG------------------GC-----------------CC------
T ss_pred ccccccccccc----------------------cc------------------cc-----------------cccccccc
Confidence 54321100000 00 00 00000000
Q ss_pred cccccCCccccCCCCccCcchhcC-CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCC------
Q 011302 320 EPINARSKSFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIG------ 392 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~------ 392 (489)
..........+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+.+..|... ...|...
T Consensus 181 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~p~~~~~~~~~ 259 (388)
T 3oz6_A 181 DDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGV-IDFPSNEDVESIQ 259 (388)
T ss_dssp ---------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH-HCCCCHHHHHTSC
T ss_pred ccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh-cCCCCHHHHHhcc
Confidence 011123455689999999999987 56899999999999999999999999999888877776531 1111100
Q ss_pred ----------------------CCCchhH-----------HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 393 ----------------------VSSSKEF-----------EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 393 ----------------------~~~~~~~-----------~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
......+ ....++.+||.+||+.||++||++. ++|+||||+.+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~----e~l~Hp~~~~~ 335 (388)
T 3oz6_A 260 SPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAN----DALKHPFVSIF 335 (388)
T ss_dssp CSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHH----HHTTSTTTTTT
T ss_pred CHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHH----HHhCCHHHHHh
Confidence 0000000 1123689999999999999999987 99999998765
Q ss_pred C
Q 011302 440 N 440 (489)
Q Consensus 440 ~ 440 (489)
.
T Consensus 336 ~ 336 (388)
T 3oz6_A 336 H 336 (388)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=417.99 Aligned_cols=299 Identities=25% Similarity=0.333 Sum_probs=200.6
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee---
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE--- 159 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~--- 159 (489)
.++|++++.||+|+||+||+|+++. +++.||||++.+.... .....++.+|+.+|+.++|||||++++++.
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~i~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 125 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKL-----EKRVVAIKKILRVFED-LIDCKRILREIAILNRLNHDHVVKVLDIVIPKD 125 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC-------CEEEEEEECSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECC-----CCcEEEEEEechhhcC-HHHHHHHHHHHHHHHhCCCCCCCceEEEEecCC
Confidence 4789999999999999999999886 5789999998653211 233456778999999999999999999984
Q ss_pred --cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCC
Q 011302 160 --ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237 (489)
Q Consensus 160 --~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~ 237 (489)
....+|+||||+ +|+|.+++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+
T Consensus 126 ~~~~~~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGl 202 (458)
T 3rp9_A 126 VEKFDELYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGL 202 (458)
T ss_dssp TTTCCCEEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred cccCceEEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeeccccc
Confidence 346799999998 78999988765 5799999999999999999999999999999999999999999999999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
|+.+......... .+..+. ..+...... .
T Consensus 203 a~~~~~~~~~~~~-------------------~~~~~~------------------------------~~~~~~~~~--~ 231 (458)
T 3rp9_A 203 ARTVDYPENGNSQ-------------------LPISPR------------------------------EDDMNLVTF--P 231 (458)
T ss_dssp CBCTTSCTTCCCC-------------------CC----------------------------------------------
T ss_pred chhccCccccccc-------------------cccCcc------------------------------ccccccccc--c
Confidence 9654321110000 000000 000000000 0
Q ss_pred cccccccCCccccCCCCccCcchhc-CCCCCCcccHHHHHHHHHHHhh-----------CCCCCCCCCc-----------
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVIS-GQGHGSAVDWWTLGVFLYEMLY-----------GTTPFKGENN----------- 374 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~-~~~~~~~~DiwSlGvil~ellt-----------G~~Pf~~~~~----------- 374 (489)
............+||+.|+|||++. +..|+.++||||||||+|||++ |.++|.+.+.
T Consensus 232 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~ 311 (458)
T 3rp9_A 232 HTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGN 311 (458)
T ss_dssp -------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC---------------
T ss_pred ccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccc
Confidence 0000112345678999999999874 5669999999999999999998 7888877542
Q ss_pred ---------HHHHHHHh---cCCC-----------------CCCCCCCCC-chhH-HHHhhHHHHHHHHhhcCcccccCC
Q 011302 375 ---------EKTLINIL---KKPL-----------------TFPRIGVSS-SKEF-EEVVKLQDLISKLLVKNPKKRIGS 423 (489)
Q Consensus 375 ---------~~~~~~i~---~~~~-----------------~~p~~~~~~-~~~~-~~~~~l~~li~~~L~~dP~~R~~~ 423 (489)
.+.+..|. ..+. .++...... ...+ ....++.+||.+||++||++|+++
T Consensus 312 ~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~ 391 (458)
T 3rp9_A 312 DFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITI 391 (458)
T ss_dssp -----CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred cccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCH
Confidence 12222221 1100 001000000 0000 113468999999999999999998
Q ss_pred CCChHHHHcCCCcCCCCccccc
Q 011302 424 LKGSVEIKRHEFFKGINWALIR 445 (489)
Q Consensus 424 ~~~~~~ll~hp~f~~~~~~~~~ 445 (489)
. |+|+||||++++|....
T Consensus 392 ~----e~L~Hp~f~~~~~~~~e 409 (458)
T 3rp9_A 392 N----ECLAHPFFKEVRIAEVE 409 (458)
T ss_dssp H----HHHHSGGGTTTCCGGGC
T ss_pred H----HHhcCHhhhhcCCCccC
Confidence 7 99999999999998764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-50 Score=388.77 Aligned_cols=266 Identities=26% Similarity=0.455 Sum_probs=226.7
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.++|++.+.||+|+||.||+|.++. +++.||+|++...... ......+.+|+.+++.++||||+++++++.+.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKT-----TGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEES 78 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEGGGCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcC-----CCceEEEEEeecccCC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCC
Confidence 4789999999999999999999886 5788999999765432 233456778999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCc---EEEcccCCCc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGH---IMLSDFDLSF 239 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~---vkl~DFG~a~ 239 (489)
..|+||||++||+|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++.
T Consensus 79 ~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~ 156 (284)
T 3kk8_A 79 FHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 156 (284)
T ss_dssp EEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence 999999999999998888765 56999999999999999999999999999999999999986655 9999999984
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
.....
T Consensus 157 ~~~~~--------------------------------------------------------------------------- 161 (284)
T 3kk8_A 157 EVNDS--------------------------------------------------------------------------- 161 (284)
T ss_dssp ECCSS---------------------------------------------------------------------------
T ss_pred EcccC---------------------------------------------------------------------------
Confidence 32110
Q ss_pred cccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhH
Q 011302 320 EPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEF 399 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 399 (489)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+..+...++.......
T Consensus 162 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 234 (284)
T 3kk8_A 162 ----EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTV--- 234 (284)
T ss_dssp ----CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTS---
T ss_pred ----ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhccc---
Confidence 0112347999999999999999999999999999999999999999999988888888877666654432221
Q ss_pred HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcccc
Q 011302 400 EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALI 444 (489)
Q Consensus 400 ~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~ 444 (489)
...+.+||.+||+.||++||++. ++++||||+...+...
T Consensus 235 --~~~~~~li~~~l~~dp~~Rps~~----~~l~h~~~~~~~~~~~ 273 (284)
T 3kk8_A 235 --TPEAKSLIDSMLTVNPKKRITAD----QALKVPWICNRERVAS 273 (284)
T ss_dssp --CHHHHHHHHHHSCSSTTTSCCHH----HHTTSHHHHSCCCGGG
T ss_pred --CHHHHHHHHHHcccChhhCCCHH----HHhcCccccCChhHHh
Confidence 12589999999999999999997 9999999998776543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=406.69 Aligned_cols=266 Identities=29% Similarity=0.440 Sum_probs=216.7
Q ss_pred hcCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-----CCCc
Q 011302 77 AQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-----HPFL 151 (489)
Q Consensus 77 ~~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----hpnI 151 (489)
..+.+..++|++++.||+|+||+||+|++.. +++.||||++.... .....+..|+.+++.+. ||||
T Consensus 28 ~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~h~~i 98 (360)
T 3llt_A 28 KKGMLLNNAFLVIRKMGDGTFGRVLLCQHID-----NKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDDINNNNI 98 (360)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEECSCH----HHHHHHHHHHHHHHHTCCCSTTGGGB
T ss_pred ecceEecCEEEEEEEEcccCCeEEEEEEECC-----CCeEEEEEEeccch----hhhhhhHHHHHHHHHhcccCCCCCCe
Confidence 3445667899999999999999999999976 57899999997532 22334556888999886 9999
Q ss_pred ccccceeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEecc-----
Q 011302 152 PTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRE----- 226 (489)
Q Consensus 152 v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~----- 226 (489)
+++++++...+.+|+||||+ +++|.+++.......+++..++.++.||+.||+|||++|||||||||+|||++.
T Consensus 99 v~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 99 VKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp CCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCE
T ss_pred ecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccc
Confidence 99999999999999999999 999999998876667999999999999999999999999999999999999975
Q ss_pred --------------------CCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCcccccccccccc
Q 011302 227 --------------------DGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGK 286 (489)
Q Consensus 227 --------------------~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (489)
++.+||+|||+|+...
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~-------------------------------------------- 213 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKS-------------------------------------------- 213 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETT--------------------------------------------
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecC--------------------------------------------
Confidence 7899999999983211
Q ss_pred ccccccccccccccccCCCCCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCC
Q 011302 287 KNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGT 366 (489)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~ 366 (489)
......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 214 -------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 256 (360)
T 3llt_A 214 -------------------------------------DYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256 (360)
T ss_dssp -------------------------------------SCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred -------------------------------------CCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCC
Confidence 0112347999999999999999999999999999999999999
Q ss_pred CCCCCCCcHHHHHHHhcCCCCCCC--------------------------CCCCCc-----------hhHHHHhhHHHHH
Q 011302 367 TPFKGENNEKTLINILKKPLTFPR--------------------------IGVSSS-----------KEFEEVVKLQDLI 409 (489)
Q Consensus 367 ~Pf~~~~~~~~~~~i~~~~~~~p~--------------------------~~~~~~-----------~~~~~~~~l~~li 409 (489)
.||.+.+..+.+..+......+|. ...... ........+.+||
T Consensus 257 ~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 336 (360)
T 3llt_A 257 LLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFL 336 (360)
T ss_dssp CSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHH
T ss_pred CCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHH
Confidence 999998877766655432211110 000000 0000113577999
Q ss_pred HHHhhcCcccccCCCCChHHHHcCCCcC
Q 011302 410 SKLLVKNPKKRIGSLKGSVEIKRHEFFK 437 (489)
Q Consensus 410 ~~~L~~dP~~R~~~~~~~~~ll~hp~f~ 437 (489)
.+||+.||++||++. ++++||||+
T Consensus 337 ~~~L~~dP~~Rpta~----elL~hp~f~ 360 (360)
T 3llt_A 337 YSILQIDPTLRPSPA----ELLKHKFLE 360 (360)
T ss_dssp HHHCCSSGGGSCCHH----HHTTSGGGC
T ss_pred HHHhcCChhhCCCHH----HHhcCcccC
Confidence 999999999999997 999999996
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-51 Score=402.33 Aligned_cols=271 Identities=26% Similarity=0.391 Sum_probs=201.0
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.++|++++.||+|+||+||+|.++. +++.||+|++..... ......+.+|+.+++.++||||+++++++.+++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 76 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKT-----TGVYVALKEVKLDSE--EGTPSTAIREISLMKELKHENIVRLYDVIHTEN 76 (317)
T ss_dssp ---------------CEEEEEECSS-----SCCEEEEEEEECCST--TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTT
T ss_pred ccceeEeeEECCCCCEEEEEEEECC-----CCcEEEEEEeecccc--cccHHHHHHHHHHHHhcCCCCcceEEEEEEECC
Confidence 4689999999999999999999876 578999999975421 122345667999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCC----CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 163 YSCLVMEYCPGGDLYAARQRQP----GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
.+|+||||++ |+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++
T Consensus 77 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~ 155 (317)
T 2pmi_A 77 KLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA 155 (317)
T ss_dssp EEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSC
T ss_pred eEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccc
Confidence 9999999996 69988876531 245899999999999999999999999999999999999999999999999998
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
+.+...
T Consensus 156 ~~~~~~-------------------------------------------------------------------------- 161 (317)
T 2pmi_A 156 RAFGIP-------------------------------------------------------------------------- 161 (317)
T ss_dssp EETTSC--------------------------------------------------------------------------
T ss_pred eecCCC--------------------------------------------------------------------------
Confidence 432110
Q ss_pred ccccccCCccccCCCCccCcchhcCC-CCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCC-----CC---
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQ-GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLT-----FP--- 389 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-----~p--- 389 (489)
.......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+...... ++
T Consensus 162 ----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 162 ----VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp ----CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred ----cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 0011234789999999999874 5899999999999999999999999998887776666431000 00
Q ss_pred ---C----C---CCCCchhH-------HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccc
Q 011302 390 ---R----I---GVSSSKEF-------EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWAL 443 (489)
Q Consensus 390 ---~----~---~~~~~~~~-------~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~ 443 (489)
. . ........ .....+.+||.+||+.||++||++. ++++||||+.+.|..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~----e~l~hp~f~~~~~~~ 304 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAK----QALHHPWFAEYYHHA 304 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHH----HHTTSGGGGGGCC--
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHH----HHhCChhhhcccchh
Confidence 0 0 00000000 1123589999999999999999987 999999999887753
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=401.04 Aligned_cols=269 Identities=26% Similarity=0.365 Sum_probs=210.5
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
+++|++++.||+|+||+||+|++.. +++.||||++...... .....+.+|+.+|+.++||||+++++++.+.+
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKL-----TDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEK 73 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSS
T ss_pred CCceEEEEEEcCCCCEEEEEEEECC-----CCcEEEEEEEeccccc--ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCC
Confidence 3689999999999999999999886 5789999999765422 22234456999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
.+|+||||++ |+|.+++... +..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 74 ~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 151 (324)
T 3mtl_A 74 SLTLVFEYLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKS 151 (324)
T ss_dssp CEEEEEECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-
T ss_pred EEEEEecccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCccccccc
Confidence 9999999995 6998888765 3569999999999999999999999999999999999999999999999999974321
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
..
T Consensus 152 ~~------------------------------------------------------------------------------ 153 (324)
T 3mtl_A 152 IP------------------------------------------------------------------------------ 153 (324)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred CC------------------------------------------------------------------------------
Confidence 10
Q ss_pred ccCCccccCCCCccCcchhcC-CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCC---chh
Q 011302 323 NARSKSFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSS---SKE 398 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~---~~~ 398 (489)
.......+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+..+.+..+.......+...... ...
T Consensus 154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 154 TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence 001123468999999999987 5689999999999999999999999999988777666654111111000000 000
Q ss_pred H------------------HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcc
Q 011302 399 F------------------EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWA 442 (489)
Q Consensus 399 ~------------------~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~ 442 (489)
+ ....++.+||.+||+.||.+||++. ++++||||.++.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~----e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAE----DAMKHPFFLSLGER 291 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHH----HHTTSGGGGGGCST
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHH----HHhcChhhhhcccc
Confidence 0 1123578999999999999999987 99999999987654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=394.76 Aligned_cols=266 Identities=26% Similarity=0.388 Sum_probs=208.2
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
++|++++.||+|+||+||+|++. .++.||+|++...... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 74 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNN------YGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKR 74 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET------TSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred ccchhhhhcccCCCEEEEEEEcC------CCCEEEEEEEeccccc-cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCe
Confidence 68999999999999999999984 3678999998654221 1223456679999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
+|+||||++ ++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 75 ~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (288)
T 1ob3_A 75 LVLVFEHLD-QDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (288)
T ss_dssp EEEEEECCS-EEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred EEEEEEecC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCc
Confidence 999999996 59998887643 5699999999999999999999999999999999999999999999999999743210
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
. .
T Consensus 153 ~------------------------------------------------------------------------------~ 154 (288)
T 1ob3_A 153 P------------------------------------------------------------------------------V 154 (288)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred c------------------------------------------------------------------------------c
Confidence 0 0
Q ss_pred cCCccccCCCCccCcchhcCC-CCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcC---C--CCCCCC------
Q 011302 324 ARSKSFVGTHEYLAPEVISGQ-GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK---P--LTFPRI------ 391 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~--~~~p~~------ 391 (489)
......+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+.+..+... . ..++..
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T 1ob3_A 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence 011234689999999999875 4899999999999999999999999998877766665431 0 001100
Q ss_pred ----CCCCchhH-----HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 392 ----GVSSSKEF-----EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 392 ----~~~~~~~~-----~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
.......+ .....+.+||.+||+.||++||++. ++++||||++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~----e~l~hp~f~~~n 288 (288)
T 1ob3_A 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAK----QALEHAYFKENN 288 (288)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHH----HHHTSGGGGC--
T ss_pred ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHH----HHhcCcchhhcC
Confidence 00000000 1123588999999999999999987 999999998753
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=404.41 Aligned_cols=256 Identities=31% Similarity=0.474 Sum_probs=206.5
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS 161 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 161 (489)
..++|++++.||+|+||+||+|+++. +++.||||++...... ...+.+|+.+++.++||||+++++++.+.
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 88 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKL-----TKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILTP 88 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETT-----TCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECC-----CCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEeeC
Confidence 45789999999999999999999986 5789999999754321 23456799999999999999999999999
Q ss_pred ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCc--EEEcccCCCc
Q 011302 162 HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGH--IMLSDFDLSF 239 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~--vkl~DFG~a~ 239 (489)
+.+|+|||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+
T Consensus 89 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~ 166 (361)
T 3uc3_A 89 THLAIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK 166 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-
T ss_pred CEEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccc
Confidence 9999999999999999998765 56999999999999999999999999999999999999987765 9999999983
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
....
T Consensus 167 ~~~~---------------------------------------------------------------------------- 170 (361)
T 3uc3_A 167 SSVL---------------------------------------------------------------------------- 170 (361)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cccc----------------------------------------------------------------------------
Confidence 2110
Q ss_pred cccccCCccccCCCCccCcchhcCCCCCCc-ccHHHHHHHHHHHhhCCCCCCCCCc----HHHHHHHhcCCCCCCCCCCC
Q 011302 320 EPINARSKSFVGTHEYLAPEVISGQGHGSA-VDWWTLGVFLYEMLYGTTPFKGENN----EKTLINILKKPLTFPRIGVS 394 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~-~DiwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~p~~~~~ 394 (489)
.......+||+.|+|||++.+..++.+ +|||||||++|||++|+.||.+... ...+..+......+|.....
T Consensus 171 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (361)
T 3uc3_A 171 ---HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRI 247 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCC
T ss_pred ---cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCC
Confidence 011233479999999999998887655 8999999999999999999987543 34555666666555543322
Q ss_pred CchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 395 SSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 395 ~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
. ..+.+||.+||+.||++||++. ++++||||..
T Consensus 248 s-------~~~~~li~~~L~~dP~~Rps~~----ell~hp~f~~ 280 (361)
T 3uc3_A 248 S-------PECCHLISRIFVADPATRISIP----EIKTHSWFLK 280 (361)
T ss_dssp C-------HHHHHHHHHHSCSCTTTSCCHH----HHHTSHHHHT
T ss_pred C-------HHHHHHHHHHccCChhHCcCHH----HHHhCcchhc
Confidence 2 2589999999999999999987 9999999943
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=397.60 Aligned_cols=271 Identities=26% Similarity=0.330 Sum_probs=207.1
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHH--HHHHHHHHHHHHHHHHhC---CCCCccccc
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALA--IRKKLHRADMEKVILTML---DHPFLPTLY 155 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~~l~~l---~hpnIv~l~ 155 (489)
+..++|++++.||+|+||+||+|++.. +++.||||++...... .......+.+|+.+++.+ +||||++++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~ 80 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPH-----SGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLM 80 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTT-----TCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECC-----CCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEee
Confidence 446899999999999999999999876 5789999998632100 000011233466666555 599999999
Q ss_pred ceeecCc-----eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcE
Q 011302 156 AEFEASH-----YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHI 230 (489)
Q Consensus 156 ~~~~~~~-----~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~v 230 (489)
+++.... .+|+||||+. |+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 81 DVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp EEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCE
T ss_pred eeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCE
Confidence 9997655 5899999995 699999988765669999999999999999999999999999999999999999999
Q ss_pred EEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCcc
Q 011302 231 MLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQE 310 (489)
Q Consensus 231 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (489)
||+|||+++....
T Consensus 160 kl~Dfg~a~~~~~------------------------------------------------------------------- 172 (308)
T 3g33_A 160 KLADFGLARIYSY------------------------------------------------------------------- 172 (308)
T ss_dssp EECSCSCTTTSTT-------------------------------------------------------------------
T ss_pred EEeeCccccccCC-------------------------------------------------------------------
Confidence 9999999843211
Q ss_pred ccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCC----
Q 011302 311 LLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL---- 386 (489)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---- 386 (489)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+.++.....
T Consensus 173 ------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (308)
T 3g33_A 173 ------------QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 240 (308)
T ss_dssp ------------CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred ------------CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 0112335799999999999999999999999999999999999999999988877777654211
Q ss_pred -CCCCCCC-----------CCchh--HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 387 -TFPRIGV-----------SSSKE--FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 387 -~~p~~~~-----------~~~~~--~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
.++.... ..... ......+.+||.+||+.||++||++. ++++||||+..+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~----e~l~h~~~~~~~ 304 (308)
T 3g33_A 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAF----RALQHSYLHKDE 304 (308)
T ss_dssp TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHH----HHHTSTTC----
T ss_pred hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHH----HHhcCccccCCC
Confidence 1111000 00000 01223588999999999999999997 999999998743
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=403.53 Aligned_cols=271 Identities=28% Similarity=0.441 Sum_probs=220.4
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHH--HHHHHHHHHHHHHHHHhCCCCCcccccceeecC
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALA--IRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS 161 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 161 (489)
++|++.+.||+|+||+||+|+++. +++.||+|++.+.... .......+.+|+.+++.++||||+++++++.+.
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQ-----TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hheeecceeeecCCeEEEEEEECC-----CCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 579999999999999999999876 5789999999876543 234456788899999999999999999999999
Q ss_pred ceEEEEEeecCCCchHHHHHhC--------------------------------------CCCCCChhhHHHHHHHHHHH
Q 011302 162 HYSCLVMEYCPGGDLYAARQRQ--------------------------------------PGKRFGISSAKFYAAETLLA 203 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~~--------------------------------------~~~~l~~~~~~~i~~qi~~~ 203 (489)
+..|+|||||+||+|.+++... ....+++..++.++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999987521 01234677788999999999
Q ss_pred HHHHHhCCCeeecCCCCCeEeccCC--cEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccc
Q 011302 204 LEYLHMMGIVYRDLKPENVLVREDG--HIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSS 281 (489)
Q Consensus 204 L~yLH~~~iiHrDIKp~NILl~~~~--~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (489)
|+|||++||+||||||+|||++.++ .+||+|||+++.+......
T Consensus 181 l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~---------------------------------- 226 (345)
T 3hko_A 181 LHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNG---------------------------------- 226 (345)
T ss_dssp HHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC----------------------------------
T ss_pred HHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCcc----------------------------------
Confidence 9999999999999999999998776 8999999998543211000
Q ss_pred cccccccccccccccccccccCCCCCCccccCCccccccccccCCccccCCCCccCcchhcC--CCCCCcccHHHHHHHH
Q 011302 282 VSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISG--QGHGSAVDWWTLGVFL 359 (489)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--~~~~~~~DiwSlGvil 359 (489)
.........||+.|+|||++.+ ..++.++|||||||++
T Consensus 227 ----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il 266 (345)
T 3hko_A 227 ----------------------------------------EYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266 (345)
T ss_dssp ------------------------------------------------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHH
T ss_pred ----------------------------------------ccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHH
Confidence 0001234479999999999976 5689999999999999
Q ss_pred HHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 360 YEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 360 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
|||++|+.||.+.+..+....+......++..... .....+.+||.+||+.||.+||++. ++++||||+.+
T Consensus 267 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~~l~~~p~~Rps~~----~~l~hp~~~~~ 337 (345)
T 3hko_A 267 HLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYN-----VLSPLARDLLSNLLNRNVDERFDAM----RALQHPWISQF 337 (345)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGG-----GSCHHHHHHHHHHSCSCTTTSCCHH----HHHHSHHHHTT
T ss_pred HHHHHCCCCCCCCChHHHHHHHHhcccccCCcccc-----cCCHHHHHHHHHHcCCChhHCCCHH----HHhcChhhccC
Confidence 99999999999999988888888766554432211 1123589999999999999999987 99999999988
Q ss_pred Ccc
Q 011302 440 NWA 442 (489)
Q Consensus 440 ~~~ 442 (489)
.|.
T Consensus 338 ~~~ 340 (345)
T 3hko_A 338 SDK 340 (345)
T ss_dssp SSC
T ss_pred hHh
Confidence 764
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=407.15 Aligned_cols=284 Identities=38% Similarity=0.708 Sum_probs=221.8
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHH-HHHHHHHHHHHHHHHHhC-CCCCcccccce
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALA-IRKKLHRADMEKVILTML-DHPFLPTLYAE 157 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~ 157 (489)
.+..++|++++.||+|+||.||+|++.... .+++.||||++++.... .......+.+|+.+|+.+ +||||++++++
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 127 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGH--DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 127 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSST--TTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccC--CCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEE
Confidence 356689999999999999999999985321 25789999998643210 001223455689999999 69999999999
Q ss_pred eecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCC
Q 011302 158 FEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237 (489)
Q Consensus 158 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~ 237 (489)
+...+.+||||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 128 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 128 FQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred EeeCceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 99999999999999999999998875 5699999999999999999999999999999999999999999999999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
++.+....
T Consensus 206 a~~~~~~~------------------------------------------------------------------------ 213 (355)
T 1vzo_A 206 SKEFVADE------------------------------------------------------------------------ 213 (355)
T ss_dssp EEECCGGG------------------------------------------------------------------------
T ss_pred CeecccCC------------------------------------------------------------------------
Confidence 84321100
Q ss_pred cccccccCCccccCCCCccCcchhcCC--CCCCcccHHHHHHHHHHHhhCCCCCCCCC----cHHHHHHHhcCCCCCCCC
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVISGQ--GHGSAVDWWTLGVFLYEMLYGTTPFKGEN----NEKTLINILKKPLTFPRI 391 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~--~~~~~~DiwSlGvil~elltG~~Pf~~~~----~~~~~~~i~~~~~~~p~~ 391 (489)
.......+||+.|+|||++.+. .++.++|||||||++|||++|..||.... .......+......+|..
T Consensus 214 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (355)
T 1vzo_A 214 -----TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 288 (355)
T ss_dssp -----GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred -----CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcc
Confidence 0112345799999999999863 47899999999999999999999997543 233444444444333321
Q ss_pred CCCCchhHHHHhhHHHHHHHHhhcCcccccCCC-CChHHHHcCCCcCCCCcccccc--CCCCCCC
Q 011302 392 GVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL-KGSVEIKRHEFFKGINWALIRS--IKPPEVP 453 (489)
Q Consensus 392 ~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~-~~~~~ll~hp~f~~~~~~~~~~--~~~p~~~ 453 (489)
. ...+.+||.+||..||.+||+.. ..++++++||||+.++|..+.. +.+|+.|
T Consensus 289 ~---------~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~~~~~~~p~~p 344 (355)
T 1vzo_A 289 M---------SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKP 344 (355)
T ss_dssp S---------CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred c---------CHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhhhccCCCCCCC
Confidence 1 12488999999999999999543 2456999999999999997743 3344433
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=399.83 Aligned_cols=267 Identities=28% Similarity=0.446 Sum_probs=224.6
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHH---HHHHHHHHHHHHHHhCCCCCcccccceee
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIR---KKLHRADMEKVILTMLDHPFLPTLYAEFE 159 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 159 (489)
.++|++.+.||+|+||.||+|++.. +++.||+|++........ .....+.+|+.+++.++||||+++++++.
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 85 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKS-----TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE 85 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECC-----CCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 3679999999999999999999886 578899999975422110 01345677999999999999999999999
Q ss_pred cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCC----cEEEccc
Q 011302 160 ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDG----HIMLSDF 235 (489)
Q Consensus 160 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~----~vkl~DF 235 (489)
+.+.+|+||||++|++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 86 NRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred cCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 999999999999999999999765 5799999999999999999999999999999999999999888 7999999
Q ss_pred CCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCc
Q 011302 236 DLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDP 315 (489)
Q Consensus 236 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (489)
|++.....
T Consensus 164 g~~~~~~~------------------------------------------------------------------------ 171 (321)
T 2a2a_A 164 GLAHEIED------------------------------------------------------------------------ 171 (321)
T ss_dssp TTCEECCT------------------------------------------------------------------------
T ss_pred ccceecCc------------------------------------------------------------------------
Confidence 99843211
Q ss_pred cccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCC
Q 011302 316 EVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSS 395 (489)
Q Consensus 316 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 395 (489)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+......++.....
T Consensus 172 -------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~- 243 (321)
T 2a2a_A 172 -------GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS- 243 (321)
T ss_dssp -------TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT-
T ss_pred -------cccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhc-
Confidence 001123469999999999999999999999999999999999999999998888888887765544321101
Q ss_pred chhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcccc
Q 011302 396 SKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALI 444 (489)
Q Consensus 396 ~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~ 444 (489)
.....+.+||.+||..||++||++. ++++||||++++|...
T Consensus 244 ----~~~~~~~~li~~~l~~dp~~Rps~~----e~l~hp~~~~~~~~~~ 284 (321)
T 2a2a_A 244 ----HTSELAKDFIRKLLVKETRKRLTIQ----EALRHPWITPVDNQQA 284 (321)
T ss_dssp ----TCCHHHHHHHHTTSCSSTTTSCCHH----HHHHSTTTSCSSHHHH
T ss_pred ----ccCHHHHHHHHHHcCCChhhCcCHH----HHhcCccccCCCcccc
Confidence 1123589999999999999999987 9999999999988654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=401.23 Aligned_cols=268 Identities=27% Similarity=0.428 Sum_probs=222.0
Q ss_pred CCceee-eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-CCCcccccceeecC
Q 011302 84 DHFRLL-RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-HPFLPTLYAEFEAS 161 (489)
Q Consensus 84 ~~y~~~-~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~ 161 (489)
+.|.+. +.||+|+||.||+|+++. +++.||+|++...... ......+.+|+.+++.+. ||||+++++++.+.
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKS-----TGQEYAAKFLKKRRRG-QDCRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEESEETT-EECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred hEEeeccceeCCCCCeEEEEEEECC-----CCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 567877 899999999999999886 5789999998753211 112245667999999885 69999999999999
Q ss_pred ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEecc---CCcEEEcccCCC
Q 011302 162 HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRE---DGHIMLSDFDLS 238 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~---~~~vkl~DFG~a 238 (489)
+.+|+||||++||+|.+++.......+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a 181 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS 181 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGC
T ss_pred CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccc
Confidence 99999999999999999886655577999999999999999999999999999999999999997 789999999998
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
+.....
T Consensus 182 ~~~~~~-------------------------------------------------------------------------- 187 (327)
T 3lm5_A 182 RKIGHA-------------------------------------------------------------------------- 187 (327)
T ss_dssp EEC-----------------------------------------------------------------------------
T ss_pred cccCCc--------------------------------------------------------------------------
Confidence 432110
Q ss_pred ccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchh
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKE 398 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 398 (489)
......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+......++.......
T Consensus 188 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~-- 260 (327)
T 3lm5_A 188 -----CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSV-- 260 (327)
T ss_dssp -----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTS--
T ss_pred -----cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhccc--
Confidence 0112347999999999999999999999999999999999999999999988888877766555443322221
Q ss_pred HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccccc
Q 011302 399 FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIR 445 (489)
Q Consensus 399 ~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~~ 445 (489)
...+.+||.+||+.||++||++. ++++||||++++|+.+.
T Consensus 261 ---~~~~~~li~~~L~~dP~~Rpt~~----~ll~h~~~~~~~~~~~~ 300 (327)
T 3lm5_A 261 ---SQLATDFIQSLLVKNPEKRPTAE----ICLSHSWLQQWDFENLF 300 (327)
T ss_dssp ---CHHHHHHHHHHSCSSGGGSCCHH----HHTTCGGGCCCCTTCC-
T ss_pred ---CHHHHHHHHHHcCCChhhCcCHH----HHhCCHhhccccccccc
Confidence 12589999999999999999987 99999999999998763
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-50 Score=398.43 Aligned_cols=256 Identities=28% Similarity=0.465 Sum_probs=194.3
Q ss_pred CCceee---eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-CCCcccccceee
Q 011302 84 DHFRLL---RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-HPFLPTLYAEFE 159 (489)
Q Consensus 84 ~~y~~~---~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~ 159 (489)
++|.+. +.||+|+||+||+|+++. +++.||||++.+.. ...+.+|+.+++.+. ||||+++++++.
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~ 76 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKK-----SNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFH 76 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETT-----TCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECC-----CCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEE
Confidence 356654 789999999999999986 57899999998643 234456999999997 999999999999
Q ss_pred cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCC---cEEEcccC
Q 011302 160 ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDG---HIMLSDFD 236 (489)
Q Consensus 160 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~---~vkl~DFG 236 (489)
+....|+||||++||+|.+++... ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg 154 (325)
T 3kn6_A 77 DQLHTFLVMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFG 154 (325)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCT
T ss_pred cCCEEEEEEEccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccc
Confidence 999999999999999999999876 6799999999999999999999999999999999999998765 89999999
Q ss_pred CCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcc
Q 011302 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPE 316 (489)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (489)
+++.....
T Consensus 155 ~a~~~~~~------------------------------------------------------------------------ 162 (325)
T 3kn6_A 155 FARLKPPD------------------------------------------------------------------------ 162 (325)
T ss_dssp TCEECCC-------------------------------------------------------------------------
T ss_pred cceecCCC------------------------------------------------------------------------
Confidence 98432110
Q ss_pred ccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCc-------HHHHHHHhcCCCCCC
Q 011302 317 VVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENN-------EKTLINILKKPLTFP 389 (489)
Q Consensus 317 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-------~~~~~~i~~~~~~~p 389 (489)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+. .+.+..+..+...++
T Consensus 163 ------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~ 236 (325)
T 3kn6_A 163 ------NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE 236 (325)
T ss_dssp ---------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC
T ss_pred ------CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC
Confidence 0112334789999999999999999999999999999999999999986543 456666666655443
Q ss_pred CCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 390 RIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 390 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
.... .....++++||.+||+.||.+||++. ++++||||++.
T Consensus 237 ~~~~-----~~~s~~~~~li~~~L~~dP~~Rpt~~----ell~h~w~~~~ 277 (325)
T 3kn6_A 237 GEAW-----KNVSQEAKDLIQGLLTVDPNKRLKMS----GLRYNEWLQDG 277 (325)
T ss_dssp SHHH-----HTSCHHHHHHHHHHHCCCTTTCCCTT----TSTTCGGGCTT
T ss_pred cccc-----cCCCHHHHHHHHHHCCCChhHCCCHH----HHhcChhhccC
Confidence 2111 11224689999999999999999998 99999999874
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=406.79 Aligned_cols=261 Identities=29% Similarity=0.447 Sum_probs=215.0
Q ss_pred Ccee--eeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 85 HFRL--LRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 85 ~y~~--~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.|.+ .+.||+|+||.||+|++.. +++.||+|++...... ....+.+|+.+|+.++||||+++++++.+.+
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~-----~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 159 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETA-----TGLKLAAKIIKTRGMK---DKEEVKNEISVMNQLDHANLIQLYDAFESKN 159 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETT-----TCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ceeeecceEEecCcCEEEEEEEEcC-----CCcEEEEEEEcccccc---cHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 3444 6789999999999999886 5788999999864332 2345778999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEe--ccCCcEEEcccCCCcc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLV--REDGHIMLSDFDLSFK 240 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl--~~~~~vkl~DFG~a~~ 240 (489)
.+||||||++||+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 160 ~~~lv~E~~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~ 238 (373)
T 2x4f_A 160 DIVLVMEYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARR 238 (373)
T ss_dssp EEEEEEECCTTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEE
T ss_pred EEEEEEeCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCcee
Confidence 999999999999999988654 2469999999999999999999999999999999999999 5678999999999843
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
+...
T Consensus 239 ~~~~---------------------------------------------------------------------------- 242 (373)
T 2x4f_A 239 YKPR---------------------------------------------------------------------------- 242 (373)
T ss_dssp CCTT----------------------------------------------------------------------------
T ss_pred cCCc----------------------------------------------------------------------------
Confidence 3210
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHH
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFE 400 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 400 (489)
......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+.++....+.++......
T Consensus 243 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~----- 314 (373)
T 2x4f_A 243 ---EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQD----- 314 (373)
T ss_dssp ---CBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTT-----
T ss_pred ---cccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhcc-----
Confidence 011234699999999999998899999999999999999999999999998888888887765544322111
Q ss_pred HHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcc
Q 011302 401 EVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWA 442 (489)
Q Consensus 401 ~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~ 442 (489)
...++++||.+||+.||.+||++. ++++||||+...|.
T Consensus 315 ~~~~~~~li~~~L~~dp~~Rps~~----e~l~hp~~~~~~~~ 352 (373)
T 2x4f_A 315 ISEEAKEFISKLLIKEKSWRISAS----EALKHPWLSDHKLH 352 (373)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHH----HHHHSHHHHCHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCCCHH----HHhcCcCcCCCchh
Confidence 123589999999999999999987 99999999987664
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-50 Score=386.59 Aligned_cols=261 Identities=28% Similarity=0.522 Sum_probs=197.2
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.++|++.+.||+|+||.||+|++.. +++.||||++............++.+|+.+++.++||||+++++++.+.+
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 84 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIH-----TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN 84 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSS
T ss_pred cccceeeeeecCCCceEEEEEEEcc-----CCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCC
Confidence 4789999999999999999999876 57889999998776554444567888999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
..|+||||+++++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 999999999999999998764 3569999999999999999999999999999999999999999999999999984321
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
..
T Consensus 164 ~~------------------------------------------------------------------------------ 165 (278)
T 3cok_A 164 MP------------------------------------------------------------------------------ 165 (278)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred CC------------------------------------------------------------------------------
Confidence 10
Q ss_pred ccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHH
Q 011302 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEV 402 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~ 402 (489)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||...+....+..+.......|.. ..
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~ 236 (278)
T 3cok_A 166 HEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSF---------LS 236 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTT---------SC
T ss_pred CCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccc---------cC
Confidence 001123468999999999999889999999999999999999999998877666665555444333321 11
Q ss_pred hhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 403 VKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 403 ~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
.++.+||.+||+.||++||++. ++++||||....
T Consensus 237 ~~~~~li~~~l~~dp~~Rps~~----~~l~h~~~~~~~ 270 (278)
T 3cok_A 237 IEAKDLIHQLLRRNPADRLSLS----SVLDHPFMSRNS 270 (278)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHH----HHTTSTTTC---
T ss_pred HHHHHHHHHHcccCHhhCCCHH----HHhcCccccCCC
Confidence 2589999999999999999987 999999998643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=421.43 Aligned_cols=262 Identities=30% Similarity=0.498 Sum_probs=217.7
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
++|++++.||+|+||+||+|+++. ++..||||++.+..... .....+.+|+.+|+.++||||++++++|.+.+.
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 110 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKV-----THVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRN 110 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETT-----TCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cCeEEeeEEecCCCEEEEEEEECC-----CCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence 579999999999999999999986 57889999998765332 224567789999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEecc---CCcEEEcccCCCcc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRE---DGHIMLSDFDLSFK 240 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~---~~~vkl~DFG~a~~ 240 (489)
+|+|||||+||+|.+.+... ..+++..++.++.||+.||.|||++|||||||||+|||++. ++.+||+|||+|..
T Consensus 111 ~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 111 YYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 99999999999999888765 56999999999999999999999999999999999999976 45599999999843
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
+...
T Consensus 189 ~~~~---------------------------------------------------------------------------- 192 (494)
T 3lij_A 189 FENQ---------------------------------------------------------------------------- 192 (494)
T ss_dssp CBTT----------------------------------------------------------------------------
T ss_pred CCCC----------------------------------------------------------------------------
Confidence 3210
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHH
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFE 400 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 400 (489)
......+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+..+.+.++.......
T Consensus 193 ---~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~---- 264 (494)
T 3lij_A 193 ---KKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNV---- 264 (494)
T ss_dssp ---BCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTS----
T ss_pred ---ccccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccC----
Confidence 11234579999999999874 5899999999999999999999999999999999988887766654332221
Q ss_pred HHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcc
Q 011302 401 EVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWA 442 (489)
Q Consensus 401 ~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~ 442 (489)
+..+++||.+||+.||.+||++. ++++||||+...+.
T Consensus 265 -s~~~~~li~~~L~~dp~~R~s~~----e~l~hp~~~~~~~~ 301 (494)
T 3lij_A 265 -SEGAKDLIKQMLQFDSQRRISAQ----QALEHPWIKEMCSK 301 (494)
T ss_dssp -CHHHHHHHHHHTCSSTTTSCCHH----HHHTCHHHHHHHHH
T ss_pred -CHHHHHHHHHHCCCChhhCccHH----HHhcCcccccCccc
Confidence 23589999999999999999987 99999999875443
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-50 Score=420.19 Aligned_cols=261 Identities=31% Similarity=0.475 Sum_probs=221.2
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
++|++++.||+|+||+||+|+++. +++.||||++.+..... .....+.+|+.+|+.++||||+++++++.+...
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 95 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRI-----TQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETT-----TCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cceEEeEEEeecCCEEEEEEEECC-----CCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCE
Confidence 689999999999999999999886 57899999998654321 224567789999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEec---cCCcEEEcccCCCcc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVR---EDGHIMLSDFDLSFK 240 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~---~~~~vkl~DFG~a~~ 240 (489)
+|+|||||.||+|.+.+... ..+++..++.++.||+.||.|||++|||||||||+|||++ .++.+||+|||+|+.
T Consensus 96 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp EEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 99999999999999988765 5799999999999999999999999999999999999995 456899999999843
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
+...
T Consensus 174 ~~~~---------------------------------------------------------------------------- 177 (486)
T 3mwu_A 174 FQQN---------------------------------------------------------------------------- 177 (486)
T ss_dssp BCCC----------------------------------------------------------------------------
T ss_pred CCCC----------------------------------------------------------------------------
Confidence 2210
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHH
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFE 400 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 400 (489)
......+||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+.+..+.+..+..+.+.++..... .
T Consensus 178 ---~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~-----~ 248 (486)
T 3mwu_A 178 ---TKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWR-----T 248 (486)
T ss_dssp -------CCTTGGGGCCGGGGGSC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGG-----G
T ss_pred ---CccCCCcCCCCCCCHHHhCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccC-----C
Confidence 112234799999999999875 9999999999999999999999999999999888888876655432211 1
Q ss_pred HHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCc
Q 011302 401 EVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINW 441 (489)
Q Consensus 401 ~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~ 441 (489)
.+..+++||.+||+.||.+||++. ++++||||+....
T Consensus 249 ~s~~~~~li~~~L~~dp~~R~t~~----~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 249 ISDDAKDLIRKMLTFHPSLRITAT----QCLEHPWIQKYSS 285 (486)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHH----HHHHCHHHHHTCC
T ss_pred CCHHHHHHHHHHcCCChhhCcCHH----HHhcCHhhccCcc
Confidence 123589999999999999999987 9999999987643
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-51 Score=426.15 Aligned_cols=266 Identities=33% Similarity=0.479 Sum_probs=224.2
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS 161 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 161 (489)
..++|++.+.||+|+||.||+|+++. +++.||||++.+...........+.+|+.+|+.++||||+++++++.+.
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 98 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKI-----TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDK 98 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred ccCceEEeeEEecCCCEEEEEEEECC-----CCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 34689999999999999999999886 5789999999754332222345677799999999999999999999999
Q ss_pred ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEe---ccCCcEEEcccCCC
Q 011302 162 HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLV---REDGHIMLSDFDLS 238 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl---~~~~~vkl~DFG~a 238 (489)
+.+|+|||||.||+|.+++... ..+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|
T Consensus 99 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 99 GYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp SEEEEEECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred CEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 9999999999999999988765 579999999999999999999999999999999999999 56789999999998
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
+.+...
T Consensus 177 ~~~~~~-------------------------------------------------------------------------- 182 (484)
T 3nyv_A 177 THFEAS-------------------------------------------------------------------------- 182 (484)
T ss_dssp HHBCCC--------------------------------------------------------------------------
T ss_pred EEcccc--------------------------------------------------------------------------
Confidence 432210
Q ss_pred ccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchh
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKE 398 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 398 (489)
......+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+..+.+.++.....
T Consensus 183 -----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~---- 252 (484)
T 3nyv_A 183 -----KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWK---- 252 (484)
T ss_dssp -----CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGG----
T ss_pred -----cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccc----
Confidence 01123479999999999987 59999999999999999999999999999999999988876655432211
Q ss_pred HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccc
Q 011302 399 FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWAL 443 (489)
Q Consensus 399 ~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~ 443 (489)
..+..+++||.+||+.||.+||++. ++++||||+...+..
T Consensus 253 -~~s~~~~~li~~~L~~dp~~R~s~~----e~l~h~~~~~~~~~~ 292 (484)
T 3nyv_A 253 -KVSESAKDLIRKMLTYVPSMRISAR----DALDHEWIQTYTKEQ 292 (484)
T ss_dssp -GSCHHHHHHHHHHTCSSGGGSCCHH----HHHTSHHHHHHTC--
T ss_pred -cCCHHHHHHHHHHCCCChhHCcCHH----HHhhChhhccccccc
Confidence 1223589999999999999999997 999999998766543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=386.16 Aligned_cols=269 Identities=28% Similarity=0.426 Sum_probs=223.2
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHH------HHHHHHHHHHHHHHHHHHhCC-CCCcccc
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREA------LAIRKKLHRADMEKVILTMLD-HPFLPTL 154 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~E~~~l~~l~-hpnIv~l 154 (489)
..++|++.+.||+|+||.||+|+++. +++.||||++.... .........+.+|+.+++.+. ||||+++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKP-----TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQL 89 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred hhhccceeeeecCCCceEEEEEEEcC-----cCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeee
Confidence 35799999999999999999999986 57899999996432 222344566778999999995 9999999
Q ss_pred cceeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcc
Q 011302 155 YAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSD 234 (489)
Q Consensus 155 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~D 234 (489)
++++.+.+..|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 90 KDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECC
T ss_pred eeeeccCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEec
Confidence 99999999999999999999999998865 5799999999999999999999999999999999999999999999999
Q ss_pred cCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCC
Q 011302 235 FDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDD 314 (489)
Q Consensus 235 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (489)
||++.....
T Consensus 168 fg~~~~~~~----------------------------------------------------------------------- 176 (298)
T 1phk_A 168 FGFSCQLDP----------------------------------------------------------------------- 176 (298)
T ss_dssp CTTCEECCT-----------------------------------------------------------------------
T ss_pred ccchhhcCC-----------------------------------------------------------------------
Confidence 999843211
Q ss_pred ccccccccccCCccccCCCCccCcchhc------CCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCC
Q 011302 315 PEVVAEPINARSKSFVGTHEYLAPEVIS------GQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTF 388 (489)
Q Consensus 315 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~ 388 (489)
........||+.|+|||++. ...++.++|||||||++|||++|..||.+.+.......+..+...+
T Consensus 177 --------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (298)
T 1phk_A 177 --------GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 248 (298)
T ss_dssp --------TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred --------CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCccc
Confidence 00112346899999999985 4567899999999999999999999999988888888887766555
Q ss_pred CCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccccc
Q 011302 389 PRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIR 445 (489)
Q Consensus 389 p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~~ 445 (489)
+..... .....+.+||.+||+.||.+||++. ++++||||+...|+.++
T Consensus 249 ~~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~----~ll~h~~~~~~~~~~~~ 296 (298)
T 1phk_A 249 GSPEWD-----DYSDTVKDLVSRFLVVQPQKRYTAE----EALAHPFFQQYVVEEVR 296 (298)
T ss_dssp CTTTGG-----GSCHHHHHHHHHHCCSSGGGSCCHH----HHTTSGGGCTTC-----
T ss_pred Cccccc-----ccCHHHHHHHHHHccCCcccCCCHH----HHHhChHhhhccchhhc
Confidence 432211 1123589999999999999999987 99999999999887665
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=390.55 Aligned_cols=271 Identities=25% Similarity=0.342 Sum_probs=211.8
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.++|++++.||+|+||+||+|++.. +++.||||++...... ......+.+|+.+++.++||||+++++++.+.+
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 75 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRD-----TGQIVAIKKFLESEDD-PVIKKIALREIRMLKQLKHPNLVNLLEVFRRKR 75 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cccceEeeEEeecCCeEEEEEEeCC-----CCcEEEEEEeeccccc-hHHHHHHHHHHHHHHhCCCCCccchhheeecCC
Confidence 3689999999999999999999986 5789999988543221 233455677999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
..|+||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 153 (311)
T 4agu_A 76 RLHLVFEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLT 153 (311)
T ss_dssp EEEEEEECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred eEEEEEEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhcc
Confidence 999999999999999887765 569999999999999999999999999999999999999999999999999984322
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
..
T Consensus 154 ~~------------------------------------------------------------------------------ 155 (311)
T 4agu_A 154 GP------------------------------------------------------------------------------ 155 (311)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred Cc------------------------------------------------------------------------------
Confidence 10
Q ss_pred ccCCccccCCCCccCcchhcC-CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcC-----------------
Q 011302 323 NARSKSFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK----------------- 384 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~----------------- 384 (489)
.......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 156 SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence 001123468999999999987 56799999999999999999999999998877665544321
Q ss_pred --CCCCCCCCCCCchh---HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccc
Q 011302 385 --PLTFPRIGVSSSKE---FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWAL 443 (489)
Q Consensus 385 --~~~~p~~~~~~~~~---~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~ 443 (489)
....+......... ......+.+||.+||+.||++||++. ++++||||+++.|..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~----ell~hp~f~~~~~~~ 295 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCE----QLLHHPYFENIREIE 295 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHH----HHHTSGGGTTCC---
T ss_pred cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHH----HHhcChHHHhccCHH
Confidence 11111111111000 01223588999999999999999987 999999999987753
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=386.27 Aligned_cols=260 Identities=28% Similarity=0.462 Sum_probs=223.6
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS 161 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 161 (489)
..++|.+.+.||+|+||.||+|++.. .++.||+|++.............+.+|+.+++.++||||+++++++.+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 87 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDAD-----TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN 87 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred cccceEEEEEEeecCCEEEEEEEECC-----CCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC
Confidence 34789999999999999999999986 5788999999765433334456677899999999999999999999999
Q ss_pred ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccc
Q 011302 162 HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKC 241 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~ 241 (489)
+..|+||||++|++|.+++... ..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 88 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 88 DFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred CEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 9999999999999999988765 57999999999999999999999999999999999999999999999999998432
Q ss_pred ccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccc
Q 011302 242 DVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEP 321 (489)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (489)
...
T Consensus 166 ~~~----------------------------------------------------------------------------- 168 (294)
T 2rku_A 166 EYD----------------------------------------------------------------------------- 168 (294)
T ss_dssp CST-----------------------------------------------------------------------------
T ss_pred ccC-----------------------------------------------------------------------------
Confidence 110
Q ss_pred cccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHH
Q 011302 322 INARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEE 401 (489)
Q Consensus 322 ~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 401 (489)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+......+|...
T Consensus 169 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--------- 238 (294)
T 2rku_A 169 -GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHI--------- 238 (294)
T ss_dssp -TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTS---------
T ss_pred -ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCcccc---------
Confidence 0011234699999999999999899999999999999999999999999888888888777665554321
Q ss_pred HhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 402 VVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 402 ~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
...+.+||.+||+.||++||++. ++++||||...
T Consensus 239 ~~~~~~li~~~l~~~p~~Rps~~----~ll~~~~~~~~ 272 (294)
T 2rku_A 239 NPVAASLIQKMLQTDPTARPTIN----ELLNDEFFTSG 272 (294)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCGG----GGGGSHHHHTS
T ss_pred CHHHHHHHHHHcccChhhCcCHH----HHhhChheecC
Confidence 12589999999999999999998 99999999764
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=400.92 Aligned_cols=278 Identities=26% Similarity=0.379 Sum_probs=213.5
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.++|++++.||+|+||.||+|.+.. +++.||||++...... .....++.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 97 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAI-----LERNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK 97 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEECTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECC-----CCceEEEEEeccccCC-hHHHHHHHHHHHHHHhcCCCCccceEEeecccc
Confidence 4789999999999999999999876 5789999999753211 233456778999999999999999999997654
Q ss_pred ------eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccC
Q 011302 163 ------YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFD 236 (489)
Q Consensus 163 ------~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG 236 (489)
.+|+||||++ |+|.+.+.. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 98 ~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 172 (371)
T 2xrw_A 98 SLEEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 172 (371)
T ss_dssp STTTCCEEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred ccccccceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEee
Confidence 7899999995 688888753 48999999999999999999999999999999999999999999999999
Q ss_pred CCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcc
Q 011302 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPE 316 (489)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (489)
+|+....
T Consensus 173 ~a~~~~~------------------------------------------------------------------------- 179 (371)
T 2xrw_A 173 LARTAGT------------------------------------------------------------------------- 179 (371)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred ccccccc-------------------------------------------------------------------------
Confidence 9843210
Q ss_pred ccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCC--------
Q 011302 317 VVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTF-------- 388 (489)
Q Consensus 317 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-------- 388 (489)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..+.......
T Consensus 180 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 180 ------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred ------ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 001123479999999999999999999999999999999999999999998887777776532110
Q ss_pred -----------CCCC------------CCCch--hHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccc
Q 011302 389 -----------PRIG------------VSSSK--EFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWAL 443 (489)
Q Consensus 389 -----------p~~~------------~~~~~--~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~ 443 (489)
+... .+... .......+++||.+||+.||++||++. ++++||||+......
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~----e~l~hp~~~~~~~~~ 329 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD----EALQHPYINVWYDPS 329 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHH----HHHHSHHHHTTCCHH
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHH----HHhCCcchhhhcCcc
Confidence 0000 00000 011234689999999999999999987 999999998644333
Q ss_pred cccCCCCCCCC
Q 011302 444 IRSIKPPEVPN 454 (489)
Q Consensus 444 ~~~~~~p~~~~ 454 (489)
.....+|.+|.
T Consensus 330 ~~~~~~~~~~~ 340 (371)
T 2xrw_A 330 EAEAPPPKIPD 340 (371)
T ss_dssp HHTCCCCCCCT
T ss_pred ccCCCCCCCCC
Confidence 34444555444
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=400.15 Aligned_cols=266 Identities=29% Similarity=0.384 Sum_probs=208.3
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.++|++++.||+|+||.||+|.+.. +++.||||++..... ......++.+|+.+|+.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 97 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGR-----TGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE 97 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETT-----TCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred cceEEEeEEeeecCCeEEEEEEECC-----CCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCC
Confidence 3789999999999999999999876 578999999864321 1234456778999999999999999999997653
Q ss_pred ------eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccC
Q 011302 163 ------YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFD 236 (489)
Q Consensus 163 ------~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG 236 (489)
.+|+||||+ |++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 173 (367)
T 1cm8_A 98 TLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFG 173 (367)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred ccccCceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeee
Confidence 469999999 8999999876 469999999999999999999999999999999999999999999999999
Q ss_pred CCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcc
Q 011302 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPE 316 (489)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (489)
+++...
T Consensus 174 ~a~~~~-------------------------------------------------------------------------- 179 (367)
T 1cm8_A 174 LARQAD-------------------------------------------------------------------------- 179 (367)
T ss_dssp TCEECC--------------------------------------------------------------------------
T ss_pred cccccc--------------------------------------------------------------------------
Confidence 984321
Q ss_pred ccccccccCCccccCCCCccCcchhcC-CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCC-------
Q 011302 317 VVAEPINARSKSFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTF------- 388 (489)
Q Consensus 317 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~------- 388 (489)
......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..|.......
T Consensus 180 -------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 252 (367)
T 1cm8_A 180 -------SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 252 (367)
T ss_dssp -------SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred -------cccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 01233578999999999987 678999999999999999999999999998877776664311110
Q ss_pred -------------CCCCCCCchh--HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccc
Q 011302 389 -------------PRIGVSSSKE--FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWAL 443 (489)
Q Consensus 389 -------------p~~~~~~~~~--~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~ 443 (489)
|......... ......+.+||.+||..||.+||++. ++++||||+.+.+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~----e~l~hp~f~~~~~~~ 318 (367)
T 1cm8_A 253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG----EALAHPYFESLHDTE 318 (367)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHH----HHHHSGGGTTTC---
T ss_pred hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHH----HHhcChHHHhhcCCc
Confidence 0000000000 01123589999999999999999987 999999999886643
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=393.73 Aligned_cols=259 Identities=28% Similarity=0.463 Sum_probs=223.4
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.++|.+.+.||+|+||.||+|++.. +++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 114 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDAD-----TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND 114 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCceEEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 4789999999999999999999987 57899999997654333344556778999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
.+|+||||+++++|.+++... ..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 115 ~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EEEEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 999999999999999988765 579999999999999999999999999999999999999999999999999984322
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
..
T Consensus 193 ~~------------------------------------------------------------------------------ 194 (335)
T 2owb_A 193 YD------------------------------------------------------------------------------ 194 (335)
T ss_dssp ST------------------------------------------------------------------------------
T ss_pred cC------------------------------------------------------------------------------
Confidence 10
Q ss_pred ccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHH
Q 011302 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEV 402 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~ 402 (489)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+.+..+......+|... .
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------~ 265 (335)
T 2owb_A 195 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHI---------N 265 (335)
T ss_dssp TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTS---------C
T ss_pred cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccC---------C
Confidence 0012234799999999999999999999999999999999999999999888887777777665555321 1
Q ss_pred hhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 403 VKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 403 ~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
..+.+||.+||+.||++||++. ++++||||...
T Consensus 266 ~~~~~li~~~l~~dp~~Rps~~----ell~~~~~~~~ 298 (335)
T 2owb_A 266 PVAASLIQKMLQTDPTARPTIN----ELLNDEFFTSG 298 (335)
T ss_dssp HHHHHHHHHHTCSSGGGSCCGG----GGGGSHHHHTS
T ss_pred HHHHHHHHHHccCChhHCcCHH----HHhcCccccCC
Confidence 2489999999999999999998 99999999764
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=418.96 Aligned_cols=262 Identities=29% Similarity=0.453 Sum_probs=218.7
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHH----------HHHHHHHHHHHHHHhCCCCCcc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIR----------KKLHRADMEKVILTMLDHPFLP 152 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~hpnIv 152 (489)
.++|++++.||+|+||+||+|+++. +++.||||++.+...... .....+.+|+.+|+.++||||+
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv 109 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKN-----GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNII 109 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETT-----TCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBC
T ss_pred ccceEEEeEecccCCeEEEEEEECC-----CCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCC
Confidence 4789999999999999999999987 578899999986543321 2345678899999999999999
Q ss_pred cccceeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCC---c
Q 011302 153 TLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDG---H 229 (489)
Q Consensus 153 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~---~ 229 (489)
++++++.+...+|+|||||+||+|.+++... ..+++..++.++.||+.||+|||++|||||||||+|||++.++ .
T Consensus 110 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 110 KLFDVFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp CEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSS
T ss_pred eEEEEEEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCcc
Confidence 9999999999999999999999999988765 5699999999999999999999999999999999999999776 6
Q ss_pred EEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCc
Q 011302 230 IMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQ 309 (489)
Q Consensus 230 vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (489)
+||+|||+|..+...
T Consensus 188 ~kl~Dfg~a~~~~~~----------------------------------------------------------------- 202 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKD----------------------------------------------------------------- 202 (504)
T ss_dssp EEECCCTTCEECCTT-----------------------------------------------------------------
T ss_pred EEEEECCCCEEcCCC-----------------------------------------------------------------
Confidence 999999998433210
Q ss_pred cccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCC
Q 011302 310 ELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFP 389 (489)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p 389 (489)
......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+..+.+.++
T Consensus 203 --------------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 267 (504)
T 3q5i_A 203 --------------YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD 267 (504)
T ss_dssp --------------SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred --------------CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 11233479999999999875 589999999999999999999999999999999999888766554
Q ss_pred CCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 390 RIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 390 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
..... ..+.++++||.+||+.||.+||++. ++++||||+...
T Consensus 268 ~~~~~-----~~s~~~~~li~~~L~~dp~~R~t~~----e~l~h~~~~~~~ 309 (504)
T 3q5i_A 268 FNDWK-----NISDEAKELIKLMLTYDYNKRCTAE----EALNSRWIKKYA 309 (504)
T ss_dssp HHHHT-----TSCHHHHHHHHHHTCSSTTTSCCHH----HHHTSHHHHHTC
T ss_pred ccccC-----CCCHHHHHHHHHHcCCChhHCCCHH----HHhcCHhhhhch
Confidence 22111 1123589999999999999999997 999999997654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=386.67 Aligned_cols=267 Identities=28% Similarity=0.435 Sum_probs=219.4
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHH-HHHHHHHHHHHHHHHhCCCCCccccccee--e
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAI-RKKLHRADMEKVILTMLDHPFLPTLYAEF--E 159 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~--~ 159 (489)
.++|++.+.||+|+||.||+|.+.. +++.||+|++....... ......+.+|+.+++.++||||+++++++ .
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSE-----TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE 78 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTT-----TCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC
T ss_pred ccceeEeeEEecCCCeEEEEEEECC-----CCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence 4789999999999999999999876 57899999998765432 23456678899999999999999999998 4
Q ss_pred cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 160 ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 160 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
+....|+||||++++ |.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 79 ~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 79 EKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp ---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeecccccc
Confidence 566899999999766 7777777666789999999999999999999999999999999999999999999999999984
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
.......
T Consensus 158 ~~~~~~~------------------------------------------------------------------------- 164 (305)
T 2wtk_C 158 ALHPFAA------------------------------------------------------------------------- 164 (305)
T ss_dssp ECCTTCS-------------------------------------------------------------------------
T ss_pred ccCcccc-------------------------------------------------------------------------
Confidence 3321000
Q ss_pred cccccCCccccCCCCccCcchhcCCCC--CCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCch
Q 011302 320 EPINARSKSFVGTHEYLAPEVISGQGH--GSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSK 397 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~--~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 397 (489)
........||+.|+|||++.+... +.++|||||||++|||++|..||.+.+..+....+......++... .
T Consensus 165 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~---~- 237 (305)
T 2wtk_C 165 ---DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDC---G- 237 (305)
T ss_dssp ---SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSS---C-
T ss_pred ---ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCcc---C-
Confidence 001123469999999999987543 7899999999999999999999999888888888877665554321 1
Q ss_pred hHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcccc
Q 011302 398 EFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALI 444 (489)
Q Consensus 398 ~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~ 444 (489)
..+.+||.+||..||.+||++. ++++||||+.......
T Consensus 238 -----~~l~~li~~~l~~dp~~Rps~~----~ll~~~~~~~~~~~~~ 275 (305)
T 2wtk_C 238 -----PPLSDLLKGMLEYEPAKRFSIR----QIRQHSWFRKKHPPAE 275 (305)
T ss_dssp -----HHHHHHHHHHTCSSTTTSCCHH----HHHHSHHHHSCCCC-C
T ss_pred -----HHHHHHHHHHccCChhhCCCHH----HHhcCcccccCCCCcC
Confidence 2489999999999999999987 9999999988765443
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-49 Score=405.11 Aligned_cols=295 Identities=24% Similarity=0.292 Sum_probs=209.8
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC-
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS- 161 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~- 161 (489)
.++|++++.||+|+||+||+|+++. +++.||||++.+... ......++.+|+.+|+.++||||+++++++...
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~-----~~~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 98 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKN-----TEKNVAIKKVNRMFE-DLIDCKRILREITILNRLKSDYIIRLYDLIIPDD 98 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETT-----TTEEEEEEEECSTTT-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECC-----CCcEEEEEEeCchhc-ChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence 4789999999999999999999987 678999999975321 123445678899999999999999999999766
Q ss_pred ----ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCC
Q 011302 162 ----HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237 (489)
Q Consensus 162 ----~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~ 237 (489)
..+|+||||+ +|+|.+++... ..+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGl 175 (432)
T 3n9x_A 99 LLKFDELYIVLEIA-DSDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGL 175 (432)
T ss_dssp TTTCCCEEEEEECC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred CCcCCeEEEEEecC-CcCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCC
Confidence 6799999999 57999998765 5699999999999999999999999999999999999999999999999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
|+............ .... ... ...
T Consensus 176 a~~~~~~~~~~~~~--------------------------~~~~------------------~~~------------~~~ 199 (432)
T 3n9x_A 176 ARTINSEKDTNIVN--------------------------DLEE------------------NEE------------PGP 199 (432)
T ss_dssp CEEC----------------------------------------------------------------------------
T ss_pred cccccccccccccc--------------------------cccc------------------ccc------------ccc
Confidence 86543211000000 0000 000 000
Q ss_pred cccccccCCccccCCCCccCcchh-cCCCCCCcccHHHHHHHHHHHhh-----------CCCCCCCCCc-----------
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVI-SGQGHGSAVDWWTLGVFLYEMLY-----------GTTPFKGENN----------- 374 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l-~~~~~~~~~DiwSlGvil~ellt-----------G~~Pf~~~~~----------- 374 (489)
............+||+.|+|||++ .+..++.++|||||||++|||++ |.++|.+.+.
T Consensus 200 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~ 279 (432)
T 3n9x_A 200 HNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKK 279 (432)
T ss_dssp -----------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC---------
T ss_pred cccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCccccccc
Confidence 000011234567899999999997 45569999999999999999998 4555555431
Q ss_pred ------HHHHHHHhc---CCC-----------------CCCCCCCCCc-hh-HHHHhhHHHHHHHHhhcCcccccCCCCC
Q 011302 375 ------EKTLINILK---KPL-----------------TFPRIGVSSS-KE-FEEVVKLQDLISKLLVKNPKKRIGSLKG 426 (489)
Q Consensus 375 ------~~~~~~i~~---~~~-----------------~~p~~~~~~~-~~-~~~~~~l~~li~~~L~~dP~~R~~~~~~ 426 (489)
.+.+..|.. .+. .++....... .. .....++.+||.+||+.||++||++.
T Consensus 280 ~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~-- 357 (432)
T 3n9x_A 280 VHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITID-- 357 (432)
T ss_dssp -CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHH--
T ss_pred ccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHH--
Confidence 122222211 000 0000000000 00 01224689999999999999999987
Q ss_pred hHHHHcCCCcCCCCcccccc
Q 011302 427 SVEIKRHEFFKGINWALIRS 446 (489)
Q Consensus 427 ~~~ll~hp~f~~~~~~~~~~ 446 (489)
++|+||||+++.|.....
T Consensus 358 --e~L~Hp~f~~~~~~~~e~ 375 (432)
T 3n9x_A 358 --QALDHPYLKDVRKKKLEN 375 (432)
T ss_dssp --HHHTCGGGTTTCCTTTC-
T ss_pred --HHhcChhhhhccCcccCc
Confidence 999999999999976643
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=385.76 Aligned_cols=258 Identities=29% Similarity=0.470 Sum_probs=212.0
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
++|++.+.||+|+||.||+|+++. .+..||+|++...... .....+.+|+.+|+.++||||+++++++.+.+.
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 94 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERS-----SGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHN 94 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEGGGCC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred hheeecceeccCCCeEEEEEEEcc-----CCceEEEEEeeccccc--hhHHHHHHHHHHHHhCCCchHHhHHHheecCCe
Confidence 689999999999999999999886 5788999999765321 123456779999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhC--CCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEe---ccCCcEEEcccCCC
Q 011302 164 SCLVMEYCPGGDLYAARQRQ--PGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLV---REDGHIMLSDFDLS 238 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl---~~~~~vkl~DFG~a 238 (489)
.|+||||++||+|.+++... .+..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 99999999999999887542 23579999999999999999999999999999999999999 45688999999998
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
..+...
T Consensus 175 ~~~~~~-------------------------------------------------------------------------- 180 (285)
T 3is5_A 175 ELFKSD-------------------------------------------------------------------------- 180 (285)
T ss_dssp CC------------------------------------------------------------------------------
T ss_pred eecCCc--------------------------------------------------------------------------
Confidence 432110
Q ss_pred ccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchh
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKE 398 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 398 (489)
......+||+.|+|||++.+ .++.++|||||||++|||++|..||.+.+..+....+......++.......
T Consensus 181 -----~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 252 (285)
T 3is5_A 181 -----EHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLT-- 252 (285)
T ss_dssp -----------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCC--
T ss_pred -----ccCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCC--
Confidence 01123469999999999864 5899999999999999999999999998887777766655444333222222
Q ss_pred HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 399 FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 399 ~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
.++.+||.+||+.||++||++. ++++||||+.
T Consensus 253 ----~~~~~li~~~L~~dP~~Rps~~----e~l~hp~f~~ 284 (285)
T 3is5_A 253 ----PQAVDLLKQMLTKDPERRPSAA----QVLHHEWFKQ 284 (285)
T ss_dssp ----HHHHHHHHHHTCSCTTTSCCHH----HHHTSGGGGC
T ss_pred ----HHHHHHHHHHccCChhhCcCHH----HHhcCHHhhc
Confidence 2588999999999999999997 9999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=382.38 Aligned_cols=261 Identities=31% Similarity=0.464 Sum_probs=217.4
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccccccee
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEF 158 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 158 (489)
+.+..++|++.+.||+|+||.||+|++.. +++.||||++.............+.+|+.+++.++||||+++++++
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 80 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQL-----TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI 80 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECC-----CCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence 45667899999999999999999999886 5788999999877655444556788899999999999999999999
Q ss_pred ecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 159 EASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
.+.+..|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~ 158 (276)
T 2h6d_A 81 STPTDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS 158 (276)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGG
T ss_pred ecCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccc
Confidence 9999999999999999999998775 56999999999999999999999999999999999999999999999999997
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
......
T Consensus 159 ~~~~~~-------------------------------------------------------------------------- 164 (276)
T 2h6d_A 159 NMMSDG-------------------------------------------------------------------------- 164 (276)
T ss_dssp GCCCC---------------------------------------------------------------------------
T ss_pred cccCCC--------------------------------------------------------------------------
Confidence 432110
Q ss_pred ccccccCCccccCCCCccCcchhcCCCC-CCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCch
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQGH-GSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSK 397 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 397 (489)
.......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......+|...
T Consensus 165 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 234 (276)
T 2h6d_A 165 -----EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYL----- 234 (276)
T ss_dssp -----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTS-----
T ss_pred -----cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhc-----
Confidence 01123368999999999998776 6899999999999999999999999888777777776655444321
Q ss_pred hHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 398 EFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 398 ~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
...+.+||.+||+.||.+||++. ++++||||+.
T Consensus 235 ----~~~l~~li~~~l~~~p~~Rps~~----~~l~h~~~~~ 267 (276)
T 2h6d_A 235 ----NRSVATLLMHMLQVDPLKRATIK----DIREHEWFKQ 267 (276)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHH----HHHHSHHHHT
T ss_pred ----CHHHHHHHHHHccCChhhCCCHH----HHHhChhhcc
Confidence 12489999999999999999997 9999999975
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=397.35 Aligned_cols=266 Identities=24% Similarity=0.338 Sum_probs=214.6
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS 161 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 161 (489)
..++|++.+.||+|+||.||+|++.. .++.||||++............++.+|+.+++.++||||+++++++...
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 84 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLR-----DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE 84 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECC-----CCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeecc
Confidence 34789999999999999999999876 5789999999865444445566788899999999999999999998765
Q ss_pred c----eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCC
Q 011302 162 H----YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237 (489)
Q Consensus 162 ~----~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~ 237 (489)
. ..|+||||++||+|.+++... +.+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 85 ~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 162 (311)
T 3ork_A 85 TPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGI 162 (311)
T ss_dssp ETTEEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred CCCCcccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccC
Confidence 4 349999999999999999765 5799999999999999999999999999999999999999999999999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
++.+.....
T Consensus 163 a~~~~~~~~----------------------------------------------------------------------- 171 (311)
T 3ork_A 163 ARAIADSGN----------------------------------------------------------------------- 171 (311)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred ccccccccc-----------------------------------------------------------------------
Confidence 843321000
Q ss_pred cccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCch
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSK 397 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 397 (489)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+.......+......
T Consensus 172 ----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-- 245 (311)
T 3ork_A 172 ----SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG-- 245 (311)
T ss_dssp --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTT--
T ss_pred ----ccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCC--
Confidence 00112345799999999999999999999999999999999999999999888777766665443322111111
Q ss_pred hHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 398 EFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 398 ~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
.+.++.+||.+||+.||++||++. +++.|+|++.
T Consensus 246 ---~~~~l~~li~~~l~~dP~~R~~~~----~~l~~~l~~~ 279 (311)
T 3ork_A 246 ---LSADLDAVVLKALAKNPENRYQTA----AEMRADLVRV 279 (311)
T ss_dssp ---CCHHHHHHHHHHTCSSGGGSCSSH----HHHHHHHHHH
T ss_pred ---CCHHHHHHHHHHHhcCHhhChhhH----HHHHHHHHHH
Confidence 123589999999999999999987 9999999865
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=390.99 Aligned_cols=257 Identities=26% Similarity=0.419 Sum_probs=215.3
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceE
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYS 164 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 164 (489)
.|...+.||+|+||.||+|+++. +++.||||++..... .....+.+|+.+++.++||||+++++++...+..
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~-----~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKH-----SGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEEL 117 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEETTTC---CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred hhhccEEeccCCCeEEEEEEECC-----CCcEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEE
Confidence 47888999999999999999876 578999999975432 2234566799999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccC
Q 011302 165 CLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVV 244 (489)
Q Consensus 165 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~ 244 (489)
|+||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 118 ~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 194 (321)
T 2c30_A 118 WVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD 194 (321)
T ss_dssp EEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred EEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccC
Confidence 999999999999998865 46999999999999999999999999999999999999999999999999998432110
Q ss_pred ccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccccc
Q 011302 245 PKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINA 324 (489)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (489)
..
T Consensus 195 ------------------------------------------------------------------------------~~ 196 (321)
T 2c30_A 195 ------------------------------------------------------------------------------VP 196 (321)
T ss_dssp ------------------------------------------------------------------------------SC
T ss_pred ------------------------------------------------------------------------------cc
Confidence 00
Q ss_pred CCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhh
Q 011302 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVK 404 (489)
Q Consensus 325 ~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~ 404 (489)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+........... ......
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~ 270 (321)
T 2c30_A 197 KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNS------HKVSPV 270 (321)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTG------GGSCHH
T ss_pred ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCcc------ccCCHH
Confidence 12345799999999999999999999999999999999999999999888777777665432211111 112235
Q ss_pred HHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 405 LQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 405 l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
+.+||.+||+.||++||++. ++++||||....
T Consensus 271 l~~li~~~l~~dp~~Rps~~----ell~hp~~~~~~ 302 (321)
T 2c30_A 271 LRDFLERMLVRDPQERATAQ----ELLDHPFLLQTG 302 (321)
T ss_dssp HHHHHHHHSCSSTTTSCCHH----HHHTSGGGGGCC
T ss_pred HHHHHHHHccCChhhCcCHH----HHhcChhhccCC
Confidence 89999999999999999987 999999997643
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=405.47 Aligned_cols=265 Identities=28% Similarity=0.449 Sum_probs=207.7
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec--
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA-- 160 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-- 160 (489)
..+|++++.||+|+||+||+|+++. +++.||||++..+. ....+|+.+|+.++|||||+++++|..
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vaiK~~~~~~-------~~~~~E~~il~~l~hpniv~l~~~~~~~~ 120 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCD-----SGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLRYFFYSSG 120 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEECCT-------TSCCHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECC-----CCcEEEEEEecccc-------hhHHHHHHHHHHcCCCCccceeeEEeccC
Confidence 3579999999999999999999986 57899999987532 123359999999999999999998843
Q ss_pred ----CceEEEEEeecCCCchHHHHHh--CCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccC-CcEEEc
Q 011302 161 ----SHYSCLVMEYCPGGDLYAARQR--QPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRED-GHIMLS 233 (489)
Q Consensus 161 ----~~~~~lV~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~-~~vkl~ 233 (489)
...+++||||++ ++|.+++.. .....+++..++.|+.||+.||+|||++|||||||||+||||+.+ +.+||+
T Consensus 121 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~ 199 (420)
T 1j1b_A 121 EKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLC 199 (420)
T ss_dssp TTTTEEEEEEEEECCC-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEEC
T ss_pred CCCcceeEEeehhccc-ccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEec
Confidence 235789999996 567665543 223679999999999999999999999999999999999999965 678999
Q ss_pred ccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccC
Q 011302 234 DFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLD 313 (489)
Q Consensus 234 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (489)
|||+|+.+..
T Consensus 200 DFG~a~~~~~---------------------------------------------------------------------- 209 (420)
T 1j1b_A 200 DFGSAKQLVR---------------------------------------------------------------------- 209 (420)
T ss_dssp CCTTCEECCT----------------------------------------------------------------------
T ss_pred cchhhhhccc----------------------------------------------------------------------
Confidence 9999843211
Q ss_pred CccccccccccCCccccCCCCccCcchhcCC-CCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcC--------
Q 011302 314 DPEVVAEPINARSKSFVGTHEYLAPEVISGQ-GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK-------- 384 (489)
Q Consensus 314 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-------- 384 (489)
.......+||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+.+.++...
T Consensus 210 ---------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 210 ---------GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280 (420)
T ss_dssp ---------TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred ---------CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 0012335799999999999875 6899999999999999999999999998877766665431
Q ss_pred ---------CCCCCCCCCCCchh-H--HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccc
Q 011302 385 ---------PLTFPRIGVSSSKE-F--EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWAL 443 (489)
Q Consensus 385 ---------~~~~p~~~~~~~~~-~--~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~ 443 (489)
.+.+|......-.. + ....++.+||.+||+.||.+||++. ++++||||+.+.+..
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~----e~l~hp~f~~~~~~~ 347 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL----EACAHSFFDELRDPN 347 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHH----HHHTSGGGGGGGCTT
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHH----HHhCCHhhccccccc
Confidence 12222211110000 0 1124689999999999999999997 999999998876654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=394.96 Aligned_cols=274 Identities=27% Similarity=0.339 Sum_probs=213.0
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHH--HHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAI--RKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
.++|++++.||+|+||.||+|++.. +++.||||++....... ......+.+|+.+++.++||||+++++++.+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKN-----TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH 83 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSS-----CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred hcccEEEeEEeecCCEEEEEEEECC-----CCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee
Confidence 4789999999999999999999876 57889999997643321 2234567789999999999999999999999
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~ 240 (489)
.+..|+||||++ ++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus 84 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 84 KSNISLVFDFME-TDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp TTCCEEEEECCS-EEHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred CCceEEEEEcCC-CCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 999999999996 5888887654 35799999999999999999999999999999999999999999999999999843
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
+...
T Consensus 162 ~~~~---------------------------------------------------------------------------- 165 (346)
T 1ua2_A 162 FGSP---------------------------------------------------------------------------- 165 (346)
T ss_dssp TTSC----------------------------------------------------------------------------
T ss_pred ccCC----------------------------------------------------------------------------
Confidence 2110
Q ss_pred ccccCCccccCCCCccCcchhcCC-CCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCC-----CCCCCCCCC
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQ-GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP-----LTFPRIGVS 394 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-----~~~p~~~~~ 394 (489)
.......+||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+..+.+.++.... ..++.....
T Consensus 166 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 243 (346)
T 1ua2_A 166 --NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 243 (346)
T ss_dssp --CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred --cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccC
Confidence 0112334799999999999765 48999999999999999999999999998887777765421 111110000
Q ss_pred ----------Cch---h-HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccccc
Q 011302 395 ----------SSK---E-FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIR 445 (489)
Q Consensus 395 ----------~~~---~-~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~~ 445 (489)
... . ......+.+||.+||+.||++||++. ++++||||+...|....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~----ell~h~~f~~~~~~~~~ 304 (346)
T 1ua2_A 244 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITAT----QALKMKYFSNRPGPTPG 304 (346)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHH----HHHTSGGGTSSSCCCCS
T ss_pred cccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHH----HHhcChhhhcCCCCCCc
Confidence 000 0 01124689999999999999999997 99999999987776543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=384.39 Aligned_cols=257 Identities=32% Similarity=0.529 Sum_probs=219.0
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
++|++.+.||+|+||.||+|.++. ++..||+|++...... ....+.+|+.+++.++||||+++++++.+.+.
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~a~k~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKG-----TRIRRAAKKIPKYFVE---DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTD 80 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEGGGCS---CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCC-----CCcEEEEEeehhhccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCe
Confidence 579999999999999999999887 5678999999764322 23456779999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEe---ccCCcEEEcccCCCcc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLV---REDGHIMLSDFDLSFK 240 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl---~~~~~vkl~DFG~a~~ 240 (489)
.|+||||++|++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~ 158 (277)
T 3f3z_A 81 IYLVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 158 (277)
T ss_dssp EEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence 99999999999999988765 569999999999999999999999999999999999999 7889999999999843
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
+..
T Consensus 159 ~~~----------------------------------------------------------------------------- 161 (277)
T 3f3z_A 159 FKP----------------------------------------------------------------------------- 161 (277)
T ss_dssp CCT-----------------------------------------------------------------------------
T ss_pred ccC-----------------------------------------------------------------------------
Confidence 221
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHH
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFE 400 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 400 (489)
........||+.|+|||++.+. ++.++|||||||++|||++|..||.+.+..+....+..+...+|..... .
T Consensus 162 --~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----~ 233 (277)
T 3f3z_A 162 --GKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWL-----N 233 (277)
T ss_dssp --TSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHT-----T
T ss_pred --ccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhh-----c
Confidence 0011234699999999999775 8999999999999999999999999999888888888776655532111 1
Q ss_pred HHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 401 EVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 401 ~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
....+.+||.+||+.||++||++. ++++||||+..
T Consensus 234 ~~~~~~~li~~~l~~dp~~R~s~~----~~l~h~~~~~~ 268 (277)
T 3f3z_A 234 VSPQAESLIRRLLTKSPKQRITSL----QALEHEWFEKQ 268 (277)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHH----HHTTSHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCcCHH----HHhcCHHHhcc
Confidence 123589999999999999999987 99999999753
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-50 Score=394.23 Aligned_cols=269 Identities=28% Similarity=0.419 Sum_probs=207.7
Q ss_pred CCceee-eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccceeecC
Q 011302 84 DHFRLL-RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAEFEAS 161 (489)
Q Consensus 84 ~~y~~~-~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~ 161 (489)
+.|++. +.||+|+||+||+|++.. +++.||||++..... .....+.+|+.++..+ +||||+++++++.++
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~ 83 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLI-----TSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFFEEE 83 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSS-----SCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred eeEEecCceecCCceEEEEEEEEcC-----CCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence 679885 789999999999999876 578999999975421 1234566799999884 799999999999999
Q ss_pred ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCc---EEEcccCCC
Q 011302 162 HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGH---IMLSDFDLS 238 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~---vkl~DFG~a 238 (489)
+.+|+||||++||+|.+++... ..+++.+++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~ 161 (316)
T 2ac3_A 84 DRFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLG 161 (316)
T ss_dssp TEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCC
T ss_pred CEEEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCc
Confidence 9999999999999999998875 56999999999999999999999999999999999999998776 999999998
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
..........
T Consensus 162 ~~~~~~~~~~---------------------------------------------------------------------- 171 (316)
T 2ac3_A 162 SGIKLNGDCS---------------------------------------------------------------------- 171 (316)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred cccccCCccc----------------------------------------------------------------------
Confidence 4332100000
Q ss_pred ccccccCCccccCCCCccCcchhcC-----CCCCCcccHHHHHHHHHHHhhCCCCCCCCCc---------------HHHH
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISG-----QGHGSAVDWWTLGVFLYEMLYGTTPFKGENN---------------EKTL 378 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---------------~~~~ 378 (489)
..........+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+... ...+
T Consensus 172 -~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 250 (316)
T 2ac3_A 172 -PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF 250 (316)
T ss_dssp -----------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHH
T ss_pred -cccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHH
Confidence 000011223479999999999975 4578999999999999999999999987642 3345
Q ss_pred HHHhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcc
Q 011302 379 INILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWA 442 (489)
Q Consensus 379 ~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~ 442 (489)
..+......+|..... .....+++||.+||+.||.+||++. ++++||||++..++
T Consensus 251 ~~i~~~~~~~~~~~~~-----~~~~~~~~li~~~L~~dP~~Rps~~----e~l~hp~~~~~~~~ 305 (316)
T 2ac3_A 251 ESIQEGKYEFPDKDWA-----HISCAAKDLISKLLVRDAKQRLSAA----QVLQHPWVQGCAPE 305 (316)
T ss_dssp HHHHHCCCCCCHHHHT-----TSCHHHHHHHHHHSCSSTTTSCCHH----HHHHSTTCC-----
T ss_pred HHHhccCcccCchhcc-----cCCHHHHHHHHHHhhCChhhCCCHH----HHhcChhhcCCCCc
Confidence 5666665555432111 1123589999999999999999987 99999999987664
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=397.24 Aligned_cols=273 Identities=26% Similarity=0.330 Sum_probs=213.6
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec--
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA-- 160 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-- 160 (489)
.++|++++.||+|+||+||+|+++. +++.||||++...... ......+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 89 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRK-----TGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKA 89 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETT-----TCCEEEEEECCCSSCS-SSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-
T ss_pred ccceeEEEEEecCCCcEEEEEEECC-----CCCEEEEEEEeccccc-ccchHHHHHHHHHHHhccCCCcccHhheeeccc
Confidence 4789999999999999999999986 5789999998644211 1123345679999999999999999999976
Q ss_pred ------CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcc
Q 011302 161 ------SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSD 234 (489)
Q Consensus 161 ------~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~D 234 (489)
.+.+|+||||++ |+|.+.+.... ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 90 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~D 167 (351)
T 3mi9_A 90 SPYNRCKGSIYLVFDFCE-HDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLAD 167 (351)
T ss_dssp -------CEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECC
T ss_pred cccccCCceEEEEEeccC-CCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEcc
Confidence 457899999995 58877776543 5699999999999999999999999999999999999999999999999
Q ss_pred cCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCC
Q 011302 235 FDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDD 314 (489)
Q Consensus 235 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (489)
||+|+.+......
T Consensus 168 fg~a~~~~~~~~~------------------------------------------------------------------- 180 (351)
T 3mi9_A 168 FGLARAFSLAKNS------------------------------------------------------------------- 180 (351)
T ss_dssp CTTCEECCCCSSS-------------------------------------------------------------------
T ss_pred chhcccccccccc-------------------------------------------------------------------
Confidence 9998543211000
Q ss_pred ccccccccccCCccccCCCCccCcchhcCC-CCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCC
Q 011302 315 PEVVAEPINARSKSFVGTHEYLAPEVISGQ-GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGV 393 (489)
Q Consensus 315 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~ 393 (489)
........+||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+....+..+......++....
T Consensus 181 -------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 253 (351)
T 3mi9_A 181 -------QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 253 (351)
T ss_dssp -------SCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred -------cccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence 01122345799999999999874 5799999999999999999999999998887776666542111111111
Q ss_pred CCchh-----------------------HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCc
Q 011302 394 SSSKE-----------------------FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINW 441 (489)
Q Consensus 394 ~~~~~-----------------------~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~ 441 (489)
..... +.....+.+||.+||+.||++||++. ++++||||+...+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~----e~l~hp~f~~~~~ 320 (351)
T 3mi9_A 254 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD----DALNHDFFWSDPM 320 (351)
T ss_dssp TTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHH----HHHTSGGGGSSSC
T ss_pred cccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHH----HHhCCCCcCCCCC
Confidence 11000 01134588999999999999999987 9999999987544
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=407.56 Aligned_cols=263 Identities=26% Similarity=0.406 Sum_probs=212.4
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC------CCCCccccc
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML------DHPFLPTLY 155 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l------~hpnIv~l~ 155 (489)
...+|++++.||+|+||+||+|.+.. +++.||||++..+.. ....+.+|+.+++.+ +|+||++++
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~-----~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~ 165 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHK-----VHQHVALKMVRNEKR----FHRQAAEEIRILEHLRKQDKDNTMNVIHML 165 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETT-----TTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHTTCTTSCSCBCCEE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECC-----CCcEEEEEEECCccc----hHHHHHHHHHHHHHHhhccccCCcCEEEEE
Confidence 34689999999999999999999887 578999999976532 223455577777766 678999999
Q ss_pred ceeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCc--EEEc
Q 011302 156 AEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGH--IMLS 233 (489)
Q Consensus 156 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~--vkl~ 233 (489)
+++...+.+|+||||+ +++|.+++.......+++..++.|+.||+.||+|||++|||||||||+||||+.++. +||+
T Consensus 166 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~ 244 (429)
T 3kvw_A 166 ENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVI 244 (429)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEEC
T ss_pred eecccCCeEEEEEecc-CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEe
Confidence 9999999999999999 579999998876667999999999999999999999999999999999999999987 9999
Q ss_pred ccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccC
Q 011302 234 DFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLD 313 (489)
Q Consensus 234 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (489)
|||+|....
T Consensus 245 DFG~a~~~~----------------------------------------------------------------------- 253 (429)
T 3kvw_A 245 DFGSSCYEH----------------------------------------------------------------------- 253 (429)
T ss_dssp CCTTCEETT-----------------------------------------------------------------------
T ss_pred ecccceecC-----------------------------------------------------------------------
Confidence 999973211
Q ss_pred CccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCC------
Q 011302 314 DPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLT------ 387 (489)
Q Consensus 314 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~------ 387 (489)
......+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+.+..+......
T Consensus 254 ----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~ 323 (429)
T 3kvw_A 254 ----------QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL 323 (429)
T ss_dssp ----------CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ----------CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 1123457999999999999999999999999999999999999999999887776665431000
Q ss_pred --------------CCCC------------------------CCCCchhHH------HHhhHHHHHHHHhhcCcccccCC
Q 011302 388 --------------FPRI------------------------GVSSSKEFE------EVVKLQDLISKLLVKNPKKRIGS 423 (489)
Q Consensus 388 --------------~p~~------------------------~~~~~~~~~------~~~~l~~li~~~L~~dP~~R~~~ 423 (489)
+|.. .......+. ....+.+||.+||++||++||++
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta 403 (429)
T 3kvw_A 324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP 403 (429)
T ss_dssp HTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence 0000 000000110 12458899999999999999999
Q ss_pred CCChHHHHcCCCcCCC
Q 011302 424 LKGSVEIKRHEFFKGI 439 (489)
Q Consensus 424 ~~~~~~ll~hp~f~~~ 439 (489)
. |+|+||||+..
T Consensus 404 ~----e~L~Hpw~~~~ 415 (429)
T 3kvw_A 404 G----QALRHPWLRRR 415 (429)
T ss_dssp H----HHHTSTTTC--
T ss_pred H----HHhCChhhccC
Confidence 7 99999999874
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=397.09 Aligned_cols=259 Identities=29% Similarity=0.474 Sum_probs=218.0
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHH-----HHHHHHHHHHHHHHHHHHhC-CCCCcccccce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREA-----LAIRKKLHRADMEKVILTML-DHPFLPTLYAE 157 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~ 157 (489)
++|.+.+.||+|+||.||+|+++. +++.||||++.... .........+.+|+.+++.+ +||||++++++
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRA-----TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhcccceEEecCCCEEEEEEEECC-----CCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 679999999999999999999976 57899999986432 22234456678899999998 79999999999
Q ss_pred eecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCC
Q 011302 158 FEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237 (489)
Q Consensus 158 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~ 237 (489)
+......|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~ 246 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGF 246 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCc
Confidence 99999999999999999999998765 5699999999999999999999999999999999999999999999999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
+..+..
T Consensus 247 ~~~~~~-------------------------------------------------------------------------- 252 (365)
T 2y7j_A 247 SCHLEP-------------------------------------------------------------------------- 252 (365)
T ss_dssp CEECCT--------------------------------------------------------------------------
T ss_pred ccccCC--------------------------------------------------------------------------
Confidence 743221
Q ss_pred cccccccCCccccCCCCccCcchhcC------CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCC
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVISG------QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRI 391 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~ 391 (489)
.......+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+....+..+..+...++..
T Consensus 253 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 327 (365)
T 2y7j_A 253 -----GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSP 327 (365)
T ss_dssp -----TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHH
T ss_pred -----CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence 011233579999999999863 357889999999999999999999999988888877777765544321
Q ss_pred CCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcC
Q 011302 392 GVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437 (489)
Q Consensus 392 ~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~ 437 (489)
... .....+.+||.+||+.||++||++. ++++||||+
T Consensus 328 ~~~-----~~~~~~~~li~~~L~~dP~~Rps~~----ell~hp~f~ 364 (365)
T 2y7j_A 328 EWD-----DRSSTVKDLISRLLQVDPEARLTAE----QALQHPFFE 364 (365)
T ss_dssp HHS-----SSCHHHHHHHHHHSCSSTTTSCCHH----HHHHSGGGC
T ss_pred ccc-----cCCHHHHHHHHHHcCCChhHCcCHH----HHhcCcccC
Confidence 110 1123589999999999999999987 999999997
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-49 Score=397.07 Aligned_cols=264 Identities=19% Similarity=0.247 Sum_probs=214.6
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCC--CCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCccccc
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPM--VGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLY 155 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~--~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~ 155 (489)
+.+..++|++.+.||+|+||+||+|++.... ....+..||||+++.... ......+.+|+.+|+.+ +||||++++
T Consensus 76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hpnIv~~~ 153 (370)
T 2psq_A 76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLL 153 (370)
T ss_dssp TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCB--HHHHHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcC--HHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 4566789999999999999999999986422 123567899999976422 23456688899999999 899999999
Q ss_pred ceeecCceEEEEEeecCCCchHHHHHhCC--------------CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCC
Q 011302 156 AEFEASHYSCLVMEYCPGGDLYAARQRQP--------------GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPEN 221 (489)
Q Consensus 156 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~N 221 (489)
+++.+.+.+|+||||++||+|.+++.... ...+++.++..++.||+.||+|||++|||||||||+|
T Consensus 154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 233 (370)
T 2psq_A 154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 233 (370)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence 99999999999999999999999998653 2358899999999999999999999999999999999
Q ss_pred eEeccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccc
Q 011302 222 VLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQ 301 (489)
Q Consensus 222 ILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (489)
|||+.+|.+||+|||+++.+.....
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~------------------------------------------------------- 258 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDY------------------------------------------------------- 258 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCT-------------------------------------------------------
T ss_pred EEECCCCCEEEccccCCcccCcccc-------------------------------------------------------
Confidence 9999999999999999853321000
Q ss_pred cCCCCCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHH
Q 011302 302 VDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLIN 380 (489)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~ 380 (489)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+.+..
T Consensus 259 ---------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~ 317 (370)
T 2psq_A 259 ---------------------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 317 (370)
T ss_dssp ---------------------TCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred ---------------------eecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 011223367899999999999999999999999999999999 9999999888777776
Q ss_pred HhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHc
Q 011302 381 ILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKR 432 (489)
Q Consensus 381 i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~ 432 (489)
+..+.... ...... .++.+||.+||+.||++||++. ++++
T Consensus 318 ~~~~~~~~--~~~~~~------~~l~~li~~~l~~dP~~Rpt~~----ell~ 357 (370)
T 2psq_A 318 LKEGHRMD--KPANCT------NELYMMMRDCWHAVPSQRPTFK----QLVE 357 (370)
T ss_dssp HHTTCCCC--CCTTSC------HHHHHHHHHHTCSSGGGSCCHH----HHHH
T ss_pred HhcCCCCC--CCCCCC------HHHHHHHHHHcCCChhhCcCHH----HHHH
Confidence 66543211 111111 2589999999999999999987 5554
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=379.43 Aligned_cols=257 Identities=21% Similarity=0.354 Sum_probs=209.2
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec--
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA-- 160 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-- 160 (489)
...|++.+.||+|+||.||+|.+.. ++..||+|++...... ......+.+|+.+++.++||||+++++++..
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~va~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTE-----TTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 98 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred ceeEEeeeeccCCCCeEEEEeEecC-----CceEEEEEEecchhhC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc
Confidence 3458999999999999999999887 5788999999764432 2335667789999999999999999998864
Q ss_pred --CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCC--CeeecCCCCCeEec-cCCcEEEccc
Q 011302 161 --SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMG--IVYRDLKPENVLVR-EDGHIMLSDF 235 (489)
Q Consensus 161 --~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDIKp~NILl~-~~~~vkl~DF 235 (489)
...+|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+||
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Df 176 (290)
T 1t4h_A 99 KGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL 176 (290)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred CCCceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeC
Confidence 46799999999999999999875 56999999999999999999999999 99999999999998 7899999999
Q ss_pred CCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCc
Q 011302 236 DLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDP 315 (489)
Q Consensus 236 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (489)
|++.....
T Consensus 177 g~~~~~~~------------------------------------------------------------------------ 184 (290)
T 1t4h_A 177 GLATLKRA------------------------------------------------------------------------ 184 (290)
T ss_dssp TGGGGCCT------------------------------------------------------------------------
T ss_pred CCcccccc------------------------------------------------------------------------
Confidence 99732110
Q ss_pred cccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCC
Q 011302 316 EVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSS 395 (489)
Q Consensus 316 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 395 (489)
.......||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.................+......
T Consensus 185 --------~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (290)
T 1t4h_A 185 --------SFAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA 255 (290)
T ss_dssp --------TSBEESCSSCCCCCGGGGGTC-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCC
T ss_pred --------cccccccCCcCcCCHHHHhcc-CCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCC
Confidence 011234699999999988754 89999999999999999999999988666554444433322211111111
Q ss_pred chhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 396 SKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 396 ~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
...+.+||.+||+.||.+||++. ++++||||++
T Consensus 256 ------~~~l~~li~~~l~~dp~~Rps~~----ell~h~~f~~ 288 (290)
T 1t4h_A 256 ------IPEVKEIIEGCIRQNKDERYSIK----DLLNHAFFQE 288 (290)
T ss_dssp ------CHHHHHHHHHHSCSSGGGSCCHH----HHHTSGGGC-
T ss_pred ------CHHHHHHHHHHccCChhhCCCHH----HHhhCccccc
Confidence 12589999999999999999987 9999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=408.34 Aligned_cols=265 Identities=32% Similarity=0.475 Sum_probs=206.1
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHH-----HHHHHHHHHHHHHHHHhCCCCCcccccce
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALA-----IRKKLHRADMEKVILTMLDHPFLPTLYAE 157 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~l~~~ 157 (489)
.++|.+.+.||+|+||+||+|.++. +++.||||++.+.... .......+.+|+.+|+.++||||++++++
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~ 208 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERK-----TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF 208 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETT-----TCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEE
T ss_pred hccEEEEeEEeeCCCeEEEEEEECC-----CCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 3789999999999999999999987 5789999999865321 22333457789999999999999999999
Q ss_pred eecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccC---CcEEEcc
Q 011302 158 FEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRED---GHIMLSD 234 (489)
Q Consensus 158 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~---~~vkl~D 234 (489)
+.. +..|+||||+++|+|.+++... ..+++.+++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|
T Consensus 209 ~~~-~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 209 FDA-EDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp EES-SEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred Eec-CceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEee
Confidence 865 4589999999999999887654 679999999999999999999999999999999999999754 4599999
Q ss_pred cCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCC
Q 011302 235 FDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDD 314 (489)
Q Consensus 235 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (489)
||+|+.+..
T Consensus 286 FG~a~~~~~----------------------------------------------------------------------- 294 (419)
T 3i6u_A 286 FGHSKILGE----------------------------------------------------------------------- 294 (419)
T ss_dssp SSTTTSCC------------------------------------------------------------------------
T ss_pred cccceecCC-----------------------------------------------------------------------
Confidence 999843211
Q ss_pred ccccccccccCCccccCCCCccCcchhcC---CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcH-HHHHHHhcCCCCCCC
Q 011302 315 PEVVAEPINARSKSFVGTHEYLAPEVISG---QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNE-KTLINILKKPLTFPR 390 (489)
Q Consensus 315 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~---~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~p~ 390 (489)
.......+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.... .....+..+...++.
T Consensus 295 --------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~ 366 (419)
T 3i6u_A 295 --------TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 366 (419)
T ss_dssp ------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCH
T ss_pred --------CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCc
Confidence 011234579999999999864 55788999999999999999999999876543 333444444433321
Q ss_pred CCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccc
Q 011302 391 IGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWAL 443 (489)
Q Consensus 391 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~ 443 (489)
.... .....+.+||.+||+.||++||++. ++++||||++.+|..
T Consensus 367 ~~~~-----~~~~~~~~li~~~L~~dP~~Rps~~----e~l~hp~~~~~~~~~ 410 (419)
T 3i6u_A 367 EVWA-----EVSEKALDLVKKLLVVDPKARFTTE----EALRHPWLQDEDMKR 410 (419)
T ss_dssp HHHT-----TSCHHHHHHHHHHSCSSTTTSCCHH----HHHHSGGGCCHHHHH
T ss_pred hhhc-----ccCHHHHHHHHHHccCChhHCcCHH----HHhCCcccCChhHHH
Confidence 1000 1123589999999999999999987 999999999887753
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=397.51 Aligned_cols=265 Identities=26% Similarity=0.348 Sum_probs=199.3
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC--
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS-- 161 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-- 161 (489)
++|++++.||+|+||.||+|.+.. +++.||||++...... .....++.+|+.+|+.++||||+++++++...
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 102 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTK-----TGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 102 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETT-----TTEEEEEEECSSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred CceEEeeEEeecCCeEEEEEEECC-----CCCEEEEEEeCccccC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCc
Confidence 789999999999999999999876 5789999998653211 23345677899999999999999999998654
Q ss_pred ----ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCC
Q 011302 162 ----HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237 (489)
Q Consensus 162 ----~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~ 237 (489)
..+|+||||+ +++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 103 LEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp GGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---
T ss_pred cccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 5689999999 8999988865 4699999999999999999999999999999999999999999999999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
++....
T Consensus 179 a~~~~~-------------------------------------------------------------------------- 184 (367)
T 2fst_X 179 ARHTAD-------------------------------------------------------------------------- 184 (367)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cccccc--------------------------------------------------------------------------
Confidence 832110
Q ss_pred cccccccCCccccCCCCccCcchhcC-CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCC---------
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLT--------- 387 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--------- 387 (489)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..|......
T Consensus 185 -------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 257 (367)
T 2fst_X 185 -------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257 (367)
T ss_dssp -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred -------cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 1123479999999999987 66899999999999999999999999999887776666431000
Q ss_pred -----------CCCCCCCCchh--HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccc
Q 011302 388 -----------FPRIGVSSSKE--FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWAL 443 (489)
Q Consensus 388 -----------~p~~~~~~~~~--~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~ 443 (489)
.+......... ......+.+||.+||+.||.+||++. ++|+||||+.+....
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~----e~L~hp~~~~~~~~~ 322 (367)
T 2fst_X 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA----QALAHAYFAQYHDPD 322 (367)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHH----HHHTSGGGTTTCCGG
T ss_pred hhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHH----HHhcChhhhhccCCC
Confidence 00000000000 01124589999999999999999997 999999999876543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-49 Score=385.89 Aligned_cols=257 Identities=30% Similarity=0.460 Sum_probs=218.0
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
++|.+.+.||+|+||.||+|++.. +++.||+|++...... ....+.+|+.+++.++||||+++++++.+.+.
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRL-----TGKLFALKCIKKSPAF---RDSSLENEIAVLKKIKHENIVTLEDIYESTTH 80 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccceeeeeccCCCCceEEEEEECC-----CCCEEEEEEEeccccc---chHHHHHHHHHHHhCCCCCeeehhhhcccCCE
Confidence 689999999999999999999886 5788999999764322 22456679999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEe---ccCCcEEEcccCCCcc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLV---REDGHIMLSDFDLSFK 240 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl---~~~~~vkl~DFG~a~~ 240 (489)
+|+||||++||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~ 158 (304)
T 2jam_A 81 YYLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158 (304)
T ss_dssp EEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred EEEEEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence 99999999999999988765 569999999999999999999999999999999999999 7789999999999732
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
...
T Consensus 159 ~~~----------------------------------------------------------------------------- 161 (304)
T 2jam_A 159 EQN----------------------------------------------------------------------------- 161 (304)
T ss_dssp CCC-----------------------------------------------------------------------------
T ss_pred cCC-----------------------------------------------------------------------------
Confidence 110
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHH
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFE 400 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 400 (489)
......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+..+...++.......
T Consensus 162 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~---- 234 (304)
T 2jam_A 162 ---GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDI---- 234 (304)
T ss_dssp ---BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTS----
T ss_pred ---CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccC----
Confidence 0112336899999999999999999999999999999999999999999888888888877655543322111
Q ss_pred HHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 401 EVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 401 ~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
+..+.+||.+||..||++||++. ++++||||++.
T Consensus 235 -~~~~~~li~~~l~~dp~~Rps~~----~~l~h~~~~~~ 268 (304)
T 2jam_A 235 -SESAKDFICHLLEKDPNERYTCE----KALSHPWIDGN 268 (304)
T ss_dssp -CHHHHHHHHHHHCSSTTTSCCHH----HHHTSHHHHSS
T ss_pred -CHHHHHHHHHHcCCChhHCcCHH----HHhcCccccCC
Confidence 23589999999999999999997 99999999764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-50 Score=397.73 Aligned_cols=262 Identities=27% Similarity=0.446 Sum_probs=212.0
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHH-----HHHHHHHHHHHHHHhCCCCCccccccee
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIR-----KKLHRADMEKVILTMLDHPFLPTLYAEF 158 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 158 (489)
++|++++.||+|+||+||+|+++. +++.||||++........ .....+.+|+.+|+.++||||++++++|
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 98 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKE-----KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF 98 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETT-----TTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE
T ss_pred cceEEEeEEEecCCEEEEEEEECC-----CCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 689999999999999999999887 578999999986532111 1234566799999999999999999999
Q ss_pred ecCceEEEEEeecCCC-chHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCC
Q 011302 159 EASHYSCLVMEYCPGG-DLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg-~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~ 237 (489)
.+.+.+|+||||+.+| +|.+++... ..+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~~~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 99 ENQGFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp ECSSEEEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred eeCCEEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeeccc
Confidence 9999999999999776 999998875 5699999999999999999999999999999999999999999999999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
++....
T Consensus 177 a~~~~~-------------------------------------------------------------------------- 182 (335)
T 3dls_A 177 AAYLER-------------------------------------------------------------------------- 182 (335)
T ss_dssp CEECCT--------------------------------------------------------------------------
T ss_pred ceECCC--------------------------------------------------------------------------
Confidence 843211
Q ss_pred cccccccCCccccCCCCccCcchhcCCCC-CCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCc
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVISGQGH-GSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSS 396 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 396 (489)
.......+||+.|+|||++.+..+ +.++|||||||++|||++|..||..... ........|.. .
T Consensus 183 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~~~~~---~- 247 (335)
T 3dls_A 183 -----GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAIHPPYL---V- 247 (335)
T ss_dssp -----TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCCCCSSC---C-
T ss_pred -----CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhccCCCcc---c-
Confidence 011233579999999999998887 8899999999999999999999976332 22222222211 1
Q ss_pred hhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC------CCccccccCCCC
Q 011302 397 KEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG------INWALIRSIKPP 450 (489)
Q Consensus 397 ~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~------~~~~~~~~~~~p 450 (489)
...+.+||.+||+.||++||++. ++++||||+. ++|+.+.....|
T Consensus 248 -----~~~l~~li~~~L~~dP~~Rps~~----ell~hp~~~~~~~~~~~~~~~~~~~~~~ 298 (335)
T 3dls_A 248 -----SKELMSLVSGLLQPVPERRTTLE----KLVTDPWVTQPVNLADYTWEEVFRVNKP 298 (335)
T ss_dssp -----CHHHHHHHHHHTCSSGGGSCCHH----HHHHCTTTTCCCCGGGCCHHHHC-----
T ss_pred -----CHHHHHHHHHHccCChhhCcCHH----HHhcCccccCCccccccCHHHHhhhcCC
Confidence 12589999999999999999987 9999999965 466665554444
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-49 Score=392.34 Aligned_cols=256 Identities=27% Similarity=0.348 Sum_probs=213.8
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
+.|.+++.||+|+||+||+|++.. +++.||||++.............+.+|+.+|+.++||||+++++++.+++.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 128 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVR-----NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT 128 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred hheeeeeEEccCCCEEEEEEEEcc-----CCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCe
Confidence 569999999999999999999876 578999999975432233445677889999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
.|+||||+. |+|.+++.... ..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 129 ~~lv~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~- 205 (348)
T 1u5q_A 129 AWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA- 205 (348)
T ss_dssp EEEEEECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS-
T ss_pred EEEEEecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecC-
Confidence 999999996 68888775432 579999999999999999999999999999999999999999999999999973221
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
T Consensus 206 -------------------------------------------------------------------------------- 205 (348)
T 1u5q_A 206 -------------------------------------------------------------------------------- 205 (348)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCccccCCCCccCcchhc---CCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHH
Q 011302 324 ARSKSFVGTHEYLAPEVIS---GQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFE 400 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~---~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 400 (489)
.....+||+.|+|||++. +..++.++|||||||++|||++|..||.+.+....+..+........... ..
T Consensus 206 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~----- 278 (348)
T 1u5q_A 206 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSG-HW----- 278 (348)
T ss_dssp -SBCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCT-TS-----
T ss_pred -CCCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC-CC-----
Confidence 012347999999999985 45689999999999999999999999999888777776665432211111 11
Q ss_pred HHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 401 EVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 401 ~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
...+.+||.+||+.||++||++. ++++||||...
T Consensus 279 -~~~l~~li~~~l~~dP~~Rps~~----~ll~h~~~~~~ 312 (348)
T 1u5q_A 279 -SEYFRNFVDSCLQKIPQDRPTSE----VLLKHRFVLRE 312 (348)
T ss_dssp -CHHHHHHHHHHTCSSGGGSCCHH----HHTTCHHHHSC
T ss_pred -CHHHHHHHHHHcccChhhCcCHH----HHhhChhhhcc
Confidence 12489999999999999999987 99999999654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=396.02 Aligned_cols=270 Identities=26% Similarity=0.393 Sum_probs=219.6
Q ss_pred HhhcCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccc
Q 011302 75 RRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTL 154 (489)
Q Consensus 75 ~~~~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l 154 (489)
....+.+..++|++++.||+|+||.||+|++.. +++.||+|++..+.. ......+.+|+.+++.++||||+++
T Consensus 24 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~va~K~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~ 96 (360)
T 3eqc_A 24 KQKVGELKDDDFEKISELGAGNGGVVFKVSHKP-----SGLVMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGF 96 (360)
T ss_dssp HHTCCCCCGGGEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEECCCC--HHHHHHHHHHHGGGGGCCCTTBCCE
T ss_pred hhcccccccccceeeeeecCCCCeEEEEEEECC-----CCcEEEEEEeccccC--HHHHHHHHHHHHHHHHCCCCCEEEE
Confidence 344556778999999999999999999999886 578999999975421 2334567789999999999999999
Q ss_pred cceeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhC-CCeeecCCCCCeEeccCCcEEEc
Q 011302 155 YAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMM-GIVYRDLKPENVLVREDGHIMLS 233 (489)
Q Consensus 155 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~iiHrDIKp~NILl~~~~~vkl~ 233 (489)
++++.+++.+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~ 174 (360)
T 3eqc_A 97 YGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLC 174 (360)
T ss_dssp EEEEEETTEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEEECCEEEEEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEE
Confidence 99999999999999999999999999875 5699999999999999999999996 99999999999999999999999
Q ss_pred ccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccC
Q 011302 234 DFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLD 313 (489)
Q Consensus 234 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (489)
|||++.....
T Consensus 175 Dfg~~~~~~~---------------------------------------------------------------------- 184 (360)
T 3eqc_A 175 DFGVSGQLID---------------------------------------------------------------------- 184 (360)
T ss_dssp CCCCCHHHHH----------------------------------------------------------------------
T ss_pred ECCCCccccc----------------------------------------------------------------------
Confidence 9999732210
Q ss_pred CccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHh-----------
Q 011302 314 DPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINIL----------- 382 (489)
Q Consensus 314 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~----------- 382 (489)
......+||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+.
T Consensus 185 ----------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 254 (360)
T 3eqc_A 185 ----------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 254 (360)
T ss_dssp ----------HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------
T ss_pred ----------ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCC
Confidence 01223479999999999999999999999999999999999999998876544322211
Q ss_pred -------------------------------cCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHH
Q 011302 383 -------------------------------KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIK 431 (489)
Q Consensus 383 -------------------------------~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll 431 (489)
.... +..... ....++.+||.+||+.||++||++. +++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~-----~~~~~~~~li~~~L~~dP~~Rpt~~----ell 323 (360)
T 3eqc_A 255 PRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP--PKLPSG-----VFSLEFQDFVNKCLIKNPAERADLK----QLM 323 (360)
T ss_dssp -------------------CCCHHHHHHHHHHSCC--CCCCTT-----TSCHHHHHHHHHHHCSSTTTSCCHH----HHH
T ss_pred CCcccCCCcccccccCCCCcccchhhhhHHhccCC--CCCCcc-----cccHHHHHHHHHHhhcChhhCCCHH----HHh
Confidence 1100 000000 0123589999999999999999987 999
Q ss_pred cCCCcCCCCcccc
Q 011302 432 RHEFFKGINWALI 444 (489)
Q Consensus 432 ~hp~f~~~~~~~~ 444 (489)
+||||+..+|+.+
T Consensus 324 ~hp~~~~~~~~~~ 336 (360)
T 3eqc_A 324 VHAFIKRSDAEEV 336 (360)
T ss_dssp TSHHHHHHHHSCC
T ss_pred hChHhhcchHhhh
Confidence 9999988777544
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-49 Score=383.98 Aligned_cols=265 Identities=22% Similarity=0.363 Sum_probs=211.8
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccccccee
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEF 158 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 158 (489)
+.+..++|++++.||+|+||.||+|++.. .++.||+|++............++.+|+.+++.++||||+++++++
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 80 (294)
T 4eqm_A 6 GKIINERYKIVDKLGGGGMSTVYLAEDTI-----LNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD 80 (294)
T ss_dssp SSCEETTEEEEEEEEEETTEEEEEEEETT-----TCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE
T ss_pred hhHhhccEEEEEEEccCCCEEEEEEEECC-----CCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee
Confidence 34556899999999999999999999886 5788999998543322234456778899999999999999999999
Q ss_pred ecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 159 EASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
.+++.+|+||||++||+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~ 158 (294)
T 4eqm_A 81 EEDDCYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIA 158 (294)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSS
T ss_pred eeCCeEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCc
Confidence 9999999999999999999998875 57999999999999999999999999999999999999999999999999998
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
+.+....
T Consensus 159 ~~~~~~~------------------------------------------------------------------------- 165 (294)
T 4eqm_A 159 KALSETS------------------------------------------------------------------------- 165 (294)
T ss_dssp TTC-----------------------------------------------------------------------------
T ss_pred ccccccc-------------------------------------------------------------------------
Confidence 4322100
Q ss_pred ccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCC-CCCCCCch
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFP-RIGVSSSK 397 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p-~~~~~~~~ 397 (489)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+......+......... .....
T Consensus 166 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--- 238 (294)
T 4eqm_A 166 ----LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRK--- 238 (294)
T ss_dssp -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCT---
T ss_pred ----ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhccc---
Confidence 0112345799999999999999999999999999999999999999999888776666555432211 00000
Q ss_pred hHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 398 EFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 398 ~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
..+..+.++|.+||+.||.+||+.. +.+.+.|.
T Consensus 239 --~~~~~l~~li~~~l~~dp~~R~~~~----~~l~~~l~ 271 (294)
T 4eqm_A 239 --DIPQSLSNVILRATEKDKANRYKTI----QEMKDDLS 271 (294)
T ss_dssp --TSCHHHHHHHHHHSCSSGGGSCSSH----HHHHHHHH
T ss_pred --CCCHHHHHHHHHHhcCCHhHccccH----HHHHHHHH
Confidence 0123589999999999999999766 44554443
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-49 Score=399.52 Aligned_cols=265 Identities=26% Similarity=0.440 Sum_probs=208.3
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee-
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE- 159 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~- 159 (489)
...++|++++.||+|+||+||+|++.. +++.||||++..+. ....+|+.+|+.++||||++++++|.
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~-----~~~~vAiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~ 71 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIE-----SGKRFALKKVLQDP-------RYKNRELDIMKVLDHVNIIKLVDYFYT 71 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETT-----TCCEEEEEEEECCT-------TSCCHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred cccceEEEEEEEEeccCEEEEEEEECC-----CCCEEEEEEEecCc-------chHHHHHHHHHHcCCCCccchhheeee
Confidence 445799999999999999999999886 57899999986542 12235999999999999999999984
Q ss_pred -------------------------------------cCceEEEEEeecCCCchHHHHHh--CCCCCCChhhHHHHHHHH
Q 011302 160 -------------------------------------ASHYSCLVMEYCPGGDLYAARQR--QPGKRFGISSAKFYAAET 200 (489)
Q Consensus 160 -------------------------------------~~~~~~lV~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi 200 (489)
+...+|+||||++ |+|.+.+.. ..+..+++..++.|+.||
T Consensus 72 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi 150 (383)
T 3eb0_A 72 TGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQL 150 (383)
T ss_dssp C-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHH
T ss_pred cCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHH
Confidence 3445899999996 688776653 234679999999999999
Q ss_pred HHHHHHHHhCCCeeecCCCCCeEec-cCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccc
Q 011302 201 LLALEYLHMMGIVYRDLKPENVLVR-EDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCF 279 (489)
Q Consensus 201 ~~~L~yLH~~~iiHrDIKp~NILl~-~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (489)
+.||+|||++||+||||||+|||++ .++.+||+|||+|+.+...
T Consensus 151 ~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~----------------------------------- 195 (383)
T 3eb0_A 151 FRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS----------------------------------- 195 (383)
T ss_dssp HHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-----------------------------------
T ss_pred HHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-----------------------------------
Confidence 9999999999999999999999998 6899999999998433210
Q ss_pred cccccccccccccccccccccccCCCCCCccccCCccccccccccCCccccCCCCccCcchhcCCC-CCCcccHHHHHHH
Q 011302 280 SSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQG-HGSAVDWWTLGVF 358 (489)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~~~~~DiwSlGvi 358 (489)
......+||+.|+|||++.+.. ++.++|||||||+
T Consensus 196 --------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 196 --------------------------------------------EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp --------------------------------------------SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred --------------------------------------------CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 1123347899999999998765 8999999999999
Q ss_pred HHHHhhCCCCCCCCCcHHHHHHHhcC-----------------CCCCCCCCCCCchh-H--HHHhhHHHHHHHHhhcCcc
Q 011302 359 LYEMLYGTTPFKGENNEKTLINILKK-----------------PLTFPRIGVSSSKE-F--EEVVKLQDLISKLLVKNPK 418 (489)
Q Consensus 359 l~elltG~~Pf~~~~~~~~~~~i~~~-----------------~~~~p~~~~~~~~~-~--~~~~~l~~li~~~L~~dP~ 418 (489)
+|||++|+.||.+.+..+.+.++... ...+|......-.. + ..+..+.+||.+||+.||+
T Consensus 232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 99999999999999888777766531 11222211110000 0 1123589999999999999
Q ss_pred cccCCCCChHHHHcCCCcCCCCc
Q 011302 419 KRIGSLKGSVEIKRHEFFKGINW 441 (489)
Q Consensus 419 ~R~~~~~~~~~ll~hp~f~~~~~ 441 (489)
+||++. ++++||||+.+.+
T Consensus 312 ~R~t~~----e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 312 LRINPY----EAMAHPFFDHLRN 330 (383)
T ss_dssp GSCCHH----HHHTSGGGHHHHH
T ss_pred hCCCHH----HHhcCHHHHHHHh
Confidence 999987 9999999987644
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=390.92 Aligned_cols=254 Identities=24% Similarity=0.322 Sum_probs=199.0
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHH-HhCCCCCcccccceeecC
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL-TMLDHPFLPTLYAEFEAS 161 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l-~~l~hpnIv~l~~~~~~~ 161 (489)
.++|+++++||+|+||+||+|+++. +++.||||++........... +...|+..+ +..+||||++++++|.++
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~-~~~~e~~~~~~~~~h~~iv~l~~~~~~~ 129 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKE-----DGRLYAVKRSMSPFRGPKDRA-RKLAEVGSHEKVGQHPCCVRLEQAWEEG 129 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT-----TSCEEEEEEESSSCCSHHHHH-HHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hhheeeeheeccCCCeEEEEEEECC-----CCeEEEEEEecccccChHHHH-HHHHHHHHHHHhcCCCcEEEEEEEEEeC
Confidence 3679999999999999999999986 578999999854322112222 223344444 445899999999999999
Q ss_pred ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccc
Q 011302 162 HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKC 241 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~ 241 (489)
+.+||||||+ +++|.+++.... ..+++..++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||++...
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 130 GILYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp TEEEEEEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred CEEEEEEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 9999999999 789988877652 56999999999999999999999999999999999999999999999999997432
Q ss_pred ccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccc
Q 011302 242 DVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEP 321 (489)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (489)
...
T Consensus 208 ~~~----------------------------------------------------------------------------- 210 (311)
T 3p1a_A 208 GTA----------------------------------------------------------------------------- 210 (311)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred ccC-----------------------------------------------------------------------------
Confidence 110
Q ss_pred cccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHH
Q 011302 322 INARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEE 401 (489)
Q Consensus 322 ~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 401 (489)
.......||+.|+|||++.+ .++.++|||||||++|||++|..||.+... ...+..+.... .... ..
T Consensus 211 --~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~-~~~~------~~ 277 (311)
T 3p1a_A 211 --GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPP-EFTA------GL 277 (311)
T ss_dssp ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCH-HHHT------TS
T ss_pred --CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCc-cccc------CC
Confidence 01123469999999999987 689999999999999999999877765432 33333322110 0000 11
Q ss_pred HhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 402 VVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 402 ~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
...+.+||.+||+.||++||++. ++++||||+.
T Consensus 278 ~~~l~~li~~~L~~dP~~Rpt~~----ell~hp~~~~ 310 (311)
T 3p1a_A 278 SSELRSVLVMMLEPDPKLRATAE----ALLALPVLRQ 310 (311)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHH----HHHTSGGGSC
T ss_pred CHHHHHHHHHHcCCChhhCcCHH----HHHhCccccC
Confidence 23589999999999999999997 9999999986
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=392.23 Aligned_cols=270 Identities=23% Similarity=0.370 Sum_probs=203.9
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.++|++++.||+|+||.||+|+++. +++.||||++..... ......+.+|+.+|+.++||||++++++|.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~-----~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 77 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKV-----DDCNYAIKRIRLPNR--ELAREKVMREVKALAKLEHPGIVRYFNAWLETP 77 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETT-----TCCEEEEEEEECCST--TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECC
T ss_pred hhcCceeeEecCCCCeEEEEEEEcC-----CCcEEEEEEeecCCc--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEec
Confidence 3689999999999999999999986 578999999974321 123456778999999999999999999985543
Q ss_pred ---------------------------------------------------------eEEEEEeecCCCchHHHHHhCCC
Q 011302 163 ---------------------------------------------------------YSCLVMEYCPGGDLYAARQRQPG 185 (489)
Q Consensus 163 ---------------------------------------------------------~~~lV~E~~~gg~L~~~l~~~~~ 185 (489)
.+|+|||||+||+|.+++.....
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 157 (332)
T 3qd2_B 78 PEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157 (332)
T ss_dssp SCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS
T ss_pred cchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC
Confidence 38999999999999999987532
Q ss_pred -CCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccC
Q 011302 186 -KRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCS 264 (489)
Q Consensus 186 -~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (489)
...++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...........
T Consensus 158 ~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~-------------- 223 (332)
T 3qd2_B 158 LEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV-------------- 223 (332)
T ss_dssp GGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------------
T ss_pred ccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccc--------------
Confidence 23445568899999999999999999999999999999999999999999998544321100000
Q ss_pred CCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCccccCCCCccCcchhcCC
Q 011302 265 IPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQ 344 (489)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~ 344 (489)
....+........+||+.|+|||++.+.
T Consensus 224 ----------------------------------------------------~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 251 (332)
T 3qd2_B 224 ----------------------------------------------------LTPMPAYATHTGQVGTKLYMSPEQIHGN 251 (332)
T ss_dssp ------------------------------------------------------------CCCSCC-CGGGSCHHHHHCC
T ss_pred ----------------------------------------------------cccccccccccccCCCcCccChHHhcCC
Confidence 0000001123445799999999999999
Q ss_pred CCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 345 GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 345 ~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
.++.++|||||||++|||++|..|+.. .......+.... +|. ........+.+||.+||+.||++||++.
T Consensus 252 ~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~--~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~ 321 (332)
T 3qd2_B 252 NYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLK--FPL------LFTQKYPQEHMMVQDMLSPSPTERPEAT 321 (332)
T ss_dssp CCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTC--CCH------HHHHHCHHHHHHHHHHHCSSGGGSCCHH
T ss_pred CCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccC--CCc------ccccCChhHHHHHHHHccCCCCcCCCHH
Confidence 999999999999999999998777532 122223333321 111 1112234578999999999999999987
Q ss_pred CChHHHHcCCCcCCC
Q 011302 425 KGSVEIKRHEFFKGI 439 (489)
Q Consensus 425 ~~~~~ll~hp~f~~~ 439 (489)
++++||||+++
T Consensus 322 ----~~l~~~~f~~~ 332 (332)
T 3qd2_B 322 ----DIIENAIFENL 332 (332)
T ss_dssp ----HHHHSTTCCCC
T ss_pred ----HHhhchhhhcC
Confidence 99999999875
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-49 Score=390.42 Aligned_cols=271 Identities=25% Similarity=0.361 Sum_probs=215.4
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS 161 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 161 (489)
..++|++++.||+|+||.||+|++.. +++.||||++...... ......+.+|+.+++.++||||+++++++.+.
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 96 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKD-----TGRIVAIKKFLESDDD-KMVKKIAMREIKLLKQLRHENLVNLLEVCKKK 96 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETT-----TCCEEEEEEEESCSSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hhhhheeeeEEeecCCEEEEEEEECC-----CCceEEEEEEecCCCc-hHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC
Confidence 45899999999999999999999886 5789999998643221 22334566799999999999999999999999
Q ss_pred ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccc
Q 011302 162 HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKC 241 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~ 241 (489)
+.+|+||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus 97 ~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 174 (331)
T 4aaa_A 97 KRWYLVFEFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL 174 (331)
T ss_dssp TEEEEEEECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred CEEEEEEecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceee
Confidence 9999999999999998876654 56999999999999999999999999999999999999999999999999998432
Q ss_pred ccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccc
Q 011302 242 DVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEP 321 (489)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (489)
...
T Consensus 175 ~~~----------------------------------------------------------------------------- 177 (331)
T 4aaa_A 175 AAP----------------------------------------------------------------------------- 177 (331)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cCC-----------------------------------------------------------------------------
Confidence 110
Q ss_pred cccCCccccCCCCccCcchhcCC-CCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcC----------------
Q 011302 322 INARSKSFVGTHEYLAPEVISGQ-GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK---------------- 384 (489)
Q Consensus 322 ~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---------------- 384 (489)
.......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+...
T Consensus 178 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 178 -GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred -ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence 0011234689999999999876 6899999999999999999999999998877666554321
Q ss_pred ---CCCCCCCCCCCchh--H-HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcc
Q 011302 385 ---PLTFPRIGVSSSKE--F-EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWA 442 (489)
Q Consensus 385 ---~~~~p~~~~~~~~~--~-~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~ 442 (489)
....+......... + .....+.+||.+||+.||++||++. ++++||||+..+|.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~----ell~hp~f~~~~~~ 316 (331)
T 4aaa_A 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCA----ELLHHDFFQMDGFA 316 (331)
T ss_dssp GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGG----GGGGSHHHHGGGHH
T ss_pred ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHH----HHhcCchhccCChh
Confidence 11112111111100 0 1124689999999999999999998 99999999886653
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=385.41 Aligned_cols=265 Identities=30% Similarity=0.483 Sum_probs=219.5
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHH---HHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIR---KKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
++|++++.||+|+||.||+|++.. +++.||+|++........ .....+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 79 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKG-----TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN 79 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhHHhhcccCceEEEEEEEcC-----CCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC
Confidence 579999999999999999999886 578999999875432110 013456779999999999999999999999
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCC----cEEEcccC
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDG----HIMLSDFD 236 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~----~vkl~DFG 236 (489)
....|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred CCeEEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 99999999999999999998764 5699999999999999999999999999999999999999877 89999999
Q ss_pred CCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcc
Q 011302 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPE 316 (489)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (489)
++......
T Consensus 158 ~~~~~~~~------------------------------------------------------------------------ 165 (283)
T 3bhy_A 158 IAHKIEAG------------------------------------------------------------------------ 165 (283)
T ss_dssp TCEECC--------------------------------------------------------------------------
T ss_pred cceeccCC------------------------------------------------------------------------
Confidence 98432110
Q ss_pred ccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCc
Q 011302 317 VVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSS 396 (489)
Q Consensus 317 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 396 (489)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+......++.....
T Consensus 166 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 236 (283)
T 3bhy_A 166 -------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFS-- 236 (283)
T ss_dssp -------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHT--
T ss_pred -------CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcc--
Confidence 01123468999999999999999999999999999999999999999998888887777655443321111
Q ss_pred hhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccc
Q 011302 397 KEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWAL 443 (489)
Q Consensus 397 ~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~ 443 (489)
.....+.+||.+||..||++||++. ++++||||+.+.+..
T Consensus 237 ---~~~~~~~~li~~~l~~dp~~Rps~~----~~l~h~~~~~~~~~~ 276 (283)
T 3bhy_A 237 ---NTSELAKDFIRRLLVKDPKRRMTIA----QSLEHSWIKAIRRRN 276 (283)
T ss_dssp ---TCCHHHHHHHHTTSCSSGGGSCCHH----HHHHCHHHHHHHHCC
T ss_pred ---cCCHHHHHHHHHHccCCHhHCcCHH----HHHhCHHHHHHHHHh
Confidence 1123589999999999999999987 999999998876643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=390.17 Aligned_cols=260 Identities=29% Similarity=0.410 Sum_probs=206.1
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCC--CCccccccee
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDH--PFLPTLYAEF 158 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~l~~~~ 158 (489)
+..++|++++.||+|+||.||+|.+. .++.||||++...... ......+.+|+.+|+.++| |||+++++++
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 78 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNE------KKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 78 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECT------TSCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeC------CCCEEEEEEeeccccc-hHHHHHHHHHHHHHHhhhhcCCceEEEeeeE
Confidence 44578999999999999999999875 3678999999754322 2344567789999999986 9999999999
Q ss_pred ecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 159 EASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
.+++.+|||||+ .+|+|.+++... ..+++.+++.|+.||+.||+|||++|||||||||+|||++ ++.+||+|||++
T Consensus 79 ~~~~~~~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a 154 (343)
T 3dbq_A 79 ITDQYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIA 154 (343)
T ss_dssp ECSSEEEEEECC-CSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSS
T ss_pred eeCCEEEEEEeC-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccc
Confidence 999999999995 589999999876 5799999999999999999999999999999999999997 788999999998
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
+.+.....
T Consensus 155 ~~~~~~~~------------------------------------------------------------------------ 162 (343)
T 3dbq_A 155 NQMQPDTT------------------------------------------------------------------------ 162 (343)
T ss_dssp CCC-----------------------------------------------------------------------------
T ss_pred cccCcccc------------------------------------------------------------------------
Confidence 54321000
Q ss_pred ccccccCCccccCCCCccCcchhcC-----------CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcH-HHHHHHhcCCC
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISG-----------QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNE-KTLINILKKPL 386 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~-----------~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~ 386 (489)
.......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.... ..+..+.....
T Consensus 163 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 238 (343)
T 3dbq_A 163 ----SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 238 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred ----cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCc
Confidence 001234579999999999975 56889999999999999999999999875443 44445544332
Q ss_pred CCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 387 TFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 387 ~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
........ . ..+.+||.+||+.||.+||++. ++++||||+.
T Consensus 239 ~~~~~~~~-~------~~l~~li~~~L~~dp~~Rpt~~----e~l~hp~~~~ 279 (343)
T 3dbq_A 239 EIEFPDIP-E------KDLQDVLKCCLKRDPKQRISIP----ELLAHPYVQI 279 (343)
T ss_dssp CCCCCCCS-C------HHHHHHHHHHTCSSTTTSCCHH----HHHTSHHHHS
T ss_pred ccCCcccC-C------HHHHHHHHHHcCCChhHCCCHH----HHHhCccccc
Confidence 22211111 1 2489999999999999999987 9999999974
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=381.13 Aligned_cols=265 Identities=28% Similarity=0.421 Sum_probs=215.1
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS 161 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 161 (489)
..++|++++.||+|+||.||+|++.. +++.||+|++..... .....+.+|+.+++.++||||+++++++.+.
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 88 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKE-----TGALAAAKVIETKSE---EELEDYIVEIEILATCDHPYIVKLLGAYYHD 88 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETT-----TCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC
T ss_pred CccceeecceeccCCCeEEEEEEEcC-----CCcEEEEEEecCCCH---HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC
Confidence 34789999999999999999999986 578899999976432 2345677799999999999999999999999
Q ss_pred ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccc
Q 011302 162 HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKC 241 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~ 241 (489)
+..|+||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 89 ~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 167 (302)
T 2j7t_A 89 GKLWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN 167 (302)
T ss_dssp -CEEEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred CeEEEEEEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence 9999999999999999887653 256999999999999999999999999999999999999999999999999986211
Q ss_pred ccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccc
Q 011302 242 DVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEP 321 (489)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (489)
...
T Consensus 168 ~~~----------------------------------------------------------------------------- 170 (302)
T 2j7t_A 168 LKT----------------------------------------------------------------------------- 170 (302)
T ss_dssp HHH-----------------------------------------------------------------------------
T ss_pred ccc-----------------------------------------------------------------------------
Confidence 000
Q ss_pred cccCCccccCCCCccCcchhc-----CCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCc
Q 011302 322 INARSKSFVGTHEYLAPEVIS-----GQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSS 396 (489)
Q Consensus 322 ~~~~~~~~~Gt~~y~aPE~l~-----~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 396 (489)
........||+.|+|||++. +..++.++|||||||++|||++|..||...+.......+............
T Consensus 171 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 246 (302)
T 2j7t_A 171 -LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPS--- 246 (302)
T ss_dssp -HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGG---
T ss_pred -ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCcc---
Confidence 00112346999999999984 667899999999999999999999999998887777776654322111111
Q ss_pred hhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccc
Q 011302 397 KEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWAL 443 (489)
Q Consensus 397 ~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~ 443 (489)
.....+.+||.+||..||++||++. ++++||||+++.|..
T Consensus 247 ---~~~~~l~~li~~~l~~dp~~Rps~~----~ll~h~~~~~~~~~~ 286 (302)
T 2j7t_A 247 ---KWSVEFRDFLKIALDKNPETRPSAA----QLLEHPFVSSITSNK 286 (302)
T ss_dssp ---GSCHHHHHHHHHHSCSCTTTSCCHH----HHTTSTTTTTCCCCH
T ss_pred ---ccCHHHHHHHHHHcccChhhCCCHH----HHhcChHHhhhccch
Confidence 1123589999999999999999987 999999999988764
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=390.74 Aligned_cols=274 Identities=25% Similarity=0.379 Sum_probs=225.8
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHH--------------HHHHHHHHHHHHhC
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKK--------------LHRADMEKVILTML 146 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~--------------~~~~~~E~~~l~~l 146 (489)
...++|++++.||+|+||.||+|++ . ++.||||++.......... ...+.+|+.+++.+
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~-~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 100 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK-D------NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI 100 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE-T------TEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc-C------CceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC
Confidence 4568999999999999999999998 2 5899999998765432111 15677899999999
Q ss_pred CCCCcccccceeecCceEEEEEeecCCCchHHH------HHhCCCCCCChhhHHHHHHHHHHHHHHHHh-CCCeeecCCC
Q 011302 147 DHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAA------RQRQPGKRFGISSAKFYAAETLLALEYLHM-MGIVYRDLKP 219 (489)
Q Consensus 147 ~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~------l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiHrDIKp 219 (489)
+||||+++++++.+.+.+|+||||++||+|.++ +.......+++..+..++.||+.||.|||+ +||+||||||
T Consensus 101 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p 180 (348)
T 2pml_X 101 KNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKP 180 (348)
T ss_dssp CCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCG
T ss_pred CCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCCh
Confidence 999999999999999999999999999999887 555435789999999999999999999999 9999999999
Q ss_pred CCeEeccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccc
Q 011302 220 ENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIR 299 (489)
Q Consensus 220 ~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (489)
+|||++.++.+||+|||++.....
T Consensus 181 ~Nil~~~~~~~kl~dfg~~~~~~~-------------------------------------------------------- 204 (348)
T 2pml_X 181 SNILMDKNGRVKLSDFGESEYMVD-------------------------------------------------------- 204 (348)
T ss_dssp GGEEECTTSCEEECCCTTCEECBT--------------------------------------------------------
T ss_pred HhEEEcCCCcEEEecccccccccc--------------------------------------------------------
Confidence 999999999999999999843211
Q ss_pred cccCCCCCCccccCCccccccccccCCccccCCCCccCcchhcCC-CCCC-cccHHHHHHHHHHHhhCCCCCCCCCc-HH
Q 011302 300 EQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQ-GHGS-AVDWWTLGVFLYEMLYGTTPFKGENN-EK 376 (489)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~-~~DiwSlGvil~elltG~~Pf~~~~~-~~ 376 (489)
.......||+.|+|||++.+. .++. ++|||||||++|||++|..||.+.+. .+
T Consensus 205 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 260 (348)
T 2pml_X 205 ------------------------KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260 (348)
T ss_dssp ------------------------TEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred ------------------------ccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 011234689999999999987 5666 99999999999999999999998877 77
Q ss_pred HHHHHhcCCCCCCCCCCCCch----------hHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccccc
Q 011302 377 TLINILKKPLTFPRIGVSSSK----------EFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIR 445 (489)
Q Consensus 377 ~~~~i~~~~~~~p~~~~~~~~----------~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~~ 445 (489)
....+......+|........ .......+.+||.+||+.||.+||++. ++++||||++.+|..+.
T Consensus 261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~----e~l~hp~f~~~~~~~~~ 335 (348)
T 2pml_X 261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSE----DALKHEWLADTNIEDLR 335 (348)
T ss_dssp HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHH----HHHTSGGGTTCCHHHHH
T ss_pred HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHH----HHhcCccccCCCHHHHH
Confidence 777777766665532110000 001123589999999999999999987 99999999999987654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-48 Score=388.74 Aligned_cols=266 Identities=24% Similarity=0.320 Sum_probs=211.0
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC--
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS-- 161 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-- 161 (489)
++|++++.||+|+||.||+|++.. +++.||||++..... ......+.+|+.+|+.++||||+++++++...
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 99 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNL-----NKVRVAIKKISPFEH--QTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 99 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECCTTC--HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred ccEEEEEEeecCCCeEEEEEEECC-----CCeEEEEEEeccccC--cHHHHHHHHHHHHHHhcCCCCCccceeEEecCCc
Confidence 689999999999999999999886 578999999974321 23345677899999999999999999998654
Q ss_pred ---ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 162 ---HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 162 ---~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
..+|+||||+. |+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 100 ~~~~~~~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 100 EQMKDVYIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred cccceEEEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcce
Confidence 47899999995 699998876 35999999999999999999999999999999999999999999999999998
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
+.......
T Consensus 176 ~~~~~~~~------------------------------------------------------------------------ 183 (364)
T 3qyz_A 176 RVADPDHD------------------------------------------------------------------------ 183 (364)
T ss_dssp EECCGGGC------------------------------------------------------------------------
T ss_pred EecCCCCC------------------------------------------------------------------------
Confidence 43321000
Q ss_pred ccccccCCccccCCCCccCcchhcC-CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCC----------
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLT---------- 387 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------- 387 (489)
........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+......
T Consensus 184 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 260 (364)
T 3qyz_A 184 ---HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260 (364)
T ss_dssp ---BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred ---ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 0011234579999999998765 44899999999999999999999999998877666665421000
Q ss_pred ----------CCCCCCCCchh--HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 388 ----------FPRIGVSSSKE--FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 388 ----------~p~~~~~~~~~--~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
.+......... .....++.+||.+||+.||++||++. ++++||||+..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~----e~l~hp~~~~~ 320 (364)
T 3qyz_A 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVE----QALAHPYLEQY 320 (364)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHH----HHHTSGGGTTT
T ss_pred hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHH----HHhcCcchhhc
Confidence 00000000000 01123589999999999999999987 99999999886
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=393.97 Aligned_cols=267 Identities=27% Similarity=0.412 Sum_probs=212.7
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-CC-----Cccc
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-HP-----FLPT 153 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp-----nIv~ 153 (489)
....++|++.+.||+|+||+||+|+++. +++.||||++.... .....+..|+.+++.+. |+ +|++
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~ 120 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRV-----EQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVH 120 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETT-----TTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCC
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcC-----CCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEE
Confidence 3456899999999999999999999886 57899999997543 22345566888888775 44 4999
Q ss_pred ccceeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHH--hCCCeeecCCCCCeEec--cCCc
Q 011302 154 LYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLH--MMGIVYRDLKPENVLVR--EDGH 229 (489)
Q Consensus 154 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH--~~~iiHrDIKp~NILl~--~~~~ 229 (489)
+++++...+.+||||||+ +|+|.+++.......+++..++.++.||+.||.||| +.|||||||||+||||+ .++.
T Consensus 121 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~ 199 (382)
T 2vx3_A 121 LKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSA 199 (382)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCC
T ss_pred eeeeeccCCceEEEEecC-CCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCc
Confidence 999999999999999999 569999998875567999999999999999999999 57999999999999995 4788
Q ss_pred EEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCc
Q 011302 230 IMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQ 309 (489)
Q Consensus 230 vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (489)
+||+|||+|+...
T Consensus 200 ~kL~DFG~a~~~~------------------------------------------------------------------- 212 (382)
T 2vx3_A 200 IKIVDFGSSCQLG------------------------------------------------------------------- 212 (382)
T ss_dssp EEECCCTTCEETT-------------------------------------------------------------------
T ss_pred EEEEeccCceecc-------------------------------------------------------------------
Confidence 9999999984321
Q ss_pred cccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCC
Q 011302 310 ELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFP 389 (489)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p 389 (489)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+.......|
T Consensus 213 --------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 278 (382)
T 2vx3_A 213 --------------QRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP 278 (382)
T ss_dssp --------------CCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred --------------cccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 012235799999999999999999999999999999999999999999888777766653110000
Q ss_pred ------------------CC--------------CCCCc-----------------------hhHHHHhhHHHHHHHHhh
Q 011302 390 ------------------RI--------------GVSSS-----------------------KEFEEVVKLQDLISKLLV 414 (489)
Q Consensus 390 ------------------~~--------------~~~~~-----------------------~~~~~~~~l~~li~~~L~ 414 (489)
.. ..+.. ....+...+++||.+||+
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 358 (382)
T 2vx3_A 279 AHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLD 358 (382)
T ss_dssp HHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTC
T ss_pred HHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcC
Confidence 00 00000 001122368999999999
Q ss_pred cCcccccCCCCChHHHHcCCCcCCCCc
Q 011302 415 KNPKKRIGSLKGSVEIKRHEFFKGINW 441 (489)
Q Consensus 415 ~dP~~R~~~~~~~~~ll~hp~f~~~~~ 441 (489)
+||++||++. ++|+||||+...|
T Consensus 359 ~dP~~Rpta~----e~L~hp~f~~~~~ 381 (382)
T 2vx3_A 359 YDPKTRIQPY----YALQHSFFKKTAD 381 (382)
T ss_dssp SCTTTSCCHH----HHTTSGGGCC---
T ss_pred CChhhCCCHH----HHhcCcccccCCC
Confidence 9999999997 9999999988654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=385.16 Aligned_cols=267 Identities=27% Similarity=0.391 Sum_probs=214.0
Q ss_pred cCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccc
Q 011302 78 QGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYA 156 (489)
Q Consensus 78 ~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~ 156 (489)
......++|++++.||+|+||.||+|++.. +++.||||++..... ....+.+|+.+++.+ +||||+++++
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~ 88 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVK-----TGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYG 88 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEE
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECC-----CCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeee
Confidence 344556899999999999999999999876 578899999864321 234566799999998 7999999999
Q ss_pred eeec------CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcE
Q 011302 157 EFEA------SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHI 230 (489)
Q Consensus 157 ~~~~------~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~v 230 (489)
++.. .+.+|+||||+++|+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 89 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp EEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCE
T ss_pred EEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCE
Confidence 9976 5689999999999999999987655679999999999999999999999999999999999999999999
Q ss_pred EEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCcc
Q 011302 231 MLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQE 310 (489)
Q Consensus 231 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (489)
||+|||++......
T Consensus 169 kl~Dfg~~~~~~~~------------------------------------------------------------------ 182 (326)
T 2x7f_A 169 KLVDFGVSAQLDRT------------------------------------------------------------------ 182 (326)
T ss_dssp EECCCTTTC-----------------------------------------------------------------------
T ss_pred EEeeCcCceecCcC------------------------------------------------------------------
Confidence 99999997432110
Q ss_pred ccCCccccccccccCCccccCCCCccCcchhc-----CCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCC
Q 011302 311 LLDDPEVVAEPINARSKSFVGTHEYLAPEVIS-----GQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP 385 (489)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~ 385 (489)
........||+.|+|||++. +..++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 183 ------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 250 (326)
T 2x7f_A 183 ------------VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 250 (326)
T ss_dssp --------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred ------------ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc
Confidence 00112346999999999997 4568999999999999999999999999888777666665543
Q ss_pred CCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcc
Q 011302 386 LTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWA 442 (489)
Q Consensus 386 ~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~ 442 (489)
...... .... ..+.+||.+||..||.+||++. ++++||||+...+.
T Consensus 251 ~~~~~~-~~~~------~~l~~li~~~l~~dp~~Rps~~----~ll~hp~~~~~~~~ 296 (326)
T 2x7f_A 251 APRLKS-KKWS------KKFQSFIESCLVKNHSQRPATE----QLMKHPFIRDQPNE 296 (326)
T ss_dssp CCCCSC-SCSC------HHHHHHHHHHCCSSGGGSCCHH----HHHTSHHHHCCTTH
T ss_pred cccCCc-cccC------HHHHHHHHHHhccChhhCCCHH----HHhhChHHhhCccc
Confidence 221111 1111 2589999999999999999987 99999999987654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=376.20 Aligned_cols=260 Identities=27% Similarity=0.438 Sum_probs=212.3
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
++|++++.||+|+||.||+|+++. +++.||+|++...... .....+.+|+.+++.++||||+++++++.+++.
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRV-----TEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNI 79 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETT-----TCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeecCCCcEEEEEEECC-----CCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCE
Confidence 689999999999999999999886 5788999999754321 233566779999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
.|+||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 80 QYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp EEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EEEEEEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 99999999999999887654 5799999999999999999999999999999999999999999999999999843221
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
... .
T Consensus 158 ~~~----------------------------------------------------------------------------~ 161 (276)
T 2yex_A 158 NNR----------------------------------------------------------------------------E 161 (276)
T ss_dssp TTE----------------------------------------------------------------------------E
T ss_pred Ccc----------------------------------------------------------------------------h
Confidence 000 0
Q ss_pred cCCccccCCCCccCcchhcCCCC-CCcccHHHHHHHHHHHhhCCCCCCCCCcH-HHHHHHhcCCCCCCCCCCCCchhHHH
Q 011302 324 ARSKSFVGTHEYLAPEVISGQGH-GSAVDWWTLGVFLYEMLYGTTPFKGENNE-KTLINILKKPLTFPRIGVSSSKEFEE 401 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~~~~~-~~~~DiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~p~~~~~~~~~~~~ 401 (489)
......+||+.|+|||++.+..+ +.++|||||||++|||++|..||.+.... ..+..+.......+... ..
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------~~ 234 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK-------KI 234 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGG-------GS
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchh-------hc
Confidence 11234579999999999988775 77999999999999999999999876543 33334443322222111 11
Q ss_pred HhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 402 VVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 402 ~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
...+.+||.+||+.||++||++. ++++||||+..
T Consensus 235 ~~~~~~li~~~l~~~p~~Rps~~----~il~~~~~~~~ 268 (276)
T 2yex_A 235 DSAPLALLHKILVENPSARITIP----DIKKDRWYNKP 268 (276)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHH----HHTTCTTTTCC
T ss_pred CHHHHHHHHHHCCCCchhCCCHH----HHhcCccccCh
Confidence 23589999999999999999987 99999999875
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=394.45 Aligned_cols=261 Identities=29% Similarity=0.409 Sum_probs=208.7
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC--CCCcccccceee
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD--HPFLPTLYAEFE 159 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~ 159 (489)
...+|++++.||+|+||+||+|.+.. ++.||||++...... ......+.+|+.+|+.++ ||||+++++++.
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~------~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~ 126 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEK------KQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 126 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT------CCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCC------CCEEEEEEEeccccc-HHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe
Confidence 34579999999999999999998653 578999999754322 234566788999999996 599999999999
Q ss_pred cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 160 ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 160 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
..+.+||||| +.+++|.+++... ..+++.+++.|+.||+.||.|||++|||||||||+|||++ ++.+||+|||+++
T Consensus 127 ~~~~~~lv~E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~ 202 (390)
T 2zmd_A 127 TDQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN 202 (390)
T ss_dssp CSSEEEEEEE-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSC
T ss_pred cCCEEEEEEe-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccc
Confidence 9999999999 5589999999876 5789999999999999999999999999999999999995 6899999999985
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
.+.....
T Consensus 203 ~~~~~~~------------------------------------------------------------------------- 209 (390)
T 2zmd_A 203 QMQPDTT------------------------------------------------------------------------- 209 (390)
T ss_dssp CC------------------------------------------------------------------------------
T ss_pred cccCCCc-------------------------------------------------------------------------
Confidence 4321000
Q ss_pred cccccCCccccCCCCccCcchhcC-----------CCCCCcccHHHHHHHHHHHhhCCCCCCCCCc-HHHHHHHhcCCCC
Q 011302 320 EPINARSKSFVGTHEYLAPEVISG-----------QGHGSAVDWWTLGVFLYEMLYGTTPFKGENN-EKTLINILKKPLT 387 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~-----------~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~ 387 (489)
.......+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+... ...+..+......
T Consensus 210 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~ 286 (390)
T 2zmd_A 210 ---SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 286 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSC
T ss_pred ---cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcccc
Confidence 001234579999999999976 3588999999999999999999999987644 3455666654433
Q ss_pred CCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 388 FPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 388 ~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
++..... . ..+.+||.+||+.||.+||++. ++++||||+...
T Consensus 287 ~~~~~~~-~------~~~~~li~~~L~~dP~~Rps~~----ell~hp~~~~~~ 328 (390)
T 2zmd_A 287 IEFPDIP-E------KDLQDVLKCCLKRDPKQRISIP----ELLAHPYVQIQT 328 (390)
T ss_dssp CCCCCCS-C------HHHHHHHHHHTCSSTTTSCCHH----HHHTSHHHHSCC
T ss_pred CCCCccc-h------HHHHHHHHHHcccChhhCCCHH----HHhhCcCccccC
Confidence 3222111 1 2489999999999999999987 999999997543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=376.53 Aligned_cols=261 Identities=24% Similarity=0.304 Sum_probs=199.8
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE 159 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 159 (489)
++..++|++++.||+|+||+||+|++.. +++.||+|++...... ......+.++...++.++||||+++++++.
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~ 76 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVP-----SGQIMAVKRIRATVNS-QEQKRLLMDLDISMRTVDCPFTVTFYGALF 76 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEC---CH-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecC-----CCeEEEEEEeecccCc-HHHHHHHHHHHHHHHhCCCCeEEEEeeeee
Confidence 4667899999999999999999999876 5789999999765322 222333445556688899999999999999
Q ss_pred cCceEEEEEeecCCCchHHHHHh--CCCCCCChhhHHHHHHHHHHHHHHHHhC-CCeeecCCCCCeEeccCCcEEEcccC
Q 011302 160 ASHYSCLVMEYCPGGDLYAARQR--QPGKRFGISSAKFYAAETLLALEYLHMM-GIVYRDLKPENVLVREDGHIMLSDFD 236 (489)
Q Consensus 160 ~~~~~~lV~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~iiHrDIKp~NILl~~~~~vkl~DFG 236 (489)
+++..|+||||++ |+|.+++.. .....+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||
T Consensus 77 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T 3fme_A 77 REGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFG 155 (290)
T ss_dssp CSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-
T ss_pred ccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecC
Confidence 9999999999996 688776654 1346799999999999999999999998 99999999999999999999999999
Q ss_pred CCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcc
Q 011302 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPE 316 (489)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (489)
++......
T Consensus 156 ~~~~~~~~------------------------------------------------------------------------ 163 (290)
T 3fme_A 156 ISGYLVDD------------------------------------------------------------------------ 163 (290)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred Cccccccc------------------------------------------------------------------------
Confidence 98432110
Q ss_pred ccccccccCCccccCCCCccCcchh----cCCCCCCcccHHHHHHHHHHHhhCCCCCCCCC-cHHHHHHHhcCC-CCCCC
Q 011302 317 VVAEPINARSKSFVGTHEYLAPEVI----SGQGHGSAVDWWTLGVFLYEMLYGTTPFKGEN-NEKTLINILKKP-LTFPR 390 (489)
Q Consensus 317 ~~~~~~~~~~~~~~Gt~~y~aPE~l----~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~~~-~~~p~ 390 (489)
.......||+.|+|||++ .+..++.++|||||||++|||++|..||.... ....+..+.... ...+.
T Consensus 164 -------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 236 (290)
T 3fme_A 164 -------VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPA 236 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCT
T ss_pred -------ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCccc
Confidence 011223699999999997 45568999999999999999999999998743 334444444332 22221
Q ss_pred CCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 391 IGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 391 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
.. . ...+.+||.+||+.||++||++. ++++||||+.
T Consensus 237 ~~--~------~~~~~~li~~~l~~~p~~Rpt~~----e~l~hp~f~~ 272 (290)
T 3fme_A 237 DK--F------SAEFVDFTSQCLKKNSKERPTYP----ELMQHPFFTL 272 (290)
T ss_dssp TT--S------CHHHHHHHHHHTCSSGGGSCCHH----HHTTSHHHHH
T ss_pred cc--C------CHHHHHHHHHHhhcChhhCcCHH----HHHhCccccc
Confidence 11 1 12589999999999999999987 9999999965
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=396.52 Aligned_cols=268 Identities=28% Similarity=0.437 Sum_probs=207.0
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS 161 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 161 (489)
...+|++++.||+|+||+||+|++.. .+ .||+|.+.... ....+|+.+|+.++||||++++++|...
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~-----~~-~~aikk~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~ 104 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVE-----SD-EVAIKKVLQDK-------RFKNRELQIMRIVKHPNVVDLKAFFYSN 104 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETT-----TE-EEEEEEEECCT-------TSCCHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECC-----CC-eEEEEEEecCc-------chHHHHHHHHHhCCCCCcceEEEEEEec
Confidence 34689999999999999999999876 23 47888775432 1123599999999999999999998543
Q ss_pred ------ceEEEEEeecCCCchHHHHHh-CCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEec-cCCcEEEc
Q 011302 162 ------HYSCLVMEYCPGGDLYAARQR-QPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVR-EDGHIMLS 233 (489)
Q Consensus 162 ------~~~~lV~E~~~gg~L~~~l~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~-~~~~vkl~ 233 (489)
..+|+||||++++.+..+... .....+++..++.|+.||+.||+|||++||+||||||+||||+ .++.+||+
T Consensus 105 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~ 184 (394)
T 4e7w_A 105 GDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLI 184 (394)
T ss_dssp SSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEEC
T ss_pred CCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEe
Confidence 348999999976544333221 1236799999999999999999999999999999999999999 79999999
Q ss_pred ccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccC
Q 011302 234 DFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLD 313 (489)
Q Consensus 234 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (489)
|||+|+.+..
T Consensus 185 DFG~a~~~~~---------------------------------------------------------------------- 194 (394)
T 4e7w_A 185 DFGSAKILIA---------------------------------------------------------------------- 194 (394)
T ss_dssp CCTTCEECCT----------------------------------------------------------------------
T ss_pred eCCCcccccC----------------------------------------------------------------------
Confidence 9999843311
Q ss_pred CccccccccccCCccccCCCCccCcchhcCC-CCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcC--------
Q 011302 314 DPEVVAEPINARSKSFVGTHEYLAPEVISGQ-GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK-------- 384 (489)
Q Consensus 314 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-------- 384 (489)
.......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+...
T Consensus 195 ---------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~ 265 (394)
T 4e7w_A 195 ---------GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQ 265 (394)
T ss_dssp ---------TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ---------CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 0112345789999999999875 4899999999999999999999999999887776665431
Q ss_pred ---------CCCCCCCCCCCchh-H--HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccccc
Q 011302 385 ---------PLTFPRIGVSSSKE-F--EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIR 445 (489)
Q Consensus 385 ---------~~~~p~~~~~~~~~-~--~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~~ 445 (489)
...+|......... + ....++.+||.+||+.||.+||++. ++++||||+.+.|....
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~----e~l~hp~f~~~~~~~~~ 334 (394)
T 4e7w_A 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAI----EALCHPFFDELRTGEAR 334 (394)
T ss_dssp HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHH----HHHTSGGGSTTTSSCCC
T ss_pred HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHH----HHhcChhhhhhcccccc
Confidence 11122111110000 0 1224689999999999999999987 99999999999886553
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=398.01 Aligned_cols=273 Identities=25% Similarity=0.317 Sum_probs=195.4
Q ss_pred CCcee-eeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccccccee--ec
Q 011302 84 DHFRL-LRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEF--EA 160 (489)
Q Consensus 84 ~~y~~-~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~--~~ 160 (489)
+.|.+ .++||+|+||+||+|++++. ..++.||||++..... ...+.+|+.+|+.++||||++++++| ..
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~---~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 91 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDG---KDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHA 91 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSS---SCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETT
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccC---CCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCC
Confidence 56777 45899999999999998752 1467899999975422 23456799999999999999999999 45
Q ss_pred CceEEEEEeecCCCchHHHHHhC-------CCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEe----ccCCc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQ-------PGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLV----REDGH 229 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~-------~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl----~~~~~ 229 (489)
...+||||||+ +|+|.+++... ....+++..++.|+.||+.||+|||++|||||||||+|||| +.++.
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 92 DRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp TTEEEEEEECC-SEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTC
T ss_pred CCeEEEEEeCC-CCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCc
Confidence 77999999999 46888776532 12349999999999999999999999999999999999999 67899
Q ss_pred EEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCc
Q 011302 230 IMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQ 309 (489)
Q Consensus 230 vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (489)
+||+|||+|+.+.....
T Consensus 171 ~kl~Dfg~a~~~~~~~~--------------------------------------------------------------- 187 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLK--------------------------------------------------------------- 187 (405)
T ss_dssp EEECCTTCCC----------------------------------------------------------------------
T ss_pred EEEEECCCceecCCCCc---------------------------------------------------------------
Confidence 99999999854321000
Q ss_pred cccCCccccccccccCCccccCCCCccCcchhcCCC-CCCcccHHHHHHHHHHHhhCCCCCCCCCc---------HHHHH
Q 011302 310 ELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQG-HGSAVDWWTLGVFLYEMLYGTTPFKGENN---------EKTLI 379 (489)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~~~~~DiwSlGvil~elltG~~Pf~~~~~---------~~~~~ 379 (489)
........+||+.|+|||++.+.. ++.++|||||||++|||++|.+||.+... .+.+.
T Consensus 188 ------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 188 ------------PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp ---------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred ------------ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 001123457999999999998854 89999999999999999999999987654 23444
Q ss_pred HHhcCCCCCCCCCCCCc-----------------------hhH------HHHhhHHHHHHHHhhcCcccccCCCCChHHH
Q 011302 380 NILKKPLTFPRIGVSSS-----------------------KEF------EEVVKLQDLISKLLVKNPKKRIGSLKGSVEI 430 (489)
Q Consensus 380 ~i~~~~~~~p~~~~~~~-----------------------~~~------~~~~~l~~li~~~L~~dP~~R~~~~~~~~~l 430 (489)
.+.......+....... ..+ .....+.+||.+||+.||.+||++. ++
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~----e~ 331 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE----QA 331 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHH----HH
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHH----HH
Confidence 44321000000000000 000 0033588999999999999999987 99
Q ss_pred HcCCCcCCCCcccc
Q 011302 431 KRHEFFKGINWALI 444 (489)
Q Consensus 431 l~hp~f~~~~~~~~ 444 (489)
|+||||++..|...
T Consensus 332 L~hp~f~~~~~~~~ 345 (405)
T 3rgf_A 332 MQDPYFLEDPLPTS 345 (405)
T ss_dssp HTSGGGTSSSCCCS
T ss_pred hcChhhccCCCCcc
Confidence 99999998766543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-49 Score=395.22 Aligned_cols=270 Identities=18% Similarity=0.229 Sum_probs=216.6
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccccccee
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEF 158 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 158 (489)
.++..++|++++.||+|+||+||+|++.+......++.||||++..... .....++.+|+.+++.++||||+++++++
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 143 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS--EQDELDFLMEALIISKFNHQNIVRCIGVS 143 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccC--hhhHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 3456689999999999999999999976533334678999999864321 12234567799999999999999999999
Q ss_pred ecCceEEEEEeecCCCchHHHHHhCC-----CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCC---cE
Q 011302 159 EASHYSCLVMEYCPGGDLYAARQRQP-----GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDG---HI 230 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg~L~~~l~~~~-----~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~---~v 230 (489)
.+....|+|||||+||+|.+++.... ...+++.++..++.||+.||+|||++|||||||||+||||+.+| .+
T Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 99999999999999999999987642 24589999999999999999999999999999999999999555 59
Q ss_pred EEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCcc
Q 011302 231 MLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQE 310 (489)
Q Consensus 231 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (489)
||+|||+|+.+....
T Consensus 224 kL~DFG~a~~~~~~~----------------------------------------------------------------- 238 (367)
T 3l9p_A 224 KIGDFGMARDIYRAG----------------------------------------------------------------- 238 (367)
T ss_dssp EECCCHHHHHHHHHS-----------------------------------------------------------------
T ss_pred EECCCcccccccccc-----------------------------------------------------------------
Confidence 999999984321100
Q ss_pred ccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCC
Q 011302 311 LLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFP 389 (489)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p 389 (489)
.........||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+..+....+
T Consensus 239 -----------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~ 307 (367)
T 3l9p_A 239 -----------YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP 307 (367)
T ss_dssp -----------SCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred -----------ccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 0011233468999999999999999999999999999999998 9999999998888887776543222
Q ss_pred CCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 390 RIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 390 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
... .. ..+.+||.+||+.||++||++. +|++|.++-.
T Consensus 308 ~~~--~~------~~l~~li~~~l~~dP~~Rps~~----eil~~l~~~~ 344 (367)
T 3l9p_A 308 PKN--CP------GPVYRIMTQCWQHQPEDRPNFA----IILERIEYCT 344 (367)
T ss_dssp CTT--CC------HHHHHHHHHHTCSSGGGSCCHH----HHHHHHHHHH
T ss_pred Ccc--CC------HHHHHHHHHHcCCCHhHCcCHH----HHHHHHHHHh
Confidence 111 11 2489999999999999999987 8888866643
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-48 Score=378.86 Aligned_cols=259 Identities=22% Similarity=0.281 Sum_probs=205.2
Q ss_pred hcCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccc
Q 011302 77 AQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYA 156 (489)
Q Consensus 77 ~~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~ 156 (489)
....+..++|++.+.||+|+||+||+|++. +..||||++...... .....++.+|+.+|+.++||||+++++
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~-------~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~ 101 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-------GSDVAVKILMEQDFH-AERVNEFLREVAIMKRLRHPNIVLFMG 101 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEET-------TEEEEEEEECCCCCS-HHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEEC-------CCcEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 345677889999999999999999999875 367999998654322 233456778999999999999999999
Q ss_pred eeecCceEEEEEeecCCCchHHHHHhCCC-CCCChhhHHHHHHHHHHHHHHHHhCC--CeeecCCCCCeEeccCCcEEEc
Q 011302 157 EFEASHYSCLVMEYCPGGDLYAARQRQPG-KRFGISSAKFYAAETLLALEYLHMMG--IVYRDLKPENVLVREDGHIMLS 233 (489)
Q Consensus 157 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDIKp~NILl~~~~~vkl~ 233 (489)
++.+.+.+|+||||++||+|.+++..... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+
T Consensus 102 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~ 181 (309)
T 3p86_A 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVC 181 (309)
T ss_dssp EECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEEC
T ss_pred EEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEEC
Confidence 99999999999999999999999976421 23899999999999999999999999 9999999999999999999999
Q ss_pred ccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccC
Q 011302 234 DFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLD 313 (489)
Q Consensus 234 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (489)
|||+++.....
T Consensus 182 Dfg~a~~~~~~--------------------------------------------------------------------- 192 (309)
T 3p86_A 182 DFGLSRLKAST--------------------------------------------------------------------- 192 (309)
T ss_dssp CCC-----------------------------------------------------------------------------
T ss_pred CCCCCcccccc---------------------------------------------------------------------
Confidence 99998421100
Q ss_pred CccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCC
Q 011302 314 DPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGV 393 (489)
Q Consensus 314 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~ 393 (489)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+.......+....
T Consensus 193 ---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 263 (309)
T 3p86_A 193 ---------FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRN 263 (309)
T ss_dssp ------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTT
T ss_pred ---------ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCcc
Confidence 00122347999999999999999999999999999999999999999998887777766433222221111
Q ss_pred CCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHc
Q 011302 394 SSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKR 432 (489)
Q Consensus 394 ~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~ 432 (489)
.. ..+.+||.+||+.||.+||++. ++++
T Consensus 264 -~~------~~l~~li~~~l~~dP~~Rps~~----~ll~ 291 (309)
T 3p86_A 264 -LN------PQVAAIIEGCWTNEPWKRPSFA----TIMD 291 (309)
T ss_dssp -SC------HHHHHHHHHHTCSSGGGSCCHH----HHHH
T ss_pred -CC------HHHHHHHHHHccCChhhCcCHH----HHHH
Confidence 11 2589999999999999999987 5655
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-48 Score=389.19 Aligned_cols=264 Identities=28% Similarity=0.373 Sum_probs=211.3
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
++|.+.+.||+|+||+||+|.++. +++.||||++...... .....++.+|+.+++.++||||+++++++...+.
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 115 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKR-----SGEKVAIKKLSRPFQS-EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS 115 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred ccEEEEeEEecCCCeEEEEEEECC-----CCCEEEEEEecccccc-hhHHHHHHHHHHHHHhcCCCCchhhhhheeccCC
Confidence 789999999999999999999887 5789999999754221 2334567789999999999999999999987765
Q ss_pred E------EEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCC
Q 011302 164 S------CLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237 (489)
Q Consensus 164 ~------~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~ 237 (489)
. |+||||+. ++|.+++. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 116 ~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 116 LRNFYDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp STTCCCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred cccceeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 5 99999995 78877663 3599999999999999999999999999999999999999999999999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
++...
T Consensus 191 a~~~~--------------------------------------------------------------------------- 195 (371)
T 4exu_A 191 ARHAD--------------------------------------------------------------------------- 195 (371)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred ccccc---------------------------------------------------------------------------
Confidence 83221
Q ss_pred cccccccCCccccCCCCccCcchhcC-CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCC--------
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTF-------- 388 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-------- 388 (489)
......+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+..+.+..+.......
T Consensus 196 ------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 269 (371)
T 4exu_A 196 ------AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL 269 (371)
T ss_dssp ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred ------cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHh
Confidence 01223478999999999987 678999999999999999999999999988777766664311000
Q ss_pred ------------CCCCCCCchh--HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccc
Q 011302 389 ------------PRIGVSSSKE--FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWAL 443 (489)
Q Consensus 389 ------------p~~~~~~~~~--~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~ 443 (489)
+......... ......+.+||.+||+.||++||++. ++++||||+.+....
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~----ell~hp~f~~~~~~~ 334 (371)
T 4exu_A 270 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAA----QALTHPFFEPFRDPE 334 (371)
T ss_dssp SCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHH----HHHTSGGGTTTCCGG
T ss_pred hhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHH----HHhcCcccccCCCcc
Confidence 0000000000 01124689999999999999999987 999999999876543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=382.47 Aligned_cols=281 Identities=26% Similarity=0.353 Sum_probs=196.7
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccccccee
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEF 158 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 158 (489)
+.+..++|++.+.||+|+||.||+|.+.. +++.||||++..+... ....++.+|+.+++.++||||+++++++
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 82 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAP-----KKEKVAIKRINLEKCQ--TSMDELLKEIQAMSQCHHPNIVSYYTSF 82 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC---------CEEEEECCC------------------CCCCCCCTTBCCEEEEE
T ss_pred cccchhhhhhhheeccccceEEEEEEECC-----CCcEEEEEEEEhhhcc--hhHHHHHHHHHHHhhcCCCCEeeEEEEE
Confidence 45677899999999999999999999875 4678999999765432 3345677899999999999999999999
Q ss_pred ecCceEEEEEeecCCCchHHHHHh------CCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEE
Q 011302 159 EASHYSCLVMEYCPGGDLYAARQR------QPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIML 232 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg~L~~~l~~------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl 232 (489)
...+..|+||||++||+|.+++.. .....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl 162 (303)
T 2vwi_A 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQI 162 (303)
T ss_dssp ESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEE
T ss_pred eecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEE
Confidence 999999999999999999998864 12356999999999999999999999999999999999999999999999
Q ss_pred cccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCcccc
Q 011302 233 SDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELL 312 (489)
Q Consensus 233 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (489)
+|||++..........
T Consensus 163 ~dfg~~~~~~~~~~~~---------------------------------------------------------------- 178 (303)
T 2vwi_A 163 ADFGVSAFLATGGDIT---------------------------------------------------------------- 178 (303)
T ss_dssp CCCHHHHHCC----------------------------------------------------------------------
T ss_pred EeccchheeccCCCcc----------------------------------------------------------------
Confidence 9999974332100000
Q ss_pred CCccccccccccCCccccCCCCccCcchhcC-CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCC
Q 011302 313 DDPEVVAEPINARSKSFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRI 391 (489)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~ 391 (489)
.........||+.|+|||++.+ ..++.++|||||||++|||++|..||.+....................
T Consensus 179 ---------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 249 (303)
T 2vwi_A 179 ---------RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249 (303)
T ss_dssp ------------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC
T ss_pred ---------chhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccc
Confidence 0011234579999999999976 568999999999999999999999999887766555544432211110
Q ss_pred CCCC-chhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccc
Q 011302 392 GVSS-SKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWAL 443 (489)
Q Consensus 392 ~~~~-~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~ 443 (489)
.... .........+.+||.+||+.||.+||++. ++++||||+...+..
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~----~ll~h~~~~~~~~~~ 298 (303)
T 2vwi_A 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAA----ELLRHKFFQKAKNKE 298 (303)
T ss_dssp -----CCCCCCCHHHHHHHHHHCCSSGGGSCCHH----HHHTSTTC-------
T ss_pred ccccchhhhhhhHHHHHHHHHHccCChhhCcCHH----HHhhChhhhcCCCCc
Confidence 0000 00001123589999999999999999987 999999999876643
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=407.22 Aligned_cols=251 Identities=14% Similarity=0.149 Sum_probs=195.6
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHH---HHHhCCCCCccccc----
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKV---ILTMLDHPFLPTLY---- 155 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~---~l~~l~hpnIv~l~---- 155 (489)
.++|++.+.||+|+||+||+|+++. +++.||||++.............+.+|+. +|+.++|||||+++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~ 146 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQE-----TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 146 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-C-----CCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBC
T ss_pred CceEEEcceeecCCCEEEEEEEECC-----CCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhh
Confidence 4789999999999999999999875 57899999997543222234456777984 55556899999999
Q ss_pred ---ceeecCc-----------------eEEEEEeecCCCchHHHHHhCCCCCCCh-------hhHHHHHHHHHHHHHHHH
Q 011302 156 ---AEFEASH-----------------YSCLVMEYCPGGDLYAARQRQPGKRFGI-------SSAKFYAAETLLALEYLH 208 (489)
Q Consensus 156 ---~~~~~~~-----------------~~~lV~E~~~gg~L~~~l~~~~~~~l~~-------~~~~~i~~qi~~~L~yLH 208 (489)
+++++.+ ..||||||+ +|+|.+++... +.+++ ..+..|+.||+.||+|||
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~--~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 223 (377)
T 3byv_A 147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL--LSHSSTHKSLVHHARLQLTLQVIRLLASLH 223 (377)
T ss_dssp CCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHH--HHTTTTTHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhc--cccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 5555443 389999999 78999998764 23444 777889999999999999
Q ss_pred hCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCcccccccccccccc
Q 011302 209 MMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKN 288 (489)
Q Consensus 209 ~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (489)
++|||||||||+||||+.+|.+||+|||+|+...
T Consensus 224 ~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~---------------------------------------------- 257 (377)
T 3byv_A 224 HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG---------------------------------------------- 257 (377)
T ss_dssp HTTEECSCCCGGGEEECTTCCEEECCGGGCEETT----------------------------------------------
T ss_pred hCCeecCCCCHHHEEEcCCCCEEEEechhheecC----------------------------------------------
Confidence 9999999999999999999999999999984211
Q ss_pred ccccccccccccccCCCCCCccccCCccccccccccCCccccCCCCccCcchhcCC-----------CCCCcccHHHHHH
Q 011302 289 KKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQ-----------GHGSAVDWWTLGV 357 (489)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-----------~~~~~~DiwSlGv 357 (489)
......+| +.|+|||++.+. .++.++|||||||
T Consensus 258 -----------------------------------~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 258 -----------------------------------ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp -----------------------------------CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred -----------------------------------CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 01223468 999999999987 7999999999999
Q ss_pred HHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcC
Q 011302 358 FLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437 (489)
Q Consensus 358 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~ 437 (489)
++|||++|+.||.+.+.......+....... +..+.+||.+||+.||++||++. ++++||||+
T Consensus 302 il~elltg~~Pf~~~~~~~~~~~~~~~~~~~-------------~~~~~~li~~~L~~dp~~Rpt~~----e~l~hp~f~ 364 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSEWIFRSCKNI-------------PQPVRALLEGFLRYPKEDRLLPL----QAMETPEYE 364 (377)
T ss_dssp HHHHHHHSSCCC------CCSGGGGSSCCCC-------------CHHHHHHHHHHTCSSGGGCCCHH----HHHTSHHHH
T ss_pred HHHHHHHCCCCCcccccccchhhhhhhccCC-------------CHHHHHHHHHHcCCCchhCCCHH----HHhhChHHH
Confidence 9999999999998766544333333321111 12589999999999999999987 999999998
Q ss_pred CCC
Q 011302 438 GIN 440 (489)
Q Consensus 438 ~~~ 440 (489)
.+.
T Consensus 365 ~~~ 367 (377)
T 3byv_A 365 QLR 367 (377)
T ss_dssp HHH
T ss_pred HHH
Confidence 753
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-48 Score=382.42 Aligned_cols=262 Identities=26% Similarity=0.357 Sum_probs=205.7
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-CCCcccccceeec
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-HPFLPTLYAEFEA 160 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~ 160 (489)
..++|++++.||+|+||+||+|++.. .++.||||++.... ...+.+|+.+++.+. ||||+++++++.+
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~ 102 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINIT-----NNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKD 102 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred CCCceEEEEEecccCCeEEEEEEECC-----CCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeecc
Confidence 35789999999999999999999876 57899999997432 234667999999997 9999999999987
Q ss_pred --CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCC-cEEEcccCC
Q 011302 161 --SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDG-HIMLSDFDL 237 (489)
Q Consensus 161 --~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~-~vkl~DFG~ 237 (489)
....|+||||+++++|.+++. .+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+
T Consensus 103 ~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~ 177 (330)
T 3nsz_A 103 PVSRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 177 (330)
T ss_dssp TTTCCEEEEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred CCCCceEEEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCC
Confidence 678999999999999988774 388999999999999999999999999999999999999776 899999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
|+.+...
T Consensus 178 a~~~~~~------------------------------------------------------------------------- 184 (330)
T 3nsz_A 178 AEFYHPG------------------------------------------------------------------------- 184 (330)
T ss_dssp CEECCTT-------------------------------------------------------------------------
T ss_pred ceEcCCC-------------------------------------------------------------------------
Confidence 8432210
Q ss_pred cccccccCCccccCCCCccCcchhcC-CCCCCcccHHHHHHHHHHHhhCCCCCCCC-CcHHHHHHHhc------------
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGE-NNEKTLINILK------------ 383 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~-~~~~~~~~i~~------------ 383 (489)
......+||+.|+|||++.+ ..++.++|||||||++|||++|..||... +..+.+..+..
T Consensus 185 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 185 ------QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 258 (330)
T ss_dssp ------CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred ------CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHH
Confidence 01223478999999999987 56899999999999999999999999543 33333322211
Q ss_pred -CCCCCCCC--------------C-CCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcc
Q 011302 384 -KPLTFPRI--------------G-VSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWA 442 (489)
Q Consensus 384 -~~~~~p~~--------------~-~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~ 442 (489)
.....+.. . ...........++.+||.+||+.||++||++. ++++||||+++.|+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~----e~l~hp~f~~~~~~ 329 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR----EAMEHPYFYTVVKD 329 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHH----HHHTSGGGTTCC--
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHH----HHhcCccHhhhccC
Confidence 11111000 0 00000001234689999999999999999987 99999999998875
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=384.54 Aligned_cols=281 Identities=23% Similarity=0.280 Sum_probs=214.4
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC-
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS- 161 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~- 161 (489)
.++|++.+.||+|+||.||+|++.. +++.||||++..... .....++.+|+.+++.++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 82 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKP-----TGEIVAIKKIEPFDK--PLFALRTLREIKILKHFKHENIITIFNIQRPDS 82 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECCCSS--HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECC-----CCcEEEEEeeccccc--chHHHHHHHHHHHHHhCcCCCcCCeeeeecccc
Confidence 4799999999999999999999886 578999999964221 12344566799999999999999999987654
Q ss_pred ----ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCC
Q 011302 162 ----HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237 (489)
Q Consensus 162 ----~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~ 237 (489)
...|+||||+. |+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (353)
T 2b9h_A 83 FENFNEVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGL 158 (353)
T ss_dssp STTCCCEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred cCccceEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccc
Confidence 78999999995 799998876 4699999999999999999999999999999999999999999999999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
++.+.........
T Consensus 159 a~~~~~~~~~~~~------------------------------------------------------------------- 171 (353)
T 2b9h_A 159 ARIIDESAADNSE------------------------------------------------------------------- 171 (353)
T ss_dssp CEECC---------------------------------------------------------------------------
T ss_pred ccccccccccccC-------------------------------------------------------------------
Confidence 8544321000000
Q ss_pred cccccccCCccccCCCCccCcchhcC-CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhc---CCCCCCCCC-
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILK---KPLTFPRIG- 392 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~~~~~p~~~- 392 (489)
...........+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+..+.+..+.. .+.......
T Consensus 172 -~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (353)
T 2b9h_A 172 -PTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRC 250 (353)
T ss_dssp ---------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTT
T ss_pred -ccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccc
Confidence 0000011234579999999999865 6689999999999999999999999999887665554432 111000000
Q ss_pred -----------------CCCchh--HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcccccc
Q 011302 393 -----------------VSSSKE--FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIRS 446 (489)
Q Consensus 393 -----------------~~~~~~--~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~~~ 446 (489)
...... ......+.+||.+||+.||++||++. ++++||||+.+.+.....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~----ell~hp~~~~~~~~~~~~ 319 (353)
T 2b9h_A 251 IESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAK----EALEHPYLQTYHDPNDEP 319 (353)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHH----HHHTSGGGTTTCCTTSSC
T ss_pred cccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHH----HHhcCccccccCCccccc
Confidence 000000 01224688999999999999999987 999999999988765443
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=385.96 Aligned_cols=263 Identities=33% Similarity=0.487 Sum_probs=207.8
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHH-----HHHHHHHHHHHHHHHHhCCCCCccccccee
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALA-----IRKKLHRADMEKVILTMLDHPFLPTLYAEF 158 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 158 (489)
++|++.+.||+|+||.||+|+++. +++.||||++...... .......+.+|+.+|+.++||||+++++++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 84 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERK-----TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF 84 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hceeEeeEEecCCCEEEEEEEEcC-----CCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEE
Confidence 679999999999999999999886 5789999999765432 122334577899999999999999999998
Q ss_pred ecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCc---EEEccc
Q 011302 159 EASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGH---IMLSDF 235 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~---vkl~DF 235 (489)
..+. .|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+||
T Consensus 85 ~~~~-~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 85 DAED-YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp ESSS-EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred cCCc-eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccC
Confidence 7665 89999999999999988764 67999999999999999999999999999999999999987664 999999
Q ss_pred CCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCc
Q 011302 236 DLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDP 315 (489)
Q Consensus 236 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (489)
|++......
T Consensus 162 g~~~~~~~~----------------------------------------------------------------------- 170 (322)
T 2ycf_A 162 GHSKILGET----------------------------------------------------------------------- 170 (322)
T ss_dssp TTCEECCCC-----------------------------------------------------------------------
T ss_pred ccceecccc-----------------------------------------------------------------------
Confidence 998432110
Q ss_pred cccccccccCCccccCCCCccCcchhc---CCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcH-HHHHHHhcCCCCCCCC
Q 011302 316 EVVAEPINARSKSFVGTHEYLAPEVIS---GQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNE-KTLINILKKPLTFPRI 391 (489)
Q Consensus 316 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~p~~ 391 (489)
......+||+.|+|||++. ...++.++|||||||++|+|++|..||.+.... .....+..+...+...
T Consensus 171 --------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (322)
T 2ycf_A 171 --------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 242 (322)
T ss_dssp --------HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHH
T ss_pred --------cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCch
Confidence 0012346999999999984 456899999999999999999999999876543 2333444443322110
Q ss_pred CCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcc
Q 011302 392 GVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWA 442 (489)
Q Consensus 392 ~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~ 442 (489)
.. ......+.+||.+||..||++||++. ++++||||+..+|.
T Consensus 243 ~~-----~~~~~~~~~li~~~l~~dP~~Rps~~----~~l~h~~~~~~~~~ 284 (322)
T 2ycf_A 243 VW-----AEVSEKALDLVKKLLVVDPKARFTTE----EALRHPWLQDEDMK 284 (322)
T ss_dssp HH-----TTSCHHHHHHHHHHSCSSTTTSCCHH----HHHTSGGGCCHHHH
T ss_pred hh-----hhcCHHHHHHHHHHcccCHhhCCCHH----HHhhCcCcCCHHHH
Confidence 00 01123589999999999999999987 99999999988774
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=394.96 Aligned_cols=263 Identities=23% Similarity=0.349 Sum_probs=206.4
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC--------CCCcc
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD--------HPFLP 152 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--------hpnIv 152 (489)
+..++|++++.||+|+||+||+|++.. +++.||||++.... .....+.+|+.+|+.+. |+||+
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv 104 (397)
T 1wak_A 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQ-----GKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSDPNDPNREMVV 104 (397)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHSCTTCGGGGGBC
T ss_pred hcCCeEEEEEEeeecCCeeEEEEEecC-----CCeEEEEEEEecCC----cchHHHHHHHHHHHHHhhcCCCCCCcceee
Confidence 345889999999999999999999886 57899999997643 23345667999988885 78899
Q ss_pred cccceee----cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhC-CCeeecCCCCCeEeccC
Q 011302 153 TLYAEFE----ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMM-GIVYRDLKPENVLVRED 227 (489)
Q Consensus 153 ~l~~~~~----~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~iiHrDIKp~NILl~~~ 227 (489)
+++++|. +...+||||||+ +++|.+.+.......+++..++.|+.||+.||+|||++ |||||||||+||||+.+
T Consensus 105 ~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~ 183 (397)
T 1wak_A 105 QLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVN 183 (397)
T ss_dssp CEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCC
T ss_pred eeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEecc
Confidence 9999997 667899999999 77777777665556799999999999999999999998 99999999999999977
Q ss_pred C-------------------------------------------------cEEEcccCCCcccccCccccCCcchhHHHh
Q 011302 228 G-------------------------------------------------HIMLSDFDLSFKCDVVPKLLRPKLSFEAIE 258 (489)
Q Consensus 228 ~-------------------------------------------------~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~ 258 (489)
+ .+||+|||+|.....
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--------------- 248 (397)
T 1wak_A 184 EQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--------------- 248 (397)
T ss_dssp HHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB---------------
T ss_pred chhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc---------------
Confidence 5 799999999843210
Q ss_pred hhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCccccCCCCccCc
Q 011302 259 KYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAP 338 (489)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aP 338 (489)
.....+||+.|+||
T Consensus 249 ------------------------------------------------------------------~~~~~~gt~~y~aP 262 (397)
T 1wak_A 249 ------------------------------------------------------------------HFTEDIQTRQYRSL 262 (397)
T ss_dssp ------------------------------------------------------------------CSCSCCSCGGGCCH
T ss_pred ------------------------------------------------------------------cCccCCCCCcccCC
Confidence 11234799999999
Q ss_pred chhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCc------HHHHHHHhc---CC---------CC---------CCCC
Q 011302 339 EVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENN------EKTLINILK---KP---------LT---------FPRI 391 (489)
Q Consensus 339 E~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~------~~~~~~i~~---~~---------~~---------~p~~ 391 (489)
|++.+..++.++|||||||++|||++|..||.+.+. ...+..+.. .. .. ....
T Consensus 263 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 342 (397)
T 1wak_A 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHI 342 (397)
T ss_dssp HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSC
T ss_pred hhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccc
Confidence 999999999999999999999999999999986542 222222211 10 00 0000
Q ss_pred CC---CC---------chhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 392 GV---SS---------SKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 392 ~~---~~---------~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
.. .. .........+.+||.+||+.||++||++. ++++||||++
T Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~----e~l~hp~~~~ 397 (397)
T 1wak_A 343 TKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAA----ECLRHPWLNS 397 (397)
T ss_dssp CCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHH----HHHTSGGGGC
T ss_pred cccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHH----HHhhCccccC
Confidence 00 00 00112334688999999999999999997 9999999974
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-48 Score=382.11 Aligned_cols=268 Identities=27% Similarity=0.369 Sum_probs=213.9
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCC------Ccc
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHP------FLP 152 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp------nIv 152 (489)
+.+..++|++++.||+|+||+||+|.+... .++.||||++.... .....+.+|+.+++.++|+ +|+
T Consensus 9 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~ 80 (339)
T 1z57_A 9 GDVLSARYEIVDTLGEGAFGKVVECIDHKA----GGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNSTFRCV 80 (339)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTT----TTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHHCTTCTTCBC
T ss_pred CCCccCceEEEEEEecCCCeEEEEEEecCC----CCcEEEEEEEecCC----chhHHHHHHHHHHHHhhhcCCCCceeeE
Confidence 345568999999999999999999998432 57899999997543 2334566788888887655 599
Q ss_pred cccceeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEecc------
Q 011302 153 TLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRE------ 226 (489)
Q Consensus 153 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~------ 226 (489)
++++++.+.+.+|+||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 81 ~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 159 (339)
T 1z57_A 81 QMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEA 159 (339)
T ss_dssp CEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEE
T ss_pred eeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccc
Confidence 9999999999999999999 999999998875567999999999999999999999999999999999999987
Q ss_pred -------------CCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccc
Q 011302 227 -------------DGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAV 293 (489)
Q Consensus 227 -------------~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (489)
++.+||+|||+++...
T Consensus 160 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~--------------------------------------------------- 188 (339)
T 1z57_A 160 YNPKIKRDERTLINPDIKVVDFGSATYDD--------------------------------------------------- 188 (339)
T ss_dssp EC----CEEEEESCCCEEECCCSSCEETT---------------------------------------------------
T ss_pred cCCccccccccccCCCceEeeCcccccCc---------------------------------------------------
Confidence 6789999999973211
Q ss_pred cccccccccCCCCCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCC
Q 011302 294 TVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGEN 373 (489)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~ 373 (489)
......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+
T Consensus 189 ------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 189 ------------------------------EHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp ------------------------------SCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred ------------------------------cccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 01123479999999999999999999999999999999999999999888
Q ss_pred cHHHHHHHhcCCCCCCCC------------------CCCC-----------------chhHHHHhhHHHHHHHHhhcCcc
Q 011302 374 NEKTLINILKKPLTFPRI------------------GVSS-----------------SKEFEEVVKLQDLISKLLVKNPK 418 (489)
Q Consensus 374 ~~~~~~~i~~~~~~~p~~------------------~~~~-----------------~~~~~~~~~l~~li~~~L~~dP~ 418 (489)
..+....+......+|.. .... .........+.+||.+||+.||.
T Consensus 239 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 318 (339)
T 1z57_A 239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA 318 (339)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence 766554442211111100 0000 00012234688999999999999
Q ss_pred cccCCCCChHHHHcCCCcCCCC
Q 011302 419 KRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 419 ~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
+||++. ++++||||+.+.
T Consensus 319 ~Rpt~~----ell~hp~f~~~~ 336 (339)
T 1z57_A 319 KRITLR----EALKHPFFDLLK 336 (339)
T ss_dssp TSCCHH----HHTTSGGGGGGG
T ss_pred cccCHH----HHhcCHHHHHHh
Confidence 999987 999999998754
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=380.47 Aligned_cols=273 Identities=26% Similarity=0.347 Sum_probs=215.0
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC---CCCCccccccee
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML---DHPFLPTLYAEF 158 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~l~~~~ 158 (489)
..++|++++.||+|+||.||+|++... .++.||+|++...... ......+.+|+.+++.+ +||||+++++++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~ 83 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKN----GGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVC 83 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTT----TTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCC----CCEEEEEEEeccCccc-ccCCchhhHHHHHHHhhhccCCCCeEeeeeee
Confidence 347899999999999999999998531 4688999998643211 11122344577766665 899999999998
Q ss_pred e-----cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEc
Q 011302 159 E-----ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLS 233 (489)
Q Consensus 159 ~-----~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~ 233 (489)
. ....+|+||||+. |+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 84 TVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp EEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred eecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEe
Confidence 7 6678999999996 699999988765679999999999999999999999999999999999999999999999
Q ss_pred ccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccC
Q 011302 234 DFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLD 313 (489)
Q Consensus 234 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (489)
|||+++.....
T Consensus 163 Dfg~~~~~~~~--------------------------------------------------------------------- 173 (326)
T 1blx_A 163 DFGLARIYSFQ--------------------------------------------------------------------- 173 (326)
T ss_dssp SCCSCCCCCGG---------------------------------------------------------------------
T ss_pred cCcccccccCC---------------------------------------------------------------------
Confidence 99998432110
Q ss_pred CccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcC-----CCCC
Q 011302 314 DPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK-----PLTF 388 (489)
Q Consensus 314 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-----~~~~ 388 (489)
.......||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..+... ...+
T Consensus 174 ----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (326)
T 1blx_A 174 ----------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 243 (326)
T ss_dssp ----------GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred ----------CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccC
Confidence 0112347899999999999999999999999999999999999999998887777666531 0011
Q ss_pred CCCCC-----------CCchh--HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccc
Q 011302 389 PRIGV-----------SSSKE--FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWAL 443 (489)
Q Consensus 389 p~~~~-----------~~~~~--~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~ 443 (489)
+.... ..... ......+.+||.+||+.||++||++. ++++||||+.+++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~----e~l~hp~~~~~~~~~ 307 (326)
T 1blx_A 244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY----SALSHPYFQDLERCK 307 (326)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHH----HHHTSGGGTTCCCCC
T ss_pred ccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHH----HHhcCccccccchhh
Confidence 10000 00000 01223588999999999999999987 999999999988753
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=377.75 Aligned_cols=262 Identities=27% Similarity=0.441 Sum_probs=213.1
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS 161 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 161 (489)
..++|++++.||+|+||.||+|.+.. +++.||||++.... ....+.+|+.+++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKE-----TGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKN 96 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETT-----TCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred chhhhhhheeeccCCCeEEEEEEECC-----CCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeC
Confidence 45789999999999999999999886 57899999997642 234567799999999999999999999999
Q ss_pred ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccc
Q 011302 162 HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKC 241 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~ 241 (489)
+.+|+||||+++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 97 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 175 (314)
T 3com_A 97 TDLWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQL 175 (314)
T ss_dssp TEEEEEEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CEEEEEeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhh
Confidence 9999999999999999998743 257999999999999999999999999999999999999999999999999998432
Q ss_pred ccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccc
Q 011302 242 DVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEP 321 (489)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (489)
...
T Consensus 176 ~~~----------------------------------------------------------------------------- 178 (314)
T 3com_A 176 TDT----------------------------------------------------------------------------- 178 (314)
T ss_dssp BTT-----------------------------------------------------------------------------
T ss_pred hhh-----------------------------------------------------------------------------
Confidence 110
Q ss_pred cccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCC-CCCCCCCCCchhHH
Q 011302 322 INARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL-TFPRIGVSSSKEFE 400 (489)
Q Consensus 322 ~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~~~ 400 (489)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+..... .+.... .
T Consensus 179 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------~ 250 (314)
T 3com_A 179 -MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPE-------L 250 (314)
T ss_dssp -BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGG-------G
T ss_pred -ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcc-------c
Confidence 0012234689999999999999999999999999999999999999998877666555544322 111110 0
Q ss_pred HHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccc
Q 011302 401 EVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWAL 443 (489)
Q Consensus 401 ~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~ 443 (489)
....+.+||.+||..||.+||++. ++++||||++..+..
T Consensus 251 ~~~~l~~li~~~l~~dp~~Rpt~~----~ll~~~~~~~~~~~~ 289 (314)
T 3com_A 251 WSDNFTDFVKQCLVKSPEQRATAT----QLLQHPFVRSAKGVS 289 (314)
T ss_dssp SCHHHHHHHHHHTCSCTTTSCCHH----HHTTSHHHHTCCCGG
T ss_pred CCHHHHHHHHHHccCChhhCcCHH----HHHhCHHHhcCCcch
Confidence 123589999999999999999987 999999999877654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-48 Score=381.09 Aligned_cols=264 Identities=24% Similarity=0.355 Sum_probs=207.8
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
+..++|++.+.||+|+||+||+|++.. +++.||||++...... .....+.+|+.+|+.++||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 78 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKK-----TGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECC-----CCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCcceEEEEeec
Confidence 345789999999999999999999987 5789999999754322 223455679999999999999999999876
Q ss_pred Cc--eEEEEEeecCCCchHHHHHhCCC-CCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEe----ccCCcEEEc
Q 011302 161 SH--YSCLVMEYCPGGDLYAARQRQPG-KRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLV----REDGHIMLS 233 (489)
Q Consensus 161 ~~--~~~lV~E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl----~~~~~vkl~ 233 (489)
.. .+|+||||++||+|.+++..... ..+++.+++.++.||+.||+|||++||+||||||+|||+ +.++.+||+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~ 158 (319)
T 4euu_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLT 158 (319)
T ss_dssp TTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEEC
T ss_pred CCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEc
Confidence 55 88999999999999999876422 339999999999999999999999999999999999999 778889999
Q ss_pred ccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccC
Q 011302 234 DFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLD 313 (489)
Q Consensus 234 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (489)
|||+++.+...
T Consensus 159 Dfg~a~~~~~~--------------------------------------------------------------------- 169 (319)
T 4euu_A 159 DFGAARELEDD--------------------------------------------------------------------- 169 (319)
T ss_dssp CCTTCEECCTT---------------------------------------------------------------------
T ss_pred cCCCceecCCC---------------------------------------------------------------------
Confidence 99998433210
Q ss_pred CccccccccccCCccccCCCCccCcchhc--------CCCCCCcccHHHHHHHHHHHhhCCCCCCCCC----cHHHHHHH
Q 011302 314 DPEVVAEPINARSKSFVGTHEYLAPEVIS--------GQGHGSAVDWWTLGVFLYEMLYGTTPFKGEN----NEKTLINI 381 (489)
Q Consensus 314 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~--------~~~~~~~~DiwSlGvil~elltG~~Pf~~~~----~~~~~~~i 381 (489)
......+||+.|+|||++. +..++.++|||||||++|||++|..||.... ..+.+.++
T Consensus 170 ----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 239 (319)
T 4euu_A 170 ----------EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (319)
T ss_dssp ----------CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHH
T ss_pred ----------CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Confidence 1122347999999999986 5678999999999999999999999997543 34555555
Q ss_pred hcCCCCC---------------C-CCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCC
Q 011302 382 LKKPLTF---------------P-RIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHE 434 (489)
Q Consensus 382 ~~~~~~~---------------p-~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp 434 (489)
..+.... . ...............+.+||.+||+.||++||++. |+++||
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~----ell~h~ 304 (319)
T 4euu_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFD----QFFAET 304 (319)
T ss_dssp HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHH----HHHHHH
T ss_pred hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHH----Hhhhcc
Confidence 5432210 0 00000111112334689999999999999999997 899885
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=384.13 Aligned_cols=271 Identities=24% Similarity=0.347 Sum_probs=215.2
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCC------ccc
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPF------LPT 153 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn------Iv~ 153 (489)
.+..++|++++.||+|+||+||+|.+... .+..||+|++.... .....+.+|+.+++.+.|++ |+.
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~ 86 (355)
T 2eu9_A 15 DWLQERYEIVGNLGEGTFGKVVECLDHAR----GKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKFLCVL 86 (355)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTT----TTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCSCBCC
T ss_pred ceecccEEEEEEeeccCCeEEEEEEecCC----CceEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCceeEEE
Confidence 34458999999999999999999998762 24789999997543 22345566888888887655 899
Q ss_pred ccceeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEe---------
Q 011302 154 LYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLV--------- 224 (489)
Q Consensus 154 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl--------- 224 (489)
+++++...+.+|+||||+ +++|.+.+.......+++.+++.++.||+.||+|||++||+||||||+|||+
T Consensus 87 ~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~ 165 (355)
T 2eu9_A 87 MSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLY 165 (355)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEE
T ss_pred eeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccc
Confidence 999999999999999999 7788777777655679999999999999999999999999999999999999
Q ss_pred ----------ccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCcccccccccccccccccccc
Q 011302 225 ----------REDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVT 294 (489)
Q Consensus 225 ----------~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (489)
+.++.+||+|||+++...
T Consensus 166 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~---------------------------------------------------- 193 (355)
T 2eu9_A 166 NEHKSCEEKSVKNTSIRVADFGSATFDH---------------------------------------------------- 193 (355)
T ss_dssp CCC-CCCEEEESCCCEEECCCTTCEETT----------------------------------------------------
T ss_pred cccccccccccCCCcEEEeecCcccccc----------------------------------------------------
Confidence 568899999999983211
Q ss_pred ccccccccCCCCCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCc
Q 011302 295 VTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENN 374 (489)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~ 374 (489)
......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.
T Consensus 194 -----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (355)
T 2eu9_A 194 -----------------------------EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244 (355)
T ss_dssp -----------------------------SCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred -----------------------------ccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 011234799999999999999999999999999999999999999998877
Q ss_pred HHHHHHHhcCCCCCCCC-------------------CCC----------------CchhHHHHhhHHHHHHHHhhcCccc
Q 011302 375 EKTLINILKKPLTFPRI-------------------GVS----------------SSKEFEEVVKLQDLISKLLVKNPKK 419 (489)
Q Consensus 375 ~~~~~~i~~~~~~~p~~-------------------~~~----------------~~~~~~~~~~l~~li~~~L~~dP~~ 419 (489)
.+.+..+.......|.. ... .........++.+||.+||+.||++
T Consensus 245 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 66554443211111100 000 0000112346889999999999999
Q ss_pred ccCCCCChHHHHcCCCcCCCCcccc
Q 011302 420 RIGSLKGSVEIKRHEFFKGINWALI 444 (489)
Q Consensus 420 R~~~~~~~~~ll~hp~f~~~~~~~~ 444 (489)
||++. ++++||||++++|+..
T Consensus 325 Rpt~~----e~l~hp~f~~~~~~~~ 345 (355)
T 2eu9_A 325 RITLA----EALLHPFFAGLTPEER 345 (355)
T ss_dssp SCCHH----HHTTSGGGGGCCHHHH
T ss_pred CcCHH----HHhcChhhcCCChhhc
Confidence 99997 9999999999998644
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-48 Score=387.37 Aligned_cols=266 Identities=20% Similarity=0.262 Sum_probs=211.6
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccce
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAE 157 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~ 157 (489)
+++..++|++.+.||+|+||.||+|++.+.....+++.||||++...... .....+.+|+.++..+ +||||++++++
T Consensus 17 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hpniv~~~~~ 94 (359)
T 3vhe_A 17 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGA 94 (359)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCH--HHHHHHHHHHHHHHhhcCCcceeeeeee
Confidence 45777999999999999999999999775444457789999999754222 2345678899999999 79999999999
Q ss_pred eecCc-eEEEEEeecCCCchHHHHHhCCC---------------------------------------------------
Q 011302 158 FEASH-YSCLVMEYCPGGDLYAARQRQPG--------------------------------------------------- 185 (489)
Q Consensus 158 ~~~~~-~~~lV~E~~~gg~L~~~l~~~~~--------------------------------------------------- 185 (489)
+.+.+ .+|+|||||+||+|.+++.....
T Consensus 95 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (359)
T 3vhe_A 95 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 174 (359)
T ss_dssp ECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred eecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence 87754 59999999999999999976532
Q ss_pred -------------CCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCccccCCcc
Q 011302 186 -------------KRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKL 252 (489)
Q Consensus 186 -------------~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~ 252 (489)
..+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+++.......
T Consensus 175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~------ 248 (359)
T 3vhe_A 175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD------ 248 (359)
T ss_dssp ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT------
T ss_pred hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc------
Confidence 1289999999999999999999999999999999999999999999999999843211000
Q ss_pred hhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCccccCC
Q 011302 253 SFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGT 332 (489)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt 332 (489)
........||
T Consensus 249 ----------------------------------------------------------------------~~~~~~~~~t 258 (359)
T 3vhe_A 249 ----------------------------------------------------------------------YVRKGDARLP 258 (359)
T ss_dssp ----------------------------------------------------------------------CEEC--CEEC
T ss_pred ----------------------------------------------------------------------chhccccCCC
Confidence 0112334689
Q ss_pred CCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHHHHH
Q 011302 333 HEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISK 411 (489)
Q Consensus 333 ~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~ 411 (489)
+.|+|||++.+..++.++|||||||++|||++ |..||.+....+.+..........+.... .. .++.+||.+
T Consensus 259 ~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~------~~l~~li~~ 331 (359)
T 3vhe_A 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDY-TT------PEMYQTMLD 331 (359)
T ss_dssp GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTT-CC------HHHHHHHHH
T ss_pred ceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCC-CC------HHHHHHHHH
Confidence 99999999999999999999999999999998 99999987755544444332222221111 11 258999999
Q ss_pred HhhcCcccccCCCCChHHHHcC
Q 011302 412 LLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 412 ~L~~dP~~R~~~~~~~~~ll~h 433 (489)
||+.||.+||++. ++++|
T Consensus 332 ~l~~dP~~Rps~~----ell~~ 349 (359)
T 3vhe_A 332 CWHGEPSQRPTFS----ELVEH 349 (359)
T ss_dssp HTCSSGGGSCCHH----HHHHH
T ss_pred HccCChhhCCCHH----HHHHH
Confidence 9999999999987 77665
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=379.99 Aligned_cols=281 Identities=20% Similarity=0.232 Sum_probs=201.5
Q ss_pred cCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccce
Q 011302 78 QGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAE 157 (489)
Q Consensus 78 ~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~ 157 (489)
...+..++|++.+.||+|+||+||+|+++.... ....||||++...... .....++.+|+.+++.++||||++++++
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 93 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDG--SFVKVAVKMLKADIIA-SSDIEEFLREAACMKEFDHPHVAKLVGV 93 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC---------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEE
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCC--cceeEEEEEecccccC-HHHHHHHHHHHHHHHHCCCCceehhhce
Confidence 345667899999999999999999999876311 1237999999765433 2345678889999999999999999999
Q ss_pred eecCceE------EEEEeecCCCchHHHHHhCC----CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccC
Q 011302 158 FEASHYS------CLVMEYCPGGDLYAARQRQP----GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRED 227 (489)
Q Consensus 158 ~~~~~~~------~lV~E~~~gg~L~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~ 227 (489)
+...... |+||||+++|+|.+++.... ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED 173 (323)
T ss_dssp EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT
T ss_pred eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCC
Confidence 9877655 99999999999999886532 1258999999999999999999999999999999999999999
Q ss_pred CcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCC
Q 011302 228 GHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHH 307 (489)
Q Consensus 228 ~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (489)
+.+||+|||+++.......
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~------------------------------------------------------------- 192 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDY------------------------------------------------------------- 192 (323)
T ss_dssp SCEEECCCCC----------------------------------------------------------------------
T ss_pred CCEEEeecccccccccccc-------------------------------------------------------------
Confidence 9999999999843321000
Q ss_pred CccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCC
Q 011302 308 DQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPL 386 (489)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~ 386 (489)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+..+..
T Consensus 193 ---------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~ 257 (323)
T 3qup_A 193 ---------------YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR 257 (323)
T ss_dssp -----------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred ---------------ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC
Confidence 001122357889999999999999999999999999999999 9999999888888777766542
Q ss_pred CCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCC---ChHHHHcCCCcCCCCccccc
Q 011302 387 TFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLK---GSVEIKRHEFFKGINWALIR 445 (489)
Q Consensus 387 ~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~---~~~~ll~hp~f~~~~~~~~~ 445 (489)
..... ... ..+.+||.+||+.||++||++.+ .+++++.|+|+.+..++.+.
T Consensus 258 ~~~~~--~~~------~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl~ 311 (323)
T 3qup_A 258 LKQPP--ECM------EEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPLY 311 (323)
T ss_dssp CCCCT--TCC------HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------------
T ss_pred CCCCC--ccC------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCCC
Confidence 21111 111 25899999999999999999543 34588999999887766553
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=400.35 Aligned_cols=261 Identities=19% Similarity=0.214 Sum_probs=190.8
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC--CCCCccccc------
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML--DHPFLPTLY------ 155 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l--~hpnIv~l~------ 155 (489)
.+|++.+.||+|+||+||+|++.. +++.||||++.............+.+|+.+++.+ +||||++++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p 136 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVE-----RLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLP 136 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCC
T ss_pred eeeeeeeeccCCCCEEEEEEEECC-----CCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEee
Confidence 459999999999999999999886 5789999999875433334455666775544444 699988755
Q ss_pred -ceeecC-----------------ceEEEEEeecCCCchHHHHHhCCCCCCChhhH------HHHHHHHHHHHHHHHhCC
Q 011302 156 -AEFEAS-----------------HYSCLVMEYCPGGDLYAARQRQPGKRFGISSA------KFYAAETLLALEYLHMMG 211 (489)
Q Consensus 156 -~~~~~~-----------------~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~------~~i~~qi~~~L~yLH~~~ 211 (489)
+++... ..+|||||||+ |+|.+++.... ..+.+..+ ..++.||+.||+|||++|
T Consensus 137 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ 214 (371)
T 3q60_A 137 SDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSKG 214 (371)
T ss_dssp CEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC
Confidence 333322 44899999997 89999987642 23445445 567799999999999999
Q ss_pred CeeecCCCCCeEeccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccc
Q 011302 212 IVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKK 291 (489)
Q Consensus 212 iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (489)
||||||||+||||+.+|.+||+|||+|+....
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~------------------------------------------------ 246 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT------------------------------------------------ 246 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTC------------------------------------------------
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCC------------------------------------------------
Confidence 99999999999999999999999999843210
Q ss_pred cccccccccccCCCCCCccccCCccccccccccCCccccCCCCccCcchhcC--CCCCCcccHHHHHHHHHHHhhCCCCC
Q 011302 292 AVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISG--QGHGSAVDWWTLGVFLYEMLYGTTPF 369 (489)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--~~~~~~~DiwSlGvil~elltG~~Pf 369 (489)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 247 ---------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 247 ---------------------------------RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp ---------------------------------EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred ---------------------------------CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 0112357799999999987 67999999999999999999999999
Q ss_pred CCCCcHHH--HHH-----HhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcc
Q 011302 370 KGENNEKT--LIN-----ILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWA 442 (489)
Q Consensus 370 ~~~~~~~~--~~~-----i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~ 442 (489)
.+...... +.. .......++... ..+..+.+||.+||+.||++||++. ++++||||+.+.|.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~li~~~L~~dP~~Rpt~~----e~l~hp~f~~~~~~ 362 (371)
T 3q60_A 294 GLVTPGIKGSWKRPSLRVPGTDSLAFGSCT-------PLPDFVKTLIGRFLNFDRRRRLLPL----EAMETPEFLQLQNE 362 (371)
T ss_dssp TBCCTTCTTCCCBCCTTSCCCCSCCCTTSS-------CCCHHHHHHHHHHTCSSTTTCCCHH----HHTTSHHHHHHHHH
T ss_pred CCcCcccccchhhhhhhhccccccchhhcc-------CCCHHHHHHHHHHcCCChhhCCCHH----HHhcCHHHHHHHHH
Confidence 87643210 000 001111222111 1123589999999999999999987 99999999998875
Q ss_pred c
Q 011302 443 L 443 (489)
Q Consensus 443 ~ 443 (489)
.
T Consensus 363 ~ 363 (371)
T 3q60_A 363 I 363 (371)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-48 Score=387.79 Aligned_cols=269 Identities=27% Similarity=0.386 Sum_probs=197.8
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.++|++.+.||+|+||+||+|+++. +++.||||++.... ....+...|+..+..++||||++++++|...+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~ 92 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKS-----TGMSVAIKKVIQDP----RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLG 92 (360)
T ss_dssp HTTEEEC----------CEEEEETT-----TCCEEEEEEEECCT----TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECC-----CCCEEEEEEEecCc----cccHHHHHHHHHHHhcCCCCcccHHHhhhccc
Confidence 4799999999999999999999986 57899999986532 12234455777788899999999999986533
Q ss_pred -------eEEEEEeecCCCchHHHHHh--CCCCCCChhhHHHHHHHHHHHHHHHH--hCCCeeecCCCCCeEecc-CCcE
Q 011302 163 -------YSCLVMEYCPGGDLYAARQR--QPGKRFGISSAKFYAAETLLALEYLH--MMGIVYRDLKPENVLVRE-DGHI 230 (489)
Q Consensus 163 -------~~~lV~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~yLH--~~~iiHrDIKp~NILl~~-~~~v 230 (489)
.+|+||||+++ +|...+.. .....+++..++.++.||+.||.||| ++||+||||||+|||++. ++.+
T Consensus 93 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 93 ERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp SSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEE
T ss_pred cccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcE
Confidence 38999999975 55443332 23467899999999999999999999 999999999999999996 8999
Q ss_pred EEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCcc
Q 011302 231 MLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQE 310 (489)
Q Consensus 231 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (489)
||+|||+++.+...
T Consensus 172 kl~Dfg~a~~~~~~------------------------------------------------------------------ 185 (360)
T 3e3p_A 172 KLCDFGSAKKLSPS------------------------------------------------------------------ 185 (360)
T ss_dssp EECCCTTCBCCCTT------------------------------------------------------------------
T ss_pred EEeeCCCceecCCC------------------------------------------------------------------
Confidence 99999998433210
Q ss_pred ccCCccccccccccCCccccCCCCccCcchhcCCC-CCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCC--
Q 011302 311 LLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQG-HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLT-- 387 (489)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-- 387 (489)
......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+....+..+......
T Consensus 186 -------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 252 (360)
T 3e3p_A 186 -------------EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252 (360)
T ss_dssp -------------SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred -------------CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCC
Confidence 0122347899999999997765 899999999999999999999999998887776666431000
Q ss_pred ---------------CCCCCCCC-chh-----HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcccc
Q 011302 388 ---------------FPRIGVSS-SKE-----FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALI 444 (489)
Q Consensus 388 ---------------~p~~~~~~-~~~-----~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~ 444 (489)
+....... ... .....++.+||.+||+.||.+||++. ++++||||+.+.+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~----e~l~hp~f~~~~~~~~ 326 (360)
T 3e3p_A 253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPY----EALCHPYFDELHDPAT 326 (360)
T ss_dssp HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHH----HHTTSGGGGGGGCTTC
T ss_pred HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHH----HHhcCccccccCCccc
Confidence 00000000 000 01234689999999999999999987 9999999998766544
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=378.69 Aligned_cols=259 Identities=23% Similarity=0.282 Sum_probs=211.1
Q ss_pred cCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccce
Q 011302 78 QGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAE 157 (489)
Q Consensus 78 ~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~ 157 (489)
..++..++|++.+.||+|+||+||+|+++.+.. .+..||||++..... ......+.+|+.+|+.++||||++++++
T Consensus 43 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 118 (325)
T 3kul_A 43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQ--RDVPVAIKALKAGYT--ERQRRDFLSEASIMGQFDHPNIIRLEGV 118 (325)
T ss_dssp CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTS--CCEEEEEEEECTTCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccccChhHeEEeeEEEeCCCcEEEEEEEecCCC--CCceEEEEecCCCCC--HHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 345677899999999999999999999875322 356799999975421 1234567789999999999999999999
Q ss_pred eecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCC
Q 011302 158 FEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237 (489)
Q Consensus 158 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~ 237 (489)
+.+++..|+||||++||+|.+++... ...+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 197 (325)
T 3kul_A 119 VTRGRLAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGL 197 (325)
T ss_dssp ECGGGCCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSS
T ss_pred EEeCCccEEEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCc
Confidence 99999999999999999999998654 35799999999999999999999999999999999999999999999999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
++.+......
T Consensus 198 a~~~~~~~~~---------------------------------------------------------------------- 207 (325)
T 3kul_A 198 SRVLEDDPDA---------------------------------------------------------------------- 207 (325)
T ss_dssp CEECC----C----------------------------------------------------------------------
T ss_pred ccccccCccc----------------------------------------------------------------------
Confidence 8543211000
Q ss_pred cccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCc
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSS 396 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 396 (489)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+..+.. .+... ...
T Consensus 208 -----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~-~~~ 280 (325)
T 3kul_A 208 -----AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYR-LPAPM-GCP 280 (325)
T ss_dssp -----CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC-CCCCT-TCC
T ss_pred -----eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCC-CCCCC-CcC
Confidence 001122357889999999998889999999999999999998 9999999988888877766522 22111 111
Q ss_pred hhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 397 KEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 397 ~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
..+.+||.+||..||++||++.
T Consensus 281 ------~~l~~li~~~l~~dp~~Rps~~ 302 (325)
T 3kul_A 281 ------HALHQLMLDCWHKDRAQRPRFS 302 (325)
T ss_dssp ------HHHHHHHHHHTCSSGGGSCCHH
T ss_pred ------HHHHHHHHHHccCChhhCcCHH
Confidence 2589999999999999999987
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=376.75 Aligned_cols=263 Identities=31% Similarity=0.469 Sum_probs=218.5
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.++|++++.||+|+||.||+|++.. +++.||||++...... ......+.+|+.+++.++||||+++++++.+.+
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~-----~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRI-----TQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSS 94 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcC-----CCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCC
Confidence 3689999999999999999999876 5788999999754321 122345677999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccC---CcEEEcccCCCc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRED---GHIMLSDFDLSF 239 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~---~~vkl~DFG~a~ 239 (489)
.+|+||||+++++|.+++... ..+++.++..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 95 SFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred eEEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 999999999999999888765 569999999999999999999999999999999999999754 479999999974
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
.....
T Consensus 173 ~~~~~--------------------------------------------------------------------------- 177 (287)
T 2wei_A 173 CFQQN--------------------------------------------------------------------------- 177 (287)
T ss_dssp TBCCC---------------------------------------------------------------------------
T ss_pred eecCC---------------------------------------------------------------------------
Confidence 32110
Q ss_pred cccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhH
Q 011302 320 EPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEF 399 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 399 (489)
.......||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+..+....+..+...++......
T Consensus 178 ----~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 248 (287)
T 2wei_A 178 ----TKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRT---- 248 (287)
T ss_dssp ----SSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTT----
T ss_pred ----CccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhh----
Confidence 011223588999999999875 89999999999999999999999999988888888777655443221111
Q ss_pred HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcc
Q 011302 400 EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWA 442 (489)
Q Consensus 400 ~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~ 442 (489)
....+.+||.+||..||++||++. ++++||||+...|+
T Consensus 249 -~~~~~~~li~~~l~~dp~~Rps~~----ell~hp~~~~~~~~ 286 (287)
T 2wei_A 249 -ISDDAKDLIRKMLTFHPSLRITAT----QCLEHPWIQKYSSE 286 (287)
T ss_dssp -SCHHHHHHHHHHTCSSGGGSCCHH----HHHHSHHHHHHCCC
T ss_pred -cCHHHHHHHHHHcccChhhCcCHH----HHhcCHHHhccccC
Confidence 123589999999999999999987 99999999877654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=381.90 Aligned_cols=282 Identities=21% Similarity=0.251 Sum_probs=223.6
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccccccee
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEF 158 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 158 (489)
+++..++|++.+.||+|+||.||+|++++.....+++.||||++...... ....++.+|+.+++.++||||+++++++
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM--RERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH--HHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCH--HHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 55677899999999999999999999874322235688999999754321 2334577899999999999999999999
Q ss_pred ecCceEEEEEeecCCCchHHHHHhCC--------CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcE
Q 011302 159 EASHYSCLVMEYCPGGDLYAARQRQP--------GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHI 230 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~v 230 (489)
.+.+..|+||||++||+|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeE
Confidence 99999999999999999999886531 1457899999999999999999999999999999999999999999
Q ss_pred EEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCcc
Q 011302 231 MLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQE 310 (489)
Q Consensus 231 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (489)
||+|||+++.......
T Consensus 178 kl~Dfg~~~~~~~~~~---------------------------------------------------------------- 193 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDY---------------------------------------------------------------- 193 (322)
T ss_dssp EECCTTCCCGGGGGGC----------------------------------------------------------------
T ss_pred EECcCccccccccccc----------------------------------------------------------------
Confidence 9999999843211000
Q ss_pred ccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCC
Q 011302 311 LLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFP 389 (489)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p 389 (489)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+..+.....
T Consensus 194 ------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 261 (322)
T 1p4o_A 194 ------------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 261 (322)
T ss_dssp ------------EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCC
T ss_pred ------------cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcCCC
Confidence 001123357899999999999899999999999999999999 8999999888887777766543211
Q ss_pred CCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHc--CCCcCCCCcccccc
Q 011302 390 RIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKR--HEFFKGINWALIRS 446 (489)
Q Consensus 390 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~--hp~f~~~~~~~~~~ 446 (489)
. .... ..+.+||.+||+.||++||++.+.++.+.+ .++|+.++|.....
T Consensus 262 ~--~~~~------~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~~~~~~~ 312 (322)
T 1p4o_A 262 P--DNCP------DMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEE 312 (322)
T ss_dssp C--TTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCSTTSTT
T ss_pred C--CCCC------HHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCcccccccccc
Confidence 1 1111 248999999999999999999733333322 28888777765543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=385.19 Aligned_cols=269 Identities=26% Similarity=0.336 Sum_probs=206.2
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHH--------HHHHHHHHHHHHHHHHHHhCCCCCcc
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREA--------LAIRKKLHRADMEKVILTMLDHPFLP 152 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~--------~~~~~~~~~~~~E~~~l~~l~hpnIv 152 (489)
...++|++.+.||+|+||.||+|.+.. ++.||||++.... ........++.+|+.+++.++||||+
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSE------GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTT------SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HhccceEEeEEeccCCCEEEEEEECCC------CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 345899999999999999999998753 6789999885321 11123346678899999999999999
Q ss_pred cccceee-----cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccC
Q 011302 153 TLYAEFE-----ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRED 227 (489)
Q Consensus 153 ~l~~~~~-----~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~ 227 (489)
++++++. ....+|+||||+. |+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~ 170 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADN 170 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCC
Confidence 9999984 4457899999996 7888887754 3579999999999999999999999999999999999999999
Q ss_pred CcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCC
Q 011302 228 GHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHH 307 (489)
Q Consensus 228 ~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (489)
+.+||+|||+++....
T Consensus 171 ~~~kl~Dfg~~~~~~~---------------------------------------------------------------- 186 (362)
T 3pg1_A 171 NDITICDFNLAREDTA---------------------------------------------------------------- 186 (362)
T ss_dssp CCEEECCTTC----------------------------------------------------------------------
T ss_pred CCEEEEecCccccccc----------------------------------------------------------------
Confidence 9999999999832110
Q ss_pred CccccCCccccccccccCCccccCCCCccCcchhcC-CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCC
Q 011302 308 DQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL 386 (489)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~ 386 (489)
.......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 187 ---------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 251 (362)
T 3pg1_A 187 ---------------DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVG 251 (362)
T ss_dssp ------------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ---------------ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence 011223478999999999987 6689999999999999999999999999887776666543100
Q ss_pred CC---------------------CCCCCCCchh--HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 387 TF---------------------PRIGVSSSKE--FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 387 ~~---------------------p~~~~~~~~~--~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
.. .......... ......+.+||.+||+.||++||++. ++++||||+.+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~----ell~hp~f~~~~ 324 (362)
T 3pg1_A 252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTE----QALRHPYFESLF 324 (362)
T ss_dssp CCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHH----HHHTSGGGTTTC
T ss_pred CCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHH----HHHcCchhhhcc
Confidence 00 0000000000 01123589999999999999999987 999999999873
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=372.21 Aligned_cols=253 Identities=21% Similarity=0.342 Sum_probs=202.1
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccceeecCc
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAEFEASH 162 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~ 162 (489)
++|++++.||+|+||+||+|++.. +++.||||++...... .....++.+|+..+..+ +||||+++++++.+.+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~ 84 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRL-----DGCIYAIKRSKKPLAG-SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD 84 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECCCTT-SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT
T ss_pred chhhhhhhhcCCCceEEEEEEEcC-----CCceEEEEEecccccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence 689999999999999999999886 5789999999753211 11234566788888888 8999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCC--CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccC-------------
Q 011302 163 YSCLVMEYCPGGDLYAARQRQP--GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRED------------- 227 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~------------- 227 (489)
..|+||||++||+|.+++.... ...+++.+++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------------
T ss_pred eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 9999999999999999987532 2568999999999999999999999999999999999999844
Q ss_pred ------CcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccc
Q 011302 228 ------GHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQ 301 (489)
Q Consensus 228 ------~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (489)
+.+||+|||++.....
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~---------------------------------------------------------- 186 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISS---------------------------------------------------------- 186 (289)
T ss_dssp -----CCCEEECCCTTCEETTC----------------------------------------------------------
T ss_pred cccCCceEEEEcccccccccCC----------------------------------------------------------
Confidence 4799999999743210
Q ss_pred cCCCCCCccccCCccccccccccCCccccCCCCccCcchhcCC-CCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHH
Q 011302 302 VDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQ-GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLIN 380 (489)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~ 380 (489)
.....||+.|+|||++.+. .++.++|||||||++|||++|.+|+.... ....
T Consensus 187 ------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~ 239 (289)
T 1x8b_A 187 ------------------------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHE 239 (289)
T ss_dssp ------------------------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHH
T ss_pred ------------------------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHH
Confidence 1123589999999999876 46789999999999999999998876543 3344
Q ss_pred HhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 381 ILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 381 i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
+..+.. +....... ..+.+||.+||+.||++||++. ++++||||++.
T Consensus 240 ~~~~~~--~~~~~~~~------~~~~~li~~~l~~dp~~Rps~~----~ll~h~~~~~~ 286 (289)
T 1x8b_A 240 IRQGRL--PRIPQVLS------QEFTELLKVMIHPDPERRPSAM----ALVKHSVLLSA 286 (289)
T ss_dssp HHTTCC--CCCSSCCC------HHHHHHHHHHTCSSGGGSCCHH----HHHTCTTC---
T ss_pred HHcCCC--CCCCcccC------HHHHHHHHHHhCCCcccCCCHH----HHhhChHhhhh
Confidence 444332 11111111 2589999999999999999987 99999999864
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=373.95 Aligned_cols=256 Identities=27% Similarity=0.418 Sum_probs=215.2
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.+.|++++.||+|+||.||+|++.. +++.||||++...... .....+.+|+.+++.++||||+++++++.+..
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 93 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNR-----TQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT 93 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETT-----TCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HHHHHHhhhhcccCCeEEEEEEECC-----CCcEEEEEEecccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence 3679999999999999999999876 5789999999754321 23456778999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
.+|+||||++|++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 94 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 170 (303)
T 3a7i_A 94 KLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 170 (303)
T ss_dssp EEEEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECB
T ss_pred eEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecC
Confidence 99999999999999998865 469999999999999999999999999999999999999999999999999984322
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
..
T Consensus 171 ~~------------------------------------------------------------------------------ 172 (303)
T 3a7i_A 171 DT------------------------------------------------------------------------------ 172 (303)
T ss_dssp TT------------------------------------------------------------------------------
T ss_pred cc------------------------------------------------------------------------------
Confidence 10
Q ss_pred ccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHH
Q 011302 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEV 402 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~ 402 (489)
........||+.|+|||++.+..++.++|||||||++|||++|..||...........+...... .......
T Consensus 173 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~------ 244 (303)
T 3a7i_A 173 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPP--TLEGNYS------ 244 (303)
T ss_dssp BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC--CCCSSCC------
T ss_pred ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCC--CCccccC------
Confidence 00123347999999999999999999999999999999999999999988877766666543321 1111111
Q ss_pred hhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 403 VKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 403 ~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
..+.+||.+||..||++||++. ++++||||..
T Consensus 245 ~~l~~li~~~l~~dp~~Rps~~----~ll~~~~~~~ 276 (303)
T 3a7i_A 245 KPLKEFVEACLNKEPSFRPTAK----ELLKHKFILR 276 (303)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHH----HHTTCHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHH----HHhhChhhhc
Confidence 2489999999999999999987 9999999954
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=383.57 Aligned_cols=265 Identities=20% Similarity=0.253 Sum_probs=216.3
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCC--CCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCccccc
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMV--GLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLY 155 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~ 155 (489)
+++..++|++.+.||+|+||+||+|++..... ......||||++..... .....++.+|+.+++.+ +||||++++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hpnIv~~~ 141 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLL 141 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccC--HHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence 45677899999999999999999999865322 23456899999976422 23446677899999999 899999999
Q ss_pred ceeecCceEEEEEeecCCCchHHHHHhCC--------------CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCC
Q 011302 156 AEFEASHYSCLVMEYCPGGDLYAARQRQP--------------GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPEN 221 (489)
Q Consensus 156 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~N 221 (489)
+++.+.+.+|+||||++||+|.+++.... ...+++.+++.|+.||+.||+|||++|||||||||+|
T Consensus 142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 221 (382)
T 3tt0_A 142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 221 (382)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence 99999999999999999999999998753 2459999999999999999999999999999999999
Q ss_pred eEeccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccc
Q 011302 222 VLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQ 301 (489)
Q Consensus 222 ILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (489)
|||+.++.+||+|||+|+.......
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~------------------------------------------------------- 246 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDY------------------------------------------------------- 246 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCT-------------------------------------------------------
T ss_pred EEEcCCCcEEEcccCcccccccccc-------------------------------------------------------
Confidence 9999999999999999843321000
Q ss_pred cCCCCCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHH
Q 011302 302 VDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLIN 380 (489)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~ 380 (489)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....
T Consensus 247 ---------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~ 305 (382)
T 3tt0_A 247 ---------------------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 305 (382)
T ss_dssp ---------------------TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred ---------------------cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 011223357889999999999999999999999999999999 9999999888877777
Q ss_pred HhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 381 ILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 381 i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
+..+...... .... .++.+||.+||+.||++||++. +++++
T Consensus 306 ~~~~~~~~~~--~~~~------~~l~~li~~~l~~dP~~Rps~~----ell~~ 346 (382)
T 3tt0_A 306 LKEGHRMDKP--SNCT------NELYMMMRDCWHAVPSQRPTFK----QLVED 346 (382)
T ss_dssp HHTTCCCCCC--SSCC------HHHHHHHHHHTCSSGGGSCCHH----HHHHH
T ss_pred HHcCCCCCCC--ccCC------HHHHHHHHHHcCCChhhCcCHH----HHHHH
Confidence 7654322111 1111 2589999999999999999987 66554
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=380.27 Aligned_cols=266 Identities=18% Similarity=0.235 Sum_probs=214.1
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccce
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAE 157 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~ 157 (489)
+++..++|.+.+.||+|+||.||+|++........+..||||++..... ......+.+|+.+|+.+ +||||++++++
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 117 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLGA 117 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 5677789999999999999999999986543334678899999975432 23456788899999999 89999999999
Q ss_pred eecCceEEEEEeecCCCchHHHHHhCCC---------------------CCCChhhHHHHHHHHHHHHHHHHhCCCeeec
Q 011302 158 FEASHYSCLVMEYCPGGDLYAARQRQPG---------------------KRFGISSAKFYAAETLLALEYLHMMGIVYRD 216 (489)
Q Consensus 158 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~---------------------~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrD 216 (489)
+...+.+|+||||++||+|.+++..... ..+++..+..++.||+.||+|||++||+|||
T Consensus 118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D 197 (344)
T 1rjb_A 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 197 (344)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 9999999999999999999999976532 2378999999999999999999999999999
Q ss_pred CCCCCeEeccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCcccccccccccccccccccccc
Q 011302 217 LKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVT 296 (489)
Q Consensus 217 IKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (489)
|||+|||++.++.+||+|||++..+.....
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-------------------------------------------------- 227 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSN-------------------------------------------------- 227 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTT--------------------------------------------------
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCcc--------------------------------------------------
Confidence 999999999999999999999843321000
Q ss_pred ccccccCCCCCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcH
Q 011302 297 TIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNE 375 (489)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~ 375 (489)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+....
T Consensus 228 --------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 281 (344)
T 1rjb_A 228 --------------------------YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 281 (344)
T ss_dssp --------------------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred --------------------------ceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH
Confidence 001123467899999999999999999999999999999998 99999988776
Q ss_pred HHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 376 KTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 376 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
..+..+.......+.... . ...+.+||.+||..||.+||++. ++++|
T Consensus 282 ~~~~~~~~~~~~~~~~~~-~------~~~l~~li~~~l~~dp~~Rps~~----~l~~~ 328 (344)
T 1rjb_A 282 ANFYKLIQNGFKMDQPFY-A------TEEIYIIMQSCWAFDSRKRPSFP----NLTSF 328 (344)
T ss_dssp HHHHHHHHTTCCCCCCTT-C------CHHHHHHHHHHTCSSGGGSCCHH----HHHHH
T ss_pred HHHHHHHhcCCCCCCCCC-C------CHHHHHHHHHHcCCCchhCcCHH----HHHHH
Confidence 666666554433322211 1 12589999999999999999987 67665
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=380.60 Aligned_cols=264 Identities=28% Similarity=0.374 Sum_probs=208.6
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.++|.+.+.||+|+||.||+|+++. +++.||||++...... .....++.+|+.+++.++||||+++++++....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 96 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKR-----SGEKVAIKKLSRPFQS-EIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS 96 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEESSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred CceEEEeeeEecCCCeEEEEEEECC-----CCCEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCCcccHhheEeccc
Confidence 3789999999999999999999886 5789999999653211 233456778999999999999999999998765
Q ss_pred e------EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccC
Q 011302 163 Y------SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFD 236 (489)
Q Consensus 163 ~------~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG 236 (489)
. +|+||||+. |+|.+++. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 97 ~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg 171 (353)
T 3coi_A 97 SLRNFYDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFG 171 (353)
T ss_dssp SGGGCCCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTT
T ss_pred ccccceeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecc
Confidence 4 599999995 78877653 359999999999999999999999999999999999999999999999999
Q ss_pred CCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcc
Q 011302 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPE 316 (489)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (489)
+++....
T Consensus 172 ~~~~~~~------------------------------------------------------------------------- 178 (353)
T 3coi_A 172 LARHADA------------------------------------------------------------------------- 178 (353)
T ss_dssp CTTC----------------------------------------------------------------------------
T ss_pred cccCCCC-------------------------------------------------------------------------
Confidence 9732110
Q ss_pred ccccccccCCccccCCCCccCcchhcC-CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCC--------
Q 011302 317 VVAEPINARSKSFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLT-------- 387 (489)
Q Consensus 317 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-------- 387 (489)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+..+.+..+......
T Consensus 179 --------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 179 --------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp -------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred --------CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 1123468999999999987 66899999999999999999999999998876666555431000
Q ss_pred ------------CCCCCCC--CchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcc
Q 011302 388 ------------FPRIGVS--SSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWA 442 (489)
Q Consensus 388 ------------~p~~~~~--~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~ 442 (489)
.+..... ..........+.+||.+||+.||++||++. ++++||||+.+...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~----e~l~hp~f~~~~~~ 315 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAA----QALTHPFFEPFRDP 315 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHH----HHHTSGGGTTTCCG
T ss_pred HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHH----HHhcCcchhhccCc
Confidence 0000000 000001123589999999999999999987 99999999987654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=366.80 Aligned_cols=255 Identities=22% Similarity=0.280 Sum_probs=212.7
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccccccee
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEF 158 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 158 (489)
+.+..++|++++.||+|+||.||+|++.+ ++.||+|++...... ..++.+|+.+++.++||||+++++++
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~ 74 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWLN------KDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVC 74 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETT------TEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred EEeChhhceeeheecCCCccEEEEEEecC------CCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 56777899999999999999999999874 467999999764322 13466799999999999999999999
Q ss_pred ecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 159 EASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
.+.+..|+||||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 153 (269)
T 4hcu_A 75 LEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT 153 (269)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGG
T ss_pred ecCCceEEEEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccc
Confidence 99999999999999999999987643 56999999999999999999999999999999999999999999999999998
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
.......
T Consensus 154 ~~~~~~~------------------------------------------------------------------------- 160 (269)
T 4hcu_A 154 RFVLDDQ------------------------------------------------------------------------- 160 (269)
T ss_dssp GGBCCHH-------------------------------------------------------------------------
T ss_pred ccccccc-------------------------------------------------------------------------
Confidence 4321100
Q ss_pred ccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCch
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSK 397 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 397 (489)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+........... .
T Consensus 161 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~-- 232 (269)
T 4hcu_A 161 ----YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRL--A-- 232 (269)
T ss_dssp ----HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTT--S--
T ss_pred ----cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCc--C--
Confidence 001123357889999999999999999999999999999999 9999999988888887776532221111 1
Q ss_pred hHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 398 EFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 398 ~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
...+.+||.+||+.||++||++. ++++|
T Consensus 233 ----~~~~~~li~~~l~~~p~~Rps~~----~ll~~ 260 (269)
T 4hcu_A 233 ----STHVYQIMNHCWRERPEDRPAFS----RLLRQ 260 (269)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHH----HHHHH
T ss_pred ----CHHHHHHHHHHccCCcccCcCHH----HHHHH
Confidence 12589999999999999999987 66664
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=379.21 Aligned_cols=265 Identities=21% Similarity=0.287 Sum_probs=216.9
Q ss_pred cCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccce
Q 011302 78 QGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAE 157 (489)
Q Consensus 78 ~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~ 157 (489)
...+..++|++++.||+|+||.||+|++.+.....+++.||||++..... ......+.+|+.+++.++||||++++++
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 35677899999999999999999999998643334568999999976432 2344567889999999999999999999
Q ss_pred eecCceEEEEEeecCCCchHHHHHhCC----------------------CCCCChhhHHHHHHHHHHHHHHHHhCCCeee
Q 011302 158 FEASHYSCLVMEYCPGGDLYAARQRQP----------------------GKRFGISSAKFYAAETLLALEYLHMMGIVYR 215 (489)
Q Consensus 158 ~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHr 215 (489)
+.+.+.+|+||||++||+|.+++.... ...+++.++..++.||+.||.|||++||+||
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~ 198 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 999999999999999999999987642 1568999999999999999999999999999
Q ss_pred cCCCCCeEeccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccc
Q 011302 216 DLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTV 295 (489)
Q Consensus 216 DIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (489)
||||+|||++.++.+||+|||+++......
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-------------------------------------------------- 228 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSAD-------------------------------------------------- 228 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGG--------------------------------------------------
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCc--------------------------------------------------
Confidence 999999999999999999999984321100
Q ss_pred cccccccCCCCCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCc
Q 011302 296 TTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENN 374 (489)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~ 374 (489)
.........||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+.
T Consensus 229 --------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 282 (343)
T 1luf_A 229 --------------------------YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 282 (343)
T ss_dssp --------------------------CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred --------------------------cccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh
Confidence 0001123468999999999999899999999999999999999 9999999988
Q ss_pred HHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHc
Q 011302 375 EKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKR 432 (489)
Q Consensus 375 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~ 432 (489)
.+....+..+...... .... ..+.+||.+||+.||++||++. ++++
T Consensus 283 ~~~~~~~~~~~~~~~~--~~~~------~~l~~li~~~l~~~p~~Rps~~----~~~~ 328 (343)
T 1luf_A 283 EEVIYYVRDGNILACP--ENCP------LELYNLMRLCWSKLPADRPSFC----SIHR 328 (343)
T ss_dssp HHHHHHHHTTCCCCCC--TTCC------HHHHHHHHHHTCSSGGGSCCHH----HHHH
T ss_pred HHHHHHHhCCCcCCCC--CCCC------HHHHHHHHHHcccCcccCCCHH----HHHH
Confidence 8887777765432111 1111 2589999999999999999986 5554
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=378.07 Aligned_cols=272 Identities=19% Similarity=0.270 Sum_probs=210.8
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccceeecC
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAEFEAS 161 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~ 161 (489)
.++|++.+.||+|+||+||+|++.. +++.||||++.... ....+.+|+.+++.+ +||||+++++++.++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 77 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLY-----TNEYVAIKLEPMKS-----RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCG 77 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETT-----TTEEEEEEEEETTC-----SSCCHHHHHHHHHHHCSCTTSCCEEEEEEET
T ss_pred cCCeEEEEEeeccCCceEEEEEECC-----CCcEEEEEEecccc-----chHHHHHHHHHHHHhhCCCCCCEEEEEEecC
Confidence 4789999999999999999999876 57899999987542 234577799999999 899999999999999
Q ss_pred ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCc-----EEEcccC
Q 011302 162 HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGH-----IMLSDFD 236 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~-----vkl~DFG 236 (489)
+..|+||||+ |++|.+++... ...+++..+..|+.||+.||+|||++|||||||||+|||++.++. +||+|||
T Consensus 78 ~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg 155 (330)
T 2izr_A 78 KYNAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFA 155 (330)
T ss_dssp TEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCT
T ss_pred CccEEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcc
Confidence 9999999999 99999999865 357999999999999999999999999999999999999998887 9999999
Q ss_pred CCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcc
Q 011302 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPE 316 (489)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (489)
+|+.+......
T Consensus 156 ~a~~~~~~~~~--------------------------------------------------------------------- 166 (330)
T 2izr_A 156 LAKEYIDPETK--------------------------------------------------------------------- 166 (330)
T ss_dssp TCEESBCTTTC---------------------------------------------------------------------
T ss_pred cceeeecCCCC---------------------------------------------------------------------
Confidence 98543211000
Q ss_pred ccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCc---HHHHHHHhcCCCCCCCCCC
Q 011302 317 VVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENN---EKTLINILKKPLTFPRIGV 393 (489)
Q Consensus 317 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~p~~~~ 393 (489)
...........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+. .+.+..+.......+...
T Consensus 167 --~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~- 243 (330)
T 2izr_A 167 --KHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEV- 243 (330)
T ss_dssp --CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHH-
T ss_pred --ccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHH-
Confidence 00001123456899999999999999999999999999999999999999988543 334444433222222100
Q ss_pred CCchhHHHHhhHHHHHHHHhhcCcccccCCCCCh---HHHH---cCCCcCCCCcc
Q 011302 394 SSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGS---VEIK---RHEFFKGINWA 442 (489)
Q Consensus 394 ~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~---~~ll---~hp~f~~~~~~ 442 (489)
.....+++.+||.+||+.||.+||++.+.. .+++ ...+...++|.
T Consensus 244 ----~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~ 294 (330)
T 2izr_A 244 ----LCENFPEMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWI 294 (330)
T ss_dssp ----HTTTCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTT
T ss_pred ----HhccChHHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCC
Confidence 000011589999999999999999985221 1111 13445578887
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=375.40 Aligned_cols=271 Identities=21% Similarity=0.278 Sum_probs=207.1
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccccccee---
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEF--- 158 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~--- 158 (489)
..++|++++.||+|+||.||+|++.. +++.||||++.... .....++.+|+.+++.++||||+++++++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 80 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDND-----CDKRVAIKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVFEILGPS 80 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETT-----TTEEEEEEEEECCS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTT
T ss_pred cCCceeEEEEeccCCCeEEEEEEECC-----CCeEEEEEEEecCC---hHHHHHHHHHHHHHHhcCCCCeeEEEEecccc
Confidence 34789999999999999999999886 57899999987542 23345677899999999999999999887
Q ss_pred -----------ecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEec-c
Q 011302 159 -----------EASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVR-E 226 (489)
Q Consensus 159 -----------~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~-~ 226 (489)
.+....|+||||++ |+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++ .
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~ 156 (320)
T 2i6l_A 81 GSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTE 156 (320)
T ss_dssp SCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT
T ss_pred ccccccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC
Confidence 34578999999996 799998864 5699999999999999999999999999999999999997 5
Q ss_pred CCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCC
Q 011302 227 DGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDH 306 (489)
Q Consensus 227 ~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (489)
++.+||+|||+++.......
T Consensus 157 ~~~~kl~Dfg~~~~~~~~~~------------------------------------------------------------ 176 (320)
T 2i6l_A 157 DLVLKIGDFGLARIMDPHYS------------------------------------------------------------ 176 (320)
T ss_dssp TTEEEECCCTTCBCC-----------------------------------------------------------------
T ss_pred CCeEEEccCccccccCCCcc------------------------------------------------------------
Confidence 67999999999843321000
Q ss_pred CCccccCCccccccccccCCccccCCCCccCcchhcC-CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCC
Q 011302 307 HDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP 385 (489)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~ 385 (489)
.........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+....
T Consensus 177 ---------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 241 (320)
T 2i6l_A 177 ---------------HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241 (320)
T ss_dssp ------------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred ---------------cccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 0011223468999999999876 668999999999999999999999999988777666665421
Q ss_pred CCCCCC-------------------CCCCchh--HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccc
Q 011302 386 LTFPRI-------------------GVSSSKE--FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWAL 443 (489)
Q Consensus 386 ~~~p~~-------------------~~~~~~~--~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~ 443 (489)
...... ....... .....++.+||.+||+.||++||++. ++++||||+.++|..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~----ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAE----EALSHPYMSIYSFPM 316 (320)
T ss_dssp CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHH----HHHTSHHHHTTCC--
T ss_pred CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHH----HHhCCcccccccCcc
Confidence 110000 0000000 01123689999999999999999987 999999999988753
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=374.33 Aligned_cols=267 Identities=21% Similarity=0.251 Sum_probs=216.3
Q ss_pred hcCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccc
Q 011302 77 AQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYA 156 (489)
Q Consensus 77 ~~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~ 156 (489)
..+.+..++|.+.+.||+|+||.||+|.+........+..||||++..... ......+.+|+.+++.++||||+++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~ 93 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS--PSELRDLLSEFNVLKQVNHPHVIKLYG 93 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCC--HHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCC--HHHHHHHHHHHHHHhhCCCCceeeEEE
Confidence 345677899999999999999999999986433223568999999975421 234456778999999999999999999
Q ss_pred eeecCceEEEEEeecCCCchHHHHHhCCC----------------------CCCChhhHHHHHHHHHHHHHHHHhCCCee
Q 011302 157 EFEASHYSCLVMEYCPGGDLYAARQRQPG----------------------KRFGISSAKFYAAETLLALEYLHMMGIVY 214 (489)
Q Consensus 157 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~----------------------~~l~~~~~~~i~~qi~~~L~yLH~~~iiH 214 (489)
++.+.+..|+||||++||+|.+++..... ..+++.++..++.||+.||+|||++||+|
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH 173 (314)
T 2ivs_A 94 ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVH 173 (314)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred EEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence 99999999999999999999999986532 34899999999999999999999999999
Q ss_pred ecCCCCCeEeccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCcccccccccccccccccccc
Q 011302 215 RDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVT 294 (489)
Q Consensus 215 rDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (489)
|||||+|||++.++.+||+|||+++.......
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~------------------------------------------------ 205 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDS------------------------------------------------ 205 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSC------------------------------------------------
T ss_pred cccchheEEEcCCCCEEEcccccccccccccc------------------------------------------------
Confidence 99999999999999999999999843321000
Q ss_pred ccccccccCCCCCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCC
Q 011302 295 VTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGEN 373 (489)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~ 373 (489)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 206 ----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 206 ----------------------------YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp ----------------------------EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ----------------------------ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 001123357899999999999889999999999999999999 999999988
Q ss_pred cHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 374 NEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 374 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
.......+........ .... ...+.+||.+||+.||++||++. +++++
T Consensus 258 ~~~~~~~~~~~~~~~~--~~~~------~~~~~~li~~~l~~dp~~Rps~~----~l~~~ 305 (314)
T 2ivs_A 258 PERLFNLLKTGHRMER--PDNC------SEEMYRLMLQCWKQEPDKRPVFA----DISKD 305 (314)
T ss_dssp GGGHHHHHHTTCCCCC--CTTC------CHHHHHHHHHHTCSSGGGSCCHH----HHHHH
T ss_pred HHHHHHHhhcCCcCCC--CccC------CHHHHHHHHHHccCChhhCcCHH----HHHHH
Confidence 8777766655432111 1111 12589999999999999999987 66554
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=370.01 Aligned_cols=260 Identities=23% Similarity=0.345 Sum_probs=213.8
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee--c
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE--A 160 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~--~ 160 (489)
.++|++++.||+|+||.||+|+++. +++.||+|++...... ......+.+|+.+++.++||||+++++++. .
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKS-----DGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT 78 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT-----TCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG
T ss_pred hhheeeehhccCCCCcEEEEEEECC-----CCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC
Confidence 4789999999999999999999886 5789999999754322 123456778999999999999999999874 4
Q ss_pred CceEEEEEeecCCCchHHHHHhC--CCCCCChhhHHHHHHHHHHHHHHHHhCC-----CeeecCCCCCeEeccCCcEEEc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQ--PGKRFGISSAKFYAAETLLALEYLHMMG-----IVYRDLKPENVLVREDGHIMLS 233 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~yLH~~~-----iiHrDIKp~NILl~~~~~vkl~ 233 (489)
...+|+||||++||+|.+++... ....+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~ 158 (279)
T 2w5a_A 79 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG 158 (279)
T ss_dssp GTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEEC
T ss_pred CceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEe
Confidence 67899999999999999988753 2245999999999999999999999999 9999999999999999999999
Q ss_pred ccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccC
Q 011302 234 DFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLD 313 (489)
Q Consensus 234 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (489)
|||+++......
T Consensus 159 dfg~~~~~~~~~-------------------------------------------------------------------- 170 (279)
T 2w5a_A 159 DFGLARILNHDT-------------------------------------------------------------------- 170 (279)
T ss_dssp CCCHHHHC---C--------------------------------------------------------------------
T ss_pred cCchheeecccc--------------------------------------------------------------------
Confidence 999974321100
Q ss_pred CccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCC
Q 011302 314 DPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGV 393 (489)
Q Consensus 314 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~ 393 (489)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+..+.... ...
T Consensus 171 ----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~--~~~ 238 (279)
T 2w5a_A 171 ----------SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR--IPY 238 (279)
T ss_dssp ----------HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC--CCT
T ss_pred ----------ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccccc--CCc
Confidence 00122468999999999999999999999999999999999999999988877777776654321 111
Q ss_pred CCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 394 SSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 394 ~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
.. ...+.+||.+||+.||++||++. ++++|+|+.+
T Consensus 239 ~~------~~~l~~li~~~l~~~p~~Rps~~----~ll~~~~~~~ 273 (279)
T 2w5a_A 239 RY------SDELNEIITRMLNLKDYHRPSVE----EILENPLILE 273 (279)
T ss_dssp TS------CHHHHHHHHHHTCSSGGGSCCHH----HHHTSTTCCG
T ss_pred cc------CHHHHHHHHHHcCCCcccCCCHH----HHHhChhhhh
Confidence 11 12589999999999999999987 9999999976
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=377.60 Aligned_cols=260 Identities=20% Similarity=0.235 Sum_probs=205.2
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE 159 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 159 (489)
.+..++|++++.||+|+||+||+|++...... ....||+|.+..... ......+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-~~~kv~~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 85 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGES-IKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP 85 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCS-CCEEEEEEEECCTTS--CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCce-EEEEEEEEecccccc--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence 35568999999999999999999998763221 233478888754321 122345667999999999999999999886
Q ss_pred cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 160 ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 160 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
++..|+||||+.+|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 86 -~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 86 -GSSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp -BSSEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred -CCccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccc
Confidence 45689999999999999998764 3579999999999999999999999999999999999999999999999999985
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
.+.....
T Consensus 164 ~~~~~~~------------------------------------------------------------------------- 170 (325)
T 3kex_A 164 LLPPDDK------------------------------------------------------------------------- 170 (325)
T ss_dssp GSCCCTT-------------------------------------------------------------------------
T ss_pred ccCcccc-------------------------------------------------------------------------
Confidence 4321000
Q ss_pred cccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCC-CCCCCCCCCch
Q 011302 320 EPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPL-TFPRIGVSSSK 397 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~ 397 (489)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+..... ..|.. ..
T Consensus 171 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~--- 243 (325)
T 3kex_A 171 ---QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQI-CT--- 243 (325)
T ss_dssp ---CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTT-BC---
T ss_pred ---cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCc-Cc---
Confidence 011223468889999999999999999999999999999999 9999999887777766665432 22221 11
Q ss_pred hHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 398 EFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 398 ~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
..+.+||.+||..||.+||++. ++++|
T Consensus 244 -----~~~~~li~~~l~~dp~~Rps~~----el~~~ 270 (325)
T 3kex_A 244 -----IDVYMVMVKCWMIDENIRPTFK----ELANE 270 (325)
T ss_dssp -----TTTTHHHHHHTCSCTTTSCCHH----HHHHH
T ss_pred -----HHHHHHHHHHcCCChhhCcCHH----HHHHH
Confidence 1478999999999999999987 55544
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=380.31 Aligned_cols=256 Identities=25% Similarity=0.365 Sum_probs=181.5
Q ss_pred ccCCceeee-eeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 82 GLDHFRLLR-RLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 82 ~~~~y~~~~-~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
..++|++++ .||+|+||+||+|+++. +++.||||++....... . .....++.++||||+++++++..
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~----~---e~~~~~~~~~h~~i~~~~~~~~~ 93 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRR-----TGQKCALKLLYDSPKAR----Q---EVDHHWQASGGPHIVCILDVYEN 93 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEESSHHHH----H---HHHHHHHHTTSTTBCCEEEEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECC-----CCCEEEEEEecCcHHHH----H---HHHHHHHhcCCCChHHHHHHHhh
Confidence 347899965 69999999999999986 57899999997643221 1 12234567899999999999976
Q ss_pred ----CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEecc---CCcEEEc
Q 011302 161 ----SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRE---DGHIMLS 233 (489)
Q Consensus 161 ----~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~---~~~vkl~ 233 (489)
+..+|+|||||+||+|.+++.......+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+
T Consensus 94 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~ 173 (336)
T 3fhr_A 94 MHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLT 173 (336)
T ss_dssp EETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred ccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEe
Confidence 566899999999999999998876567999999999999999999999999999999999999986 4569999
Q ss_pred ccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccC
Q 011302 234 DFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLD 313 (489)
Q Consensus 234 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (489)
|||+++....
T Consensus 174 Dfg~~~~~~~---------------------------------------------------------------------- 183 (336)
T 3fhr_A 174 DFGFAKETTQ---------------------------------------------------------------------- 183 (336)
T ss_dssp CCTTCEEC------------------------------------------------------------------------
T ss_pred ccccceeccc----------------------------------------------------------------------
Confidence 9999843210
Q ss_pred CccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHH----HHHHhcCCCCCC
Q 011302 314 DPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKT----LINILKKPLTFP 389 (489)
Q Consensus 314 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~----~~~i~~~~~~~p 389 (489)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+...... ...+......++
T Consensus 184 ----------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 253 (336)
T 3fhr_A 184 ----------NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFP 253 (336)
T ss_dssp ------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCC
T ss_pred ----------cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccC
Confidence 011234689999999999888899999999999999999999999987665433 222222333333
Q ss_pred CCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 390 RIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 390 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
...... ....+.+||.+||+.||++||++. ++++||||+.
T Consensus 254 ~~~~~~-----~~~~~~~li~~~L~~dP~~Rpt~~----ell~hp~~~~ 293 (336)
T 3fhr_A 254 NPEWSE-----VSEDAKQLIRLLLKTDPTERLTIT----QFMNHPWINQ 293 (336)
T ss_dssp TTTSTT-----CCHHHHHHHHHHSCSSGGGSCCHH----HHHHSHHHHT
T ss_pred chhhcc-----CCHHHHHHHHHHCCCChhHCcCHH----HHhcCccccc
Confidence 221111 123589999999999999999987 9999999976
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=367.51 Aligned_cols=257 Identities=22% Similarity=0.267 Sum_probs=210.6
Q ss_pred hcCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccc
Q 011302 77 AQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYA 156 (489)
Q Consensus 77 ~~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~ 156 (489)
..+.+..++|++++.||+|+||+||+|++++ +..||+|++...... ..++.+|+.+++.++||||+++++
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~ 86 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRG------QYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYG 86 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEETT------TEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEcC------CCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEE
Confidence 3456778999999999999999999998874 567999999864322 134667999999999999999999
Q ss_pred eeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccC
Q 011302 157 EFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFD 236 (489)
Q Consensus 157 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG 236 (489)
++.+.+.+|+||||+++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg 165 (283)
T 3gen_A 87 VCTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFG 165 (283)
T ss_dssp EECSSSSEEEEECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTT
T ss_pred EEecCCCeEEEEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccc
Confidence 999999999999999999999998763 2569999999999999999999999999999999999999999999999999
Q ss_pred CCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcc
Q 011302 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPE 316 (489)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (489)
+++......
T Consensus 166 ~~~~~~~~~----------------------------------------------------------------------- 174 (283)
T 3gen_A 166 LSRYVLDDE----------------------------------------------------------------------- 174 (283)
T ss_dssp GGGGBCCHH-----------------------------------------------------------------------
T ss_pred ccccccccc-----------------------------------------------------------------------
Confidence 984322100
Q ss_pred ccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCC
Q 011302 317 VVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSS 395 (489)
Q Consensus 317 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 395 (489)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+............
T Consensus 175 ------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 246 (283)
T 3gen_A 175 ------YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLA-- 246 (283)
T ss_dssp ------HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTC--
T ss_pred ------cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcC--
Confidence 001122357889999999998899999999999999999998 99999999888887777765332221111
Q ss_pred chhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 396 SKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 396 ~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
. ..+.+||.+||+.||++||++. ++++|
T Consensus 247 ~------~~l~~li~~~l~~~p~~Rps~~----~ll~~ 274 (283)
T 3gen_A 247 S------EKVYTIMYSCWHEKADERPTFK----ILLSN 274 (283)
T ss_dssp C------HHHHHHHHHTTCSSGGGSCCHH----HHHHH
T ss_pred C------HHHHHHHHHHccCChhHCcCHH----HHHHH
Confidence 1 2489999999999999999987 66654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=367.12 Aligned_cols=273 Identities=25% Similarity=0.401 Sum_probs=206.7
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec---
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA--- 160 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--- 160 (489)
++|++++.||+|+||.||+|++.. +++.||||++.... .....+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 76 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNAL-----DSRYYAIKKIRHTE----EKLSTILSEVMLLASLNHQYVVRYYAAWLERRN 76 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEEEH----HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCC
T ss_pred ccchhhheeccCCcEEEEEEEEcC-----CCeEEEEEEEeccH----HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcc
Confidence 579999999999999999999876 57899999997543 234567789999999999999999998754
Q ss_pred ----------CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcE
Q 011302 161 ----------SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHI 230 (489)
Q Consensus 161 ----------~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~v 230 (489)
....|+||||++||+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 77 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~ 155 (303)
T 1zy4_A 77 FVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNV 155 (303)
T ss_dssp CCC------CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCE
T ss_pred hhhhhcccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCE
Confidence 46789999999999999999864 3568889999999999999999999999999999999999999999
Q ss_pred EEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCcc
Q 011302 231 MLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQE 310 (489)
Q Consensus 231 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (489)
||+|||++.............
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~----------------------------------------------------------- 176 (303)
T 1zy4_A 156 KIGDFGLAKNVHRSLDILKLD----------------------------------------------------------- 176 (303)
T ss_dssp EECCCCCCSCTTC-------------------------------------------------------------------
T ss_pred EEeeCcchhhcccccchhccc-----------------------------------------------------------
Confidence 999999985432110000000
Q ss_pred ccCCccccccccccCCccccCCCCccCcchhcCC-CCCCcccHHHHHHHHHHHhhCCCCCCCC-CcHHHHHHHhcCCCCC
Q 011302 311 LLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQ-GHGSAVDWWTLGVFLYEMLYGTTPFKGE-NNEKTLINILKKPLTF 388 (489)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~~~~~ 388 (489)
...............||+.|+|||++.+. .++.++|||||||++|||++ ||... +.......+......+
T Consensus 177 -----~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~ 248 (303)
T 1zy4_A 177 -----SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEF 248 (303)
T ss_dssp ----------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCC
T ss_pred -----cccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhcccccccc
Confidence 00000001122345799999999999875 58999999999999999998 56432 3344555555554444
Q ss_pred CCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcc
Q 011302 389 PRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWA 442 (489)
Q Consensus 389 p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~ 442 (489)
|....... ...+.+||.+||+.||.+||++. ++++||||+...++
T Consensus 249 ~~~~~~~~-----~~~~~~li~~~l~~dp~~Rps~~----~ll~h~~~~~~~~~ 293 (303)
T 1zy4_A 249 PPDFDDNK-----MKVEKKIIRLLIDHDPNKRPGAR----TLLNSGWLPVKHQD 293 (303)
T ss_dssp CTTCCTTT-----SHHHHHHHHHHTCSSGGGSCCHH----HHHHSSCSCCCCHH
T ss_pred Cccccccc-----hHHHHHHHHHHHhcCcccCcCHH----HHhCCCCcCCCChH
Confidence 43322211 12489999999999999999987 99999999887664
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-47 Score=371.19 Aligned_cols=266 Identities=18% Similarity=0.257 Sum_probs=213.8
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccce
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAE 157 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~ 157 (489)
+++..++|++.+.||+|+||.||+|++........++.||||++...... .....+.+|+.+++.+ +||||++++++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 95 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHMNIVNLLGA 95 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhH--HHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence 45677899999999999999999999754333346789999999754322 2345677899999999 89999999999
Q ss_pred eecCceEEEEEeecCCCchHHHHHhCCC----------------CCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCC
Q 011302 158 FEASHYSCLVMEYCPGGDLYAARQRQPG----------------KRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPEN 221 (489)
Q Consensus 158 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~----------------~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~N 221 (489)
+.+.+..|+||||+++|+|.+++..... ..+++..+..++.||+.||.|||++||+||||||+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 175 (313)
T 1t46_A 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (313)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence 9999999999999999999999987532 248999999999999999999999999999999999
Q ss_pred eEeccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccc
Q 011302 222 VLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQ 301 (489)
Q Consensus 222 ILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (489)
||++.++.+||+|||++........
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~------------------------------------------------------- 200 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSN------------------------------------------------------- 200 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTT-------------------------------------------------------
T ss_pred EEEcCCCCEEEcccccccccccccc-------------------------------------------------------
Confidence 9999999999999999843321000
Q ss_pred cCCCCCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHH
Q 011302 302 VDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLIN 380 (489)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~ 380 (489)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+......+..
T Consensus 201 ---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~ 259 (313)
T 1t46_A 201 ---------------------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259 (313)
T ss_dssp ---------------------SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred ---------------------ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHH
Confidence 001123457889999999999999999999999999999998 9999998776555555
Q ss_pred HhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 381 ILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 381 i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
+.......+.... . ...+.+||.+||+.||.+||++. +++++
T Consensus 260 ~~~~~~~~~~~~~-~------~~~l~~li~~~l~~dp~~Rps~~----ell~~ 301 (313)
T 1t46_A 260 MIKEGFRMLSPEH-A------PAEMYDIMKTCWDADPLKRPTFK----QIVQL 301 (313)
T ss_dssp HHHHTCCCCCCTT-S------CHHHHHHHHHHTCSSGGGSCCHH----HHHHH
T ss_pred HhccCCCCCCccc-C------CHHHHHHHHHHcCCCchhCcCHH----HHHHH
Confidence 5443322221111 1 12589999999999999999987 55553
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=362.01 Aligned_cols=253 Identities=25% Similarity=0.383 Sum_probs=201.6
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHH-HHHHHHHHHHHHHHHhCCCCCccccccee
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAI-RKKLHRADMEKVILTMLDHPFLPTLYAEF 158 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 158 (489)
++..++|++.+.||+|+||.||+|++. +..||||++....... ......+.+|+.+++.++||||+++++++
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 75 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWI-------GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC 75 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEET-------TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEc-------CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 356689999999999999999999975 3679999997654332 23346678899999999999999999999
Q ss_pred ecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCC---CeeecCCCCCeEecc--------C
Q 011302 159 EASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMG---IVYRDLKPENVLVRE--------D 227 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDIKp~NILl~~--------~ 227 (489)
.+.+..|+||||++|++|.+++.. ..+++..+..++.||+.||+|||++| |+||||||+|||++. +
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~ 152 (271)
T 3dtc_A 76 LKEPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSN 152 (271)
T ss_dssp CCC--CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSS
T ss_pred ecCCceEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccC
Confidence 999999999999999999998854 57999999999999999999999999 999999999999986 7
Q ss_pred CcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCC
Q 011302 228 GHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHH 307 (489)
Q Consensus 228 ~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (489)
+.+||+|||++.....
T Consensus 153 ~~~kl~Dfg~~~~~~~---------------------------------------------------------------- 168 (271)
T 3dtc_A 153 KILKITDFGLAREWHR---------------------------------------------------------------- 168 (271)
T ss_dssp CCEEECCCCC----------------------------------------------------------------------
T ss_pred cceEEccCCccccccc----------------------------------------------------------------
Confidence 8899999999843211
Q ss_pred CccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCC
Q 011302 308 DQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLT 387 (489)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~ 387 (489)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......
T Consensus 169 ----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 232 (271)
T 3dtc_A 169 ----------------TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA 232 (271)
T ss_dssp -----------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCC
T ss_pred ----------------ccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCC
Confidence 0111336899999999999999999999999999999999999999998887777776665544
Q ss_pred CCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 388 FPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 388 ~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
.+..... . ..+.+||.+||+.||.+||++. ++++|
T Consensus 233 ~~~~~~~-~------~~~~~li~~~l~~~p~~Rps~~----e~l~~ 267 (271)
T 3dtc_A 233 LPIPSTC-P------EPFAKLMEDCWNPDPHSRPSFT----NILDQ 267 (271)
T ss_dssp CCCCTTC-C------HHHHHHHHHHTCSSGGGSCCHH----HHHHH
T ss_pred CCCCccc-C------HHHHHHHHHHhcCCcccCcCHH----HHHHH
Confidence 3322211 1 2489999999999999999987 66654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=363.46 Aligned_cols=255 Identities=21% Similarity=0.260 Sum_probs=212.2
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccccccee
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEF 158 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 158 (489)
.++..++|++++.||+|+||.||+|++++ +..||+|++...... ..++.+|+.+++.++||||+++++++
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~ 72 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWKG------QYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVC 72 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETT------TEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred eEechhheeeeeeeccCCCceEEEEEecC------ceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 35667899999999999999999998774 467999999764322 13466799999999999999999999
Q ss_pred ecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 159 EASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
.+.+..|+||||+++++|.+++... +..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 73 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~ 151 (268)
T 3sxs_A 73 SKEYPIYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMT 151 (268)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCE
T ss_pred ccCCceEEEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccc
Confidence 9999999999999999999998764 246999999999999999999999999999999999999999999999999998
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
.......
T Consensus 152 ~~~~~~~------------------------------------------------------------------------- 158 (268)
T 3sxs_A 152 RYVLDDQ------------------------------------------------------------------------- 158 (268)
T ss_dssp EECCTTC-------------------------------------------------------------------------
T ss_pred eecchhh-------------------------------------------------------------------------
Confidence 4322100
Q ss_pred ccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCch
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSK 397 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 397 (489)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+............ .
T Consensus 159 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~- 231 (268)
T 3sxs_A 159 ----YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLA--S- 231 (268)
T ss_dssp ----EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTS--C-
T ss_pred ----hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcC--h-
Confidence 001122357788999999999889999999999999999998 99999999888887777765433222111 1
Q ss_pred hHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 398 EFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 398 ~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
..+.+||.+||+.||++||++. ++++|
T Consensus 232 -----~~l~~li~~~l~~~p~~Rps~~----~ll~~ 258 (268)
T 3sxs_A 232 -----DTIYQIMYSCWHELPEKRPTFQ----QLLSS 258 (268)
T ss_dssp -----HHHHHHHHHTTCSSGGGSCCHH----HHHHH
T ss_pred -----HHHHHHHHHHcCCChhhCcCHH----HHHHH
Confidence 2489999999999999999987 67665
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=383.27 Aligned_cols=264 Identities=24% Similarity=0.390 Sum_probs=205.0
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-----------CC
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-----------HP 149 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------hp 149 (489)
+..++|++++.||+|+||+||+|++.. +++.||||++...... ...+.+|+.+++.+. ||
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~ 86 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMV-----NNTHVAMKIVRGDKVY----TEAAEDEIKLLQRVNDADNTKEDSMGAN 86 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECSCHHH----HHHHHHHHHHHHHHHHTCCSHHHHHHHT
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecC-----CCcEEEEEEecCCccc----hhhhhHHHHHHHHhhcccccchhccccc
Confidence 445799999999999999999999876 5789999999864332 234556888888775 89
Q ss_pred CcccccceeecCc----eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhC-CCeeecCCCCCeEe
Q 011302 150 FLPTLYAEFEASH----YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMM-GIVYRDLKPENVLV 224 (489)
Q Consensus 150 nIv~l~~~~~~~~----~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~iiHrDIKp~NILl 224 (489)
||+++++++...+ .+|+||||+ +++|.+++.......+++..++.++.||+.||+|||++ |||||||||+||||
T Consensus 87 ~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll 165 (373)
T 1q8y_A 87 HILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLM 165 (373)
T ss_dssp TBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEE
T ss_pred hHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEE
Confidence 9999999997654 899999999 99999999886666799999999999999999999998 99999999999999
Q ss_pred cc------CCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCcccccccccccccccccccccccc
Q 011302 225 RE------DGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTI 298 (489)
Q Consensus 225 ~~------~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (489)
+. .+.+||+|||++.....
T Consensus 166 ~~~~~~~~~~~~kl~Dfg~a~~~~~------------------------------------------------------- 190 (373)
T 1q8y_A 166 EIVDSPENLIQIKIADLGNACWYDE------------------------------------------------------- 190 (373)
T ss_dssp EEEETTTTEEEEEECCCTTCEETTB-------------------------------------------------------
T ss_pred eccCCCcCcceEEEcccccccccCC-------------------------------------------------------
Confidence 53 44899999999843210
Q ss_pred ccccCCCCCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCC-----
Q 011302 299 REQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGEN----- 373 (489)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~----- 373 (489)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+
T Consensus 191 --------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 191 --------------------------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp --------------------------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred --------------------------CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 1123368999999999999999999999999999999999999998654
Q ss_pred -cHHHHHHHhcCCCCCCC---------------------C---CCCC---------chhHHHHhhHHHHHHHHhhcCccc
Q 011302 374 -NEKTLINILKKPLTFPR---------------------I---GVSS---------SKEFEEVVKLQDLISKLLVKNPKK 419 (489)
Q Consensus 374 -~~~~~~~i~~~~~~~p~---------------------~---~~~~---------~~~~~~~~~l~~li~~~L~~dP~~ 419 (489)
....+..+.......|. . .... .........+.+||.+||+.||++
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 324 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 324 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence 22233333210000000 0 0000 000123446889999999999999
Q ss_pred ccCCCCChHHHHcCCCcCCC
Q 011302 420 RIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 420 R~~~~~~~~~ll~hp~f~~~ 439 (489)
||++. ++++||||++.
T Consensus 325 Rpt~~----ell~hp~f~~~ 340 (373)
T 1q8y_A 325 RADAG----GLVNHPWLKDT 340 (373)
T ss_dssp CBCHH----HHHTCGGGTTC
T ss_pred cCCHH----HHhhChhhhcc
Confidence 99997 99999999874
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=384.79 Aligned_cols=255 Identities=22% Similarity=0.292 Sum_probs=209.0
Q ss_pred cCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccce
Q 011302 78 QGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAE 157 (489)
Q Consensus 78 ~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~ 157 (489)
.+.+..++|.+.+.||+|+||+||+|+++. +++.||||+++.... ......+.+|+.+|+.++||||++++++
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~ 180 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRA-----DNTLVAVKSCRETLP--PDLKAKFLQEARILKQYSHPNIVRLIGV 180 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEECCTTSC--HHHHTTTTHHHHHHTTCCCTTBCCEEEE
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEec-----CCeEEEEEEccccCC--HHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 356677899999999999999999999986 468899999875421 2334567789999999999999999999
Q ss_pred eecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCC
Q 011302 158 FEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237 (489)
Q Consensus 158 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~ 237 (489)
+.+.+.+|+||||++||+|.+++... +..+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+
T Consensus 181 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 259 (377)
T 3cbl_A 181 CTQKQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGM 259 (377)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred EecCCCcEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCC
Confidence 99999999999999999999998764 24699999999999999999999999999999999999999999999999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
++......
T Consensus 260 s~~~~~~~------------------------------------------------------------------------ 267 (377)
T 3cbl_A 260 SREEADGV------------------------------------------------------------------------ 267 (377)
T ss_dssp CEECTTSE------------------------------------------------------------------------
T ss_pred ceecCCCc------------------------------------------------------------------------
Confidence 84321100
Q ss_pred cccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCc
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSS 396 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 396 (489)
.........+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+..+. ..+... ..+
T Consensus 268 ----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~-~~~ 341 (377)
T 3cbl_A 268 ----YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG-RLPCPE-LCP 341 (377)
T ss_dssp ----EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC-CCCCCT-TCC
T ss_pred ----eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCC-CCC
Confidence 0000111235778999999998889999999999999999998 999999988877766665542 222111 111
Q ss_pred hhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 397 KEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 397 ~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
..+.+||.+||+.||++||++.
T Consensus 342 ------~~l~~li~~cl~~dP~~Rps~~ 363 (377)
T 3cbl_A 342 ------DAVFRLMEQCWAYEPGQRPSFS 363 (377)
T ss_dssp ------HHHHHHHHHHTCSSGGGSCCHH
T ss_pred ------HHHHHHHHHHcCCCchhCcCHH
Confidence 2488999999999999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=372.55 Aligned_cols=264 Identities=20% Similarity=0.270 Sum_probs=203.8
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
+..++|++.+.||+|+||+||+|.++. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~-----~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 78 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRE-----TGEVMVMKELIRFD---EETQRTFLKEVKVMRCLEHPNVLKFIGVLYK 78 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETT-----TCCEEEEEEESCCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECC-----CCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCcCcccEEEEEec
Confidence 456899999999999999999999987 57889999885432 2334567789999999999999999999999
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~ 240 (489)
++..|+||||++||+|.+++... ...+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 157 (310)
T 3s95_A 79 DKRLNFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARL 157 (310)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEE
T ss_pred CCeeEEEEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeeccccee
Confidence 99999999999999999999874 35799999999999999999999999999999999999999999999999999854
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
+......... ......
T Consensus 158 ~~~~~~~~~~----------------------------------------------------------------~~~~~~ 173 (310)
T 3s95_A 158 MVDEKTQPEG----------------------------------------------------------------LRSLKK 173 (310)
T ss_dssp CC------------------------------------------------------------------------------
T ss_pred cccccccccc----------------------------------------------------------------cccccc
Confidence 4321100000 000000
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHH-----HHHHHhcCCCCCCCCCCCC
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEK-----TLINILKKPLTFPRIGVSS 395 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~-----~~~~i~~~~~~~p~~~~~~ 395 (489)
+........+||+.|+|||++.+..++.++|||||||++|||++|..||....... ......... .+.. .
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~---~ 248 (310)
T 3s95_A 174 PDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY--CPPN---C 248 (310)
T ss_dssp ------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT--CCTT---C
T ss_pred cccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc--CCCC---C
Confidence 11122345689999999999999999999999999999999999999987543211 011111100 0110 0
Q ss_pred chhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHc
Q 011302 396 SKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKR 432 (489)
Q Consensus 396 ~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~ 432 (489)
+..+.+||.+||+.||++||++. ++++
T Consensus 249 ------~~~l~~li~~~l~~dP~~Rps~~----~l~~ 275 (310)
T 3s95_A 249 ------PPSFFPITVRCCDLDPEKRPSFV----KLEH 275 (310)
T ss_dssp ------CTTHHHHHHHHTCSSGGGSCCHH----HHHH
T ss_pred ------CHHHHHHHHHHccCChhhCcCHH----HHHH
Confidence 11489999999999999999986 5554
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=364.30 Aligned_cols=259 Identities=25% Similarity=0.344 Sum_probs=202.3
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccccccee
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEF 158 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 158 (489)
+++..++|++.+.||+|+||.||+|.+..... ....||+|++..... ......+.+|+.+++.++||||+++++++
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 85 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPEN--PALAVAIKTCKNCTS--DSVREKFLQEALTMRQFDHPHIVKLIGVI 85 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC----CCEEEEEEECTTTTS--HHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCC--CceEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCccceEEEEE
Confidence 45667899999999999999999999875321 456899999875321 23345677899999999999999999998
Q ss_pred ecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 159 EASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
. ++..|+||||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 86 ~-~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 163 (281)
T 1mp8_A 86 T-ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 163 (281)
T ss_dssp C-SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----
T ss_pred c-cCccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccc
Confidence 5 467899999999999999997652 46999999999999999999999999999999999999999999999999998
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
+......
T Consensus 164 ~~~~~~~------------------------------------------------------------------------- 170 (281)
T 1mp8_A 164 RYMEDST------------------------------------------------------------------------- 170 (281)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cccCccc-------------------------------------------------------------------------
Confidence 4332100
Q ss_pred ccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCch
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSK 397 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 397 (489)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+...... +. ....
T Consensus 171 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~-~~-~~~~-- 242 (281)
T 1mp8_A 171 ----YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL-PM-PPNC-- 242 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-CC-CTTC--
T ss_pred ----ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC-CC-CCCC--
Confidence 001112357889999999999899999999999999999996 99999998888777777664321 11 1111
Q ss_pred hHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHc
Q 011302 398 EFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKR 432 (489)
Q Consensus 398 ~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~ 432 (489)
+..+.+||.+||+.||++||++. ++++
T Consensus 243 ----~~~l~~li~~~l~~~p~~Rps~~----~l~~ 269 (281)
T 1mp8_A 243 ----PPTLYSLMTKCWAYDPSRRPRFT----ELKA 269 (281)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHH----HHHH
T ss_pred ----CHHHHHHHHHHccCChhhCcCHH----HHHH
Confidence 12589999999999999999986 5554
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=367.11 Aligned_cols=252 Identities=25% Similarity=0.284 Sum_probs=198.0
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.++|++.+.||+|+||.||+|++.. .++.||||++.............+.+|+.+++.++||||+++++++..++
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTV-----RERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG 107 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETT-----TTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcC-----CCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence 5799999999999999999999886 57899999997654443445567888999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
.+|+||||++|++|.+++... ..+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred eEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 999999999999999998875 569999999999999999999999999999999999999999999999999974321
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
...
T Consensus 186 ~~~----------------------------------------------------------------------------- 188 (309)
T 2h34_A 186 DEK----------------------------------------------------------------------------- 188 (309)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccc-----------------------------------------------------------------------------
Confidence 100
Q ss_pred ccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHH
Q 011302 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEV 402 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~ 402 (489)
........||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+.............. +
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~ 262 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGI------P 262 (309)
T ss_dssp --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTC------C
T ss_pred cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCC------C
Confidence 0011234699999999999999899999999999999999999999988766544433333221111111111 1
Q ss_pred hhHHHHHHHHhhcCcccccCCC
Q 011302 403 VKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 403 ~~l~~li~~~L~~dP~~R~~~~ 424 (489)
..+.+||.+||+.||++||+..
T Consensus 263 ~~l~~li~~~l~~dP~~Rp~s~ 284 (309)
T 2h34_A 263 VAFDAVIARGMAKNPEDRYVTC 284 (309)
T ss_dssp THHHHHHHHHTCSSGGGSCSSH
T ss_pred HHHHHHHHHhccCCHHHHHHhH
Confidence 2589999999999999999443
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=374.32 Aligned_cols=265 Identities=17% Similarity=0.227 Sum_probs=213.9
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccce
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAE 157 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~ 157 (489)
+++..++|++.+.||+|+||.||+|.+.........+.||+|++...... .....+.+|+.+++.+ +||||++++++
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA--DEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccCh--HHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 45677899999999999999999999987554445678999999754321 2345677899999999 89999999999
Q ss_pred eecCceEEEEEeecCCCchHHHHHhCC------------CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEec
Q 011302 158 FEASHYSCLVMEYCPGGDLYAARQRQP------------GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVR 225 (489)
Q Consensus 158 ~~~~~~~~lV~E~~~gg~L~~~l~~~~------------~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~ 225 (489)
+.+.+.+|+||||+++|+|.+++.... ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence 999999999999999999999887531 24689999999999999999999999999999999999999
Q ss_pred cCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCC
Q 011302 226 EDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGD 305 (489)
Q Consensus 226 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (489)
.++.+||+|||++........
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~----------------------------------------------------------- 219 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSN----------------------------------------------------------- 219 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTT-----------------------------------------------------------
T ss_pred CCCeEEECccccccccccccc-----------------------------------------------------------
Confidence 999999999999843211000
Q ss_pred CCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcC
Q 011302 306 HHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKK 384 (489)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~ 384 (489)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+......+..+...
T Consensus 220 -----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 282 (333)
T 2i1m_A 220 -----------------YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD 282 (333)
T ss_dssp -----------------SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHH
T ss_pred -----------------eeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhc
Confidence 001123457889999999999899999999999999999998 99999987766665555543
Q ss_pred CCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHc
Q 011302 385 PLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKR 432 (489)
Q Consensus 385 ~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~ 432 (489)
....+..... . ..+.+||.+||+.||.+||++. ++++
T Consensus 283 ~~~~~~~~~~-~------~~l~~li~~~l~~~p~~Rps~~----~l~~ 319 (333)
T 2i1m_A 283 GYQMAQPAFA-P------KNIYSIMQACWALEPTHRPTFQ----QICS 319 (333)
T ss_dssp TCCCCCCTTC-C------HHHHHHHHHHTCSSGGGSCCHH----HHHH
T ss_pred CCCCCCCCCC-C------HHHHHHHHHHhccChhhCcCHH----HHHH
Confidence 3322221111 1 2589999999999999999987 6654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=371.34 Aligned_cols=255 Identities=19% Similarity=0.256 Sum_probs=197.2
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccccccee
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEF 158 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 158 (489)
..+..++|++++.||+|+||+||+|++. ++.||||++...... ......|+.+|+.++||||+++++++
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~ 87 (322)
T 3soc_A 19 LYFQSMPLQLLEVKARGRFGCVWKAQLL-------NEYVAVKIFPIQDKQ----SWQNEYEVYSLPGMKHENILQFIGAE 87 (322)
T ss_dssp EEETTEEEEEEEEEECSTTCEEEEEEET-------TEEEEEEEECGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred cccchhhchhhheecccCceEEEEEEEC-------CCEEEEEEeecCchH----HHHHHHHHHHHhcCCCCCchhhccee
Confidence 3466789999999999999999999876 378999999765322 22344588889999999999999999
Q ss_pred ecCc----eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhC----------CCeeecCCCCCeEe
Q 011302 159 EASH----YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMM----------GIVYRDLKPENVLV 224 (489)
Q Consensus 159 ~~~~----~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~----------~iiHrDIKp~NILl 224 (489)
.+.. .+|+|||||++|+|.+++... .+++..+..++.||+.||+|||++ |||||||||+|||+
T Consensus 88 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill 164 (322)
T 3soc_A 88 KRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL 164 (322)
T ss_dssp EEECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE
T ss_pred ccCCCCCceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEE
Confidence 8643 579999999999999999774 599999999999999999999999 99999999999999
Q ss_pred ccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCC
Q 011302 225 REDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDG 304 (489)
Q Consensus 225 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (489)
+.++.+||+|||+|+.+.....
T Consensus 165 ~~~~~~kL~DFg~a~~~~~~~~---------------------------------------------------------- 186 (322)
T 3soc_A 165 KNNLTACIADFGLALKFEAGKS---------------------------------------------------------- 186 (322)
T ss_dssp CTTCCEEECCCTTCEEECTTSC----------------------------------------------------------
T ss_pred CCCCeEEEccCCcccccccccC----------------------------------------------------------
Confidence 9999999999999854321000
Q ss_pred CCCCccccCCccccccccccCCccccCCCCccCcchhcCC-----CCCCcccHHHHHHHHHHHhhCCCCCCCCCc-----
Q 011302 305 DHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQ-----GHGSAVDWWTLGVFLYEMLYGTTPFKGENN----- 374 (489)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-----~~~~~~DiwSlGvil~elltG~~Pf~~~~~----- 374 (489)
.......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+...
T Consensus 187 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~ 248 (322)
T 3soc_A 187 ------------------AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248 (322)
T ss_dssp ------------------CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCT
T ss_pred ------------------ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccc
Confidence 0112335799999999999874 356688999999999999999999976432
Q ss_pred ----------HHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 375 ----------EKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 375 ----------~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
...+..........|..... .........+.+||.+||+.||++||++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 307 (322)
T 3soc_A 249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDY-WQKHAGMAMLCETIEECWDHDAEARLSAG 307 (322)
T ss_dssp THHHHCSSCCHHHHHHHHTTSCCCCCCCGG-GGSSHHHHHHHHHHHHHTCSSGGGSCCHH
T ss_pred hhhhhccCCchhhhhhhhhcccCCCCcccc-ccccchHHHHHHHHHHHccCChhhCcCHH
Confidence 12222222221111211110 01112334589999999999999999987
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=366.52 Aligned_cols=261 Identities=28% Similarity=0.394 Sum_probs=206.4
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
...++|.....||+|+||.||+|++.. +++.||||++..... .....+.+|+.+++.++||||+++++++.+
T Consensus 19 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 90 (295)
T 2clq_A 19 YEYDENGDRVVLGKGTYGIVYAGRDLS-----NQVRIAIKEIPERDS---RYSQPLHEEIALHKHLKHKNIVQYLGSFSE 90 (295)
T ss_dssp ECBCTTSSBCEEEECSSSEEEEEEETT-----TCCEEEEEEEECCCC------HHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred ccccCCCCcEEEeecCcEEEEEEEECC-----CCeEEEEEEccCCch---HHHHHHHHHHHHHHhCCCCCEeeEeeEEEe
Confidence 445667777799999999999999876 578899999875421 233456779999999999999999999999
Q ss_pred CceEEEEEeecCCCchHHHHHhCC-CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEecc-CCcEEEcccCCC
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQP-GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRE-DGHIMLSDFDLS 238 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~-~~~vkl~DFG~a 238 (489)
.+..|+||||+++++|.+++.... ...+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~ 170 (295)
T 2clq_A 91 NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTS 170 (295)
T ss_dssp TTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTC
T ss_pred CCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccc
Confidence 999999999999999999987653 235678889999999999999999999999999999999997 899999999998
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
......
T Consensus 171 ~~~~~~-------------------------------------------------------------------------- 176 (295)
T 2clq_A 171 KRLAGI-------------------------------------------------------------------------- 176 (295)
T ss_dssp EESCC---------------------------------------------------------------------------
T ss_pred cccCCC--------------------------------------------------------------------------
Confidence 432110
Q ss_pred ccccccCCccccCCCCccCcchhcCCC--CCCcccHHHHHHHHHHHhhCCCCCCCCCcHHH-HHHH--hcCCCCCCCCCC
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQG--HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKT-LINI--LKKPLTFPRIGV 393 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~--~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~-~~~i--~~~~~~~p~~~~ 393 (489)
........||+.|+|||++.+.. ++.++|||||||++|||++|..||........ .... ......++.
T Consensus 177 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--- 249 (295)
T 2clq_A 177 ----NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPE--- 249 (295)
T ss_dssp --------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCT---
T ss_pred ----CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccc---
Confidence 00112346899999999997654 78999999999999999999999976544322 2221 122222221
Q ss_pred CCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 394 SSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 394 ~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
... ..+.+||.+||+.||++||++. ++++||||+...
T Consensus 250 ~~~------~~~~~li~~~l~~dp~~Rps~~----~ll~~~~~~~~~ 286 (295)
T 2clq_A 250 SMS------AEAKAFILKCFEPDPDKRACAN----DLLVDEFLKVSS 286 (295)
T ss_dssp TSC------HHHHHHHHHTTCSSTTTSCCHH----HHHTSGGGCC--
T ss_pred cCC------HHHHHHHHHHccCChhhCCCHH----HHhcChhhhhcc
Confidence 111 2589999999999999999987 999999998754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=385.04 Aligned_cols=249 Identities=22% Similarity=0.307 Sum_probs=208.5
Q ss_pred HhhcCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccc
Q 011302 75 RRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTL 154 (489)
Q Consensus 75 ~~~~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l 154 (489)
....+++..++|++++.||+|+||+||+|.+++ +.||||+++.+. ....+.+|+.+|+.++||||+++
T Consensus 184 ~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-------~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~ 251 (450)
T 1k9a_A 184 YRSGWALNMKELKLLQTIGKGEFGDVMLGDYRG-------NKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQL 251 (450)
T ss_dssp HHTTCBCCGGGEEEEEEEEECSSEEEEEEEETT-------EEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCE
T ss_pred cccccccChHHeEEEeeecCcCCeeEEEEEecC-------CeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEE
Confidence 356678889999999999999999999998764 589999997643 34567789999999999999999
Q ss_pred cceeecCc-eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEc
Q 011302 155 YAEFEASH-YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLS 233 (489)
Q Consensus 155 ~~~~~~~~-~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~ 233 (489)
++++.... .+|+|||||++|+|.+++.......+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+
T Consensus 252 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~ 331 (450)
T 1k9a_A 252 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVS 331 (450)
T ss_dssp EEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEEC
T ss_pred EEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEe
Confidence 99976654 79999999999999999987654558999999999999999999999999999999999999999999999
Q ss_pred ccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccC
Q 011302 234 DFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLD 313 (489)
Q Consensus 234 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (489)
|||+++....
T Consensus 332 DfG~a~~~~~---------------------------------------------------------------------- 341 (450)
T 1k9a_A 332 DFGLTKEASS---------------------------------------------------------------------- 341 (450)
T ss_dssp CCTTCEECC-----------------------------------------------------------------------
T ss_pred eCCCcccccc----------------------------------------------------------------------
Confidence 9999842110
Q ss_pred CccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCC
Q 011302 314 DPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIG 392 (489)
Q Consensus 314 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 392 (489)
......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+..+.. .+..
T Consensus 342 -----------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-~~~p- 408 (450)
T 1k9a_A 342 -----------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-MDAP- 408 (450)
T ss_dssp ----------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC-CCCC-
T ss_pred -----------cccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CCCC-
Confidence 0011257889999999999999999999999999999998 9999999887777777765421 1111
Q ss_pred CCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 393 VSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 393 ~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
...+ ..+.+||.+||..||++||++.
T Consensus 409 ~~~~------~~l~~li~~cl~~dp~~Rpt~~ 434 (450)
T 1k9a_A 409 DGCP------PAVYDVMKNCWHLDAATRPTFL 434 (450)
T ss_dssp TTCC------HHHHHHHHHHTCSSGGGSCCHH
T ss_pred CcCC------HHHHHHHHHHcCCChhHCcCHH
Confidence 1111 2589999999999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=360.22 Aligned_cols=248 Identities=19% Similarity=0.285 Sum_probs=206.6
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccccccee
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEF 158 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 158 (489)
..+..++|++.+.||+|+||.||+|++++ ..||+|++...... ......+.+|+.+++.++||||+++++++
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 76 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQG-------NDIVVKVLKVRDWS-TRKSRDFNEECPRLRIFSHPNVLPVLGAC 76 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEETT-------EEEEEEEECCTTCC-HHHHHHHHHHGGGGCCCSCTTEECEEEEE
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEECC-------eeEEEEEecccccC-HHHHHHHHHHHHHHHhcCCCchhheEEEE
Confidence 45667899999999999999999999863 67999999754322 12345677899999999999999999999
Q ss_pred ecC--ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCC--CeeecCCCCCeEeccCCcEEEcc
Q 011302 159 EAS--HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMG--IVYRDLKPENVLVREDGHIMLSD 234 (489)
Q Consensus 159 ~~~--~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDIKp~NILl~~~~~vkl~D 234 (489)
.+. +..|+||||++||+|.+++.......+++..+..++.||+.||+|||++| |+||||||+|||++.++.++|+|
T Consensus 77 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~ 156 (271)
T 3kmu_A 77 QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISM 156 (271)
T ss_dssp CTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEG
T ss_pred ccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEe
Confidence 877 78999999999999999998765556999999999999999999999999 99999999999999999999999
Q ss_pred cCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCC
Q 011302 235 FDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDD 314 (489)
Q Consensus 235 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (489)
||++...
T Consensus 157 ~~~~~~~------------------------------------------------------------------------- 163 (271)
T 3kmu_A 157 ADVKFSF------------------------------------------------------------------------- 163 (271)
T ss_dssp GGSCCTT-------------------------------------------------------------------------
T ss_pred ccceeee-------------------------------------------------------------------------
Confidence 9886211
Q ss_pred ccccccccccCCccccCCCCccCcchhcCCCCCC---cccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCC
Q 011302 315 PEVVAEPINARSKSFVGTHEYLAPEVISGQGHGS---AVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRI 391 (489)
Q Consensus 315 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~---~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~ 391 (489)
......||+.|+|||++.+..++. ++|||||||++|||++|+.||.+.+..+....+.......+..
T Consensus 164 ----------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (271)
T 3kmu_A 164 ----------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIP 233 (271)
T ss_dssp ----------SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCC
T ss_pred ----------cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCC
Confidence 012236899999999999876544 7999999999999999999999988887777766544332221
Q ss_pred CCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 392 GVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 392 ~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
.. .. ..+.+||.+||+.||++||++.
T Consensus 234 ~~-~~------~~~~~li~~~l~~~p~~Rps~~ 259 (271)
T 3kmu_A 234 PG-IS------PHVSKLMKICMNEDPAKRPKFD 259 (271)
T ss_dssp TT-CC------HHHHHHHHHHTCSSGGGSCCHH
T ss_pred CC-CC------HHHHHHHHHHcCCChhhCcCHH
Confidence 11 11 2589999999999999999986
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=363.26 Aligned_cols=253 Identities=20% Similarity=0.271 Sum_probs=212.2
Q ss_pred cCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccce
Q 011302 78 QGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAE 157 (489)
Q Consensus 78 ~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~ 157 (489)
.+++..++|++.+.||+|+||.||+|.++. .+..||+|++..... ....+.+|+.+++.++||||++++++
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~ 77 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKK-----YSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGV 77 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGG-----GTEEEEEEEECSCST----HHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccccccceeEEeecCCCCceeEEEeEecC-----CCEEEEEEecCcCHH----HHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 456778999999999999999999999987 578999999975432 23456779999999999999999999
Q ss_pred eecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCC
Q 011302 158 FEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237 (489)
Q Consensus 158 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~ 237 (489)
+.+.+.+|+||||++||+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 78 ~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~ 157 (288)
T 3kfa_A 78 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL 157 (288)
T ss_dssp ECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCG
T ss_pred EccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCcc
Confidence 99999999999999999999999887667799999999999999999999999999999999999999999999999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
+.......
T Consensus 158 ~~~~~~~~------------------------------------------------------------------------ 165 (288)
T 3kfa_A 158 SRLMTGDT------------------------------------------------------------------------ 165 (288)
T ss_dssp GGTSCSSS------------------------------------------------------------------------
T ss_pred ceeccCCc------------------------------------------------------------------------
Confidence 84322100
Q ss_pred cccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCc
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSS 396 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 396 (489)
........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+..... .+... ..+
T Consensus 166 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~-~~~ 238 (288)
T 3kfa_A 166 -----YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR-MERPE-GCP 238 (288)
T ss_dssp -----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC-CCCCT-TCC
T ss_pred -----cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC-CCCCC-CCC
Confidence 001122357889999999999999999999999999999999 9999998887776666655422 11111 111
Q ss_pred hhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 397 KEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 397 ~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
..+.+||.+||..||.+||++.
T Consensus 239 ------~~l~~li~~~l~~dp~~Rps~~ 260 (288)
T 3kfa_A 239 ------EKVYELMRACWQWNPSDRPSFA 260 (288)
T ss_dssp ------HHHHHHHHHHTCSSGGGSCCHH
T ss_pred ------HHHHHHHHHHhCCChhhCcCHH
Confidence 2589999999999999999987
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=363.86 Aligned_cols=254 Identities=19% Similarity=0.252 Sum_probs=203.9
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCC--CCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccce
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPM--VGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAE 157 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~--~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~ 157 (489)
++..++|++.+.||+|+||+||+|+++... .......||+|++..... .....+.+|+.+++.++||||++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---NYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG---GGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH---HHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 456789999999999999999999988632 111236799999976432 233457789999999999999999999
Q ss_pred eecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCc--------
Q 011302 158 FEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGH-------- 229 (489)
Q Consensus 158 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~-------- 229 (489)
+.+++..|+||||++||+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccce
Confidence 999999999999999999999998752 45999999999999999999999999999999999999998887
Q ss_pred EEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCc
Q 011302 230 IMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQ 309 (489)
Q Consensus 230 vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (489)
+||+|||++.....
T Consensus 160 ~kl~Dfg~~~~~~~------------------------------------------------------------------ 173 (289)
T 4fvq_A 160 IKLSDPGISITVLP------------------------------------------------------------------ 173 (289)
T ss_dssp EEECCCCSCTTTSC------------------------------------------------------------------
T ss_pred eeeccCcccccccC------------------------------------------------------------------
Confidence 99999999732210
Q ss_pred cccCCccccccccccCCccccCCCCccCcchhcC-CCCCCcccHHHHHHHHHHHhhC-CCCCCCCCcHHHHHHHhcCCCC
Q 011302 310 ELLDDPEVVAEPINARSKSFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYG-TTPFKGENNEKTLINILKKPLT 387 (489)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~~~~ 387 (489)
.....||+.|+|||++.+ ..++.++|||||||++|||++| .+||...+.... ..+......
T Consensus 174 ----------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~-~~~~~~~~~ 236 (289)
T 4fvq_A 174 ----------------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK-LQFYEDRHQ 236 (289)
T ss_dssp ----------------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-HHHHHTTCC
T ss_pred ----------------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH-HHHhhccCC
Confidence 112357899999999988 6689999999999999999995 455555444433 334333333
Q ss_pred CCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 388 FPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 388 ~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
.+.... .++.+||.+||+.||++||++. ++++|
T Consensus 237 ~~~~~~---------~~l~~li~~~l~~dp~~Rps~~----~ll~~ 269 (289)
T 4fvq_A 237 LPAPKA---------AELANLINNCMDYEPDHRPSFR----AIIRD 269 (289)
T ss_dssp CCCCSS---------CTTHHHHHHHSCSSGGGSCCHH----HHHHH
T ss_pred CCCCCC---------HHHHHHHHHHcCCChhHCcCHH----HHHHH
Confidence 333221 1488999999999999999987 77765
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=370.86 Aligned_cols=260 Identities=20% Similarity=0.248 Sum_probs=202.6
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
+..++|++++.||+|+||+||+|++...... ....||+|.+..... .....++.+|+.+++.++||||+++++++.+
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 88 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEK-VKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC-----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEES
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCce-EEEEEEEeecccccC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence 4568899999999999999999998753221 234578888865432 2334567889999999999999999999987
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~ 240 (489)
+. .++||||+.+|+|.+++.... ..+++..+..|+.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.
T Consensus 89 ~~-~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 89 ST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp SS-EEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred CC-eEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 65 789999999999999988753 5799999999999999999999999999999999999999999999999999843
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
+.....
T Consensus 167 ~~~~~~-------------------------------------------------------------------------- 172 (327)
T 3poz_A 167 LGAEEK-------------------------------------------------------------------------- 172 (327)
T ss_dssp HTTTCC--------------------------------------------------------------------------
T ss_pred ccCCcc--------------------------------------------------------------------------
Confidence 321000
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhH
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEF 399 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 399 (489)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+..+. ..+.... .
T Consensus 173 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~-~---- 244 (327)
T 3poz_A 173 --EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-RLPQPPI-C---- 244 (327)
T ss_dssp ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCCCCTT-B----
T ss_pred --cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC-CCCCCcc-C----
Confidence 001122357889999999999999999999999999999999 999999888776665555433 2221111 1
Q ss_pred HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 400 EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 400 ~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
...+.+||.+||+.||.+||++. +++++
T Consensus 245 --~~~~~~li~~~l~~~p~~Rps~~----ell~~ 272 (327)
T 3poz_A 245 --TIDVYMIMVKCWMIDADSRPKFR----ELIIE 272 (327)
T ss_dssp --CHHHHHHHHHHTCSCGGGSCCHH----HHHHH
T ss_pred --CHHHHHHHHHHcCCChhhCCCHH----HHHHH
Confidence 12589999999999999999987 55554
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=368.96 Aligned_cols=266 Identities=20% Similarity=0.261 Sum_probs=209.7
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccce
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAE 157 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~ 157 (489)
+.+..++|++.+.||+|+||+||+|++.+.....+++.||||++...... .....+.+|+.+++.+ +||||++++++
T Consensus 22 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 22 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred eecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCc--HHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 34667899999999999999999999865433446789999999764322 2345677899999999 69999999999
Q ss_pred eecC-ceEEEEEeecCCCchHHHHHhCCC--------------CCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCe
Q 011302 158 FEAS-HYSCLVMEYCPGGDLYAARQRQPG--------------KRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENV 222 (489)
Q Consensus 158 ~~~~-~~~~lV~E~~~gg~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NI 222 (489)
+... ..+|+||||++||+|.+++..... ..+++..+..++.||+.||.|||++||+||||||+||
T Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni 179 (316)
T 2xir_A 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179 (316)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence 8765 459999999999999999987532 1288999999999999999999999999999999999
Q ss_pred EeccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCcccccccccccccccccccccccccccc
Q 011302 223 LVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQV 302 (489)
Q Consensus 223 Ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (489)
|++.++.+||+|||+++.+.....
T Consensus 180 l~~~~~~~kl~Dfg~~~~~~~~~~-------------------------------------------------------- 203 (316)
T 2xir_A 180 LLSEKNVVKICDFGLARDIYKDPD-------------------------------------------------------- 203 (316)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTT--------------------------------------------------------
T ss_pred EECCCCCEEECCCccccccccCcc--------------------------------------------------------
Confidence 999999999999999843321000
Q ss_pred CCCCCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHH
Q 011302 303 DGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINI 381 (489)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i 381 (489)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+......+...
T Consensus 204 --------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~ 263 (316)
T 2xir_A 204 --------------------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 263 (316)
T ss_dssp --------------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred --------------------ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHH
Confidence 011223468899999999999999999999999999999998 99999887654444333
Q ss_pred hcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 382 LKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 382 ~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
.......+... ... ..+.+||.+||+.||.+||++. ++++|
T Consensus 264 ~~~~~~~~~~~-~~~------~~l~~li~~~l~~dp~~Rps~~----ell~~ 304 (316)
T 2xir_A 264 LKEGTRMRAPD-YTT------PEMYQTMLDCWHGEPSQRPTFS----ELVEH 304 (316)
T ss_dssp HHHTCCCCCCT-TCC------HHHHHHHHHHTCSSGGGSCCHH----HHHHH
T ss_pred hccCccCCCCC-CCC------HHHHHHHHHHcCCChhhCcCHH----HHHHH
Confidence 32221111111 111 2589999999999999999987 77665
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=377.82 Aligned_cols=259 Identities=21% Similarity=0.269 Sum_probs=201.3
Q ss_pred cCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccce
Q 011302 78 QGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAE 157 (489)
Q Consensus 78 ~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~ 157 (489)
..++..++|.+.+.||+|+||+||+|+++... ..+..||||+++.... ......+.+|+.+|+.++||||++++++
T Consensus 39 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~--~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~ 114 (373)
T 2qol_A 39 AKELDATNISIDKVVGAGEFGEVCSGRLKLPS--KKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNIIRLEGV 114 (373)
T ss_dssp SCBCCGGGCCCCEEEEECSSSEEEEC-CBCTT--SCBCCEEEEECCTTCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred HhhcCHhhceeeeEEeeCCCeEEEEEEEecCC--CCceeEEEEEecCccC--HHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 34566789999999999999999999877321 1467899999975421 2334567889999999999999999999
Q ss_pred eecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCC
Q 011302 158 FEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237 (489)
Q Consensus 158 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~ 237 (489)
+.+.+.+|+||||++||+|.+++... ...+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 115 ~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 193 (373)
T 2qol_A 115 VTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGL 193 (373)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--
T ss_pred EeeCCceEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcc
Confidence 99999999999999999999999765 35799999999999999999999999999999999999999999999999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
++........
T Consensus 194 a~~~~~~~~~---------------------------------------------------------------------- 203 (373)
T 2qol_A 194 GRVLEDDPEA---------------------------------------------------------------------- 203 (373)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccccccCCcc----------------------------------------------------------------------
Confidence 8543210000
Q ss_pred cccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCc
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSS 396 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 396 (489)
........||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+....+..+. ..+... ..
T Consensus 204 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~-~~~~~~-~~- 275 (373)
T 2qol_A 204 -----AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY-RLPPPM-DC- 275 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTE-ECCCCT-TC-
T ss_pred -----ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCc-cc-
Confidence 000112246789999999999999999999999999999997 999999988877777665542 222111 11
Q ss_pred hhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 397 KEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 397 ~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
...+.+||.+||+.||++||++.
T Consensus 276 -----~~~l~~li~~cl~~dp~~RPs~~ 298 (373)
T 2qol_A 276 -----PAALYQLMLDCWQKDRNNRPKFE 298 (373)
T ss_dssp -----BHHHHHHHHHHTCSSGGGSCCHH
T ss_pred -----cHHHHHHHHHHhCcChhhCcCHH
Confidence 12589999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=384.89 Aligned_cols=263 Identities=25% Similarity=0.322 Sum_probs=200.2
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCccccccee
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAEF 158 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~ 158 (489)
.++..+|.+.+.||+|+||+||..... .++.||||++..+. ...+.+|+.+|+.+ +|||||++++++
T Consensus 20 ~i~~~~y~~~~~LG~G~~G~V~~~~~~------~~~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~l~~~~ 87 (432)
T 3p23_A 20 IVGKISFCPKDVLGHGAEGTIVYRGMF------DNRDVAVKRILPEC------FSFADREVQLLRESDEHPNVIRYFCTE 87 (432)
T ss_dssp EETTEEEEEEEEEEECGGGCEEEEEES------SSSEEEEEEECTTT------EEECHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred EEccEEEecCCeeecCcCEEEEEEEEe------CCeEEEEEEECHHH------HHHHHHHHHHHHhccCCCCcCeEEEEE
Confidence 345567999999999999997643332 46789999997532 23355699999999 799999999999
Q ss_pred ecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEecc---C--CcEEEc
Q 011302 159 EASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRE---D--GHIMLS 233 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~---~--~~vkl~ 233 (489)
.+...+||||||| +|+|.+++.... ..+.+.++..++.||+.||+|||++|||||||||+||||+. + ..+||+
T Consensus 88 ~~~~~~~lv~E~~-~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~ 165 (432)
T 3p23_A 88 KDRQFQYIAIELC-AATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMIS 165 (432)
T ss_dssp EETTEEEEEEECC-SEEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEEC
T ss_pred ecCCEEEEEEECC-CCCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEe
Confidence 9999999999999 579999987653 45666778899999999999999999999999999999953 2 358899
Q ss_pred ccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccC
Q 011302 234 DFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLD 313 (489)
Q Consensus 234 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (489)
|||+|+.+.....
T Consensus 166 DFG~a~~~~~~~~------------------------------------------------------------------- 178 (432)
T 3p23_A 166 DFGLCKKLAVGRH------------------------------------------------------------------- 178 (432)
T ss_dssp CTTEEECC------------------------------------------------------------------------
T ss_pred cccceeeccCCCc-------------------------------------------------------------------
Confidence 9999854321000
Q ss_pred CccccccccccCCccccCCCCccCcchhcC---CCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCC
Q 011302 314 DPEVVAEPINARSKSFVGTHEYLAPEVISG---QGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFP 389 (489)
Q Consensus 314 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~---~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p 389 (489)
........+||+.|+|||++.+ ..++.++|||||||++|||++ |..||...........+... ..+
T Consensus 179 --------~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~--~~~ 248 (432)
T 3p23_A 179 --------SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGAC--SLD 248 (432)
T ss_dssp ---------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCC--CCT
T ss_pred --------ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccC--Ccc
Confidence 0012234579999999999984 557889999999999999999 99999766554433222222 111
Q ss_pred CCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCc
Q 011302 390 RIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINW 441 (489)
Q Consensus 390 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~ 441 (489)
..... ......+.+||.+||+.||.+||++. ++++||||.+++|
T Consensus 249 ~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~----evl~hp~f~~~~~ 292 (432)
T 3p23_A 249 CLHPE----KHEDVIARELIEKMIAMDPQKRPSAK----HVLKHPFFWSLEK 292 (432)
T ss_dssp TSCTT----CHHHHHHHHHHHHHSCSSGGGSCCHH----HHHTSTTTCCHHH
T ss_pred ccCcc----ccccHHHHHHHHHHHhCCHhhCCCHH----HHHhCccccChHH
Confidence 11111 12234588999999999999999987 9999999999887
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=391.24 Aligned_cols=254 Identities=20% Similarity=0.269 Sum_probs=212.2
Q ss_pred hcCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccc
Q 011302 77 AQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYA 156 (489)
Q Consensus 77 ~~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~ 156 (489)
..+++..++|++.+.||+|+||.||+|+++. .+..||||+++.... ....+.+|+.+|+.++||||+++++
T Consensus 213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~ 283 (495)
T 1opk_A 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKK-----YSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 283 (495)
T ss_dssp SCCBCCGGGEEEEEESGGGTTSSEEEEEEGG-----GTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccCHHHceeeeEecCCCCeEEEEEEEcC-----CCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEE
Confidence 3466778899999999999999999999986 568899999975432 2345778999999999999999999
Q ss_pred eeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccC
Q 011302 157 EFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFD 236 (489)
Q Consensus 157 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG 236 (489)
++.+.+.+|||||||++|+|.+++.......+++..+..|+.||+.||+|||++|||||||||+||||+.++.+||+|||
T Consensus 284 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG 363 (495)
T 1opk_A 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFG 363 (495)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTT
T ss_pred EEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecc
Confidence 99999999999999999999999987655679999999999999999999999999999999999999999999999999
Q ss_pred CCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcc
Q 011302 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPE 316 (489)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (489)
+++......
T Consensus 364 ~a~~~~~~~----------------------------------------------------------------------- 372 (495)
T 1opk_A 364 LSRLMTGDT----------------------------------------------------------------------- 372 (495)
T ss_dssp CEECCTTCC-----------------------------------------------------------------------
T ss_pred cceeccCCc-----------------------------------------------------------------------
Confidence 984332100
Q ss_pred ccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCC
Q 011302 317 VVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSS 395 (489)
Q Consensus 317 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 395 (489)
........+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+..+. ..+... ..
T Consensus 373 ------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~-~~ 444 (495)
T 1opk_A 373 ------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY-RMERPE-GC 444 (495)
T ss_dssp ------EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-CCCCCT-TC
T ss_pred ------eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCC-CC
Confidence 001122356789999999998889999999999999999999 999999988777666655432 222111 11
Q ss_pred chhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 396 SKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 396 ~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
. ..+.+||.+||+.||++||++.
T Consensus 445 ~------~~l~~li~~cl~~dP~~RPs~~ 467 (495)
T 1opk_A 445 P------EKVYELMRACWQWNPSDRPSFA 467 (495)
T ss_dssp C------HHHHHHHHHHTCSSGGGSCCHH
T ss_pred C------HHHHHHHHHHcCcChhHCcCHH
Confidence 1 2589999999999999999987
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=368.44 Aligned_cols=265 Identities=18% Similarity=0.252 Sum_probs=212.3
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCC--CCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCccccc
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMV--GLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLY 155 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~ 155 (489)
+.+..++|++.+.||+|+||+||+|++.+... ...+..||||++..... .....++.+|+.+++.+ +||||++++
T Consensus 30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~ 107 (334)
T 2pvf_A 30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLL 107 (334)
T ss_dssp TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCc--HHHHHHHHHHHHHHHHhhcCCCEeeEE
Confidence 45677899999999999999999999864221 23567899999975432 23345677899999999 899999999
Q ss_pred ceeecCceEEEEEeecCCCchHHHHHhCCC--------------CCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCC
Q 011302 156 AEFEASHYSCLVMEYCPGGDLYAARQRQPG--------------KRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPEN 221 (489)
Q Consensus 156 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~N 221 (489)
+++.+.+.+|+||||+++|+|.+++..... ..+++.++..++.||+.||+|||++||+||||||+|
T Consensus 108 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 187 (334)
T 2pvf_A 108 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 187 (334)
T ss_dssp EEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred EEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccce
Confidence 999999999999999999999999986531 348899999999999999999999999999999999
Q ss_pred eEeccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccc
Q 011302 222 VLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQ 301 (489)
Q Consensus 222 ILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (489)
||++.++.+||+|||+++.......
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~------------------------------------------------------- 212 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDY------------------------------------------------------- 212 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSS-------------------------------------------------------
T ss_pred EEEcCCCCEEEcccccccccccccc-------------------------------------------------------
Confidence 9999999999999999843321000
Q ss_pred cCCCCCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHH
Q 011302 302 VDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLIN 380 (489)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~ 380 (489)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....
T Consensus 213 ---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~ 271 (334)
T 2pvf_A 213 ---------------------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271 (334)
T ss_dssp ---------------------EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred ---------------------ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHH
Confidence 001122357889999999998889999999999999999999 9999999888777766
Q ss_pred HhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 381 ILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 381 i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
+..+..... ..... ..+.+||.+||..||.+||++. +++++
T Consensus 272 ~~~~~~~~~--~~~~~------~~l~~li~~~l~~dp~~Rps~~----ell~~ 312 (334)
T 2pvf_A 272 LKEGHRMDK--PANCT------NELYMMMRDCWHAVPSQRPTFK----QLVED 312 (334)
T ss_dssp HHHTCCCCC--CTTCC------HHHHHHHHHHTCSSGGGSCCHH----HHHHH
T ss_pred HhcCCCCCC--CccCC------HHHHHHHHHHccCChhhCcCHH----HHHHH
Confidence 665432111 11111 2589999999999999999987 55554
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=361.70 Aligned_cols=277 Identities=19% Similarity=0.220 Sum_probs=211.6
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCccccccee
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAEF 158 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~ 158 (489)
.+..++|++.+.||+|+||.||+|++.. +++.||||++.... ....+.+|+.+++.+ +|+||+++++++
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~ 75 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLL-----NNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFG 75 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETT-----TTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECC-----CCcEEEEEEeccCC-----ccHHHHHHHHHHHHHhcCCCCCeEEeec
Confidence 4556889999999999999999999876 57899999986532 234566799999999 799999999999
Q ss_pred ecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCc-----EEEc
Q 011302 159 EASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGH-----IMLS 233 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~-----vkl~ 233 (489)
.+....|+||||+ |++|.+++... +..+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+
T Consensus 76 ~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~ 153 (298)
T 1csn_A 76 QEGLHNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVV 153 (298)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred CCCceeEEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEE
Confidence 9999999999999 99999999875 346999999999999999999999999999999999999987776 9999
Q ss_pred ccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccC
Q 011302 234 DFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLD 313 (489)
Q Consensus 234 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (489)
|||+++........
T Consensus 154 Dfg~~~~~~~~~~~------------------------------------------------------------------ 167 (298)
T 1csn_A 154 DFGMVKFYRDPVTK------------------------------------------------------------------ 167 (298)
T ss_dssp CCTTCEESBCTTTC------------------------------------------------------------------
T ss_pred ECcccccccccccc------------------------------------------------------------------
Confidence 99998543211000
Q ss_pred CccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCC---cHHHHHHHhcCCCCCCC
Q 011302 314 DPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGEN---NEKTLINILKKPLTFPR 390 (489)
Q Consensus 314 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~p~ 390 (489)
............||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+ ....+..+.......+.
T Consensus 168 -----~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (298)
T 1csn_A 168 -----QHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 242 (298)
T ss_dssp -----CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred -----ccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccH
Confidence 0000112345679999999999999999999999999999999999999998753 33344444332111110
Q ss_pred CCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCCh---HHH---HcCCCcCCCCccc
Q 011302 391 IGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGS---VEI---KRHEFFKGINWAL 443 (489)
Q Consensus 391 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~---~~l---l~hp~f~~~~~~~ 443 (489)
.... ...+..+.+||.+||+.||++||++.+.. +++ +.......++|+.
T Consensus 243 ~~~~----~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 297 (298)
T 1csn_A 243 RELC----AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNL 297 (298)
T ss_dssp HHHT----TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGC
T ss_pred HHHH----hhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccCC
Confidence 0000 00112589999999999999999986322 112 2334556667754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=387.24 Aligned_cols=252 Identities=18% Similarity=0.299 Sum_probs=208.8
Q ss_pred hcCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccc
Q 011302 77 AQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYA 156 (489)
Q Consensus 77 ~~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~ 156 (489)
..+++..++|++.+.||+|+||+||+|.++. +..||||+++.... ....+.+|+.+|+.++||||+++++
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~------~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~ 250 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNK------HTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHA 250 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETT------TEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECC------ccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEE
Confidence 3467888999999999999999999999864 46799999986432 2346778999999999999999999
Q ss_pred eeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccC
Q 011302 157 EFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFD 236 (489)
Q Consensus 157 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG 236 (489)
++. .+.+|+|||||++|+|.+++.......+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||
T Consensus 251 ~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG 329 (454)
T 1qcf_A 251 VVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFG 329 (454)
T ss_dssp EEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTT
T ss_pred EEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCC
Confidence 987 5678999999999999999976533468899999999999999999999999999999999999999999999999
Q ss_pred CCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcc
Q 011302 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPE 316 (489)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (489)
+++......
T Consensus 330 ~a~~~~~~~----------------------------------------------------------------------- 338 (454)
T 1qcf_A 330 LARVIEDNE----------------------------------------------------------------------- 338 (454)
T ss_dssp GGGGBCCHH-----------------------------------------------------------------------
T ss_pred CceEcCCCc-----------------------------------------------------------------------
Confidence 984332100
Q ss_pred ccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCC
Q 011302 317 VVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSS 395 (489)
Q Consensus 317 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 395 (489)
........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+....+..+. ..+... ..
T Consensus 339 ------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~-~~~~~~-~~ 410 (454)
T 1qcf_A 339 ------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY-RMPRPE-NC 410 (454)
T ss_dssp ------HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC-CCCCCT-TS
T ss_pred ------eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCC-CC
Confidence 000122346889999999998889999999999999999999 999999998888877776542 222211 11
Q ss_pred chhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 396 SKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 396 ~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
+..+.+||.+||..||++||++.
T Consensus 411 ------~~~l~~li~~cl~~dp~~RPt~~ 433 (454)
T 1qcf_A 411 ------PEELYNIMMRCWKNRPEERPTFE 433 (454)
T ss_dssp ------CHHHHHHHHHHTCSSGGGSCCHH
T ss_pred ------CHHHHHHHHHHccCChhHCcCHH
Confidence 12589999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=372.93 Aligned_cols=258 Identities=26% Similarity=0.351 Sum_probs=209.7
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHH---HHHHHHHHHHHHHHhCC--CCCccc
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIR---KKLHRADMEKVILTMLD--HPFLPT 153 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~E~~~l~~l~--hpnIv~ 153 (489)
+....++|++.+.||+|+||.||+|++.. +++.||||++........ ....++.+|+.+++.+. ||||++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~ 112 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVS-----DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 112 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETT-----TTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCC
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECC-----CCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceE
Confidence 34556899999999999999999999876 578999999976532210 11234556999999996 599999
Q ss_pred ccceeecCceEEEEEeecCC-CchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEec-cCCcEE
Q 011302 154 LYAEFEASHYSCLVMEYCPG-GDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVR-EDGHIM 231 (489)
Q Consensus 154 l~~~~~~~~~~~lV~E~~~g-g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~-~~~~vk 231 (489)
+++++.+.+..|+|||++.+ ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+|
T Consensus 113 ~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~k 190 (320)
T 3a99_A 113 LLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELK 190 (320)
T ss_dssp EEEEEECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEE
T ss_pred EEEEEecCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEE
Confidence 99999999999999999976 8999998775 5799999999999999999999999999999999999999 789999
Q ss_pred EcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccc
Q 011302 232 LSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQEL 311 (489)
Q Consensus 232 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (489)
|+|||+++....
T Consensus 191 L~Dfg~~~~~~~-------------------------------------------------------------------- 202 (320)
T 3a99_A 191 LIDFGSGALLKD-------------------------------------------------------------------- 202 (320)
T ss_dssp ECCCTTCEECCS--------------------------------------------------------------------
T ss_pred EeeCcccccccc--------------------------------------------------------------------
Confidence 999999843211
Q ss_pred cCCccccccccccCCccccCCCCccCcchhcCCCC-CCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCC
Q 011302 312 LDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGH-GSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPR 390 (489)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~ 390 (489)
.......||+.|+|||++.+..+ +.++|||||||++|||++|..||.... .+......++.
T Consensus 203 ------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~~ 264 (320)
T 3a99_A 203 ------------TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQ 264 (320)
T ss_dssp ------------SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSS
T ss_pred ------------ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccccccc
Confidence 01123469999999999987765 788999999999999999999997542 22333332222
Q ss_pred CCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcc
Q 011302 391 IGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWA 442 (489)
Q Consensus 391 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~ 442 (489)
. .. ..+.+||.+||+.||++||++. ++++||||+.+.+.
T Consensus 265 ~---~~------~~~~~li~~~l~~dp~~Rps~~----~ll~hp~~~~~~~~ 303 (320)
T 3a99_A 265 R---VS------SECQHLIRWCLALRPSDRPTFE----EIQNHPWMQDVLLP 303 (320)
T ss_dssp C---CC------HHHHHHHHHHTCSSGGGSCCHH----HHHTSGGGSSCCCH
T ss_pred c---CC------HHHHHHHHHHccCChhhCcCHH----HHhcCHhhcCccCc
Confidence 1 11 2589999999999999999987 99999999987653
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=365.57 Aligned_cols=262 Identities=24% Similarity=0.351 Sum_probs=196.0
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE 159 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 159 (489)
....++|++++.||+|+||.||+|+++. +++.||||++...... ......+..+..+++.++||||+++++++.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~ 94 (318)
T 2dyl_A 21 QAEINDLENLGEMGSGTCGQVWKMRFRK-----TGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSHDCPYIVQCFGTFI 94 (318)
T ss_dssp ECCGGGEEEEEEC------CEEEEEETT-----TCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred hhhhccccccceeeecCCeeEEEEEEec-----CCeEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Confidence 3456899999999999999999999986 5789999999754322 122233444556788889999999999999
Q ss_pred cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhC-CCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 160 ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMM-GIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 160 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
+.+.+|+||||+ ++.+..+.... ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~~~~lv~e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 172 (318)
T 2dyl_A 95 TNTDVFIAMELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGIS 172 (318)
T ss_dssp CSSEEEEEECCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred cCCcEEEEEecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCc
Confidence 999999999999 66666655442 35799999999999999999999995 9999999999999999999999999997
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
......
T Consensus 173 ~~~~~~-------------------------------------------------------------------------- 178 (318)
T 2dyl_A 173 GRLVDD-------------------------------------------------------------------------- 178 (318)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred hhccCC--------------------------------------------------------------------------
Confidence 432110
Q ss_pred ccccccCCccccCCCCccCcchhc-----CCCCCCcccHHHHHHHHHHHhhCCCCCCCC-CcHHHHHHHhcCCCC-CCCC
Q 011302 319 AEPINARSKSFVGTHEYLAPEVIS-----GQGHGSAVDWWTLGVFLYEMLYGTTPFKGE-NNEKTLINILKKPLT-FPRI 391 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~~~~~DiwSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~~~~-~p~~ 391 (489)
.......||+.|+|||++. +..++.++|||||||++|||++|+.||... ...+.+..+...... ++..
T Consensus 179 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 253 (318)
T 2dyl_A 179 -----KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGH 253 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSS
T ss_pred -----ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCcc
Confidence 0112236899999999995 456889999999999999999999999874 444555566554322 2211
Q ss_pred CCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 392 GVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 392 ~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
. ... ..+.+||.+||+.||.+||++. ++++||||+..
T Consensus 254 ~-~~~------~~l~~li~~~l~~dp~~Rps~~----~ll~h~~~~~~ 290 (318)
T 2dyl_A 254 M-GFS------GDFQSFVKDCLTKDHRKRPKYN----KLLEHSFIKRY 290 (318)
T ss_dssp S-CCC------HHHHHHHHHHTCSCTTTSCCHH----HHTTSHHHHHH
T ss_pred C-CCC------HHHHHHHHHHccCChhHCcCHH----HHhhCHHHHhc
Confidence 1 111 2589999999999999999987 99999999764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=370.41 Aligned_cols=268 Identities=18% Similarity=0.229 Sum_probs=209.5
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE 159 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 159 (489)
++..++|++++.||+|+||.||+|++.+.....++..||||++..... .....++.+|+.+++.++||||+++++++.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS--EQDELDFLMEALIISKFNHQNIVRCIGVSL 103 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccc--hhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence 355689999999999999999999965432233678899999864321 123346777999999999999999999999
Q ss_pred cCceEEEEEeecCCCchHHHHHhCCC-----CCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEecc---CCcEE
Q 011302 160 ASHYSCLVMEYCPGGDLYAARQRQPG-----KRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRE---DGHIM 231 (489)
Q Consensus 160 ~~~~~~lV~E~~~gg~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~---~~~vk 231 (489)
+....|+||||++||+|.+++..... ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+|
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence 99999999999999999999987532 35889999999999999999999999999999999999994 44699
Q ss_pred EcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccc
Q 011302 232 LSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQEL 311 (489)
Q Consensus 232 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (489)
|+|||++.......
T Consensus 184 l~Dfg~~~~~~~~~------------------------------------------------------------------ 197 (327)
T 2yfx_A 184 IGDFGMARDIYRAS------------------------------------------------------------------ 197 (327)
T ss_dssp ECCCHHHHHHHC--------------------------------------------------------------------
T ss_pred ECcccccccccccc------------------------------------------------------------------
Confidence 99999973221100
Q ss_pred cCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCC
Q 011302 312 LDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPR 390 (489)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~ 390 (489)
.........||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+..+....+.
T Consensus 198 ----------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~ 267 (327)
T 2yfx_A 198 ----------YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP 267 (327)
T ss_dssp --------------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred ----------ccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCCCC
Confidence 0011223468999999999999899999999999999999998 99999998887777777665332221
Q ss_pred CCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcC
Q 011302 391 IGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437 (489)
Q Consensus 391 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~ 437 (489)
.. .. ..+.+||.+||+.||.+||++. ++++|.|+-
T Consensus 268 ~~--~~------~~l~~li~~~l~~dp~~Rps~~----~ll~~l~~~ 302 (327)
T 2yfx_A 268 KN--CP------GPVYRIMTQCWQHQPEDRPNFA----IILERIEYC 302 (327)
T ss_dssp TT--CC------HHHHHHHHHHTCSSGGGSCCHH----HHHHHHHHH
T ss_pred CC--CC------HHHHHHHHHHhcCChhhCcCHH----HHHHHHHHH
Confidence 11 11 2489999999999999999987 899987763
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=355.74 Aligned_cols=255 Identities=22% Similarity=0.277 Sum_probs=211.5
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccccccee
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEF 158 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 158 (489)
+.+..++|++.+.||+|+||.||+|.+.+ +..||+|++...... ...+.+|+.+++.++||||+++++++
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~ 72 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWLN------KDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVC 72 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEETT------TEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eEEchhheeeeeEecCCCceeEEEEEecC------CCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 45667899999999999999999999864 467999999865322 13567799999999999999999999
Q ss_pred ecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 159 EASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
.+.+..|+||||++|++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 73 ~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~ 151 (267)
T 3t9t_A 73 LEQAPICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT 151 (267)
T ss_dssp CSSSSCEEEECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGG
T ss_pred ccCCCeEEEEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccc
Confidence 99999999999999999999987653 56899999999999999999999999999999999999999999999999997
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
.......
T Consensus 152 ~~~~~~~------------------------------------------------------------------------- 158 (267)
T 3t9t_A 152 RFVLDDQ------------------------------------------------------------------------- 158 (267)
T ss_dssp GGBCCHH-------------------------------------------------------------------------
T ss_pred ccccccc-------------------------------------------------------------------------
Confidence 4321100
Q ss_pred ccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCch
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSK 397 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 397 (489)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+..+........ .
T Consensus 159 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~--~-- 230 (267)
T 3t9t_A 159 ----YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRL--A-- 230 (267)
T ss_dssp ----HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTT--S--
T ss_pred ----ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCcc--C--
Confidence 001122357889999999998889999999999999999999 9999999888888777766532221111 1
Q ss_pred hHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 398 EFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 398 ~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
...+.+||.+||+.||++||++. +++++
T Consensus 231 ----~~~l~~li~~~l~~~p~~Rps~~----~ll~~ 258 (267)
T 3t9t_A 231 ----STHVYQIMNHCWRERPEDRPAFS----RLLRQ 258 (267)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHH----HHHHH
T ss_pred ----cHHHHHHHHHHccCChhhCcCHH----HHHHH
Confidence 12589999999999999999987 66553
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=365.51 Aligned_cols=266 Identities=29% Similarity=0.405 Sum_probs=207.6
Q ss_pred hhcCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC--CCCccc
Q 011302 76 RAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD--HPFLPT 153 (489)
Q Consensus 76 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~ 153 (489)
.....+..++|++++.||+|+||.||+|.+.. ++.||||++...... ......+.+|+.+++.++ ||||++
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~ 92 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK------KQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIR 92 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECTT------CCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHHGGGCTTBCC
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcCC------CcEEEEEEecccccc-ccchHHHHHHHHHHHhccccCCceEE
Confidence 33445566789999999999999999998753 578999998643221 234456778999999997 599999
Q ss_pred ccceeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEc
Q 011302 154 LYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLS 233 (489)
Q Consensus 154 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~ 233 (489)
+++++.+.+.+|+||| +.+++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+
T Consensus 93 ~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~ 168 (313)
T 3cek_A 93 LYDYEITDQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLI 168 (313)
T ss_dssp EEEEEECSSEEEEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEEC
T ss_pred EEEEeecCCEEEEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEe
Confidence 9999999999999999 4589999999875 5799999999999999999999999999999999999996 5899999
Q ss_pred ccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccC
Q 011302 234 DFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLD 313 (489)
Q Consensus 234 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (489)
|||+++.+.....
T Consensus 169 Dfg~~~~~~~~~~------------------------------------------------------------------- 181 (313)
T 3cek_A 169 DFGIANQMQPDTT------------------------------------------------------------------- 181 (313)
T ss_dssp CCSSSCC-------------------------------------------------------------------------
T ss_pred eccccccccCccc-------------------------------------------------------------------
Confidence 9999843321000
Q ss_pred CccccccccccCCccccCCCCccCcchhcC-----------CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcH-HHHHHH
Q 011302 314 DPEVVAEPINARSKSFVGTHEYLAPEVISG-----------QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNE-KTLINI 381 (489)
Q Consensus 314 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----------~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-~~~~~i 381 (489)
.......+||+.|+|||++.+ ..++.++|||||||++|||++|..||...... ..+..+
T Consensus 182 ---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 252 (313)
T 3cek_A 182 ---------SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 252 (313)
T ss_dssp -----------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred ---------cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHH
Confidence 001123469999999999976 46788999999999999999999999876443 344445
Q ss_pred hcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 382 LKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 382 ~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
.......+..... . ..+.+||.+||+.||.+||++. ++++||||+..
T Consensus 253 ~~~~~~~~~~~~~-~------~~l~~li~~~l~~dp~~Rps~~----ell~h~~~~~~ 299 (313)
T 3cek_A 253 IDPNHEIEFPDIP-E------KDLQDVLKCCLKRDPKQRISIP----ELLAHPYVQIQ 299 (313)
T ss_dssp HCTTSCCCCCCCS-C------HHHHHHHHHHTCSSTTTSCCHH----HHHTSHHHHCC
T ss_pred HhcccccCCcccc-h------HHHHHHHHHHccCCcccCcCHH----HHhcCccccCC
Confidence 4433222211111 1 2489999999999999999987 99999999764
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=374.55 Aligned_cols=291 Identities=14% Similarity=0.157 Sum_probs=206.4
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHH--------HHHHHHHHHHHHHhCCCCCccc
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRK--------KLHRADMEKVILTMLDHPFLPT 153 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~--------~~~~~~~E~~~l~~l~hpnIv~ 153 (489)
..++|++.+.||+|+||+||+|.++.+.....++.||||++......... .......|...++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34689999999999999999999987544445788999998754321111 1123445667788899999999
Q ss_pred ccceeecC----ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEec--cC
Q 011302 154 LYAEFEAS----HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVR--ED 227 (489)
Q Consensus 154 l~~~~~~~----~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~--~~ 227 (489)
+++++... ...||||||| |++|.+++... ...+++..++.|+.||+.||+|||++|||||||||+||||+ .+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence 99998764 5689999999 99999998775 35799999999999999999999999999999999999999 88
Q ss_pred CcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCC
Q 011302 228 GHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHH 307 (489)
Q Consensus 228 ~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (489)
+.+||+|||+|+.+......
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~------------------------------------------------------------ 210 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVH------------------------------------------------------------ 210 (364)
T ss_dssp TCEEECCCTTCEESSGGGCC------------------------------------------------------------
T ss_pred CeEEEEECCcceecccCCcc------------------------------------------------------------
Confidence 99999999998544311000
Q ss_pred CccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCC-
Q 011302 308 DQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL- 386 (489)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~- 386 (489)
...........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+...............
T Consensus 211 -----------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~ 279 (364)
T 3op5_A 211 -----------KAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYR 279 (364)
T ss_dssp -----------CCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHH
T ss_pred -----------cccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhh
Confidence 00001122445799999999999999999999999999999999999999986433222221111000
Q ss_pred -CCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCCh---HHHH---cCCCcCCCCccccc
Q 011302 387 -TFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGS---VEIK---RHEFFKGINWALIR 445 (489)
Q Consensus 387 -~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~---~~ll---~hp~f~~~~~~~~~ 445 (489)
..+.....+......+.++.+||..||..||++||++.+.. .+++ ..++...++|....
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~~~ 345 (364)
T 3op5_A 280 ENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVVE 345 (364)
T ss_dssp HCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC----
T ss_pred hhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceEecc
Confidence 00000000000000112589999999999999999986322 1122 24566777887553
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=358.58 Aligned_cols=261 Identities=21% Similarity=0.242 Sum_probs=206.0
Q ss_pred HHhhcCccccCCceeee-eeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcc
Q 011302 74 LRRAQGRVGLDHFRLLR-RLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLP 152 (489)
Q Consensus 74 ~~~~~~~~~~~~y~~~~-~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv 152 (489)
++.....+..++|.+.+ .||+|+||.||+|.+... ..++.||||++...... .....++.+|+.+++.++||||+
T Consensus 6 i~~~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~ 81 (291)
T 1xbb_A 6 IRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMK---KVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIV 81 (291)
T ss_dssp -----CBCCGGGEEEEEEEEEECSSEEEEEEEEECS---SSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBC
T ss_pred cCcceeeecchhhhhccCccccccCeeeEeeeecCC---CceeeEEEEeecccccC-HHHHHHHHHHHHHHHhCCCCCEE
Confidence 34445567778999998 999999999999976542 14688999999865422 23456688899999999999999
Q ss_pred cccceeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEE
Q 011302 153 TLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIML 232 (489)
Q Consensus 153 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl 232 (489)
++++++ ..+..|+||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 82 ~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl 158 (291)
T 1xbb_A 82 RMIGIC-EAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKI 158 (291)
T ss_dssp CEEEEE-ESSSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred EEEEEE-CCCCcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEE
Confidence 999998 567789999999999999999875 56999999999999999999999999999999999999999999999
Q ss_pred cccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCcccc
Q 011302 233 SDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELL 312 (489)
Q Consensus 233 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (489)
+|||++.........
T Consensus 159 ~Dfg~~~~~~~~~~~----------------------------------------------------------------- 173 (291)
T 1xbb_A 159 SDFGLSKALRADENY----------------------------------------------------------------- 173 (291)
T ss_dssp CCCTTCEECCTTCSE-----------------------------------------------------------------
T ss_pred ccCCcceeeccCCCc-----------------------------------------------------------------
Confidence 999998443211000
Q ss_pred CCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCC
Q 011302 313 DDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRI 391 (489)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~ 391 (489)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+..+... ..
T Consensus 174 ----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--~~ 241 (291)
T 1xbb_A 174 ----------YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM--GC 241 (291)
T ss_dssp ----------EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--CC
T ss_pred ----------ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--CC
Confidence 001122347889999999998889999999999999999999 99999998887777666654321 11
Q ss_pred CCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 392 GVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 392 ~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
..... ..+.+||.+||+.||.+||++.
T Consensus 242 ~~~~~------~~l~~li~~~l~~dp~~Rps~~ 268 (291)
T 1xbb_A 242 PAGCP------REMYDLMNLCWTYDVENRPGFA 268 (291)
T ss_dssp CTTCC------HHHHHHHHHHTCSSTTTSCCHH
T ss_pred CCCCC------HHHHHHHHHHcCCChhhCcCHH
Confidence 11111 2589999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=366.13 Aligned_cols=255 Identities=22% Similarity=0.304 Sum_probs=206.2
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCee--EEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccce
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCF--YAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAE 157 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~--~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~ 157 (489)
+..++|++.+.||+|+||.||+|+++. ++.. +|+|.+..... .....++.+|+.+++.+ +||||++++++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~~v~iK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 94 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKK-----DGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGA 94 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEE-----TTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEE
T ss_pred ccHHHccceeeeecCCCceEEEEEEcc-----CCcccceeeeeeccccc--hHHHHHHHHHHHHHHhccCCCchhhhcee
Confidence 456899999999999999999999886 3443 59999875321 23456678899999999 89999999999
Q ss_pred eecCceEEEEEeecCCCchHHHHHhCC--------------CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeE
Q 011302 158 FEASHYSCLVMEYCPGGDLYAARQRQP--------------GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVL 223 (489)
Q Consensus 158 ~~~~~~~~lV~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIL 223 (489)
+.+.+.+|+||||+++|+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl 174 (327)
T 1fvr_A 95 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNIL 174 (327)
T ss_dssp EEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred eeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEE
Confidence 999999999999999999999987642 246999999999999999999999999999999999999
Q ss_pred eccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccC
Q 011302 224 VREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVD 303 (489)
Q Consensus 224 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (489)
++.++.+||+|||+++....
T Consensus 175 ~~~~~~~kL~Dfg~~~~~~~------------------------------------------------------------ 194 (327)
T 1fvr_A 175 VGENYVAKIADFGLSRGQEV------------------------------------------------------------ 194 (327)
T ss_dssp ECGGGCEEECCTTCEESSCE------------------------------------------------------------
T ss_pred EcCCCeEEEcccCcCccccc------------------------------------------------------------
Confidence 99999999999999732110
Q ss_pred CCCCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHh
Q 011302 304 GDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINIL 382 (489)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~ 382 (489)
........+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+.
T Consensus 195 -------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~ 255 (327)
T 1fvr_A 195 -------------------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255 (327)
T ss_dssp -------------------ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred -------------------cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh
Confidence 001122357889999999998889999999999999999998 999999998887777776
Q ss_pred cCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 383 KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 383 ~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
.+... +.. .. ....+.+||.+||+.||.+||++. +++++
T Consensus 256 ~~~~~-~~~-~~------~~~~l~~li~~~l~~dp~~Rps~~----ell~~ 294 (327)
T 1fvr_A 256 QGYRL-EKP-LN------CDDEVYDLMRQCWREKPYERPSFA----QILVS 294 (327)
T ss_dssp GTCCC-CCC-TT------BCHHHHHHHHHHTCSSGGGSCCHH----HHHHH
T ss_pred cCCCC-CCC-CC------CCHHHHHHHHHHccCChhhCcCHH----HHHHH
Confidence 54211 111 11 112589999999999999999987 66554
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=356.77 Aligned_cols=248 Identities=23% Similarity=0.349 Sum_probs=198.3
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHH----HHHHHHHHHHHHHHHHhCCCCCcccccc
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALA----IRKKLHRADMEKVILTMLDHPFLPTLYA 156 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~~~E~~~l~~l~hpnIv~l~~ 156 (489)
+..++|++.+.||+|+||+||+|++.. +++.||+|++...... .......+.+|+.+++.++||||+++++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 90 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVK-----DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYG 90 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETT-----TCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred hhhccceehhccccCCceeEEEEEEcC-----CceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhhe
Confidence 456899999999999999999999986 5788999998542211 1122356778999999999999999999
Q ss_pred eeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCC--CeeecCCCCCeEeccCCc-----
Q 011302 157 EFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMG--IVYRDLKPENVLVREDGH----- 229 (489)
Q Consensus 157 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDIKp~NILl~~~~~----- 229 (489)
++.+.. ++||||+++|+|.+.+... ...+++..+..++.||+.||+|||++| |+||||||+|||++.++.
T Consensus 91 ~~~~~~--~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~ 167 (287)
T 4f0f_A 91 LMHNPP--RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVC 167 (287)
T ss_dssp EETTTT--EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCC
T ss_pred eecCCC--eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCcee
Confidence 997765 6999999999999888654 357999999999999999999999999 999999999999988776
Q ss_pred EEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCc
Q 011302 230 IMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQ 309 (489)
Q Consensus 230 vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (489)
+||+|||+++....
T Consensus 168 ~kl~Dfg~~~~~~~------------------------------------------------------------------ 181 (287)
T 4f0f_A 168 AKVADFGLSQQSVH------------------------------------------------------------------ 181 (287)
T ss_dssp EEECCCTTCBCCSS------------------------------------------------------------------
T ss_pred EEeCCCCccccccc------------------------------------------------------------------
Confidence 99999999732110
Q ss_pred cccCCccccccccccCCccccCCCCccCcchhc--CCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHH--HHHHhcCC
Q 011302 310 ELLDDPEVVAEPINARSKSFVGTHEYLAPEVIS--GQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKT--LINILKKP 385 (489)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~--~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~--~~~i~~~~ 385 (489)
......||+.|+|||++. ...++.++|||||||++|||++|+.||.+.+.... ...+....
T Consensus 182 ---------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 246 (287)
T 4f0f_A 182 ---------------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246 (287)
T ss_dssp ---------------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC
T ss_pred ---------------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC
Confidence 112347999999999994 44578999999999999999999999987654433 33333332
Q ss_pred CCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 386 LTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 386 ~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
...... .... ..+.+||.+||+.||++||++.
T Consensus 247 ~~~~~~-~~~~------~~l~~li~~~l~~dp~~Rps~~ 278 (287)
T 4f0f_A 247 LRPTIP-EDCP------PRLRNVIELCWSGDPKKRPHFS 278 (287)
T ss_dssp CCCCCC-TTSC------HHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCCC-cccC------HHHHHHHHHHhcCChhhCcCHH
Confidence 222111 1111 2589999999999999999987
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=356.51 Aligned_cols=260 Identities=23% Similarity=0.295 Sum_probs=207.6
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccccccee
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEF 158 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 158 (489)
+.+..++|.+.+.||+|+||+||+|++.... ..+..||+|++..... .....++.+|+.+++.++||||+++++++
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 82 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHK--GEKINVAVKTCKKDCT--LDNKEKFMSEAVIMKNLDHPHIVKLIGII 82 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTT--CCEEEEEEEECCTTSC--HHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCC--CCcceEEEEecccccC--chHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 4566789999999999999999999987532 1456799999976421 12345677899999999999999999998
Q ss_pred ecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 159 EASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
.++ ..|+||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 83 ~~~-~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 160 (281)
T 3cc6_A 83 EEE-PTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS 160 (281)
T ss_dssp CSS-SCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGG
T ss_pred cCC-CCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCC
Confidence 754 5689999999999999987642 56999999999999999999999999999999999999999999999999998
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
.......
T Consensus 161 ~~~~~~~------------------------------------------------------------------------- 167 (281)
T 3cc6_A 161 RYIEDED------------------------------------------------------------------------- 167 (281)
T ss_dssp GCC-----------------------------------------------------------------------------
T ss_pred ccccccc-------------------------------------------------------------------------
Confidence 4322100
Q ss_pred ccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCch
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSK 397 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 397 (489)
........||+.|+|||++.+..++.++|||||||++|||++ |..||...+..+....+...... +... ...
T Consensus 168 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~-~~~~-~~~- 240 (281)
T 3cc6_A 168 ----YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL-PKPD-LCP- 240 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC-CCCT-TCC-
T ss_pred ----ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC-CCCC-CCC-
Confidence 001122357889999999998899999999999999999998 99999887777666665544221 1111 111
Q ss_pred hHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 398 EFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 398 ~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
..+.+||.+||..||++||++. +++++
T Consensus 241 -----~~l~~li~~~l~~~p~~Rps~~----ell~~ 267 (281)
T 3cc6_A 241 -----PVLYTLMTRCWDYDPSDRPRFT----ELVCS 267 (281)
T ss_dssp -----HHHHHHHHHHTCSSGGGSCCHH----HHHHH
T ss_pred -----HHHHHHHHHHccCCchhCcCHH----HHHHH
Confidence 2489999999999999999987 66553
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=370.62 Aligned_cols=268 Identities=22% Similarity=0.273 Sum_probs=189.5
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHH-HHHhCCCCCcccccce
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKV-ILTMLDHPFLPTLYAE 157 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~l~~~ 157 (489)
+.+..++|++++.||+|+||.||+|.++. +++.||||++...... ....++..|.. +++.++||||++++++
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~~~~~ 89 (327)
T 3aln_A 17 WDFTAEDLKDLGEIGRGAYGSVNKMVHKP-----SGQIMAVKRIRSTVDE--KEQKQLLMDLDVVMRSSDCPYIVQFYGA 89 (327)
T ss_dssp ECCCSCSEEC-CEEEECSSEEEEEEEETT-----TTEEEEEEEEECCCCH--HHHHHHHHHHHHHHSSCCCTTBCCEEEE
T ss_pred cccCHHHhhehheeccCCCEEEEEEEEcC-----CCCEEEEEEeecccCc--hHHHHHHHHHHHHHHcCCCCcEeeeeeE
Confidence 45667899999999999999999999886 5789999999753211 12223334444 7778899999999999
Q ss_pred eecCceEEEEEeecCCCchHHHHHh---CCCCCCChhhHHHHHHHHHHHHHHHHhC-CCeeecCCCCCeEeccCCcEEEc
Q 011302 158 FEASHYSCLVMEYCPGGDLYAARQR---QPGKRFGISSAKFYAAETLLALEYLHMM-GIVYRDLKPENVLVREDGHIMLS 233 (489)
Q Consensus 158 ~~~~~~~~lV~E~~~gg~L~~~l~~---~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~iiHrDIKp~NILl~~~~~vkl~ 233 (489)
+.+.+..|+||||++ |+|.+++.. .....+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+
T Consensus 90 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~ 168 (327)
T 3aln_A 90 LFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLC 168 (327)
T ss_dssp EECSSEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEEC
T ss_pred EEeCCceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEc
Confidence 999999999999996 588776653 2246799999999999999999999999 99999999999999999999999
Q ss_pred ccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccC
Q 011302 234 DFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLD 313 (489)
Q Consensus 234 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (489)
|||+++.....
T Consensus 169 Dfg~~~~~~~~--------------------------------------------------------------------- 179 (327)
T 3aln_A 169 DFGISGQLVDS--------------------------------------------------------------------- 179 (327)
T ss_dssp CCSSSCC-------------------------------------------------------------------------
T ss_pred cCCCceecccc---------------------------------------------------------------------
Confidence 99998432110
Q ss_pred CccccccccccCCccccCCCCccCcchh----cCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcH-HHHHHHhcCC-CC
Q 011302 314 DPEVVAEPINARSKSFVGTHEYLAPEVI----SGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNE-KTLINILKKP-LT 387 (489)
Q Consensus 314 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~l----~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~-~~ 387 (489)
.......||+.|+|||++ .+..++.++|||||||++|||++|..||.+.... +.+..+..+. ..
T Consensus 180 ----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 249 (327)
T 3aln_A 180 ----------IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQ 249 (327)
T ss_dssp ------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCC
T ss_pred ----------cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCC
Confidence 001123689999999999 4566899999999999999999999999875432 2222222221 11
Q ss_pred CCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcc
Q 011302 388 FPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWA 442 (489)
Q Consensus 388 ~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~ 442 (489)
++..... .....+.+||.+||..||++||++. ++++||||...++.
T Consensus 250 ~~~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~----ell~hp~~~~~~~~ 295 (327)
T 3aln_A 250 LSNSEER-----EFSPSFINFVNLCLTKDESKRPKYK----ELLKHPFILMYEER 295 (327)
T ss_dssp CCCCSSC-----CCCHHHHHHHHHHTCSSGGGSCCHH----HHTTSHHHHHHHHS
T ss_pred CCCcccc-----cCCHHHHHHHHHHhhCChhhCcCHH----HHHhChHHHHhHhh
Confidence 1111111 1123589999999999999999987 99999999876554
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=377.52 Aligned_cols=261 Identities=23% Similarity=0.313 Sum_probs=195.0
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccceeecCc
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAEFEASH 162 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~ 162 (489)
+.|.+.+.||+|+||+||.+... .++.||||++..+.. ..+.+|+.+|+.+ +|||||++++++.+++
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~------~g~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 82 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSF------QGRPVAVKRMLIDFC------DIALMEIKLLTESDDHPNVIRYYCSETTDR 82 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEES------SSSEEEEEEEEGGGH------HHHHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred heeeccCeEeeCCCeEEEEEEEE------CCeEEEEEEEcHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence 45666788999999999875433 468999999976432 2456699999876 8999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCC-----CChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccC----------
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKR-----FGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRED---------- 227 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~-----l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~---------- 227 (489)
.+||||||| +|+|.+++....... ..+..+..++.||+.||+|||++|||||||||+|||++.+
T Consensus 83 ~~~lv~E~~-~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~ 161 (434)
T 2rio_A 83 FLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTG 161 (434)
T ss_dssp EEEEEECCC-SEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccC
Confidence 999999999 579999997652211 1344567899999999999999999999999999999754
Q ss_pred ---CcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCC
Q 011302 228 ---GHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDG 304 (489)
Q Consensus 228 ---~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (489)
+.+||+|||+++.+......
T Consensus 162 ~~~~~~kL~DFG~a~~~~~~~~~--------------------------------------------------------- 184 (434)
T 2rio_A 162 AENLRILISDFGLCKKLDSGQSS--------------------------------------------------------- 184 (434)
T ss_dssp CCSCEEEECCCTTCEECCC-------------------------------------------------------------
T ss_pred CCceEEEEcccccceecCCCCcc---------------------------------------------------------
Confidence 48999999998543211000
Q ss_pred CCCCccccCCccccccccccCCccccCCCCccCcchhcC-------CCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHH
Q 011302 305 DHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISG-------QGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEK 376 (489)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-------~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~ 376 (489)
........+||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.....
T Consensus 185 -----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 185 -----------------FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp ---------------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred -----------------ceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 0001223479999999999976 568999999999999999998 999997765443
Q ss_pred HHHHHhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 377 TLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 377 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
..+..+....+....... .....++.+||.+||+.||.+||++. ++++||||.+.
T Consensus 248 --~~i~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rps~~----eil~hp~f~~~ 302 (434)
T 2rio_A 248 --SNIIRGIFSLDEMKCLHD--RSLIAEATDLISQMIDHDPLKRPTAM----KVLRHPLFWPK 302 (434)
T ss_dssp --HHHHHTCCCCCCCTTCCC--HHHHHHHHHHHHHHTCSSGGGSCCHH----HHHTSGGGSCH
T ss_pred --HHHhcCCCCccccccccc--ccchHHHHHHHHHHhhCChhhCCCHH----HHHhCCccCCc
Confidence 344444444443322211 12334689999999999999999987 99999999754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=360.75 Aligned_cols=257 Identities=21% Similarity=0.291 Sum_probs=198.4
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE 159 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 159 (489)
.+..++|++++.||+|+||+||+|++.... ..+++.||||++.... ......+.+|+.+++.++||||+++++++.
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 81 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQ-DNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCY 81 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTC-SSCCEEEEEEEESCCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEeccc-CCCCcEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 456689999999999999999999964211 1257899999987543 233456778999999999999999999885
Q ss_pred c--CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCC
Q 011302 160 A--SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237 (489)
Q Consensus 160 ~--~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~ 237 (489)
. ...+|+||||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 82 SAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp HHHHTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred cCCCCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 4 456899999999999999998753 4699999999999999999999999999999999999999999999999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
++........
T Consensus 161 ~~~~~~~~~~---------------------------------------------------------------------- 170 (295)
T 3ugc_A 161 TKVLPQDKEF---------------------------------------------------------------------- 170 (295)
T ss_dssp CC------------------------------------------------------------------------------
T ss_pred cccccCCcce----------------------------------------------------------------------
Confidence 8543211000
Q ss_pred cccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcH----------------HHHHHH
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNE----------------KTLINI 381 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~----------------~~~~~i 381 (489)
........||+.|+|||++.+..++.++|||||||++|||++|..||...... .....+
T Consensus 171 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (295)
T 3ugc_A 171 -----FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred -----eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHH
Confidence 00112235778899999999999999999999999999999999998643211 111222
Q ss_pred hcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 382 LKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 382 ~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
.. ....+... ..+ .++.+||.+||+.||++||++.
T Consensus 246 ~~-~~~~~~~~-~~~------~~l~~li~~~l~~dp~~Rps~~ 280 (295)
T 3ugc_A 246 KN-NGRLPRPD-GCP------DEIYMIMTECWNNNVNQRPSFR 280 (295)
T ss_dssp HT-TCCCCCCT-TCC------HHHHHHHHHHSCSSGGGSCCHH
T ss_pred hc-cCcCCCCc-CcC------HHHHHHHHHHcCCChhhCCCHH
Confidence 22 22222211 111 2589999999999999999987
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=359.21 Aligned_cols=262 Identities=23% Similarity=0.321 Sum_probs=203.8
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
+..++|++++.||+|+||+||+|++.... .....||||++.............+.+|+.+++.++||||+++++++.+
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 92 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPS--GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 92 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTT--SCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCC--CceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence 45679999999999999999999976421 1234789999987655444566778889999999999999999999987
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~ 240 (489)
.. .++||||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 93 ~~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 93 PP-MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp SS-CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred CC-ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccc
Confidence 65 899999999999999887642 5699999999999999999999999999999999999999999999999999844
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
.......
T Consensus 171 ~~~~~~~------------------------------------------------------------------------- 177 (291)
T 1u46_A 171 LPQNDDH------------------------------------------------------------------------- 177 (291)
T ss_dssp CCC-CCE-------------------------------------------------------------------------
T ss_pred ccccccc-------------------------------------------------------------------------
Confidence 3210000
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhH
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEF 399 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 399 (489)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+.......+.....
T Consensus 178 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----- 250 (291)
T 1u46_A 178 --YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC----- 250 (291)
T ss_dssp --EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTC-----
T ss_pred --hhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCc-----
Confidence 001123357889999999998889999999999999999999 999999998888888877655444432211
Q ss_pred HHHhhHHHHHHHHhhcCcccccCCCCChHHHHc
Q 011302 400 EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKR 432 (489)
Q Consensus 400 ~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~ 432 (489)
+..+.+||.+||..||++||++. ++++
T Consensus 251 --~~~l~~li~~~l~~~p~~Rps~~----~l~~ 277 (291)
T 1u46_A 251 --PQDIYNVMVQCWAHKPEDRPTFV----ALRD 277 (291)
T ss_dssp --CHHHHHHHHHHTCSSGGGSCCHH----HHHH
T ss_pred --CHHHHHHHHHHccCCcccCcCHH----HHHH
Confidence 12589999999999999999987 6665
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=358.92 Aligned_cols=258 Identities=22% Similarity=0.360 Sum_probs=195.2
Q ss_pred hcCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccc
Q 011302 77 AQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYA 156 (489)
Q Consensus 77 ~~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~ 156 (489)
..+++..++|++.+.||+|+||+||+|++.+ .||+|+++..... ......+.+|+.+++.++||||+++++
T Consensus 17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~--------~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (289)
T 3og7_A 17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--------DVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMG 87 (289)
T ss_dssp -CCBCCTTSCEEEEEEEECSSEEEEEEESSS--------EEEEEEESCSSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred CCCccCccceeeeeEecCCCCeEEEEEEEcC--------ceEEEEEeccCCC-HHHHHHHHHHHHHHHhCCCCcEEEEEe
Confidence 4567888999999999999999999998653 4899998643211 233456778999999999999999999
Q ss_pred eeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccC
Q 011302 157 EFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFD 236 (489)
Q Consensus 157 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG 236 (489)
++ .....|+||||++|++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 88 ~~-~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg 165 (289)
T 3og7_A 88 YS-TAPQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFG 165 (289)
T ss_dssp EE-CSSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC
T ss_pred ec-cCCccEEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccce
Confidence 54 556789999999999999988654 3679999999999999999999999999999999999999999999999999
Q ss_pred CCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcc
Q 011302 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPE 316 (489)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (489)
+++.......
T Consensus 166 ~~~~~~~~~~---------------------------------------------------------------------- 175 (289)
T 3og7_A 166 LATEKSRWSG---------------------------------------------------------------------- 175 (289)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred eccccccccc----------------------------------------------------------------------
Confidence 9843211000
Q ss_pred ccccccccCCccccCCCCccCcchhc---CCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCC
Q 011302 317 VVAEPINARSKSFVGTHEYLAPEVIS---GQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGV 393 (489)
Q Consensus 317 ~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~ 393 (489)
........||+.|+|||++. +..++.++|||||||++|||++|+.||.+....+.+..+.......+....
T Consensus 176 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (289)
T 3og7_A 176 ------SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK 249 (289)
T ss_dssp --------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTS
T ss_pred ------cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhh
Confidence 01122346999999999997 566888999999999999999999999987776655555432222111111
Q ss_pred CCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 394 SSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 394 ~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
... ..+..+.+||.+||+.||.+||++.
T Consensus 250 ~~~---~~~~~l~~li~~~l~~~p~~Rps~~ 277 (289)
T 3og7_A 250 VRS---NCPKRMKRLMAECLKKKRDERPSFP 277 (289)
T ss_dssp SCT---TSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred ccc---cCCHHHHHHHHHHccCChhhCCCHH
Confidence 000 1113589999999999999999987
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=363.67 Aligned_cols=260 Identities=20% Similarity=0.236 Sum_probs=206.7
Q ss_pred cCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccce
Q 011302 78 QGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAE 157 (489)
Q Consensus 78 ~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~ 157 (489)
..++..++|.+.+.||+|+||+||+|+++... ......||||++..... ......+.+|+.+++.++||||++++++
T Consensus 38 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 114 (333)
T 1mqb_A 38 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSS-GKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGV 114 (333)
T ss_dssp CCBCCTTTEEEEEEEEECSSSEEEEEEEEC----CCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cccCChHHhhcccEEecCCCeEEEEEEEecCC-CCccccEEEEEcCCCCC--HHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 34567789999999999999999999987532 11346799999975421 1234467789999999999999999999
Q ss_pred eecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCC
Q 011302 158 FEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237 (489)
Q Consensus 158 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~ 237 (489)
+.+.+..|+||||+++|+|.+++... ...+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 115 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 193 (333)
T 1mqb_A 115 ISKYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGL 193 (333)
T ss_dssp ECSSSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred EecCCCcEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCc
Confidence 99999999999999999999998764 35799999999999999999999999999999999999999999999999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
++........
T Consensus 194 ~~~~~~~~~~---------------------------------------------------------------------- 203 (333)
T 1mqb_A 194 SRVLEDDPEA---------------------------------------------------------------------- 203 (333)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred chhhcccccc----------------------------------------------------------------------
Confidence 8443210000
Q ss_pred cccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCc
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSS 396 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 396 (489)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+..+. ..+... ..
T Consensus 204 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~-~~~~~~-~~- 275 (333)
T 1mqb_A 204 -----TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF-RLPTPM-DC- 275 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-CCCCCT-TC-
T ss_pred -----ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCC-cCCCcc-cC-
Confidence 000112246889999999999999999999999999999998 999999988887777776542 222111 11
Q ss_pred hhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 397 KEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 397 ~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
...+.+||.+||+.||++||++.
T Consensus 276 -----~~~l~~li~~~l~~~p~~Rps~~ 298 (333)
T 1mqb_A 276 -----PSAIYQLMMQCWQQERARRPKFA 298 (333)
T ss_dssp -----BHHHHHHHHHHTCSSTTTSCCHH
T ss_pred -----CHHHHHHHHHHcCCChhhCcCHH
Confidence 12589999999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=356.49 Aligned_cols=256 Identities=18% Similarity=0.210 Sum_probs=202.3
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccccccee-ec
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEF-EA 160 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-~~ 160 (489)
...+|++.+.||+|+||+||+|++.... .....+|+|.+..... ......+.+|+.+++.++||||+++++++ ..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~avk~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDND--GKKIHCAVKSLNRITD--IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 98 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-------CEEEEEEEETTCCS--HHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred cceehhhcceeeecCCceEEEEEEecCC--CceeEEEEEecccCCC--HHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC
Confidence 4467999999999999999999976532 1345789999875221 23445677899999999999999999985 56
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~ 240 (489)
++..|+||||+++|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 99 ~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 99 EGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred CCceEEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccc
Confidence 67889999999999999999764 35689999999999999999999999999999999999999999999999999854
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
.......
T Consensus 178 ~~~~~~~------------------------------------------------------------------------- 184 (298)
T 3f66_A 178 MYDKEYY------------------------------------------------------------------------- 184 (298)
T ss_dssp CSCGGGC-------------------------------------------------------------------------
T ss_pred ccccchh-------------------------------------------------------------------------
Confidence 3210000
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhH
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEF 399 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 399 (489)
.........||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+....+..+......... .
T Consensus 185 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~--- 258 (298)
T 3f66_A 185 -SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC--P--- 258 (298)
T ss_dssp -BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTC--C---
T ss_pred -ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccC--C---
Confidence 0011233468899999999999999999999999999999999 77788887777776666665433222111 1
Q ss_pred HHHhhHHHHHHHHhhcCcccccCCC
Q 011302 400 EEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 400 ~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
..+.+||.+||+.||++||++.
T Consensus 259 ---~~l~~li~~~l~~~p~~Rps~~ 280 (298)
T 3f66_A 259 ---DPLYEVMLKCWHPKAEMRPSFS 280 (298)
T ss_dssp ---HHHHHHHHHHTCSSGGGSCCHH
T ss_pred ---HHHHHHHHHHcCCChhhCcCHH
Confidence 2489999999999999999987
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=356.40 Aligned_cols=259 Identities=23% Similarity=0.285 Sum_probs=209.0
Q ss_pred ccccCCceeee-eeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccccccee
Q 011302 80 RVGLDHFRLLR-RLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEF 158 (489)
Q Consensus 80 ~~~~~~y~~~~-~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 158 (489)
.+..++|.+.+ .||+|+||.||+|.++... .+..||||++..... .....++.+|+.+++.++||||+++++++
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~---~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 79 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRK---KQIDVAIKVLKQGTE--KADTEEMMREAQIMHQLDNPYIVRLIGVC 79 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC------CCEEEEEEEECSSCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCC---CcceEEEEecCCccc--hhHHHHHHHHHHHHHhCCCCCEeEEEEEe
Confidence 45567898887 9999999999999876421 467899999976321 23455677899999999999999999999
Q ss_pred ecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 159 EASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
. .+..|+||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 80 ~-~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~ 157 (287)
T 1u59_A 80 Q-AEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLS 157 (287)
T ss_dssp E-SSSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred c-CCCcEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccce
Confidence 4 56799999999999999988654 356999999999999999999999999999999999999999999999999998
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
.........
T Consensus 158 ~~~~~~~~~----------------------------------------------------------------------- 166 (287)
T 1u59_A 158 KALGADDSY----------------------------------------------------------------------- 166 (287)
T ss_dssp EECTTCSCE-----------------------------------------------------------------------
T ss_pred eeeccCcce-----------------------------------------------------------------------
Confidence 443210000
Q ss_pred ccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCC-CCCCCCCCCc
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPL-TFPRIGVSSS 396 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~ 396 (489)
........||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+....+..+.. .+|. ..
T Consensus 167 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~---~~- 238 (287)
T 1u59_A 167 ----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP---EC- 238 (287)
T ss_dssp ----ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCT---TC-
T ss_pred ----eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCC---Cc-
Confidence 001122357899999999998889999999999999999998 9999999888877777766432 2221 11
Q ss_pred hhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 397 KEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 397 ~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
+..+.+||.+||..||++||++. ++++|
T Consensus 239 -----~~~l~~li~~~l~~~p~~Rps~~----~l~~~ 266 (287)
T 1u59_A 239 -----PPELYALMSDCWIYKWEDRPDFL----TVEQR 266 (287)
T ss_dssp -----CHHHHHHHHHTTCSSGGGSCCHH----HHHHH
T ss_pred -----CHHHHHHHHHHcCCChhhCcCHH----HHHHH
Confidence 12589999999999999999987 66665
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=367.70 Aligned_cols=265 Identities=23% Similarity=0.298 Sum_probs=204.2
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE 159 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 159 (489)
.+..++|++.+.||+|+||.||+|++. .++.||||++...... .....+.+|+.+++.++||||+++++++.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRLA------DGTLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECCS------SSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred HHHhhccccceeEecCCCcEEEEEEec------CCCEEEEEEeccccCc--hHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 355689999999999999999999754 3678999999865432 22335778999999999999999999999
Q ss_pred cCceEEEEEeecCCCchHHHHHhCCC--CCCChhhHHHHHHHHHHHHHHHHhC---CCeeecCCCCCeEeccCCcEEEcc
Q 011302 160 ASHYSCLVMEYCPGGDLYAARQRQPG--KRFGISSAKFYAAETLLALEYLHMM---GIVYRDLKPENVLVREDGHIMLSD 234 (489)
Q Consensus 160 ~~~~~~lV~E~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDIKp~NILl~~~~~vkl~D 234 (489)
+.+..|+||||+++|+|.+++..... ..+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 99999999999999999999986532 3489999999999999999999999 999999999999999999999999
Q ss_pred cCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCC
Q 011302 235 FDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDD 314 (489)
Q Consensus 235 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (489)
||+++......
T Consensus 178 fg~~~~~~~~~--------------------------------------------------------------------- 188 (326)
T 3uim_A 178 FGLAKLMDYKD--------------------------------------------------------------------- 188 (326)
T ss_dssp CSSCEECCSSS---------------------------------------------------------------------
T ss_pred CccccccCccc---------------------------------------------------------------------
Confidence 99984332100
Q ss_pred ccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCC----CcHHHHHHHhcCCCC---
Q 011302 315 PEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGE----NNEKTLINILKKPLT--- 387 (489)
Q Consensus 315 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~----~~~~~~~~i~~~~~~--- 387 (489)
........||+.|+|||++.+..++.++|||||||++|||++|..||... ...............
T Consensus 189 --------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (326)
T 3uim_A 189 --------THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 260 (326)
T ss_dssp --------SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCC
T ss_pred --------ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchh
Confidence 01122346999999999999888999999999999999999999999521 111111112111111
Q ss_pred CCCC---CCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 388 FPRI---GVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 388 ~p~~---~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
.... .............+.+||.+||+.||.+||++. ++++|
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~----ell~~ 305 (326)
T 3uim_A 261 LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS----EVVRM 305 (326)
T ss_dssp STTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHH----HHHHH
T ss_pred hhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHH----HHHHH
Confidence 0000 001111123445789999999999999999997 77776
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=368.43 Aligned_cols=264 Identities=20% Similarity=0.231 Sum_probs=204.8
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
...++|++.+.||+|+||.||+|+++ .++.||||++..... .....+.+|+.+++.++||||+++++++.+
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLR------DGAKVALKRRTPESS---QGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECT------TCCEEEEEECCSCCS---SHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred HHHhccCccceeecCCCeeEEEEEEC------CCCEEEEEEecccCh---HHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 45689999999999999999999965 357899999865421 234457779999999999999999999999
Q ss_pred CceEEEEEeecCCCchHHHHHhCC--CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQP--GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
.+..|+||||++||+|.+++.... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGIS 186 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccc
Confidence 999999999999999998886542 235899999999999999999999999999999999999999999999999998
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
+.......
T Consensus 187 ~~~~~~~~------------------------------------------------------------------------ 194 (321)
T 2qkw_B 187 KKGTELDQ------------------------------------------------------------------------ 194 (321)
T ss_dssp EECSSSSC------------------------------------------------------------------------
T ss_pred cccccccc------------------------------------------------------------------------
Confidence 43211000
Q ss_pred ccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHH-------HHHhcCCCCC-CC
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTL-------INILKKPLTF-PR 390 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~-------~~i~~~~~~~-p~ 390 (489)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+.. .......... ..
T Consensus 195 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (321)
T 2qkw_B 195 ----THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270 (321)
T ss_dssp ----CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSS
T ss_pred ----cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcC
Confidence 00112346899999999999888999999999999999999999999765432111 1111111110 00
Q ss_pred CCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 391 IGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 391 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
..............+.+||.+||+.||++||++. ++++|
T Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~----ell~~ 309 (321)
T 2qkw_B 271 PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMG----DVLWK 309 (321)
T ss_dssp SSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHH----HHHHH
T ss_pred hhhccccCHHHHHHHHHHHHHHcCCCcccCcCHH----HHHHH
Confidence 0001111123445689999999999999999987 77665
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=361.60 Aligned_cols=258 Identities=26% Similarity=0.343 Sum_probs=197.3
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
...++|++.+.||+|+||.||+|.+.. .++.||||++.............+.+|+.+++.++||||+++++++..
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 103 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLL-----DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE 103 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETT-----TCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcC-----CCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 456799999999999999999999876 568899999875322223345567789999999999999999999999
Q ss_pred CceEEEEEeecCCCchHHHHHhC--CCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQ--PGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
.+..|+||||+++|+|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~ 183 (310)
T 2wqm_A 104 DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG 183 (310)
T ss_dssp TTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---
T ss_pred CCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccce
Confidence 99999999999999999988642 2356899999999999999999999999999999999999999999999999997
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
......
T Consensus 184 ~~~~~~-------------------------------------------------------------------------- 189 (310)
T 2wqm_A 184 RFFSSK-------------------------------------------------------------------------- 189 (310)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred eeecCC--------------------------------------------------------------------------
Confidence 432110
Q ss_pred ccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCc--HHHHHHHhcCCCCCCCCCCCCc
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENN--EKTLINILKKPLTFPRIGVSSS 396 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~--~~~~~~i~~~~~~~p~~~~~~~ 396 (489)
........||+.|+|||++.+..++.++|||||||++|||++|..||.+... ......+..... +......
T Consensus 190 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~- 262 (310)
T 2wqm_A 190 ----TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY--PPLPSDH- 262 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCS--CCCCTTT-
T ss_pred ----CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccC--CCCcccc-
Confidence 0011234689999999999999999999999999999999999999976532 334444444322 2111111
Q ss_pred hhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHc
Q 011302 397 KEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKR 432 (489)
Q Consensus 397 ~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~ 432 (489)
...++.+||.+||..||++||++. ++++
T Consensus 263 ----~~~~l~~li~~~l~~dp~~Rps~~----~il~ 290 (310)
T 2wqm_A 263 ----YSEELRQLVNMCINPDPEKRPDVT----YVYD 290 (310)
T ss_dssp ----SCHHHHHHHHHHTCSSGGGSCCHH----HHHH
T ss_pred ----cCHHHHHHHHHHcCCChhhCCCHH----HHHH
Confidence 112589999999999999999987 6655
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=372.14 Aligned_cols=251 Identities=19% Similarity=0.233 Sum_probs=196.4
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC---CCCccccc
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD---HPFLPTLY 155 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~ 155 (489)
.++..++|.+.+.||+|+||+||+|.++.......++.||||++.... ...+..|..+++.++ |+||++++
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~ 133 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFY 133 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhh
Confidence 345678899999999999999999965432223367899999997543 224555777777776 99999999
Q ss_pred ceeecCceEEEEEeecCCCchHHHHHhC---CCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEecc------
Q 011302 156 AEFEASHYSCLVMEYCPGGDLYAARQRQ---PGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRE------ 226 (489)
Q Consensus 156 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~------ 226 (489)
+++...+..|||||||+||+|.+++... ....+++..++.|+.||+.||+|||++|||||||||+||||+.
T Consensus 134 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp EEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-
T ss_pred eeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcc
Confidence 9999999999999999999999998752 2467999999999999999999999999999999999999998
Q ss_pred -----CCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccc
Q 011302 227 -----DGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQ 301 (489)
Q Consensus 227 -----~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (489)
++.+||+|||+|+.+.....
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~------------------------------------------------------- 238 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPK------------------------------------------------------- 238 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCT-------------------------------------------------------
T ss_pred ccccccCCEEEeeCchhhhhhccCC-------------------------------------------------------
Confidence 89999999999853321100
Q ss_pred cCCCCCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHH
Q 011302 302 VDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINI 381 (489)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i 381 (489)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 239 ---------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--- 294 (365)
T 3e7e_A 239 ---------------------GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK--- 294 (365)
T ss_dssp ---------------------TEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE---
T ss_pred ---------------------CceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee---
Confidence 11223457999999999999999999999999999999999999999654321100
Q ss_pred hcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 382 LKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 382 ~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
... .++.. . ....+.+|+.+||+.+|.+|+...
T Consensus 295 ~~~--~~~~~--~------~~~~~~~~~~~~l~~~p~~r~~~~ 327 (365)
T 3e7e_A 295 PEG--LFRRL--P------HLDMWNEFFHVMLNIPDCHHLPSL 327 (365)
T ss_dssp ECS--CCTTC--S------SHHHHHHHHHHHHCCCCTTCCCCH
T ss_pred ech--hcccc--C------cHHHHHHHHHHHcCCCCCCcchHH
Confidence 000 11111 1 122478999999999999998765
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=357.21 Aligned_cols=254 Identities=23% Similarity=0.299 Sum_probs=193.0
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHh--CCCCCcccccce
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTM--LDHPFLPTLYAE 157 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l~~~ 157 (489)
++..++|++++.||+|+||+||+|++. ++.||||++..... ..+..|.+++.. ++||||++++++
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~------~~~~~e~~~~~~~~l~h~niv~~~~~ 70 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSWQ-------GENVAVKIFSSRDE------KSWFRETELYNTVMLRHENILGFIAS 70 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEET-------TEEEEEEEECGGGH------HHHHHHHHHHHHTCCCCTTBCCEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEEC-------CEEEEEEEeccccc------hhhHHHHHHHHHhhccCcCeeeEEEe
Confidence 345689999999999999999999874 47899999976532 223345666655 799999999998
Q ss_pred eec----CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHH--------hCCCeeecCCCCCeEec
Q 011302 158 FEA----SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLH--------MMGIVYRDLKPENVLVR 225 (489)
Q Consensus 158 ~~~----~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH--------~~~iiHrDIKp~NILl~ 225 (489)
+.. ...+|+||||+++|+|.++++. ..+++..+..++.||+.||+||| ++||+||||||+|||++
T Consensus 71 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~ 147 (301)
T 3q4u_A 71 DMTSRHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK 147 (301)
T ss_dssp EEEEETTEEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEEC
T ss_pred eccccCCCceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEc
Confidence 643 4578999999999999999954 46999999999999999999999 99999999999999999
Q ss_pred cCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCC
Q 011302 226 EDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGD 305 (489)
Q Consensus 226 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (489)
.++.+||+|||+|+........
T Consensus 148 ~~~~~kl~Dfg~a~~~~~~~~~---------------------------------------------------------- 169 (301)
T 3q4u_A 148 KNGQCCIADLGLAVMHSQSTNQ---------------------------------------------------------- 169 (301)
T ss_dssp TTSCEEECCCTTCEEEETTTTE----------------------------------------------------------
T ss_pred CCCCEEEeeCCCeeeccccccc----------------------------------------------------------
Confidence 9999999999998433211000
Q ss_pred CCCccccCCccccccccccCCccccCCCCccCcchhcCC------CCCCcccHHHHHHHHHHHhhC----------CCCC
Q 011302 306 HHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQ------GHGSAVDWWTLGVFLYEMLYG----------TTPF 369 (489)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~------~~~~~~DiwSlGvil~elltG----------~~Pf 369 (489)
........+||+.|+|||++.+. .++.++|||||||++|||++| ..||
T Consensus 170 ----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 170 ----------------LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ----------------EECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred ----------------ccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 00112334799999999999887 345799999999999999999 8898
Q ss_pred CCCC----cHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 370 KGEN----NEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 370 ~~~~----~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
.... ....+..+.......+..... .........+.+||.+||+.||++||++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 291 (301)
T 3q4u_A 234 YDVVPNDPSFEDMRKVVCVDQQRPNIPNR-WFSDPTLTSLAKLMKECWYQNPSARLTAL 291 (301)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGG-GGGSHHHHHHHHHHHHHCCSSGGGSCCHH
T ss_pred cccCCCCcchhhhhHHHhccCCCCCCChh-hccCccHHHHHHHHHHHhhcChhhCCCHH
Confidence 6532 233344433322222221110 00112335689999999999999999987
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=382.39 Aligned_cols=252 Identities=23% Similarity=0.297 Sum_probs=205.7
Q ss_pred hcCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccc
Q 011302 77 AQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYA 156 (489)
Q Consensus 77 ~~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~ 156 (489)
..+++..++|++.+.||+|+||+||+|.+++ ...||||+++..... .+.+.+|+.+|+.++||||+++++
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~ 246 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG------TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 246 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETT------TEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECC------CceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEE
Confidence 3467788999999999999999999999875 356999999864322 245677999999999999999999
Q ss_pred eeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccC
Q 011302 157 EFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFD 236 (489)
Q Consensus 157 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG 236 (489)
++.+ +.+||||||+++|+|.+++....+..+++.++..++.||+.||+|||++|||||||||+|||++.++.+||+|||
T Consensus 247 ~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG 325 (452)
T 1fmk_A 247 VVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG 325 (452)
T ss_dssp EECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred EEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCc
Confidence 9876 678999999999999999975434569999999999999999999999999999999999999999999999999
Q ss_pred CCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcc
Q 011302 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPE 316 (489)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (489)
+++......
T Consensus 326 ~a~~~~~~~----------------------------------------------------------------------- 334 (452)
T 1fmk_A 326 LARLIEDNE----------------------------------------------------------------------- 334 (452)
T ss_dssp TTC-----------------------------------------------------------------------------
T ss_pred cceecCCCc-----------------------------------------------------------------------
Confidence 984322100
Q ss_pred ccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCC
Q 011302 317 VVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSS 395 (489)
Q Consensus 317 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 395 (489)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+..+. ..+... ..
T Consensus 335 ------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~-~~~~~~-~~ 406 (452)
T 1fmk_A 335 ------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-RMPCPP-EC 406 (452)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CCCCCT-TS
T ss_pred ------eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCC-CC
Confidence 000112357889999999999899999999999999999999 999999998888877776542 222111 11
Q ss_pred chhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 396 SKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 396 ~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
+ ..+.+||.+||+.||++||++.
T Consensus 407 ~------~~l~~li~~cl~~dP~~Rpt~~ 429 (452)
T 1fmk_A 407 P------ESLHDLMCQCWRKEPEERPTFE 429 (452)
T ss_dssp C------HHHHHHHHHHTCSSGGGSCCHH
T ss_pred C------HHHHHHHHHHccCChhhCcCHH
Confidence 1 2489999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=377.24 Aligned_cols=259 Identities=24% Similarity=0.377 Sum_probs=203.1
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
+..++|++.+.||+|+||+||+|+++. +++.||||++...... .....+.+|+.+|+.++||||+++++++..
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 78 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKK-----TGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECC-----CCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCCCeEEEeecc
Confidence 345789999999999999999999986 5789999999754322 223455679999999999999999999986
Q ss_pred Cc--eEEEEEeecCCCchHHHHHhCC-CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEe----ccCCcEEEc
Q 011302 161 SH--YSCLVMEYCPGGDLYAARQRQP-GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLV----REDGHIMLS 233 (489)
Q Consensus 161 ~~--~~~lV~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl----~~~~~vkl~ 233 (489)
.. ..|+|||||+||+|.+++.... ...+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~ 158 (396)
T 4eut_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLT 158 (396)
T ss_dssp TTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEEC
T ss_pred CCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEe
Confidence 55 7899999999999999987642 2239999999999999999999999999999999999999 777889999
Q ss_pred ccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccC
Q 011302 234 DFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLD 313 (489)
Q Consensus 234 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (489)
|||+|+....
T Consensus 159 DFG~a~~~~~---------------------------------------------------------------------- 168 (396)
T 4eut_A 159 DFGAARELED---------------------------------------------------------------------- 168 (396)
T ss_dssp CGGGCEECCC----------------------------------------------------------------------
T ss_pred cCCCceEccC----------------------------------------------------------------------
Confidence 9999843321
Q ss_pred CccccccccccCCccccCCCCccCcchhcC--------CCCCCcccHHHHHHHHHHHhhCCCCCCC----CCcHHHHHHH
Q 011302 314 DPEVVAEPINARSKSFVGTHEYLAPEVISG--------QGHGSAVDWWTLGVFLYEMLYGTTPFKG----ENNEKTLINI 381 (489)
Q Consensus 314 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--------~~~~~~~DiwSlGvil~elltG~~Pf~~----~~~~~~~~~i 381 (489)
.......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.. ....+.+.++
T Consensus 169 ---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 239 (396)
T 4eut_A 169 ---------DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (396)
T ss_dssp ---------GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHH
T ss_pred ---------CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHH
Confidence 011233579999999999875 4578899999999999999999999965 3344566666
Q ss_pred hcCCCCCC----------------CCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCC
Q 011302 382 LKKPLTFP----------------RIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLK 425 (489)
Q Consensus 382 ~~~~~~~p----------------~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~ 425 (489)
..+..... ...............+.+||.+||++||++|+++.+
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e 299 (396)
T 4eut_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ 299 (396)
T ss_dssp HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHH
T ss_pred hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHH
Confidence 55432100 000011111123446889999999999999999873
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=355.99 Aligned_cols=252 Identities=21% Similarity=0.291 Sum_probs=206.5
Q ss_pred hcCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccc
Q 011302 77 AQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYA 156 (489)
Q Consensus 77 ~~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~ 156 (489)
..+++..++|++++.||+|+||.||+|.+.+ +..||+|++...... ...+.+|+.+++.++||||+++++
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~ 75 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNG------HTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYA 75 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETT------TEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEcC------CcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEE
Confidence 3567788999999999999999999999764 567999999764322 245677999999999999999999
Q ss_pred eeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccC
Q 011302 157 EFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFD 236 (489)
Q Consensus 157 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG 236 (489)
++.+ +..|+||||++|++|.+++....+..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 76 ~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg 154 (279)
T 1qpc_A 76 VVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFG 154 (279)
T ss_dssp EECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEcC-CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCc
Confidence 8874 568999999999999998865433369999999999999999999999999999999999999999999999999
Q ss_pred CCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcc
Q 011302 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPE 316 (489)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (489)
++.......
T Consensus 155 ~~~~~~~~~----------------------------------------------------------------------- 163 (279)
T 1qpc_A 155 LARLIEDNE----------------------------------------------------------------------- 163 (279)
T ss_dssp TCEECSSSC-----------------------------------------------------------------------
T ss_pred ccccccCcc-----------------------------------------------------------------------
Confidence 984332100
Q ss_pred ccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCC
Q 011302 317 VVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSS 395 (489)
Q Consensus 317 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 395 (489)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+..+...... ...
T Consensus 164 ------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~ 235 (279)
T 1qpc_A 164 ------YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP--DNC 235 (279)
T ss_dssp ------EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC--TTC
T ss_pred ------cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCc--ccc
Confidence 001122357889999999998889999999999999999999 99999998888777777654221111 111
Q ss_pred chhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 396 SKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 396 ~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
...+.+||.+||..||++||++.
T Consensus 236 ------~~~l~~li~~~l~~~p~~Rps~~ 258 (279)
T 1qpc_A 236 ------PEELYQLMRLCWKERPEDRPTFD 258 (279)
T ss_dssp ------CHHHHHHHHHHTCSSGGGSCCHH
T ss_pred ------cHHHHHHHHHHhccChhhCCCHH
Confidence 12589999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=365.51 Aligned_cols=255 Identities=27% Similarity=0.374 Sum_probs=198.3
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHH---HHHHHHHHHHHHHHHhC----CCCCccc
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAI---RKKLHRADMEKVILTML----DHPFLPT 153 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~E~~~l~~l----~hpnIv~ 153 (489)
...++|++.+.||+|+||.||+|++.. +++.||||++....... ......+.+|+.++..+ +||||++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~ 102 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLT-----DRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIR 102 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTT-----TCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEcc-----CCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeee
Confidence 345789999999999999999999876 57899999997543211 12233455688888888 8999999
Q ss_pred ccceeecCceEEEEEee-cCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEec-cCCcEE
Q 011302 154 LYAEFEASHYSCLVMEY-CPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVR-EDGHIM 231 (489)
Q Consensus 154 l~~~~~~~~~~~lV~E~-~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~-~~~~vk 231 (489)
+++++.+.+..|+|||| +.+++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+|
T Consensus 103 ~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 103 LLDWFETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp EEEEC-----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEE
T ss_pred EEEEEecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEE
Confidence 99999999999999999 7899999998875 5699999999999999999999999999999999999999 889999
Q ss_pred EcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccc
Q 011302 232 LSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQEL 311 (489)
Q Consensus 232 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (489)
|+|||++.....
T Consensus 181 l~dfg~~~~~~~-------------------------------------------------------------------- 192 (312)
T 2iwi_A 181 LIDFGSGALLHD-------------------------------------------------------------------- 192 (312)
T ss_dssp ECCCSSCEECCS--------------------------------------------------------------------
T ss_pred EEEcchhhhccc--------------------------------------------------------------------
Confidence 999999843211
Q ss_pred cCCccccccccccCCccccCCCCccCcchhcCCCC-CCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCC
Q 011302 312 LDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGH-GSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPR 390 (489)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~ 390 (489)
.......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+.. .+......++.
T Consensus 193 ------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~~ 254 (312)
T 2iwi_A 193 ------------EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFPA 254 (312)
T ss_dssp ------------SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCCT
T ss_pred ------------CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCcc
Confidence 01123468999999999987766 458999999999999999999997542 23333333332
Q ss_pred CCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCc
Q 011302 391 IGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINW 441 (489)
Q Consensus 391 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~ 441 (489)
. . ...+.+||.+||+.||++||++. ++++||||+....
T Consensus 255 ~---~------~~~~~~li~~~l~~~p~~Rps~~----e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 255 H---V------SPDCCALIRRCLAPKPSSRPSLE----EILLDPWMQTPAE 292 (312)
T ss_dssp T---S------CHHHHHHHHHHTCSSTTTSCCHH----HHHHSTTTCC---
T ss_pred c---C------CHHHHHHHHHHccCChhhCcCHH----HHhcChhhcCchh
Confidence 1 1 12589999999999999999987 9999999987643
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=356.07 Aligned_cols=241 Identities=23% Similarity=0.399 Sum_probs=190.6
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
+..++|++.+.||+|+||+||+|++.+ +.||||++..+. ....+.+|+.+|+.++||||+++++++.+
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 72 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWRA-------KDVAIKQIESES-----ERKAFIVELRQLSRVNHPNIVKLYGACLN 72 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEETT-------EEEEEEECSSTT-----HHHHHHHHHHHHHHCCCTTBCCEEEBCTT
T ss_pred CCHhHeeeeeEeecCCCceEEEEEECC-------eeEEEEEecChh-----HHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence 456799999999999999999998763 679999997542 23456779999999999999999998874
Q ss_pred CceEEEEEeecCCCchHHHHHhCCC-CCCChhhHHHHHHHHHHHHHHHHh---CCCeeecCCCCCeEeccCCc-EEEccc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPG-KRFGISSAKFYAAETLLALEYLHM---MGIVYRDLKPENVLVREDGH-IMLSDF 235 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDIKp~NILl~~~~~-vkl~DF 235 (489)
..|+||||++||+|.+++..... ..+++..+..++.||+.||+|||+ +||+||||||+|||++.++. +||+||
T Consensus 73 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Df 150 (307)
T 2eva_A 73 --PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDF 150 (307)
T ss_dssp --TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCC
T ss_pred --CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccc
Confidence 47999999999999999986532 247888999999999999999999 89999999999999998887 799999
Q ss_pred CCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCc
Q 011302 236 DLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDP 315 (489)
Q Consensus 236 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (489)
|++.....
T Consensus 151 g~~~~~~~------------------------------------------------------------------------ 158 (307)
T 2eva_A 151 GTACDIQT------------------------------------------------------------------------ 158 (307)
T ss_dssp CC------------------------------------------------------------------------------
T ss_pred cccccccc------------------------------------------------------------------------
Confidence 99732210
Q ss_pred cccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcH--HHHHHHhcCCCCCCCCCC
Q 011302 316 EVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNE--KTLINILKKPLTFPRIGV 393 (489)
Q Consensus 316 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--~~~~~i~~~~~~~p~~~~ 393 (489)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..... +....
T Consensus 159 ---------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~ 227 (307)
T 2eva_A 159 ---------HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR--PPLIK 227 (307)
T ss_dssp ---------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC--CCCBT
T ss_pred ---------ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC--CCccc
Confidence 011235899999999999999999999999999999999999999865432 23333333221 11111
Q ss_pred CCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 394 SSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 394 ~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
..+ ..+.+||.+||+.||++||++.
T Consensus 228 ~~~------~~l~~li~~~l~~dp~~Rps~~ 252 (307)
T 2eva_A 228 NLP------KPIESLMTRCWSKDPSQRPSME 252 (307)
T ss_dssp TCC------HHHHHHHHHHTCSSGGGSCCHH
T ss_pred ccC------HHHHHHHHHHhcCChhhCcCHH
Confidence 111 2489999999999999999987
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=354.68 Aligned_cols=276 Identities=19% Similarity=0.256 Sum_probs=204.5
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccccccee-ecC
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEF-EAS 161 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-~~~ 161 (489)
.++|++.+.||+|+||+||+|++.. +++.||||++.... ....+..|+.+++.++|++++..+..+ ...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~ 77 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIA-----AGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEG 77 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETT-----TTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEET
T ss_pred CCceEEeeeecCCCCeEEEEEEEcC-----CCceEEEEeecccc-----cchHHHHHHHHHHHhcCCCCCCeeeeecCCC
Confidence 3789999999999999999999876 57899999876543 234567799999999988776666555 677
Q ss_pred ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEe---ccCCcEEEcccCCC
Q 011302 162 HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLV---REDGHIMLSDFDLS 238 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl---~~~~~vkl~DFG~a 238 (489)
...|+||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 78 ~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a 155 (296)
T 4hgt_A 78 DYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred CceEEEEEcc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence 8899999999 999999987542 569999999999999999999999999999999999999 78999999999998
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
+........
T Consensus 156 ~~~~~~~~~----------------------------------------------------------------------- 164 (296)
T 4hgt_A 156 KKYRDARTH----------------------------------------------------------------------- 164 (296)
T ss_dssp EECBCTTTC-----------------------------------------------------------------------
T ss_pred eeccCcccC-----------------------------------------------------------------------
Confidence 543211000
Q ss_pred ccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcH---HHHHHHhcCCCCCCCCCCCC
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNE---KTLINILKKPLTFPRIGVSS 395 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~~~~~i~~~~~~~p~~~~~~ 395 (489)
............||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.. ..+..+.......+......
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (296)
T 4hgt_A 165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK 244 (296)
T ss_dssp CBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTT
T ss_pred ccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhc
Confidence 000011233457999999999999999999999999999999999999999875432 22333322221111100000
Q ss_pred chhHHHHhhHHHHHHHHhhcCcccccCCCCChH---HHH---cCCCcCCCCccccc
Q 011302 396 SKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSV---EIK---RHEFFKGINWALIR 445 (489)
Q Consensus 396 ~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~---~ll---~hp~f~~~~~~~~~ 445 (489)
..+..+.+||.+||+.||++||++.+.++ +++ ...|-..+||+.++
T Consensus 245 ----~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~~~~ 296 (296)
T 4hgt_A 245 ----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK 296 (296)
T ss_dssp ----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGGGCC
T ss_pred ----cCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchhhcC
Confidence 00125899999999999999999863221 111 24566677887653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=364.12 Aligned_cols=255 Identities=20% Similarity=0.248 Sum_probs=199.3
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
+..++|++++.||+|+||+||+|++...... ....||+|.+..... .....++.+|+.+++.++||||+++++++..
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-~~~kv~iK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 88 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEK-VKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCS-CCEEEEEEEECCCSS--CCCHHHHHHHHHHHTTCCBTTBCCCCEEEES
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCce-EEEEEEEEeeccccC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEec
Confidence 4568999999999999999999998763221 223467787753211 1223456779999999999999999999987
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~ 240 (489)
+. .++||||+.+|+|.+++.... ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~~-~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 89 ST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp SS-EEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred CC-ceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 65 789999999999999987753 5699999999999999999999999999999999999999999999999999844
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
+.....
T Consensus 167 ~~~~~~-------------------------------------------------------------------------- 172 (327)
T 3lzb_A 167 LGAEEK-------------------------------------------------------------------------- 172 (327)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccCccc--------------------------------------------------------------------------
Confidence 321000
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhH
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEF 399 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 399 (489)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+..... .+.... .
T Consensus 173 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~-~---- 244 (327)
T 3lzb_A 173 --EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-LPQPPI-C---- 244 (327)
T ss_dssp ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-CCCCTT-B----
T ss_pred --cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-CCCCcc-C----
Confidence 001122357889999999999999999999999999999999 9999999887776666555432 221111 1
Q ss_pred HHHhhHHHHHHHHhhcCcccccCCC
Q 011302 400 EEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 400 ~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
...+.+||.+||..||.+||++.
T Consensus 245 --~~~l~~li~~~l~~dp~~Rps~~ 267 (327)
T 3lzb_A 245 --TIDVYMIMRKCWMIDADSRPKFR 267 (327)
T ss_dssp --CHHHHHHHHHHTCSSGGGSCCHH
T ss_pred --CHHHHHHHHHHcCCChhHCcCHH
Confidence 12489999999999999999987
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=356.03 Aligned_cols=249 Identities=22% Similarity=0.301 Sum_probs=199.2
Q ss_pred HhhcCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccc
Q 011302 75 RRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTL 154 (489)
Q Consensus 75 ~~~~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l 154 (489)
....+.+..++|++.+.||+|+||+||+|++. ++.||||++..+. ..+.+.+|+.+++.++||||+++
T Consensus 12 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~ 79 (278)
T 1byg_A 12 YRSGWALNMKELKLLQTIGKGEFGDVMLGDYR-------GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQL 79 (278)
T ss_dssp ---CCBCCGGGEEEEEEEEECSSCEEEEEEET-------TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCE
T ss_pred hhccccCChhhceEEeEEecCCCceEEEEEEc-------CCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeE
Confidence 34456778899999999999999999999875 3689999997542 23457779999999999999999
Q ss_pred cceeec-CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEc
Q 011302 155 YAEFEA-SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLS 233 (489)
Q Consensus 155 ~~~~~~-~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~ 233 (489)
++++.+ .+.+|+||||+++|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~ 159 (278)
T 1byg_A 80 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVS 159 (278)
T ss_dssp EEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEEC
T ss_pred EEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEe
Confidence 998654 4579999999999999999876533348899999999999999999999999999999999999999999999
Q ss_pred ccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccC
Q 011302 234 DFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLD 313 (489)
Q Consensus 234 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (489)
|||++.....
T Consensus 160 Dfg~~~~~~~---------------------------------------------------------------------- 169 (278)
T 1byg_A 160 DFGLTKEASS---------------------------------------------------------------------- 169 (278)
T ss_dssp CCCC----------------------------------------------------------------------------
T ss_pred eccccccccc----------------------------------------------------------------------
Confidence 9999732110
Q ss_pred CccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCC
Q 011302 314 DPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIG 392 (489)
Q Consensus 314 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 392 (489)
......||+.|+|||++.+..++.++|||||||++|||++ |..||...+..+....+..+.. .+. .
T Consensus 170 -----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~-~~~-~ 236 (278)
T 1byg_A 170 -----------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-MDA-P 236 (278)
T ss_dssp -----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC-CCC-C
T ss_pred -----------cccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC-CCC-c
Confidence 0112257889999999999999999999999999999998 9999998887777766655421 111 1
Q ss_pred CCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 393 VSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 393 ~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
.... ..+.+||.+||+.||++||++.
T Consensus 237 ~~~~------~~l~~li~~~l~~~p~~Rps~~ 262 (278)
T 1byg_A 237 DGCP------PAVYEVMKNCWHLDAAMRPSFL 262 (278)
T ss_dssp TTCC------HHHHHHHHHHTCSSGGGSCCHH
T ss_pred ccCC------HHHHHHHHHHhcCChhhCCCHH
Confidence 1111 2589999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=357.37 Aligned_cols=264 Identities=18% Similarity=0.228 Sum_probs=203.6
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccccccee
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEF 158 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 158 (489)
..+..++|.+.+.||+|+||.||+|++.... .++..||+|++...... ......+.+|+.+++.++||||+++++++
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~--~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQED--GTSLKVAVKTMKLDNSS-QREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECTT--SCEEEEEEEEC---CCC-HHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEeccC--CceeEEEEEEEeccccc-hhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 3456689999999999999999999887532 24678999999754322 23345677899999999999999999999
Q ss_pred ecCc-----eEEEEEeecCCCchHHHHHhC----CCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCc
Q 011302 159 EASH-----YSCLVMEYCPGGDLYAARQRQ----PGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGH 229 (489)
Q Consensus 159 ~~~~-----~~~lV~E~~~gg~L~~~l~~~----~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~ 229 (489)
.+.. ..|+||||+++|+|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc
Confidence 7655 459999999999999988532 2356999999999999999999999999999999999999999999
Q ss_pred EEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCc
Q 011302 230 IMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQ 309 (489)
Q Consensus 230 vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (489)
+||+|||+++.......
T Consensus 186 ~kl~Dfg~~~~~~~~~~--------------------------------------------------------------- 202 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDY--------------------------------------------------------------- 202 (313)
T ss_dssp EEECSCSCC-----------------------------------------------------------------------
T ss_pred EEEeecCcceecccccc---------------------------------------------------------------
Confidence 99999999843221000
Q ss_pred cccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCC
Q 011302 310 ELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTF 388 (489)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~ 388 (489)
........|++.|+|||++.+..++.++|||||||++|||++ |..||.+.+.......+..+....
T Consensus 203 -------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 269 (313)
T 3brb_A 203 -------------YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLK 269 (313)
T ss_dssp ---------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC
T ss_pred -------------cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCC
Confidence 001122357889999999999999999999999999999999 999999988877777776643211
Q ss_pred CCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 389 PRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 389 p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
. ..... ..+.+||.+||..||.+||++. +++++
T Consensus 270 ~--~~~~~------~~l~~li~~~l~~dp~~Rps~~----~l~~~ 302 (313)
T 3brb_A 270 Q--PEDCL------DELYEIMYSCWRTDPLDRPTFS----VLRLQ 302 (313)
T ss_dssp C--BTTCC------HHHHHHHHHTTCSSGGGSCCHH----HHHHH
T ss_pred C--Ccccc------HHHHHHHHHHcCCChhhCcCHH----HHHHH
Confidence 1 11111 2589999999999999999987 66554
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=357.01 Aligned_cols=245 Identities=25% Similarity=0.369 Sum_probs=202.1
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec---
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA--- 160 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--- 160 (489)
++|++++.||+|+||.||+|++.. +++.||+|++.... ..+.+|+.+++.++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 78 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRI-----DGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDY 78 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETT-----TCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEE
T ss_pred cccceeeeeccCCceEEEEEEEcC-----CCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEecccc
Confidence 579999999999999999999886 57889999997542 345569999999999999999998864
Q ss_pred -------------CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccC
Q 011302 161 -------------SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRED 227 (489)
Q Consensus 161 -------------~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~ 227 (489)
...+|+||||+++|+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT 158 (284)
T ss_dssp C---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET
T ss_pred CcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCC
Confidence 4568999999999999999987655679999999999999999999999999999999999999999
Q ss_pred CcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCC
Q 011302 228 GHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHH 307 (489)
Q Consensus 228 ~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (489)
+.+||+|||++......
T Consensus 159 ~~~kl~Dfg~~~~~~~~--------------------------------------------------------------- 175 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKND--------------------------------------------------------------- 175 (284)
T ss_dssp TEEEECCCTTCEESSCC---------------------------------------------------------------
T ss_pred CCEEECcchhheecccc---------------------------------------------------------------
Confidence 99999999998432210
Q ss_pred CccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCC
Q 011302 308 DQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLT 387 (489)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~ 387 (489)
.......||+.|+|||++.+..++.++|||||||++|||++|..||... ......+.....
T Consensus 176 ----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~~~- 236 (284)
T 2a19_B 176 ----------------GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDGII- 236 (284)
T ss_dssp ----------------SCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTTCC-
T ss_pred ----------------ccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhcccc-
Confidence 0112346899999999999999999999999999999999999998532 223333333221
Q ss_pred CCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 388 FPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 388 ~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
+. .. +..+.+||.+||..||.+||++. ++++|.+.
T Consensus 237 -~~---~~------~~~~~~li~~~l~~dp~~Rps~~----e~l~~l~~ 271 (284)
T 2a19_B 237 -SD---IF------DKKEKTLLQKLLSKKPEDRPNTS----EILRTLTV 271 (284)
T ss_dssp -CT---TS------CHHHHHHHHHHTCSSGGGSCCHH----HHHHHHHH
T ss_pred -cc---cC------CHHHHHHHHHHccCChhhCcCHH----HHHHHHHH
Confidence 11 11 12488999999999999999987 88888654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=371.01 Aligned_cols=254 Identities=17% Similarity=0.199 Sum_probs=195.4
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee-cCc
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE-ASH 162 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-~~~ 162 (489)
..|.+.+.||+|+||+||+|++.... .....||+|.++... ......++.+|+.+++.++||||+++++++. .++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~--~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 164 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDND--GKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 164 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETT--TEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSS
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCC--CcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCC
Confidence 45888999999999999999986521 134578999986421 1133456778999999999999999999864 566
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
..|+||||+++|+|.+++... ...+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 165 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 165 SPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp CCEEEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CeEEEEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccc
Confidence 889999999999999999764 3568899999999999999999999999999999999999999999999999985332
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
..... .
T Consensus 244 ~~~~~--------------------------------------------------------------------------~ 249 (373)
T 3c1x_A 244 DKEFD--------------------------------------------------------------------------S 249 (373)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccccc--------------------------------------------------------------------------c
Confidence 10000 0
Q ss_pred ccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHH
Q 011302 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEE 401 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 401 (489)
........||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+....+..+........ ..
T Consensus 250 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~--~~----- 322 (373)
T 3c1x_A 250 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY--CP----- 322 (373)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTT--CC-----
T ss_pred ccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCC--CC-----
Confidence 001123357889999999999999999999999999999999 7889988777666666665433221111 11
Q ss_pred HhhHHHHHHHHhhcCcccccCCC
Q 011302 402 VVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 402 ~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
..+.+||.+||+.||++||++.
T Consensus 323 -~~l~~li~~cl~~dp~~RPs~~ 344 (373)
T 3c1x_A 323 -DPLYEVMLKCWHPKAEMRPSFS 344 (373)
T ss_dssp -HHHHHHHHHHTCSSGGGSCCHH
T ss_pred -HHHHHHHHHHcCCChhhCcCHH
Confidence 2489999999999999999987
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=350.07 Aligned_cols=254 Identities=18% Similarity=0.204 Sum_probs=200.2
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
-.|.+.+.||+|+||+||+|++..... ....||+|++..... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 96 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQ--NRIQCAIKSLSRITE--MQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEG 96 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSS--CEEEEEEEEETTCCS--HHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred eEEccCceeccCCCceEEEEEEecCCC--ceeeeeeeecccccc--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCC
Confidence 356677999999999999999875322 345799999875321 2345567789999999999999999999987665
Q ss_pred E-EEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 164 S-CLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 164 ~-~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
. |+||||+.+|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 97 ~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 97 LPHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp CCEEEECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred CcEEEEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 5 9999999999999998764 3678999999999999999999999999999999999999999999999999984332
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
.... ..
T Consensus 176 ~~~~--------------------------------------------------------------------------~~ 181 (298)
T 3pls_A 176 DREY--------------------------------------------------------------------------YS 181 (298)
T ss_dssp TGGG--------------------------------------------------------------------------GC
T ss_pred CCcc--------------------------------------------------------------------------cc
Confidence 1000 00
Q ss_pred ccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHH
Q 011302 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEE 401 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 401 (489)
........||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+....+..... .+.... ..
T Consensus 182 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~----- 254 (298)
T 3pls_A 182 VQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR-LPQPEY-CP----- 254 (298)
T ss_dssp SCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC-CCCCTT-CC-----
T ss_pred cccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC-CCCCcc-ch-----
Confidence 011233468899999999999999999999999999999999 5556666666666555554432 111111 11
Q ss_pred HhhHHHHHHHHhhcCcccccCCC
Q 011302 402 VVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 402 ~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
..+.+||.+||+.||.+||++.
T Consensus 255 -~~l~~li~~~l~~~p~~Rps~~ 276 (298)
T 3pls_A 255 -DSLYQVMQQCWEADPAVRPTFR 276 (298)
T ss_dssp -HHHHHHHHHHTCSSGGGSCCHH
T ss_pred -HHHHHHHHHHccCChhhCcCHH
Confidence 2489999999999999999987
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=386.80 Aligned_cols=252 Identities=23% Similarity=0.297 Sum_probs=208.3
Q ss_pred hcCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccc
Q 011302 77 AQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYA 156 (489)
Q Consensus 77 ~~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~ 156 (489)
..+++..++|++.+.||+|+||+||+|.+++ ...||||+++..... .+.+.+|+.+|+.++||||+++++
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~ 329 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG------TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 329 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETT------TEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECC------CceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEE
Confidence 3466778899999999999999999999875 356999999864322 245778999999999999999999
Q ss_pred eeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccC
Q 011302 157 EFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFD 236 (489)
Q Consensus 157 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG 236 (489)
++.+ +.+|||||||++|+|.+++....+..+++.++..|+.||+.||+|||++|||||||||+||||+.++.+||+|||
T Consensus 330 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG 408 (535)
T 2h8h_A 330 VVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG 408 (535)
T ss_dssp EECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTT
T ss_pred EEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccc
Confidence 9876 678999999999999999975434569999999999999999999999999999999999999999999999999
Q ss_pred CCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcc
Q 011302 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPE 316 (489)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (489)
+++......
T Consensus 409 ~a~~~~~~~----------------------------------------------------------------------- 417 (535)
T 2h8h_A 409 LARLIEDNE----------------------------------------------------------------------- 417 (535)
T ss_dssp STTTCCCHH-----------------------------------------------------------------------
T ss_pred cceecCCCc-----------------------------------------------------------------------
Confidence 984332100
Q ss_pred ccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCC
Q 011302 317 VVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSS 395 (489)
Q Consensus 317 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 395 (489)
........||..|+|||++.+..++.++|||||||+||||++ |..||.+....+.+..+..+. ..+... ..
T Consensus 418 ------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~-~~~~~~-~~ 489 (535)
T 2h8h_A 418 ------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-RMPCPP-EC 489 (535)
T ss_dssp ------HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTC-CCCCCT-TC
T ss_pred ------eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCC-CC
Confidence 000122357889999999999899999999999999999999 999999998888877776542 222111 11
Q ss_pred chhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 396 SKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 396 ~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
. ..+.+||.+||+.||++||++.
T Consensus 490 ~------~~l~~li~~cl~~dP~~RPt~~ 512 (535)
T 2h8h_A 490 P------ESLHDLMCQCWRKEPEERPTFE 512 (535)
T ss_dssp C------HHHHHHHHHHTCSSGGGSCCHH
T ss_pred C------HHHHHHHHHHcCCChhHCcCHH
Confidence 1 2489999999999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=360.72 Aligned_cols=263 Identities=24% Similarity=0.316 Sum_probs=188.9
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccccccee
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEF 158 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 158 (489)
..+..++|++++.||+|+||.||+|++. ++.||||++........ ....|+..+..++||||+++++.+
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~----~~e~~~~~~~~~~h~~i~~~~~~~ 76 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSLD-------ERPVAVKVFSFANRQNF----INEKNIYRVPLMEHDNIARFIVGD 76 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEET-------TEEEEEEEEEGGGHHHH----HHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred CCcChHHhheeeecccCCCeEEEEEEEC-------CeEEEEEEeeccchhhH----HHHHHHHHHHhccCcchhhheecc
Confidence 3567799999999999999999999764 47899999975432211 112233334558999999999744
Q ss_pred -----ecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhC---------CCeeecCCCCCeEe
Q 011302 159 -----EASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMM---------GIVYRDLKPENVLV 224 (489)
Q Consensus 159 -----~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~---------~iiHrDIKp~NILl 224 (489)
.....+|+|||||++|+|.+++... .+++..+..++.||+.||+|||++ |||||||||+||||
T Consensus 77 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill 153 (336)
T 3g2f_A 77 ERVTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV 153 (336)
T ss_dssp EEECTTSCEEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE
T ss_pred cccccCCCceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE
Confidence 3445789999999999999999774 468899999999999999999999 99999999999999
Q ss_pred ccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCC
Q 011302 225 REDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDG 304 (489)
Q Consensus 225 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (489)
+.++.+||+|||+++.+.......
T Consensus 154 ~~~~~~kL~DFG~a~~~~~~~~~~-------------------------------------------------------- 177 (336)
T 3g2f_A 154 KNDGTCVISDFGLSMRLTGNRLVR-------------------------------------------------------- 177 (336)
T ss_dssp CTTSCEEECCCTTCEECSSSSCC---------------------------------------------------------
T ss_pred cCCCcEEEeeccceeecccccccC--------------------------------------------------------
Confidence 999999999999985432110000
Q ss_pred CCCCccccCCccccccccccCCccccCCCCccCcchhcC-------CCCCCcccHHHHHHHHHHHhhCCCCCCCCCc---
Q 011302 305 DHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISG-------QGHGSAVDWWTLGVFLYEMLYGTTPFKGENN--- 374 (489)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-------~~~~~~~DiwSlGvil~elltG~~Pf~~~~~--- 374 (489)
...........+||+.|+|||++.+ ..++.++|||||||++|||++|..||.....
T Consensus 178 --------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 243 (336)
T 3g2f_A 178 --------------PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243 (336)
T ss_dssp ----------------------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred --------------ccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence 0000112234579999999999987 3456789999999999999999777643211
Q ss_pred --------------HHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCC
Q 011302 375 --------------EKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLK 425 (489)
Q Consensus 375 --------------~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~ 425 (489)
...+..+.......+...............+.+||.+||+.||++||++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 308 (336)
T 3g2f_A 244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQX 308 (336)
T ss_dssp CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHH
Confidence 112222222222222221111111223346899999999999999999873
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=354.54 Aligned_cols=258 Identities=22% Similarity=0.254 Sum_probs=198.3
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
+....|++++.||+|+||.||+|++.... ...++.||+|++..... ......+.+|+.+++.++||||+++++++.+
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEG-DNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTE 94 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTS-SSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEcccc-CccCeEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 44567999999999999999999964321 12678999999986542 2334567789999999999999999999987
Q ss_pred C--ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 161 S--HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 161 ~--~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
. ..+|+||||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 95 DGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred CCCceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccc
Confidence 6 67999999999999999986543 56999999999999999999999999999999999999999999999999998
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
.........
T Consensus 174 ~~~~~~~~~----------------------------------------------------------------------- 182 (302)
T 4e5w_A 174 KAIETDKEY----------------------------------------------------------------------- 182 (302)
T ss_dssp EECCTTCCE-----------------------------------------------------------------------
T ss_pred ccccCCCcc-----------------------------------------------------------------------
Confidence 543211000
Q ss_pred ccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCC--------------CcHHHHHHHhcC
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGE--------------NNEKTLINILKK 384 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~--------------~~~~~~~~i~~~ 384 (489)
........||+.|+|||++.+..++.++|||||||++|||++|..|+... .....+......
T Consensus 183 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (302)
T 4e5w_A 183 ----YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKE 258 (302)
T ss_dssp ----EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHT
T ss_pred ----eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhc
Confidence 01122346889999999999998999999999999999999999886322 122222222222
Q ss_pred CCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 385 PLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 385 ~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
....+..... +..+.+||.+||+.||.+||++.
T Consensus 259 ~~~~~~~~~~-------~~~l~~li~~~l~~dp~~Rps~~ 291 (302)
T 4e5w_A 259 GKRLPCPPNC-------PDEVYQLMRKCWEFQPSNRTSFQ 291 (302)
T ss_dssp TCCCCCCTTC-------CHHHHHHHHHTTCSSGGGSCCHH
T ss_pred cCCCCCCCCC-------CHHHHHHHHHHcCCCCCCCCCHH
Confidence 2222211111 12589999999999999999987
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=367.00 Aligned_cols=259 Identities=18% Similarity=0.227 Sum_probs=196.5
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCC---CCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccc------
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVG---LPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPT------ 153 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~------ 153 (489)
.++|++.+.||+|+||.||+|++..+... ..++.||||++... ..+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 37899999999999999999998863110 12678999999754 35667999999999999988
Q ss_pred ---------ccceeec-CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeE
Q 011302 154 ---------LYAEFEA-SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVL 223 (489)
Q Consensus 154 ---------l~~~~~~-~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIL 223 (489)
+++++.. +...|+||||+ |++|.+++.......+++.++..++.||+.||+|||++||+||||||+|||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 4555554 78899999999 999999998764567999999999999999999999999999999999999
Q ss_pred eccCC--cEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccc
Q 011302 224 VREDG--HIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQ 301 (489)
Q Consensus 224 l~~~~--~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (489)
++.++ .+||+|||+++.+.......
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~----------------------------------------------------- 218 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHV----------------------------------------------------- 218 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCC-----------------------------------------------------
T ss_pred EcCCCCceEEEecCcceeeccCCCccc-----------------------------------------------------
Confidence 99998 99999999985433110000
Q ss_pred cCCCCCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCC-cHHHHHH
Q 011302 302 VDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGEN-NEKTLIN 380 (489)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~-~~~~~~~ 380 (489)
...........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.. ....+..
T Consensus 219 ------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 280 (352)
T 2jii_A 219 ------------------AYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMK 280 (352)
T ss_dssp ------------------CCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHH
T ss_pred ------------------cccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHH
Confidence 000112234579999999999999999999999999999999999999998764 3322222
Q ss_pred H----hcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 381 I----LKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 381 i----~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
. ......++..... ....+..+.+||.+||+.||++||++.
T Consensus 281 ~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ 325 (352)
T 2jii_A 281 QKQKFVDKPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYA 325 (352)
T ss_dssp HHHHHHHSCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHH
T ss_pred HHHhccCChhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHH
Confidence 2 2222222111000 000113589999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=366.30 Aligned_cols=267 Identities=19% Similarity=0.185 Sum_probs=192.4
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHH--------HHHHHHHHHHHHHHHHhCCCCCccc
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALA--------IRKKLHRADMEKVILTMLDHPFLPT 153 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~--------~~~~~~~~~~E~~~l~~l~hpnIv~ 153 (489)
..++|++.+.||+|+||+||+|++.... ..+..||||++...... .......+.+|..+++.++||||++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~ 112 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKP--EKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL 112 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSC--GGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCC--CccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence 3478999999999999999999987521 14678999998753211 0111233667888999999999999
Q ss_pred ccceeec----CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCC-
Q 011302 154 LYAEFEA----SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDG- 228 (489)
Q Consensus 154 l~~~~~~----~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~- 228 (489)
+++++.. ...+|+||||+ |++|.+++... +.+++.+++.|+.||+.||+|||++||+||||||+|||++.++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSST
T ss_pred eecccccccCCCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCC
Confidence 9999987 78999999999 99999998765 4799999999999999999999999999999999999999887
Q ss_pred -cEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCC
Q 011302 229 -HIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHH 307 (489)
Q Consensus 229 -~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (489)
.+||+|||+|+.+.......
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~----------------------------------------------------------- 210 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHK----------------------------------------------------------- 210 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCC-----------------------------------------------------------
T ss_pred CcEEEEeCCCceecccccccc-----------------------------------------------------------
Confidence 99999999985442110000
Q ss_pred CccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCC-cHHHHHHHhc-CC
Q 011302 308 DQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGEN-NEKTLINILK-KP 385 (489)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~-~~ 385 (489)
...........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.. .......... ..
T Consensus 211 ------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 278 (345)
T 2v62_A 211 ------------QYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLL 278 (345)
T ss_dssp ------------CCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHH
T ss_pred ------------cchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhc
Confidence 000111234579999999999999999999999999999999999999996532 2221111111 00
Q ss_pred CCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 386 LTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 386 ~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
...|............+.++.+||.+||..||++||++.
T Consensus 279 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 317 (345)
T 2v62_A 279 DELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQ 317 (345)
T ss_dssp HTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHH
T ss_pred ccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHH
Confidence 011110000000001112589999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=359.52 Aligned_cols=274 Identities=22% Similarity=0.289 Sum_probs=204.6
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee-
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE- 159 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~- 159 (489)
+..++|++++.||+|+||.||+|++.... ...++.||||++..... .....+.+|+.+++.++||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 95 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLG-DNTGALVAVKQLQHSGP---DQQRDFQREIQILKALHSDFIVKYRGVSYG 95 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTS-SSCSEEEEEEEESSCCH---HHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCC-CCcceEEEEEEeccCCH---HHHHHHHHHHHHHHhcCCCceeEEEEEEec
Confidence 45689999999999999999999964321 12678999999975432 23355778999999999999999999886
Q ss_pred -cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 160 -ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 160 -~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
+...+|+||||++||+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 96 PGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA 174 (327)
T ss_dssp SSSCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred CCCceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccc
Confidence 5677999999999999999987642 46999999999999999999999999999999999999999999999999998
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
.........
T Consensus 175 ~~~~~~~~~----------------------------------------------------------------------- 183 (327)
T 3lxl_A 175 KLLPLDKDY----------------------------------------------------------------------- 183 (327)
T ss_dssp EECCTTCSE-----------------------------------------------------------------------
T ss_pred eecccCCcc-----------------------------------------------------------------------
Confidence 543210000
Q ss_pred ccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcH--------------HHHHHHhcC
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNE--------------KTLINILKK 384 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--------------~~~~~i~~~ 384 (489)
........||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..+......
T Consensus 184 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (327)
T 3lxl_A 184 ----YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259 (327)
T ss_dssp ----EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHT
T ss_pred ----ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhc
Confidence 01122346889999999999988999999999999999999999998654321 112222222
Q ss_pred CCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcc
Q 011302 385 PLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWA 442 (489)
Q Consensus 385 ~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~ 442 (489)
....+... .. ...+.+||.+||+.||.+||++.+.+ +.|+..|.....|.
T Consensus 260 ~~~~~~~~-~~------~~~l~~li~~~l~~dP~~Rps~~ell-~~L~~~~~~~~~~~ 309 (327)
T 3lxl_A 260 GQRLPAPP-AC------PAEVHELMKLCWAPSPQDRPSFSALG-PQLDMLWSGSRGCE 309 (327)
T ss_dssp TCCCCCCT-TC------CHHHHHHHHHHTCSSGGGSCCHHHHH-HHHHHC--------
T ss_pred ccCCCCCC-cc------cHHHHHHHHHHcCCChhhCcCHHHHH-HHHHHHHhhhcCcc
Confidence 22222111 11 12589999999999999999997222 23444455444443
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=374.50 Aligned_cols=278 Identities=19% Similarity=0.259 Sum_probs=212.4
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCC-CCcccccceeec
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDH-PFLPTLYAEFEA 160 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~ 160 (489)
..++|+++++||+|+||.||+|++.. +++.||||++.... ...++..|+.+++.+.| ++|+.+..++..
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAvK~~~~~~-----~~~~~~~E~~il~~L~~~~~i~~i~~~~~~ 74 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKT-----KHPQLLYESKIYRILQGGTGIPNVRWFGVE 74 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETT-----TCCEEEEEEEETTC-----SSCCHHHHHHHHHHTTTSTTCCCEEEEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECC-----CCcEEEEEEecccc-----ccHHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 34789999999999999999999876 57899999987542 22346679999999987 556666667778
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEe---ccCCcEEEcccCC
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLV---REDGHIMLSDFDL 237 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl---~~~~~vkl~DFG~ 237 (489)
.+..||||||+ +++|.+++.... ..+++.+++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+
T Consensus 75 ~~~~~lvme~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 152 (483)
T 3sv0_A 75 GDYNVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (483)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred CCEEEEEEECC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCc
Confidence 88999999999 999999998643 579999999999999999999999999999999999999 6889999999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
++.+......
T Consensus 153 a~~~~~~~~~---------------------------------------------------------------------- 162 (483)
T 3sv0_A 153 AKKYRDTSTH---------------------------------------------------------------------- 162 (483)
T ss_dssp CEECBCTTTC----------------------------------------------------------------------
T ss_pred ceeccCCccc----------------------------------------------------------------------
Confidence 8544321000
Q ss_pred cccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCc---HHHHHHHhcCCCCCCCCCCC
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENN---EKTLINILKKPLTFPRIGVS 394 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~p~~~~~ 394 (489)
...........+||+.|+|||++.+..++.++|||||||+||||++|+.||.+... .+.+.++.......+....
T Consensus 163 -~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l- 240 (483)
T 3sv0_A 163 -QHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL- 240 (483)
T ss_dssp -CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHH-
T ss_pred -cccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHH-
Confidence 00001123356899999999999999999999999999999999999999987543 2333333321111000000
Q ss_pred CchhHHHHhhHHHHHHHHhhcCcccccCCCCCh---HHH---HcCCCcCCCCcccccc
Q 011302 395 SSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGS---VEI---KRHEFFKGINWALIRS 446 (489)
Q Consensus 395 ~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~---~~l---l~hp~f~~~~~~~~~~ 446 (489)
......++.+||.+||..||++||++.+.. .++ +.++|+..+||+.++.
T Consensus 241 ---~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~~~ 295 (483)
T 3sv0_A 241 ---CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKY 295 (483)
T ss_dssp ---HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHHTC
T ss_pred ---hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhhcc
Confidence 000112589999999999999999986321 222 3589999999987744
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=355.66 Aligned_cols=254 Identities=23% Similarity=0.269 Sum_probs=198.0
Q ss_pred cCCc-eeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec-
Q 011302 83 LDHF-RLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA- 160 (489)
Q Consensus 83 ~~~y-~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~- 160 (489)
.++| ++++.||+|+||+||+|.++.... .+++.||||++..... ......+.+|+.+|+.++||||+++++++.+
T Consensus 29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (318)
T 3lxp_A 29 HKRYLKKIRDLGEGHFGKVSLYCYDPTND-GTGEMVAVKALKADAG--PQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA 105 (318)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECSCC---CCEEEEEEEECTTCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred cHHHHhhhheecCCCCeEEEEEEEccCCC-CCCcEEEEEEeccccC--hHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence 3455 999999999999999998754222 2678999999986521 2334567789999999999999999999987
Q ss_pred -CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 161 -SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 161 -~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
...+|+||||+++|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 106 GAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp TTTEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred CCceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccc
Confidence 46899999999999999998764 49999999999999999999999999999999999999999999999999985
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
........
T Consensus 183 ~~~~~~~~------------------------------------------------------------------------ 190 (318)
T 3lxp_A 183 AVPEGHEY------------------------------------------------------------------------ 190 (318)
T ss_dssp ECCTTCSE------------------------------------------------------------------------
T ss_pred cccccccc------------------------------------------------------------------------
Confidence 43211000
Q ss_pred cccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcH--------------HHHHHHhcCC
Q 011302 320 EPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNE--------------KTLINILKKP 385 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--------------~~~~~i~~~~ 385 (489)
........||+.|+|||++.+..++.++|||||||++|||++|..||...... ..+.......
T Consensus 191 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (318)
T 3lxp_A 191 ---YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG 267 (318)
T ss_dssp ---EEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT
T ss_pred ---cccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc
Confidence 01122346889999999999988999999999999999999999999753211 1112222222
Q ss_pred CCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 386 LTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 386 ~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
...+.... .. ..+.+||.+||+.||++||++.
T Consensus 268 ~~~~~~~~-~~------~~l~~li~~~l~~dP~~Rps~~ 299 (318)
T 3lxp_A 268 ERLPRPDK-CP------AEVYHLMKNCWETEASFRPTFE 299 (318)
T ss_dssp CCCCCCTT-CC------HHHHHHHHHHTCSSGGGSCCHH
T ss_pred cCCCCCcc-cc------HHHHHHHHHHcCCCcccCcCHH
Confidence 22222111 11 2589999999999999999987
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=356.94 Aligned_cols=264 Identities=23% Similarity=0.345 Sum_probs=199.3
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee-
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE- 159 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~- 159 (489)
+..++|++++.||+|+||.||+|++.. +++.||||++..... .....+.+|+.+++.++||||+++++++.
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 97 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLH-----DGHFYALKRILCHEQ---QDREEAQREADMHRLFNHPNILRLVAYCLR 97 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETT-----TCCEEEEEEEEESSH---HHHHHHHHHHHHHHTCCCTTBCCCCEEEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecC-----CCcEEEEEEEecCCH---HHHHHHHHHHHHHhhcCCCCeeeEEEEEEe
Confidence 455789999999999999999999876 578999999865322 23456778999999999999999999986
Q ss_pred ---cCceEEEEEeecCCCchHHHHHhC--CCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcc
Q 011302 160 ---ASHYSCLVMEYCPGGDLYAARQRQ--PGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSD 234 (489)
Q Consensus 160 ---~~~~~~lV~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~D 234 (489)
.....|+||||+++|+|.+++... ....+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~d 177 (317)
T 2buj_A 98 ERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMD 177 (317)
T ss_dssp EETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECC
T ss_pred ccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEe
Confidence 445889999999999999988752 346799999999999999999999999999999999999999999999999
Q ss_pred cCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCC
Q 011302 235 FDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDD 314 (489)
Q Consensus 235 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (489)
||++...........
T Consensus 178 fg~~~~~~~~~~~~~----------------------------------------------------------------- 192 (317)
T 2buj_A 178 LGSMNQACIHVEGSR----------------------------------------------------------------- 192 (317)
T ss_dssp CSSCEESCEEEESHH-----------------------------------------------------------------
T ss_pred cCcchhccccccccc-----------------------------------------------------------------
Confidence 999743321000000
Q ss_pred ccccccccccCCccccCCCCccCcchhcCCC---CCCcccHHHHHHHHHHHhhCCCCCCCCC--cHHHHHHHhcCCCCCC
Q 011302 315 PEVVAEPINARSKSFVGTHEYLAPEVISGQG---HGSAVDWWTLGVFLYEMLYGTTPFKGEN--NEKTLINILKKPLTFP 389 (489)
Q Consensus 315 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~---~~~~~DiwSlGvil~elltG~~Pf~~~~--~~~~~~~i~~~~~~~p 389 (489)
............||+.|+|||++.+.. ++.++|||||||++|||++|+.||.... .......+ .....+|
T Consensus 193 ----~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~ 267 (317)
T 2buj_A 193 ----QALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV-QNQLSIP 267 (317)
T ss_dssp ----HHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH-HCC--CC
T ss_pred ----ccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh-hccCCCC
Confidence 000000012336899999999998664 6889999999999999999999995421 11111222 2223333
Q ss_pred CCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 390 RIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 390 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
..... ...+.+||.+||+.||.+||++. +++++
T Consensus 268 ~~~~~-------~~~l~~li~~~l~~dp~~Rps~~----~ll~~ 300 (317)
T 2buj_A 268 QSPRH-------SSALWQLLNSMMTVDPHQRPHIP----LLLSQ 300 (317)
T ss_dssp CCTTS-------CHHHHHHHHHHTCSSGGGSCCHH----HHHHH
T ss_pred ccccC-------CHHHHHHHHHHhhcChhhCCCHH----HHHHH
Confidence 22111 12589999999999999999987 77765
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=385.68 Aligned_cols=265 Identities=23% Similarity=0.279 Sum_probs=207.7
Q ss_pred ccccCCceeee-eeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccccccee
Q 011302 80 RVGLDHFRLLR-RLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEF 158 (489)
Q Consensus 80 ~~~~~~y~~~~-~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 158 (489)
.+..+++.+.+ .||+|+||+||+|.++... .+..||||+++.... ......+.+|+.+|+.++|||||++++++
T Consensus 331 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~---~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~ 405 (613)
T 2ozo_A 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRK---KQIDVAIKVLKQGTE--KADTEEMMREAQIMHQLDNPYIVRLIGVC 405 (613)
T ss_dssp BCCTTSEEEEEEEEEECSSSEEEEEEEECSS---CEEEEEEEECCCCCS--STTHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred eccccceeEcCcEEecCCCcEEEEEEEecCC---CcEEEEEEEcCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEe
Confidence 34556777777 8999999999999987421 356799999975421 12345677899999999999999999999
Q ss_pred ecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 159 EASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
.+ +.+|||||||+||+|.+++... ...+++..+..|+.||+.||+|||++|||||||||+||||+.++.+||+|||++
T Consensus 406 ~~-~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla 483 (613)
T 2ozo_A 406 QA-EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLS 483 (613)
T ss_dssp ES-SSEEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTT
T ss_pred cc-CCeEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCc
Confidence 76 5699999999999999998654 356999999999999999999999999999999999999999999999999998
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
+.+......
T Consensus 484 ~~~~~~~~~----------------------------------------------------------------------- 492 (613)
T 2ozo_A 484 KALGADDSY----------------------------------------------------------------------- 492 (613)
T ss_dssp TTCC----------------------------------------------------------------------------
T ss_pred ccccCCCce-----------------------------------------------------------------------
Confidence 543210000
Q ss_pred ccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCC-CCCCCCCCCc
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPL-TFPRIGVSSS 396 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~ 396 (489)
........||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+....+..+.. ..|. ...
T Consensus 493 ----~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~---~~~ 565 (613)
T 2ozo_A 493 ----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP---ECP 565 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCT---TCC
T ss_pred ----eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCC---cCC
Confidence 000112246789999999999999999999999999999998 9999999998888887776532 2221 111
Q ss_pred hhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 397 KEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 397 ~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
..+.+||.+||..||++||++.+ +.+.|++.|+
T Consensus 566 ------~~l~~li~~cl~~dP~~RPs~~~-l~~~L~~~~~ 598 (613)
T 2ozo_A 566 ------PELYALMSDCWIYKWEDRPDFLT-VEQRMRACYY 598 (613)
T ss_dssp ------HHHHHHHHHTTCSSTTTSCCHHH-HHHHHHHHHH
T ss_pred ------HHHHHHHHHHcCCChhHCcCHHH-HHHHHHHHHH
Confidence 25899999999999999999862 2233444343
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=357.09 Aligned_cols=256 Identities=22% Similarity=0.313 Sum_probs=192.9
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHh--CCCCCcccccceeec
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTM--LDHPFLPTLYAEFEA 160 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l~~~~~~ 160 (489)
.++|++++.||+|+||.||+|+++ ++.||||++...... ....|.+++.. ++||||+++++++..
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~------~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 102 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR-------GEKVAVKVFFTTEEA------SWFRETEIYQTVLMRHENILGFIAADIK 102 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET-------TEEEEEEEEEGGGHH------HHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred ccceEEEeEeecCCCeEEEEEEEC-------CceEEEEEEeccccc------hhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence 468999999999999999999876 478999999754322 22334555544 489999999999987
Q ss_pred C----ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhC--------CCeeecCCCCCeEeccCC
Q 011302 161 S----HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMM--------GIVYRDLKPENVLVREDG 228 (489)
Q Consensus 161 ~----~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~--------~iiHrDIKp~NILl~~~~ 228 (489)
. ..+|+||||+++|+|.+++... .+++..+..++.|++.||+|||++ |||||||||+|||++.++
T Consensus 103 ~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~ 179 (337)
T 3mdy_A 103 GTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG 179 (337)
T ss_dssp SCGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred CCCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC
Confidence 7 7899999999999999999764 699999999999999999999999 999999999999999999
Q ss_pred cEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCC
Q 011302 229 HIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHD 308 (489)
Q Consensus 229 ~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (489)
.+||+|||+|+.+......
T Consensus 180 ~~kl~Dfg~a~~~~~~~~~------------------------------------------------------------- 198 (337)
T 3mdy_A 180 TCCIADLGLAVKFISDTNE------------------------------------------------------------- 198 (337)
T ss_dssp CEEECCCTTCEECC------------------------------------------------------------------
T ss_pred CEEEEeCCCceeecccccc-------------------------------------------------------------
Confidence 9999999998443211000
Q ss_pred ccccCCccccccccccCCccccCCCCccCcchhcCCCCCCc------ccHHHHHHHHHHHhhC----------CCCCCCC
Q 011302 309 QELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSA------VDWWTLGVFLYEMLYG----------TTPFKGE 372 (489)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~------~DiwSlGvil~elltG----------~~Pf~~~ 372 (489)
........+||+.|+|||++.+..++.. +|||||||++|||++| ..||...
T Consensus 199 -------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 199 -------------VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp -----------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred -------------ccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 0001224579999999999998776665 9999999999999999 7777653
Q ss_pred C----cHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 373 N----NEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 373 ~----~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
. .......+.......+.... ..........+.+||.+||+.||.+||++. ++++|
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~----ell~~ 325 (337)
T 3mdy_A 266 VPSDPSYEDMREIVCIKKLRPSFPN-RWSSDECLRQMGKLMTECWAHNPASRLTAL----RVKKT 325 (337)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCG-GGGGSHHHHHHHHHHHHHSCSSGGGSCCHH----HHHHH
T ss_pred cCCCCchhhhHHHHhhhccCccccc-cchhhHHHHHHHHHHHHhhhhChhhCCCHH----HHHHH
Confidence 2 22333333322111111110 001113345689999999999999999987 66654
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=386.34 Aligned_cols=250 Identities=23% Similarity=0.272 Sum_probs=199.9
Q ss_pred CCceee-eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 84 DHFRLL-RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 84 ~~y~~~-~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
..+.+. +.||+|+||+||+|.++.. ..++.||||+++..... .....++.+|+.+|+.++|||||++++++.+ +
T Consensus 368 ~~~~l~~~~LG~G~fG~Vy~~~~~~~---~~~~~vAvK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~ 442 (635)
T 4fl3_A 368 KLLTLEDKELGSGNFGTVKKGYYQMK---KVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGICEA-E 442 (635)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECS---SCEEEEEEEEECGGGGC-GGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred hhccccCCEeccCCCEEEEEEEEcCC---CcceEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 344443 4899999999999977642 14688999999865322 1234567889999999999999999999875 4
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
.+|||||||++|+|.+++... ..+++..+..|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.+.
T Consensus 443 ~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 520 (635)
T 4fl3_A 443 SWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 520 (635)
T ss_dssp SEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTT
T ss_pred CEEEEEEccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccc
Confidence 589999999999999999875 579999999999999999999999999999999999999999999999999985432
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
.....
T Consensus 521 ~~~~~--------------------------------------------------------------------------- 525 (635)
T 4fl3_A 521 ADENY--------------------------------------------------------------------------- 525 (635)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred cCccc---------------------------------------------------------------------------
Confidence 11000
Q ss_pred ccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCC-CCCCCCCCchhHH
Q 011302 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLT-FPRIGVSSSKEFE 400 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~-~p~~~~~~~~~~~ 400 (489)
........||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+....+..+... .|. ...
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~---~~~---- 598 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA---GCP---- 598 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT---TCC----
T ss_pred cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC---CCC----
Confidence 001122357889999999999999999999999999999998 99999999988887777665322 221 111
Q ss_pred HHhhHHHHHHHHhhcCcccccCCC
Q 011302 401 EVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 401 ~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
.++.+||.+||+.||++||++.
T Consensus 599 --~~l~~li~~cl~~dP~~RPs~~ 620 (635)
T 4fl3_A 599 --REMYDLMNLCWTYDVENRPGFA 620 (635)
T ss_dssp --HHHHHHHHHHTCSSTTTSCCHH
T ss_pred --HHHHHHHHHHcCCCHhHCcCHH
Confidence 2589999999999999999986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=386.87 Aligned_cols=267 Identities=24% Similarity=0.339 Sum_probs=204.4
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec--
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA-- 160 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-- 160 (489)
.++|++.+.||+|+||.||+|.++. +++.||||++..... .....++.+|+.+++.++||||+++++++..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~-----tg~~VAVKvi~~~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~ 85 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQD-----TGEQVAIKQCRQELS--PKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQ 85 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTT-----TTCCEEECCCCSCCC--HHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTC
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECC-----CCcEEEEEEecccCC--HHHHHHHHHHHHHHHhCCCCCCCceeeeecccc
Confidence 4789999999999999999999876 578899999865321 2334567789999999999999999998765
Q ss_pred ----CceEEEEEeecCCCchHHHHHhCC-CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCc---EEE
Q 011302 161 ----SHYSCLVMEYCPGGDLYAARQRQP-GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGH---IML 232 (489)
Q Consensus 161 ----~~~~~lV~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~---vkl 232 (489)
++..|+|||||+||+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||
T Consensus 86 ~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL 165 (676)
T 3qa8_A 86 KLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKI 165 (676)
T ss_dssp CCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEE
T ss_pred cccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEE
Confidence 778899999999999999998643 236999999999999999999999999999999999999997765 999
Q ss_pred cccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCcccc
Q 011302 233 SDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELL 312 (489)
Q Consensus 233 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (489)
+|||++.....
T Consensus 166 ~DFG~a~~~~~--------------------------------------------------------------------- 176 (676)
T 3qa8_A 166 IDLGYAKELDQ--------------------------------------------------------------------- 176 (676)
T ss_dssp CSCCCCCBTTS---------------------------------------------------------------------
T ss_pred ccccccccccc---------------------------------------------------------------------
Confidence 99999843211
Q ss_pred CCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHH-----------
Q 011302 313 DDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINI----------- 381 (489)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i----------- 381 (489)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||.+......+...
T Consensus 177 ----------~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 177 ----------GELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246 (676)
T ss_dssp ----------CCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred ----------ccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence 01123357999999999999999999999999999999999999999875433221110
Q ss_pred ---hcCCCCCCCCCC-CCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 382 ---LKKPLTFPRIGV-SSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 382 ---~~~~~~~p~~~~-~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
..+...++.... +....-.....+.+||.+||.+||++||++. ++++||||+.+
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~----elL~hp~F~~l 304 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDP----QNPNVGCFQAL 304 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCT----TCCCCTTHHHH
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHH----HHhcCHHHHHH
Confidence 111111111100 0000112334689999999999999999998 99999999764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=348.47 Aligned_cols=255 Identities=20% Similarity=0.256 Sum_probs=196.5
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccccccee-ecC
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEF-EAS 161 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-~~~ 161 (489)
.++|++.+.||+|+||.||+|++.. +++.||||++.... ...++.+|+.+++.++|++++..+..+ ..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~ 77 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIA-----AGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEG 77 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT-----TTEEEEEEEEESCS-----SCCHHHHHHHHHHHHTTSTTCCCEEEEEEET
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcC-----CCcEEEEEEecCCc-----chhHHHHHHHHHHHhhcCCCCCccccccCCC
Confidence 4789999999999999999999876 57899999986532 223567799999999988866666554 677
Q ss_pred ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEe---ccCCcEEEcccCCC
Q 011302 162 HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLV---REDGHIMLSDFDLS 238 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl---~~~~~vkl~DFG~a 238 (489)
...|+||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 78 ~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 155 (296)
T 3uzp_A 78 DYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred CceEEEEEec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCc
Confidence 8899999999 999999997542 579999999999999999999999999999999999999 48899999999998
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
..........
T Consensus 156 ~~~~~~~~~~---------------------------------------------------------------------- 165 (296)
T 3uzp_A 156 KKYRDARTHQ---------------------------------------------------------------------- 165 (296)
T ss_dssp EECBCTTTCC----------------------------------------------------------------------
T ss_pred cccccccccc----------------------------------------------------------------------
Confidence 5432110000
Q ss_pred ccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCc---HHHHHHHhcCCCCCCCCCCCC
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENN---EKTLINILKKPLTFPRIGVSS 395 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~p~~~~~~ 395 (489)
...........||+.|+|||++.+..++.++|||||||++|||++|+.||.+... .+.+..+.......+.....
T Consensus 166 -~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 243 (296)
T 3uzp_A 166 -HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC- 243 (296)
T ss_dssp -BCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHT-
T ss_pred -ccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHH-
Confidence 0001122445799999999999999999999999999999999999999987432 22333333222121110000
Q ss_pred chhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 396 SKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 396 ~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
...+..+.+||.+||+.||++||++.
T Consensus 244 ---~~~~~~l~~li~~~l~~dp~~Rps~~ 269 (296)
T 3uzp_A 244 ---KGYPSEFATYLNFCRSLRFDDKPDYS 269 (296)
T ss_dssp ---TTSCHHHHHHHHHHHTSCTTCCCCHH
T ss_pred ---hhCCHHHHHHHHHHHhcCcCcCCCHH
Confidence 00112589999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=355.32 Aligned_cols=264 Identities=23% Similarity=0.313 Sum_probs=182.8
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-CCCccccccee
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-HPFLPTLYAEF 158 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~ 158 (489)
.+...+|++.+.||+|+||.||+|++.. +++.||||++..... .....+.+|+.+++.+. ||||+++++++
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~~h~~iv~~~~~~ 95 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVG-----SGREYALKRLLSNEE---EKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETT-----TCCEEEEEEEEESSH---HHHHHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred eccCceEEEEEEEccCCceEEEEEEECC-----CCcEEEEEEecCCch---HHHHHHHHHHHHHHHhccCCChhhccccc
Confidence 3455789999999999999999999886 578899999865432 23345677999999996 99999999988
Q ss_pred --------ecCceEEEEEeecCCCchHHHHHh-CCCCCCChhhHHHHHHHHHHHHHHHHhCC--CeeecCCCCCeEeccC
Q 011302 159 --------EASHYSCLVMEYCPGGDLYAARQR-QPGKRFGISSAKFYAAETLLALEYLHMMG--IVYRDLKPENVLVRED 227 (489)
Q Consensus 159 --------~~~~~~~lV~E~~~gg~L~~~l~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDIKp~NILl~~~ 227 (489)
.....+|+||||+ +|+|.+++.. .....+++.++..++.||+.||+|||++| |+||||||+|||++.+
T Consensus 96 ~~~~~~~~~~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~ 174 (337)
T 3ll6_A 96 SIGKEESDTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ 174 (337)
T ss_dssp EECTTTSTTSSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTT
T ss_pred cccccccccCCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCC
Confidence 4556789999999 5899888765 22357999999999999999999999999 9999999999999999
Q ss_pred CcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCC
Q 011302 228 GHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHH 307 (489)
Q Consensus 228 ~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (489)
+.+||+|||+++.+.........
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~--------------------------------------------------------- 197 (337)
T 3ll6_A 175 GTIKLCDFGSATTISHYPDYSWS--------------------------------------------------------- 197 (337)
T ss_dssp SCEEBCCCTTCBCCSSCC--------------------------------------------------------------
T ss_pred CCEEEecCccceeccccCccccc---------------------------------------------------------
Confidence 99999999998544321110000
Q ss_pred CccccCCccccccccccCCccccCCCCccCcchh---cCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcC
Q 011302 308 DQELLDDPEVVAEPINARSKSFVGTHEYLAPEVI---SGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK 384 (489)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l---~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~ 384 (489)
.............+||+.|+|||++ .+..++.++|||||||++|||++|..||.+........ .
T Consensus 198 ---------~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~----~ 264 (337)
T 3ll6_A 198 ---------AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN----G 264 (337)
T ss_dssp -----------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------------
T ss_pred ---------ccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhc----C
Confidence 0000000112345799999999999 56668899999999999999999999998765443332 2
Q ss_pred CCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 385 PLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 385 ~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
....+...... ..+.+||.+||+.||++||++. ++++|
T Consensus 265 ~~~~~~~~~~~-------~~~~~li~~~l~~~p~~Rps~~----e~l~~ 302 (337)
T 3ll6_A 265 KYSIPPHDTQY-------TVFHSLIRAMLQVNPEERLSIA----EVVHQ 302 (337)
T ss_dssp -CCCCTTCCSS-------GGGHHHHHHHSCSSGGGSCCHH----HHHHH
T ss_pred cccCCcccccc-------hHHHHHHHHHccCChhhCcCHH----HHHHH
Confidence 22222211111 2478999999999999999987 77765
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=350.71 Aligned_cols=239 Identities=24% Similarity=0.384 Sum_probs=186.5
Q ss_pred cCCceee-eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHH-HhCCCCCcccccceeec
Q 011302 83 LDHFRLL-RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL-TMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 83 ~~~y~~~-~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l-~~l~hpnIv~l~~~~~~ 160 (489)
.++|.++ +.||+|+||.||+|.++. +++.||||++.... .+.+|+.++ +.++||||+++++++..
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~~i~~~~~~~~~ 82 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKR-----TQEKFALKMLQDCP--------KARREVELHWRASQCPHIVRIVDVYEN 82 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECSH--------HHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcC-----CCcEEEEEEecccH--------HHHHHHHHHHHhccCCCchhHHhhhhh
Confidence 4678887 789999999999999886 57899999997532 234577776 56789999999999986
Q ss_pred ----CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEecc---CCcEEEc
Q 011302 161 ----SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRE---DGHIMLS 233 (489)
Q Consensus 161 ----~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~---~~~vkl~ 233 (489)
...+|+||||++||+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~ 162 (299)
T 3m2w_A 83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT 162 (299)
T ss_dssp EETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred hcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEe
Confidence 778999999999999999998876667999999999999999999999999999999999999998 7899999
Q ss_pred ccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccC
Q 011302 234 DFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLD 313 (489)
Q Consensus 234 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (489)
|||++...
T Consensus 163 Dfg~a~~~------------------------------------------------------------------------ 170 (299)
T 3m2w_A 163 DFGFAKET------------------------------------------------------------------------ 170 (299)
T ss_dssp CCTTCEEC------------------------------------------------------------------------
T ss_pred cccccccc------------------------------------------------------------------------
Confidence 99987211
Q ss_pred CccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCC
Q 011302 314 DPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGV 393 (489)
Q Consensus 314 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~ 393 (489)
.+..++.++|||||||++|||++|..||.+.+.......+... ........
T Consensus 171 ----------------------------~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~-~~~~~~~~ 221 (299)
T 3m2w_A 171 ----------------------------TGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR-IRMGQYEF 221 (299)
T ss_dssp ----------------------------TTCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCS-SCTTCCSS
T ss_pred ----------------------------ccccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHH-HhhccccC
Confidence 1134678999999999999999999999876654332221111 11000000
Q ss_pred CCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 394 SSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 394 ~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
...........+.+||.+||+.||++||++. ++++||||+..
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~----e~l~hp~~~~~ 263 (299)
T 3m2w_A 222 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTIT----EFMNHPWIMQS 263 (299)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHH----HHHTSHHHHTG
T ss_pred CchhcccCCHHHHHHHHHHcccChhhCCCHH----HHhcChhhccc
Confidence 0000011234689999999999999999987 99999999763
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=380.01 Aligned_cols=254 Identities=25% Similarity=0.350 Sum_probs=206.3
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccccccee
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEF 158 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 158 (489)
.++..++|++.+.||+|+||+||+|.++.... ....||||.+..... ......+.+|+.+|+.++||||+++++++
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~--~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 460 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPEN--PAMAVAIKTCKNCTS--DSVREKFLQEALTMRQFDHPHIVKLIGVI 460 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSS--CCEEEEEEECSSTTC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCC--ccEEEEEEEecccCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 45667899999999999999999999875322 457899999865321 23345677899999999999999999998
Q ss_pred ecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 159 EASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
.+ +..|+||||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 461 ~~-~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 461 TE-NPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp CS-SSCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred ec-CceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCC
Confidence 54 56899999999999999997652 46899999999999999999999999999999999999999999999999998
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
+......
T Consensus 539 ~~~~~~~------------------------------------------------------------------------- 545 (656)
T 2j0j_A 539 RYMEDST------------------------------------------------------------------------- 545 (656)
T ss_dssp CSCCC---------------------------------------------------------------------------
T ss_pred eecCCCc-------------------------------------------------------------------------
Confidence 4432100
Q ss_pred ccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCC-CCCCCCCCCc
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPL-TFPRIGVSSS 396 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~ 396 (489)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+.+..+..+.. ..|. ..+
T Consensus 546 ----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~---~~~ 618 (656)
T 2j0j_A 546 ----YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP---NCP 618 (656)
T ss_dssp ------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCT---TCC
T ss_pred ----ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCc---ccc
Confidence 001122357889999999999999999999999999999997 9999999988888877766432 2221 111
Q ss_pred hhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 397 KEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 397 ~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
..+.+||.+||+.||++||++.
T Consensus 619 ------~~l~~li~~~l~~dP~~RPs~~ 640 (656)
T 2j0j_A 619 ------PTLYSLMTKCWAYDPSRRPRFT 640 (656)
T ss_dssp ------HHHHHHHHHHTCSSGGGSCCHH
T ss_pred ------HHHHHHHHHHcCCChhHCcCHH
Confidence 2589999999999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=372.09 Aligned_cols=253 Identities=15% Similarity=0.142 Sum_probs=194.1
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCC-CCcccccc-----
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDH-PFLPTLYA----- 156 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~----- 156 (489)
...|.+.+.||+|+||+||+|++.. +++.||||++.............+.+|+.+++.+.| +|+..+..
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~-----~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~ 151 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQE-----TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 151 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBC
T ss_pred ceeEEEecccccCCCEEEEEEEecC-----CCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccc
Confidence 3468899999999999999999886 578999999874332323345667789999999987 33221111
Q ss_pred ----------------eeec-----CceEEEEEeecCCCchHHHHH-----hCCCCCCChhhHHHHHHHHHHHHHHHHhC
Q 011302 157 ----------------EFEA-----SHYSCLVMEYCPGGDLYAARQ-----RQPGKRFGISSAKFYAAETLLALEYLHMM 210 (489)
Q Consensus 157 ----------------~~~~-----~~~~~lV~E~~~gg~L~~~l~-----~~~~~~l~~~~~~~i~~qi~~~L~yLH~~ 210 (489)
++.. ...+|++|+++ +++|.+++. ......+++..+..++.||+.||+|||++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 230 (413)
T 3dzo_A 152 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY 230 (413)
T ss_dssp CCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred cchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 1111 23468888877 799998885 22335688888999999999999999999
Q ss_pred CCeeecCCCCCeEeccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCcccccccccccccccc
Q 011302 211 GIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKK 290 (489)
Q Consensus 211 ~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (489)
|||||||||+||||+.++.+||+|||+++....
T Consensus 231 ~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~----------------------------------------------- 263 (413)
T 3dzo_A 231 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----------------------------------------------- 263 (413)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCGGGCEETTE-----------------------------------------------
T ss_pred CcccCCcccceEEEecCCeEEEEeccceeecCC-----------------------------------------------
Confidence 999999999999999999999999999743210
Q ss_pred ccccccccccccCCCCCCccccCCccccccccccCCccccCCCCccCcchh----------cCCCCCCcccHHHHHHHHH
Q 011302 291 KAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVI----------SGQGHGSAVDWWTLGVFLY 360 (489)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l----------~~~~~~~~~DiwSlGvil~ 360 (489)
.....+| +.|+|||++ .+..++.++|||||||++|
T Consensus 264 ----------------------------------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 264 ----------------------------------SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp ----------------------------------EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred ----------------------------------ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 1233478 999999999 5556888999999999999
Q ss_pred HHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 361 EMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 361 elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
||++|+.||.+.+..+....+......+| ..+.+||.+||+.||++||++. ++++||||+.+.
T Consensus 309 elltg~~Pf~~~~~~~~~~~~~~~~~~~~-------------~~~~~li~~~l~~dP~~Rpt~~----~~l~~~~~~~~~ 371 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGGSEWIFRSCKNIP-------------QPVRALLEGFLRYPKEDRLLPL----QAMETPEYEQLR 371 (413)
T ss_dssp HHHHSSCCCCTTGGGSCSGGGGSSCCCCC-------------HHHHHHHHHHTCSSGGGSCCHH----HHTTSHHHHHHH
T ss_pred HHHHCCCCCCCcchhhhHHHHHhhcccCC-------------HHHHHHHHHHccCChhhCcCHH----HHHhCHHHHHHH
Confidence 99999999988765544444433222111 2589999999999999999987 999999998764
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=367.42 Aligned_cols=251 Identities=18% Similarity=0.216 Sum_probs=188.8
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHH-----HHHHHHHHHHHHHHHHhCC---------
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALA-----IRKKLHRADMEKVILTMLD--------- 147 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~--------- 147 (489)
..++|++++.||+|+||+||+|++. ++.||||++...... .......+.+|+.+|+.++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~ 90 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIAD-------HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNR 90 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEET-------TEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSB
T ss_pred ccccchheeeecccCceEEEEEEeC-------CceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhcccccc
Confidence 4578999999999999999999873 488999999764211 0111245666888888776
Q ss_pred -----------------CCCcccccceeec-------------CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHH
Q 011302 148 -----------------HPFLPTLYAEFEA-------------SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYA 197 (489)
Q Consensus 148 -----------------hpnIv~l~~~~~~-------------~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~ 197 (489)
||||++++++|.+ .+.+|||||||++|++.+.+.+ ..+++..++.|+
T Consensus 91 h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~ 167 (336)
T 2vuw_A 91 TEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSIL 167 (336)
T ss_dssp CCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHH
T ss_pred CCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHH
Confidence 6666667776665 7899999999999977665533 568999999999
Q ss_pred HHHHHHHHHHH-hCCCeeecCCCCCeEeccCC--------------------cEEEcccCCCcccccCccccCCcchhHH
Q 011302 198 AETLLALEYLH-MMGIVYRDLKPENVLVREDG--------------------HIMLSDFDLSFKCDVVPKLLRPKLSFEA 256 (489)
Q Consensus 198 ~qi~~~L~yLH-~~~iiHrDIKp~NILl~~~~--------------------~vkl~DFG~a~~~~~~~~~~~~~~~~~~ 256 (489)
.||+.||+||| ++|||||||||+||||+.++ .+||+|||+|+...
T Consensus 168 ~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~-------------- 233 (336)
T 2vuw_A 168 HQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLER-------------- 233 (336)
T ss_dssp HHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEE--------------
T ss_pred HHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecC--------------
Confidence 99999999999 99999999999999999887 89999999984321
Q ss_pred HhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCccccCCCCcc
Q 011302 257 IEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYL 336 (489)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~ 336 (489)
....+||+.|+
T Consensus 234 ---------------------------------------------------------------------~~~~~gt~~y~ 244 (336)
T 2vuw_A 234 ---------------------------------------------------------------------DGIVVFCDVSM 244 (336)
T ss_dssp ---------------------------------------------------------------------TTEEECCCCTT
T ss_pred ---------------------------------------------------------------------CCcEEEeeccc
Confidence 01237999999
Q ss_pred CcchhcCCCCCCcccHHHHHHH-HHHHhhCCCCCCCCCc-HHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhh
Q 011302 337 APEVISGQGHGSAVDWWTLGVF-LYEMLYGTTPFKGENN-EKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLV 414 (489)
Q Consensus 337 aPE~l~~~~~~~~~DiwSlGvi-l~elltG~~Pf~~~~~-~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~ 414 (489)
|||++.+.. +.++||||||++ .++++.|..||.+... ......+.... .++.. .........+.++++||.+||+
T Consensus 245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~s~~~~dli~~~L~ 321 (336)
T 2vuw_A 245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQM-TFKTK-CNTPAMKQIKRKIQEFHRTMLN 321 (336)
T ss_dssp CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTC-CCSSC-CCSHHHHHHHHHHHHHHHHGGG
T ss_pred ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhh-ccCcc-cchhhhhhcCHHHHHHHHHHhc
Confidence 999999876 899999998777 7888899999954321 11222333211 11111 1111122344579999999999
Q ss_pred cCcccccCCCCChHHHH-cCCCcC
Q 011302 415 KNPKKRIGSLKGSVEIK-RHEFFK 437 (489)
Q Consensus 415 ~dP~~R~~~~~~~~~ll-~hp~f~ 437 (489)
+| ++. ++| +||||+
T Consensus 322 ~d-----sa~----e~l~~Hp~f~ 336 (336)
T 2vuw_A 322 FS-----SAT----DLLCQHSLFK 336 (336)
T ss_dssp SS-----SHH----HHHHHCGGGC
T ss_pred cC-----CHH----HHHhcCCCcC
Confidence 87 554 999 999995
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=354.48 Aligned_cols=261 Identities=19% Similarity=0.258 Sum_probs=204.2
Q ss_pred hcCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccc
Q 011302 77 AQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYA 156 (489)
Q Consensus 77 ~~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~ 156 (489)
..+++..++|++.+.||+|+||.||+|++++ .||+|++...... ......+.+|+.+++.++||||+++++
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--------~~avk~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~ 96 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--------EVAIRLIDIERDN-EDQLKAFKREVMAYRQTRHENVVLFMG 96 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--------SEEEEECCCCSCC-CCCCCCCCTTGGGGTTCCCTTBCCCCE
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC--------eEEEEEeecCCCC-HHHHHHHHHHHHHHhcCCCCCEeEEEE
Confidence 3456778999999999999999999998764 3899998643211 112344566999999999999999999
Q ss_pred eeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccC
Q 011302 157 EFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFD 236 (489)
Q Consensus 157 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG 236 (489)
++.+.+.+|+||||++|++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||
T Consensus 97 ~~~~~~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg 174 (319)
T 2y4i_B 97 ACMSPPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFG 174 (319)
T ss_dssp EEECSSCEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCS
T ss_pred EEecCCceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecC
Confidence 999999999999999999999998764 34699999999999999999999999999999999999998 7899999999
Q ss_pred CCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcc
Q 011302 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPE 316 (489)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (489)
+++........
T Consensus 175 ~~~~~~~~~~~--------------------------------------------------------------------- 185 (319)
T 2y4i_B 175 LFSISGVLQAG--------------------------------------------------------------------- 185 (319)
T ss_dssp CCC-----------------------------------------------------------------------------
T ss_pred Ccccccccccc---------------------------------------------------------------------
Confidence 97432110000
Q ss_pred ccccccccCCccccCCCCccCcchhcC---------CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCC
Q 011302 317 VVAEPINARSKSFVGTHEYLAPEVISG---------QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLT 387 (489)
Q Consensus 317 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~---------~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~ 387 (489)
..........||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.........+..+...
T Consensus 186 ----~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 261 (319)
T 2y4i_B 186 ----RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP 261 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCC
T ss_pred ----ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCC
Confidence 00011223468999999999975 34788999999999999999999999998887777776654332
Q ss_pred CCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHc
Q 011302 388 FPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKR 432 (489)
Q Consensus 388 ~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~ 432 (489)
..... ... ..+.+||.+||..||++||++. ++++
T Consensus 262 ~~~~~-~~~------~~l~~li~~~l~~~p~~Rpt~~----~l~~ 295 (319)
T 2y4i_B 262 NLSQI-GMG------KEISDILLFCWAFEQEERPTFT----KLMD 295 (319)
T ss_dssp CCCCS-SCC------TTHHHHHHHHHCSSTTTSCCHH----HHHH
T ss_pred CCCcC-CCC------HHHHHHHHHHhcCChhhCcCHH----HHHH
Confidence 21111 111 2489999999999999999987 5555
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=350.94 Aligned_cols=261 Identities=20% Similarity=0.246 Sum_probs=197.7
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHH-HHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREAL-AIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
.|...+.||+|+||.||+|.+. +..||+|++..... ........+.+|+.+++.++||||+++++++.+.+.
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 104 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYVN-------NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDD 104 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEESS-------SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ccccCCccccCCCeEEEEEEEC-------CceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCc
Confidence 3555689999999999999864 46799999864221 112234567789999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCC-CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQP-GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
.|+||||++||+|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 184 (307)
T 2nru_A 105 LCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASE 184 (307)
T ss_dssp CEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccc
Confidence 999999999999999887432 3569999999999999999999999999999999999999999999999999984322
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
....
T Consensus 185 ~~~~---------------------------------------------------------------------------- 188 (307)
T 2nru_A 185 KFAQ---------------------------------------------------------------------------- 188 (307)
T ss_dssp SCSS----------------------------------------------------------------------------
T ss_pred cccc----------------------------------------------------------------------------
Confidence 1000
Q ss_pred ccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHH----HHHHHhcCCCCCCCCC--CCCc
Q 011302 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEK----TLINILKKPLTFPRIG--VSSS 396 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~----~~~~i~~~~~~~p~~~--~~~~ 396 (489)
........||+.|+|||++.+. ++.++|||||||++|+|++|..||.+..... ....+......++... ....
T Consensus 189 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (307)
T 2nru_A 189 TVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND 267 (307)
T ss_dssp CEECSSCCSCGGGCCHHHHTTE-ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSC
T ss_pred cccccccCCCcCcCChHHhcCC-CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccc
Confidence 0012234799999999998764 7899999999999999999999998765432 2222222111110000 0000
Q ss_pred hhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 397 KEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 397 ~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
........+.+||.+||..||.+||++. +++++
T Consensus 268 ~~~~~~~~l~~li~~cl~~~p~~Rps~~----~l~~~ 300 (307)
T 2nru_A 268 ADSTSVEAMYSVASQCLHEKKNKRPDIK----KVQQL 300 (307)
T ss_dssp CCHHHHHHHHHHHHHHTCSSTTTSCCHH----HHHHH
T ss_pred cchHHHHHHHHHHHHHcCCCcccCcCHH----HHHHH
Confidence 1112334689999999999999999987 66543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=349.68 Aligned_cols=254 Identities=23% Similarity=0.316 Sum_probs=195.8
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHh--CCCCCcccccceeecC
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTM--LDHPFLPTLYAEFEAS 161 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l~~~~~~~ 161 (489)
++|++.+.||+|+||.||+|++. ++.||||++..... ..+.+|..++.. ++||||+++++++...
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~------~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKWR-------GEEVAVKIFSSREE------RSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET-------TEEEEEEEECGGGH------HHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred ccEEEEeeecCCCCcEEEEEEEc-------CccEEEEEeCchhH------HHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 68999999999999999999874 47899999975432 244568888877 7899999999999877
Q ss_pred c----eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHH--------hCCCeeecCCCCCeEeccCCc
Q 011302 162 H----YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLH--------MMGIVYRDLKPENVLVREDGH 229 (489)
Q Consensus 162 ~----~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH--------~~~iiHrDIKp~NILl~~~~~ 229 (489)
. .+|+||||+++|+|.+++... .+++.++..++.||+.||.||| ++||+||||||+|||++.++.
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~ 185 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 185 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSC
T ss_pred CCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCC
Confidence 6 899999999999999999763 5999999999999999999999 899999999999999999999
Q ss_pred EEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCc
Q 011302 230 IMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQ 309 (489)
Q Consensus 230 vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (489)
+||+|||++.........
T Consensus 186 ~kL~Dfg~~~~~~~~~~~-------------------------------------------------------------- 203 (342)
T 1b6c_B 186 CCIADLGLAVRHDSATDT-------------------------------------------------------------- 203 (342)
T ss_dssp EEECCCTTCEEEETTTTE--------------------------------------------------------------
T ss_pred EEEEECCCceeccccccc--------------------------------------------------------------
Confidence 999999998433210000
Q ss_pred cccCCccccccccccCCccccCCCCccCcchhcCCC------CCCcccHHHHHHHHHHHhhC----------CCCCCCCC
Q 011302 310 ELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQG------HGSAVDWWTLGVFLYEMLYG----------TTPFKGEN 373 (489)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~------~~~~~DiwSlGvil~elltG----------~~Pf~~~~ 373 (489)
.........||+.|+|||++.+.. ++.++|||||||++|||++| ..||....
T Consensus 204 ------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 204 ------------IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp ------------EEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred ------------cccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 000123447999999999998763 23689999999999999999 78987643
Q ss_pred ----cHHHHH-HHhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 374 ----NEKTLI-NILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 374 ----~~~~~~-~i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
....+. .+...... +.... ..........+.+||.+||+.||++||++. ++++|
T Consensus 272 ~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~Rps~~----~i~~~ 330 (342)
T 1b6c_B 272 PSDPSVEEMRKVVCEQKLR-PNIPN-RWQSCEALRVMAKIMRECWYANGAARLTAL----RIKKT 330 (342)
T ss_dssp CSSCCHHHHHHHHTTSCCC-CCCCG-GGGTSHHHHHHHHHHHHHCCSSGGGSCCHH----HHHHH
T ss_pred cCcccHHHHHHHHHHHHhC-CCCcc-cccchhHHHHHHHHHHHHhccChhhCCCHH----HHHHH
Confidence 223333 33332221 11110 001112334689999999999999999987 66654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=348.00 Aligned_cols=258 Identities=22% Similarity=0.307 Sum_probs=198.8
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE 159 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 159 (489)
.+..++|++++.||+|+||.||+|++.... ..+++.||||++.... ......+.+|+.+++.++||||+++++++.
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 112 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQ-DNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCY 112 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTS-SSCCEEEEEEEESSCC---SHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEecccc-CCCceEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence 455678999999999999999999864211 1257899999997532 233456778999999999999999999886
Q ss_pred cCc--eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCC
Q 011302 160 ASH--YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237 (489)
Q Consensus 160 ~~~--~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~ 237 (489)
..+ .+|+||||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 113 SAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp C----CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred ecCCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcc
Confidence 544 7899999999999999998753 4699999999999999999999999999999999999999999999999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
+.........
T Consensus 192 ~~~~~~~~~~---------------------------------------------------------------------- 201 (326)
T 2w1i_A 192 TKVLPQDKEY---------------------------------------------------------------------- 201 (326)
T ss_dssp CEECCSSCSE----------------------------------------------------------------------
T ss_pred hhhccccccc----------------------------------------------------------------------
Confidence 8543211000
Q ss_pred cccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCc------------H---HHHHHHh
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENN------------E---KTLINIL 382 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~------------~---~~~~~i~ 382 (489)
........||+.|+|||++.+..++.++|||||||++|||++|..||..... . ..+...+
T Consensus 202 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (326)
T 2w1i_A 202 -----YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276 (326)
T ss_dssp -----EECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred -----cccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHh
Confidence 0011223578889999999998899999999999999999999999864211 0 0111222
Q ss_pred cCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 383 KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 383 ~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
......+... .. +.++.+||.+||..||++||++.
T Consensus 277 ~~~~~~~~~~-~~------~~~l~~li~~cl~~dP~~Rps~~ 311 (326)
T 2w1i_A 277 KNNGRLPRPD-GC------PDEIYMIMTECWNNNVNQRPSFR 311 (326)
T ss_dssp HTTCCCCCCT-TC------CHHHHHHHHHHSCSSGGGSCCHH
T ss_pred hcCCCCCCCC-cc------cHHHHHHHHHHcCCChhhCcCHH
Confidence 2222222111 11 12589999999999999999986
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=340.20 Aligned_cols=224 Identities=16% Similarity=0.118 Sum_probs=179.7
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
+..++|++.+.||+|+||.||+|++.. +++.||||++............++.+|+.++..++||||+++++++.+
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 102 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTA-----LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT 102 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETT-----TTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecC-----CCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE
Confidence 444789999999999999999999876 578999999986543323445677889999999999999999999999
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~ 240 (489)
.+..|+||||++|++|.+++... ....++..|+.||+.||+|||++||+||||||+|||++.+|.+||+++|
T Consensus 103 ~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~---- 174 (286)
T 3uqc_A 103 RAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA---- 174 (286)
T ss_dssp TTEEEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC----
T ss_pred CCcEEEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc----
Confidence 99999999999999999998542 4566788999999999999999999999999999999999999998655
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
T Consensus 175 -------------------------------------------------------------------------------- 174 (286)
T 3uqc_A 175 -------------------------------------------------------------------------------- 174 (286)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHH---HHhcCCCCCCCCCCCCch
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLI---NILKKPLTFPRIGVSSSK 397 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~---~i~~~~~~~p~~~~~~~~ 397 (489)
|++| ++.++|||||||++|||++|+.||.+.+....+. +........+.....
T Consensus 175 --------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 230 (286)
T 3uqc_A 175 --------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDR--- 230 (286)
T ss_dssp --------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCT---
T ss_pred --------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhccc---
Confidence 2332 6889999999999999999999999876543211 111111110000000
Q ss_pred hHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 398 EFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 398 ~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
..+..+.+||.+||+.||++| ++.
T Consensus 231 --~~~~~l~~li~~~l~~dP~~R-s~~ 254 (286)
T 3uqc_A 231 --DIPFQISAVAARSVQGDGGIR-SAS 254 (286)
T ss_dssp --TSCHHHHHHHHHHHCTTSSCC-CHH
T ss_pred --CCCHHHHHHHHHHcccCCccC-CHH
Confidence 112358999999999999999 876
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=375.76 Aligned_cols=245 Identities=23% Similarity=0.356 Sum_probs=196.1
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE 159 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 159 (489)
.+..++|++.+.||+|+||+||+|.++.. +++.||||++..... ......+.+|+.+|+.++||||+++++++.
T Consensus 76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~----~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 149 (681)
T 2pzi_A 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNV----NGRPVVLKGLVHSGD--AEAQAMAMAERQFLAEVVHPSIVQIFNFVE 149 (681)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEEGGG----TTEEEEEEESCSSCC--HHHHHHHHHHHGGGGGCCCTTBCCEEEEEE
T ss_pred CEeCCceEEEEEEeeCCCeEEEEEEEcCC----CCcEEEEEEeCccCC--HHHHHHHHHHHHHHHhcCCCCcCeEeeeEe
Confidence 34458999999999999999999998752 468899999864321 133446678999999999999999999998
Q ss_pred cCce-----EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcc
Q 011302 160 ASHY-----SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSD 234 (489)
Q Consensus 160 ~~~~-----~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~D 234 (489)
..+. .||||||++|++|.+++.. .+++.+++.|+.||+.||.|||++|||||||||+|||++.+ .+||+|
T Consensus 150 ~~~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~D 224 (681)
T 2pzi_A 150 HTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLID 224 (681)
T ss_dssp EECTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECC
T ss_pred ecCCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEe
Confidence 7655 7999999999999887653 59999999999999999999999999999999999999975 899999
Q ss_pred cCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCC
Q 011302 235 FDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDD 314 (489)
Q Consensus 235 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (489)
||+++....
T Consensus 225 FG~a~~~~~----------------------------------------------------------------------- 233 (681)
T 2pzi_A 225 LGAVSRINS----------------------------------------------------------------------- 233 (681)
T ss_dssp CTTCEETTC-----------------------------------------------------------------------
T ss_pred cccchhccc-----------------------------------------------------------------------
Confidence 999843210
Q ss_pred ccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCC
Q 011302 315 PEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVS 394 (489)
Q Consensus 315 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~ 394 (489)
....+||+.|+|||++.+. ++.++|||||||++|||++|.+||.+.... ..+ .
T Consensus 234 -----------~~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~-----------~~~----~ 286 (681)
T 2pzi_A 234 -----------FGYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD-----------GLP----E 286 (681)
T ss_dssp -----------CSCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS-----------SCC----T
T ss_pred -----------CCccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc-----------ccc----c
Confidence 1234799999999999876 488999999999999999999998753211 011 1
Q ss_pred CchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcC
Q 011302 395 SSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437 (489)
Q Consensus 395 ~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~ 437 (489)
..........+.+||.+||+.||.+||+.. +++.|+|+.
T Consensus 287 ~~~~~~~~~~l~~li~~~l~~dP~~R~~~~----~~l~~~l~~ 325 (681)
T 2pzi_A 287 DDPVLKTYDSYGRLLRRAIDPDPRQRFTTA----EEMSAQLTG 325 (681)
T ss_dssp TCHHHHHCHHHHHHHHHHTCSSGGGSCSSH----HHHHHHHHH
T ss_pred cccccccCHHHHHHHhhhccCChhhCCCHH----HHHHHHHHH
Confidence 112222334689999999999999999987 788887774
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=322.50 Aligned_cols=189 Identities=18% Similarity=0.076 Sum_probs=132.0
Q ss_pred eeccCCceeEEEEEEccCCCCCCCeeEEEEeeehH-------HHHHHHHHHHHHHHHHHHHhC-CCCCcccccceeecCc
Q 011302 91 RLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDRE-------ALAIRKKLHRADMEKVILTML-DHPFLPTLYAEFEASH 162 (489)
Q Consensus 91 ~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~-------~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~ 162 (489)
.++.|++|.+..++..- .++.||+|++.++ ........+++.+|+.+|+++ .|+||+++++++++++
T Consensus 241 ~~~~~~~~~h~~~rr~~-----fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~ 315 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYF-----FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQ 315 (569)
T ss_dssp C-C--------CCEEEE-----ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSS
T ss_pred ccccCCccccccccccc-----ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECC
Confidence 45667777666555443 4678899999653 122334566788999999999 6999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
.+|||||||+|++|.+++... +++++. .|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+...
T Consensus 316 ~~yLVMEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EEEEEEECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EEEEEEecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 999999999999999999875 566653 589999999999999999999999999999999999999999985332
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
..
T Consensus 391 ~~------------------------------------------------------------------------------ 392 (569)
T 4azs_A 391 QD------------------------------------------------------------------------------ 392 (569)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred CC------------------------------------------------------------------------------
Confidence 10
Q ss_pred ccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCC
Q 011302 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTP 368 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~P 368 (489)
.....+.+||+.|||||++.+. +..++|+||+|+++|+|+++..+
T Consensus 393 ~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 0123456899999999999875 66789999999999888766544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-30 Score=273.61 Aligned_cols=193 Identities=16% Similarity=0.122 Sum_probs=144.3
Q ss_pred eeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeeh-----HHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 88 LLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDR-----EALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 88 ~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~-----~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
..+.||+|+||+||+|... +..+++|.... .........+++.+|+.+|+.++||||+++..++...+
T Consensus 340 ~~~~LG~G~fg~Vy~~~~~-------~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 412 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSYL-------DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD 412 (540)
T ss_dssp --------CCEEEEEEECS-------SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT
T ss_pred CCCEEeeCCCEEEEEEEEC-------CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC
Confidence 3568999999999999544 35678887532 23333344567889999999999999996666666777
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
..|||||||+||+|.+++.. +..|+.||+.||+|||++|||||||||+|||++. .+||+|||+|+...
T Consensus 413 ~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 413 NKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp TTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred ccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 78999999999999988754 5688999999999999999999999999999998 99999999985543
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
...... ...
T Consensus 481 ~~~~~~-----------------------------------------------------------------------~~~ 489 (540)
T 3en9_A 481 LDEDKA-----------------------------------------------------------------------VDL 489 (540)
T ss_dssp CHHHHH-----------------------------------------------------------------------HHH
T ss_pred Cccccc-----------------------------------------------------------------------cch
Confidence 210000 000
Q ss_pred ccCCccccCCCCccCcchhcC--CCCCCcccHHHHHHHHHHHhhCCCCCC
Q 011302 323 NARSKSFVGTHEYLAPEVISG--QGHGSAVDWWTLGVFLYEMLYGTTPFK 370 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~--~~~~~~~DiwSlGvil~elltG~~Pf~ 370 (489)
.....+++||+.|||||++.+ ..|+..+|+|+...-..+.+.++.+|.
T Consensus 490 ~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 490 IVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred hhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 001235689999999999987 568888999999998888887777663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-27 Score=230.81 Aligned_cols=134 Identities=20% Similarity=0.174 Sum_probs=108.5
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHH---------------HHHHHHHHHHHHHHhCCCC
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIR---------------KKLHRADMEKVILTMLDHP 149 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~---------------~~~~~~~~E~~~l~~l~hp 149 (489)
.|.+.+.||+|+||.||+|++ . +++.||||+++....... .....+.+|+.+|+.++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~-----~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-- 162 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-E-----KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-- 162 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-T-----TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred EEEecCEeccCCCceEEEEEe-C-----CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence 344559999999999999998 4 478999999975432211 23456778999999999
Q ss_pred CcccccceeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCc
Q 011302 150 FLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGH 229 (489)
Q Consensus 150 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~ 229 (489)
| +++.+++.. +..|+||||++||+|.+ + .......++.||+.||.|||++|||||||||+|||++ +|.
T Consensus 163 ~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l--------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~ 230 (282)
T 1zar_A 163 G-LAVPKVYAW-EGNAVLMELIDAKELYR-V--------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEG 230 (282)
T ss_dssp T-SSSCCEEEE-ETTEEEEECCCCEEGGG-C--------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTE
T ss_pred C-CCcCeEEec-cceEEEEEecCCCcHHH-c--------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCc
Confidence 5 777776654 56699999999999976 3 1234667999999999999999999999999999999 999
Q ss_pred EEEcccCCC
Q 011302 230 IMLSDFDLS 238 (489)
Q Consensus 230 vkl~DFG~a 238 (489)
+||+|||+|
T Consensus 231 vkl~DFG~a 239 (282)
T 1zar_A 231 IWIIDFPQS 239 (282)
T ss_dssp EEECCCTTC
T ss_pred EEEEECCCC
Confidence 999999997
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.2e-22 Score=192.22 Aligned_cols=140 Identities=15% Similarity=0.110 Sum_probs=106.8
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCee--EEEEeeehHHHHH---------------------HHHHHHHHHHHH
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCF--YAMKVVDREALAI---------------------RKKLHRADMEKV 141 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~--~aiK~~~~~~~~~---------------------~~~~~~~~~E~~ 141 (489)
-|.+.+.||+|+||.||+|.+.. .++. ||||+++...... ......+.+|..
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~-----~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 122 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVF-----DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFR 122 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEE-----TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcC-----CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHH
Confidence 37889999999999999999854 3567 9999875432111 111235678999
Q ss_pred HHHhCCCCCc--ccccceeecCceEEEEEeecCC-C----chHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHH-hCCCe
Q 011302 142 ILTMLDHPFL--PTLYAEFEASHYSCLVMEYCPG-G----DLYAARQRQPGKRFGISSAKFYAAETLLALEYLH-MMGIV 213 (489)
Q Consensus 142 ~l~~l~hpnI--v~l~~~~~~~~~~~lV~E~~~g-g----~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH-~~~ii 213 (489)
+|..+.|++| +.+++. ...||||||+.+ | +|.++... +++..+..++.||+.||.||| ++|||
T Consensus 123 ~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~giv 193 (258)
T 1zth_A 123 NLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELV 193 (258)
T ss_dssp HHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEE
T ss_pred HHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEE
Confidence 9999988864 333332 356899999942 3 66655322 346678899999999999999 99999
Q ss_pred eecCCCCCeEeccCCcEEEcccCCCcc
Q 011302 214 YRDLKPENVLVREDGHIMLSDFDLSFK 240 (489)
Q Consensus 214 HrDIKp~NILl~~~~~vkl~DFG~a~~ 240 (489)
||||||+|||++. .++|+|||+|..
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred eCCCCHHHEEEcC--cEEEEECccccc
Confidence 9999999999998 999999999854
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.78 E-value=4.6e-19 Score=176.53 Aligned_cols=138 Identities=14% Similarity=0.154 Sum_probs=97.1
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHH------------------HHH-HHHHHHHHHHHHHHh
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREAL------------------AIR-KKLHRADMEKVILTM 145 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~------------------~~~-~~~~~~~~E~~~l~~ 145 (489)
-|.+.+.||.|+||.||+|.+.. ++.||||+++.... ... ...-....|...|.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~------G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~r 169 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEK------GKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKA 169 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTT------CCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEecCEeeeCCceEEEEEECCC------CCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence 38999999999999999998753 67899998753210 000 000112345555666
Q ss_pred CCCCCcccccceeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEec
Q 011302 146 LDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVR 225 (489)
Q Consensus 146 l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~ 225 (489)
+.+.++. ....+... ..+|||||++|++|.++ .....+..++.||+.+|.|||++|||||||||.||||+
T Consensus 170 L~~~gv~-vp~p~~~~-~~~LVME~i~G~~L~~l--------~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~ 239 (397)
T 4gyi_A 170 LYEEGFP-VPEPIAQS-RHTIVMSLVDALPMRQV--------SSVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIR 239 (397)
T ss_dssp HHHTTCS-CCCEEEEE-TTEEEEECCSCEEGGGC--------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE
T ss_pred HHhcCCC-CCeeeecc-CceEEEEecCCccHhhh--------cccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEe
Confidence 6444332 11111111 23799999999998543 22345677899999999999999999999999999999
Q ss_pred cCC----------cEEEcccCCC
Q 011302 226 EDG----------HIMLSDFDLS 238 (489)
Q Consensus 226 ~~~----------~vkl~DFG~a 238 (489)
.+| .+.|+||+-+
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~ 262 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQM 262 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTC
T ss_pred CCCCcccccccccceEEEEeCCc
Confidence 877 3899999976
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=2e-13 Score=129.97 Aligned_cols=139 Identities=15% Similarity=0.081 Sum_probs=110.9
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-CCCcccccceeecCc
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-HPFLPTLYAEFEASH 162 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~ 162 (489)
+.|++...+|.|+++.||++... +..|++|+...... .....+.+|..+|+.+. +..|.++++++.+.+
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~-------~~~~vlK~~~~~~~---~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~ 83 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE-------NENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDG 83 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS-------SCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred ccceeEeeccCCCCCeEEEEECC-------CCcEEEEeCCcccC---CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCC
Confidence 57999999999999999998743 35789999875311 11234667999999885 677889999999889
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHh---------------------------------
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHM--------------------------------- 209 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~--------------------------------- 209 (489)
..|+||||++|.+|.+.+ .+......++.+++.+|..||+
T Consensus 84 ~~~lv~e~i~G~~l~~~~-------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T 3tm0_A 84 WSNLLMSEADGVLCSEEY-------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEEEECCSSEEHHHHC-------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGG
T ss_pred ceEEEEEecCCeehhhcc-------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccc
Confidence 999999999999997652 1223445788999999999998
Q ss_pred --------------------------CCCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 210 --------------------------MGIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 210 --------------------------~~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 448999999999999876566799999873
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.36 E-value=1.3e-12 Score=123.88 Aligned_cols=135 Identities=14% Similarity=0.068 Sum_probs=99.4
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCC--cccccceeec
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPF--LPTLYAEFEA 160 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~~~~ 160 (489)
..+|.+....+.|..+.||++... .+..|++|+.... ....+..|..+++.+.+.+ |.+++++...
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~------~g~~~vlK~~~~~------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~ 86 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQ------GRPVLFVKTDLSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTE 86 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECT------TSCCEEEEEECSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC
T ss_pred cCCCceEecccCCCCceEEEEecC------CCCeEEEEeCCcc------cchhhhHHHHHHHHHHhCCCCCCeEEEeccC
Confidence 345666555456667999999653 2456899997643 1244667899998886444 5678888888
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCC-----------------------------
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMG----------------------------- 211 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~----------------------------- 211 (489)
++..|+||||++|.+|. .. .. ....++.+++..|..||+..
T Consensus 87 ~~~~~~v~e~i~G~~l~--~~-----~~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (264)
T 1nd4_A 87 AGRDWLLLGEVPGQDLL--SS-----HL---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQD 156 (264)
T ss_dssp SSCEEEEEECCSSEETT--TS-----CC---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTT
T ss_pred CCCCEEEEEecCCcccC--cC-----cC---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccch
Confidence 88899999999998883 11 11 12356777888888888643
Q ss_pred -----------------------------CeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 212 -----------------------------IVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 212 -----------------------------iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
++|+|++|.|||++.++.+.|+|||.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 157 DLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp SCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877667799999973
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.28 E-value=8e-12 Score=124.66 Aligned_cols=143 Identities=16% Similarity=0.206 Sum_probs=106.4
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeee--hHHHHHHHHHHHHHHHHHHHHhCC--CCCcccccceeec
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVD--REALAIRKKLHRADMEKVILTMLD--HPFLPTLYAEFEA 160 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~--~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~ 160 (489)
...-++.|+.|.++.||++...+ ..+++|+.. ..... .....+.+|..+++.+. +..|++++.++.+
T Consensus 39 ~~~~~~~l~~G~sn~~y~v~~~~-------~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~ 109 (359)
T 3dxp_A 39 GPLSVEQFKGGQSNPTFKLVTPG-------QTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCED 109 (359)
T ss_dssp CCCEEEECCC-CCSCEEEEECSS-------CEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECC
T ss_pred CCceEEEcCCcccceEEEEEECC-------ceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCC
Confidence 34457789999999999987543 467888876 43221 12346677999999987 4557888888876
Q ss_pred C---ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHh----------------------------
Q 011302 161 S---HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHM---------------------------- 209 (489)
Q Consensus 161 ~---~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~---------------------------- 209 (489)
. +..|+||||++|..+.+.. ...++..+...++.+++..|..||+
T Consensus 110 ~~~~g~~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (359)
T 3dxp_A 110 ESVIGRAFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQ 185 (359)
T ss_dssp TTTTSSCEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHH
T ss_pred CCccCCeEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHH
Confidence 6 4589999999998874311 1347788888999999999999997
Q ss_pred ------------------------------CCCeeecCCCCCeEeccCCc--EEEcccCCCcc
Q 011302 210 ------------------------------MGIVYRDLKPENVLVREDGH--IMLSDFDLSFK 240 (489)
Q Consensus 210 ------------------------------~~iiHrDIKp~NILl~~~~~--vkl~DFG~a~~ 240 (489)
..+||+|+++.|||++.++. +.|+||+.+..
T Consensus 186 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 186 YKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999997753 68999999843
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.12 E-value=1.2e-10 Score=113.41 Aligned_cols=132 Identities=16% Similarity=0.080 Sum_probs=96.9
Q ss_pred eeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-CCC--cccccceeecCc---
Q 011302 89 LRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-HPF--LPTLYAEFEASH--- 162 (489)
Q Consensus 89 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpn--Iv~l~~~~~~~~--- 162 (489)
++.++.|.+..||++. ..+++|+.... .....+.+|..+|+.+. +.. +.+++......+
T Consensus 25 i~~~~~G~~n~v~~v~----------~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~ 89 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----------RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQ 89 (304)
T ss_dssp CCEEEECSSEEEEEST----------TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCS
T ss_pred eEecCCCCcceEEEEC----------CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCC
Confidence 4568999999999863 24788987654 22345667999998873 333 445554443333
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHh---------------------------------
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHM--------------------------------- 209 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~--------------------------------- 209 (489)
..|+|||+++|..|.+.... .++..+...++.+++..|..||+
T Consensus 90 ~~~~vm~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (304)
T 3sg8_A 90 MSFAGFTKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSREL 165 (304)
T ss_dssp CSCEEEECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTS
T ss_pred cceEEEcccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccC
Confidence 34899999999998754332 36777788888888888888886
Q ss_pred -------------------------CCCeeecCCCCCeEecc--CCcEEEcccCCCc
Q 011302 210 -------------------------MGIVYRDLKPENVLVRE--DGHIMLSDFDLSF 239 (489)
Q Consensus 210 -------------------------~~iiHrDIKp~NILl~~--~~~vkl~DFG~a~ 239 (489)
..++|+|++|.|||++. ++.+.|+||+.+.
T Consensus 166 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~ 222 (304)
T 3sg8_A 166 KGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAA 222 (304)
T ss_dssp CHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCE
T ss_pred CcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCc
Confidence 13799999999999998 4567899999874
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.69 E-value=1.9e-07 Score=90.72 Aligned_cols=133 Identities=14% Similarity=0.092 Sum_probs=91.8
Q ss_pred eeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCC---Ccccccceee-cCce
Q 011302 88 LLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHP---FLPTLYAEFE-ASHY 163 (489)
Q Consensus 88 ~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp---nIv~l~~~~~-~~~~ 163 (489)
-++.++.|....||+. + ..+++|+.... .....+..|..+|+.+.+. .|.+.+.+.. ..+.
T Consensus 23 ~v~~l~~G~~n~v~~v---g-------~~~VlR~~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~ 87 (306)
T 3tdw_A 23 SVESLGEGFRNYAILV---N-------GDWVFRFPKSQ-----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGN 87 (306)
T ss_dssp CEEEEEECSSEEEEEE---T-------TTEEEEEESSH-----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSC
T ss_pred eeeecCCCcceeEEEE---C-------CEEEEEecCCc-----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCc
Confidence 3566889999999987 2 34788886543 2234567799999998752 2566666653 4556
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhC---------------------------------
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMM--------------------------------- 210 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~--------------------------------- 210 (489)
.|+||||++|..|....-. .++..+...++.++...|..||+.
T Consensus 88 ~~~v~e~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~ 163 (306)
T 3tdw_A 88 PFVGYRKVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPL 163 (306)
T ss_dssp EEEEEECCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGG
T ss_pred eEEEEeccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccc
Confidence 7899999999888653221 244445555555555555555532
Q ss_pred ---------------------------CCeeecCCCCCeEecc---CCc-EEEcccCCCc
Q 011302 211 ---------------------------GIVYRDLKPENVLVRE---DGH-IMLSDFDLSF 239 (489)
Q Consensus 211 ---------------------------~iiHrDIKp~NILl~~---~~~-vkl~DFG~a~ 239 (489)
.+||+|+++.|||++. ++. +.|+||+.+.
T Consensus 164 l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 164 LDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp SCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred cchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 3599999999999997 455 4899999874
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.65 E-value=5.7e-07 Score=85.36 Aligned_cols=132 Identities=18% Similarity=0.126 Sum_probs=91.9
Q ss_pred eeccCCce-eEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-CCCcccccceeecCceEEEEE
Q 011302 91 RLGSGDIG-NVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-HPFLPTLYAEFEASHYSCLVM 168 (489)
Q Consensus 91 ~lG~G~fg-~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lV~ 168 (489)
.+..|.-| .||+..... .+..+.+|+-.... ...+..|..+|+.+. +--|.++++++.+.+..|+||
T Consensus 31 ~~~~G~S~~~v~rl~~~~-----~~~~~~lk~~~~~~------~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvm 99 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKP-----NAPELFLKHGKGSV------ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLT 99 (272)
T ss_dssp EEECSSSSCEEEEEECCT-----TCCCEEEEEEETHH------HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred EccCCCcCCeEEEEEecC-----CCeEEEEEECCCCC------HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEE
Confidence 34445444 699877654 34568899877543 234556888888775 333778888889999999999
Q ss_pred eecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhC--------------------------------------
Q 011302 169 EYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMM-------------------------------------- 210 (489)
Q Consensus 169 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-------------------------------------- 210 (489)
|+++|.++.+..... ......+..++...|.-||..
T Consensus 100 e~l~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (272)
T 4gkh_A 100 TAIPGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNG 173 (272)
T ss_dssp ECCCSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTT
T ss_pred EeeCCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccc
Confidence 999998886654321 122334445555555555531
Q ss_pred --------------------CCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 211 --------------------GIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 211 --------------------~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
.++|+|+.+.|||++.++.+-|+||+.+.
T Consensus 174 ~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 174 WPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp CCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 17999999999999987777899999874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.34 E-value=7.9e-06 Score=80.02 Aligned_cols=30 Identities=23% Similarity=0.303 Sum_probs=27.4
Q ss_pred CCCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 210 MGIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 210 ~~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
..+||+|+.+.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888899999999873
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=1.9e-06 Score=86.66 Aligned_cols=81 Identities=17% Similarity=0.190 Sum_probs=49.5
Q ss_pred eeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHH-HHH---HHHHHHHHHHHHHHhCCC--CC-cccccceee
Q 011302 87 RLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREAL-AIR---KKLHRADMEKVILTMLDH--PF-LPTLYAEFE 159 (489)
Q Consensus 87 ~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~-~~~---~~~~~~~~E~~~l~~l~h--pn-Iv~l~~~~~ 159 (489)
.-++.||.|.++.||++.... .++.|++|....... ... ....++..|..+|+.+.. |. +.+++.+
T Consensus 33 ~~~~~lg~G~~n~vyrv~~~~-----~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~-- 105 (397)
T 2olc_A 33 LTCQEIGDGNLNYVFHIYDQE-----HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-- 105 (397)
T ss_dssp CEEEECCSSSSEEEEEEEC---------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--
T ss_pred eEEEECCCCceEEEEEEEECC-----CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--
Confidence 346789999999999997553 245789998653211 000 112445668888887742 33 4455543
Q ss_pred cCceEEEEEeecCCC
Q 011302 160 ASHYSCLVMEYCPGG 174 (489)
Q Consensus 160 ~~~~~~lV~E~~~gg 174 (489)
+.+..++||||++|.
T Consensus 106 d~~~~~lvmE~l~g~ 120 (397)
T 2olc_A 106 DTEMAVTVMEDLSHL 120 (397)
T ss_dssp ETTTTEEEECCCTTS
T ss_pred cCCccEEEEEeCCCc
Confidence 344568999999774
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=9.3e-07 Score=87.56 Aligned_cols=91 Identities=12% Similarity=0.029 Sum_probs=55.4
Q ss_pred ceeeeee-ccCCceeEEEEEEccCCCCC-CCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-C--CCcccccceeec
Q 011302 86 FRLLRRL-GSGDIGNVYLCQIRNPMVGL-PQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-H--PFLPTLYAEFEA 160 (489)
Q Consensus 86 y~~~~~l-G~G~fg~Vy~a~~~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--pnIv~l~~~~~~ 160 (489)
...++.| +.|....+|++.......+. .+..+++|+..............+..|..+|+.+. + -.|.+++.+..+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3456778 88989999998754000000 13567888865432000000134566888888774 2 346778877665
Q ss_pred C---ceEEEEEeecCCCch
Q 011302 161 S---HYSCLVMEYCPGGDL 176 (489)
Q Consensus 161 ~---~~~~lV~E~~~gg~L 176 (489)
. +..|+||||++|..|
T Consensus 102 ~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp STTTSSCEEEEECCCCBCC
T ss_pred CCccCCceEEEEecCCCCh
Confidence 5 356899999988654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.82 E-value=9.3e-05 Score=71.68 Aligned_cols=78 Identities=18% Similarity=0.164 Sum_probs=59.1
Q ss_pred ceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC---CCCcccccceeecCc
Q 011302 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD---HPFLPTLYAEFEASH 162 (489)
Q Consensus 86 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~ 162 (489)
..-++.|+.|.+..+|+.... +..|++|+..... ...+..|...|+.|. ...|++++.+....+
T Consensus 38 i~~~~~l~gG~~n~~y~v~~~-------~~~~vlK~~~~~~------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g 104 (312)
T 3jr1_A 38 IKHKEKLYSGEMNEIWLINDE-------VQTVFVKINERSY------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQG 104 (312)
T ss_dssp CCEEEEECCSSSSEEEEEESS-------SCEEEEEEEEGGG------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSS
T ss_pred eeeeEEeCCccceeeeEEEEC-------CCeEEEEeCCccc------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCC
Confidence 345678999999999998742 3567889886542 234566888888774 356888888888788
Q ss_pred eEEEEEeecCCCch
Q 011302 163 YSCLVMEYCPGGDL 176 (489)
Q Consensus 163 ~~~lV~E~~~gg~L 176 (489)
..|+||||++|..+
T Consensus 105 ~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 105 HSFLLLEALNKSKN 118 (312)
T ss_dssp EEEEEEECCCCCCC
T ss_pred ceEEEEEeccCCCC
Confidence 89999999998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.68 E-value=0.00032 Score=67.93 Aligned_cols=144 Identities=17% Similarity=0.144 Sum_probs=80.1
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCC--cccccce----
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPF--LPTLYAE---- 157 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~---- 157 (489)
+...-++.|+.|....||++...+ ..|++|+..... ....+..|..++..+...+ +.+++..
T Consensus 22 ~~~~~~~~i~~G~~n~~~~v~~~~-------g~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~ 89 (322)
T 2ppq_A 22 GSLTSYKGIAEGVENSNFLLHTTK-------DPLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGE 89 (322)
T ss_dssp CCEEEEEEECC---EEEEEEEESS-------CCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCC
T ss_pred CcceEeeccCCCcccceEEEEeCC-------ccEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCC
Confidence 344556778889889999987643 257899887531 1233445777776663211 3333321
Q ss_pred --eecCceEEEEEeecCCCchH--------------HHHHhC----CCCC---CC---hhhH--------HH----HHHH
Q 011302 158 --FEASHYSCLVMEYCPGGDLY--------------AARQRQ----PGKR---FG---ISSA--------KF----YAAE 199 (489)
Q Consensus 158 --~~~~~~~~lV~E~~~gg~L~--------------~~l~~~----~~~~---l~---~~~~--------~~----i~~q 199 (489)
....+..++||+|++|..+. ..++.. .... .. +... .. +...
T Consensus 90 ~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~ 169 (322)
T 2ppq_A 90 LLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREE 169 (322)
T ss_dssp SCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHH
T ss_pred EEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHH
Confidence 12345679999999886531 011111 0000 01 1000 00 0112
Q ss_pred HHHHHHHHHh-------CCCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 200 TLLALEYLHM-------MGIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 200 i~~~L~yLH~-------~~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
+...+++++. .++||+|+.+.|||++.++.+.|+||+.+.
T Consensus 170 l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 170 IRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 3445555552 369999999999999977666899999873
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.66 E-value=9.1e-05 Score=74.98 Aligned_cols=31 Identities=26% Similarity=0.442 Sum_probs=27.4
Q ss_pred HhCCCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 208 HMMGIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 208 H~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
+...++|+|++|.|||++.++ ++|+||+.+.
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~ 260 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSF 260 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccc
Confidence 356799999999999999777 9999999874
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00014 Score=70.01 Aligned_cols=74 Identities=9% Similarity=0.030 Sum_probs=44.9
Q ss_pred ceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCc-ccccceeecCceE
Q 011302 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFL-PTLYAEFEASHYS 164 (489)
Q Consensus 86 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~ 164 (489)
+.-++.|+.|....+|++ . .|.+|+...... .......|..+++.+..-++ .++++.. .+.-
T Consensus 20 ~~~i~~l~gG~tN~~~~~--~---------~~vlR~~~~~~~----~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~ 82 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA--G---------DLCLRIPGKGTE----EYINRANEAVAAREAAKAGVSPEVLHVD--PATG 82 (301)
T ss_dssp CCSCEEEESCSSEEEEEE--T---------TEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTC
T ss_pred ccceeEcCCcccccccee--e---------eEEEECCCCCcc----ceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCC
Confidence 333788999999999998 2 267888765321 11223447777776642222 4565543 3334
Q ss_pred EEEEeec-CCCch
Q 011302 165 CLVMEYC-PGGDL 176 (489)
Q Consensus 165 ~lV~E~~-~gg~L 176 (489)
++|+||+ +|.+|
T Consensus 83 ~~v~e~i~~g~~l 95 (301)
T 3dxq_A 83 VMVTRYIAGAQTM 95 (301)
T ss_dssp CEEEECCTTCEEC
T ss_pred EEEEeecCCCccC
Confidence 7899999 66555
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00044 Score=70.11 Aligned_cols=81 Identities=22% Similarity=0.297 Sum_probs=49.5
Q ss_pred eeeeeeccCCceeEEEEEEccCCCC--CCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-CCCcccccceeecCce
Q 011302 87 RLLRRLGSGDIGNVYLCQIRNPMVG--LPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-HPFLPTLYAEFEASHY 163 (489)
Q Consensus 87 ~~~~~lG~G~fg~Vy~a~~~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~ 163 (489)
.-++.|+.|....||++...+.... ..+..|.+|+...... ...+..|..+++.+. +...+++++.+.+
T Consensus 76 ~~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~-----~~~li~E~~~l~~L~~~g~~P~l~~~~~~--- 147 (429)
T 1nw1_A 76 LRISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET-----ESHLVAESVIFTLLSERHLGPKLYGIFSG--- 147 (429)
T ss_dssp EEEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC-----HHHHHHHHHHHHHHHHTTSSSCEEEEETT---
T ss_pred eEEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc-----HHHHHHHHHHHHHHHhCCCCCcEEEEeCC---
Confidence 3456788898899999986531110 1245788998843100 012234777787775 3334677776653
Q ss_pred EEEEEeecCCCch
Q 011302 164 SCLVMEYCPGGDL 176 (489)
Q Consensus 164 ~~lV~E~~~gg~L 176 (489)
.+||||++|..|
T Consensus 148 -g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 -GRLEEYIPSRPL 159 (429)
T ss_dssp -EEEECCCCEEEC
T ss_pred -CEEEEEeCCccc
Confidence 289999987443
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00028 Score=68.82 Aligned_cols=30 Identities=27% Similarity=0.349 Sum_probs=26.5
Q ss_pred CCCeeecCCCCCeEeccC----CcEEEcccCCCc
Q 011302 210 MGIVYRDLKPENVLVRED----GHIMLSDFDLSF 239 (489)
Q Consensus 210 ~~iiHrDIKp~NILl~~~----~~vkl~DFG~a~ 239 (489)
..+||+|+.+.|||++.+ +.+.|+||+.+.
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~ 216 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK 216 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence 469999999999999874 689999999874
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.36 E-value=0.0008 Score=66.89 Aligned_cols=148 Identities=17% Similarity=0.273 Sum_probs=84.4
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCC--CCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-CCCcccccceee
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMV--GLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-HPFLPTLYAEFE 159 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~ 159 (489)
.+.+. ++.|..|-...+|++....... ....+.|.+|+..... .....+.+|..+++.|. +.-..++++.+.
T Consensus 50 ~~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~----~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~ 124 (379)
T 3feg_A 50 PEELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL----QGVDSLVLESVMFAILAERSLGPQLYGVFP 124 (379)
T ss_dssp GGGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEET
T ss_pred cCceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc----chHHHHHHHHHHHHHHHhcCCCCeEEEEcC
Confidence 45555 4567778888999998643111 1124678888864321 11233446888888774 333467777665
Q ss_pred cCceEEEEEeecCCCchH--------------HH---HHhCC---CCCCC--hhhHHHHHHHHHH---------------
Q 011302 160 ASHYSCLVMEYCPGGDLY--------------AA---RQRQP---GKRFG--ISSAKFYAAETLL--------------- 202 (489)
Q Consensus 160 ~~~~~~lV~E~~~gg~L~--------------~~---l~~~~---~~~l~--~~~~~~i~~qi~~--------------- 202 (489)
++ +||||++|..|. +. ++... ++... +.++..++.++-.
T Consensus 125 ~g----~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~ 200 (379)
T 3feg_A 125 EG----RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMY 200 (379)
T ss_dssp TE----EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHT
T ss_pred Cc----cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhH
Confidence 42 999999886552 11 11111 11111 3445555544321
Q ss_pred ----HHHHHH----hC----CCeeecCCCCCeEeccC----CcEEEcccCCCc
Q 011302 203 ----ALEYLH----MM----GIVYRDLKPENVLVRED----GHIMLSDFDLSF 239 (489)
Q Consensus 203 ----~L~yLH----~~----~iiHrDIKp~NILl~~~----~~vkl~DFG~a~ 239 (489)
.++.|. .. .++|+|+.+.|||++.+ +.+.|+||..|.
T Consensus 201 ~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 201 SLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp THHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 233332 22 49999999999999876 789999999884
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00029 Score=67.29 Aligned_cols=80 Identities=14% Similarity=0.058 Sum_probs=53.9
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCC---Ccccccceeec
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHP---FLPTLYAEFEA 160 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp---nIv~l~~~~~~ 160 (489)
....-++.+|.|..+.||+++..+ ++.|.+|+...... .....+..|...|+.|.-- -+++++++.
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~D------G~~~~vK~~~~~~~---~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~-- 83 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELAD------GTPLFVKALPDDAP---ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD-- 83 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETT------SCEEEEEECCTTCC---CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--
T ss_pred CCeEEEEecCCCCCeEEEEEEECC------CCEEEEEEeCCCCc---chhhHHHHHHHHHHHHHhhCCCCcceEEecc--
Confidence 456778899999999999998764 56789998653321 1122355688888887421 245555432
Q ss_pred CceEEEEEeecCCCch
Q 011302 161 SHYSCLVMEYCPGGDL 176 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L 176 (489)
.-++||||++++..
T Consensus 84 --~~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 84 --DRTLAMEWVDERPP 97 (288)
T ss_dssp --TTEEEEECCCCCCC
T ss_pred --CceEEEEeecccCC
Confidence 23789999987654
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0012 Score=64.15 Aligned_cols=137 Identities=17% Similarity=0.083 Sum_probs=74.5
Q ss_pred eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCC--Ccccccce-----eecCc
Q 011302 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHP--FLPTLYAE-----FEASH 162 (489)
Q Consensus 90 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~l~~~-----~~~~~ 162 (489)
..|+ |....||++...+ ++.|++|+....... ...+..|..+++.+... .+++++.. ...++
T Consensus 32 ~~l~-g~~n~~y~v~~~~------g~~~vlK~~~~~~~~----~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g 100 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDED------RRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQG 100 (328)
T ss_dssp EEEC-CSSSEEEEECCTT------CCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETT
T ss_pred Eeec-CcccceEEEEcCC------CCEEEEEEcCCCCCC----HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECC
Confidence 4566 8888999876432 346889998632111 12334466666666321 24444443 22345
Q ss_pred eEEEEEeecCCCchH-----------HH---HHh----CCC---CCCChhhH----------------------HHHHHH
Q 011302 163 YSCLVMEYCPGGDLY-----------AA---RQR----QPG---KRFGISSA----------------------KFYAAE 199 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~-----------~~---l~~----~~~---~~l~~~~~----------------------~~i~~q 199 (489)
..++||||++|..+. .. ++. ... ..++.... ...+.+
T Consensus 101 ~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 180 (328)
T 1zyl_A 101 FYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDE 180 (328)
T ss_dssp EEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHH
T ss_pred EEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHH
Confidence 678999999875431 01 111 000 01111110 011112
Q ss_pred HHHHHHHH----HhCCCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 200 TLLALEYL----HMMGIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 200 i~~~L~yL----H~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
++..++-+ ....+||+|+++.|||++ + .+.|+||+.+.
T Consensus 181 ~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 181 LIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp HHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred HHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 22222222 124589999999999999 5 89999998873
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.13 E-value=0.00055 Score=67.82 Aligned_cols=81 Identities=12% Similarity=0.155 Sum_probs=44.9
Q ss_pred eeeeeccCCceeEEEEEEccCC---CCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCC-cccccceeecCce
Q 011302 88 LLRRLGSGDIGNVYLCQIRNPM---VGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPF-LPTLYAEFEASHY 163 (489)
Q Consensus 88 ~~~~lG~G~fg~Vy~a~~~~~~---~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~~ 163 (489)
-++.|+.|....||++...+.. .......|.+|+...... .......|..+++.+...+ +.++++.+.
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~~~~E~~~l~~L~~~g~~P~~~~~~~---- 108 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD----ELYNTISEFEVYKTMSKYKIAPQLLNTFN---- 108 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG----GTSCHHHHHHHHHHHHHTTSSCCEEEEET----
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc----ceecHHHHHHHHHHHHhcCCCCceEEecC----
Confidence 3567888888899999865310 000125678888754311 1112345777887775323 456665442
Q ss_pred EEEEEeecCCCch
Q 011302 164 SCLVMEYCPGGDL 176 (489)
Q Consensus 164 ~~lV~E~~~gg~L 176 (489)
-++||||++|..|
T Consensus 109 ~~~v~e~i~G~~l 121 (369)
T 3c5i_A 109 GGRIEEWLYGDPL 121 (369)
T ss_dssp TEEEEECCCSEEC
T ss_pred CcEEEEEecCCcC
Confidence 2689999987543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0028 Score=64.66 Aligned_cols=76 Identities=16% Similarity=0.208 Sum_probs=47.8
Q ss_pred eeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCc-ccccceeecCceEEE
Q 011302 88 LLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFL-PTLYAEFEASHYSCL 166 (489)
Q Consensus 88 ~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~l 166 (489)
-++.|+.|-...+|++...+ .+..|.+|+..... ...-....|..+++.|...++ .++++.+.. .+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~-----~~~~~vLRi~g~~~----~~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~ 178 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMS-----KQAKYLIRLYGPKT----DEIINREREKKISCILYNKNIAKKIYVFFTN----GR 178 (458)
T ss_dssp EEEEECC--CEEEEEEEETT-----TTEEEEEEEECC-C----CSCSCHHHHHHHHHHHTTSSSBCCEEEEETT----EE
T ss_pred EEEEcCCCeEeEEEEEEECC-----CCceEEEEECCCCh----hhhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eE
Confidence 45678888889999998653 23667888875421 011112458888888864444 677777642 25
Q ss_pred EEeecCCCch
Q 011302 167 VMEYCPGGDL 176 (489)
Q Consensus 167 V~E~~~gg~L 176 (489)
||||++|..|
T Consensus 179 v~e~I~G~~l 188 (458)
T 2qg7_A 179 IEEFMDGYAL 188 (458)
T ss_dssp EEECCCSEEC
T ss_pred EEEeeCCccC
Confidence 9999987544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0017 Score=63.46 Aligned_cols=30 Identities=27% Similarity=0.420 Sum_probs=26.9
Q ss_pred CCCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 210 MGIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 210 ~~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
..++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPM 235 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence 359999999999999988899999998874
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0045 Score=55.81 Aligned_cols=60 Identities=13% Similarity=-0.039 Sum_probs=44.7
Q ss_pred CchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHh-CCCeeecCCCCCeEeccCCcEEEcc
Q 011302 174 GDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHM-MGIVYRDLKPENVLVREDGHIMLSD 234 (489)
Q Consensus 174 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiHrDIKp~NILl~~~~~vkl~D 234 (489)
-+|.++|+.. +.++++++++.++.|.+.+|.-+-. ..-..+=+-|..|+|..+|.|.+.+
T Consensus 33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~ 93 (229)
T 2yle_A 33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP 93 (229)
T ss_dssp EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC
T ss_pred ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc
Confidence 4788888765 4789999999999999999877621 1212333446889999999988764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.25 E-value=0.0059 Score=61.52 Aligned_cols=81 Identities=17% Similarity=0.294 Sum_probs=48.5
Q ss_pred eeeeeccCCceeEEEEEEccCCC--CCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-CCCcccccceeecCceE
Q 011302 88 LLRRLGSGDIGNVYLCQIRNPMV--GLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-HPFLPTLYAEFEASHYS 164 (489)
Q Consensus 88 ~~~~lG~G~fg~Vy~a~~~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~ 164 (489)
-++.|..|-...+|++....... ......|.+++..... .......+|..+++.+. +.-..++++.+. -
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t----~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~ 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV----GKFYDSKVELDVFRYLSNINIAPNIIADFP----E 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----T
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc----chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----C
Confidence 45677778888999998753111 0114678888865321 11122345888887774 333556665443 2
Q ss_pred EEEEeecCCCch
Q 011302 165 CLVMEYCPGGDL 176 (489)
Q Consensus 165 ~lV~E~~~gg~L 176 (489)
++||||++|..|
T Consensus 146 ~~I~efI~G~~l 157 (424)
T 3mes_A 146 GRIEEFIDGEPL 157 (424)
T ss_dssp EEEEECCCSEEC
T ss_pred CEEEEEeCCccC
Confidence 689999998664
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.44 E-value=0.11 Score=51.72 Aligned_cols=28 Identities=32% Similarity=0.498 Sum_probs=24.6
Q ss_pred CeeecCCCCCeEe------ccCCcEEEcccCCCc
Q 011302 212 IVYRDLKPENVLV------REDGHIMLSDFDLSF 239 (489)
Q Consensus 212 iiHrDIKp~NILl------~~~~~vkl~DFG~a~ 239 (489)
++|.|+.+.|||+ ++++.+.++||..|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 6899999999999 456789999999984
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=87.20 E-value=0.058 Score=54.95 Aligned_cols=64 Identities=6% Similarity=-0.018 Sum_probs=17.4
Q ss_pred eeeeeeccCCceeEEEEEEccCCCCCCCeeEEE------EeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 011302 87 RLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAM------KVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE 159 (489)
Q Consensus 87 ~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~ai------K~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 159 (489)
.+.+.|| ||+||+|.++.. ...||+ |..+..... ++....+.+|..+++.++|||+++.+++..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~-----~~~Vav~~~~~~K~~~~~~~~-~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKK-----HMPVLKETHDERDSTGQDGVS-EKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC--------------CCBGGGC------------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhccccccc-----CCchhhhhccCcccccccccc-ccccccccccccccccccccccCCCcceEE
Confidence 4556676 999999998752 345677 655443322 234456677888898999999999988553
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=83.12 E-value=2 Score=38.49 Aligned_cols=83 Identities=13% Similarity=0.043 Sum_probs=59.4
Q ss_pred CCCCCcccccceeecCceEEEEEeecCC-CchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEe
Q 011302 146 LDHPFLPTLYAEFEASHYSCLVMEYCPG-GDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLV 224 (489)
Q Consensus 146 l~hpnIv~l~~~~~~~~~~~lV~E~~~g-g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl 224 (489)
..||+.+.. .+-++++.+.+.++.-+. -++.. + ..++..+...++.+|+....+++. =+|-=|.|+||++
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i-----k~~~~~eKlr~l~ni~~l~~~~~~--r~tf~L~P~NL~f 112 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I-----KSFTKNEKLRYLLNIKNLEEVNRT--RYTFVLAPDELFF 112 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G-----GGSCHHHHHHHHHHGGGGGGGGGS--SEECCCSGGGEEE
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H-----HhcCHHHHHHHHHHHHHHHHHhcC--ceEEEEecceEEE
Confidence 468888866 455666776666665432 23322 2 347788888889888887754443 4777899999999
Q ss_pred ccCCcEEEcccCC
Q 011302 225 REDGHIMLSDFDL 237 (489)
Q Consensus 225 ~~~~~vkl~DFG~ 237 (489)
+.++.++|.--|+
T Consensus 113 ~~~~~p~i~~RGi 125 (215)
T 4ann_A 113 TRDGLPIAKTRGL 125 (215)
T ss_dssp CTTSCEEESCCEE
T ss_pred cCCCCEEEEEccC
Confidence 9999999998886
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=80.42 E-value=3 Score=37.41 Aligned_cols=84 Identities=11% Similarity=-0.031 Sum_probs=58.6
Q ss_pred CCCCCcccccceeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHH-HHHhCCCeeecCCCCCeEe
Q 011302 146 LDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALE-YLHMMGIVYRDLKPENVLV 224 (489)
Q Consensus 146 l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~-yLH~~~iiHrDIKp~NILl 224 (489)
..||++ -..+-.+++.+.+.++.-+++.=+..++ .++..+...++.+|+.... ++ ..-+|-=|.|+||++
T Consensus 47 ~~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-----~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f 117 (219)
T 4ano_A 47 EVDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-----KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMF 117 (219)
T ss_dssp GSCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-----TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEE
T ss_pred ccCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-----hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEE
Confidence 357777 2233366677777777654443334443 3778888888887776555 44 345777889999999
Q ss_pred ccCCcEEEcccCCC
Q 011302 225 REDGHIMLSDFDLS 238 (489)
Q Consensus 225 ~~~~~vkl~DFG~a 238 (489)
+.++.++|.-.|+-
T Consensus 118 ~~~~~p~i~hRGi~ 131 (219)
T 4ano_A 118 NRALEPFFLHVGVK 131 (219)
T ss_dssp CTTCCEEESCCEET
T ss_pred eCCCcEEEEEcCCc
Confidence 99999999999985
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 489 | ||||
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-36 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 9e-21 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-35 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-34 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-35 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-25 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-34 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-25 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-34 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-19 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-33 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-24 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-33 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-20 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 8e-33 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-21 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-33 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-18 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-32 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-26 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-32 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-26 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-32 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-31 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-32 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-21 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-31 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-31 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-31 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-19 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-31 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-30 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-23 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-30 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-29 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-30 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-26 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-30 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-11 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-30 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-16 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-30 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-14 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-30 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-13 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-29 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-13 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-29 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-21 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-29 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-13 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-29 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-25 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-28 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-10 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-28 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-14 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-28 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-23 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-28 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-12 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-28 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-27 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-11 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-27 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-26 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-27 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-27 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-13 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-27 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-18 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-27 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-18 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-27 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-13 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-26 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-12 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-26 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-23 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-26 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-25 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-25 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-12 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-25 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-15 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-24 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-12 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-24 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-18 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-24 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-12 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-24 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-15 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-24 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-10 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-24 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-18 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-24 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-20 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-24 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-18 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-23 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-12 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-23 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-14 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-23 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-19 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-22 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-17 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-22 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-14 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-22 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-09 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-22 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-13 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-20 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-12 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-18 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-13 |
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 3e-36
Identities = 48/155 (30%), Positives = 73/155 (47%), Gaps = 9/155 (5%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
D + ++ LG G G VY Q + A KV+D ++ ++L +E IL
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKET-----SVLAAAKVIDTKS---EEELEDYMVEIDIL 63
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLA 203
DHP + L F + +++E+C GG + A + S + +TL A
Sbjct: 64 ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDA 122
Query: 204 LEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
L YLH I++RDLK N+L DG I L+DF +S
Sbjct: 123 LNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVS 157
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.0 bits (223), Expect = 9e-21
Identities = 33/130 (25%), Positives = 51/130 (39%), Gaps = 15/130 (11%)
Query: 323 NARSKSFVGTHEYLAPEVI-----SGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKT 377
R SF+GT ++APEV+ + + D W+LG+ L EM P N +
Sbjct: 164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV 223
Query: 378 LINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437
L+ I K S F +D + K L KN R + ++ +H F
Sbjct: 224 LLKIAKSEPPTLAQPSRWSSNF------KDFLKKCLEKNVDARW----TTSQLLQHPFVT 273
Query: 438 GINWALIRSI 447
+ IR +
Sbjct: 274 VDSNKPIREL 283
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 4e-35
Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 7/159 (4%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
+ F+ + LG G V L + YA+K++++ + K+ E+ ++
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELAT-----SREYAIKILEKRHIIKENKVPYVTRERDVM 62
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLA 203
+ LDHPF LY F+ + Y G+L + + F + +FY AE + A
Sbjct: 63 SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELL--KYIRKIGSFDETCTRFYTAEIVSA 120
Query: 204 LEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242
LEYLH GI++RDLKPEN+L+ ED HI ++DF +
Sbjct: 121 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 159
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 2e-34
Identities = 41/133 (30%), Positives = 68/133 (51%), Gaps = 11/133 (8%)
Query: 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINIL 382
AR+ SFVGT +Y++PE+++ + + D W LG +Y+++ G PF+ N I+
Sbjct: 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII 223
Query: 383 KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGS--LKGSVEIKRHEFFKGIN 440
K FP K +DL+ KLLV + KR+G ++G +K H FF+ +
Sbjct: 224 KLEYDFPE-KFFP--------KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 274
Query: 441 WALIRSIKPPEVP 453
W + PP++
Sbjct: 275 WENLHQQTPPKLT 287
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 5e-35
Identities = 49/160 (30%), Positives = 75/160 (46%), Gaps = 7/160 (4%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVI 142
L+ F + R LG G GNVYL + + + A+KV+ + L H+ E I
Sbjct: 5 LEDFEIGRPLGKGKFGNVYLAREKQS-----KFILALKVLFKAQLEKAGVEHQLRREVEI 59
Query: 143 LTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLL 202
+ L HP + LY F + L++EY P G +Y Q+ +F Y E
Sbjct: 60 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELAN 117
Query: 203 ALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242
AL Y H +++RD+KPEN+L+ G + ++DF S
Sbjct: 118 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 157
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 5e-25
Identities = 40/134 (29%), Positives = 59/134 (44%), Gaps = 13/134 (9%)
Query: 305 DHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY 364
+ + D ++R + GT +YL PE+I G+ H VD W+LGV YE L
Sbjct: 140 GSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV 199
Query: 365 GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424
G PF+ ++T I + TFP V+ +DLIS+LL NP +R
Sbjct: 200 GKPPFEANTYQETYKRISRVEFTFPDF-VTEG--------ARDLISRLLKHNPSQRP--- 247
Query: 425 KGSVEIKRHEFFKG 438
E+ H +
Sbjct: 248 -MLREVLEHPWITA 260
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 129 bits (324), Expect = 5e-34
Identities = 40/162 (24%), Positives = 71/162 (43%), Gaps = 11/162 (6%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVI 142
LDH+ + LG+G G V+ R +A K V + ++ + + E
Sbjct: 25 LDHYDIHEELGTGAFGVVHRVTERAT-----GNNFAAKFVMTPHESDKETVRK---EIQT 76
Query: 143 LTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLL 202
+++L HP L L+ FE + ++ E+ GG+L+ + + A Y +
Sbjct: 77 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCK 135
Query: 203 ALEYLHMMGIVYRDLKPENVLV--REDGHIMLSDFDLSFKCD 242
L ++H V+ DLKPEN++ + + L DF L+ D
Sbjct: 136 GLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 103 bits (258), Expect = 6e-25
Identities = 43/163 (26%), Positives = 63/163 (38%), Gaps = 12/163 (7%)
Query: 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK 384
K GT E+ APEV G+ G D W++GV Y +L G +PF GEN+++TL N+
Sbjct: 181 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC 240
Query: 385 PLTFPRIGVSS-SKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINW-A 442
S S++ +D I KLL+ +P R+ + H + N
Sbjct: 241 DWNMDDSAFSGISEDG------KDFIRKLLLADPNTRM----TIHQALEHPWLTPGNAPG 290
Query: 443 LIRSIKPPEVPNNDLYCKIKKKVYVPKLSKQERDAPYQIPTHH 485
I K K + L R + Y H
Sbjct: 291 RDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKH 333
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 127 bits (321), Expect = 6e-34
Identities = 40/155 (25%), Positives = 56/155 (36%), Gaps = 7/155 (4%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
F LR +G G G VY + A+K + +K E L
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRN-----SEVVAIKKMSYSGKQSNEKWQDIIKEVRFL 69
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLA 203
L HP + H + LVMEYC G + K L
Sbjct: 70 QKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQG 127
Query: 204 LEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
L YLH +++RD+K N+L+ E G + L DF +
Sbjct: 128 LAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA 162
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 86.6 bits (214), Expect = 2e-19
Identities = 32/119 (26%), Positives = 47/119 (39%), Gaps = 14/119 (11%)
Query: 322 INARSKSFVGTHEYLAPEVISGQGHG---SAVDWWTLGVFLYEMLYGTTPFKGENNEKTL 378
I A + SFVGT ++APEVI G VD W+LG+ E+ P N L
Sbjct: 164 IMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223
Query: 379 INILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437
+I + + G S ++ + L K P+ R S + +H F
Sbjct: 224 YHIAQNESPALQSGHWSE-------YFRNFVDSCLQKIPQDRP----TSEVLLKHRFVL 271
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 128 bits (322), Expect = 1e-33
Identities = 39/162 (24%), Positives = 72/162 (44%), Gaps = 11/162 (6%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVI 142
D++ +L LGSG G V+ C + + K ++ + + E I
Sbjct: 28 YDYYDILEELGSGAFGVVHRCVEKAT-----GRVFVAKFINTPYPLDKYTVKN---EISI 79
Query: 143 LTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLL 202
+ L HP L L+ FE + L++E+ GG+L+ R + + Y +
Sbjct: 80 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELF-DRIAAEDYKMSEAEVINYMRQACE 138
Query: 203 ALEYLHMMGIVYRDLKPENVLVR--EDGHIMLSDFDLSFKCD 242
L+++H IV+ D+KPEN++ + + + DF L+ K +
Sbjct: 139 GLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 102 bits (255), Expect = 1e-24
Identities = 45/143 (31%), Positives = 66/143 (46%), Gaps = 13/143 (9%)
Query: 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINIL 382
+ K T E+ APE++ + G D W +GV Y +L G +PF GE++ +TL N+
Sbjct: 182 DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK 241
Query: 383 KKPLTFPRIGVSS-SKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINW 441
+ F SS S E +D I LL K P+KR+ + H + KG +
Sbjct: 242 RCDWEFDEDAFSSVSPE------AKDFIKNLLQKEPRKRL----TVHDALEHPWLKGDHS 291
Query: 442 ALIRSIKPPEVPNNDLYCKIKKK 464
L I P N + KIK+K
Sbjct: 292 NLTSRI--PSSRYNKIRQKIKEK 312
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 1e-33
Identities = 38/156 (24%), Positives = 63/156 (40%), Gaps = 10/156 (6%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
D F + LG+G+ G V+ + A K++ E ++ E +L
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPS-----GLVMARKLIHLEI--KPAIRNQIIRELQVL 58
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLA 203
+ P++ Y F + + ME+ GG L ++ R + +
Sbjct: 59 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKG 116
Query: 204 LEYLH-MMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
L YL I++RD+KP N+LV G I L DF +S
Sbjct: 117 LTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 152
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.6 bits (219), Expect = 4e-20
Identities = 28/154 (18%), Positives = 52/154 (33%), Gaps = 39/154 (25%)
Query: 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINIL 382
++ + SFVGT Y++PE + G + D W++G+ L EM G P + ++ +
Sbjct: 157 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFG 216
Query: 383 KKPLTFPRIGVSSSKEFEEVVK-----------------------------------LQD 407
+ + + QD
Sbjct: 217 CQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQD 276
Query: 408 LISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINW 441
++K L+KNP +R ++ H F K +
Sbjct: 277 FVNKCLIKNPAERADLK----QLMVHAFIKRSDA 306
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 8e-33
Identities = 43/160 (26%), Positives = 73/160 (45%), Gaps = 9/160 (5%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVI 142
++ + L++ LG G G V L R + A+K+VD + E I
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVT-----EEAVAVKIVDMKR--AVDCPENIKKEICI 56
Query: 143 LTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLL 202
ML+H + Y + L +EYC GG+L+ + A+ + + +
Sbjct: 57 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMA 114
Query: 203 ALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242
+ YLH +GI +RD+KPEN+L+ E ++ +SDF L+
Sbjct: 115 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR 154
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.0 bits (228), Expect = 1e-21
Identities = 28/114 (24%), Positives = 47/114 (41%), Gaps = 11/114 (9%)
Query: 325 RSKSFVGTHEYLAPEVISGQG-HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILK 383
GT Y+APE++ + H VD W+ G+ L ML G P+ ++ + K
Sbjct: 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK 220
Query: 384 KPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437
+ T+ L+ K+LV+NP RI +IK+ ++
Sbjct: 221 EKKTYLNPWKKIDSA------PLALLHKILVENPSARI----TIPDIKKDRWYN 264
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 9e-33
Identities = 37/155 (23%), Positives = 65/155 (41%), Gaps = 11/155 (7%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
+ +R+GSG G VY + A+K+++ A ++L E +L
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD--------VAVKMLNVTAPT-PQQLQAFKNEVGVL 58
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLA 203
H + + + +V ++C G LY K F + A +T
Sbjct: 59 RKTRHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQG 116
Query: 204 LEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
++YLH I++RDLK N+ + ED + + DF L+
Sbjct: 117 MDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA 151
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.7 bits (204), Expect = 3e-18
Identities = 23/102 (22%), Positives = 46/102 (45%), Gaps = 6/102 (5%)
Query: 323 NARSKSFVGTHEYLAPEVISGQGHG---SAVDWWTLGVFLYEMLYGTTPFKGENNEKTLI 379
+ + + G+ ++APEVI Q D + G+ LYE++ G P+ NN +I
Sbjct: 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII 219
Query: 380 NILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRI 421
++ + P + S + ++ L+++ L K +R
Sbjct: 220 FMVGRGYLSPDLSKVRSNCPKA---MKRLMAECLKKKRDERP 258
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 125 bits (314), Expect = 2e-32
Identities = 49/159 (30%), Positives = 86/159 (54%), Gaps = 10/159 (6%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVI 142
++ F + R +G G G VY C+ + YAMK +D++ + +++ A E+++
Sbjct: 3 MNDFSVHRIIGRGGFGEVYGCRKADT-----GKMYAMKCLDKKRIKMKQGETLALNERIM 57
Query: 143 LTML---DHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAE 199
L+++ D PF+ + F +++ GGDL+ + F + +FYAAE
Sbjct: 58 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAE 115
Query: 200 TLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+L LE++H +VYRDLKP N+L+ E GH+ +SD L+
Sbjct: 116 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 154
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 106 bits (266), Expect = 5e-26
Identities = 41/156 (26%), Positives = 73/156 (46%), Gaps = 10/156 (6%)
Query: 305 DHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVI-SGQGHGSAVDWWTLGVFLYEML 363
D H + D + + + + VGTH Y+APEV+ G + S+ DW++LG L+++L
Sbjct: 141 DEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 200
Query: 364 YGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGS 423
G +PF+ + + S S E L+ L+ LL ++ +R+G
Sbjct: 201 RGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE------LRSLLEGLLQRDVNRRLGC 254
Query: 424 LKGSV-EIKRHEFFKGINWALI--RSIKPPEVPNND 456
L E+K FF+ ++W ++ + PP +P
Sbjct: 255 LGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRG 290
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 124 bits (312), Expect = 2e-32
Identities = 64/194 (32%), Positives = 104/194 (53%), Gaps = 7/194 (3%)
Query: 45 SSSAADQTSLYNSHKPHKANQAAWEAMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQ 104
+++AA + S S K A K +Q LD F ++ LG+G G V L +
Sbjct: 2 NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61
Query: 105 IRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYS 164
+ YAMK++D++ + K++ EK IL ++ PFL L F+ +
Sbjct: 62 HKES-----GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116
Query: 165 CLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLV 224
+VMEY GG++++ +R RF A+FYAA+ +L EYLH + ++YRDLKPEN+L+
Sbjct: 117 YMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI 174
Query: 225 REDGHIMLSDFDLS 238
+ G+I ++DF +
Sbjct: 175 DQQGYIQVTDFGFA 188
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 107 bits (267), Expect = 3e-26
Identities = 50/140 (35%), Positives = 73/140 (52%), Gaps = 12/140 (8%)
Query: 318 VAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKT 377
A+ + R+ + GT E LAPE+I +G+ AVDWW LGV +YEM G PF + +
Sbjct: 187 FAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 378 LINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSV-EIKRHEFF 436
I+ + FP SS L+DL+ LL + KR G+LK V +IK H++F
Sbjct: 247 YEKIVSGKVRFPS-HFSSD--------LKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297
Query: 437 KGINWALI--RSIKPPEVPN 454
+W I R ++ P +P
Sbjct: 298 ATTDWIAIYQRKVEAPFIPK 317
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 122 bits (307), Expect = 5e-32
Identities = 60/156 (38%), Positives = 99/156 (63%), Gaps = 7/156 (4%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVI 142
L F++LR LG+G G V+L + R+ +YAMKV+ +E + K++ + E+++
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIRSRHN-----GRYYAMKVLKKEIVVRLKQVEHTNDERLM 57
Query: 143 LTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLL 202
L+++ HPF+ ++ F+ + ++M+Y GG+L+ + +RF AKFYAAE L
Sbjct: 58 LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELF--SLLRKSQRFPNPVAKFYAAEVCL 115
Query: 203 ALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
ALEYLH I+YRDLKPEN+L+ ++GHI ++DF +
Sbjct: 116 ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFA 151
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 119 bits (300), Expect = 6e-31
Identities = 51/174 (29%), Positives = 87/174 (50%), Gaps = 33/174 (18%)
Query: 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTL 378
A+ + + + GT +Y+APEV+S + + ++DWW+ G+ +YEML G TPF N KT
Sbjct: 151 AKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY 210
Query: 379 INILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSV-EIKRHEFFK 437
IL L FP + ++DL+S+L+ ++ +R+G+L+ ++K H +FK
Sbjct: 211 EKILNAELRFPP-FFNED--------VKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 261
Query: 438 GINWA--LIRSIKPPEVPNNDLYCKIKKKVYVPKLSKQERDAPYQIPTHHFDYF 489
+ W L R+I+ P Y P + + + D T FD +
Sbjct: 262 EVVWEKLLSRNIETP---------------YEPPIQQGQGD------TSQFDKY 294
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 121 bits (305), Expect = 5e-32
Identities = 40/166 (24%), Positives = 69/166 (41%), Gaps = 14/166 (8%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALA------IRKKLHRAD 137
+++ LG G V C + YA+K++D +++
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPT-----CKEYAVKIIDVTGGGSFSAEEVQELREATL 57
Query: 138 MEKVILTML-DHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFY 196
E IL + HP + L +E + + LV + G+L+ + +
Sbjct: 58 KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKI 115
Query: 197 AAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242
L + LH + IV+RDLKPEN+L+ +D +I L+DF S + D
Sbjct: 116 MRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 92.4 bits (229), Expect = 1e-21
Identities = 39/134 (29%), Positives = 58/134 (43%), Gaps = 17/134 (12%)
Query: 311 LLDDPEVVAEPINARSKSFVGTHEYLAPEVISG------QGHGSAVDWWTLGVFLYEMLY 364
L D + + GT YLAPE+I G+G VD W+ GV +Y +L
Sbjct: 151 LTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 210
Query: 365 GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVK-LQDLISKLLVKNPKKRIGS 423
G+ PF L I+ F S E+++ ++DL+S+ LV P+KR
Sbjct: 211 GSPPFWHRKQMLMLRMIMSGNYQFG------SPEWDDYSDTVKDLVSRFLVVQPQKRY-- 262
Query: 424 LKGSVEIKRHEFFK 437
+ E H FF+
Sbjct: 263 --TAEEALAHPFFQ 274
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 2e-31
Identities = 48/137 (35%), Positives = 77/137 (56%), Gaps = 14/137 (10%)
Query: 320 EPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLI 379
+A++ +F GT +Y+APE++ GQ + +VDWW+ GV LYEML G +PF G++ E+
Sbjct: 154 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 213
Query: 380 NILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439
+I +PR + +DL+ KL V+ P+KR+G +I++H F+ I
Sbjct: 214 SIRMDNPFYPR-WLEKE--------AKDLLVKLFVREPEKRLGVRG---DIRQHPLFREI 261
Query: 440 NWALI--RSIKPPEVPN 454
NW + + I PP P
Sbjct: 262 NWEELERKEIDPPFRPK 278
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (303), Expect = 2e-31
Identities = 56/157 (35%), Positives = 90/157 (57%), Gaps = 8/157 (5%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVI 142
++ F L + LG G G V+L + + F+A+K + ++ + + + +EK +
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKT-----NQFFAIKALKKDVVLMDDDVECTMVEKRV 55
Query: 143 LTM-LDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETL 201
L++ +HPFL ++ F+ VMEY GGDL Q +F +S A FYAAE +
Sbjct: 56 LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEII 113
Query: 202 LALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
L L++LH GIVYRDLK +N+L+ +DGHI ++DF +
Sbjct: 114 LGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC 150
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (298), Expect = 5e-31
Identities = 36/164 (21%), Positives = 64/164 (39%), Gaps = 15/164 (9%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
+ + +L +G+G G + ++ K +D ++ + E +L
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSD-----GKILVWKELDYGSM-TEAEKQMLVSEVNLL 57
Query: 144 TMLDHPFLPTLYAEF--EASHYSCLVMEYCPGGDL--YAARQRQPGKRFGISSAKFYAAE 199
L HP + Y + +VMEYC GGDL + + + +
Sbjct: 58 RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 117
Query: 200 TLLALEYLHMMG-----IVYRDLKPENVLVREDGHIMLSDFDLS 238
LAL+ H +++RDLKP NV + ++ L DF L+
Sbjct: 118 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.6 bits (214), Expect = 1e-19
Identities = 25/116 (21%), Positives = 45/116 (38%), Gaps = 12/116 (10%)
Query: 320 EPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLI 379
+ +K+FVGT Y++PE ++ + D W+LG LYE+ PF + ++
Sbjct: 165 NHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG 224
Query: 380 NILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEF 435
I + S L ++I+++L R EI +
Sbjct: 225 KIREGKFRRIPYRYSDE--------LNEIITRMLNLKDYHRP----SVEEILENPL 268
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 119 bits (300), Expect = 6e-31
Identities = 66/362 (18%), Positives = 115/362 (31%), Gaps = 73/362 (20%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
D ++L+R+LG G V+ +K++ K + E IL
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITN-----NEKVVVKILKPV------KKKKIKREIKIL 83
Query: 144 TML-DHPFLPTLYAEFE--ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAET 200
L P + TL + S LV E+ D +Q + +FY E
Sbjct: 84 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF-----KQLYQTLTDYDIRFYMYEI 138
Query: 201 LLALEYLHMMGIVYRDLKPENVLV-REDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEK 259
L AL+Y H MGI++RD+KP NV++ E + L D+ L+ + E
Sbjct: 139 LKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA------------EFYHPGQEY 186
Query: 260 YEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319
+ + P + +D ++A
Sbjct: 187 NVRVASRYFKGPEL----LVDYQMYDYS--------------LDMWSL-------GCMLA 221
Query: 320 EPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLI 379
I + F G Y I+ + G+ + + + E+ G ++ K
Sbjct: 222 SMIFRKEPFFHGHDNYDQLVRIA-KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRW- 279
Query: 380 NILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439
+ S E D + KLL + + R+ + E H +F +
Sbjct: 280 ----ERFVHSENQHLVSPEA------LDFLDKLLRYDHQSRLTAR----EAMEHPYFYTV 325
Query: 440 NW 441
Sbjct: 326 VK 327
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 1e-30
Identities = 32/159 (20%), Positives = 61/159 (38%), Gaps = 11/159 (6%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
+ ++G G G VY A++ ++ + ++ + E +++
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVAT-----GQEVAIRQMNLQQQPKKELIIN---EILVM 71
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLA 203
+P + + +VMEY GG L E L A
Sbjct: 72 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT---DVVTETCMDEGQIAAVCRECLQA 128
Query: 204 LEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242
LE+LH +++RD+K +N+L+ DG + L+DF +
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.5 bits (245), Expect = 1e-23
Identities = 31/115 (26%), Positives = 56/115 (48%), Gaps = 10/115 (8%)
Query: 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINIL 382
++ + VGT ++APEV++ + +G VD W+LG+ EM+ G P+ EN + L I
Sbjct: 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 229
Query: 383 KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437
+ S F +D +++ L + +KR + E+ +H+F K
Sbjct: 230 TNGTPELQNPEKLSAIF------RDFLNRCLDMDVEKRG----SAKELLQHQFLK 274
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 3e-30
Identities = 53/135 (39%), Positives = 75/135 (55%), Gaps = 12/135 (8%)
Query: 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINIL 382
A K+F GT EYLAPEV+ +G AVDWW LGV +YEM+ G PF +++E+ IL
Sbjct: 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL 218
Query: 383 KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSV-EIKRHEFFKGINW 441
+ + FPR + S E + L++ LL K+PK+R+G E+ H FF INW
Sbjct: 219 MEEIRFPR---TLSPE------AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269
Query: 442 ALI--RSIKPPEVPN 454
+ + + PP P
Sbjct: 270 QDVVQKKLLPPFKPQ 284
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 3e-29
Identities = 57/159 (35%), Positives = 86/159 (54%), Gaps = 7/159 (4%)
Query: 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADME 139
+V ++ F L+ LG G G V L + + +YAMK++ +E + + ++ E
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKAT-----GRYYAMKILRKEVIIAKDEVAHTVTE 55
Query: 140 KVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAE 199
+L HPFL L F+ C VMEY GG+L+ R+ F A+FY AE
Sbjct: 56 SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAE 113
Query: 200 TLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ ALEYLH +VYRD+K EN+++ +DGHI ++DF L
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC 152
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 4e-30
Identities = 57/165 (34%), Positives = 93/165 (56%), Gaps = 6/165 (3%)
Query: 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKK-LHRADM 138
+VG+++F LL+ LG+G G V+L R YAMKV+ + + + K
Sbjct: 20 KVGIENFELLKVLGTGAYGKVFLV--RKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRT 77
Query: 139 EKVILTMLDH-PFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYA 197
E+ +L + PFL TL+ F+ L+++Y GG+L+ ++ RF + Y
Sbjct: 78 ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYV 135
Query: 198 AETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242
E +LALE+LH +GI+YRD+K EN+L+ +GH++L+DF LS +
Sbjct: 136 GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 3e-26
Identities = 49/130 (37%), Positives = 71/130 (54%), Gaps = 12/130 (9%)
Query: 331 GTHEYLAPEVISG--QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTF 388
GT EY+AP+++ G GH AVDWW+LGV +YE+L G +PF + + + I ++ L
Sbjct: 192 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 251
Query: 389 -PRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSV-EIKRHEFFKGINWALI-- 444
P S +DLI +LL+K+PKKR+G EIK H FF+ INW +
Sbjct: 252 EPPYPQEMSAL------AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAA 305
Query: 445 RSIKPPEVPN 454
+ + P P
Sbjct: 306 KKVPAPFKPV 315
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 4e-30
Identities = 34/159 (21%), Positives = 66/159 (41%), Gaps = 11/159 (6%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
+ +L+ RLG+G G V++ A+K + + +++ L E ++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNG------HTKVAVKSLKQGSMSPDAFLA----EANLM 62
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLA 203
L H L LYA ++ EY G L + G + I+ AA+
Sbjct: 63 KQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 204 LEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242
+ ++ ++RDL+ N+LV + ++DF L+ +
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.0 bits (150), Expect = 2e-11
Identities = 18/98 (18%), Positives = 36/98 (36%), Gaps = 9/98 (9%)
Query: 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEML-YGTTPFKGENNEKTLINILK 383
+ ++ APE I+ D W+ G+ L E++ +G P+ G N + + N+ +
Sbjct: 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225
Query: 384 KPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRI 421
+L L+ + P+ R
Sbjct: 226 GYRMVRPDNCPE--------ELYQLMRLCWKERPEDRP 255
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 4e-30
Identities = 39/158 (24%), Positives = 62/158 (39%), Gaps = 4/158 (2%)
Query: 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEK 140
+G RLL +LG G G V + P A+K + + L+ + + E
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAP--SGKTVSVAVKCLKPDVLSQPEAMDDFIREV 62
Query: 141 VILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAET 200
+ LDH L LY +V E P G L ++ G F + + YA +
Sbjct: 63 NAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQV 120
Query: 201 LLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ YL ++RDL N+L+ + + DF L
Sbjct: 121 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM 158
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.6 bits (185), Expect = 6e-16
Identities = 23/98 (23%), Positives = 37/98 (37%), Gaps = 8/98 (8%)
Query: 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEML-YGTTPFKGENNEKTLINILK 383
+ + APE + + A D W GV L+EM YG P+ G N + L I K
Sbjct: 170 MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229
Query: 384 KPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRI 421
+ PR + +++ + P+ R
Sbjct: 230 EGERLPRPEDCPQ-------DIYNVMVQCWAHKPEDRP 260
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 7e-30
Identities = 42/156 (26%), Positives = 64/156 (41%), Gaps = 13/156 (8%)
Query: 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEK 140
+ + +LL+ +G G+ G+V L R V A+K + +A + E
Sbjct: 4 LNMKELKLLQTIGKGEFGDVMLGDYRGNKV-------AVKCIKNDA--TAQAFLA---EA 51
Query: 141 VILTMLDHPFLPTLY-AEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAE 199
++T L H L L E +V EY G L + + G ++ +
Sbjct: 52 SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 111
Query: 200 TLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235
A+EYL V+RDL NVLV ED +SDF
Sbjct: 112 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDF 147
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.0 bits (176), Expect = 1e-14
Identities = 17/119 (14%), Positives = 41/119 (34%), Gaps = 10/119 (8%)
Query: 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTL 378
+ ++ + ++ APE + + + D W+ G+ L+E+ K +
Sbjct: 150 TKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 209
Query: 379 INILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKR--IGSLKGSVE-IKRHE 434
+ ++K + +++ + R L+ +E IK HE
Sbjct: 210 VPRVEKGYKMDAPDGCPP-------AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 7e-30
Identities = 38/155 (24%), Positives = 61/155 (39%), Gaps = 11/155 (7%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
L+ LG+G G V + R Q A+K++ +++ + + E ++
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRG------QYDVAIKMIKEGSMSEDEFIE----EAKVM 53
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLA 203
L H L LY ++ EY G L + RF + A
Sbjct: 54 MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEA 112
Query: 204 LEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+EYL ++RDL N LV + G + +SDF LS
Sbjct: 113 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS 147
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.2 bits (166), Expect = 2e-13
Identities = 18/98 (18%), Positives = 34/98 (34%), Gaps = 9/98 (9%)
Query: 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEML-YGTTPFKGENNEKTLINILK 383
S + PEV+ S D W GV ++E+ G P++ N +T +I +
Sbjct: 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 216
Query: 384 KPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRI 421
+ S K+ ++ + +R
Sbjct: 217 GLRLYRPHLASE--------KVYTIMYSCWHEKADERP 246
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 115 bits (289), Expect = 1e-29
Identities = 37/158 (23%), Positives = 67/158 (42%), Gaps = 5/158 (3%)
Query: 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEK 140
+ + ++ + +G+G+ G V ++ P G + F A+K + K+ E
Sbjct: 23 IDISCVKIEQVIGAGEFGEVCSGHLKLP--GKREIFVAIKTLKSGY--TEKQRRDFLSEA 78
Query: 141 VILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAET 200
I+ DHP + L S ++ E+ G L + ++ G +F +
Sbjct: 79 SIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG-QFTVIQLVGMLRGI 137
Query: 201 LLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
++YL M V+RDL N+LV + +SDF LS
Sbjct: 138 AAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLS 175
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 66.7 bits (162), Expect = 9e-13
Identities = 21/98 (21%), Positives = 37/98 (37%), Gaps = 9/98 (9%)
Query: 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEML-YGTTPFKGENNEKTLINILK 383
+ + APE I + SA D W+ G+ ++E++ YG P+ N+ + I +
Sbjct: 189 SALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ 248
Query: 384 KPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRI 421
P + S L L+ K+ R
Sbjct: 249 DYRLPPPMDCPS--------ALHQLMLDCWQKDRNHRP 278
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 114 bits (286), Expect = 2e-29
Identities = 38/163 (23%), Positives = 62/163 (38%), Gaps = 11/163 (6%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
D + L LG G + V+L + A+KV+ + R E
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRL-----HRDVAVKVLRADLARDPSFYLRFRREAQNA 61
Query: 144 TMLDHPFLPTLYAEFE----ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAE 199
L+HP + +Y E A +VMEY G L + A A+
Sbjct: 62 AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIAD 119
Query: 200 TLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242
AL + H GI++RD+KP N+++ + + DF ++
Sbjct: 120 ACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 162
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 91.0 bits (225), Expect = 4e-21
Identities = 27/100 (27%), Positives = 47/100 (47%), Gaps = 7/100 (7%)
Query: 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK 384
++ + +GT +YL+PE G + D ++LG LYE+L G PF G++ +++
Sbjct: 170 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE 229
Query: 385 PLTFPRIGVSS-SKEFEEVVKLQDLISKLLVKNPKKRIGS 423
P S + L ++ K L KNP+ R +
Sbjct: 230 DPIPPSARHEGLSAD------LDAVVLKALAKNPENRYQT 263
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 5e-29
Identities = 39/160 (24%), Positives = 65/160 (40%), Gaps = 8/160 (5%)
Query: 84 DHFRLL-RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVI 142
D+ + LG G+ G+V R + A+KV+ + + E I
Sbjct: 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQID---VAIKVLKQGTE--KADTEEMMREAQI 62
Query: 143 LTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLL 202
+ LD+P++ L +A LVME GG L+ + +S+ + +
Sbjct: 63 MHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHK-FLVGKREEIPVSNVAELLHQVSM 120
Query: 203 ALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242
++YL V+RDL NVL+ + +SDF LS
Sbjct: 121 GMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.0 bits (168), Expect = 1e-13
Identities = 24/115 (20%), Positives = 43/115 (37%), Gaps = 12/115 (10%)
Query: 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEML-YGTTPFKGENNEKTLINILK 383
+ ++ APE I+ + S D W+ GV ++E L YG P+K + + I +
Sbjct: 168 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 227
Query: 384 -KPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437
K + P E L L+S + + R + R ++
Sbjct: 228 GKRMECPP---ECPPE------LYALMSDCWIYKWEDRP-DFLTVEQRMRACYYS 272
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 113 bits (284), Expect = 9e-29
Identities = 50/162 (30%), Positives = 78/162 (48%), Gaps = 12/162 (7%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
D + LG+G V L + + Q A+K + ++AL K + E +L
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRT-----QKLVAIKCIAKKAL--EGKEGSMENEIAVL 61
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLA 203
+ HP + L +E+ + L+M+ GG+L+ + + A + L A
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDA 119
Query: 204 LEYLHMMGIVYRDLKPENVLVR---EDGHIMLSDFDLSFKCD 242
++YLH +GIV+RDLKPEN+L ED IM+SDF LS D
Sbjct: 120 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 102 bits (256), Expect = 4e-25
Identities = 39/146 (26%), Positives = 60/146 (41%), Gaps = 13/146 (8%)
Query: 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINIL 382
+ + GT Y+APEV++ + + AVD W++GV Y +L G PF EN+ K IL
Sbjct: 163 GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQIL 222
Query: 383 KKPLTFPRIGVSS-SKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINW 441
K F S +D I L+ K+P+KR + +H + G
Sbjct: 223 KAEYEFDSPYWDDISDS------AKDFIRHLMEKDPEKRF----TCEQALQHPWIAGDTA 272
Query: 442 A--LIRSIKPPEVPNNDLYCKIKKKV 465
I ++ N K K+
Sbjct: 273 LDKNIHQSVSEQIKKNFAKSKWKQAF 298
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 2e-28
Identities = 29/176 (16%), Positives = 58/176 (32%), Gaps = 19/176 (10%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
+ + LG+G G V + A+K++ A + E +L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVL 80
Query: 144 TML-DHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGK---------------- 186
+ L +H + L + ++ EYC GDL +R+
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 187 RFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242
+ ++ + + +L ++RDL N+L+ + DF L+
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIK 196
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.9 bits (139), Expect = 7e-10
Identities = 18/98 (18%), Positives = 41/98 (41%), Gaps = 8/98 (8%)
Query: 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEML-YGTTPFKGENNEKTLINILK 383
+ +++APE I + D W+ G+FL+E+ G++P+ G + ++K
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 262
Query: 384 KPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRI 421
+ + + ++ D++ +P KR
Sbjct: 263 EGFRMLSPEHAPA-------EMYDIMKTCWDADPLKRP 293
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 2e-28
Identities = 39/159 (24%), Positives = 64/159 (40%), Gaps = 11/159 (6%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
+ RL +LG G G V++ A+K + ++ L E ++
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTR------VAIKTLKPGTMSPEAFLQ----EAQVM 66
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLA 203
L H L LYA +V EY G L + + GK + AA+
Sbjct: 67 KKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 125
Query: 204 LEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242
+ Y+ M V+RDL+ N+LV E+ ++DF L+ +
Sbjct: 126 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 164
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.1 bits (171), Expect = 5e-14
Identities = 20/133 (15%), Positives = 45/133 (33%), Gaps = 17/133 (12%)
Query: 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK 384
+ ++ APE D W+ G+ L E+ + +++ +++
Sbjct: 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 229
Query: 385 PLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALI 444
P L DL+ + K P++R + + ++ ++F
Sbjct: 230 GYRMPCPPECPE-------SLHDLMCQCWRKEPEERP-TFE-YLQAFLEDYFT------- 273
Query: 445 RSIKPPEVPNNDL 457
S +P P +L
Sbjct: 274 -STEPQYQPGENL 285
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 3e-28
Identities = 33/161 (20%), Positives = 62/161 (38%), Gaps = 12/161 (7%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
+ + + LG G+ G V+ C + + Y K V + E IL
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSS-----KKTYMAKFVKVK----GTDQVLVKKEISIL 55
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLA 203
+ H + L+ FE+ ++ E+ G D++ R Y + A
Sbjct: 56 NIARHRNILHLHESFESMEELVMIFEFISGLDIFE-RINTSAFELNEREIVSYVHQVCEA 114
Query: 204 LEYLHMMGIVYRDLKPENVLV--REDGHIMLSDFDLSFKCD 242
L++LH I + D++PEN++ R I + +F + +
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.4 bits (242), Expect = 5e-23
Identities = 37/130 (28%), Positives = 62/130 (47%), Gaps = 15/130 (11%)
Query: 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK 384
+ EY APEV +A D W+LG +Y +L G PF E N++ + NI+
Sbjct: 159 NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNA 218
Query: 385 PLTFPRIGVSSSKEFEEV-VKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG----I 439
TF + F+E+ ++ D + +LLVK K R+ + E +H + K +
Sbjct: 219 EYTFD------EEAFKEISIEAMDFVDRLLVKERKSRM----TASEALQHPWLKQKIERV 268
Query: 440 NWALIRSIKP 449
+ +IR++K
Sbjct: 269 STKVIRTLKH 278
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 110 bits (276), Expect = 9e-28
Identities = 38/181 (20%), Positives = 62/181 (34%), Gaps = 24/181 (13%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
++ +R +G G G V+ + + P A+K++ EA A + E ++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA--DFQREAALM 70
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLY----------------------AARQ 181
D+P + L CL+ EY GDL A
Sbjct: 71 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 182 RQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKC 241
+ A + + YL V+RDL N LV E+ + ++DF LS
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 190
Query: 242 D 242
Sbjct: 191 Y 191
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 66.0 bits (160), Expect = 1e-12
Identities = 19/98 (19%), Positives = 35/98 (35%), Gaps = 9/98 (9%)
Query: 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEML-YGTTPFKGENNEKTLINILK 383
+ ++ PE I + + D W GV L+E+ YG P+ G +E+ + +
Sbjct: 198 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRD 257
Query: 384 KPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRI 421
+ +L +L+ K P R
Sbjct: 258 GNILACPENCPL--------ELYNLMRLCWSKLPADRP 287
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 9e-28
Identities = 65/381 (17%), Positives = 117/381 (30%), Gaps = 67/381 (17%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVI 142
L ++ L+ +GSG G V A+K + R + RA E V+
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVL-----DRNVAIKKLSRP-FQNQTHAKRAYRELVL 69
Query: 143 LTMLDHPFLPTLYAEF------EASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFY 196
+ ++H + +L F E LVME + +R +
Sbjct: 70 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER-----MSYL 124
Query: 197 AAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEA 256
+ L +++LH GI++RDLKP N++V+ D + + DF L+
Sbjct: 125 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-------------- 170
Query: 257 IEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPE 316
P T + + + +V
Sbjct: 171 ---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG------------------ 209
Query: 317 VVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEK 376
E + + + +VI G L + + + G K
Sbjct: 210 ---EMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPK 266
Query: 377 TLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436
+ L + +S +DL+SK+LV +P KRI + +H +
Sbjct: 267 LFPDSLFPADSEHNKLKASQ--------ARDLLSKMLVIDPAKRISVD----DALQHPYI 314
Query: 437 KGINWALIRSIKPPEVPNNDL 457
PP++ + L
Sbjct: 315 NVWYDPAEVEAPPPQIYDKQL 335
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 109 bits (274), Expect = 1e-27
Identities = 37/179 (20%), Positives = 65/179 (36%), Gaps = 20/179 (11%)
Query: 60 PHKANQAAWEAMKRLRRAQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAM 119
P N WE + + +LG G G VY + A+
Sbjct: 4 PSSPNYDKWE-----------MERTDITMKHKLGGGQYGEVYEGVWKKY-----SLTVAV 47
Query: 120 KVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAA 179
K + + + + + L E ++ + HP L L ++ E+ G+L
Sbjct: 48 KTLKEDTMEVEEFLK----EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 103
Query: 180 RQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ + + A + A+EYL ++RDL N LV E+ + ++DF LS
Sbjct: 104 LRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS 162
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 60.9 bits (147), Expect = 6e-11
Identities = 17/97 (17%), Positives = 30/97 (30%), Gaps = 7/97 (7%)
Query: 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK 384
++ APE ++ D W GV L+E+ + + +L+K
Sbjct: 172 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 231
Query: 385 PLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRI 421
R K+ +L+ NP R
Sbjct: 232 DYRMERPEGCPE-------KVYELMRACWQWNPSDRP 261
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 1e-27
Identities = 38/130 (29%), Positives = 64/130 (49%), Gaps = 13/130 (10%)
Query: 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK 384
K+ GT E++APE+++ + G D W++GV Y +L G +PF G+ ++TL N+
Sbjct: 172 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 231
Query: 385 PLTFPRIGVSSSKEFEEV-VKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINW-- 441
F + F +D I +LLVK+PKKR+ + +H + K +
Sbjct: 232 NYEFED------EYFSNTSALAKDFIRRLLVKDPKKRM----TIQDSLQHPWIKPKDTQQ 281
Query: 442 ALIRSIKPPE 451
AL + P+
Sbjct: 282 ALSSAWSHPQ 291
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (264), Expect = 3e-26
Identities = 41/166 (24%), Positives = 72/166 (43%), Gaps = 14/166 (8%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKK---LHRADMEK 140
D++ LGSG V C+ ++ YA K + + ++ + E
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKST-----GLQYAAKFIKKRRTKSSRRGVSREDIEREV 64
Query: 141 VILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAET 200
IL + HP + TL+ +E L++E GG+L+ + + A + +
Sbjct: 65 SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQI 122
Query: 201 LLALEYLHMMGIVYRDLKPENVLVREDG----HIMLSDFDLSFKCD 242
L + YLH + I + DLKPEN+++ + I + DF L+ K D
Sbjct: 123 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 2e-27
Identities = 60/355 (16%), Positives = 103/355 (29%), Gaps = 68/355 (19%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVI 142
+ + L ++G G G V+ + R A+K V + A E +
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRET-----HEIVALKRVRLDDDD-EGVPSSALREICL 54
Query: 143 LTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLL 202
L L H + L+ + LV E+C K + + L
Sbjct: 55 LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKK--YFDSCNGDLDPEIVKSFLFQLLK 112
Query: 203 ALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEK 262
L + H +++RDLKP+N+L+ +G + L++F L+
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFG---------------IPVRC 157
Query: 263 CSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322
S +P F + + + + AE
Sbjct: 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGC---------------------IFAELA 196
Query: 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINIL 382
NA F G + I + LG E T
Sbjct: 197 NAGRPLFPGNDVDDQLKRI----------FRLLGTPTEEQWPSMTKLPDYKPYPMYPATT 246
Query: 383 KKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437
P++ + +DL+ LL NP +RI + E +H +F
Sbjct: 247 SLVNVVPKL----NATG------RDLLQNLLKCNPVQRISAE----EALQHPYFS 287
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 2e-27
Identities = 34/176 (19%), Positives = 62/176 (35%), Gaps = 22/176 (12%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
++ + LGSG G V A+K++ +A + ++ +++ K++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSEL-KMMT 95
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLY---------------------AARQR 182
+ H + L S L+ EYC GDL +
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 183 QPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+ +A + +E+L V+RDL NVLV + + DF L+
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 211
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.0 bits (168), Expect = 2e-13
Identities = 13/95 (13%), Positives = 37/95 (38%), Gaps = 8/95 (8%)
Query: 328 SFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEML-YGTTPFKGENNEKTLINILKKPL 386
+ +++APE + + D W+ G+ L+E+ G P+ G + +++
Sbjct: 225 NARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGF 284
Query: 387 TFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRI 421
+ ++ ++ ++ + +KR
Sbjct: 285 KMDQPFYATE-------EIYIIMQSCWAFDSRKRP 312
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 4e-27
Identities = 38/168 (22%), Positives = 72/168 (42%), Gaps = 20/168 (11%)
Query: 83 LDHFRLLRR-LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKV 141
+D +++ + LG G G V + Q +A+K++ A R+ ++
Sbjct: 10 IDDYKVTSQVLGLGINGKVLQIFNKRT-----QEKFALKMLQDCPKARREV-------EL 57
Query: 142 ILTMLDHPFLPTLYAEFEASH----YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYA 197
P + + +E + +VME GG+L++ Q + + F A
Sbjct: 58 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 117
Query: 198 AETLLALEYLHMMGIVYRDLKPENVLV---REDGHIMLSDFDLSFKCD 242
A++YLH + I +RD+KPEN+L R + + L+DF + +
Sbjct: 118 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.6 bits (206), Expect = 3e-18
Identities = 34/134 (25%), Positives = 52/134 (38%), Gaps = 22/134 (16%)
Query: 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENN----EKTLIN 380
+ T Y+APEV+ + + + D W+LGV +Y +L G PF +
Sbjct: 169 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 228
Query: 381 ILKKPLTFPRIGVSS-SKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439
I FP S S+E ++ LI LL P +R+ E H +
Sbjct: 229 IRMGQYEFPNPEWSEVSEE------VKMLIRNLLKTEPTQRM----TITEFMNHPWIM-- 276
Query: 440 NWALIRSIKPPEVP 453
+S K P+ P
Sbjct: 277 -----QSTKVPQTP 285
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (269), Expect = 5e-27
Identities = 38/149 (25%), Positives = 62/149 (41%), Gaps = 7/149 (4%)
Query: 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHP 149
+ LGSG+ G V + V A+K++ EA E ++ LD+P
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKT---VAVKILKNEAND-PALKDELLAEANVMQQLDNP 68
Query: 150 FLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHM 209
++ + EA + LVME G L Q+ + + + + ++YL
Sbjct: 69 YIVRMIGICEAESW-MLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEE 125
Query: 210 MGIVYRDLKPENVLVREDGHIMLSDFDLS 238
V+RDL NVL+ + +SDF LS
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLS 154
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.3 bits (200), Expect = 8e-18
Identities = 21/117 (17%), Positives = 41/117 (35%), Gaps = 10/117 (8%)
Query: 326 SKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEML-YGTTPFKGENNEKTLINILKK 384
++ APE I+ S D W+ GV ++E YG P++G + + K
Sbjct: 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG 226
Query: 385 PLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINW 441
G ++ DL++ + + R R+ ++ +N
Sbjct: 227 ERMGCPAGCPR--------EMYDLMNLCWTYDVENRP-GFAAVELRLRNYYYDVVNE 274
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 9e-27
Identities = 38/154 (24%), Positives = 61/154 (39%), Gaps = 11/154 (7%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
++ +GSG G V+L N + A+K + A++ + E ++
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLN------KDKVAIKTIREGAMSEEDFIE----EAEVM 54
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLA 203
L HP L LY CLV E+ G L + Q F + +
Sbjct: 55 MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEG 113
Query: 204 LEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237
+ YL +++RDL N LV E+ I +SDF +
Sbjct: 114 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGM 147
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.8 bits (165), Expect = 2e-13
Identities = 14/96 (14%), Positives = 36/96 (37%), Gaps = 7/96 (7%)
Query: 326 SKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP 385
S ++ +PEV S + S D W+ GV ++E+ + ++ +
Sbjct: 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 218
Query: 386 LTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRI 421
+ ++S+ + +++ + P+ R
Sbjct: 219 FRLYKPRLAST-------HVYQIMNHCWKERPEDRP 247
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (264), Expect = 2e-26
Identities = 40/155 (25%), Positives = 63/155 (40%), Gaps = 6/155 (3%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
+ L R +G G G+V+ +P P A+K + E + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSP--ENPALAVAIKTCKNCT--SDSVREKFLQEALTM 62
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLA 203
DHP + L + ++ME C G+L + Q + ++S YA + A
Sbjct: 63 RQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLSTA 120
Query: 204 LEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
L YL V+RD+ NVLV + + L DF LS
Sbjct: 121 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 155
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.4 bits (156), Expect = 4e-12
Identities = 23/98 (23%), Positives = 41/98 (41%), Gaps = 9/98 (9%)
Query: 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEML-YGTTPFKGENNEKTLINILK 383
++ +++APE I+ + SA D W GV ++E+L +G PF+G N + I
Sbjct: 165 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 224
Query: 384 KPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRI 421
+ L L++K +P +R
Sbjct: 225 GERLPMPPNCPPT--------LYSLMTKCWAYDPSRRP 254
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 3e-26
Identities = 36/160 (22%), Positives = 60/160 (37%), Gaps = 15/160 (9%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTM 145
+ +G G VY V A + L + + R E +L
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTV-----EVAWCELQDRKL-TKSERQRFKEEAEMLKG 64
Query: 146 LDHPFLPTLYAEFEAS----HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETL 201
L HP + Y +E++ LV E G L +R K I + + + L
Sbjct: 65 LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQIL 122
Query: 202 LALEYLHMMG--IVYRDLKPENVLVR-EDGHIMLSDFDLS 238
L++LH I++RDLK +N+ + G + + D L+
Sbjct: 123 KGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 162
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.0 bits (241), Expect = 3e-23
Identities = 21/113 (18%), Positives = 48/113 (42%), Gaps = 11/113 (9%)
Query: 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK 384
+K+ +GT E++APE+ + + +VD + G+ + EM P+ N + +
Sbjct: 169 FAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS 227
Query: 385 PLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437
+ + E ++++I + +N +R ++ H FF+
Sbjct: 228 GVKPASFDKVAIPE------VKEIIEGCIRQNKDERY----SIKDLLNHAFFQ 270
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (264), Expect = 4e-26
Identities = 66/364 (18%), Positives = 104/364 (28%), Gaps = 72/364 (19%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVI 142
+ + L ++G G G V+ + R A+K V E A E I
Sbjct: 9 VSKYEKLAKIGQGTFGEVFKARHRKT-----GQKVALKKVLMENE-KEGFPITALREIKI 62
Query: 143 LTMLDHPFLPTLY--------AEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAK 194
L +L H + L LV ++C +F +S K
Sbjct: 63 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNVLVKFTLSEIK 120
Query: 195 FYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSF 254
L L Y+H I++RD+K NVL+ DG + L+DF L+ +
Sbjct: 121 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA------------RAFS 168
Query: 255 EAIEKYEKCSIPSCATP-MQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLD 313
A T +P +G D +
Sbjct: 169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPP----------------IDLWGAGCIM 212
Query: 314 DPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGEN 373
PI G E +IS + P
Sbjct: 213 AEMWTRSPI------MQGNTEQHQLALIS--------------QLCGSITPEVWPNVDNY 252
Query: 374 NEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433
+ ++K + + + + L I KLLV +P +RI S + H
Sbjct: 253 ELYEKLELVKGQKRKVKDRLKAYVRDPYALDL---IDKLLVLDPAQRI----DSDDALNH 305
Query: 434 EFFK 437
+FF
Sbjct: 306 DFFW 309
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 2e-25
Identities = 66/378 (17%), Positives = 118/378 (31%), Gaps = 76/378 (20%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
+ ++ L +GSG G+V A+K + R +I R E +L
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKT-----GLRVAVKKLSRPFQSIIHA-KRTYRELRLL 71
Query: 144 TMLDHPFLPTLYAEFEASHY-----SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAA 198
+ H + L F + ++ + G DL + Q + +F
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIY 128
Query: 199 ETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIE 258
+ L L+Y+H I++RDLKP N+ V ED + + DF L+ D + A E
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 188
Query: 259 KYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318
+ + V + + G+
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGRTL------------------------------ 218
Query: 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTL 378
F GT ++I +G E+L + N ++L
Sbjct: 219 ----------FPGTDHIDQLKLI----------LRLVGTPGAELLKKISSESARNYIQSL 258
Query: 379 INILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438
+ K IG + DL+ K+LV + KRI + + H +F
Sbjct: 259 TQMPKMNFANVFIGANPL--------AVDLLEKMLVLDSDKRITAA----QALAHAYFAQ 306
Query: 439 INWALIRSIKPPEVPNND 456
+ + P + +
Sbjct: 307 YHDPDDEPVADPYDQSFE 324
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 6e-25
Identities = 46/257 (17%), Positives = 91/257 (35%), Gaps = 21/257 (8%)
Query: 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADME 139
+ + + +G G+ G V +I+ + + A+K + A + E
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGL---RMDAAIKRMKEYA--SKDDHRDFAGE 60
Query: 140 KVILTML-DHPFLPTLYAEFEASHYSCLVMEYCPGGDLY--------------AARQRQP 184
+L L HP + L E Y L +EY P G+L A
Sbjct: 61 LEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 120
Query: 185 GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVV 244
+AA+ ++YL ++RDL N+LV E+ ++DF LS +V
Sbjct: 121 ASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 180
Query: 245 PKLLRPKLSFEAI-EKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVD 303
K +L + + S+ + + + + +T + E++
Sbjct: 181 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 240
Query: 304 GDHHDQELLDDPEVVAE 320
+ ++ L+ + V +
Sbjct: 241 QGYRLEKPLNCDDEVYD 257
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.4 bits (161), Expect = 1e-12
Identities = 17/118 (14%), Positives = 46/118 (38%), Gaps = 9/118 (7%)
Query: 305 DHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEML- 363
+++ ++ D + + + ++A E ++ + + D W+ GV L+E++
Sbjct: 162 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 221
Query: 364 YGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRI 421
G TP+ G + + + + ++ DL+ + + P +R
Sbjct: 222 LGGTPYCGMTCAELYEKLPQGYRLEKPLNCDD--------EVYDLMRQCWREKPYERP 271
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 101 bits (253), Expect = 8e-25
Identities = 36/160 (22%), Positives = 62/160 (38%), Gaps = 9/160 (5%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVI 142
++ + L ++G G G VY Q +A+K + E E I
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNNYGET------FALKKIRLEKED-EGIPSTTIREISI 53
Query: 143 LTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLL 202
L L H + LY LV E+ + +AK + + L
Sbjct: 54 LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLN 111
Query: 203 ALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242
+ Y H +++RDLKP+N+L+ +G + ++DF L+
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFG 151
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 74.9 bits (183), Expect = 1e-15
Identities = 30/134 (22%), Positives = 52/134 (38%), Gaps = 25/134 (18%)
Query: 325 RSKSFVGTHEYLAPEVISGQG-HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILK 383
+ + T Y AP+V+ G + + +D W++G EM+ GT F G + L+ I +
Sbjct: 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR 215
Query: 384 KPLTFPRIGVSSSKEFEEVVK--------------------LQDLISKLLVKNPKKRIGS 423
T + E + DL+SK+L +P +RI +
Sbjct: 216 ILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA 275
Query: 424 LKGSVEIKRHEFFK 437
+ H +FK
Sbjct: 276 K----QALEHAYFK 285
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 1e-24
Identities = 38/176 (21%), Positives = 63/176 (35%), Gaps = 19/176 (10%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIR--NPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKV 141
D L + LG G G V L + + A+K++ +A K L E
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEME 70
Query: 142 ILTML-DHPFLPTLYAEFEASHYSCLVMEYCPGGDLY--------------AARQRQPGK 186
++ M+ H + L +++EY G+L P +
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 187 RFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242
+ A + +EYL ++RDL NVLV ED + ++DF L+
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 186
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.7 bits (154), Expect = 7e-12
Identities = 19/98 (19%), Positives = 43/98 (43%), Gaps = 9/98 (9%)
Query: 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEML-YGTTPFKGENNEKTLINILK 383
++ + +++APE + + + D W+ GV L+E+ G +P+ G E+ L +LK
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-LFKLLK 251
Query: 384 KPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRI 421
+ + ++ +L ++ P +R
Sbjct: 252 EGHRMDKPSNCTN-------ELYMMMRDCWHAVPSQRP 282
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 2e-24
Identities = 44/157 (28%), Positives = 62/157 (39%), Gaps = 9/157 (5%)
Query: 88 LLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKK--LHRADMEKVILTM 145
L LG G VY + +N A+K + + K A E +L
Sbjct: 2 KLDFLGEGQFATVYKARDKNT-----NQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 56
Query: 146 LDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALE 205
L HP + L F LV ++ + S K Y TL LE
Sbjct: 57 LSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLE 114
Query: 206 YLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242
YLH I++RDLKP N+L+ E+G + L+DF L+
Sbjct: 115 YLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG 151
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.6 bits (203), Expect = 4e-18
Identities = 29/129 (22%), Positives = 47/129 (36%), Gaps = 24/129 (18%)
Query: 329 FVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLT 387
V T Y APE++ G + +G VD W +G L E+L G+++ L I + T
Sbjct: 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGT 219
Query: 388 FPRIGVSSSKEFEEVVKLQ-------------------DLISKLLVKNPKKRIGSLKGSV 428
+ V + DLI L + NP RI +
Sbjct: 220 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITAT---- 275
Query: 429 EIKRHEFFK 437
+ + ++F
Sbjct: 276 QALKMKYFS 284
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 3e-24
Identities = 34/165 (20%), Positives = 59/165 (35%), Gaps = 10/165 (6%)
Query: 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEK 140
V + + R LG G G VY + + P+ A+K V+ A ++ E
Sbjct: 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEA 74
Query: 141 VILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISS-------- 192
++ + + L + ++ME GDL + +
Sbjct: 75 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134
Query: 193 AKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237
A E + YL+ V+RDL N +V ED + + DF +
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM 179
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.3 bits (158), Expect = 3e-12
Identities = 22/119 (18%), Positives = 48/119 (40%), Gaps = 11/119 (9%)
Query: 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEML-YGTTPFKGENNEKTLINILK 383
+ + +++PE + + D W+ GV L+E+ P++G +NE+ L +++
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250
Query: 384 KPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKR--IGSLKGSVEIKRHEFFKGIN 440
L L +L+ NPK R + S++ + F+ ++
Sbjct: 251 GGLLDKPDNCPD--------MLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 301
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 100 bits (249), Expect = 3e-24
Identities = 39/167 (23%), Positives = 72/167 (43%), Gaps = 17/167 (10%)
Query: 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADME 139
RVG + +RL R++GSG G++YL A+K+ ++ K + +E
Sbjct: 4 RVG-NRYRLGRKIGSGSFGDIYLGTDIAA-----GEEVAIKL-----ECVKTKHPQLHIE 52
Query: 140 KVILTMLDHP-FLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAA 198
I M+ +PT+ Y+ +VME ++F + + A
Sbjct: 53 SKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLED--LFNFCSRKFSLKTVLLLAD 110
Query: 199 ETLLALEYLHMMGIVYRDLKPENVLVREDGH---IMLSDFDLSFKCD 242
+ + +EY+H ++RD+KP+N L+ + + DF L+ K
Sbjct: 111 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 74.1 bits (181), Expect = 2e-15
Identities = 17/138 (12%), Positives = 38/138 (27%), Gaps = 3/138 (2%)
Query: 305 DHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY 364
D + D +K+ GT Y + G D +LG L
Sbjct: 149 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNL 208
Query: 365 GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424
G+ P++G + + + + ++ +
Sbjct: 209 GSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK-GYPSEFATYLNFCRSLRFDDKP-DY 266
Query: 425 KGSVEIKRHEFFK-GINW 441
++ R+ F + G ++
Sbjct: 267 SYLRQLFRNLFHRQGFSY 284
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 99 bits (248), Expect = 4e-24
Identities = 33/181 (18%), Positives = 66/181 (36%), Gaps = 16/181 (8%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
D +L + LG G G V A+K++ A + ++ K+++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE-LKILI 71
Query: 144 TMLDHPFLPTL-YAEFEASHYSCLVMEYCPGGDLY--------------AARQRQPGKRF 188
+ H + L A + +++E+C G+L A +
Sbjct: 72 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 189 GISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLL 248
+ Y+ + +E+L ++RDL N+L+ E + + DF L+ P +
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191
Query: 249 R 249
R
Sbjct: 192 R 192
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.3 bits (145), Expect = 1e-10
Identities = 18/104 (17%), Positives = 38/104 (36%), Gaps = 8/104 (7%)
Query: 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGT-TPFKGENNEKT 377
+P R +++APE I + + D W+ GV L+E+ +P+ G ++
Sbjct: 186 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245
Query: 378 LINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRI 421
LK+ ++ ++ + P +R
Sbjct: 246 FCRRLKEGTRMRAPDYTTP-------EMYQTMLDCWHGEPSQRP 282
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 6e-24
Identities = 40/172 (23%), Positives = 71/172 (41%), Gaps = 20/172 (11%)
Query: 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADM 138
R + + +G+G G VY ++ + A+K + + +
Sbjct: 15 DRPQEVSYTDTKVIGNGSFGVVYQAKLCDS-----GELVAIKK-------VLQDKRFKNR 62
Query: 139 EKVILTMLDHPFLPTLYAEFEASH------YSCLVMEYCPGGDLYAARQR-QPGKRFGIS 191
E I+ LDH + L F +S Y LV++Y P AR + + +
Sbjct: 63 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 192 SAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIM-LSDFDLSFKCD 242
K Y + +L Y+H GI +RD+KP+N+L+ D ++ L DF + +
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.1 bits (207), Expect = 2e-18
Identities = 47/205 (22%), Positives = 74/205 (36%), Gaps = 32/205 (15%)
Query: 301 QVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQ-GHGSAVDWWTLGVFL 359
+D D +L D + S++ + Y APE+I G + S++D W+ G L
Sbjct: 154 LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 213
Query: 360 YEMLYGTTPFKGENNEKTLINILKKPLT-----------------FPRIGVSSSKEFEEV 402
E+L G F G++ L+ I+K T FP+I +
Sbjct: 214 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 273
Query: 403 V---KLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIRSIKPPEVPNNDLYC 459
+ L S+LL P R+ L E H FF + ++K P +
Sbjct: 274 RTPPEAIALCSRLLEYTPTARLTPL----EACAHSFFDELRD---PNVKLPNGRDTPALF 326
Query: 460 KIKKKVYVPKLSKQERDAPYQIPTH 484
+ +LS A IP H
Sbjct: 327 NFTTQ----ELSSNPPLATILIPPH 347
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.6 bits (245), Expect = 7e-24
Identities = 37/165 (22%), Positives = 68/165 (41%), Gaps = 12/165 (7%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLH---RADMEK 140
+++ LGSG G+VY + A+K V+++ ++ +L R ME
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSD-----NLPVAIKHVEKDRISDWGELPNGTRVPMEV 58
Query: 141 VILTMLD--HPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAA 198
V+L + + L FE L++E + G A+ +
Sbjct: 59 VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFW 117
Query: 199 ETLLALEYLHMMGIVYRDLKPENVLVRED-GHIMLSDFDLSFKCD 242
+ L A+ + H G+++RD+K EN+L+ + G + L DF
Sbjct: 118 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.6 bits (219), Expect = 2e-20
Identities = 32/118 (27%), Positives = 49/118 (41%), Gaps = 20/118 (16%)
Query: 323 NARSKSFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINI 381
+ F GT Y PE I + HG + W+LG+ LY+M+ G PF+ + I
Sbjct: 163 DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EI 216
Query: 382 LKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439
++ + F + VSS Q LI L P R EI+ H + + +
Sbjct: 217 IRGQVFFRQ-RVSSE--------CQHLIRWCLALRPSDRP----TFEEIQNHPWMQDV 261
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.2 bits (246), Expect = 9e-24
Identities = 40/161 (24%), Positives = 69/161 (42%), Gaps = 7/161 (4%)
Query: 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVI 142
+++F+ + ++G G G VY + + L A+K + + A E +
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNK-----LTGEVVALKKIRLDTET-EGVPSTAIREISL 54
Query: 143 LTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLL 202
L L+HP + L + LV E+ DL + K Y + L
Sbjct: 55 LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 203 ALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243
L + H +++RDLKP+N+L+ +G I L+DF L+ V
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 154
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.2 bits (202), Expect = 5e-18
Identities = 30/134 (22%), Positives = 49/134 (36%), Gaps = 25/134 (18%)
Query: 328 SFVGTHEYLAPEVISGQGH-GSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL 386
V T Y APE++ G + +AVD W+LG EM+ F G++ L I +
Sbjct: 161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 220
Query: 387 TFPRIGVSSSKEFEEVVK--------------------LQDLISKLLVKNPKKRIGSLKG 426
T + + + L+S++L +P KRI +
Sbjct: 221 TPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAK-- 278
Query: 427 SVEIKRHEFFKGIN 440
H FF+ +
Sbjct: 279 --AALAHPFFQDVT 290
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.9 bits (243), Expect = 3e-23
Identities = 36/159 (22%), Positives = 61/159 (38%), Gaps = 5/159 (3%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
F+ ++ LGSG G VY + P + A+K + K E ++
Sbjct: 9 TEFKKIKVLGSGAFGTVYKG-LWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVM 65
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLA 203
+D+P + L S L+ + P G L + G + +
Sbjct: 66 ASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKG 123
Query: 204 LEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242
+ YL +V+RDL NVLV+ H+ ++DF L+
Sbjct: 124 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.0 bits (155), Expect = 6e-12
Identities = 17/98 (17%), Positives = 44/98 (44%), Gaps = 9/98 (9%)
Query: 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEML-YGTTPFKGENNEKTLINILK 383
++ +++A E I + + D W+ GV ++E++ +G+ P+ G + + +IL+
Sbjct: 169 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILE 227
Query: 384 KPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRI 421
K P+ + + + ++ K + + R
Sbjct: 228 KGERLPQPPICTI-------DVYMIMVKCWMIDADSRP 258
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.6 bits (242), Expect = 6e-23
Identities = 33/163 (20%), Positives = 58/163 (35%), Gaps = 14/163 (8%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
+ L +G G G V + A+K + + R E IL
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVN-----KVRVAIKKISPFEH--QTYCQRTLREIKIL 60
Query: 144 TMLDHPFLPTLYAEFEASHYS----CLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAE 199
H + + A ++ + G DLY + Q ++ +
Sbjct: 61 LRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQ 117
Query: 200 TLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242
L L+Y+H +++RDLKP N+L+ + + DF L+ D
Sbjct: 118 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.6 bits (177), Expect = 1e-14
Identities = 30/133 (22%), Positives = 53/133 (39%), Gaps = 27/133 (20%)
Query: 328 SFVGTHEYLAPEVI-SGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL 386
+V T Y APE++ + +G+ ++D W++G L EML F G++ L +IL
Sbjct: 171 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 230
Query: 387 TFPRIGVSSSKEFEEVV----------------------KLQDLISKLLVKNPKKRIGSL 424
+ + ++ + K DL+ K+L NP KRI
Sbjct: 231 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI--- 287
Query: 425 KGSVEIKRHEFFK 437
+ H + +
Sbjct: 288 -EVEQALAHPYLE 299
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.9 bits (240), Expect = 7e-23
Identities = 39/167 (23%), Positives = 62/167 (37%), Gaps = 14/167 (8%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
+ + +G G G V+ + F A+K V + E +L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKN----GGRFVALKRVRVQ-TGEEGMPLSTIREVAVL 61
Query: 144 TML---DHPFLPTLYAEFEASH-----YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKF 195
L +HP + L+ S LV E+ + P + K
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTY-LDKVPEPGVPTETIKD 120
Query: 196 YAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242
+ L L++LH +V+RDLKP+N+LV G I L+DF L+
Sbjct: 121 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS 167
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.5 bits (213), Expect = 2e-19
Identities = 30/133 (22%), Positives = 44/133 (33%), Gaps = 22/133 (16%)
Query: 327 KSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL 386
S V T Y APEV+ + + VD W++G EM F+G ++ L IL
Sbjct: 173 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 232
Query: 387 TFPRIGVSSSKEFEEVV------------------KLQDLISKLLVKNPKKRIGSLKGSV 428
+DL+ K L NP KRI +
Sbjct: 233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI----SAY 288
Query: 429 EIKRHEFFKGINW 441
H +F+ +
Sbjct: 289 SALSHPYFQDLER 301
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.0 bits (238), Expect = 2e-22
Identities = 41/165 (24%), Positives = 64/165 (38%), Gaps = 16/165 (9%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
+R L+ +GSG G V A+K + R + RA E +L
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRT-----GAKVAIKKLYRPFQS-ELFAKRAYRELRLL 71
Query: 144 TMLDHPFLPTLYAEFEASHYS------CLVMEYCPGGDLYAARQRQPGKRFGISSAKFYA 197
+ H + L F LVM + + ++ G +F
Sbjct: 72 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH----EKLGEDRIQFLV 127
Query: 198 AETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242
+ L L Y+H GI++RDLKP N+ V ED + + DF L+ + D
Sbjct: 128 YQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.9 bits (196), Expect = 5e-17
Identities = 36/162 (22%), Positives = 65/162 (40%), Gaps = 27/162 (16%)
Query: 318 VAEPINARSKSFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEK 376
+A ++ +V T Y APEVI + VD W++G + EM+ G T FKG ++
Sbjct: 167 LARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD 226
Query: 377 TLINILKKPLTFP-----------------RIGVSSSKEFEEVVK-----LQDLISKLLV 414
L I+K T P + K+F ++ +L+ K+LV
Sbjct: 227 QLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLV 286
Query: 415 KNPKKRIGSLKGSVEIKRHEFFKGINWALIRSIKPPEVPNND 456
+ ++R+ + E H +F+ ++ + D
Sbjct: 287 LDAEQRVTAG----EALAHPYFESLHDTEDEPQVQKYDDSFD 324
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 93.7 bits (232), Expect = 5e-22
Identities = 33/165 (20%), Positives = 63/165 (38%), Gaps = 18/165 (10%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
H+++ RR+G G G ++ A+K R R + E
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLN-----NQQVAIKFEPR-----RSDAPQLRDEYRTY 54
Query: 144 TMLDH-PFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLL 202
+L +P +Y + ++ LV++ G G++F + + A + L
Sbjct: 55 KLLAGCTGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLA 112
Query: 203 ALEYLHMMGIVYRDLKPENVLVRE-----DGHIMLSDFDLSFKCD 242
++ +H +VYRD+KP+N L+ I + DF +
Sbjct: 113 RVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 71.0 bits (173), Expect = 3e-14
Identities = 18/115 (15%), Positives = 29/115 (25%), Gaps = 11/115 (9%)
Query: 311 LLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFK 370
DP K+ GT Y++ G+ D LG L G+ P++
Sbjct: 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ 214
Query: 371 GENNEKTL-----INILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKR 420
G I K+ + +EF +
Sbjct: 215 GLKAATNKQKYERIGEKKQSTPLRELCAGFPEEF------YKYMHYARNLAFDAT 263
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.1 bits (233), Expect = 5e-22
Identities = 35/166 (21%), Positives = 63/166 (37%), Gaps = 20/166 (12%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTM 145
L +G G G V+ + R V A+K+ ++ + E M
Sbjct: 5 IVLQESIGKGRFGEVWRGKWRGEEV-------AVKIFSSRE----ERSWFREAEIYQTVM 53
Query: 146 LDHPFLPTLYAEFEASHYS----CLVMEYCPGGDLYAARQRQPGK-----RFGISSAKFY 196
L H + A + + LV +Y G L+ R + +S+A
Sbjct: 54 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGL 113
Query: 197 AAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242
A + + I +RDLK +N+LV+++G ++D L+ + D
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.4 bits (135), Expect = 2e-09
Identities = 17/122 (13%), Positives = 43/122 (35%), Gaps = 21/122 (17%)
Query: 320 EPINARSKSFVGTHEYLAPEVISGQGH------GSAVDWWTLGVFLYEMLYGTTPFK--- 370
+ I+ VGT Y+APEV+ + D + +G+ +E+ +
Sbjct: 163 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 222
Query: 371 -----------GENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKK 419
+ + + + ++ + P I + + E + + ++ + N
Sbjct: 223 DYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIP-NRWQSCEALRVMAKIMRECWYANGAA 281
Query: 420 RI 421
R+
Sbjct: 282 RL 283
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.4 bits (231), Expect = 6e-22
Identities = 33/155 (21%), Positives = 55/155 (35%), Gaps = 4/155 (2%)
Query: 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVIL 143
+ +G+G+ G VY ++ G + A+K + K+ E I+
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTS-SGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIM 63
Query: 144 TMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLA 203
H + L ++ EY G R+ F +
Sbjct: 64 GQFSHHNIIRLEGVISKYKPMMIITEYMENGA-LDKFLREKDGEFSVLQLVGMLRGIAAG 122
Query: 204 LEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
++YL M V+RDL N+LV + +SDF LS
Sbjct: 123 MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS 157
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.2 bits (163), Expect = 5e-13
Identities = 15/96 (15%), Positives = 34/96 (35%), Gaps = 7/96 (7%)
Query: 326 SKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP 385
+ + APE IS + SA D W+ G+ ++E++ E + ++ +
Sbjct: 170 TSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG 229
Query: 386 LTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRI 421
P + + L+ + + +R
Sbjct: 230 FRLPT-------PMDCPSAIYQLMMQCWQQERARRP 258
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.1 bits (220), Expect = 3e-20
Identities = 30/155 (19%), Positives = 62/155 (40%), Gaps = 8/155 (5%)
Query: 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILT 144
HF +G G G VY + + + A+K ++R ++ + E +I+
Sbjct: 30 HFN--EVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITD--IGEVSQFLTEGIIMK 83
Query: 145 MLDHPFLPTLY-AEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLA 203
HP + +L + +V+ Y GDL + + + + +
Sbjct: 84 DFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKG 142
Query: 204 LEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
+++L V+RDL N ++ E + ++DF L+
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 177
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.3 bits (161), Expect = 1e-12
Identities = 15/97 (15%), Positives = 32/97 (32%), Gaps = 7/97 (7%)
Query: 325 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK 384
+++A E + Q + D W+ GV L+E++ P + N + L +
Sbjct: 190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249
Query: 385 PLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRI 421
+ L +++ K + R
Sbjct: 250 GRRLLQPEYCPD-------PLYEVMLKCWHPKAEMRP 279
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 82.4 bits (202), Expect = 8e-18
Identities = 62/386 (16%), Positives = 128/386 (33%), Gaps = 70/386 (18%)
Query: 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREA---------LAIRKKLHRA 136
+ L+R+LG G V+L + AMK+V + + + ++++ A
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMV-----NNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDA 69
Query: 137 DMEKVILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAAR-QRQPGKRFGISSAKF 195
D K +H + + + +VM + G+ A ++ + + K
Sbjct: 70 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129
Query: 196 YAAETLLALEYLHM-MGIVYRDLKPENVLVREDG------HIMLSDFDLSFKCDVVPKLL 248
+ + LL L+Y+H GI++ D+KPENVL+ I ++D + D
Sbjct: 130 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 189
Query: 249 RPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHD 308
+ + E + C + + G + E D
Sbjct: 190 IQTREYRSPE-VLLGAPWGCGADIWSTACLIFELITGD-------FLFEPDEGHSYTKDD 241
Query: 309 QELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTP 368
+ E++ E P + G + + + G+ P
Sbjct: 242 DHIAQIIELLGEL----------------PSYLLRNGKYTRTFFNSRGLLRNISKLKFWP 285
Query: 369 FKGENNEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSV 428
+ ++L + F + +KE D +S +L +P+KR +
Sbjct: 286 LE---------DVLTEKYKFSK---DEAKEI------SDFLSPMLQLDPRKRADAG---- 323
Query: 429 EIKRHEFFKGINWALIRSIKPPEVPN 454
+ H + K + + I+ P+
Sbjct: 324 GLVNHPWLK--DTLGMEEIRVPDREL 347
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 64.8 bits (157), Expect = 7e-13
Identities = 29/166 (17%), Positives = 50/166 (30%), Gaps = 35/166 (21%)
Query: 88 LLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKV------ 141
+ + +G G V+ C +K + +K + D +
Sbjct: 4 IGKLMGEGKESAVFNCYSEK------FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLA 57
Query: 142 ---------ILTMLDHPFLPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISS 192
L L +P +YA + ++ME R + +
Sbjct: 58 IRSARNEFRALQKLQGLAVPKVYAWEG----NAVLMELIDAK---------ELYRVRVEN 104
Query: 193 AKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238
L + + GIV+ DL NVLV + I + DF S
Sbjct: 105 PDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV-SEEGIWIIDFPQS 149
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 489 | |||
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.6 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.05 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.91 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.2 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.6 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.58 |
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-67 Score=506.27 Aligned_cols=281 Identities=32% Similarity=0.574 Sum_probs=245.3
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
...++|++++.||+|+||+||+|+++. +++.||||++.+...........+.+|+.+|++++|||||+++++|.+
T Consensus 5 ~~p~dy~i~~~lG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 79 (288)
T d1uu3a_ 5 KRPEDFKFGKILGEGSFSTVVLARELA-----TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD 79 (288)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC
T ss_pred CCCCCCEEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE
Confidence 345789999999999999999999987 578999999998776656666788899999999999999999999999
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~ 240 (489)
++.+|||||||+||+|.+++... +.+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.
T Consensus 80 ~~~~~ivmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~ 157 (288)
T d1uu3a_ 80 DEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKV 157 (288)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCEEEEEEEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEeccccccee
Confidence 99999999999999999988875 6799999999999999999999999999999999999999999999999999854
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
+....
T Consensus 158 ~~~~~--------------------------------------------------------------------------- 162 (288)
T d1uu3a_ 158 LSPES--------------------------------------------------------------------------- 162 (288)
T ss_dssp CC------------------------------------------------------------------------------
T ss_pred cccCC---------------------------------------------------------------------------
Confidence 32100
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHH
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFE 400 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 400 (489)
......+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+.+.+|....+.+|...
T Consensus 163 -~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~-------- 233 (288)
T d1uu3a_ 163 -KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKF-------- 233 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTC--------
T ss_pred -cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccC--------
Confidence 01123456899999999999999999999999999999999999999999999999999998887776422
Q ss_pred HHhhHHHHHHHHhhcCcccccCCCCC--hHHHHcCCCcCCCCccccccCCCCCCC
Q 011302 401 EVVKLQDLISKLLVKNPKKRIGSLKG--SVEIKRHEFFKGINWALIRSIKPPEVP 453 (489)
Q Consensus 401 ~~~~l~~li~~~L~~dP~~R~~~~~~--~~~ll~hp~f~~~~~~~~~~~~~p~~~ 453 (489)
..++++||.+||+.||++|||+.+. ..++++||||++++|+.+....||.+|
T Consensus 234 -s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~~~pP~l~ 287 (288)
T d1uu3a_ 234 -FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 287 (288)
T ss_dssp -CHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCCC
T ss_pred -CHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhcCCCCCCC
Confidence 1258999999999999999999742 345899999999999999999998765
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-65 Score=506.42 Aligned_cols=281 Identities=38% Similarity=0.703 Sum_probs=249.7
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
+.+++|++++.||+|+||+||+|+++. +++.||||++++..........++.+|+.+|+.++|||||+++++|++
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~-----~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 76 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKA-----TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT 76 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECC-----CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc
Confidence 567899999999999999999999987 678999999998877666667788899999999999999999999999
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~ 240 (489)
.+.+|+|||||+||+|.+++... +.+++..++.|+.||+.||+|||++|||||||||+|||++.+|++||+|||+|+.
T Consensus 77 ~~~~~iv~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~ 154 (337)
T d1o6la_ 77 HDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKE 154 (337)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred ccccccceeccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccc
Confidence 99999999999999999998876 6799999999999999999999999999999999999999999999999999843
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
....
T Consensus 155 ~~~~---------------------------------------------------------------------------- 158 (337)
T d1o6la_ 155 GISD---------------------------------------------------------------------------- 158 (337)
T ss_dssp SCCT----------------------------------------------------------------------------
T ss_pred cccC----------------------------------------------------------------------------
Confidence 2110
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHH
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFE 400 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 400 (489)
.......+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+++..+..+.+.+|....
T Consensus 159 --~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s------- 229 (337)
T d1o6la_ 159 --GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLS------- 229 (337)
T ss_dssp --TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSC-------
T ss_pred --CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCC-------
Confidence 11234568999999999999999999999999999999999999999999999999999988887775321
Q ss_pred HHhhHHHHHHHHhhcCcccccCCCC-ChHHHHcCCCcCCCCcccc--ccCCCCCCCCc
Q 011302 401 EVVKLQDLISKLLVKNPKKRIGSLK-GSVEIKRHEFFKGINWALI--RSIKPPEVPNN 455 (489)
Q Consensus 401 ~~~~l~~li~~~L~~dP~~R~~~~~-~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~~ 455 (489)
.++++||.+||++||.+|++... .++++++||||++++|+.+ +.+.||+.|..
T Consensus 230 --~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~~~p~~P~~ 285 (337)
T d1o6la_ 230 --PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQV 285 (337)
T ss_dssp --HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCC
T ss_pred --HHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHHHHHhCCCCCCCCCCC
Confidence 25899999999999999998643 4679999999999999987 56778887754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.9e-64 Score=494.38 Aligned_cols=277 Identities=38% Similarity=0.749 Sum_probs=245.1
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS 161 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 161 (489)
.+++|++++.||+|+||+||+|+++. +++.||||++++.........+.+.+|+.+|+.++|||||++++++.++
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~-----~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 76 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRH-----NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA 76 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS
T ss_pred chhHeEEEEEEecCcCcEEEEEEECC-----CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeC
Confidence 45799999999999999999999987 5789999999988766556667888999999999999999999999999
Q ss_pred ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccc
Q 011302 162 HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKC 241 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~ 241 (489)
+.+|+|||||+||+|..++... ..+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+..
T Consensus 77 ~~~~ivmE~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~ 154 (316)
T d1fota_ 77 QQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV 154 (316)
T ss_dssp SEEEEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred CeeeeEeeecCCcccccccccc--ccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEe
Confidence 9999999999999999988876 67899999999999999999999999999999999999999999999999998433
Q ss_pred ccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccc
Q 011302 242 DVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEP 321 (489)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (489)
..
T Consensus 155 ~~------------------------------------------------------------------------------ 156 (316)
T d1fota_ 155 PD------------------------------------------------------------------------------ 156 (316)
T ss_dssp SS------------------------------------------------------------------------------
T ss_pred cc------------------------------------------------------------------------------
Confidence 21
Q ss_pred cccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHH
Q 011302 322 INARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEE 401 (489)
Q Consensus 322 ~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 401 (489)
...+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+.+.++..+...+|....
T Consensus 157 ---~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s-------- 225 (316)
T d1fota_ 157 ---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFN-------- 225 (316)
T ss_dssp ---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSC--------
T ss_pred ---ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCC--------
Confidence 123458999999999999999999999999999999999999999999999999999988776664321
Q ss_pred HhhHHHHHHHHhhcCcccccCCC-CChHHHHcCCCcCCCCcccc--ccCCCCCCCCc
Q 011302 402 VVKLQDLISKLLVKNPKKRIGSL-KGSVEIKRHEFFKGINWALI--RSIKPPEVPNN 455 (489)
Q Consensus 402 ~~~l~~li~~~L~~dP~~R~~~~-~~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~~ 455 (489)
.++++||.+||+.||.+|++.. ..++++++||||++++|+.+ +.+.+|+.|..
T Consensus 226 -~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~~~p~~p~~ 281 (316)
T d1fota_ 226 -EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPI 281 (316)
T ss_dssp -HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC
T ss_pred -HHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHHHHHhCCCCcCCCCCc
Confidence 2589999999999999998643 35679999999999999976 56778877653
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-64 Score=479.86 Aligned_cols=258 Identities=34% Similarity=0.574 Sum_probs=230.4
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
..+++|++++.||+|+||+||+|+++. +++.||||++.+..........++.+|+.+|+.++|||||++++++.+
T Consensus 3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 77 (263)
T d2j4za1 3 WALEDFEIGRPLGKGKFGNVYLAREKQ-----SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD 77 (263)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred cchhHeEEEEEEecCCCcEEEEEEECC-----CCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE
Confidence 456899999999999999999999987 578999999998776655556778889999999999999999999999
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~ 240 (489)
++.+|||||||+||+|.+++... ..+++.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.
T Consensus 78 ~~~~~ivmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~ 155 (263)
T d2j4za1 78 ATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH 155 (263)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSC
T ss_pred CCEEEEEEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeee
Confidence 99999999999999999998875 5799999999999999999999999999999999999999999999999999843
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
...
T Consensus 156 ~~~----------------------------------------------------------------------------- 158 (263)
T d2j4za1 156 APS----------------------------------------------------------------------------- 158 (263)
T ss_dssp CCC-----------------------------------------------------------------------------
T ss_pred cCC-----------------------------------------------------------------------------
Confidence 211
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHH
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFE 400 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 400 (489)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+.+.++.+..+.+|...
T Consensus 159 ---~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~-------- 227 (263)
T d2j4za1 159 ---SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV-------- 227 (263)
T ss_dssp ---CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTS--------
T ss_pred ---CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccC--------
Confidence 112345799999999999999999999999999999999999999999999999999988877766432
Q ss_pred HHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 401 EVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 401 ~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
+.++++||.+||+.||++||++. |+|+||||.+
T Consensus 228 -s~~~~~li~~~L~~dp~~R~t~~----eil~hp~~~~ 260 (263)
T d2j4za1 228 -TEGARDLISRLLKHNPSQRPMLR----EVLEHPWITA 260 (263)
T ss_dssp -CHHHHHHHHHHTCSSGGGSCCHH----HHHTCHHHHH
T ss_pred -CHHHHHHHHHHccCCHhHCcCHH----HHHcCcCcCC
Confidence 12589999999999999999987 9999999963
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.9e-64 Score=497.94 Aligned_cols=279 Identities=37% Similarity=0.674 Sum_probs=245.1
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE 159 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 159 (489)
...+++|++++.||+|+||+||+|+++. +++.||||++.+...........+.+|+.+|+.++|||||+++++|.
T Consensus 37 ~~~ld~y~i~~~lG~G~fg~Vy~a~~~~-----~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 111 (350)
T d1rdqe_ 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKE-----SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred CCCccCeEEEEEeecCcCcEEEEEEECC-----CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc
Confidence 3456899999999999999999999987 57899999999877665566677889999999999999999999999
Q ss_pred cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 160 ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 160 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
+...+|+||||+.||+|..++... +.+++.+++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+
T Consensus 112 ~~~~~~~v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~ 189 (350)
T d1rdqe_ 112 DNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189 (350)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred cccccccccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeee
Confidence 999999999999999999998776 579999999999999999999999999999999999999999999999999985
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
.+..
T Consensus 190 ~~~~---------------------------------------------------------------------------- 193 (350)
T d1rdqe_ 190 RVKG---------------------------------------------------------------------------- 193 (350)
T ss_dssp ECSS----------------------------------------------------------------------------
T ss_pred eccc----------------------------------------------------------------------------
Confidence 3321
Q ss_pred cccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhH
Q 011302 320 EPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEF 399 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 399 (489)
...+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+....+.+|......+|... +
T Consensus 194 -----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~---s--- 262 (350)
T d1rdqe_ 194 -----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF---S--- 262 (350)
T ss_dssp -----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTC---C---
T ss_pred -----ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccC---C---
Confidence 12345799999999999999999999999999999999999999999999999999988877665421 1
Q ss_pred HHHhhHHHHHHHHhhcCcccccC-CCCChHHHHcCCCcCCCCcccc--ccCCCCCCCCc
Q 011302 400 EEVVKLQDLISKLLVKNPKKRIG-SLKGSVEIKRHEFFKGINWALI--RSIKPPEVPNN 455 (489)
Q Consensus 400 ~~~~~l~~li~~~L~~dP~~R~~-~~~~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~~ 455 (489)
.++.+||.+||+.||.+|+. ....+++|++||||++++|..+ +.+.||++|..
T Consensus 263 ---~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~~p~~ 318 (350)
T d1rdqe_ 263 ---SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKF 318 (350)
T ss_dssp ---HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCC
T ss_pred ---HHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHHHHHhcCCCcCccCCC
Confidence 25899999999999999963 3345669999999999999976 45678877764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-62 Score=483.95 Aligned_cols=276 Identities=38% Similarity=0.761 Sum_probs=235.3
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHH-hCCCCCcccccceeecC
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILT-MLDHPFLPTLYAEFEAS 161 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hpnIv~l~~~~~~~ 161 (489)
+++|.+++.||+|+||+||+|+++. +++.||||++.+...........+..|..++. .++|||||++++++.++
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~-----t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~ 75 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKK-----TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK 75 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETT-----TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred CCCeEEeeEEecCCCcEEEEEEECC-----CCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC
Confidence 3789999999999999999999987 68999999999876655555566666777665 68999999999999999
Q ss_pred ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccc
Q 011302 162 HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKC 241 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~ 241 (489)
+.+|||||||+||+|.+++... ..+++.+++.++.||+.||+|||++|||||||||+|||++.+|++||+|||+|+..
T Consensus 76 ~~~yivmEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~ 153 (320)
T d1xjda_ 76 ENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 153 (320)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred CceeEEEeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhc
Confidence 9999999999999999999875 57999999999999999999999999999999999999999999999999998432
Q ss_pred ccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccc
Q 011302 242 DVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEP 321 (489)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (489)
...
T Consensus 154 ~~~----------------------------------------------------------------------------- 156 (320)
T d1xjda_ 154 MLG----------------------------------------------------------------------------- 156 (320)
T ss_dssp CCT-----------------------------------------------------------------------------
T ss_pred ccc-----------------------------------------------------------------------------
Confidence 210
Q ss_pred cccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHH
Q 011302 322 INARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEE 401 (489)
Q Consensus 322 ~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 401 (489)
.......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+++.++..+.+.+|... +
T Consensus 157 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~---s----- 227 (320)
T d1xjda_ 157 -DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWL---E----- 227 (320)
T ss_dssp -TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTS---C-----
T ss_pred -cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccC---C-----
Confidence 0112345799999999999999999999999999999999999999999999999999988877666422 1
Q ss_pred HhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcccc--ccCCCCCCCCc
Q 011302 402 VVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALI--RSIKPPEVPNN 455 (489)
Q Consensus 402 ~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~~ 455 (489)
.++++||.+||+.||++||++.. ++++||||++++|+.+ +.+.||.+|..
T Consensus 228 -~~~~dli~~~L~~dP~~R~s~~~---~l~~hpff~~~~~~~l~~~~~~pp~~p~~ 279 (320)
T d1xjda_ 228 -KEAKDLLVKLFVREPEKRLGVRG---DIRQHPLFREINWEELERKEIDPPFRPKV 279 (320)
T ss_dssp -HHHHHHHHHHSCSSGGGSBTTBS---CGGGSGGGTTCCHHHHHTTCSCC------
T ss_pred -HHHHHHHHHhcccCCCCCcCHHH---HHHhCchhccCCHHHHHhcCCCCCCCCCC
Confidence 25899999999999999999842 7999999999999976 56677777654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.8e-62 Score=487.02 Aligned_cols=279 Identities=31% Similarity=0.610 Sum_probs=229.9
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHH---HHHHHhCCCCCccccccee
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADME---KVILTMLDHPFLPTLYAEF 158 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E---~~~l~~l~hpnIv~l~~~~ 158 (489)
.+++|++++.||+|+||+||+|+++. +++.||||++.+...........+.+| +.+++.++|||||+++++|
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~-----t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~ 76 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKAD-----TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF 76 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECC-----CCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE
Confidence 56899999999999999999999987 578999999987766544333334444 5667777899999999999
Q ss_pred ecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 159 EASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
.+.+.+|||||||+||+|.+++... ..+++.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|
T Consensus 77 ~~~~~~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla 154 (364)
T d1omwa3 77 HTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 154 (364)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTC
T ss_pred EECCEEEEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeecee
Confidence 9999999999999999999999875 67999999999999999999999999999999999999999999999999998
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
+.+..
T Consensus 155 ~~~~~--------------------------------------------------------------------------- 159 (364)
T d1omwa3 155 CDFSK--------------------------------------------------------------------------- 159 (364)
T ss_dssp EECSS---------------------------------------------------------------------------
T ss_pred eecCC---------------------------------------------------------------------------
Confidence 43221
Q ss_pred ccccccCCccccCCCCccCcchhcC-CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHH---HHHHHhcCCCCCCCCCCC
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEK---TLINILKKPLTFPRIGVS 394 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~---~~~~i~~~~~~~p~~~~~ 394 (489)
......+||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+.+..+ ....+......+|..
T Consensus 160 -----~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--- 231 (364)
T d1omwa3 160 -----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS--- 231 (364)
T ss_dssp -----SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSS---
T ss_pred -----CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCC---
Confidence 11234579999999999974 568999999999999999999999998765432 233333344333321
Q ss_pred CchhHHHHhhHHHHHHHHhhcCcccccCCC-CChHHHHcCCCcCCCCcccc--ccCCCCCCCCcc
Q 011302 395 SSKEFEEVVKLQDLISKLLVKNPKKRIGSL-KGSVEIKRHEFFKGINWALI--RSIKPPEVPNND 456 (489)
Q Consensus 395 ~~~~~~~~~~l~~li~~~L~~dP~~R~~~~-~~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~~~ 456 (489)
.+ .++++||.+||+.||++||+.. ..++++++||||++++|..+ +.+.||++|...
T Consensus 232 ~s------~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~~~~~~p~~p~~~ 290 (364)
T d1omwa3 232 FS------PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRG 290 (364)
T ss_dssp SC------HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC
T ss_pred CC------HHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHHhcCCCCcCcCCCCC
Confidence 11 2589999999999999999964 34679999999999999976 667788887643
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-63 Score=473.54 Aligned_cols=260 Identities=27% Similarity=0.428 Sum_probs=212.9
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.++|++++.||+|+||+||+|+++. +++.||||++...... +..+++.+|+.+|+.++|||||++++++.+++
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~-----~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~ 76 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRV-----TEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGN 76 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred CcceEEEEEEecCcCeEEEEEEECC-----CCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCc
Confidence 4789999999999999999999987 5789999999765432 23456788999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
.+|||||||+||+|.+++... ..+++.+++.|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.+.
T Consensus 77 ~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~ 154 (271)
T d1nvra_ 77 IQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR 154 (271)
T ss_dssp EEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECE
T ss_pred eeEEEEeccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeec
Confidence 999999999999999988654 679999999999999999999999999999999999999999999999999985432
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
... .
T Consensus 155 ~~~----------------------------------------------------------------------------~ 158 (271)
T d1nvra_ 155 YNN----------------------------------------------------------------------------R 158 (271)
T ss_dssp ETT----------------------------------------------------------------------------E
T ss_pred cCC----------------------------------------------------------------------------c
Confidence 100 0
Q ss_pred ccCCccccCCCCccCcchhcCCCC-CCcccHHHHHHHHHHHhhCCCCCCCCCcHH-HHHHHhcCCCCCCCCCCCCchhHH
Q 011302 323 NARSKSFVGTHEYLAPEVISGQGH-GSAVDWWTLGVFLYEMLYGTTPFKGENNEK-TLINILKKPLTFPRIGVSSSKEFE 400 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~~-~~~~DiwSlGvil~elltG~~Pf~~~~~~~-~~~~i~~~~~~~p~~~~~~~~~~~ 400 (489)
.....+.+||+.|||||++.+..+ +.++|||||||++|||++|+.||.+.+... .+..+.......+....
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------- 231 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK------- 231 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGG-------
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCcccc-------
Confidence 112345689999999999998886 678999999999999999999998765443 33333333222221111
Q ss_pred HHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 401 EVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 401 ~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
.+.++++||.+||+.||++||++. |+++||||+.
T Consensus 232 ~s~~~~~li~~~L~~dP~~R~t~~----eil~hpwf~~ 265 (271)
T d1nvra_ 232 IDSAPLALLHKILVENPSARITIP----DIKKDRWYNK 265 (271)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHH----HHTTCTTTTC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHH----HHhcCHhhCc
Confidence 123589999999999999999987 9999999974
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-61 Score=473.21 Aligned_cols=260 Identities=32% Similarity=0.474 Sum_probs=212.1
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.+.|++++.||+|+||+||+|+++. +++.||||++.+..... ....+.+|+.+|+.++|||||+++++|.+++
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 80 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKR-----TQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGG 80 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETT-----TCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEEEEeeccCeEEEEEEECC-----CCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 3679999999999999999999987 57899999998765432 2345778999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEec---cCCcEEEcccCCCc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVR---EDGHIMLSDFDLSF 239 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~---~~~~vkl~DFG~a~ 239 (489)
.+|||||||+||+|.+++... +.+++.+++.|+.||+.||+|||++|||||||||+|||+. .+|.+||+|||+|+
T Consensus 81 ~~~lvmE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~ 158 (307)
T d1a06a_ 81 HLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158 (307)
T ss_dssp EEEEEECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred EEEEEEeccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeE
Confidence 999999999999999999775 6799999999999999999999999999999999999995 57899999999984
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
....
T Consensus 159 ~~~~---------------------------------------------------------------------------- 162 (307)
T d1a06a_ 159 MEDP---------------------------------------------------------------------------- 162 (307)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred EccC----------------------------------------------------------------------------
Confidence 3211
Q ss_pred cccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhH
Q 011302 320 EPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEF 399 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 399 (489)
.....+.+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+..+....+......++.......
T Consensus 163 ---~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~--- 236 (307)
T d1a06a_ 163 ---GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI--- 236 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTS---
T ss_pred ---CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCC---
Confidence 01123458999999999999999999999999999999999999999999999999999887766654332221
Q ss_pred HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 400 EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 400 ~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
+.++++||.+||+.||++||++. |+++||||++.
T Consensus 237 --s~~~~~li~~~L~~dP~~R~s~~----eil~hp~~~~~ 270 (307)
T d1a06a_ 237 --SDSAKDFIRHLMEKDPEKRFTCE----QALQHPWIAGD 270 (307)
T ss_dssp --CHHHHHHHHHHSCSSGGGSCCHH----HHHHSTTTTSS
T ss_pred --CHHHHHHHHHHccCCHhHCcCHH----HHhcCHhhCCC
Confidence 13589999999999999999987 99999999863
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-61 Score=469.67 Aligned_cols=256 Identities=24% Similarity=0.385 Sum_probs=218.4
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.++|++++.||+|+||+||+|+++. +++.||||++...... ..+.+.+|+.+|+.++|||||+++++|.+++
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~-----~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 90 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVA-----TGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGD 90 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTT-----TCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ccccEEEEEEecCcCcEEEEEEECC-----CCCEEEEEEEecccCh---HHHHHHHHHHHHHhCCCCCEeeEeEEEEECC
Confidence 3579999999999999999999886 5789999999765322 2345778999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
.+|||||||+||+|.+++.. +.+++.+++.|+.||+.||+|||++|||||||||+|||++.+|++||+|||+|+.+.
T Consensus 91 ~~~ivmEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~ 167 (293)
T d1yhwa1 91 ELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (293)
T ss_dssp EEEEEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEEEecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeec
Confidence 99999999999999998876 369999999999999999999999999999999999999999999999999985432
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
..
T Consensus 168 ~~------------------------------------------------------------------------------ 169 (293)
T d1yhwa1 168 PE------------------------------------------------------------------------------ 169 (293)
T ss_dssp ST------------------------------------------------------------------------------
T ss_pred cc------------------------------------------------------------------------------
Confidence 10
Q ss_pred ccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCC-CCCCCCCCCchhHHH
Q 011302 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL-TFPRIGVSSSKEFEE 401 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~~~~ 401 (489)
.......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+.+..+..... .++.... .
T Consensus 170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-------~ 242 (293)
T d1yhwa1 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK-------L 242 (293)
T ss_dssp TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGG-------S
T ss_pred cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccc-------C
Confidence 1122345899999999999999999999999999999999999999999888777776665322 2221111 1
Q ss_pred HhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 402 VVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 402 ~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
+..+++||.+||+.||++||++. |+|+||||+.
T Consensus 243 s~~~~~li~~~L~~dP~~R~s~~----eil~Hp~~~~ 275 (293)
T d1yhwa1 243 SAIFRDFLNRCLDMDVEKRGSAK----ELLQHQFLKI 275 (293)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHH----HHTTCGGGGG
T ss_pred CHHHHHHHHHHccCChhHCcCHH----HHhcCHhhCC
Confidence 23589999999999999999987 9999999974
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-61 Score=470.42 Aligned_cols=266 Identities=29% Similarity=0.458 Sum_probs=223.6
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHH---HHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIR---KKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
++|++++.||+|+||+||+|+++. +++.||||++.+...... .....+.+|+.+|+.++|||||+++++|.+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~-----~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 84 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKS-----TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN 84 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred cCEEEeEEEecCCCeEEEEEEECC-----CCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 679999999999999999999986 578999999975432211 123467789999999999999999999999
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCC----cEEEcccC
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDG----HIMLSDFD 236 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~----~vkl~DFG 236 (489)
.+.+|||||||+||+|.+++... +.+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||
T Consensus 85 ~~~~~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 85 KTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred CCEEEEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchh
Confidence 99999999999999999998775 5799999999999999999999999999999999999998776 59999999
Q ss_pred CCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcc
Q 011302 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPE 316 (489)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (489)
+|+.+..
T Consensus 163 ~a~~~~~------------------------------------------------------------------------- 169 (293)
T d1jksa_ 163 LAHKIDF------------------------------------------------------------------------- 169 (293)
T ss_dssp TCEECTT-------------------------------------------------------------------------
T ss_pred hhhhcCC-------------------------------------------------------------------------
Confidence 9844321
Q ss_pred ccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCc
Q 011302 317 VVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSS 396 (489)
Q Consensus 317 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 396 (489)
.....+.+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......++......
T Consensus 170 ------~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~- 242 (293)
T d1jksa_ 170 ------GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN- 242 (293)
T ss_dssp ------SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTT-
T ss_pred ------CccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCC-
Confidence 0112345799999999999999999999999999999999999999999999999999988766654321111
Q ss_pred hhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcccc
Q 011302 397 KEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALI 444 (489)
Q Consensus 397 ~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~ 444 (489)
.+..+++||.+||+.||++||++. ++++||||+..+|...
T Consensus 243 ----~s~~~~~li~~~L~~dP~~R~s~~----eil~hp~~~~~~~~~~ 282 (293)
T d1jksa_ 243 ----TSALAKDFIRRLLVKDPKKRMTIQ----DSLQHPWIKPKDTQQA 282 (293)
T ss_dssp ----SCHHHHHHHHTTSCSSGGGSCCHH----HHHHSTTTCC------
T ss_pred ----CCHHHHHHHHHHccCChhHCcCHH----HHhcCcccCCCChhHh
Confidence 123589999999999999999987 9999999999999754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.8e-61 Score=476.42 Aligned_cols=268 Identities=28% Similarity=0.407 Sum_probs=229.9
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
+++|++++.||+|+||+||+|+++. +++.||||++.+.... ..+.+.+|+.+|+.++|||||+++++|.+++
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~-----~g~~vAvK~i~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 96 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERA-----TGNNFAAKFVMTPHES---DKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 96 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT-----TTEEEEEEEECCCSHH---HHHHHHHHHHHHHHTCCTTBCCEEEEEEETT
T ss_pred ccCeEEEEEEecCcCeEEEEEEECC-----CCCEEEEEEEcccchh---hHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 5789999999999999999999987 6789999999765433 2346778999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEec--cCCcEEEcccCCCcc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVR--EDGHIMLSDFDLSFK 240 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~--~~~~vkl~DFG~a~~ 240 (489)
.+|||||||+||+|.+++... .+.+++.+++.|+.||+.||+|||++|||||||||+||||+ .+|.+||+|||+|+.
T Consensus 97 ~~~ivmE~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~ 175 (350)
T d1koaa2 97 EMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175 (350)
T ss_dssp EEEEEECCCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchhee
Confidence 999999999999999988654 35699999999999999999999999999999999999996 468899999999854
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
+...
T Consensus 176 ~~~~---------------------------------------------------------------------------- 179 (350)
T d1koaa2 176 LDPK---------------------------------------------------------------------------- 179 (350)
T ss_dssp CCTT----------------------------------------------------------------------------
T ss_pred cccc----------------------------------------------------------------------------
Confidence 3210
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHH
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFE 400 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 400 (489)
....+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+.+..|......++......
T Consensus 180 ---~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~----- 251 (350)
T d1koaa2 180 ---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG----- 251 (350)
T ss_dssp ---SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGG-----
T ss_pred ---cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccC-----
Confidence 112345799999999999999999999999999999999999999999999999999988776665432221
Q ss_pred HHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccccccC
Q 011302 401 EVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWALIRSI 447 (489)
Q Consensus 401 ~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~~~~~ 447 (489)
...++++||.+||+.||++|||+. |+|+||||+..+|......
T Consensus 252 ~s~~~~~li~~~L~~dP~~R~t~~----eil~hp~~~~~~~~~~~~~ 294 (350)
T d1koaa2 252 ISEDGKDFIRKLLLADPNTRMTIH----QALEHPWLTPGNAPGRDSQ 294 (350)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHH----HHHHSTTTSCTTCCSCCCC
T ss_pred CCHHHHHHHHHHccCChhHCcCHH----HHhcCcccCCCCCCCchhh
Confidence 123589999999999999999987 9999999999887654433
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-61 Score=467.64 Aligned_cols=258 Identities=30% Similarity=0.433 Sum_probs=219.1
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCce
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHY 163 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 163 (489)
+.|++++.||+|+||+||+|+++. +++.||||++.+.. ....+++.+|+.+|+.++|||||++++++.+++.
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~-----~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 83 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKE-----TSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENN 83 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECC-----CCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCe
Confidence 579999999999999999999987 57899999997542 2345677889999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccccc
Q 011302 164 SCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDV 243 (489)
Q Consensus 164 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~ 243 (489)
+|||||||+||+|.+++... .+.+++.+++.|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+....
T Consensus 84 ~~lvmEy~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 84 LWILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred EEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence 99999999999999987654 25699999999999999999999999999999999999999999999999999843211
Q ss_pred CccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccc
Q 011302 244 VPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPIN 323 (489)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (489)
. .
T Consensus 163 ~------------------------------------------------------------------------------~ 164 (288)
T d2jfla1 163 T------------------------------------------------------------------------------I 164 (288)
T ss_dssp H------------------------------------------------------------------------------H
T ss_pred C------------------------------------------------------------------------------c
Confidence 0 0
Q ss_pred cCCccccCCCCccCcchhc-----CCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchh
Q 011302 324 ARSKSFVGTHEYLAPEVIS-----GQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKE 398 (489)
Q Consensus 324 ~~~~~~~Gt~~y~aPE~l~-----~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 398 (489)
....+.+||+.|||||++. +..|+.++|||||||++|||++|+.||.+.+..+.+.++.............
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~---- 240 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSR---- 240 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGG----
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccc----
Confidence 1123457999999999984 4558899999999999999999999999999888888888764322211111
Q ss_pred HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 399 FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 399 ~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
.+.++++||.+||+.||++||++. |+++||||+.
T Consensus 241 --~s~~~~~li~~~L~~dp~~R~t~~----ell~hp~~~~ 274 (288)
T d2jfla1 241 --WSSNFKDFLKKCLEKNVDARWTTS----QLLQHPFVTV 274 (288)
T ss_dssp --SCHHHHHHHHHHSCSSTTTSCCHH----HHTTSGGGCC
T ss_pred --CCHHHHHHHHHHccCChhHCcCHH----HHhcCcccCC
Confidence 123589999999999999999987 9999999975
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-61 Score=477.68 Aligned_cols=271 Identities=25% Similarity=0.344 Sum_probs=215.6
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE 159 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 159 (489)
++..++|++++.||+|+||+||+|+++. +++.||||+++++.. .....++.+|+.+|+.++|||||+++++|.
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~-----~~~~vAiK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 74 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKP-----SGLVMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFY 74 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETT-----TTEEEEEEEEECCCC--TTHHHHHHHHGGGGGGCCCTTBCCEEEEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECC-----CCcEEEEEEEChhhC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 3556899999999999999999999986 678999999975421 123356778999999999999999999999
Q ss_pred cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHh-CCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 160 ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHM-MGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 160 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
+.+++|||||||+||+|.+++.+. +.+++..++.++.||+.||.|||+ +|||||||||+||||+.+|.+||+|||+|
T Consensus 75 ~~~~~~iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla 152 (322)
T d1s9ja_ 75 SDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 152 (322)
T ss_dssp CSSEEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred ECCEEEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCc
Confidence 999999999999999999999875 579999999999999999999997 59999999999999999999999999998
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
+.+..
T Consensus 153 ~~~~~--------------------------------------------------------------------------- 157 (322)
T d1s9ja_ 153 GQLID--------------------------------------------------------------------------- 157 (322)
T ss_dssp HHHHH---------------------------------------------------------------------------
T ss_pred cccCC---------------------------------------------------------------------------
Confidence 43210
Q ss_pred ccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHh---cCC-CCCCCC---
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINIL---KKP-LTFPRI--- 391 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~---~~~-~~~p~~--- 391 (489)
....+++||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+......... .+. ...+..
T Consensus 158 -----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
T d1s9ja_ 158 -----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232 (322)
T ss_dssp -----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred -----CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccc
Confidence 12235689999999999999999999999999999999999999998765433211100 000 000000
Q ss_pred -----------CCC-----------------CchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccc
Q 011302 392 -----------GVS-----------------SSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWAL 443 (489)
Q Consensus 392 -----------~~~-----------------~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~ 443 (489)
... .......+.+++|||.+||+.||++|||+. |+|+||||+..+|+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~----e~L~Hpf~~~~~~~~ 308 (322)
T d1s9ja_ 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK----QLMVHAFIKRSDAEE 308 (322)
T ss_dssp -------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHH----HHHTSHHHHHHHHSC
T ss_pred ccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHH----HHhhCHhhCcCCccc
Confidence 000 000000123589999999999999999997 999999998877653
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.9e-60 Score=472.21 Aligned_cols=260 Identities=28% Similarity=0.448 Sum_probs=225.5
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.++|++++.||+|+||+||+|+++. +++.||||++.+..... ...+.+|+.+|+.++|||||+++++|.+++
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~-----~~~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 99 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKA-----TGRVFVAKFINTPYPLD---KYTVKNEISIMNQLHHPKLINLHDAFEDKY 99 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECCSHHH---HHHHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred ccceEEEEEEecCCCeEEEEEEECC-----CCCEEEEEEECCcchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 4689999999999999999999886 57899999997654322 245677999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEec--cCCcEEEcccCCCcc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVR--EDGHIMLSDFDLSFK 240 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~--~~~~vkl~DFG~a~~ 240 (489)
.+|||||||+||+|.+++... +.++++.+++.|+.||+.||+|||++|||||||||+||||+ .+|.+||+|||+|+.
T Consensus 100 ~~~ivmE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~ 178 (352)
T d1koba_ 100 EMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATK 178 (352)
T ss_dssp EEEEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeeccccee
Confidence 999999999999999877554 35799999999999999999999999999999999999998 678999999999854
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
+..
T Consensus 179 ~~~----------------------------------------------------------------------------- 181 (352)
T d1koba_ 179 LNP----------------------------------------------------------------------------- 181 (352)
T ss_dssp CCT-----------------------------------------------------------------------------
T ss_pred cCC-----------------------------------------------------------------------------
Confidence 321
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHH
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFE 400 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 400 (489)
.......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+.+.+|......++........
T Consensus 182 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s--- 256 (352)
T d1koba_ 182 --DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVS--- 256 (352)
T ss_dssp --TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSC---
T ss_pred --CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCC---
Confidence 011234579999999999999999999999999999999999999999999999999998887776654332221
Q ss_pred HHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 401 EVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 401 ~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
.++.+||.+||+.||++||++. |+|+||||++.
T Consensus 257 --~~~~~li~~~L~~dp~~R~s~~----eil~Hp~~~~~ 289 (352)
T d1koba_ 257 --PEAKDFIKNLLQKEPRKRLTVH----DALEHPWLKGD 289 (352)
T ss_dssp --HHHHHHHHTTSCSSGGGSCCHH----HHHTSTTTSSC
T ss_pred --HHHHHHHHHHccCChhHCcCHH----HHhcCHhhCCC
Confidence 2589999999999999999987 99999999874
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-60 Score=453.56 Aligned_cols=254 Identities=22% Similarity=0.359 Sum_probs=208.7
Q ss_pred CCc-eeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec--
Q 011302 84 DHF-RLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA-- 160 (489)
Q Consensus 84 ~~y-~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-- 160 (489)
++| ++.++||+|+||+||+|+++. +++.||+|++...... .....++.+|+.+|+.++|||||+++++|.+
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~-----~~~~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 81 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTE-----TTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 81 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred CCEEEeeeEEecCcCcEEEEEEECC-----CCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc
Confidence 344 778899999999999999987 5678999999765432 2335668889999999999999999999864
Q ss_pred --CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCC--CeeecCCCCCeEec-cCCcEEEccc
Q 011302 161 --SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMG--IVYRDLKPENVLVR-EDGHIMLSDF 235 (489)
Q Consensus 161 --~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDIKp~NILl~-~~~~vkl~DF 235 (489)
+..+|||||||+||+|.+++.+. ..+++.+++.|+.||+.||+|||+++ ||||||||+||||+ .++.+||+||
T Consensus 82 ~~~~~~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DF 159 (270)
T d1t4ha_ 82 KGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL 159 (270)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred ccCCEEEEEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeec
Confidence 46789999999999999999875 57999999999999999999999999 99999999999997 5899999999
Q ss_pred CCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCc
Q 011302 236 DLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDP 315 (489)
Q Consensus 236 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (489)
|+|+...
T Consensus 160 Gla~~~~------------------------------------------------------------------------- 166 (270)
T d1t4ha_ 160 GLATLKR------------------------------------------------------------------------- 166 (270)
T ss_dssp TGGGGCC-------------------------------------------------------------------------
T ss_pred Ccceecc-------------------------------------------------------------------------
Confidence 9983211
Q ss_pred cccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHH-HHHHhcCCCCCCCCCCC
Q 011302 316 EVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKT-LINILKKPLTFPRIGVS 394 (489)
Q Consensus 316 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~-~~~i~~~~~~~p~~~~~ 394 (489)
.....+.+||+.|||||++.+ .++.++|||||||++|||++|+.||.+...... ...+..+.. .+.....
T Consensus 167 -------~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~-~~~~~~~ 237 (270)
T d1t4ha_ 167 -------ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK-PASFDKV 237 (270)
T ss_dssp -------TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC-CGGGGGC
T ss_pred -------CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCC-CcccCcc
Confidence 011234589999999999876 599999999999999999999999987665544 444444322 1111111
Q ss_pred CchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcC
Q 011302 395 SSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFK 437 (489)
Q Consensus 395 ~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~ 437 (489)
. .+++++||.+||+.||++||++. |+|+||||+
T Consensus 238 ~------~~~~~~li~~~l~~dp~~R~s~~----ell~Hp~fk 270 (270)
T d1t4ha_ 238 A------IPEVKEIIEGCIRQNKDERYSIK----DLLNHAFFQ 270 (270)
T ss_dssp C------CHHHHHHHHHHSCSSGGGSCCHH----HHHTSGGGC
T ss_pred C------CHHHHHHHHHHccCCHhHCcCHH----HHhCCcccC
Confidence 1 23589999999999999999987 999999996
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-60 Score=464.12 Aligned_cols=254 Identities=27% Similarity=0.353 Sum_probs=218.7
Q ss_pred CceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceE
Q 011302 85 HFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYS 164 (489)
Q Consensus 85 ~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 164 (489)
.|++++.||+|+||+||+|+++. +++.||||++.+...........+.+|+.+|+.++|||||+++++|.+++.+
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 90 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVR-----NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA 90 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETT-----TTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred hcEeeEEEecCCCeEEEEEEECC-----CCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEE
Confidence 49999999999999999999887 5789999999765444445567788899999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccC
Q 011302 165 CLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVV 244 (489)
Q Consensus 165 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~ 244 (489)
|||||||.||+|..++... +.+++.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+...
T Consensus 91 ~iv~E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~-- 166 (309)
T d1u5ra_ 91 WLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-- 166 (309)
T ss_dssp EEEEECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS--
T ss_pred EEEEEecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccC--
Confidence 9999999999997766654 679999999999999999999999999999999999999999999999999984321
Q ss_pred ccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccccc
Q 011302 245 PKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINA 324 (489)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (489)
T Consensus 167 -------------------------------------------------------------------------------- 166 (309)
T d1u5ra_ 167 -------------------------------------------------------------------------------- 166 (309)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCccccCCCCccCcchhcC---CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHH
Q 011302 325 RSKSFVGTHEYLAPEVISG---QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEE 401 (489)
Q Consensus 325 ~~~~~~Gt~~y~aPE~l~~---~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 401 (489)
.....+||+.|||||++.+ ..|+.++|||||||++|||++|..||.+.+..+.+.++..+....+.... .
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~-~------ 239 (309)
T d1u5ra_ 167 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH-W------ 239 (309)
T ss_dssp SBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTT-S------
T ss_pred CCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCC-C------
Confidence 1123479999999999975 34899999999999999999999999999888888888765443222111 1
Q ss_pred HhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 402 VVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 402 ~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
+.++++||.+||+.||++||++. ++++||||..
T Consensus 240 s~~~~~li~~~L~~dP~~Rpt~~----ell~Hp~~~~ 272 (309)
T d1u5ra_ 240 SEYFRNFVDSCLQKIPQDRPTSE----VLLKHRFVLR 272 (309)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHH----HHTTCHHHHS
T ss_pred CHHHHHHHHHHCcCChhHCcCHH----HHHhCHHhcC
Confidence 12589999999999999999987 9999999964
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-60 Score=458.43 Aligned_cols=258 Identities=24% Similarity=0.346 Sum_probs=209.2
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec--
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA-- 160 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-- 160 (489)
.++|++++.||+|+||+||+|+++. +++.||||++...... +.....+.+|+.+|+.++|||||++++++.+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~-----~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 76 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKS-----DGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT 76 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-----TCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC--
T ss_pred chhCEEeEEEecCCCeEEEEEEECC-----CCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCC
Confidence 4789999999999999999999987 5789999999765432 2334567889999999999999999999864
Q ss_pred CceEEEEEeecCCCchHHHHHhC--CCCCCChhhHHHHHHHHHHHHHHHHhCC-----CeeecCCCCCeEeccCCcEEEc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQ--PGKRFGISSAKFYAAETLLALEYLHMMG-----IVYRDLKPENVLVREDGHIMLS 233 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~yLH~~~-----iiHrDIKp~NILl~~~~~vkl~ 233 (489)
++.+|||||||+||+|.+++... ....+++..++.++.||+.||+|||++| ||||||||+||||+.+|.+||+
T Consensus 77 ~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~ 156 (269)
T d2java1 77 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG 156 (269)
T ss_dssp --CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEEC
T ss_pred CCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEe
Confidence 56789999999999999988642 2357999999999999999999999876 9999999999999999999999
Q ss_pred ccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccC
Q 011302 234 DFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLD 313 (489)
Q Consensus 234 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (489)
|||+|+.+...
T Consensus 157 DFG~a~~~~~~--------------------------------------------------------------------- 167 (269)
T d2java1 157 DFGLARILNHD--------------------------------------------------------------------- 167 (269)
T ss_dssp CHHHHHHC------------------------------------------------------------------------
T ss_pred eccceeecccC---------------------------------------------------------------------
Confidence 99998543210
Q ss_pred CccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCC
Q 011302 314 DPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGV 393 (489)
Q Consensus 314 ~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~ 393 (489)
.....+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+...+|..+...... .
T Consensus 168 ---------~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~--~ 236 (269)
T d2java1 168 ---------TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP--Y 236 (269)
T ss_dssp -----------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCC--T
T ss_pred ---------CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC--c
Confidence 01123458999999999999999999999999999999999999999999988888888776543211 1
Q ss_pred CCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 394 SSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 394 ~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
..+ .++.+||.+||+.||++||++. |+++|||.
T Consensus 237 ~~s------~~l~~li~~~L~~dp~~Rps~~----ell~hp~i 269 (269)
T d2java1 237 RYS------DELNEIITRMLNLKDYHRPSVE----EILENPLI 269 (269)
T ss_dssp TSC------HHHHHHHHHHTCSSGGGSCCHH----HHHTSTTC
T ss_pred ccC------HHHHHHHHHHcCCChhHCcCHH----HHHhCCcC
Confidence 111 2589999999999999999987 99999995
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8.3e-59 Score=446.97 Aligned_cols=262 Identities=29% Similarity=0.440 Sum_probs=224.5
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHH------HHHHHHHHHHHHHHHHHHhCC-CCCccccc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREA------LAIRKKLHRADMEKVILTMLD-HPFLPTLY 155 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~ 155 (489)
.++|++++.||+|+||+||+|+++. +++.||||++.+.. ........++.+|+.+|+.++ |||||+++
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~-----~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 76 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKP-----TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK 76 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred cccCEEceEEecCcCeEEEEEEECC-----CCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEE
Confidence 3789999999999999999999876 57899999986532 222345567888999999997 99999999
Q ss_pred ceeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEccc
Q 011302 156 AEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDF 235 (489)
Q Consensus 156 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DF 235 (489)
++|.+++.+|||||||+||+|.+++... +.+++.+++.|+.||+.||+|||++|||||||||+|||++.++.+||+||
T Consensus 77 ~~~~~~~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 77 DTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred eecccCcceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccc
Confidence 9999999999999999999999999775 57999999999999999999999999999999999999999999999999
Q ss_pred CCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCc
Q 011302 236 DLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDP 315 (489)
Q Consensus 236 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (489)
|+|+....
T Consensus 155 G~a~~~~~------------------------------------------------------------------------ 162 (277)
T d1phka_ 155 GFSCQLDP------------------------------------------------------------------------ 162 (277)
T ss_dssp TTCEECCT------------------------------------------------------------------------
T ss_pred hheeEccC------------------------------------------------------------------------
Confidence 99843321
Q ss_pred cccccccccCCccccCCCCccCcchhcC------CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCC
Q 011302 316 EVVAEPINARSKSFVGTHEYLAPEVISG------QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFP 389 (489)
Q Consensus 316 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p 389 (489)
.......+||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+..+....+..+...++
T Consensus 163 -------~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~ 235 (277)
T d1phka_ 163 -------GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 235 (277)
T ss_dssp -------TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred -------CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 011234579999999999863 3468899999999999999999999999998888888888776655
Q ss_pred CCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 390 RIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 390 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
...... .+.++++||.+||+.||++||++. +||+||||+..
T Consensus 236 ~~~~~~-----~s~~~~~li~~~L~~~p~~R~s~~----eil~h~~~~~~ 276 (277)
T d1phka_ 236 SPEWDD-----YSDTVKDLVSRFLVVQPQKRYTAE----EALAHPFFQQY 276 (277)
T ss_dssp TTTGGG-----SCHHHHHHHHHHCCSSGGGSCCHH----HHTTSGGGCTT
T ss_pred Cccccc-----CCHHHHHHHHHHccCChhHCcCHH----HHHcCHHHHHh
Confidence 432221 123589999999999999999987 99999999863
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-58 Score=455.77 Aligned_cols=258 Identities=24% Similarity=0.400 Sum_probs=222.5
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.++|++++.||+|+||+||+|+++. +++.||||++++.... ...+.+|+.+|+.++|||||+++++|++++
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~-----~~~~~AiK~i~~~~~~----~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 74 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETS-----SKKTYMAKFVKVKGTD----QVLVKKEISILNIARHRNILHLHESFESME 74 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECCCTHH----HHHHHHHHHHHHHSCCTTBCCEEEEEEETT
T ss_pred ccceEEEEEEecCCCeEEEEEEECC-----CCcEEEEEEEcCCccc----HHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 4789999999999999999999987 5789999999865432 234667999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccC--CcEEEcccCCCcc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRED--GHIMLSDFDLSFK 240 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~--~~vkl~DFG~a~~ 240 (489)
++|||||||+||+|.+++... +..+++.+++.|+.||+.||+|||++|||||||||+|||++.+ +.+||+|||+++.
T Consensus 75 ~~~lvmE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~ 153 (321)
T d1tkia_ 75 ELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred EEEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhc
Confidence 999999999999999998765 2469999999999999999999999999999999999999854 5899999999843
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
...
T Consensus 154 ~~~----------------------------------------------------------------------------- 156 (321)
T d1tkia_ 154 LKP----------------------------------------------------------------------------- 156 (321)
T ss_dssp CCT-----------------------------------------------------------------------------
T ss_pred ccc-----------------------------------------------------------------------------
Confidence 211
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHH
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFE 400 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 400 (489)
.......+||+.|+|||.+.+..|+.++|||||||++|||++|..||.+.+..+.+.+|....+.++......
T Consensus 157 --~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~----- 229 (321)
T d1tkia_ 157 --GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKE----- 229 (321)
T ss_dssp --TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTT-----
T ss_pred --CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccC-----
Confidence 0112334799999999999999999999999999999999999999999999999999998877665422111
Q ss_pred HHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 401 EVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 401 ~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
.+.++++||.+||+.||++||++. |+++||||+.
T Consensus 230 ~s~~~~~li~~~L~~dp~~R~s~~----eil~hp~~~~ 263 (321)
T d1tkia_ 230 ISIEAMDFVDRLLVKERKSRMTAS----EALQHPWLKQ 263 (321)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHH----HHHHSHHHHS
T ss_pred CCHHHHHHHHHHccCChhHCcCHH----HHhcCHhhcc
Confidence 123589999999999999999987 9999999964
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-57 Score=444.88 Aligned_cols=269 Identities=26% Similarity=0.365 Sum_probs=214.8
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
+++|++++.||+|+||+||+|+++. +++.||||+++.+... .....++.+|+.+|+.++|||||+++++|.+++
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~ 74 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKL-----TGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTEN 74 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETT-----TCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCCCEeccEEecCcCeEEEEEEECC-----CCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEEecccccccc
Confidence 4799999999999999999999987 5789999999765432 334567888999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
++|+|||||. |++.+++.......+++.+++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||+|+...
T Consensus 75 ~~~iv~e~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~ 153 (298)
T d1gz8a_ 75 KLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153 (298)
T ss_dssp EEEEEEECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHC
T ss_pred ceeEEEeecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceecc
Confidence 9999999995 556566655555779999999999999999999999999999999999999999999999999984321
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
. .
T Consensus 154 ~------------------------------------------------------------------------------~ 155 (298)
T d1gz8a_ 154 V------------------------------------------------------------------------------P 155 (298)
T ss_dssp C------------------------------------------------------------------------------C
T ss_pred C------------------------------------------------------------------------------C
Confidence 1 0
Q ss_pred ccCCccccCCCCccCcchhcCCCC-CCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCC---------
Q 011302 323 NARSKSFVGTHEYLAPEVISGQGH-GSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIG--------- 392 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~~-~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~--------- 392 (489)
.......+||+.|+|||++....+ +.++|||||||++|+|++|+.||.+.+..+.+.++...........
T Consensus 156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (298)
T d1gz8a_ 156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235 (298)
T ss_dssp SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence 112234579999999999887764 8899999999999999999999999988877776643111100000
Q ss_pred ------CCCchhH-----HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 393 ------VSSSKEF-----EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 393 ------~~~~~~~-----~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
......+ ....++++||++||+.||++|||+. |||+||||+.++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~----ell~H~ff~~~~ 290 (298)
T d1gz8a_ 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAK----AALAHPFFQDVT 290 (298)
T ss_dssp CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHH----HHHTSGGGTTCC
T ss_pred cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHH----HHhCCHhhccCC
Confidence 0000000 1123689999999999999999997 999999998763
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-58 Score=446.80 Aligned_cols=264 Identities=28% Similarity=0.355 Sum_probs=208.5
Q ss_pred eeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHH--HHHHHHHHHHHHHHHhCCCCCcccccceeecCceEE
Q 011302 88 LLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAI--RKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSC 165 (489)
Q Consensus 88 ~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 165 (489)
.+++||+|+||+||+|+++. +++.||||+++...... .....++.+|+.+|+.++|||||+++++|.+++++|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKN-----TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSS-----CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred cceEeccCcCeEEEEEEECC-----CCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCcee
Confidence 46789999999999999886 57899999997654332 223456888999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCc
Q 011302 166 LVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVP 245 (489)
Q Consensus 166 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~ 245 (489)
||||||.|+++..+... ...+++.+++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.+...
T Consensus 77 ivmE~~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~- 153 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP- 153 (299)
T ss_dssp EEEECCSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC-
T ss_pred ehhhhhcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCC-
Confidence 99999988877665543 367999999999999999999999999999999999999999999999999998433210
Q ss_pred cccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccC
Q 011302 246 KLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINAR 325 (489)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (489)
...
T Consensus 154 -----------------------------------------------------------------------------~~~ 156 (299)
T d1ua2a_ 154 -----------------------------------------------------------------------------NRA 156 (299)
T ss_dssp -----------------------------------------------------------------------------CCC
T ss_pred -----------------------------------------------------------------------------ccc
Confidence 011
Q ss_pred CccccCCCCccCcchhcCC-CCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCC-----CCCCCC-------
Q 011302 326 SKSFVGTHEYLAPEVISGQ-GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL-----TFPRIG------- 392 (489)
Q Consensus 326 ~~~~~Gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-----~~p~~~------- 392 (489)
..+.+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+..+.+.+|.+... .++...
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhh
Confidence 2345799999999999755 579999999999999999999999999998888777753100 001000
Q ss_pred -----CCCchh-H-HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 393 -----VSSSKE-F-EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 393 -----~~~~~~-~-~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
...... + ....++++||.+||+.||++|||+. |+|+||||++..
T Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~----e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITAT----QALKMKYFSNRP 287 (299)
T ss_dssp CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHH----HHHTSGGGTSSS
T ss_pred hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHH----HHhCCHhhCCCC
Confidence 000000 0 1224689999999999999999987 999999998754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-57 Score=449.95 Aligned_cols=256 Identities=25% Similarity=0.363 Sum_probs=207.8
Q ss_pred ccCCceeee-eeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHh-CCCCCcccccceee
Q 011302 82 GLDHFRLLR-RLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTM-LDHPFLPTLYAEFE 159 (489)
Q Consensus 82 ~~~~y~~~~-~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpnIv~l~~~~~ 159 (489)
..++|.++. .||+|+||+||+|+++. +++.||||++++.. .+.+|+.++.+ ++|||||+++++|+
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~~~--------~~~~E~~~~~~~~~hpnIv~l~~~~~ 75 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKR-----TQEKFALKMLQDCP--------KARREVELHWRASQCPHIVRIVDVYE 75 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETT-----TCCEEEEEEEECSH--------HHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECC-----CCCEEEEEEECCcH--------HHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 357999885 59999999999999987 57899999997532 34458887654 58999999999997
Q ss_pred c----CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEecc---CCcEEE
Q 011302 160 A----SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRE---DGHIML 232 (489)
Q Consensus 160 ~----~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~---~~~vkl 232 (489)
+ +..+|||||||+||+|.+++.......|++.+++.|+.||+.||+|||++|||||||||+|||++. ++.+||
T Consensus 76 ~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl 155 (335)
T d2ozaa1 76 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKL 155 (335)
T ss_dssp EEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEE
T ss_pred ecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccc
Confidence 5 567999999999999999998765568999999999999999999999999999999999999985 567999
Q ss_pred cccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCcccc
Q 011302 233 SDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELL 312 (489)
Q Consensus 233 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (489)
+|||+|+....
T Consensus 156 ~DFG~a~~~~~--------------------------------------------------------------------- 166 (335)
T d2ozaa1 156 TDFGFAKETTS--------------------------------------------------------------------- 166 (335)
T ss_dssp CCCTTCEECCC---------------------------------------------------------------------
T ss_pred cccceeeeccC---------------------------------------------------------------------
Confidence 99999854321
Q ss_pred CCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHH----hcCCCCC
Q 011302 313 DDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINI----LKKPLTF 388 (489)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i----~~~~~~~ 388 (489)
.......+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+.......+ ......+
T Consensus 167 ----------~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~ 236 (335)
T d2ozaa1 167 ----------HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 236 (335)
T ss_dssp ----------CCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSC
T ss_pred ----------CCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCC
Confidence 01123457999999999999999999999999999999999999999887655444333 3333334
Q ss_pred CCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 389 PRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 389 p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
|.. .....+.++++||.+||+.||++||++. ++++||||..
T Consensus 237 ~~~-----~~~~~s~~~~~li~~~L~~dP~~R~s~~----eil~hp~~~~ 277 (335)
T d2ozaa1 237 PNP-----EWSEVSEEVKMLIRNLLKTEPTQRMTIT----EFMNHPWIMQ 277 (335)
T ss_dssp CTT-----HHHHSCHHHHHHHHHHSCSSTTTSCCHH----HHHHSHHHHT
T ss_pred CCc-----ccccCCHHHHHHHHHHccCChhHCcCHH----HHHcCHHhhC
Confidence 322 1112234689999999999999999987 9999999964
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-57 Score=446.45 Aligned_cols=266 Identities=18% Similarity=0.238 Sum_probs=217.9
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccce
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAE 157 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~ 157 (489)
|++..++|++++.||+|+||+||+|++++.........||+|.+...... .....+.+|+.+|..+ +|||||+++++
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~HpnIv~l~~~ 109 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS--SEREALMSELKMMTQLGSHENIVNLLGA 109 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCH--HHHHHHHHHHHHHHHhcCCCcEeEEEEE
Confidence 56777899999999999999999999987554445568999999765322 3455677899999988 89999999999
Q ss_pred eecCceEEEEEeecCCCchHHHHHhCCC---------------------CCCChhhHHHHHHHHHHHHHHHHhCCCeeec
Q 011302 158 FEASHYSCLVMEYCPGGDLYAARQRQPG---------------------KRFGISSAKFYAAETLLALEYLHMMGIVYRD 216 (489)
Q Consensus 158 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~---------------------~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrD 216 (489)
+.+.+.+|||||||+||+|.++++.... ..+++.+++.|+.||+.||+|||++||||||
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRD 189 (325)
T d1rjba_ 110 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 189 (325)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred EeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 9999999999999999999999976431 3588999999999999999999999999999
Q ss_pred CCCCCeEeccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCcccccccccccccccccccccc
Q 011302 217 LKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVT 296 (489)
Q Consensus 217 IKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (489)
|||+|||++.++++||+|||+|+.......
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~-------------------------------------------------- 219 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSN-------------------------------------------------- 219 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTT--------------------------------------------------
T ss_pred CchhccccccCCeEEEeeccccccccCCCc--------------------------------------------------
Confidence 999999999999999999999854321100
Q ss_pred ccccccCCCCCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcH
Q 011302 297 TIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNE 375 (489)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~ 375 (489)
.....+.+||+.|||||++.+..|+.++|||||||++|||++ |.+||.+.+..
T Consensus 220 --------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 220 --------------------------YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp --------------------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred --------------------------eeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 011234568999999999999999999999999999999997 99999998877
Q ss_pred HHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 376 KTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 376 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
+.+.+++.....++..... + .++++||.+||+.||++||++. +|++|
T Consensus 274 ~~~~~~~~~~~~~~~p~~~-~------~~l~~li~~cl~~dP~~RPt~~----ei~~~ 320 (325)
T d1rjba_ 274 ANFYKLIQNGFKMDQPFYA-T------EEIYIIMQSCWAFDSRKRPSFP----NLTSF 320 (325)
T ss_dssp HHHHHHHHTTCCCCCCTTC-C------HHHHHHHHHHTCSSGGGSCCHH----HHHHH
T ss_pred HHHHHHHhcCCCCCCCCcC-C------HHHHHHHHHHcCCChhHCcCHH----HHHHH
Confidence 7777777665544332221 1 2589999999999999999987 77765
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-57 Score=447.40 Aligned_cols=286 Identities=37% Similarity=0.690 Sum_probs=229.4
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHH-HHHHHHHHHHHHHHHHhCCC-CCcccccce
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALA-IRKKLHRADMEKVILTMLDH-PFLPTLYAE 157 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~ 157 (489)
++.+++|++++.||+|+||+||+|++.... .+++.||||++++.... ......++.+|+.+|++++| |||++++++
T Consensus 20 ~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~ 97 (322)
T d1vzoa_ 20 KVGIENFELLKVLGTGAYGKVFLVRKISGH--DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 97 (322)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSST--TTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred ccchhceEEEEEEecCCCeEEEEEEECccC--CCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeee
Confidence 356789999999999999999999985421 25789999998643211 11223456679999999976 899999999
Q ss_pred eecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCC
Q 011302 158 FEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237 (489)
Q Consensus 158 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~ 237 (489)
+.+...+|+||||+.||+|.+++... +.+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+
T Consensus 98 ~~~~~~~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 98 FQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eccCCceeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccc
Confidence 99999999999999999999998876 5688999999999999999999999999999999999999999999999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
|+.+...+
T Consensus 176 a~~~~~~~------------------------------------------------------------------------ 183 (322)
T d1vzoa_ 176 SKEFVADE------------------------------------------------------------------------ 183 (322)
T ss_dssp EEECCGGG------------------------------------------------------------------------
T ss_pred hhhhcccc------------------------------------------------------------------------
Confidence 85432110
Q ss_pred cccccccCCccccCCCCccCcchhcCCC--CCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHh----cCCCCCCCC
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVISGQG--HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINIL----KKPLTFPRI 391 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~--~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~----~~~~~~p~~ 391 (489)
.....+..||+.|+|||.+.+.. ++.++|||||||+||||++|..||.+.+..+....+. .....+|..
T Consensus 184 -----~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (322)
T d1vzoa_ 184 -----TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 258 (322)
T ss_dssp -----GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred -----cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCccc
Confidence 11123457999999999998654 6889999999999999999999998875544333333 333333321
Q ss_pred CCCCchhHHHHhhHHHHHHHHhhcCcccccCCCC-ChHHHHcCCCcCCCCcccc--ccCCCCCCCCc
Q 011302 392 GVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLK-GSVEIKRHEFFKGINWALI--RSIKPPEVPNN 455 (489)
Q Consensus 392 ~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~-~~~~ll~hp~f~~~~~~~~--~~~~~p~~~~~ 455 (489)
. +.++.+||.+||+.||++|++... .++|+++||||++++|..+ +.+.+|++|..
T Consensus 259 ---~------s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~p~~p~~ 316 (322)
T d1vzoa_ 259 ---M------SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVI 316 (322)
T ss_dssp ---S------CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCC
T ss_pred ---C------CHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCcCCCCCC
Confidence 1 125899999999999999998653 4679999999999999987 56777777653
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9.2e-57 Score=433.68 Aligned_cols=262 Identities=25% Similarity=0.351 Sum_probs=211.8
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc-
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH- 162 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~- 162 (489)
++|++.+.||+|+||+||+|+++. +++.||||+++++.........++.+|+.+|+.++|||||++++++...+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~ 81 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLR-----LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP 81 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECS
T ss_pred ceeEEeEEEeeCCCeEEEEEEECC-----CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccC
Confidence 679999999999999999999987 57899999998665444455667889999999999999999999987543
Q ss_pred ---eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 163 ---YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 163 ---~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
.+|||||||+||+|.+++... +.+++.+++.|+.||+.||+|||++|||||||||+||||+.++.++|+|||+++
T Consensus 82 ~~~~~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 82 AGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp SSEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred CCceEEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhh
Confidence 489999999999999888775 679999999999999999999999999999999999999999999999999874
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
.......
T Consensus 160 ~~~~~~~------------------------------------------------------------------------- 166 (277)
T d1o6ya_ 160 AIADSGN------------------------------------------------------------------------- 166 (277)
T ss_dssp ECC-----------------------------------------------------------------------------
T ss_pred hhccccc-------------------------------------------------------------------------
Confidence 3211000
Q ss_pred cccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhH
Q 011302 320 EPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEF 399 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 399 (489)
......+.+||+.|||||++.+..++.++|||||||++|||+||++||.+.+..+.+.++.......+.......
T Consensus 167 --~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 241 (277)
T d1o6ya_ 167 --SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL--- 241 (277)
T ss_dssp --------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSC---
T ss_pred --cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCC---
Confidence 011234568999999999999999999999999999999999999999999988888888776554443222221
Q ss_pred HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 400 EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 400 ~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
+.++.+||.+||+.||.+||+.. +.+.|+|.
T Consensus 242 --s~~l~~li~~~L~~dp~~R~~sa----~~l~~~l~ 272 (277)
T d1o6ya_ 242 --SADLDAVVLKALAKNPENRYQTA----AEMRADLV 272 (277)
T ss_dssp --CHHHHHHHHHHTCSSGGGSCSSH----HHHHHHHH
T ss_pred --CHHHHHHHHHHccCCHhHCHhHH----HHHHHHHH
Confidence 12589999999999999999654 55556554
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-57 Score=432.97 Aligned_cols=262 Identities=23% Similarity=0.329 Sum_probs=207.0
Q ss_pred cCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccce
Q 011302 78 QGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAE 157 (489)
Q Consensus 78 ~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~ 157 (489)
.|++..++|++.+.||+|+||+||+|++++ .||||+++..... ....+.+.+|+.+|++++|||||+++++
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~~--------~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~ 72 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG--------DVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGY 72 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESSS--------EEEEEECCCSSCC-TTHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEECC--------EEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeeeEE
Confidence 467888999999999999999999998553 4899998643222 2334567889999999999999999997
Q ss_pred eecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCC
Q 011302 158 FEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237 (489)
Q Consensus 158 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~ 237 (489)
+.+ +.+|||||||+||+|.+++.... ..+++..+..|+.||+.||+|||++|||||||||+||||+.++.+||+|||+
T Consensus 73 ~~~-~~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGl 150 (276)
T d1uwha_ 73 STA-PQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGL 150 (276)
T ss_dssp ECS-SSCEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCC
T ss_pred Eec-cEEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccc
Confidence 654 56899999999999999987653 5699999999999999999999999999999999999999999999999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
|+.......
T Consensus 151 a~~~~~~~~----------------------------------------------------------------------- 159 (276)
T d1uwha_ 151 ATVKSRWSG----------------------------------------------------------------------- 159 (276)
T ss_dssp SCC-----------------------------------------------------------------------------
T ss_pred eeeccccCC-----------------------------------------------------------------------
Confidence 854321000
Q ss_pred cccccccCCccccCCCCccCcchhcCC---CCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCC
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVISGQ---GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVS 394 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~---~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~ 394 (489)
.....+.+||+.|||||++.+. .|+.++|||||||++|||+||+.||.+.+....+..+.......|.....
T Consensus 160 -----~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~ 234 (276)
T d1uwha_ 160 -----SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 234 (276)
T ss_dssp -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGS
T ss_pred -----cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhc
Confidence 0122345799999999999753 47899999999999999999999999988776665555433333321111
Q ss_pred CchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 395 SSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 395 ~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
.. ..+..+.+||.+||+.||++||++. +|+++
T Consensus 235 ~~---~~~~~l~~li~~cl~~dp~~RPt~~----~il~~ 266 (276)
T d1uwha_ 235 RS---NCPKAMKRLMAECLKKKRDERPLFP----QILAS 266 (276)
T ss_dssp CT---TCCHHHHHHHHHHTCSSGGGSCCHH----HHHHH
T ss_pred cc---cchHHHHHHHHHHcCCCHhHCcCHH----HHHHH
Confidence 00 1113589999999999999999987 77765
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-56 Score=436.89 Aligned_cols=271 Identities=26% Similarity=0.345 Sum_probs=212.2
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC---CCCCcccccceee
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML---DHPFLPTLYAEFE 159 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~ 159 (489)
.++|++++.||+|+||+||+|++..+ .++.||||+++..... ......+.+|+.+|+.| +||||++++++|.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~----~~~~vAiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~ 80 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKN----GGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 80 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTT----TTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECC----CCEEEEEEEEehhhcc-chHHHHHHHHHHHHHHHhhcCCCCcceeeeeec
Confidence 47899999999999999999998752 3678999998653221 11223345577776665 8999999999985
Q ss_pred -----cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcc
Q 011302 160 -----ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSD 234 (489)
Q Consensus 160 -----~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~D 234 (489)
....+|++||||.+|.+.... ......+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|
T Consensus 81 ~~~~~~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 81 VSRTDRETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp EEECSSEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred ccccccCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecc
Confidence 345789999999877765444 33456799999999999999999999999999999999999999999999999
Q ss_pred cCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCC
Q 011302 235 FDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDD 314 (489)
Q Consensus 235 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (489)
||+++....
T Consensus 160 fg~~~~~~~----------------------------------------------------------------------- 168 (305)
T d1blxa_ 160 FGLARIYSF----------------------------------------------------------------------- 168 (305)
T ss_dssp CCSCCCCCG-----------------------------------------------------------------------
T ss_pred hhhhhhhcc-----------------------------------------------------------------------
Confidence 999743211
Q ss_pred ccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCC-----CCCC
Q 011302 315 PEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKP-----LTFP 389 (489)
Q Consensus 315 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-----~~~p 389 (489)
.......+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+.+.++.... ..++
T Consensus 169 --------~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 169 --------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240 (305)
T ss_dssp --------GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred --------cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence 011234579999999999999999999999999999999999999999999888877765310 0111
Q ss_pred CCCC-----------CCchhH--HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcc
Q 011302 390 RIGV-----------SSSKEF--EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWA 442 (489)
Q Consensus 390 ~~~~-----------~~~~~~--~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~ 442 (489)
.... .....+ .....+++||.+||++||++|||+. |+|+||||+++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~----e~L~Hpff~~i~~~ 302 (305)
T d1blxa_ 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY----SALSHPYFQDLERC 302 (305)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHH----HHHTSGGGTTCCCC
T ss_pred ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHH----HHhcChhhcCchhh
Confidence 1000 000000 1123589999999999999999987 99999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-56 Score=433.03 Aligned_cols=258 Identities=20% Similarity=0.249 Sum_probs=211.5
Q ss_pred cCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccce
Q 011302 78 QGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAE 157 (489)
Q Consensus 78 ~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~ 157 (489)
.|++..++|++.+.||+|+||+||+|+++. +++.||||+++.+... .+++.+|+.+|+.++|||||+++++
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~ 81 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKK-----YSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGV 81 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGG-----GTEEEEEEECCTTCSC----HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECC-----CCeEEEEEEECCccch----HHHHHHHHHHHHhCCCCCEecCCcc
Confidence 467888999999999999999999999987 5789999999765322 3457789999999999999999999
Q ss_pred eecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCC
Q 011302 158 FEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237 (489)
Q Consensus 158 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~ 237 (489)
|.+++.+|||||||++|+|.+++.......+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+
T Consensus 82 ~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~ 161 (287)
T d1opja_ 82 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL 161 (287)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCC
T ss_pred EeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccc
Confidence 99999999999999999999999877667899999999999999999999999999999999999999999999999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
|+......
T Consensus 162 a~~~~~~~------------------------------------------------------------------------ 169 (287)
T d1opja_ 162 SRLMTGDT------------------------------------------------------------------------ 169 (287)
T ss_dssp TTTCCSSS------------------------------------------------------------------------
T ss_pred eeecCCCC------------------------------------------------------------------------
Confidence 85432100
Q ss_pred cccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCch
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSSSK 397 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 397 (489)
........||+.|+|||++.+..|+.++|||||||++|||++|..||........+.++.......+... ..+
T Consensus 170 -----~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~-~~~- 242 (287)
T d1opja_ 170 -----YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPE-GCP- 242 (287)
T ss_dssp -----SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCT-TCC-
T ss_pred -----ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCc-cch-
Confidence 0011233589999999999999999999999999999999996666544444444444444333322221 111
Q ss_pred hHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHc
Q 011302 398 EFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKR 432 (489)
Q Consensus 398 ~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~ 432 (489)
..+.+||.+||+.||++||++. ++++
T Consensus 243 -----~~l~~li~~cl~~dP~~Rps~~----ei~~ 268 (287)
T d1opja_ 243 -----EKVYELMRACWQWNPSDRPSFA----EIHQ 268 (287)
T ss_dssp -----HHHHHHHHHHTCSSGGGSCCHH----HHHH
T ss_pred -----HHHHHHHHHHcCCCHhHCcCHH----HHHH
Confidence 2589999999999999999987 6654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-57 Score=433.38 Aligned_cols=251 Identities=26% Similarity=0.366 Sum_probs=207.9
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHH---HHHHHHHHHHHHHHhCC--CCCccccccee
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIR---KKLHRADMEKVILTMLD--HPFLPTLYAEF 158 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~E~~~l~~l~--hpnIv~l~~~~ 158 (489)
++|++.+.||+|+||+||+|+++. +++.||||++.+...... ....++.+|+.+|+.++ |||||+++++|
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~ 78 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVS-----DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 78 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECC-----CCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE
Confidence 689999999999999999999987 578999999986533211 11233557999999986 89999999999
Q ss_pred ecCceEEEEEeecCC-CchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEecc-CCcEEEcccC
Q 011302 159 EASHYSCLVMEYCPG-GDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRE-DGHIMLSDFD 236 (489)
Q Consensus 159 ~~~~~~~lV~E~~~g-g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~-~~~vkl~DFG 236 (489)
.+.+.+|+||||+.+ +++.+++... ..+++.+++.++.||+.||+|||++|||||||||+|||++. ++.+||+|||
T Consensus 79 ~~~~~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 79 ERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eeCCeEEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccc
Confidence 999999999999976 6788887765 57999999999999999999999999999999999999985 4799999999
Q ss_pred CCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcc
Q 011302 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPE 316 (489)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (489)
+|+....
T Consensus 157 ~a~~~~~------------------------------------------------------------------------- 163 (273)
T d1xwsa_ 157 SGALLKD------------------------------------------------------------------------- 163 (273)
T ss_dssp TCEECCS-------------------------------------------------------------------------
T ss_pred cceeccc-------------------------------------------------------------------------
Confidence 9843211
Q ss_pred ccccccccCCccccCCCCccCcchhcCCCC-CCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCCCC
Q 011302 317 VVAEPINARSKSFVGTHEYLAPEVISGQGH-GSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGVSS 395 (489)
Q Consensus 317 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 395 (489)
....+.+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+.+ ++......++...
T Consensus 164 -------~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~~~~--- 227 (273)
T d1xwsa_ 164 -------TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRV--- 227 (273)
T ss_dssp -------SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCC---
T ss_pred -------ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCCCCC---
Confidence 11234579999999999988775 678999999999999999999997642 3445554444321
Q ss_pred chhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 396 SKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 396 ~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
+ .++++||.+||+.||++||++. |+++||||+++-
T Consensus 228 s------~~~~~li~~~L~~dp~~R~s~~----eil~hp~~~~~~ 262 (273)
T d1xwsa_ 228 S------SECQHLIRWCLALRPSDRPTFE----EIQNHPWMQDVL 262 (273)
T ss_dssp C------HHHHHHHHHHTCSSGGGSCCHH----HHHTSGGGSSCC
T ss_pred C------HHHHHHHHHHccCCHhHCcCHH----HHhcCHhhCCCC
Confidence 1 2589999999999999999987 999999998763
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-55 Score=429.79 Aligned_cols=261 Identities=21% Similarity=0.264 Sum_probs=204.4
Q ss_pred cCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccce
Q 011302 78 QGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAE 157 (489)
Q Consensus 78 ~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~ 157 (489)
..++..++|++.+.||+|+||+||+|+++.+.. ....||||.+...... ...+++.+|+.+|+.++|||||+++++
T Consensus 20 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~--~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~g~ 95 (299)
T d1jpaa_ 20 AKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGK--REIFVAIKTLKSGYTE--KQRRDFLSEASIMGQFDHPNVIHLEGV 95 (299)
T ss_dssp SCBCCGGGEEEEEEEEECSSSEEEEEEECC-----CCEEEEEEECCSSCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred chhhChhhcEEeeEEeeCCCeEEEEEEEeCCCC--EEEEEEEEEECcccCH--HHHHHHHHHHHHHHhCCCCCCccEEEE
Confidence 346777899999999999999999999875321 3457899988643222 334567889999999999999999999
Q ss_pred eecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCC
Q 011302 158 FEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237 (489)
Q Consensus 158 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~ 237 (489)
+.+++.+|+|||||+||+|.+++... .+.+++.++..|+.||+.||+|||++|||||||||+||||+.++.+||+|||+
T Consensus 96 ~~~~~~~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGl 174 (299)
T d1jpaa_ 96 VTKSTPVMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGL 174 (299)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--
T ss_pred EeeCCEEEEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCccc
Confidence 99999999999999999999988764 35699999999999999999999999999999999999999999999999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
|+.+......
T Consensus 175 a~~~~~~~~~---------------------------------------------------------------------- 184 (299)
T d1jpaa_ 175 SRFLEDDTSD---------------------------------------------------------------------- 184 (299)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ceEccCCCCc----------------------------------------------------------------------
Confidence 8543211000
Q ss_pred cccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCc
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSS 396 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 396 (489)
..........||+.|||||++.+..++.++|||||||++|||+| |+.||.+.+..+.+..+..+.. .|... ..
T Consensus 185 ---~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~-~~- 258 (299)
T d1jpaa_ 185 ---PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR-LPPPM-DC- 258 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-CCCCT-TC-
T ss_pred ---ceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CCCCc-cc-
Confidence 00011223468999999999999999999999999999999998 8999999998888887766532 22111 11
Q ss_pred hhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 397 KEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 397 ~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
+..+.+||.+||+.||++||++.
T Consensus 259 -----~~~l~~li~~cl~~~P~~RPs~~ 281 (299)
T d1jpaa_ 259 -----PSALHQLMLDCWQKDRNHRPKFG 281 (299)
T ss_dssp -----CHHHHHHHHHHTCSSTTTSCCHH
T ss_pred -----hHHHHHHHHHHcCCCHhHCcCHH
Confidence 12589999999999999999986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-56 Score=429.06 Aligned_cols=261 Identities=21% Similarity=0.315 Sum_probs=212.7
Q ss_pred hcCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccc
Q 011302 77 AQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYA 156 (489)
Q Consensus 77 ~~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~ 156 (489)
..|++..++|++++.||+|+||+||+|++++ +..||||+++..... .+.+.+|+.+|++++|||||++++
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~------~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g 75 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNG------HTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYA 75 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETT------TEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEECC------CCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEe
Confidence 4567888999999999999999999999864 567999999764322 245778999999999999999999
Q ss_pred eeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccC
Q 011302 157 EFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFD 236 (489)
Q Consensus 157 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG 236 (489)
++.+ +.+|||||||++|+|.+++.......+++.++..|+.||+.||.|||++|||||||||+||||+.++.+||+|||
T Consensus 76 ~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFG 154 (272)
T d1qpca_ 76 VVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFG 154 (272)
T ss_dssp EECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred eecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeecccc
Confidence 8765 567999999999999987765444469999999999999999999999999999999999999999999999999
Q ss_pred CCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcc
Q 011302 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPE 316 (489)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (489)
+|+.+....
T Consensus 155 la~~~~~~~----------------------------------------------------------------------- 163 (272)
T d1qpca_ 155 LARLIEDNE----------------------------------------------------------------------- 163 (272)
T ss_dssp TCEECSSSC-----------------------------------------------------------------------
T ss_pred ceEEccCCc-----------------------------------------------------------------------
Confidence 985432110
Q ss_pred ccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCC
Q 011302 317 VVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSS 395 (489)
Q Consensus 317 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 395 (489)
........||+.|||||++.+..++.++|||||||++|||+| |.+||...+..+.+..+..+.. .+.. ...
T Consensus 164 ------~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~-~~~p-~~~ 235 (272)
T d1qpca_ 164 ------YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR-MVRP-DNC 235 (272)
T ss_dssp ------EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-CCCC-TTC
T ss_pred ------cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-CCCc-ccC
Confidence 011233479999999999998889999999999999999999 4666677777777777765422 1111 111
Q ss_pred chhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHc--CCCcC
Q 011302 396 SKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKR--HEFFK 437 (489)
Q Consensus 396 ~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~--hp~f~ 437 (489)
+ .++.+||.+||+.||++||++. +|++ |+||.
T Consensus 236 ~------~~l~~li~~cl~~~P~~Rpt~~----ei~~~L~~~ft 269 (272)
T d1qpca_ 236 P------EELYQLMRLCWKERPEDRPTFD----YLRSVLEDFFT 269 (272)
T ss_dssp C------HHHHHHHHHHTCSSGGGSCCHH----HHHHHHHHHHH
T ss_pred h------HHHHHHHHHHcCCCHhHCcCHH----HHHHHhhhhhh
Confidence 1 2589999999999999999987 7776 67774
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-55 Score=426.54 Aligned_cols=264 Identities=23% Similarity=0.283 Sum_probs=213.6
Q ss_pred cccCCceeeee-eccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 011302 81 VGLDHFRLLRR-LGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE 159 (489)
Q Consensus 81 ~~~~~y~~~~~-lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 159 (489)
+..++|.+... ||+|+||+||+|.++... .+..||||+++.... .....++.+|+.+|+.++|||||++++++.
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~---~~~~vAvK~l~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~ 79 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRK---KQIDVAIKVLKQGTE--KADTEEMMREAQIMHQLDNPYIVRLIGVCQ 79 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC------CCEEEEEEEECSSCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCC---CcEEEEEEEEChhcC--HHHHHHHHHHHHHHHhCCCCCEeeEeeeec
Confidence 44578888885 999999999999887532 356799999975422 234567888999999999999999999987
Q ss_pred cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 160 ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 160 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
+ +.+|||||||+||+|.+++... ...+++.++..|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|+
T Consensus 80 ~-~~~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~ 157 (285)
T d1u59a_ 80 A-EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSK 157 (285)
T ss_dssp S-SSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred c-CeEEEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhh
Confidence 5 4689999999999999987554 3579999999999999999999999999999999999999999999999999985
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
.+......
T Consensus 158 ~~~~~~~~------------------------------------------------------------------------ 165 (285)
T d1u59a_ 158 ALGADDSY------------------------------------------------------------------------ 165 (285)
T ss_dssp ECTTCSCE------------------------------------------------------------------------
T ss_pred cccccccc------------------------------------------------------------------------
Confidence 44211000
Q ss_pred cccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCC-CCCCCCCCCch
Q 011302 320 EPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPL-TFPRIGVSSSK 397 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~ 397 (489)
.......+||+.|||||++.+..++.++|||||||++|||+| |+.||.+.+..++...+..+.. ..|. ..+
T Consensus 166 ---~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~---~~~- 238 (285)
T d1u59a_ 166 ---YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP---ECP- 238 (285)
T ss_dssp ---ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCT---TCC-
T ss_pred ---cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC---cCC-
Confidence 011233469999999999999999999999999999999998 9999999988888887776532 2221 112
Q ss_pred hHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 398 EFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 398 ~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
.++.+||.+||+.||++||++. .+.+.|+|+|+
T Consensus 239 -----~~l~~li~~cl~~~p~~RPs~~-~i~~~L~~~~~ 271 (285)
T d1u59a_ 239 -----PELYALMSDCWIYKWEDRPDFL-TVEQRMRACYY 271 (285)
T ss_dssp -----HHHHHHHHHTTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred -----HHHHHHHHHHcCCCHhHCcCHH-HHHHHHHHHHH
Confidence 2589999999999999999985 33455788877
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-56 Score=428.24 Aligned_cols=259 Identities=22% Similarity=0.271 Sum_probs=207.1
Q ss_pred eeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCceEEEEEe
Q 011302 90 RRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASHYSCLVME 169 (489)
Q Consensus 90 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lV~E 169 (489)
++||+|+||+||+|.++... .++.||||+++.+... ....+++.+|+.+|++++|||||++++++.++ ..|||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~---~~~~vAvK~~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE 87 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKK---VVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVME 87 (277)
T ss_dssp EEEEECSSEEEEEEEEECSS---SEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEE
T ss_pred CCcccCCCeEEEEEEEccCC---cCeEEEEEEEChhhCC-HHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEE
Confidence 47999999999999987532 4678999999765432 34456788999999999999999999999754 5789999
Q ss_pred ecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCccccC
Q 011302 170 YCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLR 249 (489)
Q Consensus 170 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 249 (489)
||++|+|.+++... ..+++.++..|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+......
T Consensus 88 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~-- 163 (277)
T d1xbba_ 88 MAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY-- 163 (277)
T ss_dssp CCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE--
T ss_pred cCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccc--
Confidence 99999999998875 57999999999999999999999999999999999999999999999999998543211000
Q ss_pred CcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCCccc
Q 011302 250 PKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARSKSF 329 (489)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (489)
.......
T Consensus 164 -------------------------------------------------------------------------~~~~~~~ 170 (277)
T d1xbba_ 164 -------------------------------------------------------------------------YKAQTHG 170 (277)
T ss_dssp -------------------------------------------------------------------------EEC----
T ss_pred -------------------------------------------------------------------------ccccccc
Confidence 0112234
Q ss_pred cCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCC-CCCCCCCCCchhHHHHhhHHH
Q 011302 330 VGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPL-TFPRIGVSSSKEFEEVVKLQD 407 (489)
Q Consensus 330 ~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~~~~~~~l~~ 407 (489)
.||+.|||||++.+..++.++|||||||++|||++ |+.||.+.+..+....+..+.. ..|. ..+ .++.+
T Consensus 171 ~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~---~~~------~~~~~ 241 (277)
T d1xbba_ 171 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA---GCP------REMYD 241 (277)
T ss_dssp CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT---TCC------HHHHH
T ss_pred CCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCc---ccC------HHHHH
Confidence 69999999999999999999999999999999997 9999999988887777766432 2221 112 25899
Q ss_pred HHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 408 LISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 408 li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
||.+||+.||++||++. .+.+.|+|+|++.++
T Consensus 242 li~~cl~~dp~~RPs~~-~i~~~L~~~~~~~~~ 273 (277)
T d1xbba_ 242 LMNLCWTYDVENRPGFA-AVELRLRNYYYDVVN 273 (277)
T ss_dssp HHHHHTCSSTTTSCCHH-HHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHH-HHHHHhhCHHhhcCC
Confidence 99999999999999986 233446787765443
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.5e-56 Score=430.34 Aligned_cols=265 Identities=25% Similarity=0.363 Sum_probs=209.8
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
+++|+++++||+|+||+||+|+++. ++.||||++..+... .....++.+|+.+|+.++|||||+++++|.+++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~~------~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 73 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNNY------GETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKK 73 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEETT------SCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS
T ss_pred CCCceeccEEecCCCcEEEEEEeCC------CCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC
Confidence 4799999999999999999999863 578999999765322 233467788999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
..|+||||+.++.+..+.... +.+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|....
T Consensus 74 ~~~i~~e~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~ 151 (286)
T d1ob3a_ 74 RLVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFG 151 (286)
T ss_dssp CEEEEEECCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred ceeEEEEeehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecc
Confidence 999999999777666665443 679999999999999999999999999999999999999999999999999974321
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
..
T Consensus 152 ~~------------------------------------------------------------------------------ 153 (286)
T d1ob3a_ 152 IP------------------------------------------------------------------------------ 153 (286)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred cC------------------------------------------------------------------------------
Confidence 10
Q ss_pred ccCCccccCCCCccCcchhcCCC-CCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCC-----CCCC-----
Q 011302 323 NARSKSFVGTHEYLAPEVISGQG-HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLT-----FPRI----- 391 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~-~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-----~p~~----- 391 (489)
.......+||+.|+|||.+.+.. ++.++|||||||++|||++|+.||.+.+..+.+.++...... ++..
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhh
Confidence 01123346899999999998654 699999999999999999999999998887777766431100 0000
Q ss_pred -----CCCCc---hh--HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 392 -----GVSSS---KE--FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 392 -----~~~~~---~~--~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
..... .. ......+.|||++||+.||++||++. |+|+||||+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~----ell~Hp~f~~ 286 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAK----QALEHAYFKE 286 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHH----HHHTSGGGGC
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHH----HHhcCcccCc
Confidence 00000 00 01123588999999999999999987 9999999974
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-55 Score=419.60 Aligned_cols=252 Identities=23% Similarity=0.295 Sum_probs=202.7
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS 161 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 161 (489)
..++|++++.||+|+||+||+|++++ +..||||+++..... .+++.+|+.+++.++|||||++++++.++
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~~------~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~ 72 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWLN------KDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 72 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEETT------TEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEECC------CCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccC
Confidence 45789999999999999999999874 467999999764322 23577899999999999999999999999
Q ss_pred ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccc
Q 011302 162 HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKC 241 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~ 241 (489)
+.+|+|||||++|+|.+++... ...+++..+..|+.||+.||+|||+++||||||||+|||++.++.+||+|||+|+.+
T Consensus 73 ~~~~lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 151 (263)
T d1sm2a_ 73 APICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFV 151 (263)
T ss_dssp SSCEEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----
T ss_pred CceEEEEEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheec
Confidence 9999999999999999988764 356899999999999999999999999999999999999999999999999998543
Q ss_pred ccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccc
Q 011302 242 DVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEP 321 (489)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (489)
....
T Consensus 152 ~~~~---------------------------------------------------------------------------- 155 (263)
T d1sm2a_ 152 LDDQ---------------------------------------------------------------------------- 155 (263)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cCCC----------------------------------------------------------------------------
Confidence 2100
Q ss_pred cccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHH
Q 011302 322 INARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFE 400 (489)
Q Consensus 322 ~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 400 (489)
........||+.|+|||++.+..|+.++|||||||++|||+| |.+||.+.+..+.+..+..+...... ...+
T Consensus 156 -~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p--~~~~---- 228 (263)
T d1sm2a_ 156 -YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP--RLAS---- 228 (263)
T ss_dssp ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCC--TTSC----
T ss_pred -ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCc--cccC----
Confidence 001123469999999999999999999999999999999998 67778777777777777664322111 1111
Q ss_pred HHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 401 EVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 401 ~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
.++.+||.+||+.||++||++. +|++|
T Consensus 229 --~~l~~li~~cl~~~p~~Rps~~----~il~~ 255 (263)
T d1sm2a_ 229 --THVYQIMNHCWKERPEDRPAFS----RLLRQ 255 (263)
T ss_dssp --HHHHHHHHHHTCSSGGGSCCHH----HHHHH
T ss_pred --HHHHHHHHHHccCCHhHCcCHH----HHHHH
Confidence 2589999999999999999987 77765
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-54 Score=430.50 Aligned_cols=266 Identities=29% Similarity=0.382 Sum_probs=207.6
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.++|++++.||+|+||+||+|+++. +++.||||++++.... .....++.+|+.+|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~-----~~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~ 90 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGR-----TGAKVAIKKLYRPFQS-ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE 90 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETT-----TCCEEEEEECSSTTSS-HHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred CCcEEEEEEEecCCCeEEEEEEECC-----CCCEEEEEEEchhhcC-hHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCc
Confidence 4799999999999999999999987 5789999999754322 344567888999999999999999999997654
Q ss_pred ------eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccC
Q 011302 163 ------YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFD 236 (489)
Q Consensus 163 ------~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG 236 (489)
++||||||| |++|..+.+. ..+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||
T Consensus 91 ~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg 166 (346)
T d1cm8a_ 91 TLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFG 166 (346)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred cccccceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccccccccccc
Confidence 579999999 7888887765 469999999999999999999999999999999999999999999999999
Q ss_pred CCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcc
Q 011302 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPE 316 (489)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (489)
+|+...
T Consensus 167 ~a~~~~-------------------------------------------------------------------------- 172 (346)
T d1cm8a_ 167 LARQAD-------------------------------------------------------------------------- 172 (346)
T ss_dssp TCEECC--------------------------------------------------------------------------
T ss_pred ceeccC--------------------------------------------------------------------------
Confidence 984321
Q ss_pred ccccccccCCccccCCCCccCcchhcCCC-CCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCC------
Q 011302 317 VVAEPINARSKSFVGTHEYLAPEVISGQG-HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFP------ 389 (489)
Q Consensus 317 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p------ 389 (489)
......+||+.|+|||++.+.. ++.++|||||||++|||++|++||.+.+....+..+.......|
T Consensus 173 -------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (346)
T d1cm8a_ 173 -------SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245 (346)
T ss_dssp -------SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred -------CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence 1123457999999999998754 68999999999999999999999999887766555433111100
Q ss_pred --------------CCCCCCchh--HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccc
Q 011302 390 --------------RIGVSSSKE--FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWAL 443 (489)
Q Consensus 390 --------------~~~~~~~~~--~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~ 443 (489)
......... ......+.|||.+||..||.+|||+. |||+||||+++.+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~----eiL~Hp~f~~~~~~~ 311 (346)
T d1cm8a_ 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG----EALAHPYFESLHDTE 311 (346)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHH----HHHHSGGGTTTC---
T ss_pred hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHH----HHhcChhhCcCCCcc
Confidence 000000000 01123588999999999999999987 999999999987543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-55 Score=427.94 Aligned_cols=270 Identities=26% Similarity=0.318 Sum_probs=208.7
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec--
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA-- 160 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-- 160 (489)
.++|+++++||+|+||+||+|+++. +++.||||++..+... .....++.+|+.+|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~ 82 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRK-----TGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKA 82 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT-----TCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred cCCEEEEEEEecCcCeEEEEEEECC-----CCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeeeccc
Confidence 4799999999999999999999986 6789999999765432 2344567789999999999999999998854
Q ss_pred ------CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcc
Q 011302 161 ------SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSD 234 (489)
Q Consensus 161 ------~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~D 234 (489)
+.++|+|||||.++.+..... ....+++..++.|+.||+.||.|||++|||||||||+|||++.++.+||+|
T Consensus 83 ~~~~~~~~~~~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~d 160 (318)
T d3blha1 83 SPYNRCKGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLAD 160 (318)
T ss_dssp --------CEEEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECC
T ss_pred ccccccCceEEEEEeccCCCccchhhh--cccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeee
Confidence 456899999997666654332 346799999999999999999999999999999999999999999999999
Q ss_pred cCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCC
Q 011302 235 FDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDD 314 (489)
Q Consensus 235 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (489)
||+++.+......
T Consensus 161 fg~~~~~~~~~~~------------------------------------------------------------------- 173 (318)
T d3blha1 161 FGLARAFSLAKNS------------------------------------------------------------------- 173 (318)
T ss_dssp CTTCEECCC-----------------------------------------------------------------------
T ss_pred cceeeeccccccc-------------------------------------------------------------------
Confidence 9998543211000
Q ss_pred ccccccccccCCccccCCCCccCcchhcCC-CCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCCCCC
Q 011302 315 PEVVAEPINARSKSFVGTHEYLAPEVISGQ-GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPRIGV 393 (489)
Q Consensus 315 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~ 393 (489)
......+.+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+.......+......++....
T Consensus 174 -------~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 246 (318)
T d3blha1 174 -------QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246 (318)
T ss_dssp --------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred -------ccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 01122345899999999999876 5899999999999999999999999998887766665431111111000
Q ss_pred C-----------------Cc---h---hHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCC
Q 011302 394 S-----------------SS---K---EFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKG 438 (489)
Q Consensus 394 ~-----------------~~---~---~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~ 438 (489)
. .. . .......++|||.+||++||++|+|+. |+|+||||+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~----elL~Hpff~~ 310 (318)
T d3blha1 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD----DALNHDFFWS 310 (318)
T ss_dssp TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHH----HHHHSGGGSS
T ss_pred cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHH----HHHcChhhcc
Confidence 0 00 0 011234678999999999999999997 9999999975
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-54 Score=413.08 Aligned_cols=252 Identities=22% Similarity=0.276 Sum_probs=212.5
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS 161 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 161 (489)
..++|+++++||+|+||+||+|++++ ++.||||++++.... .+.+.+|+.++++++||||+++++++.++
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~~------~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~ 71 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWRG------QYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 71 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEETT------TEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCS
T ss_pred ChHHCEEeEEEecCCCeEEEEEEECC------CCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeC
Confidence 34799999999999999999999864 578999999865433 23577899999999999999999999999
Q ss_pred ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCccc
Q 011302 162 HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKC 241 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~ 241 (489)
+.+|+||||+++|+|.+++.... ..+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 72 ~~~~iv~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~ 150 (258)
T d1k2pa_ 72 RPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 150 (258)
T ss_dssp SSEEEEEECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBC
T ss_pred CceEEEEEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheec
Confidence 99999999999999998876543 56899999999999999999999999999999999999999999999999998543
Q ss_pred ccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccc
Q 011302 242 DVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEP 321 (489)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (489)
....
T Consensus 151 ~~~~---------------------------------------------------------------------------- 154 (258)
T d1k2pa_ 151 LDDE---------------------------------------------------------------------------- 154 (258)
T ss_dssp SSSS----------------------------------------------------------------------------
T ss_pred cCCC----------------------------------------------------------------------------
Confidence 2110
Q ss_pred cccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHH
Q 011302 322 INARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFE 400 (489)
Q Consensus 322 ~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 400 (489)
........||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..++...+..+...... ....
T Consensus 155 -~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p--~~~~---- 227 (258)
T d1k2pa_ 155 -YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP--HLAS---- 227 (258)
T ss_dssp -CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCC--TTCC----
T ss_pred -ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc--cccc----
Confidence 011223469999999999999999999999999999999998 89999999988888888765322111 1111
Q ss_pred HHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 401 EVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 401 ~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
.++.+||.+||+.||++||++. +|++|
T Consensus 228 --~~l~~li~~cl~~dP~~RPt~~----eil~~ 254 (258)
T d1k2pa_ 228 --EKVYTIMYSCWHEKADERPTFK----ILLSN 254 (258)
T ss_dssp --HHHHHHHHHTTCSSGGGSCCHH----HHHHH
T ss_pred --HHHHHHHHHHccCCHhHCcCHH----HHHHH
Confidence 2589999999999999999987 77776
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-54 Score=420.92 Aligned_cols=266 Identities=19% Similarity=0.246 Sum_probs=203.9
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccce
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAE 157 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~ 157 (489)
|++..++|+++++||+|+||+||+|+++......+++.||||+++..... .....+..|..++.++ +|+||+.++++
T Consensus 8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~--~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CH--HHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCc--HHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 46777899999999999999999999987655557789999999754332 2334555666666665 68999999998
Q ss_pred eec-CceEEEEEeecCCCchHHHHHhCC--------------CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCe
Q 011302 158 FEA-SHYSCLVMEYCPGGDLYAARQRQP--------------GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENV 222 (489)
Q Consensus 158 ~~~-~~~~~lV~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NI 222 (489)
+.. +..+|+|||||+||+|.+++.... ...+++.+++.|+.||+.||+|||++|||||||||+||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NI 165 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 165 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccce
Confidence 754 557899999999999999987542 23589999999999999999999999999999999999
Q ss_pred EeccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCcccccccccccccccccccccccccccc
Q 011302 223 LVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQV 302 (489)
Q Consensus 223 Ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (489)
||+.++++||+|||+|+.+.....
T Consensus 166 Ll~~~~~~Kl~DFGla~~~~~~~~-------------------------------------------------------- 189 (299)
T d1ywna1 166 LLSEKNVVKICDFGLARDIYKDPD-------------------------------------------------------- 189 (299)
T ss_dssp EECGGGCEEECC------CCSCTT--------------------------------------------------------
T ss_pred eECCCCcEEEccCcchhhcccccc--------------------------------------------------------
Confidence 999999999999999854321100
Q ss_pred CCCCCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhC-CCCCCCCCcHHHHHHH
Q 011302 303 DGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYG-TTPFKGENNEKTLINI 381 (489)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG-~~Pf~~~~~~~~~~~i 381 (489)
.......+||+.|||||++.+..++.++|||||||++|||++| .+||.+.+..+.+..+
T Consensus 190 --------------------~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~ 249 (299)
T d1ywna1 190 --------------------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249 (299)
T ss_dssp --------------------SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred --------------------ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 1122345799999999999999999999999999999999986 6789887766655555
Q ss_pred hcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 382 LKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 382 ~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
+.....++... ..+ .++.+||.+||+.||++||++. ++++|
T Consensus 250 ~~~~~~~~~~~-~~~------~~l~~li~~cl~~dP~~Rpt~~----eil~~ 290 (299)
T d1ywna1 250 LKEGTRMRAPD-YTT------PEMYQTMLDCWHGEPSQRPTFS----ELVEH 290 (299)
T ss_dssp HHHTCCCCCCT-TCC------HHHHHHHHHHTCSSGGGSCCHH----HHHHH
T ss_pred HhcCCCCCCCc-cCC------HHHHHHHHHHcCCChhHCcCHH----HHHHH
Confidence 44333222211 112 2589999999999999999987 77776
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-54 Score=414.67 Aligned_cols=260 Identities=25% Similarity=0.345 Sum_probs=205.9
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccccccee
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEF 158 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 158 (489)
|++..++|++.+.||+|+||+||+|++..... ....||||.++.... ......+.+|+.+|+.++|||||++++++
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~--~~~~vaik~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 77 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPEN--PALAVAIKTCKNCTS--DSVREKFLQEALTMRQFDHPHIVKLIGVI 77 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC----CCEEEEEEECTTTTS--HHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCc--eeEEEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 56778999999999999999999999875321 346789999864322 23345678899999999999999999998
Q ss_pred ecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 159 EASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
.+ +.+|+|||||++|+|.+++.... ..+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|
T Consensus 78 ~~-~~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a 155 (273)
T d1mp8a_ 78 TE-NPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 155 (273)
T ss_dssp CS-SSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----
T ss_pred ec-CeEEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhh
Confidence 64 67899999999999999876643 57999999999999999999999999999999999999999999999999998
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
+.+....
T Consensus 156 ~~~~~~~------------------------------------------------------------------------- 162 (273)
T d1mp8a_ 156 RYMEDST------------------------------------------------------------------------- 162 (273)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred eeccCCc-------------------------------------------------------------------------
Confidence 5432100
Q ss_pred ccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCch
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSK 397 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 397 (489)
........||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+.+.++..+... +.. ...+
T Consensus 163 ----~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~-~~~-~~~~- 235 (273)
T d1mp8a_ 163 ----YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL-PMP-PNCP- 235 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-CCC-TTCC-
T ss_pred ----ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-CCC-CCCC-
Confidence 011233468999999999999999999999999999999997 99999999988888888765422 111 1111
Q ss_pred hHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 398 EFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 398 ~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
..+.+||.+||+.||++||++. +|++|
T Consensus 236 -----~~~~~li~~cl~~dp~~Rps~~----ei~~~ 262 (273)
T d1mp8a_ 236 -----PTLYSLMTKCWAYDPSRRPRFT----ELKAQ 262 (273)
T ss_dssp -----HHHHHHHHHHTCSSGGGSCCHH----HHHHH
T ss_pred -----HHHHHHHHHHcCCCHhHCcCHH----HHHHH
Confidence 2589999999999999999987 77665
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-54 Score=417.55 Aligned_cols=263 Identities=22% Similarity=0.295 Sum_probs=210.3
Q ss_pred hcCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccc
Q 011302 77 AQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYA 156 (489)
Q Consensus 77 ~~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~ 156 (489)
..|++..++|++.+.||+|+||+||+|++++ ...||||+++..... .+.+.+|+.+|++++|||||++++
T Consensus 10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~------~~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g 79 (285)
T d1fmka3 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG------TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 79 (285)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETT------TEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cceEcCHHHEEEeeEEeeCCCeEEEEEEECC------CCEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEE
Confidence 4577888999999999999999999999876 356999999765432 245778999999999999999999
Q ss_pred eeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccC
Q 011302 157 EFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFD 236 (489)
Q Consensus 157 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG 236 (489)
++.+ +.+|+|||||++|+|..++.......+++.+++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||
T Consensus 80 ~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfG 158 (285)
T d1fmka3 80 VVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG 158 (285)
T ss_dssp EECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred EEec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccc
Confidence 9865 567999999999999888765444569999999999999999999999999999999999999999999999999
Q ss_pred CCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcc
Q 011302 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPE 316 (489)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (489)
+|+.+....
T Consensus 159 la~~~~~~~----------------------------------------------------------------------- 167 (285)
T d1fmka3 159 LARLIEDNE----------------------------------------------------------------------- 167 (285)
T ss_dssp TTC-----------------------------------------------------------------------------
T ss_pred hhhhccCCC-----------------------------------------------------------------------
Confidence 985432100
Q ss_pred ccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhC-CCCCCCCCcHHHHHHHhcCCCCCCCCCCCC
Q 011302 317 VVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYG-TTPFKGENNEKTLINILKKPLTFPRIGVSS 395 (489)
Q Consensus 317 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 395 (489)
........||+.|+|||++.+..++.++|||||||++|||++| .+||.+....+.+..+..+. ..+... ..
T Consensus 168 ------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~-~~~~~~-~~ 239 (285)
T d1fmka3 168 ------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-RMPCPP-EC 239 (285)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CCCCCT-TS
T ss_pred ------ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-CCCCCc-cc
Confidence 0011234699999999999999999999999999999999995 55566666666666666542 222211 11
Q ss_pred chhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHc--CCCcCCC
Q 011302 396 SKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKR--HEFFKGI 439 (489)
Q Consensus 396 ~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~--hp~f~~~ 439 (489)
+ .++++||.+||+.||++||++. +|+. |+||...
T Consensus 240 ~------~~l~~li~~cl~~dP~~Rps~~----~i~~~L~~~~~~~ 275 (285)
T d1fmka3 240 P------ESLHDLMCQCWRKEPEERPTFE----YLQAFLEDYFTST 275 (285)
T ss_dssp C------HHHHHHHHHHTCSSGGGSCCHH----HHHHHHHTTTSCS
T ss_pred C------HHHHHHHHHHcccCHhHCcCHH----HHHHHHhhhhcCC
Confidence 1 2589999999999999999987 7776 7788764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.1e-54 Score=423.58 Aligned_cols=262 Identities=25% Similarity=0.377 Sum_probs=205.9
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-CCCcccccceee-
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-HPFLPTLYAEFE- 159 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~- 159 (489)
..++|+++++||+|+||+||+|+++. +++.||||++++.. ..++.+|+.+|+.+. ||||++++++|.
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~-----~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~ 101 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINIT-----NNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKD 101 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECC-----CCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEe
Confidence 34789999999999999999999886 67899999997543 235667999999985 999999999997
Q ss_pred -cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCC-cEEEcccCC
Q 011302 160 -ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDG-HIMLSDFDL 237 (489)
Q Consensus 160 -~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~-~vkl~DFG~ 237 (489)
....+|+|||||.+|+|..+. +.+++.+++.++.||+.||+|||++|||||||||+||||+.++ .+||+|||+
T Consensus 102 ~~~~~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~ 176 (328)
T d3bqca1 102 PVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 176 (328)
T ss_dssp TTTCSEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGG
T ss_pred cCCCceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeeccccc
Confidence 446799999999999996542 4699999999999999999999999999999999999998655 699999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
|+.+..
T Consensus 177 a~~~~~-------------------------------------------------------------------------- 182 (328)
T d3bqca1 177 AEFYHP-------------------------------------------------------------------------- 182 (328)
T ss_dssp CEECCT--------------------------------------------------------------------------
T ss_pred ceeccC--------------------------------------------------------------------------
Confidence 843321
Q ss_pred cccccccCCccccCCCCccCcchhcCCC-CCCcccHHHHHHHHHHHhhCCCCCCCCCcH-HHHHHHhc------------
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVISGQG-HGSAVDWWTLGVFLYEMLYGTTPFKGENNE-KTLINILK------------ 383 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~~~~~DiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~------------ 383 (489)
.......+||+.|+|||++.+.. ++.++|||||||++|||++|..||...... +....+..
T Consensus 183 -----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~ 257 (328)
T d3bqca1 183 -----GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 257 (328)
T ss_dssp -----TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred -----CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhh
Confidence 01123457999999999988765 799999999999999999999999765432 22222210
Q ss_pred -CCCC----CCCC----C-------CCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCcc
Q 011302 384 -KPLT----FPRI----G-------VSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWA 442 (489)
Q Consensus 384 -~~~~----~p~~----~-------~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~ 442 (489)
.... +... . ...........+++|||++||++||++|||+. |+|+||||+++.|+
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~----e~L~Hp~F~~v~~~ 328 (328)
T d3bqca1 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR----EAMEHPYFYTVVKD 328 (328)
T ss_dssp HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHH----HHHTSGGGTTSCCC
T ss_pred hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHH----HHhcCcccCCCCCC
Confidence 0000 0000 0 00000011234689999999999999999997 99999999999985
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-54 Score=413.66 Aligned_cols=258 Identities=23% Similarity=0.319 Sum_probs=204.7
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA 160 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 160 (489)
+..++|++++.||+|+||+||+|+++.... ....||||+++++........+++.+|+.+|+.++|||||++++++.+
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~--~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~ 82 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSG--KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 82 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTS--CEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCC--cEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 345789999999999999999999875321 345789999988776666667788999999999999999999999976
Q ss_pred CceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcc
Q 011302 161 SHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFK 240 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~ 240 (489)
+.+|+|||||++|+|.+.+.... +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 83 -~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 83 -PPMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred -cchheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhh
Confidence 46789999999999998776542 5699999999999999999999999999999999999999999999999999854
Q ss_pred cccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccc
Q 011302 241 CDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAE 320 (489)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (489)
+......
T Consensus 161 ~~~~~~~------------------------------------------------------------------------- 167 (273)
T d1u46a_ 161 LPQNDDH------------------------------------------------------------------------- 167 (273)
T ss_dssp CCC-CCE-------------------------------------------------------------------------
T ss_pred cccCCCc-------------------------------------------------------------------------
Confidence 4321100
Q ss_pred ccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhH
Q 011302 321 PINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEF 399 (489)
Q Consensus 321 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 399 (489)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+.+.++......++..... +
T Consensus 168 --~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~-~--- 241 (273)
T d1u46a_ 168 --YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC-P--- 241 (273)
T ss_dssp --EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTC-C---
T ss_pred --ceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccc-c---
Confidence 011233468889999999999999999999999999999998 899999999999988888776555443222 1
Q ss_pred HHHhhHHHHHHHHhhcCcccccCCC
Q 011302 400 EEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 400 ~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
..+.+||.+||+.||++||++.
T Consensus 242 ---~~l~~li~~cl~~dp~~RPt~~ 263 (273)
T d1u46a_ 242 ---QDIYNVMVQCWAHKPEDRPTFV 263 (273)
T ss_dssp ---HHHHHHHHHHTCSSGGGSCCHH
T ss_pred ---HHHHHHHHHHcCCChhHCcCHH
Confidence 2489999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-54 Score=428.81 Aligned_cols=262 Identities=28% Similarity=0.437 Sum_probs=205.9
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee----
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE---- 159 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~---- 159 (489)
-+|+.+++||+|+||+||+|+++. +++.||||++.++. ....+|+.+|++++|||||+++++|.
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~~~~~~~~~~~ 87 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCD-----SGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLRYFFYSSGE 87 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETT-----TCCEEEEEEEECCS-------SSCCHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred CCcEeeeEEeeCcCeEEEEEEECC-----CCCEEEEEEECccc-------hHHHHHHHHHHhcCCCCCCcEEEEEEecCc
Confidence 369999999999999999999987 57899999997642 12335999999999999999999984
Q ss_pred --cCceEEEEEeecCCCchHHHHHh-CCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCC-cEEEccc
Q 011302 160 --ASHYSCLVMEYCPGGDLYAARQR-QPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDG-HIMLSDF 235 (489)
Q Consensus 160 --~~~~~~lV~E~~~gg~L~~~l~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~-~vkl~DF 235 (489)
+..++|||||||++|.+..+... .....+++.+++.|+.||+.||+|||++|||||||||+||||+.++ .+||+||
T Consensus 88 ~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DF 167 (350)
T d1q5ka_ 88 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDF 167 (350)
T ss_dssp CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCC
T ss_pred cCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecc
Confidence 33468999999976644443321 2346799999999999999999999999999999999999999775 8999999
Q ss_pred CCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCc
Q 011302 236 DLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDP 315 (489)
Q Consensus 236 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (489)
|+|+.+..
T Consensus 168 G~a~~~~~------------------------------------------------------------------------ 175 (350)
T d1q5ka_ 168 GSAKQLVR------------------------------------------------------------------------ 175 (350)
T ss_dssp TTCEECCT------------------------------------------------------------------------
T ss_pred cchhhccC------------------------------------------------------------------------
Confidence 99843321
Q ss_pred cccccccccCCccccCCCCccCcchhcCC-CCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcC----------
Q 011302 316 EVVAEPINARSKSFVGTHEYLAPEVISGQ-GHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKK---------- 384 (489)
Q Consensus 316 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---------- 384 (489)
.....+.+||+.|+|||.+.+. .|+.++|||||||++|||++|++||.+.+..+.+.++...
T Consensus 176 -------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 176 -------GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248 (350)
T ss_dssp -------TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred -------CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence 0112345799999999998764 5899999999999999999999999998887776666421
Q ss_pred -------CCCCCCCCCCCch---hHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 385 -------PLTFPRIGVSSSK---EFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 385 -------~~~~p~~~~~~~~---~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
...++........ ......++.+||.+||++||++|||+. |+|+||||+.+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~----e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL----EACAHSFFDELR 310 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHH----HHHTSGGGGGGG
T ss_pred hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHH----HHhcCHhhcccc
Confidence 1111111110000 001223589999999999999999987 999999998764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-53 Score=411.46 Aligned_cols=258 Identities=19% Similarity=0.222 Sum_probs=201.8
Q ss_pred ccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 011302 80 RVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE 159 (489)
Q Consensus 80 ~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 159 (489)
++..+.|++.++||+|+||+||+|.++.... .....||||++...... ....++.+|+.+|+.++|||||++++++.
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~-~~~~~vAvK~~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~~~g~~~ 79 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSG-KKEVPVAIKTLKAGYTE--KQRVDFLGEAGIMGQFSHHNIIRLEGVIS 79 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC----CCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCC-EEEEEEEEEEECcccCh--HHHHHHHHHHHHHHhcCCCCEeeeeEEEe
Confidence 4666889999999999999999999886321 13467999999754322 23446788999999999999999999999
Q ss_pred cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 160 ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 160 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
+.+.+|+|||||.+|+|.+++.... ..+++.++..|+.||+.||+|||+++||||||||+||||+.++.+||+|||+|+
T Consensus 80 ~~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 80 KYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred cCCceEEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhh
Confidence 9999999999999999998876653 579999999999999999999999999999999999999999999999999985
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
.+......
T Consensus 159 ~~~~~~~~------------------------------------------------------------------------ 166 (283)
T d1mqba_ 159 VLEDDPEA------------------------------------------------------------------------ 166 (283)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cccCCCcc------------------------------------------------------------------------
Confidence 43211000
Q ss_pred cccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhC-CCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchh
Q 011302 320 EPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYG-TTPFKGENNEKTLINILKKPLTFPRIGVSSSKE 398 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 398 (489)
........||+.|||||++.+..++.++|||||||++|||++| .+||.+.+..+.+..+..+ ...+... ..+
T Consensus 167 ---~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~-~~~~~~~-~~~-- 239 (283)
T d1mqba_ 167 ---TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-FRLPTPM-DCP-- 239 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCCCCCT-TCB--
T ss_pred ---ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhcc-CCCCCch-hhH--
Confidence 0012234689999999999999999999999999999999985 5555666666666665543 2222211 111
Q ss_pred HHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 399 FEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 399 ~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
..+.+||.+||+.||++||++.
T Consensus 240 ----~~l~~li~~cl~~~p~~RPt~~ 261 (283)
T d1mqba_ 240 ----SAIYQLMMQCWQQERARRPKFA 261 (283)
T ss_dssp ----HHHHHHHHHHTCSSTTTSCCHH
T ss_pred ----HHHHHHHHHHCcCCHhHCcCHH
Confidence 2589999999999999999987
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-53 Score=414.03 Aligned_cols=267 Identities=22% Similarity=0.314 Sum_probs=212.7
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
+++|+++++||+|+||+||+|+++. +++.||||+++.+.. ......++.+|+.+|+.++||||++++++|.+..
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~-----~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 74 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRE-----THEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDK 74 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETT-----TCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCCCEeeeEEecCcCeEEEEEEECC-----CCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeecccccccc
Confidence 3689999999999999999999987 578999999975432 2234567788999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
..++|||++.|++|..++... +.+++..++.++.|++.||+|||++|||||||||+|||++.++.+||+|||.|+...
T Consensus 75 ~~~iv~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~ 152 (292)
T d1unla_ 75 KLTLVFEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFG 152 (292)
T ss_dssp EEEEEEECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred ceeEEeeeccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhccc
Confidence 999999999999998877665 678999999999999999999999999999999999999999999999999985432
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
...
T Consensus 153 ~~~----------------------------------------------------------------------------- 155 (292)
T d1unla_ 153 IPV----------------------------------------------------------------------------- 155 (292)
T ss_dssp SCC-----------------------------------------------------------------------------
T ss_pred CCC-----------------------------------------------------------------------------
Confidence 100
Q ss_pred ccCCccccCCCCccCcchhcCCC-CCCcccHHHHHHHHHHHhhCCCCC-CCCCcHHHHHHHhcCCCCCCC----------
Q 011302 323 NARSKSFVGTHEYLAPEVISGQG-HGSAVDWWTLGVFLYEMLYGTTPF-KGENNEKTLINILKKPLTFPR---------- 390 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~-~~~~~DiwSlGvil~elltG~~Pf-~~~~~~~~~~~i~~~~~~~p~---------- 390 (489)
.......+++.|+|||++.+.. ++.++|||||||++|||++|..|| .+.+..+.+.++.......+.
T Consensus 156 -~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 156 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp -SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred -ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence 0112335788999999998766 699999999999999999999885 455555555554321000000
Q ss_pred ----------CCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 391 ----------IGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 391 ----------~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
..............+.+||++||+.||.+|||+. |+|+||||+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~----e~L~Hp~f~~~ 289 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAE----EALQHPYFSDF 289 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHH----HHTTSGGGSSC
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHH----HHhcChhhcCC
Confidence 0000000001123588999999999999999997 99999999864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-53 Score=420.87 Aligned_cols=267 Identities=25% Similarity=0.334 Sum_probs=204.9
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc-
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH- 162 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~- 162 (489)
++|++++.||+|+||+||+|+++. +++.||||++.+... .....++.+|+.+|+.++||||+++++++....
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~-----~~~~vAvK~i~~~~~--~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~ 80 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNV-----NKVRVAIKKISPFEH--QTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 80 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETT-----TCSEEEEEEECCTTC--HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred CCeEEEEEEeeccCeEEEEEEECC-----CCcEEEEEEEehhcC--hHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence 579999999999999999999886 578999999975432 234556788999999999999999999986543
Q ss_pred ----eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 163 ----YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 163 ----~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
.+||+ +|+.||+|.+++... .+++.+++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|
T Consensus 81 ~~~~~~~l~-~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a 156 (345)
T d1pmea_ 81 EQMKDVYLV-THLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 156 (345)
T ss_dssp TTCCCEEEE-EECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred cccceEEEE-EeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCce
Confidence 35555 556699999999763 6999999999999999999999999999999999999999999999999998
Q ss_pred cccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccc
Q 011302 239 FKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVV 318 (489)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (489)
+.......
T Consensus 157 ~~~~~~~~------------------------------------------------------------------------ 164 (345)
T d1pmea_ 157 RVADPDHD------------------------------------------------------------------------ 164 (345)
T ss_dssp EECCGGGC------------------------------------------------------------------------
T ss_pred eeccCCCc------------------------------------------------------------------------
Confidence 54321100
Q ss_pred ccccccCCccccCCCCccCcchhcC-CCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCC-----------
Q 011302 319 AEPINARSKSFVGTHEYLAPEVISG-QGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL----------- 386 (489)
Q Consensus 319 ~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~----------- 386 (489)
........+||+.|+|||++.. ..++.++||||+||++|||++|..||.+.+..+....+.....
T Consensus 165 ---~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (345)
T d1pmea_ 165 ---HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241 (345)
T ss_dssp ---BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred ---cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence 0112234579999999999854 5579999999999999999999999998876655544322100
Q ss_pred ---------CCCCCCCCCc-hhH-HHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCC
Q 011302 387 ---------TFPRIGVSSS-KEF-EEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 387 ---------~~p~~~~~~~-~~~-~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~ 440 (489)
..+....... ..+ ....++++||.+||+.||.+||++. ++|+||||+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~----e~L~hpf~~~~~ 302 (345)
T d1pmea_ 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVE----QALAHPYLEQYY 302 (345)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHH----HHHTSGGGTTTC
T ss_pred hhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHH----HHhcCHhhccCC
Confidence 0010000000 000 1123589999999999999999987 999999998653
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-53 Score=423.89 Aligned_cols=278 Identities=26% Similarity=0.353 Sum_probs=209.1
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceee---
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFE--- 159 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~--- 159 (489)
.++|+++++||+|+||+||+|+++. +++.||||++.+.... .....++.+|+.+|+.++|||||+++++|.
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~-----t~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~ 89 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAV-----LDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK 89 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETT-----TTEEEEEEEEESTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECC-----CCCEEEEEEEChhhcC-HHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccc
Confidence 3689999999999999999999987 6899999999765332 234456788999999999999999999995
Q ss_pred ---cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccC
Q 011302 160 ---ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFD 236 (489)
Q Consensus 160 ---~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG 236 (489)
+..++|+|||||.| +|.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||
T Consensus 90 ~~~~~~~~~iv~Ey~~~-~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~ 164 (355)
T d2b1pa1 90 TLEEFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_dssp STTTCCEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred ccccCceeEEEEeccch-HHHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechh
Confidence 44789999999965 4545443 458999999999999999999999999999999999999999999999999
Q ss_pred CCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcc
Q 011302 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPE 316 (489)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (489)
+++....
T Consensus 165 ~~~~~~~------------------------------------------------------------------------- 171 (355)
T d2b1pa1 165 LARTAGT------------------------------------------------------------------------- 171 (355)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred hhhcccc-------------------------------------------------------------------------
Confidence 8733211
Q ss_pred ccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCC----------
Q 011302 317 VVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPL---------- 386 (489)
Q Consensus 317 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------- 386 (489)
.......+||+.|+|||++.+..++.++||||+||++|||++|++||.+.+......++.....
T Consensus 172 ------~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 172 ------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred ------ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence 1122345799999999999999999999999999999999999999998887666555532110
Q ss_pred ------------CCC---------CCCC--CCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCCCccc
Q 011302 387 ------------TFP---------RIGV--SSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGINWAL 443 (489)
Q Consensus 387 ------------~~p---------~~~~--~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~~~~~ 443 (489)
... .... ..........++.+||++||.+||++|||+. |||+||||+..-+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~----elL~Hpw~~~~~~~~ 321 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD----DALQHPYINVWYDPA 321 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHH----HHHTSTTTGGGCCHH
T ss_pred hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHH----HHhcCcccCCCCCcc
Confidence 000 0000 0001112345689999999999999999997 999999998754444
Q ss_pred cccCCCCCCCC
Q 011302 444 IRSIKPPEVPN 454 (489)
Q Consensus 444 ~~~~~~p~~~~ 454 (489)
.....+|.+.+
T Consensus 322 ~~~~~~~~~~~ 332 (355)
T d2b1pa1 322 EVEAPPPQIYD 332 (355)
T ss_dssp HHTCCCC----
T ss_pred cccCCCCCCCC
Confidence 44444554433
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4e-53 Score=412.94 Aligned_cols=262 Identities=21% Similarity=0.271 Sum_probs=215.7
Q ss_pred hcCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccc
Q 011302 77 AQGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYA 156 (489)
Q Consensus 77 ~~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~ 156 (489)
..++++.++|++++.||+|+||+||+|++++.....+++.||||+++..... +...++.+|+.+|+.++||||+++++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~E~~il~~l~h~niv~~~~ 83 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA--DMQADFQREAALMAEFDNPNIVKLLG 83 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH--HHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcCh--HHHHHHHHHHHHHHhcCCCCccccee
Confidence 3467788999999999999999999999876444446789999999754322 34556788999999999999999999
Q ss_pred eeecCceEEEEEeecCCCchHHHHHhCC----------------------CCCCChhhHHHHHHHHHHHHHHHHhCCCee
Q 011302 157 EFEASHYSCLVMEYCPGGDLYAARQRQP----------------------GKRFGISSAKFYAAETLLALEYLHMMGIVY 214 (489)
Q Consensus 157 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~~L~yLH~~~iiH 214 (489)
++.+.+.+++||||+++|+|.+++.... ...+++..+..|+.||+.||+|||+++|||
T Consensus 84 ~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivH 163 (301)
T d1lufa_ 84 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH 163 (301)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred eeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEe
Confidence 9999999999999999999999886531 134889999999999999999999999999
Q ss_pred ecCCCCCeEeccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCcccccccccccccccccccc
Q 011302 215 RDLKPENVLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVT 294 (489)
Q Consensus 215 rDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (489)
|||||+||||+.++.+||+|||+|+.+....
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~------------------------------------------------- 194 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSAD------------------------------------------------- 194 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGG-------------------------------------------------
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCc-------------------------------------------------
Confidence 9999999999999999999999984332100
Q ss_pred ccccccccCCCCCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCC-CCCCCCC
Q 011302 295 VTTIREQVDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGT-TPFKGEN 373 (489)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~-~Pf~~~~ 373 (489)
......+.+||+.|+|||++.+..|+.++|||||||++|||++|. +||.+.+
T Consensus 195 ---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 195 ---------------------------YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp ---------------------------CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ---------------------------cccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 011223457999999999999999999999999999999999985 7899998
Q ss_pred cHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 374 NEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 374 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
..+....+..+... ......+ .++.+||.+||+.||++||++.
T Consensus 248 ~~e~~~~v~~~~~~--~~p~~~~------~~~~~li~~cl~~~P~~RPt~~ 290 (301)
T d1lufa_ 248 HEEVIYYVRDGNIL--ACPENCP------LELYNLMRLCWSKLPADRPSFC 290 (301)
T ss_dssp HHHHHHHHHTTCCC--CCCTTCC------HHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHHHHHHcCCCC--CCCccch------HHHHHHHHHHcCCChhHCcCHH
Confidence 88888888776532 2111112 2589999999999999999987
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-53 Score=404.73 Aligned_cols=245 Identities=22% Similarity=0.307 Sum_probs=201.5
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCccccccee
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEF 158 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 158 (489)
|++..++|++++.||+|+||.||+|++++ ..||||+++++. ..+.+.+|+.+|++++||||+++++++
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-------~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~ 69 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRG-------NKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVI 69 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETT-------EEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEE
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEECC-------eEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 77889999999999999999999999864 569999997643 234577899999999999999999988
Q ss_pred e-cCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCC
Q 011302 159 E-ASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237 (489)
Q Consensus 159 ~-~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~ 237 (489)
. ..+.+||||||+++|+|.+++.......+++..++.|+.||+.||.|||+++||||||||+|||++.+|.+||+|||+
T Consensus 70 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~ 149 (262)
T d1byga_ 70 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL 149 (262)
T ss_dssp CCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred EecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeeccccc
Confidence 5 456789999999999999998765334689999999999999999999999999999999999999999999999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
++....
T Consensus 150 s~~~~~-------------------------------------------------------------------------- 155 (262)
T d1byga_ 150 TKEASS-------------------------------------------------------------------------- 155 (262)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ceecCC--------------------------------------------------------------------------
Confidence 843210
Q ss_pred cccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCc
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSS 396 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 396 (489)
......||+.|+|||++.+..++.++|||||||++|||++ |++||.+.+..+....+..+. ..+ ......
T Consensus 156 -------~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~-~~~-~~~~~~ 226 (262)
T d1byga_ 156 -------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-KMD-APDGCP 226 (262)
T ss_dssp -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC-CCC-CCTTCC
T ss_pred -------CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-CCC-CCccCC
Confidence 1122368899999999999999999999999999999998 899999988888887776542 111 111122
Q ss_pred hhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 397 KEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 397 ~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
..+.+||.+||..||++||++.
T Consensus 227 ------~~~~~li~~cl~~dP~~Rps~~ 248 (262)
T d1byga_ 227 ------PAVYEVMKNCWHLDAAMRPSFL 248 (262)
T ss_dssp ------HHHHHHHHHHTCSSGGGSCCHH
T ss_pred ------HHHHHHHHHHcccCHhHCcCHH
Confidence 2589999999999999999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=412.55 Aligned_cols=258 Identities=20% Similarity=0.240 Sum_probs=204.0
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH 162 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 162 (489)
.++|++++.||+|+||+||+|+++.+... ....||+|.++.... ....+++.+|+.+|+.++|||||++++++.++
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~- 83 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEK-VKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTS- 83 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC-----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCE-EEEEEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 46899999999999999999998763221 234689998875432 23345688899999999999999999999875
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCD 242 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~ 242 (489)
..++||||+.+|+|.+.+... ...+++..++.|+.||+.||+|||++|||||||||+||||+.++++||+|||+|+.+.
T Consensus 84 ~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 84 TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp SEEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred CeeEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecc
Confidence 567889999999999887765 3679999999999999999999999999999999999999999999999999985432
Q ss_pred cCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcccccccc
Q 011302 243 VVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPI 322 (489)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (489)
....
T Consensus 163 ~~~~---------------------------------------------------------------------------- 166 (317)
T d1xkka_ 163 AEEK---------------------------------------------------------------------------- 166 (317)
T ss_dssp TTCC----------------------------------------------------------------------------
T ss_pred cccc----------------------------------------------------------------------------
Confidence 1000
Q ss_pred ccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcCCCCCCCCCCCCchhHHH
Q 011302 323 NARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLINILKKPLTFPRIGVSSSKEFEE 401 (489)
Q Consensus 323 ~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 401 (489)
........||+.|||||++.+..|+.++|||||||++|||+| |.+||.+.+..+....+..+.. .+... ..+
T Consensus 167 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~-~~~p~-~~~----- 239 (317)
T d1xkka_ 167 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-LPQPP-ICT----- 239 (317)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCC-CCCCT-TBC-----
T ss_pred cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-CCCCc-ccC-----
Confidence 011223468999999999999999999999999999999998 8999999887777666655432 12111 111
Q ss_pred HhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 402 VVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 402 ~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
..+.+||.+||+.||++||++. +|+.|
T Consensus 240 -~~~~~li~~cl~~dP~~RPs~~----eil~~ 266 (317)
T d1xkka_ 240 -IDVYMIMVKCWMIDADSRPKFR----ELIIE 266 (317)
T ss_dssp -HHHHHHHHHHTCSSGGGSCCHH----HHHHH
T ss_pred -HHHHHHHHHhCCCChhhCcCHH----HHHHH
Confidence 2589999999999999999987 77776
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-53 Score=420.18 Aligned_cols=263 Identities=25% Similarity=0.341 Sum_probs=208.0
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecC-
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEAS- 161 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~- 161 (489)
.++|++++.||+|+||+||+|+++. +++.||||++.+.... .....++.+|+.+|+.++|||||+++++|...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~ 90 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTK-----TGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 90 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETT-----TTEEEEEEECSCTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred CCCeEEEEEEecCCCeEEEEEEECC-----CCCEEEEEEECchhcC-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecc
Confidence 3789999999999999999999886 6899999999754322 23345677899999999999999999998633
Q ss_pred ----ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCC
Q 011302 162 ----HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDL 237 (489)
Q Consensus 162 ----~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~ 237 (489)
...++||||+.||+|.+++.. +++++.+++.|+.||+.||+|||++|||||||||+|||++.+|.+|++|||+
T Consensus 91 ~~~~~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~ 167 (348)
T d2gfsa1 91 SLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL 167 (348)
T ss_dssp STTTCCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC--
T ss_pred ccccCceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccch
Confidence 334566677789999998865 4699999999999999999999999999999999999999999999999999
Q ss_pred CcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccc
Q 011302 238 SFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEV 317 (489)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (489)
|....
T Consensus 168 a~~~~--------------------------------------------------------------------------- 172 (348)
T d2gfsa1 168 ARHTD--------------------------------------------------------------------------- 172 (348)
T ss_dssp --CCT---------------------------------------------------------------------------
T ss_pred hcccC---------------------------------------------------------------------------
Confidence 73221
Q ss_pred cccccccCCccccCCCCccCcchhcCCC-CCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHhcCCCCCCC------
Q 011302 318 VAEPINARSKSFVGTHEYLAPEVISGQG-HGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINILKKPLTFPR------ 390 (489)
Q Consensus 318 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~------ 390 (489)
....+..||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+.......+.......+.
T Consensus 173 ------~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (348)
T d2gfsa1 173 ------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246 (348)
T ss_dssp ------GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred ------cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhc
Confidence 1123457999999999988765 589999999999999999999999999887776666542111110
Q ss_pred --------------CCCCCchh--HHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCcCCC
Q 011302 391 --------------IGVSSSKE--FEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFFKGI 439 (489)
Q Consensus 391 --------------~~~~~~~~--~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f~~~ 439 (489)
........ .....+++|||.+||+.||++|+|+. |+|+||||+.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~----elL~Hp~f~~~ 307 (348)
T d2gfsa1 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA----QALAHAYFAQY 307 (348)
T ss_dssp CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHH----HHHTSGGGTTT
T ss_pred cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHH----HHhcCHhhCCC
Confidence 00000000 01223589999999999999999987 99999999875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=410.73 Aligned_cols=261 Identities=18% Similarity=0.259 Sum_probs=215.1
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccce
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAE 157 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~ 157 (489)
|++..++|++.++||+|+||.||+|+++.......++.||||+++..... .....+.+|+.+++.+ +|||||+++++
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~E~~~~~~l~~HpnIv~~~g~ 95 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHMNIVNLLGA 95 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCH--HHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 56778999999999999999999999876544557889999999765332 2344677899999998 69999999999
Q ss_pred eecCceEEEEEeecCCCchHHHHHhCC----------------CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCC
Q 011302 158 FEASHYSCLVMEYCPGGDLYAARQRQP----------------GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPEN 221 (489)
Q Consensus 158 ~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~N 221 (489)
+.+.+.+|||||||++|+|.+++.... ...+++..++.|+.||+.||+|||++|||||||||+|
T Consensus 96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~N 175 (311)
T d1t46a_ 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (311)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccc
Confidence 999999999999999999999987642 2358899999999999999999999999999999999
Q ss_pred eEeccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccc
Q 011302 222 VLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQ 301 (489)
Q Consensus 222 ILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (489)
||++.++.+||+|||+++.+.....
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~------------------------------------------------------- 200 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSN------------------------------------------------------- 200 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTT-------------------------------------------------------
T ss_pred ccccccCcccccccchheeccCCCc-------------------------------------------------------
Confidence 9999999999999999854321100
Q ss_pred cCCCCCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHH
Q 011302 302 VDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLIN 380 (489)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~ 380 (489)
.......+||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+..+.+.+
T Consensus 201 ---------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~ 259 (311)
T d1t46a_ 201 ---------------------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259 (311)
T ss_dssp ---------------------SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred ---------------------ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 011234579999999999999999999999999999999998 7777878777676666
Q ss_pred HhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 381 ILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 381 i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
+.......+.... .+ ..+.+||.+||+.||++||++.
T Consensus 260 ~i~~~~~~~~~~~-~~------~~l~~Li~~cl~~dP~~RPs~~ 296 (311)
T d1t46a_ 260 MIKEGFRMLSPEH-AP------AEMYDIMKTCWDADPLKRPTFK 296 (311)
T ss_dssp HHHHTCCCCCCTT-SC------HHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHhcCCCCCCccc-cc------HHHHHHHHHHcCCChhHCcCHH
Confidence 6654443332211 11 2589999999999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-52 Score=405.93 Aligned_cols=264 Identities=20% Similarity=0.271 Sum_probs=209.5
Q ss_pred CccccCCceeeeeeccCCceeEEEEEEccCCCC--CCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCccccc
Q 011302 79 GRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVG--LPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLY 155 (489)
Q Consensus 79 ~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~ 155 (489)
|.+..++|++++.||+|+||.||+|++....+. .....||||+++++... .....+.+|...+.++ +|||||+++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~e~~~l~~~~~HpnIv~~~ 85 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE--KDLSDLISEMEMMKMIGKHKNIINLL 85 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccCh--HHHHHHHHHHHHHHHhcCCCeEEecc
Confidence 667889999999999999999999998764322 23468999999765422 3345567788888777 799999999
Q ss_pred ceeecCceEEEEEeecCCCchHHHHHhCC--------------CCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCC
Q 011302 156 AEFEASHYSCLVMEYCPGGDLYAARQRQP--------------GKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPEN 221 (489)
Q Consensus 156 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~N 221 (489)
++|.+++.+|+|||||++|+|.+++.... ...+++.+++.++.||+.||+|||+++||||||||+|
T Consensus 86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N 165 (299)
T d1fgka_ 86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 165 (299)
T ss_dssp EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence 99999999999999999999999997542 2468999999999999999999999999999999999
Q ss_pred eEeccCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccc
Q 011302 222 VLVREDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQ 301 (489)
Q Consensus 222 ILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (489)
||++.++.+||+|||+++......
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~-------------------------------------------------------- 189 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHID-------------------------------------------------------- 189 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCC--------------------------------------------------------
T ss_pred eeecCCCCeEeccchhhccccccc--------------------------------------------------------
Confidence 999999999999999985432110
Q ss_pred cCCCCCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhh-CCCCCCCCCcHHHHHH
Q 011302 302 VDGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLY-GTTPFKGENNEKTLIN 380 (489)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~ 380 (489)
........+||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+..+.+..
T Consensus 190 --------------------~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~ 249 (299)
T d1fgka_ 190 --------------------YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249 (299)
T ss_dssp --------------------TTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred --------------------cccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHH
Confidence 0112344579999999999999999999999999999999998 7999998888877776
Q ss_pred HhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHc
Q 011302 381 ILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKR 432 (489)
Q Consensus 381 i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~ 432 (489)
+..+. .++... ..+ ..+.+||.+||+.||++||++. +|++
T Consensus 250 i~~~~-~~~~p~-~~~------~~l~~li~~cl~~dP~~Rps~~----eil~ 289 (299)
T d1fgka_ 250 LKEGH-RMDKPS-NCT------NELYMMMRDCWHAVPSQRPTFK----QLVE 289 (299)
T ss_dssp HHTTC-CCCCCS-SCC------HHHHHHHHHHTCSSGGGSCCHH----HHHH
T ss_pred HHcCC-CCCCCc-cch------HHHHHHHHHHccCCHhHCcCHH----HHHH
Confidence 66542 222211 112 2489999999999999999987 5554
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=410.23 Aligned_cols=277 Identities=21% Similarity=0.252 Sum_probs=222.5
Q ss_pred cCccccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccce
Q 011302 78 QGRVGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAE 157 (489)
Q Consensus 78 ~~~~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~ 157 (489)
.|++..++|.+.+.||+|+||+||+|.++......++..||||++++.... .....+.+|+.++++++|||||+++++
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~ 91 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM--RERIEFLNEASVMKEFNCHHVVRLLGV 91 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH--HHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccCh--HHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence 467888999999999999999999999875433345678999999754322 334567889999999999999999999
Q ss_pred eecCceEEEEEeecCCCchHHHHHhC--------CCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCc
Q 011302 158 FEASHYSCLVMEYCPGGDLYAARQRQ--------PGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGH 229 (489)
Q Consensus 158 ~~~~~~~~lV~E~~~gg~L~~~l~~~--------~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~ 229 (489)
+..++..|+|||||++|+|.+++... ....+++..+..|+.|++.||.|||+++||||||||+||||+.+++
T Consensus 92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce
Confidence 99999999999999999999887642 1134688899999999999999999999999999999999999999
Q ss_pred EEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCc
Q 011302 230 IMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQ 309 (489)
Q Consensus 230 vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (489)
+||+|||+|+.+.....
T Consensus 172 ~Kl~DFGla~~~~~~~~--------------------------------------------------------------- 188 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDY--------------------------------------------------------------- 188 (308)
T ss_dssp EEECCTTCCCGGGGGGC---------------------------------------------------------------
T ss_pred EEEeecccceeccCCcc---------------------------------------------------------------
Confidence 99999999854321100
Q ss_pred cccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhC-CCCCCCCCcHHHHHHHhcCCCCC
Q 011302 310 ELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYG-TTPFKGENNEKTLINILKKPLTF 388 (489)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~~~~~ 388 (489)
.......+||+.|+|||.+.+..++.++|||||||++|||+|| .+||.+.+..+.+..+..+...
T Consensus 189 -------------~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~- 254 (308)
T d1p4oa_ 189 -------------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL- 254 (308)
T ss_dssp -------------EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCC-
T ss_pred -------------eeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCC-
Confidence 0112334789999999999999999999999999999999998 6889999888888888765432
Q ss_pred CCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHc--CCCcCCCC
Q 011302 389 PRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKR--HEFFKGIN 440 (489)
Q Consensus 389 p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~--hp~f~~~~ 440 (489)
......+ ..+.+||.+||+.||++||++.+.++.|.+ +|+|+.++
T Consensus 255 -~~p~~~~------~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~~ 301 (308)
T d1p4oa_ 255 -DKPDNCP------DMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 301 (308)
T ss_dssp -CCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHC
T ss_pred -CCcccch------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCCC
Confidence 1111112 258999999999999999999733322222 67776543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-52 Score=406.65 Aligned_cols=257 Identities=21% Similarity=0.298 Sum_probs=207.7
Q ss_pred cccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhC-CCCCcccccceee
Q 011302 81 VGLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTML-DHPFLPTLYAEFE 159 (489)
Q Consensus 81 ~~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~ 159 (489)
+..++|++.++||+|+||+||+|+++++. ....||||.+..... .+..+.+.+|+.+|+++ +|||||++++++.
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~---~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~ 81 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDG---LRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGACE 81 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETT---EEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEE
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCC---eEEEEEEEEECcccC--hHHHHHHHHHHHHHHhccCCCCEeeEEEEEe
Confidence 56689999999999999999999998731 123578888754322 23456788899999998 7999999999999
Q ss_pred cCceEEEEEeecCCCchHHHHHhC--------------CCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEec
Q 011302 160 ASHYSCLVMEYCPGGDLYAARQRQ--------------PGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVR 225 (489)
Q Consensus 160 ~~~~~~lV~E~~~gg~L~~~l~~~--------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~ 225 (489)
+++.+|+|||||+||+|.++++.. ....+++..+..++.||+.||.|||+++||||||||+|||++
T Consensus 82 ~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 82 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 161 (309)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred cCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEc
Confidence 999999999999999999998754 236799999999999999999999999999999999999999
Q ss_pred cCCcEEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCC
Q 011302 226 EDGHIMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGD 305 (489)
Q Consensus 226 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (489)
.++.+||+|||+|+.....
T Consensus 162 ~~~~~kl~DfG~a~~~~~~------------------------------------------------------------- 180 (309)
T d1fvra_ 162 ENYVAKIADFGLSRGQEVY------------------------------------------------------------- 180 (309)
T ss_dssp GGGCEEECCTTCEESSCEE-------------------------------------------------------------
T ss_pred CCCceEEcccccccccccc-------------------------------------------------------------
Confidence 9999999999998432110
Q ss_pred CCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhC-CCCCCCCCcHHHHHHHhcC
Q 011302 306 HHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYG-TTPFKGENNEKTLINILKK 384 (489)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~ 384 (489)
.......||+.|+|||.+.+..++.++|||||||++|||++| .+||.+.+..+.+..+..+
T Consensus 181 ------------------~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~ 242 (309)
T d1fvra_ 181 ------------------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 242 (309)
T ss_dssp ------------------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred ------------------ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Confidence 011234689999999999999999999999999999999996 5678888888888777664
Q ss_pred CCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 385 PLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 385 ~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
.. ++. ....+ .++.+||.+||+.||++||++. +|++|
T Consensus 243 ~~-~~~-~~~~~------~~~~~li~~cl~~dP~~RPs~~----eil~~ 279 (309)
T d1fvra_ 243 YR-LEK-PLNCD------DEVYDLMRQCWREKPYERPSFA----QILVS 279 (309)
T ss_dssp CC-CCC-CTTBC------HHHHHHHHHHTCSSGGGSCCHH----HHHHH
T ss_pred CC-CCC-CccCC------HHHHHHHHHHcCCChhHCcCHH----HHHHH
Confidence 22 111 11111 2589999999999999999997 77776
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-50 Score=390.43 Aligned_cols=255 Identities=17% Similarity=0.194 Sum_probs=197.0
Q ss_pred eeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeec-CceEEE
Q 011302 88 LLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEA-SHYSCL 166 (489)
Q Consensus 88 ~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~l 166 (489)
+.++||+|+||+||+|++..+.. ....||||++++.. ......++.+|+.+|++++|||||++++++.+ ++.+|+
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~--~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l 106 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDG--KKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 106 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC------CEEEEEEEECCCC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCC--EEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEE
Confidence 36789999999999999876321 34578999986422 22445678889999999999999999998764 568999
Q ss_pred EEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcEEEcccCCCcccccCcc
Q 011302 167 VMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHIMLSDFDLSFKCDVVPK 246 (489)
Q Consensus 167 V~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 246 (489)
|||||++|+|.+++... ...+++..+..++.|++.||.|||+.+|+||||||+||||+.++.+||+|||+++.+.....
T Consensus 107 v~E~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 107 VLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp EEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred EEEEeecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 99999999999988764 35677888999999999999999999999999999999999999999999999854432100
Q ss_pred ccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccccccccCC
Q 011302 247 LLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVAEPINARS 326 (489)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (489)
. .....
T Consensus 186 ~--------------------------------------------------------------------------~~~~~ 191 (311)
T d1r0pa_ 186 D--------------------------------------------------------------------------SVHNK 191 (311)
T ss_dssp C--------------------------------------------------------------------------CTTCT
T ss_pred c--------------------------------------------------------------------------cceec
Confidence 0 00112
Q ss_pred ccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCC-CcHHHHHHHhcCCCCCCCCCCCCchhHHHHhhH
Q 011302 327 KSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGE-NNEKTLINILKKPLTFPRIGVSSSKEFEEVVKL 405 (489)
Q Consensus 327 ~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l 405 (489)
....||+.|+|||.+.+..++.++|||||||++|||++|..||... +..+....+..+.. .+. ..... ..+
T Consensus 192 ~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~-~~~-p~~~~------~~l 263 (311)
T d1r0pa_ 192 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-LLQ-PEYCP------DPL 263 (311)
T ss_dssp TCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCC-CCC-CTTCC------HHH
T ss_pred ccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-CCC-cccCc------HHH
Confidence 2347999999999999999999999999999999999977776554 34444555554432 111 11111 258
Q ss_pred HHHHHHHhhcCcccccCCCCChHHHHcC
Q 011302 406 QDLISKLLVKNPKKRIGSLKGSVEIKRH 433 (489)
Q Consensus 406 ~~li~~~L~~dP~~R~~~~~~~~~ll~h 433 (489)
.+||.+||+.||++||++. ||++|
T Consensus 264 ~~li~~cl~~dP~~RPs~~----ei~~~ 287 (311)
T d1r0pa_ 264 YEVMLKCWHPKAEMRPSFS----ELVSR 287 (311)
T ss_dssp HHHHHHHTCSSGGGSCCHH----HHHHH
T ss_pred HHHHHHHcCCCHhHCcCHH----HHHHH
Confidence 9999999999999999997 77765
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-50 Score=393.17 Aligned_cols=263 Identities=21% Similarity=0.267 Sum_probs=197.7
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCc-ccccceeecCc
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFL-PTLYAEFEASH 162 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~ 162 (489)
++|++++.||+|+||+||+|+++. +++.||||++.... ...++..|+.+++.++|+|+ +.+.+++.+++
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~-----~~~~vAvK~~~~~~-----~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~ 76 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIA-----AGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGD 76 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT-----TTEEEEEEEEESCT-----TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETT
T ss_pred CEEEEeEEEeeCCCcEEEEEEECC-----CCCEEEEEEEchhc-----cCHHHHHHHHHHHHccCCCcccEEEEEEecCC
Confidence 579999999999999999999886 57899999987542 22456779999999987765 55556667888
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEec---cCCcEEEcccCCCc
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVR---EDGHIMLSDFDLSF 239 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~---~~~~vkl~DFG~a~ 239 (489)
..|+||||+ +|+|.+.+... ...+++..+..++.|++.||+|||++|||||||||+|||++ .+..+||+|||+|+
T Consensus 77 ~~~ivme~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~ 154 (299)
T d1ckia_ 77 YNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154 (299)
T ss_dssp EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred EEEEEEEEc-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcce
Confidence 999999999 67776666554 36799999999999999999999999999999999999986 35679999999986
Q ss_pred ccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCccccc
Q 011302 240 KCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPEVVA 319 (489)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (489)
.+...... .
T Consensus 155 ~~~~~~~~-----------------------------------------------------------------------~ 163 (299)
T d1ckia_ 155 KYRDARTH-----------------------------------------------------------------------Q 163 (299)
T ss_dssp ECBCTTTC-----------------------------------------------------------------------C
T ss_pred eccccccc-----------------------------------------------------------------------c
Confidence 54321100 0
Q ss_pred cccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcHHHHHHHh---cCCCCCCC--CCCC
Q 011302 320 EPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNEKTLINIL---KKPLTFPR--IGVS 394 (489)
Q Consensus 320 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~---~~~~~~p~--~~~~ 394 (489)
..........+||+.|||||++.+..++.++|||||||++|||++|+.||.+.........+. ......|. ....
T Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (299)
T d1ckia_ 164 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG 243 (299)
T ss_dssp BCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTT
T ss_pred ceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccC
Confidence 000122345689999999999999999999999999999999999999998765543322221 11111110 0001
Q ss_pred CchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHcCCCc
Q 011302 395 SSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKRHEFF 436 (489)
Q Consensus 395 ~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~hp~f 436 (489)
. +.++.+||.+||+.||++||++. .+.++|+|+|.
T Consensus 244 ~------p~~~~~li~~cl~~~p~~RP~~~-~i~~~l~~~~~ 278 (299)
T d1ckia_ 244 Y------PSEFATYLNFCRSLRFDDKPDYS-YLRQLFRNLFH 278 (299)
T ss_dssp S------CHHHHHHHHHHHHSCTTCCCCHH-HHHHHHHHHHH
T ss_pred C------CHHHHHHHHHHccCChhHCcCHH-HHHHHHHHHHH
Confidence 1 12589999999999999999874 34467787765
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-49 Score=385.13 Aligned_cols=256 Identities=22% Similarity=0.292 Sum_probs=189.8
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCCCCcccccceeecCc-
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDHPFLPTLYAEFEASH- 162 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~- 162 (489)
.+|.+.+.||+|+||.||+|+++ ++.||||+++.+... ......|+..+..++|||||++++++.+.+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-------g~~vAvK~~~~~~~~----~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~ 71 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-------GEEVAVKIFSSREER----SWFREAEIYQTVMLRHENILGFIAADNKDNG 71 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-------TEEEEEEEECGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-------CEEEEEEEECccchh----HHHHHHHHHHHhhCCCCcCcceEEEEEeCCC
Confidence 57999999999999999999865 478999999765322 111223555566789999999999997543
Q ss_pred ---eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHh--------CCCeeecCCCCCeEeccCCcEE
Q 011302 163 ---YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHM--------MGIVYRDLKPENVLVREDGHIM 231 (489)
Q Consensus 163 ---~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~--------~~iiHrDIKp~NILl~~~~~vk 231 (489)
.+|||||||++|+|.+++++. .+++..+..++.|++.||+|||+ +|||||||||+||||+.+|.+|
T Consensus 72 ~~~~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~K 148 (303)
T d1vjya_ 72 TWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 148 (303)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred cceEEEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeE
Confidence 689999999999999999874 59999999999999999999996 5999999999999999999999
Q ss_pred EcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccc
Q 011302 232 LSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQEL 311 (489)
Q Consensus 232 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (489)
|+|||+++.+......
T Consensus 149 l~DFGl~~~~~~~~~~---------------------------------------------------------------- 164 (303)
T d1vjya_ 149 IADLGLAVRHDSATDT---------------------------------------------------------------- 164 (303)
T ss_dssp ECCCTTCEEEETTTTE----------------------------------------------------------------
T ss_pred EEecCccccccCCCcc----------------------------------------------------------------
Confidence 9999998543211000
Q ss_pred cCCccccccccccCCccccCCCCccCcchhcCCC------CCCcccHHHHHHHHHHHhhCCCCCCCCC------------
Q 011302 312 LDDPEVVAEPINARSKSFVGTHEYLAPEVISGQG------HGSAVDWWTLGVFLYEMLYGTTPFKGEN------------ 373 (489)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~------~~~~~DiwSlGvil~elltG~~Pf~~~~------------ 373 (489)
........+||+.|||||++.+.. ++.++|||||||+||||+||..||....
T Consensus 165 ----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 165 ----------IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp ----------ECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred ----------eeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 001223457999999999997653 5678999999999999999988874321
Q ss_pred --cHHHHHHHhcCCCCCCCCCCCCchhHHHHhhHHHHHHHHhhcCcccccCCCCChHHHHc
Q 011302 374 --NEKTLINILKKPLTFPRIGVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSLKGSVEIKR 432 (489)
Q Consensus 374 --~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~~~~~~ll~ 432 (489)
....+..........|..... ....+....+.+||.+||+.||++||++. ||++
T Consensus 235 ~~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~----ei~~ 290 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQKLRPNIPNR-WQSCEALRVMAKIMRECWYANGAARLTAL----RIKK 290 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGG-GGGCHHHHHHHHHHHTTCCSSGGGSCCHH----HHHH
T ss_pred cchHHHHHHHHhccccCCCCCcc-cCChHHHHHHHHHHHHHcccCHhHCcCHH----HHHH
Confidence 222233332222111211110 00112234588999999999999999987 6554
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.2e-48 Score=379.51 Aligned_cols=253 Identities=19% Similarity=0.229 Sum_probs=198.9
Q ss_pred cCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCC-CCcccccceeecC
Q 011302 83 LDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDH-PFLPTLYAEFEAS 161 (489)
Q Consensus 83 ~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~ 161 (489)
-++|++++.||+|+||+||+|++.. +++.||||++.... ....+.+|+.+++.+.| +||+.+++++..+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~-----~~~~vAvK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~ 73 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLL-----NNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEG 73 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETT-----TTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEET
T ss_pred CCceEEEEEEecCCCeEEEEEEECC-----CCCEEEEEEEcccc-----CcHHHHHHHHHHHHhcCCCCCCEEEEEeecC
Confidence 3689999999999999999999887 57899999986532 22345668889999975 8999999999999
Q ss_pred ceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEecc-----CCcEEEcccC
Q 011302 162 HYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVRE-----DGHIMLSDFD 236 (489)
Q Consensus 162 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~-----~~~vkl~DFG 236 (489)
...|+||||+ ||+|.+++... +..+++.++..++.|++.||+|||++|||||||||+||||+. ++.+||+|||
T Consensus 74 ~~~~~vme~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG 151 (293)
T d1csna_ 74 LHNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 151 (293)
T ss_dssp TEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred CccEEEEEec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccc
Confidence 9999999999 89999988765 357999999999999999999999999999999999999974 5789999999
Q ss_pred CCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCccccccccccccccccccccccccccccCCCCCCccccCCcc
Q 011302 237 LSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQVDGDHHDQELLDDPE 316 (489)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (489)
+|+.+.......
T Consensus 152 ~a~~~~~~~~~~-------------------------------------------------------------------- 163 (293)
T d1csna_ 152 MVKFYRDPVTKQ-------------------------------------------------------------------- 163 (293)
T ss_dssp TCEESBCTTTCC--------------------------------------------------------------------
T ss_pred eeEEcccCcccc--------------------------------------------------------------------
Confidence 996543210000
Q ss_pred ccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcH---HHHHHHhcCCCCCC--CC
Q 011302 317 VVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNE---KTLINILKKPLTFP--RI 391 (489)
Q Consensus 317 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~~~~~i~~~~~~~p--~~ 391 (489)
........+++||+.|||||++.+..++.++|||||||++|||++|..||.+.... ....++.......+ ..
T Consensus 164 ---~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (293)
T d1csna_ 164 ---HIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240 (293)
T ss_dssp ---BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH
T ss_pred ---ceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHh
Confidence 00012234568999999999999999999999999999999999999999865432 23333322111111 00
Q ss_pred CCCCchhHHHHhhHHHHHHHHhhcCcccccCCC
Q 011302 392 GVSSSKEFEEVVKLQDLISKLLVKNPKKRIGSL 424 (489)
Q Consensus 392 ~~~~~~~~~~~~~l~~li~~~L~~dP~~R~~~~ 424 (489)
... .+.++.+|+..|+..+|++||+..
T Consensus 241 ~~~------~p~~l~~ii~~~~~~~~~~rP~y~ 267 (293)
T d1csna_ 241 CAG------FPEEFYKYMHYARNLAFDATPDYD 267 (293)
T ss_dssp TTT------SCHHHHHHHHHHHHCCTTCCCCHH
T ss_pred cCC------CCHHHHHHHHHHhcCCcccCcCHH
Confidence 000 112589999999999999999863
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.4e-46 Score=370.40 Aligned_cols=263 Identities=24% Similarity=0.386 Sum_probs=194.2
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-----------CCCcc
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-----------HPFLP 152 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------hpnIv 152 (489)
++|+++++||+|+||+||+|+++. +++.||||+++++... .+.+.+|+.+++.++ |+||+
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~-----~g~~vAvKvi~~~~~~----~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv 83 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMV-----NNTHVAMKIVRGDKVY----TEAAEDEIKLLQRVNDADNTKEDSMGANHIL 83 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECSCHHH----HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBC
T ss_pred CcEEEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEeccccc----hHHHHHHHHHHHHhcchhhhhhhhcCcCceE
Confidence 569999999999999999999987 5789999999876433 234455777777664 68899
Q ss_pred cccceeec--CceEEEEEeecCCCch-HHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHh-CCCeeecCCCCCeEeccCC
Q 011302 153 TLYAEFEA--SHYSCLVMEYCPGGDL-YAARQRQPGKRFGISSAKFYAAETLLALEYLHM-MGIVYRDLKPENVLVREDG 228 (489)
Q Consensus 153 ~l~~~~~~--~~~~~lV~E~~~gg~L-~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiHrDIKp~NILl~~~~ 228 (489)
++++++.. ....++||+++..+.. ...........+++..++.++.||+.||+|||+ .||+||||||+||||+.++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~ 163 (362)
T d1q8ya_ 84 KLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD 163 (362)
T ss_dssp CCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred EEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccC
Confidence 99998864 3566777777655543 344444555789999999999999999999998 8999999999999998765
Q ss_pred c------EEEcccCCCcccccCccccCCcchhHHHhhhhccCCCCCCCCCCCcccccccccccccccccccccccccccc
Q 011302 229 H------IMLSDFDLSFKCDVVPKLLRPKLSFEAIEKYEKCSIPSCATPMQPVLSCFSSVSHGKKNKKKAVTVTTIREQV 302 (489)
Q Consensus 229 ~------vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (489)
. ++|+|||.|....
T Consensus 164 ~~~~~~~~kl~dfg~s~~~~------------------------------------------------------------ 183 (362)
T d1q8ya_ 164 SPENLIQIKIADLGNACWYD------------------------------------------------------------ 183 (362)
T ss_dssp TTTTEEEEEECCCTTCEETT------------------------------------------------------------
T ss_pred cccccceeeEeecccccccc------------------------------------------------------------
Confidence 3 9999999973221
Q ss_pred CCCCCCccccCCccccccccccCCccccCCCCccCcchhcCCCCCCcccHHHHHHHHHHHhhCCCCCCCCCcH------H
Q 011302 303 DGDHHDQELLDDPEVVAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFLYEMLYGTTPFKGENNE------K 376 (489)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~------~ 376 (489)
......+||+.|+|||++.+..++.++|||||||+++||++|+.||...+.. +
T Consensus 184 ---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 184 ---------------------EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp ---------------------BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred ---------------------cccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 1123457999999999999999999999999999999999999999764321 1
Q ss_pred HHHHH---hcCC-----------------C----CCCCCCCCCch---------hHHHHhhHHHHHHHHhhcCcccccCC
Q 011302 377 TLINI---LKKP-----------------L----TFPRIGVSSSK---------EFEEVVKLQDLISKLLVKNPKKRIGS 423 (489)
Q Consensus 377 ~~~~i---~~~~-----------------~----~~p~~~~~~~~---------~~~~~~~l~~li~~~L~~dP~~R~~~ 423 (489)
.+..+ +... . ........... .-....+++|||.+||++||.+|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 11111 1100 0 00000000000 01234568999999999999999999
Q ss_pred CCChHHHHcCCCcCCCC
Q 011302 424 LKGSVEIKRHEFFKGIN 440 (489)
Q Consensus 424 ~~~~~~ll~hp~f~~~~ 440 (489)
. |+|+||||+...
T Consensus 323 ~----e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 323 G----GLVNHPWLKDTL 335 (362)
T ss_dssp H----HHHTCGGGTTCT
T ss_pred H----HHhcCcccCCCC
Confidence 7 999999999654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=4e-27 Score=212.62 Aligned_cols=134 Identities=24% Similarity=0.240 Sum_probs=105.7
Q ss_pred ceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHH---------------HHHHHHHHHHHHHHHHhCCCCC
Q 011302 86 FRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALA---------------IRKKLHRADMEKVILTMLDHPF 150 (489)
Q Consensus 86 y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~---------------~~~~~~~~~~E~~~l~~l~hpn 150 (489)
+.+.++||+|+||+||+|++.+ ++.||||+++..... ..........|...+..+.|.+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~------g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~ 75 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEK------FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLA 75 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETT------TEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSS
T ss_pred chhCCEeeeCcceEEEEEECCC------CCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCC
Confidence 4578999999999999998753 678999987532211 0112233456888899999999
Q ss_pred cccccceeecCceEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHHhCCCeeecCCCCCeEeccCCcE
Q 011302 151 LPTLYAEFEASHYSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLHMMGIVYRDLKPENVLVREDGHI 230 (489)
Q Consensus 151 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NILl~~~~~v 230 (489)
++..+++.. .++||||++++.+. .++...+..++.||+.+|+|||++||+||||||+|||++++ .+
T Consensus 76 v~~~~~~~~----~~lvme~~~~~~~~---------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~ 141 (191)
T d1zara2 76 VPKVYAWEG----NAVLMELIDAKELY---------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GI 141 (191)
T ss_dssp SCCEEEEET----TEEEEECCCCEEGG---------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EE
T ss_pred cceEEEecC----CEEEEEeecccccc---------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CE
Confidence 998876532 37999999877652 35667788999999999999999999999999999999965 48
Q ss_pred EEcccCCCc
Q 011302 231 MLSDFDLSF 239 (489)
Q Consensus 231 kl~DFG~a~ 239 (489)
+|+|||+|.
T Consensus 142 ~liDFG~a~ 150 (191)
T d1zara2 142 WIIDFPQSV 150 (191)
T ss_dssp EECCCTTCE
T ss_pred EEEECCCcc
Confidence 999999984
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.60 E-value=9.4e-08 Score=88.08 Aligned_cols=139 Identities=15% Similarity=0.084 Sum_probs=90.3
Q ss_pred CCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-CCCcccccceeecCc
Q 011302 84 DHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-HPFLPTLYAEFEASH 162 (489)
Q Consensus 84 ~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~ 162 (489)
+.|++.+..+-++.+.||+.... +..+.+|+...... .....+.+|..++..+. +--+.+++++..+++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~~-------~~~~vlk~~~~~~~---~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~ 83 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVGE-------NENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDG 83 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEECS-------SCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred hceEEEEcCCCCCCCcEEEEEeC-------CCeEEEEEcCCCcc---cchhhHHHHHHHHHHHhccCCCCcEEEEEecCC
Confidence 57888877666666789988643 34567888764421 12234556888887764 333678888888889
Q ss_pred eEEEEEeecCCCchHHHHHhCCCCCCChhhHHHHHHHHHHHHHHHH----------------------------------
Q 011302 163 YSCLVMEYCPGGDLYAARQRQPGKRFGISSAKFYAAETLLALEYLH---------------------------------- 208 (489)
Q Consensus 163 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~yLH---------------------------------- 208 (489)
..|+||++++|..+...... ......++.++...|+.||
T Consensus 84 ~~~lv~~~l~G~~~~~~~~~-------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 84 WSNLLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEEEECCSSEEHHHHTTT-------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred ceEEEEEecccccccccccc-------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence 99999999998877442211 0111112222222222222
Q ss_pred -------------------hC------CCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 209 -------------------MM------GIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 209 -------------------~~------~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
.. .++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 21 27999999999999977667799999873
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.05 E-value=9e-06 Score=73.88 Aligned_cols=137 Identities=15% Similarity=0.070 Sum_probs=81.9
Q ss_pred eeccCC-ceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCC--CCcccccceeecCceEEEE
Q 011302 91 RLGSGD-IGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDH--PFLPTLYAEFEASHYSCLV 167 (489)
Q Consensus 91 ~lG~G~-fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~~~~~lV 167 (489)
.+..|. -+.||+....+ +..+.+|...... ...+..|...|+.+.. -.+.+++++..+++..++|
T Consensus 17 ~~~~G~s~~~v~r~~~~~------~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v 84 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQG------RPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 84 (255)
T ss_dssp ECSCTTSSCEEEEEECTT------SCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred EcCCcccCCeEEEEEeCC------CCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEE
Confidence 444554 46899987654 4457888876432 2234557777776643 2367788888888899999
Q ss_pred EeecCCCchHH--------------HHHh-C--C--CCCCChhhHHH-------H---------------HHHHHHHHHH
Q 011302 168 MEYCPGGDLYA--------------ARQR-Q--P--GKRFGISSAKF-------Y---------------AAETLLALEY 206 (489)
Q Consensus 168 ~E~~~gg~L~~--------------~l~~-~--~--~~~l~~~~~~~-------i---------------~~qi~~~L~y 206 (489)
||+++|.++.. .+.+ + . ...+....... + .......+..
T Consensus 85 ~~~i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (255)
T d1nd4a_ 85 LGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 164 (255)
T ss_dssp EECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred EEeeeccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence 99998866521 1111 0 0 00010000000 0 0011223344
Q ss_pred HHhC-------CCeeecCCCCCeEeccCCcEEEcccCCCc
Q 011302 207 LHMM-------GIVYRDLKPENVLVREDGHIMLSDFDLSF 239 (489)
Q Consensus 207 LH~~-------~iiHrDIKp~NILl~~~~~vkl~DFG~a~ 239 (489)
+... .+||+|+.|.|||++.++.+-|+||+.+.
T Consensus 165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 4432 37999999999999987667899999873
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.91 E-value=1.4e-05 Score=77.84 Aligned_cols=82 Identities=17% Similarity=0.231 Sum_probs=48.0
Q ss_pred eeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHH----HHHHHHHHHHHHHHhCC-C--CCcccccceeec
Q 011302 88 LLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIR----KKLHRADMEKVILTMLD-H--PFLPTLYAEFEA 160 (489)
Q Consensus 88 ~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~~~E~~~l~~l~-h--pnIv~l~~~~~~ 160 (489)
-.+.||.|....||++.... .++.|.+|.-........ ....+...|...|+.+. + ..+++++.+ +
T Consensus 30 ~~~eig~G~~N~vfrV~~~~-----~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d 102 (392)
T d2pula1 30 TCQEIGDGNLNYVFHIYDQE-----HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D 102 (392)
T ss_dssp EEEECCSSSSEEEEEEEC---------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E
T ss_pred eEEEeCCCceEeEEEEEeCC-----CCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--c
Confidence 36689999999999998664 345678886432110000 11234455777777653 2 345666643 4
Q ss_pred CceEEEEEeecCCCch
Q 011302 161 SHYSCLVMEYCPGGDL 176 (489)
Q Consensus 161 ~~~~~lV~E~~~gg~L 176 (489)
....++|||++.+..+
T Consensus 103 ~~~~~lvmE~L~~~~~ 118 (392)
T d2pula1 103 TEMAVTVMEDLSHLKI 118 (392)
T ss_dssp TTTTEEEECCCTTSEE
T ss_pred CCCCEEEEeccCCccc
Confidence 4456799999977543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.20 E-value=0.00049 Score=66.54 Aligned_cols=85 Identities=25% Similarity=0.380 Sum_probs=52.7
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCC--CCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCC-CCCccccccee
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVG--LPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLD-HPFLPTLYAEF 158 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~ 158 (489)
..+++++ +.|+.|-.=.+|++........ ...+.|.+++....... ....+|..+++.+. +.-..++++++
T Consensus 41 ~~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~-----idr~~E~~i~~~ls~~gl~Pkll~~~ 114 (395)
T d1nw1a_ 41 PLEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETE-----SHLVAESVIFTLLSERHLGPKLYGIF 114 (395)
T ss_dssp CGGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCH-----HHHHHHHHHHHHHHHTTSSSCEEEEE
T ss_pred CccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchh-----hHHHHHHHHHHHHHhCCCCCeEEEEc
Confidence 4455655 5788888889999987653221 12345666665421111 12335888888775 44456788777
Q ss_pred ecCceEEEEEeecCCCch
Q 011302 159 EASHYSCLVMEYCPGGDL 176 (489)
Q Consensus 159 ~~~~~~~lV~E~~~gg~L 176 (489)
.+ .+||||++|..|
T Consensus 115 ~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 115 SG----GRLEEYIPSRPL 128 (395)
T ss_dssp TT----EEEECCCCEEEC
T ss_pred CC----ceEEEEeccccC
Confidence 54 589999987554
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.60 E-value=0.0044 Score=57.83 Aligned_cols=68 Identities=13% Similarity=0.084 Sum_probs=40.7
Q ss_pred eeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCC-----CCccccc--ceeecCceEEEEEee
Q 011302 98 GNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDH-----PFLPTLY--AEFEASHYSCLVMEY 170 (489)
Q Consensus 98 g~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-----pnIv~l~--~~~~~~~~~~lV~E~ 170 (489)
-.||+++..+ +..|++|+.+..... ..++..|...|..|.. +..+..- ..+..++..+.|+++
T Consensus 36 N~vy~v~~~d------g~~~VlK~~rp~~~s----~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~ 105 (325)
T d1zyla1 36 NRVYQFQDED------RRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 105 (325)
T ss_dssp SEEEEECCTT------CCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred ceeEEEEcCC------CCEEEEEEeCCCCCC----HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEee
Confidence 5799998764 567899998754222 1234446666666532 1222221 133456678999999
Q ss_pred cCCCc
Q 011302 171 CPGGD 175 (489)
Q Consensus 171 ~~gg~ 175 (489)
++|..
T Consensus 106 ~~G~~ 110 (325)
T d1zyla1 106 VGGRQ 110 (325)
T ss_dssp CCCEE
T ss_pred cCCcC
Confidence 97743
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.58 E-value=0.011 Score=54.39 Aligned_cols=145 Identities=14% Similarity=0.082 Sum_probs=78.0
Q ss_pred ccCCceeeeeeccCCceeEEEEEEccCCCCCCCeeEEEEeeehHHHHHHHHHHHHHHHHHHHHhCCC-----CCcccccc
Q 011302 82 GLDHFRLLRRLGSGDIGNVYLCQIRNPMVGLPQCFYAMKVVDREALAIRKKLHRADMEKVILTMLDH-----PFLPTLYA 156 (489)
Q Consensus 82 ~~~~y~~~~~lG~G~fg~Vy~a~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-----pnIv~l~~ 156 (489)
.++...-.+.|..|---+.|+.+..+ ..|.+|+..... ....+..|..+|..|.. |..+...+
T Consensus 16 ~lg~~~~~~~i~~G~~N~ny~v~t~~-------g~yVLri~~~~~-----~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~ 83 (316)
T d2ppqa1 16 DVGSLTSYKGIAEGVENSNFLLHTTK-------DPLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKD 83 (316)
T ss_dssp CCCCEEEEEEECC---EEEEEEEESS-------CCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTT
T ss_pred CCCCceEeecCCCCcccCeEEEEECC-------CcEEEEEcCCCC-----CHHHHHHHHHHHHhhhhccccccccceecC
Confidence 44555656667777778899987654 358999986531 12334446666666632 22222211
Q ss_pred ---eeecCceEEEEEeecCCCchH--------------HHHHhC-CC------------------------CCCChhhHH
Q 011302 157 ---EFEASHYSCLVMEYCPGGDLY--------------AARQRQ-PG------------------------KRFGISSAK 194 (489)
Q Consensus 157 ---~~~~~~~~~lV~E~~~gg~L~--------------~~l~~~-~~------------------------~~l~~~~~~ 194 (489)
+..-....+.++.++.|.... ..++.. .. .........
T Consensus 84 g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (316)
T d2ppqa1 84 GELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLR 163 (316)
T ss_dssp CCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHH
T ss_pred CCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHH
Confidence 122344566777777664331 011100 00 001111122
Q ss_pred HHHHHHHHHHHHHHh----CCCeeecCCCCCeEeccCCcEEEcccCCC
Q 011302 195 FYAAETLLALEYLHM----MGIVYRDLKPENVLVREDGHIMLSDFDLS 238 (489)
Q Consensus 195 ~i~~qi~~~L~yLH~----~~iiHrDIKp~NILl~~~~~vkl~DFG~a 238 (489)
..+..+...+.-.+. .|+||+|+.+.||+++.+...-|+||+.+
T Consensus 164 ~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~ 211 (316)
T d2ppqa1 164 EEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFA 211 (316)
T ss_dssp HHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred HHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccc
Confidence 233333333333332 46999999999999998877789999987
|